PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Oh, RS; Pan, WC; Yalcin, A; Zhang, H; Guilarte, TR; Hotamisligil, GS; Christiani, DC; Lu, Q				Oh, Raymond S.; Pan, Wen-Chi; Yalcin, Abdullah; Zhang, Hong; Guilarte, Tomas R.; Hotamisligil, Goekhan S.; Christiani, David C.; Lu, Quan			Functional RNA Interference (RNAi) Screen Identifies System A Neutral Amino Acid Transporter 2 (SNAT2) as a Mediator of Arsenic-induced Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; P70 S6 KINASE; MESSENGER-RNA; ER STRESS; MAMMALIAN TARGET; OXIDATIVE STRESS; COMPOSITE SITE; CHOP PROMOTER; MUSCLE-CELLS; TUMOR-GROWTH	Exposure to the toxic metalloid arsenic is associated with diabetes and cancer and causes proteotoxicity and endoplasmic reticulum (ER) stress at the cellular level. Adaptive responses to ER stress are implicated in cancer and diabetes; thus, understanding mechanisms of arsenic-induced ER stress may offer insights into pathogenesis. Here, we identify genes required for arsenite-induced ER stress response in a genome-wide RNAi screen. Using an shRNA library targeting similar to 20,000 human genes, together with an ER stress cell model, we performed flow cytometry-based cell sorting to isolate cells with defective response to arsenite. Our screen discovered several genes modulating arsenite-induced ER stress, including sodium-dependent neutral amino acid transporter, SNAT2. SNAT2 expression and activity are up-regulated by arsenite, in a manner dependent on activating transcription factor 4 (ATF4), an important mediator of the integrated stress response. Inhibition of SNAT2 expression or activity or deprivation of its primary substrate, glutamine, specifically suppressed ER stress induced by arsenite but not tunicamycin. Induction of SNAT2 is coincident with the activation of the nutrient-sensing mammalian target of rapamycin (mTOR) pathway, which is at least partially required for arsenite-induced ER stress. Importantly, inhibition of the SNAT2 or the System L transporter, LAT1, suppressed mTOR activation by arsenite, supporting a role for these transporters in modulating amino acid signaling. These findings reveal SNAT2 as an important and specific mediator of arsenic-induced ER stress, and suggest a role for aberrant mTOR activation in arsenic-related human diseases. Further-more, this study demonstrates the utility of RNAi screens in elucidating cellular mechanisms of environmental toxins.	[Oh, Raymond S.; Pan, Wen-Chi; Lu, Quan] Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; [Oh, Raymond S.; Pan, Wen-Chi; Christiani, David C.; Lu, Quan] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Oh, Raymond S.; Yalcin, Abdullah; Hotamisligil, Goekhan S.] Harvard Univ, Dept Genet & Complex Dis, Dept Environm Hlth, Boston, MA 02115 USA; [Zhang, Hong] Univ Massachusetts, Dept Cell Biol, Sch Med, Worcester, MA 01655 USA; [Guilarte, Tomas R.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Columbia University	Lu, Q (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Bldg I-305,665 Huntington Ave, Boston, MA 02115 USA.	qlu@hsph.harvard.edu	Yalcin, Abdullah/AAG-4175-2019	Yalcin, Abdullah/0000-0001-8604-4749; Pan, Wen-Chi/0000-0002-0588-8083	National Institutes of Health; Harvard-NIEHS Center [P30ES000002]; NIEHS [P42ES016454]; National Institutes of Health [DK052539, DK090942]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539, RC4DK090942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, P42ES016454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-NIEHS Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, Harvard-NIEHS Center, Grant P30ES000002 and NIEHS Superfund Research Program Grant P42ES016454 (to Q. L.) and National Institutes of Health Grants DK052539 and DK090942 (to G. S. H.).	Alfieri RR, 2001, BIOCHEM BIOPH RES CO, V283, P174, DOI 10.1006/bbrc.2001.4729; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; BARBER EF, 1982, J BIOL CHEM, V257, P4960; Bernstam L, 2000, J TOXICOL ENV HEAL B, V3, P293, DOI 10.1080/109374000436355; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Del Razo LM, 2001, TOXICOL APPL PHARM, V177, P132, DOI 10.1006/taap.2001.9291; Donze O, 1999, MOL CELL BIOL, V19, P8422, DOI 10.1128/mcb.19.12.8422; Evans K, 2007, J AM SOC NEPHROL, V18, P1426, DOI 10.1681/ASN.2006091014; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fung H, 2007, MOL CELL BIOL, V27, P8834, DOI 10.1128/MCB.00974-07; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gazzola RF, 2001, FEBS LETT, V490, P11; Gjymishka A, 2008, J BIOL CHEM, V283, P27736, DOI 10.1074/jbc.M803781200; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Jiang HY, 2007, J BIOL CHEM, V282, P3755, DOI 10.1074/jbc.M606461200; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Jung DK, 2003, EXP CELL RES, V290, P144, DOI 10.1016/S0014-4827(03)00320-3; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lin AMY, 2007, TOXICOL APPL PHARM, V224, P138, DOI 10.1016/j.taap.2007.06.016; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu TH, 2011, TOXICOL LETT, V201, P15, DOI 10.1016/j.toxlet.2010.11.019; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; McDowell HE, 1998, FEBS LETT, V441, P15, DOI 10.1016/S0014-5793(98)01508-7; McGivan JD, 2007, FRONT BIOSCI, V12, P874, DOI 10.2741/2109; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Patterson J, 2008, CANCER CHEMOTH PHARM, V61, P923, DOI 10.1007/s00280-007-0546-0; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rossman TG, 2003, MUTAT RES-FUND MOL M, V533, P37, DOI 10.1016/j.mrfmmm.2003.07.009; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sambrook J., 2001, MOL CLONING LAB MANU; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shao J, 2001, J BIOL CHEM, V276, P206, DOI 10.1074/jbc.M007583200; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Varoqui H, 2002, BIOCHEM BIOPH RES CO, V290, P903, DOI 10.1006/bbrc.2001.6281; Walton FS, 2004, TOXICOL APPL PHARM, V198, P424, DOI 10.1016/j.taap.2003.10.026; Wang XM, 1997, BIOCHEM BIOPH RES CO, V238, P207, DOI 10.1006/bbrc.1997.7273; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wu XN, 2011, J BIOL CHEM, V286, P31501, DOI 10.1074/jbc.M111.233122; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	66	26	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6025	6034		10.1074/jbc.M111.311217	http://dx.doi.org/10.1074/jbc.M111.311217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215663	Green Published, hybrid			2022-12-25	WOS:000300638000075
J	Grimaldi, M; Visintainer, R; Jurman, G				Grimaldi, Marco; Visintainer, Roberto; Jurman, Giuseppe			RegnANN: Reverse Engineering Gene Networks Using Artificial Neural Networks	PLOS ONE			English	Article							REGULATORY NETWORKS; EXPRESSION; INFERENCE; RECONSTRUCTION; ALGORITHMS	RegnANN is a novel method for reverse engineering gene networks based on an ensemble of multilayer perceptrons. The algorithm builds a regressor for each gene in the network, estimating its neighborhood independently. The overall network is obtained by joining all the neighborhoods. RegnANN makes no assumptions about the nature of the relationships between the variables, potentially capturing high-order and non linear dependencies between expression patterns. The evaluation focuses on synthetic data mimicking plausible submodules of larger networks and on biological data consisting of submodules of Escherichia coli. We consider Barabasi and Erdos-Renyi topologies together with two methods for data generation. We verify the effect of factors such as network size and amount of data to the accuracy of the inference algorithm. The accuracy scores obtained with RegnANN is methodically compared with the performance of three reference algorithms: ARACNE, CLR and KELLER. Our evaluation indicates that RegnANN compares favorably with the inference methods tested. The robustness of RegnANN, its ability to discover second order correlations and the agreement between results obtained with this new methods on both synthetic and biological data are promising and they stimulate its application to a wider range of problems.	[Grimaldi, Marco; Visintainer, Roberto; Jurman, Giuseppe] Fdn Bruno Kessler, Trento, Italy	Fondazione Bruno Kessler	Grimaldi, M (corresponding author), Fdn Bruno Kessler, Trento, Italy.	marco.grimaldi@gmail.com	Jurman, Giuseppe/GRS-8221-2022	Visintainer, Roberto/0000-0003-1289-6871; Jurman, Giuseppe/0000-0002-2705-5728	European Union; Italian Ministry of Health [RF2007conv.42]	European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	The authors acknowledge funding by the European Union FP7 Project HiperDART, by the Italian Ministry of Health Project ISITAD (RF2007conv.42), and by the PAT funded Project ENVIROCHANGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Altay G, 2010, BIOINFORMATICS, V26, P1738, DOI 10.1093/bioinformatics/btq259; Bailly-Bechet M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-355; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baralla A, 2009, ANN NY ACAD SCI, V1158, P246, DOI 10.1111/j.1749-6632.2008.04099.x; Bishop C. M., 1995, NEURAL NETWORKS PATT; Braunstein A, 2008, J PHYS CONF SER, V95, pU168, DOI 10.1088/1742-6596/95/1/012016; Braunstein A, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/12/P12001; Cover T. M, 2006, ELEMENTS INFORM THEO, V2nd, DOI 10.1002/0471200611; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Di Camillo B, 2009, ANN NY ACAD SCI, V1158; Dimitrova ES, 2007, ISSAC 2007: PROCEEDINGS OF THE 2007 INTERNATIONAL SYMPOSIUM ON SYMBOLIC AND ALGEBRAIC COMPUTATION, P122; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kauffman Stuart A., 1993; Keedwell E, 2005, IEEE ACM T COMPUT BI, V2, P231, DOI 10.1109/TCBB.2005.40; Krishnan A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000562; Lahabar S, 2008, P NAT C COMP VIS PAT, P154; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Marr C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000836; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Neal R. M., 1996, THESIS U TORONTO; Neal R.M., 2012, BAYESIAN LEARNING NE, V118, DOI DOI 10.1007/978-1-4612-0745-0; Nemenman I, 2007, ANN NY ACAD SCI, V1115, P102, DOI 10.1196/annals.1407.013; Peregrin-Alvarez JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000523; R Core Team, 2021, R LANG ENV STAT COMP; Song L, 2009, BIOINFORMATICS, V25, pI128, DOI 10.1093/bioinformatics/btp192; Steinhoff C, 2006, BRIEF BIOINFORM, V7, P166, DOI 10.1093/bib/bbl002; Stokic D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-253; Supper J, 2007, LECT NOTES COMPUT SC, V4447, P270; Tuna S, 2009, LECT N BIOINFORMAT, V5780, P439, DOI 10.1007/978-3-642-04031-3_38; Zhang YJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-203	44	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28646	10.1371/journal.pone.0028646	http://dx.doi.org/10.1371/journal.pone.0028646			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216103	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300009
J	Hasemann, C; Soltwedel, T				Hasemann, Christiane; Soltwedel, Thomas			Small-Scale Heterogeneity in Deep-Sea Nematode Communities around Biogenic Structures	PLOS ONE			English	Article							HABITAT HETEROGENEITY; SPECIES-DIVERSITY; TAXONOMIC DISTINCTNESS; FUNCTIONAL DIVERSITY; ECOSYSTEM FUNCTION; MARINE NEMATODES; FRESH-WATER; BIODIVERSITY; ASSEMBLAGES; RICHNESS	The unexpected high species richness of deep-sea sediments gives rise to the questions, which processes produce and maintain diversity in the deep sea, and at what spatial scales do these processes operate? The idea of a small-scale habitat structure at the deep-sea floor provides the background for this study. At small scales biogenic structures create a heterogeneous environment that influences the structure of the surrounding communities and the dynamics of the meiobenthic populations. As an example for biogenic structures, small deep-sea sponges (Tentorium semisuberites Schmidt 1870) and their sedimentary environment were investigated for small-scale distribution patterns of benthic deep-sea nematodes. Sampling was carried out with the remotely operated vehicle Victor 6000 at the Arctic deep-sea observatory HAUSGARTEN. In order to investigate nematode community patterns sediment cores around three small sponges and corresponding control cores were analysed. A total of approx. 5800 nematodes were identified. The comparison of the nematode communities from sponge and control samples indicated an influence of the biogenic structure `` sponge'' on diversity patterns and habitat heterogeneity. The increased number of nematode species and functional groups found in the sediments around the sponges suggest that on a small scale the sponge acts as a gradient and creates a more divers habitat structure. The nematode community from the sponge sediments shows a greater taxonomic variance and species richness together with lower relative abundances of the species compared to those from control sediments. Obviously, the more homogeneous habitat conditions of the control sediments offer less micro-habitats than the sediments around the sponges. This seems to reduce the number of functional groups and species coexisting in the control sediments.	[Hasemann, Christiane; Soltwedel, Thomas] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Hasemann, C (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	Christiane.Hasemann@awi.de	Hasemann, Christiane/AAJ-1352-2020; Soltwedel, Thomas/P-1852-2016	Soltwedel, Thomas/0000-0002-8214-5937	Alfred Wegener Institute for Polar and Marine Research	Alfred Wegener Institute for Polar and Marine Research	Funding was provided by institutional support (Alfred Wegener Institute for Polar and Marine Research). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS P, 1983, ANNU REV ECOL SYST, V14, P359, DOI 10.1146/annurev.es.14.110183.002043; ALLER JY, 1986, DEEP-SEA RES, V33, P755, DOI 10.1016/0198-0149(86)90088-9; Armenteros M, 2009, ESTUAR COAST SHELF S, V85, P179, DOI 10.1016/j.ecss.2009.08.002; Begon M, 2006, ECOLOGY INDIVIDUALS; BELL SS, 1978, J EXP MAR BIOL ECOL, V35, P99, DOI 10.1016/0022-0981(78)90069-2; Bengtsson J, 1998, APPL SOIL ECOL, V10, P191, DOI 10.1016/S0929-1393(98)00120-6; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bongers Tom, 1995, Russian Journal of Nematology, V3, P61; BOUCHER G, 1972, CAH BIOL MAR, V13, P457; Boucher G, 1995, CONSERV BIOL, V9, P1594, DOI 10.1046/j.1523-1739.1995.09061594.x; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Carney RS, 1997, BIODIVERS CONSERV, V6, P1463, DOI 10.1023/A:1018310302215; Carney RS, 1983, DEEP SEA BIOL, P371; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clarke K. R., 2001, CHANGES MARINE COMMU; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cramer MJ, 2005, OIKOS, V108, P209, DOI 10.1111/j.0030-1299.2005.12944.x; Danovaro R, 2002, MAR BIOL, V141, P667, DOI 10.1007/s00227-002-0857-y; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Davidowitz G, 1998, J BIOGEOGR, V25, P553, DOI 10.1046/j.1365-2699.1998.2530553.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; DINET A, 1979, CAH BIOL MAR, V20, P109; ECKMAN JE, 1985, J MAR RES, V43, P419, DOI 10.1357/002224085788438685; Elliot JM, 1971, FRESHWATER BIOL ASS, V25, P144; Etter RJ, 2001, MARINE COMMUNITY ECOLOGY, P367; Folke C, 1996, ECOL APPL, V6, P1018, DOI 10.2307/2269584; Fortes RR, 2010, MAR ECOL-EVOL PERSP, V31, P483, DOI 10.1111/j.1439-0485.2010.00357.x; French DD, 2002, J BIOGEOGR, V29, P231, DOI 10.1046/j.1365-2699.2002.00664.x; Friedrichs M, 2000, MAR ECOL PROG SER, V192, P219, DOI 10.3354/meps192219; Gage J.D., 1991, DEEP SEA BIOL; Gage JD, 1996, J EXP MAR BIOL ECOL, V200, P257, DOI 10.1016/S0022-0981(96)02638-X; Gambi C, 2003, DEEP-SEA RES PT I, V50, P103, DOI 10.1016/S0967-0637(02)00143-7; Gaston Kevin J., 1996, P202; Gerino M, 2003, VIE MILIEU, V53, P221; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Gingold R, 2010, MAR BIOL, V157, P1741, DOI 10.1007/s00227-010-1447-z; Grant A, 2000, MAR ECOL-P S Z N I, V21, P97, DOI 10.1046/j.1439-0485.2000.00713.x; GRASSLE JF, 1989, TRENDS ECOL EVOL, V4, P12, DOI 10.1016/0169-5347(89)90007-4; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hartley S, 2002, J ANIM ECOL, V71, P651, DOI 10.1046/j.1365-2656.2002.00628.x; Heino J, 2005, LIMNOL OCEANOGR, V50, P978, DOI 10.4319/lo.2005.50.3.0978; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Heip C., 1982, Helminthologia (Bratislava), V51, P1; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Higgins R.P., 1988, P1; Holt AR, 2004, J ANIM ECOL, V73, P841, DOI 10.1111/j.0021-8790.2004.00862.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston M. A., 1994, BIOL DIVERSITY; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; JENSEN P, 1988, DEEP-SEA RES, V35, P1173, DOI 10.1016/0198-0149(88)90008-8; JENSEN P, 1987, MAR ECOL PROG SER, V35, P187, DOI 10.3354/meps035187; Jumars PA, 1982, ENV DEEP SEA, P217; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kingsland SE., 1985, MODELING NATURE; Krebs C. J., 2014, ECOLOGICAL METHODOLO; Lambshead PJD, 2002, MAR ECOL PROG SER, V236, P129, DOI 10.3354/meps236129; Landsberg J, 1999, PEOPLE AND RANGELANDS BUILDING THE FUTURE, VOLS 1 AND 2, P911; LAWTON JH, 1993, ECOL STU AN, V99, P255; Lawton JH, 1999, BIODIVERSITY ECOSYST, P119; Legendre P., 1998, DEV ENV MODELLING, V20; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; Leibold MA, 1998, EVOL ECOL, V12, P95, DOI 10.1023/A:1006511124428; LEVIN LA, 1986, MAR ECOL PROG SER, V29, P99, DOI 10.3354/meps029099; LEVIN LA, 1991, AM ZOOL, V31, P886; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Lorenzen S, 1994, PHYLOGENETIC SYSTEMA, V152; Macpherson E, 2003, BIOL J LINN SOC, V80, P437, DOI 10.1046/j.1095-8312.2003.00256.x; Magurram AE, 2003, MEASURING BIOL DIVER; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McClain CR, 2010, ECOLOGY, V91, P964, DOI 10.1890/09-0087.1; McIntyre AD, 1984, METHODS STUDY MARINE, P217; Moens T, 1999, MAR BIOL, V133, P69, DOI 10.1007/s002270050444; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Mouillot D, 2005, ECOL INDIC, V5, P1, DOI 10.1016/j.ecolind.2004.04.004; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; NEE S, 1991, OIKOS, V62, P83, DOI 10.2307/3545450; Netto SA, 2005, DEEP-SEA RES PT I, V52, P845, DOI 10.1016/j.dsr.2004.11.009; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2004, FUNCT ECOL, V18, P297, DOI 10.1111/j.0269-8463.2004.00852.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Platt H.M., 1980, Systematics Association Special Volume Series, P729; Platt HM, 1983, FREE LIVING MARINE 1; Primer-E, 2006, PLYM ROUT MULT EC RE; Putman R. J., 1994, COMMUNITY ECOLOGY; Queric NV, 2008, MAR ECOL PROG SER, V370, P87, DOI 10.3354/meps07582; Reimann F., 1974, Mikrofauna Meeresbodens, VNo. 40, P1; Rex M. A, 2010, DEEP SEA BIODIVERSIT; REX MA, 1973, SCIENCE, V181, P1051, DOI 10.1126/science.181.4104.1051; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; Rosenfeld JS, 2002, OIKOS, V98, P156, DOI 10.1034/j.1600-0706.2002.980116.x; Roughgarden J., 1986, Ecological Studies, P179; Ruesink JL, 2001, OIKOS, V93, P221, DOI 10.1034/j.1600-0706.2001.930206.x; Rzeznik-Orignac J, 2003, ESTUAR COAST SHELF S, V58, P77, DOI 10.1016/S0272-7714(03)00061-1; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schmid B, 2001, FUNCTIONAL CONSEQUEN, P120; Schratzberger M, 2007, MAR ENVIRON RES, V63, P368, DOI 10.1016/j.marenvres.2006.10.006; Shannon Claude E, 1963, MATH THEORY COMMUNIC; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Snyder RE, 2004, AM NAT, V164, P633, DOI 10.1086/424969; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; Soltwedel T, 2001, MAR ECOL PROG SER, V219, P291, DOI 10.3354/meps219291; Soltwedel T., 2005, OCEANOGRAPHY, V18, P46, DOI [10.5670/oceanog.2005.24, DOI 10.5670/0CEAN0G.2005.24]; Steneck Robert S., 2001, P121; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; THISTLE D, 1985, DEEP-SEA RES, V32, P1077, DOI 10.1016/0198-0149(85)90063-9; THISTLE D, 1993, DEEP-SEA RES PT I, V40, P151, DOI 10.1016/0967-0637(93)90058-B; THISTLE D, 1983, DEEP-SEA RES, V30, P1235, DOI 10.1016/0198-0149(83)90082-1; THISTLE D, 1990, DEEP-SEA RES, V37, P541, DOI 10.1016/0198-0149(90)90089-E; Thistle D, 1995, VIE MILIEU, V45, P107; Thistle D, 1999, DEEP-SEA RES PT I, V46, P2041, DOI 10.1016/S0967-0637(99)00040-0; TIETJEN JH, 1989, DEEP-SEA RES, V36, P1579, DOI 10.1016/0198-0149(89)90059-9; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; TILMAN D, 2001, FUNCTIONAL CONSEQUEN, P9; Tita G, 2001, CAH BIOL MAR, V42, P263; Tita G, 1999, J MAR BIOL ASSOC UK, V79, P1007, DOI 10.1017/S0025315499001241; Tolimieri N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010653; Traunspurger W, 2000, FRESHWATER BIOL, V44, P29, DOI 10.1046/j.1365-2427.2000.00585.x; Vanaverbeke J, 2004, MAR ECOL PROG SER, V273, P139, DOI 10.3354/meps273139; Vanaverbeke J, 2003, MAR ECOL PROG SER, V249, P157, DOI 10.3354/meps249157; Vanhove S, 1999, MAR ECOL PROG SER, V181, P237, DOI 10.3354/meps181237; Vanhove S, 2004, DEEP-SEA RES PT II, V51, P1665, DOI 10.1016/j.dsr2.2004.06.029; VANHOVE S, 1995, MAR ECOL PROG SER, V127, P65, DOI 10.3354/meps127065; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; VITOUSEK PM, 1993, ECOL STU AN, V99, P3; Vogel S., 1981, pi; von Euler F, 2001, OECOLOGIA, V129, P304, DOI 10.1007/s004420100732; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; WARD AR, 1975, MAR BIOL, V30, P217, DOI 10.1007/BF00390744; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Warwick RM, 2002, HYDROBIOLOGIA, V473, P121, DOI 10.1023/A:1016533801827; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207; WIENS JA, 1977, AM SCI, V65, P590; WIESER W, 1960, LIMNOL OCEANOGR, V5, P121, DOI 10.4319/lo.1960.5.2.0121; WIESER W., 1953, ARKIV ZOOL, V4, P439; Wilson JB, 1999, OIKOS, V86, P507, DOI 10.2307/3546655; Witte U, 1997, MAR ECOL PROG SER, V154, P241, DOI 10.3354/meps154241; Witte U, 1995, BER SONDERFORSCHUNGS, V313, P1; ZAR JH, 1996, BIOSTATISTICAL ANAL; ZOBEL M, 1992, OIKOS, V65, P314, DOI 10.2307/3545024	152	40	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29152	10.1371/journal.pone.0029152	http://dx.doi.org/10.1371/journal.pone.0029152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216193	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300031
J	Giraudi, PJ; Bellarosa, C; Coda-Zabetta, CD; Peruzzo, P; Tiribelli, C				Giraudi, Pablo J.; Bellarosa, Cristina; Coda-Zabetta, Carlos D.; Peruzzo, Paolo; Tiribelli, Claudio			Functional Induction of the Cystine-Glutamate Exchanger System X-c(-) Activity in SH-SY5Y Cells by Unconjugated Bilirubin	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; HUMAN NT2-N NEURONS; OXIDATIVE STRESS; HUMAN-FIBROBLASTS; REDOX REGULATION; NEUROBLASTOMA SH-SY5Y; INDUCED NEUROTOXICITY; SOLVENT PARTITION; INDUCED APOPTOSIS; PLASMA-MEMBRANE	We have previously reported that exposure of SH-SY5Y neuroblastoma cells to unconjugated bilirubin (UCB) resulted in a marked up-regulation of the mRNA encoding for the Na+-independent cystine: glutamate exchanger System X-c(-) (SLC7A11 and SLC3A2 genes). In this study we demonstrate that SH-SY5Y cells treated with UCB showed a higher cystine uptake due to a significant and specific increase in the activity of System X-c(-), without the contribution of the others two cystine transporters (X-AG(-) and GGT) reported in neurons. The total intracellular glutathione content was 2 folds higher in the cells exposed to bilirubin as compared to controls, suggesting that the internalized cystine is used for gluthathione synthesis. Interestingly, these cells were significantly less sensitive to an oxidative insult induced by hydrogen peroxide. If System X-c(-) is silenced the protection is lost. In conclusion, these results suggest that bilirubin can modulate the gluthathione levels in neuroblastoma cells through the induction of the System X-c(-), and this renders the cell less prone to oxidative damage.	[Giraudi, Pablo J.; Bellarosa, Cristina; Coda-Zabetta, Carlos D.; Peruzzo, Paolo] Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy; [Tiribelli, Claudio] Univ Trieste, Dipartimento Univ Clin Scienze Med Chirurg & Salu, Trieste, Italy	University of Trieste	Giraudi, PJ (corresponding author), Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy.	cristina.bellarosa@csf.units.it	Peruzzo, Paolo/AAB-9667-2019; Tiribelli, Claudio/A-4716-2014	Tiribelli, Claudio/0000-0001-6596-7595	Telethon [GGP05062, GGP10051]; Italian Ministry of Foreign Affairs, Rome, Italy; Area Science Park, Trieste, Italy	Telethon(Fondazione Telethon); Italian Ministry of Foreign Affairs, Rome, Italy; Area Science Park, Trieste, Italy	This work was supported by the Telethon Grants GGP05062 and GGP10051 and founded by Friulia Venezia Giulia Region LR 26/2005. PJG and CDC-Z were sponsored by a fellowship from the Italian Ministry of Foreign Affairs, Rome, Italy. Part of the work of PJG was also sponsored by a fellowship of Area Science Park, Trieste, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2001, BRAIN RES, V894, P131, DOI 10.1016/S0006-8993(01)01988-6; BANNAI S, 1989, J BIOL CHEM, V264, P18480; BANNAI S, 1984, J BIOL CHEM, V259, P2435; BANNAI S, 1984, NATURE, V311, P308; BANNAI S, 1986, J BIOL CHEM, V261, P2256; BANNAI S, 1982, J CELL PHYSIOL, V112, P265, DOI 10.1002/jcp.1041120216; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Brito MA, 2004, BRAIN RES, V1026, P33, DOI 10.1016/j.brainres.2004.07.063; Brito MA, 2010, MOL MED, V16, P372, DOI 10.2119/molmed.2009.00152; Calligaris R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-543; Calligaris SD, 2007, PEDIATR RES, V62, P576, DOI 10.1203/PDR.0b013e3181568c94; Cesaratto L, 2007, J MOL MED, V85, P1099, DOI 10.1007/s00109-007-0204-3; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; DAY RL, 1954, P SOC EXP BIOL MED, V85, P261; Deganuto M, 2010, PROTEOMICS, V10, P1645, DOI 10.1002/pmic.200900579; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Dore S, 1999, ANN NY ACAD SCI, V890, P167, DOI 10.1111/j.1749-6632.1999.tb07991.x; Gomez LD, 2004, J EXP BOT, V55, P1851, DOI 10.1093/jxb/erh202; Gourley G R, 1997, Adv Pediatr, V44, P173; Granato A, 2003, GUT, V52, P1774, DOI 10.1136/gut.52.12.1774; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Grojean S, 2001, PEDIATR RES, V49, P507, DOI 10.1203/00006450-200104000-00012; HAHM JS, 1992, J LIPID RES, V33, P1123; Hanko E, 2006, PEDIATR RES, V59, P72, DOI 10.1203/01.pdr.0000191135.63586.08; Hanko E, 2005, PEDIATR RES, V57, P179, DOI 10.1203/01.PDR.0000148711.11519.A5; ISHII T, 1985, J CELL PHYSIOL, V125, P151, DOI 10.1002/jcp.1041250119; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Maines MD, 2000, CELL MOL BIOL, V46, P573; MAKOWSKE M, 1982, J BIOL CHEM, V257, P5663; Malik Safarina G, 2010, BMC Res Notes, V3, P162, DOI 10.1186/1756-0500-3-162; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; McBean GJ, 2002, TRENDS PHARMACOL SCI, V23, P299, DOI 10.1016/S0165-6147(02)02060-6; McDonald JW, 1998, EXP NEUROL, V150, P21, DOI 10.1006/exnr.1997.6762; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Oakes GH, 2005, J BIOCHEM MOL TOXIC, V19, P244, DOI 10.1002/jbt.20086; Ollinger R, 2007, CELL CYCLE, V6, P3078, DOI 10.4161/cc.6.24.5022; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; Ostrow JD, 2007, TRANSL RES, V149, P37, DOI 10.1016/j.trsl.2006.07.006; Ostrow JD, 2004, TRENDS MOL MED, V10, P65, DOI 10.1016/j.molmed.2003.12.003; Ostrow JD, 2003, PEDIATR RES, V54, P98, DOI 10.1203/01.PDR.0000067486.79854.D5; Patel SA, 2004, NEUROPHARMACOLOGY, V46, P273, DOI 10.1016/j.neuropharm.2003.08.006; Rigacci S, 1997, BIOCHEM J, V324, P791, DOI 10.1042/bj3240791; Roca L, 2006, PEDIATR RES, V60, P724, DOI 10.1203/01.pdr.0000245992.89965.94; Rodrigues CMP, 2002, J LIPID RES, V43, P885; Rodrigues CMP, 2002, J HEPATOL, V36, P335, DOI 10.1016/S0168-8278(01)00279-3; Rodrigues CMP, 2000, MOL MED, V6, P936, DOI 10.1007/BF03401828; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; SATO H, 1995, BIOCHEM J, V310, P547, DOI 10.1042/bj3100547; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Satoh T, 2007, TRENDS NEUROSCI, V30, P37, DOI 10.1016/j.tins.2006.11.004; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; Shackelford RE, 2005, ANTIOXID REDOX SIGN, V7, P940, DOI 10.1089/ars.2005.7.940; Shanker G, 2001, J NEUROSCI RES, V66, P998, DOI 10.1002/jnr.10066; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102; TENHUNEN R, 1976, ANN CLIN RES, V8, P2; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; TOOHEY JI, 1975, P NATL ACAD SCI USA, V72, P73, DOI 10.1073/pnas.72.1.73; Tyrrell R, 1999, FREE RADICAL RES, V31, P335, DOI 10.1080/10715769900300901; VOGT MT, 1968, J NEUROCHEM, V15, P1313, DOI 10.1111/j.1471-4159.1968.tb05909.x; Wang PJ, 2003, J BIOL CHEM, V278, P20695, DOI 10.1074/jbc.M301100200; Watchko JF, 2006, NEUROMOL MED, V8, P513, DOI 10.1385/NMM:8:4:513; ZETTERSTROM R, 1956, NATURE, V178, P1335, DOI 10.1038/1781335a0; Zucker SD, 1999, J BIOL CHEM, V274, P10852, DOI 10.1074/jbc.274.16.10852	69	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29078	10.1371/journal.pone.0029078	http://dx.doi.org/10.1371/journal.pone.0029078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216172	Green Published, Green Submitted, gold			2022-12-25	WOS:000300674900010
J	Mikkelsen, H; McMullan, R; Filloux, A				Mikkelsen, Helga; McMullan, Rachel; Filloux, Alain			The Pseudomonas aeruginosa Reference Strain PA14 Displays Increased Virulence Due to a Mutation in ladS	PLOS ONE			English	Article							III SECRETION SYSTEM; CAENORHABDITIS-ELEGANS; VI SECRETION; MOLECULAR-MECHANISMS; IN-VITRO; BACTERIAL; INFECTION; PATHOGENICITY; IDENTIFICATION; EXPRESSION	Pseudomonas aeruginosa is a pathogen that causes acute and chronic infections in a variety of hosts. The pathogenic potential of P. aeruginosa is strain-dependent. PA14 is a highly virulent strain that causes disease in a wide range of organisms, whereas PAO1 is moderately virulent. Although PA14 carries pathogenicity islands that are absent in PAO1, the presence or absence of specific gene clusters is not predictive of virulence. Here, we show that the virulent strain PA14 has an acquired mutation in the ladS gene. This mutation has a deleterious impact on biofilm, while it results in elevated type III secretion system (T3SS) activity and increased cytotoxicity towards mammalian cells. These phenotypes can be reverted by repairing the ladS mutation on the PA14 genome. The RetS/LadS/GacS signaling cascade is associated with virulence and the switch between acute and chronic infections. RetS is a sensor that down-regulates biofilm formation and up-regulates the T3SS. Mutations in retS are acquired in strains isolated from chronically infected cystic fibrosis patients and lead to hyperbiofilm formation and reduced cytotoxicity. Conversely, the LadS sensor promotes biofilm formation and represses the T3SS. We conclude that the ladS mutation is partly responsible for the high cytotoxicity of PA14, and our findings corroborate the central role of RetS and LadS in the switch between acute and chronic infections. Given the extensive use of the reference strain PA14 in infection and virulence models, the bias caused by the ladS mutation on the observed phenotypes will be crucial to consider in future research.	[Mikkelsen, Helga; McMullan, Rachel; Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Dept Life Sci, London, England	Imperial College London	Mikkelsen, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Dept Life Sci, London, England.	a.filloux@imperial.ac.uk	McMullan, Rachel/ABJ-3519-2022	McMullan, Rachel/0000-0003-2677-8016	Royal Society; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019645/1]; Biotechnology and Biological Sciences Research Council [BB/F019645/1] Funding Source: researchfish; BBSRC [BB/F019645/1] Funding Source: UKRI	Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Alain Filloux is supported by the Royal Society. Alain Filloux and Helga Mikkelsen are supported by the Biotechnology and Biological Sciences Research Council (BBSRC) grant N<SUP>o</SUP>: BB/F019645/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Bianconi I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001270; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Chand NS, 2011, J BACTERIOL, V193, P2989, DOI 10.1128/JB.01546-10; Choi JY, 2002, J BACTERIOL, V184, P952, DOI 10.1128/jb.184.4.952-961.2002; Clatworthy AE, 2009, INFECT IMMUN, V77, P1293, DOI 10.1128/IAI.01181-08; Coleman FT, 2003, P NATL ACAD SCI USA, V100, P1949, DOI 10.1073/pnas.0437901100; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Garvis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000540; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Harrison EM, 2010, INFECT IMMUN, V78, P1437, DOI 10.1128/IAI.00621-09; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; Huse HK, 2010, MBIO, V1, DOI 10.1128/mBio.00199-10; Irie Y, 2010, MOL MICROBIOL, V78, P158, DOI 10.1111/j.1365-2958.2010.07320.x; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lau GW, 2003, INFECT IMMUN, V71, P4059, DOI 10.1128/IAI.71.7.4059-4066.2003; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mikkelsen H, 2011, ENV MICROBIOL; Mikkelsen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006018; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Nicastro GG, 2009, FEMS MICROBIOL LETT, V301, P115, DOI 10.1111/j.1574-6968.2009.01803.x; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Records AR, 2010, J BACTERIOL, V192, P3584, DOI 10.1128/JB.00114-10; Rodrigue A, 2000, TRENDS MICROBIOL, V8, P498, DOI 10.1016/S0966-842X(00)01833-3; Sivaneson M, 2011, MOL MICROBIOL, V79, P1353, DOI 10.1111/j.1365-2958.2010.07527.x; Starkey M, 2009, NAT PROTOC, V4, P117, DOI 10.1038/nprot.2008.224; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wareham DW, 2005, FEMS MICROBIOL LETT, V242, P209, DOI 10.1016/j.femsle.2004.11.018; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	56	95	96	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29113	10.1371/journal.pone.0029113	http://dx.doi.org/10.1371/journal.pone.0029113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216178	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000299684700030
J	Serra, DO; Conover, MS; Arnal, L; Sloan, GP; Rodriguez, ME; Yantorno, OM; Deora, R				Serra, Diego O.; Conover, Matt S.; Arnal, Laura; Sloan, Gina Parise; Rodriguez, Maria E.; Yantorno, Osvaldo M.; Deora, Rajendar			FHA-Mediated Cell-Substrate and Cell-Cell Adhesions Are Critical for Bordetella pertussis Biofilm Formation on Abiotic Surfaces and in the Mouse Nose and the Trachea	PLOS ONE			English	Article							RESPIRATORY EPITHELIAL-CELLS; TRANSFORM INFRARED-SPECTROSCOPY; LARGE SECRETED PROTEIN; FILAMENTOUS HEMAGGLUTININ; STAPHYLOCOCCUS-AUREUS; 2-PARTNER SECRETION; MICROBIAL BIOFILMS; BPS POLYSACCHARIDE; VIRULENCE FACTORS; HUMAN NEUTROPHILS	Bordetella spp. form biofilms in the mouse nasopharynx, thereby providing a potential mechanism for establishing chronic infections in humans and animals. Filamentous hemagglutinin (FHA) is a major virulence factor of B. pertussis, the causative agent of the highly transmissible and infectious disease, pertussis. In this study, we dissected the role of FHA in the distinct biofilm developmental stages of B. pertussis on abiotic substrates and in the respiratory tract by employing a murine model of respiratory biofilms. Our results show that the lack of FHA reduced attachment and decreased accumulation of biofilm biomass on artificial surfaces. FHA contributes to biofilm development by promoting the formation of microcolonies. Absence of FHA from B. pertussis or antibody-mediated blockade of surface-associated FHA impaired the attachment of bacteria to the biofilm community. Exogenous addition of FHA resulted in a dose-dependent inhibitory effect on bacterial association with the biofilms. Furthermore, we show that FHA is important for the structural integrity of biofilms formed on the mouse nose and trachea. Together, these results strongly support the hypothesis that FHA promotes the formation and maintenance of biofilms by mediating cell-substrate and inter-bacterial adhesions. These discoveries highlight FHA as a key factor in establishing structured biofilm communities in the respiratory tract.	[Serra, Diego O.; Arnal, Laura; Rodriguez, Maria E.; Yantorno, Osvaldo M.] Univ Nacl La Plata, CONICET CCT La Plata, Fac Ciencias Exactas, Ctr Invest & Desarrollo Fermentac Ind CINDEFI, La Plata, Buenos Aires, Argentina; [Conover, Matt S.; Deora, Rajendar] Wake Forest Univ Hlth Sci, Program Mol Genet, Winston Salem, NC USA; [Sloan, Gina Parise; Deora, Rajendar] Wake Forest Univ Hlth Sci, Dept Microbiol & Immunol, Winston Salem, NC USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Serra, DO (corresponding author), Univ Nacl La Plata, CONICET CCT La Plata, Fac Ciencias Exactas, Ctr Invest & Desarrollo Fermentac Ind CINDEFI, La Plata, Buenos Aires, Argentina.	yantorno@quimica.unlp.edu.ar; rdeora@wfubmc.edu			Agencia Nacional de Promocion Cientifica y Tecnologica [BID 1728/OC-AR-PICT 34836]; National Institutes of Health (NIH) [1R01AI075081, T32 AI07401]; ASM (American Society for Microbiology); IUBMB (International Union of Biochemistry and Molecular Biology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075081, T32AI007401] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASM (American Society for Microbiology); IUBMB (International Union of Biochemistry and Molecular Biology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (grant BID 1728/OC-AR-PICT 34836). Research in the laboratory of Dr. Deora is supported from the National Institutes of Health (NIH) (grant no. 1R01AI075081). Dr. Serra is grateful to ASM (American Society for Microbiology) and IUBMB (International Union of Biochemistry and Molecular Biology) for fellowship awards for an internship in Dr. Deoras' laboratory. Dr. Serra and Dr. Arnal are fellows from CONICET. Dr. Rodriguez is a research career member from CONICET. Dr. Conover is supported by a NIH predoctoral training grant, T32 AI07401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson T, 2001, INFECT IMMUN, V69, P2650, DOI 10.1128/IAI.69.4.2650-2658.2001; Abramson T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003825; Birkebaek NH, 1999, CLIN INFECT DIS, V29, P1239, DOI 10.1086/313448; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Carbonetti NH, 2004, INFECT IMMUN, V72, P3350, DOI 10.1128/IAI.72.6.3350-3358.2004; Carbonetti NH, 2007, CURR OPIN PHARMACOL, V7, P272, DOI 10.1016/j.coph.2006.12.004; Cherry JD, 1999, CLIN INFECT DIS, V28, pS112, DOI 10.1086/515058; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; Cotter PA, 1998, INFECT IMMUN, V66, P5921, DOI 10.1128/IAI.66.12.5921-5929.1998; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Folkesson A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001891; Geuijen CAW, 1997, INFECT IMMUN, V65, P4222, DOI 10.1128/IAI.65.10.4222-4228.1997; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Halperin SA, 2007, NEW ENGL J MED, V356, P110, DOI 10.1056/NEJMp068288; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; Irie Y, 2007, FEMS MICROBIOL LETT, V275, P191, DOI 10.1111/j.1574-6968.2007.00852.x; Ishibashi Y, 2001, MICROB PATHOGENESIS, V30, P279, DOI 10.1006/mpat.2001.0432; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jurcisek JA, 2007, MOL MICROBIOL, V65, P1288, DOI 10.1111/j.1365-2958.2007.05864.x; KASUGA TADAYOSHI, 1953, KITASATO ARCH EXPTL MED, V26, P121; KIMURA A, 1990, INFECT IMMUN, V58, P7, DOI 10.1128/IAI.58.1.7-16.1990; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Lasa I, 2006, INT MICROBIOL, V9, P21; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991; Lenz DH, 2000, INFECT IMMUN, V68, P956, DOI 10.1128/IAI.68.2.956-959.2000; LOCHT C, 1992, EMBO J, V11, P3175, DOI 10.1002/j.1460-2075.1992.tb05394.x; LOCHT C, 1993, MOL MICROBIOL, V9, P653, DOI 10.1111/j.1365-2958.1993.tb01725.x; Luke NR, 2007, INFECT IMMUN, V75, P5559, DOI 10.1128/IAI.00946-07; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; MAKHOV AM, 1994, J MOL BIOL, V241, P110, DOI 10.1006/jmbi.1994.1478; MARKS MI, 1980, J PEDIATR-US, V97, P156; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mclntyre P, 2009, CURR OPIN INFECT DIS, V22, P215, DOI 10.1097/QCO.0b013e32832b3540; MENOZZI FD, 1994, INFECT IMMUN, V62, P4261, DOI 10.1128/IAI.62.10.4261-4269.1994; MENOZZI FD, 1991, INFECT IMMUN, V59, P3982, DOI 10.1128/IAI.59.11.3982-3988.1991; Mobberley-Schuman PS, 2003, J INFECT DIS, V187, P1646, DOI 10.1086/374741; NELSON JD, 1978, AM J DIS CHILD, V132, P371, DOI 10.1001/archpedi.1978.02120290043006; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; PRASAD SM, 1993, INFECT IMMUN, V61, P2780, DOI 10.1128/IAI.61.7.2780-2785.1993; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rodriguez ME, 2006, FEMS IMMUNOL MED MIC, V46, P39, DOI 10.1111/j.1574-695X.2005.00001.x; Serra D, 2007, ANAL BIOANAL CHEM, V387, P1759, DOI 10.1007/s00216-006-1079-9; Serra DO, 2008, PROTEOMICS, V8, P4995, DOI 10.1002/pmic.200800218; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Smith AM, 2001, FEMS MICROBIOL REV, V25, P309, DOI 10.1016/S0168-6445(01)00056-0; Soane MC, 2000, RESP MED, V94, P791, DOI 10.1053/rmed.2000.0823; TUOMANEN EI, 1983, INFECT IMMUN, V42, P692, DOI 10.1128/IAI.42.2.692-695.1983; van den Akker WMR, 1998, BIOCHEM BIOPH RES CO, V252, P128, DOI 10.1006/bbrc.1998.9610; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Weingart CL, 2000, INFECT IMMUN, V68, P1735, DOI 10.1128/IAI.68.3.1735-1739.2000; WILSON R, 1991, INFECT IMMUN, V59, P337, DOI 10.1128/IAI.59.1.337-345.1991	67	52	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28811	10.1371/journal.pone.0028811	http://dx.doi.org/10.1371/journal.pone.0028811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216115	Green Submitted, gold, Green Published			2022-12-25	WOS:000299684700012
J	Switzer, WM; Zheng, HQ; Simmons, G; Zhou, YC; Tang, SH; Shankar, A; Kapusinszky, B; Delwart, EL; Heneine, W				Switzer, William M.; Zheng, HaoQiang; Simmons, Graham; Zhou, Yanchen; Tang, Shaohua; Shankar, Anupama; Kapusinszky, Beatrix; Delwart, Eric L.; Heneine, Walid			No Evidence of Murine Leukemia Virus-Related Viruses in Live Attenuated Human Vaccines	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; MOUSE DNA; XMRV; CONTAMINATION; PCR; RETROVIRUS; BLOOD; TRANSMISSION; ASSOCIATION	Background: The association of xenotropic murine leukemia virus (MLV)-related virus (XMRV) in prostate cancer and chronic fatigue syndrome reported in previous studies remains controversial as these results have been questioned by recent data. Nonetheless, concerns have been raised regarding contamination of human vaccines as a possible source of introduction of XMRV and MLV into human populations. To address this possibility, we tested eight live attenuated human vaccines using generic PCR for XMRV and MLV sequences. Viral metagenomics using deep sequencing was also done to identify the possibility of other adventitious agents. Results: All eight live attenuated vaccines, including Japanese encephalitis virus (JEV) (SA-14-14-2), varicella (Varivax), measles, mumps, and rubella (MMR-II), measles (Attenuvax), rubella (Meruvax-II), rotavirus (Rotateq and Rotarix), and yellow fever virus were negative for XMRV and highly related MLV sequences. However, residual hamster DNA, but not RNA, containing novel endogenous gammaretrovirus sequences was detected in the JEV vaccine using PCR. Metagenomics analysis did not detect any adventitious viral sequences of public health concern. Intracisternal A particle sequences closest to those present in Syrian hamsters and not mice were also detected in the JEV SA-14-14-2 vaccine. Combined, these results are consistent with the production of the JEV vaccine in Syrian hamster cells. Conclusions: We found no evidence of XMRV and MLV in eight live attenuated human vaccines further supporting the safety of these vaccines. Our findings suggest that vaccines are an unlikely source of XMRV and MLV exposure in humans and are consistent with the mounting evidence on the absence of these viruses in humans.	[Switzer, William M.; Zheng, HaoQiang; Tang, Shaohua; Shankar, Anupama; Heneine, Walid] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Simmons, Graham; Zhou, Yanchen; Kapusinszky, Beatrix; Delwart, Eric L.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA; [Simmons, Graham; Zhou, Yanchen; Kapusinszky, Beatrix; Delwart, Eric L.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	bswitzer@cdc.gov	Simmons, Graham/G-3523-2012	Simmons, Graham/0000-0002-9615-7023; Delwart, Eric/0000-0002-6296-4484	US Congress; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105770] Funding Source: NIH RePORTER	US Congress; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	As a US government institution, funding is provided by the US Congress. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley DWC, 2008, EXPERT OPIN BIOL TH, V8, P95, DOI 10.1517/14712598.8.1.95; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017592; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hussain AI, 2003, J VIROL, V77, P1105, DOI 10.1128/JVI.77.2.1105-1111.2003; Knox K, 2011, SCIENCE; Lintas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016609; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lobigs M, 2010, J GEN VIROL, V91, P1407, DOI 10.1099/vir.0.019190-0; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Maric R, 2011, RETROVIROLOGY, V8, pA213; Miyazawa T, 2010, BIOLOGICALS, V38, P371, DOI 10.1016/j.biologicals.2010.03.003; Morse II H. C., 2007, MOUSE BIOMEDICAL RES, V2, P269; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE; Qiu X, 2011, RETROVIROLOGY, V8, pA222; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; Shepherd AJ, 2003, BIOLOGICALS, V31, P251, DOI 10.1016/S1045-1056(03)00065-4; Shin CH, 2011, J VIROL; Shirato K, 2005, J VIROL METHODS, V126, P119, DOI 10.1016/j.jviromet.2005.02.001; Silverman RH, 2010, NAT REV UROL, V7, P392, DOI 10.1038/nrurol.2010.77; Simmons G, 2011, TRANSFUSION, V51, P643, DOI 10.1111/j.1537-2995.2011.03063.x; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tsang SX, 1999, J VIROL, V73, P5843, DOI 10.1128/JVI.73.7.5843-5851.1999; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; van der Kuyl AC, 2011, FRONTIERS MICROBIOLO, V1, P1; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Yu YX, 2010, VACCINE, V28, P3635, DOI 10.1016/j.vaccine.2010.02.105	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29223	10.1371/journal.pone.0029223	http://dx.doi.org/10.1371/journal.pone.0029223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216219	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700042
J	Wilmer, JW; Murray, L; Elkin, C; Wilcox, C; Niejalke, D; Possingham, HP				Wilmer, Jessica Worthington; Murray, Lynde; Elkin, Che; Wilcox, Chris; Niejalke, Darren; Possingham, Hugh P.			Catastrophic Floods May Pave the Way for Increased Genetic Diversity in Endemic Artesian Spring Snail Populations	PLOS ONE			English	Article							FALSE DISCOVERY RATE; SPECIES-DIVERSITY; FONSCOCHLEA-ACCEPTA; SOUTH-AUSTRALIA; SIZE; DISTURBANCE; RECOVERY; DIFFERENTIATION; HETEROZYGOSITY; INVERTEBRATES	The role of disturbance in the promotion of biological heterogeneity is widely recognised and occurs at a variety of ecological and evolutionary scales. However, within species, the impact of disturbances that decimate populations are neither predicted nor known to result in conditions that promote genetic diversity. Directly examining the population genetic consequences of catastrophic disturbances however, is rarely possible, as it requires both longitudinal genetic data sets and serendipitous timing. Our long-term study of the endemic aquatic invertebrates of the artesian spring ecosystem of arid central Australia has presented such an opportunity. Here we show a catastrophic flood event, which caused a near total population crash in an aquatic snail species (Fonscochlea accepta) endemic to this ecosystem, may have led to enhanced levels of within species genetic diversity. Analyses of individuals sampled and genotyped from the same springs sampled both pre (1988-1990) and post (1995, 2002-2006) a devastating flood event in 1992, revealed significantly higher allelic richness, reduced temporal population structuring and greater effective population sizes in nearly all post flood populations. Our results suggest that the response of individual species to disturbance and severe population bottlenecks is likely to be highly idiosyncratic and may depend on both their ecology (whether they are resilient or resistant to disturbance) and the stability of the environmental conditions (i.e. frequency and intensity of disturbances) in which they have evolved.	[Wilmer, Jessica Worthington; Murray, Lynde] Queensland Museum, Biodivers & Geosci Program, Brisbane, Qld 4101, Australia; [Murray, Lynde; Elkin, Che; Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Wilcox, Chris] CSIRO, Marine & Atmospher Res Div, Hobart, Tas, Australia; [Niejalke, Darren] Olymp Dam Expans Project, BHP Billiton, Adelaide, SA, Australia	Queensland Museum; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); BHP Billiton	Wilmer, JW (corresponding author), Queensland Museum, Biodivers & Geosci Program, POB 300, Brisbane, Qld 4101, Australia.	jessica.wilmer@qm.qld.gov.au	POSSINGHAM, HUGH/R-8310-2019; Possingham, Hugh/B-1337-2008; Wilcox, Chris/A-3585-2010	POSSINGHAM, HUGH/0000-0001-7755-996X; Possingham, Hugh/0000-0001-7755-996X; Wilcox, Chris/0000-0002-5983-657X	Australian Research Council [LP0560890]; Queensland Museum; BHP Billiton	Australian Research Council(Australian Research Council); Queensland Museum; BHP Billiton	This research was supported by a collaborative Australian Research Council (http://www.arc.gov.au/) Linkage Grant (LP0560890) to the University of Queensland, the Queensland Museum and BHP Billiton (formerly Western Mining Corporation). The Australian Research Council (ARC) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BHP Billiton and the Queensland Museum as industry partners contributed both cash and in-kind support to the ARC Linkage Grant. Researchers (authors) working for these organisations participated in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2000, GENETICS, V156, P2109; Aspi J, 2006, MOL ECOL, V15, P1561, DOI 10.1111/j.1365-294X.2006.02877.x; ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P247, DOI 10.1016/0378-1127(94)90114-7; Baker AJ, 2008, CONSERV GENET, V9, P495, DOI 10.1007/s10592-007-9358-3; Beaumont MA, 2003, GENETICS, V164, P1139; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BHP Billiton, 2006, OL DAM ENV MAN MON R; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; CHAKRABORTY R, 1977, EVOLUTION, V31, P347, DOI 10.1111/j.1558-5646.1977.tb01017.x; Cleary DFR, 2006, ECOL LETT, V9, P301, DOI 10.1111/j.1461-0248.2005.00876.x; Clegg S, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P293; Clegg SM, 2008, EVOLUTION, V62, P2393, DOI 10.1111/j.1558-5646.2008.00437.x; Colson I, 2004, MOL ECOL, V13, P2223, DOI 10.1111/j.1365-294X.2004.02245.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cornuet JM, 1999, GENETICS, V153, P1989; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; England PR, 2003, CONSERV GENET, V4, P595, DOI 10.1023/A:1025639811865; Evanno G, 2009, MOL ECOL, V18, P1137, DOI 10.1111/j.1365-294X.2009.04102.x; Falush D, 2003, GENETICS, V164, P1567; Fatchen TJ, 1993, DYNAMICS VEGETATION; Fensham RJ, 2004, BIOL CONSERV, V119, P41, DOI 10.1016/j.biocon.2003.10.019; Framenau VW, 2006, J ARACHNOL, V34, P1, DOI 10.1636/H03-72.1; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Garcia LV, 2003, TRENDS ECOL EVOL, V18, P553, DOI 10.1016/j.tree.2003.08.011; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Habermehl M. A., 1980, BMR Journal of Australian Geology & Geophysics, V5, P9; Holt RD, 2006, P NATL ACAD SCI USA, V103, P2005, DOI 10.1073/pnas.0600289103; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Kingsford RT, 1999, BIOL CONSERV, V88, P231, DOI 10.1016/S0006-3207(98)00098-6; Kinhill-Stearns, 1984, OLYMPIC DAM PROJECT; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; McMahon TA., 2005, HYDROLOGY LAKE EYRE; Murphy NP, 2010, FRESHWATER BIOL, V55, P2499, DOI 10.1111/j.1365-2427.2010.02479.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Niejalke D, 1998, P 2 MOUND SPRING RES, P25; Ortego J, 2007, BIOL LETTERS, V3, P585, DOI 10.1098/rsbl.2007.0268; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Pearman PB, 2005, ECOL LETT, V8, P401, DOI 10.1111/j.1461-0248.2005.00735.x; Peel D., 2004, NEESTIMATOR SOFTWARE; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Ponder W.F., 1995, Occasional Papers of the IUCN Species Survival Commission, V9, P13; PONDER WF, 1989, MALACOLOGIA, V31, P1; Ponder WF, 1995, BIOL J LINN SOC, V56, P553; Ponder WF, 1984, DISTRIBUTION SIGNIFI; Pritchard JK, 2000, GENETICS, V155, P945; Puckridge JT, 2000, REGUL RIVER, V16, P385, DOI 10.1002/1099-1646(200009/10)16:5<385::AID-RRR592>3.3.CO;2-N; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Roshier DA, 2002, BIOL CONSERV, V106, P399, DOI 10.1016/S0006-3207(01)00268-3; Schoener TW, 2006, P NATL ACAD SCI USA, V103, P2220, DOI 10.1073/pnas.0510355103; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; Tyre AJ, 2001, ENVIRON INT, V27, P225, DOI 10.1016/S0160-4120(01)00091-5; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Vignieri SN, 2010, AM NAT, V175, P126, DOI 10.1086/648606; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2003, GENETICS, V163, P429; WAPLES RS, 1989, GENETICS, V121, P379; Watkins MW, 2005, MULTIPLE PAIRWISE TE; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White PS, 2001, PROG BOT, V62, P399; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Wilmer JW, 2008, MOL ECOL, V17, P3733, DOI 10.1111/j.1365-294X.2008.03861.x; Wilmer JW, 2007, CONSERV GENET, V8, P617, DOI 10.1007/s10592-006-9206-x; Wilmer JW, 2005, MOL ECOL NOTES, V5, P205, DOI 10.1111/j.1471-8286.2004.00877.x; Wright S, 1931, GENETICS, V16, P0097; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	72	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28645	10.1371/journal.pone.0028645	http://dx.doi.org/10.1371/journal.pone.0028645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205959	gold, Green Published, Green Submitted			2022-12-25	WOS:000298666200008
J	Fan, YF; Fan, YB; Li, ZY; Loan, M; Lv, CS; Bo, Z				Fan, Yifang; Fan, Yubo; Li, Zhiyu; Loan, Mushtaq; Lv, Changsheng; Bo, Zhang			Optimal Principle of Bone Structure	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; WOLFF LAW; STRENGTH; DENSITY; MODEL	Bone modeling and remodeling is an optimization process where no agreement has been reached regarding a unified theory or model. We measured 384 pieces of bone in vivo by 64-slice CT and discovered that the bone's center of mass approximately superposes its centroid of shape. This phenomenon indicates that the optimization process of non-homogeneous materials such as bone follows the same law of superposition of center of mass and centroid of shape as that of homogeneous materials. Based upon this principle, an index revealing the relationship between the center of mass and centroid of shape of the compact bone is proposed. Another index revealing the relationship between tissue density and distribution radius is followed. Applying these indexes to evaluate the strength of bone, we have some new findings.	[Fan, Yifang; Lv, Changsheng; Bo, Zhang] Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China; [Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing, Peoples R China; [Li, Zhiyu] Jinan Univ, Coll Foreign Studies, Guangzhou, Guangdong, Peoples R China; [Loan, Mushtaq] Jinan Univ, Int Sch, Guangzhou, Guangdong, Peoples R China	Guangzhou Sport University; Beihang University; Jinan University; Jinan University	Fan, YF (corresponding author), Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China.	tfyf@gipe.edu.cn; yubofan@buaa.edu.cn	Fan, Yifang/V-6281-2019	Fan, Yifang/0000-0001-5338-9847	National Natural Science Foundation of China [10772053, 10925208, 10972061, 11172073]; Guangdong Natural Science Foundation [S2011010001829]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This project was funded by National Natural Science Foundation of China (http://www.nsfc.gov.cn) under the grant numbers of 10772053, 10925208, 10972061 and 11172073 and by Guangdong Natural Science Foundation (http://gdsf.gdstc.gov.cn/) under the grant numbers of S2011010001829. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspden RM, 2003, METH MOLEC MED, V80, P369; Bagge M, 2000, J BIOMECH, V33, P1349, DOI 10.1016/S0021-9290(00)00124-X; Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; CARTER DR, 1978, CLIN ORTHOP RELAT R, P192; CIARELLI MJ, 1991, J ORTHOPAED RES, V9, P674, DOI 10.1002/jor.1100090507; Coburn JC, 2007, J BIOMECH, V40, P203, DOI 10.1016/j.jbiomech.2005.11.015; Currey JD, 1999, J EXP BIOL, V202, P2495; EVANS FG, 1957, J APPL PHYSIOL, V10, P127, DOI 10.1152/jappl.1957.10.1.127; Fan YF, 2010, ARXIV10100617; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; FROST HM, 1992, BONE MINER, V18, P227, DOI 10.1016/0169-6009(92)90809-R; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446; HARRIGAN TP, 1994, J BIOMECH, V27, P323, DOI 10.1016/0021-9290(94)90008-6; HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3; HUISKES R, 1993, J BIOMECH ENG-T ASME, V115, P520, DOI 10.1115/1.2895534; Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0; RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F; ROESLER H, 1987, J BIOMECH, V20, P1025, DOI 10.1016/0021-9290(87)90020-0; Rusconi M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.128101; Salter DM, 1997, J BONE MINER RES, V12, P1133, DOI 10.1359/jbmr.1997.12.7.1133; Sherwood RJ, 1999, J MORPHOL, V241, P127, DOI 10.1002/(SICI)1097-4687(199908)241:2<127::AID-JMOR3>3.3.CO;2-G; Tao ZL, 2000, ADV MECH, V30, P433; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; TURNER CH, 1992, BONE, V13, P403, DOI 10.1016/8756-3282(92)90082-8; Turner CH, 1999, CALCIFIED TISSUE INT, V65, P466, DOI 10.1007/s002239900734; TURNER CH, 1992, J BIOMECH, V25, P1, DOI 10.1016/0021-9290(92)90240-2; Wang YL, 1999, ADV MECH, V29, P232; Wolff J., 1986, LAW BONE REMODELING	30	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28868	10.1371/journal.pone.0028868	http://dx.doi.org/10.1371/journal.pone.0028868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194933	gold, Green Submitted, Green Published			2022-12-25	WOS:000298664400021
J	Lu, WY; Lin, CH; Roberts, MJ; Waud, WR; Piazza, GA; Li, YH				Lu, Wenyan; Lin, Cuihong; Roberts, Michael J.; Waud, William R.; Piazza, Gary A.; Li, Yonghe			Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/beta-Catenin Pathway	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; COLORECTAL-CANCER; BETA-CATENIN; SIGNAL-TRANSDUCTION; COLON-CANCER; CYCLIN D1; ACTIVATION; EXPRESSION; APOPTOSIS; TUMORIGENESIS	The Wnt/beta-catenin signaling pathway is important for tumor initiation and progression. The low density lipoprotein receptor-related protein-6 (LRP6) is an essential Wnt co-receptor for Wnt/beta-catenin signaling and represents a promising anticancer target. Recently, the antihelminthic drug, niclosamide was found to inhibit Wnt/beta-catenin signaling, although the mechanism was not well defined. We found that niclosamide was able to suppress LRP6 expression and phosphorylation, block Wnt3A-induced beta-catenin accumulation, and inhibit Wnt/beta-catenin signaling in HEK293 cells. Furthermore, the inhibitory effects of niclosamide on LRP6 expression/phosphorylation and Wnt/beta-catenin signaling were conformed in human prostate PC-3 and DU145 and breast MDA-MB-231 and T-47D cancer cells. Moreover, we showed that the mechanism by which niclosamide suppressed LRP6 resulted from increased degradation as evident by a shorter half-life. Finally, we demonstrated that niclosamide was able to induce cancer cell apoptosis, and displayed excellent anticancer activity with IC(50) values less than 1 mu M for prostate PC-3 and DU145 and breast MDA-MB-231 and T-47D cancer cells. The IC(50) values are comparable to those shown to suppress the activities of Wnt/beta-catenin signaling in prostate and breast cancer cells. Our data indicate that niclosamide is a unique small molecule Wnt/beta-catenin signaling inhibitor targeting the Wnt co-receptor LRP6 on the cell surface, and that niclosamide has a potential to be developed a novel chemopreventive or therapeutic agent for human prostate and breast cancer.	[Lu, Wenyan; Lin, Cuihong; Li, Yonghe] So Res Inst, Drug Discovery Div, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA; [Roberts, Michael J.] So Res Inst, Drug Dev Div, Dept Cell Biol & Immunol, Birmingham, AL 35255 USA; [Waud, William R.] So Res Inst, Drug Dev Div, Dept Canc Therapeut, Birmingham, AL 35255 USA; [Piazza, Gary A.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA	University of South Alabama	Lu, WY (corresponding author), So Res Inst, Drug Discovery Div, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA.	y.li@southernresearch.org		Piazza, Gary/0000-0003-4418-887X	National Institutes of Health [RO1CA124531]; NATIONAL CANCER INSTITUTE [R01CA124531] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health (RO1CA124531; to Y.L.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Craig P, 2007, CURR OPIN INFECT DIS, V20, P524, DOI 10.1097/QCO.0b013e3282ef579e; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; King TD, 2011, J CELL BIOC IN PRESS; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Lin CH, 2011, FEBS LETT, V585, P3120, DOI 10.1016/j.febslet.2011.08.046; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Lu WY, 2008, FEBS LETT, V582, P643, DOI 10.1016/j.febslet.2008.01.035; Lu WY, 2010, BIOCHEMISTRY-US, V49, P4635, DOI 10.1021/bi1001486; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Merschiohann K, 2008, EXP PARASITOL, V118, P637, DOI 10.1016/j.exppara.2007.12.001; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rey JP, 2010, DEV DYNAM, V239, P102, DOI 10.1002/dvdy.22181; Sack U, 2011, JNCI-J NATL CANCER I, V103, P1018, DOI 10.1093/jnci/djr190; Shi YH, 2007, INT J CANCER, V121, P1175, DOI 10.1002/ijc.22848; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tanowitz H B, 1993, Gastroenterologist, V1, P265; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; Ueno K, 2008, NEOPLASIA, V10, P697, DOI 10.1593/neo.08320; Valkenburg Kenneth C, 2011, Cancers (Basel), V3, P2050, DOI 10.3390/cancers3022050; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yang L, 2011, ONCOGENE; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339	50	156	161	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29290	10.1371/journal.pone.0029290	http://dx.doi.org/10.1371/journal.pone.0029290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195040	gold, Green Published, Green Submitted			2022-12-25	WOS:000298664400044
J	Bordenstein, SR; Bordenstein, SR				Bordenstein, Sarah R.; Bordenstein, Seth R.			Temperature Affects the Tripartite Interactions between Bacteriophage WO, Wolbachia, and Cytoplasmic Incompatibility	PLOS ONE			English	Article							WASP NASONIA-VITRIPENNIS; INFECTION DENSITY; DROSOPHILA; DNA; EVOLUTION; BACTERIUM; SYMBIONT; SEQUENCE; DAMAGE; SPERM	Wolbachia infections are a model for understanding intracellular, bacterial symbioses. While the symbiosis is often studied from a binary perspective of host and bacteria, it is increasingly apparent that additional trophic levels can influence the symbiosis. For example, Wolbachia in arthropods harbor a widespread temperate bacteriophage, termed WO, that forms virions and rampantly transfers between coinfections. Here we test the hypothesis that temperatures at the extreme edges of an insect's habitable range alter bacteriophage WO inducibility and in turn, Wolbachia densities and the penetrance of cytoplasmic incompatibility. We report four key findings using the model wasp, Nasonia vitripennis: First, both cold treatment at 18 C and heat treatment at 30 C reduce Wolbachia densities by as much as 74% relative to wasps reared at 25 C. Second, in all cases where Wolbachia densities decline due to temperature changes, phage WO densities increase and inversely associate with Wolbachia densities. Heat has a marked effect on phage WO, yielding phage densities that are 552% higher than the room temperature control. Third, there is a significant affect of insect family on phage WO and endoysmbiont densities. Fourth, at extreme temperatures, there was a temperature-mediated adjustment to the density threshold at which Wolbachia cause complete cytoplasmic incompatibility. Taken together, these results demonstrate that temperature simultaneously affects phage WO densities, endosymbiont densities, and the penetrance of cytoplasmic incompatibility. While temperature shock enhances bacteriophage inducibility and the ensuing bacterial mortality in a wide range of medically and industrially-important bacteria, this is the first investigation of the associations in an obligate intracellular bacteria. Implications to a SOS global sensing feedback mechanism in Wolbachia are discussed.	[Bordenstein, Sarah R.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Bordenstein, SR (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	s.bordenstein@vanderbilt.edu			NSF [IOS-0852344]; NIH [RO1 GM085163]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085163] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NSF IOS-0852344 and NIH RO1 GM085163 to SRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbutsu H, 2008, APPL ENVIRON MICROB, V74, P6053, DOI 10.1128/AEM.01503-08; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; Bordenstein SR, 2005, NAT REV MICROBIOL, V3, P688, DOI 10.1038/nrmicro1233; Bordenstein SR, 1998, GENETICS, V148, P1833; Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211; BREEUWER JAJ, 1993, GENETICS, V135, P565; Brentlinger KL, 2002, J BACTERIOL, V184, P1089, DOI 10.1128/jb.184.4.1089-1094.2002; Chafee ME, 2011, GENETICS, V187, P203, DOI 10.1534/genetics.110.120675; Chafee ME, 2010, MOL BIOL EVOL, V27, P501, DOI 10.1093/molbev/msp275; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761; Clark ME, 2008, HEREDITY, V101, P420, DOI 10.1038/hdy.2008.71; Degnan PH, 2008, MOL ECOL, V17, P916, DOI 10.1111/j.1365-294X.2007.03616.x; Fujii Y, 2004, BIOCHEM BIOPH RES CO, V317, P1183, DOI 10.1016/j.bbrc.2004.03.164; Gavotte L, 2007, MOL BIOL EVOL, V24, P427, DOI 10.1093/molbev/msl171; Grassberger M, 2003, MED VET ENTOMOL, V17, P257, DOI 10.1046/j.1365-2915.2003.00439.x; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hsia RC, 2000, MICROBES INFECT, V2, P761, DOI 10.1016/S1286-4579(00)90356-3; Hurst GDD, 2000, GENETICS, V156, P699; Jaenike J, 2009, OIKOS, V118, P353, DOI 10.1111/j.1600-0706.2008.17110.x; Kent BN, 2011, GENOME BIOL EVOL, V3, P209, DOI 10.1093/gbe/evr007; Kent BN, 2010, TRENDS MICROBIOL, V18, P173, DOI 10.1016/j.tim.2009.12.011; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Newton ILG, 2011, CURR MICROBIOL, V62, P198, DOI 10.1007/s00284-010-9693-3; Noda H, 2001, INSECT BIOCHEM MOLEC, V31, P727, DOI 10.1016/S0965-1748(00)00180-6; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; PerrotMinnot MJ, 1996, GENETICS, V143, P961; Reynolds KT, 2003, GENETICS, V164, P1027; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Sanogo YO, 2006, INSECT BIOCHEM MOLEC, V36, P80, DOI 10.1016/j.ibmb.2005.11.001; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; SAUER RT, 1982, J BIOL CHEM, V257, P4458; Shinagawa H, 1996, EXS, V77, P221; Snook RR, 2000, GENETICS, V155, P167; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; Wei W, 2008, P NATL ACAD SCI USA, V105, P11827, DOI 10.1073/pnas.0805237105; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; WERREN JH, 2009, CSH PROTOC; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069	41	72	76	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29106	10.1371/journal.pone.0029106	http://dx.doi.org/10.1371/journal.pone.0029106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194999	Green Published, gold, Green Submitted			2022-12-25	WOS:000298370400031
J	Baebler, S; Stare, K; Kovac, M; Blejec, A; Prezelj, N; Stare, T; Kogovsek, P; Pompe-Novak, M; Rosahl, S; Ravnikar, M; Gruden, K				Baebler, Spela; Stare, Katja; Kovac, Maja; Blejec, Andrej; Prezelj, Nina; Stare, Tjasa; Kogovsek, Polona; Pompe-Novak, Marusa; Rosahl, Sabine; Ravnikar, Maja; Gruden, Kristina			Dynamics of Responses in Compatible Potato - Potato virus Y Interaction Are Modulated by Salicylic Acid	PLOS ONE			English	Article							GENE-EXPRESSION; DEFENSE-MECHANISMS; SOLANUM-TUBEROSUM; NTN INFECTION; REAL-TIME; PLANTS; RESISTANCE; CARBOHYDRATE; LEAVES; GENOTYPES	To investigate the dynamics of the potato - Potato virus Y (PVY) compatible interaction in relation to salicylic acid - controlled pathways we performed experiments using non-transgenic potato cv. Desiree, transgenic NahG-Desiree, cv. Igor and PVYNTN, the most aggressive strain of PVY. The importance of salicylic acid in viral multiplication and symptom development was confirmed by pronounced symptom development in NahG-Desiree, depleted in salicylic acid, and reversion of the effect after spraying with 2,6-dichloroisonicotinic acid (a salicylic acid - analogue). We have employed quantitative PCR for monitoring virus multiplication, as well as plant responses through expression of selected marker genes of photosynthetic activity, carbohydrate metabolism and the defence response. Viral multiplication was the slowest in inoculated potato of cv. Desiree, the only asymptomatic genotype in the study. The intensity of defence-related gene expression was much stronger in both sensitive genotypes (NahG-Desiree and cv. Igor) at the site of inoculation than in asymptomatic plants (cv. Desiree). Photosynthesis and carbohydrate metabolism gene expression differed between the symptomatic and asymptomatic phenotypes. The differential gene expression pattern of the two sensitive genotypes indicates that the outcome of the interaction does not rely simply on one regulatory component, but similar phenotypical features can result from distinct responses at the molecular level.	[Baebler, Spela; Stare, Katja; Kovac, Maja; Blejec, Andrej; Prezelj, Nina; Stare, Tjasa; Kogovsek, Polona; Pompe-Novak, Marusa; Ravnikar, Maja; Gruden, Kristina] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia; [Rosahl, Sabine] Leibniz Inst Plant Biochem, Dept Stress & Dev Biol, Halle, Saale, Germany	National Institute of Biology - Slovenia; Leibniz Institut fur Pflanzenbiochemie	Baebler, S (corresponding author), Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia.	spela.baebler@nib.si	Blejec, Andrej/M-5215-2019; Blejec, Andrej/A-8470-2010; Gruden, kristina/AAI-6439-2020; Baebler, Spela/D-1486-2010	Blejec, Andrej/0000-0001-7484-6031; Blejec, Andrej/0000-0001-7484-6031; Baebler, Spela/0000-0003-4776-7164; Prezelj, Nina/0000-0002-0500-8699; gruden, kristina/0000-0001-5906-8569; Ravnikar, Maja/0000-0002-6630-1362; Kogovsek, Polona/0000-0002-4035-0115; Pompe Novak, Marusa/0000-0003-4176-849X	Slovenian Research Agency [P4 0165, J4-2228]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The work was supported by the Slovenian Research Agency (http://www.arrs.gov.si/en/dobrodoslica.asp; grant Nos.: P4 0165, J4-2228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamillo JM, 2006, PLANT J, V48, P217, DOI 10.1111/j.1365-313X.2006.02861.x; Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Baebler S, 2009, MOL PLANT PATHOL, V10, P263, DOI 10.1111/j.1364-3703.2008.00530.x; Beffa RS, 1996, PLANT CELL, V8, P1001, DOI 10.1105/tpc.8.6.1001; COQUOZ JL, 1995, PHYTOPATHOLOGY, V85, P1219, DOI 10.1094/Phyto-85-1219; Garcia-Marcos A, 2009, MOL PLANT MICROBE IN, V22, P1431, DOI 10.1094/MPMI-22-11-1431; Halim VA, 2004, PHYSIOL MOL PLANT P, V64, P311, DOI 10.1016/j.pmpp.2004.10.003; Halim VA, 2007, MOL PLANT MICROBE IN, V20, P1346, DOI 10.1094/MPMI-20-11-1346; Handford MG, 2007, J GEN VIROL, V88, P337, DOI 10.1099/vir.0.82376-0; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Herbers K, 2000, MOL PLANT PATHOL, V1, P51, DOI 10.1046/j.1364-3703.2000.00007.x; Hoegen E, 2002, MOL PLANT PATHOL, V3, P329, DOI 10.1046/j.1364-3703.2002.00126.x; Hren M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-460; Huang ZL, 2005, PLANT PHYSIOL, V137, P1147, DOI 10.1104/pp.104.056028; Iglesias VA, 2000, PLANT J, V21, P157, DOI 10.1046/j.1365-313x.2000.00658.x; Kogovsek P, 2008, J VIROL METHODS, V149, P1, DOI 10.1016/j.jviromet.2008.01.025; Kogovsek P, 2010, PLANT PATHOL, V59, P1121, DOI 10.1111/j.1365-3059.2010.02340.x; Komatsu K, 2010, MOL PLANT MICROBE IN, V23, P283, DOI 10.1094/MPMI-23-3-0283; Krecic-Stres H, 2005, PLANT PATHOL, V54, P441, DOI 10.1111/j.1365-3059.2005.01209.x; Lewsey M, 2009, ANNU PLANT REV, V34, P134, DOI 10.1111/b.9781405175326.2009.00006.x; LINTHORST HJM, 1990, P NATL ACAD SCI USA, V87, P8756, DOI 10.1073/pnas.87.22.8756; Milavec M, 2001, PLANT PHYSIOL BIOCH, V39, P891, DOI 10.1016/S0981-9428(01)01303-1; Naderi M, 1997, PHYSIOL MOL PLANT P, V51, P41, DOI 10.1006/pmpp.1997.0101; Navarre DA, 2004, PHYSIOL MOL PLANT P, V64, P179, DOI 10.1016/j.pmpp.2004.09.001; Naylor M, 1998, MOL PLANT MICROBE IN, V11, P860, DOI 10.1094/MPMI.1998.11.9.860; Nie Xianzhou, 2006, Phytopathology, V96, P255, DOI 10.1094/PHYTO-96-0255; Oufir M, 2008, PLANT SCI, V175, P839, DOI 10.1016/j.plantsci.2008.08.010; Pompe-Novak M, 2001, PHYTON-ANN REI BOT A, V41, P215; Pompe-Novak M, 2005, PHYSIOL MOL PLANT P, V67, P237, DOI 10.1016/j.pmpp.2006.02.005; Radwan DEM, 2007, PLANT PHYSIOL BIOCH, V45, P480, DOI 10.1016/j.plaphy.2007.03.002; Sanchez G, 2010, MOL PLANT MICROBE IN, V23, P394, DOI 10.1094/MPMI-23-4-0394; Shalitin D, 2000, PLANT PHYSIOL, V123, P597, DOI 10.1104/pp.123.2.597; Singh DP, 2004, MOL PLANT PATHOL, V5, P57, DOI 10.1111/j.1364-3703.2004.00203.x; Singh RP, 2008, ARCH VIROL, V153, P1, DOI 10.1007/s00705-007-1059-1; Synkova H, 2006, PLANT SCI, V171, P607, DOI 10.1016/j.plantsci.2006.06.002; Vlot AC, 2008, CURR OPIN PLANT BIOL, V11, P436, DOI 10.1016/j.pbi.2008.05.003; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Vuorinen AL, 2010, ANN APPL BIOL, V157, P229, DOI 10.1111/j.1744-7348.2010.00424.x; Wang SD, 2011, PLANTA, V234, P171, DOI 10.1007/s00425-011-1391-2; WARD ER, 1991, PLANT PHYSIOL, V96, P390, DOI 10.1104/pp.96.2.390; Weller SA, 2000, APPL ENVIRON MICROB, V66, P2853, DOI 10.1128/AEM.66.7.2853-2858.2000; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Yang CL, 2007, MOL PLANT MICROBE IN, V20, P358, DOI 10.1094/MPMI-20-4-0358; Yu DQ, 1997, PLANT PHYSIOL, V115, P343, DOI 10.1104/pp.115.2.343; Zhou YH, 2004, PHOTOSYNTHETICA, V42, P417, DOI 10.1023/B:PHOT.0000046161.16215.dd	47	60	64	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29009	10.1371/journal.pone.0029009	http://dx.doi.org/10.1371/journal.pone.0029009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194976	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100140
J	Belu, M; Mizutani, CM				Belu, Mirela; Mizutani, Claudia M.			Variation in Mesoderm Specification across Drosophilids Is Compensated by Different Rates of Myoblast Fusion during Body Wall Musculature Development	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; MUSCLE DEVELOPMENT; HOMEOBOX GENE; IDENTIFIED NEUROBLASTS; EMBRYONIC-DEVELOPMENT; COLUMN IDENTITY; FLY DROSOPHILA; CELL FATES; EXPRESSION	Background: It has been shown that species separated by relatively short evolutionary distances may have extreme variations in egg size and shape. Those variations are expected to modify the polarized morphogenetic gradients that pattern the dorso-ventral axis of embryos. Currently, little is known about the effects of scaling over the embryonic architecture of organisms. We began examining this problem by asking if changes in embryo size in closely related species of Drosophila modify all three dorso-ventral germ layers or only particular layers, and whether or not tissue patterning would be affected at later stages. Principal Findings: Here we report that changes in scale affect predominantly the mesodermal layer at early stages, while the neuroectoderm remains constant across the species studied. Next, we examined the fate of somatic myoblast precursor cells that derive from the mesoderm to test whether the assembly of the larval body wall musculature would be affected by the variation in mesoderm specification. Our results show that in all four species analyzed, the stereotyped organization of the body wall musculature is not disrupted and remains the same as in D. melanogaster. Instead, the excess or shortage of myoblast precursors is compensated by the formation of individual muscle fibers containing more or less fused myoblasts. Conclusions: Our data suggest that changes in embryonic scaling often lead to expansions or retractions of the mesodermal domain across Drosophila species. At later stages, two compensatory cellular mechanisms assure the formation of a highly stereotyped larval somatic musculature: an invariable selection of 30 muscle founder cells per hemisegment, which seed the formation of a complete array of muscle fibers, and a variable rate in myoblast fusion that modifies the number of myoblasts that fuse to individual muscle fibers.	[Belu, Mirela; Mizutani, Claudia M.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Mizutani, Claudia M.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Belu, M (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.	claudia.mizutani@case.edu			National Science Foundation [IOS-1051662]; College of Arts and Sciences of Case Western Reserve University	National Science Foundation(National Science Foundation (NSF)); College of Arts and Sciences of Case Western Reserve University	This work was supported by a National Science Foundation grant number IOS-1051662 to CM and Startup Funds provided by the College of Arts and Sciences of Case Western Reserve University to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MS, 1988, J NEUROSCI, V8, P242; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183; Bataille L, 2010, DEV CELL, V19, P317, DOI 10.1016/j.devcel.2010.07.008; BATE M, 1990, DEVELOPMENT, V110, P791; Bate Michael, 1993, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V316, P1047; Bate Michael, 1993, P1013; BODMER R, 1993, DEVELOPMENT, V118, P719; Borkowski OMD, 1995, DEVELOPMENT, V121, P4183; BOULAY JL, 1987, NATURE, V330, P395, DOI 10.1038/330395a0; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; Capovilla M, 2001, DEVELOPMENT, V128, P1221; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cunha PMF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001014; Demontis F, 2009, DEVELOPMENT, V136, P983, DOI 10.1242/dev.027466; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; DOE CQ, 1992, DEVELOPMENT, V116, P855; Estrada Beatriz, 2008, V475, P299, DOI 10.1007/978-1-59745-250-2_17; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Furlong EE, 2004, CURR OPIN GENET DEV, V14, P343, DOI 10.1016/j.gde.2004.06.011; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Guruharsha KG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006960; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Isshiki T, 1997, DEVELOPMENT, V124, P3099; JIMENEZ F, 1995, EMBO J, V14, P3487, DOI 10.1002/j.1460-2075.1995.tb07355.x; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Junion G, 2007, GENE DEV, V21, P3163, DOI 10.1101/gad.437307; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Landgraf M, 1997, J NEUROSCI, V17, P9642; Liberman LM, 2009, DEV BIOL, V327, P578, DOI 10.1016/j.ydbio.2008.12.020; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Lott SE, 2007, P NATL ACAD SCI USA, V104, P10926, DOI 10.1073/pnas.0701359104; Markow TA, 2009, J EVOLUTION BIOL, V22, P430, DOI 10.1111/j.1420-9101.2008.01649.x; MARTINBERMUDO MD, 1993, DEVELOPMENT, V118, P1003; McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603; Mellerick DM, 2002, J NEUROBIOL, V50, P118, DOI 10.1002/neu.10022; Mizutani CM, 2008, NAT REV GENET, V9, P663, DOI 10.1038/nrg2417; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Oda H, 2008, DEV GROWTH DIFFER, V50, P203, DOI [10.1111/j.1440-169X.2008.00998.x, 10.1111/j.1440-169x.2008.00998.x]; Orgogozo V, 2007, EVOL DEV, V9, P368, DOI 10.1111/j.1525-142X.2007.00174.x; Paululat A, 1999, CELL TISSUE RES, V296, P151, DOI 10.1007/s004410051276; POWELL JR, 1997, PROGR PROSPECTS EVOL, V14; Riechmann V, 1997, DEVELOPMENT, V124, P2915; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Sackton TB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000797; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Sousa-Neves R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010485; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Tixier V, 2010, EXP CELL RES, V316, P3019, DOI 10.1016/j.yexcr.2010.07.013; Ungerer P, 2008, P ROY SOC B-BIOL SCI, V275, P369, DOI 10.1098/rspb.2007.1391; Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Whitington PM, 1996, SEMIN CELL DEV BIOL, V7, P605, DOI 10.1006/scdb.1996.0074	67	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28970	10.1371/journal.pone.0028970	http://dx.doi.org/10.1371/journal.pone.0028970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194964	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100134
J	Chan, CX; Reyes-Prieto, A; Bhattacharya, D				Chan, Cheong Xin; Reyes-Prieto, Adrian; Bhattacharya, Debashish			Red and Green Algal Origin of Diatom Membrane Transporters: Insights into Environmental Adaptation and Cell Evolution	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PHOTOSYNTHETIC EUKARYOTES; CYANIDIOSCHYZON-MEROLAE; GALDIERIA-SULPHURARIA; GENOME SEQUENCE; PROTEIN; REVEALS; TREE; DINOFLAGELLATE; ENDOSYMBIOSIS	Membrane transporters (MTs) facilitate the movement of molecules between cellular compartments. The evolutionary history of these key components of eukaryote genomes remains unclear. Many photosynthetic microbial eukaryotes (e. g., diatoms, haptophytes, and dinoflagellates) appear to have undergone serial endosymbiosis and thereby recruited foreign genes through endosymbiotic/horizontal gene transfer (E/HGT). Here we used the diatoms Thalassiosira pseudonana and Phaeodactylum tricornutum as models to examine the evolutionary origin of MTs in this important group of marine primary producers. Using phylogenomics, we used 1,014 diatom MTs as query against a broadly sampled protein sequence database that includes novel genome data from the mesophilic red algae Porphyridium cruentum and Calliarthron tuberculosum, and the stramenopile Ectocarpus siliculosus. Our conservative approach resulted in 879 maximum likelihood trees of which 399 genes show a non-lineal history between diatoms and other eukaryotes and prokaryotes (at the bootstrap value >= 70%). Of the eukaryote-derived MTs, 172 (ca. 25% of 697 examined phylogenies) have members of both red/green algae as sister groups, with 103 putatively arising from green algae, 19 from red algae, and 50 have an unresolved affiliation to red and/or green algae. We used topology tests to analyze the most convincing cases of non-lineal gene history in which red and/or green algae were nested within stramenopiles. This analysis showed that ca. 6% of all trees (our most conservative estimate) support an algal origin of MTs in stramenopiles with the majority derived from green algae. Our findings demonstrate the complex evolutionary history of photosynthetic eukaryotes and indicate a reticulate origin of MT genes in diatoms. We postulate that the algal-derived MTs acquired via E/HGT provided diatoms and other related microbial eukaryotes the ability to persist under conditions of fluctuating ocean chemistry, likely contributing to their great success in marine environments.	Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Chan, CX (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	bhattacharya@aesop.rutgers.edu	Chan, Cheong Xin/A-7005-2008	Chan, Cheong Xin/0000-0002-3729-8176	National Institutes of Health [R01-ES013679-01A2]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially supported by grant from the National Institutes of Health (R01-ES013679-01A2) to DB. We also acknowledge generous support from Rutgers University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Barbier G, 2005, PLANT PHYSIOL, V137, P460, DOI 10.1104/pp.104.051169; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; CAVALIERSMITH T, 1986, PROGR PHYCOLOGICAL R, V14, P461; Chan CX, 2011, J BACTERIOL, V193, P3964, DOI 10.1128/JB.01524-10; Chan CX, 2011, CURR BIOL, V21, P328, DOI 10.1016/j.cub.2011.01.037; Chan CX, 2009, GENOME BIOL EVOL, V1, P429, DOI 10.1093/gbe/evp044; Chan CX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004524; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dahl SG, 2004, J PHARMACOL EXP THER, V309, P853, DOI 10.1124/jpet.103.059972; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2009, BIOESSAYS, V31, P1273, DOI 10.1002/bies.200900117; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Frommolt R, 2008, MOL BIOL EVOL, V25, P2653, DOI 10.1093/molbev/msn206; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Gschloessl B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-393; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hackett Jeremiah D., 2008, P48; Hanikenne M, 2005, PLANT PHYSIOL, V137, P428, DOI 10.1104/pp.104.054189; Huysman MJJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r17; Inagaki Y, 2006, P NATL ACAD SCI USA, V103, P4528, DOI 10.1073/pnas.0600744103; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Kamp A, 2011, P NATL ACAD SCI USA, V108, P5649, DOI 10.1073/pnas.1015744108; Kang LK, 2011, APPL ENVIRON MICROB, V77, P122, DOI 10.1128/AEM.01315-10; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; Li SL, 2006, MOL BIOL EVOL, V23, P663, DOI 10.1093/molbev/msj075; Linka M, 2008, PLANT PHYSIOL, V148, P1487, DOI 10.1104/pp.108.129478; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant S, 1998, ANNU REV PLANT PHYS, V49, P25, DOI 10.1146/annurev.arplant.49.1.25; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Moustafa A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-6; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Niklas KJ, 2010, NEW PHYTOL, V185, P27, DOI 10.1111/j.1469-8137.2009.03054.x; Nikoh N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-12; Nosenko T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-173; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Sanchez-Puerta MV, 2007, PROTIST, V158, P105, DOI 10.1016/j.protis.2006.09.004; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Weber APM, 2006, EUKARYOT CELL, V5, P609, DOI 10.1128/EC.5.3.609-612.2006; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	68	33	33	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29138	10.1371/journal.pone.0029138	http://dx.doi.org/10.1371/journal.pone.0029138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195008	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100161
J	Culleton, R; Coban, C; Zeyrek, FY; Cravo, P; Kaneko, A; Randrianarivelojosia, M; Andrianaranjaka, V; Kano, S; Farnert, A; Arez, AP; Sharp, PM; Carter, R; Tanabe, K				Culleton, Richard; Coban, Cevayir; Zeyrek, Fadile Yildiz; Cravo, Pedro; Kaneko, Akira; Randrianarivelojosia, Milijaona; Andrianaranjaka, Voahangy; Kano, Shigeyuki; Farnert, Anna; Arez, Ana Paula; Sharp, Paul M.; Carter, Richard; Tanabe, Kazuyuki			The Origins of African Plasmodium vivax; Insights from Mitochondrial Genome Sequencing	PLOS ONE			English	Article							NEGATIVE INDIVIDUALS; MALARIA; FALCIPARUM; GENE; POPULATION; ANTIGEN; EXPRESSION; EXPANSION; HUMANS; SYSTEM	Plasmodium vivax, the second most prevalent of the human malaria parasites, is estimated to affect 75 million people annually. It is very rare, however, in west and central Africa, due to the high prevalence of the Duffy negative phenotype in the human population. Due to its rarity in Africa, previous studies on the phylogeny of world-wide P. vivax have suffered from insufficient samples of African parasites. Here we compare the mitochondrial sequence diversity of parasites from Africa with those from other areas of the world, in order to investigate the origin of present-day African P. vivax. Mitochondrial genome sequencing revealed relatively little polymorphism within the African population compared to parasites from the rest of the world. This, combined with sequence similarity with parasites from India, suggests that the present day African P. vivax population in humans may have been introduced relatively recently from the Indian subcontinent. Haplotype network analysis also raises the possibility that parasites currently found in Africa and South America may be the closest extant relatives of the ancestors of the current world population. Lines of evidence are adduced that this ancestral population may be from an ancient stock of P. vivax in Africa.	[Culleton, Richard; Tanabe, Kazuyuki] Osaka Univ, Lab Malariol, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Osaka, Japan; [Culleton, Richard] Nagasaki Univ, Inst Trop Med, Malaria Unit, Nagasaki 852, Japan; [Coban, Cevayir] Osaka Univ, World Premier Inst Immunol, Lab Malaria Immunol, Immunol Frontier Res Ctr, Osaka, Japan; [Zeyrek, Fadile Yildiz] Harran Univ, Sch Med, Dept Microbiol, Sanliurfa, Turkey; [Cravo, Pedro; Arez, Ana Paula] Univ Nova Lisboa, Unidade Parasitol, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal; [Cravo, Pedro] Inst Patol Trop & Saude Publ CAPES PVE, Goiania, Go, Brazil; [Kaneko, Akira; Farnert, Anna] Karolinska Univ Hosp, Dept Med, Solna, Sweden; [Randrianarivelojosia, Milijaona; Andrianaranjaka, Voahangy] Inst Pasteur Madagascar, Unite Reserche Paludisme, Antananarivo, Madagascar; [Kano, Shigeyuki] Int Med Ctr Japan, Res Inst, Tokyo, Japan; [Sharp, Paul M.; Carter, Richard] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland	Osaka University; Nagasaki University; Osaka University; Harran University; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Karolinska Institutet; Karolinska University Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; National Center for Global Health & Medicine - Japan; University of Edinburgh	Culleton, R (corresponding author), Osaka Univ, Lab Malariol, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Osaka, Japan.	richard@nagasaki-u.ac.jp; kztanabe@biken.osaka-u.ac.jp	Cravo, Pedro VL/G-3532-2012; Cravo, Pedro/AET-0639-2022; Sharp, Paul M/F-5783-2010; ZEYREK, FADİLE YILDIZ/AAA-5368-2021; Arez, Ana Paula/I-1729-2012; Sharp, Paul/Y-3787-2019; Coban, Cevayir/B-2129-2012; COBAN, Cevayir/P-1928-2019; Sharp, Paul M/GPX-1497-2022; Culleton, Richard/H-8327-2014	Cravo, Pedro VL/0000-0003-1675-4504; Cravo, Pedro/0000-0003-1675-4504; Sharp, Paul M/0000-0001-9771-543X; Arez, Ana Paula/0000-0002-0497-6532; COBAN, Cevayir/0000-0002-4467-7799; Sharp, Paul M/0000-0001-9771-543X; Culleton, Richard/0000-0001-8808-5771; Farnert, Anna/0000-0001-7583-282X; Randrianarivelojosia, Milijaona/0000-0003-2767-0349; , Akira/0000-0003-2411-3352	Japanese Ministry of Education, Culture, Sports, Science and Technology [18073013]; Japan Society for the Promotion of Science (JSPS) [17-05495, 18390131, 18GS03140013]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research on Priority Areas from The Japanese Ministry of Education, Culture, Sports, Science and Technology (18073013) and Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (17-05495, 18390131, 18GS03140013). CC and FYZ were supported by a JSPS bilateral research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; [Anonymous], AM J TROP MED HYG, DOI DOI 10.4269/AJTMH.2006.75.790; Carter R, 2003, TRENDS PARASITOL, V19, P214, DOI 10.1016/S1471-4922(03)00070-9; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; CAVALLISFORZA LL, 1994, AFRICA HIST GEOGRAPH, P158; Cavasini CE, 2007, T ROY SOC TROP MED H, V101, P1042, DOI 10.1016/j.trstmh.2007.04.011; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornejo OE, 2006, TRENDS PARASITOL, V22, P558, DOI 10.1016/j.pt.2006.09.007; Culleton R, 2009, J INFECT DIS, V200, P1465, DOI 10.1086/644510; Culleton RL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-174; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; HADLEY TJ, 1994, J CLIN INVEST, V94, P985, DOI 10.1172/JCI117465; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Horuk R, 1997, J IMMUNOL, V158, P2882; Jongwutiwes S, 2005, MOL BIOL EVOL, V22, P1733, DOI 10.1093/molbev/msi168; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Nei M., 1987, MOL EVOLUTIONARY GEN; Pease JE, 1998, SEMIN IMMUNOL, V10, P169, DOI 10.1006/smim.1998.0129; Sakihama N, 2006, AM J TROP MED HYG, V74, P31, DOI 10.4269/ajtmh.2006.74.31; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224	27	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29137	10.1371/journal.pone.0029137	http://dx.doi.org/10.1371/journal.pone.0029137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195007	Green Published, gold			2022-12-25	WOS:000298369100160
J	Posch, MG; Waldmuller, S; Muller, M; Scheffold, T; Fournier, D; Andrade-Navarro, MA; De Geeter, B; Guillaumont, S; Dauphin, C; Yousseff, D; Schmitt, KR; Perrot, A; Berger, F; Hetzer, R; Bouvagnet, P; Ozcelik, C				Posch, Maximilian G.; Waldmuller, Stephan; Mueller, Melanie; Scheffold, Thomas; Fournier, David; Andrade-Navarro, Miguel A.; De Geeter, Bernard; Guillaumont, Sophie; Dauphin, Claire; Yousseff, Dany; Schmitt, Katharina R.; Perrot, Andreas; Berger, Felix; Hetzer, Roland; Bouvagnet, Patrice; Oezcelik, Cemil			Cardiac Alpha-Myosin (MYH6) Is the Predominant Sarcomeric Disease Gene for Familial Atrial Septal Defects	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; HYPERTROPHIC CARDIOMYOPATHY; HEAVY-CHAIN; DILATED CARDIOMYOPATHY; VENTRICULAR MYOCARDIUM; MUTATIONS; RECURRENCE; PHENOTYPES; MYBPC3; MUSCLE	Secundum-type atrial septal defects (ASDII) account for approximately 10% of all congenital heart defects (CHD) and are associated with a familial risk. Mutations in transcription factors represent a genetic source for ASDII. Yet, little is known about the role of mutations in sarcomeric genes in ASDII etiology. To assess the role of sarcomeric genes in patients with inherited ASDII, we analyzed 13 sarcomeric genes (MYH7, MYBPC3, TNNT2, TCAP, TNNI3, MYH6, TPM1, MYL2, CSRP3, ACTC1, MYL3, TNNC1, and TTN kinase region) in 31 patients with familial ASDII using array-based resequencing. Genotyping of family relatives and control subjects as well as structural and homology analyses were used to evaluate the pathogenic impact of novel non-synonymous gene variants. Three novel missense mutations were found in the MYH6 gene encoding alpha-myosin heavy chain (R17H, C539R, and K543R). These mutations co-segregated with CHD in the families and were absent in 370 control alleles. Interestingly, all three MYH6 mutations are located in a highly conserved region of the alpha-myosin motor domain, which is involved in myosin-actin interaction. In addition, the cardiomyopathy related MYH6-A1004S and the MYBPC3-A833T mutations were also found in one and two unrelated subjects with ASDII, respectively. No mutations were found in the 11 other sarcomeric genes analyzed. The study indicates that sarcomeric gene mutations may represent a so far underestimated genetic source for familial recurrence of ASDII. In particular, perturbations in the MYH6 head domain seem to play a major role in the genetic origin of familial ASDII.	[Posch, Maximilian G.; Hetzer, Roland] Deutsch Herzzentrum Berlin, Dept Cardiothorac & Vasc Surg, Berlin, Germany; [Posch, Maximilian G.; Perrot, Andreas; Oezcelik, Cemil] Charite, ECRC, D-13353 Berlin, Germany; [Waldmuller, Stephan; Mueller, Melanie; Scheffold, Thomas] Inst Heart & Circulat Res, Dortmund, Germany; [Fournier, David; Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, Computat Biol & Data Min Grp, Berlin, Germany; [De Geeter, Bernard] Clin St Odile, Serv Cardiol, Strasbourg, France; [Guillaumont, Sophie] Inst Marin St Pierre, Palavas Les Flots, France; [Dauphin, Claire] Ctr Hosp Gabriel Montpied, Clermont Ferrand, France; [Yousseff, Dany] Hop Enfants, Vandoeuvre Les Nancy, France; [Schmitt, Katharina R.; Berger, Felix] Deutsch Herzzentrum Berlin, Dept Congenital Heart Dis Pediat Cardiol, Berlin, Germany; [Bouvagnet, Patrice] Hosp Civils Lyon, Lab Cardiogenet, Lyon, France	German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; CHU Clermont Ferrand; CHU de Nancy; German Heart Center Berlin; CHU Lyon	Posch, MG (corresponding author), Deutsch Herzzentrum Berlin, Dept Cardiothorac & Vasc Surg, Berlin, Germany.	posch@dhzb.de	Andrade, Miguel A/B-6565-2008; Schmitt, Katharina Rose Luise/AEU-1004-2022	Andrade, Miguel A/0000-0001-6650-1711; Perrot, Andreas/0000-0002-8800-342X; Berger, Felix/0000-0001-7881-1557	regional PHRC; national PHRC; foundation Renaud Febvre; Competence Network of Heart Failure (CNHF) [01GI0205]; Charite research grants; Collaborative Research Centre [618]; Deutsche Forschungsgemeinschaft (DFG); Helmholtz Alliance on Systems Biology (HGF)	regional PHRC; national PHRC; foundation Renaud Febvre; Competence Network of Heart Failure (CNHF); Charite research grants; Collaborative Research Centre; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Alliance on Systems Biology (HGF)	The "Registre National Francais des Familles de Cardiaques Congenitaux" is supported by grant regional PHRC 2003, national PHRC 2008 and foundation Renaud Febvre. Rajae El Malti and Patrice Bouvagnet are members of the Centre de Reference Maladies Rares des troubles du rythme cardiaque, Lyon, France. Further, the work was funded by the Competence Network of Heart Failure (CNHF; 01GI0205) and Charite research grants. D. F. receives support from the Collaborative Research Centre 618: Theoretical Biology, Robustness, Modularity and Evolutionary Design of Living Systems from the Deutsche Forschungsgemeinschaft (DFG) and M.A.A.-N. from The Helmholtz Alliance on Systems Biology (HGF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alders M, 2003, EUR HEART J, V24, P1848, DOI 10.1016/S0195-668X(03)00466-4; [Anonymous], EXOME VARIANT SERVER; BOUVAGNET P, 1984, CIRC RES, V55, P794, DOI 10.1161/01.RES.55.6.794; BOUVAGNET P, 1987, CIRC RES, V61, P329, DOI 10.1161/01.RES.61.3.329; Budde BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001362; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Granados-Riveron JT, 2010, HUM MOL GENET, V19, P4007, DOI 10.1093/hmg/ddq315; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Matsson H, 2008, HUM MOL GENET, V17, P256, DOI 10.1093/hmg/ddm302; MEDER B, CIRC CARDIOVASC GENE, V4, P110; Monserrat L, 2007, EUR HEART J, V28, P1953, DOI 10.1093/eurheartj/ehm239; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Morner S, 2003, J MOL CELL CARDIOL, V35, P841, DOI 10.1016/S0022-2828(03)00146-9; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Oldfors A, 2007, NEUROMUSCULAR DISORD, V17, P355, DOI 10.1016/j.nmd.2007.02.008; Oyen N, 2009, CIRCULATION, V120, P295, DOI 10.1161/CIRCULATIONAHA.109.857987; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; Posch MG, 2010, CLIN RES CARDIOL, V99, P137, DOI 10.1007/s00392-009-0095-0; Postma AV, 2011, CIRC-CARDIOVASC GENE, V4, P43, DOI 10.1161/CIRCGENETICS.110.957985; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rutland C, 2009, J ANAT, V214, P905, DOI 10.1111/j.1469-7580.2009.01079.x; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Waldmuller S, 2008, CLIN CHEM, V54, P682, DOI 10.1373/clinchem.2007.099119; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098	35	56	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28872	10.1371/journal.pone.0028872	http://dx.doi.org/10.1371/journal.pone.0028872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194935	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100114
J	Walcott, BP; Kuklina, EV; Nahed, BV; George, MG; Kahle, KT; Simard, JM; Asaad, WF; Coumans, JVCE				Walcott, Brian P.; Kuklina, Elena V.; Nahed, Brian V.; George, Mary G.; Kahle, Kristopher T.; Simard, J. Marc; Asaad, Wael F.; Coumans, Jean-Valery C. E.			Craniectomy for Malignant Cerebral Infarction: Prevalence and Outcomes in US Hospitals	PLOS ONE			English	Article							ARTERY INFARCTION; DECOMPRESSIVE HEMICRANIECTOMY; ISCHEMIC-STROKE; MULTICENTER; RECOVERY; SURGERY; TRIAL	Object: Randomized trials have demonstrated the efficacy of craniectomy for the treatment of malignant cerebral edema following ischemic stroke. We sought to determine the prevalence and outcomes related to this by using a national database. Methods: Patient discharges with ischemic stroke as the primary diagnosis undergoing craniectomy were queried from the US Nationwide Inpatient Sample from 1999 to 2008. A subpopulation of patients was identified that underwent thrombolysis. Two primary end points were examined: in-hospital mortality and discharge to home/routine care. To facilitate interpretations, adjusted prevalence was calculated from the overall prevalence and two age-specific logistic regression models. The predictive margin was then generated using a multivariate logistic regression model to estimate the probability of in-hospital mortality after adjustment for admission type, admission source, length of stay, total hospital charges, chronic comorbidities, and medical complications. Results: After excluding 71,996 patients with the diagnosis of intracranial hemorrhage and posterior intracranial circulation occlusion, we identified 4,248,955 adult hospitalizations with ischemic stroke as a primary diagnosis. The estimated rates of hospitalizations in craniectomy per 10,000 hospitalizations with ischemic stroke increased from 3.9 in 1999-2000 to 14.46 in 2007-2008 (p for linear trend<0.001). Patients 60+ years of age had in-hospital mortality of 44% while the 18-59 year old group was found to be 24%(p = 0.14). Outcomes were comparable if recombinant tissue plasminogen activator had been administered. Conclusions: Craniectomy is being increasingly performed for malignant cerebral edema following large territory cerebral ischemia. We suspect that the increase in the annual incidence of DC for malignant cerebral edema is directly related to the expanding collection of evidence in randomized trials that the operation is efficacious when performed in the correct patient population. In hospital mortality is high for all patients undergoing this procedure.	[Walcott, Brian P.; Nahed, Brian V.; Kahle, Kristopher T.; Coumans, Jean-Valery C. E.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Walcott, Brian P.; Nahed, Brian V.; Kahle, Kristopher T.; Coumans, Jean-Valery C. E.] Harvard Univ, Sch Med, Boston, MA USA; [Kuklina, Elena V.; George, Mary G.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Asaad, Wael F.] Brown Univ, Sch Med, Dept Neurosurg, Providence, RI 02912 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Centers for Disease Control & Prevention - USA; University System of Maryland; University of Maryland Baltimore; Brown University	Walcott, BP (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA.	walcott.brian@mgh.harvard.edu	Kuklina, Elena/AAF-3532-2020; Asaad, Wael/I-8485-2012; Nahed, Brian/E-4239-2014	Asaad, Wael/0000-0003-4406-9096; Nahed, Brian/0000-0001-8537-106X; Kuklina, Elena/0000-0002-9686-6495	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082517] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL082517] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Alshekhlee A, 2011, J STROKE CEREBROVASC, V20, P196, DOI 10.1016/j.jstrokecerebrovasdis.2009.11.019; Arac A, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0958; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; Dandy WE, 1937, ANN SURG, V106, P492, DOI 10.1097/00000658-193710000-00002; DELASHAW JB, 1990, STROKE, V21, P874, DOI 10.1161/01.STR.21.6.874; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Foerch C, 2004, J NEUROSURG, V101, P248, DOI 10.3171/jns.2004.101.2.0248; Gasche Y, 2003, ANN FR ANESTH, V22, P312, DOI 10.1016/S0750-7658(03)00069-8; Gupta R, 2004, STROKE, V35, P539, DOI 10.1161/01.STR.0000109772.64650.18; Heo JH, 2005, FREE RADICAL BIO MED, V39, P51, DOI 10.1016/j.freeradbiomed.2005.03.035; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Ingeman Annette, 2010, Clin Epidemiol, V2, P5; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kastrau F, 2005, STROKE, V36, P825, DOI 10.1161/01.STR.0000157595.93115.70; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Kleindorfer D, 2008, STROKE, V39, P924, DOI 10.1161/STROKEAHA.107.490375; KONDZIOLKA D, 1988, NEUROSURGERY, V23, P143, DOI 10.1227/00006123-198808000-00002; Palestrant David, 2005, Curr Neurol Neurosci Rep, V5, P494, DOI 10.1007/s11910-005-0040-1; Pillai A, 2007, J NEUROSURG, V106, P59, DOI 10.3171/jns.2007.106.1.59; Rabinstein AA, 2006, NEUROLOGY, V67, P891, DOI 10.1212/01.wnl.0000233895.03152.66; SCARCELLA G, 1956, J NEURSURG; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schneck MJ, 2008, NEUROSURG CLIN N AM, V19, P459, DOI 10.1016/j.nec.2008.07.016; SCHNECK MJ, 2008, NEUROSURG CLIN N AM, pR19; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Simard JM, 2011, CURR TREAT OPTION NE, V13, P217, DOI 10.1007/s11940-010-0110-9; STEIGER HJ, 1991, ACTA NEUROCHIR, V111, P73, DOI 10.1007/BF01400491; Tong X, 2010, STROKE, V41, P980, DOI 10.1161/STROKEAHA.110.578674; Tsuji K, 2005, STROKE, V36, P1954, DOI 10.1161/01.STR.0000177517.01203.eb; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; Zhu HF, 2008, NEUROLOGY, V71, P283, DOI 10.1212/01.wnl.0000318278.41347.94	37	36	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29193	10.1371/journal.pone.0029193	http://dx.doi.org/10.1371/journal.pone.0029193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195021	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100166
J	Budic, M; Rijavec, M; Petkovsek, Z; Zgur-Bertok, D				Budic, Maruska; Rijavec, Matija; Petkovsek, Ziva; Zgur-Bertok, Darja			Escherichia coli Bacteriocins: Antimicrobial Efficacy and Prevalence among Isolates from Patients with Bacteraemia	PLOS ONE			English	Article							URINARY-TRACT INFECTION; INHIBITORY-ACTIVITY; VIRULENCE FACTORS; MULTIDRUG-RESISTANCE; POSTWEANING DIARRHEA; BIOFILM PRODUCTION; STRAINS; MICROCINS; E1; O157-H7	Bacteriocins are antimicrobial peptides generally active against bacteria closely related to the producer. Escherichia coli produces two types of bacteriocins, colicins and microcins. The in vitro efficacy of isolated colicins E1, E6, E7, K and M, was assessed against Escherichia coli strains from patients with bacteraemia of urinary tract origin. Colicin E7 was most effective, as only 13% of the tested strains were resistant. On the other hand, 32%, 33%, 43% and 53% of the tested strains exhibited resistance to colicins E6, K, M and E1. Moreover, the inhibitory activity of individual colicins E1, E6, E7, K and M and combinations of colicins K, M, E7 and E1, E6, E7, K, M were followed in liquid broth for 24 hours. Resistance against individual colicins developed after 9 hours of treatment. On the contrary, resistance development against the combined action of 5 colicins was not observed. One hundred and five E. coli strains from patients with bacteraemia were screened by PCR for the presence of 5 colicins and 7 microcins. Sixty-six percent of the strains encoded at least one bacteriocin, 43% one or more colicins, and 54% one or more microcins. Microcins were found to co-occur with toxins, siderophores, adhesins and with the Toll/Interleukin-1 receptor domain-containing protein involved in suppression of innate immunity, and were significantly more prevalent among strains from non-immunocompromised patients. In addition, microcins were highly prevalent among non-multidrug-resistant strains compared to multidrug-resistant strains. Our results indicate that microcins contribute to virulence of E. coli instigating bacteraemia of urinary tract origin.	[Budic, Maruska; Rijavec, Matija; Petkovsek, Ziva; Zgur-Bertok, Darja] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia	University of Ljubljana	Budic, M (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia.	darja.zgur.bertok@bf.uni-lj.si		Rijavec, Matija/0000-0002-2596-4952	Slovenian Research Agency [P1-0198]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was financed by grant P1-0198 from the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderluh G, 2003, PROTEIN EXPRES PURIF, V28, P173, DOI 10.1016/S1046-5928(02)00681-2; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Azpiroz MF, 2009, MICROB PATHOGENESIS, V47, P274, DOI 10.1016/j.micpath.2009.09.003; BRADLEY DE, 1991, CAN J MICROBIOL, V37, P97, DOI 10.1139/m91-014; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Cao Z, 2002, BIOCHIMIE, V84, P399, DOI 10.1016/S0300-9084(02)01455-4; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Cooke NM, 2010, J CLIN MICROBIOL, V48, P1099, DOI 10.1128/JCM.02017-09; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Cutler SA, 2007, ANTIMICROB AGENTS CH, V51, P3830, DOI 10.1128/AAC.00360-07; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Gillor O, 2004, ADV APPL MICROBIOL, V54, P129, DOI 10.1016/S0065-2164(04)54005-4; Gordon DM, 2006, MICROBIOL-SGM, V152, P3239, DOI 10.1099/mic.0.28690-0; Gordon DM., 2007, BACTERIOCINS ECOLOGY, P5; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; GYLES CL, 1994, ESCHERICHIA COLI DOM, P151; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Jaureguy F, 2007, CLIN MICROBIOL INFEC, V13, P854, DOI 10.1111/j.1469-0691.2007.01775.x; JOHNSON JR, 1994, CLIN INFECT DIS, V18, P1014, DOI 10.1093/clinids/18.6.1014; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; JOHNSON JR, 1988, INFECT IMMUN, V56, P405, DOI 10.1128/IAI.56.2.405-412.1988; Johnson JR, 2005, J INFECT DIS, V191, P46, DOI 10.1086/426450; Jordi BJAM, 2001, FEMS MICROBIOL LETT, V204, P329, DOI 10.1016/S0378-1097(01)00418-9; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Martinez JA, 2006, J CLIN MICROBIOL, V44, P1468, DOI 10.1128/JCM.44.4.1468-1474.2006; MASLOW JN, 1993, CLIN INFECT DIS, V17, P89, DOI 10.1093/clinids/17.1.89; Murinda SE, 1996, APPL ENVIRON MICROB, V62, P3196, DOI 10.1128/AEM.62.9.3196-3202.1996; Otto G, 2001, CLIN INFECT DIS, V32, P1523, DOI 10.1086/320511; Patton BS, 2007, J FOOD PROTECT, V70, P1256, DOI 10.4315/0362-028X-70.5.1256; Patton BS, 2008, J FOOD PROTECT, V71, P2519, DOI 10.4315/0362-028X-71.12.2519; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Poey ME, 2006, ANTIMICROB AGENTS CH, V50, P1411, DOI 10.1128/AAC.50.4.1411-1418.2006; PUGSLEY AP, 1985, J GEN MICROBIOL, V131, P369; Raggett EM, 1998, MOL MICROBIOL, V28, P1335, DOI 10.1046/j.1365-2958.1998.00899.x; Rijavec M, 2008, J MED MICROBIOL, V57, P1329, DOI 10.1099/jmm.0.2008/002543-0; Rijavec M, 2007, APPL ENVIRON MICROB, V73, P1029, DOI 10.1128/AEM.01780-06; Rijavec M, 2006, CURR MICROBIOL, V53, P158, DOI 10.1007/s00284-005-0501-4; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Schamberger GP, 2004, APPL ENVIRON MICROB, V70, P6053, DOI 10.1128/AEM.70.10.6053-6060.2004; Schamberger GP, 2004, J FOOD PROTECT, V67, P486, DOI 10.4315/0362-028X-67.3.486; Schamberger GP, 2002, J FOOD PROTECT, V65, P1381, DOI 10.4315/0362-028X-65.9.1381; Smajs D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-288; Stahl CH, 2004, ANTIMICROB AGENTS CH, V48, P3119, DOI 10.1128/AAC.48.8.3119-3121.2004; TAGG JR, 1976, BACTERIOL REV, V40, P722, DOI 10.1128/MMBR.40.3.722-756.1976; Toshima H, 2007, EPIDEMIOL INFECT, V135, P110, DOI 10.1017/S0950268806006510; Trautner BW, 2005, J ANTIMICROB CHEMOTH, V56, P413, DOI 10.1093/jac/dki228; Wood A.J., 1996, NEW ENGL J MED, V335, P1445; Zhao LX, 2009, UROLOGY, V74, P702, DOI 10.1016/j.urology.2009.01.042; Zihler A, 2009, LETT APPL MICROBIOL, V49, P31, DOI 10.1111/j.1472-765X.2009.02614.x	51	54	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28769	10.1371/journal.pone.0028769	http://dx.doi.org/10.1371/journal.pone.0028769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205967	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600007
J	Chi, ZX; Liu, RT; Yang, HX; Shen, HM; Wang, J				Chi, Zhenxing; Liu, Rutao; Yang, Hongxu; Shen, Hengmei; Wang, Jing			Binding of Tetracycline and Chlortetracycline to the Enzyme Trypsin: Spectroscopic and Molecular Modeling Investigations	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; RAT EXOCRINE PANCREAS; OXYTETRACYCLINE; ANTIBIOTICS; INHIBITION; SECRETION; SITE	Tetracycline (TC) and chlortetracycline (CTC) are common members of the widely used veterinary drug tetracyclines, the residue of which in the environment can enter human body, being potentially harmful. In this study, we establish a new strategy to probe the binding modes of TC and CTC with trypsin based on spectroscopic and computational modeling methods. Both TC and CTC can interact with trypsin with one binding site to form trypsin-TC (CTC) complex, mainly through van der Waals' interactions and hydrogen bonds with the affinity order: TC>CTC. The bound TC (CTC) can result in inhibition of trypsin activity with the inhibition order: CTC>TC. The secondary structure and the microenvironment of the tryptophan residues of trypsin were also changed. However, the effect of CTC on the secondary structure content of trypsin was contrary to that of TC. Both the molecular docking study and the trypsin activity experiment revealed that TC bound into S1 binding pocket, competitively inhibiting the enzyme activity, and CTC was a non-competitive inhibitor which bound to a non-active site of trypsin, different from TC due to the Cl atom on the benzene ring of CTC which hinders CTC entering into the S1 binding pocket. CTC does not hinder the binding of the enzyme substrate, but the CTC-trypsin-substrate ternary complex can not further decompose into the product. The work provides basic data for clarifying the binding mechanisms of TC (CTC) with trypsin and can help to comprehensively understanding of the enzyme toxicity of different members of tetracyclines in vivo.	[Chi, Zhenxing; Liu, Rutao; Yang, Hongxu; Shen, Hengmei; Wang, Jing] Shandong Univ, Shandong Prov Key Lab Water Pollut Control & Reso, Sch Environm Sci & Engn, China Amer CRC Environm & Hlth, Jinan, Shandong, Peoples R China	Shandong University	Chi, ZX (corresponding author), Shandong Univ, Shandong Prov Key Lab Water Pollut Control & Reso, Sch Environm Sci & Engn, China Amer CRC Environm & Hlth, Jinan, Shandong, Peoples R China.	rutaoliu@sdu.edu.cn	Chi, Zhenxing/AAX-2123-2021	chi, zhen xing/0000-0001-7513-1580	National Nature Science Foundation of China (NSFC) [20875055]; Cultivation Fund of the Key Scientific and Technical Innovation Project; Shanghai Tongji Gao Tingyao Environmental Science & Technology Development Foundation (STGEF); Graduate Independent Innovation Foundation of Shandong University [yzc10056]; Ministry of Education of China [708058]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Cultivation Fund of the Key Scientific and Technical Innovation Project(Ministry of Education, China); Shanghai Tongji Gao Tingyao Environmental Science & Technology Development Foundation (STGEF); Graduate Independent Innovation Foundation of Shandong University; Ministry of Education of China(Ministry of Education, China)	The work is supported by National Nature Science Foundation of China (NSFC, 20875055), the Cultivation Fund of the Key Scientific and Technical Innovation Project, Shanghai Tongji Gao Tingyao Environmental Science & Technology Development Foundation (STGEF), Graduate Independent Innovation Foundation of Shandong University (yzc10056) and Ministry of Education of China (708058) are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Chen WR, 2010, CHEMOSPHERE, V79, P779, DOI 10.1016/j.chemosphere.2010.03.020; Chi ZX, 2011, BIOMACROMOLECULES, V12, P203, DOI 10.1021/bm1011568; Chi ZX, 2010, BIOMACROMOLECULES, V11, P2454, DOI 10.1021/bm100633h; Forster T., 1965, MODERN QUANTUM CHEM, V3, P93; Ghosh S, 2008, COLLOID SURFACE B, V66, P178, DOI 10.1016/j.colsurfb.2008.06.011; Gokara M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008834; GRAF L, 1988, P NATL ACAD SCI USA, V85, P4961, DOI 10.1073/pnas.85.14.4961; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; HOBUSCH D, 1971, EXP PATHOL-JENA, V5, P298; HONG MZ, 2010, J LUMIN, V130, P781; Hossain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018333; Hu YJ, 2009, BIOMACROMOLECULES, V10, P517, DOI 10.1021/bm801120k; Huang YB, 2010, J LUMIN, V130, P360, DOI 10.1016/j.jlumin.2009.09.020; Imamura T, 2001, ANTIMICROB AGENTS CH, V45, P2871, DOI 10.1128/AAC.45.10.2871-2876.2001; Khan SN, 2008, EUR J PHARM SCI, V35, P371, DOI 10.1016/j.ejps.2008.07.010; Lorenzo C, 1999, INT J PANCREATOL, V26, P181, DOI 10.1385/IJGC:26:3:181; Ma WZ, 2005, BIOPHYS J, V89, P1183, DOI 10.1529/biophysj.104.057158; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nilsson MT, 2009, J MOL BIOL, V393, P504, DOI 10.1016/j.jmb.2009.08.028; Shyamali S. S., 1979, BIOCHEMISTRY-US, V18, P1026; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; TUCKER PC, 1972, AM J DIG DIS, V17, P675, DOI 10.1007/BF02231634; Uslu MO, 2009, SCI TOTAL ENVIRON, V407, P3450, DOI 10.1016/j.scitotenv.2009.01.045; Wang YQ, 2007, INT J BIOL MACROMOL, V41, P243, DOI 10.1016/j.ijbiomac.2007.02.011; Wei X, 2009, J ENVIRON SCI HEAL B, V44, P461, DOI 10.1080/03601230902935139; Wollenberger L, 2000, CHEMOSPHERE, V40, P723, DOI 10.1016/S0045-6535(99)00443-9; Wu TQ, 2007, BIOMACROMOLECULES, V8, P1899, DOI 10.1021/bm061189v; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yang M, 2006, ANAL CHEM, V78, P5900, DOI 10.1021/ac060742w; Yang QQ, 2009, J PHYS CHEM B, V113, P10454, DOI 10.1021/jp904004w; Ye ZQ, 2007, ANAL CHEM, V79, P1135, DOI 10.1021/ac060972a; Yuan T, 1998, BIOCHEMISTRY-US, V37, P3187, DOI 10.1021/bi9716579; Zhang B, 2009, NANO LETT, V9, P2280, DOI 10.1021/nl900437n; Zhang YZ, 2009, J HAZARD MATER, V163, P1345, DOI 10.1016/j.jhazmat.2008.07.132	35	20	21	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28361	10.1371/journal.pone.0028361	http://dx.doi.org/10.1371/journal.pone.0028361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205948	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600005
J	Liu, YC; Zhou, ZG; Miao, W; Zhang, YT; Cao, YA; He, SX; Bai, DQ; Yao, B				Liu, Yuchun; Zhou, Zhigang; Miao, Wei; Zhang, Yuting; Cao, Yanan; He, Suxu; Bai, Dongqing; Yao, Bin			A Chitinase from Aeromonas veronii CD3 with the Potential to Control Myxozoan Disease	PLOS ONE			English	Article							MYXOBOLUS-CEREBRALIS; DEVELOPMENTAL-STAGES; ANTIFUNGAL ACTIVITY; WHIRLING DISEASE; MYXOSPOREA; INFECTION; PURIFICATION; RESISTANCE; BACTERIUM; PARASITES	Background: The class Myxosporea encompasses about 2,400 species, most of which are parasites of fish and cause serious damage in aquaculture. Due to the concerns about food safety issues and limited knowledge of Myxozoa life cycle and fish immune system, no chemicals, antibiotics or immune modulators are available to control myxozoa infection. Therefore, little can be done once Myxozoa establishment has occurred. Methodology/Principal Findings: In this paper we isolated Aeromonas veronii CD3 with significant myxospore shell valve-degrading ability from pond sediment. A 3,057-bp full-length chitinase gene was consequently cloned, and the corresponding mature, recombinant chitinase (ChiCD3) produced by Escherichia coli had substantial chitinase activity. The deduced sequence of ChiCD3 contained one catalytic domain, two chitin-binding domains, and one putative signal peptide. ChiCD3 had an optimal activity at 50u degrees C and pH 6.0, and retained more than 50% of its optimal activity under warm water aquaculture conditions (similar to 30 degrees C and pH similar to 7.0). After incubation with ChiCD3, 38.0 +/- 4.8% of the myxospores had damaged shell valves, whereas myxospores incubated with commercially available chitinases remained intact. Conclusion/Significance: This study reveals a new strategy to control myxozoan disease. ChiCD3 that has capacity to damage the shell valve of myxospores can be supplemented into fish feed and used to control Myxozoa-induced diseases specifically.	[Liu, Yuchun; Zhou, Zhigang; Zhang, Yuting; Cao, Yanan; He, Suxu; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China; [Miao, Wei] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Bai, Dongqing] Tianjin Agr Univ, Fisheries Sci Dept, Tianjin Key Lab Aquaecol & Aquaculture, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Tianjin Agricultural University	Liu, YC (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	zhou_zg@msn.com; yaobin@caas-bio.net.cn	Cao, Yanan/AAF-7356-2021	miao, wei/0000-0003-3440-8322; yuchun, liu/0000-0001-9818-9996	Special funds for Technology Development and Research for Research Institutes; Chinese Academy of Agricultural Sciences	Special funds for Technology Development and Research for Research Institutes; Chinese Academy of Agricultural Sciences	This research was supported by the Special funds for Technology Development and Research for Research Institutes (Project Title: Research and Development of New and Safe Microbial Agent of Chitinase Used in Aquaculture) and the Basic Research Operating Expenses of Chinese Academy of Agricultural Sciences (Project Title: High Expression of Chitinase Gene Originated from the Bacterium to Degrade the Myxospores). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER M, 1997, DIS AQUAT ORGAN, V28, P115; Bartholomew JL, 1998, J AQUAT ANIM HEALTH, V10, P112, DOI 10.1577/1548-8667(1998)010&lt;0112:HRTIBT&gt;2.0.CO;2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; EGUSA S, 1981, Fish Pathology, V15, P213; El-Matbouli M, 1991, J AQUAT ANIM HEALTH, V4, P44; Hedrick RP, 2003, DIS AQUAT ORGAN, V55, P37, DOI 10.3354/dao055037; Hoster F, 2005, APPL MICROBIOL BIOT, V66, P434, DOI 10.1007/s00253-004-1664-9; HSU SC, 1975, APPL MICROBIOL, V29, P422, DOI 10.1128/AEM.29.3.422-426.1975; Hsu T. C., 1981, Developments in Biological Standardization, V49, P101; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kaltner H, 2007, J FISH DIS, V30, P637, DOI 10.1111/j.1365-2761.2007.00846.x; Knaus M, 2005, PARASITOL RES, V97, P505, DOI 10.1007/s00436-005-1468-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu Y, 2011, VET PARASITOL, V178, P355, DOI 10.1016/j.vetpar.2011.01.008; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Liu YC, 2008, AQUAC RES, V39, P635, DOI 10.1111/j.1365-2109.2008.01934.x; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; LU YS, 2004, ACTA HYDROBIO SIN, V6, P587; LUKES J, 1993, PARASITOL RES, V79, P439, DOI 10.1007/BF00931837; Mathivanan N, 1998, CAN J MICROBIOL, V44, P646, DOI 10.1139/cjm-44-7-646; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moshu A, 1997, DIS AQUAT ORGAN, V28, P115, DOI 10.3354/dao028115; Munoz P, 1999, FOLIA PARASIT, V46, P241; Redondo MJ, 2008, PARASITOL RES, V102, P1257, DOI 10.1007/s00436-008-0903-x; Rhee J K, 1990, Kisaengchunghak Chapchi, V28, P183, DOI 10.3347/kjp.1990.28.3.183; Rojas-Avelizapa LI, 1999, WORLD J MICROB BIOT, V15, P299, DOI 10.1023/A:1008947029713; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; Sitja-Bobadilla A, 2008, PARASITE, V15, P420, DOI 10.1051/parasite/2008153420; Stanimirovic Z, 2007, MUTAT RES-GEN TOX EN, V628, P1, DOI 10.1016/j.mrgentox.2006.09.014; Stefanidi E, 2008, EXTREMOPHILES, V12, P541, DOI 10.1007/s00792-008-0155-9; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; TSUJIBO H, 1993, J BACTERIOL, V175, P176, DOI 10.1128/JB.175.1.176-181.1993; Wang SL, 2002, J AGR FOOD CHEM, V50, P2241, DOI 10.1021/jf010885d; Yokoyama H, 1998, FISH PATHOL, V33, P85, DOI 10.3147/jsfp.33.85; Zhang Z, 2001, PHYTOPATHOLOGY, V91, P204, DOI 10.1094/PHYTO.2001.91.2.204; Zhou Li, 1998, Journal of Ocean University of Qingdao, V28, P59	36	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29091	10.1371/journal.pone.0029091	http://dx.doi.org/10.1371/journal.pone.0029091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205999	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600028
J	Martins, JR; Anhezini, L; Dallacqua, RP; Simoes, ZLP; Bitondi, MMG				Martins, Juliana R.; Anhezini, Lucas; Dallacqua, Rodrigo P.; Simoes, Zila L. P.; Bitondi, Marcia M. G.			A Honey Bee Hexamerin, HEX 70a, Is Likely to Play an Intranuclear Role in Developing and Mature Ovarioles and Testioles	PLOS ONE			English	Article							APIS-MELLIFERA L; HORMONE-BINDING-PROTEIN; HIGH-MOLECULAR-WEIGHT; JUVENILE-HORMONE; STORAGE PROTEINS; MANDUCA-SEXTA; IN-VITRO; CAMPONOTUS-FESTINATUS; DEVELOPMENTAL STAGES; LOCUSTA-MIGRATORIA	Insect hexamerins have long been known as storage proteins that are massively synthesized by the larval fat body and secreted into hemolymph. Following the larval-to-pupal molt, hexamerins are sequestered by the fat body via receptor-mediated endocytosis, broken up, and used as amino acid resources for metamorphosis. In the honey bee, the transcript and protein subunit of a hexamerin, HEX 70a, were also detected in ovaries and testes. Aiming to identify the subcellular localization of HEX 70a in the female and male gonads, we used a specific antibody in whole mount preparations of ovaries and testes for analysis by confocal laser-scanning microscopy. Intranuclear HEX 70a foci were evidenced in germ and somatic cells of ovarioles and testioles of pharate-adult workers and drones, suggesting a regulatory or structural role. Following injection of the thymidine analog EdU we observed co-labeling with HEX 70a in ovariole cell nuclei, inferring possible HEX 70a involvement in cell proliferation. Further support to this hypothesis came from an injection of anti-HEX 70a into newly ecdysed queen pupae where it had a negative effect on ovariole thickening. HEX 70a foci were also detected in ovarioles of egg laying queens, particularly in the nuclei of the highly polyploid nurse cells and in proliferating follicle cells. Additional roles for this storage protein are indicated by the detection of nuclear HEX 70a foci in post-meiotic spermatids and spermatozoa. Taken together, these results imply undescribed roles for HEX 70a in the developing gonads of the honey bee and raise the possibility that other hexamerins may also have tissue specific functions.	[Martins, Juliana R.] Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Anhezini, Lucas] Univ Sao Paulo, Dept Biol Mol & Celular Bioagentes Patogen, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Dallacqua, Rodrigo P.; Simoes, Zila L. P.; Bitondi, Marcia M. G.] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Martins, JR (corresponding author), Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, Sao Paulo, Brazil.	mmgbit@usp.br	Dallacqua, Rodrigo P/I-6592-2012; Martins, Juliana Ramos/F-6726-2012; Simoes, Zila Luz Paulino/H-7314-2014; Bitondi, Marcia MG/E-8014-2012; Martins, Juliana Ramos/AAD-4694-2021; de Araujo, Lucas Anhezini/J-5071-2016	Bitondi, Marcia MG/0000-0002-5619-6378; Martins, Juliana Ramos/0000-0002-7185-6477; Simoes, Zila Luz Paulino/0000-0003-2363-6178	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/03926-5, 10/16380-9, 08/00541-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants 05/03926-5 and 10/16380-9), which also provided a fellowship to JRM (08/00541-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANCSIN JB, 1990, MOL INSECT SCI, P275; BAKER HG, 1973, NATURE, V241, P543, DOI 10.1038/241543b0; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BEINTEMA JJ, 1994, MOL BIOL EVOL, V11, P493; Bitondi MMG, 2006, ARCH INSECT BIOCHEM, V63, P57, DOI 10.1002/arch.20142; Blackburn MB, 2004, ARCH INSECT BIOCHEM, V55, P26, DOI 10.1002/arch.10119; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun RP, 1996, J BIOL CHEM, V271, P31756, DOI 10.1074/jbc.271.49.31756; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Burmester T, 1999, NATURWISSENSCHAFTEN, V86, P468, DOI 10.1007/s001140050656; Capella ICS, 2002, CELL TISSUE RES, V307, P265, DOI 10.1007/s00441-001-0490-y; Capurro MD, 1997, INSECT MOL BIOL, V6, P97, DOI 10.1046/j.1365-2583.1997.00162.x; Cermenati G, 2007, ISJ-INVERT SURVIV J, V4, P119; CRUZLANDIM C, 2009, MORFOLOGIA FUNCAO SI, P15; Cunha AD, 2005, J INSECT PHYSIOL, V51, P1135, DOI 10.1016/j.jinsphys.2005.06.004; Danty E, 1998, INSECT BIOCHEM MOLEC, V28, P387, DOI 10.1016/S0965-1748(98)00011-3; Ditzel N, 2003, COMP BIOCHEM PHYS B, V134, P489, DOI 10.1016/S1096-4959(02)00291-9; ENGELS W, 1968, INSECT SOC, V15, P271, DOI 10.1007/BF02225850; FLEIG R, 1991, CELL TISSUE RES, V265, P297, DOI 10.1007/BF00398077; GUTZEIT HO, 1993, ROUX ARCH DEV BIOL, V202, P181, DOI 10.1007/BF00365309; Hahn DA, 2003, J INSECT PHYSIOL, V49, P1189, DOI 10.1016/j.jinsphys.2003.09.002; Hakim RS, 2007, ARCH INSECT BIOCHEM, V64, P63, DOI 10.1002/arch.20155; HOAGE TR, 1968, J ULTRA MOL STRUCT R, V24, P6, DOI 10.1016/S0022-5320(68)80014-0; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; ISMAIL SM, 1995, ARCH INSECT BIOCHEM, V29, P415, DOI 10.1002/arch.940290408; Jamroz RC, 1996, J INSECT PHYSIOL, V42, P115, DOI 10.1016/0022-1910(95)00093-3; Johnston ML, 2007, INSECT SOC, V54, P383, DOI 10.1007/s00040-007-0957-2; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; KONIG M, 1986, ROUX ARCH DEV BIOL, V195, P296, DOI 10.1007/BF00376062; KOOPMANSCHAP AB, 1988, ARCH INSECT BIOCHEM, V7, P105, DOI 10.1002/arch.940070204; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVENBOOK L, 1984, INSECT BIOCHEM, V14, P77, DOI 10.1016/0020-1790(84)90086-6; Levenbook L., 1985, P307; LIN HF, 1994, DEVELOPMENT, V120, P947; Loeb MJ, 1996, J INSECT PHYSIOL, V42, P1103, DOI 10.1016/S0022-1910(96)00050-9; Louveaux J., 1977, Bulletin Techq apic, V4, P43; MARTINEZ T, 1993, INSECT BIOCHEM MOLEC, V23, P309, DOI 10.1016/0965-1748(93)90013-I; MARTINEZ T, 1994, J INSECT PHYSIOL, V40, P723, DOI 10.1016/0022-1910(94)90100-7; Martins JR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-23; Martins JR, 2008, J INSECT PHYSIOL, V54, P867, DOI 10.1016/j.jinsphys.2008.03.009; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Munn E.A., 1967, BIOCHEM J, V102, P5; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; PAGE RE, 1988, BEHAV ECOL SOCIOBIOL, V23, P117, DOI 10.1007/BF00299895; Pan M. L., 2001, Journal of Insect Science (Tucson), V1, P1; Pan ML, 1996, ARCH INSECT BIOCHEM, V33, P149, DOI 10.1002/(SICI)1520-6327(1996)33:2&lt;149::AID-ARCH5&gt;3.0.CO;2-T; Pan ML, 1999, ARCH INSECT BIOCHEM, V42, P138, DOI 10.1002/(SICI)1520-6327(199910)42:2&lt;138::AID-ARCH4&gt;3.0.CO;2-1; Rachinsky A, 1998, IN VITRO CELL DEV-AN, V34, P646; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; ROBERTS DB, 1981, EXPERIENTIA, V37, P103, DOI 10.1007/BF01963174; RYAN RO, 1984, INSECT BIOCHEM, V14, P515, DOI 10.1016/0020-1790(84)90005-2; SadrudDin S, 1996, J EXP BIOL, V199, P319, DOI 10.1016/0022-0981(95)00175-1; SADRUDDIN SY, 1994, INVERTEBR REPROD DEV, V26, P197, DOI 10.1080/07924259.1994.9672418; Scharf Michael E., 2007, Journal of Experimental Biology, V210, P4390, DOI 10.1242/jeb.010876; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Spradling Allan C., 1993, P1; Tanaka ED, 2004, ARTHROPOD STRUCT DEV, V33, P431, DOI 10.1016/j.asd.2004.06.006; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Telfer WH, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.26; Tozetto SDO, 2007, APIDOLOGIE, V38, P1, DOI 10.1051/apido:2006045; WEBB BA, 1988, DEV BIOL, V130, P671, DOI 10.1016/0012-1606(88)90359-4; Wheeler DE, 1996, J INSECT PHYSIOL, V42, P961, DOI 10.1016/0022-1910(96)00049-2; Wheeler DE, 2000, J INSECT PHYSIOL, V46, P951, DOI 10.1016/S0022-1910(99)00202-4; Wilson MJ, 2011, EVOL DEV, V13, P127, DOI 10.1111/j.1525-142X.2011.00463.x; WU M, 1995, ARCH INSECT BIOCHEM, V28, P257, DOI 10.1002/arch.940280307; Zakharkin SO, 2001, EUR J BIOCHEM, V268, P5713, DOI 10.1046/j.0014-2956.2001.02514.x; Zalewska M, 2009, BBA-BIOMEMBRANES, V1788, P1695, DOI 10.1016/j.bbamem.2009.04.022; Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103; Zhou XG, 2007, DEVELOPMENT, V134, P601, DOI 10.1242/dev.02755	70	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29006	10.1371/journal.pone.0029006	http://dx.doi.org/10.1371/journal.pone.0029006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205988	gold, Green Submitted, Green Published			2022-12-25	WOS:000298665600020
J	Raycroft, MT; Harvey, BP; Bruck, MJ; Mamula, MJ				Raycroft, Maurice T.; Harvey, Bohdan P.; Bruck, Matthew J.; Mamula, Mark J.			Inhibition of Antigen Trafficking through Scavenger Receptor A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELLS; T-CELLS; LYMPHOCYTES; AUTOIMMUNITY; MACROPHAGES; CONSUMPTION; IMMUNITY; LIGANDS; MOUSE; JOINT	B cell acquisition and presentation of specific autoantigens (auto-Ags) are thought to play an important and complex role in autoimmunity development. We previously identified scavenger receptor A (SR-A) as an early target in altering B cell-mediated autoimmunity. SR-A is highly expressed on professional antigen-presenting cells such as macrophages (M Phi s) and dendritic cells (DCs). In this study, we demonstrate that SR-A is responsible for controlling B cell interactions with DCs/M Phi s to promote Ag transfer from B cells to qDCs/M Phi s. We established a high-throughput ELISA-based screen to identify novel SR-A inhibitors, the specificity of which was determined by dose dependence and Biacore surface plasmon resonance testing. We identified small molecule inhibitors (SMIs) able to reduce SR-A-mediated Ag transfer in human cells. In particular, the SMIs prevented SR-A-positive cells from accumulating/loading Ag over time. Furthermore, we determined that one SMI, sennoside B, can reduce SR-A-mediated capture of B cells. Finally, SMI-mediated decreases in Ag transfer or accumulation reduced T cell proliferation in vitro and in vivo. These observations demonstrate that B cell-DC/M Phi interactions are conducive to promoting Ag trafficking between these cell types via SR-A. Inhibitors of SR-A may provide a novel therapeutic strategy in ameliorating autoimmune disease development.	[Raycroft, Maurice T.; Harvey, Bohdan P.; Bruck, Matthew J.; Mamula, Mark J.] Yale Univ, Sch Med, Rheumatol Sect, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Mamula, MJ (corresponding author), Yale Univ, Sch Med, Rheumatol Sect, Dept Internal Med, 300 Cedar St,TAC S-525,POB 208031, New Haven, CT 06520 USA.	mark.mamula@yale.edu			National Institutes of Health [AR41032]; Alliance for Lupus Research Target Identification in Lupus award; Heimbold Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041032, R29AR041032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research Target Identification in Lupus award; Heimbold Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR41032. This work was also supported by an Alliance for Lupus Research Target Identification in Lupus award (to M. J. M.) and by Leif and Adrienne Heimbold with a generous contribution from the Heimbold Foundation.	Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chen YC, 2009, LIFE SCI, V84, P915, DOI 10.1016/j.lfs.2009.04.003; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; Guarize L., 2011, NAT PROD RES, V1, P1; Guo CQ, 2012, IMMUNOL CELL BIOL, V90, P101, DOI 10.1038/icb.2011.10; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Harvey BP, 2008, J IMMUNOL, V181, P4043, DOI 10.4049/jimmunol.181.6.4043; Harvey BP, 2007, EUR J IMMUNOL, V37, P1739, DOI 10.1002/eji.200636452; Howell AB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-94; Hueza IM, 2007, J VET MED A, V54, P179, DOI 10.1111/j.1439-0442.2007.00917.x; Juthani-Mehta M, 2010, J AM GERIATR SOC, V58, P2028, DOI 10.1111/j.1532-5415.2010.03080.x; Krajka-Kuzniak V, 2003, TOXICOL LETT, V143, P209, DOI 10.1016/S0378-4274(03)00177-2; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Maranon C, 2004, P NATL ACAD SCI USA, V101, P6092, DOI 10.1073/pnas.0304860101; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; PIERCE SK, 1988, IMMUNOL REV, V106, P149, DOI 10.1111/j.1600-065X.1988.tb00778.x; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Pluddemann Annette, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000159; Santiago-Garcia J, 2001, J BIOL CHEM, V276, P30655, DOI 10.1074/jbc.M102879200; Scheinecker C, 2011, NAT REV RHEUMATOL, V7, P73, DOI 10.1038/nrrheum.2010.226; Shukla M, 2008, NUTRITION, V24, P733, DOI 10.1016/j.nut.2008.03.013; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; TZEHOVAL E, 1983, EUR J IMMUNOL, V13, P89, DOI 10.1002/eji.1830130202; Wang XY, 2007, CANCER RES, V67, P4996, DOI 10.1158/0008-5472.CAN-06-3138; Yan J, 2005, INT IMMUNOL, V17, P869, DOI 10.1093/intimm/dxh266; Yan J, 2002, INT IMMUNOL, V14, P963, DOI 10.1093/intimm/dxf064; Yan J, 2006, J IMMUNOL, V177, P4481, DOI 10.4049/jimmunol.177.7.4481; Yokota T, 1998, EXP CELL RES, V239, P16, DOI 10.1006/excr.1997.3876	28	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5310	5316		10.1074/jbc.M111.316356	http://dx.doi.org/10.1074/jbc.M111.316356			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215667	Green Published, hybrid			2022-12-25	WOS:000300638000013
J	Kurazumi, H; Kubo, M; Ohshima, M; Yamamoto, Y; Takemoto, Y; Suzuki, R; Ikenaga, S; Mikamo, A; Udo, K; Hamano, K; Li, TS				Kurazumi, Hiroshi; Kubo, Masayuki; Ohshima, Mako; Yamamoto, Yumi; Takemoto, Yoshihiro; Suzuki, Ryo; Ikenaga, Shigeru; Mikamo, Akihito; Udo, Koichi; Hamano, Kimikazu; Li, Tao-Sheng			The Effects of Mechanical Stress on the Growth, Differentiation, and Paracrine Factor Production of Cardiac Stem Cells	PLOS ONE			English	Article							BONE-MARROW-CELLS; MYOCARDIAL-INFARCTION; INTRAMYOCARDIAL IMPLANTATION; PROGENITOR CELLS; HEART; CARDIOMYOCYTES; REGENERATION; THERAPY; STRETCH; IDENTIFICATION	Stem cell therapies have been clinically employed to repair the injured heart, and cardiac stem cells are thought to be one of the most potent stem cell candidates. The beating heart is characterized by dynamic mechanical stresses, which may have a significant impact on stem cell therapy. The purpose of this study is to investigate how mechanical stress affects the growth and differentiation of cardiac stem cells and their release of paracrine factors. In this study, human cardiac stem cells were seeded in a silicon chamber and mechanical stress was then induced by cyclic stretch stimulation (60 cycles/min with 120% elongation). Cells grown in non-stretched silicon chambers were used as controls. Our result revealed that mechanical stretching significantly reduced the total number of surviving cells, decreased Ki-67-positive cells, and increased TUNELpositive cells in the stretched group 24 hrs after stretching, as compared to the control group. Interestingly, mechanical stretching significantly increased the release of the inflammatory cytokines IL-6 and IL-1b as well as the angiogenic growth factors VEGF and bFGF from the cells in 12 hrs. Furthermore, mechanical stretching significantly reduced the percentage of c-kit-positive stem cells, but increased the expressions of cardiac troponin-I and smooth muscle actin in cells 3 days after stretching. Using a traditional stretching model, we demonstrated that mechanical stress suppressed the growth and proliferation of cardiac stem cells, enhanced their release of inflammatory cytokines and angiogenic factors, and improved their myogenic differentiation. The development of this in vitro approach may help elucidate the complex mechanisms of stem cell therapy for heart failure.	[Kurazumi, Hiroshi; Kubo, Masayuki; Ohshima, Mako; Yamamoto, Yumi; Takemoto, Yoshihiro; Suzuki, Ryo; Ikenaga, Shigeru; Mikamo, Akihito; Hamano, Kimikazu] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan; [Udo, Koichi] Yamaguchi Univ, Inst Biomed Res & Educ, Ctr Sci Res, Ube, Yamaguchi 755, Japan; [Li, Tao-Sheng] Nagasaki Univ, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 852, Japan	Yamaguchi University; Yamaguchi University; Nagasaki University	Kurazumi, H (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan.	litaoshe@nagasaki-u.ac.jp		Li, Tao-Sheng/0000-0002-7653-8873	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Cheng M, 2010, CIRC RES, V107, P1083, DOI 10.1161/CIRCRESAHA.110.220970; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; CLARKE MSF, 1995, CIRC RES, V76, P927, DOI 10.1161/01.RES.76.6.927; Dangers M, 2010, J VASC RES, V47, P432, DOI 10.1159/000281583; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014; Kada K, 1999, J MOL CELL CARDIOL, V31, P247, DOI 10.1006/jmcc.1998.0865; Kanzaki M, 1999, SCIENCE, V285, P882, DOI 10.1126/science.285.5429.882; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Li TS, 2008, CELL TRANSPLANT, V17, P695, DOI 10.3727/096368908786092702; Li TS, 2007, J THORAC CARDIOV SUR, V134, P1347, DOI 10.1016/j.jtcvs.2007.07.016; Li TS, 2007, STEM CELLS, V25, P911, DOI 10.1634/stemcells.2006-0497; Li TS, 2011, CARDIOVASC RES, V89, P157, DOI 10.1093/cvr/cvq251; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Li TS, 2009, CIRCULATION, V120, pS255, DOI 10.1161/CIRCULATIONAHA.108.837039; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018; Marban E, 2010, CIRCULATION, V121, P1981, DOI 10.1161/CIRCULATIONAHA.110.952580; Matsuda T, 2005, BIOCHEM BIOPH RES CO, V326, P228, DOI 10.1016/j.bbrc.2004.11.019; McNeil Paul L., 1993, Trends in Cell Biology, V3, P302, DOI 10.1016/0962-8924(93)90012-P; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Salameh A, 2010, CIRC RES, V106, P1592, DOI 10.1161/CIRCRESAHA.109.214429; Suzuki R, 2007, J THORAC CARDIOV SUR, V133, P1051, DOI 10.1016/j.jtcvs.2006.12.026; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Weir Robin A P, 2006, Curr Heart Fail Rep, V3, P175, DOI 10.1007/s11897-006-0019-5	31	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28890	10.1371/journal.pone.0028890	http://dx.doi.org/10.1371/journal.pone.0028890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216136	gold, Green Published, Green Submitted			2022-12-25	WOS:000300676300015
J	Wu, K; Feskanich, D; Fuchs, CS; Chan, AT; Willett, WC; Hollis, BW; Pollak, MN; Giovannucci, E				Wu, Kana; Feskanich, Diane; Fuchs, Charles S.; Chan, Andrew T.; Willett, Walter C.; Hollis, Bruce W.; Pollak, Michael N.; Giovannucci, Edward			Interactions between Plasma Levels of 25-Hydroxyvitamin D, Insulin-Like Growth Factor (IGF)-1 and C-Peptide with Risk of Colorectal Cancer	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; IGF-BINDING PROTEIN-3; FACTOR BINDING-PROTEIN-3 CONCENTRATIONS; MALE HEALTH-PROFESSIONALS; BODY-MASS INDEX; FACTOR-I; VITAMIN-D; COLON-CANCER; LIFE-STYLE; POSTMENOPAUSAL WOMEN	Background: Vitamin D status and levels of insulin-like growth factor (IGF)-1 and C-peptide have been implicated in colorectal carcinogenesis. However, in contrast to vitamin D IGF-1 is not an easily modifiable risk factor. Methods: Combining data from the Health Professionals Follow up Study (HPFS) and the Nurses' Health Study cohort (NHS) additive and multiplicative interactions were examined between plasma 25-hydroxyvitamin D (25(OH) D) and IGF-1, IGFBP-3 as well as C-peptide levels in 499 cases and 992 matched controls. For the various analytes, being high or low was based on being either above (or equal) or below the medians, respectively. Results: Compared to participants with high 25(OH) D and low IGF-1/IGFBP-3 ratio (reference group), participants with a high IGF-1/IGFBP-3 ratio were at elevated risk of colorectal cancer when 25(OH) D was low (odds ratio (OR): 2.05 (95% CI: 1.43 to 2.92), but not when 25(OH) D was high (OR: 1.20 (95% CI: 0.84 to 1.71, p(interaction): additive = 0.06, multiplicative = 0.25). Similarly, compared to participants with high 25(OH) D and low molar IGF-1/IGFBP-3 ratio and low C-peptide levels (reference group), participants with a combination of either high IGF-1/IGFBP-3 ratio or high C-peptide were at elevated risk for colorectal cancer when 25(OH) D was low (OR = 1.90, 95% CI: 1.22 to 2.94) but not when 25(OH) D was high (OR = 1.15, 95% CI: 0.74 to 1.77, p(interaction): additive = 0.004; multiplicative = 0.04). Conclusion: The results from this study suggest that improving vitamin D status may help lower risk of colorectal cancer associated with higher IGF-1/IGFBP-3 ratio or C-peptide levels.	[Wu, Kana; Willett, Walter C.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Feskanich, Diane; Fuchs, Charles S.; Chan, Andrew T.; Willett, Walter C.; Giovannucci, Edward] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Fuchs, Charles S.] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Willett, Walter C.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hollis, Bruce W.] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Pollak, Michael N.] McGill Univ, Jewish Gen Hosp, Dept Med & Oncol, Montreal, PQ H3T 1E2, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Medical University of South Carolina; McGill University	Wu, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	kana.wu@channing.harvard.edu	Chan, Andrew T/P-8293-2014; Pollak, Michael/G-9094-2011	Chan, Andrew T/0000-0001-7284-6767; Pollak, Michael/0000-0003-3047-0604	National Cancer Institute, National Institutes of Health [CA055075, CA49449, CA87969]; NATIONAL CANCER INSTITUTE [U01CA049449, P01CA055075, P01CA087969, R01CA049449] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grants CA055075, CA49449 and CA87969 from the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2003, CANCER CAUSE CONTROL, V14, P65, DOI 10.1023/A:1022518321634; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; BONSER AM, 1984, CRC CR REV CL LAB SC, V19, P297, DOI 10.3109/10408368409165766; Boyle BJ, 2001, J UROLOGY, V165, P1319, DOI 10.1016/S0022-5347(01)69892-6; BRAUN MM, 1995, AM J EPIDEMIOL, V142, P608, DOI 10.1093/oxfordjournals.aje.a117682; Chang S, 2002, CANCER EPIDEM BIOMAR, V11, P758; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Colditz G A, 1995, J Am Med Womens Assoc (1972), V50, P40; Cotton S, 1996, CRIT REV ONCOGENESIS, V7, P293, DOI 10.1615/CritRevOncog.v7.i5-6.10; Crowe FL, 2009, CANCER EPIDEM BIOMAR, V18, P1333, DOI 10.1158/1055-9965.EPI-08-0781; DeLellis K, 2004, CANCER EPIDEM BIOMAR, V13, P1444; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Gapstur SM, 2004, CANCER EPIDEM BIOMAR, V13, P2208; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Garland CF, 2005, INT J EPIDEMIOL; Giovannucci E, 2006, CURR OPIN GASTROEN, V22, P24, DOI 10.1097/01.mog.0000196150.36701.c2; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P84; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Gunter MJ, 2008, CANCER RES, V68, P329, DOI 10.1158/0008-5472.CAN-07-2946; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; Hollis BW, 1997, METHOD ENZYMOL, V282, P174; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P852; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P862; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697; JUUL A, 1995, J CLIN ENDOCR METAB, V80, P2534, DOI 10.1210/jc.80.8.2534; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Karlson EW, 2010, ANN RHEUM DIS, V69, P54, DOI 10.1136/ard.2008.102962; Komninou D, 2003, EXP BIOL MED, V228, P396, DOI 10.1177/153537020322800410; Lamprecht SA, 2001, ANN NY ACAD SCI, V952, P73, DOI 10.1111/j.1749-6632.2001.tb02729.x; Lukanova A, 2004, EUR J ENDOCRINOL, V150, P161, DOI 10.1530/eje.0.1500161; Lukanova A, 2001, EUR J CANCER PREV, V10, P443, DOI 10.1097/00008469-200110000-00008; Lundberg M, 1996, EPIDEMIOLOGY, V7, P655; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Ma J, 2001, J NATL CANCER I, V93, P1330, DOI 10.1093/jnci/93.17.1330; Matilainen M, 2005, NUCLEIC ACIDS RES, V33, P5521, DOI 10.1093/nar/gki872; Max JB, 2008, CANCER EPIDEM BIOMAR, V17, P1832, DOI 10.1158/1055-9965.EPI-08-0345; Norman AW, 1990, PRESENT KNOWLEDGE NU, P212; Otani T, 2007, BRIT J CANCER, V97, P446, DOI 10.1038/sj.bjc.6603892; Otani T, 2007, INT J CANCER, V120, P2007, DOI 10.1002/ijc.22556; Palmqvist R, 2002, GUT, V50, P642, DOI 10.1136/gut.50.5.642; Peng LH, 2004, MOL ENDOCRINOL, V18, P1109, DOI 10.1210/me.2003-0344; Pisani Paola, 2008, Archives of Physiology and Biochemistry, V114, P63, DOI 10.1080/13813450801954451 ; Platz EA, 1999, CANCER EPIDEM BIOMAR, V8, P1107; Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a; Probst-Hensch NM, 2001, BRIT J CANCER, V85, P1695, DOI 10.1054/bjoc.2001.2172; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rinaldi S, 2009, INT J CANC; Rothman KJ, 2002, EPIDEMIOLOGY; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Tangrea J, 1997, CANCER CAUSE CONTROL, V8, P615, DOI 10.1023/A:1018450531136; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Voskuil DW, 2001, CANCER CAUSE CONTROL, V12, P951, DOI 10.1023/A:1013708627664; Vrieling A, 2004, CANCER CAUSE CONTROL, V15, P787, DOI 10.1023/B:CACO.0000043429.51915.c6; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Wei EK, 2006, CANCER EPIDEM BIOMAR, V15, P750, DOI 10.1158/1055-9965.EPI-05-0820; Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661; Willett W., 1998, NUTR EPIDEMIOLOGY, V30, P321, DOI [DOI 10.1093/AJCN/69.5.1020, DOI 10.1093/acprof:oso/9780195122978.003.13]; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Woolcott CG, 2010, CANCER EPIDEM BIOMAR, V19, P130, DOI 10.1158/1055-9965.EPI-09-0475; Wu K, 2002, JNCI-J NATL CANCER I, V94, P437, DOI 10.1093/jnci/94.6.437; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038; Wu TY, 2009, J NUTR, V139, P547, DOI 10.3945/jn.108.089920; Yamaji T, 2005, INT J OBESITY	76	35	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28520	10.1371/journal.pone.0028520	http://dx.doi.org/10.1371/journal.pone.0028520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216097	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300005
J	Zhu, DX; Lossos, C; Chapman-Fredricks, JR; Matthews, JM; Ikpatt, OF; Ruiz, P; Lossos, IS				Zhu, Daxing; Lossos, Chen; Chapman-Fredricks, Jennifer R.; Matthews, Julie M.; Ikpatt, Offiong F.; Ruiz, Phillip; Lossos, Izidore S.			Biased Use of the IGHV4 Family and Evidence for Antigen Selection in Chlamydophila psittaci-Negative Ocular Adnexal Extranodal Marginal Zone Lymphomas	PLOS ONE			English	Article							B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; HEAVY-CHAIN GENE; CHLAMYDIA-PSITTACI; MALT LYMPHOMA; IMMUNOGLOBULIN GENES; NO EVIDENCE; STAPHYLOCOCCAL-ENTEROTOXIN; SOMATIC HYPERMUTATION; PERIPHERAL-BLOOD	Extranodal marginal zone lymphomas (EMZL) are the most common lymphomas in the ocular adnexa. The etiology and potential role for antigenic stimulation in these lymphomas are still controversial. We have examined IGHV gene usage and mutations in 67 Chlamydophila psittaci-negative ocular adnexal EMZL. Clonal IGHV gene sequences were identified in 43 tumors originating from the orbit (19), conjunctivae (18) and lacrimal gland (6). Forty four potentially functional clonal IGHV gene sequences were detected with overrepresentation of the IGHV4 family and IGHV4-34 gene. All but 3 sequences were mutated with the average percent homology to the germ line of 93.5+/-6.1. Multinomial model and Focused binomial test demonstrated evidence for positive and/or negative antigen selection in 59% of the potentially functional IGHV genes. Intraclonal variation was detected in 8 of 11 tumor specimens. Overall our findings demonstrate that C. psittaci-negative ocular adnexal EMZL exhibit biased usage of IGHV families and genes with evidence for intraclonal heterogeneity and antigen selection in multiple tumors, implicating B-cell receptor-mediated antigen stimulation in the pathogenesis of these lymphomas.	[Zhu, Daxing; Lossos, Chen; Matthews, Julie M.; Lossos, Izidore S.] Univ Miami, Dept Med, Sylvester Comprehens Canc Ctr, Div Hematol Oncol, Miami, FL 33145 USA; [Chapman-Fredricks, Jennifer R.; Ikpatt, Offiong F.; Ruiz, Phillip] Univ Miami, Dept Pathol, Miami, FL USA; [Matthews, Julie M.; Lossos, Izidore S.] Univ Miami, Dept Mol & Cellular Pharmacol, Sylvester Comprehens Canc Ctr, Miami, FL USA	University of Miami; University of Miami; University of Miami	Zhu, DX (corresponding author), Univ Miami, Dept Med, Sylvester Comprehens Canc Ctr, Div Hematol Oncol, Miami, FL 33145 USA.	Ilossos@med.miami.edu			National Institutes of Health (NIH) [NIH CA109335, NIH CA122105]; Dwoskin Foundation; NATIONAL CANCER INSTITUTE [R01CA109335, R01CA122105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dwoskin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ISL is supported by National Institutes of Health (NIH) grants NIH CA109335 and NIH CA122105, and the Dwoskin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2008, HAEMATOLOGICA, V93, P319, DOI 10.3324/haematol.11950; Bahler DW, 2009, MODERN PATHOL, V22, P833, DOI 10.1038/modpathol.2009.42; Bertoni F, 1999, LEUKEMIA LYMPHOMA, V35, P57, DOI 10.3109/10428199909145705; Bessudo A, 1998, BLOOD, V92, P1317, DOI 10.1182/blood.V92.4.1317.416k23_1317_1323; Bhat NM, 1997, CLIN EXP IMMUNOL, V108, P151, DOI 10.1046/j.1365-2249.1997.d01-976.x; BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; CAMPBELL MJ, 1992, MOL IMMUNOL, V29, P193, DOI 10.1016/0161-5890(92)90100-C; Chanudet E, 2006, J PATHOL, V209, P344, DOI 10.1002/path.1984; CLEARY ML, 1986, CELL, V44, P97, DOI 10.1016/0092-8674(86)90488-5; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; Coupland SE, 1999, INVEST OPHTH VIS SCI, V40, P555; Dagklis A, 2011, LEUKEMIA IN PRESS; Daibata M, 2006, BRIT J HAEMATOL, V132, P651, DOI 10.1111/j.1365-2141.2005.05943.x; Darzentas N, 2010, LEUKEMIA, V24, P125, DOI 10.1038/leu.2009.186; Decaudin D, 2008, ANTI-CANCER DRUG, V19, P761, DOI 10.1097/CAD.0b013e32830b58c4; Domiati-Saad R, 1998, J IMMUNOL, V161, P1257; DomiatiSaad R, 1996, J IMMUNOL, V156, P3608; Ferreri AJM, 2004, J NATL CANCER I, V96, P586, DOI 10.1093/jnci/djh102; Ferreri AJM, 2008, INT J CANCER, V123, P1089, DOI 10.1002/ijc.23596; GUIGOU V, 1990, MOL IMMUNOL, V27, P935, DOI 10.1016/0161-5890(90)90161-R; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hara Y, 2001, INVEST OPHTH VIS SCI, V42, P2450; HYJEK E, 1988, HUM PATHOL, V19, P1315, DOI 10.1016/S0046-8177(88)80287-9; KRAJ P, 1995, J IMMUNOL, V154, P6406; Kurosu K, 1998, AM J RESP CRIT CARE, V158, P1613, DOI 10.1164/ajrccm.158.5.9709132; LEVINSON AI, 1995, J CLIN IMMUNOL, V15, pS26, DOI 10.1007/BF01540891; Lossos IS, 2000, J IMMUNOL, V165, P5122, DOI 10.4049/jimmunol.165.9.5122; Lossos IS, 2000, P NATL ACAD SCI USA, V97, P10209, DOI 10.1073/pnas.180316097; Lossos IS, 2000, BLOOD, V95, P1797, DOI 10.1182/blood.V95.5.1797.005k30_1797_1803; MacDonald CM, 2010, LUPUS, V19, P1161, DOI 10.1177/0961203310367657; Mannami T, 2001, MODERN PATHOL, V14, P641, DOI 10.1038/modpathol.3880366; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Matthews JM, 2008, BRIT J HAEMATOL, V142, P246, DOI 10.1111/j.1365-2141.2008.07112.x; Mulder MMS, 2006, LEUKEMIA RES, V30, P1305, DOI 10.1016/j.leukres.2005.12.003; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Parsonnet J, 2004, NEW ENGL J MED, V350, P213, DOI 10.1056/NEJMp038200; PASCUAL V, 1992, ARTHRITIS RHEUM-US, V35, P11, DOI 10.1002/art.1780350103; PASCUAL V, 1991, J IMMUNOL, V146, P4385; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; Rosado MF, 2006, BLOOD, V107, P467, DOI 10.1182/blood-2005-06-2332; Ruiz A, 2007, AM J SURG PATHOL, V31, P792, DOI 10.1097/01.pas.0000249445.28713.88; SCHMID U, 1982, VIRCHOWS ARCH A, V395, P11, DOI 10.1007/BF00443482; Stefanovic A, 2009, BLOOD, V114, P501, DOI 10.1182/blood-2008-12-195453; Swerdlow E., 2008, WHO CLASSIFICATION T; Thiede C, 1998, J CLIN ONCOL, V16, P3822, DOI 10.1200/JCO.1998.16.12.3822; Thompsett AR, 1999, BLOOD, V94, P1738, DOI 10.1182/blood.V94.5.1738.417k10_1738_1746; Tierens A, 1999, BLOOD, V93, P226, DOI 10.1182/blood.V93.1.226.401a30_226_234; Uduman M, 2011, NUCLEIC ACIDS RES, V39, pW499, DOI 10.1093/nar/gkr413; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Yoo C, 2007, AM J HEMATOL, V82, P821, DOI 10.1002/ajh.20962; Zhang GS, 2007, LEUKEMIA LYMPHOMA, V48, P577, DOI 10.1080/10428190601132105	53	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29114	10.1371/journal.pone.0029114	http://dx.doi.org/10.1371/journal.pone.0029114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216179	Green Published, Green Submitted, gold			2022-12-25	WOS:000300674900014
J	Breban, R				Breban, Romulus			Health Newscasts for Increasing Influenza Vaccination Coverage: An Inductive Reasoning Game Approach	PLOS ONE			English	Article							RISK	Both pandemic and seasonal influenza are receiving more attention from mass media than ever before. Topics such as epidemic severity and vaccination are changing the way in which we perceive the utility of disease prevention. Voluntary influenza vaccination has been recently modeled using inductive reasoning games. It has thus been found that severe epidemics may occur because individuals do not vaccinate and, instead, attempt to benefit from the immunity of their peers. Such epidemics could be prevented by voluntary vaccination if incentives were offered. However, a key assumption has been that individuals make vaccination decisions based on whether there was an epidemic each influenza season; no other epidemiological information is available to them. In this work, we relax this assumption and investigate the consequences of making more informed vaccination decisions while no incentives are offered. We obtain three major results. First, individuals will not cooperate enough to constantly prevent influenza epidemics through voluntary vaccination no matter how much they learned about influenza epidemiology. Second, broadcasting epidemiological information richer than whether an epidemic occurred may stabilize the vaccination coverage and suppress severe influenza epidemics. Third, the stable vaccination coverage follows the trend of the perceived benefit of vaccination. However, increasing the amount of epidemiological information released to the public may either increase or decrease the perceived benefit of vaccination. We discuss three scenarios where individuals know, in addition to whether there was an epidemic, (i) the incidence, (ii) the vaccination coverage and (iii) both the incidence and the vaccination coverage, every influenza season. We show that broadcasting both the incidence and the vaccination coverage could yield either better or worse vaccination coverage than broadcasting each piece of information on its own.	Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Breban, R (corresponding author), Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.	romulus.breban@pasteur.fr		Breban, Romulus/0000-0002-5821-8139				ARTHUR WB, 1994, AM ECON REV, V84, P406; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Blank PR, 2009, INFECTION, V37, P390, DOI 10.1007/s15010-009-8467-y; Breban R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031127; Brown KF, 2010, VACCINE, V28, P4235, DOI 10.1016/j.vaccine.2010.04.052; CDC, 2011, INFL VACC COV; CHALLET D., 2005, MINORITY GAMES; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Cornforth DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001062; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; Fabry P, 2011, VACCINE, V29, P1824, DOI 10.1016/j.vaccine.2010.12.109; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Hackett Alison Jane, 2008, Community Pract, V81, P22; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Li YF, 2009, COMMUN NONLINEAR SCI, V14, P2353, DOI 10.1016/j.cnsns.2008.06.024; Liu R. S., 2007, COMP MATH MATH PHYS, V8, P153, DOI [10.1080/17486700701425870, DOI 10.1080/17486700701425870]; Lloyd AJ, 2001, QUAL HEALTH CARE, V10, pI14; Manfredi P, 2009, VACCINE, V28, P98, DOI 10.1016/j.vaccine.2009.09.109; Myers LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-15; Ott E, 2002, CHAOS DYNAMICAL SYST; Samba E, 2004, NEW ENGL J MED, V350, P645, DOI 10.1056/NEJMp038210; Tchuenche JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S5; Thomas EA, 2011, VACCINE, V29, P570, DOI 10.1016/j.vaccine.2010.09.101; Thomson R, 2005, CLIN MED, V5, P465, DOI 10.7861/clinmedicine.5-5-465; Vardavas R, 2007, PLOS COMPUT BIOL, V3, P796, DOI 10.1371/journal.pcbi.0030085; WEINSTEIN ND, 1989, SCIENCE, V246, P1232, DOI 10.1126/science.2686031	29	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28300	10.1371/journal.pone.0028300	http://dx.doi.org/10.1371/journal.pone.0028300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205944	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600013
J	Almeida, FBD; Carvalho, FC; Mariano, VS; Alegre, ACP; Silva, RD; Hanna, ES; Roque-Barreira, MC				Dos Reis Almeida, Fausto Bruno; Carvalho, Fernanda Caroline; Mariano, Vania Sammartino; Paiva Alegre, Ana Claudia; Silva, Roberto do Nascimento; Hanna, Ebert Seixas; Roque-Barreira, Maria Cristina			Influence of N-Glycosylation on the Morphogenesis and Growth of Paracoccidioides brasiliensis and on the Biological Activities of Yeast Proteins	PLOS ONE			English	Article							BINDING LECTIN; PURIFICATION; TUNICAMYCIN; CHITINASE; SECRETION; VIRULENCE; LAMININ	The fungus Paracoccidioides brasiliensis is a human pathogen that causes paracoccidioidomycosis, the most prevalent systemic mycosis in Latin America. The cell wall of P. brasiliensis is a network of glycoproteins and polysaccharides, such as chitin, that perform several functions. N-linked glycans are involved in glycoprotein folding, intracellular transport, secretion, and protection from proteolytic degradation. Here, we report the effects of tunicamycin (TM)-mediated inhibition of N-linked glycosylation on P. brasiliensis yeast cells. The underglycosylated yeasts were smaller than their fully glycosylated counterparts and exhibited a drastic reduction of cell budding, reflecting impairment of growth and morphogenesis by TM treatment. The intracellular distribution in TM-treated yeasts of the P. brasiliensis glycoprotein paracoccin was investigated using highly specific antibodies. Paracoccin was observed to accumulate at intracellular locations, far from the yeast wall. Paracoccin derived from TM-treated yeasts retained the ability to bind to laminin despite their underglycosylation. As paracoccin has N-acetyl-beta-D-glucosaminidase (NAGase) activity and induces the production of TNF-alpha and nitric oxide (NO) by macrophages, we compared these properties between glycosylated and underglycosylated yeast proteins. Paracoccin demonstrated lower NAGase activity when underglycosylated, although no difference was detected between the pH and temperature optimums of the two forms. Murine macrophages stimulated with underglycosylated yeast proteins produced significantly lower levels of TNF-alpha and NO. Taken together, the impaired growth and morphogenesis of tunicamycin-treated yeasts and the decreased biological activities of underglycosylated fungal components suggest that N-glycans play important roles in P. brasiliensis yeast biology.	[Dos Reis Almeida, Fausto Bruno; Carvalho, Fernanda Caroline; Mariano, Vania Sammartino; Paiva Alegre, Ana Claudia; Hanna, Ebert Seixas; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, Ribeirao Preto, SP, Brazil; [Silva, Roberto do Nascimento] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil; [Hanna, Ebert Seixas] Univ Sao Paulo, Invent Biotecnol Ltda ME, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Almeida, FBD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, Ribeirao Preto, SP, Brazil.	mcrbarre@fmrp.usp.br	HANNA, EBERT S/C-9569-2012; Silva, Roberto/F-3897-2012; Mariano, Vania/L-1953-2014; Mariano, Vânia Sammartino/AAV-1851-2020; Almeida, Fausto/N-6540-2013; Roque-Barreira, Maria-Cristina/A-4552-2008; HANNA, EBERT SEIXAS/H-7512-2019	Silva, Roberto/0000-0002-8992-7130; Mariano, Vânia Sammartino/0000-0002-5399-5676; Almeida, Fausto/0000-0002-3782-3698; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; 	Sao Paulo State Research Funding Agency (FAPESP); National Research Council (CNPq)	Sao Paulo State Research Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo State Research Funding Agency (FAPESP). Additional financial help was provided by the National Research Council (CNPq). FBRA, FCC, VSM, and ACPA were supported by fellowships from FAPESP. MCRB is indebted to CNPq for her research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA EM, 1993, J IMMUNOL METHODS, V160, P207, DOI 10.1016/0022-1759(93)90179-B; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brooks S.A., 2002, FUNCTIONAL MOL GLYCO; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BRUMMER E, 1990, INFECT IMMUN, V58, P2628, DOI 10.1128/IAI.58.8.2628-2636.1990; Almeida FBDR, 2007, BIOTECHNOL LETT, V29, P1189, DOI 10.1007/s10529-007-9372-z; Coltri KC, 2006, MICROBES INFECT, V8, P704, DOI 10.1016/j.micinf.2005.09.008; de Barros MC, 2009, CARBOHYD RES, V344, P1682, DOI 10.1016/j.carres.2009.06.006; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Almeida FBD, 2010, YEAST, V27, P67, DOI 10.1002/yea.1731; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Eriksen SH, 1998, CURR MICROBIOL, V37, P117, DOI 10.1007/s002849900348; Ganiko L, 2007, MICROBES INFECT, V9, P695, DOI 10.1016/j.micinf.2007.02.012; Gesztesi JL, 1996, HYBRIDOMA, V15, P415, DOI 10.1089/hyb.1996.15.415; Kung LA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.64; Kurokawa Cilmery S., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P257, DOI 10.1590/S0036-46652005000500004; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Linehan SA, 2000, MICROBES INFECT, V2, P279, DOI 10.1016/S1286-4579(00)00300-2; Macoris SAG, 2006, MEM I OSWALDO CRUZ, V101, P331, DOI 10.1590/S0074-02762006000300019; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; MOROSOLI R, 1988, ARCH BIOCHEM BIOPHYS, V265, P183, DOI 10.1016/0003-9861(88)90383-9; Nagai K, 1997, GLYCOBIOLOGY, V7, P769, DOI 10.1093/glycob/7.6.769; Netto C F, 1969, Rev Inst Med Trop Sao Paulo, V11, P177; Rast DM, 2003, PHYTOCHEMISTRY, V64, P339, DOI 10.1016/S0031-9422(03)00350-9; SANBLAS G, 1993, J MED VET MYCOL, V31, P99; Seidl Verena, 2008, Fungal Biology Reviews, V22, P36, DOI 10.1016/j.fbr.2008.03.002; Mendes-Giannini MJS, 2006, MICROBES INFECT, V8, P1550, DOI 10.1016/j.micinf.2006.01.012; Svidzinski Terezinha Inez Estivalet, 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P279, DOI 10.1590/S0036-46651999000500003; Tomazett PK, 2005, GENET MOL RES, V4, P309; ULHOA CJ, 1992, ENZYME MICROB TECH, V14, P236, DOI 10.1016/0141-0229(92)90072-V; Ulhoa CJ, 2001, BBA-GEN SUBJECTS, V1528, P39, DOI 10.1016/S0304-4165(01)00170-2; Varki A., 1999, ESSENTIALS GLYCOBIOL; VILLAR LA, 1989, J MED VET MYCOL, V27, P141; YABUKI M, 1986, J GEN APPL MICROBIOL, V32, P25, DOI 10.2323/jgam.32.25	39	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29216	10.1371/journal.pone.0029216	http://dx.doi.org/10.1371/journal.pone.0029216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216217	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600068
J	Pessina, A; Bonomi, A; Cocce, V; Invernici, G; Navone, S; Cavicchini, L; Sisto, F; Ferrari, M; Vigano, L; Locatelli, A; Ciusani, E; Cappelletti, G; Cartelli, D; Arnaldo, C; Parati, E; Marfia, G; Pallini, R; Falchetti, ML; Alessandri, G				Pessina, Augusto; Bonomi, Arianna; Cocce, Valentina; Invernici, Gloria; Navone, Stefania; Cavicchini, Loredana; Sisto, Francesca; Ferrari, Maura; Vigano, Lucia; Locatelli, Alberta; Ciusani, Emilio; Cappelletti, Graziella; Cartelli, Daniele; Arnaldo, Caruso; Parati, Eugenio; Marfia, Giovanni; Pallini, Roberto; Falchetti, Maria Laura; Alessandri, Giulio			Mesenchymal Stromal Cells Primed with Paclitaxel Provide a New Approach for Cancer Therapy	PLOS ONE			English	Article							HUMAN BONE-MARROW; UMBILICAL-CORD BLOOD; STEM-CELLS; MULTIDRUG-RESISTANCE; IN-VITRO; ADIPOSE-TISSUE; MELANOMA GROWTH; LARGE ANIMALS; GENE-THERAPY; DELIVERY	Background: Mesenchymal stromal cells may represent an ideal candidate to deliver anti-cancer drugs. In a previous study, we demonstrated that exposure of mouse bone marrow derived stromal cells to Doxorubicin led them to acquire anti-proliferative potential towards co-cultured haematopoietic stem cells (HSCs). We thus hypothesized whether freshly isolated human bone marrow Mesenchymal stem cells (hMSCs) and mature murine stromal cells (SR4987 line) primed in vitro with anti-cancer drugs and then localized near cancer cells, could inhibit proliferation. Methods and Principal Findings: Paclitaxel (PTX) was used to prime culture of hMSCs and SR4987. Incorporation of PTX into hMSCs was studied by using FICT-labelled-PTX and analyzed by FACS and confocal microscopy. Release of PTX in culture medium by PTX primed hMSCs (hMSCsPTX) was investigated by HPLC. Culture of Endothelial cells (ECs) and aorta ring assay were used to test the anti-angiogenic activity of hMSCsPTX and PTX primed SR4987(SR4987PTX), while antitumor activity was tested in vitro on the proliferation of different tumor cell lines and in vivo by co-transplanting hMSCsPTX and SR4987PTX with cancer cells in mice. Nevertheless, despite a loss of cells due to chemo-induced apoptosis, both hMSCs and SR4987 were able to rapidly incorporate PTX and could slowly release PTX in the culture medium in a time dependent manner. PTX primed cells acquired a potent anti-tumor and anti-angiogenic activity in vitro that was dose dependent, and demonstrable by using their conditioned medium or by co-culture assay. Finally, hMSCsPTX and SR4987PTX co-injected with human cancer cells (DU145 and U87MG) and mouse melanoma cells (B16) in immunodeficient and in syngenic mice significantly delayed tumor takes and reduced tumor growth. Conclusions: These data demonstrate, for the first time, that without any genetic manipulation, mesenchymal stromal cells can uptake and subsequently slowly release PTX. This may lead to potential new tools to increase efficacy of cancer therapy.	[Pessina, Augusto; Bonomi, Arianna; Cocce, Valentina; Cavicchini, Loredana; Sisto, Francesca] Univ Milan, Dept Publ Hlth, Milan, Italy; [Invernici, Gloria; Navone, Stefania; Parati, Eugenio; Marfia, Giovanni; Alessandri, Giulio] Fdn IRCCS Neurol Inst Carlo Besta, Dept Cerebrovasc Dis, Milan, Italy; [Ferrari, Maura] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Vigano, Lucia; Locatelli, Alberta] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Ciusani, Emilio] Fdn IRCCS Neurol Inst Carlo Besta, Dept Diagnost & Appl Technol, Milan, Italy; [Cappelletti, Graziella; Cartelli, Daniele] Univ Milan, Dept Biol, Milan, Italy; [Arnaldo, Caruso] Univ Brescia, Dept Expt & Appl Med, Brescia, Italy; [Pallini, Roberto] Univ Cattolica Sacro Cuore, Sch Med, Inst Neurosurg, I-00168 Rome, Italy; [Falchetti, Maria Laura] CNR, Inst Neurobiol & Mol Med, Rome, Italy	University of Milan; IRCCS Istituto Neurologico Besta; IZS Lombardia e Emilia; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Istituto Neurologico Besta; University of Milan; University of Brescia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR)	Pessina, A (corresponding author), Univ Milan, Dept Publ Hlth, Milan, Italy.	augusto.pessina@unimi.it	PALLINI, Roberto/AAA-3747-2019; falchetti, maria laura/AAA-5586-2019; LOCATELLI, ALBERTA/K-6960-2018; Marfia, Giovanni/AAB-8702-2020; Marfia, Giovanni/N-4650-2014; Cartelli, Daniele/AAI-3424-2021; Cartelli, Daniele/K-5110-2018; navone, stefania/Y-4779-2019; navone, stefania e/K-7264-2016; Parati, Eugenio Agostino/AAN-5893-2021; Cappelletti, Graziella/AAS-7780-2021; Viganò, Lucia/AAN-3826-2020; Pallini, Roberto/AAA-3760-2019; Ciusani, Emilio/J-9822-2016	PALLINI, Roberto/0000-0002-4611-8827; Marfia, Giovanni/0000-0002-5849-7000; Marfia, Giovanni/0000-0002-5849-7000; Cartelli, Daniele/0000-0002-7069-420X; Cartelli, Daniele/0000-0002-7069-420X; navone, stefania/0000-0002-0097-9146; navone, stefania e/0000-0002-0097-9146; Parati, Eugenio Agostino/0000-0001-5020-6523; Ciusani, Emilio/0000-0002-7285-123X; alessandri, giulio/0000-0002-1861-8461; Vigano, Lucia/0000-0003-4538-4354; SISTO, FRANCESCA/0000-0003-0166-2164; Cappelletti, Graziella/0000-0003-0903-5392	AIRC (Associazione Italiana per la Ricerca sul Cancro) [AIRC IG-9062]; National Italian Grant; Fondazione Banca del Monte di Lombardia	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); National Italian Grant; Fondazione Banca del Monte di Lombardia	This research was partially supported by AIRC (Associazione Italiana per la Ricerca sul Cancro) Project AIRC IG-9062, National Italian Grant PUR 2008 and Fondazione Banca del Monte di Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axel DI, 1997, CIRCULATION, V96, P636; Belotti D, 1996, CLIN CANCER RES, V2, P1843; BREEDEN JH, 1982, CANCER, V50, P1728, DOI 10.1002/1097-0142(19821101)50:9<1728::AID-CNCR2820500913>3.0.CO;2-N; Caruso A, 2002, J MED VIROL, V67, P528, DOI 10.1002/jmv.10133; CHAUDHARY PM, 1993, J NATL CANCER I, V85, P632, DOI 10.1093/jnci/85.8.632; Ciavarella S, 2011, STEM CELLS DEV, V20, P1, DOI 10.1089/scd.2010.0223; Comite P, 2010, TRANSPL P, V42, P1341, DOI 10.1016/j.transproceed.2010.03.080; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Elsdale T, 1992, J CELL BIO, V54, P5539; Elzaouk L, 2006, EXP DERMATOL, V15, P865, DOI 10.1111/j.1600-0625.2006.00479.x; GIANNI L, 1995, J CLIN ONCOL, V13, P180, DOI 10.1200/JCO.1995.13.1.180; Gille L, 1997, FREE RADICAL BIO MED, V23, P775, DOI 10.1016/S0891-5849(97)00025-7; Invernici G, 2007, AM J PATHOL, V170, P1879, DOI 10.2353/ajpath.2007.060646; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; KANE SE, 1990, J BIOENERG BIOMEMBR, V22, P593, DOI 10.1007/BF00762963; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Kumar G, 1995, CANCER CHEMOTH PHARM, V36, P129; Kunstfeld R, 2003, J INVEST DERMATOL, V120, P476, DOI 10.1046/j.1523-1747.2003.12057.x; LALANDE ME, 1981, P NATL ACAD SCI-BIOL, V78, P363, DOI 10.1073/pnas.78.1.363; LAMPIDIS TJ, 1985, CANCER RES, V45, P2626; Li J, 2004, BRIT J HAEMATOL, V127, P326, DOI 10.1111/j.1365-2141.2004.05200.x; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; Maestroni GJM, 1999, CELL MOL LIFE SCI, V55, P663, DOI 10.1007/s000180050322; Menon L.G., 2009, STEM CELL RES COMMUN, DOI [10.3824/stembook.1.35.1, DOI 10.3824/STEMBOOK.1.35.1, 10.3824/stembook.1.35.1.]; MICKEY DD, 1977, CANCER RES, V37, P4049; MINOWADA J, 1972, J NATL CANCER I, V49, P891; Molinari A, 1998, INT J CANCER, V75, P885, DOI 10.1002/(SICI)1097-0215(19980316)75:6<885::AID-IJC11>3.0.CO;2-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller LP, 2006, STEM CELLS, V24, P2753, DOI 10.1634/stemcells.2006-0108; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; NEYFAKH AA, 1988, EXP CELL RES, V178, P513, DOI 10.1016/0014-4827(88)90419-3; NEYFAKH AA, 1988, EXP CELL RES, V174, P168, DOI 10.1016/0014-4827(88)90152-8; NICOSIA RF, 1990, LAB INVEST, V63, P115; Nobili S, 2006, CURR DRUG TARGETS, V7, P861, DOI 10.2174/138945006777709593; Pessina A, 1999, LIFE SCI, V65, P513, DOI 10.1016/S0024-3205(99)00272-6; Pessina A, 2004, BIOCHEM BIOPH RES CO, V323, P315, DOI 10.1016/j.bbrc.2004.08.088; PESSINA A, 1992, CYTOTECHNOLOGY, V8, P93, DOI 10.1007/BF02525491; Pessina A, 2011, CELL BIOL TOXICOL, V27, P169, DOI 10.1007/s10565-010-9179-x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polioudaki H, 2009, CELL PROLIFERAT, V42, P434, DOI 10.1111/j.1365-2184.2009.00607.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; RENNISON ME, 1992, J CELL SCI, V102, P239; RILEY V, 1963, ANN NY ACAD SCI, V100, P762, DOI 10.1111/j.1749-6632.1963.tb42889.x; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Singla AK, 2002, INT J PHARMACEUT, V235, P179, DOI 10.1016/S0378-5173(01)00986-3; Stagg J, 2004, HUM GENE THER, V15, P597, DOI 10.1089/104303404323142042; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Studeny M, 2002, CANCER RES, V62, P3603; Tormin A, 2009, CYTOTHERAPY, V11, P114, DOI 10.1080/14653240802716590; Weldon JE, 2009, BLOOD, V113, P3792, DOI 10.1182/blood-2008-08-173195; Yong RL, 2009, CANCER RES, V69, P8932, DOI 10.1158/0008-5472.CAN-08-3873; Zhang J, 2007, BLOOD PURIFICAT, V25, P155, DOI 10.1159/000098018; Zhang Peng, 2006, Ai Zheng, V25, P1243; Zhang XB, 2008, J CLIN INVEST, V118, P1502, DOI 10.1172/JCI34371	56	118	121	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28321	10.1371/journal.pone.0028321	http://dx.doi.org/10.1371/journal.pone.0028321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205945	Green Published, gold, Green Submitted			2022-12-25	WOS:000298666200006
J	Morello, LG; Coltri, PP; Quaresma, AJC; Simabuco, FM; Silva, TCL; Singh, G; Nickerson, JA; Oliveira, CC; Moore, MJ; Zanchin, NIT				Morello, Luis G.; Coltri, Patricia P.; Quaresma, Alexandre J. C.; Simabuco, Fernando M.; Silva, Tereza C. L.; Singh, Guramrit; Nickerson, Jeffrey A.; Oliveira, Carla C.; Moore, Melissa J.; Zanchin, Nilson I. T.			The Human Nucleolar Protein FTSJ3 Associates with NIP7 and Functions in Pre-rRNA Processing	PLOS ONE			English	Article							BIOGENESIS; YEAST; INTERACTS; BINDING; P53; EXOSOME; U3; EXPRESSION; MATURATION; MULTIPLE	NIP7 is one of the many trans-acting factors required for eukaryotic ribosome biogenesis, which interacts with nascent preribosomal particles and dissociates as they complete maturation and are exported to the cytoplasm. By using conditional knockdown, we have shown previously that yeast Nip7p is required primarily for 60S subunit synthesis while human NIP7 is involved in the biogenesis of 40S subunit. This raised the possibility that human NIP7 interacts with a different set of proteins as compared to the yeast protein. By using the yeast two-hybrid system we identified FTSJ3, a putative ortholog of yeast Spb1p, as a human NIP7-interacting protein. A functional association between NIP7 and FTSJ3 is further supported by colocalization and coimmunoprecipitation analyses. Conditional knockdown revealed that depletion of FTSJ3 affects cell proliferation and causes pre-rRNA processing defects. The major pre-rRNA processing defect involves accumulation of the 34S pre-rRNA encompassing from site A' to site 2b. Accumulation of this pre-rRNA indicates that processing of sites A0, 1 and 2 are slower in cells depleted of FTSJ3 and implicates FTSJ3 in the pathway leading to 18S rRNA maturation as observed previously for NIP7. The results presented in this work indicate a close functional interaction between NIP7 and FTSJ3 during pre-rRNA processing and show that FTSJ3 participates in ribosome synthesis in human cells.	[Morello, Luis G.; Simabuco, Fernando M.; Silva, Tereza C. L.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil; [Coltri, Patricia P.; Oliveira, Carla C.] Univ Sao Paulo, Dept Biochem, Sao Paulo, Brazil; [Quaresma, Alexandre J. C.; Nickerson, Jeffrey A.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Quaresma, Alexandre J. C.; Nickerson, Jeffrey A.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA USA; [Morello, Luis G.; Singh, Guramrit; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Morello, Luis G.; Singh, Guramrit; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Zanchin, Nilson I. T.] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Curitiba, Parana, Brazil	Universidade de Sao Paulo; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Fundacao Oswaldo Cruz	Morello, LG (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil.	nilson.zanchin@pq.cnpq.br	Zanchin, Nilson Ivo Tonin/AAB-4907-2019; Quaresma, Alexandre Jose Christino/E-4229-2010; Oliveira, Carla C/F-2323-2011; Coltri, Patricia P./E-6294-2014; Simabuco, Fernando M/G-8421-2017; Simabuco, Fernando M/GQA-4176-2022	Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694; Oliveira, Carla C/0000-0002-1098-9241; Coltri, Patricia P./0000-0001-8447-7516; Simabuco, Fernando M/0000-0002-1672-9686; Simabuco, Fernando M/0000-0002-1672-9686	FAPESP [06/02083-7, 2007/58371-3, 2003/06299-6, 2008/57110-4]; CNPq [473551/2008-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP (grant 06/02083-7) and CNPq (grant 473551/2008-0) to NITZ. LGM, PPC, and FMS were recipients of FAPESP fellowships (2007/58371-3, 2003/06299-6 and 2008/57110-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2007, MOL THER, V15, P938, DOI 10.1038/sj.mt.6300118; Bonnerot C, 2003, MOL CELL, V12, P1309, DOI 10.1016/S1097-2765(03)00435-0; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; BOWMAN LH, 1981, NUCLEIC ACIDS RES, V9, P4951, DOI 10.1093/nar/9.19.4951; Carron C, 2011, NUCLEIC ACIDS RES, V39, P280, DOI 10.1093/nar/gkq734; Chen WD, 2003, NUCLEIC ACIDS RES, V31, P690, DOI 10.1093/nar/gkg145; Coltri PP, 2007, BIOCHEMISTRY-US, V46, P14177, DOI 10.1021/bi7015876; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Fujiyama S, 2002, J BIOL CHEM, V277, P23773, DOI 10.1074/jbc.M201181200; Fujiyama-Nakamura S, 2009, MOL CELL PROTEOMICS, V8, P1552, DOI 10.1074/mcp.M900147-MCP200; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Granato DC, 2005, FEBS J, V272, P4450, DOI 10.1111/j.1742-4658.2005.04861.x; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hesling C, 2007, EXP CELL RES, V313, P4180, DOI 10.1016/j.yexcr.2007.06.024; Holzel M, 2010, ONCOTARGET, V1, P43; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kota KP, 2008, J CELL SCI, V121, P1526, DOI 10.1242/jcs.021055; Kressler D, 1999, NUCLEIC ACIDS RES, V27, P4598, DOI 10.1093/nar/27.23.4598; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Lapeyre B, 2004, MOL CELL, V16, P663, DOI 10.1016/j.molcel.2004.10.022; Lebreton A, 2008, NUCLEIC ACIDS RES, V36, P4988, DOI 10.1093/nar/gkn469; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Luz JS, 2009, YEAST, V26, P287, DOI 10.1002/yea.1668; Miles TD, 2005, MOL CELL BIOL, V25, P10419, DOI 10.1128/MCB.25.23.10419-10432.2005; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Morello LG, 2011, NUCLEIC ACIDS RES, V39, P648, DOI 10.1093/nar/gkq758; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Orru S, 2007, MOL CELL PROTEOMICS, V6, P382, DOI 10.1074/mcp.M600156-MCP200; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sambrook J., MOL CLONING LAB MANU; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Takahashi N, 2003, MASS SPECTROM REV, V22, P287, DOI 10.1002/mas.10057; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Wagner S, 2003, P NATL ACAD SCI USA, V100, P3269, DOI 10.1073/pnas.0438055100; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001; Zanchin NIT, 1999, NUCLEIC ACIDS RES, V27, P1283, DOI 10.1093/nar/27.5.1283; Zanchin NIT, 1999, MOL CELL BIOL, V19, P1518	53	23	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29174	10.1371/journal.pone.0029174	http://dx.doi.org/10.1371/journal.pone.0029174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195017	Green Published, gold, Green Submitted			2022-12-25	WOS:000298664400039
J	Rigottier-Gois, L; Alberti, A; Houel, A; Taly, JF; Palcy, P; Manson, J; Pinto, D; Matos, RC; Carrilero, L; Montero, N; Tariq, M; Karsens, H; Repp, C; Kropec, A; Budin-Verneuil, A; Benachour, A; Sauvageot, N; Bizzini, A; Gilmore, MS; Bessieres, P; Kok, J; Huebner, J; Lopes, F; Gonzalez-Zorn, B; Hartke, A; Serror, P				Rigottier-Gois, Lionel; Alberti, Adriana; Houel, Armel; Taly, Jean-Francois; Palcy, Philippe; Manson, Janet; Pinto, Daniela; Matos, Renata C.; Carrilero, Laura; Montero, Natalia; Tariq, Muhammad; Karsens, Harma; Repp, Christian; Kropec, Andrea; Budin-Verneuil, Aurelie; Benachour, Abdellah; Sauvageot, Nicolas; Bizzini, Alain; Gilmore, Michael S.; Bessieres, Philippe; Kok, Jan; Huebner, Johannes; Lopes, Fatima; Gonzalez-Zorn, Bruno; Hartke, Axel; Serror, Pascale			Large-Scale Screening of a Targeted Enterococcus faecalis Mutant Library Identifies Envelope Fitness Factors	PLOS ONE			English	Article							OXIDATIVE-STRESS-RESPONSE; GRAM-POSITIVE BACTERIA; CATIONIC ANTIMICROBIAL PEPTIDES; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; POLYSACCHARIDE BIOSYNTHESIS; CAPSULAR POLYSACCHARIDE; CELL-WALL; RESISTANT ENTEROCOCCI; LIPOTEICHOIC ACID	Spread of antibiotic resistance among bacteria responsible for nosocomial and community-acquired infections urges for novel therapeutic or prophylactic targets and for innovative pathogen-specific antibacterial compounds. Major challenges are posed by opportunistic pathogens belonging to the low GC% Gram-positive bacteria. Among those, Enterococcus faecalis is a leading cause of hospital-acquired infections associated with life-threatening issues and increased hospital costs. To better understand the molecular properties of enterococci that may be required for virulence, and that may explain the emergence of these bacteria in nosocomial infections, we performed the first large-scale functional analysis of E. faecalis V583, the first vancomycin-resistant isolate from a human bloodstream infection. E. faecalis V583 is within the high-risk clonal complex 2 group, which comprises mostly isolates derived from hospital infections worldwide. We conducted broad-range screenings of candidate genes likely involved in host adaptation (e. g., colonization and/or virulence). For this purpose, a library was constructed of targeted insertion mutations in 177 genes encoding putative surface or stress-response factors. Individual mutants were subsequently tested for their i) resistance to oxidative stress, ii) antibiotic resistance, iii) resistance to opsonophagocytosis, iv) adherence to the human colon carcinoma Caco-2 epithelial cells and v) virulence in a surrogate insect model. Our results identified a number of factors that are involved in the interaction between enterococci and their host environments. Their predicted functions highlight the importance of cell envelope glycopolymers in E. faecalis host adaptation. This study provides a valuable genetic database for understanding the steps leading E. faecalis to opportunistic virulence.	[Rigottier-Gois, Lionel; Alberti, Adriana; Houel, Armel; Palcy, Philippe; Serror, Pascale] INRA, UMR Micalis 1319, Jouy En Josas, France; [Rigottier-Gois, Lionel; Alberti, Adriana; Houel, Armel; Palcy, Philippe; Serror, Pascale] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Taly, Jean-Francois; Bessieres, Philippe] INRA, MIG, UR1077, Jouy En Josas, France; [Manson, Janet; Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Manson, Janet; Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Pinto, Daniela; Matos, Renata C.; Lopes, Fatima] Inst Biol Expt & Tecnol, Oeiras, Portugal; [Carrilero, Laura; Montero, Natalia; Gonzalez-Zorn, Bruno] Univ Complutense Madrid, Fac Vet, Dept Sanidad Anim, Madrid, Spain; [Carrilero, Laura; Montero, Natalia; Gonzalez-Zorn, Bruno] Univ Complutense Madrid, VISAVET, Madrid, Spain; [Tariq, Muhammad; Karsens, Harma; Kok, Jan] Univ Groningen, Ctr Life Sci, Groningen, Netherlands; [Repp, Christian; Kropec, Andrea; Huebner, Johannes] Univ Hosp Freiburg, Div Infect Dis, Freiburg, Germany; [Budin-Verneuil, Aurelie; Benachour, Abdellah; Sauvageot, Nicolas; Bizzini, Alain; Hartke, Axel] Univ Caen, IBFA, Lab Environm Microbiol, F-14032 Caen, France; [Lopes, Fatima] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Complutense University of Madrid; Complutense University of Madrid; University of Groningen; University of Freiburg; Universite de Caen Normandie; Universidade Nova de Lisboa	Rigottier-Gois, L (corresponding author), INRA, UMR Micalis 1319, Jouy En Josas, France.	pascale.serror@jouy.inra.fr	Natalia, Montero/A-6508-2013; Alberti, Adriana/E-7142-2017; Kok, Jan/C-9972-2012; studies, IT VISAVET Account for bibliometric/C-3115-2014; Pinto, Daniela/D-1496-2013; Lopes, Maria de Fátima/J-7019-2018; Alberti, Adriana/AAZ-2013-2021; Serror, Pascale/ABA-1314-2021	Alberti, Adriana/0000-0003-3372-9423; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Pinto, Daniela/0000-0002-2405-8755; Alberti, Adriana/0000-0003-3372-9423; Serror, Pascale/0000-0002-8446-9011; Matos, Renata C./0000-0001-7480-6099; Huebner, Johannes/0000-0003-1232-4646; Rigottier-Gois, Lionel/0000-0003-1561-7700; BUDIN-VERNEUIL, Aurelie/0000-0002-1173-251X; Bizzini, Alain/0000-0001-5282-2266	French (Agence Nationale de la Recherche), German [ANR-06-PATHO-008, 0313933]; French (Agence Nationale de la Recherche), Spanish [GEN2006-27767-E/PAT]; French (Agence Nationale de la Recherche), Portuguese; ERA-Net PathoGenoMics [ERA-PTG/0001/2006, PEst-OE/EQB/LA0004/2011]; National Institutes of Health (NIH) [AI072360, AI083214]; Higher Education Commission of the Government of Pakistan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072360, P01AI083214] Funding Source: NIH RePORTER	French (Agence Nationale de la Recherche), German(French National Research Agency (ANR)); French (Agence Nationale de la Recherche), Spanish(French National Research Agency (ANR)); French (Agence Nationale de la Recherche), Portuguese(French National Research Agency (ANR)); ERA-Net PathoGenoMics; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higher Education Commission of the Government of Pakistan(Higher Education Commission of Pakistan); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by French (Agence Nationale de la Recherche grant ANR-06-PATHO-008), German, (0313933), Spanish (GEN2006-27767-E/PAT) and Portuguese (Fundacao para a Ciencia e Tecnologia through grant ERA-PTG/0001/2006 and PEst-OE/EQB/LA0004/2011) grants from the 1st call of the ERA-Net PathoGenoMics, a European program for cooperation and coordination of genome sequencing and functional genomics of human-pathogenic microorganisms. This work was also supported by National Institutes of Health (NIH) grant AI072360, and the Harvard-Wide Antibiotic Resistance Project NIH grant AI083214. MT was supported by a scholarship from the Higher Education Commission of the Government of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2004, APPL ENVIRON MICROB, V70, P5177, DOI 10.1128/AEM.70.9.5177-5182.2004; Baldwin TJ, 1998, J MED MICROBIOL, V47, P283, DOI 10.1099/00222615-47-4-283; Ballering KS, 2009, J BACTERIOL, V191, P2806, DOI 10.1128/JB.01688-08; Bar K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-145; Barcelona-Andres B, 2002, J BACTERIOL, V184, P6289, DOI 10.1128/JB.184.22.6289-6300.2002; Beard SJ, 2000, FEMS MICROBIOL LETT, V184, P231, DOI 10.1016/S0378-1097(00)00055-0; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Brinster S, 2007, J BACTERIOL, V189, P1244, DOI 10.1128/JB.00773-06; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P565; Cesselin B, 2009, MICROBIOL-SGM, V155, P2274, DOI 10.1099/mic.0.027797-0; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Donskey CJ, 2004, CLIN INFECT DIS, V39, P219, DOI 10.1086/422002; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dubnau E, 2003, MICROBES INFECT, V5, P629, DOI 10.1016/S1286-4579(03)00090-X; Franz CMAP, 1999, INT J FOOD MICROBIOL, V47, P1, DOI 10.1016/S0168-1605(99)00007-0; Garsin DA, 2004, J BACTERIOL, V186, P7280, DOI 10.1128/JB.186.21.7280-7289.2004; Gilmore MS, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P301; Gilmore MS, 2003, SCIENCE, V299, P1999, DOI 10.1126/science.1083534; Giraffa G, 2003, INT J FOOD MICROBIOL, V88, P215, DOI 10.1016/S0168-1605(03)00183-1; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; HOOPER DC, 1984, ANTIMICROB AGENTS CH, V25, P586, DOI 10.1128/AAC.25.5.586; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kayaoglu G, 2004, CRIT REV ORAL BIOL M, V15, P308, DOI 10.1177/154411130401500506; Kleerebezem M, 1999, ANTON LEEUW INT J G, V76, P357, DOI 10.1023/A:1002084822851; Koch S, 2004, VACCINE, V22, P822, DOI 10.1016/j.vaccine.2003.11.027; Krueger WA, 2004, CRIT CARE MED, V32, P467, DOI 10.1097/01.CCM.0000109447.04893.48; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Le Breton Y, 2002, CURR MICROBIOL, V45, P434, DOI 10.1007/s00284-002-3714-3; Lund B, 2003, J CLIN MICROBIOL, V41, P5183, DOI 10.1128/JCM.41.11.5183-5185.2003; Maadani A, 2007, INFECT IMMUN, V75, P2634, DOI 10.1128/IAI.01372-06; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Manson JM, 2003, ANTIMICROB AGENTS CH, V47, P204, DOI 10.1128/AAC.47.1.204-210.2003; Mater DDG, 2008, J MOL MICROB BIOTECH, V14, P123, DOI 10.1159/000106091; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; McIver KS, 2002, MOL MICROBIOL, V43, P1591, DOI 10.1046/j.1365-2958.2002.02849.x; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Mollerach M, 1998, J EXP MED, V188, P2047, DOI 10.1084/jem.188.11.2047; Mundy LM, 2000, CLIN MICROBIOL REV, V13, P513, DOI 10.1128/CMR.13.4.513-522.2000; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Ogier JC, 2008, INT J FOOD MICROBIOL, V126, P291, DOI 10.1016/j.ijfoodmicro.2007.08.017; Palmer KL, 2010, J BACTERIOL, V192, P2469, DOI 10.1128/JB.00153-10; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; PEEL T, 2011, CLIN MICROBIOL INFEC, DOI DOI 10.1111/J.1469-0691.2011.03591.X; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sava IG, 2009, J BIOL CHEM, V284, P18194, DOI 10.1074/jbc.M901460200; Schaible U E, 1999, Adv Immunol, V71, P267; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shepard BD, 2002, MICROBES INFECT, V4, P215, DOI 10.1016/S1286-4579(01)01530-1; SINHA RP, 1989, FEMS MICROBIOL LETT, V57, P349, DOI [10.1111/j.1574-6968.1989.tb03362.x, 10.1016/0378-1097(89)90327-3]; Solheim M, 2007, APPL ENVIRON MICROB, V73, P5767, DOI 10.1128/AEM.00651-07; Solheim M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-3; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; Teng F, 2002, INFECT IMMUN, V70, P1991, DOI 10.1128/IAI.70.4.1991-1996.2002; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; Theilacker C, 2004, VACCINE, V22, pS31, DOI 10.1016/j.vaccine.2004.08.014; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Thurlow LR, 2009, J BACTERIOL, V191, P6203, DOI 10.1128/JB.00592-09; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Verneuil N, 2005, MICROBIOL-SGM, V151, P3997, DOI 10.1099/mic.0.28325-0; Verneuil N, 2005, FEMS MICROBIOL LETT, V252, P137, DOI 10.1016/j.femsle.2005.08.043; Verneuil N, 2004, INFECT IMMUN, V72, P4424, DOI 10.1128/IAI.72.8.4424-4431.2004; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; WELLS CL, 1990, J INFECT DIS, V162, P82, DOI 10.1093/infdis/162.1.82; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xu Y, 1998, INFECT IMMUN, V66, P4313; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000; Zeng J, 2004, J CLIN MICROBIOL, V42, P1149, DOI 10.1128/JCM.42.3.1149-1154.2004; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	84	44	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29023	10.1371/journal.pone.0029023	http://dx.doi.org/10.1371/journal.pone.0029023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194979	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000298370400027
J	Farlay, D; Duclos, ME; Gineyts, E; Bertholon, C; Viguet-Carrin, S; Nallala, J; Sockalingum, GD; Bertrand, D; Roger, T; Hartmann, DJ; Chapurlat, R; Boivin, G				Farlay, Delphine; Duclos, Marie-Eve; Gineyts, Evelyne; Bertholon, Cindy; Viguet-Carrin, Stephanie; Nallala, Jayakrupakar; Sockalingum, Ganesh D.; Bertrand, Dominique; Roger, Thierry; Hartmann, Daniel J.; Chapurlat, Roland; Boivin, Georges			The Ratio 1660/1690 cm(-1) Measured by Infrared Microspectroscopy Is Not Specific of Enzymatic Collagen Cross-Links in Bone Tissue	PLOS ONE			English	Article							AMIDE-I BAND; BETA-AMINOPROPRIONITRILE; MECHANICAL-PROPERTIES; VIBRATIONAL ANALYSIS; HELICAL STRUCTURE; OSTEONAL BONE; CHICK BONE; PROTEINS; MATRIX; POLYPEPTIDES	In postmenopausal osteoporosis, an impairment in enzymatic cross-links (ECL) occurs, leading in part to a decline in bone biomechanical properties. Biochemical methods by high performance liquid chromatography (HPLC) are currently used to measure ECL. Another method has been proposed, by Fourier Transform InfraRed Imaging (FTIRI), to measure a mature PYD/immature DHLNL cross-links ratio, using the 1660/1690 cm(-1) area ratio in the amide I band. However, in bone, the amide I band composition is complex (collagens, non-collagenous proteins, water vibrations) and the 1660/1690 cm(-1) by FTIRI has never been directly correlated with the PYD/DHLNL by HPLC. A study design using lathyritic rats, characterized by a decrease in the formation of ECL due to the inhibition of lysyl oxidase, was used in order to determine the evolution of 1660/1690 cm(-1) by FTIR Microspectroscopy in bone tissue and compare to the ECL quantified by HPLC. The actual amount of ECL was quantified by HPLC on cortical bone from control and lathyritic rats. The lathyritic group exhibited a decrease of 78% of pyridinoline content compared to the control group. The 1660/1690 cm(-1) area ratio was increased within center bone compared to inner bone, and this was also correlated with an increase in both mineral maturity and mineralization index. However, no difference in the 1660/1690 cm(-1) ratio was found between control and lathyritic rats. Those results were confirmed by principal component analysis performed on multispectral infrared images. In bovine bone, in which PYD was physically destructed by UV-photolysis, the PYD/DHLNL (measured by HPLC) was strongly decreased, whereas the 1660/1690 cm(-1) was unmodified. In conclusion, the 1660/1690 cm(-1) is not related to the PYD/DHLNL ratio, but increased with age of bone mineral, suggesting that a modification of this ratio could be mainly due to a modification of the collagen secondary structure related to the mineralization process.	[Farlay, Delphine; Gineyts, Evelyne; Bertholon, Cindy; Viguet-Carrin, Stephanie; Chapurlat, Roland; Boivin, Georges] INSERM, UMR 1033, F-69008 Lyon, France; [Farlay, Delphine; Duclos, Marie-Eve; Gineyts, Evelyne; Bertholon, Cindy; Viguet-Carrin, Stephanie; Roger, Thierry; Hartmann, Daniel J.; Chapurlat, Roland; Boivin, Georges] Univ Lyon, Lyon, France; [Duclos, Marie-Eve; Nallala, Jayakrupakar; Sockalingum, Ganesh D.] Univ Reims, CNRS MEDyC UMR6237, MeDIAN, Reims, France; [Duclos, Marie-Eve; Bertrand, Dominique] INRA, F-44026 Nantes, France; [Roger, Thierry] VetAgro Sup Lyon, UPSP 2011 03 101, Lyon, France; [Hartmann, Daniel J.] Univ Lyon 1, UMR CNRS 5510, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; INRAE; VetAgro Sup; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Farlay, D (corresponding author), INSERM, UMR 1033, F-69008 Lyon, France.	delphine.farlay@inserm.fr	CHAPURLAT, ROLAND/AAU-1165-2021; FARLAY, Delphine/AGF-1234-2022	FARLAY, Delphine/0000-0001-6487-0337; ROGER, Thierry/0000-0001-5684-8770; Nallala, Jayakrupakar/0000-0002-9473-5782	GRIO (Groupe de Recherche et d'Information sur les Osteoporoses)	GRIO (Groupe de Recherche et d'Information sur les Osteoporoses)	D. Farlay is recipient of a grant from GRIO (Groupe de Recherche et d'Information sur les Osteoporoses). Website: www.grio.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AJ, 1999, EXP GERONTOL, V34, P337, DOI 10.1016/S0531-5565(99)00016-9; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B; BANDEKAR J, 1979, P NATL ACAD SCI USA, V76, P774, DOI 10.1073/pnas.76.2.774; BANDEKAR J, 1980, BIOPOLYMERS, V19, P31, DOI 10.1002/bip.1980.360190103; Bonnelye E, 2002, ENDOCRINOLOGY, V143, P3658, DOI 10.1210/en.2002-220095; Bonnier F, 2008, ANALYST, V133, P784, DOI 10.1039/b717164a; Bruel A, 1998, ATHEROSCLEROSIS, V140, P135, DOI 10.1016/S0021-9150(98)00130-0; Dowd TL, 2003, BIOCHEMISTRY-US, V42, P7769, DOI 10.1021/bi034470s; Farlay D, 2010, J BONE MINER METAB, V28, P433, DOI 10.1007/s00774-009-0146-7; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Gineyts E, 2010, J CHROMATOGR B, V878, P1449, DOI 10.1016/j.jchromb.2010.03.039; Gourion-Arsiquaud S, 2009, J BONE MINER RES, V24, P1271, DOI [10.1359/JBMR.090201, 10.1359/jbmr.090201]; HAMRE CJ, 1957, ARCH PATHOL, V64, P426; HAMRE CJ, 1958, ARCH PATHOL, V65, P215; HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; KUNDEL HL, 1964, RADIOLOGY, V82, P67, DOI 10.1148/82.1.67; LALICH JJ, 1970, ARCH PATHOL, V90, P22; LAZAREV YA, 1985, BIOPOLYMERS, V24, P1449, DOI 10.1002/bip.360240804; LAZAREV YA, 1992, BIOPOLYMERS, V32, P189, DOI 10.1002/bip.360320209; Le Quang T., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P109, DOI 10.1080/10255840701479248; LEES S, 1987, CONNECT TISSUE RES, V16, P281, DOI 10.3109/03008208709005616; LEES S, 1990, CONNECT TISSUE RES, V24, P95, DOI 10.3109/03008209009152426; Masse PG, 1996, BONE, V18, P567, DOI 10.1016/8756-3282(96)00072-5; MASSE PG, 1995, J NUTR, V125, P26; MASSE PG, 1990, SCANNING MICROSCOPY, V4, P667; Miller LM, 1999, P SOC PHOTO-OPT INS, V3775, P104, DOI 10.1117/12.366634; Nanci A, 1999, J STRUCT BIOL, V126, P256, DOI 10.1006/jsbi.1999.4137; Nyman JS, 2006, J BIOMECH, V39, P931, DOI 10.1016/j.jbiomech.2005.01.012; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; OPSAHL W, 1982, J NUTR, V112, P708, DOI 10.1093/jn/112.4.708; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/BF00369214; ROBINSON RA, 1975, CLIN ORTHOP RELAT R, P263; ROBINSON RA, 1957, J BONE JOINT SURG AM, V39, P167, DOI 10.2106/00004623-195739010-00015; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; SAKURA S, 1982, CAN J BIOCHEM CELL B, V60, P525, DOI 10.1139/o82-064; SANDHU HS, 1982, CALCIFIED TISSUE INT, V34, P80, DOI 10.1007/BF02411213; SANDHU HS, 1982, ACTA ANAT, V112, P242; SANDHU HS, 1981, ACTA ANAT, V111, P281; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; SPENGLER DM, 1977, J BONE JOINT SURG AM, V59, P670, DOI 10.2106/00004623-197759050-00014; SROGA G, 2009, J BONE MINER RES S1, V24; SROGA GE, 2011, J CHROMATOGR B; SUSI H, 1967, J BIOL CHEM, V242, P5460; Susi H, 1972, Methods Enzymol, V26, P381; Tye CE, 2003, J BIOL CHEM, V278, P7949, DOI 10.1074/jbc.M211915200; Viguet-Carrin S, 2009, J CHROMATOGR B, V877, P1, DOI 10.1016/j.jchromb.2008.10.043; Yeni YN, 2006, CALCIFIED TISSUE INT, V78, P363, DOI 10.1007/s00223-005-0301-7	52	67	66	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28736	10.1371/journal.pone.0028736	http://dx.doi.org/10.1371/journal.pone.0028736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194900	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100089
J	Rajan, P; Dalgliesh, C; Carling, PJ; Buist, T; Zhang, CL; Grellscheid, SN; Armstrong, K; Stockley, J; Simillion, C; Gaughan, L; Kalna, G; Zhang, MQ; Robson, CN; Leung, HY; Elliott, DJ				Rajan, Prabhakar; Dalgliesh, Caroline; Carling, Phillippa J.; Buist, Thomas; Zhang, Chaolin; Grellscheid, Sushma N.; Armstrong, Kelly; Stockley, Jacqueline; Simillion, Cedric; Gaughan, Luke; Kalna, Gabriela; Zhang, Michael Q.; Robson, Craig N.; Leung, Hing Y.; Elliott, David J.			Identification of Novel Androgen-Regulated Pathways and mRNA Isoforms through Genome-Wide Exon-Specific Profiling of the LNCaP Transcriptome	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; TUBEROUS-SCLEROSIS; RECEPTOR; EXPRESSION; GENES; PROLIFERATION; PROTEINS; BROWSER	Androgens drive the onset and progression of prostate cancer (PCa) by modulating androgen receptor (AR) transcriptional activity. Although several microarray-based studies have identified androgen-regulated genes, here we identify in-parallel global androgen-dependent changes in both gene and alternative mRNA isoform expression by exon-level analyses of the LNCaP transcriptome. While genome-wide gene expression changes correlated well with previously-published studies, we additionally uncovered a subset of 226 novel androgen-regulated genes. Gene expression pathway analysis of this subset revealed gene clusters associated with, and including the tyrosine kinase LYN, as well as components of the mTOR (mammalian target of rapamycin) pathway, which is commonly dysregulated in cancer. We also identified 1279 putative androgen-regulated alternative events, of which 325 (similar to 25%) mapped to known alternative splicing events or alternative first/last exons. We selected 30 androgen-dependent alternative events for RT-PCR validation, including mRNAs derived from genes encoding tumour suppressors and cell cycle regulators. Of seven positively-validating events (similar to 23%), five events involved transcripts derived from alternative promoters of known AR gene targets. In particular, we found a novel androgen-dependent mRNA isoform derived from an alternative internal promoter within the TSC2 tumour suppressor gene, which is predicted to encode a protein lacking an interaction domain required for mTOR inhibition. We confirmed that expression of this alternative TSC2 mRNA isoform was directly regulated by androgens, and chromatin immunoprecipitation indicated recruitment of AR to the alternative promoter region at early timepoints following androgen stimulation, which correlated with expression of alternative transcripts. Together, our data suggest that alternative mRNA isoform expression might mediate the cellular response to androgens, and may have roles in clinical PCa.	[Rajan, Prabhakar; Dalgliesh, Caroline; Carling, Phillippa J.; Buist, Thomas; Grellscheid, Sushma N.; Elliott, David J.] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rajan, Prabhakar; Kalna, Gabriela; Leung, Hing Y.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Rajan, Prabhakar; Leung, Hing Y.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Zhang, Chaolin; Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Armstrong, Kelly; Stockley, Jacqueline; Gaughan, Luke; Robson, Craig N.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Simillion, Cedric] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Beatson Institute; University of Glasgow; Cold Spring Harbor Laboratory; Newcastle University - UK; Newcastle University - UK	Rajan, P (corresponding author), Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	david.elliott@ncl.ac.uk	Coffey, Kelly/AAZ-4433-2020	Coffey, Kelly/0000-0003-0502-2914; Rajan, Prabhakar/0000-0001-8064-9878; Stockley, Jacqueline/0000-0001-6601-5107; Elliott, David/0000-0002-6930-0699; Leung, Hing Y./0000-0002-3933-3975; Simillion, Cedric/0000-0002-2026-6741	Association for International Cancer Research [06-705]; Medical Research Council [G0500482]; Royal College of Surgeons of England; Wellcome Trust [080388]; National Institutes for Health [GM074688]; MRC [G0500482] Funding Source: UKRI; Cancer Research UK [15151] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074688] Funding Source: NIH RePORTER	Association for International Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal College of Surgeons of England; Wellcome Trust(Wellcome Trust); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an Association for International Cancer Research project grant (06-705 to DJE and HYL), a Medical Research Council Clinical Research Training Fellowship (G0500482 to PR), a Royal College of Surgeons of England Surgical Research Fellowship (to PR), an Academy of Medical Sciences/Wellcome Trust Starter Grant for Clinical Lecturers (to PR), a Wellcome Trust Project grant (080388 to DJE) and a National Institutes for Health grant (GM074688 to MQZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen HM, 2000, MOL BIOL CELL, V11, P1357, DOI 10.1091/mbc.11.4.1357; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Cochrane DR, 2007, J BIOL CHEM, V282, P2278, DOI 10.1074/jbc.M608162200; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; DePrimo SE, 2002, GENOME BIOL, V3; Dutertre M, 2010, CANCER RES, V70, P3760, DOI 10.1158/0008-5472.CAN-09-3988; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Gangisetty O, 2004, ONCOGENE, V23, P2559, DOI 10.1038/sj.onc.1207424; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Rahrmann EP, 2009, CANCER RES, V69, P4388, DOI 10.1158/0008-5472.CAN-08-3901; Rajan P, 2008, J PATHOL, V215, P67, DOI 10.1002/path.2324; Rajan P, 2009, NAT REV UROL, V6, P454, DOI 10.1038/nrurol.2009.125; Rosner M, 2008, MUTAT RES-REV MUTAT, V658, P234, DOI 10.1016/j.mrrev.2008.01.001; Segawa T, 2002, ONCOGENE, V21, P8749, DOI 10.1038/sj.onc.1205992; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suh Y, 2010, CARCINOGENESIS, V31, P1424, DOI 10.1093/carcin/bgq115; Sun J, 2007, J STEROID BIOCHEM, V107, P131, DOI 10.1016/j.jsbmb.2007.05.031; Velasco AM, 2004, ENDOCRINOLOGY, V145, P3913, DOI 10.1210/en.2004-0311; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xu LL, 2001, INT J CANCER, V92, P322, DOI 10.1002/ijc.1196; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yap TA, 2011, NAT REV CLIN ONCOL, V8, P597, DOI 10.1038/nrclinonc.2011.117; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yu YP, 2005, BBA-GENE STRUCT EXPR, V1729, P1, DOI 10.1016/j.bbaexp.2005.02.006	42	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29088	10.1371/journal.pone.0029088	http://dx.doi.org/10.1371/journal.pone.0029088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194994	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000298369100152
J	Zou, L; Nair, A; Weng, H; Tsai, YT; Hu, ZB; Tang, LP				Zou, Ling; Nair, Ashwin; Weng, Hong; Tsai, Yi-Ting; Hu, Zhibing; Tang, Liping			Intraocular Pressure Changes: An Important Determinant of the Biocompatibility of Intravitreous Implants	PLOS ONE			English	Article							OCULAR DRUG-DELIVERY; CYTOMEGALOVIRUS RETINITIS; INTRAVENOUS CIDOFOVIR; ALBUMIN NANOPARTICLES; TRABECULAR MESHWORK; ANTERIOR UVEITIS; TISSUE RESPONSES; RISK-FACTORS; IN-VITRO; GLAUCOMA	Background: In recent years, research efforts exploring the possibility of using biomaterial nanoparticles for intravitreous drug delivery has increased significantly. However, little is known about the effect of material properties on intravitreous tissue responses. Principal Findings: To find the answer, nanoparticles made of hyaluronic acid (HA), poly (l-lactic acid) (PLLA), polystyrene (PS), and Poly N-isopropyl acrylamide (PNIPAM) were tested using intravitreous rabbit implantation model. Shortly after implantation, we found that most of the implants accumulated in the trabecular meshwork area followed by clearance from the vitreous. Interestingly, substantial reduction of intraocular pressure (IOP) was observed in eyes implanted with particles made of PS, PNIPAM and PLLA, but not HA nanoparticles and buffered salt solution control. On the other hand, based on histology, we found that the particle implantation had no influence on cornea, iris and even retina. Surprisingly, substantial CD11b+ inflammatory cells were found to accumulate in the trabecular meshwork area in some animals. In addition, there was a good relationship between recruited CD11b+ cells and IOP reduction. Conclusions: Overall, the results reveal the potential influence of nanoparticle material properties on IOP reduction and inflammatory responses in trabecular meshwork. Such interactions may be critical for the development of future ocular nanodevices with improved safety and perhaps efficacy.	[Zou, Ling; Nair, Ashwin; Weng, Hong; Tsai, Yi-Ting; Tang, Liping] Univ Texas SW Med Ctr Dallas, Joint Program Bioengn, Dallas, TX 75390 USA; [Zou, Ling; Nair, Ashwin; Weng, Hong; Tsai, Yi-Ting; Tang, Liping] Univ Texas Arlington, Arlington, TX 76019 USA; [Hu, Zhibing] Univ N Texas, Dept Phys, Denton, TX 76203 USA; [Hu, Zhibing] Univ N Texas, Dept Mat Sci & Engn, Denton, TX 76203 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Arlington; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Zou, L (corresponding author), Univ Texas SW Med Ctr Dallas, Joint Program Bioengn, Dallas, TX 75390 USA.	ltang@uta.edu	Nair, Ashwin/B-8307-2011	Nair, Ashwin/0000-0002-7334-3114	National Institutes of Health [EB007271]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grant EB007271. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akler ME, 1998, OPHTHALMOLOGY, V105, P651, DOI 10.1016/S0161-6420(98)94019-2; Ambati J, 1999, BRIT J OPHTHALMOL, V83, P1153, DOI 10.1136/bjo.83.10.1153; Amrite AC, 2005, J PHARM PHARMACOL, V57, P1555, DOI 10.1211/jpp.57.12.0005; AMRITE AC, 2003, DRUG DEV DELIVERY, V3; Amrite AC, 2008, MOL VIS, V14, P150; Avitabile T, 2001, BIOMATERIALS, V22, P195, DOI 10.1016/S0142-9612(00)00169-1; Beeley NRF, 2005, J BIOMED MATER RES A, V73A, P437, DOI 10.1002/jbm.a.30294; BINKHORST CD, 1980, AM INTRAOCULAR IMPLA, V6, P340; Bourges JL, 2003, INVEST OPHTH VIS SCI, V44, P3562, DOI 10.1167/iovs.02-1068; Cao YX, 2007, J CONTROL RELEASE, V120, P186, DOI 10.1016/j.jconrel.2007.05.009; Cejkova J, 2010, J COLLOID INTERF SCI, V346, P352, DOI 10.1016/j.jcis.2010.02.060; Cheng L, 2008, BRIT J OPHTHALMOL, V92, P705, DOI 10.1136/bjo.2007.133587; Choonara YE, 2010, J PHARM SCI-US, V99, P2219, DOI 10.1002/jps.21987; Davis JL, 1997, ARCH OPHTHALMOL-CHIC, V115, P733, DOI 10.1001/archopht.1997.01100150735008; De Jesus OLP, 2002, BIOCONJUGATE CHEM, V13, P453, DOI 10.1021/bc010103m; Dietlein TS, 2003, OPHTHALMOLOGE, V100, P991, DOI 10.1007/s00347-003-0831-1; Einmahl S, 2003, J BIOMED MATER RES A, V67A, P44, DOI 10.1002/jbm.a.10597; Fernandez-Cossio S, 2006, PLAST RECONSTR SURG, V117, P1789, DOI 10.1097/01.prs.0000214656.07273.b0; FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0; FESSI H, 1986, Patent No. 2; Fitzpatrick SD, 2010, BIOMACROMOLECULES, V11, P2261, DOI 10.1021/bm100299j; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Gao QX, 2009, POLYMER, V50, P2587, DOI 10.1016/j.polymer.2009.03.049; GIORDANO GG, 1995, CURR EYE RES, V14, P761, DOI 10.3109/02713689508995797; Herbert HM, 2004, J GLAUCOMA, V13, P96, DOI 10.1097/00061198-200404000-00003; Hsiue GH, 2002, BIOMATERIALS, V23, P457, DOI 10.1016/S0142-9612(01)00127-2; Hsu J, 2007, CURR OPIN OPHTHALMOL, V18, P235, DOI 10.1097/ICU.0b013e3281108000; HU Z, 2009, PROCESS SYNTHESIZING; Huhtala A, 2008, J MATER SCI-MATER M, V19, P645, DOI 10.1007/s10856-007-3192-5; INSLER MS, 1987, ARCH OPHTHALMOL-CHIC, V105, P922; Irache JM, 2005, MINI-REV MED CHEM, V5, P293, DOI 10.2174/1389557053175335; Janoria KG, 2007, EXPERT OPIN DRUG DEL, V4, P371, DOI 10.1517/17425247.4.4.371; JOHNSON M, 1978, ARCH OPHTHALMOL-CHIC, V96, P664; Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649; Kamelger FS, 2004, BIOMATERIALS, V25, P1649, DOI 10.1016/S0142-9612(03)00520-9; KANEKO M, 1987, OPHTHALMIC RES, V19, P330, DOI 10.1159/000265517; Kaur IP, 2002, DRUG DEV IND PHARM, V28, P473; Kawakami S, 2004, INT J PHARMACEUT, V278, P255, DOI 10.1016/j.ijpharm.2004.03.013; KAWASHIMA Y, 1989, J PHARM SCI, V78, P68, DOI 10.1002/jps.2600780118; KHOOBEHI B, 1991, OPHTHALMIC SURG LAS, V22, P175; KINSHUCK D, 1991, BRIT J OPHTHALMOL, V75, P575, DOI 10.1136/bjo.75.9.575; Kymionis GD, 2008, J REFRACT SURG, V24, P633, DOI 10.3928/1081597X-20080601-14; Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980; Li H, 2006, EXP EYE RES, V83, P824, DOI 10.1016/j.exer.2006.04.014; Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555; Lim JI, 1999, AM J OPHTHALMOL, V127, P288, DOI 10.1016/S0002-9394(98)00443-7; Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049; Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4; Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; MA WJ, 2011, LASERS MED SCI; Merodio M, 2002, BIOMATERIALS, V23, P1587, DOI 10.1016/S0142-9612(01)00284-8; Musa F, 2006, J CATARACT REFR SURG, V32, P177, DOI 10.1016/j.jcrs.2005.11.024; Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973; Nair A, 2010, TISSUE ENG PART C-ME, V16, P23, DOI [10.1089/ten.tec.2009.0094, 10.1089/ten.TEC.2009.0094]; Nair A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/48/485102; Nair A, 2008, J BIOMED NANOTECHNOL, V4, P410, DOI 10.1166/jbn.2008.004; Nguyen KT, 2009, J BIOMED MATER RES A, V88A, P1022, DOI 10.1002/jbm.a.31734; Nishida K, 2011, GRAEF ARCH CLIN EXP, V249, P833, DOI 10.1007/s00417-010-1566-8; OHNO S, 1989, OPHTHALMOLOGICA, V199, P41, DOI 10.1159/000310013; Pignatello R, 2002, BIOMATERIALS, V23, P3247, DOI 10.1016/S0142-9612(02)00080-7; PONTE F, 1994, DOC OPHTHALMOL, V85, P203, DOI 10.1007/BF01664928; Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781; Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602; Raju HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017452; Riley T, 1999, COLLOID SURFACE B, V16, P147, DOI 10.1016/S0927-7765(99)00066-1; Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3; Rosa N, 2011, OPHTHALMOLOGY, V118, P260, DOI 10.1016/j.ophtha.2010.06.020; Sahoo SK, 2008, DRUG DISCOV TODAY, V13, P144, DOI 10.1016/j.drudis.2007.10.021; Sakuma S, 1999, INT J PHARM, V177, P161, DOI 10.1016/S0378-5173(98)00346-9; Sakurai E, 2001, OPHTHALMIC RES, V33, P31, DOI 10.1159/000055638; Stoiber J, 2005, OPHTHAL SURG LAS IM, V36, P471, DOI 10.3928/1542-8877-20051101-07; Taniguchi T, 1998, CURR EYE RES, V17, P308, DOI 10.1076/ceyr.17.3.308.5225; Thevenot P, 2008, CURR TOP MED CHEM, V8, P270; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; Ueda J, 1998, JPN J OPHTHALMOL, V42, P337, DOI 10.1016/S0021-5155(98)00026-4; Urcola JH, 2006, EXP EYE RES, V83, P429, DOI 10.1016/j.exer.2006.01.025; Vandervoort J, 2007, NANOMEDICINE-UK, V2, P11, DOI 10.2217/17435889.2.1.11; Vega E, 2006, J PHARM SCI-US, V95, P2393, DOI 10.1002/jps.20685; Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106; WILLIAMSON J, 1981, T OPHTHAL SOC UK, V101, P27; Yasukawa T, 2005, ADV DRUG DELIVER REV, V57, P2033, DOI 10.1016/j.addr.2005.09.005	82	9	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28720	10.1371/journal.pone.0028720	http://dx.doi.org/10.1371/journal.pone.0028720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194895	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100085
J	Buchanan, GM; Donald, PF; Butchart, SHM				Buchanan, Graeme M.; Donald, Paul F.; Butchart, Stuart H. M.			Identifying Priority Areas for Conservation: A Global Assessment for Forest-Dependent Birds	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; SPECIES RICHNESS; PROTECTED AREAS; RANGE SIZE; HOTSPOTS; CONCORDANCE; ENDEMISM; IMPACTS; CARBON; WORLDS	Limited resources are available to address the world's growing environmental problems, requiring conservationists to identify priority sites for action. Using new distribution maps for all of the world's forest-dependent birds (60.6% of all bird species), we quantify the contribution of remaining forest to conserving global avian biodiversity. For each of the world's partly or wholly forested 5-km cells, we estimated an impact score of its contribution to the distribution of all the forest bird species estimated to occur within it, and so is proportional to the impact on the conservation status of the world's forest-dependent birds were the forest it contains lost. The distribution of scores was highly skewed, a very small proportion of cells having scores several orders of magnitude above the global mean. Ecoregions containing the highest values of this score included relatively species-poor islands such as Hawaii and Palau, the relatively species-rich islands of Indonesia and the Philippines, and the megadiverse Atlantic Forests and northern Andes of South America. Ecoregions with high impact scores and high deforestation rates (2000-2005) included montane forests in Cameroon and the Eastern Arc of Tanzania, although deforestation data were not available for all ecoregions. Ecoregions with high impact scores, high rates of recent deforestation and low coverage by the protected area network included Indonesia's Seram rain forests and the moist forests of Trinidad and Tobago. Key sites in these ecoregions represent some of the most urgent priorities for expansion of the global protected areas network to meet Convention on Biological Diversity targets to increase the proportion of land formally protected to 17% by 2020. Areas with high impact scores, rapid deforestation, low protection and high carbon storage values may represent significant opportunities for both biodiversity conservation and climate change mitigation, for example through Reducing Emissions from Deforestation and Forest Degradation (REDD+) initiatives.	[Buchanan, Graeme M.] Royal Soc Protect Birds, Edinburgh, Midlothian, Scotland; [Donald, Paul F.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England	Royal Society for Protection of Birds; Royal Society for Protection of Birds; BirdLife International	Buchanan, GM (corresponding author), Royal Soc Protect Birds, Edinburgh, Midlothian, Scotland.	graeme.buchanan@rspb.org.uk	Butchart, Stuart/AAJ-1852-2021; Butchart, Stuart HM/Y-2711-2018	Butchart, Stuart/0000-0002-1140-4049; Donald, Paul F./0000-0003-0023-6200				Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Beresford AE, 2011, ANIM CONSERV, V14, P99, DOI 10.1111/j.1469-1795.2010.00398.x; Beresford AE, 2011, ANIM CONSERV, V14, P114, DOI 10.1111/j.1469-1795.2011.00453.x; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; *BIRDLIFE INT, 2011, STAT WORLDS BIRDS; BirdLife International and NatureServe, 2011, BIRD SPEC DISTR MAPS; Blackburn TM, 1997, PHILOS T ROY SOC B, V352, P419, DOI 10.1098/rstb.1997.0030; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Buchanan GM, 2008, BIOL CONSERV, V141, P56, DOI 10.1016/j.biocon.2007.08.023; Convention on Biological Diversity (CBD), 2010, COP DEC X 2 STRAT PL; Davies RG, 2006, P ROY SOC B-BIOL SCI, V273, P2127, DOI 10.1098/rspb.2006.3551; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Funk SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008923; Giri C, 2005, REMOTE SENS ENVIRON, V94, P123, DOI 10.1016/j.rse.2004.09.005; Global Soil Data Task Group, 2000, GLOB GRIDD SURF SEL; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Harvey CA, 2010, CONSERV LETT, V3, P53, DOI 10.1111/j.1755-263X.2009.00086.x; Hilton-Taylor C, 2009, WILDLIFE CHANGING WO, P15, DOI DOI 10.2305/IUCN.CH.2009.17.EN; IUCN, 2012, IUCN RED LIST CATEGO, VSecond; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kapos V., 2008, CARBON BIODIVERSITY; Kier G, 2001, BIODIVERS CONSERV, V10, P1513, DOI 10.1023/A:1011812528849; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; Murdoch W, 2010, TRADE OFFS CONSERVAT, P35; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Sandker M, 2010, CONSERV LETT, V3, P114, DOI 10.1111/j.1755-263X.2010.00095.x; Scharlemann JPW, 2010, ORYX, V44, P352, DOI 10.1017/S0030605310000542; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; *UNEP I, 2009, WORLD BAD PROT AR WD; USGS, 2004, SHUTTL RAD TOP MISS; Visconti P, 2010, CONSERV LETT, V3, P404, DOI 10.1111/j.1755-263X.2010.00130.x; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	49	69	73	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29080	10.1371/journal.pone.0029080	http://dx.doi.org/10.1371/journal.pone.0029080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205998	gold, Green Submitted, Green Published			2022-12-25	WOS:000298665600027
J	Tarcic, G; Avraham, R; Pines, G; Amit, I; Shay, T; Lu, YL; Zwang, Y; Katz, M; Ben-Chetrit, N; Jacob-Hirsch, J; Virgilio, L; Rechavi, G; Mavrothalassitis, G; Mills, GB; Domany, E; Yarden, Y				Tarcic, Gabi; Avraham, Roi; Pines, Gur; Amit, Ido; Shay, Tal; Lu, Yiling; Zwang, Yaara; Katz, Menachem; Ben-Chetrit, Nir; Jacob-Hirsch, Jasmine; Virgilio, Laura; Rechavi, Gideon; Mavrothalassitis, George; Mills, Gordon B.; Domany, Eytan; Yarden, Yosef			EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF	FASEB JOURNAL			English	Article						growth factor; phosphorylation; transcription; negative feedback	TRANSCRIPTION FACTOR EGR1; EARLY GROWTH RESPONSE-1; MEDIATED MOTILITY; FEEDBACK LOOP; MAP KINASE; IN-VIVO; PROTEIN; CANCER; P53; CONTRIBUTES	The signaling pathways that commit cells to migration are incompletely understood. We employed human mammary cells and two stimuli: epidermal growth factor (EGF), which induced cellular migration, and serum factors, which stimulated cell growth. In addition to strong activation of ERK by EGF, and AKT by serum, early transcription remarkably differed: while EGF induced early growth response-1 (EGR1), and this was required for migration, serum induced c-Fos and FosB to enhance proliferation. We demonstrate that induction of EGR1 involves ERK-mediated down-regulation of microRNA-191 and phosphorylation of the ETS2 repressor factor (ERF) repressor, which subsequently leaves the nucleus. Unexpectedly, knockdown of ERF inhibited migration, which implies migratory roles for exported ERF molecules. On the other hand, chromatin immunoprecipitation identified a subset of direct EGR1 targets, including EGR1 autostimulation and SERPINB2, whose transcription is essential for EGF-induced cell migration. In summary, EGR1 and the EGF-ERK-ERF axis emerge from our study as major drivers of growth factor-induced mammary cell migration.-Tarcic, G., Avraham, R., Pines, G., Amit, I., Shay, T., Lu, Y., Zwang, Y., Katz, M., Ben-Chetrit, N., Jacob-Hirsch, J., Virgilio, L., Rechavi, G., Mavrothalassitis, G., Mills, G. B., Domany, E., Yarden, Y. EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF. FASEB J. 26, 1582-1592 (2012). www.fasebj.org	[Tarcic, Gabi; Avraham, Roi; Pines, Gur; Amit, Ido; Zwang, Yaara; Katz, Menachem; Ben-Chetrit, Nir; Yarden, Yosef] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Shay, Tal; Domany, Eytan] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Jacob-Hirsch, Jasmine; Rechavi, Gideon] Chaim Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Jacob-Hirsch, Jasmine; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Virgilio, Laura; Mavrothalassitis, George] Univ Crete, Sch Med, Iraklion, Greece; [Virgilio, Laura; Mavrothalassitis, George] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece	Weizmann Institute of Science; Weizmann Institute of Science; University of Texas System; UTMD Anderson Cancer Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	YARDEN, YOSEF/K-1467-2012; Pines, Gur/X-7501-2019; DOMANY, EYTAN/K-1560-2012; Shay, Tal/J-4028-2016	Pines, Gur/0000-0002-1757-6722; Shay, Tal/0000-0003-0755-1350; Avraham, Roi/0000-0002-9098-3885	U.S. National Cancer Institute [CA072981, CA121994-01, CA120248-01]; European Commission; German-Israeli Project Cooperation; Israel Cancer Research Fund; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Kekst Family Institute for Medical Genetics; Kirk Center for Childhood Cancer and Immunological Disorders; Women's Health Research Center; Bennett-Pritzker Endowment Fund; Marvelle Koffler Program for Breast Cancer Research; Leir Charitable Foundation; M. D. Moross Institute for Cancer Research; Susan G. Komen Foundation; NATIONAL CANCER INSTITUTE [R21CA120248, P50CA098258, R37CA072981, R01CA072981, P30CA016672, K23CA121994] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Commission(European CommissionEuropean Commission Joint Research Centre); German-Israeli Project Cooperation; Israel Cancer Research Fund; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Kekst Family Institute for Medical Genetics; Kirk Center for Childhood Cancer and Immunological Disorders; Women's Health Research Center; Bennett-Pritzker Endowment Fund; Marvelle Koffler Program for Breast Cancer Research; Leir Charitable Foundation; M. D. Moross Institute for Cancer Research; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge research funding by the U.S. National Cancer Institute (CA072981, CA121994-01, and CA120248-01); the European Commission; the German-Israeli Project Cooperation; the Israel Cancer Research Fund; the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; the Kekst Family Institute for Medical Genetics; the Kirk Center for Childhood Cancer and Immunological Disorders; the Women's Health Research Center, funded by the Bennett-Pritzker Endowment Fund; the Marvelle Koffler Program for Breast Cancer Research; the Leir Charitable Foundation; the M. D. Moross Institute for Cancer Research; and The Susan G. Komen Foundation. Y.Y. is the incumbent of the Harold and Zelda Goldenberg Professorial Chair. E. D. is the recipient of the Henry J. Leir Professorial Chair.	Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Avraham R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000876; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Cermak V, 2010, CELL MOL LIFE SCI, V67, P3557, DOI 10.1007/s00018-010-0395-6; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Damm S, 2010, J INVEST DERMATOL, V130, P1893, DOI 10.1038/jid.2010.45; de Mestre AM, 2005, J BIOL CHEM, V280, P35136, DOI 10.1074/jbc.M503414200; Fitzgerald JS, 2005, CHEM IMMUNOL ALLERGY, V88, P181, DOI 10.1159/000087834; Gilles C, 1999, J CELL SCI, V112, P4615; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Kasneci A, 2009, CARDIOVASC RES, V81, P695, DOI 10.1093/cvr/cvn357; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Laufs S, 2006, CELL CYCLE, V5, P1760; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Le Gallic L, 1999, MOL CELL BIOL, V19, P4121; McCawley LJ, 1997, ENDOCRINOLOGY, V138, P121, DOI 10.1210/en.138.1.121; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Salah Z, 2007, CANCER RES, V67, P9835, DOI 10.1158/0008-5472.CAN-07-1886; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sauer L, 2010, ONCOGENE, V29, P2628, DOI 10.1038/onc.2010.24; Scharnhorst V, 2000, ONCOGENE, V19, P791, DOI 10.1038/sj.onc.1203390; SCHLEGEL J, 1994, J NEURO-ONCOL, V22, P201, DOI 10.1007/BF01052920; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; TAIT L, 1990, CANCER RES, V50, P6087; Tang C, 2010, ELECTROPHORESIS, V31, P2936, DOI 10.1002/elps.201000094; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Wells A, 1998, MICROSC RES TECHNIQ, V43, P395, DOI 10.1002/(SICI)1097-0029(19981201)43:5<395::AID-JEMT6>3.0.CO;2-T; Xian CJ, 2004, FRONT BIOSCI-LANDMRK, V9, P85, DOI 10.2741/1210; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	55	71	72	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1582	1592		10.1096/fj.11-194654	http://dx.doi.org/10.1096/fj.11-194654			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22198386	Green Published			2022-12-25	WOS:000302359700020
J	Orme, CM; Bogan, JS				Orme, Charisse M.; Bogan, Jonathan S.			The Ubiquitin Regulatory X (UBX) Domain-containing Protein TUG Regulates the p97 ATPase and Resides at the Endoplasmic Reticulum-Golgi Intermediate Compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; AAA-ATPASE; CONFORMATIONAL-CHANGES; CELL-SURFACE; SECRETORY PATHWAY; MEMBRANE-FUSION; MATRIX PROTEIN; BREFELDIN-A; GLUT4; BINDING	p97/VCP is a hexameric ATPase that is coupled to diverse cellular processes, such as membrane fusion and proteolysis. How p97 activity is regulated is not fully understood. Here we studied the potential role of TUG, a widely expressed protein containing a UBX domain, to control mammalian p97. In HEK293 cells, the vast majority of TUG was bound to p97. Surprisingly, the TUG UBX domain was neither necessary nor sufficient for this interaction. Rather, an extended sequence, comprising three regions of TUG, bound to the p97 N-terminal domain. The TUG C terminus resembled the Arabidopsis protein PUX1. Similar to the previously described action of PUX1 on AtCDC48, TUG caused the conversion of p97 hexamers into monomers. Hexamer disassembly was stoichiometric rather than catalytic and was not greatly affected by the p97 ATP-binding state or by TUG N-terminal regions in vitro. In HeLa cells, TUG localized to the endoplasmic reticulum-to-Golgi intermediate compartment and endoplasmic reticulum exit sites. Although siRNA-mediated TUG depletion had no marked effect on total ubiquitylated proteins or p97 localization, TUG overexpression caused an accumulation of ubiquitylated substrates and targeted both TUG and p97 to the nucleus. A physiologic role of TUG was revealed by siRNA-mediated depletion, which showed that TUG is required for efficient reassembly of the Golgi complex after brefeldin A removal. Together, these data support a model in which TUG controls p97 oligomeric status at a particular location in the early secretory pathway and in which this process regulates membrane trafficking in various cell types.	[Bogan, Jonathan S.] Yale Univ, Sect Endocrinol & Metab, Dept Internal Med, Sch Med, New Haven, CT 06520 USA; Yale Univ, Dept Cell Biol, Sch Med, New Haven, CT 06520 USA	Yale University; Yale University	Bogan, JS (corresponding author), Yale Univ, Sect Endocrinol & Metab, Dept Internal Med, Sch Med, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Bogan, Jonathan S/A-1575-2010	Bogan, Jonathan S/0000-0001-6463-8466	National Institutes of Health [R21 DK70812, R01 DK075772, T32 GM07205, F30 DK086109]; O'Brien Kidney Center at Yale [P30 DK079310]; W.M. Keck Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075772, R21DK070812, P30DK079310, F30DK086109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); O'Brien Kidney Center at Yale; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DK70812 and R01 DK075772. This work was also supported by a pilot grant from the O'Brien Kidney Center at Yale (P30 DK079310) and by a W.M. Keck Foundation Distinguished Young Scholar in Medical Research Award (to J.S.B.).; Supported by National Institutes of Health Grants T32 GM07205 and F30 DK086109.	Aker J, 2007, PLANT PHYSIOL, V145, P339, DOI 10.1104/pp.107.103986; Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Brandon E, 2003, EUR J CELL BIOL, V82, P411, DOI 10.1078/0171-9335-00327; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Grieve AG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005298; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hauri HP, 2000, J CELL SCI, V113, P587; Hicks SW, 2006, TRAFFIC, V7, P1666, DOI 10.1111/j.1600-0854.2006.00504.x; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; Kaneko Y, 2010, FEBS LETT, V584, P3873, DOI 10.1016/j.febslet.2010.07.061; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; KREIS TE, 1986, CELL, V46, P929, DOI 10.1016/0092-8674(86)90075-9; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Ladanyi M, 2001, ONCOGENE, V20, P48, DOI 10.1038/sj.onc.1204074; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Nagahama M, 2009, BIOCHEM BIOPH RES CO, V382, P303, DOI 10.1016/j.bbrc.2009.03.012; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; ORCI L, 1991, CELL, V64, P1183; Paro S, 2007, J BIOL CHEM, V282, P5217, DOI 10.1074/jbc.M609042200; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Ren JH, 2008, J BIOL CHEM, V283, P21599, DOI 10.1074/jbc.M802982200; Rezvani K, 2009, J NEUROSCI, V29, P6883, DOI 10.1523/JNEUROSCI.4723-08.2009; Rubin BR, 2009, VITAM HORM, V80, P155, DOI 10.1016/S0083-6729(08)00607-9; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Shin HY, 2010, ACTA CRYSTALLOGR F, V66, P41, DOI 10.1107/S1744309109047691; Shugrue CA, 1999, J CELL SCI, V112, P4547; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, P816, DOI 10.1093/nar/gki233; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tang DM, 2008, J BIOL CHEM, V283, P6085, DOI 10.1074/jbc.M707715200; Tettamanzi MC, 2006, PROTEIN SCI, V15, P498, DOI 10.1110/ps.051901806; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Uchiyama K, 2003, J CELL BIOL, V161, P1067, DOI 10.1083/jcb.200303048; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200	77	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6679	6692		10.1074/jbc.M111.284232	http://dx.doi.org/10.1074/jbc.M111.284232			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207755	Green Published, hybrid			2022-12-25	WOS:000300791800054
J	Huang, Z; Hoffmann, FW; Fay, JD; Hashimoto, AC; Chapagain, ML; Kaufusi, PH; Hoffmann, PR				Huang, Zhi; Hoffmann, FuKun W.; Fay, Jeffrey D.; Hashimoto, Ann C.; Chapagain, Moti L.; Kaufusi, Pakieli H.; Hoffmann, Peter R.			Stimulation of Unprimed Macrophages with Immune Complexes Triggers a Low Output of Nitric Oxide by Calcium-dependent Neuronal Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE MACROPHAGES; MAMMALIAN-CELLS; L-ARGININE; GAMMA; PHAGOCYTOSIS; EXPRESSION; LOCATION; DYSFUNCTION; ACTIVATION; INHIBITION	Immune complexes composed of IgG-opsonized pathogens, particles, or proteins are phagocytosed by macrophages through Fc gamma receptors (Fc gamma Rs). Macrophages primed with IFN gamma or other pro-inflammatory mediators respond to Fc gamma R engagement by secreting high levels of cytokines and nitric oxide (NO). We found that unprimed macrophages produced lower levels of NO, which required efficient calcium (Ca2+) flux as demonstrated by using macrophages lacking selenoprotein K, which is required for Fc gamma R-induced Ca2+ flux. Thus, we further investigated the signaling pathways involved in low output NO and its functional significance. Evaluation of inducible, endothelial, and neuronal nitric-oxide synthases (iNOS, eNOS, and nNOS) revealed that Fc gamma R stimulation in unprimed macrophages caused a marked Ca2+-dependent increase in both total and phosphorylated nNOS and slightly elevated levels of phosphorylated eNOS. Also activated were three MAP kinases, ERK, JNK, and p38, of which ERK activation was highly dependent on Ca2+ flux. Inhibition of ERK reduced both nNOS activation and NO secretion. Finally, Transwell experiments showed that Fc gamma R-induced NO functioned to increase the phagocytic capacity of other macrophages and required both NOS and ERK activity. The production of NO by macrophages is conventionally attributed to iNOS, but we have revealed an iNOS-independent receptor/enzyme system in unprimed macrophages that produces low output NO. Under these conditions, Fc gamma R engagement relies on Ca2+-dependent ERK phosphorylation, which in turn increases nNOS and, to a lesser extent, eNOS, both of which produce low levels of NO that function to promote phagocytosis.	[Huang, Zhi; Hoffmann, FuKun W.; Fay, Jeffrey D.; Hashimoto, Ann C.; Hoffmann, Peter R.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Chapagain, Moti L.; Kaufusi, Pakieli H.] Univ Hawaii, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96813 USA; [Huang, Zhi] Jinan Univ, Coll Life Sci & Technol, Dept Biotechnol, Guangzhou 510632, Guangdong, Peoples R China	University of Hawaii System; University of Hawaii System; Jinan University	Hoffmann, PR (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, 651 Ilalo St, Honolulu, HI 96813 USA.	peterh@pbrc.hawaii.edu			National Institutes of Health [R21AT004844, R01AI089999]; Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China [20975045]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AT004844 and R01AI089999. This work was also supported by the Fundamental Research Funds for the Central Universities and the National Natural Science Foundation (Grant 20975045) of China.	BIRMELIN M, 1983, EUR J BIOCHEM, V131, P539, DOI 10.1111/j.1432-1033.1983.tb07295.x; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Braun A, 2009, BLOOD, V113, P1097, DOI 10.1182/blood-2008-05-158477; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Chauhan SD, 2003, FASEB J, V17, P773, DOI 10.1096/fj.02-0668fje; CHESROWN SE, 1994, BIOCHEM BIOPH RES CO, V200, P126, DOI 10.1006/bbrc.1994.1424; Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fernandez-Boyanapalli R, 2010, J IMMUNOL, V185, P4030, DOI 10.4049/jimmunol.1001778; Fox SW, 1998, BONE, V23, P1, DOI 10.1016/S8756-3282(98)00070-2; GRANGER DL, 1988, J CLIN INVEST, V81, P1129, DOI 10.1172/JCI113427; HECKER M, 1992, J CARDIOVASC PHARM, V20, pS139, DOI 10.1097/00005344-199204002-00039; Huang Z, 2011, J BIOL CHEM, V286, P34830, DOI 10.1074/jbc.M111.265520; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; KASTEN TP, 1994, P NATL ACAD SCI USA, V91, P3569, DOI 10.1073/pnas.91.9.3569; Kim J, 2008, ARCH BIOCHEM BIOPHYS, V472, P58, DOI 10.1016/j.abb.2008.01.020; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; Miller L, 1996, J LEUKOCYTE BIOL, V59, P442, DOI 10.1002/jlb.59.3.442; MOZAFFARIAN N, 1995, J LEUKOCYTE BIOL, V57, P657, DOI 10.1002/jlb.57.4.657; Mungrue IN, 2004, J CELL SCI, V117, P2627, DOI 10.1242/jcs.01187; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nicolin V, 2005, ANAT REC PART A, V286A, P945, DOI 10.1002/ar.a.20239; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Paludan SR, 2000, J LEUKOCYTE BIOL, V67, P18, DOI 10.1002/jlb.67.1.18; Roman V, 1997, IMMUNOLOGY, V91, P643, DOI 10.1046/j.1365-2567.1997.d01-2263.x; Rose DM, 1997, J IMMUNOL, V158, P3433; SCHMIDT HHHW, 1992, MOL PHARMACOL, V41, P615; Schodel J, 2009, ATHEROSCLEROSIS, V206, P383, DOI 10.1016/j.atherosclerosis.2009.02.033; Schwartz D, 1997, J CLIN INVEST, V100, P439, DOI 10.1172/JCI119551; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Tumer C, 2007, CELL BIOL INT, V31, P565, DOI 10.1016/j.cellbi.2006.11.029; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Waterman PM, 2010, FEBS LETT, V584, P4878, DOI 10.1016/j.febslet.2010.09.029; YOUNG JDE, 1984, P NATL ACAD SCI-BIOL, V81, P5430, DOI 10.1073/pnas.81.17.5430	43	44	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4492	4502		10.1074/jbc.M111.315598	http://dx.doi.org/10.1074/jbc.M111.315598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22205701	hybrid, Green Published			2022-12-25	WOS:000300608500013
J	Chan, HY; Sivakamasundari, V; Xing, X; Kraus, P; Yap, SP; Ng, P; Lim, SL; Lufkin, T				Chan, Hsiao Yun; Sivakamasundari, V; Xing, Xing; Kraus, Petra; Yap, Sook Peng; Ng, Patricia; Lim, Siew Lan; Lufkin, Thomas			Comparison of IRES and F2A-Based Locus-Specific Multicistronic Expression in Stable Mouse Lines	PLOS ONE			English	Article							RIBOSOME ENTRY SITES; CLEAVAGE ACTIVITIES; LENTIVIRAL VECTORS; GENE-EXPRESSION; HOMEOBOX GENE; IN-VITRO; 2A; CELLS; SOX9; PROTEINS	Efficient and stoichiometric expression of genes concatenated by bi- or multi-cistronic vectors has become an invaluable tool not only in basic biology to track and visualize proteins in vivo, but also for vaccine development and in the clinics for gene therapy. To adequately compare, in vivo, the effectiveness of two of the currently popular co-expression strategies the internal ribosome entry site (IRES) derived from the picornavirus and the 2A peptide from the foot-and-mouth disease virus (FDMV) (F2A), we analyzed two locus-specific knock-in mouse lines co-expressing SRY-box containing gene 9 (Sox9) and enhanced green fluorescent protein (EGFP) linked by the IRES (Sox9(IRES-EGFP)) or the F2A (Sox9(F2A-EGFP)) sequence. Both the constructs expressed Sox9 and EGFP proteins in the appropriate Sox9 expression domains, with the IRES construct expressing reduced levels of EGFP compared to that of the F2A. The latter, on the other hand, produced about 42.2% Sox9-EGFP fusion protein, reflecting an inefficient ribosome 'skipping' mechanism. To investigate if the discrepancy in the 'skipping' process was locus-dependent, we further analyzed the FLAG(3)-Bapx1(F2A-EGFP) mouse line and found similar levels of fusion protein being produced. To assess if EGFP was hindering the 'skipping' mechanism, we examined another mouse line co-expressing Bagpipe homeobox gene 1 homolog (Bapx1), Cre recombinase and EGFP (Bapx1(F2A-Cre-F2A-EGFP)). While the 'skipping' was highly efficient between Bapx1 and Cre, the 'skipping' between Cre and EGFP was highly inefficient. We have thus demonstrated in our comparison study that the efficient and close to equivalent expression of genes linked by F2A is achievable in stable mouse lines, but the EGFP reporter may cause undesirable inhibition of the 'skipping' at the F2A sequence. Hence, the use of other reporter genes should be explored when utilizing F2A peptides.	[Chan, Hsiao Yun; Sivakamasundari, V; Xing, Xing; Kraus, Petra; Yap, Sook Peng; Ng, Patricia; Lim, Siew Lan; Lufkin, Thomas] Genome Inst Singapore, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Chan, HY (corresponding author), Genome Inst Singapore, Singapore, Singapore.	Lufkin@gis.a-star.edu.sg	Kraus, Petra/I-5849-2014; Lufkin, Thomas/AAG-7476-2019; Ng, Patricia ML/B-3939-2008; Lufkin, Thomas/B-5352-2011	Kraus, Petra/0000-0002-6716-5550; Lufkin, Thomas/0000-0002-7902-4771; Ng, Patricia ML/0000-0001-5043-5596; Lufkin, Thomas/0000-0002-7902-4771; Xing, Xing/0000-0001-9682-815X; Chan, Hsiao Yun/0000-0001-7939-4134	Genome Institute of Singapore	Genome Institute of Singapore	This work was supported by internal funds of the Genome Institute of Singapore. There have been no past or current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; de Felipe P., 2002, Current Gene Therapy, V2, P355, DOI 10.2174/1566523023347742; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Funston GM, 2008, J GEN VIROL, V89, P389, DOI 10.1099/vir.0.83444-0; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; Ghim CM, 2010, BMB REP, V43, P451, DOI 10.5483/BMBRep.2010.43.7.451; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Howard PW, 2010, TRANSGENIC RES, V19, P121, DOI 10.1007/s11248-009-9292-x; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kraus P, 2010, GENESIS, V48, P394, DOI 10.1002/dvg.20627; Licursi M, 2011, GENE THER, V18, P631, DOI 10.1038/gt.2011.11; Lorens JB, 2004, J BIOCHEM BIOPH METH, V58, P101, DOI 10.1016/S0165-022X(03)00147-7; McLenachan S, 2008, TRANSGENIC RES, V17, P1103, DOI 10.1007/s11248-008-9210-7; Mir FA, 2009, CLIN VACCINE IMMUNOL, V16, P1467, DOI 10.1128/CVI.00237-09; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Rothwell DG, 2010, HUM GENE THER, V21, P1631, DOI 10.1089/hum.2009.197; Sivakamasundari V, 2011, GENESIS; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tribioli C, 1997, MECH DEVELOP, V65, P145, DOI 10.1016/S0925-4773(97)00067-1; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yap S, 2011, BIOTECHNOL LETT, P1; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	41	58	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28885	10.1371/journal.pone.0028885	http://dx.doi.org/10.1371/journal.pone.0028885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216134	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600049
J	Shechter, R; Raposo, C; London, A; Sagi, I; Schwartz, M				Shechter, Ravid; Raposo, Catarina; London, Anat; Sagi, Irit; Schwartz, Michal			The Glial Scar-Monocyte Interplay: A Pivotal Resolution Phase in Spinal Cord Repair	PLOS ONE			English	Article							REACTIVE ASTROCYTES; FUNCTIONAL RECOVERY; CHONDROITINASE ABC; AXON REGENERATION; DENDRITIC CELLS; INJURY; MACROPHAGES; MICROGLIA; DEPLETION; MICE	The inflammatory response in the injured spinal cord, an immune privileged site, has been mainly associated with the poor prognosis. However, recent data demonstrated that, in fact, some leukocytes, namely monocytes, are pivotal for repair due to their alternative anti-inflammatory phenotype. Given the pro-inflammatory milieu within the traumatized spinal cord, known to skew monocytes towards a classical phenotype, a pertinent question is how parenchymal-invading monocytes acquire resolving properties essential for healing, under such unfavorable conditions. In light of the spatial association between resolving (interleukin (IL)-10 producing) monocytes and the glial scar matrix chondroitin sulfate proteoglycan (CSPG), in this study we examined the mutual relationship between these two components. By inhibiting the de novo production of CSPG following spinal cord injury, we demonstrated that this extracellular matrix, mainly known for its ability to inhibit axonal growth, serves as a critical template skewing the entering monocytes towards the resolving phenotype. In vitro cell culture studies demonstrated that this matrix alone is sufficient to induce such monocyte polarization. Reciprocal conditional ablation of the monocyte-derived macrophages concentrated at the lesion margins, using diphtheria toxin, revealed that these cells have scar matrix-resolving properties. Replenishment of monocytic cell populations to the ablated mice demonstrated that this extracellular remodeling ability of the infiltrating monocytes requires their expression of the matrix-degrading enzyme, matrix metalloproteinase 13 (MMP-13), a property that was found here to be crucial for functional recovery. Altogether, this study demonstrates that the glial scar-matrix, a known obstacle to regeneration, is a critical component skewing the encountering monocytes towards a resolving phenotype. In an apparent feedback loop, monocytes were found to regulate scar resolution. This cross-regulation between the glial scar and monocytes primes the resolution of this interim phase of spinal cord repair, thereby providing a fundamental platform for the dynamic healing response.	[Shechter, Ravid; Raposo, Catarina; London, Anat; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Shechter, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	michal.schwartz@weizmann.ac.il	Shechter, Ravid/GYA-5446-2022	Shechter, Ravid/0000-0002-5956-413X	Israel Science Foundation (ISF); European Research Council (ERC)	Israel Science Foundation (ISF)(Israel Science Foundation); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported in part by the Israel Science Foundation (ISF)-Legacy-Bio-Med program and the European Research Council (ERC)-Advanced Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Luo Yuling, 1994, Current Opinion in Neurobiology, V4, P648, DOI 10.1016/0959-4388(94)90005-1; Ma MH, 2002, J NEUROSCI RES, V68, P691, DOI 10.1002/jnr.10269; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; ROSAMOND S, 1987, J IMMUNOL, V139, P1946; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Vallieres N, 2006, GLIA, V53, P103, DOI 10.1002/glia.20266; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	39	86	90	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e27969	10.1371/journal.pone.0027969	http://dx.doi.org/10.1371/journal.pone.0027969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205935	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600007
J	Douville, JM; Cheung, DYC; Herbert, KL; Moffatt, T; Wigle, JT				Douville, Josette M.; Cheung, David Y. C.; Herbert, Krista L.; Moffatt, Teri; Wigle, Jeffrey T.			Mechanisms of MEOX1 and MEOX2 Regulation of the Cyclin Dependent Kinase Inhibitors p21(CIP1/WAF1) and p16(INK4a) in Vascular Endothelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HOMEOBOX GENE GAX; SP-FAMILY MEMBERS; P21(WAF1/CIP1) GENE; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; HUMAN ATHEROSCLEROSIS; HOMEODOMAIN PROTEINS; NITRIC-OXIDE; EXPRESSION	Senescence, the state of permanent cell cycle arrest, has been associated with endothelial cell dysfunction and atherosclerosis. The cyclin dependent kinase inhibitors p21(CIP1/WAF1) and p16(INK4a) govern the G(1)/S cell cycle checkpoint and are essential for determining whether a cell enters into an arrested state. The homeodomain transcription factor MEOX2 is an important regulator of vascular cell proliferation and is a direct transcriptional activator of both p21(CIP1/WAF1) and p16(INK4a). MEOX1 and MEOX2 have been shown to be partially functionally redundant during development, suggesting that they regulate similar target genes in vivo. We compared the ability of MEOX1 and MEOX2 to activate p21(CIP1/WAF1) and p16(INK4a) expression and induce endothelial cell cycle arrest. Our results demonstrate for the first time that MEOX1 regulates the MEOX2 target genes p21(CIP1/WAF1) and p16(INK4a). In addition, increased expression of either of the MEOX homeodomain transcription factors leads to cell cycle arrest and endothelial cell senescence. Furthermore, we show that the mechanism of transcriptional activation of these cyclin dependent kinase inhibitor genes by MEOX1 and MEOX2 is distinct. MEOX1 and MEOX2 activate p16(INK4a) in a DNA binding dependent manner, whereas they induce p21(CIP1/WAF1) in a DNA binding independent manner.	[Douville, Josette M.; Cheung, David Y. C.; Herbert, Krista L.; Moffatt, Teri; Wigle, Jeffrey T.] St Boniface Gen Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB R2H 2A6, Canada; [Douville, Josette M.; Wigle, Jeffrey T.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba	Douville, JM (corresponding author), St Boniface Gen Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB R2H 2A6, Canada.	jwigle@sbrc.ca	Wigle, J.t./G-2005-2014	Wigle, J.t./0000-0002-4985-7684	Canadian Institutes of Health Research; Manitoba Health Research Council; Institute of Cardiovascular Sciences	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; Institute of Cardiovascular Sciences	This work was supported by an operating grant from the Canadian Institutes of Health Research. JMD was a recipient of studentships from the Manitoba Health Research Council and the Institute of Cardiovascular Sciences. JTW is a Manitoba Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatschek S, 2007, BLOOD, V109, P4777, DOI 10.1182/blood-2006-10-053280; Amini S, 2004, J BIOL CHEM, V279, P46046, DOI 10.1074/jbc.M403792200; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Bloor Colin M., 2005, Angiogenesis, V8, P263, DOI 10.1007/s10456-005-9013-x; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Chen Y, 2007, J BIOL CHEM, V282, P507, DOI 10.1074/jbc.M606604200; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Fisher SA, 1997, DEVELOPMENT, V124, P4405; Foreman KE, 2003, EXP GERONTOL, V38, P1251, DOI 10.1016/j.exger.2003.09.005; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gianakopoulos PJ, 2005, J BIOL CHEM, V280, P21022, DOI 10.1074/jbc.M502977200; Gorski DH, 2003, J SURG RES, V111, P91, DOI 10.1016/S0022-4804(03)00042-8; GORSKI DH, 1993, MOL CELL BIOL, V13, P3722, DOI 10.1128/MCB.13.6.3722; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Irelan JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005067; Jukkola T, 2005, GENESIS, V43, P148, DOI 10.1002/gene.20163; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kessler DS, 1997, P NATL ACAD SCI USA, V94, P13017, DOI 10.1073/pnas.94.24.13017; Kivinen L, 1999, ONCOGENE, V18, P6252, DOI 10.1038/sj.onc.1203000; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; Koutsodontis G, 2002, BIOCHEMISTRY-US, V41, P12771, DOI 10.1021/bi026141q; Le TN, 2007, J BIOL CHEM, V282, P19071, DOI 10.1074/jbc.M607486200; Li William W, 2005, Adv Skin Wound Care, V18, P491, DOI 10.1097/00129334-200511000-00013; Lu S, 2000, MOL ENDOCRINOL, V14, P753, DOI 10.1210/me.14.5.753; Mandal S, 2010, J CELL PHYSIOL, V224, P28, DOI 10.1002/jcp.22078; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Matsushita H, 2001, CIRC RES, V89, P793, DOI 10.1161/hh2101.098443; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Oma Y, 2004, J BIOL CHEM, V279, P21217, DOI 10.1074/jbc.M309887200; Paraguison RC, 2007, J NEUROSCI RES, V85, P479, DOI 10.1002/jnr.21137; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Rodrigo I, 2004, MOL CELL BIOL, V24, P2757, DOI 10.1128/MCB.24.7.2757-2766.2004; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; SATO I, 1993, BIOCHEM BIOPH RES CO, V195, P1070, DOI 10.1006/bbrc.1993.2153; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Simmons SO, 2006, BIOCHEM J, V393, P397, DOI 10.1042/BJ20051030; Skopicki HA, 1997, CIRC RES, V80, P452, DOI 10.1161/01.RES.80.4.452; Smith RC, 1997, GENE DEV, V11, P1674, DOI 10.1101/gad.11.13.1674; Smith SK, 2001, TRENDS ENDOCRIN MET, V12, P147, DOI 10.1016/S1043-2760(01)00379-4; Stamataki D, 2001, FEBS LETT, V499, P274, DOI 10.1016/S0014-5793(01)02556-X; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; Vasile E, 2001, FASEB J, V15, P458, DOI 10.1096/fj.00-0051com; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; WEIR L, 1995, J BIOL CHEM, V270, P5457, DOI 10.1074/jbc.270.10.5457; Wu XM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206078; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Zeng Jin-Hua, 2006, Hepatobiliary Pancreat Dis Int, V5, P242	59	38	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e29099	10.1371/journal.pone.0029099	http://dx.doi.org/10.1371/journal.pone.0029099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22206000	Green Published, gold, Green Submitted			2022-12-25	WOS:000298666200019
J	Ji, XY; Feng, XQ				Ji, Xiang-Ying; Feng, Xi-Qiao			Mechanochemical Modeling of Dynamic Microtubule Growth Involving Sheet-to-Tube Transition	PLOS ONE			English	Article							END-TRACKING PROTEINS; PLUS-END; ASSEMBLY DYNAMICS; TUBULIN PROTOFILAMENTS; STABILIZE MICROTUBULES; ELECTRON-MICROSCOPY; GTP HYDROLYSIS; INSTABILITY; LATTICE; CAP	Microtubule dynamics is largely influenced by nucleotide hydrolysis and the resultant tubulin configuration changes. The GTP cap model has been proposed to interpret the stabilizing mechanisms of microtubule growth from the view of hydrolysis effects. Besides, the growth of a microtubule involves the closure of a curved sheet at its growing end. The curvature conversion from the longitudinal direction to the circumferential direction also helps to stabilize the successive growth, and the curved sheet is referred to as the conformational cap. However, there still lacks theoretical investigation on the mechanical-chemical coupling growth process of microtubules. In this paper, we study the growth mechanisms of microtubules by using a coarse-grained molecular method. First, the closure process involving a sheet-to-tube transition is simulated. The results verify the stabilizing effect of the sheet structure and predict that the minimum conformational cap length that can stabilize the growth is two dimers. Then, we show that the conformational cap and the GTP cap can function independently and harmoniously, signifying the pivotal role of mechanical factors. Furthermore, based on our theoretical results, we describe a Tetris-like growth style of microtubules: the stochastic tubulin assembly is regulated by energy and harmonized with the seam zipping such that the sheet keeps a practically constant length during growth.	[Ji, Xiang-Ying; Feng, Xi-Qiao] Tsinghua Univ, Dept Engn Mech, Inst Biomech & Med Engn, Beijing 100084, Peoples R China	Tsinghua University	Ji, XY (corresponding author), Tsinghua Univ, Dept Engn Mech, Inst Biomech & Med Engn, Beijing 100084, Peoples R China.	fengxq@tsinghua.edu.cn	Feng, Xi-Qiao/A-1696-2009	Feng, Xi-Qiao/0000-0001-6894-7979	National Natural Science Foundation of China [10732050]; MOST [2010CB631005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST	This work was supported by the National Natural Science Foundation of China (Grant No. 10732050 to XQF) and the 973 Program of MOST (2010CB631005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOS LA, 1979, NATURE, V279, P607, DOI 10.1038/279607a0; AMOS LA, 1995, TRENDS CELL BIOL, V5, P48, DOI 10.1016/S0962-8924(00)88938-2; Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Asbury CL, 2011, TRENDS CELL BIOL, V21, P38, DOI 10.1016/j.tcb.2010.09.003; BAYLEY P, 1989, FEBS LETT, V259, P181, DOI 10.1016/0014-5793(89)81523-6; BAYLEY PM, 1989, J CELL SCI, V93, P241; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; Caplow M, 1996, MOL BIOL CELL, V7, P663, DOI 10.1091/mbc.7.4.663; CARLIER MF, 1989, INT REV CYTOL, V115, P139; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Cassimeris L, 2009, CURR BIOL, V19, pR174, DOI 10.1016/j.cub.2008.12.035; CHEN YD, 1987, P NATL ACAD SCI USA, V84, P8419, DOI 10.1073/pnas.84.23.8419; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Chretien D, 1999, CELL STRUCT FUNCT, V24, P299, DOI 10.1247/csf.24.299; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Coquelle FM, 2009, BIOCHEM SOC T, V37, P997, DOI 10.1042/BST0370997; Deriu MA, 2007, J MATER SCI, V42, P8864, DOI 10.1007/s10853-007-1784-6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; Enemark S, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913330; ERICKSON HP, 1992, ANNU REV BIOPH BIOM, V21, P145, DOI 10.1146/annurev.bb.21.060192.001045; Erickson HP, 1996, J CELL BIOL, V135, P5, DOI 10.1083/jcb.135.1.5; ERICKSON HP, 1981, BIOPHYS J, V34, P293, DOI 10.1016/S0006-3495(81)84850-3; Felgner H, 1997, J CELL BIOL, V138, P1067, DOI 10.1083/jcb.138.5.1067; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gardner MK, 2008, CURR OPIN CELL BIOL, V20, P64, DOI 10.1016/j.ceb.2007.12.003; GASKIN F, 1977, J BIOL CHEM, V252, P6918; Grafmuller A, 2011, STRUCTURE, V19, P409, DOI 10.1016/j.str.2010.12.020; Hawkins T, 2010, J BIOMECH, V43, P23, DOI 10.1016/j.jbiomech.2009.09.005; Heald R, 2002, J CELL SCI, V115, P3; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; Janosi IM, 2002, BIOPHYS J, V83, P1317, DOI 10.1016/S0006-3495(02)73902-7; Ji XY, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031933; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kikkawa M, 2006, CELL, V127, P1302, DOI 10.1016/j.cell.2006.12.009; KIRSCHNER MW, 1975, J MOL BIOL, V99, P263, DOI 10.1016/S0022-2836(75)80144-6; Krebs A, 2005, EMBO REP, V6, P227, DOI 10.1038/sj.embor.7400360; Mahadevan L, 2005, NATURE, V435, P895, DOI 10.1038/435895a; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MARTIN SR, 1993, BIOPHYS J, V65, P578, DOI 10.1016/S0006-3495(93)81091-9; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Molodtsov MI, 2005, BIOPHYS J, V88, P3167, DOI 10.1529/biophysj.104.051789; Mozziconacci J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003821; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pampaloni F, 2008, TRENDS BIOTECHNOL, V26, P302, DOI 10.1016/j.tibtech.2008.03.002; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Sept D, 2007, CURR BIOL, V17, pR764, DOI 10.1016/j.cub.2007.07.002; SIMON JR, 1990, J CELL SCI, V96, P571; STEINBERG IZ, 1963, J BIOL CHEM, V238, P172; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Tran PT, 1997, J CELL BIOL, V138, P105, DOI 10.1083/jcb.138.1.105; Tseng HC, 1999, P NATL ACAD SCI USA, V96, P9503, DOI 10.1073/pnas.96.17.9503; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Wang HW, 2005, CELL CYCLE, V4, P1157, DOI 10.4161/cc.4.9.2042; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007291; Zovko S, 2008, MOL BIOL CELL, V19, P3138, DOI 10.1091/mbc.E07-07-0681	72	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e29049	10.1371/journal.pone.0029049	http://dx.doi.org/10.1371/journal.pone.0029049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205994	Green Published, Green Submitted, gold			2022-12-25	WOS:000298666200016
J	Schmitt, J; Keller, A; Nourkami-Tutdibi, N; Heisel, S; Habel, N; Leidinger, P; Ludwig, N; Gessler, M; Graf, N; Berthold, F; Lenhof, HP; Meese, E				Schmitt, Jana; Keller, Andreas; Nourkami-Tutdibi, Nasenien; Heisel, Sabrina; Habel, Nunja; Leidinger, Petra; Ludwig, Nicole; Gessler, Manfred; Graf, Norbert; Berthold, Frank; Lenhof, Hans-Peter; Meese, Eckart			Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients	PLOS ONE			English	Article							HEPARAN-SULFATE; N-MYC; SERUM AUTOANTIBODIES; SUPPRESSORS EXT1; NEURO-BLASTOMA; ALLELIC LOSS; LUNG-CANCER; CHILDREN; AMPLIFICATION; THERAPY	Several studies report autoantibody signatures in cancer. The majority of these studies analyzed adult tumors and compared the seroreactivity pattern of tumor patients with the pattern in healthy controls. Here, we compared the autoimmune response in patients with neuroblastoma and patients with Wilms tumor representing two different childhood tumors. We were able to differentiate untreated neuroblastoma patients from untreated Wilms tumor patients with an accuracy of 86.8%, a sensitivity of 87.0% and a specificity of 86.7%. The separation of treated neuroblastoma patients from treated Wilms tumor patients' yielded comparable results with an accuracy of 83.8%. We furthermore identified the antigens that contribute most to the differentiation between both tumor types. The analysis of these antigens revealed that neuroblastoma was considerably more immunogenic than Wilms tumor. The reported antigens have not been found to be relevant for comparative analyses between other tumors and controls. In summary, neuroblastoma appears as a highly immunogenic tumor as demonstrated by the extended number of antigens that separate this tumor from Wilms tumor.	[Schmitt, Jana; Keller, Andreas; Heisel, Sabrina; Habel, Nunja; Leidinger, Petra; Ludwig, Nicole; Meese, Eckart] Univ Saarland, Sch Med, Dept Human Genet, D-6650 Homburg, Germany; [Nourkami-Tutdibi, Nasenien; Graf, Norbert] Univ Saarland, Sch Med, Dept Paediat Oncol & Haematol, D-6650 Homburg, Germany; [Gessler, Manfred] Univ Wurzburg, Bioctr, Wurzburg, Germany; [Berthold, Frank] Univ Cologne, Dept Paediat Oncol & Haematol, D-50931 Cologne, Germany; [Lenhof, Hans-Peter] Univ Saarland, Ctr Bioinformat, Saarbrucken, Germany	Saarland University; Saarland University; University of Wurzburg; University of Cologne; Saarland University	Schmitt, J (corresponding author), Univ Saarland, Sch Med, Dept Human Genet, D-6650 Homburg, Germany.	jana.schmitt@uniklinikum-saarland.de	Meese, Eckart Ulrich/ABD-1983-2021; Graf, Norbert/H-1328-2011; Keller, Andreas/ABB-6412-2021	Graf, Norbert/0000-0002-2248-323X; Keller, Andreas/0000-0002-5361-0895; Gessler, Manfred/0000-0002-7915-6045	Hedwig Stalter Foundation, Homfor; Deutsche Forschungsgemeinschaft [ME917/20-1]	Hedwig Stalter Foundation, Homfor; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by Hedwig Stalter Foundation, Homfor and Deutsche Forschungsgemeinschaft ME917/20-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard MA, 2001, CELL MOTIL CYTOSKEL, V48, P149, DOI 10.1002/1097-0169(200102)48:2<149::AID-CM1005>3.0.CO;2-3; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brodeur G M, 1985, Prog Clin Biol Res, V175, P105; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; CARON H, 1995, MED PEDIATR ONCOL, V24, P215, DOI 10.1002/mpo.2950240402; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; CORVI R, 1995, ONCOGENE, V10, P1081; Davidoff AM, 2010, SEMIN PEDIATR SURG, V19, P225, DOI 10.1053/j.sempedsurg.2010.03.007; DeStefano AL, 2008, HUM GENET, V124, P95, DOI 10.1007/s00439-008-0526-4; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; Forni PE, 2011, J NEUROSCI, V31, P480, DOI 10.1523/JNEUROSCI.4698-10.2011; Hero B, 2002, KLIN PADIATR, V214, P157, DOI 10.1055/s-2002-33182; JINBO T, 1989, JPN J CANCER RES, V80, P299, DOI 10.1111/j.1349-7006.1989.tb02309.x; Kaste SC, 2008, PEDIATR RADIOL, V38, P2, DOI 10.1007/s00247-007-0687-7; Keller A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-539; Leidinger P, 2008, INT J CANCER, V123, P1631, DOI 10.1002/ijc.23680; Leidinger P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-18; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; LUDWIG N, 2010, INT J CANC; Ludwig N, 2008, CLIN CANCER RES, V14, P4767, DOI 10.1158/1078-0432.CCR-07-4715; Ludwig N, 2009, NEOPLASIA, V11, P1383, DOI 10.1593/neo.91018; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Metzger ML, 2005, ONCOLOGIST, V10, P815, DOI 10.1634/theoncologist.10-10-815; Miniati D, 2008, J PEDIATR SURG, V43, P1301, DOI 10.1016/j.jpedsurg.2008.02.077; Monclair T, 2009, J CLIN ONCOL, V27, P298, DOI 10.1200/JCO.2008.16.6876; Nishi M, 2003, J EXP CLIN CANC RES, V22, P673; Reijnders CMA, 2010, AM J PATHOL, V177, P1946, DOI 10.2353/ajpath.2010.100296; SAWADA T, 1984, LANCET, V2, P271; Schilling FH, 2002, NEW ENGL J MED, V346, P1047, DOI 10.1056/NEJMoa012277; Spix C, 2006, EUR J CANCER, V42, P2081, DOI 10.1016/j.ejca.2006.05.008; TAKEDA T, 1989, MED PEDIATR ONCOL, V17, P368, DOI 10.1002/mpo.2950170504; Tan HT, 2009, FEBS J, V276, P6880, DOI 10.1111/j.1742-4658.2009.07396.x; TREUNER J, 1995, EUR J CANCER, V31A, P565, DOI 10.1016/0959-8049(95)00034-G; VALLEE RB, 1984, J CELL BIOL, V99, P38; Vapnik V. N., 2000, NATURE STAT LEARNING; VOORHESS ML, 1962, PEDIATRICS, V30, P241; Woods WG, 1996, LANCET, V348, P1682, DOI 10.1016/S0140-6736(96)06020-5; Woods WG, 2002, NEW ENGL J MED, V346, P1041, DOI 10.1056/NEJMoa012387; Woods WG, 1997, EUR J CANCER, V33, P2106, DOI 10.1016/S0959-8049(97)00310-9; Yamamoto K, 2002, J CLIN ONCOL, V20, P1209, DOI 10.1200/JCO.2002.20.5.1209	44	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28951	10.1371/journal.pone.0028951	http://dx.doi.org/10.1371/journal.pone.0028951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194956	Green Published, gold, Green Submitted			2022-12-25	WOS:000298664400024
J	Shen, GM; Dou, W; Niu, JZ; Jiang, HB; Yang, WJ; Jia, FX; Hu, F; Cong, L; Wang, JJ				Shen, Guang-Mao; Dou, Wei; Niu, Jin-Zhi; Jiang, Hong-Bo; Yang, Wen-Jia; Jia, Fu-Xian; Hu, Fei; Cong, Lin; Wang, Jin-Jun			Transcriptome Analysis of the Oriental Fruit Fly (Bactrocera dorsalis)	PLOS ONE			English	Article							GENE-EXPRESSION; RESISTANCE; FLIES; MUTATIONS; CARBOXYLESTERASES; CHOLINESTERASES; BIOLOGY; HENDEL	Background: The oriental fruit fly, Bactrocera dorsalis (Hendel), is one of the most economically important pests in the world, causing serious damage to fruit production. However, lack of genetic information on this organism is an obstacle to understanding the mechanisms behind its development and its ability to resist insecticides. Analysis of the B. dorsalis transcriptome and its expression profile data is essential to extending the genetic information resources on this species, providing a shortcut that will support studies on B. dorsalis. Methodology/Principal Findings: We performed de novo assembly of a transcriptome using short read sequencing technology (Illumina). The results generated 484,628 contigs, 70,640 scaffolds, and 49,804 unigenes. Of those unigenes, 27,455 (55.13%) matched known proteins in the NCBI database, as determined by BLAST search. Clusters of orthologous groups (COG), gene orthology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations were performed to better understand the functions of these unigenes. Genes related to insecticide resistance were analyzed in additional detail. Digital gene expression (DGE) libraries showed differences in gene expression profiles at different developmental stages (eggs, third-instar larvae, pupae, and adults). To confirm the DGE results, the expression profiles of six randomly selected genes were analyzed. Conclusion/Significance: This transcriptome greatly improves our genetic understanding of B. dorsalis and makes a huge number of gene sequences available for further study, including both genes of known importance and genes of unknown function. The DGE data provide comprehensive insight into gene expression profiles at different developmental stages. This facilitates the study of the role of each gene in the developmental process and in insecticide resistance.	[Shen, Guang-Mao; Dou, Wei; Niu, Jin-Zhi; Jiang, Hong-Bo; Yang, Wen-Jia; Jia, Fu-Xian; Hu, Fei; Cong, Lin; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Southwest University - China	Wang, JJ (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	jjwang7008@yahoo.com		HU, FEI/0000-0001-6164-0536	National Basic Research Program of China [2009CB125903, 2009CB119200]; Natural Science Foundation of Chongqing (CSTC) [2009BA1042]; Program for Innovative Research Team in University [IRT0976]; earmarked fund for Modern Agro-industry (Citrus) Technology Research System, China [CARS-27-06B]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Program for Innovative Research Team in University; earmarked fund for Modern Agro-industry (Citrus) Technology Research System, China	This study was funded in part by the National Basic Research Program of China (2009CB125903, 2009CB119200), Natural Science Foundation of Chongqing (CSTC, 2009BA1042), the Program for Innovative Research Team in University (IRT0976), and the earmarked fund for Modern Agro-industry (Citrus) Technology Research System (CARS-27-06B) of China to Dr. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aketarawong N, 2006, MOL ECOL NOTES, V6, P1138, DOI 10.1111/j.1471-8286.2006.01463.x; Alias Z, 2010, PESTIC BIOCHEM PHYS, V98, P94, DOI 10.1016/j.pestbp.2010.05.005; Aluja M, 2008, ANNU REV ENTOMOL, V53, P473, DOI 10.1146/annurev.ento.53.103106.093350; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Attardo GM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-160; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BATEMAN MA, 1972, ANNU REV ENTOMOL, V17, P493, DOI 10.1146/annurev.en.17.010172.002425; Burke GR, 2011, INSECT MOL BIOL, V20, P357, DOI 10.1111/j.1365-2583.2011.01070.x; Chen P, 2008, J APPL ENTOMOL, V132, P530, DOI 10.1111/j.1439-0418.2008.01302.x; Chen SL, 2008, INSECT BIOCHEM MOLEC, V38, P155, DOI 10.1016/j.ibmb.2007.10.003; CHRISTENSON LD, 1960, ANNU REV ENTOMOL, V5, P171, DOI 10.1146/annurev.en.05.010160.001131; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; FLETCHER BS, 1987, ANNU REV ENTOMOL, V32, P115, DOI 10.1146/annurev.en.32.010187.000555; Follett PA, 2006, ANNU REV ENTOMOL, V51, P359, DOI 10.1146/annurev.ento.49.061802.123314; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hotelier T, 2010, J PESTIC SCI, V35, P315, DOI 10.1584/jpestics.R10-10; Hsu JC, 2008, INSECT BIOCHEM MOLEC, V38, P146, DOI 10.1016/j.ibmb.2007.10.002; Hsu JC, 2006, INSECT BIOCHEM MOLEC, V36, P396, DOI 10.1016/j.ibmb.2006.02.002; Jiang Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-1; Jin T, 2011, PEST MANAG SCI, V67, P370, DOI 10.1002/ps.2076; Jin T, 2010, PESTIC BIOCHEM PHYS, V96, P1, DOI 10.1016/j.pestbp.2009.07.013; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kim SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015074; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Mittapalli O, 2011, PLOS ONE, V5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Suganya R, 2010, ARCH INSECT BIOCHEM, V75, P45, DOI 10.1002/arch.20383; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303	43	113	123	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29127	10.1371/journal.pone.0029127	http://dx.doi.org/10.1371/journal.pone.0029127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195006	Green Submitted, gold, Green Published			2022-12-25	WOS:000298370400034
J	McFarland, R; Majolo, B				McFarland, Richard; Majolo, Bonaventura			Exploring the Components, Asymmetry and Distribution of Relationship Quality in Wild Barbary Macaques (Macaca sylvanus)	PLOS ONE			English	Article							SOCIAL RELATIONSHIPS; NONHUMAN-PRIMATES; MARKET FORCES; RECIPROCITY; BABOONS; AGGRESSION; RECONCILIATION; INTERCHANGE; DYNAMICS; COERCION	Social relationships between group members are a key feature of many animal societies. The quality of social relationships has been described by three main components: value, compatibility and security, based on the benefits, tenure and stability of social exchanges. We aimed to analyse whether this three component structure could be used to describe the quality of social relationships in wild Barbary macaques (Macaca sylvanus). Moreover, we examined whether relationship quality was affected by the sex, age and rank differences between social partners, and investigated the asymmetric nature of social relationships. We collected over 1,900 hours of focal data on seven behavioural variables measuring relationship quality, and used principal component analysis to investigate how these variables clustered together. We found that relationship quality in wild Barbary macaques can be described by a three component structure that represents the value, compatibility and security of a relationship. Female-female dyads had more valuable relationships and same-age dyads more compatible relationships than any other dyad. Rank difference had no effect on the quality of a social relationship. Finally, we found a high degree of asymmetry in how members of a dyad exchange social behaviour. We argue that the asymmetry of social relationships should be taken into account when exploring the pattern and function of social behaviour in animal societies.	[McFarland, Richard; Majolo, Bonaventura] Lincoln Univ, Sch Psychol, Lincoln, England	University of Lincoln	McFarland, R (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	rmcfarland@lincoln.ac.uk		McFarland, Richard/0000-0001-8245-9269; Majolo, Bonaventura/0000-0002-0235-3040	University of Lincoln, UK	University of Lincoln, UK	This research project received financial support from the University of Lincoln, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Barrett L, 1999, P ROY SOC B-BIOL SCI, V266, P665, DOI 10.1098/rspb.1999.0687; Bissonnette A, 2009, ANIM BEHAV, V78, P329, DOI 10.1016/j.anbehav.2009.05.010; Borgatti S. P., 2002, UCINET 6 WINDOWS SOF; Clarke PMR, 2010, BEHAV ECOL, V21, P1211, DOI 10.1093/beheco/arq125; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; COLLINS NL, 1993, J PERS SOC PSYCHOL, V65, P1243, DOI 10.1037/0022-3514.65.6.1243; Colmenares F, 2002, BEHAVIOUR, V139, P1525, DOI 10.1163/15685390260514753; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; Cords M., 2000, NATURAL CONFLICT RES, P177; Cords M., 1997, MACHIAVELLIAN INTELL, P24; DEWAAL FBM, 1986, FOLIA PRIMATOL, V46, P215, DOI 10.1159/000156255; Fraser ON, 2008, ETHOLOGY, V114, P834, DOI 10.1111/j.1439-0310.2008.01527.x; Fraser ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018118; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; Fruteau C, 2011, ANIM BEHAV, V81, P1223, DOI 10.1016/j.anbehav.2011.03.008; HEMELRIJK CK, 1991, ANIM BEHAV, V41, P923, DOI 10.1016/S0003-3472(05)80630-X; Hinde R., 1979, UNDERSTANDING RELATI; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Koski SE, 2007, AM J PRIMATOL, V69, P158, DOI 10.1002/ajp.20338; KUMMER H, 1978, SOC SCI INFORM, V17, P687, DOI 10.1177/053901847801700418; Majolo B, 2010, INT J PRIMATOL, V31, P736, DOI 10.1007/s10764-010-9424-4; Majolo B, 2009, ETHOLOGY, V115, P152, DOI 10.1111/j.1439-0310.2008.01591.x; McFarland R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026893; McFarland R, 2011, ETHOLOGY, V117, P928, DOI 10.1111/j.1439-0310.2011.01948.x; MENARD N, 1993, AM J PRIMATOL, V30, P101, DOI 10.1002/ajp.1350300203; NOE R, 1990, ANIM BEHAV, V39, P78, DOI 10.1016/S0003-3472(05)80728-6; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Perry S, 1996, AM J PRIMATOL, V40, P167, DOI 10.1002/(SICI)1098-2345(1996)40:2<167::AID-AJP4>3.0.CO;2-W; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rebecchini L, 2011, ETHOLOGY, V117, P691, DOI 10.1111/j.1439-0310.2011.01923.x; Schino G, 2005, PRIMATES, V46, P207, DOI 10.1007/s10329-004-0124-6; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Schino G, 2010, ECOL LETT, V13, P45, DOI 10.1111/j.1461-0248.2009.01396.x; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Shaw P.J.A., 2003, MULTIVARIATE STAT EN; SILK JB, 1982, BEHAVIOUR, V79, P162, DOI 10.1163/156853982X00238; Silk JB, 2002, ANNU REV ANTHROPOL, V31, P21, DOI 10.1146/annurev.anthro.31.032902.101743; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; StataCorp L, 2007, STAT DAT AN STAT SOF; Thierry B., 2004, MACAQUE SOC MODEL ST; Thierry Bernard, 2000, P106; van Schaik C.P., 2000, INFANTICIDE MALES IT; van Schaik Carel P., 2000, P307; van Schaik CP., 1989, COMP SOCIOECOLOGY BE, P195; VANSCHAIK CP, 1994, BEHAV ECOL SOCIOBIOL, V35, P261, DOI 10.1007/s002650050097; Ventura R, 2006, AM J PRIMATOL, V68, P1138, DOI 10.1002/ajp.20314; Watts David P., 2000, P281; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	58	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28826	10.1371/journal.pone.0028826	http://dx.doi.org/10.1371/journal.pone.0028826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194923	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100107
J	Shaked, M; Ketzinel-Gilad, M; Cerasi, E; Kaiser, N; Leibowitz, G				Shaked, Maayan; Ketzinel-Gilad, Mali; Cerasi, Erol; Kaiser, Nurit; Leibowitz, Gil			AMP-Activated Protein Kinase (AMPK) Mediates Nutrient Regulation of Thioredoxin-Interacting Protein (TXNIP) in Pancreatic Beta-Cells	PLOS ONE			English	Article							CARBOHYDRATE RESPONSE ELEMENT; BINDING PROTEIN; INSULIN-SECRETION; GENE-EXPRESSION; GLUCOSE; APOPTOSIS; CHREBP; METABOLISM; FAILURE; ISLETS	Thioredoxin-interacting protein (TXNIP) regulates critical biological processes including inflammation, stress and apoptosis. TXNIP is upregulated by glucose and is a critical mediator of hyperglycemia-induced beta-cell apoptosis in diabetes. In contrast, the saturated long-chain fatty acid palmitate, although toxic to the beta-cell, inhibits TXNIP expression. The mechanisms involved in the opposing effects of glucose and fatty acids on TXNIP expression are unknown. We found that both palmitate and oleate inhibited TXNIP in a rat beta-cell line and islets. Palmitate inhibition of TXNIP was independent of fatty acid beta-oxidation or esterification. AMP-activated protein kinase (AMPK) has an important role in cellular energy sensing and control of metabolic homeostasis; therefore we investigated its involvement in nutrient regulation of TXNIP. As expected, glucose inhibited whereas palmitate stimulated AMPK. Pharmacologic activators of AMPK mimicked fatty acids by inhibiting TXNIP. AMPK knockdown increased TXNIP expression in presence of high glucose with and without palmitate, indicating that nutrient (glucose and fatty acids) effects on TXNIP are mediated in part via modulation of AMPK activity. TXNIP is transcriptionally regulated by carbohydrate response element-binding protein (ChREBP). Palmitate inhibited glucose-stimulated ChREBP nuclear entry and recruitment to the Txnip promoter, thereby inhibiting Txnip transcription. We conclude that AMPK is an important regulator of Txnip transcription via modulation of ChREBP activity. The divergent effects of glucose and fatty acids on TXNIP expression result in part from their opposing effects on AMPK activity. In light of the important role of TXNIP in beta-cell apoptosis, its inhibition by fatty acids can be regarded as an adaptive/protective response to glucolipotoxicity. The finding that AMPK mediates nutrient regulation of TXNIP may have important implications for the pathophysiology and treatment of diabetes.	[Shaked, Maayan; Ketzinel-Gilad, Mali; Cerasi, Erol; Kaiser, Nurit; Leibowitz, Gil] Hadassah Hebrew Univ, Med Ctr, Dept Med, Endocrinol & Metab Serv, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Shaked, M (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Med, Endocrinol & Metab Serv, Jerusalem, Israel.	gleib@hadassah.org.il			Israel Science Foundation; Diab RD (Paris)	Israel Science Foundation(Israel Science Foundation); Diab RD (Paris)	This study was supported by grants from the Israel Science Foundation, who had no role in study design, data collection or decision to publish the manuscript, and Diab R&D (Paris). Erol Cerasi, the founder of Diab R&D, was involved in the analysis and interpretation of the data and discussions of the manuscript.	Burke SJ, 2009, FASEB J, V23, P2855, DOI 10.1096/fj.08-126631; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2006, BIOCHEM BIOPH RES CO, V346, P1067, DOI 10.1016/j.bbrc.2006.06.027; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jonas JC, 2009, DIABETES OBES METAB, V11, P65, DOI 10.1111/j.1463-1326.2009.01112.x; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KAISER N, 1988, ENDOCRINOLOGY, V123, P834, DOI 10.1210/endo-123-2-834; Kaiser N, 2009, FRONT BIOSCI-LANDMRK, V14, P1099, DOI 10.2741/3296; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; LACHAAL M, 1993, AM J PHYSIOL, V265, pE914, DOI 10.1152/ajpendo.1993.265.6.E914; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Meares GP, 2010, J BIOL CHEM, V285, P3191, DOI 10.1074/jbc.M109.047365; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; NybIorn HK, 2008, J MOL ENDOCRINOL, V41, P187, DOI 10.1677/JME-08-0006; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Shaked M, 2009, DIABETOLOGIA, V52, P636, DOI 10.1007/s00125-009-1274-2; Shao WJ, 2010, CELL SIGNAL, V22, P1240, DOI 10.1016/j.cellsig.2010.04.001; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Wang X, 2007, BIOCHEM BIOPH RES CO, V352, P463, DOI 10.1016/j.bbrc.2006.11.032; Xavier GD, 2000, P NATL ACAD SCI USA, V97, P4023, DOI 10.1073/pnas.97.8.4023; Yoshioka J, 2006, ANTIOXID REDOX SIGN, V8, P2143, DOI 10.1089/ars.2006.8.2143; Yu FX, 2010, J BIOL CHEM, V285, P25822, DOI 10.1074/jbc.M110.108290; Za'tara G, 2008, BIOCHEM PHARMACOL, V76, P1263, DOI 10.1016/j.bcp.2008.08.028	46	55	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28804	10.1371/journal.pone.0028804	http://dx.doi.org/10.1371/journal.pone.0028804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194917	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100102
J	Uriz, M; Saez, E; Prieto, J; Medina, JF; Banales, JM				Uriz, Miriam; Saez, Elena; Prieto, Jesus; Medina, Juan F.; Banales, Jesus M.			Ursodeoxycholic Acid Is Conjugated with Taurine to Promote Secretin-Stimulated Biliary Hydrocholeresis in the Normal Rat	PLOS ONE			English	Article							TAUROURSODEOXYCHOLIC ACID; BICARBONATE SECRETION; HEPATIC CYSTOGENESIS; ABNORMAL EXPRESSION; ANIMAL-MODEL; BILE-SALTS; METABOLISM; TRANSPORT; LIVER; ATP	Background & Aims: Secretin induces bicarbonate-rich hydrocholeresis in healthy individuals, but not in untreated patients with primary biliary cirrhosis (PBC). Ursodeoxycholic acid (UDCA) - the first choice treatment for PBC - restores the secretin response. Compared with humans, secretin has poor effect in experimental normal-rat models with biliary drainage, although it may elicit hydrocholeresis when the bile-acid pool is maintained. In view of the benefits of UDCA in PBC, we used normal-rat models to unravel the acute contribution of UDCA (and/or taurine-conjugated TUDCA) for eliciting the biliary secretin response. Methods: Intravascular and/or intrabiliary administration of agonists and inhibitors was performed in normal rats with biliary monitoring. Secretin/bile-acid interplay was analyzed in 3D cultured rat cholangiocytes that formed expansive cystic structures with intralumenal hydroionic secretion. Results: In vivo, secretin stimulates hydrocholeresis upon UDCA/TUDCA infusion, but does not modify the intrinsic hypercholeretic effect of dehydrocholic acid (DHCA). The former effect is dependent on microtubule polymerization, and involves PKC alpha, PI3K and MEK pathways, as shown by colchicine (i.p.) and retrograde biliary inhibitors. In vitro, while secretin alone accelerates the spontaneous expansion of 3D-cystic structures, this effect is enhanced in the presence of TUDCA, but not UDCA or DHCA. Experiments with inhibitors and Ca2+-chelator confirmed that the synergistic effect of secretin plus TUDCA involves microtubules, intracellular Ca2+, PKC alpha, PI3K, PKA and MEK pathways. Gene silencing also demonstrated the involvement of the bicarbonate extruder Ae2. Conclusions: UDCA is conjugated in order to promote secretin-stimulated hydrocholeresis in rats through Ae2, microtubules, intracellular Ca2+, PKC alpha, PI3K, PKA, and MEK.	[Uriz, Miriam] Univ Navarra, Ctr Invest Biomed Red El Area Temat Enfermedades, Div Gene Therapy & Hepatol, CIMA Clin, E-31080 Pamplona, Spain; Univ Navarra, Ctr Invest Biomed Red El Area Temat Enfermedades, Sch Med, E-31080 Pamplona, Spain	University of Navarra; University of Navarra	Uriz, M (corresponding author), Univ Navarra, Ctr Invest Biomed Red El Area Temat Enfermedades, Div Gene Therapy & Hepatol, CIMA Clin, E-31080 Pamplona, Spain.	jfmedina@unav.es; jmbanales@unav.es	Banales, Jesus M/R-9739-2019	Prieto, Jesus/0000-0002-1091-9593; Saez De Blas, Elena/0000-0002-6494-9739; Banales, Jesus/0000-0002-5224-2373	Spanish "UTE for CIMA project"; Spanish Ministry of Science and Innovation [SAF2006-07818, SAF2009-11538]; Carlos III Institute of Health [Ciberehd CB06/04/0067]	Spanish "UTE for CIMA project"; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Institute of Health(Instituto de Salud Carlos III)	This work was supported through the Spanish "UTE for CIMA project", by grants from the Spanish Ministry of Science and Innovation (SAF2006-07818 and SAF2009-11538), and by the Carlos III Institute of Health (Ciberehd CB06/04/0067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpini G, 2005, HEPATOLOGY, V41, P1037, DOI 10.1002/hep.20653; Banales JM, 2006, WORLD J GASTROENTERO, V12, P3496, DOI 10.3748/wjg.v12.i22.3496; Banales JM, 2009, HEPATOLOGY, V49, P160, DOI 10.1002/hep.22636; Banales JM, 2008, AM J PATHOL, V173, P1637, DOI 10.2353/ajpath.2008.080125; Banales JM, 2006, HEPATOLOGY, V43, P266, DOI 10.1002/hep.21042; Beuers U, 2006, NAT CLIN PRACT GASTR, V3, P318, DOI 10.1038/ncpgasthep0521; Beuers U, 2010, HEPATOLOGY, V52, P1489, DOI 10.1002/hep.23810; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Denk GU, 2010, HEPATOLOGY, V52, P1758, DOI 10.1002/hep.23911; Fiorotto R, 2007, GASTROENTEROLOGY, V133, P1603, DOI 10.1053/j.gastro.2007.08.071; HOHENESTER S, 2011, HEPATOLOGY IN PRESS; Invernizzi P, 1999, HEPATOLOGY, V29, P320, DOI 10.1002/hep.510290220; Ishizaki K, 2005, HEPATOL RES, V33, P174, DOI 10.1016/j.hepres.2005.09.029; ITO T, 2011, AMINO ACIDS IN PRESS; Kanno N, 2001, AM J PHYSIOL-GASTR L, V281, pG612, DOI 10.1152/ajpgi.2001.281.3.G612; Kurz AK, 2001, GASTROENTEROLOGY, V121, P407, DOI 10.1053/gast.2001.26262; Lindor K, 2007, NEW ENGL J MED, V357, P1524, DOI 10.1056/NEJMct074694; Mancinelli R, 2010, AM J PATHOL, V176, P1790, DOI 10.2353/ajpath.2010.090677; Marzioni M, 2006, AM J PATHOL, V168, P398, DOI 10.2353/ajpath.2006.050126; Medina JF, 1997, HEPATOLOGY, V25, P12, DOI 10.1053/jhep.1997.v25.pm0008985258; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Nathanson MH, 2001, BIOCHEM J, V358, P1, DOI 10.1042/0264-6021:3580001; PODDA M, 1990, GASTROENTEROLOGY, V98, P1044, DOI 10.1016/0016-5085(90)90032-V; Poupon R, 2010, J HEPATOL, V52, P745, DOI 10.1016/j.jhep.2009.11.027; PRIETO J, 1993, GASTROENTEROLOGY, V105, P572, DOI 10.1016/0016-5085(93)90735-U; Prieto J, 1999, GASTROENTEROLOGY, V117, P167, DOI 10.1016/S0016-5085(99)70564-0; Rembacz KP, 2010, HEPATOLOGY, V52, P2167, DOI 10.1002/hep.23954; Rodriguez-Ortigosa CM, 2010, HEPATOLOGY, V52, P667, DOI 10.1002/hep.23709; ROMA MG, 1991, BIOCHEM PHARMACOL, V42, P1775, DOI 10.1016/0006-2952(91)90515-7; SAKISAKA S, 1994, HEPATOLOGY, V20, P1015, DOI 10.1002/hep.1840200434; Setchell KDR, 1996, GUT, V38, P439, DOI 10.1136/gut.38.3.439; SOLOWAY RD, 1973, J CLIN INVEST, V52, P715, DOI 10.1172/JCI107233; STURMAN JA, 1975, J NUTR, V105, P1206; SUBBIAH MT, 1969, CAN J BIOCHEM CELL B, V47, P847, DOI 10.1139/o69-133; Tietz PS, 2003, J BIOL CHEM, V278, P20413, DOI 10.1074/jbc.M302108200; Uriarte I, 2010, HEPATOLOGY, V51, P891, DOI 10.1002/hep.23403; Wimmer R, 2008, GUT, V57, P1448, DOI 10.1136/gut.2007.140871	37	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28717	10.1371/journal.pone.0028717	http://dx.doi.org/10.1371/journal.pone.0028717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194894	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100084
J	Burns, JHR; Takabayashi, M				Burns, John H. R.; Takabayashi, Misaki			Histopathology of Growth Anomaly Affecting the Coral, Montipora capitata: Implications on Biological Functions and Population Viability	PLOS ONE			English	Article							TUMOR FORMATIONS; DISEASE; SYMBIOSES; ACROPORA; LESIONS	Growth anomalies (GAs) affect the coral, Montipora capitata, at Wai'opae, southeast Hawai'i Island. Our histopathological analysis of this disease revealed that the GA tissue undergoes changes which compromise anatomical machinery for biological functions such as defense, feeding, digestion, and reproduction. GA tissue exhibited significant reductions in density of ova (66.1-93.7%), symbiotic dinoflagellates (38.8-67.5%), mesenterial filaments (11.2-29.0%), and nematocytes (28.8-46.0%). Hyperplasia of the basal body wall but no abnormal levels of necrosis and algal or fungal invasion was found in GA tissue. Skeletal density along the basal body wall was significantly reduced in GAs compared to healthy or unaffected sections. The reductions in density of the above histological features in GA tissue were collated with disease severity data to quantify the impact of this disease at the colony and population level. Resulting calculations showed this disease reduces the fecundity of M. capitata colonies at Wai'opae by 0.7-49.6%, depending on GA severity, and the overall population fecundity by 2.41 +/- 0.29%. In sum, GA in this M. capitata population reduces the coral's critical biological functions and increases susceptibility to erosion, clearly defining itself as a disease and an ecological threat.	[Burns, John H. R.; Takabayashi, Misaki] Univ Hawaii, Dept Marine Sci, Hilo, HI 96720 USA	University of Hawaii System; University Hawaii Hilo	Burns, JHR (corresponding author), Univ Hawaii, Dept Marine Sci, Hilo, HI 96720 USA.	johnhr@hawaii.edu			National Oceanographic and Atmospheric Administration Hawaii Sea Grant College [42.R/HE-4]; University of Hawai'i Sea Grant College [NA0OAR4170060, UNIHI-SEAGRANT-JC-09-36]; National Science Foundation Center for Research Excellence in Science and Technology [0833211]	National Oceanographic and Atmospheric Administration Hawaii Sea Grant College; University of Hawai'i Sea Grant College; National Science Foundation Center for Research Excellence in Science and Technology	This research was funded by a grant/cooperative agreement from the National Oceanographic and Atmospheric Administration Hawaii Sea Grant College Program Project 42.R/HE-4 to MT, which is sponsored by the University of Hawai'i Sea Grant College Program, under Institutional Grant No. NA0OAR4170060, publication number UNIHI-SEAGRANT-JC-09-36, and by National Science Foundation Center for Research Excellence in Science and Technology Grant No. 0833211 to MT for the Center in Tropical Ecology and Evolution in Marine and Terrestrial Environments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby G.S, 2004, NW HAW ISL 3 SCI S 2; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; BOSSCHER H, 1993, CORAL REEFS, V12, P97, DOI 10.1007/BF00302109; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Burns JHR, 2011, CORAL REEFS, DOI [10.1007/s003388-011-0761-3, DOI 10.1007/S003388-011-0761-3]; Domart-Coulon IJ, 2006, CORAL REEFS, V25, P531, DOI 10.1007/s00338-006-0133-6; Dorland WAN, 2006, DORLANDS ILLUSTRATED; Friedlander Alan, 2005, NOAA Technical Memorandum NOS NCCOS, V11, P222; Gateno D, 2003, MAR ECOL PROG SER, V258, P97, DOI 10.3354/meps258097; Glynn Peter W., 1997, P68; Goldberg J., 2004, STATUS CORAL REEFS W, V2004, P67; GOLDBERG WM, 1984, BIOL BULL, V166, P368, DOI 10.2307/1541223; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2007, OCEANOGRAPHY, V20, P58; HATCHER BG, 1988, TRENDS ECOL EVOL, V3, P106, DOI 10.1016/0169-5347(88)90117-6; Hayes RL, 1998, REV BIOL TROP, V46, P173; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Kaczmarsky L, 2007, J INVERTEBR PATHOL, V94, P218, DOI 10.1016/j.jip.2006.11.007; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; LOYA Y, 1984, HELGOLANDER MEERESUN, V37, P99, DOI 10.1007/BF01989297; McClanahan TR, 2009, GLOBAL CHANGE BIOL, V15, P1804, DOI 10.1111/j.1365-2486.2008.01799.x; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Ogden J., 1977, STUDIES GEOLOGY, V4, P281; PETERS EC, 1984, HELGOLANDER MEERESUN, V37, P113, DOI 10.1007/BF01989298; PETERS EC, 1986, JNCI-J NATL CANCER I, V76, P895; Petes LE, 2003, MAR ECOL PROG SER, V264, P167, DOI 10.3354/meps264167; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; SQUIRES DF, 1965, SCIENCE, V148, P503, DOI 10.1126/science.148.3669.503; Takabayashi M., 2010, P 11 INT COR REEF S, V18, P820; TRENCH RK, 1993, ENDOCYTOBIOSIS CELL, V9, P135; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Williams GJ, 2011, J INVERTEBR PATHOL, V106, P165, DOI 10.1016/j.jip.2010.08.002; Woodley CM, 2008, 80 NOS NCCOS, P85; Work TM, 2008, DIS AQUAT ORGAN, V78, P255, DOI 10.3354/dao01881; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Work TM, 2005, CORAL REEFS, V24, P384, DOI 10.1007/s00338-005-0018-0; Yamashiro H, 2000, DIS AQUAT ORGAN, V41, P211, DOI 10.3354/dao041211	38	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28854	10.1371/journal.pone.0028854	http://dx.doi.org/10.1371/journal.pone.0028854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205976	Green Published, gold, Green Submitted			2022-12-25	WOS:000298665600011
J	Frith, MC				Frith, Martin C.			Gentle Masking of Low-Complexity Sequences Improves Homology Search	PLOS ONE			English	Article							PROTEIN DATABASE SEARCHES; ALIGNMENT	Detection of sequences that are homologous, i.e. descended from a common ancestor, is a fundamental task in computational biology. This task is confounded by low-complexity tracts (such as atatatatatat), which arise frequently and independently, causing strong similarities that are not homologies. There has been much research on identifying low-complexity tracts, but little research on how to treat them during homology search. We propose to find homologies by aligning sequences with "gentle" masking of low-complexity tracts. Gentle masking means that the match score involving a masked letter is min(0, S), where S is the unmasked score. Gentle masking slightly but noticeably improves the sensitivity of homology search (compared to "harsh" masking), without harming specificity. We show examples in three useful homology search problems: detection of NUMTs (nuclear copies of mitochondrial DNA), recruitment of metagenomic DNA reads to reference genomes, and pseudogene detection. Gentle masking is currently the best way to treat low-complexity tracts during homology search.	Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Frith, MC (corresponding author), Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan.	martin@cbrc.jp		Frith, Martin/0000-0003-0998-2859				ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chiaromonte F, 2002, Pac Symp Biocomput, P115; Forslund K, 2009, BIOINFORMATICS, V25, P2500, DOI 10.1093/bioinformatics/btp446; Frith M, 2011, BIOINFORMATICS; Frith MC, 2008, NUCLEIC ACIDS RES, V36, P5863, DOI 10.1093/nar/gkn579; Frith MC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1212; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Harris R. S., 2007, THESIS PENNSYLVANIA; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Lunter G, 2008, GENOME RES, V18, P298, DOI 10.1101/gr.6725608; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sheetlin S, 2005, NUCLEIC ACIDS RES, V33, P4987, DOI 10.1093/nar/gki800; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Zhang Z, 1997, J COMPUT BIOL, V4, P339, DOI 10.1089/cmb.1997.4.339	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28819	10.1371/journal.pone.0028819	http://dx.doi.org/10.1371/journal.pone.0028819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205972	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600008
J	Harkewicz, R; Du, HJ; Tong, ZZ; Alkuraya, H; Bedell, M; Sun, WO; Wang, XL; Hsu, YH; Esteve-Rudd, J; Hughes, G; Su, ZG; Zhang, M; Lopes, VS; Molday, RS; Williams, DS; Dennis, EA; Zhang, K				Harkewicz, Richard; Du, Hongjun; Tong, Zongzhong; Alkuraya, Hisham; Bedell, Matthew; Sun, Woong; Wang, Xiaolei; Hsu, Yuan-Hao; Esteve-Rudd, Julian; Hughes, Guy; Su, Zhiguang; Zhang, Ming; Lopes, Vanda S.; Molday, Robert S.; Williams, David S.; Dennis, Edward A.; Zhang, Kang			Essential Role of ELOVL4 Protein in Very Long Chain Fatty Acid Synthesis and Retinal Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACULAR DYSTROPHY; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; CRE RECOMBINASE; TRANSGENIC MICE; COA DESATURASE; GENE; BIOSYNTHESIS; MOUSE; EXPRESSION	Very long chain polyunsaturated fatty acid (VLC-PUFA)-containing glycerophospholipids are highly enriched in the retina; however, details regarding the specific synthesis and function of these highly unusual retinal glycerophospholipids are lacking. Elongation of very long chain fatty acids-4 (ELOVL4) has been identified as a fatty acid elongase protein involved in the synthesis of VLC-PUFAs. Mutations in ELOVL4 have also been implicated in an autosomal dominant form of Stargardt disease (STGD3), a type of juvenile macular degeneration. We have generated photoreceptor-specific conditional knock-out mice and used high performance liquid chromatography-massspectrometry (HPLC-MS) to examine and analyze the fatty acid composition of retinal membrane glycerophosphatidylcholine and glycerophosphatidylethanolamine species. We also used immunofluorescent staining and histology coupled with electrophysiological data to assess retinal morphology and visual response. The conditional knock-out mice showed a significant decrease in retinal glycerophospholipids containing VLC-PUFAs, specifically contained in the sn-1 position of glycerophosphatidylcholine, implicating the role of Elovl4 in their synthesis. Conditional knock-out mice were also found to have abnormal accumulation of lipid droplets and lipofuscin-like granules while demonstrating photoreceptor-specific abnormalities in visual response, indicating the critical role of Elovl4 for proper rod or cone photoreceptor function. Altogether, this study demonstrates the essential role of ELOVL4 in VLCPUFA synthesis and retinal function.	[Harkewicz, Richard; Hsu, Yuan-Hao; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, Dept Pharmacol, La Jolla, CA 92093 USA; [Harkewicz, Richard; Hsu, Yuan-Hao; Dennis, Edward A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Du, Hongjun; Tong, Zongzhong; Alkuraya, Hisham; Bedell, Matthew; Sun, Woong; Wang, Xiaolei; Hughes, Guy; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Du, Hongjun; Tong, Zongzhong; Alkuraya, Hisham; Bedell, Matthew; Sun, Woong; Wang, Xiaolei; Hughes, Guy; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Du, Hongjun; Su, Zhiguang; Zhang, Ming; Zhang, Kang] Sichuan Univ, W China Hosp, Mol Med Res Ctr, Chengdu 610041, Peoples R China; [Du, Hongjun; Su, Zhiguang; Zhang, Ming; Zhang, Kang] Sichuan Univ, W China Hosp, Dept Ophthalmol, Chengdu 610041, Peoples R China; [Du, Hongjun] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 710032, Peoples R China; [Wang, Xiaolei] Tong Ren Eye Hosp, Beijing 100730, Peoples R China; [Esteve-Rudd, Julian; Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Esteve-Rudd, Julian; Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Esteve-Rudd, Julian; Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Dept Ophthalmol & Visual Sci, Vancouver, BC V6T 1Z3, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sichuan University; Sichuan University; Air Force Military Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of British Columbia; University of British Columbia	Dennis, EA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	edennis@ucsd.edu; kang.zhang@gmail.com	Zhang, Kang/Y-2740-2019; Su, Zhiguang/AFS-0022-2022; Dennis, Edward A./M-5554-2019; hsu, yuan-hao/B-5744-2009	Zhang, Kang/0000-0002-4549-1697; Dennis, Edward A./0000-0003-3738-3140; sun, woong/0000-0003-1792-4894; Su, Zhiguang/0000-0001-8635-9310	National Institutes of Health from NEI [EY014428, EY018660, EY019270, EY07042, U54 GM069338]; NIGMS; Research to Prevent Blindness; National Basic Research Program of China (973 Program [2011CB510200]; Veterans Affairs; Wellcome Fund; King Abdulaziz City for Science and Technology (KACST); NATIONAL EYE INSTITUTE [R01EY002422, R01EY007042, R01EY021374, R01EY019270, R01EY014428, R01EY018660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Basic Research Program of China (973 Program(National Basic Research Program of China); Veterans Affairs(US Department of Veterans Affairs); Wellcome Fund(Burroughs Wellcome Fund); King Abdulaziz City for Science and Technology (KACST); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY014428, EY018660, and EY019270 (to K. Z.) and EY07042 (to D. S. W.) from the NEI and Grant U54 GM069338, a LIPID MAPS large scale collaborative "glue" grant from the NIGMS(to E. A. D.).; Supported by Research to Prevent Blindness Jules and Doris Stein Professorship.; Supported by the National Basic Research Program of China (973 Program, Grant 2011CB510200), a Veterans Affairs merit award, Research to Prevent Blindness, a Burroughs Wellcome Fund clinical scientist award in translational research, and the King Abdulaziz City for Science and Technology (KACST).	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; AVELDANO MI, 1988, BIOCHEMISTRY-US, V27, P1229, DOI 10.1021/bi00404a024; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Bernstein PS, 2001, INVEST OPHTH VIS SCI, V42, P3331; Boon CJF, 2009, OPHTHALMOLOGY, V116, P771, DOI 10.1016/j.ophtha.2008.12.019; Cameron DJ, 2007, INT J BIOL SCI, V3, P111; CINTI DL, 1992, PROG LIPID RES, V31, P1, DOI 10.1016/0163-7827(92)90014-A; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Edwards AO, 2001, INVEST OPHTH VIS SCI, V42, P2652; FOX BG, 1994, BIOCHEMISTRY-US, V33, P12776, DOI 10.1021/bi00209a008; Galle-Le Bastard AM, 2000, PHYSIOL PLANTARUM, V108, P118, DOI 10.1034/j.1399-3054.2000.108002118.x; Grayson C, 2005, J BIOL CHEM, V280, P32521, DOI 10.1074/jbc.M503411200; GRIFFITHS G, 1988, BIOCHEM J, V252, P641, DOI 10.1042/bj2520641; Harkewicz R, 2011, ANNU REV BIOCHEM, V80, P301, DOI 10.1146/annurev-biochem-060409-092612; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HAZLETT TL, 1985, TOXICON, V23, P457, DOI 10.1016/0041-0101(85)90029-7; Jackson FM, 1998, EUR J BIOCHEM, V252, P513, DOI 10.1046/j.1432-1327.1998.2520513.x; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; KAPLAN J, 1990, HUM GENET, V85, P635; Karan G, 2005, MOL VIS, V11, P657; Kokotos G, 2010, J MED CHEM, V53, P3602, DOI 10.1021/jm901872v; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Le YZ, 2006, MOL VIS, V12, P389; Le YZ, 2004, MOL VIS, V10, P1011; Libby RT, 2003, EXP EYE RES, V77, P731, DOI 10.1016/j.exer.2003.07.007; Liu AH, 2010, J LIPID RES, V51, P3217, DOI 10.1194/jlr.M007518; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Mandal MNA, 2004, GENOMICS, V83, P626, DOI 10.1016/j.ygeno.2003.09.020; Maugeri A, 2004, INVEST OPHTH VIS SCI, V45, P4263, DOI 10.1167/iovs.04-0078; McMahon A, 2007, FEBS LETT, V581, P5459, DOI 10.1016/j.febslet.2007.10.050; McMahon A, 2011, J LIPID RES, V52, P1128, DOI 10.1194/jlr.M014415; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Newsome D. A., 1988, RETINAL DYSTROPHIES, P135; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; OKAYASU T, 1981, ARCH BIOCHEM BIOPHYS, V206, P21, DOI 10.1016/0003-9861(81)90061-8; REZANKA T, 1989, PROG LIPID RES, V28, P147, DOI 10.1016/0163-7827(89)90011-8; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sprecher H, 1999, Curr Opin Clin Nutr Metab Care, V2, P135, DOI 10.1097/00075197-199903000-00007; Sprecher H, 1995, J LIPID RES, V36, P2471; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Suh M, 2005, CURR EYE RES, V30, P959, DOI 10.1080/02713680500246957; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Vasireddy V, 2005, MOL VIS, V11, P665; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhang XM, 2003, MOL VIS, V9, P301	53	63	68	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11469	11480		10.1074/jbc.M111.256073	http://dx.doi.org/10.1074/jbc.M111.256073			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22199362	Green Published, hybrid			2022-12-25	WOS:000302780100075
J	Chan, CY; Prudom, C; Raines, SM; Charkhzarrin, S; Melman, SD; De Haro, LP; Allen, C; Lee, SA; Sklar, LA; Parra, KJ				Chan, Chun-Yuan; Prudom, Catherine; Raines, Summer M.; Charkhzarrin, Sahba; Melman, Sandra D.; De Haro, Leyma P.; Allen, Chris; Lee, Samuel A.; Sklar, Larry A.; Parra, Karlett J.			Inhibitors of V-ATPase Proton Transport Reveal Uncoupling Functions of Tether Linking Cytosolic and Membrane Domains of V-0 Subunit a (Vph1p)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; VACUOLAR ATPASE; NONHOMOLOGOUS REGION; MUTATIONAL ANALYSIS; NEUROSPORA-CRASSA; CELLULAR PH; YEAST; CHLORHEXIDINE; HOMEOSTASIS; ALEXIDINE	Vacuolar ATPases (V-ATPases) are important for many cellular processes, as they regulate pH by pumping cytosolic protons into intracellular organelles. The cytoplasm is acidified when V-ATPase is inhibited; thus we conducted a high-throughput screen of a chemical library to search for compounds that acidify the yeast cytosol in vivo using pHluorin-based flow cytometry. Two inhibitors, alexidine dihydrochloride (EC50 = 39 mu M) and thonzonium bromide (EC50 = 69 mu M), prevented ATP-dependent proton transport in purified vacuolar membranes. They acidified the yeast cytosol and caused pH-sensitive growth defects typical of V-ATPase mutants (vma phenotype). At concentrations greater than 10 mu M the inhibitors were cytotoxic, even at the permissive pH (pH 5.0). Membrane fractions treated with alexidine dihydrochloride and thonzonium bromide fully retained concanamycin A-sensitive ATPase activity despite the fact that proton translocation was inhibited by 80-90%, indicating that V-ATPases were uncoupled. Mutant V-ATPase membranes lacking residues 362-407 of the tether of Vph1p subunit a of V-0 were resistant to thonzonium bromide but not to alexidine dihydrochloride, suggesting that this conserved sequence confers uncoupling potential to V1V0 complexes and that alexidine dihydrochloride uncouples the enzyme by a different mechanism. The inhibitors also uncoupled the Candida albicans enzyme and prevented cell growth, showing further specificity for V-ATPases. Thus, a new class of V-ATPase inhibitors (uncouplers), which are not simply ionophores, provided new insights into the enzyme mechanism and original evidence supporting the hypothesis that V-ATPases may not be optimally coupled in vivo. The consequences of uncoupling V-ATPases in vivo as potential drug targets are discussed.	[Chan, Chun-Yuan; Raines, Summer M.; Charkhzarrin, Sahba; Melman, Sandra D.; De Haro, Leyma P.; Parra, Karlett J.] Univ New Mexico, Dept Biochem & Mol Biol, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Lee, Samuel A.] Univ New Mexico, Dept Internal Med, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Sklar, Larry A.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Sklar, Larry A.] Univ New Mexico, Ctr Canc, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Prudom, Catherine; Allen, Chris; Sklar, Larry A.] Univ New Mexico, Ctr Mol Discovery, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Parra, KJ (corresponding author), Univ New Mexico, Dept Biochem & Mol Biol, Hlth Sci Ctr, Sch Med, MSC08 4670, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu	Chan, Chun Yuan/F-5811-2010	Allen, Christopher/0000-0003-3808-5209	National Institutes of Health [5R01GM086495, 1U54MH084690, CA118100, K12GM088021]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021, R01GM086495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM086495 (to K. J. P.), 1U54MH084690 (to L. A. S., C. P., and C. A.), and CA118100 (to the University of New Mexico Cancer Center).; Supported by National Institutes of Health Grant K12GM088021.	ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Bockelmann S, 2010, J BIOL CHEM, V285, P38304, DOI 10.1074/jbc.M110.137539; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; Bowman EJ, 2000, J EXP BIOL, V203, P97; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; CHAWNER JA, 1989, J APPL BACTERIOL, V66, P253, DOI 10.1111/j.1365-2672.1989.tb02476.x; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; Edwards BS, 2004, CURR OPIN CHEM BIOL, V8, P392, DOI 10.1016/j.cbpa.2004.06.007; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Forster C, 2000, J BIOL CHEM, V275, P38245, DOI 10.1074/jbc.M006650200; Ganendren R, 2004, ANTIMICROB AGENTS CH, V48, P1561, DOI 10.1128/AAC.48.5.1561-1569.2004; Hilty J, 2008, MOL MICROBIOL, V70, P127, DOI 10.1111/j.1365-2958.2008.06395.x; Huss M, 2011, EUR J CELL BIOL, V90, P688, DOI 10.1016/j.ejcb.2011.04.009; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Mahon Matthew J, 2011, Adv Biosci Biotechnol, V2, P132; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Mijaljica D, 2011, AUTOPHAGY, V7, P666, DOI 10.4161/auto.7.6.15812; Moriyama Y, 1988, Prog Clin Biol Res, V273, P387; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ochotny N, 2011, J BONE MINER RES, V26, P1484, DOI 10.1002/jbmr.355; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Owegi MA, 2006, J BIOL CHEM, V281, P30001, DOI 10.1074/jbc.M605006200; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; ROBERTS WR, 1981, J CLIN PERIODONTOL, V8, P213, DOI 10.1111/j.1600-051X.1981.tb02032.x; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Shum WWC, 2011, J ANDROL, V32, P576, DOI 10.2164/jandrol.111.012971; Soares DA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-241; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Vasilyeva E, 1998, J BIOL CHEM, V273, P23823, DOI 10.1074/jbc.273.37.23823; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200; Zhang JW, 1998, J BIOL CHEM, V273, P18470, DOI 10.1074/jbc.273.29.18470; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zorko M, 2008, J ANTIMICROB CHEMOTH, V62, P730, DOI 10.1093/jac/dkn270	59	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10236	10250		10.1074/jbc.M111.321133	http://dx.doi.org/10.1074/jbc.M111.321133			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22215674	hybrid, Green Published			2022-12-25	WOS:000302167200054
J	Liao, HC; Chen, MY				Liao, Hsien-Ching; Chen, Mei-Yu			Target of Rapamycin Complex 2 Signals to Downstream Effector Yeast Protein Kinase 2 (Ypk2) through Adheres-Voraciously-to-Target-of-Rapamycin-2 Protein 1 (Avo1) in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL INTEGRITY; ACTIN CYTOSKELETON; MOTIF PHOSPHORYLATION; GROWTH CONTROL; TOR COMPLEX-2; MTOR COMPLEX; AGC KINASES; RAPTOR; BIOSYNTHESIS; ORGANIZATION	The conserved Ser/Thr kinase target of rapamycin (TOR) serves as a central regulator in controlling cell growth-related functions. There exist two distinct TOR complexes, TORC1 and TORC2, each coupling to specific downstream effectors and signaling pathways. In Saccharomyces cerevisiae, TORC2 is involved in regulating actin organization and maintaining cell wall integrity. Ypk2 (yeast protein kinase 2), a member of the cAMP-dependent, cGMP-dependent, and PKC (AGC) kinase family, is a TORC2 substrate known to participate in actin and cell wall regulation. Employing avo3(ts) mutants with defects in TORC2 functions that are suppressible by active Ypk2, we investigated the molecular interactions involved in mediating TORC2 signaling to Ypk2. GST pulldown assays in yeast lysates demonstrated physical interactions between Ypk2 and components of TORC2. In vitro binding assays revealed that Avo1 directly binds to Ypk2. In avo3ts mutants, the TORC2-Ypk2 interaction was reduced and could be restored by AVO1 overexpression, highlighting the important role of Avo1 in coupling TORC2 to Ypk2. The interaction was mapped to an internal region (amino acids 600-840) of Avo1 and a C-terminal region of Ypk2. Ypk2(334-677), a truncated form of Ypk2 containing the Avo1-interacting region, was able to interfere with Avo1-Ypk2 interaction in vitro. Overexpressing Ypk2(334-677) in yeast cells resulted in a perturbation of TORC2 functions, causing defective cell wall integrity, aberrant actin organization, and diminished TORC2-dependent Ypk2 phosphorylation evidenced by the loss of an electrophoretic mobility shift. Together, our data support the conclusion that the direct Avo1-Ypk2 interaction is crucial for TORC2 signaling to the downstream Ypk2 pathway.	[Liao, Hsien-Ching; Chen, Mei-Yu] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University	Chen, MY (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155,Sec 2,Li Nong St, Taipei 11221, Taiwan.	meychen@ym.edu.tw		CHEN, MEI-YU/0000-0002-5765-9178	National Science Council, Taiwan [NSC94-2311-B-010-010, NSC95-2311-B-010-013]; Ministry of Education, Taiwan [100AC-T506]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by Grants NSC94-2311-B-010-010 and NSC95-2311-B-010-013 from the National Science Council, Taiwan, and "Aim for the Top University Plan" grant 100AC-T506 from the Ministry of Education, Taiwan.	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Cameron AJM, 2011, BIOCHEM J, V439, P287, DOI 10.1042/BJ20110678; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; CHEN P, 1993, MOL GEN GENET, V236, P443, DOI 10.1007/BF00277146; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Goodson HV, 1996, J CELL BIOL, V133, P1277, DOI 10.1083/jcb.133.6.1277; Grosshans BL, 2006, J BIOL CHEM, V281, P11104, DOI 10.1074/jbc.M508933200; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Ho HL, 2005, CURR GENET, V47, P273, DOI 10.1007/s00294-005-0570-8; Ho HL, 2008, EUKARYOT CELL, V7, P1328, DOI 10.1128/EC.00065-08; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu M, 2011, J BIOL CHEM, V286, P30647, DOI 10.1074/jbc.M111.257592; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Shinozaki-Yabana S, 2000, MOL CELL BIOL, V20, P1234, DOI 10.1128/MCB.20.4.1234-1242.2000; SIKORSKI RS, 1989, GENETICS, V122, P19; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	43	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6089	6099		10.1074/jbc.M111.303701	http://dx.doi.org/10.1074/jbc.M111.303701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207764	Green Published, hybrid			2022-12-25	WOS:000300791800003
J	Williams, DJ; Sidaway, P; Cunnane, TC; Brain, KL				Williams, Damian J.; Sidaway, Peter; Cunnane, Thomas C.; Brain, Keith L.			Mechanisms Involved in Nicotinic Acetylcholine Receptor-Induced Neurotransmitter Release from Sympathetic Nerve Terminals in the Mouse Vas Deferens	PLOS ONE			English	Article							PRESYNAPTIC CALCIUM STORES; GUINEA-PIG; SYNAPTIC-TRANSMISSION; NORADRENALINE RELEASE; DOPAMINE RELEASE; CA2+ CHANNELS; NEURONS; STIMULATION; EPIBATIDINE; MODULATION	Prejunctional nicotinic acetylcholine receptors (nAChRs) amplify postganglionic sympathetic neurotransmission, and there are indications that intraterminal Ca2+ stores might be involved. However, the mechanisms by which nAChR activation stimulates neurotransmitter release at such junctions is unknown. Rapid local delivery (picospritzing) of the nAChR agonist epibatidine was combined with intracellular sharp microelectrode recording to monitor spontaneous and field-stimulation-evoked neurotransmitter release from sympathetic nerve terminals in the mouse isolated vas deferens. Locally applied epibatidine (1 mu M) produced 'epibatidine-induced depolarisations' (EIDs) that were similar in shape to spontaneous excitatory junction potentials (SEJPs) and were abolished by nonselective nAChR antagonists and the purinergic desensitizing agonist alpha,beta-methylene ATP. The amplitude distribution of EIDs was only slightly shifted towards lower amplitudes by the selective alpha 7 nAChR antagonists alpha-bungarotoxin and methyllcaconitine, the voltage-gated Na+ channel blocker tetrodotoxin or by blocking voltage-gated Ca2+ channels with Cd2+. Lowering the extracellular Ca2+ concentration reduced the frequency of EIDs by 69%, but more surprisingly, the Ca2+-induced Ca2+ release blocker ryanodine greatly decreased the amplitude (by 41%) and the frequency of EIDs by 36%. Ryanodine had no effect on electrically-evoked neurotransmitter release, paired-pulse facilitation, SEJP frequency, SEJP amplitude or SEJP amplitude distribution. These results show that activation of non-alpha 7 nAChRs on sympathetic postganglionic nerve terminals induces high-amplitude junctional potentials that are argued to represent multipacketed neurotransmitter release synchronized by intraterminal Ca2+-induced Ca2+ release, triggered by Ca2+ influx directly through the nAChR. This nAChR-induced neurotransmitter release can be targeted pharmacologically without affecting spontaneous or electrically-evoked neurotransmitter release.	[Williams, Damian J.; Cunnane, Thomas C.] Univ Oxford, Dept Pharmacol, Oxford, England; [Sidaway, Peter; Brain, Keith L.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England	University of Oxford; University of Birmingham	Williams, DJ (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford, England.	k.l.brain@bham.ac.uk	Brain, Keith L./AFU-7168-2022	Brain, Keith L./0000-0002-0906-7012; Williams, Damian/0000-0001-5891-6300	Wellcome Trust [074128]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (www.wellcome.ac.uk; Programme grant to TCC; research fellowship 074128 to KLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKONDON M, 1992, MOL PHARMACOL, V41, P802; BADIO B, 1994, MOL PHARMACOL, V45, P563; BOEHM S, 1995, NEUROSCIENCE, V69, P221, DOI 10.1016/0306-4522(95)00235-B; Brain KL, 1997, J PHYSIOL-LONDON, V502, P521, DOI 10.1111/j.1469-7793.1997.521bj.x; Brain KL, 2001, NEUROSCIENCE, V106, P395, DOI 10.1016/S0306-4522(01)00280-9; BROCK JA, 1988, J PHYSIOL-LONDON, V399, P607; Collin T, 2005, CURR OPIN NEUROBIOL, V15, P275, DOI 10.1016/j.conb.2005.05.003; Cuprian AM, 2005, BRIT J PHARMACOL, V146, P927, DOI 10.1038/sj.bjp.0706357; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; David R, 2010, EUR J NEUROSCI, V31, P978, DOI 10.1111/j.1460-9568.2010.07133.x; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dolezal V, 1996, BRAIN RES, V740, P75, DOI 10.1016/S0006-8993(96)00876-1; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fischer H, 2005, J PHYSIOL-LONDON, V563, P119, DOI 10.1113/jphysiol.2004.075788; FUDER H, 1995, REV PHYSIOL BIOCH P, V126, P265, DOI 10.1007/BFb0049778; GERZANICH V, 1995, MOL PHARMACOL, V48, P774; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Haass M, 1997, CARDIOVASC DRUG THER, V10, P657, DOI 10.1007/BF00053022; Harte CB, 2008, J SEX MED, V5, P110, DOI 10.1111/j.1743-6109.2007.00637.x; Kristufek D, 1999, J PHYSIOL-LONDON, V516, P739, DOI 10.1111/j.1469-7793.1999.0739u.x; Le Magueresse C, 2007, HIPPOCAMPUS, V17, P316, DOI 10.1002/hipo.20271; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; NEDERGAARD OA, 1977, EUR J PHARMACOL, V42, P315, DOI 10.1016/0014-2999(77)90165-0; Parker LK, 2010, BRIT J PHARMACOL, V159, P797, DOI 10.1111/j.1476-5381.2009.00574.x; Picciotto MR, 2002, J NEUROBIOL, V53, P641, DOI 10.1002/neu.10102; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; PLENZ E, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology, V341, pR86; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; RICHARDT G, 1988, KLIN WOCHENSCHR, V66, P21; Sargent PB, 1993, REV NEUROSCI, V16, P403; SCHULZ DW, 1989, NEUROSCI LETT, V98, P310, DOI 10.1016/0304-3940(89)90420-5; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; SJOSTRAND NO, 1965, ACTA PHYSL SCAND   S, V257, P1; Smith AB, 1996, J PHYSIOL-LONDON, V497, P657, DOI 10.1113/jphysiol.1996.sp021797; Smith DA, 1998, NEUROSCI LETT, V255, P127, DOI 10.1016/S0304-3940(98)00725-3; SOLIAKOV L, 1995, NEUROPHARMACOLOGY, V34, P1535, DOI 10.1016/0028-3908(95)00122-M; TODOROV L, 1991, BRIT J PHARMACOL, V102, P186, DOI 10.1111/j.1476-5381.1991.tb12151.x; VONKUGELGEN I, 1991, N-S ARCH PHARMACOL, V344, P419, DOI 10.1007/BF00172581; Welsby P, 2006, EUR J NEUROSCI, V24, P3109, DOI 10.1111/j.1460-9568.2006.05187.x; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Williams DJ, 2007, BRIT J PHARMACOL, V150, P906, DOI 10.1038/sj.bjp.0707183; Zago WM, 1999, BRAZ J MED BIOL RES, V32, P999, DOI 10.1590/S0100-879X1999000800010	47	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29209	10.1371/journal.pone.0029209	http://dx.doi.org/10.1371/journal.pone.0029209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216213	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700040
J	Watanabe, M; Shinohara, S; Shimojo, S				Watanabe, Masataka; Shinohara, Shion; Shimojo, Shinsuke			Mirror Adaptation in Sensory-Motor Simultaneity	PLOS ONE			English	Article							PERCEPTION; RECALIBRATION; REPRESENTATION; MECHANISMS; IMITATION; ATTENTION; SELECTION; MOVEMENT; DYNAMICS; PREMOTOR	Background: When one watches a sports game, one may feel her/his own muscles moving in synchrony with the player's. Such parallels between observed actions of others and one's own has been well supported in the latest progress in neuroscience, and coined "mirror system.'' It is likely that due to such phenomena, we are able to learn motor skills just by observing an expert's performance. Yet it is unknown whether such indirect learning occurs only at higher cognitive levels, or also at basic sensorimotor levels where sensorimotor delay is compensated and the timing of sensory feedback is constantly calibrated. Methodology/Principal Findings: Here, we show that the subject's passive observation of an actor manipulating a computer mouse with delayed auditory feedback led to shifts in subjective simultaneity of self mouse manipulation and auditory stimulus in the observing subjects. Likewise, self adaptation to the delayed feedback modulated the simultaneity judgment of the other subjects manipulating a mouse and an auditory stimulus. Meanwhile, subjective simultaneity of a simple visual disc and the auditory stimulus (flash test) was not affected by observation of an actor nor self-adaptation. Conclusions/Significance: The lack of shift in the flash test for both conditions indicates that the recalibration transfer is specific to the action domain, and is not due to a general sensory adaptation. This points to the involvement of a system for the temporal monitoring of actions, one that processes both one's own actions and those of others.	[Watanabe, Masataka; Shinohara, Shion] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo, Japan; [Shimojo, Shinsuke] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Tokyo; California Institute of Technology	Watanabe, M (corresponding author), Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo, Japan.	watanabe@tuebingen.mpg.de		Watanabe, Masataka/0000-0003-0128-3690	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Science & Technology Agency ERATO Shimojo	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Science & Technology Agency ERATO Shimojo	This study was supported by the Grant-in-Aid for Scientific Research on Priority Areas - System study on higher-order brain functions - from the Ministry of Education, Culture, Sports, Science and Technology of Japan. It is also partly supported by the Japanese Science & Technology Agency ERATO Shimojo "Implicit brain function'' project and CREST "Implicit InterPersonal Information'' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford FL, 1999, TRENDS COGN SCI, V3, P4, DOI 10.1016/S1364-6613(98)01266-2; Blakemore SJ, 2005, NEUROPSYCHOLOGIA, V43, P260, DOI 10.1016/j.neuropsychologia.2004.11.012; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; CAMPBELL WW, 1981, MUSCLE NERVE, V4, P520, DOI 10.1002/mus.880040609; CHAUDHURI A, 1990, NATURE, V344, P60, DOI 10.1038/344060a0; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Cunningham DW, 2001, PSYCHOL SCI, V12, P532, DOI 10.1111/1467-9280.d01-17; Engbert K, 2007, J EXP PSYCHOL HUMAN, V33, P1261, DOI 10.1037/0096-1523.33.6.1261; EVARTS EV, 1974, J NEUROPHYSIOL, V37, P373, DOI 10.1152/jn.1974.37.2.373; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Harrar V, 2008, EXP BRAIN RES, V186, P517, DOI 10.1007/s00221-007-1253-0; Held R, 1958, PERCEPT MOTOR SKILL, V8, P4; Heron J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007681; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kennedy JS, 2009, Q J EXP PSYCHOL, V62, P453, DOI 10.1080/17470210801985235; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Lyons DE, 2006, CURR OPIN NEUROBIOL, V16, P230, DOI 10.1016/j.conb.2006.03.015; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pesavento MJ, 2006, EXP BRAIN RES, V174, P435, DOI 10.1007/s00221-006-0476-9; Piaget J, DREAMS IMITATION CHI; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; Romanes GJ, MENTAL EVOLUTION ANI; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Suzuki S, 2003, VISION RES, V43, P549, DOI 10.1016/S0042-6989(02)00683-1; Thorndike E. L., 1898, PSYCHOL REV MONOGRAP, V2, P1, DOI DOI 10.1037/H0092987; TOMASELLO M, 1993, CHILD DEV, V64, P1688, DOI 10.1111/j.1467-8624.1993.tb04207.x; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Verstraten FAJ, 2005, VISION RES, V45, P1313, DOI 10.1016/j.visres.2004.11.007; von Helmholtz H, 1962, HELMHOLTZS TREATISE, P242; Waszak F, 2005, EXP BRAIN RES, V162, P346, DOI 10.1007/s00221-004-2183-8	39	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28080	10.1371/journal.pone.0028080	http://dx.doi.org/10.1371/journal.pone.0028080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205937	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000299113600009
J	Calhim, S; Double, MC; Margraf, N; Birkhead, TR; Cockburn, A				Calhim, Sara; Double, Michael C.; Margraf, Nicolas; Birkhead, Tim R.; Cockburn, Andrew			Maintenance of Sperm Variation in a Highly Promiscuous Wild Bird	PLOS ONE			English	Article							SUPERB FAIRY-WRENS; POSTCOPULATORY SEXUAL SELECTION; EXTRA-PAIR; COMPETITION GAMES; REPRODUCTIVE SUCCESS; MALURUS-CYANEUS; SWIMMING SPEED; LOADED RAFFLE; PASSERINE; STORAGE	Postcopulatory sexual selection is an important force in the evolution of reproductive traits, including sperm morphology. In birds, sperm morphology is known to be highly heritable and largely condition-independent. Theory predicts, and recent comparative work corroborates, that strong selection in such traits reduces intraspecific phenotypic variation. Here we show that some variation can be maintained despite extreme promiscuity, as a result of opposing, copulation-role-specific selection forces. After controlling for known correlates of siring success in the superb fairy-wren (Malurus cyaneus), we found that (a) lifetime extra-pair paternity success was associated with sperm with a shorter flagellum and relatively large head, and (b) males whose sperm had a longer flagellum and a relatively smaller head achieved higher within-pair paternity. In this species extrapair copulations occur in the same morning, but preceding, pair copulations during a female's fertile period, suggesting that shorter and relatively larger-headed sperm are most successful in securing storage (defense), whereas the opposite phenotype might be better at outcompeting stored sperm (offense). Furthermore, since cuckolding ability is a major contributor to differential male reproductive output, stronger selection on defense sperm competition traits might explain the short sperm of malurids relative to other promiscuous passerines.	[Calhim, Sara] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Double, Michael C.; Margraf, Nicolas; Cockburn, Andrew] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Birkhead, Tim R.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Turku; Australian National University; University of Sheffield	Calhim, S (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	s.calhim@gmail.com	Calhim, Sara/D-5335-2009; Cockburn, Andrew/A-4864-2008		Portuguese Science and Technology Foundation [SFRH/BD/12040/2003]; Australian Research Council; Swiss National Science Foundation [PA00A-117491]	Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); Australian Research Council(Australian Research Council); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Dr. Calhim was supported by a doctoral grant from the Portuguese Science and Technology Foundation (SFRH/BD/12040/2003; www.fct.pt), the Australian Research Council supported Dr. Cockburn (www.arc.gov.au), and Dr. Margraf was financially supported by the Swiss National Science Foundation (PA00A-117491; www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MA, 2000, J THEOR BIOL, V206, P487, DOI 10.1006/jtbi.2000.2142; Birkhead TR, 2006, AUK, V123, P383, DOI 10.1642/0004-8038(2006)123[383:USMITE]2.0.CO;2; Birkhead TR, 2005, NATURE, V434, P383, DOI 10.1038/nature03374; Birkhead TR, 1998, BEHAV ECOL, V9, P253, DOI 10.1093/beheco/9.3.253; BIRKHEAD TR, 1987, J ZOOL, V212, P103, DOI 10.1111/j.1469-7998.1987.tb05117.x; Birkhead TR, 1998, REV REPROD, V3, P123; BRILLARD JP, 1993, POULTRY SCI, V72, P923, DOI 10.3382/ps.0720923; Briskie JV, 1997, EVOLUTION, V51, P937, DOI 10.1111/j.1558-5646.1997.tb03674.x; BRISKIE JV, 1993, CONDOR, V95, P442, DOI 10.2307/1369366; Burness G, 2004, BEHAV ECOL SOCIOBIOL, V56, P65, DOI 10.1007/s00265-003-0752-7; CALHIM S, 2008, THESIS U SHEFFIELD U; Calhim S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000413; CARDULLO RA, 1991, CELL MOTIL CYTOSKEL, V19, P180, DOI 10.1002/cm.970190306; Chiba A, 2001, ACTA ZOOL-STOCKHOLM, V82, P299, DOI 10.1046/j.1463-6395.2001.00091.x; Civetta A, 2000, P NATL ACAD SCI USA, V97, P13162, DOI 10.1073/pnas.230305397; Cockburn A, 2003, J ANIM ECOL, V72, P189, DOI 10.1046/j.1365-2656.2003.00694.x; Cockburn A, 2008, P R SOC B, V275, P605, DOI 10.1098/rspb.2007.0916; Cockburn A, 2008, J ANIM ECOL, V77, P297, DOI 10.1111/j.1365-2656.2007.01335.x; Cockburn A, 2009, BEHAV ECOL, V20, P501, DOI 10.1093/beheco/arp024; Cornwallis CK, 2006, EVOLUTION, V60, P1486, DOI 10.1111/j.0014-3820.2006.tb01227.x; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; Crawley MJ., 2007, R BOOK; Cummins J, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P185, DOI 10.1016/B978-0-12-372568-4.00005-7; Delhey K, 2003, P ROY SOC B-BIOL SCI, V270, P2057, DOI 10.1098/rspb.2003.2460; Double M, 2000, P ROY SOC B-BIOL SCI, V267, P465, DOI 10.1098/rspb.2000.1023; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Double MC, 2003, P ROY SOC B-BIOL SCI, V270, P379, DOI 10.1098/rspb.2002.2261; Dunn PO, 1999, EVOLUTION, V53, P938, DOI 10.1111/j.1558-5646.1999.tb05387.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Froman DP, 2005, BIOL REPROD, V72, P562, DOI 10.1095/biolreprod.104.035113; Froman DP, 2002, P ROY SOC B-BIOL SCI, V269, P607, DOI 10.1098/rspb.2001.1925; Green DJ, 1995, P ROY SOC B-BIOL SCI, V262, P297, DOI 10.1098/rspb.1995.0209; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith Simon C., 2007, P271; Griffith SC, 2009, J AVIAN BIOL, V40, P97, DOI 10.1111/j.1600-048X.2009.04562.x; Helfenstein F, 2010, BEHAV ECOL SOCIOBIOL, V64, P557, DOI 10.1007/s00265-009-0871-x; House CM, 2006, BEHAV ECOL SOCIOBIOL, V60, P131, DOI 10.1007/s00265-005-0149-x; Humphries S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-319; Immler S, 2005, IBIS, V147, P827, DOI 10.1111/j.1474-919x.2005.00456.x; Immler S, 2008, EVOLUTION, V62, P1538, DOI 10.1111/j.1558-5646.2008.00393.x; Immler S, 2011, P NATL ACAD SCI USA, V108, P5325, DOI 10.1073/pnas.1009059108; Immler S, 2010, EVOLUTION, V64, P1634, DOI 10.1111/j.1558-5646.2009.00924.x; Katz D.F., 1990, P125; KELLER L, 1995, ADV STUD BEHAV, V24, P291, DOI 10.1016/S0065-3454(08)60397-6; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Lupold S, 2009, BEHAV ECOL SOCIOBIOL, V63, P899, DOI 10.1007/s00265-009-0733-6; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; McFarlane ML, 2010, BEHAV ECOL, V21, P26, DOI 10.1093/beheco/arp147; MCFARLANE RW, 1963, P 13 INT ORN C, V11, P91; McGlothlin JW, 2010, AM NAT, V175, P687, DOI 10.1086/652469; Mossman J, 2009, EVOLUTION, V63, P2730, DOI 10.1111/j.1558-5646.2009.00753.x; MULDER RA, 1993, AUK, V110, P588, DOI 10.2307/4088422; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Neff BD, 2003, BEHAV ECOL, V14, P634, DOI 10.1093/beheco/arg032; Nilsson T, 2003, BEHAV ECOL SOCIOBIOL, V53, P227, DOI 10.1007/s00265-002-0565-0; Parker GA, 2010, J THEOR BIOL, V264, P1003, DOI 10.1016/j.jtbi.2010.03.003; Parker G.A., 1984, P1; PARKER G A, 1970, Evolution, V24, P774, DOI 10.1111/j.1558-5646.1970.tb01812.x; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P245, DOI 10.1098/rspb.1993.0110; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P127, DOI 10.1098/rspb.1990.0115; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pattarini JA, 2006, EVOLUTION, V60, P2064, DOI 10.1111/j.0014-3820.2006.tb01844.x; Peters A, 2001, BEHAV ECOL SOCIOBIOL, V50, P519, DOI 10.1007/s002650100403; Peters A, 2000, BEHAV ECOL SOCIOBIOL, V47, P438, DOI 10.1007/s002650050688; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P247, DOI 10.1016/B978-0-12-372568-4.00007-0; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Pizzari T, 2002, BIOL REV, V77, P183, DOI 10.1017/S1464793101005863; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Rowe M, 2006, AVIAN POULT BIOL REV, V17, P21, DOI 10.3184/147020606783437949; Rowe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015720; Sardell RJ, 2011, P ROY SOC B-BIOL SCI, V278, P3251, DOI 10.1098/rspb.2011.0173; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Simmons LW, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P405, DOI 10.1016/B978-0-12-372568-4.00010-0; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Tuttle EM, 1996, P ROY SOC B-BIOL SCI, V263, P1359, DOI 10.1098/rspb.1996.0199; Tuttle EM, 2004, ANIM BEHAV, V68, P541, DOI 10.1016/j.anbehav.2003.09.014; Vernon GG, 1999, CELL MOTIL CYTOSKEL, V42, P149, DOI 10.1002/(SICI)1097-0169(1999)42:2<149::AID-CM6>3.0.CO;2-0; Webster MS, 1995, EVOLUTION, V49, P1147, DOI [10.2307/2410439, 10.1111/j.1558-5646.1995.tb04441.x]; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Whittingham LA, 2005, BEHAV ECOL, V16, P138, DOI 10.1093/beheco/arh140	85	31	32	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28809	10.1371/journal.pone.0028809	http://dx.doi.org/10.1371/journal.pone.0028809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194918	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000298370400021
J	Breed, AC; Breed, MF; Meers, J; Field, HE				Breed, Andrew C.; Breed, Martin F.; Meers, Joanne; Field, Hume E.			Evidence of Endemic Hendra Virus Infection in Flying-Foxes (Pteropus conspicillatus)-Implications for Disease Risk Management	PLOS ONE			English	Article							NIPAH VIRUS; PTEROPUS-CONSPICILLATUS; BATS; PREVALENCE; RESERVOIR; PATTERNS	This study investigated the seroepidemiology of Hendra virus in a spectacled flying-fox (Pteropus conspicillatus) population in northern Australia, near the location of an equine and associated human Hendra virus infection in late 2004. The pattern of infection in the population was investigated using a serial cross-sectional serological study over a 25-month period, with blood sampled from 521 individuals over six sampling sessions. Antibody titres to the virus were determined by virus neutralisation test. In contrast to the expected episodic infection pattern, we observed that seroprevalence gradually increased over the two years suggesting infection was endemic in the population over the study period. Our results suggested age, pregnancy and lactation were significant risk factors for a detectable neutralizing antibody response. Antibody titres were significantly higher in females than males, with the highest titres occurring in pregnant animals. Temporal variation in antibody titres suggests that herd immunity to the virus may wax and wane on a seasonal basis. These findings support an endemic infection pattern of henipaviruses in bat populations suggesting their infection dynamics may differ significantly from the acute, self limiting episodic pattern observed with related viruses (e. g. measles virus, phocine distemper virus, rinderpest virus) hence requiring a much smaller critical host population size to sustain the virus. These findings help inform predictive modelling of henipavirus infection in bat populations, and indicate that the life cycle of the reservoir species should be taken into account when developing risk management strategies for henipaviruses.	[Breed, Andrew C.; Meers, Joanne] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Breed, Andrew C.] Anim Hlth & Vet Labs Agcy, Ctr Epidemiol & Risk Anal, Addlestone, Surrey, England; [Breed, Martin F.] Univ Adelaide, ACEBB, Adelaide, SA, Australia; [Breed, Martin F.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Field, Hume E.] Biosecur Queensland, Dept Employment Econ Dev & Innovat, Queensland Ctr Emerging Infect Dis, Coopers Plains, Qld, Australia	University of Queensland; Veterinary Laboratories Agency; University of Adelaide; University of Adelaide; Queensland Department of Agriculture & Fisheries	Breed, AC (corresponding author), Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia.	andrew.breed@ahvla.gsi.gov.uk	Breed, Andrew C/A-5682-2011; Meers, Joanne/B-4141-2011; Breed, Martin/G-5482-2011	Breed, Andrew C/0000-0002-3439-9510; Meers, Joanne/0000-0001-9305-0469; Breed, Martin/0000-0001-7810-9696	Australian Biosecurity CRC for Emerging Infectious Disease; Henipavirus Ecology Research Group (HERG); NIH/NSF; John E. Fogarty International Center [R01-TW05869]; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER	Australian Biosecurity CRC for Emerging Infectious Disease(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Henipavirus Ecology Research Group (HERG); NIH/NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John E. Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors acknowledge support from the Australian Biosecurity CRC for Emerging Infectious Disease (http://www.abcrc.org.au/) and the Henipavirus Ecology Research Group (HERG), funded in part by an NIH/NSF "Ecology of Infectious Diseases" award from the John E. Fogarty International Center R01-TW05869. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2004, ECOLOGY HENDRA VIRUS; BREED AC, 2005, MICROBIOL AUST, V26, P59; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Daniels P, 2001, MICROBES INFECT, V3, P289, DOI 10.1016/S1286-4579(01)01382-X; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Epstein Jonathan H, 2006, Curr Infect Dis Rep, V8, P59, DOI 10.1007/s11908-006-0036-2; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hanna JN, 2006, MED J AUSTRALIA, V185, P562, DOI 10.5694/j.1326-5377.2006.tb00692.x; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Jonsson NN, 2004, VET REC, V154, P664, DOI 10.1136/vr.154.21.664; MacLachlan J, 2011, FENNERS VET VIROLOGY; *OIE, 2010, HENDR NIP VIR DIS MA, P1; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Parsons JG, 2006, AUST J ZOOL, V54, P417, DOI 10.1071/ZO06092; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; *QUEENSL GOV, HENDR VIR UPD VET; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Shilton LA, 2008, AUSTRAL ECOL, V33, P549, DOI 10.1111/j.1442-9993.2008.01910.x; Sohayati AR, 2011, EPIDEMIOL INFECT, V139, P1570, DOI 10.1017/S0950268811000550; Tan CT, 2002, ANN NEUROL, V51, P703, DOI 10.1002/ana.10212; Towers P.A., 1985, Australian Mammalogy, V8, P257; Turmelle AS, 2010, VECTOR-BORNE ZOONOT, V10, P165, DOI 10.1089/vbz.2008.0163; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Wilson D. E., 2005, MAMMAL SPECIES WORLD	34	34	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28816	10.1371/journal.pone.0028816	http://dx.doi.org/10.1371/journal.pone.0028816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194920	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000298369100104
J	Pan, CL				Pan, Chongle			Measuring Dissociation Rate Constants of Protein Complexes through Subunit Exchange: Experimental Design and Theoretical Modeling	PLOS ONE			English	Article							MASS-SPECTROMETRY; QUANTITATIVE PROTEOMICS	Protein complexes are dynamic macromolecules that constantly dissociate into, and simultaneously are assembled from, free subunits. Dissociation rate constants, koff, provide structural and functional information on protein complexes. However, because all existing methods for measuring koff require high-quality purification and specific modifications of protein complexes, dissociation kinetics has only been studied for a small set of model complexes. Here, we propose a new method, called Metabolically-labeled Affinity-tagged Subunit Exchange (MASE), to measure koff using metabolic stable isotope labeling, affinity purification and mass spectrometry. MASE is based on a subunit exchange process between an unlabeled affinity-tagged variant and a metabolically-labeled untagged variant of a complex. The subunit exchange process was modeled theoretically for a heterodimeric complex. The results showed that koff determines, and hence can be estimated from, the observed rate of subunit exchange. This study provided the theoretical foundation for future experiments that can validate and apply the MASE method.	[Pan, Chongle] Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN 37831 USA; [Pan, Chongle] Oak Ridge Natl Lab, BioSci Div, Oak Ridge, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Pan, CL (corresponding author), Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN 37831 USA.	panc@ornl.gov	Pan, Chongle/C-6960-2008	Pan, Chongle/0000-0003-2860-0334	United States Department of Energy, Office of Science, Biological and Environmental Research; U.S. Department of Energy [DE-AC05-00OR22725]	United States Department of Energy, Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This research was sponsored by the Genomic Science Program, United States Department of Energy, Office of Science, Biological and Environmental Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; W. Hayes McDonald, Gregory B. Hurst and Dale A. Pelletier are thanked for very helpful discussions. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725.	Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; HARDING SE, PROTEIN LIGAND INTER; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hyung SJ, 2009, CHEM BIOL, V16, P382, DOI 10.1016/j.chembiol.2009.02.008; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD195, DOI 10.1093/nar/gkj017; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Miranker AD, 2000, CURR OPIN STRUC BIOL, V10, P601, DOI 10.1016/S0959-440X(00)00137-8; Pan CL, 2006, ANAL CHEM, V78, P7121, DOI 10.1021/ac060654b; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Zhou HX, 2003, PROTEIN SCI, V12, P2379, DOI 10.1110/ps.03216203	17	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28827	10.1371/journal.pone.0028827	http://dx.doi.org/10.1371/journal.pone.0028827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194924	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100108
J	Xi, GJ; Hui, JJ; Zhang, ZJ; Liu, SS; Zhang, XR; Teng, GJ; Chan, KC; Wu, EX; Nie, BB; Shan, BC; Li, LJ; Reynolds, GP				Xi, Guangjun; Hui, Jiaojie; Zhang, Zhijun; Liu, Shanshan; Zhang, Xiangrong; Teng, Gaojun; Chan, Kevin C.; Wu, Ed X.; Nie, Binbin; Shan, Baoci; Li, Lingjiang; Reynolds, Gavin P.			Learning and Memory Alterations Are Associated with Hippocampal N-acetylaspartate in a Rat Model of Depression as Measured by H-1-MRS	PLOS ONE			English	Article							CHRONIC MILD STRESS; MAGNETIC-RESONANCE-SPECTROSCOPY; CHRONIC UNPREDICTABLE STRESS; LONG-TERM POTENTIATION; DECLARATIVE MEMORY; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; RECEPTOR ACTIVATION; CELL-PROLIFERATION; MR SPECTROSCOPY	It is generally accepted that cognitive processes, such as learning and memory, are affected in depression. The present study used a rat model of depression, chronic unpredictable mild stress (CUMS), to determine whether hippocampal volume and neurochemical changes were involved in learning and memory alterations. A further aim was to determine whether these effects could be ameliorated by escitalopram treatment, as assessed with the non-invasive techniques of structural magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS). Our results demonstrated that CUMS had a dramatic influence on spatial cognitive performance in the Morris water maze task, and CUMS reduced the concentration of neuronal marker N-acetylaspartate (NAA) in the hippocampus. These effects could be significantly reversed by repeated administration of escitalopram. However, neither chronic stress nor escitalopram treatment influenced hippocampal volume. Of note, the learning and memory alterations of the rats were associated with right hippocampal NAA concentration. Our results indicate that in depression, NAA may be a more sensitive measure of cognitive function than hippocampal volume.	[Xi, Guangjun; Hui, Jiaojie; Zhang, Zhijun; Liu, Shanshan; Zhang, Xiangrong] Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Xi, Guangjun; Hui, Jiaojie; Zhang, Zhijun; Liu, Shanshan; Zhang, Xiangrong] Southeast Univ, Inst Neuropsychiat, Nanjing, Jiangsu, Peoples R China; [Teng, Gaojun] Southeast Univ, Inst Mol Imaging, Nanjing, Jiangsu, Peoples R China; [Chan, Kevin C.; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Pokfulam, Hong Kong, Peoples R China; [Chan, Kevin C.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Pokfulam, Hong Kong, Peoples R China; [Nie, Binbin; Shan, Baoci] Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Analyt Tech, Beijing, Peoples R China; [Li, Lingjiang] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Reynolds, Gavin P.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England	Southeast University - China; Southeast University - China; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Central South University; Sheffield Hallam University	Xi, GJ (corresponding author), Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	zhijunzhang838@yahoo.com.cn	Reynolds, Gavin/AAM-9985-2020; Chan, Kevin C/AAK-7665-2020; Wu, Ed Xuekui/C-1579-2009	Reynolds, Gavin/0000-0001-9026-7726; Chan, Kevin C/0000-0003-4012-7084; Shan, Baoci/0000-0001-7417-5063; Wu, Ed Xuekui/0000-0001-5581-1546; Nie, Binbin/0000-0002-8038-7772	National Natural Science Foundation of China [30770779, 30825014, 30830046]; National Basic Research Program of China (973 Program) [2007CB512308, 2009CB918303]; National Hi-Tech Research and Development Program of China (863 Program) [2008AA02Z413]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This research was partly supported by National Natural Science Foundation of China (No. 30770779 and No. 30825014 to ZZ; No. 30830046 to LL), National Basic Research Program of China (973 Program) (No. 2007CB512308 to ZZ; No. 2009CB918303 to LL) and National Hi-Tech Research and Development Program of China (863 Program) (No. 2008AA02Z413 to ZZ). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarez DN, 2003, EUR J NEUROSCI, V17, P1928, DOI 10.1046/j.1460-9568.2003.02622.x; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Block W, 2009, INT J NEUROPSYCHOPH, V12, P415, DOI 10.1017/S1461145708009516; BRUHN H, 1989, RADIOLOGY, V172, P541, DOI 10.1148/radiology.172.2.2748837; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Chan KC, 2009, J MAGN RESON IMAGING, V29, P1013, DOI 10.1002/jmri.21736; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Chiou SH, 2006, BIOCHEM BIOPH RES CO, V343, P391, DOI 10.1016/j.bbrc.2006.02.180; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Crochemore C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0577com; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Didic M, 2010, J ALZHEIMERS DIS, V22, P1269, DOI 10.3233/JAD-2010-101257; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Duman RS, 2000, BIOL PSYCHIAT, V48, P732, DOI 10.1016/S0006-3223(00)00935-5; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Eichenbaum H, 1999, BEHAV BRAIN RES, V103, P123, DOI 10.1016/S0166-4328(99)00044-3; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Gouirand AM, 2005, PHYSIOL BEHAV, V86, P21, DOI 10.1016/j.physbeh.2005.06.027; HAAGA DAF, 1995, BEHAV RES THER, V33, P41, DOI 10.1016/0005-7967(94)E0016-C; Harmer CJ, 2002, PSYCHOPHARMACOLOGY, V163, P106, DOI 10.1007/s00213-002-1151-x; Hui JJ, 2011, BEHAV BRAIN RES, V217, P122, DOI 10.1016/j.bbr.2010.10.014; Hui JJ, 2010, EUR NEUROPSYCHOPHARM, V20, P875, DOI 10.1016/j.euroneuro.2010.08.010; Kuzis G, 1997, ARCH NEUROL-CHICAGO, V54, P982, DOI 10.1001/archneur.1997.00550200046009; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Meneses A, 2002, NEUROSCI BIOBEHAV R, V26, P309, DOI 10.1016/S0149-7634(02)00005-2; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; Nie BB, 2010, J MAGN RESON IMAGING, V32, P830, DOI 10.1002/jmri.22283; Nowakowska E, 2001, J PHYSIOL PHARMACOL, V52, P863; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Pfeuffer J, 1998, MAGN RESON IMAGING, V16, P1023, DOI 10.1016/S0730-725X(98)00107-6; Pilatus U, 2009, PSYCHIAT RES-NEUROIM, V173, P1, DOI 10.1016/j.pscychresns.2008.07.015; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Premkumar P, 2010, PSYCHIAT RES-NEUROIM, V182, P251, DOI 10.1016/j.pscychresns.2010.02.008; Ravnkilde B, 2002, SCAND J PSYCHOL, V43, P239, DOI 10.1111/1467-9450.00292; Sairanen M, 2007, NEUROSCIENCE, V144, P368, DOI 10.1016/j.neuroscience.2006.08.069; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Mantoan MAS, 2009, EPILEPSY BEHAV, V16, P447, DOI 10.1016/j.yebeh.2009.08.032; Song L, 2006, PHARMACOL BIOCHEM BE, V83, P186, DOI 10.1016/j.pbb.2006.01.004; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Sun MK, 2004, NEUROSCIENCE, V129, P129, DOI 10.1016/j.neuroscience.2004.07.041; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Xi GJ, 2011, PSYCHOPHARMACOLOGY, V214, P747, DOI 10.1007/s00213-010-2077-3; Yau JLW, 2002, J NEUROSCI, V22, P1436, DOI 10.1523/JNEUROSCI.22-04-01436.2002; Yildiz-Yesiloglu A, 2006, PSYCHIAT RES-NEUROIM, V147, P1, DOI 10.1016/j.pscychresns.2005.12.004; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111; Zheng H, 2006, BEHAV BRAIN RES, V168, P47, DOI 10.1016/j.bbr.2005.10.007; Zimmerman ME, 2008, NEUROLOGY, V70, P1594, DOI 10.1212/01.wnl.0000306314.77311.be; Zusso M, 2008, BIOCHEM PHARMACOL, V76, P391, DOI 10.1016/j.bcp.2008.05.014; 1997, PHYSL BEHAV, V62, P421	58	50	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28686	10.1371/journal.pone.0028686	http://dx.doi.org/10.1371/journal.pone.0028686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194886	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100078
J	Klutho, PJ; Costanzo-Garvey, DL; Lewis, RE				Klutho, Paula J.; Costanzo-Garvey, Diane L.; Lewis, Robert E.			Regulation of Glucose Homeostasis by KSR1 and MARK2	PLOS ONE			English	Article							SCAFFOLD KINASE SUPPRESSOR; MESSENGER-RNA EXPRESSION; PROTEIN-KINASE; 14-3-3 BINDING; CYTOPLASMIC LOCALIZATION; CAENORHABDITIS-ELEGANS; EPITHELIAL POLARITY; CELL POLARITY; HUMAN CDC25C; ERK CASCADE	Protein scaffolds control the intensity and duration of signaling and dictate the specificity of signaling through MAP kinase pathways. KSR1 is a molecular scaffold of the Raf/MEK/ERK MAP kinase cascade that regulates the intensity and duration of ERK activation. Relative to wild- type mice, ksr1(-/-) mice are modestly glucose intolerant, but show a normal response to exogenous insulin. However, ksr1(-/-) mice also demonstrate a three-fold increase in serum insulin levels in response to a glucose challenge, suggesting a role for KSR1 in insulin secretion. The kinase MARK2 is closely related to C-TAK1, a known regulator of KSR1. Mice lacking MARK2 have an increased rate of glucose disposal in response to exogenous insulin, increased glucose tolerance, and are resistant to diet-induced obesity. mark2(-/-) ksr1(-/-) (DKO) mice were compared to wild type, mark2(-/-), and ksr1(-/-) mice for their ability to regulate glucose homeostasis. Here we show that disruption of KSR1 in mark2(-/-) mice reverses the increased sensitivity to exogenous insulin resulting from MARK2 deletion. DKO mice respond to exogenous insulin similarly to wild type and ksr1(-/-) mice. These data suggest a model whereby MARK2 negatively regulates insulin sensitivity in peripheral tissue through inhibition of KSR1. Consistent with this model, we found that MARK2 binds and phosphorylates KSR1 on Ser392. Phosphorylation of Ser392 is a critical regulator of KSR1 stability, subcellular location, and ERK activation. These data reveal an unexpected role for the molecular scaffold KSR1 in insulin-regulated glucose metabolism.	[Klutho, Paula J.; Costanzo-Garvey, Diane L.; Lewis, Robert E.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Klutho, PJ (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	rlewis@unmc.edu	Lewis, Robert E./H-3404-2019		US Army [W081XWH-10-1-0139]; NCI [CA90400];  [CA09476]; NATIONAL CANCER INSTITUTE [T32CA009476, R01CA090400] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER	US Army(United States Department of DefenseUnited States Army); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for the study was provided by US Army (W081XWH-10-1-0139); NCI (CA90400) to REL. PJK was supported by training fellowship (CA09476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Dequiedt F, 2006, MOL CELL BIOL, V26, P7086, DOI 10.1128/MCB.00231-06; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Hurd D, 2003, DEV BIOL, V253, P54, DOI 10.1006/dbio.2002.0866; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; Hurov J, 2007, CELL CYCLE, V6, P1966, DOI 10.4161/cc.6.16.4576; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kato T, 2001, NEOPLASIA, V3, P4, DOI 10.1038/sj.neo.7900132; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kortum RL, 2006, MOL CELL BIOL, V26, P2202, DOI 10.1128/MCB.26.6.2202-2214.2006; Kortum RL, 2005, MOL CELL BIOL, V25, P7592, DOI 10.1128/MCB.25.17.7592-7604.2005; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Kusakabe M, 2004, EMBO J, V23, P4190, DOI 10.1038/sj.emboj.7600381; Lennerz JK, 2010, MOL CELL BIOL, V30, P5043, DOI 10.1128/MCB.01472-09; Lin J, 2009, J IMMUNOL, V183, P1215, DOI 10.4049/jimmunol.0803887; Lozano J, 2003, CANCER RES, V63, P4232; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Martinez-deMena R, 2005, J MOL ENDOCRINOL, V34, P139, DOI 10.1677/jme.1.01568; Matenia D, 2005, MOL BIOL CELL, V16, P4410, DOI 10.1091/mbc.E05-01-0081; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2003, EMBO J, V22, P4431, DOI 10.1093/emboj/cdg426; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; PARSA I, 1988, CANCER RES, V48, P2265; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Razidlo GL, 2009, J BIOL CHEM, V284, P6705, DOI 10.1074/jbc.M806457200; Razidlo GL, 2004, J BIOL CHEM, V279, P47808, DOI 10.1074/jbc.M406395200; Riechmann V, 2002, NAT CELL BIOL, V4, P337, DOI 10.1038/ncb782; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Segu L, 2008, NEUROBIOL AGING, V29, P231, DOI 10.1016/j.neurobiolaging.2006.10.014; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Wang C, 2007, ACTA PHARMACOL SIN, V28, P334, DOI 10.1111/j.1745-7254.2007.00497.x; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Yoder JH, 2004, EMBO J, V23, P111, DOI 10.1038/sj.emboj.7600025; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X	52	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29304	10.1371/journal.pone.0029304	http://dx.doi.org/10.1371/journal.pone.0029304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206009	gold, Green Published, Green Submitted			2022-12-25	WOS:000298665600034
J	Lin, KP; Soong, BW; Yang, CC; Huang, LW; Chang, MH; Lee, IH; Antonellis, A; Lee, YC				Lin, Kon-Ping; Soong, Bing-Wen; Yang, Chih-Chao; Huang, Li-Wen; Chang, Ming-Hong; Lee, I-Hui; Antonellis, Antony; Lee, Yi-Chung			The Mutational Spectrum in a Cohort of Charcot-Marie-Tooth Disease Type 2 among the Han Chinese in Taiwan	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; DIFFERENTIATION-ASSOCIATED PROTEIN-1; HEREDITARY MOTOR; CAUSE DOMINANT; GENE; NEUROPATHY; HSPB1; HSP27; CMT; GLUTATHIONE	Background: Charcot-Marie-Tooth disease type 2 (CMT2) is a clinically and genetically heterogeneous group of inherited axonal neuropathies. The aim of this study was to extensively investigate the mutational spectrum of CMT2 in a cohort of patients of Han Chinese. Methodology and Principal Findings: Genomic DNA from 36 unrelated Taiwanese CMT2 patients of Han Chinese descent was screened for mutations in the coding regions of the MFN2, RAB7, TRPV4, GARS, NEFL, HSPB1, MPZ, GDAP1, HSPB8, DNM2, AARS and YARS genes. Ten disparate mutations were identified in 14 patients (38.9% of the cohort), including p.N71Y in AARS (2.8%), p.T164A in HSPB1 (2.8%), and p.[H256R]+[R282H] in GDAP1 (2.8%) in one patient each, three NEFL mutations in six patients (16.7%) and four MFN2 mutations in five patients (13.9%). The following six mutations were novel: the individual AARS, HSPB1 and GDAP1 mutations and c.475-1G>T, p.L233V and p.E744M mutations in MFN2. An in vitro splicing assay revealed that the MFN2 c.475-1G>T mutation causes a 4 amino acid deletion (p.T159_Q162del). Despite an extensive survey, the genetic causes of CMT2 remained elusive in the remaining 22 CMT2 patients (61.1%). Conclusions and Significance: This study illustrates the spectrum of CMT2 mutations in a Taiwanese CMT2 cohort and expands the number of CMT2-associated mutations. The relevance of the AARS and HSPB1 mutations in the pathogenesis of CMT2 is further highlighted. Moreover, the frequency of the NEFL mutations in this study cohort was unexpectedly high. Genetic testing for NEFL and MFN2 mutations should, therefore, be the first step in the molecular diagnosis of CMT2 in ethnic Chinese.	[Lin, Kon-Ping; Soong, Bing-Wen; Huang, Li-Wen; Chang, Ming-Hong; Lee, I-Hui; Lee, Yi-Chung] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Lin, Kon-Ping; Soong, Bing-Wen; Huang, Li-Wen; Lee, Yi-Chung] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan; [Yang, Chih-Chao] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chang, Ming-Hong] Taichung Vet Gen Hosp, Neurol Sect, Taichung, Taiwan; [Lee, I-Hui] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan; [Antonellis, Antony] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; [Antonellis, Antony] Univ Michigan, Dept Neurol, Sch Med, Ann Arbor, MI USA	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lee, YC (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan.	ycli@vghtpe.gov.tw	Lee, Yi-Chung/H-8813-2019; Lee, Yi-Chung/GZK-7162-2022	Lee, Yi-Chung/0000-0003-0102-164X; Yang, Chih-Chao/0000-0002-0352-3144	National Science Council [NSC97-2314-B-075A-002-MY3]; Brain Research Center, National Yang-Ming University, Taiwan [V100-E6-006]	National Science Council(Ministry of Science and Technology, Taiwan); Brain Research Center, National Yang-Ming University, Taiwan	This study was partially funded by National Science Council (NSC97-2314-B-075A-002-MY3), and Brain Research Center, National Yang-Ming University (V100-E6-006), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2009, J HUM GENET, V54, P94, DOI 10.1038/jhg.2008.13; Almeida-Souza L, 2010, J BIOL CHEM, V285, P12778, DOI 10.1074/jbc.M109.082644; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Baranova EV, 2011, J MOL BIOL, V411, P110, DOI 10.1016/j.jmb.2011.05.024; Boaretto F, 2010, NEUROLOGY, V74, P1919, DOI 10.1212/WNL.0b013e3181e240f9; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Calvo J, 2009, ARCH NEUROL-CHICAGO, V66, P1511, DOI 10.1001/archneurol.2009.284; Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006; Choi Byung-Ok, 2004, Hum Mutat, V24, P185, DOI 10.1002/humu.9261; Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174; Claramunt R, 2005, J MED GENET, V42, P358, DOI 10.1136/jmg.2004.022178; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; De Jonghe P, 1999, BRAIN, V122, P281, DOI 10.1093/brain/122.2.281; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fabrizi GM, 2007, NEUROLOGY, V69, P291, DOI 10.1212/01.wnl.0000265820.51075.61; Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; KLEIN CJ, 2005, PERIPHERAL NEUROPATH, P1094; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Leal A, 2009, NEUROGENETICS, V10, P275, DOI 10.1007/s10048-009-0183-3; Marrosu MG, 1998, NEUROLOGY, V50, P1397, DOI 10.1212/WNL.50.5.1397; Mastaglia FL, 1999, J NEUROL NEUROSUR PS, V67, P174, DOI 10.1136/jnnp.67.2.174; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Nelis E, 2002, NEUROLOGY, V59, P1865, DOI 10.1212/01.WNL.0000036272.36047.54; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Shield AJ, 2006, BIOCHEM BIOPH RES CO, V347, P859, DOI 10.1016/j.bbrc.2006.06.189; Shy ME, 2005, NEUROLOGY, V64, P1209, DOI 10.1212/01.WNL.0000156517.00615.A3; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zuchner S, 2004, NEUROMUSCULAR DISORD, V14, P147, DOI 10.1016/j.nmd.2003.10.003	45	59	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29393	10.1371/journal.pone.0029393	http://dx.doi.org/10.1371/journal.pone.0029393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206013	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600036
J	Miro-Bueno, JM; Rodriguez-Paton, A				Miro-Bueno, Jesus M.; Rodriguez-Paton, Alfonso			A Simple Negative Interaction in the Positive Transcriptional Feedback of a Single Gene Is Sufficient to Produce Reliable Oscillations	PLOS ONE			English	Article							NEUROSPORA CIRCADIAN CLOCK; CELLULAR CONTROL PROCESSES; GOODWIN MODEL; RHYTHMS; NOISE; NETWORKS; LOOPS; MATHEMATICS; SIMULATION; EXPRESSION	Negative and positive transcriptional feedback loops are present in natural and synthetic genetic oscillators. A single gene with negative transcriptional feedback needs a time delay and sufficiently strong nonlinearity in the transmission of the feedback signal in order to produce biochemical rhythms. A single gene with only positive transcriptional feedback does not produce oscillations. Here, we demonstrate that this single-gene network in conjunction with a simple negative interaction can also easily produce rhythms. We examine a model comprised of two well-differentiated parts. The first is a positive feedback created by a protein that binds to the promoter of its own gene and activates the transcription. The second is a negative interaction in which a repressor molecule prevents this protein from binding to its promoter. A stochastic study shows that the system is robust to noise. A deterministic study identifies that the dynamics of the oscillator are mainly driven by two types of biomolecules: the protein, and the complex formed by the repressor and this protein. The main conclusion of this paper is that a simple and usual negative interaction, such as degradation, sequestration or inhibition, acting on the positive transcriptional feedback of a single gene is a sufficient condition to produce reliable oscillations. One gene is enough and the positive transcriptional feedback signal does not need to activate a second repressor gene. This means that at the genetic level an explicit negative feedback loop is not necessary. The model needs neither cooperative binding reactions nor the formation of protein multimers. Therefore, our findings could help to clarify the design principles of cellular clocks and constitute a new efficient tool for engineering synthetic genetic oscillators.	[Miro-Bueno, Jesus M.; Rodriguez-Paton, Alfonso] Univ Politecn Madrid, Dept Inteligencia Artificial, Fac Informat, Madrid, Spain	Universidad Politecnica de Madrid	Miro-Bueno, JM (corresponding author), Univ Politecn Madrid, Dept Inteligencia Artificial, Fac Informat, Madrid, Spain.	jmiro@fi.upm.es; arpaton@fi.upm.es	Miro-Bueno, Jesus/F-7046-2013; Rodríguez-Patón, Alfonso/H-1003-2011	Miro-Bueno, Jesus/0000-0002-4543-0616; Rodríguez-Patón, Alfonso/0000-0001-7289-2114	Spanish Ministry of Science and Innovation (MICINN) [BES-2007-16220, TIN2009-14421]; UPM and Madrid Regional Government; European Commission	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); UPM and Madrid Regional Government; European Commission(European CommissionEuropean Commission Joint Research Centre)	This research has been partially funded by Spanish Ministry of Science and Innovation (MICINN) grant BES-2007-16220 and project TIN2009-14421, by the UPM and Madrid Regional Government and by research project BACTOCOM funded by European Commission under FP7, FET proactive program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Conrad E, 2008, J R SOC INTERFACE, V5, pS9, DOI 10.1098/rsif.2008.0046.focus; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fall CP, 2002, COMPUTATIONAL CELL B, P468; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Francois P, 2005, BIOPHYS J, V88, P2369, DOI 10.1529/biophysj.104.053975; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBETER A, 1995, P ROY SOC B-BIOL SCI, V261, P319, DOI 10.1098/rspb.1995.0153; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; GRIFFITH JS, 1968, J THEOR BIOL, V20, P209, DOI 10.1016/0022-5193(68)90190-2; Guantes R, 2006, PLOS COMPUT BIOL, V2, P188, DOI 10.1371/journal.pcbi.0020030; Hasty J, 2001, CHAOS, V11, P207, DOI 10.1063/1.1345702; Hong CI, 2008, BIOPHYS J, V94, P1221, DOI 10.1529/biophysj.107.115154; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Mondragon-Palomino O, 2011, SCIENCE, V333, P1315, DOI 10.1126/science.1205369; Munteanu A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-66; Murray JD, 2002, MATH BIOL, VSpringer, P551; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Ruoff P, 1996, J THEOR BIOL, V179, P275, DOI 10.1006/jtbi.1996.0067; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Smolen P, 2001, J NEUROSCI, V21, P6644, DOI 10.1523/JNEUROSCI.21-17-06644.2001; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz SH., 1994, NONLINEAR DYNAMICS C, P498; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Toettcher JE, 2010, P NATL ACAD SCI USA, V107, P17047, DOI 10.1073/pnas.1005615107; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Widder S, 2007, J THEOR BIOL, V246, P395, DOI 10.1016/j.jtbi.2007.01.004; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	50	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2011	6	11							e27414	10.1371/journal.pone.0027414	http://dx.doi.org/10.1371/journal.pone.0027414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HQ	22205920	gold, Green Submitted, Green Published			2022-12-25	WOS:000297348800024
J	Arumugam, K; MacNicol, MC; Wang, YY; Cragle, CE; Tackett, AJ; Hardy, LL; MacNicol, AM				Arumugam, Karthik; MacNicol, Melanie C.; Wang, Yiying; Cragle, Chad E.; Tackett, Alan J.; Hardy, Linda L.; MacNicol, Angus M.			Ringo/Cyclin-dependent Kinase and Mitogen-activated Protein Kinase Signaling Pathways Regulate the Activity of the Cell Fate Determinant Musashi to Promote Cell Cycle Re-entry in Xenopus Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CYTOPLASMIC POLYADENYLATION; MAP KINASE; CPEB ACTIVATION; IN-VITRO; C-MOS; MATURATION; INDUCTION; PHOSPHORYLATION; IDENTIFICATION	Cell cycle re-entry during vertebrate oocyte maturation is mediated through translational activation of select target mRNAs, culminating in the activation of mitogen-activated protein kinase and cyclin B/cyclin-dependent kinase (CDK) signaling. The temporal order of targeted mRNA translation is crucial for cell cycle progression and is determined by the timing of activation of distinct mRNA-binding proteins. We have previously shown in oocytes from Xenopus laevis that the mRNA-binding protein Musashi targets translational activation of early class mRNAs including the mRNA encoding the Mos proto-oncogene. However, the molecular mechanism by which Musashi function is activated is unknown. We report here that activation of Musashi1 is mediated by Ringo/CDK signaling, revealing a novel role for early Ringo/CDK function. Interestingly, Musashi1 activation is subsequently sustained through mitogen-activated protein kinase signaling, the downstream effector of Mos mRNA translation, thus establishing a positive feedback loop to amplify Musashi function. The identified regulatory sites are present in mammalian Musashi proteins, and our data suggest that phosphorylation may represent an evolutionarily conserved mechanism to control Musashi-dependent target mRNA translation.	[MacNicol, Melanie C.; Hardy, Linda L.; MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA; [Arumugam, Karthik; Wang, Yiying; MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [MacNicol, Melanie C.] Univ Arkansas Med Sci, Ctr Translat Neurosci, Little Rock, AR 72205 USA; [Cragle, Chad E.] Univ Arkansas Med Sci, Interdisciplinary BioSci Grad Program, Little Rock, AR 72205 USA; [Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	MacNicol, AM (corresponding author), Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, 4301 W Markham,Slot 814, Little Rock, AR 72205 USA.	Angus@UAMS.edu	Arumugam, Karthik/L-2233-2014	Arumugam, Karthik/0000-0001-5204-2331	National Institutes of Health [RO1 HD35688, RR020146, P20RR015569, P20RR16460]; University of Arkansas for Medical Sciences Proteomics Facility; National Institutes of Health National Center for Research Resources [UL1 RR029884]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020146, UL1RR029884, P20RR015569, P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas for Medical Sciences Proteomics Facility; National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HD35688 (to A. M. M.) and RR020146 (to M. C. M.).; Mass spectrometry support was provided by the University of Arkansas for Medical Sciences Proteomics Facility and National Institutes of Health Grants P20RR015569 and P20RR16460. DNA sequencing was provided by the University of Arkansas for Medical Sciences Translational Research Institute supported by National Institutes of Health National Center for Research Resources Grant UL1 RR029884.	Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Bettegowda A, 2007, FRONT BIOSCI-LANDMRK, V12, P3713, DOI 10.2741/2346; Cao QP, 2010, RNA, V16, P221, DOI 10.1261/rna.1884610; Chang EJ, 2004, ANAL CHEM, V76, P4472, DOI 10.1021/ac049637h; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Cheng A, 2005, CELL CYCLE, V4, P155, DOI 10.4161/cc.4.1.1347; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Deng J, 2009, STEROIDS, V74, P595, DOI 10.1016/j.steroids.2008.11.010; Downs SM, 2010, MOL REPROD DEV, V77, P566, DOI 10.1002/mrd.21175; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Ferrell JE, 2009, FEBS LETT, V583, P3999, DOI 10.1016/j.febslet.2009.10.068; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Gradolatto A, 2009, MOL CELL BIOL, V29, P4604, DOI 10.1128/MCB.00160-09; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; Haccard O, 2006, CELL CYCLE, V5, P1152, DOI 10.4161/cc.5.11.2800; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Howard EL, 1999, MOL CELL BIOL, V19, P1990; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Karaiskou A, 2001, J BIOL CHEM, V276, P36028, DOI 10.1074/jbc.M104722200; Keady BT, 2007, J CELL SCI, V120, P1093, DOI 10.1242/jcs.03416; Lenormand JL, 1999, EMBO J, V18, P1869, DOI 10.1093/emboj/18.7.1869; Machaca K, 2002, J CELL BIOL, V156, P75, DOI 10.1083/jcb.200110059; MACNICOL AM, 1993, CELL, V73, P571, DOI 10.1016/0092-8674(93)90143-E; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Matten WT, 1996, DEV BIOL, V179, P485, DOI 10.1006/dbio.1996.0277; Moore MAS, 2010, NAT MED, V16, P963, DOI 10.1038/nm0910-963; MUSLIN AJ, 1993, MOL CELL BIOL, V13, P4197, DOI 10.1128/MCB.13.7.4197; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; Nishimoto Y, 2010, CELL RES, V20, P1083, DOI 10.1038/cr.2010.122; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Ota R, 2011, J BIOL CHEM, V286, P2853, DOI 10.1074/jbc.M110.155523; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Roy LM, 1996, ONCOGENE, V12, P2203; Ruiz EJ, 2008, MOL CELL, V32, P210, DOI 10.1016/j.molcel.2008.08.029; Sakakibara S, 1997, J NEUROSCI, V17, P8300; SHIBUYA EK, 1993, MOL BIOL CELL, V4, P781, DOI 10.1091/mbc.4.8.781; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Villalba A, 2011, CURR OPIN GENET DEV, V21, P452, DOI 10.1016/j.gde.2011.04.006; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221	49	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10639	10649		10.1074/jbc.M111.300681	http://dx.doi.org/10.1074/jbc.M111.300681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22215682	Green Published, hybrid			2022-12-25	WOS:000302167200089
J	Cabello-Verrugio, C; Santander, C; Cofre, C; Acuna, MJ; Melo, F; Brandan, E				Cabello-Verrugio, Claudio; Santander, Cristian; Cofre, Catalina; Jose Acuna, Maria; Melo, Francisco; Brandan, Enrique			The Internal Region Leucine-rich Repeat 6 of Decorin Interacts with Low Density Lipoprotein Receptor-related Protein-1, Modulates Transforming Growth Factor (TGF)-beta-dependent Signaling, and Inhibits TGF-beta-dependent Fibrotic Response in Skeletal Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; CELL-GROWTH; EXPRESSION; BIGLYCAN; FIBROSIS; COLLAGEN; DISEASE; CORE; REGENERATION	Decorin is a small proteoglycan, composed of 12 leucine-rich repeats (LRRs) that modulates the activity of transforming growth factor type beta (TGF-beta) and other growth factors, and thereby influences proliferation and differentiation in a wide array of physiological and pathological processes, such as fibrosis, in several tissues and organs. Previously we described two novel modulators of the TGF-beta-dependent signaling pathway: LDL receptor-related protein (LRP-1) and decorin. Here we have determined the regions in decorin that are responsible for interaction with LRP-1 and are involved in TGF-beta-dependent binding and signaling. Specifically, we used decorin deletion mutants, as well as peptides derived from internal LRR regions, to determine the LRRs responsible for these decorin functions. Our results indicate that LRR6 and LRR5 participate in the interaction with LRP-1 and TGF-beta as well as in its dependent signaling. Furthermore, the internal region (LRR6i), composed of 11 amino acids, is responsible for decorin binding to LRP-1 and subsequent TGF-beta-dependent signaling. Furthermore, using an in vivo approach, we also demonstrate that the LRR6 region of decorin can inhibit TGF-beta mediated action in response to skeletal muscle injury.	[Brandan, Enrique] Pontificia Univ Catolica Chile, CRCP, Ctr Regenerac & Envejecimiento CARE, Dept Biol Celular & Mol,Fac Ciencias Biol, Santiago, Chile; [Melo, Francisco] Pontificia Univ Catolica Chile, Millennium Inst Immunol & Immunotherapy, Fac Ciencias Biol, Santiago, Chile; [Melo, Francisco] Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Fac Ciencias Biol, Santiago, Chile; [Cabello-Verrugio, Claudio] Univ Desarrollo, CGH, Fac Med, Clin Alemana, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Clinica Alemana; Universidad del Desarrollo	Brandan, E (corresponding author), Pontificia Univ Catolica Chile, CRCP, Ctr Regenerac & Envejecimiento CARE, Dept Biol Celular & Mol,Fac Ciencias Biol, Casilla 114-D, Santiago, Chile.	ebrandan@bio.puc.cl	Acuna, Maria Jose/V-5926-2019; Melo, Francisco/I-5139-2012; Melo, Francisco/M-3923-2014; Cabello-Verrugio, Claudio/AAD-1454-2020; Brandan, Enrique/A-7063-2017	Acuna, Maria Jose/0000-0002-7117-3844; Cabello-Verrugio, Claudio/0000-0001-7273-2102; Brandan, Enrique/0000-0002-6820-5059; Melo, Francisco/0000-0002-0424-5991	FONDAP-Biomedicin [13980001, CARE PFB12/2007, FONDECYT 11080212, FONDECYT 1110400, ICM P09-016-F, MDA 89419]; Fundacion Chilena para Biologia Celular Proyecto [MF-100]	FONDAP-Biomedicin(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Fundacion Chilena para Biologia Celular Proyecto	This work was supported by FONDAP-Biomedicine Grants 13980001, CARE PFB12/2007, FONDECYT 11080212, FONDECYT 1110400, ICM P09-016-F, and MDA 89419 and Fundacion Chilena para Biologia Celular Proyecto MF-100.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alvarez K, 2002, J CELL BIOCHEM, V85, P703, DOI 10.1002/jcb.10184; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; BOLSTER MB, 1993, BAILLIERE CLIN RHEUM, V7, P79, DOI 10.1016/S0950-3579(05)80269-9; Brandan E, 1996, EUR J CELL BIOL, V71, P170; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Cabello-Verrugio C, 2007, J BIOL CHEM, V282, P18842, DOI 10.1074/jbc.M700243200; Cabello-Verrugio C, 2011, CELL SIGNAL, V23, P449, DOI 10.1016/j.cellsig.2010.10.019; Caceres S, 2000, EUR J CELL BIOL, V79, P173, DOI 10.1078/S0171-9335(04)70020-5; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; Denton CP, 2001, CURR OPIN RHEUMATOL, V13, P505, DOI 10.1097/00002281-200111000-00010; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fadic R, 2006, J CELL MOL MED, V10, P758, DOI 10.1111/j.1582-4934.2006.tb00435.x; Folger PA, 2001, INVEST OPHTH VIS SCI, V42, P2534; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Giri SN, 2003, ANNU REV PHARMACOL, V43, P73, DOI 10.1146/annurev.pharmtox.43.100901.135740; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; Gray PC, 2002, MOL CELL ENDOCRINOL, V188, P253, DOI 10.1016/S0303-7207(02)00037-0; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hu K, 2007, J CLIN INVEST, V117, P3821, DOI 10.1172/JCI32301; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 2010, FEBS J, V277, P3863, DOI 10.1111/j.1742-4658.2010.07796.x; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; McLennan IS, 1997, DEV DYNAM, V208, P278, DOI 10.1002/(SICI)1097-0177(199702)208:2<278::AID-AJA14>3.0.CO;2-#; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Olguin HC, 2003, DEV BIOL, V259, P209, DOI 10.1016/S0012-1606(03)00180-5; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Riquelme C, 2001, J BIOL CHEM, V276, P3589, DOI 10.1074/jbc.M004602200; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Shinozaki M, 1997, BIOCHEM BIOPH RES CO, V237, P292, DOI 10.1006/bbrc.1997.7134; Slater Clarke R., 2008, V3, P303; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; Vial C, 2011, J BIOL CHEM, V286, P24242, DOI 10.1074/jbc.M110.189365; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; ZIYADEH FN, 1993, AM J KIDNEY DIS, V22, P736, DOI 10.1016/S0272-6386(12)80440-9	64	54	58	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6773	6787		10.1074/jbc.M111.312488	http://dx.doi.org/10.1074/jbc.M111.312488			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22203668	hybrid, Green Published			2022-12-25	WOS:000300791800063
J	Dochow, M; Krumm, SA; Crowe, JE; Moore, ML; Plemper, RK				Dochow, Melanie; Krumm, Stefanie A.; Crowe, James E., Jr.; Moore, Martin L.; Plemper, Richard K.			Independent Structural Domains in Paramyxovirus Polymerase Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; RESPIRATORY SYNCYTIAL VIRUS; VESICULAR STOMATITIS-VIRUS; CANINE-DISTEMPER VIRUS; AMINO-ACID-SEQUENCES; SENDAI-VIRUS; RINDERPEST VIRUS; MESSENGER-RNA; MOLECULAR CHARACTERIZATION; PARAINFLUENZA VIRUS	All enzymatic activities required for genomic replication and transcription of nonsegmented negative strand RNA viruses (or Mononegavirales) are believed to be concentrated in the viral polymerase (L) protein. However, our insight into the organization of these different enzymatic activities into a bioactive tertiary structure remains rudimentary. Fragments of Mononegavirales polymerases analyzed to date cannot restore bioactivity through trans-complementation, unlike the related L proteins of segmented NSVs. We investigated the domain organization of phylogenetically diverse Paramyxovirus L proteins derived from measles virus (MeV), Nipah virus (NiV), and respiratory syncytial virus (RSV). Through a comprehensive in silico and experimental analysis of domain intersections, we defined MeV L position 615 as an interdomain candidate in addition to the previously reported residue 1708. Only position 1708 of MeV and the homologous positions in NiV and RSV L also tolerated the insertion of epitope tags. Splitting of MeV L at residue 1708 created fragments that were unable to physically interact and trans-complement, but strikingly, these activities were reconstituted by the addition of dimerization tags to the fragments. Equivalently split fragments of NiV, RSV, and MeV L oligomerized with comparable efficiency in all homo- and heterotypic combinations, but only the homotypic pairs were able to trans-complement. These results demonstrate that synthesis as a single polypeptide is not required for the Mononegavirales polymerases to adopt a proper tertiary conformation. Paramyxovirus polymerases are composed of at least two truly independent folding domains that lack a traditional interface but require molecular compatibility for bioactivity. The functional probing of the L domain architecture through trans-complementation is anticipated to be applicable to all Mononegavirales polymerases.	[Moore, Martin L.; Plemper, Richard K.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pediat & Pathol, Med Ctr, Nashville, TN 37232 USA; [Dochow, Melanie; Krumm, Stefanie A.; Moore, Martin L.; Plemper, Richard K.] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA	Children's Healthcare of Atlanta (CHOA); Vanderbilt University; Emory University	Plemper, RK (corresponding author), Emory Univ, Dept Pediat & Childrens Healthcare Atlanta, Sch Med, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	rplempe@emory.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079	National Institutes of Health (NIAID) [AI071002, AI085328]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083402, R01AI087798, R21AI085328, R01AI071002] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI071002 and AI085328 (NIAID to R. K. P.).	Bailey D, 2005, VIRUS RES, V110, P119, DOI 10.1016/j.virusres.2005.01.013; Bankamp B, 1999, J GEN VIROL, V80, P1617, DOI 10.1099/0022-1317-80-7-1617; BARON MD, 1995, J GEN VIROL, V76, P593, DOI 10.1099/0022-1317-76-3-593; Baron MD, 1996, J GEN VIROL, V77, P3041, DOI 10.1099/0022-1317-77-12-3041; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brown DD, 2005, J VIROL, V79, P14330, DOI 10.1128/JVI.79.22.14330-14338.2005; Brunotte L, 2011, J VIROL, V85, P324, DOI 10.1128/JVI.00721-10; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Cevik B, 2004, VIROLOGY, V327, P297, DOI 10.1016/j.virol.2004.07.002; Cevik B, 2003, VIROLOGY, V313, P525, DOI 10.1016/S0042-6822(03)00342-8; Chandonia JM, 1999, PROTEINS, V35, P293; Chandonia JM, 2007, BIOINFORMATICS, V23, P2018, DOI 10.1093/bioinformatics/btm269; CHANDRIKA R, 1995, VIROLOGY, V213, P352, DOI 10.1006/viro.1995.0008; Chattopadhyay A, 2004, VIRUS GENES, V28, P169, DOI 10.1023/B:VIRU.0000016855.25662.95; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; De Clercq E, 2004, NAT REV MICROBIOL, V2, P704, DOI 10.1038/nrmicro975; Deore RR, 2010, CURR MED CHEM, V17, P3806; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Druelle J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-22; Duprex WP, 2002, J VIROL, V76, P7322, DOI 10.1128/JVI.76.14.7322-7328.2002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Ferrer-Orta C, 2009, CURR OPIN STRUC BIOL, V19, P752, DOI 10.1016/j.sbi.2009.10.016; Ferron F, 2005, J GEN VIROL, V86, P743, DOI 10.1099/vir.0.80590-0; Ferron F, 2002, TRENDS BIOCHEM SCI, V27, P222, DOI 10.1016/S0968-0004(02)02091-1; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Gassen U, 2000, J VIROL, V74, P10737, DOI 10.1128/JVI.74.22.10737-10744.2000; Gopinath M, 2009, J GEN VIROL, V90, P1748, DOI 10.1099/vir.0.010975-0; Grdzelishvili VZ, 2005, J VIROL, V79, P7327, DOI 10.1128/JVI.79.12.7327-7337.2005; GROSFELD H, 1995, J VIROL, V69, P5677, DOI 10.1128/JVI.69.9.5677-5686.1995; Halpin K, 2004, J GEN VIROL, V85, P701, DOI 10.1099/vir.0.19685-0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harcourt BH, 2001, VIROLOGY, V287, P192, DOI 10.1006/viro.2001.1026; Holmes DE, 2002, J VIROL, V76, P3078, DOI 10.1128/JVI.76.6.3078-3083.2002; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; HORIKAMI SM, 1994, VIROLOGY, V205, P540, DOI 10.1006/viro.1994.1676; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; Koch U, 2007, CURR TOP MED CHEM, V7, P1302; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Kusumaningtyas E, 2004, ARCH VIROL, V149, P1859, DOI 10.1007/s00705-004-0336-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Lij J, 2008, J VIROL, V82, P775, DOI 10.1128/JVI.02107-07; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Malur AG, 2002, GENE EXPRESSION, V10, P93; McIlhatton MA, 1997, J GEN VIROL, V78, P571, DOI 10.1099/0022-1317-78-3-571; Moulin E, 2011, J MED VIROL, V83, P1614, DOI 10.1002/jmv.22152; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Nishio M, 2005, J VIROL, V79, P8591, DOI 10.1128/JVI.79.13.8591-8601.2005; Nishio M, 2011, J VIROL, V85, P725, DOI 10.1128/JVI.01226-10; Ogino T, 2005, J BIOL CHEM, V280, P4429, DOI 10.1074/jbc.M411167200; Ogino T, 2007, MOL CELL, V25, P85, DOI 10.1016/j.molcel.2006.11.013; OHGIMOTO S, 1990, VIROLOGY, V177, P116, DOI 10.1016/0042-6822(90)90465-4; OKAZAKI K, 1992, VIROLOGY, V188, P926, DOI 10.1016/0042-6822(92)90555-4; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Palacios G, 2011, EMERG INFECT DIS, V17, P711, DOI 10.3201/eid1704.100883; Parks CL, 2001, J VIROL, V75, P910, DOI 10.1128/JVI.75.2.910-920.2001; Plemper RK, 2005, ANTIMICROB AGENTS CH, V49, P3755, DOI 10.1128/AAC.49.9.3755-3761.2005; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Rahmeh AA, 2010, P NATL ACAD SCI USA, V107, P20075, DOI 10.1073/pnas.1013559107; Rima BK, 2005, VIRUS GENES, V30, P113, DOI 10.1007/s11262-004-4588-7; Roth JP, 2009, ANTIVIR RES, V82, P12, DOI 10.1016/j.antiviral.2009.01.001; Ruedas JB, 2009, J VIROL, V83, P12241, DOI 10.1128/JVI.01273-09; Schaeffer RD, 2011, PROTEIN ENG DES SEL, V24, P11, DOI 10.1093/protein/gzq096; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; SIDHU MS, 1993, VIROLOGY, V193, P50, DOI 10.1006/viro.1993.1102; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; SLEAT DE, 1993, J VIROL, V67, P1334, DOI 10.1128/JVI.67.3.1334-1339.1993; Smallwood S, 2004, VIROLOGY, V318, P439, DOI 10.1016/j.virol.2003.09.045; Suyama M, 2003, BIOINFORMATICS, V19, P673, DOI 10.1093/bioinformatics/btg031; Takimoto T, 2000, VIRUS RES, V70, P45, DOI 10.1016/S0168-1702(00)00207-0; Tao YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000943; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tidona CA, 1999, VIROLOGY, V258, P425, DOI 10.1006/viro.1999.9693; Uversky Vladimir N., 2007, V408, P69; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; White LK, 2007, ANTIMICROB AGENTS CH, V51, P2293, DOI 10.1128/AAC.00289-07; Whitehead SS, 1998, J VIROL, V72, P4467, DOI 10.1128/JVI.72.5.4467-4471.1998; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-58; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yea C, 2009, VIRUSES-BASEL, V1, P26, DOI 10.3390/v1010026; Yoon JJ, 2009, ANTIMICROB AGENTS CH, V53, P3860, DOI 10.1128/AAC.00503-09	90	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6878	6891		10.1074/jbc.M111.325258	http://dx.doi.org/10.1074/jbc.M111.325258			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215662	Green Published, hybrid			2022-12-25	WOS:000300791800073
J	Alahari, S; Mehmood, R; Johnson, CL; Pin, CL				Alahari, Sruthi; Mehmood, Rashid; Johnson, Charis L.; Pin, Christopher L.			The Absence of MIST1 Leads to Increased Ethanol Sensitivity and Decreased Activity of the Unfolded Protein Response in Mouse Pancreatic Acinar Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR MIST1; SEROUS EXOCRINE CELLS; ALCOHOLIC PANCREATITIS; GENE; EXOCYTOSIS; ORGANIZATION; METABOLISM; ACTIVATION; EXPRESSION	Background: Alcohol abuse is a leading cause of pancreatitis in humans. However, rodent models suggest that alcohol only sensitizes the pancreas to subsequent insult, indicating that additional factors play a role in alcohol- induced pancreatic injury. The goal of this study was to determine if an absence of MIST1, a transcription factor required for complete differentiation of pancreatic acinar cells in mice, increased the sensitivity to alcohol. Methods: Two to four month-old mice lacking MIST1 (Mist1(-/-)) or congenic C57 Bl6 mice were placed on a Lieber-DeCarli diet (36% of total kcal from ethanol and fat), a control liquid diet (36% kcal from fat) or a regular breeding chow diet (22% kcal from fat). After six weeks, pancreatic morphology was assessed. Biochemical and immunofluorescent analysis was used to assess mediators of the unfolded protein response (UPR). Results: Ethanol- fed Mist1(-/-) mice developed periductal accumulations of inflammatory cells that did not appear in wild type or control- fed Mist1(-/-) mice. Wild type mice fed diets high in ethanol or fat showed enhancement of the UPR based on increased accumulation of peIF2 alpha and spliced XBP1. These increases were not observed in Mist1(-/-) pancreatic tissue, which had elevated levels of UPR activity prior to diet exposure. Indeed, exposure to ethanol resulted in a reduction of UPR activity in Mist1(-/-) mice. Conclusions: Our findings suggest that an absence of MIST1 increases the sensitivity to ethanol that correlated with decreased activity of the UPR. Therefore, events that affect the expression and/or function of MIST1 may be confounding factors in pancreatitis.	[Alahari, Sruthi; Mehmood, Rashid; Johnson, Charis L.; Pin, Christopher L.] Childrens Hlth Res Inst, London, ON, Canada; [Alahari, Sruthi; Mehmood, Rashid; Johnson, Charis L.; Pin, Christopher L.] Univ Western Ontario, Dept Paediat, London, ON, Canada; [Alahari, Sruthi; Mehmood, Rashid; Johnson, Charis L.; Pin, Christopher L.] Univ Western Ontario, Dept Physiol, London, ON, Canada; [Alahari, Sruthi; Mehmood, Rashid; Johnson, Charis L.; Pin, Christopher L.] Univ Western Ontario, Dept Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Alahari, S (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.	cpin@uwo.ca		Pin, Christopher/0000-0002-1245-1058	Canadian Institutes of Health Research (CIHR) [MOP-53083]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR) Grant MOP-53083 (www.cihr.ca/e/193.html), the Children's Health Research Institute (www.chri.org), and the Lawson Health Research Institute (www.lawsonresearch.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Ammann RW, 2001, INTERNAL MED, V40, P368, DOI 10.2169/internalmedicine.40.368; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Cosen-Binker LI, 2007, GASTROENTEROLOGY, V132, P1527, DOI 10.1053/j.gastro.2007.01.042; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Garside VC, 2010, EXP CELL RES, V316, P2859, DOI 10.1016/j.yexcr.2010.06.014; Gonzalez A, 2008, ALCOHOL, V42, P565, DOI 10.1016/j.alcohol.2008.06.005; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; Johnson CL, 2004, MECH DEVELOP, V121, P261, DOI 10.1016/j.mod.2004.01.003; Kowalik AS, 2007, AM J PHYSIOL-GASTR L, V292, pG1123, DOI 10.1152/ajpgi.00512.2006; Kubisch CH, 2006, AM J PHYSIOL-GASTR L, V291, pG238, DOI 10.1152/ajpgi.00471.2005; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; LIEBER CS, 1986, ALCOHOL CLIN EXP RES, V10, P550, DOI 10.1111/j.1530-0277.1986.tb05140.x; Lugea A, 2011, GASTROENTEROLOGY; Luo X, 2005, J BIOL CHEM, V280, P12668, DOI 10.1074/jbc.M411973200; Mulvihill EE, 2009, DIABETES, V58, P2198, DOI 10.2337/db09-0634; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pandol SJ, 2003, J GASTROENTEROL, V38, P623, DOI 10.1007/s00535-003-1134-7; Pandol SJ, 1999, GASTROENTEROLOGY, V117, P706, DOI 10.1016/S0016-5085(99)70465-8; Pandol SJ, 2010, DIGEST DIS, V28, P776, DOI 10.1159/000327212; Pin CL, 2008, BIOL REPROD, V78, P91, DOI 10.1095/biolreprod.107.064196; Pin CL, 2000, ANAT REC, V259, P157, DOI 10.1002/(SICI)1097-0185(20000601)259:2<157::AID-AR6>3.0.CO;2-0; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Saluja AK, 2003, PANCREAS, V27, P327, DOI 10.1097/00006676-200311000-00010; Sans MD, 2003, AM J PHYSIOL-GASTR L, V285, pG517, DOI 10.1152/ajpgi.00540.2002; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Vonlaufen A, 2007, ALCOHOL RES HEALTH, V30, P48; Wang Y, 2000, J BIOL CHEM, V275, P27013; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wilson JS, 2003, PANCREAS, V27, P311, DOI 10.1097/00006676-200311000-00007; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	35	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28863	10.1371/journal.pone.0028863	http://dx.doi.org/10.1371/journal.pone.0028863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216129	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300013
J	Choi, I; Song, HD; Lee, S; Yang, YI; Nam, JH; Kim, SJ; Sung, JJ; Kang, T; Yi, J				Choi, Inhee; Song, Hyeon Don; Lee, Suseung; Yang, Young In; Nam, Joo Hyun; Kim, Sung Joon; Sung, Jung-Joon; Kang, Taewook; Yi, Jongheop			Direct Observation of Defects and Increased Ion Permeability of a Membrane Induced by Structurally Disordered Cu/Zn-Superoxide Dismutase Aggregates	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ATOMIC-FORCE MICROSCOPY; MUTANT SOD1; WILD-TYPE; CU,ZN-SUPEROXIDE DISMUTASE; LIPID-BILAYERS; FAMILIAL ALS; MOUSE MODEL; PROTEIN; PRION	Interactions between protein aggregates and a cellular membrane have been strongly implicated in many protein conformational diseases. However, such interactions for the case of Cu/Zn superoxide dismutase (SOD1) protein, which is related to fatal neurodegenerative disorder amyotrophic lateral sclerosis (ALS), have not been explored yet. For the first time, we report the direct observation of defect formation and increased ion permeability of a membrane induced by SOD1 aggregates using a supported lipid bilayer and membrane patches of human embryonic kidney cells as model membranes. We observed that aggregated SOD1 significantly induced the formation of defects within lipid membranes and caused the perturbation of membrane permeability, based on surface plasmon resonance spectroscopy, atomic force microscopy and electrophysiology. In the case of apo SOD1 with an unfolded structure, we found that it bound to the lipid membrane surface and slightly perturbed membrane permeability, compared to other folded proteins (holo SOD1 and bovine serum albumin). The changes in membrane integrity and permeability were found to be strongly dependent on the type of proteins and the amount of aggregates present. We expect that the findings presented herein will advance our understanding of the pathway by which structurally disordered SOD1 aggregates exert toxicity in vivo.	[Choi, Inhee; Song, Hyeon Don; Lee, Suseung; Yang, Young In; Yi, Jongheop] Seoul Natl Univ, Inst Chem Proc, Sch Chem & Biol Engn, Seoul, South Korea; [Nam, Joo Hyun; Kim, Sung Joon] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Sung, Jung-Joon] Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Kang, Taewook] Sogang Univ, Dept Chem & Biomol Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Sogang University	Choi, I (corresponding author), Seoul Natl Univ, Inst Chem Proc, Sch Chem & Biol Engn, Seoul, South Korea.	twkang@sogang.ac.kr; jyi@snu.ac.kr	Kim, Sung Joon/H-1825-2012; Choi, Inhee/E-4232-2010	Choi, Inhee/0000-0002-1996-2926; Kim, Sung-Joon/0000-0002-0289-121X	Basic Research Program of Korea Science and Engineering [R01-2006-000-10239-0]; Ministry of Environment [101082-032]; WCU (World Class University) through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-10013]; Sogang University; Korea Research Foundation; Korea Government (MOEHRD) [KRF-2008-331-D00134, 2011K00213]; Ministry of Education, Science and Technology, Korea	Basic Research Program of Korea Science and Engineering(Korea Science and Engineering Foundation); Ministry of Environment(Ministry of Environment (ME), Republic of Korea); WCU (World Class University) through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Sogang University; Korea Research Foundation(National Research Foundation of Korea); Korea Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant (no. R01-2006-000-10239-0) from the Basic Research Program of Korea Science and Engineering and a grant (101082-032) from the Ministry of Environment as "The Eco-technopia 21 project". This research was also supported by the WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10013); and by the Sogang University research grant, the Korea Research Foundation Grant funded by the Korea Government (MOEHRD, Basic Research Promotion Fund) (KRF-2008-331-D00134), and a grant (code # : 2011K00213) from 'Center for Nanostructured Materials Technology' under '21st Century Frontier R& D Programs' of the Ministry of Education, Science and Technology, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2005, SCIENCE, V308, P1420, DOI 10.1126/science.1114168; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; Calamai M, 2005, J MOL BIOL, V346, P603, DOI 10.1016/j.jmb.2004.11.067; Chi EY, 2007, BIOCHEMISTRY-US, V46, P1913, DOI 10.1021/bi062177x; Choi I, 2006, BIOMATERIALS, V27, P4655, DOI 10.1016/j.biomaterials.2006.04.023; Choi I, 2011, BBA-MOL BASIS DIS, V1812, P41, DOI 10.1016/j.bbadis.2010.09.003; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Green JD, 2004, J MOL BIOL, V342, P877, DOI 10.1016/j.jmb.2004.07.052; Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kang T, 2006, J AM CHEM SOC, V128, P12870, DOI 10.1021/ja0632198; Kang TW, 2005, CHEM COMMUN, P2360, DOI 10.1039/b500652j; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim YH, 2004, JPN J APPL PHYS 1, V43, P3860, DOI 10.1143/JJAP.43.3860; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; Lashuel Hilal A, 2005, Sci Aging Knowledge Environ, V2005, ppe28, DOI 10.1126/sageke.2005.38.pe28; Madine J, 2004, BIOCHEM SOC T, V32, P1127, DOI 10.1042/BST0321127; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nagami H, 2005, J BIOSCI BIOENG, V99, P423, DOI 10.1263/jbb.99.423; OKAMOTO K, 1991, NEUROSCI LETT, V129, P233, DOI 10.1016/0304-3940(91)90469-A; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stieber A, 2000, J NEUROL SCI, V173, P53, DOI 10.1016/S0022-510X(99)00300-7; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061	46	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28982	10.1371/journal.pone.0028982	http://dx.doi.org/10.1371/journal.pone.0028982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216152	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300019
J	Lucien, F; Brochu-Gaudreau, K; Arsenault, D; Harper, K; Dubois, CM				Lucien, Fabrice; Brochu-Gaudreau, Karine; Arsenault, Dominique; Harper, Kelly; Dubois, Claire M.			Hypoxia-Induced Invadopodia Formation Involves Activation of NHE-1 by the p90 Ribosomal S6 Kinase (p90RSK)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; H EXCHANGER NHE1; NA+/H+ EXCHANGER; CANCER-CELLS; INTRACELLULAR PH; TUMOR PH; KAPPA-B; EXPRESSION; RSK; DEGRADATION	The hypoxic and acidic microenvironments in tumors are strongly associated with malignant progression and metastasis, and have thus become a central issue in tumor physiology and cancer treatment. Despite this, the molecular links between acidic pH-and hypoxia-mediated cell invasion/metastasis remain mostly unresolved. One of the mechanisms that tumor cells use for tissue invasion is the generation of invadopodia, which are actin-rich invasive plasma membrane protrusions that degrade the extracellular matrix. Here, we show that hypoxia stimulates the formation of invadopodia as well as the invasive ability of cancer cells. Inhibition or shRNA-based depletion of the Na+/H+ exchanger NHE-1, along with intracellular pH monitoring by live-cell imaging, revealed that invadopodia formation is associated with alterations in cellular pH homeostasis, an event that involves activation of the Na+/H+ exchange rate by NHE-1. Further characterization indicates that hypoxia triggered the activation of the p90 ribosomal S6 kinase (p90 RSK), which resulted in invadopodia formation and site-specific phosphorylation and activation of NHE-1. This study reveals an unsuspected role of p90RSK in tumor cell invasion and establishes p90RS kinase as a link between hypoxia and the acidic microenvironment of tumors.	[Lucien, Fabrice; Brochu-Gaudreau, Karine; Arsenault, Dominique; Harper, Kelly; Dubois, Claire M.] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pediat, Div Immunol, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Lucien, F (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pediat, Div Immunol, Sherbrooke, PQ J1K 2R1, Canada.	Claire.Dubois@usherbrooke.ca	Brochu-Gaudreau, Karine/GWC-1767-2022; Dubois, Claire M/K-1985-2013	Brochu-Gaudreau, Karine/0000-0003-1163-2196; 	Canadian Institutes for Health Research [MOP-89810]; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institutes for Health Research (grant MOP-89810 to Dr. Dubois). Dr. Dubois is a member of the Fonds de la Recherche en Sante du Quebec (FRSQ)-funded Centre de Recherche Clinique Etienne-LeBel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault D, 2011, J CELL PHYSL; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Avkiran M, 2008, CURR OPIN PHARMACOL, V8, P133, DOI 10.1016/j.coph.2007.12.007; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Busco G, 2010, FASEB J, V24, P3903, DOI 10.1096/fj.09-149518; Caldieri G, 2009, J CELL MOL MED, V13, P1728, DOI 10.1111/j.1582-4934.2008.00568.x; Chen WT, 1996, ENZYME PROTEIN, V49, P59, DOI 10.1159/000468616; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Clark DE, 2005, CANCER RES, V65, P3108; Coopman PJ, 1998, CLIN CANCER RES, V4, P507; Corvera JS, 2003, ANN THORAC SURG, V76, P1614, DOI 10.1016/S0003-4975(03)00958-5; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Garciarena CD, 2009, J APPL PHYSIOL, V106, P1325, DOI 10.1152/japplphysiol.91300.2008; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper K, 2010, CANCER RES, V70, P4634, DOI 10.1158/0008-5472.CAN-09-3813; Hockel M, 1999, CANCER RES, V59, P4525; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; Karmazyn M, 2001, DRUGS, V61, P375, DOI 10.2165/00003495-200161030-00006; Kimura F, 2010, CANCER SCI, V101, P1133, DOI 10.1111/j.1349-7006.2010.01527.x; Kinsella JL, 1998, BIOCHEM CELL BIOL, V76, P743, DOI 10.1139/bcb-76-5-743; Lee E, 2002, MOL CELLS, V14, P9; Liu LL, 2010, INT J CANCER, V127, P820, DOI 10.1002/ijc.25098; Maekawa N, 2006, CIRCULATION, V113, P2516, DOI 10.1161/CIRCULATIONAHA.105.563486; Mandal S, 2008, EXP CELL RES, V314, P3478, DOI 10.1016/j.yexcr.2008.09.013; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; McCarty MF, 2010, ALTERN MED REV, V15, P264; Mishra OP, 2010, NEUROCHEM RES, V35, P1471, DOI 10.1007/s11064-010-0208-1; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; MONSKY WL, 1994, CANCER RES, V54, P5702; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Park YK, 2010, J BIOL CHEM, V285, P3289, DOI 10.1074/jbc.M109.059212; Parks SK, 2011, J CELL PHYSIOL, V226, P299, DOI 10.1002/jcp.22400; Putney LK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-46; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Rios EJ, 2005, AM J PHYSIOL-LUNG C, V289, pL867, DOI 10.1152/ajplung.00455.2004; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Romeo Y, 2011, EXPERT OPIN THER TAR, V15, P5, DOI 10.1517/14728222.2010.531014; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Schwab A, 2008, PHYSIOLOGY, V23, P212, DOI 10.1152/physiol.00003.2008; Seko Y, 1996, BIOCHEM BIOPH RES CO, V226, P530, DOI 10.1006/bbrc.1996.1389; Shimoda LA, 2006, AM J PHYSIOL-LUNG C, V291, pL941, DOI 10.1152/ajplung.00528.2005; Smith JA, 2005, CANCER RES, V65, P1027; Spring DJ, 1999, MOL CELL BIOL, V19, P317; Steffan JJ, 2009, TRAFFIC, V10, P737, DOI 10.1111/j.1600-0854.2009.00904.x; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Taves J, 2008, ARCH BIOCHEM BIOPHYS, V477, P60, DOI 10.1016/j.abb.2008.05.007; Tekpli X, 2008, J CELL PHYSIOL, V216, P207, DOI 10.1002/jcp.21395; Vishnubhotla R, 2007, LAB INVEST, V87, P1149, DOI 10.1038/labinvest.3700674; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; WIKEHOOLEY JL, 1984, EUR J CANCER CLIN ON, V20, P619, DOI 10.1016/0277-5379(84)90006-3; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xu L, 2002, J BIOL CHEM, V277, P11368, DOI 10.1074/jbc.M108347200; Xu L, 2000, CANCER RES, V60, P4610; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yang XK, 2010, CANCER LETT, V295, P198, DOI 10.1016/j.canlet.2010.03.001; Yu LY, 2008, AM J RESP CRIT CARE, V177, P1276, DOI 10.1164/rccm.200710-1522OC	74	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e28851	10.1371/journal.pone.0028851	http://dx.doi.org/10.1371/journal.pone.0028851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216126	gold, Green Published, Green Submitted			2022-12-25	WOS:000300674900005
J	Dodd, PJ; White, RG; Corbett, EL				Dodd, Peter J.; White, Richard G.; Corbett, Elizabeth L.			Periodic Active Case Finding for TB: When to Look?	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; PULMONARY TUBERCULOSIS; SOUTH-AFRICA; RISK-FACTORS; HIV; INFECTION; COMMUNITY; DISEASE; IMPACT; DETERMINANTS	Objective: To investigate the factors influencing the performance and cost-efficacy of periodic rounds of active case finding (ACF) for TB. Methods: A mathematical model of TB dynamics and periodic ACF (PACF) in the HIV era, simplified by assuming constant prevalence of latent TB infection, is analyzed for features that control intervention outcome, measured as cases averted and cases found. Explanatory variables include baseline TB incidence, interval between PACF rounds, and different routine and PACF case-detection rates among HIV-infected and uninfected TB cases. Findings: PACF can be cost-saving over a 10 year time frame if the cost-per-round is lower than a threshold proportional to initial incidence and cost-per-case-treated. More cases are averted at higher baseline incidence rates, when more potent PACF strategies are used, intervals between PACF rounds are shorter, and when the ratio of HIV-negative to positive TB cases detected is higher. More costly approaches, e.g. radiographic screening, can be as cost-effective as less costly alternatives if PACF case-detection is higher and/or implementation less frequent. Conclusion: Periodic ACF can both improve control and save medium-term health care costs in high TB burden settings. Greater costs of highly effective PACF at frequent (e.g. yearly) intervals may be offset by higher numbers of cases averted in populations with high baseline TB incidence, higher prevalence of HIV-uninfected cases, higher costs per-case-treated, and more effective routine case-detection. Less intensive approaches may still be cost-neutral or cost-saving in populations lacking one or more of these key determinants.	[Dodd, Peter J.; White, Richard G.; Corbett, Elizabeth L.] London Sch Hyg & Trop Med, London WC1, England; [Corbett, Elizabeth L.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi	University of London; London School of Hygiene & Tropical Medicine; University of Malawi	Dodd, PJ (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	peter.dodd@lshtm.ac.uk	White, Richard G/D-5407-2009	White, Richard G/0000-0003-4410-6635; Dodd, Pete/0000-0001-5825-9347; Corbett, Elizabeth/0000-0002-3552-3181	Medical Research Council (UK) [G0802414]; European Commission [242061]; Bill and Melinda Gates Foundation [19790.01]; MRC [G0802414] Funding Source: UKRI; Medical Research Council [G0802414] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RGW is funded by a Medical Research Council (UK) Methodology Research Fellowship (G0802414) and the European Commission Seventh Framework Programme FP7 (242061). All authors were supported by the Bill and Melinda Gates Foundation (19790.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, TUBERCLE, V62, P155; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Churchyard GJ, 2010, THORAX; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Dimairo M, 2009, CROI 2009; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Espinal RA, 2000, LANCET, V355, P275, DOI 10.1016/S0140-6736(99)04402-5; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Getahun H, 2010, LANCET, V376, P1205, DOI 10.1016/S0140-6736(10)61503-6; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Heller RF, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-35; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Murray CJL, 1998, INT J TUBERC LUNG D, V2, pS9; R Development Core Team, 2009, R FDN STAT COMP; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Styblo K, 1969, Bull Int Union Tuberc, V42, P1; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Ward HA, 2004, INT J TUBERC LUNG D, V8, P593; World Health Organization, 2010, GLOB TUB CONTR REP 2	33	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29130	10.1371/journal.pone.0029130	http://dx.doi.org/10.1371/journal.pone.0029130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216182	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700032
J	Manning, L; Laman, M; Law, I; Bona, C; Aipit, S; Teine, D; Warrell, J; Rosanas-Urgell, A; Lin, E; Kiniboro, B; Vince, J; Hwaiwhanje, I; Karunajeewa, H; Michon, P; Siba, P; Mueller, I; Davis, TME				Manning, Laurens; Laman, Moses; Law, Irwin; Bona, Cathy; Aipit, Susan; Teine, David; Warrell, Jonathan; Rosanas-Urgell, Anna; Lin, Enmoore; Kiniboro, Benson; Vince, John; Hwaiwhanje, Ilomo; Karunajeewa, Harin; Michon, Pascal; Siba, Peter; Mueller, Ivo; Davis, Timothy M. E.			Features and Prognosis of Severe Malaria Caused by Plasmodium falciparum, Plasmodium vivax and Mixed Plasmodium Species in Papua New Guinean Children	PLOS ONE			English	Article							LIFE-THREATENING MALARIA; AFRICAN CHILDREN; CEREBRAL MALARIA; CLINICAL-FEATURES; INFECTIONS; DISEASE; ALPHA(+)-THALASSEMIA; AREA; OVALOCYTOSIS; CHLOROQUINE	Background: Mortality from severe pediatric falciparum malaria appears low in Oceania but Plasmodium vivax is increasingly recognized as a cause of complications and death. The features and prognosis of mixed Plasmodium species infections are poorly characterized. Detailed prospective studies that include accurate malaria diagnosis and detection of co-morbidities are lacking. Methods and Findings: We followed 340 Papua New Guinean (PNG) children with PCR-confirmed severe malaria (77.1% P. falciparum, 7.9% P. vivax, 14.7% P. falciparum/vivax) hospitalized over a 3-year period. Bacterial cultures were performed to identify co-incident sepsis. Clinical management was under national guidelines. Of 262 children with severe falciparum malaria, 30.9%, 24.8% and 23.2% had impaired consciousness, severe anemia, and metabolic acidosis/hyperlactatemia, respectively. Two (0.8%) presented with hypoglycemia, seven (2.7%) were discharged with neurologic impairment, and one child died (0.4%). The 27 severe vivax malaria cases presented with similar phenotypic features to the falciparum malaria cases but respiratory distress was five times more common (P = 0.001); one child died (3.7%). The 50 children with P. falciparum/vivax infections shared phenotypic features of mono-species infections, but were more likely to present in deep coma and had the highest mortality (8.0%; P = 0.003 vs falciparum malaria). Overall, bacterial cultures were positive in only two non-fatal cases. 83.6% of the children had alpha-thalassemia trait and seven with coma/impaired consciousness had South Asian ovalocytosis (SAO). Conclusions: The low mortality from severe falciparum malaria in PNG children may reflect protective genetic factors other than alpha-thalassemia trait/SAO, good nutrition, and/or infrequent co-incident sepsis. Severe vivax malaria had similar features but severe P. falciparum/vivax infections were associated with the most severe phenotype and worst prognosis.	[Manning, Laurens; Laman, Moses; Karunajeewa, Harin; Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA, Australia; [Laman, Moses; Law, Irwin; Bona, Cathy; Aipit, Susan; Teine, David; Warrell, Jonathan; Rosanas-Urgell, Anna; Lin, Enmoore; Kiniboro, Benson; Michon, Pascal; Siba, Peter; Mueller, Ivo] Papua New Guinea Inst Med Res, Madang, Madang Province, Papua N Guinea; [Vince, John] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea; [Hwaiwhanje, Ilomo] Goroka Base Hosp, Dept Pediat, Goroka, Eastern Highlan, Papua N Guinea	University of Western Australia; PNG Institute Of Medical Research; University of Papua New Guinea	Manning, L (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA, Australia.	tdavis@cyllene.uwa.edu.au	Rosanas-Urgell, Anna/D-3193-2015; Manning, Laurens A/H-5360-2014; Mueller, Ivo/C-7251-2013; Davis, Timothy ME/M-5144-2014	Rosanas-Urgell, Anna/0000-0002-0432-5203; Manning, Laurens A/0000-0003-4334-5351; Mueller, Ivo/0000-0001-6554-6889; Lin, Enmoore/0000-0002-8584-7627; Davis, Timothy/0000-0003-0749-7411; Law, Irwin/0000-0002-1194-677X; Laman, Moses/0000-0003-0964-805X	National Health and Medical Research Council (NHMRC) [513782]; MalariaGen Genomic Epidemiology Network; Fogarty Foundation; Royal Australian College of Physician	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); MalariaGen Genomic Epidemiology Network; Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Royal Australian College of Physician	This study was funded by a National Health and Medical Research Council (NHMRC) grant (#513782). The authors also acknowledge support from the MalariaGen Genomic Epidemiology Network. ML was supported by a Fogarty Foundation scholarship, LM by a Basser scholarship from the Royal Australian College of Physicians and an NHMRC scholarship, and TMED by an NHMRC Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Allen SJ, 1996, QJM-INT J MED, V89, P779, DOI 10.1093/qjmed/89.10.779; Allen SJ, 1999, AM J TROP MED HYG, V60, P1056, DOI 10.4269/ajtmh.1999.60.1056; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Davis TME, 1997, BRIT J CLIN PHARMACO, V44, P1, DOI 10.1046/j.1365-2125.1997.00597.x; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Fernandez-Becerra C, 2009, TRENDS PARASITOL, V25, P44, DOI 10.1016/j.pt.2008.09.012; GENTON B, 1995, NATURE, V378, P564, DOI 10.1038/378564a0; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Imbert P, 2002, T ROY SOC TROP MED H, V96, P278, DOI 10.1016/S0035-9203(02)90099-4; Imrie H, 2006, AM J TROP MED HYG, V74, P965, DOI 10.4269/ajtmh.2006.74.965; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Karunajeewa HA, 2006, ANTIMICROB AGENTS CH, V50, P968, DOI 10.1128/AAC.50.3.968-974.2006; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; Lacerda MVG, 2004, ACTA TROP, V90, P187, DOI 10.1016/j.actatropica.2003.12.001; Laman M, 2010, CLIN INFECT DIS, V51, P534, DOI 10.1086/655679; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Maitland K, 1997, T ROY SOC TROP MED H, V91, P562, DOI 10.1016/S0035-9203(97)90026-2; Manning L, 2011, AM J TROP MED HYG, V85, P50, DOI 10.4269/ajtmh.2011.11-0095; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Mockenhaupt FP, 2004, AM J TROP MED HYG, V71, P167, DOI 10.4269/ajtmh.2004.71.167; MOLYNEUX ME, 1989, Q J MED, V71, P441; MOOSA AA, 1995, LANCET, V345, P1290, DOI 10.1016/S0140-6736(95)90931-1; Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938; Okeniyi John, 2008, Congenit Heart Dis, V3, P73, DOI 10.1111/j.1747-0803.2007.00153.x; Paediatrics Society of PNG, 2005, STAND TREATM COMM IL; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Ranque S, 2008, PEDIATR INFECT DIS J, V27, P130, DOI 10.1097/INF.0b013e31815988ed; SCHAPIRA A, 1993, T ROY SOC TROP MED H, V87, P299, DOI 10.1016/0035-9203(93)90136-E; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Smith T, 2001, T ROY SOC TROP MED H, V95, P1, DOI 10.1016/S0035-9203(01)90314-1; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; STACE J, 1982, PAPUA NEW GUINEA MED, V25, P230; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; UNAIDS, 2010, GLOB REP FACT SHEET; WHITE NJ, 1992, LANCET, V339, P317, DOI 10.1016/0140-6736(92)91644-N; YENCHITSOMANUS PT, 1985, AM J HUM GENET, V37, P778; Zimmerman PA, 2004, TRENDS PARASITOL, V20, P440, DOI 10.1016/j.pt.2004.07.004	54	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29203	10.1371/journal.pone.0029203	http://dx.doi.org/10.1371/journal.pone.0029203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216212	Green Published, gold			2022-12-25	WOS:000299684700039
J	Masumoto, H; Nakato, R; Kanemaki, M; Shirahige, K; Hachinohe, M				Masumoto, Hiroshi; Nakato, Ryuichiro; Kanemaki, Masato; Shirahige, Katsuhiko; Hachinohe, Mayumi			The Inheritance of Histone Modifications Depends upon the Location the Chromosome in Saccharomyces cerevisiae	PLOS ONE			English	Article							TELOMERIC HETEROCHROMATIN; SILENCED CHROMATIN; DNA-REPLICATION; H3-H4 TETRAMERS; ACTIVE GENES; CELL-CYCLE; ACETYLATION; SEGREGATION; METHYLATION; LYSINE-56	Histone modifications are important epigenetic features of chromatin that must be replicated faithfully. However, the molecular mechanisms required to duplicate and maintain histone modification patterns in chromatin remain to be determined. Here, we show that the introduction of histone modifications into newly deposited nucleosomes depends upon their location in the chromosome. In Saccharomyces cerevisiae, newly deposited nucleosomes consisting of newly synthesized histone H3-H4 tetramers are distributed throughout the entire chromosome. Methylation of lysine 4 on histone H3 (H3-K4), a hallmark of euchromatin, is introduced into these newly deposited nucleosomes, regardless of whether the neighboring preexisting nucleosomes harbor the K4 mutation in histone H3. Furthermore, if the heterochromatin-binding protein Sir3 is unavailable during DNA replication, histone H3-K4 methylation is introduced onto newly deposited nucleosomes in telomeric heterochromatin. Thus, a conservative distribution model most accurately explains the inheritance of histone modifications because the location of histones within euchromatin or heterochromatin determines which histone modifications are introduced.	[Masumoto, Hiroshi; Hachinohe, Mayumi] Univ Tsukuba, Fac Life & Environm Sci, Initiat Promot Young Scientists Independent Res, Tsukuba, Ibaraki, Japan; [Nakato, Ryuichiro; Shirahige, Katsuhiko] Univ Tokyo, Res Ctr Epigenet Dis, Lab Genome Struct & Funct, Tokyo, Japan; [Kanemaki, Masato] Res Org Informat & Syst, Frontier Res Ctr, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan	University of Tsukuba; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Masumoto, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Initiat Promot Young Scientists Independent Res, Tsukuba, Ibaraki, Japan.	himasumo@sakura.cc.tsukuba.ac.jp	Kanemaki, Masato/Q-3246-2019; Nakato, Ryuichiro/AAV-6405-2020	Kanemaki, Masato/0000-0002-7657-1649; Nakato, Ryuichiro/0000-0003-3019-5817	Ministry of Education, Culture, Sports, Science and Technology from the Japanese Government; Japan Science and Technology Agency (JST) [23131502]	Ministry of Education, Culture, Sports, Science and Technology from the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology from the Japanese Government, and Japan Science and Technology Agency (JST) (Grant number: 23131502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Cheung P, 2005, MOL ENDOCRINOL, V19, P563, DOI 10.1210/me.2004-0496; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6930, DOI 10.1021/bi00345a027; Katan-Khaykovich Y, 2011, P NATL ACAD SCI USA, V108, P1296, DOI 10.1073/pnas.1018308108; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; SUGASAWA K, 1992, P NATL ACAD SCI USA, V89, P1055, DOI 10.1073/pnas.89.3.1055; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Verzijlbergen KF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-76; Wolffe A. P., 1999, CHROMATIN STRUCTURE; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28980	10.1371/journal.pone.0028980	http://dx.doi.org/10.1371/journal.pone.0028980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216151	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600054
J	Olivares-Chauvet, P; Fennessy, D; Jackson, DA; Maya-Mendoza, A				Olivares-Chauvet, Pedro; Fennessy, Dorota; Jackson, Dean A.; Maya-Mendoza, Apolinar			Innate Structure of DNA Foci Restricts the Mixing of DNA from Different Chromosome Territories	PLOS ONE			English	Article							NUCLEAR-ORGANIZATION; HISTONE ACETYLATION; CHROMATIN DYNAMICS; GENE-EXPRESSION; S-PHASE; REPLICATION; GENOME; TRANSCRIPTION; ARCHITECTURE; REVEALS	The distribution of chromatin within the mammalian nucleus is constrained by its organization into chromosome territories (CTs). However, recent studies have suggested that promiscuous intra-and inter-chromosomal interactions play fundamental roles in regulating chromatin function and so might define the spatial integrity of CTs. In order to test the extent of DNA mixing between CTs, DNA foci of individual CTs were labeled in living cells following incorporation of Alexa-488 and Cy-3 conjugated replication precursor analogues during consecutive cell cycles. Uniquely labeled chromatin domains, resolved following random mitotic segregation, were visualized as discrete structures with defined borders. At the level of resolution analysed, evidence for mixing of chromatin from adjacent domains was only apparent within the surface volumes where neighboring CTs touched. However, while less than 1% of the nuclear volume represented domains of inter-chromosomal mixing, the dynamic plasticity of DNA foci within individual CTs allows continual transformation of CT structure so that different domains of chromatin mixing evolve over time. Notably, chromatin mixing at the boundaries of adjacent CTs had little impact on the innate structural properties of DNA foci. However, when TSA was used to alter the extent of histone acetylation changes in chromatin correlated with increased chromatin mixing. We propose that DNA foci maintain a structural integrity that restricts widespread mixing of DNA and discuss how the potential to dynamically remodel genome organization might alter during cell differentiation.	[Olivares-Chauvet, Pedro; Fennessy, Dorota; Jackson, Dean A.; Maya-Mendoza, Apolinar] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Olivares-Chauvet, P (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	dean.jackson@manchester.ac.uk; Apolinar.Maya-Mendoza@manchester.ac.uk		Maya-Mendoza, Apolinar/0000-0001-7452-9896	BBSRC [BBS/B/06091]; Wellcome Trust [080172/Z/06]; EU [LSBH-CT511965]; CONACyT (National Council for Science and Technology, Mexico); Biotechnology and Biological Sciences Research Council [BBS/B/06091] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); CONACyT (National Council for Science and Technology, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was from: BBSRC (grant BBS/B/06091), The Wellcome Trust (grant 080172/Z/06) and EU (Project LSBH-CT511965). The funding source for PO-C is credited to: CONACyT (National Council for Science and Technology, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Bazett-Jones DP, 2008, CHROMOSOME RES, V16, P397, DOI 10.1007/s10577-008-1237-3; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bornfleth H, 1999, BIOPHYS J, V77, P2871, DOI 10.1016/S0006-3495(99)77119-5; Botta M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.79; Branco MR, 2008, CHROMOSOME RES, V16, P413, DOI 10.1007/s10577-008-1230-x; Branco MR, 2007, TRENDS CELL BIOL, V17, P127, DOI 10.1016/j.tcb.2006.12.006; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chen SB, 2009, J PROTEOME RES, V8, P4693, DOI 10.1021/pr900396d; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Edelmann P, 2001, BBA-REV CANCER, V1551, pM29, DOI 10.1016/S0304-419X(01)00023-3; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lande-Diner L, 2009, MOL CELL, V34, P767, DOI 10.1016/j.molcel.2009.05.027; Levi V, 2005, BIOPHYS J, V89, P4275, DOI 10.1529/biophysj.105.066670; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; MANDERS EMM, 1992, J CELL SCI, V103, P857; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Maya-Mendoza A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000900; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murray JM, 2007, J MICROSC-OXFORD, V228, P390, DOI 10.1111/j.1365-2818.2007.01861.x; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pliss A, 2009, CHROMOSOMA, V118, P459, DOI 10.1007/s00412-009-0208-6; Ragoczy T, 2010, NAT GENET, V42, P16, DOI 10.1038/ng0110-16; Ronneberger O, 2008, CHROMOSOME RES, V16, P523, DOI 10.1007/s10577-008-1236-4; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schindelin J, 2008, P 2 IMAGEJ US DEV C; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Visser AE, 1999, J CELL SCI, V112, P3353; Volpi EV, 2000, J CELL SCI, V113, P1565; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686; Zink D, 2006, CHROMOSOMA, V115, P273, DOI 10.1007/s00412-006-0062-8	52	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e27527	10.1371/journal.pone.0027527	http://dx.doi.org/10.1371/journal.pone.0027527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205925	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600003
J	Signorello, LB; Shi, JJ; Cai, QY; Zheng, W; Williams, SM; Long, JR; Cohen, SS; Li, GL; Hollis, BW; Smith, JR; Blot, WJ				Signorello, Lisa B.; Shi, Jiajun; Cai, Qiuyin; Zheng, Wei; Williams, Scott M.; Long, Jirong; Cohen, Sarah S.; Li, Guoliang; Hollis, Bruce W.; Smith, Jeffrey R.; Blot, William J.			Common Variation in Vitamin D Pathway Genes Predicts Circulating 25-Hydroxyvitamin D Levels among African Americans	PLOS ONE			English	Article							D-BINDING PROTEIN; GENOME-WIDE ASSOCIATION; FOOD FREQUENCY QUESTIONNAIRE; SOUTHERN COMMUNITY COHORT; D DEFICIENCY; PLASMA-CONCENTRATIONS; MULTIPLE-SCLEROSIS; HYPOVITAMINOSIS-D; ASTHMA FAMILIES; PROSTATE-CANCER	Vitamin D is implicated in a wide range of health outcomes, and although environmental predictors of vitamin D levels are known, the genetic drivers of vitamin D status remain to be clarified. African Americans are a group at particularly high risk for vitamin D insufficiency but to date have been virtually absent from studies of genetic predictors of circulating vitamin D levels. Within the Southern Community Cohort Study, we investigated the association between 94 single nucleotide polymorphisms (SNPs) in five vitamin D pathway genes (GC, VDR, CYP2R1, CYP24A1, CYP27B1) and serum 25-hydroxyvitamin D (25(OH) D) levels among 379 African American and 379 Caucasian participants. We found statistically significant associations with three SNPs (rs2298849 and rs2282679 in the GC gene, and rs10877012 in the CYP27B1 gene), although only for African Americans. A genotype score, representing the number of risk alleles across the three SNPs, alone accounted for 4.6% of the variation in serum vitamin D among African Americans. A genotype score of 5 (vs. 1) was also associated with a 7.1 ng/mL reduction in serum 25(OH) D levels and a six-fold risk of vitamin D insufficiency (<20 ng/mL) (odds ratio 6.0, p = 0.01) among African Americans. With African ancestry determined from a panel of 276 ancestry informative SNPs, we found that high risk genotypes did not cluster among those with higher African ancestry. This study is one of the first to investigate common genetic variation in relation to vitamin D levels in African Americans, and the first to evaluate how vitamin D-associated genotypes vary in relation to African ancestry. These results suggest that further evaluation of genetic contributors to vitamin D status among African Americans may help provide insights regarding racial health disparities or enable the identification of subgroups especially in need of vitamin D-related interventions.	[Signorello, Lisa B.; Cohen, Sarah S.; Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Signorello, Lisa B.; Shi, Jiajun; Cai, Qiuyin; Zheng, Wei; Long, Jirong; Li, Guoliang; Blot, William J.] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA; [Signorello, Lisa B.; Shi, Jiajun; Cai, Qiuyin; Zheng, Wei; Long, Jirong; Li, Guoliang; Blot, William J.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Williams, Scott M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Div Human Genom, Nashville, TN 37232 USA; [Hollis, Bruce W.] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Smith, Jeffrey R.] Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Medical University of South Carolina; Vanderbilt University	Signorello, LB (corresponding author), Int Epidemiol Inst, Rockville, MD USA.	Lisa@iei.us	zhang, weihua/GXV-1334-2022; Williams, Scott/Q-4812-2019; LI, GUOLIANG/E-7359-2015; Williams, Scott/B-9491-2012; Smith, Jeff/C-3484-2012; Zheng, Wei/O-3351-2013	Williams, Scott/0000-0002-4835-9544; LI, GUOLIANG/0000-0001-8493-4684; Zheng, Wei/0000-0003-1226-070X; Cohen, Sarah/0000-0003-0421-1983; Smith, Jeffrey/0000-0001-8424-910X; Long, Jirong/0000-0002-7433-9766	National Cancer Institute [R01 CA092447]; Komen for the Cure Foundation [OP05-0927-DR1]; Vanderbilt-Ingram Cancer Center [P30 CA68485]; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA092447] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Southern Community Cohort Study is funded by a grant from the National Cancer Institute (R01 CA092447) (www.cancer.gov). Genotyping work was partially supported by a grant from the Komen for the Cure Foundation (OP05-0927-DR1) (ww5.komen.org). Sample preparation and most genotyping was conducted at the Survey and Biospecimen Shared Resource that is supported in part by the Vanderbilt-Ingram Cancer Center (P30 CA68485) (www.cancer.gov). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, CANCER EPIDEM BIOMAR, V17, P1339, DOI 10.1158/1055-9965.EPI-08-0162; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; [Anonymous], STRUCTURE SOFTWARE; Arguelles LM, 2009, J CLIN ENDOCR METAB, V94, P3273, DOI 10.1210/jc.2008-1532; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjamin A, 2009, OSTEOPOROSIS INT, V20, P1795, DOI 10.1007/s00198-009-0873-6; Bu FX, 2010, HUM GENET, V128, P549, DOI 10.1007/s00439-010-0881-9; Buchowski MS, 2003, CELL MOL BIOL, V49, P1295; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chan J, 2010, CANCER CAUSE CONTROL, V21, P501, DOI 10.1007/s10552-009-9481-1; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Egan KM, 2008, CANCER CAUSE CONTROL, V19, P527, DOI 10.1007/s10552-008-9115-z; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Fang Y, 2009, CALCIFIED TISSUE INT, V85, P85, DOI 10.1007/s00223-009-9251-9; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Fu L, 2009, CLIN BIOCHEM, V42, P1174, DOI 10.1016/j.clinbiochem.2009.03.008; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Gozdzik A, 2011, J STEROID BIOCH 0612, V12; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Hypponen E, 2009, ALLERGY, V64, P613, DOI 10.1111/j.1398-9995.2008.01865.x; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950; Kurylowicz A, 2006, EXP CLIN ENDOCR DIAB, V114, P329, DOI 10.1055/s-2006-924256; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCullough ML, 2009, ANNU REV NUTR, V29, P111, DOI 10.1146/annurev-nutr-080508-141248; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Orton SM, 2008, AM J CLIN NUTR, V88, P441, DOI 10.1093/ajcn/88.2.441; Poynter JN, 2010, CANCER EPIDEM BIOMAR, V19, P525, DOI 10.1158/1055-9965.EPI-09-0662; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos-Lopez E, 2008, DIABETES OBES METAB, V10, P683, DOI 10.1111/j.1463-1326.2008.00879.x; Ramos-Lopez E, 2007, DIABETES-METAB RES, V23, P631, DOI 10.1002/dmrr.719; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Signorello LB, 2010, CANCER EPIDEM BIOMAR, V19, P2325, DOI 10.1158/1055-9965.EPI-10-0482; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Signorello LB, 2009, AM J EPIDEMIOL, V170, P104, DOI 10.1093/aje/kwp098; Simon KC, 2010, MULT SCLER J, V16, P133, DOI 10.1177/1352458509355069; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Tiwari HK, 2008, HUM HERED, V66, P67, DOI 10.1159/000119107; Tseng M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-191; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Watanabe RM, 2011, METHODS MOL BIOL, V700, P17, DOI 10.1007/978-1-61737-954-3_2; Wjst M, 2007, J STEROID BIOCHEM, V103, P799, DOI 10.1016/j.jsbmb.2006.12.053; Wjst M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-60; Yanoff LB, 2006, CLIN ENDOCRINOL, V64, P523, DOI 10.1111/j.1365-2265.2006.02502.x	54	89	98	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28623	10.1371/journal.pone.0028623	http://dx.doi.org/10.1371/journal.pone.0028623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205958	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600024
J	Tsuda, K; Yamanaka, K; Linan, W; Miyahara, Y; Akeda, T; Nakanishi, T; Kitagawa, H; Kakeda, M; Kurokawa, I; Shiku, H; Gabazza, EC; Mizutani, H				Tsuda, Kenshiro; Yamanaka, Keiichi; Linan, Wang; Miyahara, Yoshihiro; Akeda, Tomoko; Nakanishi, Takehisa; Kitagawa, Hiroshi; Kakeda, Masato; Kurokawa, Ichiro; Shiku, Hiroshi; Gabazza, Esteban C.; Mizutani, Hitoshi			Intratumoral Injection of Propionibacterium acnes Suppresses Malignant Melanoma by Enhancing Th1 Immune Responses	PLOS ONE			English	Article							REGULATORY T-CELLS; PURIFIED SOLUBLE POLYSACCHARIDE; CORYNEBACTERIUM-PARVUM; ANTITUMOR IMMUNITY; INTERFERON-GAMMA; INTERLEUKIN-12; IMMUNOTHERAPY; TUMORS; MICE; DISEASE	Malignant melanoma ( MM) is an aggressive cutaneous malignancy associated with poor prognosis; many putatively therapeutic agents have been administered, but with mostly unsuccessful results. Propionibacterium acnes ( P. acnes) is an aerotolerant anaerobic gram-positive bacteria that causes acne and inflammation. After being engulfed and processed by phagocytes, P. acnes induces a strong Th1-type cytokine immune response by producing cytokines such as IL-12, IFN-gamma and TNF-alpha. The characteristic Th2-mediated allergic response can be counteracted by Th1 cytokines induced by P. acnes injection. This inflammatory response induced by P. acnes has been suggested to have antitumor activity, but its effect on MM has not been fully evaluated. We analyzed the anti-tumor activity of P. acnes vaccination in a mouse model of MM. Intratumoral administration of P. acnes successfully protected the host against melanoma progression in vivo by inducing both cutaneous and systemic Th1 type cytokine expression, including TNF-alpha and IFN-gamma, which are associated with subcutaneous granuloma formation. P. acnes-treated tumor lesions were infiltrated with TNF-alpha and IFN-gamma positive T cells. In the spleen, TNF-alpha as well as IFN-gamma producing CD8(+) T cells were increased, and interestingly, the number of monocytes was also increased following P. acnes administration. These observations suggest that P. acnes vaccination induces both systemic and local antitumor responses. In conclusion, this study shows that P. acnes vaccination may be a potent therapeutic alternative in MM.	[Tsuda, Kenshiro; Yamanaka, Keiichi; Akeda, Tomoko; Nakanishi, Takehisa; Kitagawa, Hiroshi; Kakeda, Masato; Kurokawa, Ichiro; Mizutani, Hitoshi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan; [Linan, Wang; Miyahara, Yoshihiro; Shiku, Hiroshi] Mie Univ, Grad Sch Med, Dept Immunogene Therapy, Tsu, Mie 514, Japan; [Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University	Tsuda, K (corresponding author), Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan.	yamake@clin.medic.mie-u.ac.jp	Shiku, Hiroshi/U-7321-2019	Kakeda, Masato/0000-0001-9011-3655; Gabazza, Esteban/0000-0001-5748-1499; Nakanishi, Takehisa/0000-0002-4035-1695; Shiku, Hiroshi/0000-0002-0362-755X	Ministry of Education, Culture, Sports, Science and Technology, Japan [23591643, 21591461, 22590859]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Dr. Yamanaka (23591643), Dr. Mizutani (21591461), and Dr. Gabazza (22590859) received grants for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Other authors do not receive any financial support. (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2007, J ALLERGY CLIN IMMUN, V119, P780, DOI 10.1016/j.jaci.2007.01.022; Ananias RZ, 2007, SCAND J IMMUNOL, V65, P538, DOI 10.1111/j.1365-3083.2007.01939.x; Scutti JAB, 2011, TRANSL ONCOL, V4, P101, DOI 10.1593/tlo.10250; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Daud AI, 2011, CANCER CHEMOTH PHARM, V67, P657, DOI 10.1007/s00280-010-1326-9; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; DeMatos P, 1998, J SURG ONCOL, V68, P79, DOI 10.1002/(SICI)1096-9098(199806)68:2<79::AID-JSO3>3.0.CO;2-H; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; KELLER R, 1991, INT J CANCER, V49, P796, DOI 10.1002/ijc.2910490526; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Kitagawa H, 2011, EXP DERMATOL, V20, P157, DOI 10.1111/j.1600-0625.2010.01180.x; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; LIPTON A, 1991, J CLIN ONCOL, V9, P1151, DOI 10.1200/JCO.1991.9.7.1151; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Morello S, 2011, NEOPLASIA, V13, P365, DOI 10.1593/neo.101628; Romagnani S, 2004, IMMUNOLOGY, V112, P352, DOI 10.1111/j.1365-2567.2004.01925.x; ROOK G, 1992, NATURE, V357, P545, DOI 10.1038/357545a0; Squaiella CC, 2006, IMMUNOBIOLOGY, V211, P105, DOI 10.1016/j.imbio.2005.10.013; Sugisaki H, 2009, J DERMATOL SCI, V55, P47, DOI 10.1016/j.jdermsci.2009.02.015; Tsutsui H, 1997, J IMMUNOL, V159, P3961; Yamanaka K, 2009, J ALLERGY CLIN IMMUN, V124, P842, DOI 10.1016/j.jaci.2009.06.020; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35	25	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29020	10.1371/journal.pone.0029020	http://dx.doi.org/10.1371/journal.pone.0029020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216160	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600055
J	Waldorf, KMA; Gravett, MG; McAdams, RM; Paolella, LJ; Gough, GM; Carl, DJ; Bansal, A; Liggitt, HD; Kapur, RP; Reitz, FB; Rubens, CE				Waldorf, Kristina M. Adams; Gravett, Michael G.; McAdams, Ryan M.; Paolella, Louis J.; Gough, G. Michael; Carl, David J.; Bansal, Aasthaa; Liggitt, H. Denny; Kapur, Raj P.; Reitz, Frederick B.; Rubens, Craig E.			Choriodecidual Group B Streptococcal Inoculation Induces Fetal Lung Injury without Intra-Amniotic Infection and Preterm Labor in Macaca nemestrina	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RESPIRATORY-DISTRESS-SYNDROME; AMNIOTIC-FLUID; MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSE; CLINICAL-SIGNIFICANCE; BRONCHOPULMONARY DYSPLASIA; INTRAUTERINE INFECTION; PREMATURE-INFANTS; LAVAGE FLUID	Background: Early events leading to intrauterine infection and fetal lung injury remain poorly defined, but may hold the key to preventing neonatal and adult chronic lung disease. Our objective was to establish a nonhuman primate model of an early stage of chorioamnionitis in order to determine the time course and mechanisms of fetal lung injury in utero. Methodology/Principal Findings: Ten chronically catheterized pregnant monkeys (Macaca nemestrina) at 118-125 days gestation (term = 172 days) received one of two treatments: 1) choriodecidual and intra-amniotic saline (n = 5), or 2) choriodecidual inoculation of Group B Streptococcus (GBS) 1x10(6) colony forming units (n = 5). Cesarean section was performed regardless of labor 4 days after GBS or 7 days after saline infusion to collect fetal and placental tissues. Only two GBS animals developed early labor with no cervical change in the remaining animals. Despite uterine quiescence in most cases, blinded review found histopathological evidence of fetal lung injury in four GBS animals characterized by intraalveolar neutrophils and interstitial thickening, which was absent in controls. Significant elevations of cytokines in amniotic fluid (TNF-alpha, IL-8, IL-1 beta, IL-6) and fetal plasma (IL-8) were detected in GBS animals and correlated with lung injury (p < 0.05). Lung injury was not directly caused by GBS, because GBS was undetectable in amniotic fluid (similar to 10 samples tested/animal), maternal and fetal blood by culture and polymerase chain reaction. In only two cases was GBS cultured from the inoculation site in low numbers. Chorioamnionitis occurred in two GBS animals with lung injury, but two others with lung injury had normal placental histology. Conclusions/Significance: A transient choriodecidual infection can induce cytokine production, which is associated with fetal lung injury without overt infection of amniotic fluid, chorioamnionitis or preterm labor. Fetal lung injury may, thus, occur silently without symptoms and before the onset of the fetal systemic inflammatory response syndrome.	[Waldorf, Kristina M. Adams; Gravett, Michael G.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Gravett, Michael G.; Paolella, Louis J.; Rubens, Craig E.] Global Alliance Prevent Prematur & Stillbirth, Seattle, WA USA; [McAdams, Ryan M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Gough, G. Michael] Washington Natl Primate Res Ctr, Seattle, WA USA; [Carl, David J.] Ross Univ, Sch Med, Portsmouth, Dominica; [Bansal, Aasthaa] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Liggitt, H. Denny] Univ Washington, Dept Comparat Med, Seattle, WA USA; [Kapur, Raj P.] Seattle Childrens, Dept Labs, Seattle, WA USA; [Reitz, Frederick B.] Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA; [Rubens, Craig E.] Seattle Childrens, Div Infect Dis, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.	adamsk@u.washington.edu		Reitz, Frederick/0000-0003-2777-6856	March of Dimes [21-FY06-77]; National Institutes of Health [AI067910]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI067910] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the March of Dimes (21-FY06-77) and the National Institutes of Health (AI067910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BL, 2007, AM J OBSTET GYNECOL, V196, P524; BAGCHI A, 1994, PEDIATR RES, V36, P244, DOI 10.1203/00006450-199408000-00017; Baier RJ, 2004, PEDIATR PULM, V37, P137, DOI 10.1002/ppul.10417; Been JV, 2010, J PEDIATR-US, V156, P10, DOI 10.1016/j.jpeds.2009.07.044; Behrman R.E, 2006, PRETERM BIRTH CAUSES; Borchardt SM, 2004, J CLIN MICROBIOL, V42, P146, DOI 10.1128/JCM.42.1.146-150.2004; Curley AE, 2003, AM J OBSTET GYNECOL, V188, P871, DOI 10.1067/mob.2003.215; Davey A, 2011, EUR RESPIR J, V38, P959, DOI 10.1183/09031936.00032111; Fukunaga S, 2009, PEDIATR PULM, V44, P267, DOI 10.1002/ppul.20993; Ghezzi F, 1998, EUR J OBSTET GYN R B, V78, P5, DOI 10.1016/S0301-2115(97)00236-4; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gomez-Lopez N, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.019; Grigsby PL, 2010, REPROD SCI, V17, P85, DOI 10.1177/1933719109348025; GRONECK P, 1993, PEDIATR RES, V34, P586, DOI 10.1203/00006450-199311000-00006; Hartling L, 2011, ARCH DIS CHILD FETAL; HILLIER SL, 1991, AM J OBSTET GYNECOL, V165, P955, DOI 10.1016/0002-9378(91)90447-Y; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2009, AM J PHYSIOL-LUNG C, V297, pL512, DOI 10.1152/ajplung.00105.2009; KENT ASH, 1994, J REPROD FERTIL, V100, P81; Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49; Kramer BW, 2009, SEMIN FETAL NEONAT M, V14, P2, DOI 10.1016/j.siny.2008.08.011; Kramer BW, 2002, AM J PHYSIOL-LUNG C, V283, pL452, DOI 10.1152/ajplung.00407.2001; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Lee J, 2009, J MATERN-FETAL NEO M, V22, P917, DOI 10.1080/14767050902994705; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Maymon E, 2001, AM J OBSTET GYNECOL, V185, P1149, DOI 10.1067/mob.2001.118165; Morris AE, 2009, AM J PHYSIOL-LUNG C, V297, pL1112, DOI 10.1152/ajplung.00155.2009; Munshi UK, 1997, PEDIATR PULM, V24, P331; Oh KJ, 2009, AM J OBSTET GYNECOL, V201, pS166, DOI 10.1016/j.ajog.2009.10.600; ROJAS MA, 1995, J PEDIATR-US, V126, P605, DOI 10.1016/S0022-3476(95)70362-4; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P813, DOI 10.1016/0002-9378(91)90422-N; ROMERO R, 1989, AM J OBSTET GYNECOL, V160, P1117, DOI 10.1016/0002-9378(89)90172-5; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Schock BC, 2001, PEDIATR RES, V50, P29, DOI 10.1203/00006450-200107000-00008; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Speer Christian P, 2003, Semin Neonatol, V8, P29, DOI 10.1016/S1084-2756(02)00190-2; Speer Christian P, 2009, Neonatology, V95, P353, DOI 10.1159/000209301; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Thomas W, 2011, NEONATOLOGY, V99, P177, DOI 10.1159/000320170; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x; Vadillo-Ortega F, 2002, AM J OBSTET GYNECOL, V186, P128, DOI 10.1067/mob.2002.118916; Van Marter LJ, 2002, J PEDIATR-US, V140, P171, DOI 10.1067/mpd.2002.121381; Waldorf KMA, 2008, REPROD SCI, V15, P121, DOI 10.1177/1933719107310992; Watterberg KL, 1996, PEDIATRICS, V97, P210; WATTS CL, 1992, J PEDIATR-US, V120, P614, DOI 10.1016/S0022-3476(05)82492-8; Yoon BH, 1999, AM J OBSTET GYNECOL, V181, P773, DOI 10.1016/S0002-9378(99)70299-1; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Zaga V, 2004, BIOL REPROD, V71, P1296, DOI 10.1095/biolreprod.104.028621; Zaga-Clavellina V, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-13	55	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28972	10.1371/journal.pone.0028972	http://dx.doi.org/10.1371/journal.pone.0028972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216148	gold, Green Submitted, Green Published			2022-12-25	WOS:000299113600053
J	Wang, T; Molliver, DC; Jing, XT; Schwartz, ES; Yang, FC; Samad, OA; Ma, QF; Davis, BM				Wang, Ting; Molliver, Derek C.; Jing, Xiaotang; Schwartz, Erica S.; Yang, Fu-Chia; Samad, Omar Abdel; Ma, Qiufu; Davis, Brian M.			Phenotypic Switching of Nonpeptidergic Cutaneous Sensory Neurons following Peripheral Nerve Injury	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; GDNF FAMILY LIGANDS; NEUROTROPHIC FACTOR; NEUROPATHIC PAIN; DRG NEURONS; SPINAL-CORD; RECEPTOR COMPONENTS; TRIGEMINAL GANGLION; GENE-EXPRESSION; MESSENGER-RNA	In adult mammals, the phenotype of half of all pain-sensing (nociceptive) sensory neurons is tonically modulated by growth factors in the glial cell line-derived neurotrophic factor (GDNF) family that includes GDNF, artemin (ARTN) and neurturin (NRTN). Each family member binds a distinct GFRa family co-receptor, such that GDNF, NRTN and ARTN bind GFR alpha 1, -alpha 2, and -alpha 3, respectively. Previous studies revealed transcriptional regulation of all three receptors in following axotomy, possibly in response to changes in growth factor availability. Here, we examined changes in the expression of GFR alpha 1-3 in response to injury in vivo and in vitro. We found that after dissociation of adult sensory ganglia, up to 27% of neurons die within 4 days (d) in culture and this can be prevented by nerve growth factor (NGF), GDNF and ARTN, but not NRTN. Moreover, up-regulation of ATF3 (a marker of neuronal injury) in vitro could be prevented by NGF and ARTN, but not by GDNF or NRTN. The lack of NRTN efficacy was correlated with rapid and near-complete loss of GFR alpha 2 immunoreactivity. By retrogradely-labeling cutaneous afferents in vivo prior to nerve cut, we demonstrated that GFR alpha 2-positive neurons switch phenotype following injury and begin to express GFR alpha 3 as well as the capsaicin receptor, transient receptor potential vanilloid 1(TRPV1), an important transducer of noxious stimuli. This switch was correlated with down-regulation of Runtrelated transcription factor 1 (Runx1), a transcription factor that controls expression of GFR alpha 2 and TRPV1 during development. These studies show that NRTN-responsive neurons are unique with respect to their plasticity and response to injury, and suggest that Runx1 plays an ongoing modulatory role in the adult.	[Wang, Ting; Molliver, Derek C.; Jing, Xiaotang; Schwartz, Erica S.; Davis, Brian M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Molliver, Derek C.; Davis, Brian M.] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Wang, Ting; Molliver, Derek C.; Jing, Xiaotang; Davis, Brian M.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Schwartz, Erica S.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA USA; [Wang, Ting; Molliver, Derek C.; Jing, Xiaotang; Schwartz, Erica S.; Davis, Brian M.] Univ Pittsburgh, Pittsburgh Ctr Pain Res, Pittsburgh, PA USA; [Yang, Fu-Chia; Ma, Qiufu] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Yang, Fu-Chia; Ma, Qiufu] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Samad, Omar Abdel] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Yale University	Wang, T (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	bmd1@pitt.edu	samad, omar/K-1921-2012	Davis, Brian/0000-0002-4646-0569; Molliver, Derek/0000-0002-4406-7384	NIH [NS31826, DK063922, NS056122, DEP18025, NS047572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK063922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031826, P01NS047572, R01NS056122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH with the following assignment numbers: NS31826 (BMD), DK063922 (ESS), NS056122 (DCM), DEP18025 and NS047572 (QM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Albers KM, 2006, J NEUROSCI, V26, P2981, DOI 10.1523/JNEUROSCI.4863-05.2006; Averill S, 2004, EUR J NEUROSCI, V19, P1437, DOI 10.1111/j.1460-9568.2004.03241.x; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Baudet C, 2000, DEVELOPMENT, V127, P4335; Bennett DLH, 2006, J PERIPHER NERV SYST, V11, P330, DOI 10.1111/j.1529-8027.2006.00106.x; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bennett DLH, 2000, J NEUROSCI, V20, P427, DOI 10.1523/JNEUROSCI.20-01-00427.2000; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Cao JP, 2008, J COMP NEUROL, V509, P203, DOI 10.1002/cne.21739; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; DAVIES A, 1984, J COMP NEUROL, V223, P124, DOI 10.1002/cne.902230110; Dussor GO, 2003, MOL BRAIN RES, V118, P156, DOI 10.1016/S0169-328X(03)00335-8; Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; ERNFORS P, 1993, MOL BRAIN RES, V17, P217, DOI 10.1016/0169-328X(93)90005-A; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Jankowski MP, 2009, J NEUROSCI, V29, P1636, DOI 10.1523/JNEUROSCI.3474-08.2009; Kalous A, 2007, J COMP NEUROL, V504, P238, DOI 10.1002/cne.21412; Kerr BJ, 1999, J NEUROSCI, V19, P5138; Koerber HR, 2002, PHYSIOL BEHAV, V77, P589, DOI 10.1016/S0031-9384(02)00904-6; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Lindfors PH, 2006, J NEUROSCI, V26, P1953, DOI 10.1523/JNEUROSCI.4065-05.2006; Lu JJ, 2001, NEUROSCI RES, V41, P355, DOI 10.1016/S0168-0102(01)00293-0; Lu SG, 2010, PAIN, V151, P633, DOI 10.1016/j.pain.2010.08.030; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Mendell LM, 1999, MICROSC RES TECHNIQ, V45, P252, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<252::AID-JEMT9>3.0.CO;2-N; Mikaels-Edman A, 2003, DEV DYNAM, V227, P27, DOI 10.1002/dvdy.10280; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; NEGOESCU A, 1994, J HISTOCHEM CYTOCHEM, V42, P433, DOI 10.1177/42.3.7508473; Orozco OE, 2001, EUR J NEUROSCI, V13, P2177, DOI 10.1046/j.0953-816x.2001.01596.x; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Sakai A, 2008, PAIN, V137, P378, DOI 10.1016/j.pain.2007.09.020; Samad OA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-45; Schmutzler BS, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-22; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Stucky CL, 2002, J PHYSIOL-LONDON, V545, P43, DOI 10.1113/jphysiol.2002.027656; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Valdes-Sanchez T, 2010, DEV BIOL, V339, P465, DOI 10.1016/j.ydbio.2010.01.001; VERGE VMK, 1992, J NEUROSCI, V12, P4011; Wang R, 2003, NEUROSCIENCE, V121, P815, DOI 10.1016/S0306-4522(03)00491-3; Wang R, 2008, NAT NEUROSCI, V11, P488, DOI 10.1038/nn2069; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Xiao YY, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-28; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	56	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28908	10.1371/journal.pone.0028908	http://dx.doi.org/10.1371/journal.pone.0028908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216140	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600051
J	Wang, Y; Yang, JK; Lee, OO; Li, TG; Al-Suwailem, A; Danchin, A; Qian, PY				Wang, Yong; Yang, Jiang Ke; Lee, On On; Li, Tie Gang; Al-Suwailem, Abdulaziz; Danchin, Antoine; Qian, Pei-Yuan			Bacterial Niche-Specific Genome Expansion Is Coupled with Highly Frequent Gene Disruptions in Deep-Sea Sediments	PLOS ONE			English	Article							ATLANTIS-II DEEP; RED-SEA; EVOLUTION; ADAPTATION; AMPLIFICATION; DIVERSITY; DYNAMICS; BRINES; TRENDS; SIZE	The complexity and dynamics of microbial metagenomes may be evaluated by genome size, gene duplication and the disruption rate between lineages. In this study, we pyrosequenced the metagenomes of microbes obtained from the brine and sediment of a deep-sea brine pool in the Red Sea to explore the possible genomic adaptations of the microbes in response to environmental changes. The microbes from the brine and sediments (both surface and deep layers) of the Atlantis II Deep brine pool had similar communities whereas the effective genome size varied from 7.4 Mb in the brine to more than 9 Mb in the sediment. This genome expansion in the sediment samples was due to gene duplication as evidenced by enrichment of the homologs. The duplicated genes were highly disrupted, on average by 47.6% and 70% for the surface and deep layers of the Atlantis II Deep sediment samples, respectively. The disruptive effects appeared to be mainly due to point mutations and frameshifts. In contrast, the homologs from the Atlantis II Deep brine sample were highly conserved and they maintained relatively small copy numbers. Likely, the adaptation of the microbes in the sediments was coupled with pseudogenizations and possibly functional diversifications of the paralogs in the expanded genomes. The maintenance of the pseudogenes in the large genomes is discussed.	[Wang, Yong; Yang, Jiang Ke; Lee, On On; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res, Clear Water Bay, Hong Kong, Peoples R China; [Wang, Yong] Chinese Acad Sci, Inst Oceanog, Qingdao, Peoples R China; [Li, Tie Gang; Al-Suwailem, Abdulaziz] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia; [Danchin, Antoine] SAS, AMAbiot, Evry, France; [Danchin, Antoine] CEA Genoscope, Evry, France	Hong Kong University of Science & Technology; Chinese Academy of Sciences; King Abdullah University of Science & Technology; CEA; UDICE-French Research Universities; Universite Paris Saclay	Wang, Y (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res, Clear Water Bay, Hong Kong, Peoples R China.	boqianpy@ust.hk	Danchin, Antoine/F-3745-2018	Danchin, Antoine/0000-0002-6350-5001; wang, yong/0000-0003-3595-3867; Qian, Pei-Yuan/0000-0003-4074-9078	KAUST [SA-C0040/UK-C0016]	KAUST(King Abdullah University of Science & Technology)	This study was supported by KAUST Special Partnership Program (SA-C0040/UK-C0016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AMAbiotics did have a role in the preparation of the manuscript but not in design, data collection or analysis, or decision to publish.	AMANN H, 1982, PHILOS T R SOC A, V307, P377, DOI 10.1098/rsta.1982.0118; Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Anschutz P, 2000, GEOCHIM COSMOCHIM AC, V64, P3995, DOI 10.1016/S0016-7037(00)00486-5; Baani M, 2008, P NATL ACAD SCI USA, V105, P10203, DOI 10.1073/pnas.0702643105; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; BLANC G, 1995, GEOLOGY, V23, P543, DOI 10.1130/0091-7613(1995)023<0543:NSITHB>2.3.CO;2; BOWER AS, 2009, R V OCEANUS VOYAGE 4; Brazelton WJ, 2009, ISME J, V3, P1420, DOI 10.1038/ismej.2009.79; BREWER PG, 1971, NATURE, V231, P37, DOI 10.1038/231037a0; CASJENS S, 2003, ANNU REV GENET, V32, P339; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; CRONAN DS, 1977, GEOLOGICAL SOC LONDO, V7, P80; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; EDLUND T, 1981, NATURE, V292, P269, DOI 10.1038/292269a0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ERICKSON AJ, 1969, HOT BRINES RECENT HE, P114; Ettema TJG, 2009, BIOL LETTERS, V5, P429, DOI 10.1098/rsbl.2008.0793; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Frank AC, 2002, GENETICA, V115, P1; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gurvich E., 2006, METALLIFEROUS SEDIME; Hartmann M, 1998, MAR GEOL, V144, P311, DOI 10.1016/S0025-3227(97)00055-8; Hooper SD, 2003, MOL BIOL EVOL, V20, P945, DOI 10.1093/molbev/msg101; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Liu Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r64; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; MILLER AR, 1966, GEOCHIM COSMOCHIM AC, V30, P341, DOI 10.1016/0016-7037(66)90007-X; Mira A, 2002, CURR OPIN MICROBIOL, V5, P506, DOI 10.1016/S1369-5274(02)00358-2; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Ochman H, 2006, SCIENCE, V311, P1730, DOI 10.1126/science.1119966; Ohno S., 1970, EVOLUTION GENE DUPLI; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; ROMERO D, 1997, ANN REV GENET, V31; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; SIMONEIT BRT, 1992, ORIGINS LIFE EVOL B, V22, P43, DOI 10.1007/BF01808018; SWALLOW JC, 1965, NATURE, V205, P165, DOI 10.1038/205165a0; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Wang Y, 2011, ISME J, V5, P1652, DOI 10.1038/ismej.2011.42	52	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29149	10.1371/journal.pone.0029149	http://dx.doi.org/10.1371/journal.pone.0029149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216192	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600060
J	Yamao, M; Naoki, H; Ishii, S				Yamao, Masataka; Naoki, Honda; Ishii, Shin			Multi-Cellular Logistics of Collective Cell Migration	PLOS ONE			English	Article							MODEL; DYNAMICS; INVASION; PROLIFERATION; MORPHOGENESIS; PROGRESSION; CHEMOTAXIS; TRANSITION; PLASTICITY; MOVEMENT	During development, the formation of biological networks (such as organs and neuronal networks) is controlled by multicellular transportation phenomena based on cell migration. In multi-cellular systems, cellular locomotion is restricted by physical interactions with other cells in a crowded space, similar to passengers pushing others out of their way on a packed train. The motion of individual cells is intrinsically stochastic and may be viewed as a type of random walk. However, this walk takes place in a noisy environment because the cell interacts with its randomly moving neighbors. Despite this randomness and complexity, development is highly orchestrated and precisely regulated, following genetic (and even epigenetic) blueprints. Although individual cell migration has long been studied, the manner in which stochasticity affects multi-cellular transportation within the precisely controlled process of development remains largely unknown. To explore the general principles underlying multicellular migration, we focus on the migration of neural crest cells, which migrate collectively and form streams. We introduce a mechanical model of multi-cellular migration. Simulations based on the model show that the migration mode depends on the relative strengths of the noise from migratory and non-migratory cells. Strong noise from migratory cells and weak noise from surrounding cells causes "collective migration,'' whereas strong noise from non-migratory cells causes "dispersive migration.'' Moreover, our theoretical analyses reveal that migratory cells attract each other over long distances, even without direct mechanical contacts. This effective interaction depends on the stochasticity of the migratory and non-migratory cells. On the basis of these findings, we propose that stochastic behavior at the single-cell level works effectively and precisely to achieve collective migration in multi-cellular systems.	[Yamao, Masataka] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara, Japan; [Naoki, Honda; Ishii, Shin] Kyoto Univ, Grad Sch Informat, Uji, Kyoto, Japan; [Ishii, Shin] RIKEN Computat Sci Res Program, Wako, Saitama, Japan	Nara Institute of Science & Technology; Kyoto University; RIKEN	Yamao, M (corresponding author), Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara, Japan.	n-honda@sys.i.kyoto-u.ac.jp	Naoki, Honda/N-5674-2017; Naoki, Honda/AAW-6284-2020	Naoki, Honda/0000-0001-6816-9126; Naoki, Honda/0000-0001-6816-9126; Ishii, Shin/0000-0001-9385-8230	NAIST; MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan; Japan Society for the Promotion of Science from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan [19-11235]; MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan [100081400012]	NAIST; MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Masataka Yamao was supported by Global COE Program in NAIST (Frontier Biosciences: Strategies for survival and adaptation in a changing global environment), MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan. Honda Naoki was supported by a research fellowship from the Japan Society for the Promotion of Science from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan. Grant number: 19-11235, http://www.jsps.go.jp/j-pd/index.html. Shin Ishii and Honda Naoki were supported by the Next Generation Supercomputing Project (Shin Ishii and Honda Naoki) from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan. Grant number: 100081400012, http://www.nsc.riken.jp/index-eng.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Burstyn-Cohen T, 2004, DEVELOPMENT, V131, P5327, DOI 10.1242/dev.01424; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Couzin ID, 2003, P ROY SOC B-BIOL SCI, V270, P139, DOI 10.1098/rspb.2002.2210; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Dzubiella J, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021402; Eickholt BJ, 1999, DEVELOPMENT, V126, P2181; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; FROJMOVIC M, 1990, BIOPHYS J, V58, P309, DOI 10.1016/S0006-3495(90)82378-X; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; HONDA H, 1978, J THEOR BIOL, V72, P523, DOI 10.1016/0022-5193(78)90315-6; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720; Kulesa PM, 2008, DEV BIOL, V316, P275, DOI 10.1016/j.ydbio.2008.01.029; Kulesa PM, 1998, DEV BIOL, V204, P327, DOI 10.1006/dbio.1998.9082; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Lowengrub JS, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031926; McLennan R, 2007, DEV BIOL, V301, P227, DOI 10.1016/j.ydbio.2006.08.019; Megason SG, 2002, DEVELOPMENT, V129, P2087; Morishita Y, 2008, B MATH BIOL, V70, P1957, DOI 10.1007/s11538-008-9334-1; Murray J, 2008, MATH BIOL SPATIAL MO, V2; Nagatani T, 2002, REP PROG PHYS, V65, P1331, DOI 10.1088/0034-4885/65/9/203; Naoki H, 2008, J THEOR BIOL, V255, P259, DOI 10.1016/j.jtbi.2008.08.012; Naoki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019034; Nishinari K, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036120; Nonaka S, NEURAL NETW IN PRESS; Palsson E, 2000, P NATL ACAD SCI USA, V97, P10448, DOI 10.1073/pnas.97.19.10448; Raz E, 2006, CURR OPIN GENET DEV, V16, P355, DOI 10.1016/j.gde.2006.06.007; Schmidt C, 2007, DEV DYNAM, V236, P2502, DOI 10.1002/dvdy.21260; Shao DY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.108104; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toner J, 1998, PHYS REV E, V58, P4828, DOI 10.1103/PhysRevE.58.4828; Ueda M, 2007, BIOPHYS J, V93, P11, DOI 10.1529/biophysj.106.100263; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Young HM, 2004, DEV BIOL, V270, P455, DOI 10.1016/j.ydbio.2004.03.015	39	35	36	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e27950	10.1371/journal.pone.0027950	http://dx.doi.org/10.1371/journal.pone.0027950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205934	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600006
J	von Klitzing, C; Huss, R; Illert, AL; Froschl, A; Wotzel, S; Peschel, C; Bassermann, F; Duyster, J				von Klitzing, Christine; Huss, Richard; Illert, Anna Lena; Froeschl, Astrid; Woetzel, Sabine; Peschel, Christian; Bassermann, Florian; Duyster, Justus			APC/C-Cdh1-Mediated Degradation of the F-Box Protein NIPA Is Regulated by Its Association with Skp1	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; UBIQUITIN LIGASE ACTIVITY; SUBCELLULAR-LOCALIZATION; MITOTIC ENTRY; YEAST HCT1; PHOSPHORYLATION; CYCLIN; APC; DESTRUCTION; CDC20	NIPA (Nuclear Interaction Partner of Alk kinase) is an F-box like protein that targets nuclear Cyclin B1 for degradation. Integrity and therefore activity of the SCFNIPA E3 ligase is regulated by cell-cycle-dependent phosphorylation of NIPA, restricting substrate ubiquitination to interphase. Here we show that phosphorylated NIPA is degraded in late mitosis in an APC/C-Cdh1-dependent manner. Binding of the unphosphorylated form of NIPA to Skp1 interferes with binding to the APC/C-adaptor protein Cdh1 and therefore protects unphosphorylated NIPA from degradation in interphase. Our data thus define a novel mode of regulating APC/C-mediated ubiquitination.	[von Klitzing, Christine; Huss, Richard; Illert, Anna Lena; Froeschl, Astrid; Woetzel, Sabine; Peschel, Christian; Bassermann, Florian; Duyster, Justus] Tech Univ Munich, Dept Internal Med 3, Munich, Germany	Technical University of Munich; University of Munich	von Klitzing, C (corresponding author), Tech Univ Munich, Dept Internal Med 3, Munich, Germany.	justus.duyster@lrz.tum.de	Illert, Anna L/G-8127-2019		DFG (Deutsch Forschungsgemeinschaft) [SFB456]; German cancer aid	DFG (Deutsch Forschungsgemeinschaft); German cancer aid(Deutsche Krebshilfe)	This work was supported by a DFG (Deutsch Forschungsgemeinschaft, www.dfg.de) grant to J.D. (SFB456). FB is supported by a DFG grant (Emmy Noether Program) and the German cancer aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Araki M, 2005, GENE DEV, V19, P2458, DOI 10.1101/gad.1361905; Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bassermann F, 2007, J BIOL CHEM, V282, P15965, DOI 10.1074/jbc.M610819200; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; Crane R, 2004, J CELL SCI, V117, P5975, DOI 10.1242/jcs.01418; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; DUYSTER J, 1995, P NATL ACAD SCI USA, V92, P1555, DOI 10.1073/pnas.92.5.1555; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Ouyang T, 2003, J BIOL CHEM, V278, P30028, DOI 10.1074/jbc.M300883200; Pfleger CM, 2000, GENE DEV, V14, P655; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	31	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28998	10.1371/journal.pone.0028998	http://dx.doi.org/10.1371/journal.pone.0028998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205987	Green Submitted, gold, Green Published			2022-12-25	WOS:000298666200015
J	Lee, DS; Yoon, WJ; Cho, ES; Kim, HJ; Gronostajski, RM; Cho, MI; Park, JC				Lee, Dong-Seol; Yoon, Won-Joon; Cho, Eui Sic; Kim, Heung-Joong; Gronostajski, Richard M.; Cho, Moon-Il; Park, Joo-Cheol			Crosstalk between Nuclear Factor I-C and Transforming Growth Factor-beta 1 Signaling Regulates Odontoblast Differentiation and Homeostasis	PLOS ONE			English	Article							BETA ACTIVATION ELEMENT; TOOTH ROOT DEVELOPMENT; TRANSCRIPTION; GENE; SMAD; UBIQUITIN; PROTEINS; MICE; DEGRADATION; PROMOTER	Transforming growth factor-beta 1 (TGF-beta 1) signaling plays a key role in vertebrate development, homeostasis, and disease. Nuclear factor I-C (NFI-C) has been implicated in TGF-beta 1 signaling, extracellular matrix gene transcription, and tooth root development. However, the functional relationship between NFI-C and TGF-beta 1 signaling remains uncharacterized. The purpose of this study was to identify the molecular interactions between NFI-C and TGF-beta 1 signaling in mouse odontoblasts. Real-time polymerase chain reaction and western analysis demonstrated that NFI-C expression levels were inversely proportional to levels of TGF-beta 1 signaling molecules during in vitro odontoblast differentiation. Western blot and immunofluorescence results showed that NFI-C was significantly degraded after TGF-beta 1 addition in odontoblasts, and the formation of the Smad3 complex was essential for NFI-C degradation. Additionally, ubiquitination assay results showed that Smurf1 and Smurf2 induced NFI-C degradation and polyubiquitination in a TGF-beta 1-dependent manner. Both kinase and in vitro binding assays revealed that the interaction between NFI-C and Smurf1/Smurf2 requires the activation of the mitogen-activated protein kinase pathway by TGF-beta 1. Moreover, degradation of NFI-C induced by TGF-beta 1 occurred generally in cell types other than odontoblasts in normal human breast epithelial cells. In contrast, NFI-C induced dephosphorylation of p-Smad2/3. These results show that crosstalk between NFI-C and TGF-beta 1 signaling regulates cell differentiation and homeostatic processes in odontoblasts, which might constitute a common cellular mechanism.	[Lee, Dong-Seol; Park, Joo-Cheol] Seoul Natl Univ, Dept Oral Histol Dev Biol, Seoul, South Korea; [Lee, Dong-Seol; Park, Joo-Cheol] Seoul Natl Univ, Dent Res Inst, Sch Dent, Seoul, South Korea; [Yoon, Won-Joon] Seoul Natl Univ, Dept Mol Genet, BK21 Project, Sch Dent, Seoul, South Korea; [Cho, Eui Sic] Chonbuk Natl Univ, Lab Craniofacial Biol, Inst Oral Biosci, Jeon Ju, South Korea; [Kim, Heung-Joong] Chosun Univ, Coll Dent, Dept Oral Anat & Dev Biol, Kwangju, South Korea; [Gronostajski, Richard M.] SUNY Buffalo, Dept Biochem, Program Neurosci, Dev Genom Grp, Buffalo, NY 14214 USA; [Gronostajski, Richard M.] SUNY Buffalo, Sch Med, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA; [Cho, Moon-Il] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Jeonbuk National University; Chosun University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lee, DS (corresponding author), Seoul Natl Univ, Dept Oral Histol Dev Biol, Seoul, South Korea.	jcapark@snu.ac.kr	Park, Joo Cheol/D-6437-2012; Lee, Dong-Seol/GLN-3829-2022	Park, Joo Cheol/0000-0002-3162-7557; 	Korea Research Foundation; Korean Government (MOEHRD) [KRF-2008-314-E00214]; National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University at Korea [2011-0028234]	Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University at Korea(National Research Foundation of Korea)	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD), Basic Research Promotion Fund (KRF-2008-314-E00214) and National Research Foundation of Korea grant No. 2011-0028234 through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University at Korea. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Butler W T, 1995, Connect Tissue Res, V33, P59, DOI 10.3109/03008209509016983; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Luciakova K, 2008, BIOCHEM J, V412, P123, DOI 10.1042/BJ20071440; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Moustakas A, 2001, J CELL SCI, V114, P4359; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Ogata Y, 1997, J CELL BIOCHEM, V65, P501, DOI 10.1002/(SICI)1097-4644(19970615)65:4<501::AID-JCB6>3.0.CO;2-S; Ouellet S, 2006, NUCLEIC ACIDS RES, V34, P6472, DOI 10.1093/nar/gkl861; Plasari G, 2009, MOL CELL BIOL, V29, P6006, DOI 10.1128/MCB.01921-08; RICCIO A, 1992, MOL CELL BIOL, V12, P1846, DOI 10.1128/MCB.12.4.1846; RITZENTHALER JD, 1993, J BIOL CHEM, V268, P13625; RUCH JV, 1995, INT J DEV BIOL, V39, P51; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shu TZ, 2003, J NEUROSCI, V23, P203; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Stefancsik R, 2003, DNA SEQUENCE, V14, P233, DOI 10.1080/1085566031000141126; Thyagarajan T, 2001, J BIOL CHEM, V276, P11016, DOI 10.1074/jbc.M010502200	31	35	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29160	10.1371/journal.pone.0029160	http://dx.doi.org/10.1371/journal.pone.0029160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195013	gold, Green Published, Green Submitted			2022-12-25	WOS:000298664400038
J	Li, F; Mahon, AR; Barnes, MA; Feder, J; Lodge, DM; Hwang, CT; Schafer, R; Ruggiero, ST; Tanner, CE				Li, Frank; Mahon, Andrew R.; Barnes, Matthew A.; Feder, Jeffery; Lodge, David M.; Hwang, Ching-Ting; Schafer, Robert; Ruggiero, Steven T.; Tanner, Carol E.			Quantitative and Rapid DNA Detection by Laser Transmission Spectroscopy	PLOS ONE			English	Article								Laser transmission spectroscopy (LTS) is a quantitative and rapid in vitro technique for measuring the size, shape, and number of nanoparticles in suspension. Here we report on the application of LTS as a novel detection method for species-specific DNA where the presence of one invasive species was differentiated from a closely related invasive sister species. The method employs carboxylated polystyrene nanoparticles functionalized with short DNA fragments that are complimentary to a specific target DNA sequence. In solution, the DNA strands containing targets bind to the tags resulting in a sizable increase in the nanoparticle diameter, which is rapidly and quantitatively measured using LTS. DNA strands that do not contain the target sequence do not bind and produce no size change of the carboxylated beads. The results show that LTS has the potential to become a quantitative and rapid DNA detection method suitable for many real-world applications.	[Li, Frank; Hwang, Ching-Ting; Schafer, Robert; Ruggiero, Steven T.; Tanner, Carol E.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Mahon, Andrew R.; Barnes, Matthew A.; Feder, Jeffery; Lodge, David M.; Hwang, Ching-Ting] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Mahon, Andrew R.; Barnes, Matthew A.; Feder, Jeffery; Lodge, David M.; Hwang, Ching-Ting] Univ Notre Dame, Ctr Aquat Conservat, Notre Dame, IN 46556 USA; [Mahon, Andrew R.] Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA; [Mahon, Andrew R.] Cent Michigan Univ, Inst Great Lakes Res, Mt Pleasant, MI 48859 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; Central Michigan University; Central Michigan University	Li, F (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	ctanner@nd.edu	Lodge, David Michael/AAX-1781-2021; Barnes, Matthew A/K-5113-2012	Barnes, Matthew A/0000-0002-5550-8587; Hwang, Ching-Ting/0000-0001-5223-8975; Mahon, Andrew/0000-0002-5074-8725	NDnano/MIND Center; Office of the Vice President for Research; Departments of Phycis and Biological Sciences; Center for Aquatic Conservation at the University of Notre Dame; Great Lakes Protection Fund [867]; College of Science	NDnano/MIND Center; Office of the Vice President for Research; Departments of Phycis and Biological Sciences; Center for Aquatic Conservation at the University of Notre Dame; Great Lakes Protection Fund; College of Science	The authors wish to acknowledge support from the NDnano/MIND Center, the Office of the Vice President for Research, and College of Science, the Departments of Phycis and Biological Sciences, and the Center for Aquatic Conservation at the University of Notre Dame and the Great Lakes Protection Fund (proposal #867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeissa A, 2010, ACS APPL MATER INTER, V2, P3594, DOI 10.1021/am100780d; Bailey VJ, 2009, GENOME RES, V19, P1455, DOI 10.1101/gr.088831.108; Bangs Laboratories, 2008, 205 BANGS LAB; Basuray S, 2009, ACS NANO, V3, P1823, DOI 10.1021/nn9004632; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bohren C.F., 2000, ABSORPTION SCATTERIN; Chen XJ, 2010, ANAL CHEM, V82, P5958, DOI 10.1021/ac1003135; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Ferapontova EE, 2010, CHEM COMMUN, V46, P1836, DOI 10.1039/b924627d; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; Henegariu O, 2001, BIOTECHNIQUES, V31, P246, DOI 10.2144/01312bm01; Interuniversity Microelectronics Centre (IMEC), 2010, SCIENCEDAILY    1227; Khan HU, 2010, ADV MATER, V22, P4452, DOI 10.1002/adma.201000790; Li F, 2010, APPL OPTICS, V49, P6602, DOI 10.1364/AO.49.006602; Li J, 2003, NANO LETT, V3, P579; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Ma XY, 2003, PHYS MED BIOL, V48, P4165, DOI 10.1088/0031-9155/48/24/013; Mahon AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017280; Mishchenko M. I., 2002, SCATTERING ABSORPTIO; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Rivetti C, 2001, ULTRAMICROSCOPY, V87, P55, DOI 10.1016/S0304-3991(00)00064-4; Stromberg M, 2009, ANAL CHEM, V81, P3398, DOI 10.1021/ac900561r; Tsai CY, 2005, MICROELECTRON ENG, V78-79, P546, DOI 10.1016/j.mee.2004.12.070; Wu J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1035; Yamashita K, 2004, LAB CHIP, V4, P1, DOI 10.1039/b311571b	25	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29224	10.1371/journal.pone.0029224	http://dx.doi.org/10.1371/journal.pone.0029224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195026	Green Submitted, Green Published, gold			2022-12-25	WOS:000298664400042
J	Razaq, A; Nystrom, G; Stromme, M; Mihranyan, A; Nyholm, L				Razaq, Aamir; Nystrom, Gustav; Stromme, Maria; Mihranyan, Albert; Nyholm, Leif			High-Capacity Conductive Nanocellulose Paper Sheets for Electrochemically Controlled Extraction of DNA Oligomers	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; MODULATED LIQUID-CHROMATOGRAPHY; POLYPYRROLE FILMS; STATIONARY-PHASE; CLADOPHORA CELLULOSE; MICRO-EXTRACTION; ADSORPTION; BINDING; POLYMERS; ANIONS	Highly porous polypyrrole (PPy)-nanocellulose paper sheets have been evaluated as inexpensive and disposable electrochemically controlled three-dimensional solid phase extraction materials. The composites, which had a total anion exchange capacity of about 1.1 mol kg(-1), were used for extraction and subsequent release of negatively charged fluorophore tagged DNA oligomers via galvanostatic oxidation and reduction of a 30-50 nm conformal PPy layer on the cellulose substrate. The ion exchange capacity, which was, at least, two orders of magnitude higher than those previously reached in electrochemically controlled extraction, originated from the high surface area (i.e. 80 m(2) g(-1)) of the porous composites and the thin PPy layer which ensured excellent access to the ion exchange material. This enabled the extractions to be carried out faster and with better control of the PPy charge than with previously employed approaches. Experiments in equimolar mixtures of (dT)(6), (dT)(20), and (dT)(40) DNA oligomers showed that all oligomers could be extracted, and that the smallest oligomer was preferentially released with an efficiency of up to 40% during the reduction of the PPy layer. These results indicate that the present material is very promising for the development of inexpensive and efficient electrochemically controlled ion-exchange membranes for batch-wise extraction of biomolecules.	[Razaq, Aamir; Nystrom, Gustav; Stromme, Maria; Mihranyan, Albert] Dept Engn Sci Nanotechnol & Funct Mat, Angstrom Lab, Uppsala, Sweden; [Nyholm, Leif] Dept Mat Chem Uppsala, Angstrom Lab, Uppsala, Sweden		Razaq, A (corresponding author), Dept Engn Sci Nanotechnol & Funct Mat, Angstrom Lab, Uppsala, Sweden.	maria.stromme@angstrom.uu.se; albert.mihranyan@angstrom.uu.se; leif.nyholm@mkem.uu.se	Nystrom, Gustav/J-4383-2013; Nyholm, Leif/E-5360-2011; Nyholm, Leif/ABE-8067-2020	Nystrom, Gustav/0000-0003-2739-3222; Nyholm, Leif/0000-0001-9292-016X; Nyholm, Leif/0000-0001-9292-016X; Mihranyan, Albert/0000-0002-8105-2317	Swedish Foundation for Strategic Research (SSF) [RMA08-0025]; Swedish Research Council (VR) [621-2008-3690, 621-2009-4626]; Higher Education Commission of Pakistan (HEC)	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Research Council (VR)(Swedish Research Council); Higher Education Commission of Pakistan (HEC)(Higher Education Commission of Pakistan)	The work was financially supported by the Swedish Foundation for Strategic Research (SSF) (grant RMA08-0025), the Swedish Research Council (VR) (grants 621-2008-3690 and 621-2009-4626) and the Higher Education Commission of Pakistan (HEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahin Y, 2008, J APPL POLYM SCI, V108, P3298, DOI 10.1002/app.27952; BOYLE A, 1990, J ELECTROANAL CHEM, V279, P179, DOI 10.1016/0022-0728(90)85175-5; Chainet E, 1998, J ELECTROANAL CHEM, V451, P273; CHRISWANTO H, 1993, CHROMATOGRAPHIA, V37, P423, DOI 10.1007/BF02272259; DEINHAMMER RS, 1995, J ELECTROANAL CHEM, V387, P35, DOI 10.1016/0022-0728(95)03879-L; DEINHAMMER RS, 1991, ANAL CHEM, V63, P1889, DOI 10.1021/ac00017a040; Gambhir A, 2001, APPL BIOCHEM BIOTECH, V96, P303; Gbatu TP, 1999, ANAL COMMUN, V36, P203, DOI 10.1039/a901991j; GE HL, 1990, J LIQ CHROMATOGR, V13, P3245, DOI 10.1080/01483919008049099; GE HL, 1991, J CHROMATOGR, V544, P305, DOI 10.1016/S0021-9673(01)83993-5; Geetha S, 2006, ANAL CHIM ACTA, V568, P119, DOI 10.1016/j.aca.2005.10.011; Gelin K, 2009, ELECTROCHIM ACTA, V54, P3394, DOI 10.1016/j.electacta.2009.01.010; Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012; Harnisch JA, 2001, ANALYST, V126, P1841, DOI 10.1039/b105249g; HEINZE J, 2001, ORGANIC ELECTROCHEMI, P1309; Inzelt G., 1994, ELECTROANALYTICAL CH, V18, P89; Inzelt G., 2008, CONDUCTING POLYM NEW; Jiang M, 2001, J ELECTROANAL CHEM, V500, P584, DOI 10.1016/S0022-0728(00)00443-5; Kaykhaii M, 2010, ANAL LETT, V43, P1546, DOI 10.1080/00032711003653809; Lange U, 2008, ANAL CHIM ACTA, V614, P1, DOI 10.1016/j.aca.2008.02.068; Li YF, 2000, ELECTROCHIM ACTA, V45, P1727, DOI 10.1016/S0013-4686(99)00392-8; Liljegren G, 2005, ANALYST, V130, P1358, DOI 10.1039/b508388e; Liljegren G, 2003, ANALYST, V128, P232, DOI 10.1039/b211398h; Liljegren G, 2002, ANALYST, V127, P591, DOI 10.1039/b111381j; Livache T, 1998, ANAL BIOCHEM, V255, P188, DOI 10.1006/abio.1997.2462; Mandal SK, 2004, J NANOSCI NANOTECHNO, V4, P972, DOI 10.1166/jnn.2004.127; Mihranyan A, 2004, INT J PHARMACEUT, V269, P433, DOI 10.1016/j.ijpharm.2003.09.030; Mihranyan A, 2008, J PHYS CHEM B, V112, P12249, DOI 10.1021/jp805123w; MILLER LL, 1986, ABSTR PAP AM CHEM S, V192, P33; Minehan DS, 2001, J MACROMOL SCI PURE, V38, P1245, DOI 10.1081/MA-100108381; MINEHAN DS, 1994, MACROMOLECULES, V27, P777, DOI 10.1021/ma00081a024; Misoska V, 2001, SYNTHETIC MET, V123, P279, DOI 10.1016/S0379-6779(01)00313-7; NAGAOKA T, 1993, J ELECTROANAL CHEM, V350, P337, DOI 10.1016/0022-0728(93)80216-5; Nystrom G, 2009, NANO LETT, V9, P3635, DOI 10.1021/nl901852h; Olsson H, 2011, ELECTROCHEM COMMUN, V13, P869, DOI 10.1016/j.elecom.2011.05.024; PANDE R, 1993, MATER RES SOC SYMP P, V292, P135; Pande R, 1998, BIOMATERIALS, V19, P1657, DOI 10.1016/S0142-9612(98)00043-X; Park DH, 2008, J NANOSCI NANOTECHNO, V8, P5014, DOI 10.1166/jnn.2008.1368; Pawliszyn J., 1997, SOLID PHASE MICROEXT; Tam PD, 2009, J PHYS CONF SER, V187, DOI 10.1088/1742-6596/187/1/012042; Ponton LM, 2004, ANAL CHEM, V76, P5823, DOI 10.1021/ac049257w; Razaq A, 2009, J PHYS CHEM B, V113, P426, DOI 10.1021/jp806517h; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Rubino S, 2010, J PHYS CHEM B, V114, P13644, DOI 10.1021/jp106317p; Saoudi B, 2004, SPECTROSC-INT J, V18, P519, DOI 10.1155/2004/943729; Saoudi B, 1997, J COLLOID INTERF SCI, V192, P269, DOI 10.1006/jcis.1997.5000; Saoudi B, 2000, SENSOR ACTUAT B-CHEM, V62, P35, DOI 10.1016/S0925-4005(99)00356-1; Saoudi B, 1997, SYNTHETIC MET, V87, P97, DOI 10.1016/S0379-6779(96)03812-X; Svirskis D, 2010, ELECTROANAL, V22, P439, DOI 10.1002/elan.200900401; Tamer U, 2005, TALANTA, V67, P245, DOI 10.1016/j.talanta.2005.03.003; Tamer U, 2004, J ELECTROANAL CHEM, V570, P6, DOI 10.1016/j.jelechem.2004.03.010; Wallace GG, 2002, ADV MATER, V14, P953, DOI 10.1002/1521-4095(20020704)14:13/14<953::AID-ADMA953>3.0.CO;2-W; Wu JC, 2002, ANAL CHEM, V74, P4855, DOI 10.1021/ac025595q; Yates BJ, 2002, TALANTA, V58, P739, DOI 10.1016/S0039-9140(02)00376-4; Zanuy D, 2008, J PHYS CHEM B, V112, P3222, DOI 10.1021/jp711010t	55	44	45	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29243	10.1371/journal.pone.0029243	http://dx.doi.org/10.1371/journal.pone.0029243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195031	gold, Green Published, Green Submitted			2022-12-25	WOS:000298370400043
J	Veld, RAGHI; Willemsen, AM; Hubertus, A; van Kampen, C; Bradley, EJ; Baas, F; Pannekoek, Y; van der Ende, A				Veld, Robert Antonius Gerhardus Huis In 'T; Willemsen, Antonius Marcellinus; Hubertus, Antonius; van Kampen, Cornelis; Bradley, Edward John; Baas, Frank; Pannekoek, Yvonne; van der Ende, Arie			Deep Sequencing Whole Transcriptome Exploration of the sigma(E) Regulon in Neisseria meningitidis	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; METHIONINE SULFOXIDE REDUCTASES; MESSENGER-RNA DECAY; TIME RT-PCR; GENE-EXPRESSION; NITRIC-OXIDE; REGULATORY RNA; GROUP-B; IDENTIFICATION; GENOME	Bacteria live in an ever-changing environment and must alter protein expression promptly to adapt to these changes and survive. Specific response genes that are regulated by a subset of alternative sigma(70)-like transcription factors have evolved in order to respond to this changing environment. Recently, we have described the existence of a sigma(E) regulon including the anti-sigma-factor MseR in the obligate human bacterial pathogen Neisseria meningitidis. To unravel the complete sigma(E) regulon in N. meningitidis, we sequenced total RNA transcriptional content of wild type meningococci and compared it with that of mseR mutant cells (Delta mseR) in which sigma(E) is highly expressed. Eleven coding genes and one non-coding gene were found to be differentially expressed between H44/76 wildtype and H44/76 Delta mseR cells. Five of the 6 genes of the sigma(E) operon, msrA/msrB, and the gene encoding a pepSY-associated TM helix family protein showed enhanced transcription, whilst aniA encoding a nitrite reductase and nspA encoding the vaccine candidate Neisserial surface protein A showed decreased transcription. Analysis of differential expression in IGRs showed enhanced transcription of a non-coding RNA molecule, identifying a sigma(E) dependent small non-coding RNA. Together this constitutes the first complete exploration of an alternative sigma-factor regulon in N. meningitidis. The results direct to a relatively small regulon indicative for a strictly defined response consistent with a relatively stable niche, the human throat, where N. meningitidis resides.	[Veld, Robert Antonius Gerhardus Huis In 'T; Pannekoek, Yvonne; van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Willemsen, Antonius Marcellinus; Hubertus, Antonius] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Hubertus, Antonius] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1105 AZ Amsterdam, Netherlands; [Bradley, Edward John; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Reference Lab Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Veld, RAGHI (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.a.g.huisintveld@amc.nl	Baas, Frank/F-9574-2010; van der Ende, Arie/A-4346-2012	Baas, Frank/0000-0003-3912-5428; Pannekoek, Yvonne/0000-0003-1154-652X				Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anjum MF, 2002, J BACTERIOL, V184, P2987, DOI 10.1128/JB.184.11.2987-2993.2002; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhagwat AA, 2003, J MICROBIOL METH, V55, P399, DOI 10.1016/S0167-7012(03)00175-1; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Brooks BE, 2008, BBA-BIOMEMBRANES, V1778, P1930, DOI 10.1016/j.bbamem.2007.06.005; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Delany I, 2006, J BACTERIOL, V188, P2483, DOI 10.1128/JB.188.7.2483-2492.2006; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Fantappie L, 2009, INFECT IMMUN, V77, P1842, DOI 10.1128/IAI.01216-08; Feucht A, 2003, MICROBIOL-SGM, V149, P3023, DOI 10.1099/mic.0.26413-0; Franze de Fernandez M T, 1972, J Biol Chem, V247, P824; FRASCH CE, 1985, REV INFECT DIS, V7, P504; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Gruez A, 2010, J BIOL CHEM, V285, P25033, DOI 10.1074/jbc.M110.134528; Gunesekere IC, 2006, J BACTERIOL, V188, P3463, DOI 10.1128/JB.188.10.3463-3469.2006; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hopman CTP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-164; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Pannekoek Y, 2009, FEMS MICROBIOL LETT, V294, P216, DOI 10.1111/j.1574-6968.2009.01568.x; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Penno C, 2006, MOL MICROBIOL, V62, P1460, DOI 10.1111/j.1365-2958.2006.05456.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piet JR, 2011, J BACTERIOL, V193, P2371, DOI 10.1128/JB.01331-10; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rincon-Enriquez G, 2008, MOL MICROBIOL, V67, P1257, DOI 10.1111/j.1365-2958.2008.06118.x; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rock JD, 2007, J BACTERIOL, V189, P1138, DOI 10.1128/JB.01368-06; SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shaik YB, 2007, J BACTERIOL, V189, P663, DOI 10.1128/JB.01638-06; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sideri TC, 2009, MICROBIOL-SGM, V155, P612, DOI 10.1099/mic.0.022665-0; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thorgersen MP, 2009, MICROBIOL-SGM, V155, P295, DOI 10.1099/mic.0.020727-0; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Udekwu KI, 2007, NUCLEIC ACIDS RES, V35, P1279, DOI 10.1093/nar/gkl1154; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Van der Ende A, 1999, INFECT IMMUN, V67, P2928, DOI 10.1128/IAI.67.6.2928-2934.1999; Viegas SC, 2007, NUCLEIC ACIDS RES, V35, P7651, DOI 10.1093/nar/gkm916; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Yeats C, 2004, TRENDS BIOCHEM SCI, V29, P169, DOI 10.1016/j.tibs.2004.02.004; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29002	10.1371/journal.pone.0029002	http://dx.doi.org/10.1371/journal.pone.0029002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194974	Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400026
J	Wei, Q; Tarighi, S; Dotsch, A; Haussler, S; Musken, M; Wright, VJ; Camara, M; Williams, P; Haenen, S; Boerjan, B; Bogaerts, A; Vierstraete, E; Verleyen, P; Schoofs, L; Willaert, R; De Groote, VN; Michiels, J; Vercammen, K; Crabbe, A; Cornelis, P				Wei, Qing; Tarighi, Saeed; Doetsch, Andreas; Haeussler, Susanne; Muesken, Mathias; Wright, Victoria J.; Camara, Miguel; Williams, Paul; Haenen, Steven; Boerjan, Bart; Bogaerts, Annelies; Vierstraete, Evy; Verleyen, Peter; Schoofs, Liliane; Willaert, Ronnie; De Groote, Valerie N.; Michiels, Jan; Vercammen, Ken; Crabbe, Aurelie; Cornelis, Pierre			Phenotypic and Genome-Wide Analysis of an Antibiotic-Resistant Small Colony Variant (SCV) of Pseudomonas aeruginosa	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; CYSTIC-FIBROSIS LUNG; BIOFILM FORMATION; AMINOGLYCOSIDE RESISTANCE; HIGHLY ADHERENT; PHASE VARIATION; EFFLUX SYSTEM; PHOP-PHOQ; INTRINSIC RESISTANCE; GENETIC-DETERMINANTS	Background: Small colony variants (SCVs) are slow-growing bacteria, which often show increased resistance to antibiotics and cause latent or recurrent infections. It is therefore important to understand the mechanisms at the basis of this phenotypic switch. Methodology/Principal Findings: One SCV (termed PAO-SCV) was isolated, showing high resistance to gentamicin and to the cephalosporine cefotaxime. PAO-SCV was prone to reversion as evidenced by emergence of large colonies with a frequency of 10(-5) on media without antibiotics while it was stably maintained in presence of gentamicin. PAO-SCV showed a delayed growth, defective motility, and strongly reduced levels of the quorum sensing Pseudomonas quinolone signal (PQS). Whole genome expression analysis further suggested a multi-layered antibiotic resistance mechanism, including simultaneous over-expression of two drug efflux pumps (MexAB-OprM, MexXY-OprM), the LPS modification operon arnBCADTEF, and the PhoP-PhoQ two-component system. Conversely, the genes for the synthesis of PQS were strongly down-regulated in PAO-SCV. Finally, genomic analysis revealed the presence of mutations in phoP and phoQ genes as well as in the mexZ gene encoding a repressor of the mexXY and mexAB-oprM genes. Only one mutation occurred only in REV, at nucleotide 1020 of the tufA gene, a paralog of tufB, both encoding the elongation factor Tu, causing a change of the rarely used aspartic acid codon GAU to the more common GAC, possibly causing an increase of tufA mRNA translation. High expression of phoP and phoQ was confirmed for the SCV variant while the revertant showed expression levels reduced to wild-type levels. Conclusions: By combining data coming from phenotypic, gene expression and proteome analysis, we could demonstrate that resistance to aminoglycosides in one SCV mutant is multifactorial including overexpression of efflux mechanisms, LPS modification and is accompanied by a drastic down-regulation of the Pseudomonas quinolone signal quorum sensing system.	[Wei, Qing; Tarighi, Saeed; Vercammen, Ken; Cornelis, Pierre] Vrije Univ Brussel, Dept Bioengn Sci, VIB Dept Struct Biol, Microbiol Res Grp, Brussels, Belgium; [Doetsch, Andreas; Haeussler, Susanne; Muesken, Mathias] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Haeussler, Susanne; Muesken, Mathias] Helmholtz Ctr Infect Res, Ctr Expt & Clin Infect Res, Hannover, Germany; [Haeussler, Susanne; Muesken, Mathias] Hannover Med Sch, D-3000 Hannover, Germany; [Wright, Victoria J.; Camara, Miguel; Williams, Paul] Univ Nottingham, Ctr Biomol Sci, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Haenen, Steven; Boerjan, Bart; Bogaerts, Annelies; Vierstraete, Evy; Verleyen, Peter; Schoofs, Liliane] Katholieke Univ Leuven, Fac Sci, Louvain, Belgium; [Willaert, Ronnie] Vrije Univ Brussel, VIB Dept Struct Biol, Brussels, Belgium; [De Groote, Valerie N.; Michiels, Jan] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Heverlee, Belgium; [Crabbe, Aurelie] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ USA	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; University of Nottingham; KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; KU Leuven; Arizona State University; Arizona State University-Tempe	Wei, Q (corresponding author), Vrije Univ Brussel, Dept Bioengn Sci, VIB Dept Struct Biol, Microbiol Res Grp, Brussels, Belgium.	pcornel@vub.ac.be	Cornelis, Pierre/H-3058-2019; schoofs, liliane/ABD-2943-2020; Michiels, Jan/F-1601-2010; Pohl, Sarah/B-3102-2016; Häussler, Susanne/I-2605-2014; Tarighi, Saeed/AAA-2987-2020; Dötsch, Andreas/H-1383-2013; Williams, Paul/P-5224-2019; Dötsch, Andreas/AAL-6015-2020; Williams, Paul/A-5629-2011; Schoofs, Liliane/F-2815-2010	Michiels, Jan/0000-0001-5829-0897; Pohl, Sarah/0000-0003-2655-7037; Häussler, Susanne/0000-0001-6141-9102; Tarighi, Saeed/0000-0003-1021-9877; Dötsch, Andreas/0000-0001-9086-2584; Williams, Paul/0000-0002-1920-5036; Dötsch, Andreas/0000-0001-9086-2584; Camara, Miguel/0000-0003-4585-7385; Willaert, Ronnie/0000-0002-5400-7019; Schoofs, Liliane/0000-0002-1673-432X; Musken, Mathias/0000-0002-5624-1378; Crabbe, Aurelie/0000-0003-3084-4418	FWO Belgium (Fonds voor Wetenschappelijk Onderzoek Vlaanderen); BBSRC UK [BBF0143921]; FEMS; CSC-VUB; Biotechnology and Biological Sciences Research Council [BB/F014392/1] Funding Source: researchfish; BBSRC [BB/F014392/1] Funding Source: UKRI	FWO Belgium (Fonds voor Wetenschappelijk Onderzoek Vlaanderen)(FWO); BBSRC UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FEMS; CSC-VUB; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by two research grants from the FWO Belgium (Fonds voor Wetenschappelijk Onderzoek Vlaanderen) and a grant from BBSRC UK (BBF0143921). QW has a CSC-VUB scholarship and got a FEMS student fellowship to perform experiments in the lab of Dr. Susanne Haussler. BB and AB are research assistants and PV is a postdoctoral researcher of the FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouak W, 2004, MOL PLANT MICROBE IN, V17, P872, DOI 10.1094/MPMI.2004.17.8.872; Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Aendekerk S, 2002, MICROBIOL-SGM, V148, P2371, DOI 10.1099/00221287-148-8-2371; Aires JR, 1999, ANTIMICROB AGENTS CH, V43, P2624, DOI 10.1128/AAC.43.11.2624; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; CORNELIS P, 1989, MOL MICROBIOL, V3, P421, DOI 10.1111/j.1365-2958.1989.tb00187.x; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; De Groote VN, 2009, FEMS MICROBIOL LETT, V297, P73, DOI 10.1111/j.1574-6968.2009.01657.x; Dean CR, 2003, ANTIMICROB AGENTS CH, V47, P972, DOI 10.1128/AAC.47.3.972-978.2003; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2006, INT J MED MICROBIOL, V296, P83, DOI 10.1016/j.ijmm.2006.01.038; Dotsch A, 2009, ANTIMICROB AGENTS CH, V53, P2522, DOI 10.1128/AAC.00035-09; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fletcher MP, 2007, NAT PROTOC, V2, P1254, DOI 10.1038/nprot.2007.158; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Gooderham WJ, 2009, MICROBIOL-SGM, V155, P699, DOI 10.1099/mic.0.024554-0; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Hammarlof DL, 2008, MOL MICROBIOL, V70, P1194, DOI 10.1111/j.1365-2958.2008.06472.x; Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hocquet D, 2003, ANTIMICROB AGENTS CH, V47, P1371, DOI 10.1128/AAC.47.4.1371-1375.2003; Hung RJ, 2007, J BIOL CHEM, V282, P17738, DOI 10.1074/jbc.M701824200; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; Kinscherf TG, 1999, J BACTERIOL, V181, P4133, DOI 10.1128/JB.181.13.4133-4136.1999; Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kwon DH, 2006, ANTIMICROB AGENTS CH, V50, P1615, DOI 10.1128/AAC.50.5.1615-1622.2006; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li XZ, 2003, ANTIMICROB AGENTS CH, V47, P27, DOI 10.1128/AAC.47.1.27-33.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Macfarlane ELA, 2000, MICROBIOL-SGM, V146, P2543, DOI 10.1099/00221287-146-10-2543; Macfarlane ELA, 1999, MOL MICROBIOL, V34, P305, DOI 10.1046/j.1365-2958.1999.01600.x; Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P2242, DOI 10.1128/AAC.44.9.2242-2246.2000; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; MULCAHY LR, 2010, J BACTERIOL; NELSON LK, 2010, MICROBIOLOGY; Nestorovich EM, 2006, J BIOL CHEM, V281, P16230, DOI 10.1074/jbc.M600650200; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Poole Keith, 2002, Current Pharmaceutical Biotechnology, V3, P77, DOI 10.2174/1389201023378454; Poon KKH, 2008, J BACTERIOL, V190, P1857, DOI 10.1128/JB.01546-07; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Sanchez-Contreras M, 2002, J BACTERIOL, V184, P1587, DOI 10.1128/JB.184.6.1587-1596.2002; Schneider M, 2008, J CLIN MICROBIOL, V46, P1832, DOI 10.1128/JCM.00361-08; Schurek KN, 2008, ANTIMICROB AGENTS CH, V52, P4213, DOI 10.1128/AAC.00507-08; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Swift S, 1997, J BACTERIOL, V179, P5271, DOI 10.1128/jb.179.17.5271-5281.1997; Tamber S, 2006, J BACTERIOL, V188, P45, DOI 10.1128/JB.188.1.45-54.2006; Tarighi S, 2008, MICROBIOL-SGM, V154, P2979, DOI 10.1099/mic.0.2008/018465-0; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Turner KH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000779; van den Broek D, 2005, MICROBIOL-SGM, V151, P1403, DOI 10.1099/mic.0.27777-0; van den Broek D, 2005, J BACTERIOL, V187, P593, DOI 10.1128/JB.187.2.593-600.2005; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Vogne C, 2004, ANTIMICROB AGENTS CH, V48, P1676, DOI 10.1128/AAC.48.5.1676-1680.2004; von Gotz F, 2004, J BACTERIOL, V186, P3837, DOI 10.1128/JB.186.12.3837-3847.2004; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Williams P, 2006, INT J MED MICROBIOL, V296, P57, DOI 10.1016/j.ijmm.2006.01.034; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; YAMANO Y, 1993, MOL MICROBIOL, V8, P993, DOI 10.1111/j.1365-2958.1993.tb01643.x; Yamano Y, 1998, FEMS MICROBIOL LETT, V162, P31, DOI 10.1111/j.1574-6968.1998.tb12975.x; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	88	58	60	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29276	10.1371/journal.pone.0029276	http://dx.doi.org/10.1371/journal.pone.0029276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195037	gold, Green Published, Green Submitted			2022-12-25	WOS:000298370400046
J	Haft, DH; Varghese, N				Haft, Daniel H.; Varghese, Neha			GlyGly-CTERM and Rhombosortase: A C-Terminal Protein Processing Signal in a Many-to-One Pairing with a Rhomboid Family Intramembrane Serine Protease	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BIOLOGICAL FUNCTIONS; SURFACE-PROTEINS; PROTEOLYSIS; GENOMES; MODEL; MOTIF	The rhomboid family of serine proteases occurs in all domains of life. Its members contain at least six hydrophobic membrane-spanning helices, with an active site serine located deep within the hydrophobic interior of the plasma membrane. The model member GlpG from Escherichia coli is heavily studied through engineered mutant forms, varied model substrates, and multiple X-ray crystal studies, yet its relationship to endogenous substrates is not well understood. Here we describe an apparent membrane anchoring C-terminal homology domain that appears in numerous genera including Shewanella, Vibrio, Acinetobacter, and Ralstonia, but excluding Escherichia and Haemophilus. Individual genomes encode up to thirteen members, usually homologous to each other only in this C-terminal region. The domain's tripartite architecture consists of motif, transmembrane helix, and cluster of basic residues at the protein C-terminus, as also seen with the LPXTG recognition sequence for sortase A and the PEP-CTERM recognition sequence for exosortase. Partial Phylogenetic Profiling identifies a distinctive rhomboid-like protease subfamily almost perfectly co-distributed with this recognition sequence. This protease subfamily and its putative target domain are hereby renamed rhombosortase and GlyGly-CTERM, respectively. The protease and target are encoded by consecutive genes in most genomes with just a single target, but far apart otherwise. The signature motif of the Rhombo-CTERM domain, often SGGS, only partially resembles known cleavage sites of rhomboid protease family model substrates. Some protein families that have several members with C-terminal GlyGly-CTERM domains also have additional members with LPXTG or PEP-CTERM domains instead, suggesting there may be common themes to the post-translational processing of these proteins by three different membrane protein superfamilies.	[Haft, Daniel H.] J Craig Venter Inst, Dept Bioinformat, Rockville, MD USA; [Varghese, Neha] Georgia Inst Technol, Atlanta, GA 30332 USA	J. Craig Venter Institute; University System of Georgia; Georgia Institute of Technology	Haft, DH (corresponding author), J Craig Venter Inst, Dept Bioinformat, Rockville, MD USA.	haft@jcvi.org		Varghese, Neha/0000-0003-0580-0675	National Human Genome Research Institute [R01 HG004881]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004881] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project has been funded in whole with federal funds from the National Human Genome Research Institute, under grant number R01 HG004881, and National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Haft DH, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-29; HAFT DH, 2011, J BACTERIOL IN PRESS; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Payne SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-460; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Selengut JD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-52; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; SUGANO Y, 1993, APPL ENVIRON MICROB, V59, P1549; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Urban S, 2010, BIOCHEM J, V425, P501, DOI 10.1042/BJ20090861; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	29	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28886	10.1371/journal.pone.0028886	http://dx.doi.org/10.1371/journal.pone.0028886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194940	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100118
J	Huvenne, VAI; Tyler, PA; Masson, DG; Fisher, EH; Hauton, C; Huhnerbach, V; Le Bas, TP; Wolff, GA				Huvenne, Veerle A. I.; Tyler, Paul A.; Masson, Doug G.; Fisher, Elizabeth H.; Hauton, Chris; Huehnerbach, Veit; Le Bas, Timothy P.; Wolff, George A.			A Picture on the Wall: Innovative Mapping Reveals Cold-Water Coral Refuge in Submarine Canyon	PLOS ONE			English	Article							LAST EUROPEAN DEGLACIATION; ARMORICAN MARGIN BAY; DEEP-WATER; SEDIMENT TRANSPORT; TURBIDITE; ATLANTIC; ADJACENT; BIOLOGY; SYSTEMS; BISCAY	Cold-water corals are azooxanthellate species found throughout the ocean at water depths down to 5000 m. They occur in patches, reefs or large mound structures up to 380 m high, and as ecosystem engineers create important habitats for a diverse fauna. However, the majority of these habitats are now within reach of deep-sea bottom trawling. Many have been severely damaged or are under threat, despite recent protection initiatives. Here we present a cold-water coral habitat type that so far has been overlooked - quite literally - and that has received minimal impact from human activities. Vertical and overhanging cliffs in deep-sea canyons, revealed using an innovative approach to marine habitat mapping, are shown to provide the perfect substratum for extensive cold-water coral-based communities. Typical canyon-related processes, including locally enhanced internal tides and focussed downslope organic carbon transport, provide favourable environmental conditions (current regime, food input) to sustain the communities, even outside the optimal depth and density envelopes reported elsewhere in the NE Atlantic. Our findings show that deep-sea canyons can form natural refuges for faunal communities sensitive to anthropogenic disturbance, and have the potential to fulfil the crucial role of larval sources for the recolonisation of damaged sites elsewhere on the margin.	[Huvenne, Veerle A. I.; Masson, Doug G.; Huehnerbach, Veit; Le Bas, Timothy P.] Natl Oceanog Ctr, Southampton, Hants, England; [Tyler, Paul A.; Hauton, Chris] Univ Southampton, Sch Ocean & Earth Sci, Southampton, Hants, England; [Fisher, Elizabeth H.; Wolff, George A.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England	NERC National Oceanography Centre; NERC National Oceanography Centre; University of Southampton; University of Liverpool	Huvenne, VAI (corresponding author), Natl Oceanog Ctr, Southampton, Hants, England.	vaih@noc.ac.uk	Fisher, Elizabeth/B-8802-2011; Wolff, George/B-7982-2018; Le+Bas, Tim/AAP-9805-2020	Fisher, Elizabeth/0000-0002-6124-3618; Wolff, George/0000-0002-9380-1039; Hauton, Chris/0000-0002-2313-4226; Huvenne, Veerle A.I./0000-0001-7135-6360	EU [GOCE-CT-2005-511234, 226354]; European Research Council [258482]; UK NERC (Natural Environment Research Council); NERC [noc010004, noc010011] Funding Source: UKRI; Natural Environment Research Council [noc010004, noc010011] Funding Source: researchfish	EU(European Commission); European Research Council(European Research Council (ERC)European Commission); UK NERC (Natural Environment Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The data were collected and analysed within the framework of the EU FP6 and FP7 projects HERMES (Hotspot Ecosystem Research on the Margins of European Seas, Contract number GOCE-CT-2005-511234) and HERMIONE (Hotspot Ecosystem Research and Man's Impact ON European Seas, Contract number 226354), the European Research Council Starting Grant Project CODEMAP (Complex Deep-Sea Environments: Mapping habitat heterogeneity As Proxy for biodiversity, Starting Grant no: 258482) and with support of the UK NERC (Natural Environment Research Council) OCEANS2025 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CW, 2008, MAR POLICY, V32, P66, DOI 10.1016/j.marpol.2007.04.007; Cairns SD, 2007, B MAR SCI, V81, P311; COWIE GL, 1995, GEOCHIM COSMOCHIM AC, V59, P33, DOI 10.1016/0016-7037(94)00329-K; Cunningham MJ, 2005, SEDIMENT GEOL, V179, P99, DOI 10.1016/j.sedgeo.2005.04.014; Davies AJ, 2010, DEEP-SEA RES PT I, V57, P199, DOI 10.1016/j.dsr.2009.10.012; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; De Mol B, 2007, INT J EARTH SCI, V96, P103, DOI 10.1007/s00531-005-0496-x; De Santo EM, 2007, MAR POLICY, V31, P336, DOI 10.1016/j.marpol.2006.10.001; de Stigter HC, 2007, MAR GEOL, V246, P144, DOI 10.1016/j.margeo.2007.04.011; DEMOL L, 2010, MAR GEOL, V282, P40; Duineveld G, 2001, OCEANOL ACTA, V24, P69, DOI 10.1016/S0399-1784(00)01129-4; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; Freiwald A., 2004, COLD WATER CORAL REE; Huvenne VAI, 2005, ERLANGEN EARTH C SER, P535, DOI 10.1007/3-540-27673-4_27; IOC IHO and BODC, 2003, CENT ED GEBCO DIG AT; Ivanov VV, 2004, PROG OCEANOGR, V60, P47, DOI 10.1016/j.pocean.2003.12.002; Jeffreys RM, 2009, DEEP-SEA RES PT II, V56, P358, DOI 10.1016/j.dsr2.2008.06.012; Joint I, 2001, DEEP-SEA RES PT II, V48, P3049, DOI 10.1016/S0967-0645(01)00032-7; Kiriakoulakis K, 2007, INT J EARTH SCI, V96, P159, DOI 10.1007/s00531-006-0078-6; Kiriakoulakis K, 2004, DEEP-SEA RES PT I, V51, P1937, DOI 10.1016/j.dsr.2004.07.010; Lavaleye M, 2009, OCEANOGRAPHY, V22, P76, DOI 10.5670/oceanog.2009.08; Masson DG, 2010, GEOLOGY, V38, P831, DOI 10.1130/G30895.1; Mienis F, 2006, MAR GEOL, V233, P1, DOI 10.1016/j.margeo.2006.08.003; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Orejas C, 2009, MAR ECOL PROG SER, V397, P37, DOI 10.3354/meps08314; Pollard RT, 1996, PROG OCEANOGR, V37, P167, DOI 10.1016/S0079-6611(96)00008-0; Reveillaud J, 2008, FACIES, V54, P317, DOI 10.1007/s10347-008-0138-4; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Toucanne S, 2008, MAR GEOL, V247, P84, DOI 10.1016/j.margeo.2007.08.006; VANROOIJ D, 2010, DEEP SEA RES, V1; Vetter EW, 1998, DEEP-SEA RES PT II, V45, P25, DOI 10.1016/S0967-0645(97)00048-9; Waller RG, 2005, CORAL REEFS, V24, P514, DOI 10.1007/s00338-005-0501-7; Wheeler AJ, 2005, ERLANGEN EARTH C SER, P393, DOI 10.1007/3-540-27673-4_19; White M, 2010, EARTH PLANET SC LETT, V296, P395, DOI 10.1016/j.epsl.2010.05.025; Young I. T., 1995, FUNDAMENTALS IMAGE P; Zaragosi S, 2006, GEO-MAR LETT, V26, P317, DOI 10.1007/s00367-006-0048-9	37	121	122	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28755	10.1371/journal.pone.0028755	http://dx.doi.org/10.1371/journal.pone.0028755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194903	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000298369100091
J	Jarosik, V; Pysek, P; Foxcroft, LC; Richardson, DM; Rouget, M; MacFadyen, S				Jarosik, Vojtech; Pysek, Petr; Foxcroft, Llewellyn C.; Richardson, David M.; Rouget, Mathieu; MacFadyen, Sandra			Predicting Incursion of Plant Invaders into Kruger National Park, South Africa: The Interplay of General Drivers and Species-Specific Factors	PLOS ONE			English	Article							INVASIVE ALIEN PLANTS; BIOLOGICAL INVASIONS; NATURE-RESERVES; RISK-ASSESSMENT; PATTERNS; FRAMEWORK; RANGE; CLASSIFICATION; SUCCESS; SEARCH	Background: Overcoming boundaries is crucial for incursion of alien plant species and their successful naturalization and invasion within protected areas. Previous work showed that in Kruger National Park, South Africa, this process can be quantified and that factors determining the incursion of invasive species can be identified and predicted confidently. Here we explore the similarity between determinants of incursions identified by the general model based on a multispecies assemblage, and those identified by species-specific models. We analyzed the presence and absence of six invasive plant species in 1.0x1.5 km segments along the border of the park as a function of environmental characteristics from outside and inside the KNP boundary, using two data-mining techniques: classification trees and random forests. Principal Findings: The occurrence of Ageratum houstonianum, Chromolaena odorata, Xanthium strumarium, Argemone ochroleuca, Opuntia stricta and Lantana camara can be reliably predicted based on landscape characteristics identified by the general multispecies model, namely water runoff from surrounding watersheds and road density in a 10 km radius. The presence of main rivers and species-specific combinations of vegetation types are reliable predictors from inside the park. Conclusions: The predictors from the outside and inside of the park are complementary, and are approximately equally reliable for explaining the presence/absence of current invaders; those from the inside are, however, more reliable for predicting future invasions. Landscape characteristics determined as crucial predictors from outside the KNP serve as guidelines for management to enact proactive interventions to manipulate landscape features near the KNP to prevent further incursions. Predictors from the inside the KNP can be used reliably to identify high-risk areas to improve the cost-effectiveness of management, to locate invasive plants and target them for eradication.	[Jarosik, Vojtech; Pysek, Petr] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Jarosik, Vojtech; Pysek, Petr] Acad Sci Czech Republ, Inst Bot, Dept Invas Ecol, CS-25243 Pruhonice, Czech Republic; [Foxcroft, Llewellyn C.; MacFadyen, Sandra] S African Natl Pk, Conservat Serv, Skukuza, South Africa; [Foxcroft, Llewellyn C.; Richardson, David M.] Univ Stellenbosch, Ctr Invas Biol, Dept Bot & Zool, ZA-7600 Stellenbosch, South Africa; [Rouget, Mathieu] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Stellenbosch University; University of Pretoria	Jarosik, V (corresponding author), Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic.	jarosik@cesnet.cz	Richardson, David M/A-1495-2008; Rouget, Mathieu/B-7249-2008; Pysek, Petr/B-1957-2012	Richardson, David M/0000-0001-9574-8297; Rouget, Mathieu/0000-0003-1836-7727; Rouget, Mathieu/0000-0002-6172-3152	Ministry of Education, Youth and Sports of the Czech Republic [557 MSM0021620828]; Academy of Sciences of the Czech Republic [AV0Z60050516]; Academy of Sciences of the Czech Republic; DST-NRF Centre of Excellence for Invasion Biology; NRF; Stellenbosch University; South African National Parks	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); DST-NRF Centre of Excellence for Invasion Biology(Department of Science & Technology (India)); NRF; Stellenbosch University; South African National Parks	VJ and PP were funded by long-term research plans nos. 557 MSM0021620828 from the Ministry of Education, Youth and Sports of the Czech Republic, and AV0Z60050516 from the Academy of Sciences of the Czech Republic. PP acknowledges support by Praemium Academiae award from the Academy of Sciences of the Czech Republic. LCF and DMR acknowledge support from the DST-NRF Centre of Excellence for Invasion Biology. LCF acknowledges support from the NRF incentive fund, and Stellenbosch University, for rated researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank South African National Parks for support to conduct this study.	Alston KP, 2006, BIOL CONSERV, V132, P183, DOI 10.1016/j.biocon.2006.03.023; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bourg NA, 2005, ECOLOGY, V86, P2793, DOI 10.1890/04-1666; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BREIMAN L, 2004, RANDOMFORESTS IMPLEM; Breiman L., 2017, CLASSIFICATION REGRE; Cadenasso ML, 2003, BIOSCIENCE, V53, P750, DOI 10.1641/0006-3568(2003)053[0750:AFFATO]2.0.CO;2; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Chytry M, 2005, PRESLIA, V77, P339; Chytry M, 2008, ECOLOGY, V89, P1541, DOI 10.1890/07-0682.1; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Chytry M, 2009, PRESLIA, V81, P187; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Foxcroft L. C., 2008, Plant invasions: human perception, ecological impacts and management, P387; Foxcroft LC, 2004, DIVERS DISTRIB, V10, P427, DOI 10.1111/j.1366-9516.2004.00117.x; Foxcroft LC, 2008, ENVIRON MANAGE, V41, P32, DOI 10.1007/s00267-007-9027-9; Foxcroft LC, 2007, ORYX, V41, P160, DOI 10.1017/S0030605307001871; Foxcroft LC, 2007, CONSERV BIOL, V21, P412, DOI 10.1111/j.1523-1739.2007.00673.x; Foxcroft LC, 2011, CONSERV BIOL, V25, P400, DOI 10.1111/j.1523-1739.2010.01617.x; Foxcroft LC, 2009, DIVERS DISTRIB, V15, P367, DOI 10.1111/j.1472-4642.2008.00544.x; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gertenbach W.P.D., 1984, Koedoe, V26, P9; Hejda M, 2009, GLOBAL ECOL BIOGEOGR, V18, P372, DOI 10.1111/j.1466-8238.2009.00445.x; Hochachka WM, 2007, J WILDLIFE MANAGE, V71, P2427, DOI 10.2193/2006-503; Hui C, 2011, J APPL ECOL, V48, P768, DOI 10.1111/j.1365-2664.2011.01974.x; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Jarosik V, 2011, ENCY BIOL INVASIONS, P104; Koenig R, 2009, SCIENCE, V325, P562, DOI 10.1126/science.325_562; Kruger JM, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i2.1010; Lambdon PW, 2008, PRESLIA, V80, P101; MACFADYEN S, 2005, KRUGER NATL PARK CYB; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Meek CS, 2010, BIOL CONSERV, V143, P156, DOI 10.1016/j.biocon.2009.09.021; Millennium Ecosystem Assessment (MA), 2005, ECOSYSTEMS HUMAN WEL; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Pysek P, 2002, BIOL CONSERV, V104, P13, DOI 10.1016/S0006-3207(01)00150-1; Pysek P, 2003, CONSERV BIOL, V17, P1414, DOI 10.1046/j.1523-1739.2003.02248.x; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Pysek P, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P66; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Pysek P, 2010, GLOBAL ECOL BIOGEOGR, V19, P317, DOI 10.1111/j.1466-8238.2009.00514.x; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Steinberg D., 2006, CART 6 0 USERS MANUA; STEINBERG G, 1997, CART CLASSIFICATION; STEINBERG G, 1995, CART TREE STRUCTURED; Stohlgren TJ, 2006, PRESLIA, V78, P405; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; USHER MB, 1988, BIOL CONSERV, V44, P119, DOI 10.1016/0006-3207(88)90007-9; Van Wilgen BW, 2007, FRESHWATER BIOL, V52, P711, DOI 10.1111/j.1365-2427.2006.01711.x; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Vila M, 2007, J VEG SCI, V18, P35, DOI 10.1111/j.1654-1103.2007.tb02513.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x; Wilson JRU, 2011, DIVERS DISTRIB, V17, P1030, DOI 10.1111/j.1472-4642.2011.00815.x	60	16	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28711	10.1371/journal.pone.0028711	http://dx.doi.org/10.1371/journal.pone.0028711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194893	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100083
J	Kutyshenko, VP; Molchanov, M; Beskaravayny, P; Uversky, VN; Timchenko, MA				Kutyshenko, Viktor P.; Molchanov, Maxim; Beskaravayny, Peter; Uversky, Vladimir N.; Timchenko, Maria A.			Analyzing and Mapping Sweat Metabolomics by High-Resolution NMR Spectroscopy	PLOS ONE			English	Article							FREE FATTY-ACIDS; MAGNETIC-RESONANCE; STRATUM-CORNEUM; GLAND-FUNCTION; ECCRINE SWEAT; BIOLOGY; GENERATION; DISORDERS; URINE	The content of human sweat is studied by high-resolution NMR, and the majority of organic components most often found in sweat of conditionally healthy people are identified. Original and simple tools are designed for sweat sampling from different areas of human body. The minimal surface area needed for sampling is in the range of 50-100 cm(2). On all the surface parts of the human body examined in this work, the main constituents forming a sweat metabolic profile are lactate, glycerol, pyruvate, and serine. The only exception is the sole of the foot (planta pedis), where trace amounts of glycerol are found. An attempt is made to explain the presence of specified metabolites and their possible origin.	[Kutyshenko, Viktor P.; Molchanov, Maxim; Beskaravayny, Peter; Timchenko, Maria A.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Moscow Region, Russia; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia; [Uversky, Vladimir N.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Russian Academy of Sciences; State University System of Florida; University of South Florida	Kutyshenko, VP (corresponding author), Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Moscow Region, Russia.	kutyshenko@rambler.ru; vuversky@health.usf.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857	Russian Foundation for Basic Research [10-02-00996-a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by a grant from Russian Foundation for Basic Research (10-02-00996-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram HC, 2009, ANAL CHEM, V81, P9188, DOI 10.1021/ac9020598; Bollard ME, 2005, NMR BIOMED, V18, P143, DOI 10.1002/nbm.935; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; Embden G, 1910, BIOCHEM Z, V28, P230; Feingold KR, 2007, J LIPID RES, V48, P2529, DOI 10.1194/jlr.E700004-JLR200; Fluhr JW, 2001, J INVEST DERMATOL, V117, P44, DOI 10.1046/j.0022-202x.2001.01399.x; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Harker M, 2006, METABOLOMICS, V2, P105, DOI 10.1007/s11306-006-0024-4; Haugen CO, 1928, AM J PHYSIOL, V85, P224, DOI 10.1152/ajplegacy.1928.85.2.224; HIER SW, 1946, J BIOL CHEM, V166, P327; JOKURA Y, 1995, J INVEST DERMATOL, V104, P806, DOI 10.1111/1523-1747.ep12607005; Kutyshenko VP, 2008, DOKL BIOCHEM BIOPHYS, V422, P270, DOI 10.1134/S1607672908050062; Kutyshenko VP, 2008, DOKL BIOCHEM BIOPHYS, V420, P99, DOI 10.1134/S1607672908030010; Kutyshenko V P, 2006, Dokl Biochem Biophys, V410, P300, DOI 10.1134/S1607672906050139; Lenz EM, 2004, J PHARMACEUT BIOMED, V36, P841, DOI 10.1016/j.jpba.2004.08.002; LIAPPIS N, 1979, EUR J APPL PHYSIOL, V42, P227, DOI 10.1007/BF00423292; Malina L, 2003, Cas Lek Cesk, V142, P470; McSWINEY B. A., 1934, PROC ROY SOC MED, V27, P839; Mechin MC, 2005, CELL MOL LIFE SCI, V62, P1984, DOI 10.1007/s00018-005-5196-y; Mickelsen O, 1943, J BIOL CHEM, V149, P479; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; MOSHER HH, 1932, AM DYESTUFF REPTR, V21, P341; Rieg S, 2006, J INVEST DERMATOL, V126, P354, DOI 10.1038/sj.jid.5700041; SATO K, 1989, J AM ACAD DERMATOL, V20, P713, DOI 10.1016/S0190-9622(89)70081-5; SATO K, 1989, J AM ACAD DERMATOL, V20, P537, DOI 10.1016/S0190-9622(89)70063-3; Schuette CG, 2001, GLYCOBIOLOGY, V11, p81R, DOI 10.1093/glycob/11.6.81R; Schwarz Thomas, 2005, Keio Journal of Medicine, V54, P165, DOI 10.2302/kjm.54.165; SHALITA AR, 1974, J INVEST DERMATOL, V62, P332, DOI 10.1111/1523-1747.ep12724289; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; van Kuilenburg ABP, 2004, BIOCHEM J, V379, P119, DOI 10.1042/BJ20031463; Wilke K., 2007, International Journal of Cosmetic Science, V29, P169, DOI 10.1111/j.1467-2494.2007.00387.x; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007	32	58	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28824	10.1371/journal.pone.0028824	http://dx.doi.org/10.1371/journal.pone.0028824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194922	Green Submitted, gold, Green Published			2022-12-25	WOS:000298369100106
J	Maia, J; Dekkers, BJW; Provart, NJ; Ligterink, W; Hilhorst, HWM				Maia, Julio; Dekkers, Bas J. W.; Provart, Nicholas J.; Ligterink, Wilco; Hilhorst, Henk W. M.			The Re-Establishment of Desiccation Tolerance in Germinated Arabidopsis thaliana Seeds and Its Associated Transcriptome	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA SEEDS; METABOLIC PATHWAYS; GENE-EXPRESSION; SOMATIC EMBRYOS; HYBRIDIZATION; MECHANISMS; INDUCTION; RESOURCE; GENOMICS; RADICLES	The combination of robust physiological models with "omics" studies holds promise for the discovery of genes and pathways linked to how organisms deal with drying. Here we used a transcriptomics approach in combination with an in vivo physiological model of re-establishment of desiccation tolerance (DT) in Arabidopsis thaliana seeds. We show that the incubation of desiccation sensitive (DS) germinated Arabidopsis seeds in a polyethylene glycol (PEG) solution re-induces the mechanisms necessary for expression of DT. Based on a SNP-tile array gene expression profile, our data indicates that the reestablishment of DT, in this system, is related to a programmed reversion from a metabolic active to a quiescent state similar to prior to germination. Our findings show that transcripts of germinated seeds after the PEG-treatment are dominated by those encoding LEA, seed storage and dormancy related proteins. On the other hand, a massive repression of genes belonging to many other classes such as photosynthesis, cell wall modification and energy metabolism occurs in parallel. Furthermore, comparison with a similar system for Medicago truncatula reveals a significant overlap between the two transcriptomes. Such overlap may highlight core mechanisms and key regulators of the trait DT. Taking into account the availability of the many genetic and molecular resources for Arabidopsis, the described system may prove useful for unraveling DT in higher plants.	[Maia, Julio; Dekkers, Bas J. W.; Ligterink, Wilco; Hilhorst, Henk W. M.] Wageningen Univ, Lab Plant Physiol, Wageningen Seed Lab, Wageningen, Netherlands; [Dekkers, Bas J. W.] Univ Utrecht, Dept Mol Plant Physiol, Utrecht, Netherlands; [Provart, Nicholas J.] Univ Toronto, Dept Cell & Syst Biol, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	Wageningen University & Research; Utrecht University; University of Toronto	Maia, J (corresponding author), Wageningen Univ, Lab Plant Physiol, Wageningen Seed Lab, Wageningen, Netherlands.	wilco.ligterink@wur.nl	Hilhorst, Henk/K-1658-2013; Ligterink, Wilco/C-8103-2009	Ligterink, Wilco/0000-0002-0228-169X; hilhorst, henk/0000-0002-6743-583X	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); ERA-NET Plant Genomics; Wageningen University	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ERA-NET Plant Genomics; Wageningen University(European Commission)	This work was supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; J.M.), the ERA-NET Plant Genomics grant vSEED (B.J.W.D.) and by Wageningen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelovici R, 2010, TRENDS PLANT SCI, V15, P211, DOI 10.1016/j.tplants.2010.01.003; ATTREE SM, 1992, PLANTA, V187, P395, DOI 10.1007/BF00195664; Berjak P, 2006, SEED SCI RES, V16, P1, DOI 10.1079/SSR2005236; BEWLEY J. D, 2013, SEEDS, V3, DOI [DOI 10.1007/978-1-4614-4693-4_1, 10.1017/S0960258513000287]; Black M, 1999, PLANT PHYSIOL, V120, P463, DOI 10.1104/pp.120.2.463; Boudet J, 2006, PLANT PHYSIOL, V140, P1418, DOI 10.1104/pp.105.074039; BRUGGINK T, 1995, SEED SCI RES, V5, P1, DOI 10.1017/S096025850000252X; Buitink J, 2003, SEED SCI RES, V13, P273, DOI 10.1079/SSR2003145; Buitink J, 2008, CR BIOL, V331, P788, DOI 10.1016/j.crvi.2008.08.002; Buitink J, 2006, PLANT J, V47, P735, DOI 10.1111/j.1365-313X.2006.02822.x; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Daws MI, 2007, SEED SCI RES, V17, P273, DOI 10.1017/S0960258507837755; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faria JMR, 2005, J EXP BOT, V56, P2119, DOI 10.1093/jxb/eri210; Farrant JM, 2000, PLANT ECOL, V151, P29, DOI 10.1023/A:1026534305831; Illing N, 2005, INTEGR COMP BIOL, V45, P771, DOI 10.1093/icb/45.5.771; ISTA, 2009, INT RUL SEED TEST; JOOSEN RVL, 2011, VISUALIZATION MOL PR, P1; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829; Leopold A. C., 1986, MEMBRANES METABOLISM, p[23, 23]; Leprince O, 2010, PLANT SCI, V179, P554, DOI 10.1016/j.plantsci.2010.02.011; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Moore JP, 2008, PHYSIOL PLANTARUM, V134, P237, DOI 10.1111/j.1399-3054.2008.01134.x; Moore JP, 2009, TRENDS PLANT SCI, V14, P110, DOI 10.1016/j.tplants.2008.11.007; Nakashima K, 2006, PLANT MOL BIOL, V60, P51, DOI 10.1007/s11103-005-2418-5; Ntuli TM, 2009, J INTEGR PLANT BIOL, V51, P1002, DOI 10.1111/j.1744-7909.2009.00875.x; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Oliver MJ, 2009, PHYSIOL PLANTARUM, V136, P437, DOI 10.1111/j.1399-3054.2009.01245.x; Oliver MJ, 2005, INTEGR COMP BIOL, V45, P788, DOI 10.1093/icb/45.5.788; Oliver MJ, 2000, PLANT ECOL, V151, P85, DOI 10.1023/A:1026550808557; Phillips Jonathan R., 2002, P319, DOI 10.1079/9780851995342.0319; RODRIGUEZ MCS, 2010, PLANT J CELL MOL BIO, P212; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sreedhar L, 2002, ANN BOT-LONDON, V89, P391, DOI 10.1093/aob/mcf057; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; VIEIRA CV, 2010, PLANT GROWTH REGULAT; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538	39	86	86	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29123	10.1371/journal.pone.0029123	http://dx.doi.org/10.1371/journal.pone.0029123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195004	gold, Green Submitted, Green Published			2022-12-25	WOS:000298369100158
J	Shimada, Y; Shikano, T; Kuparinen, A; Gonda, A; Leinonen, T; Merila, J				Shimada, Yukinori; Shikano, Takahito; Kuparinen, Anna; Gonda, Abigel; Leinonen, Tuomas; Merila, Juha			Quantitative Genetics of Body Size and Timing of Maturation in Two Nine-Spined Stickleback (Pungitius pungitius) Populations	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT GENES; SEXUAL-MATURITY; LIFE-HISTORY; NATURAL-POPULATIONS; ATLANTIC SALMON; G-MATRIX; EVOLUTION; SELECTION; AGE; GROWTH	Due to its influence on body size, timing of maturation is an important life-history trait in ectotherms with indeterminate growth. Comparison of patterns of growth and maturation within and between two populations (giant vs. normal sized) of nine-spined sticklebacks (Pungitius pungitius) in a breeding experiment revealed that the difference in mean adult body size between the populations is caused by differences in timing of maturation, and not by differential growth rates. The fish in small-sized population matured earlier than those from large-sized population, and maturation was accompanied by a reduction in growth rate in the small-sized population. Males matured earlier and at smaller size than females, and the fish that were immature at the end of the experiment were larger than those that had already matured. Throughout the experimental period, body size in both populations was heritable (h(2) = 0.10-0.64), as was the timing of maturation in the small-sized population (h(2) = 0.13-0.16). There was a significant positive genetic correlation between body size and timing of maturation at 140 DAH, but not earlier (at 80 or 110 DAH). Comparison of observed body size divergence between the populations revealed that Q(ST) exceeded F-ST at older ages, indicating adaptive basis for the observed divergence. Hence, the results suggest that the body size differences within and between populations reflect heritable genetic differences in the timing of maturation, and that the observed body size divergence is adaptive.	[Shimada, Yukinori; Shikano, Takahito; Kuparinen, Anna; Gonda, Abigel; Leinonen, Tuomas; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	University of Helsinki	Shimada, Y (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	yukinori.shimada@helsinki.fi	Merila, Juha/A-4061-2008; Shikano, Takahito/D-7347-2015	Merila, Juha/0000-0001-9614-0072; 	Academy of Finland [118673, 134728, 213491, 129662]; University of Helsinki; Japanese Society for Promotion of Science; Finnish National Animal Experiment Board [STH379A]	Academy of Finland(Academy of Finland); University of Helsinki; Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Finnish National Animal Experiment Board	Our research was supported by the Academy of Finland (grant #118673, 134728, 213491 and 129662), University of Helsinki (JM) and Japanese Society for Promotion of Science (TS and YS). The experiments were conducted under the license of the Finnish National Animal Experiment Board (ELLA, #STH379A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019579; Angilletta MJ, 2003, AM NAT, V162, P332; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; Baer CF, 2003, GENET RES, V81, P123, DOI 10.1017/S0016672303006098; BANARESCU PM, 2001, FRESHWATER FISHES EU, V5, P305; Bekkevold D, 2007, MAR ECOL PROG SER, V337, P187, DOI 10.3354/meps337187; Browman HI, 2000, MAR ECOL PROG SER, V208, P299, DOI 10.3354/meps208299; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; CAMPTON DE, 1988, AQUACULTURE, V68, P221, DOI 10.1016/0044-8486(88)90355-9; Cano JM, 2004, EVOLUTION, V58, P2013, DOI 10.1111/j.0014-3820.2004.tb00486.x; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; Fowler K, 2002, P ROY SOC B-BIOL SCI, V269, P677, DOI 10.1098/rspb.2001.1931; GALL GAE, 1983, AQUACULTURE, V33, P383, DOI 10.1016/0044-8486(83)90417-9; GJEDREM T, 1983, AQUACULTURE, V33, P51, DOI 10.1016/0044-8486(83)90386-1; GJERDE B, 1984, AQUACULTURE, V36, P97, DOI 10.1016/0044-8486(84)90057-7; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Green BS, 2008, ADV MAR BIOL, V54, P1, DOI 10.1016/S0065-2881(08)00001-1; Grift RE, 2003, MAR ECOL PROG SER, V257, P247, DOI 10.3354/meps257247; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Herczeg G, 2009, J EVOLUTION BIOL, V22, P544, DOI 10.1111/j.1420-9101.2008.01674.x; Herczeg G, 2010, J ANIM ECOL, V79, P581, DOI 10.1111/j.1365-2656.2010.01665.x; Herczeg G, 2009, EVOLUTION, V63, P3190, DOI 10.1111/j.1558-5646.2009.00781.x; Herczeg G, 2009, ANIM BEHAV, V77, P575, DOI 10.1016/j.anbehav.2008.10.023; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Holderegger R, 2008, PLANT ECOL DIVERS, V1, P273, DOI 10.1080/17550870802338420; HOUDE AE, 1992, HEREDITY, V69, P229, DOI 10.1038/hdy.1992.120; Hutchings JA, 2008, MOL ECOL, V17, P294, DOI 10.1111/j.1365-294X.2007.03485.x; JONSSON B, 1984, OECOLOGIA, V61, P319, DOI 10.1007/BF00379628; Kause A, 2003, AQUACULTURE, V228, P53, DOI 10.1016/S0044-8486(03)00244-8; Knopp T, 2007, CONSERV GENET, V8, P45, DOI 10.1007/s10592-006-9147-4; Kolstad K, 2006, ICES J MAR SCI, V63, P246, DOI 10.1016/j.icesjms.2005.11.007; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kuparinen A, 2008, SCIENCE, V320, P47; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Kuparinen A, 2011, OECOLOGIA, V167, P435, DOI 10.1007/s00442-011-1989-x; Kuusela K, 2006, INT VER THEOR ANGEW, V29, P1409; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Leinonen T, 2011, HEREDITY, V106, P218, DOI 10.1038/hdy.2010.104; Leinonen T, 2011, J EVOLUTION BIOL, V24, P206, DOI 10.1111/j.1420-9101.2010.02161.x; Lynch M, 1999, EVOLUTION, V53, P100, DOI 10.1111/j.1558-5646.1999.tb05336.x; Lynch M., 1998, GENETICS ANAL QUANTI; Mangel M, 1996, EVOL ECOL, V10, P249, DOI 10.1007/BF01237683; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; Moore PJ, 2007, AM NAT, V169, P311, DOI 10.1086/510687; Morita K, 2002, J FISH BIOL, V61, P1230, DOI [10.1006/jfbi.2002.2138, 10.1111/j.1095-8649.2002.tb02467.x]; Morita K, 2006, EVOLUTION, V60, P1516, DOI 10.1111/j.0014-3820.2006.tb01230.x; Mousseau TA, 1998, HEREDITY, V80, P218, DOI 10.1046/j.1365-2540.1998.00269.x; Nakajima M, 2002, AQUACULTURE, V204, P393, DOI 10.1016/S0044-8486(01)00826-2; O'Hara RB, 2005, GENETICS, V171, P1331, DOI 10.1534/genetics.105.044545; OLDORF W, 1989, AQUACULTURE, V77, P123, DOI 10.1016/0044-8486(89)90196-8; Paez DJ, 2011, P ROY SOC B-BIOL SCI, V278, P2150, DOI 10.1098/rspb.2010.2045; Partridge L, 1997, EVOLUTION, V51, P632, DOI 10.1111/j.1558-5646.1997.tb02454.x; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; R Development Core Team, 2009, R FDN STAT COMP; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Reznick DN, 2005, CAN J FISH AQUAT SCI, V62, P791, DOI 10.1139/F05-079; ROBERTSON A, 1952, GENETICS, V37, P188; Roff D, 2000, HEREDITY, V84, P135, DOI 10.1046/j.1365-2540.2000.00695.x; Roff Derek A., 1992; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Sears MW, 2004, INTEGR COMP BIOL, V44, P433, DOI 10.1093/icb/44.6.433; Shikano T, 2010, MOL BIOL EVOL, V27, P2775, DOI 10.1093/molbev/msq167; Shikano T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-334; Shikano T, 2010, MOL ECOL, V19, P1147, DOI 10.1111/j.1365-294X.2010.04553.x; SNYDER RJ, 1991, ENVIRON BIOL FISH, V31, P381, DOI 10.1007/BF00002363; SPITZE K, 1993, GENETICS, V135, P367; Stearns S.C., 1992, pi; STEARNS SC, 1984, EVOLUTION, V38, P368, DOI 10.1111/j.1558-5646.1984.tb00295.x; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; STIBOR H, 1994, FUNCT ECOL, V8, P97, DOI 10.2307/2390117; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Vandeputte M, 2009, AQUACULTURE, V286, P20, DOI 10.1016/j.aquaculture.2008.09.008; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitlock MC, 1999, GENETICS, V152, P345; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x	81	25	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28859	10.1371/journal.pone.0028859	http://dx.doi.org/10.1371/journal.pone.0028859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194929	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100112
J	Soldatini, C; Albores-Barajas, YV; Lovato, T; Andreon, A; Torricelli, P; Montemaggiori, A; Corsa, C; Georgalas, V				Soldatini, Cecilia; Albores-Barajas, Yuri Vladimir; Lovato, Tomas; Andreon, Adriano; Torricelli, Patrizia; Montemaggiori, Alessandro; Corsa, Cosimo; Georgalas, Vyron			Wildlife Strike Risk Assessment in Several Italian Airports: Lessons from BRI and a New Methodology Implementation	PLOS ONE			English	Article							FRAMEWORK; URBAN; SIZE	The presence of wildlife in airport areas poses substantial hazards to aviation. Wildlife aircraft collisions (hereafter wildlife strikes) cause losses in terms of human lives and direct monetary losses for the aviation industry. In recent years, wildlife strikes have increased in parallel with air traffic increase and species habituation to anthropic areas. In this paper, we used an ecological approach to wildlife strike risk assessment to eight Italian international airports. The main achievement is a site-specific analysis that avoids flattening wildlife strike events on a large scale while maintaining comparable airport risk assessments. This second version of the Birdstrike Risk Index (BRI2) is a sensitive tool that provides different time scale results allowing appropriate management planning. The methodology applied has been developed in accordance with the Italian Civil Aviation Authority, which recognizes it as a national standard implemented in the advisory circular ENAC APT-01B.	[Soldatini, Cecilia; Albores-Barajas, Yuri Vladimir; Lovato, Tomas; Torricelli, Patrizia; Georgalas, Vyron] Univ CaFoscari Venice, Dept Environm Sci Informat & Stat, Venice, Italy; [Andreon, Adriano] Aeroporto Venezia Marco Polo SpA SAVE, Venice, Italy; [Montemaggiori, Alessandro] Stn Romana Osservaz Prot Uccelli, Rome, Italy; [Corsa, Cosimo] ENAC Ente Nazl Aviaz Civile, Rome, Italy; [Lovato, Tomas] CMCC Ctr Euromed Cambiamenti Climatici, Bologna, Italy	Universita Ca Foscari Venezia; Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC)	Soldatini, C (corresponding author), Univ CaFoscari Venice, Dept Environm Sci Informat & Stat, Venice, Italy.	cecil@unive.it	Albores-Barajas, Yuri V/C-5042-2009; Soldatini, Cecilia/F-2950-2011; Georgalas, Vyron/G-5845-2011	Albores-Barajas, Yuri V/0000-0002-9255-4865; Soldatini, Cecilia/0000-0002-8112-3162; LOVATO, Tomas/0000-0002-5188-6767	SAVE S.p.A.	SAVE S.p.A.	This project was funded by SAVE S.p.A. SAVE safety manager (Adriano Andreon) provided crucial technical information about safety management also useful for the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish.	Allan J, 2006, RISK ANAL, V26, P723, DOI 10.1111/j.1539-6924.2006.00776.x; BACCETTI N., 2002, RISULTATI CENSIMENTI; Blackwell BF, 2009, LANDSCAPE URBAN PLAN, V93, P1, DOI 10.1016/j.landurbplan.2009.07.005; Dolbeer RA, 2000, WILDLIFE SOC B, V28, P372; Duhem C, 2008, POPUL ECOL, V50, P91, DOI 10.1007/s10144-007-0059-z; Efroymson RA, 2001, RISK ANAL, V21, P251, DOI 10.1111/0272-4332.212109; *ENAC, 2009, GUID EV ATTR SOURC W; *ENAC, 2007, APT01A ENAC; *ENAC, 2010, REL ANN BIRD STRIK C; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Evans KL, 2010, BIOL REV, V85, P643, DOI 10.1111/j.1469-185X.2010.00121.x; Fusani L, 2011, HORM BEHAV, V59, P187, DOI 10.1016/j.yhbeh.2010.11.013; *ICAO, 2009, EB200937 ICAO; *ICAO, 2009, ANNEX 14 CONV INT CI; Mallord JW, 2007, J APPL ECOL, V44, P185, DOI 10.1111/j.1365-2664.2006.01242.x; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Montemaggiori Alessandro, 2009, Alula (Roma), V16, P420; MORGENROTH C, 2003, BIRD AVIATION, V23, P1; Rock Peter, 2005, British Birds, V98, P338; Soldatini C, 2008, ITAL J ZOOL, V75, P295, DOI 10.1080/11250000701884805; Soldatini C, 2010, EUR J WILDLIFE RES, V56, P623, DOI 10.1007/s10344-009-0359-z; Spina F., 2008, ATLANTE MIGRAZIONE U; *STATSOFT I, 2003, STATISTICA DAT AN SO; Thorpe J., 2010, UPDATE FATALITIES DE; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Zakrajsek EJ, 2005, WILDLIFE SOC B, V33, P258, DOI 10.2193/0091-7648(2005)33[258:RTROWS]2.0.CO;2	27	19	19	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28920	10.1371/journal.pone.0028920	http://dx.doi.org/10.1371/journal.pone.0028920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194950	Green Published, gold			2022-12-25	WOS:000298369100126
J	Venkatareddy, M; Cook, L; Abuarquob, K; Verma, R; Garg, P				Venkatareddy, Madhusudan; Cook, Leslie; Abuarquob, Kamal; Verma, Rakesh; Garg, Puneet			Nephrin Regulates Lamellipodia Formation by Assembling a Protein Complex That Includes Ship2, Filamin and Lamellipodin	PLOS ONE			English	Article							KIDNEY SLIT DIAPHRAGM; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; ESCHERICHIA-COLI; 5'-INOSITOL PHOSPHATASE; ACTIN CYTOSKELETON; GLOMERULAR PROTEIN; ADAPTER PROTEIN; CELL-MIGRATION; ALPHA-ACTININ	Actin dynamics has emerged at the forefront of podocyte biology. Slit diaphragm junctional adhesion protein Nephrin is necessary for development of the podocyte morphology and transduces phosphorylation-dependent signals that regulate cytoskeletal dynamics. The present study extends our understanding of Nephrin function by showing in cultured podocytes that Nephrin activation induced actin dynamics is necessary for lamellipodia formation. Upon activation Nephrin recruits and regulates a protein complex that includes Ship2 (SH2 domain containing 5' inositol phosphatase), Filamin and Lamellipodin, proteins important in regulation of actin and focal adhesion dynamics, as well as lamellipodia formation. Using the previously described CD16-Nephrin clustering system, Nephrin ligation or activation resulted in phosphorylation of the actin crosslinking protein Filamin in a p21 activated kinase dependent manner. Nephrin activation in cell culture results in formation of lamellipodia, a process that requires specialized actin dynamics at the leading edge of the cell along with focal adhesion turnover. In the CD16-Nephrin clustering model, Nephrin ligation resulted in abnormal morphology of actin tails in human podocytes when Ship2, Filamin or Lamellipodin were individually knocked down. We also observed decreased lamellipodia formation and cell migration in these knock down cells. These data provide evidence that Nephrin not only initiates actin polymerization but also assembles a protein complex that is necessary to regulate the architecture of the generated actin filament network and focal adhesion dynamics.	[Venkatareddy, Madhusudan; Cook, Leslie; Abuarquob, Kamal; Verma, Rakesh; Garg, Puneet] Univ Michigan, Sch Med, Div Nephrol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Venkatareddy, M (corresponding author), Univ Michigan, Sch Med, Div Nephrol, Ann Arbor, MI 48109 USA.	pungarg@umich.edu		Garg, Puneet/0000-0001-7439-459X	National Institutes of Health [DK081403]; National Kidney Foundation; George O'Brien Kidney Center [P30 DK081943]; MDTRC Cell and Molecular Biology Core NIH [P60 DK020572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK081943, K08DK081403, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; George O'Brien Kidney Center; MDTRC Cell and Molecular Biology Core NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health grant number DK081403 (P. G.) and the National Kidney Foundation Young Investigator Award (P. G.). Support was also obtained from the George O'Brien Kidney Center grant P30 DK081943 and MDTRC Cell and Molecular Biology Core NIH grant P60 DK020572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Campellone KG, 2010, CELL HOST MICROBE, V7, P1, DOI 10.1016/j.chom.2009.12.006; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dyson JM, 2005, INT J BIOCHEM CELL B, V37, P2260, DOI 10.1016/j.biocel.2005.05.003; Dyson JM, 2003, BLOOD, V102, P940, DOI 10.1182/blood-2002-09-2897; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Geier SJ, 1997, BLOOD, V89, P1876, DOI 10.1182/blood.V89.6.1876; Goosney DL, 1999, TRENDS CELL BIOL, V9, P11, DOI 10.1016/S0962-8924(98)01418-4; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Habib T, 1998, J BIOL CHEM, V273, P18605, DOI 10.1074/jbc.273.29.18605; Hamano Y, 2002, J BIOL CHEM, V277, P31154, DOI 10.1074/jbc.M204806200; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Hogan A, 2004, J BIOL CHEM, V279, P53717, DOI 10.1074/jbc.M410654200; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Majerus PW, 1996, GENE DEV, V10, P1051, DOI 10.1101/gad.10.9.1051; MARCHAND JB, 1995, J CELL BIOL, V130, P331, DOI 10.1083/jcb.130.2.331; Martin TFJ, 1997, CURR OPIN NEUROBIOL, V7, P331, DOI 10.1016/S0959-4388(97)80060-8; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; ONJI T, 1987, BIOCHIM BIOPHYS ACTA, V912, P283, DOI 10.1016/0167-4838(87)90099-9; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prasad N, 2002, J CELL SCI, V115, P3807, DOI 10.1242/jcs.00070; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Prasad NK, 2009, INT J ONCOL, V34, P97, DOI 10.3892/ijo_00000133; Prasad NK, 2005, J BIOL CHEM, V280, P13129, DOI 10.1074/jbc.M410289200; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Ravid D, 2008, EXP CELL RES, V314, P2762, DOI 10.1016/j.yexcr.2008.06.004; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sly LM, 2003, EXP HEMATOL, V31, P1170, DOI 10.1016/j.exphem.2003.09.011; Smith K, 2010, CELL HOST MICROBE, V7, P13, DOI 10.1016/j.chom.2009.12.004; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Weiger MC, 2009, J CELL SCI, V122, P313, DOI 10.1242/jcs.037564; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	60	37	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28710	10.1371/journal.pone.0028710	http://dx.doi.org/10.1371/journal.pone.0028710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194892	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100082
J	Xiao, ZM; Liu, WH; Gao, K; Wan, QR; Yang, C; Wang, HL; Wang, XP; Wang, GH; Liu, ZC				Xiao, Zheman; Liu, Wanhong; Gao, Kai; Wan, Qirong; Yang, Can; Wang, Huiling; Wang, Xiaoping; Wang, Gaohua; Liu, Zhongchun			Interaction between CRHR1 and BDNF Genes Increases the Risk of Recurrent Major Depressive Disorder in Chinese Population	PLOS ONE			English	Article							NEUROTROPHIC-FACTOR; ENVIRONMENT INTERACTIONS; VAL66MET POLYMORPHISM; MEDIATED INDUCTION; MOOD DISORDERS; BRAIN; ASSOCIATION; STRESS; ACTIVATION; RECEPTORS	Background: An important etiological hypothesis about depression is stress has neurotoxic effects that damage the hippocampal cells. Corticotropin-releasing hormone (CRH) regulates brain-derived neurotrophic factor (BDNF) expression through influencing cAMP and Ca2+ signaling pathways during the course. The aim of this study is to examine the single and combined effects of CRH receptor 1 (CRHR1) and BDNF genes in recurrent major depressive disorder (MDD). Methodology/Principal Finding: The sample consists of 181 patients with recurrent MDD and 186 healthy controls. Whether genetic variations interaction between CRHR1 and BDNF genes might be associated with increased susceptibility to recurrent MDD was studied by using a gene-based association analysis of single-nucleotide polymorphisms (SNPs). CRHR1 gene (rs1876828, rs242939 and rs242941) and BDNF gene (rs6265) were identified in the samples of patients diagnosed with recurrent MDD and matched controls. Allelic association between CRHR1 rs242939 and recurrent MDD was found in our sample (allelic: p = 0.018, genotypic: p = 0.022) with an Odds Ratio 0.454 (95% CI 0.266-0.775). A global test of these four haplotypes showed a significant difference between recurrent MDD group and control group (chi-2 = 13.117, df = 3, P = 0.016. Furthermore, BDNF and CRHR1 interactions were found in the significant 2-locus, gene-gene interaction models (p = 0.05) using a generalized multifactor dimensionality reduction (GMDR) method. Conclusion: Our results suggest that an interaction between CRHR1 and BDNF genes constitutes susceptibility to recurrent MDD.	[Xiao, Zheman; Wang, Gaohua; Liu, Zhongchun] Wuhan Univ, Inst Neuropsychiat, Wuhan 430072, Peoples R China; [Liu, Wanhong] Wuhan Univ, Sch Med, Wuhan 430072, Peoples R China; [Gao, Kai; Wan, Qirong; Yang, Can; Wang, Huiling; Wang, Xiaoping; Wang, Gaohua; Liu, Zhongchun] Wuhan Univ, Dept Psychiat, Renmin Hosp, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Xiao, ZM (corresponding author), Wuhan Univ, Inst Neuropsychiat, Wuhan 430072, Peoples R China.	zcliu6@whu.edu.cn	yang, can/GXV-5624-2022		National Natural Science Foundation of China [30971040]; National Key Technology R&D Program of China [2007BAI17B05]; Nature Science Foundation of Hubei Province [2005ABA105]; Youth Talent Foundation of Hubei Province Hygiene Department [QJX2008-23]; Wuhan University, P. R. China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); Nature Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Youth Talent Foundation of Hubei Province Hygiene Department; Wuhan University, P. R. China	This research was supported by the National Natural Science Foundation of China (30971040), National Key Technology R&D Program during the 11th Five-Year of China (2007BAI17B05), Nature Science Foundation of Hubei Province (2005ABA105), Youth Talent Foundation of Hubei Province Hygiene Department (QJX2008-23), the 985 Project of Cognitive and Neural Information Science, Wuhan University, P. R. China within the promotional emphasis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayatti N, 2005, ENDOCRINOLOGY, V146, P1205, DOI 10.1210/en.2004-1154; Botto LD, 2001, AM J EPIDEMIOL, V153, P1016, DOI 10.1093/aje/153.10.1016; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chalmers DT, 1996, TRENDS PHARMACOL SCI, V17, P166, DOI 10.1016/0165-6147(96)81594-X; Duffy A, 2000, J CLIN PSYCHIAT, V61, P630, DOI 10.4088/JCP.v61n0906; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Galter D, 2000, J NEUROSCI RES, V61, P295, DOI 10.1002/1097-4547(20000801)61:3<295::AID-JNR7>3.0.CO;2-4; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Guy W., 1976, ASSESSMENT MANUAL PS, P218, DOI DOI 10.1186/1471-244X-7-7; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Holmans P, 2004, AM J HUM GENET, V74, P1154, DOI 10.1086/421333; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Jiang XY, 2005, NEUROPSYCHOPHARMACOL, V30, P1353, DOI 10.1038/sj.npp.1300703; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lezoualc'h F, 2000, MOL ENDOCRINOL, V14, P147, DOI 10.1210/me.14.1.147; Licinio J, 2004, MOL PSYCHIATR, V9, P1, DOI 10.1038/sj.mp.4001467; Liu ZC, 2007, NEUROSCI LETT, V414, P155, DOI 10.1016/j.neulet.2006.12.013; Liu ZC, 2006, NEUROSCI LETT, V404, P358, DOI 10.1016/j.neulet.2006.06.016; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Oswald P, 2005, EUR NEUROPSYCHOPHARM, V15, P491, DOI 10.1016/j.euroneuro.2005.01.001; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ressler KJ, 2010, AM J MED GENET B, V153B, P812, DOI 10.1002/ajmg.b.31052; Saarelainen T, 2003, J NEUROSCI, V23, P349; Schneider S, 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Schule C, 2006, PSYCHONEUROENDOCRINO, V31, P1019, DOI 10.1016/j.psyneuen.2006.06.002; Schumacher J, 2005, BIOL PSYCHIAT, V58, P307, DOI 10.1016/j.biopsych.2005.04.006; Tsai SJ, 2003, AM J MED GENET B, V123B, P19, DOI 10.1002/ajmg.b.20026; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Zubenko GS, 2001, AM J MED GENET, V105, P690, DOI 10.1002/ajmg.1554	36	27	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28733	10.1371/journal.pone.0028733	http://dx.doi.org/10.1371/journal.pone.0028733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194899	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100088
J	Cordeiro, S; Guseva, D; Wulfsen, I; Bauer, CK				Cordeiro, Soenke; Guseva, Daria; Wulfsen, Iris; Bauer, Christiane K.			Expression Pattern of Kv11 (Ether a-go-go-Related Gene; erg) K+ Channels in the Mouse Retina	PLOS ONE			English	Article							POTASSIUM CHANNELS; PIGMENT EPITHELIUM; MAMMALIAN RETINA; BIPOLAR CELL; COMPONENT; CASCADE; FAMILY	In response to light, most retinal neurons exhibit gradual changes in membrane potential. Therefore K+ channels that mediate threshold currents are well-suited for the fine-tuning of signal transduction. In the present study we demonstrate the expression of the different Kv11 (ether-a-go-go related gene; erg) channel subunits in the human and mouse retina by RT PCR and quantitative PCR, respectively. Immunofluorescence analysis with cryosections of mouse retinae revealed the following local distribution of the three Kv11 subunits: Kv11.1 (m-erg1) displayed the most abundant expression with the strongest immunoreactivity in rod bipolar cells. In addition, immunoreactivity was found in the inner part of the outer plexiform layer (OPL), in the inner plexiform layer (IPL) and in the inner segments of photoreceptors. Immunoreactivity for Kv11.2 (m-erg2) was observed in the outer part of the OPL and throughout the IPL. Double-labeling for vGluT1 or synaptophysin indicated a mainly presynaptic localization of Kv11.2. While no significant staining for Kv11.3 (m-erg3) was detected in the neuronal retina, strong Kv11.3 immunoreactivity was present in the apical membrane of the retinal pigment epithelium. The different expression levels were confirmed by real-time PCR showing almost equal levels of Kv11.1 and Kv11.2, while Kv11.3 mRNA expression was significantly lower. The two main splice variants of Kv11.1, isoforms a and b were detected in comparable levels suggesting a possible formation of cGMP/cGK-sensitive Kv11.1 channels in photoreceptors and rod bipolar cells. Taken together, the immunohistological results revealed different expression patterns of the three Kv11 channels in the mouse retina supposing distinct physiological roles.	[Cordeiro, Soenke; Guseva, Daria] Hannover Med Sch, Inst Neurophysiol, D-30623 Hannover, Germany; [Cordeiro, Soenke] Univ Kiel, Inst Physiol, D-2300 Kiel, Germany; [Wulfsen, Iris] Univ Klinikum Hamburg Eppendorf, Inst Pharmakol Pharmazeuten, Hamburg, Germany; [Wulfsen, Iris; Bauer, Christiane K.] Univ Klinikum Hamburg Eppendorf, Inst Zellulare & Integrat Physiol, Hamburg, Germany	Hannover Medical School; University of Kiel; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Cordeiro, S (corresponding author), Hannover Med Sch, Inst Neurophysiol, D-30623 Hannover, Germany.	c.bauer@uke.uni-hamburg.de	Cordeiro, Soenke/H-9002-2012; Guseva, Daria/S-8582-2018; Guseva, Daria/AAW-2546-2021; Cordeiro, Soenke/A-1782-2012	Cordeiro, Soenke/0000-0002-1049-8303; Bauer, Christiane K./0000-0002-2078-3503; Guseva, PD, PhD, Daria/0000-0002-8844-572X				Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; BEECH DJ, 1989, NEURON, V3, P573, DOI 10.1016/0896-6273(89)90267-5; Feigenspan A, 2009, PFLUG ARCH EUR J PHY, V458, P359, DOI 10.1007/s00424-008-0609-z; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hirdes W, 2009, PFLUG ARCH EUR J PHY, V459, P55, DOI 10.1007/s00424-009-0709-4; Ho WK, 1998, J PHYSIOL-LONDON, V507, P631, DOI 10.1111/j.1469-7793.1998.631bs.x; Jow GM, 2008, NEUROSCI LETT, V431, P12, DOI 10.1016/j.neulet.2007.11.017; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; London B, 1997, CIRC RES, V81, P870; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mewe M, 2010, J MOL CELL CARDIOL, V49, P48, DOI 10.1016/j.yjmcc.2010.02.015; Polvani S, 2003, GENE EXPR PATTERNS, V3, P767, DOI 10.1016/S1567-133X(03)00124-8; Schledermann W, 2001, J PHYSIOL-LONDON, V532, P143, DOI 10.1111/j.1469-7793.2001.0143g.x; Shi WM, 1997, J NEUROSCI, V17, P9423; Shimura M, 2001, J PHYSIOL-LONDON, V531, P329, DOI 10.1111/j.1469-7793.2001.0329i.x; Snellman J, 2004, J NEUROSCI, V24, P6621, DOI 10.1523/JNEUROSCI.1474-04.2004; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sturm P, 2005, J PHYSIOL-LONDON, V564, P329, DOI 10.1113/jphysiol.2004.078840; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wimmers S, 2001, PFLUG ARCH EUR J PHY, V441, P450, DOI 10.1007/s004240000467; Wimmers S, 2007, INVEST OPHTH VIS SCI, V48, P5767, DOI 10.1167/iovs.07-0412	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29490	10.1371/journal.pone.0029490	http://dx.doi.org/10.1371/journal.pone.0029490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206018	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600040
J	Hiller, NL; Eutsey, RA; Powell, E; Earl, JP; Janto, B; Martin, DP; Dawid, S; Ahmed, A; Longwell, MJ; Dahlgren, ME; Ezzo, S; Tettelin, H; Daugherty, SC; Mitchell, TJ; Hillman, TA; Buchinsky, FJ; Tomasz, A; de Lencastre, H; Sa-Leao, R; Post, JC; Hu, FZ; Ehrlich, GD				Hiller, N. Luisa; Eutsey, Rory A.; Powell, Evan; Earl, Joshua P.; Janto, Benjamin; Martin, Darren P.; Dawid, Suzanne; Ahmed, Azad; Longwell, Mark J.; Dahlgren, Margaret E.; Ezzo, Suzanne; Tettelin, Herve; Daugherty, Sean C.; Mitchell, Timothy J.; Hillman, Todd A.; Buchinsky, Farrel J.; Tomasz, Alexander; de Lencastre, Herminia; Sa-Leao, Raquel; Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.			Differences in Genotype and Virulence among Four Multidrug-Resistant Streptococcus pneumoniae Isolates Belonging to the PMEN1 Clone	PLOS ONE			English	Article							CHINCHILLA-LANIGER MODEL; DAY-CARE-CENTERS; HAEMOPHILUS-INFLUENZAE; IN-VIVO; MOLECULAR EPIDEMIOLOGY; ANTIBIOTIC-RESISTANCE; SURFACE-PROTEINS; GENOME SEQUENCE; OTITIS-MEDIA; PAN-GENOME	We report on the comparative genomics and characterization of the virulence phenotypes of four S. pneumoniae strains that belong to the multidrug resistant clone PMEN1 (Spain(23F) ST81). Strains SV35-T23 and SV36-T3 were recovered in 1996 from the nasopharynx of patients at an AIDS hospice in New York. Strain SV36-T3 expressed capsule type 3 which is unusual for this clone and represents the product of an in vivo capsular switch event. A third PMEN1 isolate - PN4595-T23 - was recovered in 1996 from the nasopharynx of a child attending day care in Portugal, and a fourth strain - ATCC700669 - was originally isolated from a patient with pneumococcal disease in Spain in 1984. We compared the genomes among four PMEN1 strains and 47 previously sequenced pneumococcal isolates for gene possession differences and allelic variations within core genes. In contrast to the 47 strains - representing a variety of clonal types - the four PMEN1 strains grouped closely together, demonstrating high genomic conservation within this lineage relative to the rest of the species. In the four PMEN1 strains allelic and gene possession differences were clustered into 18 genomic regions including the capsule, the blp bacteriocins, erythromycin resistance, the MM1-2008 prophage and multiple cell wall anchored proteins. In spite of their genomic similarity, the high resolution chinchilla model was able to detect variations in virulence properties of the PMEN1 strains highlighting how small genic or allelic variation can lead to significant changes in pathogenicity and making this set of strains ideal for the identification of novel virulence determinants.	[Hiller, N. Luisa; Eutsey, Rory A.; Powell, Evan; Earl, Joshua P.; Janto, Benjamin; Ahmed, Azad; Longwell, Mark J.; Dahlgren, Margaret E.; Ezzo, Suzanne; Hillman, Todd A.; Buchinsky, Farrel J.; Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.] Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; [Martin, Darren P.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dawid, Suzanne] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Tettelin, Herve; Daugherty, Sean C.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA; [Mitchell, Timothy J.] Univ Glasgow, Inst Infect Immunol & Inflammat, Glasgow, Lanark, Scotland; [Buchinsky, Farrel J.; Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.] Drexel Univ, Dept Microbiol & Immunol, Coll Med, Pittsburgh, PA USA; [Buchinsky, Farrel J.; Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.] Drexel Univ, Dept Otolaryngol Head & Neck Surg, Coll Med, Pittsburgh, PA USA; [Tomasz, Alexander; de Lencastre, Herminia] Rockefeller Univ, New York, NY 10021 USA; [de Lencastre, Herminia; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Allegheny General Hospital; University of Cape Town; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore; University of Glasgow; Drexel University; Drexel University; Rockefeller University; Universidade Nova de Lisboa	Hiller, NL (corresponding author), Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA.	gehrlich@wpahs.org	Sá-Leão, Raquel/A-9341-2011; Hiller, N. Luisa/A-3739-2016; Martin, Darren/ABE-3614-2021; Buchinsky, Farrel/AAC-2080-2020; Martin, Darren P/C-4599-2008; Dawid, Suzanne/AAP-6564-2020; Janto, Benjamin/E-7459-2010	Sá-Leão, Raquel/0000-0001-9804-827X; Hiller, N. Luisa/0000-0001-6572-1368; Buchinsky, Farrel/0000-0002-2830-6023; Janto, Benjamin/0000-0002-3841-4917; /0000-0001-6816-8932; Tomasz, Alexander/0000-0003-1520-1983; Mitchell, Timothy/0000-0002-8309-5556; Ehrlich, Garth/0000-0003-1140-6594	Allegheny General Hospital, Allegheny Singer Research Institute; HRSA (Health Resources and Services Administration) [C76HF03009, C76HF00659, C76HF09819]; NIH (National Institutes of Health) [AI080935, DC05659, DC02148, DC02148 S1, DC04173]; US Public Health Service [1R01AI080935-01A1]; NIDCD (National Institute on Deafness and Other Communication Disorders) [K99DC011422]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004173, R01DC002148, R01DC005659, R01DC011422] Funding Source: NIH RePORTER	Allegheny General Hospital, Allegheny Singer Research Institute; HRSA (Health Resources and Services Administration); NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NIDCD (National Institute on Deafness and Other Communication Disorders)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Allegheny General Hospital, Allegheny Singer Research Institute; HRSA (Health Resources and Services Administration) grants C76HF03009 (GDE), C76HF00659 (GDE), C76HF09819 (GDE) and NIH (National Institutes of Health) grants AI080935 (GDE), DC05659 (JCP), DC02148 (GDE), DC02148 S1 (GDE), DC04173 (GDE). Partial support was provided by a grant from the US Public Health Service 1R01AI080935-01A1 on which Alexander Tomasz is a Co-PI, as well as NIDCD (National Institute on Deafness and Other Communication Disorders) grant K99DC011422 (NLH). The funders had no role in study design, data collection and analysis, decistion to publish, or preparation of the manuscript.	Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Buchinsky FJ, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-56; Bumbaca D, 2004, OMICS, V8, P341, DOI 10.1089/omi.2004.8.341; Camilli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-25; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Darling Aaron E., 2007, V396, P135; Dawid S, 2007, INFECT IMMUN, V75, P443, DOI 10.1128/IAI.01775-05; de Lencastre H, 2002, J ANTIMICROB CHEMOTH, V50, P75, DOI 10.1093/jac/dkf511; de Saizieu A, 2000, J BACTERIOL, V182, P4696, DOI 10.1128/JB.182.17.4696-4703.2000; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Dybvig K, 1998, P NATL ACAD SCI USA, V95, P13923, DOI 10.1073/pnas.95.23.13923; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feil EJ, 2000, GENETICS, V154, P1439; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Forbes ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001969; GORDON D, 2004, VIEWING EDITING ASSE; Hall BG, 2010, MICROBIOL-SGM, V156, P1060, DOI 10.1099/mic.0.035188-0; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; HERMANS PWM, 2000, STREPTOCOCCUS PNEUMO, P457; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hiller NL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001108; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jedrzejas MJ, 2007, CELL MOL LIFE SCI, V64, P2799, DOI 10.1007/s00018-007-7125-8; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Loeffler JM, 2006, INFECT IMMUN, V74, P4486, DOI 10.1128/IAI.00020-06; Lux T, 2007, J BACTERIOL, V189, P7741, DOI 10.1128/JB.00474-07; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Nesin M, 1998, J INFECT DIS, V177, P707, DOI 10.1086/514242; Obregon V, 2003, J BACTERIOL, V185, P2362, DOI 10.1128/JB.185.7.2362-2368.2003; Overweg K, 2000, INFECT IMMUN, V68, P4604, DOI 10.1128/IAI.68.8.4604-4610.2000; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P3491, DOI 10.1128/AAC.48.9.3491-3497.2004; Reinert RR, 2005, J CLIN MICROBIOL, V43, P1294, DOI 10.1128/JCM.43.3.1294-1300.2005; Rozen S, 2000, Methods Mol Biol, V132, P365; Sa-Leado R, 2008, J CLIN MICROBIOL, V46, P225, DOI 10.1128/JCM.01551-07; Sa-Leao R, 2000, J CLIN MICROBIOL, V38, P4137; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; Son MR, 2011, MBIO IN PRESS; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Vilhelmsson SE, 2000, J CLIN MICROBIOL, V38, P1375, DOI 10.1128/JCM.38.4.1375-1381.2000; Warburton PJ, 2007, J ANTIMICROB CHEMOTH, V60, P973, DOI 10.1093/jac/dkm331; World Health Organizaiton website, 2008, STREPT PNEUM	53	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28850	10.1371/journal.pone.0028850	http://dx.doi.org/10.1371/journal.pone.0028850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205975	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000298665600010
J	Nacer, A; Roux, E; Pomel, S; Scheidig-Benatar, C; Sakamoto, H; Lafont, F; Scherf, A; Mattei, D				Nacer, Adela; Roux, Emeric; Pomel, Sebastien; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Lafont, Frank; Scherf, Artur; Mattei, Denise			clag9 Is Not Essential for PfEMP1 Surface Expression in Non-Cytoadherent Plasmodium falciparum Parasites with a Chromosome 9 Deletion	PLOS ONE			English	Article							MEMBRANE PROTEIN-1 PFEMP1; ERYTHROCYTE-MEMBRANE; CHONDROITIN SULFATE; INFECTED ERYTHROCYTES; ANTIGENIC VARIATION; RED-CELLS; VAR GENES; MALARIA; BINDING; FAMILY	Background: The expression of the clonally variant virulence factor PfEMP1 mediates the sequestration of Plasmodium falciparum infected erythrocytes in the host vasculature and contributes to chronic infection. Non-cytoadherent parasites with a chromosome 9 deletion lack clag9, a gene linked to cytoadhesion in previous studies. Here we present new clag9 data that challenge this view and show that surface the non-cytoadherence phenotype is linked to the expression of a nonfunctional PfEMP1. Methodology/Principal Findings: Loss of adhesion in P. falciparum D10, a parasite line with a large chromosome 9 deletion, was investigated. Surface iodination analysis of non-cytoadherent D10 parasites and COS-7 surface expression of the CD36-binding PfEMP1 CIDR1 alpha domain were performed and showed that these parasites express an unusual trypsin-resistant, nonfunctional PfEMP1 at the erythrocyte surface. However, the CIDR1 alpha domain of this var gene expressed in COS-7 cells showed strong binding to CD36. Atomic Force Microscopy showed a slightly modified D10 knob morphology compared to adherent parasites. Trafficking of PfEMP1 and KAHRP remained functional in D10. We link the non-cytoadherence phenotype to a chromosome 9 breakage and healing event resulting in the loss of 25 subtelomeric genes including clag9. In contrast to previous studies, knockout of the clag9 gene from 3D7 did not interfere with parasite adhesion to CD36. Conclusions/Significance: Our data show the surface expression of non-functional PfEMP1 in D10 strongly indicating that genes other than clag9 deleted from chromosome 9 are involved in this virulence process possibly via post-translational modifications.	[Nacer, Adela; Roux, Emeric; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Scherf, Artur; Mattei, Denise] Inst Pasteur, Biol Parasite Host Interact Unit, Dept Parasitol & Mycol, Paris, France; [Nacer, Adela; Roux, Emeric; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Scherf, Artur; Mattei, Denise] CNRS, URA2581, Paris, France; [Lafont, Frank] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Lafont, Frank] INSERM, U1019, F-59045 Lille, France; [Lafont, Frank] Univ Lille Nord France, Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Nacer, A (corresponding author), Inst Pasteur, Biol Parasite Host Interact Unit, Dept Parasitol & Mycol, Paris, France.	denise.mattei@pasteur.fr	Scherf, Artur/A-9674-2014; Mattei, Denise M/B-1088-2014	Scherf, Artur/0000-0003-2411-3328; Nacer, Adela/0000-0002-5326-7935; Lafont, frank/0000-0001-8668-2580; Sakamoto, Hiroshi/0000-0002-8767-2111	Fondation pour la Recherche Medicale [DMI20091117309]; Conseil Regional Nord Pas-de-Calais	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil Regional Nord Pas-de-Calais(Region Hauts-de-France)	This work was funded by Fondation pour la Recherche Medicale grant number DMI20091117309 and Conseil Regional Nord Pas-de-Calais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS RF, 1983, P NATL ACAD SCI-BIOL, V80, P6652, DOI 10.1073/pnas.80.21.6652; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; CHAIYAROJ SC, 1994, MOL BIOCHEM PARASIT, V67, P21, DOI 10.1016/0166-6851(94)90092-2; CHAIYAROJ SC, 1994, P NATL ACAD SCI USA, V91, P10805, DOI 10.1073/pnas.91.23.10805; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; DEGOWIN RL, 1965, AM J TROP MED HYG, V14, P519, DOI 10.4269/ajtmh.1965.14.519; Dixon MWA, 2011, MOL MICROBIOL, V81, P982, DOI 10.1111/j.1365-2958.2011.07740.x; EPSTEIN N, 1981, J IMMUNOL, V127, P212; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GAY F, 1995, J IMMUNOL METHODS, V184, P15, DOI 10.1016/0022-1759(95)00070-Q; Goel S, 2010, P NATL ACAD SCI USA, V107, P16643, DOI 10.1073/pnas.1002568107; Hanssen E, 2008, MOL MICROBIOL, V69, P938, DOI 10.1111/j.1365-2958.2008.06329.x; HernandezRivas R, 1997, MOL CELL BIOL, V17, P604, DOI 10.1128/MCB.17.2.604; HINTERBERG K, 1994, EXP PARASITOL, V79, P279, DOI 10.1006/expr.1994.1091; JENSEN JB, 1978, AM J TROP MED HYG, V27, P743, DOI 10.4269/ajtmh.1978.27.743; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Miller LH, 2002, MOL BIOCHEM PARASIT, V120, P321, DOI 10.1016/S0166-6851(02)00011-7; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Nowakowski R, 2001, BBA-BIOMEMBRANES, V1514, P170, DOI 10.1016/S0005-2736(01)00365-0; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Rowe JA, 1998, MOL BIOCHEM PARASIT, V92, P177, DOI 10.1016/S0166-6851(97)00237-5; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Smith JD, 1998, MOL BIOCHEM PARASIT, V97, P133, DOI 10.1016/S0166-6851(98)00145-5; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Stowers A, 1995, PARASITE IMMUNOL, V17, P631, DOI 10.1111/j.1365-3024.1995.tb01009.x; TAYLOR DW, 1987, MOL BIOCHEM PARASIT, V25, P165, DOI 10.1016/0166-6851(87)90005-3; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; UDEINYA IJ, 1983, NATURE, V303, P429, DOI 10.1038/303429a0; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Waller KL, 2002, MOL BIOCHEM PARASIT, V119, P125, DOI 10.1016/S0166-6851(01)00395-4; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	51	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29039	10.1371/journal.pone.0029039	http://dx.doi.org/10.1371/journal.pone.0029039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205992	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600024
J	Pohjala, L; Utt, A; Varjak, M; Lulla, A; Merits, A; Ahola, T; Tammela, P				Pohjala, Leena; Utt, Age; Varjak, Margus; Lulla, Aleksei; Merits, Andres; Ahola, Tero; Tammela, Paivi			Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; SINDBIS-VIRUS; IN-VITRO; NONSTRUCTURAL PROTEIN-2; ANTIVIRAL ACTIVITY; GENE-EXPRESSION; NSP2 PROTEINS; RNA-SYNTHESIS; HOST-CELLS; BHK CELLS	Chikungunya virus (CHIKV), an alphavirus, has recently caused epidemic outbreaks and is therefore considered a re-emerging pathogen for which no effective treatment is available. In this study, a CHIKV replicon containing the virus replicase proteins together with puromycin acetyltransferase, EGFP and Renilla luciferase marker genes was constructed. The replicon was transfected into BHK cells to yield a stable cell line. A non-cytopathic phenotype was achieved by a Pro718 to Gly substitution and a five amino acid insertion within non-structural protein 2 (nsP2), obtained through selection for stable growth. Characterization of the replicon cell line by Northern blotting analysis revealed reduced levels of viral RNA synthesis. The CHIKV replicon cell line was validated for antiviral screening in 96-well format and used for a focused screen of 356 compounds (natural compounds and clinically approved drugs). The 5,7-dihydroxyflavones apigenin, chrysin, naringenin and silybin were found to suppress activities of EGFP and Rluc marker genes expressed by the CHIKV replicon. In a concomitant screen against Semliki Forest virus (SFV), their anti-alphaviral activity was confirmed and several additional inhibitors of SFV with IC50 values between 0.4 and 24 mu M were identified. Chlorpromazine and five other compounds with a 10H-phenothiazinyl structure were shown to inhibit SFV entry using a novel entry assay based on a temperature-sensitive SFV mutant. These compounds also reduced SFV and Sindbis virus-induced cytopathic effect and inhibited SFV virion production in virus yield experiments. Finally, antiviral effects of selected compounds were confirmed using infectious CHIKV. In summary, the presented approach for discovering alphaviral inhibitors enabled us to identify potential lead structures for the development of alphavirus entry and replication phase inhibitors as well as demonstrated the usefulness of CHIKV replicon and SFV as biosafe surrogate models for anti-CHIKV screening.	[Pohjala, Leena; Ahola, Tero] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Pohjala, Leena; Tammela, Paivi] Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland; [Pohjala, Leena] Univ Helsinki, Div Pharmaceut Biol, Fac Pharm, Helsinki, Finland; [Utt, Age; Varjak, Margus; Lulla, Aleksei; Merits, Andres] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Helsinki; University of Helsinki; University of Helsinki; University of Tartu	Pohjala, L (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	paivi.tammela@helsinki.fi	Utt, Age/G-6335-2019; Tammela, Päivi/A-4670-2010; Hanski, Leena/AAD-5096-2019; Merits, Andres/H-3125-2015	Utt, Age/0000-0002-6709-2507; Tammela, Päivi/0000-0003-4697-8066; Hanski, Leena/0000-0002-3121-8542; Merits, Andres/0000-0001-8193-0071; Varjak, Margus/0000-0003-2608-5148	European Union [261202 (ICRES)]; Estonian Science Foundation [7407]; European Union via Center of Excellence in Chemical Biology in Estonia; Academy of Finland [127214]; Finnish Cultural Foundation	European Union(European Commission); Estonian Science Foundation; European Union via Center of Excellence in Chemical Biology in Estonia; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	The research leading to these results has received funding from the European Union Seventh Framework Programme under grant agreement nu 261202 (ICRES), from the Estonian Science Foundation grant 7407, and from the European Union through the European Regional Development Fund via Center of Excellence in Chemical Biology in Estonia, as well as from Academy of Finland grant 127214 and Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapov EV, 1998, P NATL ACAD SCI USA, V95, P12989, DOI 10.1073/pnas.95.22.12989; Asres K, 2005, PHYTOTHER RES, V19, P557, DOI 10.1002/ptr.1629; Balistreri G, 2007, J VIROL, V81, P2849, DOI 10.1128/JVI.02078-06; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Briolant S, 2004, ANTIVIR RES, V61, P111, DOI 10.1016/j.antiviral.2003.09.005; Casales E, 2008, VIROLOGY, V376, P242, DOI 10.1016/j.virol.2008.03.016; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049; DECLERCQ E, 1990, BIOCHEM PHARMACOL, V39, P319, DOI 10.1016/0006-2952(90)90031-F; DECLERCQ E, 1985, ANTIMICROB AGENTS CH, V28, P84, DOI 10.1128/AAC.28.1.84; Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685; Dryga SA, 1997, VIROLOGY, V228, P74, DOI 10.1006/viro.1996.8364; FROLOV I, 1994, J VIROL, V68, P1721, DOI 10.1128/JVI.68.3.1721-1727.1994; Frolov I, 1999, J VIROL, V73, P3854, DOI 10.1128/JVI.73.5.3854-3865.1999; Frolov I, 2009, J VIROL, V83, P9031, DOI 10.1128/JVI.00850-09; Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10; Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05; Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107; Gould EA, 2010, ANTIVIR RES, V87, P111, DOI 10.1016/j.antiviral.2009.07.007; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; HELENIUS A, 1982, J GEN VIROL, V58, P47, DOI 10.1099/0022-1317-58-1-47; HUFFMAN JH, 1973, ANTIMICROB AGENTS CH, V3, P235, DOI 10.1128/AAC.3.2.235; Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x; Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003; Leyssen P, 2005, J VIROL, V79, P1943, DOI 10.1128/JVI.79.3.1943-1947.2005; Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841; LILJESTROM P, 1991, J VIROL, V65, P4107; Lulla V, 2006, J VIROL, V80, P3108, DOI 10.1128/JVI.80.6.3108-3111.2006; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906; Perri S, 2000, J VIROL, V74, P9802, DOI 10.1128/JVI.74.20.9802-9807.2000; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Pohjala L, 2008, ANTIVIR RES, V78, P215, DOI 10.1016/j.antiviral.2008.01.001; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987; RIKKONEN M, 1992, VIROLOGY, V189, P462, DOI 10.1016/0042-6822(92)90570-F; Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Sawicki DL, 2006, J VIROL, V80, P360, DOI 10.1128/JVI.80.1.360-371.2006; Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tamm K, 2008, J GEN VIROL, V89, P676, DOI 10.1099/vir.0.83320-0; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	52	170	177	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28923	10.1371/journal.pone.0028923	http://dx.doi.org/10.1371/journal.pone.0028923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205980	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000298665600015
J	Xie, P; Kamei, M; Suzuki, M; Matsumura, N; Nishida, K; Sakimoto, S; Sakaguchi, H; Nishida, K				Xie, Ping; Kamei, Motohiro; Suzuki, Mihoko; Matsumura, Nagakazu; Nishida, Kentaro; Sakimoto, Susumu; Sakaguchi, Hirokazu; Nishida, Kohji			Suppression and Regression of Choroidal Neovascularization in Mice by a Novel CCR2 Antagonist, INCB3344	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHEMOKINE RECEPTOR 2; MACULAR DEGENERATION; SIGNAL-TRANSDUCTION; PHARMACOLOGICAL CHARACTERIZATION; SOD1-DEFICIENT MICE; MACROPHAGES; ACTIVATION; EXPRESSION	Purpose: To investigate the effect of an intravitreally administered CCR2 antagonist, INCB3344, on a mouse model of choroidal neovascularization (CNV). Methods: CNV was induced by laser photocoagulation on Day 0 in wild type mice. INCB3344 or vehicle was administered intravitreally immediately after laser application. On Day 14, CNV areas were measured on retinal pigment epithelium (RPE)-choroid flat mounts and histopathologic examination was performed on 7 mu m-thick sections. Macrophage infiltration was evaluated by immunohistochemistry on RPE-choroid flat mounts and quantified by flow cytometry on Day 3. Expression of vascular endothelial growth factor (VEGF) protein in RPE-choroid tissue was examined by immunohistochemistry and ELISA, VEGF mRNA in sorted macrophages in RPE-choroid tissue was examine by real-time PCR and expression of phosphorylated extracellular signal-regulated kinase (p-ERK 1/2) in RPE-choroid tissue was measured by Western blot analysis on Day 3. We also evaluated the efficacy of intravitreal INCB3344 to spontaneous CNV detected in Cu, Zn-superoxide dismutase (SOD1) deficient mice. Changes in CNV size were assessed between pre- and 1week post-INCB3344 or vehicle administration in fundus photography and fluorescence angiography (FA). Results: The mean CNV area in INCB3344-treated mice decreased by 42.4% compared with the vehicle-treated control mice (p<0.001). INCB3344 treatment significantly inhibited macrophage infiltration into the laser-irradiated area (p<0.001), and suppressed the expression of VEGF protein (p = 0.012), VEGF mRNA in infiltrating macrophages (p<0.001) and the phosphorylation of ERK1/2 (p<0.001). The area of spontaneous CNV in Sod1(-/-) mice regressed by 70.35% in INCB3344-treated animals while no change was detected in vehicle-treated control mice (p<0.001). Conclusions: INCB3344 both inhibits newly forming CNV and regresses established CNV. Controlling inflammation by suppressing macrophage infiltration and angiogenic ability via the CCR-2/MCP-1 signal may be a useful therapeutic strategy for treating CNV associated with age-related macular degeneration.	[Xie, Ping; Kamei, Motohiro; Suzuki, Mihoko; Matsumura, Nagakazu; Nishida, Kentaro; Sakimoto, Susumu; Sakaguchi, Hirokazu; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan	Osaka University	Xie, P (corresponding author), Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan.	mkamei@ophthal.med.osaka-u.ac.jp		Xie, Ping/0000-0003-4257-8970; Nishida, Kohji/0000-0001-9069-3610	Ministry of Education, Science and Culture of Japan [15591853]; Grants-in-Aid for Scientific Research [21592231] Funding Source: KAKEN	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (#15591853) from the Ministry of Education, Science and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Benny O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012515; Brodmerkel CM, 2005, J IMMUNOL, V175, P5370, DOI 10.4049/jimmunol.175.8.5370; Caicedo A, 2005, EXP EYE RES, V81, P38, DOI 10.1016/j.exer.2005.01.013; Cambien B, 2001, BLOOD, V97, P359, DOI 10.1182/blood.V97.2.359; Campa C, 2008, INVEST OPHTH VIS SCI, V49, P1178, DOI 10.1167/iovs.07-1194; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Cousins SW, 2004, ARCH OPHTHALMOL-CHIC, V122, P1013, DOI 10.1001/archopht.122.7.1013; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Dansereau MA, 2008, J NEUROCHEM, V106, P757, DOI 10.1111/j.1471-4159.2008.05429.x; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; FURIE MB, 1995, AM J PATHOL, V146, P1287; Goyal S, 2009, ARCH OPHTHALMOL-CHIC, V127, P882, DOI 10.1001/archophthalmol.2009.125; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Grossniklaus HE, 2002, MOL VIS, V8, P119; Guymer RH, 2011, INVEST OPHTH VIS SCI, V52, P4639, DOI 10.1167/iovs.10-7120; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Inoue Y, 2007, BRIT J OPHTHALMOL, V91, P1720, DOI 10.1136/bjo.2006.111583; *INT, 2006, CCR2 ANTAGONIST PROG; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Itaya M, 2007, INVEST OPHTH VIS SCI, V48, P5677, DOI 10.1167/iovs.07-0156; Izumi-Nagai K, 2007, ARTERIOSCL THROM VAS, V27, P2555, DOI 10.1161/ATVBAHA.107.151431; Jonas JB, 2010, ARCH OPHTHALMOL-CHIC, V128, P1281, DOI 10.1001/archophthalmol.2010.227; Kamei M, 2007, INVEST OPHTH VIS SCI, V48, P1801, DOI 10.1167/iovs.06-0699; Koto T, 2007, INVEST OPHTH VIS SCI, V48, P4328, DOI 10.1167/iovs.06-1148; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Liu SM, 2010, BBA-MOL CELL BIOL L, V1801, P106, DOI 10.1016/j.bbalip.2009.09.022; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Noda K, 2008, FASEB J, V22, P2928, DOI 10.1096/fj.07-105346; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Power Christine A., 2001, Current Opinion in Pharmacology, V1, P417, DOI 10.1016/S1471-4892(01)00072-8; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Satofuka S, 2008, AM J PATHOL, V173, P1911, DOI 10.2353/ajpath.2008.080457; Shin N, 2009, BIOCHEM BIOPH RES CO, V387, P251, DOI 10.1016/j.bbrc.2009.06.135; Sodhi A, 2002, J INTERF CYTOK RES, V22, P517, DOI 10.1089/10799900252981990; Strieter RM, 1996, J IMMUNOL, V156, P3583; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tsutsumi-Miyahara C, 2004, BRIT J OPHTHALMOL, V88, P1217, DOI 10.1136/bjo.2003.036392; Wain JH, 2002, CLIN EXP IMMUNOL, V127, P436, DOI 10.1046/j.1365-2249.2002.01764.x; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085; Yen HH, 1997, J LEUKOCYTE BIOL, V61, P529, DOI 10.1002/jlb.61.4.529; Yi XJ, 1997, GRAEF ARCH CLIN EXP, V235, P313, DOI 10.1007/BF01739641	51	32	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28933	10.1371/journal.pone.0028933	http://dx.doi.org/10.1371/journal.pone.0028933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205983	Green Submitted, Green Published, gold			2022-12-25	WOS:000298665600017
J	Liu, CH; Ren, JQ; You, ZR; Yang, JS; Liu, CM; Uppal, R; Liu, PK				Liu, Christina H.; Ren, Jia Q.; You, Zerong; Yang, Jinsheng; Liu, Charng-Ming; Uppal, Ritika; Liu, Philip K.			Noninvasive detection of neural progenitor cells in living brains by MRI	FASEB JOURNAL			English	Article						angiogenesis; drug delivery; pericyte; pharmacokinetics	ENDOTHELIAL GROWTH-FACTOR; CARDIOPULMONARY-RESUSCITATION; CEREBRAL-ISCHEMIA; GENE TRANSCRIPTS; CARDIAC-ARREST; PERICYTES; DAMAGE; ANGIOGENESIS; TRAFFICKING; AMPHETAMINE	The presence of pericytes in brain regions undergoing repair is evident of the recruitment of bone marrow-derived multipotent regenerative cells to the neurovascular unit during angiogenesis. At present, post mortem sampling is the only way to identify them. Therefore, such cell typing is inadequate for preserving neural progenitor cells for any meaningful stem cell therapy. We aimed to target cerebral pericytes in vivo using dual gene transcript-targeted MRI (GT-tMRI) in male C57black6 mice after a 60-min bilateral carotid artery occlusion (BCAO). We attached super-paramagnetic iron oxide nanoparticles (SPIONs) to phosphorothioate-modified micro-DNA that targets actin or nestin mRNA. Because BCAO compromises the blood-brain barrier (BBB) and induces expression of alpha-smooth muscle (alpha SM)-actin and nestin antigens by pericytes in new vessels, we delivered pericyte-specific magnetic resonance contrast agents (SPION-actin or SPION-nestin at 4 mg Fe/kg) by i.p. injection to C57black6 mice that had experienced BCAO. We demonstrated that the surge in cerebral iron content by inductively coupled plasma-mass spectrometry matched the increase in the frequency of relaxivity. We also found that SPION-nestin was colocalized in alpha SM-actin- and nestin-expressing pericytes in BCAO-treated C57black6 or transgenic mice [B6.Cg-Tg(CAG-mRFP1) 1F1Hadj/J, expressing red fluorescent protein by actin promoter]. We identified pericytes in the repair patch in living brains after BCAO with a voxel size of 0.03 mm(3). The presence of electron-dense nanoparticles in vascular pericytes in the region of BBB injury led us to draw the conclusion that GT-tMRI can noninvasively reveal neural progenitor cells during vascularization.-Liu, C. H., Ren, J. Q., You, Z., Yang, J., Liu, C.-M., Uppal, R., Liu, P. K. Noninvasive detection of neural progenitor cells in living brains by MRI. FASEB J. 26, 1652-1662 (2012). www.fasebj.org	[Liu, Christina H.; Ren, Jia Q.; Yang, Jinsheng; Liu, Charng-Ming; Uppal, Ritika; Liu, Philip K.] Massachusetts Gen Hosp, Dept Radiol, AA Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [You, Zerong] Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Liu, PK (corresponding author), Massachusetts Gen Hosp, Dept Radiol, AA Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	philipl@nmr.mgh.harvard.edu		Liu, Christina/0000-0002-5723-177X	American Heart Association [2060416]; U.S. National Institutes of Health [AT004974, DA026108, DA029889, EB013768]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029889, R01DA026108] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank M. McKee for assistance in TEM and N. Eusemann for help with editing. This project was supported by grants from the American Heart Association (grant 2060416) and the U.S. National Institutes of Health (grant AT004974 to J.Q.R. and grants DA026108, DA029889, and EB013768 to P.K.L.).	Abrahams JM, 2009, NEUROL RES, V31, P528, DOI 10.1179/174313209X380801; Alliot F, 1999, J NEUROSCI RES, V58, P367; BELTINGER C, 1995, J CLIN INVEST, V95, P1814, DOI 10.1172/JCI117860; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Cobbs CS, 1998, NEUROSCI LETT, V249, P79, DOI 10.1016/S0304-3940(98)00377-2; Cui JK, 1999, J NEUROCHEM, V73, P1164, DOI 10.1046/j.1471-4159.1999.0731164.x; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Fischer AJ, 2010, GLIA, V58, P633, DOI 10.1002/glia.20950; Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200; Fornai F, 2004, PSYCHOPHARMACOLOGY, V173, P353, DOI 10.1007/s00213-003-1708-3; Greenberg DA, 1998, DRUG NEWS PERSPECT, V11, P265, DOI 10.1358/dnp.1998.11.5.657287; Huang DY, 2000, FASEB J, V14, P407, DOI 10.1096/fasebj.14.2.407; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Kalaria RN, 1998, MOL BRAIN RES, V62, P101, DOI 10.1016/S0169-328X(98)00190-9; Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214; Krupinski J, 2008, FRONT BIOSCI-LANDMRK, V13, P6472, DOI 10.2741/3167; Lee HJ, 2002, J NUCL MED, V43, P948; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Liu CH, 2008, FASEB J, V22, P1193, DOI 10.1096/fj.07-9557com; Liu CH, 2007, FASEB J, V21, P3004, DOI 10.1096/fj.07-8203com; Liu CH, 2007, MOL IMAGING, V6, P156, DOI 10.2310/7290.2007.00011; Liu CH, 2007, J NEUROSCI, V27, P713, DOI 10.1523/JNEUROSCI.4660-06.2007; Liu CH, 2009, J NEUROSCI, V29, P10663, DOI 10.1523/JNEUROSCI.2167-09.2009; Liu CH, 2009, J NEUROSCI, V29, P3508, DOI 10.1523/JNEUROSCI.5332-08.2009; Liu PK, 1996, J NEUROSCI, V16, P6795; Malberg JE, 1998, J NEUROSCI, V18, P5086; Minamishima S, 2011, CIRCULATION, V124, P1645, DOI 10.1161/CIRCULATIONAHA.111.025395; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; MULDOON LL, 1995, AM J PATHOL, V147, P1840; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; RICAURTE G, 1985, SCIENCE, V229, P986, DOI 10.1126/science.4023719; Rodriguez-Baeza A, 1998, ANAT RECORD, V252, P176, DOI 10.1002/(SICI)1097-0185(199810)252:2<176::AID-AR3>3.0.CO;2-1; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Yoshioka H, 2011, J CEREBR BLOOD F MET, V31, P868, DOI 10.1038/jcbfm.2010.166; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhu M., BIOMED PHARMACOTHER, V64, P208	38	22	22	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1652	1662		10.1096/fj.11-199547	http://dx.doi.org/10.1096/fj.11-199547			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22198388	Bronze, Green Published			2022-12-25	WOS:000302359700026
J	Zhou, ZQ; Li, KL; Rieck, D; Ouyang, YX; Chandra, M; Dong, WJ				Zhou, Zhiqun; Li, King-Lun; Rieck, Daniel; Ouyang, Yexin; Chandra, Murali; Dong, Wen-Ji			Structural Dynamics of C-domain of Cardiac Troponin I Protein in Reconstituted Thin Filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY REGION; CONFORMATIONAL TRANSITIONS; MUSCLE-CONTRACTION; ACTIN-TROPOMYOSIN; 3-STATE MODEL; RESONANCE; COMPLEX; KINETICS; CA2+; CALCIUM	The regulatory function of cardiac troponin I (cTnI) involves three important contiguous regions within its C-domain: the inhibitory region (IR), the regulatory region (RR), and the mobile domain (MD). Within these regions, the dynamics of regional structure and kinetics of transitions in dynamic state are believed to facilitate regulatory signaling. This study was designed to use fluorescence anisotropy techniques to acquire steady-state and kinetic information on the dynamic state of the C-domain of cTnI in the reconstituted thin filament. A series of single cysteine cTnI mutants was generated, labeled with the fluorophore tetramethylrhodamine, and subjected to various anisotropy experiments at the thin filament level. The structure of the IR was found to be less dynamic than that of the RR and the MD, and Ca2+ binding induced minimal changes in IR dynamics: the flexibility of the RR decreased, whereas the MD became more flexible. Anisotropy stopped-flow experiments showed that the kinetics describing the transition of the MD and RR from the Ca2+-bound to the Ca2+-free dynamic states were significantly faster (53.2-116.8 s(-1)) than that of the IR (14.1 s(-1)). Our results support the fly casting mechanism, implying that an unstructured MD with rapid dynamics and kinetics plays a critical role to initiate relaxation upon Ca2+ dissociation by rapidly interacting with actin to promote the dissociation of the RR from the N-domain of cTnC. In contrast, the IR responds to Ca2+ signals with slow structural dynamics and transition kinetics. The collective findings suggested a fourth state of activation.	[Zhou, Zhiqun; Ouyang, Yexin; Dong, Wen-Ji] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; [Li, King-Lun; Rieck, Daniel; Chandra, Murali] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA	Washington State University; Washington State University	Dong, WJ (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, 205 Wegner Hall, Pullman, WA 99164 USA.	wdong@vetmed.wsu.edu	Dong, Wenji/A-8579-2011	zhou, zhiqun/0000-0001-5248-8931	National Institutes of Health [HL80186, HL80186-5S1, HL075643]; M. J. Murdock Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080186, R01HL075643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL80186 (to W.-J. D.), HL80186-5S1 (to W.-J. D.), and HL075643 (to M. C.). This work was also supported by the M. J. Murdock Charitable Trust (to W.-J. D.).	Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; Brown MP, 1997, CURR OPIN BIOTECH, V8, P45, DOI 10.1016/S0958-1669(97)80156-5; CACHIA PJ, 1983, BIOCHEMISTRY-US, V22, P4145, DOI 10.1021/bi00286a024; Chandra M, 1999, BIOCHEM BIOPH RES CO, V263, P219, DOI 10.1006/bbrc.1999.1341; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6745, DOI 10.1021/bi962226d; Dong WJ, 2003, J BIOL CHEM, V278, P42394, DOI 10.1074/jbc.M304858200; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gomez-Hens A, 2003, COMB CHEM HIGH T SCR, V6, P177, DOI 10.2174/138620703106298356; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HASELGROVE JC, 1973, COLD SPRING HARB SYM, V37, P341, DOI 10.1101/SQB.1973.037.01.044; Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; Julien O, 2011, PROTEINS, V79, P1240, DOI 10.1002/prot.22959; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 2000, BIOCHEMISTRY-US, V39, P86, DOI 10.1021/bi991903b; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P285; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; Lehman W, 2009, J MOL BIOL, V388, P673, DOI 10.1016/j.jmb.2009.03.060; Lehrer SS, 2011, J MUSCLE RES CELL M, V32, P203, DOI 10.1007/s10974-011-9263-8; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; LIAO RL, 1992, BIOPHYS J, V63, P986, DOI 10.1016/S0006-3495(92)81685-5; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Mudalige WAKA, 2009, J MOL BIOL, V389, P575, DOI 10.1016/j.jmb.2009.04.027; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Narolska NA, 2006, CIRC RES, V99, P1012, DOI 10.1161/01.RES.0000248753.30340.af; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; Serdyuk IN, 2007, METHODS IN MOLECULAR BIOPHYSICS: STRUCTURE, DYNAMICS, FUNCTION, P1; Shitaka Y, 2004, BIOCHEMISTRY-US, V43, P10739, DOI 10.1021/bi0492713; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Sykes BD, 2003, NAT STRUCT BIOL, V10, P588, DOI 10.1038/nsb0803-588; Tachampa K, 2008, J BIOL CHEM, V283, P15114, DOI 10.1074/jbc.M801636200; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; XING J, 1994, ARCH BIOCHEM BIOPHYS, V313, P229, DOI 10.1006/abbi.1994.1381; Xing J, 2009, J BIOL CHEM, V284, P16432, DOI 10.1074/jbc.M808075200; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x; Zhou X, 2000, BIOCHEMISTRY-US, V39, P1128, DOI 10.1021/bi992327m	50	25	25	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7661	7674		10.1074/jbc.M111.281600	http://dx.doi.org/10.1074/jbc.M111.281600			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22207765	Green Published, hybrid			2022-12-25	WOS:000301060200065
J	Lan, HC; Wu, CF; Shih, HM; Chung, BC				Lan, Hsin-Chieh; Wu, Chih-Feng; Shih, Hsiu-Ming; Chung, Bon-chu			Death-associated Protein 6 (Daxx) Mediates cAMP-dependent Stimulation of Cyp11a1 (P450scc) Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; C-JUN; INTERACTING PROTEIN; STEROIDOGENIC FACTOR-1; SUMO MODIFICATION; INDUCED APOPTOSIS; BINDING PROTEIN; JNK ACTIVATION; CYCLIC-AMP; CELL-DEATH	SF-1 is a key transcription factor for all steroidogenic genes. It up-regulates the expression of the steroidogenic Cyp11a1 gene in the adrenal in a pathway stimulated by cAMP through HIPK3-mediated JNK/c-Jun phosphorylation. In the present study, we have investigated the factors mediating cAMP-dependent HIPK3 action to potentiate the activity of SF-1 for Cyp11a1 transcription in mouse adrenocortical Y1 cells. We found Daxx, a HIPK kinase substrate in the apoptosis pathway, was phosphorylated by HIPK3 at Ser-669 in response to cAMP stimulation. Daxx participated in SF-1-dependent Cyp11a1 expression as shown by experiments involving both overexpression and down-regulation via a dominant negative Daxx mutant. The S669A mutant of Daxx, which could not be phosphorylated by HIPK3, lost the ability to potentiate SF-1 activity for Cyp11a1 expression. The enhancement of SF-1 activity by Daxx required JNK and c-Jun phosphorylation. Thus, Daxx functioned as a signal transducer linking cAMP-stimulated HIPK3 activity with JNK/c-Jun phosphorylation and SF-1-dependent Cyp11a1 transcription for steroid synthesis.	[Lan, Hsin-Chieh; Wu, Chih-Feng; Chung, Bon-chu] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Lan, Hsin-Chieh] Natl Def Med Ctr, Inst Biol & Anat, Taipei 114, Taiwan; [Wu, Chih-Feng; Chung, Bon-chu] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Defense Medical Center; National Yang Ming Chiao Tung University	Chung, BC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	mbchung@sinica.edu.tw	Shih, Hsiu-Ming/S-7023-2018	Chung, Bon-chu/0000-0002-8612-0219	Academia Sinica, NHRI [NHRI-EX100-9710SI]; National Science Council [NSC100-2321-B-001-006]	Academia Sinica, NHRI; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica, NHRI (NHRI-EX100-9710SI), and the National Science Council (NSC100-2321-B-001-006).	Auwerx J, 1999, CELL, V97, P161; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Chen WY, 2005, MOL CELL BIOL, V25, P10442, DOI 10.1128/MCB.25.23.10442-10453.2005; Chen WY, 2004, J BIOL CHEM, V279, P38730, DOI 10.1074/jbc.M405006200; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; Guo IC, 2007, J BIOMED SCI, V14, P509, DOI 10.1007/s11373-007-9177-z; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Hofmann TG, 2003, CANCER RES, V63, P8271; Hu MC, 1999, ENDOCRINOLOGY, V140, P5609, DOI 10.1210/en.140.12.5609; HU MC, 1991, BIOCHEM J, V274, P813, DOI 10.1042/bj2740813; Khelifi AF, 2005, CELL DEATH DIFFER, V12, P724, DOI 10.1038/sj.cdd.4401559; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lalioti VS, 2009, J CELL PHYSIOL, V218, P416, DOI 10.1002/jcp.21614; Lan HC, 2007, MOL CELL BIOL, V27, P2027, DOI 10.1128/MCB.02253-06; Li LA, 1999, MOL ENDOCRINOL, V13, P1588, DOI 10.1210/me.13.9.1588; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Luo XR, 1999, J STEROID BIOCHEM, V69, P13, DOI 10.1016/S0960-0760(98)00146-0; McDonough H, 2009, J BIOL CHEM, V284, P20649, DOI 10.1074/jbc.M109.011767; Meloni A, 2010, J BIOL CHEM, V285, P13012, DOI 10.1074/jbc.M109.037747; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Moilanen AM, 1998, MOL BIOL CELL, V9, P2527, DOI 10.1091/mbc.9.9.2527; Monte D, 1998, J BIOL CHEM, V273, P4585, DOI 10.1074/jbc.273.8.4585; Morozov VM, 2008, ONCOGENE, V27, P2177, DOI 10.1038/sj.onc.1210865; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Shih MCM, 2011, MOL CELL ENDOCRINOL, V336, P80, DOI 10.1016/j.mce.2010.12.017; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Song JJ, 2004, J BIOL CHEM, V279, P30573, DOI 10.1074/jbc.M404512200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tzeng SL, 2006, J BIOL CHEM, V281, P15405, DOI 10.1074/jbc.M601807200; Val Pierre, 2003, Nucl Recept, V1, P8, DOI 10.1186/1478-1336-1-8; Wethkamp N, 2009, J BIOL CHEM, V284, P28783, DOI 10.1074/jbc.M109.041186; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9	42	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5910	5916		10.1074/jbc.M111.307603	http://dx.doi.org/10.1074/jbc.M111.307603			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22199361	Green Published, hybrid			2022-12-25	WOS:000300638000065
J	Luhovy, AY; Jaberi, A; Papillon, J; Guillemette, J; Cybulsky, AV				Luhovy, Artem Y.; Jaberi, Aala; Papillon, Joan; Guillemette, Julie; Cybulsky, Andrey V.			Regulation of the Ste20-like Kinase, SLK INVOLVEMENT OF ACTIVATION SEGMENT PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL CENTER KINASE; STE20-RELATED KINASE; PROTEIN-KINASES; MAP KINASES; APOPTOSIS; EXPRESSION; AUTOPHOSPHORYLATION; MECHANISM; DOMAIN; CELLS	Expression and activation of the Ste20-like kinase, SLK, is increased during kidney development and recovery from ischemic acute kidney injury. SLK promotes apoptosis, and it may regulate cell survival during injury or repair. This study addresses the role of phosphorylation in the regulation of kinase activity. We mutated serine and threonine residues in the putative activation segment of the SLK catalytic domain and expressed wild type (WT) and mutant proteins in COS-1 or glomerular epithelial cells. Compared with SLK WT, the T183A, S189A, and T183A/S189A mutants showed reduced in vitro kinase activity. SLK WT, but not mutants, increased activation-specific phosphorylation of c-Jun N-terminal kinase (JNK) and p38 kinase. Similarly, SLK WT stimulated activator protein-1 reporter activity, but activation of activator protein-1 by the three SLK mutants was ineffective. To test if homodimerization of SLK affects phosphorylation, the cDNA encoding SLK amino acids 1-373 (which include the catalytic domain) was fused with a cDNA for a modified FK506-binding protein, Fv (Fv-SLK 1-373). After transfection, the addition of AP20187 (an FK506 analog) induced regulated dimerization of Fv-SLK 1-373. AP20187-stimulated dimerization enhanced the kinase activity of Fv-SLK 1-373 WT. In contrast, kinase activity of Fv-SLK 1-373 T183A/S189A was weak and was not enhanced after dimerization. Finally, apoptosis was increased after expression of Fv-SLK 1-373 WT but not T183A/S189A. Thus, phosphorylation of Thr-183 and Ser-189 plays a key role in the activation and signaling of SLK and could represent a target for novel therapeutic approaches to renal injury.	[Luhovy, Artem Y.; Jaberi, Aala; Papillon, Joan; Guillemette, Julie; Cybulsky, Andrey V.] McGill Univ, Dept Med, McGill Univ Hlth Ctr, Montreal, PQ H3A 1A1, Canada	McGill University	Cybulsky, AV (corresponding author), Royal Victoria Hosp, Div Nephrol, 687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	andrey.cybulsky@mcgill.ca	Cybulsky, Andrey V./AAG-8238-2020; Jaberi, Aala/J-9239-2019	Cybulsky, Andrey V./0000-0003-4348-2348; Jaberi, Aala/0000-0003-0318-2826	Canadian Institutes of Health Research [MOP-53264, MOP-84213]; Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair	This work was supported by Canadian Institutes of Health Research Grants MOP-53264 and MOP-84213 and the Kidney Foundation of Canada.; Supported by the Catherine McLaughlin Hakim Chair. To whom correspondence should be addressed: Division of Nephrology, Royal Victoria Hospital, 687 Pine Ave. W., Montreal, Quebec, Canada H3A 1A1. Tel.: 514-398-8148; Fax: 514-843-2815; E-mail: andrey.cybulsky@mcgill.ca.	Ali AS, 2009, CANCER TREAT REV, V35, P1, DOI 10.1016/j.ctrv.2008.07.006; Amara JF, 1997, P NATL ACAD SCI USA, V94, P10618, DOI 10.1073/pnas.94.20.10618; Burakov AV, 2008, MOL BIOL CELL, V19, P1952, DOI 10.1091/mbc.E06-12-1156; Chaar Z, 2006, J BIOL CHEM, V281, P28193, DOI 10.1074/jbc.M605665200; Chang David W, 2003, Sci STKE, V2003, pPL1, DOI 10.1126/stke.2003.167.pl1; Coers W, 1996, EXP NEPHROL, V4, P184; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Cowley BD, 2008, KIDNEY INT, V73, P251, DOI 10.1038/sj.ki.5002695; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Cybulsky AV, 2007, AM J PHYSIOL-RENAL, V292, pF845, DOI 10.1152/ajprenal.00234.2006; Cybulsky AV, 2010, AM J PATHOL, V177, P2290, DOI 10.2353/ajpath.2010.100263; Cybulsky AV, 2009, AM J PHYSIOL-RENAL, V297, pF971, DOI 10.1152/ajprenal.00294.2009; Cybulsky AV, 2004, AM J PHYSIOL-RENAL, V286, pF16, DOI 10.1152/ajprenal.00144.2003; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Delarosa S, 2011, AM J PHYSIOL-RENAL, V301, pF554, DOI 10.1152/ajprenal.00062.2011; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; Guilluy C, 2008, CIRC RES, V102, P1265, DOI 10.1161/CIRCRESAHA.107.164764; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Hassoun HT, 2009, AM J PHYSIOL-RENAL, V297, pF125, DOI 10.1152/ajprenal.90666.2008; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li Y, 2009, PROTEIN SCI, V18, P678, DOI 10.1002/pro.98; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Roovers K, 2009, ONCOGENE, V28, P2839, DOI 10.1038/onc.2009.146; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; Yamada E, 2000, BBA-MOL CELL RES, V1495, P250, DOI 10.1016/S0167-4889(99)00164-0; Zhang YH, 2002, DEV BRAIN RES, V139, P205, DOI 10.1016/S0165-3806(02)00551-5; ZHAO ZS, 1995, MOL CELL BIOL, V15, P5246; Zinovkina LA, 1997, FEBS LETT, V414, P135, DOI 10.1016/S0014-5793(97)00952-6	49	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5446	5458		10.1074/jbc.M111.302018	http://dx.doi.org/10.1074/jbc.M111.302018			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203681	Green Published, hybrid			2022-12-25	WOS:000300638000025
J	Michaloski, JS; Galante, PAF; Nagai, MH; Armelin-Correa, L; Chien, MS; Matsunami, H; Malnic, B				Michaloski, Jussara S.; Galante, Pedro A. F.; Nagai, Maira H.; Armelin-Correa, Lucia; Chien, Ming-Shan; Matsunami, Hiroaki; Malnic, Bettina			Common Promoter Elements in Odorant and Vomeronasal Receptor Genes	PLOS ONE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; CHEMOSENSORY RECEPTORS; TRANSCRIPTION FACTORS; EXPRESSION; SEQUENCE; PROTEINS; MOTIFS; DOMAIN; LHX2	In mammals, odorants and pheromones are detected by hundreds of odorant receptors (ORs) and vomeronasal receptors (V1Rs and V2Rs) expressed by sensory neurons that are respectively located in the main olfactory epithelium and in the vomeronasal organ. Even though these two olfactory systems are functionally and anatomically separate, their sensory neurons show a common mechanism of receptor gene regulation: each neuron expresses a single receptor gene from a single allele. The mechanisms underlying OR and VR gene expression remain unclear. Here we investigated if OR and V1R genes share common sequences in their promoter regions. We conducted a comparative analysis of promoter regions of 39 mouse V1R genes and found motifs that are common to a large number of promoters. We then searched mouse OR promoter regions for motifs that resemble the ones found in the V1R promoters. We identified motifs that are present in both the V1R and OR promoter regions. Some of these motifs correspond to the known O/ E like binding sites while others resemble binding sites for transcriptional repressors. We show that one of these motifs specifically interacts with proteins extracted from both nuclei from olfactory and vomeronasal neurons. Our study is the first to identify motifs that resemble binding sites for repressors in the promoters of OR and V1R genes. Analysis of these motifs and of the proteins that bind to these motifs should reveal important aspects of the mechanisms of OR/ V1R gene regulation.	[Michaloski, Jussara S.; Galante, Pedro A. F.; Nagai, Maira H.; Armelin-Correa, Lucia; Malnic, Bettina] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Galante, Pedro A. F.] Ludwig Inst Canc Res, Sao Paulo, Brazil; [Chien, Ming-Shan; Matsunami, Hiroaki] Duke Univ, Dept Mol Genet & Microbiol & Neurobiol, Durham, NC USA	Universidade de Sao Paulo; Ludwig Institute for Cancer Research; Duke University	Michaloski, JS (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	bmalnic@iq.usp.br	Galante, Pedro A. F./C-6564-2012; Malnic, Bettina/A-4905-2008; Armelin-Correa, Lúcia M/N-6440-2014; Armelin Correa, Lucia Maria/AAZ-6167-2021; Galante, Pedro/U-8594-2019	Galante, Pedro A. F./0000-0002-4820-4155; Malnic, Bettina/0000-0002-5877-4784; Galante, Pedro/0000-0002-4820-4155; Armelin-Correa, Lucia M./0000-0002-7200-5463	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005782, R01DC010857] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by research grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bilic I, 2007, IMMUNOL LETT, V108, P1, DOI 10.1016/j.imlet.2006.09.007; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Capello L, 2009, EUR J NEUROSCI, V29, P671, DOI 10.1111/j.1460-9568.2009.06630.x; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Hirota J, 2007, MOL CELL NEUROSCI, V34, P679, DOI 10.1016/j.mcn.2007.01.014; Hoppe R, 2003, GENOME RES, V13, P2674, DOI 10.1101/gr.1372203; Hoppe R, 2006, GENOMICS, V87, P711, DOI 10.1016/j.ygeno.2006.02.005; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kolterud A, 2004, DEVELOPMENT, V131, P5319, DOI 10.1242/dev.01416; Lane RP, 2002, P NATL ACAD SCI USA, V99, P291, DOI 10.1073/pnas.012608399; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McIntyre JC, 2008, CHEM SENSES, V33, P825, DOI 10.1093/chemse/bjn061; Michaloski JS, 2006, GENOME RES, V16, P1091, DOI 10.1101/gr.5185406; Okado H, 2009, DEV BIOL, V331, P140, DOI 10.1016/j.ydbio.2009.04.030; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Roppolo D, 2007, EMBO J, V26, P3423, DOI 10.1038/sj.emboj.7601782; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; Stewart R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-253; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Takahashi A, 2008, BIOCHEM BIOPH RES CO, V368, P637, DOI 10.1016/j.bbrc.2008.01.147; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Wang SS, 1997, J NEUROSCI, V17, P4149; Wang SS, 2002, MOL CELL NEUROSCI, V20, P404, DOI 10.1006/mcne.2002.1138; Young JM, 2005, GENOME RES, V15, P231, DOI 10.1101/gr.3339905; Zhang XM, 2004, GENOMICS, V83, P802, DOI 10.1016/j.ygeno.2003.10.009; Zhang YQ, 2007, MOL CELL NEUROSCI, V36, P95, DOI 10.1016/j.mcn.2007.06.005	62	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29065	10.1371/journal.pone.0029065	http://dx.doi.org/10.1371/journal.pone.0029065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216168	Green Submitted, Green Published, gold			2022-12-25	WOS:000300676300025
J	Garcia, M; Stathopoulos, A				Garcia, Mayra; Stathopoulos, Angelike			Lateral Gene Expression in Drosophila Early Embryos Is Supported by Grainyhead-Mediated Activation and Tiers of Dorsally-Localized Repression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; VENTRAL AXIS; DORSOVENTRAL AXIS; PIPSQUEAK ENCODES; NERVOUS-SYSTEM; HOMEOBOX GENE; DPP; NEUROECTODERM; SCHNURRI; PATHWAY	The general consensus in the field is that limiting amounts of the transcription factor Dorsal establish dorsal boundaries of genes expressed along the dorsal-ventral (DV) axis of early Drosophila embryos, while repressors establish ventral boundaries. Yet recent studies have provided evidence that repressors act to specify the dorsal boundary of intermediate neuroblasts defective (ind), a gene expressed in a stripe along the DV axis in lateral regions of the embryo. Here we show that a short 12 base pair sequence ("the A-box'') present twice within the ind CRM is both necessary and sufficient to support transcriptional repression in dorsal regions of embryos. To identify binding factors, we conducted affinity chromatography using the A-box element and found a number of DNA-binding proteins and chromatin-associated factors using mass spectroscopy. Only Grainyhead (Grh), a CP2 transcription factor with a unique DNA-binding domain, was found to bind the A-box sequence. Our results suggest that Grh acts as an activator to support expression of ind, which was surprising as we identified this factor using an element that mediates dorsally-localized repression. Grh and Dorsal both contribute to ind transcriptional activation. However, another recent study found that the repressor Capicua (Cic) also binds to the A-box sequence. While Cic was not identified through our A-box affinity chromatography, utilization of the same site, the A-box, by both factors Grh (activator) and Cic (repressor) may also support a "switch-like'' response that helps to sharpen the ind dorsal boundary. Furthermore, our results also demonstrate that TGF-beta signaling acts to refine ind CRM expression in an A-box independent manner in dorsal-most regions, suggesting that tiers of repression act in dorsal regions of the embryo.	[Garcia, Mayra; Stathopoulos, Angelike] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Garcia, M (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	angelike@caltech.edu			NSF; NIH [R01GM077668]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077668] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a predoctoral NSF fellowship to M. G. and grant R01GM077668 from the NIH to A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adryan B, 2009, FLYTF ORG DROSOPHILA; Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; Biehs B, 1996, GENE DEV, V10, P2922, DOI 10.1101/gad.10.22.2922; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613; Cornell R, 2000, CURRENT OPINION NEUR, V10, P8; Cowden J, 2003, DEV BIOL, V262, P335, DOI 10.1016/S0012-1606(03)00395-6; Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901; DOYLE HJ, 1989, GENE DEV, V3, P1518, DOI 10.1101/gad.3.10.1518; DYNLACHT BD, 1989, GENE DEV, V3, P1677, DOI 10.1101/gad.3.11.1677; Ferguson E, 1992, CELL, V71, P10; Ghiglione C, 2002, DEVELOPMENT, V129, P175; GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5; Grillo M, 2011, GENETICS, V187, P513, DOI 10.1534/genetics.110.121624; Harrison MM, 2010, DEV BIOL, V345, P248, DOI 10.1016/j.ydbio.2010.06.026; Hodgson JW, 2001, MOL CELL BIOL, V21, P4528, DOI 10.1128/MCB.21.14.4528-4543.2001; Huang DH, 2002, MOL CELL BIOL, V22, P6261, DOI 10.1128/MCB.22.17.6261-6271.2002; Huang JD, 1995, GENE DEV, V9, P3177, DOI 10.1101/gad.9.24.3177; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Isshiki T, 1997, DEVELOPMENT, V124, P3099; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; Jiang J, 1991, GENE DEV, V5, P10; JIMENEZ F, 1995, EMBO J, V14, P3487, DOI 10.1002/j.1460-2075.1995.tb07355.x; Jimenez G, 2000, GENE DEV, V14, P224; Kadonaga J, 1991, CURRENT PROTOCOLS MO; Kim M, 2011, P NATL ACAD SCI USA, V108, P650, DOI 10.1073/pnas.1016386108; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lee HY, 2004, MECH DEVELOP, V121, P37, DOI 10.1016/j.mod.2003.11.002; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Liaw GJ, 1995, GENE DEV, V9, P3163, DOI 10.1101/gad.9.24.3163; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Liberman LM, 2009, DEV BIOL, V327, P578, DOI 10.1016/j.ydbio.2008.12.020; Luschnig S, 2004, GENETICS, V167, P325, DOI 10.1534/genetics.167.1.325; Mizutani C, 2006, PLOS BIOL, V4, P12; Morel V, 2000, GENE DEV, V14, P11; Nusslein-Volhard C, 1984, ROUX ARCH DEVEL BIOL, V193, P15; Ozdemir A, 2011, GENOME RES, V21, P566, DOI 10.1101/gr.104018.109; Perrimon N, 1998, INT J DEV BIOL, V42, P243; Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008; RAY RP, 1991, DEVELOPMENT, V113, P35; Reeves G. T., 2009, PERSPECTIVES GENERAT; Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; STAEHLINGHAMPTON K, 1995, DEVELOPMENT, V121, P3393; Stathopoulos A, 2005, DEV BIOL, V280, P482, DOI 10.1016/j.ydbio.2005.02.003; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Von Ohlen T, 2000, DEV BIOL, V224, P362, DOI 10.1006/dbio.2000.9789; Wang SQ, 2009, NAT CELL BIOL, V11, P890, DOI 10.1038/ncb1898; Weber U, 1995, EMBO J, V14, P6247, DOI 10.1002/j.1460-2075.1995.tb00315.x; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; Zandi E, 1997, GENE DEV, V11, P1299, DOI 10.1101/gad.11.10.1299	61	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29172	10.1371/journal.pone.0029172	http://dx.doi.org/10.1371/journal.pone.0029172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216201	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000299684700035
J	Zhang, Y; Murshid, A; Prince, T; Calderwood, SK				Zhang, Yue; Murshid, Ayesha; Prince, Thomas; Calderwood, Stuart K.			Protein Kinase A Regulates Molecular Chaperone Transcription and Protein Aggregation	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; RNA-POLYMERASE-II; P-TEFB; HUNTINGTONS-DISEASE; IN-VIVO; MEDIATED TRANSCRIPTION; GENE-EXPRESSION; ELONGATION; RECRUITMENT; DROSOPHILA	Heat shock factor 1 (HSF1) regulates one of the major pathways of protein quality control and is essential for deterrence of protein-folding disorders, particularly in neuronal cells. However, HSF1 activity declines with age, a change that may open the door to progression of neurodegenerative disorders such as Huntington's disease. We have investigated mechanisms of HSF1 regulation that may become compromised with age. HSF1 binds stably to the catalytic domain of protein kinase A (PKAc alpha) and becomes phosphorylated on at least one regulatory serine residue (S320). We show here that PKA is essential for effective transcription of HSP genes by HSF1. PKA triggers a cascade involving HSF1 binding to the histone acetylase p300 and positive translation elongation factor 1 (p-TEFb) and phosphorylation of the c-terminal domain of RNA polymerase II, a key mechanism in the downstream steps of HSF1-mediated transcription. This cascade appears to play a key role in protein quality control in neuronal cells expressing aggregation-prone proteins with long poly-glutamine (poly-Q) tracts. Such proteins formed inclusion bodies that could be resolved by HSF1 activation during heat shock. Resolution of the inclusions was inhibited by knockdown of HSF1, PKAc alpha, or the pTEFb component CDK9, indicating a key role for the HSF1-PKA cascade in protein quality control.	[Zhang, Yue; Murshid, Ayesha; Prince, Thomas; Calderwood, Stuart K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiat Oncol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Zhang, Y (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiat Oncol, Boston, MA 02215 USA.	scalderw@bidmc.harvard.edu			National Institutes of Health [RO-1CA047407, R01CA119045, RO-1CA094397]; NATIONAL CANCER INSTITUTE [R01CA047407, R01CA094397, R01CA119045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health research grants RO-1CA047407, R01CA119045, and RO-1CA094397. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biamonti G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000695; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Eymery A, 2010, EXP CELL RES, V316, P1845, DOI 10.1016/j.yexcr.2010.02.002; Hayashida N, 2010, EMBO J, V29, P3459, DOI 10.1038/emboj.2010.225; Iijima-Andot K, 2005, P NATL ACAD SCI USA, V102, P10261, DOI 10.1073/pnas.0503937102; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Li GC, 2009, INT J HYPERTHER, V25, P258, DOI 10.1080/02656730902862106; Lis JT, 2000, GENE DEV, V14, P792; Meriin AB, 2001, J CELL BIOL, V153, P851, DOI 10.1083/jcb.153.4.851; MOYZIS RK, 1987, CHROMOSOMA, V95, P375, DOI 10.1007/BF00333988; Murshid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013830; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Ovakim DH, 2003, GENESIS, V36, P88, DOI 10.1002/gene.10202; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Sharma M, 2007, J BIOL CHEM, V282, P20887, DOI 10.1074/jbc.M701420200; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Sugars KL, 2004, J BIOL CHEM, V279, P4988, DOI 10.1074/jbc.M310226200; Sunagawa Y, 2010, J BIOL CHEM, V285, P9556, DOI 10.1074/jbc.M109.070458; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhao YM, 2006, CELL RES, V16, P566, DOI 10.1038/sj.cr.7310074; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	30	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28950	10.1371/journal.pone.0028950	http://dx.doi.org/10.1371/journal.pone.0028950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216146	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700019
J	Jiang, XT; Zhang, MX; Lai, QT; Huang, X; Li, YY; Sun, J; Abbott, WGH; Ma, SW; Hou, JL				Jiang, Xiaotao; Zhang, Mingxia; Lai, Qintao; Huang, Xuan; Li, Yongyin; Sun, Jian; Abbott, William G. H.; Ma, Shiwu; Hou, Jinlin			Restored Circulating Invariant NKT Cells Are Associated with Viral Control in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							NATURAL-KILLER-T; C VIRUS-INFECTION; PRIMARY BILIARY-CIRRHOSIS; INNATE IMMUNE-SYSTEM; LIVER-INJURY; AUTOIMMUNE HEPATITIS; EX-VIVO; EXPRESSION; DISEASE; MICE	Invariant NKT (iNKT) cells are involved in the pathogenesis of various infectious diseases. However, their role in hepatitis B virus (HBV) infection is not fully understood, especially in human species. In this study, 35 chronic hepatitis B (CHB) patients, 25 inactive carriers (IC) and 36 healthy controls (HC) were enrolled and the proportions of circulating iNKT cells in fresh isolated peripheral blood mononuclear cells (PBMC) were detected by flow cytometry. A longitudinal analysis was also conducted in 19 CHB patients who received antiviral therapy with telbivudine. Thereafter, the immune functions of iNKT cells were evaluated by cytokine secretion and a two-chamber technique. The median frequency of circulating iNKT cells in CHB patients (0.13%) was lower than that in HC (0.24%, P = 0.01) and IC (0.19%, P = 0.02), and increased significantly during antiviral therapy with telbivudine (P = 0.0176). The expressions of CC chemokine receptor 5 (CCR5) and CCR6 were dramatically higher on iNKT cells (82.83%+/- 9.87%, 67.67%+/- 16.83% respectively) than on conventional T cells (30.5%+/- 5.65%, 14.02%+/- 5.92%, both P<0.001) in CHB patients. Furthermore, iNKT cells could migrate toward the CC chemokine ligand 5. Patients with a high ratio (>= 1.0) of CD4-/CD4+ iNKT cells at baseline had a higher rate (58.33%) of HBeAg seroconversion than those with a low ratio (<1.0, 0%, P = 0.0174). In conclusion, there is a low frequency of peripheral iNKT cells in CHB patients, which increases to normal levels with viral control. The ratio of CD4-/CD4+ iNKT cells at baseline may be a useful predictor for HBeAg seroconversion in CHB patients on telbivudine therapy.	[Jiang, Xiaotao; Zhang, Mingxia; Lai, Qintao; Huang, Xuan; Li, Yongyin; Sun, Jian; Abbott, William G. H.; Ma, Shiwu; Hou, Jinlin] So Med Univ, Nanfang Hosp, Inst Hepatol, Guangzhou, Guangdong, Peoples R China; [Jiang, Xiaotao; Zhang, Mingxia; Lai, Qintao; Huang, Xuan; Li, Yongyin; Sun, Jian; Abbott, William G. H.; Ma, Shiwu; Hou, Jinlin] So Med Univ, Nanfang Hosp, Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Jiang, Xiaotao] So Med Univ, Basic Med Sch, Dept Immunol, Guangzhou, Guangdong, Peoples R China; [Abbott, William G. H.] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Auckland City Hospital	Jiang, XT (corresponding author), So Med Univ, Nanfang Hosp, Inst Hepatol, Guangzhou, Guangdong, Peoples R China.	jlhousmu@yahoo.com.cn	, sunjian/Y-6548-2019	Jiang, Xiaotao/0000-0001-7571-1593; sun, jian/0000-0001-5320-227X	National Natural Science Foundation of China [30730082, 30901271]; National Grand Program on Key Infectious Disease [2008ZX10002-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease	This study was supported by grants from the National Natural Science Foundation of China (No. 30730082 and No. 30901271), and the National Grand Program on Key Infectious Disease (No. 2008ZX10002-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bertoletti A, 2003, ANTIVIR RES, V60, P61, DOI 10.1016/j.antiviral.2003.08.012; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chuang YH, 2008, HEPATOLOGY, V47, P571, DOI 10.1002/hep.22052; de Lalla C, 2004, J IMMUNOL, V173, P1417, DOI 10.4049/jimmunol.173.2.1417; Dennert G, 2006, CRIT REV IMMUNOL, V26, P453, DOI 10.1615/CritRevImmunol.v26.i5.50; Dong ZJ, 2007, HEPATOLOGY, V45, P1400, DOI 10.1002/hep.21597; Durante-Mangoni E, 2004, J IMMUNOL, V173, P2159, DOI 10.4049/jimmunol.173.3.2159; EXLEY MA, 2003, CURR PROTOC IMMUNOL, pCH14; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Inoue M, 2006, J HEPATOL, V45, P190, DOI 10.1016/j.jhep.2006.01.034; Ito H, 2008, INT IMMUNOL, V20, P869, DOI 10.1093/intimm/dxn046; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kawamura H, 2006, J IMMUNOL, V176, P2152, DOI 10.4049/jimmunol.176.4.2152; Kim CH, 2002, TRENDS IMMUNOL, V23, P516, DOI 10.1016/S1471-4906(02)02323-2; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lichterfeld M, 2002, J INFECT DIS, V185, P1803, DOI 10.1086/340829; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Margalit M, 2005, INT J CANCER, V115, P443, DOI 10.1002/ijc.20889; Masson MJ, 2008, HEPATOLOGY, V48, P889, DOI 10.1002/hep.22400; Minagawa M, 2004, GASTROENTEROLOGY, V126, P1387, DOI 10.1053/j.gastro.2004.01.022; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Snyder-Cappione JE, 2009, AIDS, V23, P1965, DOI 10.1097/QAD.0b013e32832b5134; Woltman AM, 2009, ANTIVIR THER, V14, P809, DOI 10.3851/IMP1295; Wu L, 2009, TISSUE ANTIGENS, V73, P535, DOI 10.1111/j.1399-0039.2009.01256.x	34	26	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28871	10.1371/journal.pone.0028871	http://dx.doi.org/10.1371/journal.pone.0028871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194934	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400022
J	Lin, LC; Fang, WG; Liao, XG; Wang, FQ; Wei, DZ; Leger, RJS				Lin, Liangcai; Fang, Weiguo; Liao, Xinggang; Wang, Fengqing; Wei, Dongzhi; Leger, Raymond J. St.			The MrCYP52 Cytochrome P450 Monoxygenase Gene of Metarhizium robertsii Is Important for Utilizing Insect Epicuticular Hydrocarbons	PLOS ONE			English	Article							FUNGUS BEAUVERIA-BASSIANA; ENTOMOPATHOGENIC FUNGUS; ANISOPLIAE; CUTICLE; HOST; DEGRADATION; METABOLISM; VIRULENCE; ENZYMES; ALKANES	Fungal pathogens of plants and insects infect their hosts by direct penetration of the cuticle. Plant and insect cuticles are covered by a hydrocarbon-rich waxy outer layer that represents the first barrier against infection. However, the fungal genes that underlie insect waxy layer degradation have received little attention. Here we characterize the single cytochrome P450 monoxygenase family 52 (MrCYP52) gene of the insect pathogen Metarhizium robertsii, and demonstrate that it encodes an enzyme required for efficient utilization of host hydrocarbons. Expressing a green florescent protein gene under control of the MrCYP52 promoter confirmed that MrCYP52 is up regulated on insect cuticle as well as by artificial media containing decane (C10), extracted cuticle hydrocarbons, and to a lesser extent long chain alkanes. Disrupting MrCYP52 resulted in reduced growth on epicuticular hydrocarbons and delayed developmental processes on insect cuticle, including germination and production of appressoria (infection structures). Extraction of alkanes from cuticle prevented induction of MrCYP52 and reduced growth. Insect bioassays against caterpillars (Galleria mellonella) confirmed that disruption of MrCYP52 significantly reduces virulence. However, MrCYP52 was dispensable for normal germination and appressorial formation in vitro when the fungus was supplied with nitrogenous nutrients. We conclude therefore that MrCYP52 mediates degradation of epicuticular hydrocarbons and these are an important nutrient source, but not a source of chemical signals that trigger infection processes.	[Lin, Liangcai; Wang, Fengqing; Wei, Dongzhi] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Newworld Inst Biotechnol, Shanghai 200237, Peoples R China; [Lin, Liangcai; Fang, Weiguo; Liao, Xinggang; Leger, Raymond J. St.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	East China University of Science & Technology; University System of Maryland; University of Maryland College Park	Lin, LC (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Newworld Inst Biotechnol, Shanghai 200237, Peoples R China.	dzhwei@ecust.edu.cn; stleger@umd.edu	St. Leger, Raymond/N-3219-2013; weiguo, fang/F-5933-2010; Fang, Weiguo/G-6680-2012; Wei, Dongzhi/AAJ-3404-2021	Fang, Weiguo/0000-0002-8431-8256; Lin, Liangcai/0000-0003-0645-1446	United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2010-6510620580]	United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was funded by United States Department of Agriculture Cooperative State Research, Education, and Extension Service grant 2010-6510620580. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson DA, 1998, J CHEM ECOL, V24, P1845, DOI 10.1023/A:1022311701355; Chapman R.F., 2012, INSECTS STRUCTURE FU; Crespo R, 2008, MICROBIOL RES, V163, P148, DOI 10.1016/j.micres.2006.03.013; Crespo R, 2000, MYCOLOGIA, V92, P528, DOI 10.2307/3761512; Crespo R, 2002, BIOCONTROL, V47, P685, DOI 10.1023/A:1020545613148; Fang WG, 2006, CAN J MICROBIOL, V52, P623, DOI 10.1139/W06-014; Fang WG, 2010, PLANT PHYSIOL, V154, P1549, DOI 10.1104/pp.110.163014; [方卫国 Fang Weiguo], 2002, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V8, P305; Fang W, 2009, FUNGAL GENET BIOL, V46, P277, DOI 10.1016/j.fgb.2008.12.001; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Jarrold SL, 2007, MYCOL RES, V111, P240, DOI 10.1016/j.mycres.2006.10.007; Lin L, 2011, J MICROBIOL IN PRESS; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; OHKUMA M, 1995, DNA CELL BIOL, V14, P163, DOI 10.1089/dna.1995.14.163; Pedrini N, 2007, COMP BIOCHEM PHYS C, V146, P124, DOI 10.1016/j.cbpc.2006.08.003; Pedrini N, 2010, MICROBIOL-SGM, V156, P2549, DOI 10.1099/mic.0.039735-0; Powell AJ, 2003, MYCOLOGIA, V95, P809, DOI 10.2307/3762009; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Sambrook J., 2001, MOL CLONING LAB MANU, P2344; Screen S, 1997, CURR GENET, V31, P511, DOI 10.1007/s002940050238; STLEGER RJ, 1988, J INVERTEBR PATHOL, V52, P356, DOI 10.1016/0022-2011(88)90147-4; STLEGER RJ, 1986, J INVERTEBR PATHOL, V48, P85, DOI 10.1016/0022-2011(86)90146-1; STLEGER RJ, 1989, EXP MYCOL, V13, P274, DOI 10.1016/0147-5975(89)90049-2; StLeger RJ, 1996, APPL ENVIRON MICROB, V62, P907, DOI 10.1128/AEM.62.3.907-912.1996; Van Bogaert INA, 2011, FEBS J, V278, P206, DOI 10.1111/j.1742-4658.2010.07949.x; Van Bogaert INA, 2009, FEMS YEAST RES, V9, P87, DOI 10.1111/j.1567-1364.2008.00454.x; Wang CS, 2007, J BIOL CHEM, V282, P21110, DOI 10.1074/jbc.M609592200; Wang CS, 2005, EUKARYOT CELL, V4, P937, DOI 10.1128/EC.4.5.937-947.2005	28	36	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28984	10.1371/journal.pone.0028984	http://dx.doi.org/10.1371/journal.pone.0028984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194968	Green Submitted, gold, Green Published			2022-12-25	WOS:000298664400031
J	Cortes, M; Singh, AK; Reyrat, JM; Gaillard, JL; Nassif, X; Herrmann, JL				Cortes, Melanie; Singh, Anil Kumar; Reyrat, Jean-Marc; Gaillard, Jean-Louis; Nassif, Xavier; Herrmann, Jean-Louis			Conditional Gene Expression in Mycobacterium abscessus	PLOS ONE			English	Article							TRANSPOSON MUTAGENESIS; TETRACYCLINE; SYSTEM; INFECTION; MUTANTS; MODEL	Mycobacterium abscessus is an emerging human pathogen responsible for lung infections, skin and soft-tissue infections and disseminated infections in immunocompromised patients. It may exist either as a smooth (S) or rough (R) morphotype, the latter being associated with increased pathogenicity in various models. Genetic tools for homologous recombination and conditional gene expression are desperately needed to allow the study of M. abscessus virulence. However, descriptions of knock-out (KO) mutants in M. abscessus are rare, with only one KO mutant from an S strain described so far. Moreover, of the three major tools developed for homologous recombination in mycobacteria, only the one based on expression of phage recombinases is working. Several conditional gene expression tools have recently been engineered for Mycobacterium tuberculosis and Mycobacterium smegmatis, but none have been tested yet in M. abscessus. Based on previous experience with genetic tools allowing homologous recombination and their failure in M. abscessus, we evaluated the potential interest of a conditional gene expression approach using a system derived from the two repressors system, TetR/PipOFF. After several steps necessary to adapt TetR/PipOFF for M. abscessus, we have shown the efficiency of this system for conditional expression of an essential mycobacterial gene, fadD32. Inhibition of fadD32 was demonstrated for both the S and R isotypes, with marginally better efficiency for the R isotype. Conditional gene expression using the dedicated TetR/PipOFF systemvectors developed here is effective in S and R M. abscessus, and may constitute an interesting approach for future genetic studies in this pathogen.	[Cortes, Melanie; Singh, Anil Kumar; Reyrat, Jean-Marc; Nassif, Xavier] Univ Paris 05, Fac Med, Paris, France; [Cortes, Melanie; Singh, Anil Kumar; Reyrat, Jean-Marc; Nassif, Xavier] INSERM, U1002, Paris, France; [Gaillard, Jean-Louis; Herrmann, Jean-Louis] Univ Versailles St Quentin, EA Physiopathol & Diagnost Infect Microbiennes 36, Garches, France; [Gaillard, Jean-Louis; Herrmann, Jean-Louis] Hop Raymond Poincare, AP HP, Microbiol Lab, Garches, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Cortes, M (corresponding author), Univ Paris 05, Fac Med, Paris, France.	jean-louis.herrmann@rpc.aphp.fr		Nassif, Xavier/0000-0003-2855-3240; Herrmann, Jean-Louis/0000-0003-2347-6418	DIM Malinf; Marie-Curie IIF fellowship; Region Ile-de-France; Conseil Regional d'Ile de France; INSERM	DIM Malinf; Marie-Curie IIF fellowship(European Commission); Region Ile-de-France(Region Ile-de-France); Conseil Regional d'Ile de France(Region Ile-de-France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	MC is funded by a postdoctoral grant from DIM Malinf. AKS was funded by Marie-Curie IIF fellowship. This work was supported by grants from Region Ile-de-France. The authors gratefully acknowledge Conseil Regional d'Ile de France and INSERM for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Brown BA, 1996, ANTIMICROB AGENTS CH, V40, P874, DOI 10.1128/AAC.40.4.874; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Byrd TF, 1999, INFECT IMMUN, V67, P4700, DOI 10.1128/IAI.67.9.4700-4707.1999; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Catherinot E, 2009, J CLIN MICROBIOL, V47, P271, DOI 10.1128/JCM.01478-08; CORTES MA, 2010, CURR PROTOC MICROBIO, pCH10; Cullen AR, 2000, AM J RESP CRIT CARE, V161, P641, DOI 10.1164/ajrccm.161.2.9903062; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Feldman Evan M, 2009, J Plast Reconstr Aesthet Surg, V62, pe330, DOI 10.1016/j.bjps.2007.11.058; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Garcia-Navarro X, 2008, CLIN EXP DERMATOL, V33, P658, DOI 10.1111/j.1365-2230.2008.02869.x; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Jonsson BE, 2007, J CLIN MICROBIOL, V45, P1497, DOI 10.1128/JCM.02592-06; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; MEDJAHED H, 2010, TRENDS MICROBIOL; Medjahed Halima, 2010, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10d02s18; Medjahed H, 2009, APPL ENVIRON MICROB, V75, P1331, DOI 10.1128/AEM.01914-08; Miller JH., 1992, SHORT COURSE BACTERI; Newman MI, 2005, PLAST RECONSTR SURG, V115, P964, DOI 10.1097/01.PRS.0000153818.99552.CC; Ordway D, 2008, J LEUKOCYTE BIOL, V83, P1502, DOI 10.1189/jlb.1007696; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Ripoll F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-114; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; ROUX AL, 2010, CELL MICROBIOL; Roux AL, 2009, J CLIN MICROBIOL, V47, P4124, DOI 10.1128/JCM.01257-09; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Sermet-Gaudelus I, 2003, EMERG INFECT DIS, V9, P1587, DOI 10.3201/eid0912.020774; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Talati NJ, 2008, LANCET INFECT DIS, V8, P390, DOI 10.1016/S1473-3099(08)70127-0; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wallace RJ, 2002, ANTIMICROB AGENTS CH, V46, P3164, DOI 10.1128/AAC.46.10.3164-3167.2002; WALLACE RJ, 1994, CLIN INFECT DIS, V18, P121, DOI 10.1093/clinids/18.1.121; Zhang YS, 2004, J CLIN MICROBIOL, V42, P5582, DOI 10.1128/JCM.42.12.5582-5587.2004	46	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29306	10.1371/journal.pone.0029306	http://dx.doi.org/10.1371/journal.pone.0029306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195042	Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400049
J	Han, XX; Xu, JJ; Chu, ZX; Dai, D; Lu, CM; Wang, X; Zhao, L; Zhang, C; Ji, YT; Zhang, H; Shang, H				Han, Xiaoxu; Xu, Junjie; Chu, Zhenxing; Dai, Di; Lu, Chunming; Wang, Xu; Zhao, Li; Zhang, Cheng; Ji, Yangtao; Zhang, Hui; Shang, Hong			Screening Acute HIV Infections among Chinese Men Who Have Sex with Men from Voluntary Counseling & Testing Centers	PLOS ONE			English	Article							NUCLEIC-ACID-AMPLIFICATION; COST-EFFECTIVENESS; WINDOW PERIOD; BLOOD-DONORS; TRANSMISSION; PREVALENCE; VIRUS; SEROCONVERSION; RISK; 3RD-GENERATION	Background: Recent studies have shown the public health importance of identifying acute HIV infection (AHI) in the men who have sex with men (MSM) of China, which has a much higher risk of HIV transmission. However, cost-utility analyses to guide policy around AHI screening are lacking. Methodology/Principal Findings: An open prospective cohort was recruited among MSM living in Liaoning Province, Northeast China. Blood samples and epidemiological information were collected every 10 weeks. Third-generation ELISA and rapid test were used for HIV antibody screening, western blot assay (WB) served for assay validation. Antibody negative specimens were tested with 24 mini-pool nucleic acid amplification testing (NAAT). Specimens with positive ELISA but negative or indeterminate WB results were tested with NAAT individually without mixing. A cost-utility analysis of NAAT screening was assessed. Among the 5,344 follow-up visits of 1,765 MSM in 22 months, HIV antibody tests detected 114 HIV chronic infections, 24 seroconverters and 21 antibody indeterminate cases. 29 acute HIV infections were detected with NAAT from 21 antibody indeterminate and 1,606 antibody negative cases. The HIV-1 prevalence and incidence density were 6.6% (95% CI: 5.5-7.9) and 7.1 (95% CI: 5.4-9.2)/100 person-years, respectively. With pooled NAAT and individual NAAT strategy, the cost of an HIV transmission averted was $1,480. The addition of NAAT after HIV antibody tests had a cost-utility ratio of $3,366 per gained quality-adjusted life year (QALY). The input-output ratio of NAAT was about 1:16.9. Conclusions/Significance: The HIV infections among MSM continue to rise at alarming rates. Despite the rising cost, adding pooled NAAT to the HIV antibody screening significantly increases the identification of acute HIV infections in MSM. Early treatment and target-oriented publicity and education programs can be strengthened to decrease the risk of HIV transmission and to save medical resources in the long run.	[Han, Xiaoxu; Xu, Junjie; Chu, Zhenxing; Dai, Di; Zhang, Cheng; Ji, Yangtao; Zhang, Hui; Shang, Hong] China Med Univ, Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang, Liaoning, Peoples R China; [Lu, Chunming] Liaoning Ctr Dis Control & Prevent, HIV & Sexually Transmitted Dis Prevent & Control, Shenyang, Liaoning, Peoples R China; [Wang, Xu] Fushun Ctr Dis Control & Prevent, HIV & Sexually Transmitted Dis Prevent & Control, Fushun, Liaoning, Peoples R China; [Zhao, Li] Anshan Ctr Dis Control & Prevent, HIV & Sexually Transmitted Dis Prevent & Control, Anshan, Liaoning, Peoples R China	China Medical University	Han, XX (corresponding author), China Med Univ, Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang, Liaoning, Peoples R China.	hongshang100@hotmail.com		xu, junjie/0000-0003-4303-7295	Mega-Projects of National Science Research [2012ZX10001-006]; Project for Medical Peak Construction of Liaoning Province [[2010]696]; Fund of National Natural Science [30800969]	Mega-Projects of National Science Research; Project for Medical Peak Construction of Liaoning Province; Fund of National Natural Science(National Natural Science Foundation of China (NSFC))	This work was supported by Mega-Projects of National Science Research for the 12th Five-Year Plan (2012ZX10001-006); Project for Medical Peak Construction of Liaoning Province [2010]696; and Fund of National Natural Science (30800969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprili G, 2003, TRANSFUSION, V43, P848, DOI 10.1046/j.1537-2995.2003.00423.x; BARAL S, 2011, AIDS RES HUM RETROVI; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Fall-Malick F Z, 2010, Bull Soc Pathol Exot, V103, P243, DOI 10.1007/s13149-010-0042-3; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fisher M, 2010, AIDS, V24, P1739, DOI 10.1097/QAD.0b013e32833ac9e6; *GOV MYANM, 2009, REP HIV SENT SER SUR; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; Han Mei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P878; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hutchinson AB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000342; Karim SSA, 2007, AIDS, V21, P653, DOI 10.1097/QAD.0b013e3280327923; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lou J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S10; Ly TD, 2001, EUR J CLIN MICROBIOL, V20, P104, DOI 10.1007/s100960000430; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Nubling CM, 2009, TRANSFUSION, V49, P1850, DOI 10.1111/j.1537-2995.2009.02212.x; Palla P, 2006, VOX SANG, V90, P59, DOI 10.1111/j.1423-0410.2005.00716.x; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Patel P, 2006, JAIDS-J ACQ IMM DEF, V42, P75, DOI 10.1097/01.qai.0000218363.21088.ad; Patel P, 2010, ARCH INTERN MED, V170, P66, DOI 10.1001/archinternmed.2009.445; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Prabhu VS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019936; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Sanders GD, 2010, J GEN INTERN MED, V25, P556, DOI 10.1007/s11606-010-1265-5; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Scuracchio PSP, 2007, TRANSFUSION MED, V17, P200, DOI 10.1111/j.1365-3148.2007.00748.x; Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085; Thorstensson R, 1998, J VIROL METHODS, V70, P139, DOI 10.1016/S0166-0934(97)00176-6; TOMONO T, 2002, ADV TRANSFUSION SAFE, V2001, P29; van Griensven F, 2010, JAIDS-J ACQ IMM DEF, V53, P234, DOI 10.1097/QAI.0b013e3181c2fc86; van Hulst M, 2008, VALUE HEALTH, V11, P809, DOI 10.1111/j.1524-4733.2008.00337.x; Wang HL, 2008, CHIN J PUBL HLTH, V24, P995; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132; ZAAIJER HL, 1992, LANCET, V340, P770, DOI 10.1016/0140-6736(92)92303-W; ZHANG B, 2002, PREVENTION CONTROL, V8, P197	40	33	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28792	10.1371/journal.pone.0028792	http://dx.doi.org/10.1371/journal.pone.0028792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194914	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100099
J	Usuki, S; Tsai, YY; Morikawa, K; Nonaka, S; Okuhara, Y; Kise, M; Yu, RK				Usuki, Seigo; Tsai, Ying-Ying; Morikawa, Keiko; Nonaka, Shota; Okuhara, Yasuhide; Kise, Mitsuo; Yu, Robert K.			IGF-1 Induction by Acylated Steryl beta-Glucosides Found in a Pre-Germinated Brown Rice Diet Reduces Oxidative Stress in Streptozotocin-Induced Diabetes	PLOS ONE			English	Article							GROWTH-FACTOR-I; EXTRACELLULAR-SUPEROXIDE-DISMUTASE; CELL GROWTH; INS-1 CELLS; MALE RATS; INSULIN; HOMOCYSTEINE; NEUROPATHY; LINES; EXPRESSION	Background: The pathology of diabetic neuropathy involves oxidative stress on pancreatic beta-cells, and is related to decreased levels of Insulin-like growth factor 1 (IGF-1). Acylated steryl beta-glucoside (PR-ASG) found in pre-germiated brown rice is a bioactive substance exhibiting properties that enhance activity of homocysteine-thiolactonase (HTase), reducing oxidative stress in diabetic neuropathy. The biological importance of PR-ASG in pancreatic beta-cells remains unknown. Here we examined the effects of PR-ASG on IGF-1 and glucose metabolism in beta-cells exposed to oxidative stress. Methodology/Principal Findings: In the present study, a pre-germinated brown rice (PR)-diet was tested in streptozotocin (STZ)-induced diabetic rats. Compared with diabetic rats fed control diets, the PR-diet fed rats showed an improvement of serum metabolic and neurophysiological parameters. In addition, IGF-1 levels were found to be increased in the serum, liver, and pancreas of diabetic rats fed the PR-diet. The increased IGF-1 level in the pancreas led us to hypothesize that PR-ASG is protective for islet beta-cells against the extensive injury of advanced or severe diabetes. Thus we examined PR-ASG to determine whether it showed anti-apoptotic, pro-proliferative effects on the insulin-secreting beta-cells line, INS-1; and additionally, whether PR-ASG stimulated IGF-1 autocrine secretion/IGF-1-dependent glucose metabolism. We have demonstrated for the first time that PR-ASG increases IGF-1 production and secretion from pancreatic beta-cells. Conclusion/Significance: These findings suggest that PR-ASG may affect pancreatic beta-cells through the activation of an IGF-1-dependent mechanism in the diabetic condition. Thus, intake of pre-germinated brown rice may have a beneficial effect in the treatment of diabetes, in particular diabetic neuropathy.	[Usuki, Seigo; Tsai, Ying-Ying; Yu, Robert K.] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA; [Morikawa, Keiko; Nonaka, Shota; Okuhara, Yasuhide; Kise, Mitsuo] FANCL Corp, FANCL Res Inst, Yokohama, Kanagawa, Japan	University System of Georgia; Augusta University; FANCL Corporation	Usuki, S (corresponding author), Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA.	susuki@georgiahealth.edu			FANCL Corporation	FANCL Corporation	This work was supported by a research grant from FANCL Corporation (http://www.fancl.com/) to MCG Research Institute, Inc. (MCGRI). The funders had input on study design, decision to publish, and preparation of manuscript, but no role in data collection and analysis.	AMSTAD P, 1994, J BIOL CHEM, V269, P1606; ANDERSEN H, 1994, MUSCLE NERVE, V17, P80, DOI 10.1002/mus.880170111; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Dimitrova KR, 2002, CARDIOVASC RES, V53, P589, DOI 10.1016/S0008-6363(01)00403-5; *FANCL, 2005, PREG BROWN RIC; FOLCH J, 1957, J BIOL CHEM, V226, P497; Guo HL, 1999, CHINESE MED J-PEKING, V112, P76; Gustafsson H, 2004, J NEUROSCI RES, V77, P285, DOI 10.1002/jnr.20142; Hagiwara H, 2004, BIOSCI BIOTECH BIOCH, V68, P444, DOI 10.1271/bbb.68.444; Han HJ, 2006, J VET MED SCI, V68, P413, DOI 10.1292/jvms.68.413; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; ISHII DN, 1995, BRAIN RES REV, V20, P47, DOI 10.1016/0165-0173(94)00005-A; Kamiya H, 2006, DIABETOLOGIA, V49, P2763, DOI 10.1007/s00125-006-0379-0; KANETO H, 1995, DIABETES, V44, P733, DOI 10.2337/diabetes.44.7.733; Kosaka T, 2005, CLIN CHIM ACTA, V359, P156, DOI 10.1016/j.cccn.2005.03.046; Long LH, 2009, BIOCHEM BIOPH RES CO, V388, P700, DOI 10.1016/j.bbrc.2009.08.069; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; MARKLUND SL, 1990, BIOCHEM J, V266, P213, DOI 10.1042/bj2660213; NUKATSUKA M, 1988, FEBS LETT, V239, P295, DOI 10.1016/0014-5793(88)80938-4; Pegel KH, 1997, S AFR J SCI, V93, P263; Robertson K, 2008, AM J PHYSIOL-ENDOC M, V294, pE928, DOI 10.1152/ajpendo.00606.2007; ROSSINI AA, 1977, DIABETES, V26, P1120, DOI 10.2337/diabetes.26.12.1120; Saini KS, 1996, BIOCHEM MOL BIOL INT, V39, P1229; Sharma PK, 2010, CANCER LETT, V295, P154, DOI 10.1016/j.canlet.2010.02.021; Usuki S, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-25; Usuki S, 2008, J LIPID RES, V49, P2188, DOI 10.1194/jlr.M800257-JLR200; Yamamoto M, 2000, FEBS LETT, V486, P159, DOI 10.1016/S0014-5793(00)02260-2; Yang Q, 2002, DIABETES, V51, P1785, DOI 10.2337/diabetes.51.6.1785; Zhang XD, 2006, ANTICANCER RES, V26, P3561	29	19	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28693	10.1371/journal.pone.0028693	http://dx.doi.org/10.1371/journal.pone.0028693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194889	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100080
J	Wang, JH; Andersson-Gunneras, S; Gaboreanu, I; Hertzberg, M; Tucker, MR; Zheng, B; Lesniewska, J; Mellerowicz, EJ; Laux, T; Sandberg, G; Jones, B				Wang, Jiehua; Andersson-Gunneras, Sara; Gaboreanu, Ioana; Hertzberg, Magnus; Tucker, Matthew R.; Zheng, Bo; Lesniewska, Joanna; Mellerowicz, Ewa J.; Laux, Thomas; Sandberg, Goran; Jones, Brian			Reduced Expression of the SHORT-ROOT Gene Increases the Rates of Growth and Development in Hybrid Poplar and Arabidopsis	PLOS ONE			English	Article							LEAF INITIATION; CELL-CYCLE; SCARECROW; THALIANA; MERISTEM; PLANTS; SHOOT; TRANSFORMATION; MATURATION; MOVEMENT	SHORT-ROOT (SHR) is a well characterized regulator of cell division and cell fate determination in the Arabidopsis primary root. However, much less is known about the functions of SHR in the aerial parts of the plant. In this work, we cloned SHR gene from Populus trichocarpa (PtSHR1) as an AtSHR ortholog and down-regulated its expression in hybrid poplar (Populus tremula x P. tremuloides Michx-clone T89) in order to determine its physiological functions in shoot development. Sharing a 90% similarity to AtSHR at amino acid level, PtSHR1 was able to complement the Arabidopsis shr mutant. Down regulation of PtSHR1 led to a strong enhancement of primary (height) and secondary (girth) growth rates in the transgenic poplars. A similar approach in Arabidopsis showed a comparable accelerated growth and development phenotype. Our results suggest that the response to SHR could be dose-dependent and that a partial down-regulation of SHR could lead to enhanced meristem activity and a coordinated acceleration of plant growth in woody species. Therefore, SHR functions in plant growth and development as a regulator of cell division and meristem activity not only in the roots but also in the shoots. Reducing SHR expression in transgenic poplar was shown to lead to significant increases in primary and secondary growth rates. Given the current interest in bioenergy crops, SHR has a broader role as a key regulator of whole plant growth and development and SHR suppression has considerable potential for accelerating biomass accumulation in a variety of species.	[Wang, Jiehua] Tianjin Univ, Coll Agr & Bioengn, Tianjin 300072, Peoples R China; [Wang, Jiehua; Gaboreanu, Ioana; Zheng, Bo; Sandberg, Goran; Jones, Brian] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Andersson-Gunneras, Sara; Hertzberg, Magnus; Lesniewska, Joanna; Mellerowicz, Ewa J.] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Tucker, Matthew R.; Laux, Thomas] Univ Freiburg, Fac Biol 3, D-79106 Freiburg, Germany; [Jones, Brian] Univ Sydney, Fac Agr Food & Nat Resources, Sydney, NSW 2006, Australia	Tianjin University; Umea University; Swedish University of Agricultural Sciences; Umea University; University of Freiburg; University of Sydney	Wang, JH (corresponding author), Tianjin Univ, Coll Agr & Bioengn, Tianjin 300072, Peoples R China.	brian.jones@sydney.edu.au	Tucker, Matthew R/C-6207-2008; Jones, Brian m/E-8848-2016	Tucker, Matthew R/0000-0003-4661-6700; 	National Program on Key Basic Research Project [2012CB114500]; National Natural Science Foundation of China [31070600]	National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by National Program on Key Basic Research Project (2012CB114500) and National Natural Science Foundation of China (31070600) to J. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TF, 1951, T NEW YORK ACAD SCI, V13, P130, DOI 10.1111/j.2164-0947.1951.tb01007.x; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Chaffey N, 2002, PHYSIOL PLANTARUM, V114, P594, DOI 10.1034/j.1399-3054.2002.1140413.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cockcroft CE, 2000, NATURE, V405, P575, DOI 10.1038/35014621; Conway LJ, 1997, P NATL ACAD SCI USA, V94, P10209, DOI 10.1073/pnas.94.19.10209; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Dhondt S, 2010, PLANT PHYSIOL, V154, P1183, DOI 10.1104/pp.110.158857; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Fukaki H, 1996, PLANT PHYSIOL, V110, P945, DOI 10.1104/pp.110.3.945; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hoogwijk M, 2003, BIOMASS BIOENERG, V25, P119, DOI 10.1016/S0961-9534(02)00191-5; Itoh JI, 1998, PLANT CELL, V10, P1511, DOI 10.1105/tpc.10.9.1511; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kawakatsu T, 2006, PLANT CELL, V18, P612, DOI 10.1105/tpc.105.037622; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Nilsson Ove, 1992, Transgenic Research, V1, P209, DOI 10.1007/BF02524751; Paquette AJ, 2005, PLANT PHYSIOL, V138, P636, DOI 10.1104/pp.104.058362; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Scheres B, 2007, NAT REV MOL CELL BIO, V8, P345, DOI 10.1038/nrm2164; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Sole A, 2008, TREE PHYSIOL, V28, P1629, DOI 10.1093/treephys/28.11.1629; Sozzani R, 2010, NATURE, V466, P128, DOI 10.1038/nature09143; Tucker MR, 2007, TRENDS CELL BIOL, V17, P403, DOI 10.1016/j.tcb.2007.06.002; Veit B, 1998, NATURE, V393, P166, DOI 10.1038/30239; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Yu NI, 2010, MOL CELLS, V30, P113, DOI 10.1007/s10059-010-0095-y	33	21	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28878	10.1371/journal.pone.0028878	http://dx.doi.org/10.1371/journal.pone.0028878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194939	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000298369100117
J	Zhu, JS; Krom, BP; Sanglard, D; Intapa, C; Dawson, CC; Peters, BM; Shirtliff, ME; Jabra-Rizk, MA				Zhu, Jingsong; Krom, Bastiaan P.; Sanglard, Dominique; Intapa, Chaidan; Dawson, Clinton C.; Peters, Brian M.; Shirtliff, Mark E.; Jabra-Rizk, Mary Ann			Farnesol-Induced Apoptosis in Candida albicans Is Mediated by Cdr1-p Extrusion and Depletion of Intracellular Glutathione	PLOS ONE			English	Article							BIOFILM FORMATION; OXIDATIVE STRESS; MULTIDRUG TRANSPORTER; RESISTANCE MECHANISMS; ANTIFUNGAL AGENTS; YEAST; GENE; DISRUPTION; REDOX; DNA	Farnesol is a key derivative in the sterol biosynthesis pathway in eukaryotic cells previously identified as a quorum sensing molecule in the human fungal pathogen Candida albicans. Recently, we demonstrated that above threshold concentrations, farnesol is capable of triggering apoptosis in C. albicans. However, the exact mechanism of farnesol cytotoxicity is not fully elucidated. Lipophilic compounds such as farnesol are known to conjugate with glutathione, an antioxidant crucial for cellular detoxification against damaging compounds. Glutathione conjugates act as substrates for ATP-dependent ABC transporters and are extruded from the cell. To that end, this current study was undertaken to validate the hypothesis that farnesol conjugation with intracellular glutathione coupled with Cdr1p-mediated extrusion of glutathione conjugates, results in total glutathione depletion, oxidative stress and ultimately fungal cell death. The combined findings demonstrated a significant decrease in intracellular glutathione levels concomitant with up-regulation of CDR1 and decreased cell viability. However, addition of exogenous reduced glutathione maintained intracellular glutathione levels and enhanced viability. In contrast, farnesol toxicity was decreased in a mutant lacking CDR1, whereas it was increased in a CDR1-overexpressing strain. Further, gene expression studies demonstrated significant up-regulation of the SOD genes, primary enzymes responsible for defense against oxidative stress, with no changes in expression in CDR1. This is the first study describing the involvement of Cdr1p-mediated glutathione efflux as a mechanism preceding the farnesol-induced apoptotic process in C. albicans. Understanding of the mechanisms underlying farnesol-cytotoxicity in C. albicans may lead to the development of this redox-cycling agent as an alternative antifungal agent.	[Zhu, Jingsong; Intapa, Chaidan; Dawson, Clinton C.; Jabra-Rizk, Mary Ann] Univ Maryland, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Krom, Bastiaan P.] Univ Amsterdam, Dept Prevent Dent, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Krom, Bastiaan P.] Free Univ Amsterdam, Amsterdam, Netherlands; [Sanglard, Dominique] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland; [Sanglard, Dominique] Univ Hosp Ctr, Lausanne, Switzerland; [Intapa, Chaidan] Naresuan Univ, Dept Oral Diagnost Sci, Fac Dentisty, Phitsanulok, Thailand; [Peters, Brian M.] Univ Maryland, Grad Program Life Sci, Microbiol & Immunol Program, Sch Med, Baltimore, MD 21201 USA; [Peters, Brian M.; Shirtliff, Mark E.] Univ Maryland, Dept Microbial Pathogenesis, Sch Dent, Baltimore, MD 21201 USA; [Shirtliff, Mark E.; Jabra-Rizk, Mary Ann] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Lausanne; Naresuan University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zhu, JS (corresponding author), Univ Maryland, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	mrizk@umaryland.edu	Shirtliff, Mark E/H-2563-2017; Krom, Bastiaan/ABC-7026-2020; Sanglard, Dominique/K-6032-2017	Shirtliff, Mark E/0000-0002-8913-3445; Krom, Bastiaan/0000-0002-1497-1161; Sanglard, Dominique/0000-0002-5244-4178	National Institutes of Health [R01-AI69568]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01-AI69568. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek YU, 2004, FEBS LETT, V556, P47, DOI 10.1016/S0014-5793(03)01363-2; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chauhan N, 2006, NAT REV MICROBIOL, V4, P435, DOI 10.1038/nrmicro1426; Costa Vitor, 2001, Molecular Aspects of Medicine, V22, P217, DOI 10.1016/S0098-2997(01)00012-7; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Enjalbert B, 2005, EUKARYOT CELL, V4, P1203, DOI 10.1128/EC.4.7.1203-1210.2005; Fidel P L Jr, 2006, Adv Dent Res, V19, P80; Gauthier C, 2003, ANTIMICROB AGENTS CH, V47, P1543, DOI 10.1128/AAC.47.5.1543-1554.2003; Gonzalez-Parraga P, 2005, BBA-GEN SUBJECTS, V1722, P324, DOI 10.1016/j.bbagen.2005.01.006; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Hengartner MO, 2001, NATURE, V412, P27, DOI 10.1038/35083663; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Jabra-Rizk MA, 2006, ANTIMICROB AGENTS CH, V50, P1463, DOI 10.1128/AAC.50.4.1463-1469.2006; Jayatilake JAMS, 2005, J ORAL PATHOL MED, V34, P240, DOI 10.1111/j.1600-0714.2005.00307.x; Krishnamurthy S, 1998, FEMS MICROBIOL LETT, V158, P69, DOI 10.1111/j.1574-6968.1998.tb12802.x; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Lamarre C, 2001, J BIOL CHEM, V276, P43784, DOI 10.1074/jbc.M108095200; Lorico A, 1997, CANCER RES, V57, P5238; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Niimi M, 2004, J ANTIMICROB CHEMOTH, V54, P999, DOI 10.1093/jac/dkh456; Oh KB, 2001, P NATL ACAD SCI USA, V98, P4664, DOI 10.1073/pnas.071404698; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Rappa G, 1997, CANCER RES, V57, P5232; Sanglard D, 1996, ANTIMICROB AGENTS CH, V40, P2300, DOI 10.1128/AAC.40.10.2300; Sanglard D, 1997, MICROBIOL-UK, V143, P405, DOI 10.1099/00221287-143-2-405; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Scheper MA, 2008, NEOPLASIA, V10, P954, DOI 10.1593/neo.08444; Sharma M, 2011, ANTIMICROB AGENTS CH; Shirtliff ME, 2009, ANTIMICROB AGENTS CH, V53, P2392, DOI 10.1128/AAC.01551-08; Standards NCfCL, 2002, M27A2 STAND NCFCL; Toyoda Y, 2008, XENOBIOTICA, V38, P833, DOI [10.1080/00498250701883514, 10.1080/00498250701883514 ]; Trompier D, 2004, CANCER RES, V64, P4950, DOI 10.1158/0008-5472.CAN-04-0143; Westwater C, 2005, EUKARYOT CELL, V4, P1654, DOI 10.1128/EC.4.10.1654-1661.2005; White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382	44	47	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28830	10.1371/journal.pone.0028830	http://dx.doi.org/10.1371/journal.pone.0028830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205973	Green Published, gold, Green Submitted			2022-12-25	WOS:000298665600009
J	Wang, LW; Cvetkov, TL; Chance, MR; Moiseenkova-Bell, VY				Wang, Liwen; Cvetkov, Teresa L.; Chance, Mark R.; Moiseenkova-Bell, Vera Y.			Identification of in Vivo Disulfide Conformation of TRPA1 Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; REDOX REGULATION; COVALENT MODIFICATION; TRPV1 CHANNEL; RECEPTOR; ACTIVATION; GLUTATHIONYLATION; PHOSPHATASE; MASSMATRIX; PEPTIDES	TRPA1(transient receptor potential ankyrin 1) is an ion channel expressed in the termini of sensory neurons and is activated in response to a broad array of noxious exogenous and endogenous thiol-reactive compounds, making it a crucial player in chemical nociception. A number of conserved cysteine residues on the N-terminal domain of the channel have been identified as critical for sensing these electrophilic pungent chemicals, and our recent EM structure with modeled domains predicts that these cysteines form a ligand-binding pocket, allowing for the possibility of disulfide bonding between the cysteine residues. Here, we present a comprehensive mass spectrometry investigation of the in vivo disulfide bonding conformation and in vitro reactivity of 30 of the 31 cysteine residues in the TRPA1 ion channel. Four disulfide bonds were detected in the in vivo TRPA1 structure: Cys-666-Cys-622, Cys-666-Cys-463, Cys-622-Cys-609, and Cys-666-Cys-193. All of the cysteines detected were reactive to N-methylmaleimide (NMM) in vitro, with varying degrees of labeling efficiency. Comparison of the ratio of the labeling efficiency at 300 mu M versus 2 mM NMM identified a number of cysteine residues that were outliers from the mean labeling ratio, suggesting that protein conformation changes rendered these cysteines either more or less protected from labeling at the higher NMM concentrations. These results indicate that the activation mechanism of TRPA1 may involve N-terminal conformation changes and disulfide bonding between critical cysteine residues.	[Cvetkov, Teresa L.; Moiseenkova-Bell, Vera Y.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Wang, Liwen; Chance, Mark R.] Case Western Reserve Univ, Sch Med, Ctr Prote, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Moiseenkova-Bell, VY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Wood Bldg,W151D,10900 Euclid Ave, Cleveland, OH 44106 USA.	vxm102@case.edu			National Institutes of Health, NIBIB [R01 EB09688]; American Lung Association [RG-166985-N]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009688] Funding Source: NIH RePORTER	National Institutes of Health, NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); American Lung Association; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EB09688 from NIBIB (to M. R. C.). This work was also supported by American Lung Association Biomedical Research Grant RG-166985-N (to V.Y.M.-B.).	Auchere F, 2008, HUM MOL GENET, V17, P2790, DOI 10.1093/hmg/ddn178; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Caterina MJ, 2007, NATURE, V445, P491, DOI 10.1038/nature05565; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Filomeni G, 2005, CELL DEATH DIFFER, V12, P1555, DOI 10.1038/sj.cdd.4401754; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Moiseenkova VY, 2003, BIOCHEM BIOPH RES CO, V310, P196, DOI 10.1016/j.bbrc.2003.09.011; Moiseenkova-Bell V, 2011, ADV EXP MED BIOL, V704, P25, DOI 10.1007/978-94-007-0265-3_2; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Moiseenkova-Bell VY, 2009, J GEN PHYSIOL, V133, P239, DOI 10.1085/jgp.200810123; Murray DB, 2011, BBA-GEN SUBJECTS, V1810, P945, DOI 10.1016/j.bbagen.2011.04.005; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Myers BR, 2008, J GEN PHYSIOL, V132, P481, DOI 10.1085/jgp.200810104; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Rodriguez CE, 2004, TOXICOLOGY, V201, P185, DOI 10.1016/j.tox.2004.04.016; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z; Xu H, 2009, PROTEOMICS, V9, P1763, DOI 10.1002/pmic.200800282; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322	34	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6169	6176		10.1074/jbc.M111.329748	http://dx.doi.org/10.1074/jbc.M111.329748			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207754	Green Published, hybrid			2022-12-25	WOS:000300791800010
J	Reid, DW; Nicchitta, CV				Reid, David W.; Nicchitta, Christopher V.			Primary Role for Endoplasmic Reticulum-bound Ribosomes in Cellular Translation Identified by Ribosome Profiling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; PANCREATIC EXOCRINE CELL; GENOME-WIDE ANALYSIS; PROTEIN-SYNTHESIS; MAMMALIAN-CELLS; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; RAT-LIVER; MEMBRANE; LOCALIZATION	In eukaryotic cells, the spatial regulation of protein expression is frequently conferred through the coupling of mRNA localization and the local control of translation. mRNA localization to the endoplasmic reticulum (ER) is a prominent example of such regulation and serves a ubiquitous role in segregating the synthesis of secretory and integral membrane proteins to the ER. Recent genomic and biochemical studies have now expanded this view to suggest a more substantial role for the ER cellular protein synthesis. We have utilized cell fractionation and ribosome profiling to obtain a genomic survey of the subcellular organization of mRNA translation and report that ribosomal loading of mRNAs, a proxy for mRNA translation, is biased to the ER. Notably, ER-associated mRNAs encoding both cytosolic and topogenic signal-encoding proteins display similar ribosome loading densities, suggesting that ER-associated ribosomes serve a global role in mRNA translation. We propose that the partitioning of mRNAs and their translation between the cytosol and ER compartments may represent a novel mechanism for the post-transcriptional regulation of gene expression.	[Reid, David W.; Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Nicchitta, CV (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	christopher.nicchitta@duke.edu			National Institutes of Health [GM077382, GM077382-OS31]; Duke University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077382, R01GM101533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077382 and GM077382-OS31 (to C. V. N.). This work was also supported by a Core Facilities voucher from the Duke University School of Medicine.	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; ARNONE A, 1971, J BIOL CHEM, V246, P2302; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Blobel G, 1979, Symp Soc Exp Biol, V33, P9; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; CARO LG, 1964, J CELL BIOL, V20, P473, DOI 10.1083/jcb.20.3.473; Chen Q, 2011, MOL BIOL CELL, V22, P2646, DOI 10.1091/mbc.E11-03-0239; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Diehn M, 2006, PLOS GENET, V2, P39, DOI 10.1371/journal.pgen.0020011; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HEINS JN, 1967, J BIOL CHEM, V242, P1016; HICKS SJ, 1969, SCIENCE, V164, P584, DOI 10.1126/science.164.3879.584; Hyde M, 2002, J CELL BIOL, V156, P993, DOI 10.1083/jcb.200112008; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19; JAMIESON JD, 1967, J CELL BIOL, V34, P577, DOI 10.1083/jcb.34.2.577; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lerner RS, 2006, RNA, V12, P775, DOI 10.1261/rna.2318906; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; Liao GN, 2011, J CELL SCI, V124, P589, DOI 10.1242/jcs.072421; Mansfield KD, 2009, BIOL CELL, V101, P169, DOI 10.1042/BC20080055; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; MATLASHEWSKI G, 1984, EMBO J, V3, P3257, DOI 10.1002/j.1460-2075.1984.tb02287.x; MECHLER B, 1981, J CELL BIOL, V88, P29, DOI 10.1083/jcb.88.1.29; MUECKLER MM, 1981, J CELL BIOL, V90, P495, DOI 10.1083/jcb.90.2.495; Nicchitta CV, 2005, BIOCHEM CELL BIOL, V83, P687, DOI 10.1139/O05-147; Potter MD, 2000, J BIOL CHEM, V275, P33828, DOI 10.1074/jbc.M005294200; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; RABINOVITZ M, 1962, J BIOL CHEM, V237, P477; REDMAN CM, 1969, J BIOL CHEM, V244, P4308; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; SIEKEVITZ P, 1958, J BIOPHYS BIOCHEM CY, V4, P203, DOI 10.1083/jcb.4.2.203; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; Stephens SB, 2007, METHOD ENZYMOL, V431, P47, DOI 10.1016/S0076-6879(07)31004-5; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Unsworth H, 2010, FASEB J, V24, P3370, DOI 10.1096/fj.09-151142; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1981, J CELL BIOL, V91, P551, DOI 10.1083/jcb.91.2.551; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x	45	130	133	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5518	5527		10.1074/jbc.M111.312280	http://dx.doi.org/10.1074/jbc.M111.312280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22199352	hybrid, Green Published			2022-12-25	WOS:000300638000031
J	Athanasiadis, G; Buil, A; Souto, JC; Borrell, M; Lopez, S; Martinez-Perez, A; Lathrop, M; Fontcuberta, J; Almasy, L; Soria, JM				Athanasiadis, Georgios; Buil, Alfonso; Carlos Souto, Juan; Borrell, Montserrat; Lopez, Sonia; Martinez-Perez, Angel; Lathrop, Mark; Fontcuberta, Jordi; Almasy, Laura; Manuel Soria, Jose			A Genome-Wide Association Study of the Protein C Anticoagulant Pathway	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; THROMBOPHILIA GAIT PROJECT; FACTOR-VA-INACTIVATION; VENOUS THROMBOSIS; EPCR GENE; RISK-FACTORS; SEPCR LEVELS; RECEPTOR; COMPLEX; POLYMORPHISMS	The Protein C anticoagulant pathway regulates blood coagulation by preventing the inadequate formation of thrombi. It has two main plasma components: protein C and protein S. Individuals with protein C or protein S deficiency present a dramatically increased incidence of thromboembolic disorders. Here, we present the results of a genome-wide association study (GWAS) for protein C and protein S plasma levels in a set of extended pedigrees from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project. A total number of 397 individuals from 21 families were typed for 307,984 SNPs using the InfiniumH 317 k Beadchip (Illumina). Protein C and protein S (free, functional and total) plasma levels were determined with biochemical assays for all participants. Association with phenotypes was investigated through variance component analysis. After correcting for multiple testing, two SNPs for protein C plasma levels (rs867186 and rs8119351) and another two for free protein S plasma levels (rs1413885 and rs1570868) remained significant on a genome-wide level, located in and around the PROCR and the DNAJC6 genomic regions respectively. No SNPs were significantly associated with functional or total protein S plasma levels, although rs1413885 from DNAJC6 showed suggestive association with the functional protein S phenotype, possibly indicating that this locus plays an important role in protein S metabolism. Our results provide evidence that PROCR and DNAJC6 might play a role in protein C and free protein S plasma levels in the population studied, warranting further investigation on the role of these loci in the etiology of venous thromboembolism and other thrombotic diseases.	[Athanasiadis, Georgios; Lopez, Sonia; Martinez-Perez, Angel; Manuel Soria, Jose] Hosp Santa Creu & Sant Pau, Res Inst, Unit Genom Complex Dis, Barcelona, Spain; [Buil, Alfonso] Univ Geneva, Dept Genet & Dev, Geneva, Switzerland; [Carlos Souto, Juan; Borrell, Montserrat; Fontcuberta, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Hematol, Haemostasis & Thrombosis Unit, E-08193 Barcelona, Spain; [Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Almasy, Laura] SW Fdn Biomed Res, Dept Populat Genet, San Antonio, TX 78284 USA	Hospital of Santa Creu i Sant Pau; University of Geneva; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CEA; UDICE-French Research Universities; Universite Paris Saclay; Texas Biomedical Research Institute	Athanasiadis, G (corresponding author), Hosp Santa Creu & Sant Pau, Res Inst, Unit Genom Complex Dis, Barcelona, Spain.	jsoria@santpau.cat	Athanasiadis, Georgios/A-7745-2012; Almasy, Laura/V-3156-2019; Soria Fernández, José Manuel/AAD-6761-2019; Martinez-Perez, Angel/AAC-4339-2019; Lopez, Sonia/AAC-8830-2019	Athanasiadis, Georgios/0000-0002-2927-4035; Soria Fernández, José Manuel/0000-0002-6226-4293; Martinez-Perez, Angel/0000-0002-5934-1454; Lopez, Sonia/0000-0002-5023-5153; Buil, Alfonso/0000-0002-3097-1014	American National Institutes of Health [2 R01 HL070751-05]; "Instituto de Salud Carlos III" of the Spanish "Ministerio de Ciencia e Innovacion" (MICINN) [PI-08/0420, PI-08/0756, RECAVA-RD06/0014]; MICINN [SAF2005/04738, SAF2008/01859]; "Programa d'Estabilitzacio d'Investigadors de la Direccio d'Estrategia I Coordinacio del Departament de Salut" (Generalitat de Catalunya); Fondo Investigacion Sanitaria; "Subprograma Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva" (MICINN); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070751] Funding Source: NIH RePORTER	American National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Instituto de Salud Carlos III" of the Spanish "Ministerio de Ciencia e Innovacion" (MICINN); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); "Programa d'Estabilitzacio d'Investigadors de la Direccio d'Estrategia I Coordinacio del Departament de Salut" (Generalitat de Catalunya)(Generalitat de Catalunya); Fondo Investigacion Sanitaria(Instituto de Salud Carlos III); "Subprograma Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva" (MICINN); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by grant 2 R01 HL070751-05 from the American National Institutes of Health; grants PI-08/0420, PI-08/0756 and RECAVA-RD06/0014 from the "Instituto de Salud Carlos III" of the Spanish "Ministerio de Ciencia e Innovacion" (MICINN); and grants SAF2005/04738 and SAF2008/01859 (MICINN). JMS was supported by the "Programa d'Estabilitzacio d'Investigadors de la Direccio d'Estrategia I Coordinacio del Departament de Salut" (Generalitat de Catalunya), SL was supported by the programa "Sara Borell" from Fondo Investigacion Sanitaria and GA by the "Subprograma Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva" (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 2003, ARTERIOSCL THROM VAS, V23, P508, DOI 10.1161/01.ATV.0000055740.22563.C5; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blangero J, 2003, J THROMB HAEMOST, V1, P1391, DOI 10.1046/j.1538-7836.2003.00310.x; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Blangero J, 2000, HUM BIOL, V72, P35; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Buil A, 2004, ARTERIOSCL THROM VAS, V24, P1321, DOI 10.1161/01.ATV.0000132408.13064.09; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Dahlback B, 2007, THROMB HAEMOSTASIS, V98, P90, DOI 10.1160/TH07-04-0269; De Willige SU, 2004, J THROMB HAEMOST, V2, P1305, DOI 10.1046/j.1538-7836.2004.00855.x; Franco RF, 2001, HUM GENET, V109, P369, DOI 10.1007/s004390100593; Galanaud JP, 2010, J THROMB HAEMOST, V8, P707, DOI 10.1111/j.1538-7836.2010.03770.x; GANDRILLE S, 1995, BLOOD, V85, P130, DOI 10.1182/blood.V85.1.130.bloodjournal851130; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; Koeleman BPC, 1997, SEMIN HEMATOL, V34, P256; Lane DA, 1996, THROMB HAEMOSTASIS, V76, P651; Laszik Z, 1997, CIRCULATION, V96, P3633; Maurissen LFA, 2008, BLOOD, V111, P3034, DOI 10.1182/blood-2007-06-089987; Medina P, 2005, THROMB HAEMOSTASIS, V94, P389, DOI 10.1160/TH05-02-0089; Navarro S, 2008, HAEMATOLOGICA, V93, P885, DOI 10.3324/haematol.12448; Pintao MC, 2011, J THROMB HAEMOST, V9, P969, DOI 10.1111/j.1538-7836.2011.04256.x; Reiner AP, 2008, J THROMB HAEMOST, V6, P1625, DOI 10.1111/j.1538-7836.2008.03118.x; REITSMA PH, 1995, THROMB HAEMOSTASIS, V73, P876; Simioni P, 2006, THROMB RES, V117, P523, DOI 10.1016/j.thromres.2005.04.029; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; SPEK CA, 1995, ARTERIOSCL THROM VAS, V15, P214, DOI 10.1161/01.ATV.15.2.214; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Tanck MWT, 2011, THROMB HAEMOSTASIS, V105, P199, DOI 10.1160/TH10-06-0383; Tang WH, 2010, BLOOD, V116, P5032, DOI 10.1182/blood-2010-05-283739; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; WALKER FJ, 1981, J BIOL CHEM, V256, P1128; WALKER FJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P322, DOI 10.1016/0003-9861(87)90037-3; Wichers IM, 2009, THROMB HAEMOSTASIS, V101, P465, DOI 10.1160/TH08-06-0405	37	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29168	10.1371/journal.pone.0029168	http://dx.doi.org/10.1371/journal.pone.0029168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216198	Green Submitted, gold, Green Published			2022-12-25	WOS:000300676300032
J	Neubauer, O; Reiffler, C; Behrendt, L; Eitinger, T				Neubauer, Olivia; Reiffler, Christin; Behrendt, Laura; Eitinger, Thomas			Interactions among the A and T Units of an ECF-Type Biotin Transporter Analyzed by Site-Specific Crosslinking	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTERS; ESCHERICHIA-COLI; ABC TRANSPORTERS; LACTOSE PERMEASE; PROKARYOTES; MECHANISM; PROTEINS; AFFINITY	Energy-coupling factor (ECF) transporters are a huge group of micronutrient importers in prokaryotes. They are composed of a substrate-specific transmembrane protein (S component) and a module consisting of a moderately conserved transmembrane protein (T component) and two ABC ATPase domains (A components). Modules of A and T units may be dedicated to a specific S component or shared by many different S units in an organism. The mode of subunit interactions in ECF transporters is largely unknown. BioMNY, the focus of the present study, is a biotin transporter with a dedicated AT module. It consists of the S unit BioY, the A unit BioM and the T unit BioN. Like all T units, BioN contains two three-amino-acid signatures with a central Arg residue in a cytoplasmic helical region. Our previous work had demonstrated a central role of the two motifs in T units for stability and function of BioMNY and other ECF transporters. Here we show by site-specific crosslinking of pairs of mono-cysteine variants that the Ala-Arg-Ser and Ala-Arg-Gly signatures in BioN are coupling sites to the BioM ATPases. Analysis of 64 BioN-BioM pairs uncovered interactions of both signatures predominantly with a segment of,13 amino acid residues C-terminal of the Q loop of BioM. Our results further demonstrate that portions of all BioN variants with single Cys residues in the two signatures are crosslinked to homodimers. This finding may point to a dimeric architecture of the T unit in BioMNY complexes.	[Neubauer, Olivia; Reiffler, Christin; Behrendt, Laura; Eitinger, Thomas] Univ Berlin, Inst Biol Mikrobiol, Berlin, Germany		Neubauer, O (corresponding author), Univ Berlin, Inst Biol Mikrobiol, Berlin, Germany.	thomas.eitinger@cms.hu-berlin.de	Eitinger, Thomas/C-3926-2019	Eitinger, Thomas/0000-0003-1449-6433	Deutsche Forschungsgemeinschaft [EI 374/3-1, EI 374/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been financially supported by grants EI 374/3-1 and EI 374/4-1 from the Deutsche Forschungsgemeinschaft (http://www.dfg.de) to T. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright RA, 2007, J BIOL CHEM, V282, P35046, DOI 10.1074/jbc.M704260200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; Entcheva P, 2002, APPL ENVIRON MICROB, V68, P2843, DOI 10.1128/AEM.68.6.2843-2848.2002; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Erkens GB, 2010, BIOCHEMISTRY-US, V49, P3203, DOI 10.1021/bi100154r; Ermolova N, 2003, P NATL ACAD SCI USA, V100, P10187, DOI 10.1073/pnas.1434239100; Eudes A, 2008, J BACTERIOL, V190, P7591, DOI 10.1128/JB.01070-08; Finkenwirth F, 2010, BIOCHEM J, V431, P373, DOI 10.1042/BJ20100813; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; Guillen-Navarro K, 2005, FEMS MICROBIOL LETT, V250, P209, DOI 10.1016/j.femsle.2005.07.020; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Siche S, 2010, RES MICROBIOL, V161, P824, DOI 10.1016/j.resmic.2010.09.010; ter Beek J, 2011, J BIOL CHEM, V286, P5471, DOI 10.1074/jbc.M110.199224; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wen PC, 2011, BIOPHYS J, V101, P680, DOI 10.1016/j.bpj.2011.06.031; Zhang P, 2010, NATURE, V468, P717, DOI 10.1038/nature09488	25	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29087	10.1371/journal.pone.0029087	http://dx.doi.org/10.1371/journal.pone.0029087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216173	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900011
J	Holbein, S; Scola, S; Loll, B; Dichtl, BS; Hubner, W; Meinhart, A; Dichtl, B				Holbein, Sandra; Scola, Simonetta; Loll, Bernhard; Dichtl, Beatriz Solange; Huebner, Wolfgang; Meinhart, Anton; Dichtl, Bernhard			The P-Loop Domain of Yeast Clp1 Mediates Interactions Between CF IA and CPF Factors in Pre-mRNA 3 ' End Formation	PLOS ONE			English	Article							POLYADENYLATION FACTOR CPSF-73; POLYMERASE-II TRANSCRIPTION; 3'-END FORMATION; PROCESSING ENDONUCLEASE; SPECIFICITY FACTOR; CONTAINS HOMOLOGS; BINDING PROTEIN; 3-END FORMATION; IN-VIVO; CLEAVAGE	Cleavage factor IA (CF IA), cleavage and polyadenylation factor (CPF), constitute major protein complexes required for pre-mRNA 3' end formation in yeast. The Clp1 protein associates with Pcf11, Rna15 and Rna14 in CF IA but its functional role remained unclear. Clp1 carries an evolutionarily conserved P-loop motif that was previously shown to bind ATP. Interestingly, human and archaean Clp1 homologues, but not the yeast protein, carry 5' RNA kinase activity. We show that depletion of Clp1 in yeast promoted defective 3' end formation and RNA polymerase II termination; however, cells expressing Clp1 with mutant P-loops displayed only minor defects in gene expression. Similarly, purified and reconstituted mutant CF IA factors that interfered with ATP binding complemented CF IA depleted extracts in coupled in vitro transcription/3' end processing reactions. We found that Clp1 was required to assemble recombinant CF IA and that certain P-loop mutants failed to interact with the CF IA subunit Pcf11. In contrast, mutations in Clp1 enhanced binding to the 3' endonuclease Ysh1 that is a component of CPF. Our results support a structural role for the Clp1 P-loop motif. ATP binding by Clp1 likely contributes to CF IA formation and cross-factor interactions during the dynamic process of 3' end formation.	[Holbein, Sandra; Scola, Simonetta; Dichtl, Beatriz Solange; Dichtl, Bernhard] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Dichtl, Beatriz Solange; Dichtl, Bernhard] Deakin Univ, Ctr Cellular & Mol Biol, Sch Life & Environm Sci, Burwood, Australia; [Loll, Bernhard] Free Univ Berlin, Fachbereich Biol, Inst Chem & Biochem, AG Strukturbiochem, Berlin, Germany; [Huebner, Wolfgang] EMBL Heidelberg, Heidelberg, Germany; [Loll, Bernhard; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, Heidelberg, Germany	University of Zurich; Deakin University; Free University of Berlin; European Molecular Biology Laboratory (EMBL); Max Planck Society	Holbein, S (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	Bernhard@deakin.edu.au	Meinhart, Anton/M-9647-2014; Loll, Bernhard/J-4815-2019; Hubner, Wolfgang/O-7907-2016	Loll, Bernhard/0000-0001-7928-4488; Hubner, Wolfgang/0000-0002-1128-6468; Dichtl, Bernhard/0000-0001-5514-4982	German Research Foundation [ME3135/1-1]; Swiss National Science Foundation [PP0033_120490]; I. Schlichting	German Research Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); I. Schlichting	This research was supported by grant ME3135/1-1 to Dr. Meinhart from the German Research Foundation. Dr. Meinhart is a member of CellNetworks - Cluster of Excellence (EXC81). Work in the laboratory of Dr. Dichtl was supported by the Swiss National Science Foundation (PP0033_120490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Beate Schwer for providing the K136A T137A and D161A Clp1 mutants, and to Dr. Francoise Stutz for the GST-Yral expression construct. A. M. and B. L. thank J. Eschenbach for HPLC analysis and acknowledge the continuous encouragement and support of I. Schlichting.	Alexander RD, 2010, RNA, V16, P2570, DOI 10.1261/rna.2162610; Amrani N, 1997, MOL CELL BIOL, V17, P1102, DOI 10.1128/MCB.17.3.1102; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Garas M, 2008, RNA, V14, P2671, DOI 10.1261/rna.1293008; Gross S, 2001, P NATL ACAD SCI USA, V98, P6080, DOI 10.1073/pnas.101046598; Halbach A, 2009, EMBO J, V28, P2959, DOI 10.1038/emboj.2009.240; Holbein S, 2009, RNA, V15, P837, DOI 10.1261/rna.1458909; Jain R, 2009, RNA, V15, P923, DOI 10.1261/rna.1492809; Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Kessler MM, 1996, J BIOL CHEM, V271, P27167, DOI 10.1074/jbc.271.43.27167; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kyburz A, 2003, NUCLEIC ACIDS RES, V31, P3936, DOI 10.1093/nar/gkg478; MANDART E, 1995, MOL CELL BIOL, V15, P6979; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Mariconti L, 2010, RNA, V16, P2205, DOI 10.1261/rna.2172510; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Minvielle-Sebastia L, 1998, EMBO J, V17, P7454, DOI 10.1093/emboj/17.24.7454; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Noble CG, 2007, NUCLEIC ACIDS RES, V35, P87, DOI 10.1093/nar/gkl1010; PARK EC, 1992, P NATL ACAD SCI USA, V89, P1249, DOI 10.1073/pnas.89.4.1249; Preker PJ, 1997, EMBO J, V16, P4727, DOI 10.1093/emboj/16.15.4727; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; SWIDA U, 1988, YEAST, V4, P209, DOI 10.1002/yea.320040306; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; Xing DH, 2008, PLANT PHYSIOL, V148, P2059, DOI 10.1104/pp.108.129817; Zhao J, 1997, J BIOL CHEM, V272, P10831; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	36	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29139	10.1371/journal.pone.0029139	http://dx.doi.org/10.1371/journal.pone.0029139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216186	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700034
J	Suzuki, E; Demo, S; Deu, E; Keats, J; Arastu-Kapur, S; Bergsagel, PL; Bennett, MK; Kirk, CJ				Suzuki, Erika; Demo, Susan; Deu, Edgar; Keats, Jonathan; Arastu-Kapur, Shirin; Bergsagel, P. Leif; Bennett, Mark K.; Kirk, Christopher J.			Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells	PLOS ONE			English	Article							PROTEASOME INHIBITORS; IRREVERSIBLE INHIBITOR; CRYSTAL-STRUCTURE; MULTIPLE-MYELOMA; LYMPHOMA-CELLS; 20S PROTEASOME; GENE; PSMB5; SENSITIVITY; UBIQUITIN	Bortezomib (Velcade (TM)) is a reversible proteasome inhibitor that is approved for the treatment of multiple myeloma (MM). Despite its demonstrated clinical success, some patients are deprived of treatment due to primary refractoriness or development of resistance during therapy. To investigate the role of the duration of proteasome inhibition in the anti-tumor response of bortezomib, we established clonal isolates of HT-29 adenocarcinoma cells adapted to continuous exposure of bortezomib. These cells were similar to 30-fold resistant to bortezomib. Two novel and distinct mutations in the beta 5 subunit, Cys63Phe, located distal to the binding site in a helix critical for drug binding, and Arg24Cys, found in the propeptide region were found in all resistant clones. The latter mutation is a natural variant found to be elevated in frequency in patients with MM. Proteasome activity and levels of both the constitutive and immunoproteasome were increased in resistant cells, which correlated to an increase in subunit gene expression. These changes correlated with a more rapid recovery of proteasome activity following brief exposure to bortezomib. Increased recovery rate was not due to increased proteasome turnover as similar findings were seen in cells co-treated with cycloheximide. When we exposed resistant cells to the irreversible proteasome inhibitor carfilzomib we noted a slower rate of recovery of proteasome activity as compared to bortezomib in both parental and resistant cells. Importantly, carfilzomib maintained its cytotoxic potential in the bortezomib resistant cell lines. Therefore, resistance to bortezomib, can be overcome with irreversible inhibitors, suggesting prolonged proteasome inhibition induces a more potent anti-tumor response.	[Suzuki, Erika; Demo, Susan; Arastu-Kapur, Shirin; Bennett, Mark K.; Kirk, Christopher J.] Onyx Pharmaceut, San Francisco, CA 94080 USA; [Deu, Edgar] Stanford Univ, Stanford, CA 94305 USA; [Keats, Jonathan] Translat Genom Res Inst, Phoenix, AZ USA; [Bergsagel, P. Leif] Mayo Clin, Scottsdale, AZ USA	Stanford University; Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix	Suzuki, E (corresponding author), Onyx Pharmaceut, San Francisco, CA 94080 USA.	ckirk@onyx-pharm.com	Bergsagel, Peter Leif/A-7842-2011	Bergsagel, Peter Leif/0000-0003-1523-7388; Keats, Jonathan/0000-0003-4375-7399	Onyx Pharmaceuticals; National Institutes of Health [R01-CA136671]; NATIONAL CANCER INSTITUTE [R01CA136671] Funding Source: NIH RePORTER	Onyx Pharmaceuticals; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by Onyx Pharmaceuticals who had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The array work was funded by an National Institutes of Health grant - R01-CA136671 (www.nih.gov) awarded to P. Leif Bergsagel. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Arastu-Kapur S, 2011, CLIN CANC RES; Arendt CS, 1999, EMBO J, V18, P3575, DOI 10.1093/emboj/18.13.3575; Bennett MK, 2008, CURR OPIN DRUG DISC, V11, P616; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Busse A, 2008, CANCER, V112, P659, DOI 10.1002/cncr.23224; Chauhan D, 2003, CANCER RES, V63, P6174; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Dasmahapatra G, 2010, BLOOD, V115, P4478, DOI 10.1182/blood-2009-12-257261; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Dick LR, 2010, DRUG DISCOV TODAY, V15, P243, DOI 10.1016/j.drudis.2010.01.008; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Jager S, 1999, J MOL BIOL, V291, P997, DOI 10.1006/jmbi.1999.2995; Kisselev AF, 2003, J BIOL CHEM, V278, P35869, DOI 10.1074/jbc.M303725200; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Kraus M, 2007, LEUKEMIA, V21, P84, DOI 10.1038/sj.leu.2404414; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Kumar S, 2008, BLOOD, V112, P2177, DOI 10.1182/blood-2008-07-167767; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Lu SQ, 2008, EXP HEMATOL, V36, P1278, DOI 10.1016/j.exphem.2008.04.013; Lu SQ, 2009, EXP HEMATOL, V37, P831, DOI 10.1016/j.exphem.2009.04.001; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Parlati F, 2009, BLOOD, V114, P3439, DOI 10.1182/blood-2009-05-223677; Politou M, 2006, LEUKEMIA RES, V30, P240, DOI 10.1016/j.leukres.2005.06.014; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Ruckrich T, 2009, LEUKEMIA, V23, P1098, DOI 10.1038/leu.2009.8; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Shringarpure R, 2006, BRIT J HAEMATOL, V134, P145, DOI 10.1111/j.1365-2141.2006.06132.x; Siegel DS, 2011, ASH 2010; Wang LW, 2008, CLIN CANCER RES, V14, P3503, DOI 10.1158/1078-0432.CCR-07-5150	35	58	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e27996	10.1371/journal.pone.0027996	http://dx.doi.org/10.1371/journal.pone.0027996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216088	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700002
J	Sarkar, G; Curran, GL; Mahlum, E; Decklever, T; Wengenack, TM; Blahnik, A; Hoesley, B; Lowe, VJ; Poduslo, JF; Jenkins, RB				Sarkar, Gobinda; Curran, Geoffry L.; Mahlum, Eric; Decklever, Teresa; Wengenack, Thomas M.; Blahnik, Anthony; Hoesley, Bridget; Lowe, Val J.; Poduslo, Joseph F.; Jenkins, Robert B.			A Carrier for Non-Covalent Delivery of Functional Beta-Galactosidase and Antibodies against Amyloid Plaques and IgM to the Brain	PLOS ONE			English	Article							IN-VIVO; DRUG-DELIVERY; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; TROJAN HORSES; BARRIER; RECEPTOR; PROTEINS; PEPTIDE; PERMEABILITY	Background: Therapeutic intervention of numerous brain-associated disorders currently remains unrealized due to serious limitations imposed by the blood-brain-barrier (BBB). The BBB generally allows transport of small molecules, typically <600 daltons with high octanol/water partition coefficients, but denies passage to most larger molecules. However, some receptors present on the BBB allow passage of cognate proteins to the brain. Utilizing such receptor-ligand systems, several investigators have developed methods for delivering proteins to the brain, a critical requirement of which involves covalent linking of the target protein to a carrier entity. Such covalent modifications involve extensive preparative and post-preparative chemistry that poses daunting limitations in the context of delivery to any organ. Here, we report creation of a 36-amino acid peptide transporter, which can transport a protein to the brain after routine intravenous injection of the transporter-protein mixture. No covalent linkage of the protein with the transporter is necessary. Approach: A peptide transporter comprising sixteen lysine residues and 20 amino acids corresponding to the LDLR-binding domain of apolipoprotein E (ApoE) was synthesized. Transport of beta-galactosidase, IgG, IgM, and antibodies against amyloid plques to the brain upon iv injection of the protein-transporter mixture was evaluated through staining for enzyme activity or micro single photon emission tomography (micro-SPECT) or immunostaining. Effect of the transporter on the integrity of the BBB was also investigated. Principal Findings: The transporter enabled delivery to the mouse brain of functional beta-galactosidase, human IgG and IgM, and two antibodies that labeled brain-associated amyloid beta plaques in a mouse model of Alzheimer's disease. Significance: The results suggest the transporter is able to transport most or all proteins to the brain without the need for chemically linking the transporter to a protein. Thus, the approach offers an avenue for rapid clinical evaluation of numerous candidate drugs against neurological diseases including cancer. (299 words).	[Sarkar, Gobinda; Mahlum, Eric; Jenkins, Robert B.] Mayo Clin, Dept Expt Pathol, Rochester, MN 55905 USA; [Sarkar, Gobinda] Mayo Clin, Dept Orthoped, Rochester, MN USA; [Curran, Geoffry L.; Wengenack, Thomas M.; Poduslo, Joseph F.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Decklever, Teresa; Lowe, Val J.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Blahnik, Anthony; Hoesley, Bridget] Mayo Clin, Tissue & Cell Mol Anal Lab, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Sarkar, G (corresponding author), Mayo Clin, Dept Expt Pathol, Rochester, MN 55905 USA.	sarkar.gobinda@mayo.edu; rjenkins@mayo.edu			Mayo Foundation	Mayo Foundation	This work has been supported by the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Boado RJ, 2010, J PHARMACOL EXP THER, V333, P961, DOI 10.1124/jpet.109.165092; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Carlson SK, 2006, MOL IMAGING BIOL, V8, P324, DOI 10.1007/s11307-006-0058-z; Daveson H, 1989, IMPLICATIONS BLOOD B, V1, P27; Deane R, 2005, J NEUROSCI, V25, P11495, DOI 10.1523/JNEUROSCI.3697-05.2005; DEBOER AG, 1994, J ROY COLL PHYS LOND, V28, P502; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Denora N, 2009, CURR TOP MED CHEM, V9, P182, DOI 10.2174/156802609787521571; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; FRIDEN PM, 1993, SCIENCE, V259, P373, DOI 10.1126/science.8420006; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Karkan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002469; Mahlitin E, 2007, ANAL BIOCHEM, V365, P215, DOI 10.1016/j.ab.2007.03.020; Mazza M, 2008, BRIT J PHARMACOL, V155, P149, DOI 10.1038/bjp.2008.274; Misra A, 2003, J PHARM PHARM SCI, V6, P252; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Patel MM, 2009, CNS DRUGS, V23, P35, DOI 10.2165/0023210-200923010-00003; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Poduslo JF, 1996, J NEUROCHEM, V66, P1599; Poduslo JF, 2004, BIOCHEMISTRY-US, V43, P6064, DOI 10.1021/bi0359574; Poduslo JF, 2001, NEUROREPORT, V12, P3197, DOI 10.1097/00001756-200110290-00011; Poduslo JF, 2007, J NEUROCHEM, V102, P420, DOI 10.1111/j.1471-4159.2007.04591.x; Ruan XZ, 1998, NEPHROL DIAL TRANSPL, V13, P1391, DOI 10.1093/ndt/13.6.1391; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Weiss DJ, 1997, HUM GENE THER, V8, P1545, DOI 10.1089/hum.1997.8.13-1545; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wengenack TM, 2000, NAT BIOTECHNOL, V18, P868, DOI 10.1038/78482; Wengenack TM, 2000, NEUROSCIENCE, V101, P939, DOI 10.1016/S0306-4522(00)00388-2; Zlokovic BV, 2000, ENDOCRINOLOGY, V141, P1434, DOI 10.1210/en.141.4.1434	34	37	39	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28881	10.1371/journal.pone.0028881	http://dx.doi.org/10.1371/journal.pone.0028881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216132	gold, Green Published			2022-12-25	WOS:000299113600047
J	Chiang, YS; Takahashi, N				Chiang, Yen-Sheng; Takahashi, Nobuyuki			Network Homophily and the Evolution of the Pay-It-Forward Reciprocity	PLOS ONE			English	Article							UPSTREAM RECIPROCITY; COOPERATION; ASSORTMENT; ALTRUISM; DYNAMICS; BEHAVIOR; SPREAD; BIRDS; GAMES	The pay-it-forward reciprocity is a type of cooperative behavior that people who have benefited from others return favors to third parties other than the benefactors, thus pushing forward a cascade of kindness. The phenomenon of the pay-it-forward reciprocity is ubiquitous, yet how it evolves to be part of human sociality has not been fully understood. We develop an evolutionary dynamics model to investigate how network homophily influences the evolution of the pay-it-forward reciprocity. Manipulating the extent to which actors carrying the same behavioral trait are linked in networks, the computer simulation model shows that strong network homophily helps consolidate the adaptive advantage of cooperation, yet introducing some heterophily to the formation of network helps advance cooperation's scale further. Our model enriches the literature of inclusive fitness theory by demonstrating the conditions under which cooperation or reciprocity can be selected for in evolution when social interaction is not confined exclusively to relatives.	[Chiang, Yen-Sheng] Univ Calif Irvine, Dept Sociol, Irvine, CA 92717 USA; [Chiang, Yen-Sheng] Univ Calif Irvine, Inst Math Behav Sci, Irvine, CA USA; [Takahashi, Nobuyuki] Hokkaido Univ, Dept Behav Sci, Sapporo, Hokkaido, Japan	University of California System; University of California Irvine; University of California System; University of California Irvine; Hokkaido University	Chiang, YS (corresponding author), Univ Calif Irvine, Dept Sociol, Irvine, CA 92717 USA.	yenshenc@uci.edu						AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barros B., 2008, J LAW PUBLIC POLICY, V18, P203; Barta Z, 2011, P ROY SOC B-BIOL SCI, V278, P843, DOI 10.1098/rspb.2010.1634; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Becker H., 1956, MAN RECIPROCITY; BOYD R, 1989, SOC NETWORKS, V11, P213, DOI 10.1016/0378-8733(89)90003-8; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chiang YS, 2007, J MATH SOCIOL, V31, P47, DOI 10.1080/00222500601013536; Christakis N.A., 2009, CONNECTED SURPRISING; EHSEL I, 1998, AM ECON REV, V88, P157; Ekeh P., 1974, SOCIAL EXCHANGE THEO; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; GOULDNER AW, 1960, AM SOCIOL REV, V25, P161, DOI 10.2307/2092623; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hyde C. R, 2000, PAY IT FORWARD; Iwagami A, 2010, J THEOR BIOL, V265, P297, DOI 10.1016/j.jtbi.2010.05.010; Judd S, 2010, P NATL ACAD SCI USA, V107, P14978, DOI 10.1073/pnas.1001280107; Kalmijn M, 1998, ANNU REV SOCIOL, V24, P395, DOI 10.1146/annurev.soc.24.1.395; KOLM SC, 2009, RECIRPOCITY EC SOCIA; LEVISTRUSS C, 1969, ELEMENTARY STRUCTURE; Marshall JAR, 2011, BEHAV ECOL SOCIOBIOL, V65, P503, DOI 10.1007/s00265-010-1110-1; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mitchell M., 1998, INTRO GENETIC ALGORI; Moody J, 2001, AM J SOCIOL, V107, P679, DOI 10.1086/338954; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Nowak MA, 2007, P R SOC B, V274, P605, DOI 10.1098/rspb.2006.0125; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Rankin DJ, 2009, EVOLUTION, V63, P1913, DOI 10.1111/j.1558-5646.2009.00656.x; Santamaria JP, 2011, PSYCHOL SCI, V22, P584, DOI 10.1177/0956797611406444; Simpson B, 2008, SOC PSYCHOL QUART, V71, P37, DOI 10.1177/019027250807100106; Takahashi N, 2000, AM J SOCIOL, V105, P1105, DOI 10.1086/210400; TAYLOR PD, 1992, EVOLUTIONARY ECOLOGY, V5, P352; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Valente TW, 1997, SOC SCI MED, V45, P677, DOI 10.1016/S0277-9536(96)00385-1; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; Yamauchi A, 2010, BIOSYSTEMS, V102, P82, DOI 10.1016/j.biosystems.2010.07.017	45	11	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29188	10.1371/journal.pone.0029188	http://dx.doi.org/10.1371/journal.pone.0029188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866HE	22195019	Green Published, gold			2022-12-25	WOS:000298370400037
J	Dhanushkodi, A; McDonald, MP				Dhanushkodi, Anandh; McDonald, Michael P.			Intracranial V. cholerae Sialidase Protects against Excitotoxic Neurodegeneration	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MITOCHONDRIAL PERMEABILITY TRANSITION; GM1 GANGLIOSIDE TREATMENT; MICE LACKING; MONOSIALOGANGLIOSIDE GM1; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; GD3 GANGLIOSIDE; MOUSE MODEL; NEURONAL APOPTOSIS	Converging evidence shows that GD3 ganglioside is a critical effector in a number of apoptotic pathways, and GM1 ganglioside has neuroprotective and nootropic properties. Targeted deletion of GD3 synthase (GD3S) eliminates GD3 and increases GM1 levels. Primary neurons from GD3S-/- mice are resistant to neurotoxicity induced by amyloid-beta or hyperhomocysteinemia, and when GD3S is eliminated in the APP/PSEN1 double-transgenic model of Alzheimer's disease the plaque-associated oxidative stress and inflammatory response are absent. To date, no small-molecule inhibitor of GD3S exists. In the present study we used sialidase from Vibrio cholerae (VCS) to produce a brain ganglioside profile that approximates that of GD3S deletion. VCS hydrolyzes GD1a and complex b-series gangliosides to GM1, and the apoptogenic GD3 is degraded. VCS was infused by osmotic minipump into the dorsal third ventricle in mice over a 4-week period. Sensorimotor behaviors, anxiety, and cognition were unaffected in VCS-treated mice. To determine whether VCS was neuroprotective in vivo, we injected kainic acid on the 25th day of infusion to induce status epilepticus. Kainic acid induced a robust lesion of the CA3 hippocampal subfield in aCSF-treated controls. In contrast, all hippocampal regions in VCS-treated mice were largely intact. VCS did not protect against seizures. These results demonstrate that strategic degradation of complex gangliosides and GD3 can be used to achieve neuroprotection without adversely affecting behavior.	[Dhanushkodi, Anandh] Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN USA; Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Dhanushkodi, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN USA.	mike@tennessee.edu	Dhanushkodi, Anandh/AFN-9176-2022	McDonald, Michael P./0000-0002-9642-964X	National Institutes of Health [NIA R01AG031253]; NATIONAL INSTITUTE ON AGING [R01AG031253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by National Institutes of Health (NIA R01AG031253 to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Ariga  T., 2010, ASN NEURO, V2; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Bachis A, 2002, NEUROTOX RES, V4, P225, DOI 10.1080/10298420290015836; Bazalakova MH, 2007, GENES BRAIN BEHAV, V6, P411, DOI 10.1111/j.1601-183X.2006.00269.x; Ben-Ari Y, 2001, EPILEPSIA, V42, P5, DOI 10.1046/j.1528-1157.2001.042suppl.3005.x; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bernardo A, 2007, NEUROBIOL AGING, V28, P1195, DOI 10.1016/j.neurobiolaging.2006.05.035; Bernardo A, 2009, NEUROBIOL AGING, V30, P1777, DOI 10.1016/j.neurobiolaging.2007.12.022; CAROLEI A, 1991, CEREBROVAS BRAIN MET, V3, P134; Chuang YC, 2009, SEIZURE-EUR J EPILEP, V18, P420, DOI 10.1016/j.seizure.2009.03.002; Copani A, 2002, J NEUROSCI, V22, P3963, DOI 10.1523/JNEUROSCI.22-10-03963.2002; De Maria R, 1998, J EXP MED, V187, P897, DOI 10.1084/jem.187.6.897; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Dhanushkodi A, 2008, NEUROSCI BIOBEHAV R, V32, P657, DOI 10.1016/j.neubiorev.2007.10.004; FAVARON M, 1988, P NATL ACAD SCI USA, V85, P7351, DOI 10.1073/pnas.85.19.7351; Ferrari G, 1996, PERSPECT DEV NEUROBI, V3, P93; FERRARI G, 1995, J BIOL CHEM, V270, P3074, DOI 10.1074/jbc.270.7.3074; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Guelman LR, 1996, NEUROCHEM INT, V29, P521, DOI 10.1016/0197-0186(96)00016-2; Harrison FE, 2010, PHARMACOL BIOCHEM BE, V94, P543, DOI 10.1016/j.pbb.2009.11.009; Harrison FE, 2009, NUTR NEUROSCI, V12, P203, DOI 10.1179/147683009X423364; Harrison FE, 2009, PHARMACOL BIOCHEM BE, V93, P443, DOI 10.1016/j.pbb.2009.06.006; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Harrison FE, 2008, J NEUROCHEM, V106, P1198, DOI 10.1111/j.1471-4159.2008.05469.x; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; HILBUSH BS, 1992, J BIOL CHEM, V267, P24789; Hof PR., 2000, COMP CYTOARCHITECTON; Huang F, 2007, NUTR NEUROSCI, V10, P105, DOI 10.1080/10284150701406752; KARPIAK SE, 1991, J NEUROSCI RES, V30, P512, DOI 10.1002/jnr.490300308; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; KOTANI M, 1993, GLYCOBIOLOGY, V3, P137, DOI 10.1093/glycob/3.2.137; Kristal BS, 1999, J BIOL CHEM, V274, P23169, DOI 10.1074/jbc.274.33.23169; LAINETTI RD, 1993, BRAZ J MED BIOL RES, V26, P841; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Liu YJ, 1997, P NATL ACAD SCI USA, V94, P8138, DOI 10.1073/pnas.94.15.8138; MAHADIK SP, 1993, NEUROCHEM INT, V23, P163, DOI 10.1016/0197-0186(93)90094-L; MAHADIK SP, 1988, J NEUROSCI RES, V20, P479, DOI 10.1002/jnr.490200411; Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179; Malisan F, 1999, FEBS LETT, V452, P100, DOI 10.1016/S0014-5793(99)00543-8; Mann MC, 2004, BIOORG MED CHEM LETT, V14, P5555, DOI 10.1016/j.bmcl.2004.08.064; McDonald MP, 1998, LEARN MEMORY, V5, P289; McDonald MP, 2001, BEHAV PHARMACOL, V12, P477, DOI 10.1097/00008877-200111000-00009; Melchiorri D, 2002, CELL DEATH DIFFER, V9, P609, DOI 10.1038/sj.cdd.4401020; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Molander M, 2000, J NEUROSCI RES, V60, P531, DOI 10.1002/(SICI)1097-4547(20000515)60:4<531::AID-JNR12>3.0.CO;2-6; Morales A, 2004, GLYCOCONJUGATE J, V20, P579; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; Pitto M, 1998, FEBS LETT, V439, P93, DOI 10.1016/S0014-5793(98)01344-1; Rabin SJ, 2002, J BIOL CHEM, V277, P49466, DOI 10.1074/jbc.M203240200; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RAPPORT MM, 1985, ANN NEUROL, V18, P60, DOI 10.1002/ana.410180111; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Saito M, 2007, ALCOHOL CLIN EXP RES, V31, P665, DOI 10.1111/j.1530-0277.2007.00351.x; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sautter J, 2000, EXP NEUROL, V164, P121, DOI 10.1006/exnr.2000.7410; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schneider JS, 2010, J NEUROL SCI, V292, P45, DOI 10.1016/j.jns.2010.02.009; Schneider JS, 1998, NEUROLOGY, V50, P1630, DOI 10.1212/WNL.50.6.1630; SCHNEIDER JS, 1995, NEUROLOGY, V45, P1149, DOI 10.1212/WNL.45.6.1149; Scorrano L, 1999, J BIOL CHEM, V274, P22581, DOI 10.1074/jbc.274.32.22581; Shevchuk NA, 2007, BBA-MOL CELL BIOL L, V1771, P1226, DOI 10.1016/j.bbalip.2007.05.008; Siesser WB, 2006, GENES BRAIN BEHAV, V5, P282, DOI 10.1111/j.1601-183X.2005.00161.x; Siesser WB, 2005, PSYCHOPHARMACOLOGY, V181, P653, DOI 10.1007/s00213-005-0024-5; Silajdzic E, 2009, J NEUROSCI RES, V87, P2467, DOI 10.1002/jnr.22085; Silva RH, 1999, PSYCHOPHARMACOLOGY, V141, P111, DOI 10.1007/s002130050814; SKAPER SD, 1993, J NEUROSCI RES, V34, P478, DOI 10.1002/jnr.490340413; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; WIERASZKO A, 1986, BRAIN RES, V378, P120, DOI 10.1016/0006-8993(86)90292-1; Wu GS, 2005, J NEUROSCI, V25, P11014, DOI 10.1523/JNEUROSCI.3635-05.2005; Xie X, 2002, J NEUROCHEM, V81, P1185, DOI 10.1046/j.1471-4159.2002.00917.x; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yanagisawa M, 2006, GLYCOBIOLOGY, V16, p19G, DOI 10.1093/glycob/cwl003; Yang LJS, 2006, P NATL ACAD SCI USA, V103, P11057, DOI 10.1073/pnas.0604613103	77	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29285	10.1371/journal.pone.0029285	http://dx.doi.org/10.1371/journal.pone.0029285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195039	Green Submitted, Green Published, gold			2022-12-25	WOS:000298370400048
J	Belleudi, F; Scrofani, C; Torrisi, MR; Mancini, P				Belleudi, Francesca; Scrofani, Cristina; Torrisi, Maria Rosaria; Mancini, Patrizia			Polarized Endocytosis of the Keratinocyte Growth Factor Receptor in Migrating Cells: Role of Src-Signaling and Cortactin	PLOS ONE			English	Article							MEDIATED ENDOCYTOSIS; DYNAMIC ACTIN; BINDING; PHOSPHORYLATION; INTERNALIZATION; TRAFFICKING; ACTIVATION; REGULATORS; TRANSPORT	Cell migration is a physiological process that requires endocytic trafficking and polarization of adhesion molecules and receptor tyrosine kinases (RTKs) to the leading edge. Many growth factors are able to induce motility by binding to specific RTK on target cells. Among them, keratinocyte growth factor (KGF or FGF7) and fibroblast growth factor 10 (FGF10), members of the FGF family, are motogenic for keratinocytes, and exert their action by binding to the keratinocyte growth factor receptor (KGFR), a splicing variant of FGFR2, exclusively expressed on epithelial cells. Here we analyzed the possible role of cortactin, an F-actin binding protein which is tyrosine phosphorylated by Src and is involved in KGFR-mediated cell migration, in the KGFR endocytosis and polarization to the leading edge of migrating cells upon ligand-induced stimulation. Biochemical phosphorylation study revealed that both KGF and FGF10 were able to induce tyrosine phosphorylation of Src and in turn of cortactin, as demonstrated by using the specific pharmacological Src-inhibitor SU6656, although FGF10 effect was delayed with respect to that promoted by KGF. Immunofluorescence analysis demonstrated the polarized localization of KGFR upon ligand stimulation to the leading edge of migrating keratinocytes, process that was regulated by Src. Moreover, we showed that the colocalization of cortactin with KGFR at the plasma membrane protrusions and on early endosomes after KGF and FGF10 treatment was Src-dependent. Further, by using a RNA interference approach through microinjection, we showed that cortactin is required for KGFR endocytosis and that the clathrin-dependent internalization of the receptor is a critical event for its polarization. Finally, KGFR expression and polarization enhanced cell migration in a scratch assay. Our results indicate that both Src and cortactin play a key role in the KGFR endocytosis and polarization at the leading edge of migrating keratinocytes, supporting the crucial involvement of RTK trafficking in cell motility.	[Belleudi, Francesca; Scrofani, Cristina; Torrisi, Maria Rosaria] Univ Roma La Sapienza, Dipartimento Med Clin & Mol, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Torrisi, Maria Rosaria] Azienda Osped S Andrea, Rome, Italy; [Mancini, Patrizia] Univ Roma La Sapienza, Dipartimento Med Sperimentale, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome	Torrisi, MR (corresponding author), Univ Roma La Sapienza, Dipartimento Med Clin & Mol, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy.	patrizia.mancini@uniroma1.it; mara.torrisi@uniroma1.it		mancini, patrizia/0000-0003-0556-2056	MIUR; AIRC - Associazione Italiana per la Ricerca sul Cancro, Italy [IG 10272]	MIUR(Ministry of Education, Universities and Research (MIUR)); AIRC - Associazione Italiana per la Ricerca sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by grants from MIUR and from AIRC - Associazione Italiana per la Ricerca sul Cancro (IG 10272), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Assaker G, 2010, P NATL ACAD SCI USA, V107, P22558, DOI 10.1073/pnas.1010795108; BAO J, 2003, P NATL ACAD SCI USA; Belleudi F, 2002, HISTOCHEM CELL BIOL, V118, P1, DOI 10.1007/S00418-002-0424-0; Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x; Belleudi F, 2006, FASEB J, V20, P395, DOI 10.1096/fj.05-3934fje; Belleudi F, 2011, FASEB J, V25, P170, DOI 10.1096/fj.10-162156; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Broudy VC, 1999, BLOOD, V94, P1979; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Ceccarelli S, 2007, EXP CELL RES, V313, P1758, DOI 10.1016/j.yexcr.2007.03.013; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; de Diesbach MT, 2010, EXP CELL RES, V316, P3239, DOI 10.1016/j.yexcr.2010.09.001; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Galiacy S, 2003, EXP CELL RES, V283, P215, DOI 10.1016/S0014-4827(02)00049-6; Janssens K, 2010, P NATL ACAD SCI USA, V107, P7323, DOI 10.1073/pnas.0915075107; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jimenez PA, 1999, J SURG RES, V81, P238, DOI 10.1006/jsre.1998.5501; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kaksonen M, 2000, J CELL SCI, V113, P4421; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; Luo C, 2006, J BIOL CHEM, V281, P30081, DOI 10.1074/jbc.M605837200; Marchese C, 1998, J CELL SCI, V111, P3517; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Reilly JF, 2004, DNA CELL BIOL, V23, P538, DOI 10.1089/1044549041939223; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; TSUBOI R, 1993, J INVEST DERMATOL, V101, P49, DOI 10.1111/1523-1747.ep12358892; Ulrich F, 2009, TRAFFIC, V10, P811, DOI 10.1111/j.1600-0854.2009.00929.x; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Xia YP, 1999, J PATHOL, V188, P431, DOI 10.1002/(SICI)1096-9896(199908)188:4<431::AID-PATH362>3.0.CO;2-B; Zhu JW, 2007, J BIOL CHEM, V282, P16086, DOI 10.1074/jbc.M701997200; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668	43	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29159	10.1371/journal.pone.0029159	http://dx.doi.org/10.1371/journal.pone.0029159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195012	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100164
J	Montaseri, A; Busch, F; Mobasheri, A; Buhrmann, C; Aldinger, C; Rad, JS; Shakibaei, M				Montaseri, Azadeh; Busch, Franziska; Mobasheri, Ali; Buhrmann, Constanze; Aldinger, Constance; Rad, Jafar Soleimani; Shakibaei, Mehdi			IGF-1 and PDGF-bb Suppress IL-1 beta-Induced Cartilage Degradation through Down-Regulation of NF-kappa B Signaling: Involvement of Src/PI-3K/AKT Pathway	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; GROWTH-FACTOR RECEPTOR; NITRIC-OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3-KINASE; MATRIX-METALLOPROTEINASE; DEPENDENT TRANSCRIPTION; IN-VITRO; EXPRESSION; ACTIVATION; INHIBITION	Objective: Interleukin-1 beta (IL-1 beta) is a pro-inflammatory cytokine that plays a key role in the pathogenesis of osteoarthritis (OA). Growth factors (GFs) capable of antagonizing the catabolic actions of cytokines may have therapeutic potential in the treatment of OA. Herein, we investigated the potential synergistic effects of insulin-like growth factor (IGF-1) and platelet-derived growth factor (PDGF-bb) on different mechanisms participating in IL-1 beta-induced activation of nuclear transcription factor-kappa B (NF-kappa B) and apoptosis in chondrocytes. Methods: Primary chondrocytes were treated with IL-1 beta to induce dedifferentiation and co-treated with either IGF-1 or/and PDGF-bb and evaluated by immunoblotting and electron microscopy. Results: Pretreatment of chondrocytes with IGF-1 or/and PDGF-bb suppressed IL-1b-induced NF-kappa B activation via inhibition of IkB-alpha kinase. Inhibition of IkB-alpha kinase by GFs led to the suppression of IkB-alpha phosphorylation and degradation, p65 nuclear translocation and NF-kappa B-regulated gene products involved in inflammation and cartilage degradation (COX-2, MMPs) and apoptosis (caspase-3). GFs or BMS-345541 (specific inhibitor of the IKK) reversed the IL-1 beta-induced down-regulation of collagen type II, cartilage specific proteoglycans, beta 1-integrin, Shc, activated MAPKinase, Sox-9 and up-regulation of active caspase-3. Furthermore, the inhibitory effects of IGF-1 or/and PDGF-bb on IL-1 beta-induced NF-kappa B activation were sensitive to inhibitors of Src (PP1), PI-3K (wortmannin) and Akt (SH-5), suggesting that the pathway consisting of non-receptor tyrosine kinase (Src), phosphatidylinositol 3-kinase and protein kinase B must be involved in IL-1 beta signaling. Conclusion: The results presented suggest that IGF-1 and PDGF-bb are potent inhibitors of IL-1 beta-mediated activation of NF kappa B and apoptosis in chondrocytes, may be mediated in part through suppression of Src/PI-3K/AKT pathway, which may contribute to their anti-inflammatory effects.	[Montaseri, Azadeh; Rad, Jafar Soleimani] Tabriz Univ Med Sci, Dept Anat Sci, Tabriz, Iran; [Busch, Franziska; Buhrmann, Constanze; Aldinger, Constance; Shakibaei, Mehdi] Univ Munich, Inst Anat, Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Div Vet Med, Loughborough, England	Tabriz University of Medical Science; University of Munich; University of Nottingham	Montaseri, A (corresponding author), Tabriz Univ Med Sci, Dept Anat Sci, Tabriz, Iran.	mehdi.shakibaei@med.uni-muenchen.de	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020; Soleimani Rad, J./H-8410-2019; Mobasheri, Ali/D-5770-2011; Montaseri, Azadeh/G-3871-2015	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Mobasheri, Ali/0000-0001-6261-1286; Montaseri, Azadeh/0000-0003-4250-3629; Buhrmann, Constanze/0000-0002-0786-0463	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust (UK)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust (UK)(Wellcome Trust)	A. Mobasheri would like to acknowledge support from the Biotechnology and Biological Sciences Research Council (BBSRC) and The Wellcome Trust (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bauman JE, 2007, CLIN CANCER RES, V13, p4632S, DOI 10.1158/1078-0432.CCR-07-0212; Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cao L, 1999, MATRIX BIOL, V18, P343, DOI 10.1016/S0945-053X(99)00027-X; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Desai BJ, 1999, P SOC EXP BIOL MED, V221, P1, DOI 10.1046/j.1525-1373.1999.d01-49.x; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Hashimoto M, 2008, MED RES REV, V28, P464, DOI 10.1002/med.20113; Hickey Derrick G, 2003, Am J Orthop (Belle Mead NJ), V32, P70; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kieswetter K, 1997, ENDOCRINE, V6, P257, DOI 10.1007/BF02820501; Kim SJ, 2002, J BIOL CHEM, V277, P1332, DOI 10.1074/jbc.M107231200; Kulyk WM, 2000, EXP CELL RES, V255, P327, DOI 10.1006/excr.1999.4784; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Li WQ, 2001, J IMMUNOL, V166, P3491, DOI 10.4049/jimmunol.166.5.3491; Lin CC, 2007, J CELL PHYSIOL, V211, P771, DOI 10.1002/jcp.20987; MAIER R, 1994, BBA-PROTEIN STRUCT M, V1208, P145, DOI 10.1016/0167-4838(94)90171-6; Mandl EW, 2002, TISSUE ENG, V8, P573, DOI 10.1089/107632702760240490; Martel-Pelletier J, 1998, OSTEOARTHR CARTILAGE, V6, P374, DOI 10.1053/joca.1998.0140; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Ozes ON, 1999, NATURE, V401, P82; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Robbins JR, 2000, ARTHRITIS RHEUM, V43, P2189, DOI 10.1002/1529-0131(200010)43:10<2189::AID-ANR6>3.0.CO;2-S; Roman-Blas JA, 2006, OSTEOARTHR CARTILAGE, V14, P839, DOI 10.1016/j.joca.2006.04.008; Sakai T, 2001, J BONE MINER RES, V16, P1272, DOI 10.1359/jbmr.2001.16.7.1272; Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011; Schulze-Tanzil G, 2004, OSTEOARTHR CARTILAGE, V12, P448, DOI 10.1016/j.joca.2004.02.007; Seguin CA, 2003, J CELL PHYSIOL, V197, P357, DOI 10.1002/jcp.10371; Seifarth C, 2009, HISTOL HISTOPATHOL, V24, P1245, DOI 10.14670/HH-24.1245; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; SHAKIBAEI M, 1993, HISTOL HISTOPATHOL, V8, P715; Shakibaei M, 2001, J BIOL CHEM, V276, P13289, DOI 10.1074/jbc.M010859200; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2007, ANN NY ACAD SCI, V1095, P554, DOI 10.1196/annals.1397.060; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shakibaei M, 2006, BIOCHEM PHARMACOL, V72, P1382, DOI 10.1016/j.bcp.2006.08.022; Singh R, 2002, ARTHRITIS RHEUM, V46, P2079, DOI 10.1002/art.10443; Sitcheran R, 2003, GENE DEV, V17, P2368, DOI 10.1101/gad.1114503; Wu CY, 2008, J NEUROCHEM, V105, P1499, DOI 10.1111/j.1471-4159.2008.05318.x; Wu LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018447; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	52	148	157	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28663	10.1371/journal.pone.0028663	http://dx.doi.org/10.1371/journal.pone.0028663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194879	gold, Green Published			2022-12-25	WOS:000298369100073
J	Osiak, A; Radecke, F; Guhl, E; Radecke, S; Dannemann, N; Lutge, F; Glage, S; Rudolph, C; Cantz, T; Schwarz, K; Heilbronn, R; Cathomen, T				Osiak, Anna; Radecke, Frank; Guhl, Eva; Radecke, Sarah; Dannemann, Nadine; Luetge, Fabienne; Glage, Silke; Rudolph, Cornelia; Cantz, Tobias; Schwarz, Klaus; Heilbronn, Regine; Cathomen, Toni			Selection-Independent Generation of Gene Knockout Mouse Embryonic Stem Cells Using Zinc-Finger Nucleases	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; RESTRICTION ENZYMES; MAJOR DETERMINANT; GENOME; CLEAVAGE; REPAIR; CONSTRUCTION; TOXICITY; PATIENT; MICE	Gene knockout in murine embryonic stem cells (ESCs) has been an invaluable tool to study gene function in vitro or to generate animal models with altered phenotypes. Gene targeting using standard techniques, however, is rather inefficient and typically does not exceed frequencies of 10(-6). In consequence, the usage of complex positive/negative selection strategies to isolate targeted clones has been necessary. Here, we present a rapid single-step approach to generate a gene knockout in mouse ESCs using engineered zinc-finger nucleases (ZFNs). Upon transient expression of ZFNs, the target gene is cleaved by the designer nucleases and then repaired by non-homologous end-joining, an error-prone DNA repair process that introduces insertions/deletions at the break site and therefore leads to functional null mutations. To explore and quantify the potential of ZFNs to generate a gene knockout in pluripotent stem cells, we generated a mouse ESC line containing an X-chromosomally integrated EGFP marker gene. Applying optimized conditions, the EGFP locus was disrupted in up to 8% of ESCs after transfection of the ZFN expression vectors, thus obviating the need of selection markers to identify targeted cells, which may impede or complicate downstream applications. Both activity and ZFN-associated cytotoxicity was dependent on vector dose and the architecture of the nuclease domain. Importantly, teratoma formation assays of selected ESC clones confirmed that ZFN-treated ESCs maintained pluripotency. In conclusion, the described ZFN-based approach represents a fast strategy for generating gene knockouts in ESCs in a selection-independent fashion that should be easily transferrable to other pluripotent stem cells.	[Osiak, Anna; Dannemann, Nadine; Luetge, Fabienne; Cathomen, Toni] Hannover Med Sch, Inst Expt Hematol, D-3000 Hannover, Germany; [Osiak, Anna; Guhl, Eva; Heilbronn, Regine; Cathomen, Toni] Charite, Inst Virol CBF, Berlin, Germany; [Radecke, Frank; Schwarz, Klaus] Univ Ulm, Inst Transfus Med, Ulm, Germany; [Radecke, Sarah; Schwarz, Klaus] German Red Cross Blood Serv Baden Wurttemberg Hes, Inst Clin Transfus Med & Immunogenet, Ulm, Germany; [Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Rudolph, Cornelia] Hannover Med Sch, REBIRTH Cluster Excellence, JRG Genet & Epigenet Integr, D-3000 Hannover, Germany; [Cantz, Tobias] Hannover Med Sch, REBIRTH Cluster Excellence, JRG Stem Cell Biol, D-3000 Hannover, Germany	Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ulm University; Hannover Medical School; Hannover Medical School; Hannover Medical School	Osiak, A (corresponding author), Max Delbruck Ctr Mol Med, Mobile DNA Grp, Berlin, Germany.	cathomen.toni@mh-hannover.de	Heilbronn, Regine/E-1349-2013; Cathomen, Toni/ABG-8410-2021; Cantz, Tobias/Q-7081-2019; Cathomen, Toni/GZL-2702-2022	Cathomen, Toni/0000-0002-7757-4630; Cathomen, Toni/0000-0002-7757-4630; Heilbronn, Regine/0000-0001-6412-3278; Cantz, Tobias/0000-0002-1382-9577	German Research Foundation [SFB/TR19-TPC5, EXC 62/1]; European Commission [ZNIP-037783, PERSIST-222878]	German Research Foundation(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants of the German Research Foundation (SFB/TR19-TPC5 to T. Cathomen, EXC 62/1 to SG, CR, and T. Cantz) and the European Commission's Framework Programmes (ZNIP-037783 to KS and T. Cathomen, and PERSIST-222878 to T. Cathomen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bobis-Wozowicz S, 2011, METHODS, V53, P339, DOI 10.1016/j.ymeth.2010.12.019; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Connelly JP, 2010, MOL THER, V18, P1103, DOI 10.1038/mt.2010.57; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; FAUST N, 1994, DNA CELL BIOL, V13, P901, DOI 10.1089/dna.1994.13.901; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gupta A, 2011, NUCLEIC ACIDS RES, V39, P381, DOI 10.1093/nar/gkq787; Handel EM, 2011, CURR GENE THER, V11, P28, DOI 10.2174/156652311794520120; Handel EM, 2009, MOL THER, V17, P104, DOI 10.1038/mt.2008.233; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Kim S, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7a; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Lei YN, 2011, MOL THER, V19, P942, DOI 10.1038/mt.2011.12; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mitsui K, 2009, BIOCHEM BIOPH RES CO, V388, P711, DOI 10.1016/j.bbrc.2009.08.075; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; MUSSOLINO C, 2011, NUCL ACIDS RES  0803; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; PFAFF N, 2011, STEM CELLS DEV  0824; Radecke F, 2004, J GENE MED, V6, P1257, DOI 10.1002/jgm.613; Rahman SH, 2011, HUM GENE THER, V22, P925, DOI 10.1089/hum.2011.087; Ramalingam S, 2011, J MOL BIOL, V405, P630, DOI 10.1016/j.jmb.2010.10.043; Rebuzzini P, 2008, CYTOGENET GENOME RES, V121, P18, DOI 10.1159/000124377; Rudolph Cornelia, 2009, V506, P453, DOI 10.1007/978-1-59745-409-4_30; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schambach A, 2010, EXPERT OPIN BIOL TH, V10, P1089, DOI 10.1517/14712598.2010.496775; Shimizu Y, 2011, BIOCHEMISTRY-US, V50, P5033, DOI 10.1021/bi200393g; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	62	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28911	10.1371/journal.pone.0028911	http://dx.doi.org/10.1371/journal.pone.0028911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194948	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100124
J	Tang, YP; Liu, D; Zhang, LJ; Ingvarsson, S; Chen, HP				Tang, Yanping; Liu, Dong; Zhang, Lijie; Ingvarsson, Sigurdur; Chen, Huiping			Quantitative Analysis of miRNA Expression in Seven Human Foetal and Adult Organs	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; REGULATED MICRORNA; CELL-DEATH; DIFFERENTIATION; IDENTIFICATION; SYSTEM; CANCER; GENE; PROLIFERATION; DROSOPHILA	miRNAs have been found to repress gene expression at posttranscriptional level in cells. Studies have shown that expression of miRNAs is tissue-specific and developmental-stage-specific. The mechanism behind this could be explained by miRNA pathways. In this study, totally 54 miRNAs were analysed in 7 matched human foetal and adult organs (brain, colon, heart, kidney, liver, lung and spleen) using real-time PCR. Quantitative analysis showed that a big proportion of the 54 miRNAs have higher general expression in the organs of the foetal period than the adult period, with the exception of the heart. The miRNA gene promoter methylation level in the adult stages was higher than in the foetal stages. Moreover, there is a high general expression level of several miRNAs in both stages of brain, kidney, liver, lung and spleen, but not seen in colon and heart. Our results indicate that the miRNAs may play a bigger role in the foetal stage than the adult stage of brain, colon, kidney, liver, lung and spleen. The majority of the miRNAs analysed may play an important role in the growth and development of brain, kidney, liver, lung and spleen. However, a minority of the miRNAs may be functional in colon and heart.	[Tang, Yanping; Liu, Dong; Chen, Huiping] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Med Genet, Wuhan, Hubei, Peoples R China; [Zhang, Lijie] Wuhan Blood Ctr, Dept Blood Transfus, Wuhan, Hubei, Peoples R China; [Ingvarsson, Sigurdur] Univ Iceland, Fac Med, Inst Expt Pathol, Reykjavik, Iceland	Huazhong University of Science & Technology; University of Iceland	Tang, YP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Med Genet, Wuhan, Hubei, Peoples R China.	huiping@mail.hust.edu.cn	Ingvarsson, Sigurdur/E-7448-2011	Ingvarsson, Sigurdur/0000-0003-4125-1714	Huazhong University of Science and Technology [2010MS034]	Huazhong University of Science and Technology	This project was supported by the Huazhong University of Science and Technology (2010MS034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dhanantwari P, 2009, CIRCULATION, V120, P343, DOI 10.1161/CIRCULATIONAHA.108.796698; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; FU H, 2003, FEBS LETT, V579, P3849; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Liu D, 2010, HEPATOL RES, V40, P813, DOI 10.1111/j.1872-034X.2010.00683.x; Liu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007594; Nan Y, 2010, BRAIN RES, V1359, P14, DOI 10.1016/j.brainres.2010.08.074; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; RAZIN A, 1994, PROG NUCLEIC ACID RE, V48, P53, DOI 10.1016/S0079-6603(08)60853-3; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Zhang B, 2009, CANCER RES, V69, P75, DOI 10.1158/0008-5472.CAN-08-1393; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	31	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28730	10.1371/journal.pone.0028730	http://dx.doi.org/10.1371/journal.pone.0028730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194897	Green Published, gold			2022-12-25	WOS:000298369100086
J	Zanucco, E; Gotz, R; Potapenko, T; Carraretto, I; Ceteci, S; Ceteci, F; Seeger, W; Savai, R; Rapp, UR				Zanucco, Emanuele; Goetz, Rudolf; Potapenko, Tamara; Carraretto, Irene; Ceteci, Semra; Ceteci, Fatih; Seeger, Werner; Savai, Rajkumar; Rapp, Ulf R.			Expression of B-RAF V600E in Type II Pneumocytes Causes Abnormalities in Alveolar Formation, Airspace Enlargement and Tumor Formation in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-CANCER; SOMATIC MUTATIONS; EPITHELIAL-CELLS; MOUSE MODELS; PROTEIN; KINASE; INFLAMMATION; ACTIVATION; PATHWAY	Growth factor induced signaling cascades are key regulatory elements in tissue development, maintenance and regeneration. Perturbations of these cascades have severe consequences, leading to developmental disorders and neoplastic diseases. As a major function in signal transduction, activating mutations in RAF family kinases are the cause of human tumorigenesis, where B-RAF V600E has been identified as the prevalent mutant. In order to address the oncogenic function of B-RAF V600E, we have generated transgenic mice expressing the activated oncogene specifically in lung alveolar epithelial type II cells. Constitutive expression of B-RAF V600E caused abnormalities in alveolar epithelium formation that led to airspace enlargements. These lung lesions showed signs of tissue remodeling and were often associated with chronic inflammation and low incidence of lung tumors. The inflammatory cell infiltration did not precede the formation of the lung lesions but was rather accompanied with late tumor development. These data support a model where the continuous regenerative process initiated by oncogenic B-RAF-driven alveolar disruption provides a tumor-promoting environment associated with chronic inflammation.	[Zanucco, Emanuele; Ceteci, Semra; Ceteci, Fatih; Rapp, Ulf R.] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany; [Goetz, Rudolf; Potapenko, Tamara; Carraretto, Irene] Univ Wurzburg, Inst Med Radiat & Cell Res, Wurzburg, Germany; [Seeger, Werner; Savai, Rajkumar; Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Bad Nauheim, Germany	Max Planck Society; University of Wurzburg; Max Planck Society	Zanucco, E (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany.	rapp@biochem.mpg.de		Seeger, Werner/0000-0003-1946-0894; Savai, Rajkumar/0000-0003-1538-2091	Max Planck Society; German Excellence Initiative	Max Planck Society(Max Planck Society); German Excellence Initiative	This work has been supported by an institutional grant from the Max Planck Society to Ulf R. Rapp. He is a Max Planck Senior Fellow. Emanuele Zanucco was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MH, 2004, CANCER RES, V64, P5456, DOI 10.1158/0008-5472.CAN-04-0937; Andersson CK, 2010, AM J RESP CRIT CARE, V181, P206, DOI 10.1164/rccm.200906-0932OC; Barnes PJ, 2000, CHEST, V117, P10; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Krupke DM, 2008, NAT REV CANCER, V8, P459, DOI 10.1038/nrc2390; Lee G, 2009, CURR OPIN PULM MED, V15, P303, DOI 10.1097/MCP.0b013e32832c975a; Li Y, 2007, CANCER RES, V67, P8494, DOI 10.1158/0008-5472.CAN-07-0647; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Qu P, 2009, LUNG CANCER, V63, P341, DOI 10.1016/j.lungcan.2008.05.025; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schubbert S, 2007, CURR OPIN GENET DEV, V17, P15, DOI 10.1016/j.gde.2006.12.004; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Yildirim AO, 2010, AM J RESP CRIT CARE, V181, P705, DOI 10.1164/rccm.200804-573OC; Zebisch A, 2006, CELL MOL LIFE SCI, V63, P1314, DOI 10.1007/s00018-006-6005-y	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29093	10.1371/journal.pone.0029093	http://dx.doi.org/10.1371/journal.pone.0029093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194995	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100153
J	Felisbino, MB; Tamashiro, WMSC; Mello, MLS				Felisbino, Marina Barreto; Tamashiro, Wirla M. S. C.; Mello, Maria Luiza S.			Chromatin Remodeling, Cell Proliferation and Cell Death in Valproic Acid-Treated HeLa Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; GENE-EXPRESSION; EPIGENETIC MODULATION; NUCLEAR PHENOTYPES; MOUSE HEPATOCYTES; IMAGE-ANALYSIS; IN-VITRO; PHASE-I; TRICHOSTATIN; CANCER	Background: Valproic acid (VPA) is a potent anticonvulsant that inhibits histone deacetylases. Because of this inhibitory action, we investigated whether VPA would affect chromatin supraorganization, mitotic indices and the frequency of chromosome abnormalities and cell death in HeLa cells. Methodology/Principal Findings: Image analysis was performed by scanning microspectrophotometry for cells cultivated for 24 h, treated with 0.05, 0.5 or 1.0 mM VPA for 1-24 h, and subjected to the Feulgen reaction. TSA-treated cells were used as a predictable positive control. DNA fragmentation was investigated with the TUNEL assay. Chromatin decondensation was demonstrated under TSA and all VPA treatments, but no changes in chromosome abnormalities, mitotic indices or morphologically identified cell death were found with the VPA treatment conditions mentioned above, although decreased mitotic indices were detected under higher VPA concentration and longer exposure time. The frequency of DNA fragmentation identified with the TUNEL assay in HeLa cells increased after a 24-h VPA treatment, although this fragmentation occurred much earlier after treatment with TSA. Conclusions/Significance: The inhibition of histone deacetylases by VPA induces chromatin remodeling in HeLa cells, which suggests an association to altered gene expression. Under VPA doses close to the therapeutic antiepileptic plasma range no changes in cell proliferation or chromosome abnormalities are elicited. The DNA fragmentation results indicate that a longer exposure to VPA or a higher VPA concentration is required for the induction of cell death.	[Felisbino, Marina Barreto; Mello, Maria Luiza S.] Univ Campinas UNICAMP, Inst Biol, Dept Struct & Physiol Biol, Sao Paulo, Brazil; [Tamashiro, Wirla M. S. C.] Univ Campinas UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Felisbino, MB (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Struct & Physiol Biol, Sao Paulo, Brazil.	mlsmello@unicamp.br	Mello, Maria Luiza Silveira/D-9158-2012; felisbino, marina/G-7146-2012; Felisbino, Marina/N-9311-2019; TAMASHIRO, WIRLA/D-2519-2013	Mello, Maria Luiza Silveira/0000-0003-1629-5619; felisbino, marina/0000-0002-2407-0260; TAMASHIRO, WIRLA/0000-0001-8023-9027	Sao Paulo State Research Foundation (FAPESP) [2010/50015-6, 2009/11763-0]; Brazilian National Council for Research and Development (CNPq) [471303/2009-7, 301943/2009-5]; CNPq [301943/2009-5, 132345/2010-2]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grant no. 2010/50015-6 from the Sao Paulo State Research Foundation (FAPESP) and grants no. 471303/2009-7 and 301943/2009-5 from the Brazilian National Council for Research and Development (CNPq). MBF received a Master's fellowship from CNPq (132345/2010-2) and FAPESP (2009/11763-0) and MLSM received a research fellowship from CNPq (301943/2009-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmaca A, 2007, BRIT J CANCER, V97, P177, DOI 10.1038/sj.bjc.6603851; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Braiteh F, 2008, CLIN CANCER RES, V14, P6296, DOI 10.1158/1078-0432.CCR-08-1247; Dejligbjerg M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-70; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Elknerova K, 2011, NEOPLASMA, V58, P35, DOI 10.4149/neo_2011_01_35; Eyal S, 2004, EPILEPSIA, V45, P737, DOI 10.1111/j.0013-9580.2004.00104.x; Fortson WS, 2011, INT J ONCOL, V39, P111, DOI 10.3892/ijo.2011.1014; Frazee LA, 2008, ANN PHARMACOTHER, V42, P403, DOI 10.1345/aph.1K531; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; Gan YH, 2008, BIOCHEM BIOPH RES CO, V365, P386, DOI 10.1016/j.bbrc.2007.11.002; Gotfryd K, 2011, BASIC CLIN PHARMACOL, V109, P164, DOI 10.1111/j.1742-7843.2011.00702.x; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hayakawa F, 2008, J BIOL CHEM, V283, P24420, DOI 10.1074/jbc.M802217200; Jergil M, 2011, TOXICOL SCI, V121, P328, DOI 10.1093/toxsci/kfr070; Johnson R T, 1978, Methods Cell Biol, V20, P255, DOI 10.1016/S0091-679X(08)62023-3; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kortenhorst MSQ, 2009, MOL CANCER THER, V8, P802, DOI 10.1158/1535-7163.MCT-08-1076; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lagace DC, 2004, ENDOCRINOLOGY, V145, P5493, DOI 10.1210/en.2004-0877; Li XN, 2005, MOL CANCER THER, V4, P1912, DOI 10.1158/1535-7163.MCT-05-0184; Liu PY, 2008, MOL CANCER RES, V6, P1204, DOI 10.1158/1541-7786.MCR-08-0123; Machado CML, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-291; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Marinova Z, 2011, NEUROPHARMACOLOGY, V60, P1109, DOI 10.1016/j.neuropharm.2010.09.022; Mello MLS, 2009, MICRON, V40, P577, DOI 10.1016/j.micron.2009.02.010; MELLO MLS, 1980, CHROMOSOMA, V81, P419, DOI 10.1007/BF00368153; MELLO MLS, 1990, BIOCHEM CELL BIOL, V68, P1026, DOI 10.1139/o90-151; MELLO MLS, 1995, EXP CELL RES, V220, P374, DOI 10.1006/excr.1995.1328; MELLO MLS, 1994, ACTA HISTOCHEM CYTOC, V27, P23, DOI 10.1267/ahc.27.23; Milutinovic S, 2007, CARCINOGENESIS, V28, P560, DOI 10.1093/carcin/bgl167; Moraes AS, 2007, CYTOM PART A, V71A, P28, DOI 10.1002/cyto.a.20356; Moraes AS, 2005, CYTOM PART A, V63A, P94, DOI 10.1002/cyto.a.20113; Noh EL, 2009, BIOCHEM BIOPH RES CO, V378, P326, DOI 10.1016/j.bbrc.2008.11.057; Perucca E, 2002, EPILEPSY RES, V52, P25, DOI 10.1016/S0920-1211(02)00182-1; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Platta CS, 2007, J SURG RES, V142, P219, DOI 10.1016/j.jss.2006.12.555; Qiao LP, 2006, ENDOCRINOLOGY, V147, P865, DOI 10.1210/en.2005-1030; Rao J, 2007, BIOCHEM BIOPH RES CO, V363, P263, DOI 10.1016/j.bbrc.2007.08.120; Sami S, 2008, J BIOCHEM, V144, P357, DOI 10.1093/jb/mvn074; Shin HJ, 2003, ONCOGENE, V22, P3853, DOI 10.1038/sj.onc.1206502; Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x; Soriano AO, 2007, BLOOD, V110, P2302, DOI 10.1182/blood-2007-03-078576; Tabolacci E, 2008, PHARMACOGENET GENOM, V18, P738, DOI 10.1097/FPC.0b013e32830500a1; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Tung EWY, 2010, TOXICOL APPL PHARM, V248, P201, DOI 10.1016/j.taap.2010.08.001; Vidal BD, 1998, EXP CELL RES, V244, P77, DOI 10.1006/excr.1998.4171; VIDAL BD, 1984, BIOL CELL, V50, P137, DOI 10.1111/j.1768-322X.1984.tb00260.x; VIDAL BDC, 1973, ACTA CYTOL, V17, P510; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Xu XXS, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-17	52	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29144	10.1371/journal.pone.0029144	http://dx.doi.org/10.1371/journal.pone.0029144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206001	Green Submitted, Green Published, gold			2022-12-25	WOS:000298665600029
J	Rienmuller, F; Dreyer, I; Schonknecht, G; Schulz, A; Schumacher, K; Nagy, R; Martinoia, E; Marten, I; Hedrich, R				Rienmueller, Florian; Dreyer, Ingo; Schoenknecht, Gerald; Schulz, Alexander; Schumacher, Karin; Nagy, Reka; Martinoia, Enrico; Marten, Irene; Hedrich, Rainer			Luminal and Cytosolic pH Feedback on Proton Pump Activity and ATP Affinity of V-type ATPase from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; GUARD-CELLS; COUPLING RATIO; STORAGE TISSUE; BETA-VULGARIS; SUBUNIT-C; VACUOLAR; CHANNELS; TONOPLAST; K+	Proton pumping of the vacuolar-type H+-ATPase into the lumen of the central plant organelle generates a proton gradient of often 1-2 pH units or more. Although structural aspects of the V-type ATPase have been studied in great detail, the question of whether and how the proton pump action is controlled by the proton concentration on both sides of the membrane is not understood. Applying the patch clamp technique to isolated vacuoles from Arabidopsis mesophyll cells in the whole-vacuole mode, we studied the response of the V-ATPase to protons, voltage, and ATP. Current-voltage relationships at different luminal pH values indicated decreasing coupling ratios with acidification. A detailed study of ATP-dependent H+-pump currents at a variety of different pH conditions showed a complex regulation of V-ATPase activity by both cytosolic and vacuolar pH. At cytosolic pH 7.5, vacuolar pH changes had relative little effects. Yet, at cytosolic pH 5.5, a 100-fold increase in vacuolar proton concentration resulted in a 70-fold increase of the affinity for ATP binding on the cytosolic side. Changes in pH on either side of the membrane seem to be transferred by the V-ATPase to the other side. A mathematical model was developed that indicates a feedback of proton concentration on peak H+ current amplitude (v(max)) and ATP consumption (K-m) of the V-ATPase. It proposes that for efficient V-ATPase function dissociation of transported protons from the pump protein might become higher with increasing pH. This feature results in an optimization of H+ pumping by the V-ATPase according to existing H+ concentrations.	[Dreyer, Ingo] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Pozuelo De Alarcon 28223, Madrid, Spain; [Rienmueller, Florian; Schulz, Alexander; Marten, Irene; Hedrich, Rainer] Univ Wurzburg, Inst Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany; [Schoenknecht, Gerald] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA; [Schumacher, Karin] Heidelberg Univ, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany; [Nagy, Reka; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Hedrich, Rainer] King Saud Univ, Riyadh 11451, Saudi Arabia	Universidad Politecnica de Madrid; University of Wurzburg; Oklahoma State University System; Oklahoma State University - Stillwater; Ruprecht Karls University Heidelberg; University of Zurich; King Saud University	Dreyer, I (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Campus Montegancedo,Carretera M-40,Km 37-7, Pozuelo De Alarcon 28223, Madrid, Spain.	ingo.dreyer@upm.es; hedrich@botanik.uni-wuerzburg.de	Hedrich, Rainer/G-8771-2011; Schoenknecht, Gerald/L-8848-2013; Dreyer, Ingo/N-4747-2014; Schumacher, Karin/E-8500-2014; Martinoia, Enrico/AAH-8712-2021; Marten, Irene/AAS-8555-2021	Hedrich, Rainer/0000-0003-3224-1362; Schoenknecht, Gerald/0000-0003-3762-4880; Dreyer, Ingo/0000-0002-2781-0359; Schumacher, Karin/0000-0001-6484-8105; Marten, Irene/0000-0001-8402-869X	Deutsche Forschungsgemeinschaft [FOR1061, GK1342]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR1061 and GK1342 (to R. H.) and GK1342 (to I. M.).	BENNETT AB, 1984, PLANT PHYSIOL, V74, P545, DOI 10.1104/pp.74.3.545; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; BETHMANN B, 1995, PLANT PHYSIOL, V109, P1317, DOI 10.1104/pp.109.4.1317; Beyhl D, 2009, PLANT J, V58, P715, DOI 10.1111/j.1365-313X.2009.03820.x; BLATT MR, 1992, J GEN PHYSIOL, V99, P615, DOI 10.1085/jgp.99.4.615; BRISKIN DP, 1992, J EXP BOT, V43, P269, DOI 10.1093/jxb/43.3.269; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; CROSS RL, 1990, FEBS LETT, V259, P227, DOI 10.1016/0014-5793(90)80014-A; Dadacz-Narloch B, 2011, PLANT CELL, V23, P2696, DOI 10.1105/tpc.111.086751; DAVIES JM, 1994, P NATL ACAD SCI USA, V91, P8547, DOI 10.1073/pnas.91.18.8547; GAMBALE F, 1994, EUR BIOPHYS J BIOPHY, V22, P399, DOI 10.1007/BF00180161; Grabe M, 2000, BIOPHYS J, V78, P2798, DOI 10.1016/S0006-3495(00)76823-8; GUERN J, 1989, PLANT PHYSIOL, V89, P27, DOI 10.1104/pp.89.1.27; Hedrich R, 2011, MOL PLANT, V4, P428, DOI 10.1093/mp/ssr017; Hirata T, 2000, J BIOL CHEM, V275, P386, DOI 10.1074/jbc.275.1.386; Ivashikina N, 2005, PLANT J, V41, P606, DOI 10.1111/j.1365-313X.2004.02324.x; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kettner C, 2003, BIOPHYS J, V85, P3730, DOI 10.1016/S0006-3495(03)74789-4; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Krebs M, 2010, P NATL ACAD SCI USA, V107, P3251, DOI 10.1073/pnas.0913035107; LOHSE G, 1992, PLANTA, V188, P206, DOI 10.1007/BF00216815; Marcel D, 2010, FEBS LETT, V584, P2433, DOI 10.1016/j.febslet.2010.04.038; Meyer S, 2011, PLANT J, V67, P247, DOI 10.1111/j.1365-313X.2011.04587.x; Muller ML, 2002, J MEMBRANE BIOL, V185, P209, DOI 10.1007/s00232-001-0124-z; Muller ML, 1999, J BIOL CHEM, V274, P10706, DOI 10.1074/jbc.274.16.10706; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Ruppert C, 2001, FEMS MICROBIOL LETT, V195, P47, DOI 10.1111/j.1574-6968.2001.tb10496.x; SCHMIDT AL, 1993, ARCH BIOCHEM BIOPHYS, V301, P165, DOI 10.1006/abbi.1993.1129; Schulz A, 2011, PLANT J, V68, P129, DOI 10.1111/j.1365-313X.2011.04672.x; SCHULZLESSDORF B, 1995, PLANTA, V197, P655; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Voelker C, 2010, PLANT BIOLOGY, V12, P56, DOI 10.1111/j.1438-8677.2010.00353.x; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; Yabe I, 1999, J BIOL CHEM, V274, P34903, DOI 10.1074/jbc.274.49.34903; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	40	30	30	1	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8986	8993		10.1074/jbc.M111.310367	http://dx.doi.org/10.1074/jbc.M111.310367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22215665	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000301797800029
J	Lee, HH; Nemecek, D; Schindler, C; Smith, WJ; Ghirlando, R; Steven, AC; Bonifacino, JS; Hurley, JH				Lee, Hyung Ho; Nemecek, Daniel; Schindler, Christina; Smith, William J.; Ghirlando, Rodolfo; Steven, Alasdair C.; Bonifacino, Juan S.; Hurley, James H.			Assembly and Architecture of Biogenesis of Lysosome-related Organelles Complex-1 (BLOC-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERMANSKY-PUDLAK-SYNDROME; ANALYTICAL ULTRACENTRIFUGATION; PROTEIN COMPLEX; MOUSE MODEL; DYSBINDIN; GENE; PALLIDIN; SUBUNIT; ENCODES; PIGMENTATION	BLOC-1 (biogenesis of lysosome-related organelles complex-1) is critical for melanosome biogenesis and has also been implicated in neurological function and disease. We show that BLOC-1 is an elongated complex that contains one copy each of the eight subunits pallidin, Cappuccino, dysbindin, Snapin, Muted, BLOS1, BLOS2, and BLOS3. The complex appears as a linear chain of eight globular domains, similar to 300 angstrom long and similar to 30 angstrom in diameter. The individual domains are flexibly connected such that the linear chain undergoes bending by as much as 45 degrees. Two stable subcomplexes were defined, pallidin-Cappuccino-BLOS1 and dysbindin-Snapin-BLOS2. Both subcomplexes are 1:1:1 heterotrimers that form extended structures as indicated by their hydrodynamic properties. The two subcomplexes appear to constitute flexible units within the larger BLOC-1 chain, an arrangement conducive to simultaneous interactions with multiple BLOC-1 partners in the course of tubular endosome biogenesis and sorting.	[Steven, Alasdair C.] NIAMS, NIH, Bethesda, MD 20892 USA; [Lee, Hyung Ho] Kookmin Univ, Dept Bio & Nano Chem, Seoul 136702, South Korea; [Lee, Hyung Ho] Kookmin Univ, Dept Integrat Biomed Sci & Engn, Seoul 136702, South Korea; [Lee, Hyung Ho; Ghirlando, Rodolfo; Hurley, James H.] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA; [Schindler, Christina; Smith, William J.; Bonifacino, Juan S.] Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Kookmin University; Kookmin University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Steven, AC (corresponding author), NIAMS, NIH, Bldg 50,Rm 1517, Bethesda, MD 20892 USA.	stevena@mail.nih.gov; juan@helix.nih.gov; hurley@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	National Institutes of Health of NIDDK; NICHD; NIAMS; Deutsche Forschungsgemeinschaft; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036130, ZIADK033007] Funding Source: NIH RePORTER	National Institutes of Health of NIDDK; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Programs of NIDDK (to J. H. H.), NICHD (to J. S. B.), and NIAMS (to A. C. S.). This work was also supported by a fellowship from the Deutsche Forschungsgemeinschaft (to C. S.).	Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cullinane AR, 2011, AM J HUM GENET, V88, P778, DOI 10.1016/j.ajhg.2011.05.009; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; Gwynn B, 2000, BLOOD, V96, P4227; Hayes MJ, 2011, TRAFFIC, V12, P260, DOI 10.1111/j.1600-0854.2010.01151.x; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hierro A, 2005, METHOD ENZYMOL, V403, P322, DOI 10.1016/S0076-6879(05)03027-2; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Larimore J, 2011, MOL BIOL CELL, V22, P4854, DOI 10.1091/mbc.E11-07-0592; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Monfregola J, 2010, J BIOL CHEM, V285, P16951, DOI 10.1074/jbc.M109.078501; Morgan NV, 2006, AM J HUM GENET, V78, P160, DOI 10.1086/499338; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; Rodriguez-Fernandez IA, 2009, J INHERIT METAB DIS, V32, P190, DOI 10.1007/s10545-008-1014-7; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; VALENTINE RC, 1967, J MOL BIOL, V27, P615, DOI 10.1016/0022-2836(67)90063-0; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	42	44	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5882	5890		10.1074/jbc.M111.325746	http://dx.doi.org/10.1074/jbc.M111.325746			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203680	Green Published, hybrid			2022-12-25	WOS:000300638000062
J	Gilmore, SF; Nanduri, H; Parikh, AN				Gilmore, Sean F.; Nanduri, Harika; Parikh, Atul N.			Programmed Bending Reveals Dynamic Mechanochemical Coupling in Supported Lipid Bilayers	PLOS ONE			English	Article							MEMBRANE CURVATURE; RAFTS; PROTEINS	In living cells, mechanochemical coupling represents a dynamic means by which membrane components are spatially organized. An extra-ordinary example of such coupling involves curvature-dependent polar localization of chemically-distinct lipid domains at bacterial poles, which also undergo dramatic reequilibration upon subtle changes in their interfacial environment such as during sporulation. Here, we demonstrate that such interfacially-triggered mechanochemical coupling can be recapitulated in vitro by simultaneous, real-time introduction of mechanically-generated periodic curvatures and attendant strain-induced lateral forces in lipid bilayers supported on elastomeric substrates. In particular, we show that real-time wrinkling of the elastomeric substrate prompts a dynamic domain reorganization within the adhering bilayer, producing large, oriented liquid-ordered domains in regions of low curvature. Our results suggest a mechanism in which interfacial forces generated during surface wrinkling and the topographical deformation of the bilayer combine to facilitate dynamic reequilibration prompting the observed domain reorganization. We anticipate this curvature-generating model system will prove to be a simple and versatile tool for a broad range of studies of curvature-dependent dynamic reorganizations in membranes that are constrained by the interfacial elastic and dynamic frameworks such as the cell wall, glycocalyx, and cytoskeleton.	[Gilmore, Sean F.; Parikh, Atul N.] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA; [Nanduri, Harika; Parikh, Atul N.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Parikh, Atul N.] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Gilmore, SF (corresponding author), Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA.	anparikh@ucdavis.edu	Gilmore, Sean/AAX-1554-2020; PARIKH, ATUL/T-8268-2019; PARIKH, ATUL N/D-2243-2014	PARIKH, ATUL N/0000-0002-5927-4968	Chemical, Bioengineering, Environmental, and Transport Systems (CBET) National Science Foundation [1034569];  [T32 GM008799]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008799] Funding Source: NIH RePORTER	Chemical, Bioengineering, Environmental, and Transport Systems (CBET) National Science Foundation; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work reported here is supported by a grant from Chemical, Bioengineering, Environmental, and Transport Systems (CBET) National Science Foundation under award number 1034569. SFG is Biotech Fellow in Biotechnology Program partially supported by T32 training grant in Biomolecular Technology under award number T32 GM008799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Bettache N, 2003, J CELL SCI, V116, P2277, DOI 10.1242/jcs.00424; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Boulbitch A, 2002, EUROPHYS LET, V56; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; DUWE HP, 1990, J PHYS-PARIS, V51, P945, DOI 10.1051/jphys:019900051010094500; Efimenko K, 2005, NAT MATER, V4, P293, DOI 10.1038/nmat1342; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Hovis JS, 2000, LANGMUIR, V16, P894, DOI 10.1021/la991175t; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Oliver AE, 2008, LAB CHIP, V8, P892, DOI 10.1039/b800370j; Parthasarathy R, 2006, LANGMUIR, V22, P5095, DOI 10.1021/la060390o; PETROU S, 1995, PROSTAG LEUKOTR ESS, V52, P173, DOI 10.1016/0952-3278(95)90018-7; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Sanii B, 2008, NANO LETT, V8, P866, DOI 10.1021/nl073085b; SEUL M, 1990, PHYS REV LETT, V64, P1903, DOI 10.1103/PhysRevLett.64.1903; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	33	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28517	10.1371/journal.pone.0028517	http://dx.doi.org/10.1371/journal.pone.0028517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216096	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700008
J	Valle, CW; Min, TH; Bodas, M; Mazur, S; Begum, S; Tang, DN; Vij, N				Valle, Christopher W.; Min, Taehong; Bodas, Manish; Mazur, Steven; Begum, Shahnaz; Tang, Danni; Vij, Neeraj			Critical Role of VCP/p97 in the Pathogenesis and Progression of Non-Small Cell Lung Carcinoma	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; AAA ATPASE P97/VCP; KAPPA-B; SIGNALING PATHWAY; UBIQUITIN SYSTEM; EXPRESSION LEVEL; P97; PROGNOSIS; DEGRADATION; CANCER	Background: Valosin-containing protein (VCP)/p97 is an AAA ATPase molecular chaperone that regulates vital cellular functions and protein-processing. A recent study indicated that VCP expression levels are correlated with prognosis and progression of non-small cell lung carcinoma (NSCLC). We not only verified these findings but also identified the specific role of VCP in NSCLC pathogenesis and progression. Methodology/Principal Findings: Our results show that VCP is significantly overexpressed in non-small cell lung carcinoma (NSCLC) as compared to normal tissues and cell lines (p < 0.001). Moreover, we observed the corresponding accumulation of ubiquitinated-proteins in NSCLC cell lines and tissues as compared to the normal controls. VCP inhibition by si/shRNA or small-molecule (Eeyarestatin I, EerI) significantly (p < 0.05, p < 0.00007) suppressed H1299 proliferation and migration but induced (p < 0.00001) apoptosis. Cell cycle analysis by flow cytometry verified this data and shows that VCP inhibition significantly (p < 0.001, p < 0.003) induced cell cycle arrest in the G0/G1 phases. We also found that VCP directly regulates p53 and NF kappa B protein levels as a potential mechanism to control tumor cell proliferation and progression. Finally, we evaluated the therapeutic potential of VCP inhibition and observed significantly reduced NSCLC tumor growth in both in vitro and xenograft murine (athymic-nude) models after EerI treatment (p, 0.05). Conclusions/Significance: Thus, targeting VCP in NSCLC may provide a novel strategy to restore p53 and NFkB levels and ameliorate the growth and tumorigenicity, leading to improved clinical outcomes.	[Valle, Christopher W.; Min, Taehong; Bodas, Manish; Mazur, Steven; Tang, Danni; Vij, Neeraj] Johns Hopkins Sch Med, Dept Pediat Resp Sci, Baltimore, MD 21205 USA; [Vij, Neeraj] Johns Hopkins Sch Med, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Vij, Neeraj] Johns Hopkins Sch Med, Inst NanoBiotechnol, Baltimore, MD USA; [Begum, Shahnaz] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Valle, CW (corresponding author), Johns Hopkins Sch Med, Dept Pediat Resp Sci, Baltimore, MD 21205 USA.	nvij1@jhmi.edu	Bodas, Manish/AAE-4016-2020	Bodas, Manish/0000-0002-1046-9799	Flight Attendant Medical Research Institutes (FAMRI); National Institutes of Health [U54CA141868, CTSA UL RR 025005, RHL096931]; NATIONAL CANCER INSTITUTE [R43CA141868] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL096931] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institutes (FAMRI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported by the Flight Attendant Medical Research Institutes (FAMRI) Young Clinical Scientist Award Program (YCSAP) and by the National Institutes of Health (U54CA141868, CTSA UL RR 025005 and RHL096931) grants to NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Bodas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015480; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Ishigaki S, 2004, J BIOL CHEM, V279, P51376, DOI 10.1074/jbc.M406683200; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Koldehoff M, 2008, J LEUKOCYTE BIOL, V84, P561, DOI 10.1189/jlb.0907632; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Pan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013298; Partridge JJ, 2003, MOL BIOL CELL, V14, P4221, DOI 10.1091/mbc.E03-02-0111; Qiu Y, 2009, CANCER SCI, V100, P1198, DOI 10.1111/j.1349-7006.2009.01156.x; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Saeed Z, 2008, J CYST FIBROS, V7, P222, DOI 10.1016/j.jcf.2007.09.001; Singh A, 2010, ANTIOXID REDOX SIGNA; Tseng RC, 2009, NEOPLASIA, V11, P763, DOI 10.1593/neo.09470; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; Vij N, 2008, MOL VIS, V14, P1020; Vij N, 2011, EXPERT OPIN THER TAR, V15, P233, DOI 10.1517/14728222.2011.553610; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Waning DL, 2010, PHARMACEUTICALS, V3, P1576, DOI 10.3390/ph3051576; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2004, CLIN CANCER RES, V10, P651, DOI 10.1158/1078-0432.CCR-1576-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	46	65	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29073	10.1371/journal.pone.0029073	http://dx.doi.org/10.1371/journal.pone.0029073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216170	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700029
J	Werner, B; Lutz, D; Brummendorf, TH; Traulsen, A; Balabanov, S				Werner, Benjamin; Lutz, David; Bruemmendorf, Tim H.; Traulsen, Arne; Balabanov, Stefan			Dynamics of Resistance Development to Imatinib under Increasing Selection Pressure: A Combination of Mathematical Models and In Vitro Data	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; RESIDUAL DISEASE DETECTION; POLYMERASE-CHAIN-REACTION; KINASE INHIBITOR THERAPY; MUTANT BCR-ABL; STEM-CELLS; ANTIBIOTIC-RESISTANCE; DOMAIN MUTATIONS; CANCER PROGRAM; GENE	In the last decade, cancer research has been a highly active and rapidly evolving scientific area. The ultimate goal of all efforts is a better understanding of the mechanisms that discriminate malignant from normal cell biology in order to allow the design of molecular targeted treatment strategies. In individual cases of malignant model diseases addicted to a specific, ideally single oncogene, e. g. Chronic myeloid leukemia (CML), specific tyrosine kinase inhibitors (TKI) have indeed been able to convert the disease from a ultimately life-threatening into a chronic disease with individual patients staying in remission even without treatment suggestive of operational cure. These developments have been raising hopes to transfer this concept to other cancer types. Unfortunately, cancer cells tend to develop both primary and secondary resistance to targeted drugs in a substantially higher frequency often leading to a failure of treatment clinically. Therefore, a detailed understanding of how cells can bypass targeted inhibition of signaling cascades crucial for malignant growths is necessary. Here, we have performed an in vitro experiment that investigates kinetics and mechanisms underlying resistance development in former drug sensitive cancer cells over time in vitro. We show that the dynamics observed in these experiments can be described by a simple mathematical model. By comparing these experimental data with the mathematical model, important parameters such as mutation rates, cellular fitness and the impact of individual drugs on these processes can be assessed. Excitingly, the experiment and the model suggest two fundamentally different ways of resistance evolution, i.e. acquisition of mutations and phenotype switching, each subject to different parameters. Most importantly, this complementary approach allows to assess the risk of resistance development in the different phases of treatment and thus helps to identify the critical periods where resistance development is most likely to occur.	[Werner, Benjamin; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany; [Lutz, David; Balabanov, Stefan] Univ Hosp Eppendorf, Hubertus Wald Tumor Zentrum, Dept Oncol Hematol Bone Marrow Transplantat & Pne, Hamburg, Germany; [Bruemmendorf, Tim H.] RWTH Med Sch, Dept Hematol & Oncol, Aachen, Germany	Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; RWTH Aachen University	Werner, B (corresponding author), Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany.	werner@evolbio.mpg.de	Traulsen, Arne/A-4955-2009; Lutz, David/AAX-1607-2021; Balabanov, Stefan/E-9765-2014	Traulsen, Arne/0000-0002-0669-5267; Werner, Benjamin/0000-0002-6857-8699				Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; Balabanov S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019164; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bernoulli J, 1695, ACTA ERUDITORUM, V1, P65; Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Blagosklonny MV, 2002, LEUKEMIA, V16, P570, DOI 10.1038/sj.leu.2402409; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Chomel JC, 2011, ONCOTARGET, V2, P713; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Cortes J, 2011, BLOOD; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Demidenko ZN, 2005, CANCER BIOL THER, V4, P484, DOI 10.4161/cbt.4.4.1702; Dingli D, 2008, CLIN LEUK, V2, P133, DOI [10.3816/CLK.2008.n.017, DOI 10.3816/CLK.2008.N.017]; Dingli D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000002; Drake JW, 1998, GENETICS, V148, P1667; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Hanfstein B, 2011, HAEMATOL-HEMATOL J, V96, P360, DOI 10.3324/haematol.2010.030999; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Hochhaus A, 2011, CELL CYCLE, V10, P250, DOI 10.4161/cc.10.2.14537; Jiang XY, 2007, J NATL CANCER I, V99, P680, DOI 10.1093/jnci/djk150; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Katouli AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012300; Klawitter J, 2009, BRIT J PHARMACOL, V158, P588, DOI 10.1111/j.1476-5381.2009.00345.x; Komarova NL, 2011, MATH BIOSCI ENG, V8, P289, DOI 10.3934/mbe.2011.8.289; Komarova NL, 2009, CANCER RES, V69, P4904, DOI 10.1158/0008-5472.CAN-08-1959; Komarova NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004423; Kominsky DJ, 2009, CLIN CANCER RES, V15, P3442, DOI 10.1158/1078-0432.CCR-08-3291; Lange T, 2005, CELL CYCLE, V4, P1761, DOI 10.4161/cc.4.12.2261; Lenaerts T, 2011, CELL CYCLE, V10, P1540, DOI 10.4161/cc.10.10.15518; Lenaerts T, 2010, HAEMATOL-HEMATOL J, V95, P900, DOI 10.3324/haematol.2009.015271; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Moran P., 1962, STAT PROCESSES EVOLU; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Page KM, 2002, J THEOR BIOL, V219, P93, DOI 10.1006/yjtbi.3112; Patterson MK, 1979, METHODS ENZYMOL, P58; Pene-Dumitrescu T, 2010, J BIOL CHEM, V285, P21446, DOI 10.1074/jbc.M109.090043; Peng C, 2010, ONCOTARGET, V1, P156, DOI 10.18632/oncotarget.119; Rodriguez-Brenes IA, 2011, P NATL ACAD SCI USA, V108, P18983, DOI 10.1073/pnas.1107621108; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103; Vicente-Duenas C, 2010, AGING-US, V2, P908, DOI 10.18632/aging.100244; von Bubnoff N, 2003, LEUKEMIA, V17, P829, DOI 10.1038/sj.leu.2402889; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Werner B, 2011, PLOS COMPUT IN PRESS; Wu J, 2008, J NATL CANCER I, V100, P926, DOI 10.1093/jnci/djn188	53	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28955	10.1371/journal.pone.0028955	http://dx.doi.org/10.1371/journal.pone.0028955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216147	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700020
J	Whelan, AO; Villarreal-Ramos, B; Vordermeier, HM; Hogarth, PJ				Whelan, Adam O.; Villarreal-Ramos, Bernardo; Vordermeier, H. Martin; Hogarth, Philip J.			Development of an Antibody to Bovine IL-2 Reveals Multifunctional CD4 T-EM Cells in Cattle Naturally Infected with Bovine Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; GAMMA-INTERFERON; POLYFUNCTIONAL CD4(+); BCG VACCINATION; RESPONSES; MEMORY; EXPRESSION; PROTECTION; CORRELATE; INTERLEUKIN-2	Gaining a better understanding of the T cell mechanisms underlying natural immunity to bovine tuberculosis would help to identify immune correlates of disease progression and facilitate the rational design of improved vaccine and diagnostic strategies. CD4 T cells play an established central role in immunity to TB, and recent interest has focussed on the potential role of multifunctional CD4 T cells expressing IFN-gamma, IL-2 and TNF-alpha. Until now, it has not been possible to assess the contribution of these multifunctional CD4 T cells in cattle due to the lack of reagents to detect bovine IL-2 (bIL-2). Using recombinant phage display technology, we have identified an antibody that recognises biologically active bIL-2. Using this antibody, we have developed a polychromatic flow cytometric staining panel that has allowed the investigation of multifunctional CD4 T-cells responses in cattle naturally infected with M. bovis. Assessment of the frequency of antigen specific CD4 T cell subsets reveals a dominant IFN-gamma(+) IL-2(+)TNF-alpha(+) and IFN-gamma(+) TNF-alpha(+) response in naturally infected cattle. These multifunctional CD4 T cells express a CD44(hi)CD45RO(+)CD62L(lo) T-effector memory (T-EM) phenotype and display higher cytokine median fluorescence intensities than single cytokine producers, consistent with an enhanced 'quality of response' as reported for multifunctional cells in human and murine systems. Through our development of these novel immunological bovine tools, we provide the first description of multifunctional TEM cells in cattle. Application of these tools will improve our understanding of protective immunity in bovine TB and allow more direct comparisons of the complex T cell mediated immune responses between murine models, human clinical studies and bovine TB models in the future.	[Whelan, Adam O.; Villarreal-Ramos, Bernardo; Vordermeier, H. Martin; Hogarth, Philip J.] Anim Hlth & Vet Labs Agcy, Res Grp, Addlestone, Surrey, England	Veterinary Laboratories Agency	Whelan, AO (corresponding author), Anim Hlth & Vet Labs Agcy, Res Grp, Addlestone, Surrey, England.	Philip.hogarth@ahvla.gsi.gov.uk	Whelan, Adam O/C-9497-2011; Hogarth, Philip/C-6085-2011; Vordermeier, H Martin/C-6936-2011	Hogarth, Philip/0000-0002-6343-7846; 	Department for Environment, Food and Rural Affairs, UK	Department for Environment, Food and Rural Affairs, UK(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs (Defra; www.defra.gov), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Ashford DA, 2001, REV SCI TECH OIE, V20, P325, DOI 10.20506/rst.20.1.1266; Bembridge GP, 1995, IMMUNOLOGY, V86, P537; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; CERRETTI DP, 1986, P NATL ACAD SCI USA, V83, P3223, DOI 10.1073/pnas.83.10.3223; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Endsley JJ, 2007, VACCINE, V25, P8384, DOI 10.1016/j.vaccine.2007.10.011; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Krebs J., 1997, PB3423 HMSO; Kwong LS, 2010, VET IMMUNOL IMMUNOP, V135, P320, DOI 10.1016/j.vetimm.2010.01.001; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; Ng KH, 1997, VET IMMUNOL IMMUNOP, V57, P59, DOI 10.1016/S0165-2427(96)05760-1; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Schiott A, 2004, IMMUNOLOGY, V113, P363, DOI 10.1111/j.1365-2567.2004.01974.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Sopp P, 2001, VET IMMUNOL IMMUNOP, V81, P85, DOI 10.1016/S0165-2427(01)00334-8; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Waters WR, 2003, INFECT IMMUN, V71, P317, DOI 10.1128/IAI.71.1.317-326.2003; WEINBERG AD, 1988, J IMMUNOL, V141, P1174; Weynants V, 1998, VET IMMUNOL IMMUNOP, V66, P309, DOI 10.1016/S0165-2427(98)00205-0; WOOD PR, 1990, VET IMMUNOL IMMUNOP, V25, P37, DOI 10.1016/0165-2427(90)90108-5	34	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29194	10.1371/journal.pone.0029194	http://dx.doi.org/10.1371/journal.pone.0029194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216206	gold, Green Published, Green Submitted			2022-12-25	WOS:000299684700037
J	Renoult, JP; Schaefer, HM; Salle, B; Charpentier, MJE				Renoult, Julien P.; Schaefer, H. Martin; Salle, Bettina; Charpentier, Marie J. E.			The Evolution of the Multicoloured Face of Mandrills: Insights from the Perceptual Space of Colour Vision	PLOS ONE			English	Article							SECONDARY SEXUAL ADORNMENTS; REPRODUCTIVE SUCCESS; RECEIVER PSYCHOLOGY; SIGNAL; RECEPTOR; SKIN; MATE; TESTOSTERONE; CHROMATICITY; DOMINANCE	Multicomponent signals consist of several traits that are perceived as a whole. Although many animals rely on multicomponent signals to communicate, the selective pressures shaping these signals are still poorly understood. Previous work has mainly investigated the evolution of multicomponent signals by studying each trait individually, which may not accurately reflect the selective pressures exerted by the holistic perception of signal receivers. Here, we study the design of the multicoloured face of an Old World primate, the mandrill (Mandrillus sphinx), in relation to two aspects of signalling that are expected to be selected by receivers: conspicuousness and information. Using reflectance data on the blue and red colours of the faces of 34 males and a new method of hue vectorisation in a perceptual space of colour vision, we show that the blue hue maximises contrasts to both the red hue and the foliage background colouration, thereby increasing the conspicuousness of the whole display. We further show that although blue saturation, red saturation and the contrast between blue and red colours are all correlated with dominance, dominance is most accurately indicated by the blue-red contrast. Taken together our results suggest that the evolution of blue and red facial colours in male mandrills are not independent and are likely driven by the holistic perception of conspecifics. In this view, we propose that the multicoloured face of mandrills acts as a multicomponent signal. Last, we show that information accuracy increases with the conspicuousness of the whole display, indicating that both aspects of signalling can evolve in concert.	[Renoult, Julien P.; Schaefer, H. Martin] Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, Fac Biol, D-79106 Freiburg, Germany; [Salle, Bettina] Ctr Int Rech Med Franceville, Ctr Primatol, Franceville, Gabon; [Charpentier, Marie J. E.] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, Montpellier, France	University of Freiburg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Renoult, JP (corresponding author), Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	jujurenoult@hotmail.com	Charpentier, Marie JE/A-5108-2016	Charpentier, Marie/0000-0001-6530-5874	Volkswagen Foundation; Laboratoire International Associe CNRS (France)/CIRMF (Gabon) - PATHOS	Volkswagen Foundation(Volkswagen); Laboratoire International Associe CNRS (France)/CIRMF (Gabon) - PATHOS	This study was funded by the Volkswagen Foundation (www.volkswagenstiftung.de) to JPR and by the Laboratoire International Associe CNRS (France)/CIRMF (Gabon) - PATHOS to MJEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KA, 2002, J ZOOL, V258, P131, DOI 10.1017/S0952836902001267; Andersson Staffan, 2000, P47; Boynton RM, 1996, J OPT SOC AM A, V13, P1609, DOI 10.1364/JOSAA.13.001609; Bradbury Jack W., 1998, pi; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; BURLEY N, 1985, AVIAN MONOGAMY, V37, P22; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Charpentier M, 2005, P NATL ACAD SCI USA, V102, P16723, DOI 10.1073/pnas.0507205102; Charpentier M, 2005, BEHAV ECOL, V16, P614, DOI 10.1093/beheco/ari034; *CIE CENTR BUR, 2004, 152004 CIE CENTR BUR; Darwin G., 1871, P423; Doucet SM, 2007, AM NAT, V169, pS62, DOI 10.1086/510162; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Fairchild M. D., 2005, COLOR APPEARANCE MOD; Fernandez AA, 2007, AM NAT, V170, P10, DOI 10.1086/518566; Gomez D, 2007, AM NAT, V169, pS42, DOI 10.1086/510138; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Higham JP, 2008, HORM BEHAV, V53, P452, DOI 10.1016/j.yhbeh.2007.11.019; Higham JP, 2010, BEHAV ECOL, V21, P739, DOI 10.1093/beheco/arq047; HOLLDOBLER B, 1995, P NATL ACAD SCI USA, V92, P19, DOI 10.1073/pnas.92.1.19; JACOBS GH, 2008, VIS NEUROSCI, V25; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; Lind O, 2009, VISION RES, V49, P1939, DOI 10.1016/j.visres.2009.05.003; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Markiewicz M, 2007, J DERMATOL SCI, V47, P217, DOI 10.1016/j.jdermsci.2007.05.008; Markova MS, 2004, J INVEST DERMATOL, V123, P1052, DOI 10.1111/j.0022-202X.2004.23494.x; Marty JS, 2009, INT J PRIMATOL, V30, P807, DOI 10.1007/s10764-009-9382-x; Obana N, 1997, ENDOCRINOLOGY, V138, P356, DOI 10.1210/en.138.1.356; Prum RO, 2004, J EXP BIOL, V207, P2157, DOI 10.1242/jeb.00989; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Rhodes L, 1997, J REPROD FERTIL, V111, P51; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Rowe C, 1999, EVOL ECOL, V13, P655, DOI 10.1023/A:1011021630244; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; Scheuber H, 2003, P ROY SOC B-BIOL SCI, V270, P1779, DOI 10.1098/rspb.2003.2449; SCHLUTER D, 1993, P ROY SOC B-BIOL SCI, V253, P117, DOI 10.1098/rspb.1993.0089; Setchell JM, 2005, INT J PRIMATOL, V26, P715, DOI 10.1007/s10764-005-5305-7; Setchell JM, 2002, AM J PRIMATOL, V56, P9, DOI 10.1002/ajp.1060; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Setchell JM, 2001, AM J PHYS ANTHROPOL, V115, P245, DOI 10.1002/ajpa.1079; Setchell JM, 2001, AM J PRIMATOL, V53, P109, DOI 10.1002/1098-2345(200103)53:3<109::AID-AJP2>3.0.CO;2-I; Setchell JM, 2009, INT J PRIMATOL, V30, P825, DOI 10.1007/s10764-009-9371-0; Steck K, 2011, J EXP BIOL, V214, P1307, DOI 10.1242/jeb.053579; Stevens M, 2009, INT J PRIMATOL, V30, P893, DOI 10.1007/s10764-009-9356-z; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Stuart-Fox D, 2008, PLOS BIOL, V6, P22, DOI 10.1371/journal.pbio.0060025; Sumner P, 2000, J EXP BIOL, V203, P1987; Sumner P, 2000, J EXP BIOL, V203, P1963; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; WHITE PF, 1982, ANESTHESIOLOGY, V56, P119, DOI 10.1097/00000542-198202000-00007; WICKINGS EJ, 1992, PHYSIOL BEHAV, V52, P909, DOI 10.1016/0031-9384(92)90370-H; ZUK M, 1992, ANIM BEHAV, V44, P999, DOI 10.1016/S0003-3472(05)80312-4	58	26	26	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29117	10.1371/journal.pone.0029117	http://dx.doi.org/10.1371/journal.pone.0029117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216180	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600057
J	Boros, A; Pankovics, P; Simmonds, P; Reuter, G				Boros, Akos; Pankovics, Peter; Simmonds, Peter; Reuter, Gabor			Novel Positive-Sense, Single-Stranded RNA ( plus ssRNA) Virus with Di-Cistronic Genome from Intestinal Content of Freshwater Carp (Cyprinus carpio)	PLOS ONE			English	Article							MARINE FUNGOID PROTIST; SEQUENCE; HARNAV	A novel positive-sense, single-stranded RNA (+ssRNA) virus (Halastavi arva RNA virus, HalV; JN000306) with di-cistronic genome organization was serendipitously identified in intestinal contents of freshwater carps (Cyprinus carpio) fished by line-fishing from fishpond "Lorinte halasto" located in Veszprem County, Hungary. The complete nucleotide (nt) sequence of the genomic RNA is 9565 nt in length and contains two long - non-in-frame - open reading frames (ORFs), which are separated by an intergenic region. The ORF1 (replicase) is preceded by an untranslated sequence of 827 nt, while an untranslated region of 139 nt follows the ORF2 (capsid proteins). The deduced amino acid (aa) sequences of the ORFs showed only low (less than 32%) and partial similarity to the non-structural (2C-like helicase, 3C-like cystein protease and 3D-like RNA dependent RNA polymerase) and structural proteins (VP2/VP4/VP3) of virus families in Picornavirales especially to members of the viruses with dicistronic genome. Halastavi arva RNA virus is present in intestinal contents of omnivorous freshwater carps but the origin and the host species of this virus remains unknown. The unique viral sequence and the actual position indicate that Halastavi arva RNA virus seems to be the first member of a new di-cistronic ssRNA virus. Further studies are required to investigate the specific host species (and spectrum), ecology and role of Halastavi arva RNA virus in the nature.	[Boros, Akos; Pankovics, Peter; Reuter, Gabor] ANTSZ Reg Inst State Publ Hlth Serv, Reference Lab Gastroenter Viruses, Reg Lab Virol, Pecs, Hungary; [Simmonds, Peter] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Edinburgh	Boros, A (corresponding author), ANTSZ Reg Inst State Publ Hlth Serv, Reference Lab Gastroenter Viruses, Reg Lab Virol, Pecs, Hungary.	reuter.gabor@ddr.antsz.hu	Reuter, Gábor/I-7412-2013	Reuter, Gábor/0000-0002-5857-4934; Boros, Akos/0000-0001-5843-4360; Simmonds, Peter/0000-0002-7964-4700	Hungarian Scientific Research Fund (OTKA) [K83013]; Hungarian Academy of Sciences	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by a grant from the Hungarian Scientific Research Fund (OTKA, K83013). GR was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonning BC, 2010, ANNU REV ENTOMOL, V55, P129, DOI 10.1146/annurev-ento-112408-085457; Culley AI, 2003, NATURE, V424, P1054, DOI 10.1038/nature01886; Culley AI, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-69; Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264; ICTVwebsite, 2011, ICTV2009MASTERSPECIE; Kapoor A, 2010, J VIROL, V84, P10322, DOI 10.1128/JVI.00601-10; Lang AS, 2004, VIROLOGY, V320, P206, DOI 10.1016/j.virol.2003.10.015; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Nagasaki K, 2004, APPL ENVIRON MICROB, V70, P704, DOI 10.1128/AEM.70.2.704-711.2004; Nakashima N, 2010, ARCH VIROL, V155, P1477, DOI 10.1007/s00705-010-0723-z; Nakashima N, 2009, VIRUS RES, V139, P137, DOI 10.1016/j.virusres.2008.06.006; Nicholas KB., 1997, GENEDOC TOOL EDITING; Shirai Y, 2008, APPL ENVIRON MICROB, V74, P4022, DOI 10.1128/AEM.00509-08; Tai V, 2003, J PHYCOL, V39, P343, DOI 10.1046/j.1529-8817.2003.01162.x; Takao Y, 2006, J GEN VIROL, V87, P723, DOI 10.1099/vir.0.81204-0; Takao Y, 2005, APPL ENVIRON MICROB, V71, P4516, DOI 10.1128/AEM.71.8.4516-4522.2005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thole V, 2002, J GEN VIROL, V83, P3179, DOI 10.1099/0022-1317-83-12-3179; Tomaru Y, 2009, APPL ENVIRON MICROB, V75, P2375, DOI 10.1128/AEM.02580-08; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	21	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29145	10.1371/journal.pone.0029145	http://dx.doi.org/10.1371/journal.pone.0029145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195010	gold, Green Published, Green Submitted			2022-12-25	WOS:000298664400037
J	Jiang, GJ; Wang, K; Miao, DQ; Guo, L; Hou, Y; Schatten, H; Sun, QY				Jiang, Guang-Jian; Wang, Ke; Miao, De-Qiang; Guo, Lei; Hou, Yi; Schatten, Heide; Sun, Qing-Yuan			Protein Profile Changes during Porcine Oocyte Aging and Effects of Caffeine on Protein Expression Patterns	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; AGE-RELATED-CHANGES; MOUSE OOCYTES; BRAIN; MITOSIS; PHASE; MODEL; ACID	It has been shown that oocyte aging critically affects reproduction and development. By using proteomic tools, in the present study, changes in protein profiles during porcine oocyte aging and effects of caffeine on oocyte aging were investigated. By comparing control MII oocytes with aging MII oocytes, we identified 23 proteins that were up-regulated and 3 proteins that were down-regulated during the aging process. In caffeine-treated oocytes, 6 proteins were identified as up-regulated and 12 proteins were identified as down-regulated. A total of 38 differentially expressed proteins grouped into 5 regulation patterns were determined to relate to the aging and anti-aging process. By using the Gene Ontology system, we found that numerous functional gene products involved in metabolism, stress response, reactive oxygen species and cell cycle regulation were differentially expressed during the oocyte aging process, and most of these proteins are for the first time reported in our study, including 2 novel proteins. In addition, several proteins were found to be modified during oocyte aging. These data contribute new information that may be useful for future research on cellular aging and for improvement of oocyte quality.	[Jiang, Guang-Jian; Wang, Ke; Miao, De-Qiang; Guo, Lei; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Jiang, Guang-Jian; Wang, Ke] He Bei Union Univ, Coll Life Sci, Tangshan, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Missouri System; University of Missouri Columbia	Jiang, GJ (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	Miao, Deqiang/F-1226-2015	Miao, Deqiang/0000-0001-9731-9322	National Basic Research Program of China [2011CB944501, 2010CB535015]	National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Basic Research Program of China (2011CB944501, 2010CB535015). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett DGS, 2011, BRAIN RES BULL, V85, P9, DOI 10.1016/j.brainresbull.2010.11.016; Ghneim HK, 2010, CELL BIOCHEM FUNCT, V28, P283, DOI 10.1002/cbf.1653; Gil Del Valle L, 2010, BIOMED PHARMACOTHER; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Goud PT, 1999, MOL HUM REPROD, V5, P227, DOI 10.1093/molehr/5.3.227; Hou Y, 2010, EXP GERONTOL, V45, P323, DOI 10.1016/j.exger.2009.10.006; Jin XF, 2004, CELL STRESS CHAPERON, V9, P69, DOI 10.1379/477.1; Johnson RM, 2010, FREE RADICAL BIO MED, V48, P519, DOI 10.1016/j.freeradbiomed.2009.11.021; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Kikuchi Kazuhiro, 2002, Cloning and Stem Cells, V4, P211, DOI 10.1089/15362300260339494; Lee JH, 2008, CLONING STEM CELLS, V10, P381, DOI 10.1089/clo.2007.0091; Lee MS, 2010, J ASSIST REPROD GEN, V27, P629, DOI 10.1007/s10815-010-9459-7; Mailhes JB, 1998, BIOL REPROD, V58, P1206, DOI 10.1095/biolreprod58.5.1206; Matsumoto M, 2000, JPN J PHYSIOL, V50, P329, DOI 10.2170/jjphysiol.50.329; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Njemini R, 2007, BIOGERONTOLOGY, V8, P353, DOI 10.1007/s10522-006-9078-y; Opii W, 2008, NEUROBIOL AGING, V29, P51, DOI 10.1016/j.neurobiolaging.2006.09.012; POOL TB, 1990, FERTIL STERIL, V54, P166; Romano Antonino D, 2010, J Nephrol, V23 Suppl 15, pS29; Shimada N, 2010, J NEUROSCI RES, V88, P798, DOI 10.1002/jnr.22255; SMYTHE C, 1992, CELL, V68, P787, DOI 10.1016/0092-8674(92)90153-4; Sudheesh NP, 2009, FOOD CHEM TOXICOL, V47, P2124, DOI 10.1016/j.fct.2009.05.032; Sultana R, 2007, NEUROCHEM RES, V32, P655, DOI 10.1007/s11064-006-9123-x; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Tarin JJ, 1999, BIOL REPROD, V61, P1347, DOI 10.1095/biolreprod61.5.1347; Tatone C, 2006, BIOL REPROD, V74, P395, DOI 10.1095/biolreprod.105.046169; Tatone C, 2008, HUM REPROD UPDATE, V14, P131, DOI 10.1093/humupd/dmm048; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Ye XF, 2010, REPROD FERT DEVELOP, V22, P1254, DOI 10.1071/RD10062; Yoon SY, 2007, REPRODUCTION, V134, P695, DOI 10.1530/REP-07-0259	31	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28996	10.1371/journal.pone.0028996	http://dx.doi.org/10.1371/journal.pone.0028996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194971	Green Published, gold, Green Submitted			2022-12-25	WOS:000298664400033
J	Moelants, EAV; Van Damme, J; Proost, P				Moelants, Eva A. V.; Van Damme, Jo; Proost, Paul			Detection and Quantification of Citrullinated Chemokines	PLOS ONE			English	Article							PEPTIDYLARGININE DEIMINASE; POSTTRANSLATIONAL MODIFICATION; RHEUMATOID-ARTHRITIS; MESENCHYMAL CELLS; INTERFERON-GAMMA; HOST-DEFENSE; NEUTROPHIL; PEPTIDE; PROTEIN; CXCL10	Background: Posttranslational deimination or citrullination by peptidylarginine deiminases (PAD) regulates the biological function of proteins and may be involved in the development of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. This posttranslational modification of arginine was recently discovered on inflammatory chemokines including CXCL8 and CXCL10, and significantly reduced their biological activity. To evaluate the importance of these modified chemokines in patients, methods for the detection and quantification of citrullinated chemokines are needed. Since citrullination only results in an increase of the protein mass with one mass unit and the loss of one positive charge, selective biochemical detection is difficult. Therefore, we developed an antibody-based method to specifically detect and quantify citrullination on a protein of interest. Methodology/Principal Findings: First, the citrullinated proteins were chemically modified with antipyrine and 2,3-butanedione at low pH. Such selectively modified citrullines were subsequently detected and quantified by specific antibodies raised against a modified citrulline-containing peptide. The specificity of this two-step procedure was validated for citrullinated CXCL8 ([Cit(5)] CXCL8). Specific detection of [Cit(5)] CXCL8 concentrations between 1 and 50 ng/ml was possible, also in complex samples containing an excess of contaminating proteins. This novel detection method was used to evaluate the effect of lipopolysaccharide (LPS) on the citrullination of inflammatory chemokines induced in peripheral blood mononuclear cells (PBMCs) and granulocytes. LPS had no significant effect on the induction of CXCL8 citrullination in human PBMCs and granulocytes. However, granulocytes, known to contain PAD, were essential for the production of significant amounts of [Cit(5)] CXCL8. Conclusion/Significance: The newly developed antibody-based method to specifically detect and quantify chemically modified citrullinated proteins is proven to be effective. This study furthermore demonstrates that granulocytes were essential to obtain significant levels of [Cit(5)] CXCL8. For human PBMCs and granulocytes stimulation with LPS did not affect the citrullination of CXCL8.	[Moelants, Eva A. V.; Van Damme, Jo; Proost, Paul] Katholieke Univ Leuven, Lab Mol Immunol, Rega Inst, Louvain, Belgium	KU Leuven	Moelants, EAV (corresponding author), Katholieke Univ Leuven, Lab Mol Immunol, Rega Inst, Louvain, Belgium.	paul.proost@rega.kuleuven.be	Proost, Paul/V-3052-2017	Proost, Paul/0000-0002-0133-5545; Van Damme, Jo/0000-0002-6707-1167	Centers of Excellence of the K.U. Leuven [EF/05/15]; Regional Government of Flanders [G.O.A./2007/15]; Fund for Scientific Research of Flanders (F.W.O.-Vlaanderen); Interuniversity Attraction Poles Program-Belgian Science Policy	Centers of Excellence of the K.U. Leuven; Regional Government of Flanders; Fund for Scientific Research of Flanders (F.W.O.-Vlaanderen)(FWO); Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by the Centers of Excellence (credit no. EF/05/15) of the K.U. Leuven, the Concerted Research Actions (G.O.A./2007/15) of the Regional Government of Flanders, the Fund for Scientific Research of Flanders (F.W.O.-Vlaanderen), and the Interuniversity Attraction Poles Program-Belgian Science Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaga H, 2001, J LEUKOCYTE BIOL, V70, P46; BAZZONI F, 1991, J EXP MED, V173, P771, DOI 10.1084/jem.173.3.771; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Holm A, 2006, ANAL BIOCHEM, V352, P68, DOI 10.1016/j.ab.2006.02.007; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Loos T, 2008, BLOOD, V112, P2648, DOI 10.1182/blood-2008-04-149039; Loos T, 2009, HAEMATOL-HEMATOL J, V94, P1346, DOI 10.3324/haematol.2009.006973; Loos T, 2009, METHOD ENZYMOL, V461, P3, DOI 10.1016/S0076-6879(09)05401-9; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; Michiels K, 2009, EUR J ORAL SCI, V117, P362, DOI 10.1111/j.1600-0722.2009.00644.x; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Murphy PM, 2000, PHARMACOL REV, V52, P145; Musse AA, 2006, P NATL ACAD SCI USA, V103, P4422, DOI 10.1073/pnas.0509158103; Ordonez A, 2010, THROMB HAEMOSTASIS, V104, P1143, DOI 10.1160/TH10-05-0297; Proost P, 2004, J LEUKOCYTE BIOL, V75, P777, DOI 10.1189/jlb.1003524; Proost P., 2003, METH MOL B, V239, P27; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Proost P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1997; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; SCHRODER JM, 1987, J IMMUNOL, V139, P3474; Sebbag M, 2004, JOINT BONE SPINE, V71, P493, DOI 10.1016/j.jbspin.2004.07.004; Stensland M, 2009, RAPID COMMUN MASS SP, V23, P2754, DOI 10.1002/rcm.4185; STRIETER RM, 1992, AM J PATHOL, V141, P397; Struyf S, 2009, J IMMUNOL, V182, P666, DOI 10.4049/jimmunol.182.1.666; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; VANDAMME J, 1989, EUR J IMMUNOL, V19, P1189; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wuyts A, 2003, LAB INVEST, V83, P23, DOI 10.1097/01.LAB.0000048719.53282.00; Wuyts Anja, 1998, P271; Yamada R, 2007, NAT CLIN PRACT RHEUM, V3, P644, DOI 10.1038/ncprheum0592; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233	41	26	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28976	10.1371/journal.pone.0028976	http://dx.doi.org/10.1371/journal.pone.0028976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194966	Green Published, gold, Green Submitted			2022-12-25	WOS:000298664400029
J	Otis, JP; Sahoo, D; Drover, VA; Yen, CLE; Carey, HV				Otis, Jessica P.; Sahoo, Daisy; Drover, Victor A.; Yen, Chi-Liang Eric; Carey, Hannah V.			Cholesterol and Lipoprotein Dynamics in a Hibernating Mammal	PLOS ONE			English	Article							MANTLED GROUND-SQUIRREL; HIGH-DENSITY-LIPOPROTEINS; BEARS URSUS-AMERICANUS; HDL PARTICLE-SIZE; SPERMOPHILUS-LATERALIS; SEASONAL-CHANGES; GENE-EXPRESSION; BLACK BEARS; TRIACYLGLYCEROL SYNTHESIS; QUANTITATIVE-ANALYSIS	Hibernating mammals cease feeding during the winter and rely primarily on stored lipids to fuel alternating periods of torpor and arousal. How hibernators manage large fluxes of lipids and sterols over the annual hibernation cycle is poorly understood. The aim of this study was to investigate lipid and cholesterol transport and storage in ground squirrels studied in spring, summer, and several hibernation states. Cholesterol levels in total plasma, HDL and LDL particles were elevated in hibernators compared with spring or summer squirrels. Hibernation increased plasma apolipoprotein A-I expression and HDL particle size. Expression of cholesterol 7 alpha-hydroxylase was 13-fold lower in hibernators than in active season squirrels. Plasma triglycerides were reduced by fasting in spring but not summer squirrels. In hibernators plasma beta-hydroxybutyrate was elevated during torpor whereas triglycerides were low relative to normothermic states. We conclude that the switch to a lipid-based metabolism during winter, coupled with reduced capacity to excrete cholesterol creates a closed system in which efficient use of lipoproteins is essential for survival.	[Otis, Jessica P.; Carey, Hannah V.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Sahoo, Daisy; Drover, Victor A.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Yen, Chi-Liang Eric] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison	Otis, JP (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.	careyh@vetmed.wisc.edu	CAREY, HANNAH/ABF-1868-2021		University of Wisconsin School of Veterinary Medicine; National Science Foundation [IOS-1050311]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088210] Funding Source: NIH RePORTER	University of Wisconsin School of Veterinary Medicine; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by funds from the University of Wisconsin School of Veterinary Medicine (www.vetmed.wisc.edu), and was based on work supported by the National Science Foundation, while working at the Foundation (#IOS-1050311; www.nsf.gov). Any opinion, finding, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALADJEM F, 1954, AM J PHYSIOL, V178, P267, DOI 10.1152/ajplegacy.1954.178.2.267; ALLAIN CC, 1974, CLIN CHEM, V20, P470; ALOIA RC, 1989, BIOCHIM BIOPHYS ACTA, V988, P123, DOI 10.1016/0304-4157(89)90007-5; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Araki S, 2003, EXP GERONTOL, V38, P499, DOI 10.1016/S0531-5565(03)00038-X; Baker Julie A, 2009, Comp Hepatol, V8, P2, DOI 10.1186/1476-5926-8-2; Barger JL, 2006, J APPL PHYSIOL, V101, P339, DOI 10.1152/japplphysiol.01260.2005; BAUMBER J, 1971, LIFE SCI 2-BIOCH GEN, V10, P463, DOI 10.1016/0024-3205(71)90308-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CAREY HV, 1990, AM J PHYSIOL, V259, pR385, DOI 10.1152/ajpregu.1990.259.2.R385; Carey HV, 1996, AM J PHYSIOL-GASTR L, V271, pG805, DOI 10.1152/ajpgi.1996.271.5.G805; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; CAYEN MN, 1969, BIOCHIM BIOPHYS ACTA, V187, P546; Chauhan V, 2002, BIOCHIMIE, V84, P1031, DOI 10.1016/S0300-9084(02)00006-8; Cockerill GW, 2001, FASEB J, V15, P1941, DOI 10.1096/fj.01-0075com; CONSOLAZIO CF, 1967, AM J CLIN NUTR, V20, P684, DOI 10.1093/ajcn/20.7.684; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; DIETSCHY JM, 1967, J LIPID RES, V8, P97; ENDE N, 1960, J NUTR, V71, P85, DOI 10.1093/jn/71.1.85; Epperson LE, 2004, MOL CELL PROTEOMICS, V3, P920, DOI 10.1074/mcp.M400042-MCP200; Epperson LE, 2002, PHYSIOL GENOMICS, V10, P93, DOI 10.1152/physiolgenomics.00004.2002; ESHER RJ, 1973, COMP BIOCHEM PHYSIOL, V45, P933, DOI 10.1016/0300-9629(73)90329-0; Fedorov VB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-171; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; Fleck CC, 2005, AM J PHYSIOL-REG I, V289, pR586, DOI 10.1152/ajpregu.00100.2005; FLORANT GL, 1990, AM J PHYSIOL, V258, pR1123, DOI 10.1152/ajpregu.1990.258.5.R1123; FORGER NG, 1986, BIOL REPROD, V34, P831, DOI 10.1095/biolreprod34.5.831; FRANK CL, 1995, J COMP PHYSIOL B, V164, P536; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; Geiser F, 1997, J COMP PHYSIOL B, V167, P416, DOI 10.1007/s003600050091; GEISER F, 1994, J COMP PHYSIOL B, V164, P299, DOI 10.1007/BF00346446; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; KRILOWICZ BL, 1985, AM J PHYSIOL, V249, pR462, DOI 10.1152/ajpregu.1985.249.4.R462; Kurtz CC, 2006, AM J PHYSIOL-GASTR L, V291, pG895, DOI 10.1152/ajpgi.00155.2006; LAPLAUD PM, 1989, BIOCHIM BIOPHYS ACTA, V1005, P143, DOI 10.1016/0005-2760(89)90180-X; LeBlanc PJ, 2001, J COMP PHYSIOL B, V171, P327, DOI 10.1007/s003600100180; Lindell SL, 2005, AM J PHYSIOL-GASTR L, V288, pG473, DOI 10.1152/ajpgi.00223.2004; MACALA LJ, 1983, J LIPID RES, V24, P1243; MARKEL A, 1985, POSTGRAD MED J, V61, P395, DOI 10.1136/pgmj.61.715.395; Martin SL, 2008, AM J PHYSIOL-REG I, V295, pR316, DOI 10.1152/ajpregu.00418.2007; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; MOSTAFA N, 1993, J COMP PHYSIOL B, V163, P463; Mountassif D, 2007, BIOCHIMIE, V89, P1019, DOI 10.1016/j.biochi.2007.04.001; Nelson CJ, 2010, COMP BIOCHEM PHYS D, V5, P265, DOI 10.1016/j.cbd.2010.07.002; OTIS JP, 2009, J COMP PHYSIOL B, V180, P265; Pascot A, 2001, J LIPID RES, V42, P2007; PENGELLEY E, 1961, CAN J ZOOLOG, V39, P105, DOI 10.1139/z61-013; RAUCH JC, 1981, CAN J ZOOL, V59, P754, DOI 10.1139/z81-108; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Russeth KP, 2006, J PROTEOME RES, V5, P829, DOI 10.1021/pr050306a; RUSSOM JM, 1992, COMP BIOCHEM PHYS B, V102, P573, DOI 10.1016/0305-0491(92)90049-W; Serkova NJ, 2007, PHYSIOL GENOMICS, V31, P15, DOI 10.1152/physiolgenomics.00028.2007; Sokolovic M, 2010, J HEPATOL, V52, P737, DOI 10.1016/j.jhep.2009.11.028; SWANER JC, 1975, AM J PHYSIOL, V229, P365, DOI 10.1152/ajplegacy.1975.229.2.365; Tacer KF, 2007, PHYSIOL GENOMICS, V31, P216, DOI 10.1152/physiolgenomics.00264.2006; TALL AR, 1990, J CLIN INVEST, V86, P379, DOI 10.1172/JCI114722; TURLEY SD, 1991, METABOLISM, V40, P1063, DOI 10.1016/0026-0495(91)90131-F; van der Steeg WA, 2008, J AM COLL CARDIOL, V51, P634, DOI 10.1016/j.jacc.2007.09.060; Wang P, 1997, COMP BIOCHEM PHYS B, V118, P261, DOI 10.1016/S0305-0491(97)00102-8; Watanabe H, 2006, ARTERIOSCL THROM VAS, V26, P897, DOI 10.1161/01.ATV.0000209577.04246.c0; WENBERG GM, 1973, COMP BIOCHEM PHYSIOL, V44, P577, DOI 10.1016/0300-9629(73)90509-4; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200	62	24	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29111	10.1371/journal.pone.0029111	http://dx.doi.org/10.1371/journal.pone.0029111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195001	gold, Green Published, Green Submitted			2022-12-25	WOS:000298370400032
J	Brezar, V; Culina, S; Osterbye, T; Guillonneau, F; Chiappetta, G; Verdier, Y; Vinh, J; Wong, FS; Buus, S; Mallone, R				Brezar, Vedran; Culina, Slobodan; Osterbye, Thomas; Guillonneau, Francois; Chiappetta, Giovanni; Verdier, Yann; Vinh, Joelle; Wong, F. Susan; Buus, Soren; Mallone, Roberto			T Cells Recognizing a Peptide Contaminant Undetectable by Mass Spectrometry	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; SYNTHETIC PEPTIDES; NOD MICE; IDENTIFICATION; ISLETS	Synthetic peptides are widely used in immunological research as epitopes to stimulate their cognate T cells. These preparations are never completely pure, but trace contaminants are commonly revealed by mass spectrometry quality controls. In an effort to characterize novel major histocompatibility complex (MHC) Class I-restricted beta-cell epitopes in non-obese diabetic (NOD) mice, we identified islet-infiltrating CD8+ T cells recognizing a contaminating peptide. The amount of this contaminant was so small to be undetectable by direct mass spectrometry. Only after concentration by liquid chromatography, we observed a mass peak corresponding to an immunodominant islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)(206-214) epitope described in the literature. Generation of CD8+ T-cell clones recognizing IGRP(206-214) using a novel method confirmed the identity of the contaminant, further underlining the immunodominance of IGRP(206-214). If left undetected, minute impurities in synthetic peptide preparations may thus give spurious results.	[Brezar, Vedran; Culina, Slobodan; Mallone, Roberto] St Vincent de Paul Hosp, INSERM, U986, DeAR Lab Avenir, Paris, France; [Brezar, Vedran; Culina, Slobodan; Mallone, Roberto] Univ Paris 05, Fac Med, Paris, France; [Osterbye, Thomas; Buus, Soren] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Guillonneau, Francois] Univ Paris 05, Prote Facil 3P5, Paris, France; [Chiappetta, Giovanni; Verdier, Yann; Vinh, Joelle] ESPCI ParisTech, CNRS, USR 3149, Ecole Super Phys & Chim Ind Paris, Paris, France; [Wong, F. Susan] Cardiff Univ, Ctr Endocrine & Diabet Sci, Cardiff, S Glam, Wales; [Mallone, Roberto] Hop Cochin, AP HP, F-75674 Paris, France; [Mallone, Roberto] Hop Hotel Dieu, Serv Diabetol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Brezar, V (corresponding author), St Vincent de Paul Hosp, INSERM, U986, DeAR Lab Avenir, Paris, France.	roberto.mallone@inserm.fr	Buus, Soren/F-5446-2010; Mallone, Roberto/H-4430-2013; Vinh, Joelle/K-1347-2015	Mallone, Roberto/0000-0002-9846-8861; Vinh, Joelle/0000-0001-7184-2668; Verdier, Yann/0000-0002-3319-0053; Buus, Soren/0000-0001-8363-1999; Wong, F. Susan/0000-0002-2812-8845; Guillonneau, Francois/0000-0003-1484-4696	Juvenile Diabetes Research Foundation (JDRF) [1-2008-106]; European Foundation for the Study of Diabetes; Domaine d'Interet Majeur: Cardiovasculaire - Obesite - Diabete (Ile-de-France CODDIM)	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); European Foundation for the Study of Diabetes; Domaine d'Interet Majeur: Cardiovasculaire - Obesite - Diabete (Ile-de-France CODDIM)	This research was supported by the Juvenile Diabetes Research Foundation (JDRF grant 1-2008-106), the European Foundation for the Study of Diabetes (EFSD/JDRF/Novo Nordisk European Programme in Type 1 Diabetes Research 2007) and the Domaine d'Interet Majeur: Cardiovasculaire - Obesite - Diabete (Ile-de-France CODDIM). R. M. is an INSERM Avenir Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Brezar V, 2011, ENDOCR REV, V32, P623, DOI 10.1210/er.2011-0010; Culina S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/286248; Currier JR, 2008, CLIN VACCINE IMMUNOL, V15, P267, DOI 10.1128/CVI.00284-07; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; de Graaf MT, 2008, CYTOM PART A, V73A, P1079, DOI 10.1002/cyto.a.20636; De Spiegeleer B, 2008, ANAL BIOCHEM, V376, P229, DOI 10.1016/j.ab.2008.02.014; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; Diana J, 2011, J EXP MED, V208, P729, DOI 10.1084/jem.20101692; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Jarchum I, 2008, J IMMUNOL METHODS, V339, P66, DOI 10.1016/j.jim.2008.08.007; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; Mallone Roberto, 2005, Am J Ther, V12, P534, DOI 10.1097/01.mjt.0000178772.54396.38; Mallone R, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/513210; Mannering SI, 2003, VACCINE, V21, P3638, DOI 10.1016/S0264-410X(03)00402-X; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; SANTAMARIA P, 1995, J IMMUNOL, V154, P2494; Wong FS, 2009, DIABETES, V58, P1156, DOI 10.2337/db08-0800; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; WONG S, 1995, DIABETES, V44, P326, DOI 10.2337/diabetes.44.3.326	23	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28866	10.1371/journal.pone.0028866	http://dx.doi.org/10.1371/journal.pone.0028866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194932	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000298369100113
J	Scannella, JB; Horner, JR				Scannella, John B.; Horner, John R.			'Nedoceratops': An Example of a Transitional Morphology	PLOS ONE			English	Article							TAXONOMIC IMPLICATIONS; CRANIOFACIAL ONTOGENY; UGROSAURUS-OLSONI; TRICERATOPS; DINOSAURS; ORNITHISCHIA; ALBERTA; SKULL; CERATOPSIDAE; SYSTEMATICS	Background: The holotype and only specimen of the chasmosaurine ceratopsid dinosaur 'Nedoceratops hatcheri' has been the source of considerable taxonomic debate since its initial description. At times it has been referred to its own genus while at others it has been considered synonymous with the contemporaneous chasmosaurine Triceratops. Most recently, the debate has focused on whether the specimen represents an intermediate ontogenetic stage between typical young adult Triceratops and the proposed mature morphology, which was previously considered to represent a distinct genus, 'Torosaurus'. Methodology/Principal Findings: The only specimen of 'Nedoceratops hatcheri' was examined and the proposed diagnostic features of this taxon were compared with other chasmosaurine ceratopsids. Every suggested autapomorphy of 'Nedoceratops' is found in specimens of Triceratops. In this study, Triceratops includes the adult 'Torosaurus' morphology. The small parietal fenestra and elongate squamosals of Nedoceratops are consistent with a transition from a short, solid parietal-squamosal frill to an expanded, fenestrated condition. Objections to this hypothesis regarding the number of epiossifications of the frill and alternations of bone surface texture were explored through a combination of comparative osteology and osteohistology. The synonymy of the three taxa was further supported by these investigations. Conclusions/Significance: The Triceratops, 'Torosaurus', and 'Nedoceratops' morphologies represent ontogenetic variation within a single genus of chasmosaurine: Triceratops. This study highlights how interpretations of dinosaur paleobiology, biodiversity, and systematics may be affected by ascribing ontogenetic and other intraspecific variation a taxonomic significance.	[Scannella, John B.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Scannella, JB (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	jscannella@gmail.com			AMNH; UCMP	AMNH; UCMP	This research was funded in part by grants from the Theodore Roosevelt Memorial Fund of the AMNH and the Doris O. and Samuel P. Welles Research Fund of the UCMP to JBS. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHIBALD DJ, 1996, DINOSAUR EXTINCTION, P237; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; COBABE EA, 1987, J PALEONTOL, V61, P148, DOI 10.1017/S0022336000028298; Currie Philip J., 2008, P1; Dodson P., 1990, P231, DOI 10.1017/CBO9780511608377.020; DODSON P, 1988, CAN J EARTH SCI, V25, P926, DOI 10.1139/e88-090; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; Dodson P., 1996, HORNED DINOSAURS; Farke Andrew A., 2007, P235; Farke AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016196; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P246, DOI 10.1080/02724634.1996.10011312; FORSTER CA, 1993, J PALEONTOL, V67, P316, DOI 10.1017/S0022336000032273; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P259, DOI 10.1080/02724634.1996.10011313; Forster Catherine A., 1993, Journal of Vertebrate Paleontology, V13, P161; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Francillon-Vieillot H., 1990, SKELETAL BIOMINERALI, V1, P471; Godfrey SJ, 1995, J VERTEBR PALEONTOL, V15, P726, DOI 10.1080/02724634.1995.10011258; Goodwin Mark B., 2010, P551; Hieronymus TL, 2006, J MORPHOL, V267, P954, DOI 10.1002/jmor.10450; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2011, CR PALEVOL, V10, P439, DOI 10.1016/j.crpv.2011.04.006; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Lehman T.M., 1990, DINOSAUR SYSTEMATICS, P221; Lehman TM, 1998, J PALEONTOL, V72, P894, DOI 10.1017/S0022336000027220; Lull RS, 1905, AM J SCI, V20, P420; LULL RS, 1933, YALE PEABODY MUSEUM, V3, P1; Marsh O. C., 1898, American Journal of Science, V(4), P92; Marsh O.C., 1889, AM J SCI, V38, P173, DOI [10.2475/ajs.s3-38.224.173, DOI 10.2475/AJS.S3-38.224.173]; MARSH OC, 1892, AM J SCI 3, V43, P81; MARSH OC, 1891, AM J SCI 3, V42, P265, DOI DOI 10.2475/AJS.S3-42.249.265; Mateus O, 2008, J PALEONTOL, V82, P423, DOI 10.1666/07-069.1; Ostrom J.H., 1986, Zitteliana, V14, P111; Ostrom J.H., 1990, P245, DOI 10.1017/CBO9780511608377.021; Rozhdestvensky AK, 1965, PALEONTOL ZH, V3, P95; Ryan MJ, 2005, CAN J EARTH SCI, V42, P1369, DOI 10.1139/E05-029; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; Scannella J.B., 2009, CINCINNATI MUSEUM CT, V3, P148; SCANNELLA JB, 2010, J VERTEBR PALEONTOL, pA158; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; Tanke Darren H., 2007, P319; Tsuihiji T, 2010, ANAT REC, V293, P1360, DOI 10.1002/ar.21191; Tumarkin-Deratzian Allison R., 2010, P251; Ukrainsky A.S., 2007, Zoosystematica Rossica, V16, P292; UKRAINSKY AS, 2009, PALEONTOL ZH, P108; Wu XC, 2007, CAN J EARTH SCI, V44, P1243, DOI 10.1139/e07-011	53	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28705	10.1371/journal.pone.0028705	http://dx.doi.org/10.1371/journal.pone.0028705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194891	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100081
J	Zhou, JP; Chen, X; Feng, S; Luo, SD; Pan, YL; Zhong, L; Ji, P; Wang, ZR; Ma, S; Li, LL; Wei, YQ; Yang, SY				Zhou, Jian-Ping; Chen, Xin; Feng, Shan; Luo, Shi-Dong; Pan, You-Li; Zhong, Lei; Ji, Pan; Wang, Ze-Rong; Ma, Shuang; Li, Lin-Li; Wei, Yu-Quan; Yang, Sheng-Yong			Systems Biology Modeling Reveals a Possible Mechanism of the Tumor Cell Death upon Oncogene Inactivation in EGFR Addicted Cancers	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRANSFORMED-CELLS; REGULATES GROWTH; LUNG CANCERS; PATHWAY; ERK; PHOSPHORYLATION; SENSITIZATION; ENDOCYTOSIS; INHIBITION	Despite many evidences supporting the concept of "oncogene addiction" and many hypotheses rationalizing it, there is still a lack of detailed understanding to the precise molecular mechanism underlying oncogene addiction. In this account, we developed a mathematic model of epidermal growth factor receptor (EGFR) associated signaling network, which involves EGFR-driving proliferation/pro-survival signaling pathways Ras/extracellular-signal-regulated kinase (ERK) and phosphoinositol-3 kinase (PI3K)/AKT, and pro-apoptotic signaling pathway apoptosis signal-regulating kinase 1 (ASK1)/p38. In the setting of sustained EGFR activation, the simulation results show a persistent high level of proliferation/pro-survival effectors phospho-ERK and phospho-AKT, and a basal level of pro-apoptotic effector phospho-p38. The potential of p38 activation (apoptotic potential) due to the elevated level of reactive oxygen species (ROS) is largely suppressed by the negative crosstalk between PI3K/AKT and ASK1/p38 pathways. Upon acute EGFR inactivation, the survival signals decay rapidly, followed by a fast increase of the apoptotic signal due to the release of apoptotic potential. Overall, our systems biology modeling together with experimental validations reveals that inhibition of survival signals and concomitant release of apoptotic potential jointly contribute to the tumor cell death following the inhibition of addicted oncogene in EGFR addicted cancers.	[Zhou, Jian-Ping; Chen, Xin; Feng, Shan; Luo, Shi-Dong; Pan, You-Li; Zhong, Lei; Ji, Pan; Wang, Ze-Rong; Ma, Shuang; Li, Lin-Li; Wei, Yu-Quan; Yang, Sheng-Yong] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Zhou, Jian-Ping; Chen, Xin; Feng, Shan; Luo, Shi-Dong; Pan, You-Li; Zhong, Lei; Ji, Pan; Wang, Ze-Rong; Ma, Shuang; Li, Lin-Li; Wei, Yu-Quan; Yang, Sheng-Yong] Sichuan Univ, W China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China; [Zhou, Jian-Ping] Panzhihua Univ, Sch Med, Panzhihua, Sichuan, Peoples R China	Sichuan University; Sichuan University; Panzhihua University	Zhou, JP (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	yangsy@scu.edu.cn	ma, shuang/GQH-5344-2022		National Natural Science Foundation of China [20872100]; Youth Foundation of Sichuan Province [08ZQ026-030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Sichuan Province	This work was supported by the National Natural Science Foundation of China (20872100, http://www.nsfc.gov.cn/Portal0/default124.htm) and the Youth Foundation of Sichuan Province (08ZQ026-030, http://www.qnjj.sc.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Faber AC, 2010, CELL CYCLE, V9, P851, DOI 10.4161/cc.9.5.11096; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Felsher DW, 2008, CANCER RES, V68, P3081, DOI 10.1158/0008-5472.CAN-07-5832; Garber K, 2007, J NATL CANCER I, V99, P264, DOI 10.1093/jnci/djk087; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Hinoda Y, 2004, CANCER SCI, V95, P621, DOI 10.1111/j.1349-7006.2004.tb03319.x; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Hui ABY, 2005, CANCER RES, V65, P8125, DOI 10.1158/0008-5472.CAN-05-0648; Jin H, 2010, NAT NANOTECHNOL, V5, P302, DOI [10.1038/nnano.2010.24, 10.1038/NNANO.2010.24]; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamb A, 2003, MOL BIOL CELL, V14, P2201, DOI 10.1091/mbc.E02-11-0732; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kohl P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.51; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Liao Y, 2003, MOL CELL BIOL, V23, P6836, DOI 10.1128/MCB.23.19.6836-6848.2003; Materi W, 2007, DRUG DISCOV TODAY, V12, P295, DOI 10.1016/j.drudis.2007.02.013; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Mills GB, 2001, P NATL ACAD SCI USA, V98, P10031, DOI 10.1073/pnas.191379498; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ongkeko WM, 2005, AM J CLIN PATHOL, V124, P71, DOI 10.1309/BTLN5WTMJ3PCNRRC; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Raddatz E, 2011, AM J PHYSIOL-HEART C, V300, pH820, DOI 10.1152/ajpheart.00827.2010; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; Tikhomirov O, 2004, J BIOL CHEM, V279, P12988, DOI 10.1074/jbc.M311655200; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Ung CY, 2008, FEBS LETT, V582, P2283, DOI 10.1016/j.febslet.2008.05.026; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Wang Z, 2006, INVEST OPHTH VIS SCI, V47, P5267, DOI 10.1167/iovs.06-0642; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weinstein IB, 2000, CARCINOGENESIS, V21, P857, DOI 10.1093/carcin/21.5.857; Wolkenhauer Olaf, 2010, Cancer Res, V70, P12, DOI 10.1158/0008-5472.CAN-09-2676; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Zhang H, 2008, LEUKEMIA, V22, P1191, DOI 10.1038/leu.2008.74; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zou J, 2011, MOL BIOSYST, V7, P169, DOI 10.1039/c0mb00004c	70	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28930	10.1371/journal.pone.0028930	http://dx.doi.org/10.1371/journal.pone.0028930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194952	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100128
J	Kobayashi, Y; Mercado, N; Barnes, PJ; Ito, K				Kobayashi, Yoshiki; Mercado, Nicolas; Barnes, Peter J.; Ito, Kazuhiro			Defects of Protein Phosphatase 2A Causes Corticosteroid Insensitivity in Severe Asthma	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR PHOSPHORYLATION; N-TERMINAL KINASE; ACETYLATION; MODULATION; ACTIVATION; BINDING	Background: Corticosteroid insensitivity is a major barrier of treatment for some chronic inflammatory diseases, such as severe asthma, but the molecular mechanism of the insensitivity has not been fully elucidated. The object of this study is to investigate the role of protein phosphate 2A (PP2A), a serine/threonine phosphatase, on corticosteroid sensitivity in severe asthma. Methodology/Principal Findings: Corticosteroid sensitivity was determined by the dexamethasone ability to inhibit TNF alpha-induced IL-8 or LPS-induced TNF alpha production. PP2A expression, glucocorticoid receptor (GR) nuclear translocation defined as the nuclear/cytoplasmic GR ratio and phosphorylation of GR-Ser(226), c-Jun N-terminal kinase 1 (JNK1) and PP2A were analysed by Western-blotting. Phosphatase activity was measured by fluorescence-based assay. Okadaic acid (OA), a PP2A inhibitor, reduced corticosteroid sensitivity with reduced GR nuclear translocation and increased GR phosphorylation in U937 monocytic cells. PP2A knockdown by RNA interference showed similar effects. IL-2/IL-4 treatment to U937 reduced corticosteroid sensitivity, and PP2A expression/activity. In peripheral blood mononuclear cells (PBMCs) from severe asthma, the PP2A expression and activity were significantly reduced with concomitant enhancement of PP2A(C)-Tyr(307) phosphorylation compared with those in healthy volunteers. As the results, GR-Ser(226) and JNK1 phosphorylation were increased. The expression and activity of PP2A were negatively correlated with phosphorylation levels of GR-Ser(226). Furthermore, co-immunoprecipitation assay in U937 cells revealed that PP2A associated with GR and JNK1 and IL-2/IL-4 exposure caused dissociation of each molecule. Lastly, PP2A overexpression increased corticosteroid sensitivity in U937 cells. Conclusions/Significance: PP2A regulates GR nuclear translocation and corticosteroid sensitivity possibly by dephosphorylation of GR-Ser(226) via dephosphorylation of upstream JNK1. This novel mechanism will provide new insight for the development of new therapy for severe asthma.	[Kobayashi, Yoshiki; Mercado, Nicolas; Barnes, Peter J.; Ito, Kazuhiro] Univ London Imperial Coll Sci Technol & Med, Airway Dis Sect, Natl Heart & Lung Inst, London, England	Imperial College London	Kobayashi, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Airway Dis Sect, Natl Heart & Lung Inst, London, England.	k.ito@imperial.ac.uk	Ito, Kazuhiro/AAF-5994-2019	Barnes, Peter/0000-0002-5122-4018; mercado, nicolas/0000-0002-8728-0994	AstraZeneca; AsthmaUK; GlaxoSmithKline	AstraZeneca(AstraZeneca); AsthmaUK; GlaxoSmithKline(GlaxoSmithKline)	This study is funded by AstraZeneca (project grant), AsthmaUK (project grant), and GlaxoSmithKline (non-restricted grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Budziszewska B, 2010, J PHYSIOL PHARMACOL, V61, P207; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; Dean DA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-6; DEFRANCO DB, 1991, MOL ENDOCRINOL, V5, P1215, DOI 10.1210/mend-5-9-1215; Goleva E, 2009, AM J RESP CELL MOL, V40, P223, DOI 10.1165/rcmb.2007-0327OC; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K., 2001, FASEB Journal, V15, P1110; Ito K, 2009, EXPERT OPIN THER TAR, V13, P1053, DOI 10.1517/14728220903078431; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; KAM JC, 1993, J IMMUNOL, V151, P3460; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; Mercado N, 2011, MOL PHARM; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Sim ATR, 2006, PHARMACOL THERAPEUT, V112, P425, DOI 10.1016/j.pharmthera.2006.04.011; Sousa AR, 1999, J ALLERGY CLIN IMMUN, V104, P565, DOI 10.1016/S0091-6749(99)70325-8; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tsuchiya Y, 2007, FREE RADICAL BIO MED, V43, P1604, DOI 10.1016/j.freeradbiomed.2007.08.024; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; Webster JC, 1997, J BIOL CHEM, V272, P9287; Wenzel SE, 2007, J ALLERGY CLIN IMMUN, V119, P14, DOI 10.1016/j.jaci.2006.10.025; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017	32	57	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27627	10.1371/journal.pone.0027627	http://dx.doi.org/10.1371/journal.pone.0027627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205926	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600001
J	Chruszcz, M; Pomes, A; Glesner, J; Vailes, LD; Osinski, T; Porebski, PJ; Majorek, KA; Heymann, PW; Platts-Mills, TAE; Minor, W; Chapman, MD				Chruszcz, Maksymilian; Pomes, Anna; Glesner, Jill; Vailes, Lisa D.; Osinski, Tomasz; Porebski, Przemyslaw J.; Majorek, Karolina A.; Heymann, Peter W.; Platts-Mills, Thomas A. E.; Minor, Wladek; Chapman, Martin D.			Molecular Determinants for Antibody Binding on Group 1 House Dust Mite Allergens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DER-P-I; X-RAY-DIFFRACTION; DERMATOPHAGOIDES-PTERONYSSINUS; EPITOPE SPECIFICITY; CROSS-REACTIVITY; MAJOR ALLERGEN; HOT-SPOTS; F-I; IGE; EXPOSURE	House dust mites produce potent allergens, Der p 1 and Der f 1, that cause allergic sensitization and asthma. Der p 1 and Der f 1 are cysteine proteases that elicit IgE responses in 80% of mite-allergic subjects and have proinflammatory properties. Their antigenic structure is unknown. Here, we present crystal structures of natural Der p 1 and Der f 1 in complex with a monoclonal antibody, 4C1, which binds to a unique cross-reactive epitope on both allergens associated with IgE recognition. The 4C1 epitope is formed by almost identical amino acid sequences and contact residues. Mutations of the contact residues abrogate mAb 4C1 binding and reduce IgE antibody binding. These surface-exposed residues are molecular targets that can be exploited for development of recombinant allergen vaccines.	[Chruszcz, Maksymilian; Osinski, Tomasz; Porebski, Przemyslaw J.; Majorek, Karolina A.; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Pomes, Anna; Glesner, Jill; Vailes, Lisa D.; Chapman, Martin D.] INDOOR Biotechnol Inc, Charlottesville, VA 22903 USA; [Heymann, Peter W.; Platts-Mills, Thomas A. E.] Univ Virginia Hlth Syst, Div Allergy, Charlottesville, VA 22908 USA	University of Virginia; INDOOR Biotechnologies; University of Virginia	Chruszcz, M (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	maks@iwonka.med.virginia.edu; wladek@iwonka.med.virginia.edu	Minor, Wladek/F-3096-2014; Chruszcz, Maksymilian/E-6407-2011; Pomés, Anna/H-7010-2019; Porebski, Przemyslaw/D-9661-2018	Minor, Wladek/0000-0001-7075-7090; Chruszcz, Maksymilian/0000-0001-7521-5485; Pomés, Anna/0000-0002-8729-1829; Porebski, Przemyslaw/0000-0001-8012-5791; Osinski, Tomasz/0000-0001-9933-346X; Chapman, Martin/0000-0002-0845-3632; Platts-Mills, Thomas/0000-0002-1263-329X	National Institutes of Health [AI077653, GM53163, AI120565]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077653, GM53163, and AI120565.; We thank David Cooper and Rob Solberg for valuable discussions and Igor Shumilin for help with isothermal titration calorimetry experiments. The structural results shown in this report are derived from work performed at Argonne National Laboratory at the Structural Biology Center of the Advanced Photon Source. Argonne is operated by University of Chicago Argonne, LLC for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERZOFSKY JA, 1981, MOL IMMUNOL, V18, P751, DOI 10.1016/0161-5890(81)90067-5; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; CHAPMAN MD, 1987, J IMMUNOL, V139, P1479; CHAPMAN MD, 1980, J IMMUNOL, V125, P587; Cheong N, 2003, ALLERGY, V58, P912, DOI 10.1034/j.1398-9995.2003.00215.x; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Chruszcz M, 2009, J MOL BIOL, V386, P520, DOI 10.1016/j.jmb.2008.12.049; Cruz LM, 2008, P R HEALTH SCI J, V27, P163; Cymborowski M., 2010, Journal of Structural and Functional Genomics, V11, P211, DOI 10.1007/s10969-010-9092-9; de Halleux S, 2006, J ALLERGY CLIN IMMUN, V117, P571, DOI 10.1016/j.jaci.2005.11.032; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Earle CD, 2007, J ALLERGY CLIN IMMUN, V119, P428, DOI 10.1016/j.jaci.2006.11.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fellouse FA, 2006, J MOL BIOL, V357, P100, DOI 10.1016/j.jmb.2005.11.092; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Gront D, 2006, BIOINFORMATICS, V22, P621, DOI 10.1093/bioinformatics/btk037; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; HEYMANN PW, 1986, J IMMUNOL, V137, P2841; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; King EM, 2007, J ALLERGY CLIN IMMUN, V120, P1126, DOI 10.1016/j.jaci.2007.06.043; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LIND P, 1988, J IMMUNOL, V140, P4256; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McElveen JE, 1998, CLIN EXP ALLERGY, V28, P1427, DOI 10.1046/j.1365-2222.1998.00378.x; Meno K, 2005, J IMMUNOL, V175, P3835, DOI 10.4049/jimmunol.175.6.3835; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2006, J INVEST DERMATOL, V126, P2719, DOI 10.1038/sj.jid.5700584; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Piboonpocanun S, 2006, CLIN EXP ALLERGY, V36, P510, DOI 10.1111/j.1365-2222.2006.02464.x; Platts-Mills TAE, 2009, AM J RESP CRIT CARE, V180, P109, DOI 10.1164/rccm.200811-1756PR; Rashin AA, 2010, BIOCHEMISTRY-US, V49, P5683, DOI 10.1021/bi100110x; Rashin AA, 2009, ACTA CRYSTALLOGR D, V65, P1140, DOI 10.1107/S090744490903145X; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Salo PM, 2008, J ALLERGY CLIN IMMUN, V121, P678, DOI 10.1016/j.jaci.2007.12.1164; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Takai T, 2005, J ALLERGY CLIN IMMUN, V115, P555, DOI 10.1016/j.jaci.2004.11.024; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Victor BC, 2007, BIOL CHEM, V388, P1131, DOI 10.1515/BC.2007.150; Wu Di, 2010, Immunome Res, V6 Suppl 1, pS1, DOI 10.1186/1745-7580-6-S1-S1; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006; Zimmerman M, 2005, ACTA CRYSTALLOGR A, V61, pC178, DOI 10.1107/S0108767305092391	58	67	71	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7388	7398		10.1074/jbc.M111.311159	http://dx.doi.org/10.1074/jbc.M111.311159			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22210776	Green Published, hybrid			2022-12-25	WOS:000301060200040
J	Kedar, VP; Zucconi, BE; Wilson, GM; Blackshear, PJ				Kedar, Vishram P.; Zucconi, Beth E.; Wilson, Gerald M.; Blackshear, Perry J.			Direct Binding of Specific AUF1 Isoforms to Tandem Zinc Finger Domains of Tristetraprolin (TTP) Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEADENYLATION; RICH ELEMENT; POLY(A) TAIL; POLY(A)-BINDING PROTEIN; DEFICIENCY SYNDROME; TNF-ALPHA; TURNOVER; STABILITY; YEAST; DECAY	Tristetraprolin (TTP) is the prototype of a family of CCCH tandem zinc finger proteins that can bind to AU-rich elements in mRNAs and promote their decay. TTP binds to mRNA through its central tandem zinc finger domain; it then promotes mRNA deadenylation, considered to be the rate-limiting step in eukaryotic mRNA decay. We found that TTP and its related family members could bind to certain isoforms of another AU-rich element-binding protein, HNRNPD/AUF1, as well as a related protein, laAUF1. The interaction domain within AUF1p45 appeared to be a C-terminal "GY" region, and the interaction domain within TTP was the tandem zinc finger domain. Surprisingly, binding of AUF1p45 to TTP occurred even with TTP mutants that lacked RNA binding activity. In cell extracts, binding of AUF1p45 to TTP potentiated TTP binding to ARE-containing RNA probes, as determined by RNA gel shift assays; AUF1p45 did not bind to the RNA probes under these conditions. Using purified, recombinant proteins and a synthetic RNA target in FRET assays, we demonstrated that AUF1p45, but not AUF1p37, increased TTP binding affinity for RNA similar to 5-fold. These data suggest that certain isoforms of AUF1 can serve as "co-activators" of TTP family protein binding to RNA. The results raise interesting questions about the ability of AUF1 isoforms to regulate the mRNA binding and decay-promoting activities of TTP and its family members as well as the ability of AUF1 proteins to serve as possible physical links between TTP and other mRNA decay proteins and structures.	[Kedar, Vishram P.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Zucconi, Beth E.; Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University System of Maryland; University of Maryland Baltimore; Duke University; Duke University	Blackshear, PJ (corresponding author), F1-13 NIEHS,111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019; Wilson, Gerald/AAF-3874-2019	Blackshear, Perry J./0000-0002-9561-8529; Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health (NIEHS); American Heart Association [11PRE6900008]; National Institutes of Health [T32 GM066706];  [R01 CA102428]; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (NIEHS) and by Grant R01 CA102428 (to G. M. W.).; Supported by American Heart Association Grant 11PRE6900008 and National Institutes of Health Grant T32 GM066706.	Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carman JA, 2004, BIOCHEM BIOPH RES CO, V315, P445, DOI 10.1016/j.bbrc.2004.01.080; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; DeGrado-Warren J, 2008, BIOTECHNIQUES, V44, P265, DOI 10.2144/000112674; Doi A, 1998, BBA-GENE STRUCT EXPR, V1396, P51, DOI 10.1016/S0167-4781(97)00223-6; Frederick ED, 2008, J BIOL CHEM, V283, P14792, DOI 10.1074/jbc.M801234200; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Kedar VP, 2010, PLOS ONE, V5, pA213, DOI 10.1371/journal.pone.0009588; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Sadri N, 2009, J INVEST DERMATOL, V129, P657, DOI 10.1038/jid.2008.298; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wilson GM, 2005, REV FLUORESCENCE, V2, P223; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zucconi B. E., 2012, FRONT BIOSCI, V17, P2307; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182	52	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5459	5471		10.1074/jbc.M111.312652	http://dx.doi.org/10.1074/jbc.M111.312652			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203679	hybrid, Green Published			2022-12-25	WOS:000300638000026
J	Yang, HJ; Sugiura, Y; Ikegami, K; Konishi, Y; Setou, M				Yang, Hyun-Jeong; Sugiura, Yuki; Ikegami, Koji; Konishi, Yoshiyuki; Setou, Mitsutoshi			Axonal Gradient of Arachidonic Acid-containing Phosphatidylcholine and Its Dependence on Actin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION MASS-SPECTROMETRY; PHOSPHOLIPASE A(2); DOCOSAHEXAENOIC ACID; MITOCHONDRIAL-FUNCTION; ALZHEIMERS-DISEASE; MEMBRANE-LIPIDS; MYOSIN-II; CELLS; NEURONS; BRAIN	Phosphatidylcholine (PC) is the most abundant component of lipid bilayers and exists in various molecular forms, through combinations of two acylated fatty acids. Arachidonic acid (AA)-containing PC (AA-PC) can be a source of AA, which is a crucial mediator of synaptic transmission and intracellular signaling. However, the distribution of AA-PC within neurons has not been indicated. In the present study, we used imaging mass spectrometry to characterize the distribution of PC species in cultured neurons of superior cervical ganglia. Intriguingly, PC species exhibited a unique distribution that was dependent on the acyl chains at the sn-2 position. In particular, we found that AA-PC is enriched within the axon and is distributed across a proximal-to-distal gradient. Inhibitors of actin dynamics (cytochalasin D and phallacidin) disrupted this gradient. This is the first report of the gradual distribution of AA-PC along the axon and its association with actin dynamics.	[Yang, Hyun-Jeong; Sugiura, Yuki; Ikegami, Koji; Konishi, Yoshiyuki; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp		Sugiura, Yuki/0000-0002-6983-8958	Japanese Science and Technology Agency; Monbu Kagakusho; Grants-in-Aid for Scientific Research [23500443] Funding Source: KAKEN	Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Monbu Kagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for SENTAN (Development of Systems and Technology for Advanced Measurement and Analysis) from the Japanese Science and Technology Agency, Wakate S, and Tokutei (to M. S.). The "Lipid Machineries" research was supported by Monbu Kagakusho.	BARAK LS, 1981, J CELL BIOL, V89, P368, DOI 10.1083/jcb.89.2.368; Boland LM, 2008, CELL BIOCHEM BIOPHYS, V52, P59, DOI 10.1007/s12013-008-9027-2; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DAI JW, 1995, CELL, V83, P693; DIEZ E, 1990, J BIOL CHEM, V265, P14654; Farber SA, 2000, FASEB J, V14, P2198, DOI 10.1096/fj.99-0853; Ferreri C, 2004, J AM CHEM SOC, V126, P1063, DOI 10.1021/ja038072o; Hanson RM, 2010, J APPL CRYSTALLOGR, V43, P1250, DOI 10.1107/S0021889810030256; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; HOLTE LL, 1995, BIOPHYS J, V68, P2396, DOI 10.1016/S0006-3495(95)80422-4; Ikegami K, 2003, NEUROSCIENCE, V122, P617, DOI 10.1016/j.neuroscience.2003.08.057; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; KOBAYASHI H, 1977, J BIOCHEM-TOKYO, V81, P1071, DOI 10.1093/oxfordjournals.jbchem.a131530; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; LIN TN, 1988, LIPIDS, V23, P942, DOI 10.1007/BF02536341; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Morioka N, 2002, J NEUROCHEM, V80, P989, DOI 10.1046/j.0022-3042.2002.00722.x; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Nakanishi H, 2009, METHODS MOL BIOL, V579, P287, DOI 10.1007/978-1-60761-322-0_15; Nomura T, 2001, LIFE SCI, V68, P2885, DOI 10.1016/S0024-3205(01)01072-4; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; QUIK M, 1987, J NEUROCHEM, V48, P217, DOI 10.1111/j.1471-4159.1987.tb13150.x; Rubakhin SS, 2007, NAT PROTOC, V2, P1987, DOI 10.1038/nprot.2007.277; Rubakhin SS, 2006, ANAL CHEM, V78, P7267, DOI 10.1021/ac0607010; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Sanchez-Mejia RO, 2010, BBA-MOL CELL BIOL L, V1801, P784, DOI 10.1016/j.bbalip.2010.05.013; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Shetty HU, 1996, J NEUROCHEM, V67, P1702; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Sjovall P, 2003, ANAL CHEM, V75, P3429, DOI 10.1021/ac0207675; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Sugiura Y, 2009, J LIPID RES, V50, P1776, DOI 10.1194/jlr.M900047-JLR200; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; Yang HJ, 2010, SURF INTERFACE ANAL, V42, P1606, DOI 10.1002/sia.3581	49	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5290	5300		10.1074/jbc.M111.316877	http://dx.doi.org/10.1074/jbc.M111.316877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22207757	hybrid, Green Published			2022-12-25	WOS:000300638000011
J	Coetzee, MPA; Bloomer, P; Wingfield, MJ; Wingfield, BD				Coetzee, Martin P. A.; Bloomer, Paulette; Wingfield, Michael J.; Wingfield, Brenda D.			Paleogene Radiation of a Plant Pathogenic Mushroom	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; PHYLOGENETIC-RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; NEW-ZEALAND; SOUTHERN-HEMISPHERE; MOLECULAR CLOCKS; RIBOSOMAL DNA; ARMILLARIA; ECTOMYCORRHIZAL; VICARIANCE	Background: The global movement and speciation of fungal plant pathogens is important, especially because of the economic losses they cause and the ease with which they are able to spread across large areas. Understanding the biogeography and origin of these plant pathogens can provide insights regarding their dispersal and current day distribution. We tested the hypothesis of a Gondwanan origin of the plant pathogenic mushroom genus Armillaria and the currently accepted premise that vicariance accounts for the extant distribution of the species. Methods: The phylogeny of a selection of Armillaria species was reconstructed based on Maximum Parsimony (MP), Maximum Likelihood (ML) and Bayesian Inference (BI). A timeline was then placed on the divergence of lineages using a Bayesian relaxed molecular clock approach. Results: Phylogenetic analyses of sequenced data for three combined nuclear regions provided strong support for three major geographically defined clades: Holarctic, South American-Australasian and African. Molecular dating placed the initial radiation of the genus at 54 million years ago within the Early Paleogene, postdating the tectonic break-up of Gondwana. Conclusions: The distribution of extant Armillaria species is the result of ancient long-distance dispersal rather than vicariance due to continental drift. As these finding are contrary to most prior vicariance hypotheses for fungi, our results highlight the important role of long-distance dispersal in the radiation of fungal pathogens from the Southern Hemisphere.	[Coetzee, Martin P. A.; Wingfield, Michael J.; Wingfield, Brenda D.] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst FABI, ZA-0002 Pretoria, South Africa; [Bloomer, Paulette] Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme MEEP, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Coetzee, MPA (corresponding author), Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst FABI, ZA-0002 Pretoria, South Africa.	martin.coetzee@fabi.up.ac.za	Coetzee, Martin P.A./B-1732-2008; Wingfield, Brenda D./B-1376-2008; Bloomer, Paulette/F-5501-2010; Wingfield, Michael J/A-9473-2008	Coetzee, Martin P.A./0000-0001-7848-4111; Wingfield, Brenda D./0000-0002-6189-1519; Bloomer, Paulette/0000-0002-6357-0153; 	Tree Protection Co-operative Programme (TPCP); Mellon Foundation; National Research Foundation (NRF); Department of Science and Technology (DST)/NRF Centre of Excellence in Tree Health Biotechnology (CTHB); THRIP initiative of the Department of Trade and Industry (DTI) South Africa	Tree Protection Co-operative Programme (TPCP); Mellon Foundation; National Research Foundation (NRF); Department of Science and Technology (DST)/NRF Centre of Excellence in Tree Health Biotechnology (CTHB)(Department of Science & Technology (India)); THRIP initiative of the Department of Trade and Industry (DTI) South Africa	The work was financially supported by the Tree Protection Co-operative Programme (TPCP), the Mellon Foundation, the National Research Foundation (NRF), the Department of Science and Technology (DST)/NRF Centre of Excellence in Tree Health Biotechnology (CTHB) and the THRIP initiative of the Department of Trade and Industry (DTI) South Africa. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALVARADOROSALES D, 1994, PHYTOPATHOLOGY, V84, P1106; [Anonymous], 2000, ARMILLARIA ROOT ROT; Baumgartner K, 2010, PHYTOPATHOLOGY, V100, P708, DOI 10.1094/PHYTO-100-7-0708; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Berbee ML, 2001, MYCOTA, V7, P229; Binder M, 2010, MYCOLOGIA, V102, P865, DOI 10.3852/09-288; BURDON JJ, 1982, AUST J BIOL SCI, V35, P231, DOI 10.1071/BI9820231; Coetzee MPA, 2005, MYCOL RES, V109, P1223, DOI 10.1017/S095375620500393X; Coetzee MPA, 2005, PLANT PATHOL, V54, P36, DOI 10.1111/j.1365-3059.2005.01110.x; Coetzee MPA, 2003, PLANT PATHOL, V52, P604, DOI 10.1046/j.1365-3059.2003.00879.x; Coetzee MPA, 2003, MYCOLOGIA, V95, P285, DOI 10.2307/3762039; Coetzee MPA, 2000, MYCOLOGIA, V92, P105, DOI 10.2307/3761454; Coetzee MPA, 2001, MYCOLOGIA, V93, P887, DOI 10.2307/3761754; Coetzee MPA, 2001, MOL ECOL, V10, P387, DOI 10.1046/j.1365-294x.2001.01187.x; Cox CB, 2001, J BIOGEOGR, V28, P511; Crother BI, 1996, HERPETOLOGICA, V52, P440; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUMAS MT, 1988, CAN J FOREST RES, V18, P872, DOI 10.1139/x88-134; Dunne CP, 2002, AUSTRALAS PLANT PATH, V31, P241, DOI 10.1071/AP02015; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galloway D. J., 1996, P199; Garraway M. O., 1991, USDA FOREST SERVICE, V691, P21; Givnish TJ, 2004, INT J PLANT SCI, V165, pS1, DOI 10.1086/424022; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Gregory S.C., 1991, ARMILLARIA ROOT DIS, P76; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HALLING RE, 1987, MYCOLOGIA, V79, P674, DOI 10.2307/3807818; Halling RE, 2001, ANN MO BOT GARD, V88, P5, DOI 10.2307/2666128; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Hibbett DS, 1997, AM J BOT, V84, P981, DOI 10.2307/2446289; Hibbett DS, 2001, J BIOGEOGR, V28, P231, DOI 10.1046/j.1365-2699.2001.00528.x; Hopple JS, 1999, MOL PHYLOGENET EVOL, V13, P1, DOI 10.1006/mpev.1999.0634; HORAK E, 1983, AUST J BOT, P1; Hosaka K, 2008, MYCOL RES, V112, P448, DOI 10.1016/j.mycres.2007.06.004; Ingold C., 1971, MYCOLOGIA; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kauserud H, 2001, MYCOL RES, V105, P676, DOI 10.1017/S0953756201004191; Kile G.A., 1991, ARMILLARIA ROOT DIS, V691, P122; Kile GA, 1994, P 8 INT C ROOT BUTT, P411; Knapp M, 2005, PLOS BIOL, V3, P38, DOI 10.1371/journal.pbio.0030014; Korhonen Kari, 1995, Acta Universitatis Upsaliensis Symbolae Botanicae Upsalienses, V30, P153; Li DW, 2005, MYCOL RES, V109, P1235, DOI 10.1017/S0953756205003953; Liang Y, 2004, MYCORRHIZA, V14, P235, DOI 10.1007/s00572-003-0260-7; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Lumbsch HT, 2008, MYCOL RES, V112, P423, DOI 10.1016/j.mycres.2008.02.002; Maphosa L, 2006, AUSTRALAS PLANT PATH, V35, P513, DOI 10.1071/AP06056; Martin F, 2002, NEW PHYTOL, V153, P345, DOI 10.1046/j.0028-646X.2001.00313.x; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Matheny PB, 2009, J BIOGEOGR, V36, P577, DOI 10.1111/j.1365-2699.2008.02055.x; Mayr E., 1942, SYSTEMATICS ORIGIN S; McDowall RM, 2008, J BIOGEOGR, V35, P197, DOI 10.1111/j.1365-2699.2007.01830.x; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; MICKEVICH MF, 1981, SYST ZOOL, V30, P351, DOI 10.2307/2413255; Moncalvo JM, 2008, MYCOL RES, V112, P425, DOI 10.1016/j.mycres.2007.12.001; Moncalvo JM, 2000, SYST BIOL, V49, P278, DOI 10.1093/sysbio/49.2.278; Moyersoen B, 2006, NEW PHYTOL, V172, P753, DOI 10.1111/j.1469-8137.2006.01860.x; Mwenje E, 2003, MYCOL RES, V107, P291, DOI 10.1017/S0953756203007408; PADY SM, 1955, MYCOLOGIA, V47, P34, DOI 10.2307/3755754; Piercey-Normore MD, 1998, MOL PHYLOGENET EVOL, V10, P49, DOI 10.1006/mpev.1997.0485; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PROFFER TJ, 1987, PHYTOPATHOLOGY, V77, P941, DOI 10.1094/Phyto-77-941; Regan C. T., 1926, REPORT BRIT ASS ADV, V1925, P75; Renner SS, 2005, TRENDS PLANT SCI, V10, P550, DOI 10.1016/j.tplants.2005.09.010; Roets F, 2009, MOL PHYLOGENET EVOL, V51, P111, DOI 10.1016/j.ympev.2008.05.041; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Volk T.J., 1995, NOMENCLATURAL STUDY; Waters JM, 2006, SYST BIOL, V55, P351, DOI 10.1080/10635150600681659; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wolfe C. B., 1993, Australian Systematic Botany, V6, P187, DOI 10.1071/SB9930187; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239	80	25	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28545	10.1371/journal.pone.0028545	http://dx.doi.org/10.1371/journal.pone.0028545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216099	Green Submitted, Green Published, gold			2022-12-25	WOS:000300676300006
J	Zaal, KJM; Reid, E; Mousavi, K; Zhang, T; Mehta, A; Bugnard, E; Sartorelli, V; Ralston, E				Zaal, Kristien J. M.; Reid, Ericka; Mousavi, Kambiz; Zhang, Tan; Mehta, Amisha; Bugnard, Elisabeth; Sartorelli, Vittorio; Ralston, Evelyn			Who Needs Microtubules? Myogenic Reorganization of MTOC, Golgi Complex and ER Exit Sites Persists Despite Lack of Normal Microtubule Tracks	PLOS ONE			English	Article							MUSCLE-CELL DIFFERENTIATION; HAMSTER OVARY CELLS; ENDOPLASMIC-RETICULUM; SKELETAL-MUSCLE; LIVING CELLS; CENTROSOME PROTEINS; ORGANIZING CENTERS; SIGNALING PATHWAY; BINDING-PROTEIN; MANNOSIDASE-II	A wave of structural reorganization involving centrosomes, microtubules, Golgi complex and ER exit sites takes place early during skeletal muscle differentiation and completely remodels the secretory pathway. The mechanism of these changes and their functional implications are still poorly understood, in large part because all changes occur seemingly simultaneously. In an effort to uncouple the reorganizations, we have used taxol, nocodazole, and the specific GSK3-beta inhibitor DW12, to disrupt the dynamic microtubule network of differentiating cultures of the mouse skeletal muscle cell line C2. Despite strong effects on microtubules, cell shape and cell fusion, none of the treatments prevented early differentiation. Redistribution of centrosomal proteins, conditional on differentiation, was in fact increased by taxol and nocodazole and normal in DW12. Redistributions of Golgi complex and ER exit sites were incomplete but remained tightly linked under all circumstances, and conditional on centrosomal reorganization. We were therefore able to uncouple microtubule reorganization from the other events and to determine that centrosomal proteins lead the reorganization hierarchy. In addition, we have gained new insight into structural and functional aspects of the reorganization of microtubule nucleation during myogenesis.	[Zaal, Kristien J. M.; Reid, Ericka; Zhang, Tan; Mehta, Amisha; Bugnard, Elisabeth; Ralston, Evelyn] NIAMSD, Light Imaging Sect, Off Sci & Technol, NIH, Bethesda, MD 20892 USA; [Mousavi, Kambiz; Sartorelli, Vittorio] NIAMSD, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Bugnard, Elisabeth] Ctr Univ Orsay, Inst Curie, F-91405 Orsay, France	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Zaal, KJM (corresponding author), NIAMSD, Light Imaging Sect, Off Sci & Technol, NIH, Bethesda, MD 20892 USA.	zaalk@mail.nih.gov		Sartorelli, Vittorio/0000-0002-9284-3675	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041126, ZIAAR041132, ZICAR041186] Funding Source: NIH RePORTER; Medical Research Council [G0800435] Funding Source: researchfish; MRC [G0800435] Funding Source: UKRI	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atilla-Gokcumen GE, 2006, CHEMBIOCHEM, V7, P1443, DOI 10.1002/cbic.200600117; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; CAMERON DA, 1968, CLIN ORTHOP RELAT R, P191; Cardone Monica, 2008, Pathogenetics, V1, P6, DOI 10.1186/1755-8417-1-6; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; DaSilva LLP, 2004, PLANT CELL, V16, P1753, DOI 10.1105/tpc.022673; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fant X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008303; Flory MR, 2003, GENOMICS, V82, P401, DOI 10.1016/S0888-7543(03)00119-8; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; GONATAS NK, 1992, AM J PATHOL, V140, P731; Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; HOLTZER H, 1985, ANN NY ACAD SCI, V455, P106, DOI 10.1111/j.1749-6632.1985.tb50407.x; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Kaisto T, 2002, CELL TISSUE RES, V308, P381, DOI 10.1007/s00441-002-0556-5; KING DG, 1988, J MORPHOL, V196, P253, DOI 10.1002/jmor.1051960302; Kondylis V, 2009, FEBS LETT; Lippincott-Schwartz J, 1998, TRENDS CELL BIOL, V8, P16, DOI 10.1016/S0962-8924(97)01199-9; Lu ZM, 2001, MOL BIOL CELL, V12, P795, DOI 10.1091/mbc.12.4.795; LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Miyoshi K, 2006, BIOCHEM BIOPH RES CO, V351, P745, DOI 10.1016/j.bbrc.2006.10.101; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Mulari MTK, 2003, EXP CELL RES, V285, P221, DOI 10.1016/S0014-4827(03)00033-8; Nevalainen M, 2010, CELL TISSUE RES, V342, P107, DOI 10.1007/s00441-010-1041-1; Percival JM, 2007, TRAFFIC, V8, P1424, DOI 10.1111/j.1600-0854.2007.00622.x; Percival JM, 2007, TRAFFIC, V8, P184, DOI 10.1111/j.1600-0854.2006.00523.x; Pizon V, 2005, EMBO J, V24, P3781, DOI 10.1038/sj.emboj.7600842; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Prins KW, 2009, J CELL BIOL, V186, P363, DOI 10.1083/jcb.200905048; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Rabouille C, 1999, J CELL SCI, V112, P3319; Rahkila P, 1998, J CELL BIOL, V140, P1101, DOI 10.1083/jcb.140.5.1101; Rahkila P, 1997, EXP CELL RES, V234, P452, DOI 10.1006/excr.1997.3633; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; RALSTON E, 1993, J CELL BIOL, V120, P399, DOI 10.1083/jcb.120.2.399; Ralston E, 1999, J NEUROSCI, V19, P10694, DOI 10.1523/JNEUROSCI.19-24-10694.1999; RAMBOURG A, 1984, AM J ANAT, V170, P163, DOI 10.1002/aja.1001700204; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; SAITOH O, 1988, CELL TISSUE RES, V252, P263; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; Srsen V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-28; TASSIN AM, 1985, J CELL BIOL, V101, P630, DOI 10.1083/jcb.101.2.630; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; THYBERG J, 1992, J SUBMICR CYTOL PATH, V24, P495; WARREN RH, 1968, J CELL BIOL, V39, P544, DOI 10.1083/jcb.39.3.544; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Williams DS, 2005, ANGEW CHEM INT EDIT, V44, P1984, DOI 10.1002/anie.200462501; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255	68	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29057	10.1371/journal.pone.0029057	http://dx.doi.org/10.1371/journal.pone.0029057			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216166	gold, Green Submitted, Green Published			2022-12-25	WOS:000300674900009
J	Murrell, B; Weighill, T; Buys, J; Ketteringham, R; Moola, S; Benade, G; du Buisson, L; Kaliski, D; Hands, T; Scheffler, K				Murrell, Ben; Weighill, Thomas; Buys, Jan; Ketteringham, Robert; Moola, Sasha; Benade, Gerdus; du Buisson, Lise; Kaliski, Daniel; Hands, Tristan; Scheffler, Konrad			Non-Negative Matrix Factorization for Learning Alignment-Specific Models of Protein Evolution	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; SOLVENT ACCESSIBILITY; SECONDARY STRUCTURE; PHYLOGENETICS; SEQUENCES; INFERENCE; SELECTION	Models of protein evolution currently come in two flavors: generalist and specialist. Generalist models (e. g. PAM, JTT, WAG) adopt a one-size-fits-all approach, where a single model is estimated from a number of different protein alignments. Specialist models (e. g. mtREV, rtREV, HIVbetween) can be estimated when a large quantity of data are available for a single organism or gene, and are intended for use on that organism or gene only. Unsurprisingly, specialist models outperform generalist models, but in most instances there simply are not enough data available to estimate them. We propose a method for estimating alignment-specific models of protein evolution in which the complexity of the model is adapted to suit the richness of the data. Our method uses non-negative matrix factorization (NNMF) to learn a set of basis matrices from a general dataset containing a large number of alignments of different proteins, thus capturing the dimensions of important variation. It then learns a set of weights that are specific to the organism or gene of interest and for which only a smaller dataset is available. Thus the alignment-specific model is obtained as a weighted sum of the basis matrices. Having been constrained to vary along only as many dimensions as the data justify, the model has far fewer parameters than would be required to estimate a specialist model. We show that our NNMF procedure produces models that outperform existing methods on all but one of 50 test alignments. The basis matrices we obtain confirm the expectation that amino acid properties tend to be conserved, and allow us to quantify, on specific alignments, how the strength of conservation varies across different properties. We also apply our new models to phylogeny inference and show that the resulting phylogenies are different from, and have improved likelihood over, those inferred under standard models.	[Murrell, Ben] MRC, eHlth Res & Innovat Platform, Biomed Informat Res Div, Cape Town, Western Cape, South Africa; [Murrell, Ben; Weighill, Thomas; Buys, Jan; Ketteringham, Robert; Benade, Gerdus; du Buisson, Lise; Scheffler, Konrad] Univ Stellenbosch, ZA-7600 Stellenbosch, Western Cape, South Africa; [Moola, Sasha; Kaliski, Daniel; Hands, Tristan] Univ Cape Town, ZA-7925 Cape Town, Western Cape, South Africa	Stellenbosch University; University of Cape Town	Murrell, B (corresponding author), MRC, eHlth Res & Innovat Platform, Biomed Informat Res Div, Cape Town, Western Cape, South Africa.	kscheffler@cs.sun.ac.za	Murrell, Ben/AAM-1188-2021; Buys, Jan/AFK-8751-2022	Buys, Jan/0000-0003-1994-5832; Murrell, Ben/0000-0002-0393-4445; Scheffler, Konrad/0000-0002-6041-8367	European Commission [SANTE/2007/174-790]; Joint DMS/NIGMS Mathematical Biology Initiative [NSF-0714991]; National Institutes of Health [AI47745]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI047745, R01AI047745, R56AI047745] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Joint DMS/NIGMS Mathematical Biology Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by Europeaid grant number SANTE/2007/174-790 from the European Commission. Funding for the UCSD computing cluster was provided by the Joint DMS/NIGMS Mathematical Biology Initiative through Grant NSF-0714991 and the National Institutes of Health grant AI47745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adachi J, 1996, J MOL EVOL, V42, P459; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cao Y, 1998, MOL BIOL EVOL, V15, P1637, DOI 10.1093/oxfordjournals.molbev.a025891; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DAYHOFF MO, 1972, ATLAS PROTEIN SEQUEN, V5, P89; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Dimmic MW, 2002, J MOL EVOL, V55, P65, DOI 10.1007/s00239-001-2304-y; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Goldman N, 1998, GENETICS, V149, P445; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kosiol C, 2005, MOL BIOL EVOL, V22, P193, DOI 10.1093/molbev/msi005; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Le SQ, 2010, SYST BIOL, V59, P277, DOI 10.1093/sysbio/syq002; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LIPMAN DJ, 1989, P NATL ACAD SCI USA, V86, P4412, DOI 10.1073/pnas.86.12.4412; Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Stanfel LE, 1996, J THEOR BIOL, V183, P195, DOI 10.1006/jtbi.1996.0213; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whelan S, 2006, NUCLEIC ACIDS RES, V34, pD327, DOI 10.1093/nar/gkj087; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zoller S, 2011, MOL BIOL EVOL	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28898	10.1371/journal.pone.0028898	http://dx.doi.org/10.1371/journal.pone.0028898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216138	Green Published, gold			2022-12-25	WOS:000299684700016
J	Campioli, E; Batarseh, A; Li, JH; Papadopoulos, V				Campioli, Enrico; Batarseh, Amani; Li, Jiehan; Papadopoulos, Vassilios			The Endocrine Disruptor Mono-(2-Ethylhexyl) Phthalate Affects the Differentiation of Human Liposarcoma Cells (SW 872)	PLOS ONE			English	Article							PROTEIN-KINASE-C; BENZODIAZEPINE-RECEPTOR; GENE-EXPRESSION; ADIPOSE-TISSUE; FATTY-ACIDS; PPAR-ALPHA; PEROXISOME PROLIFERATORS; CHOLESTEROL BINDING; 18 KDA; GAMMA	Esters of phthalic acid (phthalates) are largely used in industrial plastics, medical devices, and pharmaceutical formulations. They are easily released from plastics into the environment and can be found in measurable levels in human fluids. Phthalates are agonists for peroxisome proliferator-activated receptors (PPARs), through which they regulate translocator protein (TSPO; 18 kDa) transcription in a tissue-specific manner. TSPO is a drug-and cholesterol-binding protein involved in mitochondrial respiration, steroid formation, and cell proliferation. TSPO has been shown to increase during differentiation and decrease during maturation in mouse adipocytes. The purpose of this study was to establish the effect of mono-(2-ethylhexyl) phthalate (MEHP) on the differentiation of human SW 872 preadipocyte cells, and examine the role of TSPO in the process. After 4 days of treatment with 10 mu M MEHP, we observed changes in the transcription of acetyl-CoA carboxylase alpha, adenosine triphosphate citrate lyase, glucose transporters 1 and 4, and the S100 calcium binding protein B, all of which are markers of preadipocyte differentiation. These observed gene expression changes coincided with a decrease in cellular proliferation without affecting cellular triglyceride content. Taken together, these data suggest that MEHP exerts a differentiating effect on human preadipocytes. Interestingly, MEHP was able to temporarily increase TSPO mRNA levels through the PPAR-alpha and beta/delta pathways. These results suggest that TSPO can be considered an important player in the differentiation process itself, or alternatively a factor whose presence is essential for adipocyte development.	[Campioli, Enrico; Batarseh, Amani; Li, Jiehan; Papadopoulos, Vassilios] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Campioli, Enrico; Batarseh, Amani; Li, Jiehan; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ, Canada; [Campioli, Enrico; Batarseh, Amani; Li, Jiehan; Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Campioli, Enrico; Batarseh, Amani; Li, Jiehan; Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Campioli, Enrico] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy	McGill University; McGill University; McGill University; McGill University; Universita di Modena e Reggio Emilia	Campioli, E (corresponding author), McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019	Papadopoulos, Vassilios/0000-0002-1183-8568; Batarseh, Amani/0000-0002-7020-2498	National Institutes of Health [R01 ES07747]; Canadian Institutes of Health Research [MOP-111131]; Canada Research Chair in Biochemical Pharmacology; Le Fonds de la recherche en sante du Quebec; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology; Le Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Institutes of Health (R01 ES07747) and the Canadian Institutes of Health Research (MOP-111131), and a Canada Research Chair in Biochemical Pharmacology to VP. The Research Institute of the McGill University Health Centre is supported by a grant from Le Fonds de la recherche en sante du Quebec. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; [Anonymous], 2001, DEHP MED DEV; ATSDR, 1993, TOX PROF DI 2 ETH PH; AUTIAN J, 1982, ENVIRON HEALTH PERSP, V45, P115, DOI 10.2307/3429393; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; Batarseh A, 2008, BIOCHEMISTRY-US, V47, P12886, DOI 10.1021/bi8012643; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI 10.1016/j.jchromb.2004.02.006; Campioli E, 2011, OBESITY, V19, P703, DOI 10.1038/oby.2010.244; Carmel JF, 2009, J CELL BIOCHEM, V106, P608, DOI 10.1002/jcb.22037; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649; De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155; Dees JH, 2001, REPROD TOXICOL, V15, P171, DOI 10.1016/S0890-6238(01)00110-1; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; Dillingham E O, 1973, Environ Health Perspect, V3, P81, DOI 10.2307/3428033; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005; Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1111/j.1600-0668.2004.00223.x; Gazouli M, 2002, ENDOCRINOLOGY, V143, P2571, DOI 10.1210/en.143.7.2571; Gesler R M, 1973, Environ Health Perspect, V3, P73, DOI 10.2307/3428032; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302; Izem L, 2001, J BIOL CHEM, V276, P26534, DOI 10.1074/jbc.M103624200; KATO K, 1988, EUR J BIOCHEM, V177, P461, DOI 10.1111/j.1432-1033.1988.tb14395.x; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kluwe WM, ENV HLTH PERSPECT, V45, P129; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; MICHETTI F, 1983, BRAIN RES, V262, P352, DOI 10.1016/0006-8993(83)91032-6; Nofziger C, 2009, AM J PHYSIOL-RENAL, V297, pF55, DOI 10.1152/ajprenal.00090.2009; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; ORELLANA A, 1990, EUR J BIOCHEM, V190, P57, DOI 10.1111/j.1432-1033.1990.tb15545.x; PAPADOPOULOS V, 1994, MOL CELL ENDOCRINOL, V104, pR5, DOI 10.1016/0303-7207(94)90061-2; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Reza JZ, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-38; Ribet C, 2010, ENDOCRINOLOGY, V151, P123, DOI 10.1210/en.2009-0726; ROCK G, 1986, ENVIRON HEALTH PERSP, V65, P309, DOI 10.2307/3430198; Rubin R J, 1973, Environ Health Perspect, V3, P53, DOI 10.2307/3428030; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Sarafidis PA, 2006, AM J HYPERTENS, V19, P646, DOI 10.1016/j.amjhyper.2005.12.017; Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321; SINGH AR, 1974, TOXICOL APPL PHARM, V29, P35, DOI 10.1016/0041-008X(74)90159-8; SMYTH MJ, 1993, J CELL SCI, V106, P1; SOLVEYRA CG, 1988, LIFE SCI, V42, P393, DOI 10.1016/0024-3205(88)90077-X; TOMITA I, 1982, ENVIRON HEALTH PERSP, V45, P119, DOI 10.2307/3429394; *US DEP HHS, 2006, NIH PUBL; Wade FM, 2005, OBES RES, V13, P818, DOI 10.1038/oby.2005.93; Wassef H, 2004, J NUTR, V134, P2935, DOI 10.1093/jn/134.11.2935; Zhao Y, 2010, TOXICOL IN VITRO, V24, P154, DOI 10.1016/j.tiv.2009.08.001	58	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28750	10.1371/journal.pone.0028750	http://dx.doi.org/10.1371/journal.pone.0028750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205965	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600031
J	Davidson, LB; Nessar, R; Kempaiah, P; Perkins, DJ; Byrd, TF				Davidson, Lisa B.; Nessar, Rachid; Kempaiah, Prakasha; Perkins, Douglas J.; Byrd, Thomas F.			Mycobacterium abscessus Glycopeptidolipid Prevents Respiratory Epithelial TLR2 Signaling as Measured by HbD2 Gene Expression and IL-8 Release	PLOS ONE			English	Article							RAPIDLY GROWING MYCOBACTERIA; HUMAN BETA-DEFENSIN-2; CYSTIC-FIBROSIS; TNF-ALPHA; TUBERCULOSIS; CELLS; INDUCTION; MACROPHAGES; INFECTION; DISEASE	Mycobacterium abscessus has emerged as an important cause of lung infection, particularly in patients with bronchiectasis. Innate immune responses must be highly effective at preventing infection with M. abscessus because it is a ubiquitous environmental saprophyte and normal hosts are not commonly infected. M. abscessus exists as either a glycopeptidolipid (GPL) expressing variant (smooth phenotype) in which GPL masks underlying bioactive cell wall lipids, or as a variant lacking GPL which is immunostimulatory and invasive in macrophage infection models. Respiratory epithelium has been increasingly recognized as playing an important role in the innate immune response to pulmonary pathogens. Respiratory epithelial cells express toll-like receptors (TLRs) which mediate the innate immune response to pulmonary pathogens. Both interleukin-8 (IL-8) and human beta-defensin 2 (H beta D2) are expressed by respiratory epithelial cells in response to toll-like receptor 2 (TLR2) receptor stimulation. In this study, we demonstrate that respiratory epithelial cells respond to M. abscessus variants lacking GPL with expression of IL-8 and H beta D2. Furthermore, we demonstrate that this interaction is mediated through TLR2. Conversely, M. abscessus expressing GPL does not stimulate expression of IL-8 or HbD2 by respiratory epithelial cells which is consistent with "masking'' of underlying bioactive cell wall lipids by GPL. Because GPL-expressing smooth variants are the predominant phenotype existing in the environment, this provides an explanation whereby initial M. abscessus colonization of abnormal lung airways escapes detection by the innate immune system.	[Davidson, Lisa B.; Byrd, Thomas F.] New Mexico Vet Hlth Care Syst, Dept Med, Albuquerque, NM USA; [Nessar, Rachid] Univ Paris 05, Fac Med, Paris, France; [Kempaiah, Prakasha; Perkins, Douglas J.] Univ New Mexico, Sch Med, Ctr Global Hlth, Albuquerque, NM 87131 USA; [Byrd, Thomas F.] Univ New Mexico, Sch Med, Div Infect Dis, Albuquerque, NM 87131 USA	UDICE-French Research Universities; Universite Paris Cite; University of New Mexico; University of New Mexico	Davidson, LB (corresponding author), New Mexico Vet Hlth Care Syst, Dept Med, Albuquerque, NM USA.	tbyrd@salud.unm.edu	Kempaiah, Prakasha/ABC-6485-2020	Kempaiah, Prakasha/0000-0002-2901-0339; Byrd, Thomas F./0000-0001-7156-8857	United States of America Department of Veterans Affairs; University of New Mexico Research Allocation Committee; New Mexico Sonographics	United States of America Department of Veterans Affairs(US Department of Veterans Affairs); University of New Mexico Research Allocation Committee; New Mexico Sonographics	TB receives support from the United States of America Department of Veterans Affairs, with this project funded by a University of New Mexico Research Allocation Committee Grant, and a grant from New Mexico Sonographics administered by the Biomedical Research Institute of New Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; Birkness KA, 1999, INFECT IMMUN, V67, P653, DOI 10.1128/IAI.67.2.653-658.1999; Byrd TF, 1999, INFECT IMMUN, V67, P4700, DOI 10.1128/IAI.67.9.4700-4707.1999; Chmura K, 2008, AM J PHYSIOL-LUNG C, V295, pL220, DOI 10.1152/ajplung.90204.2008; Corbiere V, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-15; Cullen AR, 2000, AM J RESP CRIT CARE, V161, P641, DOI 10.1164/ajrccm.161.2.9903062; De Groote MA, 2006, CLIN INFECT DIS, V42, P1756, DOI 10.1086/504381; Fauroux B, 1997, PEDIATR INFECT DIS J, V16, P354, DOI 10.1097/00006454-199704000-00004; Garcia-Perez BE, 2003, MICROB PATHOGENESIS, V35, P49, DOI 10.1016/S0882-4010(03)00089-5; Greco E, 2009, CELL IMMUNOL, V259, P1, DOI 10.1016/j.cellimm.2009.06.002; Greendyke R, 2008, ANTIMICROB AGENTS CH, V52, P2019, DOI 10.1128/AAC.00986-07; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Howard ST, 2000, MICROBES INFECT, V2, P1845, DOI 10.1016/S1286-4579(00)01338-1; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Jonsson BE, 2007, J CLIN MICROBIOL, V45, P1497, DOI 10.1128/JCM.02592-06; KINNULA VL, 1994, AM J RESP CELL MOL, V11, P568, DOI 10.1165/ajrcmb.11.5.7946385; Kisich KO, 2001, INFECT IMMUN, V69, P2692, DOI 10.1128/IAI.69.4.2692-2699.2001; Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medjahed H, 2009, APPL ENVIRON MICROB, V75, P1331, DOI 10.1128/AEM.01914-08; Nessar R, 2011, MICROBIOL-SGM, V157, P1187, DOI 10.1099/mic.0.046557-0; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Ripoll F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-114; Rivas-Santiago B, 2005, INFECT IMMUN, V73, P4505, DOI 10.1128/IAI.73.8.4505-4511.2005; Sermet-Gaudelus I, 2003, EMERG INFECT DIS, V9, P1587, DOI 10.3201/eid0912.020774; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wang XR, 2003, FASEB J, V17, P1727, DOI 10.1096/fj.02-0616fje; Wheeler DS, 2004, J NUTR, V134, P1039, DOI 10.1093/jn/134.5.1039	35	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29148	10.1371/journal.pone.0029148	http://dx.doi.org/10.1371/journal.pone.0029148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216191	Green Submitted, gold, Green Published			2022-12-25	WOS:000299113600059
J	Bleicher, L; Lemke, N; Garratt, RC				Bleicher, Lucas; Lemke, Ney; Garratt, Richard Charles			Using Amino Acid Correlation and Community Detection Algorithms to Identify Functional Determinants in Protein Families	PLOS ONE			English	Article							STATISTICAL COUPLING ANALYSIS; PEROXIDASE; NETWORKS; RESIDUES	Correlated mutation analysis has a long history of interesting applications, mostly in the detection of contact pairs in protein structures. Based on previous observations that, if properly assessed, amino acid correlation data can also provide insights about functional sub-classes in a protein family, we provide a complete framework devoted to this purpose. An amino acid specific correlation measure is proposed, which can be used to build networks summarizing all correlation and anti-correlation patterns in a protein family. These networks can be submitted to community structure detection algorithms, resulting in subsets of correlated amino acids which can be further assessed by specific parameters and procedures that provide insight into the relationship between different communities, the individual importance of community members and the adherence of a given amino acid sequence to a given community. By applying this framework to three protein families with contrasting characteristics (the Fe/Mn-superoxide dismutases, the peroxidase-catalase family and the C-type lysozyme/alpha-lactalbumin family), we show how our method and the proposed parameters and procedures are related to biological characteristics observed in these protein families, highlighting their potential use in protein characterization and gene annotation.	[Bleicher, Lucas] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Lemke, Ney] Univ Estadual Paulista, Dept Fis & Biofis, Botucatu, SP, Brazil; [Garratt, Richard Charles] Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Informat, Sao Carlos, SP, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual Paulista; Universidade de Sao Paulo	Bleicher, L (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	lbleicher@icb.ufmg.br	Biotec molecular, Cepid/I-4314-2013; Inbeqmedi, Inct/I-1929-2013; Lemke, Ney/L-6761-2019; Bleicher, Lucas/B-7967-2013; garratt, richard c/F-6921-2011; Bleicher, Lucas/AAH-9397-2021; 4, INCT/H-4499-2013; Bleicher, Lucas/R-5153-2019; Lemke, Ney/A-8213-2008	Lemke, Ney/0000-0001-7463-4303; Bleicher, Lucas/0000-0001-7121-4952; Bleicher, Lucas/0000-0001-7121-4952; Lemke, Ney/0000-0001-7463-4303; garratt, richard/0000-0002-2016-3179	Fundacao de Amparao a Pesquisa do Estado de Sao Paulo (FAPESP) [08/58734-1, 98/14138-2]	Fundacao de Amparao a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was partially supported by Fundacao de Amparao a Pesquisa do Estado de Sao Paulo (FAPESP, www.fapesp.br, grants 08/58734-1 and 98/14138-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arenas A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/176; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Atchley WR, 1999, J MOL EVOL, V48, P501, DOI 10.1007/PL00006494; Baker RD, 2006, BIOCHEMISTRY-US, V45, P7113, DOI 10.1021/bi052392y; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Dima RI, 2006, PROTEIN SCI, V15, P258, DOI 10.1110/ps.051767306; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gomez S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016114; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Newman M.E.J., 2004, PHYS REV E, V70; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; NITTA K, 1989, EUR J BIOCHEM, V182, P111, DOI 10.1111/j.1432-1033.1989.tb14806.x; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Bachega JFR, 2009, PROTEINS, V77, P26, DOI 10.1002/prot.22412; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Watanabe L, 2010, J STRUCT BIOL, V169, P226, DOI 10.1016/j.jsb.2009.10.009; Wintjens R, 2008, PROTEINS, V70, P1564, DOI 10.1002/prot.21650	25	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e27786	10.1371/journal.pone.0027786	http://dx.doi.org/10.1371/journal.pone.0027786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205928	Green Published, Green Submitted, gold			2022-12-25	WOS:000298666200001
J	Dushoff, J; Patocs, A; Shi, CF				Dushoff, Jonathan; Patocs, Audrey; Shi, Chyun-Fung			Modeling the Population-Level Effects of Male Circumcision as an HIV-Preventive Measure: A Gendered Perspective	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; SUB-SAHARAN AFRICA; SEXUAL TRANSMISSION; RISK BEHAVIOR; IMPACT; INFECTION; UGANDA; KENYA; RAKAI	Background: Evidence from biological, epidemiological, and controlled intervention studies has demonstrated that male circumcision (MC) protects males from HIV infection, and MC is now advocated as a public-health intervention against HIV. MC provides direct protection only to men, but is expected to provide indirect protection to women at risk of acquiring HIV from heterosexual transmission. How such indirect protection interacts with the possibility that MC campaigns will lead to behavior changes, however, is not yet well understood. Our objective here is to investigate the link between individual-level effects of MC campaigns and long-term population-level outcomes resulting from disease dynamics, looking at both genders separately, over a broad range of parameters. Methods and Findings: We use simple mathematical models of heterosexual transmission to investigate the potential effects of a circumcision scale-up, combined with possible associated behavioral disinhibition. We examine patterns in expected long-term prevalence using a simple equilibrium model based on transmission factors, and validate our results with ODE-based simulations, focusing on the link between effects on females and those on males. We find that the long-term population-level effects on females and males are not strongly linked: there are many possible ways in which an intervention which reduces prevalence in males might nonetheless increase prevalence in females. Conclusions: Since an intervention that reduces long-term male prevalence could nonetheless increase long-term female prevalence, MC campaigns should explicitly consider both the short-term and long-term effects of MC interventions on females. Our findings strongly underline the importance of pairing MC programs with education, support programs and HIV testing and counseling, together with other prevention measures.	[Dushoff, Jonathan] McMaster Univ, Dept Biol, Hamilton, ON, Canada; McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University	Dushoff, J (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	dushoff@mcmaster.ca			James S. McDonnell Foundation; Natural Sciences and Engineering Research Council of Canada	James S. McDonnell Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by the James S. McDonnell Foundation and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; Alsallaq RA, 2009, EPIDEMICS-NETH, V1, P139, DOI 10.1016/j.epidem.2009.08.001; Andersson N, 2011, MALE CIRCUMCISION AT; Andersson Neil, 2007, BMC Womens Health, V7, P11; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey N. T. J., 1982, BIOMATHEMATICS MALAR; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Group UE, 2009, PLOS MED, V6; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; JACKSON DJ, 1995, AIDS, V9, P1279, DOI 10.1097/00002030-199511000-00010; Jewkes R, 2010, SCIENCE, V329, P145, DOI 10.1126/science.1193794; Joint United Nations Programme on HIV/AIDS, 2009, COUNTR EXP SCAL UP M; Joint United Nations Programme on HIV/AIDS, 2008, REP GLOB AIDS EP COM; Kalichman S, 2007, PLOS MED, V4, P597, DOI 10.1371/journal.pmed.0040138; Kort Rodney, 2010, J Int AIDS Soc, V13 Suppl 1, pS5, DOI 10.1186/1758-2652-13-S1-S5; Londish GJ, 2008, INT J EPIDEMIOL, V37, P1246, DOI 10.1093/ije/dyn038; Matovu JKB, 2007, REPROD HEALTH MATTER, V15, P68, DOI 10.1016/S0968-8080(07)29306-1; Melo MG, 2008, SEX TRANSM DIS, V35, P912, DOI 10.1097/OLQ.0b013e31817e2491; MISHRA V, 2009, 62 DHS; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Poddera CN, 2007, B MATH BIOL, V69, P2447, DOI 10.1007/s11538-007-9226-9; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; R Development Core Team, 2008, R PROJ STAT COMP; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; W.H. Organization, 2009, WORLD HLTH STAT 2009; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	40	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28608	10.1371/journal.pone.0028608	http://dx.doi.org/10.1371/journal.pone.0028608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205956	Green Published, gold, Green Submitted			2022-12-25	WOS:000298666200007
J	Yin, P; Bousquet-Moore, D; Annangudi, SP; Southey, BR; Mains, RE; Eipper, BA; Sweedler, JV				Yin, Ping; Bousquet-Moore, Danielle; Annangudi, Suresh P.; Southey, Bruce R.; Mains, Richard E.; Eipper, Betty A.; Sweedler, Jonathan V.			Probing the Production of Amidated Peptides following Genetic and Dietary Copper Manipulations	PLOS ONE			English	Article							ALPHA-HYDROXYLATING MONOOXYGENASE; QUANTITATIVE PEPTIDOMICS; MASS-SPECTROMETRY; SECRETORY GRANULE; SIGNALING PEPTIDES; JOINING PEPTIDE; MOUSE-BRAIN; MICE; NEUROPEPTIDE; PITUITARY	Amidated neuropeptides play essential roles throughout the nervous and endocrine systems. Mice lacking peptidylglycine alpha-amidating monooxygenase (PAM), the only enzyme capable of producing amidated peptides, are not viable. In the amidation reaction, the reactant (glycine-extended peptide) is converted into a reaction intermediate (hydroxyglycine-extended peptide) by the copper-dependent peptidylglycine-alpha-hydroxylating monooxygenase (PHM) domain of PAM. The hydroxyglycine-extended peptide is then converted into amidated product by the peptidyl-alpha-hydroxyglycine alpha-amidating lyase (PAL) domain of PAM. PHM and PAL are stitched together in vertebrates, but separated in some invertebrates such as Drosophila and Hydra. In addition to its luminal catalytic domains, PAM includes a cytosolic domain that can enter the nucleus following release from the membrane by gamma-secretase. In this work, several glycine-and hydroxyglycine-extended peptides as well as amidated peptides were qualitatively and quantitatively assessed from pituitaries of wild-type mice and mice with a single copy of the Pam gene (PAM(+/-)) via liquid chromatography-mass spectrometry-based methods. We provide the first evidence for the presence of a peptidyl-alpha-hydroxyglycine in vivo, indicating that the reaction intermediate becomes free and is not handed directly from PHM to PAL in vertebrates. Wild-type mice fed a copper deficient diet and PAM(+/-) mice exhibit similar behavioral deficits. While glycine-extended reaction intermediates accumulated in the PAM(+/-) mice and reflected dietary copper availability, amidated products were far more prevalent under the conditions examined, suggesting that the behavioral deficits observed do not simply reflect a lack of amidated peptides.	[Yin, Ping; Annangudi, Suresh P.; Southey, Bruce R.; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst, Dept Chem, Urbana, IL 61801 USA; [Bousquet-Moore, Danielle; Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Connecticut	Yin, P (corresponding author), Univ Illinois, Beckman Inst, Dept Chem, Urbana, IL 61801 USA.	eipper@uchc.edu; jsweedle@illinois.edu	Sweedler, Jonathan V/A-9405-2009; Annangudi, Suresh/AAD-6408-2020	Sweedler, Jonathan V/0000-0003-3107-9922; Southey, Bruce/0000-0002-8959-7709	National Science Foundation [CHE-05-26692]; National Institute on Drug Abuse [P30DA018310]; National Institute of Diabetes and Digestive and Kidney Diseases [DK32949]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032949, R37DK032949, R56DK032949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Science Foundation by Award No. CHE-05-26692, the National Institute on Drug Abuse by Award No. P30DA018310 (JVS), and the National Institute of Diabetes and Digestive and Kidney Diseases by Award No. DK32949 (BAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaoutova I, 2008, MOL ENDOCRINOL, V22, P1924, DOI 10.1210/me.2007-0434; Asada A, 2005, FEBS J, V272, P942, DOI 10.1111/j.1742-4658.2004.04528.x; Bora A, 2008, J PROTEOME RES, V7, P4992, DOI 10.1021/pr800394e; Bousquet-Moore D, 2009, ENDOCRINOLOGY, V150, P1739, DOI 10.1210/en.2008-1202; Bousquet-Moore D, 2010, NEUROBIOL DIS, V37, P130, DOI 10.1016/j.nbd.2009.09.016; BRADBURY AF, 1987, BIOSCIENCE REP, V7, P907, DOI 10.1007/BF01122123; Brockmann A, 2009, P NATL ACAD SCI USA, V106, P2383, DOI 10.1073/pnas.0813021106; BUNDGAARD H, 1991, PEPTIDES, V12, P745, DOI 10.1016/0196-9781(91)90127-B; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Che FY, 2006, J MOL NEUROSCI, V28, P265, DOI 10.1385/JMN:28:3:265; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; Che FY, 2005, J MASS SPECTROM, V40, P238, DOI 10.1002/jms.743; Che FY, 2003, CELL MOL BIOL, V49, P713; Cho SJ, 2002, P NATL ACAD SCI USA, V99, P4720, DOI 10.1073/pnas.072083499; CICCOTOSTO GD, 1992, AM J PHYSIOL, V263, pG802, DOI 10.1152/ajpgi.1992.263.5.G802; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; EIPPER BA, 1991, J BIOL CHEM, V266, P7827; EIPPER BA, 1986, J BIOL CHEM, V261, P8686; Francone VP, 2010, MOL ENDOCRINOL, V24, P1543, DOI 10.1210/me.2009-0381; Greis KD, 2006, J AM SOC MASS SPECTR, V17, P815, DOI 10.1016/j.jasms.2006.02.019; Gutstein HB, 2008, MASS SPECTROM REV, V27, P316, DOI 10.1002/mas.20161; HUSTEN EJ, 1993, J BIOL CHEM, V268, P9709; Jakubowski JA, 2006, NEUROCHEM INT, V49, P223, DOI 10.1016/j.neuint.2006.01.007; KEMENADE BMLV, 1987, NEUROENDOCRINOLOGY, V46, P289; Koh TJ, 2004, CANCER RES, V64, P196, DOI 10.1158/0008-5472.CAN-03-2112; Kolhekar AS, 1997, BIOCHEMISTRY-US, V36, P10901, DOI 10.1021/bi9708747; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Li LJ, 2008, ANNU REV ANAL CHEM, V1, P451, DOI 10.1146/annurev.anchem.1.031207.113053; MAINS RE, 1991, MOL ENDOCRINOL, V5, P187, DOI 10.1210/mend-5-2-187; Mair GR, 2004, FASEB J, V18, P114, DOI 10.1096/fj.03-0429com; MERKLER DJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P594, DOI 10.1016/0003-9861(92)90730-K; MERKLER DJ, 1992, BIOCHEMISTRY-US, V31, P7282, DOI 10.1021/bi00147a011; MERKLER DJ, 1994, ENZYME MICROB TECH, V16, P450, DOI 10.1016/0141-0229(94)90014-0; Neubert H, 2008, J PROTEOME RES, V7, P2270, DOI 10.1021/pr700705u; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; Nillni EA, 2002, J BIOL CHEM, V277, P48587, DOI 10.1074/jbc.M206702200; Nittis T, 2004, J BIOL CHEM, V279, P25696, DOI 10.1074/jbc.M401151200; OUAFIK L, 1992, MOL ENDOCRINOL, V6, P1571, DOI 10.1210/me.6.10.1571; Pan H, 2005, BIOCHEMISTRY-US, V44, P4939, DOI 10.1021/bi047852m; PHLIPPONNEAU M, 1993, J CLIN ENDOCR METAB, V76, P325, DOI 10.1210/jc.76.2.325; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Prohaska JR, 2006, COMP BIOCHEM PHYS B, V143, P360, DOI 10.1016/j.cbpb.2005.12.010; Prohaska JR, 2005, ARCH BIOCHEM BIOPHYS, V434, P212, DOI 10.1016/j.abb.2004.10.030; Rajagopal C, 2010, J BIOL CHEM, V285, P34632, DOI 10.1074/jbc.M110.145334; Rajagopal C, 2009, J BIOL CHEM, V284, P25723, DOI 10.1074/jbc.M109.035782; Romanova EV, 2008, ANAL CHEM, V80, P3379, DOI 10.1021/ac7026047; Romanova EV, 2010, AAPS J, V12, P443, DOI 10.1208/s12248-010-9204-2; Rubakhin SS, 2008, ANAL CHEM, V80, P7128, DOI 10.1021/ac8010389; Rubakhin SS, 2006, ANAL CHEM, V78, P7267, DOI 10.1021/ac0607010; Schlief ML, 2006, MOL NEUROBIOL, V33, P81, DOI 10.1385/MN:33:2:81; Takahashi K, 2009, BIOCHEMISTRY-US, V48, P1654, DOI 10.1021/bi8018866; Tenn WJ, 2001, ORG LETT, V3, P75, DOI 10.1021/ol0067944; Wang SH, 2001, J CHROMATOGR A, V924, P345, DOI 10.1016/S0021-9673(01)00961-X; Williamson M, 2000, BIOCHEM BIOPH RES CO, V277, P7, DOI 10.1006/bbrc.2000.3629; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x; Zong YM, 1998, GASTROENTEROLOGY, V114, pA1197, DOI 10.1016/S0016-5085(98)84862-2	58	17	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28679	10.1371/journal.pone.0028679	http://dx.doi.org/10.1371/journal.pone.0028679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194882	gold, Green Published, Green Submitted			2022-12-25	WOS:000298664400014
J	Chow, S; Jeffs, A; Miyake, Y; Konishi, K; Okazaki, M; Suzuki, N; Abdullah, MF; Imai, H; Wakabayasi, T; Sakai, M				Chow, Seinen; Jeffs, Andrew; Miyake, Yoichi; Konishi, Kooichi; Okazaki, Makoto; Suzuki, Nobuaki; Abdullah, Muhamad F.; Imai, Hideyuki; Wakabayasi, Toshie; Sakai, Mitsuo			Genetic Isolation between the Western and Eastern Pacific Populations of Pronghorn Spiny Lobster Panulirus penicillatus	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCE; GENUS PANULIRUS; MOLECULAR PHYLOGENY; PHYLLOSOMA LARVAE; PALINURIDAE; DECAPODA; COAST; EVOLUTION; JAPONICUS; CRUSTACEA	The pronghorn spiny lobster, Panulirus penicillatus, is a circumtropical species which has the widest global distribution among all the species of spiny lobster, ranging throughout the entire Indo-Pacific region. Partial nucleotide sequences of mitochondrial DNA COI (1,142-1,207 bp) and 16S rDNA (535-546 bp) regions were determined for adult and phyllosoma larval samples collected from the Eastern Pacific (EP)(Galapagos Islands and its adjacent water), Central Pacific (CP)(Hawaii and Tuamotu) and the Western Pacific (WP)(Japan, Indonesia, Fiji, New Caledonia and Australia). Phylogenetic analyses revealed two distinct large clades corresponding to the geographic origin of samples (EP and CP+WP). No haplotype was shared between the two regional samples, and average nucleotide sequence divergence (Kimura's two parameter distance) between EP and CP+WP samples was 3.8 +/- 0.5% for COI and 1.0 +/- 0.4% for 16S rDNA, both of which were much larger than those within samples. The present results indicate that the Pacific population of the pronghorn spiny lobster is subdivided into two distinct populations (Eastern Pacific and Central to Western Pacific), with no gene flow between them. Although the pronghorn spiny lobster have long-lived teleplanic larvae, the vast expanse of Pacific Ocean with no islands and no shallow substrate which is known as the East Pacific Barrier appears to have isolated these two populations for a long time (c.a. 1MY).	[Chow, Seinen] Natl Res Inst Aquaculture, Stock Enhancement & Aquaculture Div, Yokosuka, Kanagawa, Japan; [Jeffs, Andrew] Univ Auckland, Dept Marine Sci, Auckland 1, New Zealand; [Miyake, Yoichi] Nagasaki Univ, Dept Marine Sci, Nagasaki 852, Japan; [Konishi, Kooichi; Okazaki, Makoto] Natl Res Inst Fisheries Sci, Res Ctr Fisheries Oceanog & Marine Ecosyst, Yokohama, Kanagawa, Japan; [Suzuki, Nobuaki] Seikai Natl Res Inst, Ishigaki Trop Stn, Okinawa, Japan; [Abdullah, Muhamad F.; Imai, Hideyuki] Univ Ryukyus, Okinawa, Japan; [Wakabayasi, Toshie; Sakai, Mitsuo] Natl Res Inst Far Seas Fisheries, Ocean Resources Div, Yokohama, Kanagawa, Japan	University of Auckland; Nagasaki University; Japan Fisheries Research & Education Agency (FRA); University of the Ryukyus; Japan Fisheries Research & Education Agency (FRA)	Chow, S (corresponding author), Natl Res Inst Aquaculture, Stock Enhancement & Aquaculture Div, Yokosuka, Kanagawa, Japan.	chow@affrc.go.jp	Miyake, Yoichi/I-5796-2017; Jeffs, Andrew G/D-9474-2012	Miyake, Yoichi/0000-0003-2799-7827; Jeffs, Andrew/0000-0002-8504-1949; Chow, Seinen/0000-0001-9552-2669	Ministry of Agriculture, Forestry and Fisheries of Japan; Japan Society for the Promotion Science (JSPS); Foundation for Research, Science and Technology (FRST)	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for Research, Science and Technology (FRST)(New Zealand Foundation for Research, Science and Technology)	This study was supported in part by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan, and Japan Society for the Promotion Science (JSPS) and Foundation for Research, Science and Technology (FRST) under the Japan-New Zealand Research Cooperative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baez R.P., 1983, Revista de Biologia Marina, V19, P79; Baldwin JD, 1998, MOL PHYLOGENET EVOL, V10, P399, DOI 10.1006/mpev.1998.0537; BERRY P F, 1974, Crustaceana (Leiden), V27, P31, DOI 10.1163/156854074X00208; Bradford RW, 2005, NEW ZEAL J MAR FRESH, V39, P593, DOI 10.1080/00288330.2005.9517338; Butler MJ, 2011, MAR ECOL PROG SER, V422, P223, DOI 10.3354/meps08878; Chan TY, 1996, J NAT HIST, V30, P367, DOI 10.1080/00222939600770201; Chan TY, 2001, CRUSTACEANA, V74, P123, DOI 10.1163/156854001505307; Chow S, 2006, CRUSTACEANA, V79, P745, DOI 10.1163/156854006778026771; Chow S, 2006, MAR BIOTECHNOL, V8, P260, DOI 10.1007/s10126-005-5151-9; Coates Anthony G., 1996, P21; Diniz FM, 2005, MAR BIOTECHNOL, V7, P462, DOI 10.1007/s10126-004-4062-5; Ekman S., 1953, P417; Garcia-Rodriguez FJ, 2006, MAR BIOL, V148, P621, DOI 10.1007/s00227-005-0101-7; Garcia-Rodriguez FJ, 2008, FISH B-NOAA, V106, P204; Garcia-Rodriguez FJ, 2008, MAR ECOL PROG SER, V361, P203, DOI 10.3354/meps07381; George RW, 2005, CRUSTACEANA, V78, P1281, DOI 10.1163/156854005776759780; George R. W., 1965, Zoologische Verhandelingen, V72, P1; GEORGE RW, 1967, EVOLUTION, V21, P803, DOI 10.1111/j.1558-5646.1967.tb03435.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hearn A, 2005, EVALUACION POBLACION; Hearn A, 2008, PAC SCI, V62, P191, DOI 10.2984/1534-6188(2008)62[191:LHOTRS]2.0.CO;2; HOLTHUIS LB, 1966, CRUSTACEANA, V12, P214; HOLTHUIS LB, 1991, MARINE LOBSTERS WORL, P1; Hunter J. R., 1967, Fishery Bulletin Fish and Wildlife Service US, V66, P13; Inoue N, 2007, FISHERIES SCI, V73, P550, DOI 10.1111/j.1444-2906.2007.01367.x; JOHNSON MW, 1974, FISH B-NOAA, V72, P639; JOKIEL PL, 1989, MAR BIOL, V101, P483, DOI 10.1007/BF00541650; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; KITTAKA J, 1989, NIPPON SUISAN GAKK, V55, P963; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Konishi K, 2006, J PLANKTON RES, V28, P841, DOI 10.1093/plankt/fbl019; Lessios HA, 2006, P ROY SOC B-BIOL SCI, V273, P2201, DOI 10.1098/rspb.2006.3543; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Lessios HA, 1998, P ROY SOC B-BIOL SCI, V265, P583, DOI 10.1098/rspb.1998.0334; Lipcius R.N., 1994, P1; Marko PB, 2002, MOL BIOL EVOL, V19, P2005, DOI 10.1093/oxfordjournals.molbev.a004024; Matsuda H, 2006, J CRUSTACEAN BIOL, V26, P579, DOI 10.1651/S-2630.1; MCNALLY GJ, 1983, J GEOPHYS RES-OCEANS, V88, P7507, DOI 10.1029/JC088iC12p07507; MCWILLIAM PS, 1995, J CRUSTACEAN BIOL, V15, P542, DOI 10.2307/1548775; Palumbi S., 1991, SIMPLE FOOLS GUIDE P; Phillips B.F., 1980, P11; POLLOCK DE, 1992, B MAR SCI, V51, P135; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ptacek MB, 2001, MAR FRESHWATER RES, V52, P1037, DOI 10.1071/MF01070; Ravago RG, 2002, CRUSTACEANA, V75, P1047, DOI 10.1163/156854002763270455; Sarver SK, 1998, J CRUSTACEAN BIOL, V18, P177, DOI 10.2307/1549532; SCHELTEMA RS, 1988, BIOL BULL, V174, P145, DOI 10.2307/1541781; Sekiguchi H, 2005, NEW ZEAL J MAR FRESH, V39, P563, DOI 10.1080/00288330.2005.9517335; Sekiguchi H, 2002, J OCEANOGR, V58, P747, DOI 10.1023/A:1022806726150; SEKIGUCHI H, 1991, P JAPANESE SOC SYSTE, V44, P15; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; YAMAKAWA T, 1989, NIPPON SUISAN GAKK, V55, P745, DOI 10.2331/suisan.55.745; Yamauchi MM, 2002, GENE, V295, P89, DOI 10.1016/S0378-1119(02)00824-7	54	32	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29280	10.1371/journal.pone.0029280	http://dx.doi.org/10.1371/journal.pone.0029280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195038	Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400047
J	Barry, DP; Asim, M; Scull, BP; Piazuelo, MB; de Sablet, T; Lewis, ND; Coburn, LA; Singh, K; Ellies, LG; Gobert, AP; Chaturvedi, R; Wilson, KT				Barry, Daniel P.; Asim, Mohammad; Scull, Brooks P.; Piazuelo, M. Blanca; de Sablet, Thibaut; Lewis, Nuruddeen D.; Coburn, Lori A.; Singh, Kshipra; Ellies, Lesley G.; Gobert, Alain P.; Chaturvedi, Rupesh; Wilson, Keith T.			Cationic Amino Acid Transporter 2 Enhances Innate Immunity during Helicobacter pylori Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN DENDRITIC CELLS; HOST-DEFENSE; ADAPTIVE IMMUNITY; IL-12; MICE; INTERLEUKIN-12; GASTRITIS; MACROPHAGES; RELEASE	Once acquired, Helicobacter pylori infection is lifelong due to an inadequate innate and adaptive immune response. Our previous studies indicate that interactions among the various pathways of arginine metabolism in the host are critical determinants of outcomes following infection. Cationic amino acid transporter 2 (CAT2) is essential for transport of L-arginine (L-Arg) into monocytic immune cells during H. pylori infection. Once within the cell, this amino acid is utilized by opposing pathways that lead to elaboration of either bactericidal nitric oxide (NO) produced from inducible NO synthase (iNOS), or hydrogen peroxide, which causes macrophage apoptosis, via arginase and the polyamine pathway. Because of its central role in controlling L-Arg availability in macrophages, we investigated the importance of CAT2 in vivo during H. pylori infection. CAT2(-/-) mice infected for 4 months exhibited decreased gastritis and increased levels of colonization compared to wild type mice. We observed suppression of gastric macrophage levels, macrophage expression of iNOS, dendritic cell activation, and expression of granulocyte-colony stimulating factor in CAT2(-/-) mice suggesting that CAT2 is involved in enhancing the innate immune response. In addition, cytokine expression in CAT2(-/-) mice was altered from an antimicrobial Th1 response to a Th2 response, indicating that the transporter has downstream effects on adaptive immunity as well. These findings demonstrate that CAT2 is an important regulator of the immune response during H. pylori infection.	[Barry, Daniel P.; Asim, Mohammad; Scull, Brooks P.; Piazuelo, M. Blanca; de Sablet, Thibaut; Lewis, Nuruddeen D.; Coburn, Lori A.; Singh, Kshipra; Gobert, Alain P.; Chaturvedi, Rupesh; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37203 USA; [Barry, Daniel P.; Asim, Mohammad; de Sablet, Thibaut; Coburn, Lori A.; Singh, Kshipra; Gobert, Alain P.; Chaturvedi, Rupesh; Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Lewis, Nuruddeen D.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Ellies, Lesley G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Gobert, Alain P.] Inst Natl Rech Agron, Unite Microbiol UR454, St Genes Champanelle, France; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; University of California System; University of California San Diego; INRAE; Vanderbilt University	Barry, DP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37203 USA.	keith.wilson@vanderbilt.edu	Barry, Daniel P/B-5647-2008; de Sablet, Thibaut/AAI-4513-2020; Gobert, Alain P/AHB-1368-2022	Barry, Daniel P/0000-0002-3972-3914; Lewis, Nuruddeen/0000-0002-1233-6607; Wilson, Keith/0000-0003-4421-1830; Coburn, Lori/0000-0003-3249-9806	National Institutes of Health (NIH) [R01DK053620, R01AT004821, 3R01AT004821S1, P01CA028842, P01CA116087, T32DK007673]; Vanderbilt University Digestive Disease Research Center [P30DK058404]; Office of Medical Research, Department of Veterans Affairs; Philippe Foundation; NATIONAL CANCER INSTITUTE [P01CA116087, P01CA028842, T32CA009592] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053620, T32DK007673, P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Digestive Disease Research Center; Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); Philippe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health (NIH) grants R01DK053620, R01AT004821, 3R01AT004821S1, and P01CA028842 (to KTW), P01CA116087 (KTW), T32DK007673 (DPB), the Vanderbilt University Digestive Disease Research Center grant (P30DK058404), and a Merit Review Grant from the Office of Medical Research, Department of Veterans Affairs (to KTW). TS and APG were supported by the Philippe Foundation (http://fundingopps.cos.com/cgi-bin/getRec?id=3732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhiani AA, 2002, J IMMUNOL, V169, P6977, DOI 10.4049/jimmunol.169.12.6977; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Andres S, 2011, FEMS IMMUNOL MED MIC, V61, P168, DOI 10.1111/j.1574-695X.2010.00761.x; Asim M, 2010, J BIOL CHEM, V285, P20343, DOI 10.1074/jbc.M110.116988; Barry DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017510; Bussiere FI, 2005, J BIOL CHEM, V280, P2409, DOI 10.1074/jbc.C400498200; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Eaton KA, 1999, INFECT IMMUN, V67, P4594, DOI 10.1128/IAI.67.9.4594-4602.1999; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Eck M, 2000, CLIN EXP IMMUNOL, V122, P192, DOI 10.1046/j.1365-2249.2000.01374.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Gobert AP, 2002, J IMMUNOL, V168, P6002, DOI 10.4049/jimmunol.168.12.6002; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; Guiney DG, 2003, INFECT IMMUN, V71, P4163, DOI 10.1128/IAI.71.7.4163-4166.2003; Heinzel FP, 1997, J IMMUNOL, V158, P4381; Ismail HF, 2003, J IMMUNOL, V170, P3782, DOI 10.4049/jimmunol.170.7.3782; Kao JY, 2006, AM J PHYSIOL-GASTR L, V291, pG73, DOI 10.1152/ajpgi.00139.2005; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Kranzer K, 2004, INFECT IMMUN, V72, P4416, DOI 10.1128/IAI.72.8.4416-4423.2004; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lewis ND, 2011, J IMMUNOL, V186, P3632, DOI 10.4049/jimmunol.1003431; Lewis ND, 2010, J IMMUNOL, V184, P2572, DOI 10.4049/jimmunol.0902436; Marotti B, 2008, DIGEST LIVER DIS, V40, P240, DOI 10.1016/j.dld.2007.11.021; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Obata F, 2006, SCAND J IMMUNOL, V63, P125, DOI 10.1111/j.1365-3083.2005.01718.x; Rea IM, 2000, CYTOKINE, V12, P156, DOI 10.1006/cyto.1999.0537; Rothenberg ME, 2006, P NATL ACAD SCI USA, V103, P14895, DOI 10.1073/pnas.0605478103; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Wilson KT, 1996, GASTROENTEROLOGY, V111, P1524, DOI 10.1016/S0016-5085(96)70014-8; Zu YL, 2000, ULTRASTRUCT PATHOL, V24, P319, DOI 10.1080/019131200750035049	41	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29046	10.1371/journal.pone.0029046	http://dx.doi.org/10.1371/journal.pone.0029046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194986	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100148
J	van Zuiden, M; Heijnen, CJ; van de Schoot, R; Amarouchi, K; Maas, M; Vermetten, E; Geuze, E; Kavelaars, A				van Zuiden, Mirjam; Heijnen, Cobi J.; van de Schoot, Rens; Amarouchi, Karima; Maas, Mirjam; Vermetten, Eric; Geuze, Elbert; Kavelaars, Annemieke			Cytokine Production by Leukocytes of Military Personnel with Depressive Symptoms after Deployment to a Combat-Zone: A Prospective, Longitudinal Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SELF-RATING INVENTORY; NECROSIS-FACTOR-ALPHA; MAJOR DEPRESSION; IMMUNE ACTIVATION; IN-VITRO; PROINFLAMMATORY CYTOKINES; SCREENING INSTRUMENTS; INTERFERON-ALPHA; CALMETTE-GUERIN	Major depressive disorder (MDD) is frequently diagnosed in military personnel returning from deployment. Literature suggests that MDD is associated with a pro-inflammatory state. To the best of our knowledge, no prospective, longitudinal studies on the association between development of depressive symptomatology and cytokine production by peripheral blood leukocytes have been published. The aim of this study was to investigate whether the presence of depressive symptomatology six months after military deployment is associated with the capacity to produce cytokines, as assessed before and after deployment. 1023 military personnel were included before deployment. Depressive symptoms and LPS- and T-cell mitogen-induced production of 16 cytokines and chemokines in whole blood cultures were measured before (T0), 1 (T1), and 6 (T2) months after return from deployment. Exploratory structural equation modeling (ESEM) was used for data reduction into cytokine patterns. Multiple group latent growth modeling was used to investigate differences in the longitudinal course of cytokine production between individuals with (n=68) and without (n=665) depressive symptoms at T2. Individuals with depressive symptoms after deployment showed higher T-cell cytokine production before deployment. Moreover, pre-deployment T-cell cytokine production significantly predicted the presence of depressive symptomatology 6 months after return. There was an increase in T-cell cytokine production over time, but this increase was significantly smaller in individuals developing depressive symptoms. T-cell chemokine and LPS-induced innate cytokine production decreased over time and were not associated with depressive symptoms. These results indicate that increased T-cell mitogen-induced cytokine production before deployment may be a vulnerability factor for development of depressive symptomatology in response to deployment to a combat-zone. In addition, deployment to a combat-zone affects the capacity of T-cells and monocytes to produce cytokines and chemokines until at least 6 months after return.	[van Zuiden, Mirjam; Heijnen, Cobi J.; Amarouchi, Karima; Maas, Mirjam; Kavelaars, Annemieke] Univ Med Ctr, Lab Neuroimmunol & Dev Origins Dis NIDOD, Utrecht, Netherlands; [van Zuiden, Mirjam; Vermetten, Eric; Geuze, Elbert] Minist Def, Res Ctr Mil Mental Hlth, Utrecht, Netherlands; [van de Schoot, Rens] Univ Utrecht, Fac Social Sci, Dept Methodol & Stat, Utrecht, Netherlands; [Vermetten, Eric; Geuze, Elbert] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center	van Zuiden, M (corresponding author), Univ Med Ctr, Lab Neuroimmunol & Dev Origins Dis NIDOD, Utrecht, Netherlands.	a.kavelaars@umcutrecht.nl	Vermetten, Eric/B-1335-2008	Vermetten, Eric/0000-0003-0579-4404; Geuze, Elbert/0000-0003-3479-2379; van Zuiden, Mirjam/0000-0002-1225-2702	Dutch Ministry of Defence	Dutch Ministry of Defence	This study was funded by a grant from the Dutch Ministry of Defence. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Aikake H., 1973, 2 INT S INF THEOR, P267; Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; Anisman H, 1999, BIOL PSYCHIAT, V46, P1649, DOI 10.1016/S0006-3223(99)00211-5; Arrindell WA, 2003, SYMPTOM CHECKLIST HA; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Bauer ME, 2003, PSYCHONEUROENDOCRINO, V28, P49, DOI 10.1016/S0306-4530(02)00009-4; Blume J, 2011, BRAIN BEHAV IMMUN, V25, P221, DOI 10.1016/j.bbi.2010.10.008; Bollen K. A., 1989, J STAT ASS; Boscarino JA, 1997, PSYCHOSOM MED, V59, P605, DOI 10.1097/00006842-199711000-00008; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Capuron L, 2009, J AFFECT DISORDERS, V119, P181, DOI 10.1016/j.jad.2009.02.017; Carvalho LA, 2008, NEUROPSYCHOPHARMACOL, V33, P3182, DOI 10.1038/npp.2008.44; Castro CA, 2007, TRAUMATOLOGY, V13, P6, DOI [10.1177/1534765607309950, DOI 10.1177/1534765607309950]; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Cyranowski JM, 2007, BRAIN BEHAV IMMUN, V21, P229, DOI 10.1016/j.bbi.2006.07.005; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Eller T, 2009, MED LITH, V45, P971, DOI 10.3390/medicina45120124; Houtveen JH, 2007, BRAIN BEHAV IMMUN, V21, P1075, DOI 10.1016/j.bbi.2007.04.008; HOVENS JE, 1994, ACTA PSYCHIAT SCAND, V90, P172, DOI 10.1111/j.1600-0447.1994.tb01574.x; Hovens JE, 2002, PERCEPT MOTOR SKILL, V94, P996, DOI 10.2466/PMS.94.2.996-1008; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Ikin JF, 2010, J AFFECT DISORDERS, V125, P279, DOI 10.1016/j.jad.2009.12.005; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Kagaya A, 2001, NEUROPSYCHOBIOLOGY, V43, P59, DOI 10.1159/000054867; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P1044, DOI 10.1016/j.pnpbp.2007.03.004; Kline RB, 2005, PRINCIPLES PRACTICE; Korenromp IHE, 2011, BRAIN BEHAV IMMUN, V25, P1498, DOI 10.1016/j.bbi.2011.06.004; Marsh HW, 2010, PSYCHOL ASSESSMENT, V22, P471, DOI 10.1037/a0019227; Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; Miller GE, 2005, J PSYCHOSOM RES, V59, P231, DOI 10.1016/j.jpsychores.2005.06.004; Miller GE, 2005, PSYCHOSOM MED, V67, P679, DOI 10.1097/01.psy.0000174172.82428.ce; Mommersteeg PMC, 2008, PSYCHONEUROENDOCRINO, V33, P1041, DOI 10.1016/j.psyneuen.2008.05.007; Muthen, 2010, STAT ANAL LATENT VAR; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; O'Toole BI, 2009, AM J EPIDEMIOL, V170, P318, DOI 10.1093/aje/kwp146; Preacher K.J., 2008, LATENT GROWTH CURVE; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Rothermundt M, 2001, J AFFECT DISORDERS, V63, P93, DOI 10.1016/S0165-0327(00)00157-9; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schlatter J, 2004, PSYCHIAT RES, V128, P259, DOI 10.1016/j.psychres.2004.06.004; Schmitz N, 1999, SOC PSYCH PSYCH EPID, V34, P360, DOI 10.1007/s001270050156; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SEIDEL A, 1995, SCAND J IMMUNOL, V41, P534, DOI 10.1111/j.1365-3083.1995.tb03604.x; SEWELL WA, 1986, P NATL ACAD SCI USA, V83, P8718, DOI 10.1073/pnas.83.22.8718; Sluzewska A, 1996, PSYCHIAT RES, V64, P161, DOI 10.1016/S0165-1781(96)02783-7; Smith KJ, 2011, NEUROPSYCH DIS TREAT, V7, P275, DOI 10.2147/NDT.S13917; Strik JJMH, 2001, PSYCHOSOMATICS, V42, P423, DOI 10.1176/appi.psy.42.5.423; Suarez EC, 2004, PSYCHONEUROENDOCRINO, V29, P1119, DOI 10.1016/j.psyneuen.2004.01.002; Suarez EC, 2003, PSYCHOSOM MED, V65, P362, DOI 10.1097/01.PSY.0000035719.79068.2B; ter Wolbeek M, 2007, BRAIN BEHAV IMMUN, V21, P1063, DOI 10.1016/j.bbi.2007.04.007; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Uddin M, 2011, PSYCHOL MED, V41, P997, DOI 10.1017/S0033291710001674; van Zuiden M, 2011, AM J PSYCHIAT, V168, P89, DOI 10.1176/appi.ajp.2010.10050706; van Zuiden M, 2009, BRAIN BEHAV IMMUN, V23, P1132, DOI 10.1016/j.bbi.2009.07.004; VANLIER RAW, 1988, EUR J IMMUNOL, V18, P167; WEIZMAN R, 1994, BIOL PSYCHIAT, V35, P42, DOI 10.1016/0006-3223(94)91166-5; Wichers MC, 2006, BIOL PSYCHIAT, V60, P77, DOI 10.1016/j.biopsych.2005.11.024; Zorrilla EP, 2001, BRAIN BEHAV IMMUN, V15, P199, DOI 10.1006/brbi.2000.0597	62	29	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29142	10.1371/journal.pone.0029142	http://dx.doi.org/10.1371/journal.pone.0029142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195009	Green Submitted, gold, Green Published			2022-12-25	WOS:000298369100162
J	de Boer, HJ; Vongsombath, C; Kafer, J				de Boer, Hugo J.; Vongsombath, Chanda; Kaefer, Jos			A Fly in the Ointment: Evaluation of Traditional Use of Plants to Repel and Kill Blowfly Larvae in Fermented Fish	PLOS ONE			English	Article							CHRYSOMYA-MEGACEPHALA; MUSCA-DOMESTICA; DIPTERA; CALLIPHORIDAE; FOODS	Introduction: In rural areas in Laos, fly larvae infestations are common in fermenting fish. Blowflies (Chrysomya megacephala, Diptera: Calliphoridae) are attracted to oviposit (and/ or larviposit) onto fermenting fish which results in infestations with fly larvae. Knowledge of traditional use of plants to repel larvae during the production of fermented fish is common and widespread in Lao PDR. Research Questions: How effective are the most salient species in repelling, and killing fly larvae in fermenting fish? Material and Methods: The three plant species most frequently reported to repel fly larvae during an ethnobotanical survey throughout Lao PDR were tested for repellence and larvicidal activity of fly larvae infesting fermented fish. The lethality and repellence of Tadehagi triquetrum (L.) H. Ohashi (Fabaceae), Uraria crinita (L.) Desv. ex DC. (Fabaceae) and Bambusa multiplex (Lour.) Raeusch. ex Schult. & Schult. f. (Poaceae) were tested in an experimental design using fermenting fish in Vientiane, Lao PDR. Results: The repellent effect of fresh material of T. triquetrum and U. crinita, and the larvicidal effect of fresh B. multiplex, is significantly more effective than that of dried material of the same species, and the total effect (repellence and larvicidal effect combined) for each of the three species was significantly more effective for fresh than for dry material. Fresh material of T. triquetrum, U. crinita, or B. multiplex added on top of the fermenting fish repelled 50%, 54%, 37%, and killed 22%, 28%, and 40% of fly larvae. The total effect was not significantly different per species at 72%, 82%, and 77%, respectively. Discussion and Conclusions: The three most salient species are effective in repelling and killing fly larvae in the production of fermented fish, and may be essential to augment food safety during traditional fermentation in open jars.	[de Boer, Hugo J.; Vongsombath, Chanda] Uppsala Univ, Evolutionary Biol Ctr, Dept Systemat Biol, Uppsala, Sweden; [Vongsombath, Chanda] Natl Univ Laos, Fac Sci, Dept Biol, Viangchan, Laos; [Kaefer, Jos] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France	Uppsala University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	de Boer, HJ (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Systemat Biol, Uppsala, Sweden.	chanda.vongsombath@ebc.uu.se	de Boer, Hugo/B-5640-2015; Käfer, Jos/E-7714-2017; Käfer, Jos/AAR-1547-2021; de Boer, Hugo Joris/AAS-7585-2020	de Boer, Hugo/0000-0003-1985-7859; Käfer, Jos/0000-0002-0561-8008; Käfer, Jos/0000-0002-0561-8008; de Boer, Hugo Joris/0000-0003-1985-7859	Sida-Swedish Agency of Research Cooperation; Developing Countries (SAREC) bilateral program; Lao PDR; Sida-SAREC [SWE-2005-338]; Helge Ax:son Johnsons Stiftelse; Regnells botaniska resestipendium; Smalands nation's Anna Maria Lundins stipendiefond	Sida-Swedish Agency of Research Cooperation; Developing Countries (SAREC) bilateral program; Lao PDR; Sida-SAREC; Helge Ax:son Johnsons Stiftelse; Regnells botaniska resestipendium; Smalands nation's Anna Maria Lundins stipendiefond	This work was supported by: Sida-Swedish Agency of Research Cooperation with Developing Countries (SAREC) bilateral program with Lao PDR (to C.V.); Sida-SAREC Grant SWE-2005-338, Helge Ax:son Johnsons Stiftelse; Regnells botaniska resestipendium, and Smalands nation's Anna Maria Lundins stipendiefond (to H.d.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkill IH, 1930, GARDENS B STRAITS SE, V6, P165, DOI DOI 10.1093/BIOINFORMATICS/BTP348; Chuakul W., 2002, THAI J PHYTOPHARM, V9, P22; Cooke R. D., 1993, FISH FERMENTATION TE, P291; de Boer H, 2010, J MED ENTOMOL, V47, P400, DOI 10.1603/ME09273; De Jesus AJ, 2004, INT J FOOD MICROBIOL, V93, P259, DOI 10.1016/j.ijfoodmicro.2003.12.003; ESSER JR, 1991, B ENTOMOL RES, V81, P33, DOI 10.1017/S0007485300053219; Forster M, 2007, PARASITOL RES, V101, P243, DOI 10.1007/s00436-007-0522-y; GREENBERG B, 1970, Infection and Immunity, V2, P800; Hamid F, 2004, PHARM BIOL, V42, P114, DOI 10.1080/13880200490510892; Hamid H, 2007, PHARM BIOL, V45, P140, DOI 10.1080/13880200601113107; Hinna Hamid, 2006, Hamdard Medicus, V49, P31; Ishige N., 1993, FISH FERMENTATION TE, P13; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; LAWSON JR, 1990, PARASITOLOGY, V100, P143, DOI 10.1017/S0031182000060224; Lee CH, 1997, FOOD CONTROL, V8, P259, DOI 10.1016/S0956-7135(97)00015-7; [李树荣 Li Shurong], 2003, [云南农业大学学报, Journal of Yunnan Agricultural University], V18, P170; LI SR, 2002, J YUNNAN AGR SCI TEC, V5, P38; Liu T., 1952, LIST EC PLANTS TAIWA; LWIN KS, 1968, UNION BURMA J LIFE S, V1, P166; Phithakpol B., 1993, FISH FERMENTATION TE, P155; Satya S, 2010, TRENDS FOOD SCI TECH, V21, P181, DOI 10.1016/j.tifs.2009.11.002; SUCHARIT S, 1998, MED ENTOMOLOGY, P408; Sukontason Kabkaew L., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P38; Wells JD, 1999, J MED ENTOMOL, V36, P638, DOI 10.1093/jmedent/36.5.638; Xiang W, 2005, J AGR FOOD CHEM, V53, P267, DOI 10.1021/jf0483117; Yen GC, 2001, FOOD CHEM, V74, P471, DOI 10.1016/S0308-8146(01)00165-0; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	27	2	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29521	10.1371/journal.pone.0029521	http://dx.doi.org/10.1371/journal.pone.0029521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206019	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600041
J	Kluver, N; Yang, LX; Busch, W; Scheffler, K; Renner, P; Strahle, U; Scholz, S				Kluever, Nils; Yang, Lixin; Busch, Wibke; Scheffler, Katja; Renner, Patrick; Straehle, Uwe; Scholz, Stefan			Transcriptional Response of Zebrafish Embryos Exposed to Neurotoxic Compounds Reveals a Muscle Activity Dependent hspb11 Expression	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; CHAPERONE FUNCTION; INDUCED MYOPATHY; SKELETAL-MUSCLE; NEURITE GROWTH; DANIO-RERIO; CALCIUM; ACETYLCHOLINESTERASE	Acetylcholinesterase (AChE) inhibitors are widely used as pesticides and drugs. Their primary effect is the overstimulation of cholinergic receptors which results in an improper muscular function. During vertebrate embryonic development nerve activity and intracellular downstream events are critical for the regulation of muscle fiber formation. Whether AChE inhibitors and related neurotoxic compounds also provoke specific changes in gene transcription patterns during vertebrate development that allow them to establish a mechanistic link useful for identification of developmental toxicity pathways has, however, yet not been investigated. Therefore we examined the transcriptomic response of a known AChE inhibitor, the organophosphate azinphos-methyl (APM), in zebrafish embryos and compared the response with two non-AChE inhibiting unspecific control compounds, 1,4-dimethoxybenzene (DMB) and 2,4-dinitrophenol (DNP). A highly specific cluster of APM induced gene transcripts was identified and a subset of strongly regulated genes was analyzed in more detail. The small heat shock protein hspb11 was found to be the most sensitive induced gene in response to AChE inhibitors. Comparison of expression in wildtype, ache and sop fixe mutant embryos revealed that hspb11 expression was dependent on the nicotinic acetylcholine receptor (nAChR) activity. Furthermore, modulators of intracellular calcium levels within the whole embryo led to a transcriptional up-regulation of hspb11 which suggests that elevated intracellular calcium levels may regulate the expression of this gene. During early zebrafish development, hspb11 was specifically expressed in muscle pioneer cells and Hspb11 morpholino-knockdown resulted in effects on slow muscle myosin organization. Our findings imply that a comparative toxicogenomic approach and functional analysis can lead to the identification of molecular mechanisms and specific marker genes for potential neurotoxic compounds.	[Kluever, Nils; Busch, Wibke; Scheffler, Katja; Renner, Patrick; Scholz, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany; [Yang, Lixin; Straehle, Uwe] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Karlsruhe Institute of Technology	Kluver, N (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.	nils.kluever@ufz.de	yang, lixin/AAW-5386-2021; yang, lixin/GSO-1670-2022; Straehle, Uwe/K-7054-2013; Klüver, Nils/D-8678-2015; yang, lixin/F-9597-2013; Busch, Wibke/I-9348-2012; Scholz, Stefan/B-7776-2014	yang, lixin/0000-0003-3377-1998; yang, lixin/0000-0003-3377-1998; Busch, Wibke/0000-0002-5497-6266; Scholz, Stefan/0000-0002-6990-4716	Federal Ministry of Education and Research (BMBF) [PTJ-BIO/0315190]; European Commission [HEALTH-F4-2010-242048]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Federal Ministry of Education and Research (BMBF) GenDarT2 [PTJ-BIO/0315190] and by the European Commission Integrating Project ZF Health [HEALTH-F4-2010-242048]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankley GT, 2006, ENVIRON SCI TECHNOL, V40, P4055, DOI 10.1021/es0630184; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Behra M, 2004, TOXICOL SCI, V77, P325, DOI 10.1093/toxsci/kfh020; Behra M, 2002, NAT NEUROSCI, V5, P111, DOI 10.1038/nn788; Benndorf R, 2004, NAT GENET, V36, P547, DOI 10.1038/ng0604-547; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bertrand C, 2001, J BIOL CHEM, V276, P464, DOI 10.1074/jbc.M006308200; Brennan C, 2005, J CELL SCI, V118, P5181, DOI 10.1242/jcs.02625; Corvi R, 2006, ENVIRON HEALTH PERSP, V114, P420, DOI 10.1289/ehp.8247; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Downes GB, 2004, DEV BIOL, V270, P232, DOI 10.1016/j.ydbio.2004.02.027; Elicker KS, 2007, GENE, V403, P60, DOI 10.1016/j.gene.2007.08.003; Etard C, 2005, DEV DYNAM, V234, P1016, DOI 10.1002/dvdy.20592; FUKUTO T R, 1990, Environmental Health Perspectives, V87, P245, DOI 10.2307/3431032; Hardingham GE, 1999, MICROSC RES TECHNIQ, V46, P348, DOI 10.1002/(SICI)1097-0029(19990915)46:6<348::AID-JEMT3>3.3.CO;2-1; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; Jin HJ, 2008, MOL IMMUNOL, V45, P1258, DOI 10.1016/j.molimm.2007.09.015; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; Krebs DL, 2000, J CELL SCI, V113, P2813; Kuster E, 2005, AQUAT TOXICOL, V75, P76, DOI 10.1016/j.aquatox.2005.07.005; Lefebvre JL, 2004, DEVELOPMENT, V131, P2605, DOI 10.1242/dev.01123; LEONARD JP, 1982, EXP NEUROL, V76, P121, DOI 10.1016/0014-4886(82)90106-6; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; Marvin M, 2008, DEV DYNAM, V237, P454, DOI 10.1002/dvdy.21414; MESHUL CK, 1989, BRAIN RES, V497, P142, DOI 10.1016/0006-8993(89)90980-3; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; MITCHELL P, 1967, BIOCHEM J, V105, P1147, DOI 10.1042/bj1051147; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pope CN, 1999, J TOXICOL ENV HEAL B, V2, P161, DOI 10.1080/109374099281205; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sawle AD, 2010, TOXICOL SCI, V118, P128, DOI 10.1093/toxsci/kfq237; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Suter L, 2004, CHEM BIOL, V11, P161, DOI 10.1016/j.chembiol.2004.02.003; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Aggelen G, 2010, ENVIRON HEALTH PERSP, V118, P1, DOI 10.1289/ehp.0900985; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Velthuis AJWT, 2007, GENE EXPR PATTERNS, V7, P297, DOI 10.1016/j.modgep.2006.09.001; Voelker D, 2007, AQUAT TOXICOL, V81, P355, DOI 10.1016/j.aquatox.2006.12.013; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227	56	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29063	10.1371/journal.pone.0029063	http://dx.doi.org/10.1371/journal.pone.0029063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205996	Green Published, gold, Green Submitted			2022-12-25	WOS:000298665600026
J	Qiu, C; Kershner, A; Wang, YM; Holley, CP; Wilinski, D; Keles, S; Kimble, J; Wickens, M; Hall, TMT				Qiu, Chen; Kershner, Aaron; Wang, Yeming; Holley, Cynthia P.; Wilinski, Daniel; Keles, Sunduz; Kimble, Judith; Wickens, Marvin; Hall, Traci M. Tanaka			Divergence of Pumilio/fem-3 mRNA Binding Factor (PUF) Protein Specificity through Variations in an RNA-binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RECOGNITION; TARGETS; FEM-3; GENE; CODE	mRNA control networks depend on recognition of specific RNA sequences. Pumilio-fem-3 mRNA binding factor (PUF) RNA-binding proteins achieve that specificity through variations on a conserved scaffold. Saccharomyces cerevisiae Puf3p achieves specificity through an additional binding pocket for a cytosine base upstream of the core RNA recognition site. Here we demonstrate that this chemically simple adaptation is prevalent and contributes to the diversity of RNA specificities among PUF proteins. Bioinformatics analysis shows that mRNAs associated with Caenorhabditis elegans fem-3 mRNA binding factor (FBF)-2 in vivo contain an upstream cytosine required for biological regulation. Crystal structures of FBF-2 and C. elegans PUF-6 reveal binding pockets structurally similar to that of Puf3p, whereas sequence alignments predict a pocket in PUF-11. For Puf3p, FBF-2, PUF-6, and PUF-11, the upstream pockets and a cytosine are required for maximal binding to RNA, but the quantitative impact on binding affinity varies. Furthermore, the position of the upstream cytosine relative to the core PUF recognition site can differ, which in the case of FBF-2 originally masked the identification of this consensus sequence feature. Importantly, other PUF proteins lack the pocket and so do not discriminate upstream bases. A structure-based alignment reveals that these proteins lack key residues that would contact the cytosine, and in some instances, they also present amino acid side chains that interfere with binding. Loss of the pocket requires only substitution of one serine, as appears to have occurred during the evolution of certain fungal species.	[Wilinski, Daniel; Kimble, Judith; Wickens, Marvin] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kershner, Aaron; Kimble, Judith; Wickens, Marvin] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Keles, Sunduz] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Keles, Sunduz] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; [Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Qiu, Chen; Wang, Yeming; Holley, Cynthia P.; Hall, Traci M. Tanaka] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	wickens@biochem.wisc.edu; hall4@niehs.nih.gov	Hall, Traci/F-5849-2019; Wang, Yeming/C-9082-2013	Hall, Traci/0000-0001-6166-3009; Wilinski, Daniel/0000-0002-6178-8925	National Institutes of Health [GM50942, HG003747]; Howard Hughes Medical Institute; National Institute of Environmental Health Sciences; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM50942 (to M.W.) and HG003747 (to S.K.). This work was also supported by a Howard Hughes Medical Institute grant (to J.K.) and by the Intramural Research Program of the National Institute of Environmental Health Sciences (to T.M.T.H.).; We thank Cary Valley for discussions and creating and testing mutant constructs; Maria Wooten for assistance with site-directed mutagenesis; Kathryne Hawthorne for assistance with PUF-6 protein purification, crystallization, and RNA-binding analyses; and Dr. Lars Pedersen and the staff at the Southeast Regional Collaborative Access Team beamline for help with x-ray data collection. Data were collected at Southeast Regional Collaborative Access Team 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; BARTON MK, 1987, GENETICS, V115, P107; Bembom O, 2007, STAT APPL GENET MOL, V6; Bernstein D, 2005, RNA, V11, P447, DOI 10.1261/rna.7255805; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dong SY, 2011, J BIOL CHEM, V286, P26732, DOI 10.1074/jbc.M111.244889; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipovska A, 2011, NAT CHEM BIOL, V7, P425, DOI [10.1038/NCHEMBIO.577, 10.1038/nchembio.577]; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kershner AM, 2010, P NATL ACAD SCI USA, V107, P3936, DOI 10.1073/pnas.1000495107; Koh YY, 2011, RNA, V17, P718, DOI 10.1261/rna.2540311; Koh YY, 2009, RNA, V15, P1090, DOI 10.1261/rna.1545309; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merritt C, 2010, DEVELOPMENT, V137, P1787, DOI 10.1242/dev.050799; Miller MT, 2008, NAT STRUCT MOL BIOL, V15, P397, DOI 10.1038/nsmb.1390; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Opperman L, 2005, NAT STRUCT MOL BIOL, V12, P945, DOI 10.1038/nsmb1010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Stumpf CR, 2008, RNA, V14, P1550, DOI 10.1261/rna.1095908; Thompson B, 2007, TRANSLATIONAL CONTRO, V48, P507; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106	35	33	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6949	6957		10.1074/jbc.M111.326264	http://dx.doi.org/10.1074/jbc.M111.326264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22205700	Green Published, hybrid			2022-12-25	WOS:000300791800079
J	La, D; Czarnecki, C; El-Gabalawy, H; Kumar, A; Meyers, AFA; Bastien, N; Simonsen, JN; Plummer, FA; Luo, M				La, David; Czarnecki, Chris; El-Gabalawy, Hani; Kumar, Anand; Meyers, Adrienne F. A.; Bastien, Nathalie; Simonsen, J. Neil; Plummer, Francis A.; Luo, Ma			Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study	PLOS ONE			English	Article							HLA-C; ALLELE FREQUENCIES; VIRUS-INFECTION; SWINE FLU; INFLUENZA; KIR; IDENTIFICATION; DISEASE; BINDING; POLYMORPHISMS	Background: Infection by the pandemic influenza A (H1N1/09) virus resulted in significant pathology among specific ethnic groups worldwide. Natural Killer (NK) cells are important in early innate immune responses to viral infections. Activation of NK cells, in part, depend on killer-cell immunoglobulin-like receptors (KIR) and HLA class I ligand interactions. To study factors involved in NK cell dysfunction in overactive immune responses to H1N1 infection, KIR3DL1/S1 and KIR2DL2/L3 allotypes and cognate HLA ligands of H1N1/09 intensive-care unit (ICU) patients were determined. Methodology and Findings: KIR3DL1/S1, KIR2DL2/L3, and HLA -B and -C of 51 H1N1/09 ICU patients and 105 H1N1negative subjects (St. Theresa Point, Manitoba) were characterized. We detected an increase of 3DL1 ligand-negative pairs (3DL1/S1(+)Bw6(+)Bw4(-)), and a lack of 2DL1 HLA-C2 ligands, among ICU patients. They were also significantly enriched for 2DL2/L3 ligand-positive pairs (P<0.001, Pc<0.001; Odds Ratio: 6.3158, CI95%: 2.481-16.078). Relative to St. Theresa aboriginals (STh) and Venezuelan Amerindians (VA), allotypes enriched among aboriginal ICU patients (Ab) were: 2DL3 (Ab>VA, P = 0.024, Pc = 0.047; Odds Ratio: 2.563, CI95%: 1.109-5.923), 3DL1* 00101 (Ab>VA, P<0.001, Pc<0.001), 3DL1* 01502 (Ab>STh, P = 0.034, Pc = 0.268), and 3DL1* 029 (Ab>STh, P = 0.039, Pc = 0.301). Aboriginal patients ligandpositive for 3DL1/S1 and 2DL1 had the lowest probabilities of death (R-d) (R-d = 28%), compared to patients that were 3DL1/ S1 ligand-negative (Rd = 52%) or carried 3DL1*029 (Rd = 52%). Relative to Caucasoids (CA), two allotypes were enriched among non-aboriginal ICU patients (NAb): 3DL1*00401 (NAb>CA, P<0.001, Pc<0.001) and 3DL1*01502 (CA, NAb, P = 0.012, Pc = 0.156). Non-aboriginal patients with ligands for all three KIRs (3DL1/S1, 2DL2/L3, and 2DL1) had the lowest probabilities of death (R-d = 36%), compared to subjects with 3DL1* 01502 (R-d = 48%) and/or 3DL1*00401 (R-d = 58%). Conclusions: Specific KIR3DL1/S1 allotypes, 3DL1/S1 and 2DL1 ligand-negative pairs, and 2DL2/L3 ligand-positive pairs were enriched among ICU patients. This suggests a possible association with NK cell dysfunction in patients with overactive immune responses to H1N1/09, leading to severe disease.	[La, David; Czarnecki, Chris; Meyers, Adrienne F. A.; Bastien, Nathalie; Simonsen, J. Neil; Plummer, Francis A.; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Meyers, Adrienne F. A.; Plummer, Francis A.; Luo, Ma] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [El-Gabalawy, Hani] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, Hlth Sci Ctr, Sect Crit Care Med, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, St Boniface Hosp, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	La, D (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	ma.luo@phac-aspc.gc.ca		El-Gabalawy, Hani/0000-0002-0796-4422	Federal funding for H1N1 research; Roche, Canada	Federal funding for H1N1 research; Roche, Canada(Roche Holding)	This study was supported by the Federal funding for H1N1 research and in part by Roche, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PAND H1N1 2009 UPD 7; Carlson J.M., 2009, MSRTR200953; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carrington M, 2004, HUM IMMUNOL, V65, P1191, DOI 10.1016/j.humimm.2004.08.154; Carrington M, 2003, THE KIR GENE CLUSTER; Chitnis Amit S, 2010, WMJ, V109, P201; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Dee S, 2010, NEW ZEAL MED J, V123, P45; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Embree J, 2010, BIOCHEM CELL BIOL, V88, P589, DOI 10.1139/O10-025; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; Gendzekhadze K, 2006, IMMUNOGENETICS, V58, P474, DOI 10.1007/s00251-006-0108-3; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Hardie RA, 2010, HUM IMMUNOL, V71, P1251, DOI 10.1016/j.humimm.2010.09.013; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Jamil KM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/298348; Kaufman MA, 2009, MED J AUSTRALIA, V191, P154, DOI 10.5694/j.1326-5377.2009.tb02726.x; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; La Ruche G, 2009, EURO SURVEILL, V14; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu BX, 2004, J GEN VIROL, V85, P423, DOI 10.1099/vir.0.19596-0; Lowry R., 2011, VASSARSTATS WEBSITE; Luo M, 2002, TISSUE ANTIGENS, V59, P370, DOI 10.1034/j.1399-0039.2002.590503.x; LUTZ CT, 1994, J IMMUNOL, V153, P4099; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Paine S, 2010, EUROSURVEILLANCE, V15, P9; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Reinders J, 2005, HUM IMMUNOL, V66, P912, DOI 10.1016/j.humimm.2005.06.010; Rempel JD, 2011, EUR J HUM GENET, V19, P1276, DOI 10.1038/ejhg.2011.114; Robinson J, 2005, NUCLEIC ACIDS RES, V33, pD523, DOI 10.1093/nar/gki032; Robinson J, 2000, TISSUE ANTIGENS, V55, P280, DOI 10.1034/j.1399-0039.2000.550314.x; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Turner SJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-130; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wada K, 2010, INFLUENZA OTHER RESP, V4, P179, DOI 10.1111/j.1750-2659.2010.00143.x; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Webster P, 2009, CAN MED ASSOC J, V181, pE90, DOI 10.1503/cmaj.091355; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	51	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29200	10.1371/journal.pone.0029200	http://dx.doi.org/10.1371/journal.pone.0029200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216211	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300036
J	LaJeunesse, TC; Thornhill, DJ				LaJeunesse, Todd C.; Thornhill, Daniel J.			Improved Resolution of Reef-Coral Endosymbiont (Symbiodinium) Species Diversity, Ecology, and Evolution through psbA Non-Coding Region Genotyping	PLOS ONE			English	Article							GREAT-BARRIER-REEF; HOST-SPECIFICITY; ALGAL SYMBIONT; INDO-PACIFIC; ACROPORA; COMMUNITIES; STABILITY; RDNA; ZOOXANTHELLAE; BIODIVERSITY	Ribosomal DNA sequence data abounds from numerous studies on the dinoflagellate endosymbionts of corals, and yet the multi-copy nature and intragenomic variability of rRNA genes and spacers confound interpretations of symbiont diversity and ecology. Making consistent sense of extensive sequence variation in a meaningful ecological and evolutionary context would benefit from the application of additional genetic markers. Sequences of the non-coding region of the plastid psbA minicircle (psbA (ncr)) were used to independently examine symbiont genotypic and species diversity found within and between colonies of Hawaiian reef corals in the genus Montipora. A single psbA(ncr) haplotype was recovered in most samples through direct sequencing (similar to 80-90%) and members of the same internal transcribed spacer region 2 (ITS2) type were phylogenetically differentiated from other ITS2 types by substantial psbA ncr sequence divergence. The repeated sequencing of bacterially-cloned fragments of psbA ncr from samples and clonal cultures often recovered a single numerically common haplotype accompanied by rare, highly-similar, sequence variants. When sequence artifacts of cloning and intragenomic variation are factored out, these data indicate that most colonies harbored one dominant Symbiodinium genotype. The cloning and sequencing of ITS2 DNA amplified from these same samples recovered numerically abundant variants (that are diagnostic of distinct Symbiodinium lineages), but also generated a large amount of sequences comprising PCR/cloning artifacts combined with ancestral and/or rare variants that, if incorporated into phylogenetic reconstructions, confound how small sequence differences are interpreted. Finally, psbA ncr sequence data from a broad sampling of Symbiodinium diversity obtained from various corals throughout the Indo-Pacific were concordant with ITS lineage membership (defined by denaturing gradient gel electrophoresis screening), yet exhibited substantially greater sequence divergence and revealed strong phylogeographic structure corresponding to major biogeographic provinces. The detailed genetic resolution provided by psbA(ncr) data brings further clarity to the ecology, evolution, and systematics of symbiotic dinoflagellates.	[LaJeunesse, Todd C.] Penn State Univ, Dept Biol, Mueller Lab, University Pk, PA 16802 USA; [Thornhill, Daniel J.] Defenders Wildlife, Washington, DC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	LaJeunesse, TC (corresponding author), Penn State Univ, Dept Biol, Mueller Lab, University Pk, PA 16802 USA.	tcl3@psu.edu	LaJeunesse, Todd C/B-1720-2009	LaJeunesse, Todd C/0000-0001-7607-9358	Edwin W. Pauley foundation; Pennsylvania State University; National Science Foundation [IOB 544854, OCE-09287664]	Edwin W. Pauley foundation; Pennsylvania State University; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Edwin W. Pauley foundation, the Pennsylvania State University, and National Science Foundation grants (IOB 544854 and OCE-09287664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apprill AM, 2007, MOL ECOL, V16, P1127, DOI 10.1111/j.1365-294X.2006.03214.x; Avise JC, 1997, P NATL ACAD SCI USA, V94, P7748, DOI 10.1073/pnas.94.15.7748; Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Barbrook AC, 2006, PROTIST, V157, P159, DOI 10.1016/j.protis.2005.12.002; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Dang YK, 2010, J BIOL CHEM, V285, P5196, DOI 10.1074/jbc.M109.058545; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Finney JC, 2010, MICROB ECOL, V60, P250, DOI 10.1007/s00248-010-9681-y; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Howe CJ, 2008, J EXP BOT, V59, P1035, DOI 10.1093/jxb/erm292; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kemp DW, 2008, CORAL REEFS, V27, P289, DOI 10.1007/s00338-007-0333-8; Koumandou VL, 2007, PROTIST, V158, P89, DOI 10.1016/j.protis.2006.08.003; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2007, MOL PHYLOGENET EVOL, V45, P417, DOI 10.1016/j.ympev.2007.06.017; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Mayr E., 1957, Publications of the American Association for the Advancement of Science, VNo. 50, P1; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Moore RB, 2003, INT J SYST EVOL MICR, V53, P1725, DOI 10.1099/ijs.0.02594-0; Nelson MJ, 2005, GENE, V358, P102, DOI 10.1016/j.gene.2005.05.024; Nylander J. A. A., 2002, MRMODELTEST V2 PROGR; Pettay DT, 2009, MOL ECOL RESOUR, V9, P1022, DOI 10.1111/j.1755-0998.2009.02561.x; Pettay DT, 2011, MOL ECOL; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pinzon JH, 2011, CONSERV GENET RESOUR, V3, P45, DOI 10.1007/s12686-010-9283-5; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Rodriguez-Lanetty M, 2004, MAR ECOL PROG SER, V275, P97, DOI 10.3354/meps275097; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Santos SR, 2003, MAR BIOL, V143, P111, DOI 10.1007/s00227-003-1065-0; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Smith RT, 2009, J PHYCOL, V45, P1030, DOI 10.1111/j.1529-8817.2009.00730.x; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen MJH, 2004, MAR BIOL, V144, P9, DOI 10.1007/s00227-003-1188-3; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Wham DC, 2011, CONSERV GENET RESOUR, V3, P541, DOI 10.1007/s12686-011-9399-2; Zhang ZD, 2002, MOL BIOL EVOL, V19, P489, DOI 10.1093/oxfordjournals.molbev.a004104	61	140	142	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29013	10.1371/journal.pone.0029013	http://dx.doi.org/10.1371/journal.pone.0029013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216157	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300022
J	Grosso, S; Pesce, E; Brina, D; Beugnet, A; Loreni, F; Biffo, S				Grosso, Stefano; Pesce, Elisa; Brina, Daniela; Beugnet, Anne; Loreni, Fabrizio; Biffo, Stefano			Sensitivity of Global Translation to mTOR Inhibition in REN Cells Depends on the Equilibrium between eIF4E and 4E-BP1	PLOS ONE			English	Article							RNA-POLYMERASE-III; PROTEIN-SYNTHESIS; C-MYC; MALIGNANT MESOTHELIOMA; INITIATION-FACTORS; IN-VIVO; PHOSPHORYLATION; GROWTH; ACTIVATION; CYCLE	Initiation is the rate-limiting phase of protein synthesis, controlled by signaling pathways regulating the phosphorylation of translation factors. Initiation has three steps, 43S, 48S and 80S formation. 43S formation is repressed by eIF2 alpha phosphorylation. The subsequent steps, 48S and 80S formation are enabled by growth factors. 48S relies on eIF4E-mediated assembly of eIF4F complex; 4E-BPs competitively displace eIF4E from eIF4F. Two pathways control eIF4F: 1) mTORc1 phosphorylates and inactivates 4E-BPs, leading to eIF4F formation; 2) the Ras-Mnk cascade phosphorylates eIF4E. We show that REN and NCI-H28 mesothelioma cells have constitutive activation of both pathways and maximal translation rate, in the absence of exogenous growth factors. Translation is rapidly abrogated by phosphorylation of eIF2a. Surprisingly, pharmacological inhibition of mTORc1 leads to the complete dephosphorylation of downstream targets, without changes in methionine incorporation. In addition, the combined administration of mTORc1 and MAPK/Mnk inhibitors has no additive effect. The inhibition of both mTORc1 and mTORc2 does not affect the metabolic rate. In spite of this, mTORc1 inhibition reduces eIF4F complex formation, and depresses translocation of TOP mRNAs on polysomes. Downregulation of eIF4E and overexpression of 4E-BP1 induce rapamycin sensitivity, suggesting that disruption of eIF4F complex, due to eIF4E modulation, competes with its recycling to ribosomes. These data suggest the existence of a dynamic equilibrium in which eIF4F is not essential for all mRNAs and is not displaced from translated mRNAs, before recycling to the next.	[Grosso, Stefano; Pesce, Elisa; Brina, Daniela; Beugnet, Anne; Biffo, Stefano] DIBIT HSR, Milan, Italy; [Grosso, Stefano; Pesce, Elisa; Biffo, Stefano] Univ Piemonte Orientale, Dipartimento Sci Ambiente & Vita, Alessandria, Italy; [Loreni, Fabrizio] Univ Roma Tor Vergata, Dept Biol, Rome, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Rome Tor Vergata	Grosso, S (corresponding author), DIBIT HSR, Milan, Italy.	grosso.stefano@hsr.it	Pesce, Elisa/GXH-1752-2022	Pesce, Elisa/0000-0003-4214-1904; Grosso, Stefano/0000-0003-2911-2826; biffo, stefano/0000-0002-3780-1050	Fondazione Buzzi Unicem [P23]; Associazione Italiana per la Ricerca sul Cancro [IG5463]; Association for International Cancer Research [09-0061]; Regione Piemonte	Fondazione Buzzi Unicem; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research; Regione Piemonte(Regione Piemonte)	Funding provided by the Fondazione Buzzi Unicem #P23 (http://www.buzziunicem.it/online/BuzziUnicem/Home.html), Associazione Italiana per la Ricerca sul Cancro (#IG5463 http://www.airc.it/), Association for International Cancer Research (#09-0061 http://www.aicr.org.uk) and a Regione Piemonte Fellowship to SG (http://www.regione.piemonte.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Brostrom CO, 1996, J BIOL CHEM, V271, P24995, DOI 10.1074/jbc.271.40.24995; Caldarola S, 2004, J BIOL CHEM, V279, P13522, DOI 10.1074/jbc.M310574200; Caldarola S, 2009, FEBS J, V276, P3199, DOI 10.1111/j.1742-4658.2009.07036.x; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Constantinou C, 2005, ONCOGENE, V24, P4839, DOI 10.1038/sj.onc.1208648; Cook JW, 2003, LUNG CANCER-J IASLC, V42, P263, DOI 10.1016/S0169-5002(03)00363-5; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Gorrini C, 2005, P NATL ACAD SCI USA, V102, P9200, DOI 10.1073/pnas.0409513102; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grosso S, 2008, BIOCHEM J, V415, P77, DOI 10.1042/BJ20080463; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hopkins-Donaldson S, 2006, NEOPLASIA, V8, P551, DOI 10.1593/neo.06148; Huang BPH, 2009, AM J PHYSIOL-HEART C, V296, pH505, DOI 10.1152/ajpheart.01105.2008; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jacobson BA, 2009, BRIT J CANCER, V101, P424, DOI 10.1038/sj.bjc.6605184; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Miluzio A, 2009, EMBO REP, V10, P459, DOI 10.1038/embor.2009.70; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Naegele S, 2004, J BIOL CHEM, V279, P46023, DOI 10.1074/jbc.M404945200; Orecchia S, 2004, LUNG CANCER, V45, pS37, DOI 10.1016/j.lungcan.2004.04.027; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Ranzato E, 2009, J CELL BIOCHEM, V108, P867, DOI 10.1002/jcb.22316; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Stumpf CR, 2011, CURR OPIN GENET DEV, V21, P474, DOI 10.1016/j.gde.2011.03.007; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; Wang XM, 2011, J MOL CELL BIOL, V3, P206, DOI 10.1093/jmcb/mjq038; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Westman B, 2005, RNA, V11, P1505, DOI 10.1261/rna.2132505; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008	64	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29136	10.1371/journal.pone.0029136	http://dx.doi.org/10.1371/journal.pone.0029136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216185	Green Published, gold			2022-12-25	WOS:000299684700033
J	Cai, WJ; Huang, JH; Zhang, SQ; Wu, B; Kapahi, P; Zhang, XM; Shen, ZY				Cai, Wai-Jiao; Huang, Jian-Hua; Zhang, Su-Qin; Wu, Bin; Kapahi, Pankaj; Zhang, Xin-Min; Shen, Zi-Yin			Icariin and its Derivative Icariside II Extend Healthspan via Insulin/IGF-1 Pathway in C. elegans	PLOS ONE			English	Article							HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; STRESS RESISTANCE; LONGEVITY; DAF-16; DISEASE; RESTRICTION; METABOLITES	Compounds that delay aging might also postpone age-related diseases and extend healthspan in humans. Icariin is a flavonol extracted from several plant species of the Epimedium family. The icariin and its metabolic derivatives have been shown to exert wide protective effects in age-related diseases. However, whether icariin and its derivatives have the potency of delaying aging remains unclear. Here, we report that icariin and its derivative icariside II extend C. elegans lifespan. Using HPLC, we found high level of icariside II in the animals treated with icariin, suggesting icariside II is the bioactive form in vivo of icariin. Icariside II also increased the thermo and oxidative stress tolerance, slowed locomotion decline in late adulthood and delayed the onset of paralysis mediated by polyQ and A beta(1-42) proteotoxicity. The lifespan extension effect of icariside II is dependent on the insulin/IGF-1 signaling (IIS) since the daf-16(mu86) and daf-2(e1370) failed to show any lifespan extension upon icariside II treatment. Consistently, icariside II treatment upregulates the expression of DAF-16 targets in the wild-type. Moreover, our data suggests that the heat shock transcription factor HSF-1 has a role in icariside II-dependent lifespan extension further implicating the IIS pathway. In conclusion, we demonstrate a novel natural compound, icariside II as the bioactive form of icariin, extends the healthspan via IIS pathway in C. elegans.	[Cai, Wai-Jiao; Huang, Jian-Hua; Zhang, Su-Qin; Wu, Bin; Zhang, Xin-Min; Shen, Zi-Yin] Fudan Univ, Inst Tradit Chinese & Western Med, Huashan Hosp, Shanghai 200433, Peoples R China; [Cai, Wai-Jiao; Kapahi, Pankaj] Buck Inst Res Aging, Novato, CA USA; [Zhang, Su-Qin] Hangzhou Normal Univ, Clin Med Coll, Hangzhou, Zhejiang, Peoples R China; [Zhang, Su-Qin] Hangzhou Normal Univ, Hosp Hangzhou 2, Hangzhou, Zhejiang, Peoples R China	Fudan University; Buck Institute for Research on Aging; Hangzhou Normal University; Hangzhou Normal University	Cai, WJ (corresponding author), Fudan Univ, Inst Tradit Chinese & Western Med, Huashan Hosp, Shanghai 200433, Peoples R China.	pkapahi@buckinstitute.org; xmzhang54@yahoo.com; ziyinshen@126.com		Cai, Waijiao/0000-0003-4730-1145	NIH; 973 program in China [2007CB507400]; NATIONAL INSTITUTE ON AGING [R01AG038688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 program in China(National Basic Research Program of China); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Shu-Fen Liu for technical assistance in HPLC analysis. We thank Di Chen, Silvestre Alavez for the helpful discussion. Grateful thank Rahul Gaur, Lakisha Barrett, Miguel Vargas for revising the manuscript. Some strains used in this work were provided by the Caenorhabditis Genetic Center (CGC), which is funded by NIH.; This work was supported by 973 program in China (code: 2007CB507400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Cai Wai-Jiao, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P522; Chateau MT, 2010, AGING-US, V2, P567, DOI 10.18632/aging.100195; Ching TT, 2010, AGING CELL, V9, P545, DOI 10.1111/j.1474-9726.2010.00580.x; Fitzgerald VK, 2009, BIOTECHNIQUES, V47, pIX, DOI 10.2144/000113277; Fridell YWC, 2009, AGING-US, V1, P699, DOI 10.18632/aging.100067; Garigan D, 2002, GENETICS, V161, P1101; Harrison DE, 2009, NATURE; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Industry C, 2000, CHIN PHARM, VI, P267; Iwasa H, 2010, AGING CELL, V9, P490, DOI 10.1111/j.1474-9726.2010.00575.x; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Lithgow GJ, 2002, MECH AGEING DEV, V123, P765, DOI 10.1016/S0047-6374(01)00422-5; Liu BJ, 2011, BRAIN RES, V1375, P59, DOI 10.1016/j.brainres.2010.12.053; Liu J, 2004, J PHARMACEUT BIOMED, V36, P365, DOI 10.1016/j.jpba.2004.06.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nian H, 2009, PHYTOMEDICINE, V16, P320, DOI 10.1016/j.phymed.2008.12.006; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002; Saul N, 2009, MECH AGEING DEV, V130, P477, DOI 10.1016/j.mad.2009.05.005; Shen ZY, 2005, CHIN J GERONTOL, V25, P3; Song YH, 2008, INT J MOL MED, V21, P117, DOI 10.1002/jnm.659; Swindell WR, 2009, AGING-US, V1, P573, DOI 10.18632/aging.100058; Sze SCW, 2010, MOLECULES, V15, P7861, DOI 10.3390/molecules15117861; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Wang YP, 2010, EUR J PHARMACOL, V635, P40, DOI 10.1016/j.ejphar.2010.03.017; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Williams TW, 2010, AGING-US, V2, P742, DOI 10.18632/aging.100214; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wu B, 2008, MOL BIOSYST, V4, P855, DOI 10.1039/b800923f; Yan SK, 2009, MOL BIOSYST, V5, P1204, DOI 10.1039/b816407j	47	96	110	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28835	10.1371/journal.pone.0028835	http://dx.doi.org/10.1371/journal.pone.0028835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216122	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600041
J	Forrest, MJ; Schlaepfer, MA				Forrest, Matthew J.; Schlaepfer, Martin A.			Nothing a Hot Bath Won't Cure: Infection Rates of Amphibian Chytrid Fungus Correlate Negatively with Water Temperature under Natural Field Settings	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS INFECTION; LOWLAND LEOPARD FROGS; EMERGING DISEASE; RANA-PIPIENS; CHYTRIDIOMYCOSIS; PREVALENCE; PATHOGEN; POPULATION; DYNAMICS; TADPOLES	Dramatic declines and extinctions of amphibian populations throughout the world have been associated with chytridiomycosis, an infectious disease caused by the pathogenic chytrid fungus Batrachochytrium dendrobatidis (Bd). Previous studies indicated that Bd prevalence correlates with cooler temperatures in the field, and laboratory experiments have demonstrated that Bd ceases growth at temperatures above 28 degrees C. Here we investigate how small-scale variations in water temperature correlate with Bd prevalence in the wild. We sampled 221 amphibians, including 201 lowland leopard frogs (Rana [Lithobates] yavapaiensis), from 12 sites in Arizona, USA, and tested them for Bd. Amphibians were encountered in microhabitats that exhibited a wide range of water temperatures (10-50 degrees C), including several geothermal water sources. There was a strong inverse correlation between the water temperature in which lowland leopard frogs were captured and Bd prevalence, even after taking into account the influence of year, season, and host size. In locations where Bd was known to be present, the prevalence of Bd infections dropped from 75-100% in water <15 degrees C, to less than 10% in water>30 degrees C. A strong inverse correlation between Bd infection status and water temperature was also observed within sites. Our findings suggest that microhabitats where water temperatures exceed 30 degrees C provide lowland leopard frogs with significant protection from Bd, which could have important implications for disease dynamics, as well as management applications. There must be quite a few things a hot bath won't cure, but I don't know many of them -Sylvia Plath, "The Bell Jar'' (1963).	[Forrest, Matthew J.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Schlaepfer, Martin A.] SUNY Syracuse, Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Schlaepfer, Martin A.] INRA SCRIBE, Rennes, France	University of California System; University of California San Diego; Scripps Institution of Oceanography; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; INRAE	Forrest, MJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	mjforrest@ucsd.edu			Scripps Institution of Oceanography; Integrative Graduate Education and Research Training Mini-grant	Scripps Institution of Oceanography(University of California System); Integrative Graduate Education and Research Training Mini-grant	Partial funding for this work was provided to MF by the Halliday Student Field Research Award from the Scripps Institution of Oceanography, and from the Integrative Graduate Education and Research Training Mini-grant. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Berger L, 2010, DIS AQUAT ORGAN, V92, P165, DOI 10.3354/dao02238; Bradford DF, 2004, SOUTHWEST NAT, V49, P218, DOI 10.1894/0038-4909(2004)049<0218:PSADOA>2.0.CO;2; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; C?lix M., 2018, EUROPEAN RED LIST SA; Chatfield MWH, 2011, DIS AQUAT ORGAN, V94, P235, DOI 10.3354/dao02337; CLARKSON RW, 1989, SOUTHWEST NAT, V34, P531, DOI 10.2307/3671513; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garner TWJ, 2009, DIS AQUAT ORGAN, V83, P257, DOI 10.3354/dao02008; Geiger CC, 2011, AMPHIBIA-REPTILIA, V32, P276, DOI 10.1163/017353711X556970; GREENDONNELLY N, 1977, DEV COMP IMMUNOL, V1, P59, DOI 10.1016/S0145-305X(77)80051-7; Han BA, 2008, BEHAV ECOL SOCIOBIOL, V63, P241, DOI 10.1007/s00265-008-0655-8; Hawk J, 2000, THESIS IDAHO STATE U; Jaeger JR, 2001, COPEIA, P339; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; KLUGER MJ, 1977, J THERM BIOL, V2, P79, DOI 10.1016/0306-4565(77)90042-0; Knapp RA, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00028.1; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Livo LJ, 2003, COLORADO DIVISION WI, P15; Maniero GD, 1997, J COMP PHYSIOL B, V167, P256, DOI 10.1007/s003600050072; Mason IL, 1939, J EXP BIOL, V16, P487; Mendez MA, 2009, J THERM BIOL, V34, P342, DOI 10.1016/j.jtherbio.2009.06.006; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Olah-Hemmings V, 2010, J ZOOL, V280, P343, DOI 10.1111/j.1469-7998.2009.00667.x; Pessier A. P., 2008, International Zoo Yearbook, V42, P30, DOI 10.1111/j.1748-1090.2008.00047.x; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Schlaepfer MA, 2007, ECOHEALTH, V4, P421, DOI 10.1007/s10393-007-0136-y; Scott Jr. NJ, 1985, 3 U NEW MEX; Sredl M.J., 2005, AMPHIBIAN DECLINES C, P596; Sredl MJ, 2003, 208 AR GAM FISH DEP; Stuart S. N., 2008, THREATENED AMPHIBIAN; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; VAUGHN LK, 1974, NATURE, V252, P473, DOI 10.1038/252473a0; Voordouw Maarten J., 2010, BMC Ecology, V10, P6, DOI 10.1186/1472-6785-10-6; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Waring GA, 1965, 492 US GEOL SURV; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Wright A, 1949, HDB FROGS TOADS US C; Wu CS, 2005, HERPETOLOGICA, V61, P35, DOI 10.1655/04-50; ZAPATA AG, 1992, IMMUNOL TODAY, V13, P142, DOI 10.1016/0167-5699(92)90112-K	59	78	79	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28444	10.1371/journal.pone.0028444	http://dx.doi.org/10.1371/journal.pone.0028444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205950	Green Submitted, Green Published, gold			2022-12-25	WOS:000299113600016
J	Fletcher, ML				Fletcher, Max L.			Analytical Processing of Binary Mixture Information by Olfactory Bulb Glomeruli	PLOS ONE			English	Article							CENTER-SURROUND INHIBITION; ODOR MIXTURES; CHANNEL CATFISH; SENSORY NEURONS; AMINO-ACIDS; IN-VIVO; RAT; RESPONSES; PATTERNS; REPRESENTATIONS	Odors are rarely composed of a single compound, but rather contain a large and complex variety of chemical components. Often, these mixtures are perceived as having unique qualities that can be quite different than the combination of their components. In many cases, a majority of the components of a mixture cannot be individually identified. This synthetic processing of odor information suggests that individual component representations of the mixture must interact somewhere along the olfactory pathway. The anatomical nature of sensory neuron input into segregated glomeruli with the bulb suggests that initial input of odor information into the bulb is analytic. However, a large network of interneurons within the olfactory bulb could allow for mixture interactions via mechanisms such as lateral inhibition. Currently in mammals, it is unclear if postsynaptic mitral/tufted cell glomerular mixture responses reflect the analytical mixture input, or provide the initial basis for synthetic processing with the olfactory system. To address this, olfactory bulb glomerular binary mixture representations were compared to representations of each component using transgenic mice expressing the calcium indicator G-CaMP2 in olfactory bulb mitral/tufted cells. Overall, dorsal surface mixture representations showed little mixture interaction and often appeared as a simple combination of the component representations. Based on this, it is concluded that dorsal surface glomerular mixture representations remain largely analytical with nearly all component information preserved.	[Fletcher, Max L.] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Fletcher, ML (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	mfletch4@uthsc.edu			NIH [DC009853]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC009853] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grant DC009853 to MLF (http://www.nidcd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; BELL GA, 1987, BRAIN RES, V426, P8, DOI 10.1016/0006-8993(87)90419-7; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Carlsson MA, 2007, CHEM SENSES, V32, P433, DOI 10.1093/chemse/bjm009; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; DEISIG N, 2010, J NEUROPHYSIOL; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Duchamp-Viret P, 2003, EUR J NEUROSCI, V18, P2690, DOI 10.1111/j.1460-9568.2003.03001.x; Fletcher ML, 2009, J NEUROPHYSIOL, V102, P817, DOI 10.1152/jn.00020.2009; Frederick DE, 2009, BEHAV NEUROSCI, V123, P430, DOI 10.1037/a0014729; Giraudet P, 2002, J NEUROPHYSIOL, V88, P829, DOI 10.1152/jn.2002.88.2.829; GLEESON RA, 1985, BRAIN RES, V335, P99, DOI 10.1016/0006-8993(85)90280-X; Grossman KJ, 2008, EUR J NEUROSCI, V27, P2676, DOI 10.1111/j.1460-9568.2008.06213.x; Johnson BA, 2010, J COMP NEUROL, V518, P1542, DOI 10.1002/cne.22289; Kadohisa M, 2006, J NEUROPHYSIOL, V95, P1888, DOI 10.1152/jn.00812.2005; KANG JS, 1995, J NEUROPHYSIOL, V74, P1435, DOI 10.1152/jn.1995.74.4.1435; Kang JS, 1997, J NEUROPHYSIOL, V77, P1; Kay LM, 2005, BEHAV NEUROSCI, V119, P726, DOI 10.1037/0735-7044.119.3.726; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Koulakov A, 2007, J NEUROPHYSIOL, V98, P3134, DOI 10.1152/jn.00560.2007; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; LAING DG, 1989, PHYSIOL BEHAV, V45, P689, DOI 10.1016/0031-9384(89)90280-1; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rospars JP, 2008, J NEUROSCI, V28, P2659, DOI 10.1523/JNEUROSCI.4670-07.2008; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Vucinic D, 2006, J NEUROPHYSIOL, V95, P1881, DOI 10.1152/jn.00918.2005; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wiltrout C, 2003, BEHAV NEUROSCI, V117, P236, DOI 10.1037/0735-7044.117.2.236; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	36	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e29360	10.1371/journal.pone.0029360	http://dx.doi.org/10.1371/journal.pone.0029360			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22206012	Green Submitted, gold, Green Published			2022-12-25	WOS:000298666200024
J	Turkina, MV; Arstrand, HK; Vener, AV				Turkina, Maria V.; Arstrand, Hanna Klang; Vener, Alexander V.			Differential Phosphorylation of Ribosomal Proteins in Arabidopsis thaliana Plants during Day and Night	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-SIZE; KINASE; S6; MAIZE; AUXIN	Protein synthesis in plants is characterized by increase in the translation rates for numerous proteins and central metabolic enzymes during the day phase of the photoperiod. The detailed molecular mechanisms of this diurnal regulation are unknown, while eukaryotic protein translation is mainly controlled at the level of ribosomal initiation complexes, which also involves multiple events of protein phosphorylation. We characterized the extent of protein phosphorylation in cytosolic ribosomes isolated from leaves of the model plant Arabidopsis thaliana harvested during day or night. Proteomic analyses of preparations corresponding to both phases of the photoperiod detected phosphorylation at eight serine residues in the C-termini of six ribosomal proteins: S2-3, S6-1, S6-2, P0-2, P1 and L29-1. This included previously unknown phosphorylation of the 40S ribosomal protein S6 at Ser-231. Relative quantification of the phosphorylated peptides using stable isotope labeling and mass spectrometry revealed a 2.2 times increase in the day/night phosphorylation ratio at this site. Phosphorylation of the S6-1 and S6-2 variants of the same protein at Ser-240 increased by the factors of 4.2 and 1.8, respectively. The 1.6 increase in phosphorylation during the day was also found at Ser-58 of the 60S ribosomal protein L29-1. It is suggested that differential phosphorylation of the ribosomal proteins S6-1, S6-2 and L29-1 may contribute to modulation of the diurnal protein synthesis in plants.	[Turkina, Maria V.; Arstrand, Hanna Klang; Vener, Alexander V.] Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Turkina, MV (corresponding author), Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden.	alexander.vener@liu.se			Swedish Research Council; Swedish Research Council for Environment, Agriculture and Spatial Planning	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agriculture and Spatial Planning(Swedish Research Council Formas)	This work was supported by grants from the Swedish Research Council (www.vr.se) and from the Swedish Research Council for Environment, Agriculture and Spatial Planning (http://www.formas.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran-Pena E, 2002, PHYSIOL PLANTARUM, V115, P291, DOI 10.1034/j.1399-3054.2002.1150216.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Fristedt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024565; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JOHNSON SP, 1987, MOL CELL BIOL, V7, P1338, DOI 10.1128/MCB.7.4.1338; Jufvas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015960; Khandal D, 2009, P NATL ACAD SCI USA, V106, P13112, DOI 10.1073/pnas.0903522106; Lemeille S, 2010, MOL CELL PROTEOMICS, V9, P1281, DOI 10.1074/mcp.M000020-MCP201; Noren H, 2004, PHYSIOL PLANTARUM, V121, P343, DOI 10.1111/j.0031-9317.2004.00350.x; PEREZ L, 1987, PHYSIOL PLANTARUM, V69, P517, DOI 10.1111/j.1399-3054.1987.tb09234.x; Piques M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.68; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P499, DOI 10.1016/j.tplants.2010.05.011; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; SCHARF KD, 1982, CELL, V30, P427, DOI 10.1016/0092-8674(82)90240-9; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Szick K, 1998, P NATL ACAD SCI USA, V95, P2378, DOI 10.1073/pnas.95.5.2378; Thines B, 2011, CURR OPIN PLANT BIOL, V14, P31, DOI 10.1016/j.pbi.2010.09.009; Turck F, 2004, PLANT PHYSIOL, V134, P1527, DOI 10.1104/pp.103.035873; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; Williams AJ, 2003, PLANT PHYSIOL, V132, P2086, DOI 10.1104/pp.103.022749	27	45	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29307	10.1371/journal.pone.0029307	http://dx.doi.org/10.1371/journal.pone.0029307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195043	gold, Green Published, Green Submitted			2022-12-25	WOS:000298664400046
J	Yuan, LQ; Zhu, JH; Wang, HW; Liang, QH; Xie, H; Wu, XP; Zhou, H; Cui, RR; Sheng, ZF; Zhou, HD; Zhu, X; Liu, GY; Liu, YS; Liao, EY				Yuan, Ling-Qing; Zhu, Jia-Hua; Wang, Hua-Wen; Liang, Qiu-Hua; Xie, Hui; Wu, Xian-Ping; Zhou, Hua; Cui, Rong-Rong; Sheng, Zhi-Feng; Zhou, Hou-De; Zhu, Xiao; Liu, Guan-Ying; Liu, You-Shuo; Liao, Er-Yuan			RANKL Is a Downstream Mediator for Insulin-Induced Osteoblastic Differentiation of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; GROWTH-FACTOR; SIGNALING PATHWAYS; OSTEOPROTEGERIN; EXPRESSION; OSTEOCLASTOGENESIS; RESISTANCE; MICE	Several reports have shown that circulating insulin level is positively correlated with arterial calcification; however, the relationship between insulin and arterial calcification remains controversial and the mechanism involved is still unclear. We used calcifying vascular smooth muscle cells (CVSMCs), a specific subpopulation of vascular smooth muscle cells that could spontaneously express osteoblastic phenotype genes and form calcification nodules, to investigate the effect of insulin on osteoblastic differentiation of CVSMCs and the cell signals involved. Our experiments demonstrated that insulin could promote alkaline phosphatase (ALP) activity, osteocalcin expression and the formation of mineralized nodules in CVSMCs. Suppression of receptor activator of nuclear factor kappa B ligand (RANKL) with small interfering RNA (siRNA) abolished the insulin-induced ALP activity. Insulin induced the activation of extracellular signal-regulated kinase (ERK) 1/2, mitogen-activated protein kinase (MAPK) and RAC-alpha serine/threonine-protein kinase (Akt). Furthermore, pretreatment of human osteoblasts with the ERK1/2 inhibitor PD98059, but not the phosphoinositide 3-kinase (PI3K) inhibitor, LY294002, or the Akt inhibitor, 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate (HIMO), abolished the insulin-induced RANKL secretion and blocked the promoting effect of insulin on ALP activities of CVSMCs. Recombinant RANKL protein recovered the ALP activities decreased by RANKL siRNA in insulin-stimulated CVSMCs. These data demonstrated that insulin could promote osteoblastic differentiation of CVSMCs by increased RANKL expression through ERK1/2 activation, but not PI3K/Akt activation.	[Yuan, Ling-Qing; Liang, Qiu-Hua; Xie, Hui; Wu, Xian-Ping; Zhou, Hua; Cui, Rong-Rong; Sheng, Zhi-Feng; Zhou, Hou-De; Zhu, Xiao; Liu, Guan-Ying; Liao, Er-Yuan] Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China; [Zhu, Jia-Hua; Wang, Hua-Wen; Liu, You-Shuo] Cent S Univ, Xiang Ya Hosp 2, Dept Geriatr, Changsha, Hunan, Peoples R China; [Yuan, Ling-Qing; Liu, You-Shuo] Cent S Univ, Xiang Ya Hosp 2, Inst Aging & Geratol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Yuan, LQ (corresponding author), Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China.	liuyoushuo@medmail.com.cn; eyliao007@yahoo.com.cn	Xie, Hui/AAF-8152-2020; Yuan, Ling-Qing/D-2102-2019	Yuan, Ling-Qing/0000-0001-8602-7113; Sheng, Zhi-feng/0000-0003-2308-3024; Zhou, Hou-De/0000-0001-9131-4141	National Natural Science Foundation of China [30801174, 30900622, 30871191]; Ph.D. Programs Foundation of the Ministry of Education of China [200805331017]; Chinese Society of Endocrinology [10020040226]; Hunan Provincial Natural Science Foundation [09JJ3037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Chinese Society of Endocrinology; Hunan Provincial Natural Science Foundation(Natural Science Foundation of Hunan Province)	This work was supported by the National Natural Science Foundation of China (Nos. 30801174, 30900622 and 30871191), the Ph.D. Programs Foundation of the Ministry of Education of China (No. 200805331017), Youth Scientific Funds of the Chinese Society of Endocrinology (No. 10020040226) and the Hunan Provincial Natural Science Foundation (No. 09JJ3037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2010, INT J CARDIOL, V144, P163, DOI 10.1016/j.ijcard.2008.12.200; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Cosson E, 2009, DIABETES METAB, V35, P364, DOI 10.1016/j.diabet.2009.02.007; Dhore CR, 2001, ARTERIOSCL THROM VAS, V21, P1998, DOI 10.1161/hq1201.100229; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Inoue A, 2009, MOD RHEUMATOL, V19, P125, DOI 10.1007/s10165-008-0131-3; Isenovic ER, 2009, EXP CLIN ENDOCR DIAB, V117, P214, DOI 10.1055/s-0028-1085470; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kaden JJ, 2004, J HEART VALVE DIS, V13, P560; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Kobayashi S, 2008, CLIN J AM SOC NEPHRO, V3, P1289, DOI 10.2215/CJN.00010108; Lee KK, 2009, AM HEART J, V157, P939, DOI 10.1016/j.ahj.2009.02.006; Li FH, 2005, J BONE MINER RES, V20, P1161, DOI 10.1359/JBMR.050207; Li GL, 2005, ENDOCRINOLOGY, V146, P4690, DOI 10.1210/en.2005-0505; Liu YS, 2010, AMINO ACIDS, V38, P763, DOI 10.1007/s00726-009-0281-4; Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Ndip A, 2011, DIABETES, V60, P2187, DOI 10.2337/db10-1220; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; Olesen P, 2007, AM J PHYSIOL-HEART C, V292, pH1058, DOI 10.1152/ajpheart.00047.2006; Panizo S, 2009, CIRC RES, V104, P1041, DOI 10.1161/CIRCRESAHA.108.189001; Price PA, 2001, ARTERIOSCL THROM VAS, V21, P1610, DOI 10.1161/hq1001.097102; Qasim A, 2008, J AM COLL CARDIOL, V52, P231, DOI 10.1016/j.jacc.2008.04.016; Shan PF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017938; Sista AK, 2005, AM J PHYSIOL-HEART C, V289, pH845, DOI 10.1152/ajpheart.00134.2005; Snell-Bergeon JK, 2003, DIABETES CARE, V26, P2923, DOI 10.2337/diacare.26.10.2923; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Stout RW, 1996, DIABETES, V45, pS45, DOI 10.2337/diab.45.3.S45; SUDA T, 1995, BONE S2, V17, P87; Taha C, 1999, J MEMBRANE BIOL, V169, P1, DOI 10.1007/PL00005896; Takami M, 2000, ENDOCRINOLOGY, V141, P4711, DOI 10.1210/en.141.12.4711; Tanaka M, 2010, J ATHEROSCLER THROMB, V17, P1033, DOI 10.5551/jat.5116; Tseng W, 2010, J BIOL CHEM, V285, P29925, DOI 10.1074/jbc.M110.117366; Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31; Wang CCL, 2003, DIABETES, V52, P2562, DOI 10.2337/diabetes.52.10.2562; Wang Cecilia C Low, 2007, Atherosclerosis, V195, pe65, DOI 10.1016/j.atherosclerosis.2007.02.032; Xie H, 2011, CARDIOVASC RES; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	40	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29037	10.1371/journal.pone.0029037	http://dx.doi.org/10.1371/journal.pone.0029037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194983	Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400028
J	Berenreiterova, M; Flegr, J; Kubena, AA; Nemec, P				Berenreiterova, Miroslava; Flegr, Jaroslav; Kubena, Ales A.; Nemec, Pavel			The Distribution of Toxoplasma gondii Cysts in the Brain of a Mouse with Latent Toxoplasmosis: Implications for the Behavioral Manipulation Hypothesis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; VENTRAL HIPPOCAMPUS; NOVELTY DISCRIMINATION; SPATIAL REPRESENTATION; MURINE SUSCEPTIBILITY; DEFENSIVE BEHAVIOR; TRAFFIC ACCIDENTS; ALTERED BEHAVIOR; FEAR EXPRESSION; DECREASED LEVEL	Background: The highly prevalent parasite Toxoplasma gondii reportedly manipulates rodent behavior to enhance the likelihood of transmission to its definitive cat host. The proximate mechanisms underlying this adaptive manipulation remain largely unclear, though a growing body of evidence suggests that the parasite-entrained dysregulation of dopamine metabolism plays a central role. Paradoxically, the distribution of the parasite in the brain has received only scant attention. Methodology/Principal Findings: The distributions of T. gondii cysts and histopathological lesions in the brains of CD1 mice with latent toxoplasmosis were analyzed using standard histological techniques. Mice were infected per orally with 10 tissue cysts of the avirulent HIF strain of T. gondii at six months of age and examined 18 weeks later. The cysts were distributed throughout the brain and selective tropism of the parasite toward a particular functional system was not observed. Importantly, the cysts were not preferentially associated with the dopaminergic system and absent from the hypothalamic defensive system. The striking interindividual differences in the total parasite load and cyst distribution indicate a probabilistic nature of brain infestation. Still, some brain regions were consistently more infected than others. These included the olfactory bulb, the entorhinal, somatosensory, motor and orbital, frontal association and visual cortices, and, importantly, the hippocampus and the amygdala. By contrast, a consistently low incidence of tissue cysts was recorded in the cerebellum, the pontine nuclei, the caudate putamen and virtually all compact masses of myelinated axons. Numerous perivascular and leptomeningeal infiltrations of inflammatory cells were observed, but they were not associated with intracellular cysts. Conclusion/Significance: The observed pattern of T. gondii distribution stems from uneven brain colonization during acute infection and explains numerous behavioral abnormalities observed in the chronically infected rodents. Thus, the parasite can effectively change behavioral phenotype of infected hosts despite the absence of well targeted tropism.	[Berenreiterova, Miroslava; Flegr, Jaroslav; Kubena, Ales A.; Nemec, Pavel] Charles Univ Prague, Fac Sci, Biol Sect, Prague, Czech Republic	Charles University Prague	Berenreiterova, M (corresponding author), Charles Univ Prague, Fac Sci, Biol Sect, Prague, Czech Republic.	flegr@cesnet.cz	Kuběna, Aleš Antonín/A-3766-2015; Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021; Nemec, Pavel/K-1163-2012	Kuběna, Aleš Antonín/0000-0002-9599-8277; Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126; Nemec, Pavel/0000-0003-0277-0239	Ministry of Education, Youth and Sport of the Czech Republic [0021620828]; Grand Agency of Czech Republic [P303/11/1398]	Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grand Agency of Czech Republic	This work was supported by the Ministry of Education, Youth and Sport of the Czech Republic (Grant No. 0021620828) and Grand Agency of Czech Republic (Grant No. P303/11/1398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAUJO FG, 1976, INFECT IMMUN, V13, P1528, DOI 10.1128/IAI.13.5.1528-1530.1976; Arendt G, 1999, ACTA NEUROL SCAND, V100, P178, DOI 10.1111/j.1600-0404.1999.tb00735.x; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Beijamini V, 2006, BEHAV BRAIN RES, V170, P52, DOI 10.1016/j.bbr.2006.01.025; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; BERDOY M, 1995, PARASITOLOGY, V111, P403, DOI 10.1017/S0031182000065902; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Canteras NS, 1997, BRAIN RES BULL, V44, P297, DOI 10.1016/S0361-9230(97)00141-X; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Comoli E, 2003, BEHAV BRAIN RES, V138, P17, DOI 10.1016/S0166-4328(02)00197-3; CONLEY FK, 1981, INFECT IMMUN, V31, P1184, DOI 10.1128/IAI.31.3.1184-1192.1981; Darcy F., 1994, Parasitic infections and the immune system., P163; de Olmos J.S., 2004, RAT NERVOUS SYSTEM, V3rd, P509, DOI [DOI 10.1016/B978-012547638-6/50020-1, 10.1016/B978-012547638-6/50020-1]; Dellacasa-Lindberg I, 2007, MICROBES INFECT, V9, P1291, DOI 10.1016/j.micinf.2007.06.003; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Di Cristina M, 2008, INFECT IMMUN, V76, P3491, DOI 10.1128/IAI.00254-08; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fagard R, 1999, PARASITOL TODAY, V15, P504, DOI 10.1016/S0169-4758(99)01568-9; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; FERGUSON DJP, 1991, INT J EXP PATHOL, V72, P463; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2010, FOLIA PARASIT, V57, P81, DOI 10.14411/fp.2010.010; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gonzalez LE, 2007, BEHAV BRAIN RES, V177, P70, DOI 10.1016/j.bbr.2006.11.012; Groenewegen HJ, 2004, RAT NERVOUS SYSTEM, P407, DOI [10.1016/B978-012547638-6/50018-3, DOI 10.1016/B978-012547638-6/50018-3]; Gulinello M, 2010, MICROBES INFECT, V12, P528, DOI 10.1016/j.micinf.2010.03.009; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; HAY J, 1984, ANN TROP MED PARASIT, V78, P611, DOI 10.1080/00034983.1984.11811872; HAY J, 1983, ANN TROP MED PARASIT, V77, P483, DOI 10.1080/00034983.1983.11811741; HAY J, 1985, Z PARASITENKD, V71, P459, DOI 10.1007/BF00928348; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; HEVNER RF, 1995, NEUROSCIENCE, V65, P313, DOI 10.1016/0306-4522(94)00514-6; Hodkova H, 2007, PARASITOLOGY, V134, P1329, DOI 10.1017/S0031182007002673; Horacek J, 2012, WORLD J BIOL PSYCHIA, V13, P501, DOI 10.3109/15622975.2011.573809; Hrda S, 2000, J PARASITOL, V86, P657, DOI 10.1645/0022-3395(2000)086[0657:TNOTGI]2.0.CO;2; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P145, DOI 10.1080/00034983.1980.11687324; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P337, DOI 10.1080/00034983.1980.11687350; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P507, DOI 10.1080/00034983.1980.11687376; HUTCHISON WM, 1969, NEW SCI, V29, P464; JOHNSON AM, 1984, Z PARASITENKD, V70, P303, DOI 10.1007/BF00927816; Kannan G, 2010, FOLIA PARASIT, V57, P151, DOI 10.14411/fp.2010.019; KITTAS S, 1984, BRIT J EXP PATHOL, V65, P67; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kodym P, 2002, ACTA PARASITOL, V47, P239; Lambert H, 2011, MICROBES INFECT, V13, P96, DOI 10.1016/j.micinf.2010.10.002; Lamberton PHL, 2008, PARASITOLOGY, V135, P1143, DOI 10.1017/S0031182008004666; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee YH, 1999, EXP PARASITOL, V91, P212, DOI 10.1006/expr.1998.4359; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Li CI, 2004, BEHAV NEUROSCI, V118, P324, DOI 10.1037/0735-7044.118.2.324; Liu ZH, 2008, NEUROPSYCHOPHARMACOL, V33, P3010, DOI 10.1038/npp.2008.4; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McGregor IS, 2004, J NEUROSCI, V24, P4134, DOI 10.1523/JNEUROSCI.0187-04.2004; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pentkowski NS, 2006, EUR J NEUROSCI, V23, P2185, DOI 10.1111/j.1460-9568.2006.04754.x; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; PIEKARSKI G, 1978, Z PARASITENKD, V57, P1, DOI 10.1007/BF00927625; PORTER SB, 1992, NEW ENGL J MED, V327, P1643, DOI 10.1056/NEJM199212033272306; POST MJD, 1983, AM J ROENTGENOL, V140, P861, DOI 10.2214/ajr.140.5.861; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Reiter-Owona I, 2000, J PARASITOL, V86, P531, DOI 10.1645/0022-3395(2000)086[0531:ISCTIE]2.0.CO;2; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schwienbacher I, 2004, BRAIN RES, V1027, P87, DOI 10.1016/j.brainres.2004.08.037; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Skallova A, 2005, NEUROENDOCRINOL LETT, V26, P480; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Staples LG, 2008, NEUROSCIENCE, V151, P937, DOI 10.1016/j.neuroscience.2007.11.039; STIBBS HH, 1985, ANN TROP MED PARASIT, V79, P153, DOI 10.1080/00034983.1985.11811902; Supiot F, 1997, CLIN NEUROL NEUROSUR, V99, P287, DOI 10.1016/S0303-8467(97)00101-7; Takeda H, 1998, EUR J PHARMACOL, V350, P21, DOI 10.1016/S0014-2999(98)00223-4; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TOHYAMA M, 1998, ATLAS NEUROACTIVE RE; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; TORREY EF, 1995, SCHIZOPHRENIA BULL, V21, P167, DOI 10.1093/schbul/21.2.167; Trivedi MA, 2004, NEUROBIOL LEARN MEM, V81, P172, DOI 10.1016/j.nlm.2004.02.005; Unno A, 2008, PARASITOL INT, V57, P515, DOI 10.1016/j.parint.2008.06.004; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vyas A, 2007, NEUROSCIENCE, V148, P342, DOI 10.1016/j.neuroscience.2007.06.021; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Vyas A, 2010, FOLIA PARASIT, V57, P88, DOI 10.14411/fp.2010.011; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; WEBSTER JP, 1994, PARASITOLOGY, V109, P583, DOI 10.1017/S0031182000076460; Webster JP, 2006, P ROY SOC B-BIOL SCI, V273, P1023, DOI 10.1098/rspb.2005.3413; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; WITTING PA, 1979, Z PARASITENKD, V61, P29, DOI 10.1007/BF00927085; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yereli K, 2006, FORENSIC SCI INT, V163, P34, DOI 10.1016/j.forsciint.2005.11.002; ZASTERA M, 1987, ACTA HYG EPIDEMIOL S, V3, P3	101	128	138	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28925	10.1371/journal.pone.0028925	http://dx.doi.org/10.1371/journal.pone.0028925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194951	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100127
J	Smeekens, SP; Plantinga, TS; van de Veerdonk, FL; Heinhuis, B; Hoischen, A; Joosten, LAB; Arkwright, PD; Gennery, A; Kullberg, BJ; Veltman, JA; Lilic, D; van der Meer, JWM; Netea, MG				Smeekens, Sanne P.; Plantinga, Theo S.; van de Veerdonk, Frank L.; Heinhuis, Bas; Hoischen, Alexander; Joosten, Leo A. B.; Arkwright, Peter D.; Gennery, Andrew; Kullberg, Bart Jan; Veltman, Joris A.; Lilic, Desa; van der Meer, Jos W. M.; Netea, Mihai G.			STAT1 Hyperphosphorylation and Defective IL12R/IL23R Signaling Underlie Defective Immunity in Autosomal Dominant Chronic Mucocutaneous Candidiasis	PLOS ONE			English	Article							FUNGAL-INFECTIONS; DEFICIENCY; MUTATIONS; PATHWAYS; IL-17; CYTOKINES; RESPONSES; DISEASE; JAK	We recently reported the genetic cause of autosomal dominant chronic mucocutaneous candidiasis (AD-CMC) as a mutation in the STAT1 gene. In the present study we show that STAT1 Arg274Trp mutations in the coiled-coil (CC) domain is the genetic cause of AD-CMC in three families of patients. Cloning and transfection experiments demonstrate that mutated STAT1 inhibits IL12R/IL-23R signaling, with hyperphosphorylation of STAT1 as the likely underlying molecular mechanism. Inhibition of signaling through the receptors for IL-12 and IL-23 leads to strongly diminished Th1/Th17 responses and hence to increased susceptibility to fungal infections. The challenge for the future is to translate this knowledge into novel strategies for the treatment of this severe immunodeficiency.	[Smeekens, Sanne P.; Plantinga, Theo S.; van de Veerdonk, Frank L.; Joosten, Leo A. B.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Hoischen, Alexander; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Heinhuis, Bas] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Smeekens, Sanne P.; Plantinga, Theo S.; van de Veerdonk, Frank L.; Joosten, Leo A. B.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Netea, Mihai G.] N4i, Nijmegen, Netherlands; [Arkwright, Peter D.] Univ Manchester, Royal Manchester Hosp, Manchester, Lancs, England; [Gennery, Andrew; Lilic, Desa] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Royal Manchester Children's Hospital; University of Manchester; Newcastle University - UK	Smeekens, SP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	m.netea@aig.umcn.nl	Hoischen, Alexander/AGF-7293-2022; Plantinga, Theo S./A-6895-2015; Smeekens, Sanne/AAZ-2061-2021; Veltman, Joris A/F-5128-2010; Kullberg, BJ/C-8520-2013; Netea, Mihai/N-5155-2014; Joosten, Leo AB/H-3138-2015; van der Meer, Jos W.M./C-8521-2013; Arkwright, Peter/C-5149-2012; Heinhuis, Bas/G-6076-2016; Hoischen, Alexander/D-1282-2013; van de Veerdonk, Frank L/C-7256-2008; Smeekens, Sanne/G-8307-2011	Hoischen, Alexander/0000-0002-8072-4476; Plantinga, Theo S./0000-0003-4990-6084; Smeekens, Sanne/0000-0002-7835-914X; Veltman, Joris A/0000-0002-3218-8250; Kullberg, BJ/0000-0002-6813-8167; Joosten, Leo AB/0000-0001-6166-9830; van der Meer, Jos W.M./0000-0001-5120-3690; Hoischen, Alexander/0000-0002-8072-4476; van de Veerdonk, Frank L/0000-0002-1121-4894; Smeekens, Sanne/0000-0002-7835-914X; Arkwright, Peter/0000-0002-7411-5375	Netherlands Organization for Scientific Research; Bubble Appeal UK charity	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Bubble Appeal UK charity	This study was partly supported by a Vici Grant of the Netherlands Organization for Scientific Research (to MGN) and the Bubble Appeal UK charity (to DL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; KIRKPATRICK CH, 1994, J AM ACAD DERMATOL, V31, pS14, DOI 10.1016/S0190-9622(08)81260-1; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Laan M, 1999, J IMMUNOL, V162, P2347; Lilic D, 2002, CURR OPIN INFECT DIS, V15, P143, DOI 10.1097/00001432-200204000-00007; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Ng WF, 2010, J ALLERGY CLIN IMMUN, V126, P1006, DOI 10.1016/j.jaci.2010.08.027; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102	22	81	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29248	10.1371/journal.pone.0029248	http://dx.doi.org/10.1371/journal.pone.0029248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195034	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100170
J	Girard, E; Paul, JL; Fournier, N; Beaune, P; Johannes, L; Lamaze, C; Vedie, B				Girard, Emmanuelle; Paul, Jean Louis; Fournier, Natalie; Beaune, Philippe; Johannes, Ludger; Lamaze, Christophe; Vedie, Benoit			The Dynamin Chemical Inhibitor Dynasore Impairs Cholesterol Trafficking and Sterol-Sensitive Genes Transcription in Human HeLa Cells and Macrophages	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ENDOPLASMIC-RETICULUM; REGULATED TRANSPORT; ABC TRANSPORTERS; ACYL-COENZYME; MODIFIED LDL; EFFLUX; GOLGI; ATHEROSCLEROSIS; HOMEOSTASIS	Intracellular transport of cholesterol contributes to the regulation of cellular cholesterol homeostasis by mechanisms that are yet poorly defined. In this study, we characterized the impact of dynasore, a recently described drug that specifically inhibits the enzymatic activity of dynamin, a GTPase regulating receptor endocytosis and cholesterol trafficking. Dynasore strongly inhibited the uptake of low-density lipoprotein (LDL) in HeLa cells, and to a lower extent in human macrophages. In both cell types, dynasore treatment led to the abnormal accumulation of LDL and free cholesterol (FC) within the endolysosomal network. The measure of cholesterol esters (CE) further showed that the delivery of regulatory cholesterol to the endoplasmic reticulum (ER) was deficient. This resulted in the inhibition of the transcriptional control of the three major sterol-sensitive genes, sterol-regulatory element binding protein 2 (SREBP-2), 3-hydroxy-3-methyl-coenzymeA reductase (HMGCoAR), and low-density lipoprotein receptor (LDLR). The sequestration of cholesterol in the endolysosomal compartment impaired both the active and passive cholesterol efflux in HMDM. Our data further illustrate the importance of membrane trafficking in cholesterol homeostasis and validate dynasore as a new pharmacological tool to study the intracellular transport of cholesterol.	[Girard, Emmanuelle; Paul, Jean Louis; Fournier, Natalie; Beaune, Philippe; Vedie, Benoit] Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Paris, France; [Girard, Emmanuelle; Paul, Jean Louis; Fournier, Natalie] Univ Paris 11, EA 4529, UFR Pharm, Chatenay Malabry, France; [Johannes, Ludger; Lamaze, Christophe] CNRS, UMR144, Paris, France; [Johannes, Ludger; Lamaze, Christophe] Ctr Rech, Inst Curie, Lab Traf Signalisat & Ciblage Intracellulaires, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Girard, E (corresponding author), Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Paris, France.	christophe.lamaze@curie.fr	FOURNIER, Natalie C/D-6217-2011; Johannes, Ludger/M-9778-2017; Johannes, Ludger/W-8593-2019; paul, jean-louis/D-8071-2017; Lamaze, Christophe/M-4912-2017	FOURNIER, Natalie C/0000-0002-8172-382X; Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; LAMAZE, Christophe/0000-0001-5430-2707; Beaune, Philippe/0000-0002-6569-9014; Girard, Emmanuelle/0000-0001-8375-7970	Agence Nationale de la Recherche [ANR-08-GENO-002-01]; Ministere de la Recherche; Contrat Hospitalier de Recherche Translationnelle (CHRT); Institut National de la Sante et de la Recherche Medicale (INSERM)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Contrat Hospitalier de Recherche Translationnelle (CHRT); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was funded by a grant from Agence Nationale de la Recherche (ANR-08-GENO-002-01). E.G. is supported by a doctoral fellowship from Ministere de la Recherche. C.L. is the recipient of a Contrat Hospitalier de Recherche Translationnelle (CHRT) with Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; *APPL BIOS, 1997, US B APPL BIOS, V2, P11; Attia N, 2010, ATHEROSCLEROSIS, V209, P422, DOI 10.1016/j.atherosclerosis.2009.09.025; BONET B, 1995, ATHEROSCLEROSIS, V112, P125, DOI 10.1016/0021-9150(94)05404-7; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Du XM, 2004, J BIOL CHEM, V279, P47010, DOI 10.1074/jbc.M408690200; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jones NL, 2000, ARTERIOSCL THROM VAS, V20, P773, DOI 10.1161/01.ATV.20.3.773; Khelef N, 2000, ARTERIOSCL THROM VAS, V20, P1769; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; KRITHARIDES L, 1995, ARTERIOSCL THROM VAS, V15, P276, DOI 10.1161/01.ATV.15.2.276; KRITHARIDES L, 1993, ANAL BIOCHEM, V213, P79, DOI 10.1006/abio.1993.1389; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McPherson R, 2004, BIOCHEM CELL BIOL, V82, P201, DOI 10.1139/o03-090; Out R, 2008, CIRC RES, V102, P113, DOI 10.1161/CIRCRESAHA.107.161711; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Robinet P, 2006, TRAFFIC, V7, P811, DOI 10.1111/j.1600-0854.2006.00435.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sakashita N, 2010, J LIPID RES, V51, P1263, DOI [10.1194/jlr.M900288-JLR200, 10.1194/jlr.M900288]; Schroeder B, 2010, EMBO J, V29, P3039, DOI 10.1038/emboj.2010.190; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; STEPHAN ZF, 1993, J LIPID RES, V34, P325; Sugii S, 2003, J BIOL CHEM, V278, P27180, DOI 10.1074/jbc.M300542200; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Waldo SW, 2008, AM J PATHOL, V172, P1112, DOI 10.2353/ajpath.2008.070513; Wang M, 2007, J LIPID RES, V48, P633, DOI 10.1194/jlr.M600470-JLR200; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888	42	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29042	10.1371/journal.pone.0029042	http://dx.doi.org/10.1371/journal.pone.0029042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205993	gold, Green Published, Green Submitted			2022-12-25	WOS:000298665600025
J	Mijouin, L; Rosselin, M; Bottreau, E; Pizarro-Cerda, J; Cossart, P; Velge, P; Wiedemann, A				Mijouin, Lily; Rosselin, Manon; Bottreau, Elisabeth; Pizarro-Cerda, Javier; Cossart, Pascale; Velge, Philippe; Wiedemann, Agnes			Salmonella enteritidis Rck-mediated invasion requires activation of Rac1, which is dependent on the class I PI 3-kinases-Akt signaling pathway	FASEB JOURNAL			English	Article						bacterial internalization; phosphoinositides	GROUP-B STREPTOCOCCUS; PROTEIN-KINASE B; EPITHELIAL-CELLS; PHOSPHOINOSITIDE 3-KINASE; LISTERIA-MONOCYTOGENES; PHOSPHATIDYLINOSITOL 3-KINASE; YERSINIA-PSEUDOTUBERCULOSIS; BACTERIAL INVASION; E-CADHERIN; AKT	The Salmonella outer membrane protein Rck mediates a Zipper-like entry mechanism controlled by Rac, the Arp2/3 complex, and actin polymerization. However, little is known about the early steps leading to Rac activation and Rck-mediated internalization. The use of pharmacological inhibitors or PI 3-kinase dominant-negative mutant induced more than 80% less invasion without affecting attachment. Moreover, Rck-mediated internalization caused an increase in the association of p85 with at least one tyrosine-phosphorylated protein, indicating that class I PI 3-kinase activity was stimulated. We also report that this PI 3-kinase activity is essential for Rac1 activation. However, Rac recruitment at the Rck-mediated entry site was independent of its activation. Using a pharmacological approach or Akt-knockout cells, we also demonstrated that Akt was phosphorylated in response to Rck-mediated internalization as demonstrated by immunoblotting analysis and that all three Akt isoforms were required during this process. Overall, our results describe a signaling pathway involving tyrosine phosphorylation, class I PI 3-kinase, Akt activation, and Rac activation, leading to Rck-dependent Zipper entry. The specificity of this signaling pathway with regard to that of the type 3 secretion system, which is the other invasion process of Salmonella, is discussed.-Mijouin, L., Rosselin, M., Bottreau, E., Pizarro-Cerda, J., Cossart, P., Velge, P., Wiedemann, A. Salmonella enteritidis Rck-mediated invasion requires activation of Rac1, which is dependent on the class I PI 3-kinases-Akt signaling pathway. FASEB J. 26, 1569-1581 (2012). www.fasebj.org	[Mijouin, Lily; Rosselin, Manon; Bottreau, Elisabeth; Velge, Philippe; Wiedemann, Agnes] INRA, Infectiol Anim & Sante Publ UR1282, Nouzilly, France; [Mijouin, Lily; Rosselin, Manon; Bottreau, Elisabeth; Velge, Philippe; Wiedemann, Agnes] Univ Tours, Agents Transmissibles & Infectiol IFR136, Tours, France; [Pizarro-Cerda, Javier; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France	INRAE; Universite de Tours; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wiedemann, A (corresponding author), INRA Tours Nouzilly, UR Infectiol Anim & Sante Publ 1282, F-37380 Nouzilly, France.	awiedemann@tours.inra.fr	velge, philippe/AAK-4165-2021	Wiedemann, Agnes/0000-0001-8237-3545	Region Centre [2008-00036085]; Delegation Regionale a la Recherche et a la Technologie du Centre [1634-32245]; Institut National de la Recherche Agronomique	Region Centre(Region Centre-Val de Loire); Delegation Regionale a la Recherche et a la Technologie du Centre; Institut National de la Recherche Agronomique	This work was supported by the Region Centre and performed within the SAVIRE project, funded by the Delegation Regionale a la Recherche et a la Technologie du Centre (FEDER; 1634-32245) and by the Region Centre (2008-00036085). M. R. holds a doctoral fellowship funded by the Region Centre and the Institut National de la Recherche Agronomique. The authors thank Dr. Keith Ireton (Institut Pasteur) for donating plasmids.	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bonazzi M, 2008, CELL MICROBIOL, V10, P2208, DOI 10.1111/j.1462-5822.2008.01200.x; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; Burnham CAD, 2007, MICROBIOL-SGM, V153, P4240, DOI 10.1099/mic.0.2007/008417-0; Burnham CAD, 2007, FEMS MICROBIOL LETT, V272, P8, DOI 10.1111/j.1574-6968.2007.00768.x; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Clark CS, 2007, INFECT IMMUN, V75, P2531, DOI 10.1128/IAI.01866-06; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cougoule C, 2006, J BIOL CHEM, V281, P8756, DOI 10.1074/jbc.M513731200; Eitel J, 2005, CELL MICROBIOL, V7, P63, DOI 10.1111/j.1462-5822.2004.00434.x; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HEFFERNAN EJ, 1994, INFECT IMMUN, V62, P5183, DOI 10.1128/IAI.62.11.5183-5186.1994; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hilbi H, 2006, CELL MICROBIOL, V8, P1697, DOI 10.1111/j.1462-5822.2006.00793.x; Hu YH, 2000, J MED CHEM, V43, P3045, DOI 10.1021/jm000117y; Huang FC, 2005, FEMS MICROBIOL LETT, V243, P265, DOI 10.1016/j.femsle.2004.12.013; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kim EK, 2008, EXP MOL MED, V40, P445, DOI 10.3858/emm.2008.40.4.445; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Liao Y, 2010, AM J TRANSL RES, V2, P19; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Masure S, 1999, EUR J BIOCHEM, V265, P353, DOI 10.1046/j.1432-1327.1999.00774.x; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; ROSENSHINE I, 1994, INFECT IMMUN, V62, P4969, DOI 10.1128/IAI.62.11.4969-4974.1994; Rosselin M, 2010, CELL RES, V20, P647, DOI 10.1038/cr.2010.45; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Seveau S, 2007, CELL MICROBIOL, V9, P790, DOI 10.1111/j.1462-5822.2006.00832.x; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; Uliczka F, 2009, CELL MICROBIOL, V11, P1782, DOI 10.1111/j.1462-5822.2009.01371.x; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Velge P, 2005, VET RES, V36, P267, DOI 10.1051/vetres:2005005; VELGE P, 1994, MICROB PATHOGENESIS, V17, P37, DOI 10.1006/mpat.1994.1050; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	49	19	22	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1569	1581		10.1096/fj.11-189647	http://dx.doi.org/10.1096/fj.11-189647			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22210834				2022-12-25	WOS:000302359700019
J	Kanade, SR; Eckert, RL				Kanade, Santosh R.; Eckert, Richard L.			Protein Arginine Methyltransferase 5 (PRMT5) Signaling Suppresses Protein Kinase C delta- and p38 delta-dependent Signaling and Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INVOLUCRIN PROMOTER; HUMAN EPIDERMAL-KERATINOCYTES; DISTAL REGULATORY REGION; GREEN TEA POLYPHENOL; P38 MAP KINASE; GENE-EXPRESSION; CROSS-LINKING; PKC-DELTA; CORNIFIED ENVELOPE; P38-DELTA MAPK	PKC delta is a key regulator of keratinocyte differentiation that activates p38 delta phosphorylation leading to increased differentiation as measured by an increased expression of the structural protein involucrin. Our previous studies suggest that p38 delta exists in association with protein partners. A major goal is to identify these partners and understand their role in regulating keratinocyte differentiation. In this study we use affinity purification and mass spectrometry to identify protein arginine methyltransferase 5 (PRMT5) as part of the p38 delta signaling complex. PRMT5 is an arginine methyltransferase that symmetrically dimethylates arginine residues on target proteins to alter target protein function. We show that PRMT5 knockdown is associated with increased p38 delta phosphorylation, suggesting that PRMT5 impacts the p38 delta signaling complex. At a functional level we show that PRMT5 inhibits the PKC delta- or 12-O-tetradecanoylphorbol- 13-acetate-dependent increase in human involucrin expression, and PRMT5 dimethylates proteins in the p38 delta complex. Moreover, PKC delta expression reduces the PRMT5 level, suggesting that PKC delta activates differentiation in part by reducing PRMT5 level. These studies indicate antagonism between the PKC delta and PRMT5 signaling in control of keratinocyte differentiation.	[Kanade, Santosh R.; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Reprod Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Kanade, Santosh/V-7054-2019	Kanade, Santosh/0000-0002-2184-9973	National Institutes of Health [R01 AR046494]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR046494 (to R. L. E.).	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Balasubramanian S, 2002, J BIOL CHEM, V277, P1828, DOI 10.1074/jbc.M110376200; Balasubramanian S, 2007, TOXICOL APPL PHARM, V224, P214, DOI 10.1016/j.taap.2007.03.020; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Cai QS, 2009, J BIOL CHEM, V284, P2150, DOI 10.1074/jbc.M803235200; Cesaro E, 2009, J BIOL CHEM, V284, P32321, DOI 10.1074/jbc.M109.043349; Chang YI, 2010, J BIOL CHEM, V285, P20595, DOI 10.1074/jbc.M109.092411; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Dashti SR, 2001, J BIOL CHEM, V276, P27214, DOI 10.1074/jbc.M100465200; Dashti SR, 2001, J BIOL CHEM, V276, P8059, DOI 10.1074/jbc.C000862200; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Eckert RL, 2006, MOL NUTR FOOD RES, V50, P123, DOI 10.1002/mnfr.200500125; Eckert RL, 2004, BIOCHEM PHARMACOL, V68, P1125, DOI 10.1016/j.bcp.2004.04.029; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Eckert RL, 2003, J INVEST DERMATOL, V120, P823, DOI 10.1046/j.1523-1747.2003.12120.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Hong S, 2010, P NATL ACAD SCI USA, V107, P21211, DOI 10.1073/pnas.1011987107; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Igarashi H, 2009, MOL IMMUNOL, V46, P1031, DOI 10.1016/j.molimm.2008.08.272; Kanamaluru D, 2011, MOL CELL BIOL, V31, P1540, DOI 10.1128/MCB.01212-10; Kraft CA, 2007, ARCH DERMATOL RES, V299, P71, DOI 10.1007/s00403-006-0727-4; LaCelle PT, 1998, SKIN PHARMACOL APPL, V11, P214, DOI 10.1159/000029830; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Nemes Z, 1999, J BIOL CHEM, V274, P11013, DOI 10.1074/jbc.274.16.11013; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Robinson NA, 1996, J INVEST DERMATOL, V107, P101, DOI 10.1111/1523-1747.ep12298323; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Steinert PM, 1999, MOL BIOL CELL, V10, P4247, DOI 10.1091/mbc.10.12.4247; Tanaka H, 2009, MOL CANCER RES, V7, P557, DOI 10.1158/1541-7786.MCR-08-0197; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Yadav V, 2010, AM J PATHOL, V176, P1091, DOI 10.2353/ajpath.2010.090816	62	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7313	7323		10.1074/jbc.M111.331660	http://dx.doi.org/10.1074/jbc.M111.331660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22199349	Green Published, hybrid			2022-12-25	WOS:000301060200033
J	Guerin, F; Barbe, S; Pizzut-Serin, S; Potocki-Veronese, G; Guieysse, D; Guillet, V; Monsan, P; Mourey, L; Remaud-Simeon, M; Andre, I; Tranier, S				Guerin, Frederic; Barbe, Sophie; Pizzut-Serin, Sandra; Potocki-Veronese, Gabrielle; Guieysse, David; Guillet, Valerie; Monsan, Pierre; Mourey, Lionel; Remaud-Simeon, Magali; Andre, Isabelle; Tranier, Samuel			Structural Investigation of the Thermostability and Product Specificity of Amylosucrase from the Bacterium Deinococcus geothermalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; NEISSERIA-POLYSACCHAREA; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; ALPHA-AMYLASE; FORCE-FIELD; SUCROSE; SEQUENCE; CLASSIFICATION; SIMULATIONS	Amylosucrases are sucrose-utilizing alpha-transglucosidases that naturally catalyze the synthesis of alpha-glucans, linked exclusively through alpha 1,4-linkages. Side products and in particular sucrose isomers such as turanose and trehalulose are also produced by these enzymes. Here, we report the first structural and biophysical characterization of the most thermostable amylosucrase identified so far, the amylosucrase from Deinoccocus geothermalis (DgAS). The three-dimensional structure revealed a homodimeric quaternary organization, never reported before for other amylosucrases. A sequence signature of dimerization was identified from the analysis of the dimer interface and sequence alignments. By rigidifying the DgAS structure, the quaternary organization is likely to participate in the enhanced thermal stability of the protein. Amylosucrase specificity with respect to sucrose isomer formation (turanose or trehalulose) was also investigated. We report the first structures of the amylosucrases from Deinococcus geothermalis and Neisseria polysaccharea in complex with turanose. In the amylosucrase from N. polysaccharea (NpAS), key residues were found to force the fructosyl moiety to bind in an open state with the O3' ideally positioned to explain the preferential formation of turanose by NpAS. Such residues are either not present or not similarly placed in DgAS. As a consequence, DgAS binds the furanoid tautomers of fructose through a weak network of interactions to enable turanose formation. Such topology at subsite +1 is likely favoring other possible fructose binding modes in agreement with the higher amount of trehalulose formed by DgAS. Our findings help to understand the inter-relationships between amylosucrase structure, flexibility, function, and stability and provide new insight for amylosucrase design.	[Andre, Isabelle] Univ Toulouse, INSA, UPS, INP,LISBP,CNRS UMR5504,UMR INRA 792, F-31077 Toulouse 4, France; [Guerin, Frederic; Barbe, Sophie; Pizzut-Serin, Sandra; Potocki-Veronese, Gabrielle; Guieysse, David; Monsan, Pierre; Remaud-Simeon, Magali; Andre, Isabelle] CNRS, UMR5504, F-31400 Toulouse, France; [Guerin, Frederic; Barbe, Sophie; Pizzut-Serin, Sandra; Potocki-Veronese, Gabrielle; Guieysse, David; Monsan, Pierre; Remaud-Simeon, Magali; Andre, Isabelle] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Guerin, Frederic; Guillet, Valerie; Mourey, Lionel; Tranier, Samuel] CNRS, IPBS, Dept Biol Struct & Biophys, F-31077 Toulouse, France; [Guerin, Frederic; Guillet, Valerie; Mourey, Lionel; Tranier, Samuel] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Monsan, Pierre] Inst Univ France, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut Universitaire de France	Andre, I (corresponding author), Univ Toulouse, INSA, UPS, INP,LISBP,CNRS UMR5504,UMR INRA 792, 135 Ave Rangueil, F-31077 Toulouse 4, France.	isabelle.andre@insa-toulouse.fr; samuel.tranier@ipbs.fr	Tranier, Samuel/C-6059-2011; Veronese, Gabrielle/GTF-3473-2022; Mourey, Lionel/B-5662-2009; Barbe, Sophie/ABD-9530-2020	Mourey, Lionel/0000-0002-8259-1259; Barbe, Sophie/0000-0003-2581-5022; Tranier, Samuel/0000-0001-9751-163X; GUIEYSSE, David/0000-0002-8802-4968	Center of Region Midi-Pyrenees (CALMIP, Toulouse, France); Center for Computing Resources (CRI) of INSA-Toulouse; Poles de Recherche et d'Enseignement Superieur de I'Universite de Toulouse; Region Midi-Pyrenees, France	Center of Region Midi-Pyrenees (CALMIP, Toulouse, France)(Region Occitanie); Center for Computing Resources (CRI) of INSA-Toulouse; Poles de Recherche et d'Enseignement Superieur de I'Universite de Toulouse; Region Midi-Pyrenees, France(Region Occitanie)	We thank the Computing Center of Region Midi-Pyrenees (CALMIP, Toulouse, France) and the Center for Computing Resources (CRI) of INSA-Toulouse for providing computing resources and support. We are grateful to the staff of Synchrotron beamlines ID14-1 and ID29 at the European Synchrotron Radiation Facility (Grenoble, France) for providing assistance in using the beamlines. We are grateful to Javier Perez (Synchrotron SOLEIL) for the fruitful discussions. We also thank Stephanie Terme (Wyatt technology France) for helpful assistance in the SEC-MALLS experiments.; Supported by a Ph.D. grant from the Poles de Recherche et d'Enseignement Superieur de I'Universite de Toulouse and the Region Midi-Pyrenees, France.	Andre I, 2010, TOP CURR CHEM, V294, P25, DOI 10.1007/128_2010_52; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case D, 2006, AMBER 9; Champion E, 2009, J AM CHEM SOC, V131, P7379, DOI 10.1021/ja900183h; Chang A, 2011, CURR OPIN BIOTECH, V22, P800, DOI 10.1016/j.copbio.2011.04.013; de Montalk GP, 2000, FEBS LETT, V471, P219, DOI 10.1016/S0014-5793(00)01406-X; De Montalk GP, 1999, J BACTERIOL, V181, P375; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emond S, 2008, FEMS MICROBIOL LETT, V285, P25, DOI 10.1111/j.1574-6968.2008.01204.x; Emond S, 2008, PROTEIN SCI, V17, P967, DOI 10.1110/ps.083492608; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fritzsche HB, 2003, EUR J BIOCHEM, V270, P2332, DOI 10.1046/j.1432-1033.2003.03603.x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Goulter KC, 2012, ENZYME MICROB TECH, V50, P57, DOI 10.1016/j.enzmictec.2011.09.011; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Ha SJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1505, DOI 10.1271/bbb.80891; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Jung JH, 2009, CARBOHYD RES, V344, P1612, DOI 10.1016/j.carres.2009.04.019; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; LICHTENTHALER FW, 1990, J CHEM SOC PERK T 2, P1489, DOI 10.1039/p29900001489; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OKADA G, 1974, J BIOL CHEM, V249, P126; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Pizzut-Serin S, 2005, FEBS LETT, V579, P1405, DOI 10.1016/j.febslet.2004.12.097; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prakash O, 2010, APPL BIOCHEM BIOTECH, V160, P2401, DOI 10.1007/s12010-009-8735-4; Ravaud S, 2007, J BIOL CHEM, V282, P28126, DOI 10.1074/jbc.M704515200; Ravaud S, 2009, FEBS LETT, V583, P1964, DOI 10.1016/j.febslet.2009.05.002; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarcabal P, 2000, FEBS LETT, V474, P33, DOI 10.1016/S0014-5793(00)01567-2; Seo DH, 2009, J MOL CATAL B-ENZYM, V60, P113, DOI 10.1016/j.molcatb.2009.04.006; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; Skov LK, 2000, ACTA CRYSTALLOGR D, V56, P203, DOI 10.1107/S0907444999015887; Thompson J, 2012, MOL ORAL MICROBIOL, V27, P34, DOI 10.1111/j.2041-1014.2011.00627.x; Zhang DH, 2003, FEBS LETT, V534, P151, DOI 10.1016/S0014-5793(02)03835-8	50	50	52	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6642	6654		10.1074/jbc.M111.322917	http://dx.doi.org/10.1074/jbc.M111.322917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22210773	Green Published, hybrid			2022-12-25	WOS:000300791800051
J	Bloem, E; Meems, H; van den Biggelaar, M; Van der Zwaan, C; Mertens, K; Meijer, AB				Bloem, Esther; Meems, Henriet; van den Biggelaar, Maartje; Van der Zwaan, Carmen; Mertens, Koen; Meijer, Alexander B.			Mass Spectrometry-assisted Study Reveals That Lysine Residues 1967 and 1968 Have Opposite Contribution to Stability of Activated Factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-IXA; FACTOR-V; CATALYZED INACTIVATION; SUBUNIT DISSOCIATION; CHARGED RESIDUES; LIGHT-CHAIN; A2 SUBUNIT; PROTEIN-C; IDENTIFICATION; QUANTIFICATION	The A2 domain rapidly dissociates from activated factor VIII (FVIIIa) resulting in a dampening of the activity of the activated factor X-generating complex. The amino acid residues that affect A2 domain dissociation are therefore critical for FVIII cofactor function. We have now employed chemical footprinting in conjunction with mass spectrometry to identify lysine residues that contribute to the stability of activated FVIII. We hypothesized that lysine residues, which are buried in FVIII and surface-exposed in dissociated activated FVIII (dis-FVIIIa), may contribute to interdomain interactions. Mass spectrometry analysis revealed that residues Lys(1967) and Lys(1968) of region Thr(1964)-Tyr(1971) are buried in FVIII and exposed to the surface in dis-FVIIIa. This result, combined with the observation that the FVIII variant K1967I is associated with hemophilia A, suggests that these residues contribute to the stability of activated FVIII. Kinetic analysis revealed that the FVIII variants K1967A and K1967I exhibit an almost normal cofactor activity. However, these variants also showed an increased loss in cofactor activity over time compared with that of FVIII WT. Remarkably, the cofactor activity of a K1968A variant was enhanced and sustained for a prolonged time relative to that of FVIII WT. Surface plasmon resonance analysis demonstrated that A2 domain dissociation from activated FVIII was reduced for K1968A and enhanced for K1967A. In conclusion, mass spectrometry analysis combined with site-directed mutagenesis studies revealed that the lysine couple Lys(1967)-Lys(1968) within region Thr(1964)-Tyr(1971) has an opposite contribution to the stability of FVIIIa.	[Bloem, Esther; Meems, Henriet; van den Biggelaar, Maartje; Van der Zwaan, Carmen; Mertens, Koen; Meijer, Alexander B.] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CG Utrecht, Netherlands	Utrecht University	Meijer, AB (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.meijer@sanquin.nl						Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; CHURCH WR, 1984, P NATL ACAD SCI-BIOL, V81, P6934, DOI 10.1073/pnas.81.22.6934; Dayon L, 2010, J PROTEOMICS, V73, P769, DOI 10.1016/j.jprot.2009.10.015; DUFFY EJ, 1992, J BIOL CHEM, V267, P17006; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FAY PJ, 1993, J BIOL CHEM, V268, P17861; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Gale AJ, 2006, J THROMB HAEMOST, V4, P1315, DOI 10.1111/j.1538-7836.2006.01951.x; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; LAMPHEAR BJ, 1992, J BIOL CHEM, V267, P3725; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Lillicrap D, 2008, THROMB RES, V122, pS2, DOI 10.1016/S0049-3848(08)70027-6; LIND P, 1995, EUR J BIOCHEM, V232, P19, DOI 10.1111/j.1432-1033.1995.tb20776.x; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; MERTENS K, 1980, BIOCHEM J, V185, P647, DOI 10.1042/bj1850647; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Nogami K, 2007, J BIOL CHEM, V282, P5287, DOI 10.1074/jbc.M607816200; OBRIEN DP, 1992, BIOCHEMISTRY-US, V31, P2805, DOI 10.1021/bi00125a022; Pipe SW, 1999, BLOOD, V93, P176, DOI 10.1182/blood.V93.1.176.401k07_176_183; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Stel H. V., 1984, THESIS U AMSTERDAM; Thingholm TE, 2010, J PROTEOME RES, V9, P4045, DOI 10.1021/pr100230q; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; van Haren SD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002246; van Helden PMW, 2008, BRIT J HAEMATOL, V142, P644, DOI 10.1111/j.1365-2141.2008.07232.x; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; Venkateswarlu D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-7; Wakabayashi H, 2009, J THROMB HAEMOST, V7, P438, DOI 10.1111/j.1538-7836.2008.03256.x; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158; Wakabayashi H, 2008, J BIOL CHEM, V283, P11645, DOI 10.1074/jbc.M710252200; Wakabayashi H, 2011, J BIOL CHEM, V286, P25748, DOI 10.1074/jbc.M111.241109	43	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5775	5783		10.1074/jbc.M111.308627	http://dx.doi.org/10.1074/jbc.M111.308627			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215677	Green Published, hybrid			2022-12-25	WOS:000300638000053
J	Sekiguchi, H; Ii, M; Jujo, K; Yokoyama, A; Hagiwara, N; Asahara, T				Sekiguchi, Haruki; Ii, Masaaki; Jujo, Kentaro; Yokoyama, Ayumi; Hagiwara, Nobuhisa; Asahara, Takayuki			Improved Culture-Based Isolation of Differentiating Endothelial Progenitor Cells from Mouse Bone Marrow Mononuclear Cells	PLOS ONE			English	Article							MOBILIZATION; NEOVASCULARIZATION; ISCHEMIA; INJURY; TRANSPLANTATION; ANGIOGENESIS; RECRUITMENT; ESTROGEN	Numerous endothelial progenitor cell (EPC)-related investigations have been performed in mouse experiments. However, defined characteristics of mouse cultured EPC have not been examined. We focused on fast versus slow adherent cell population in bone marrow mononuclear cells (BMMNCs) in culture and examined their characteristics. After 24 h-culture of BMMNCs, attached (AT) cells and floating (FL) cells were further cultured in endothelial differentiation medium separately. Immunological and molecular analyses exhibited more endothelial-like and less monocyte/ macrophage-like characteristics in FL cells compared with AT cells. FL cells formed thick/ stable tube and hypoxia or shear stress overload further enhanced these endothelial-like features with increased angiogenic cytokine/ growth factor mRNA expressions. Finally, FL cells exhibited therapeutic potential in a mouse myocardial infarction model showing the specific local recruitment to ischemic border zone and tissue preservation. These findings suggest that slow adherent (FL) but not fast attached (AT) BMMNCs in culture are EPC-rich population in mouse.	[Sekiguchi, Haruki; Ii, Masaaki; Yokoyama, Ayumi; Asahara, Takayuki] RIKEN Ctr Dev Biol, Grp Vasc Regenerat Res, Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; [Sekiguchi, Haruki; Jujo, Kentaro] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Sekiguchi, Haruki; Hagiwara, Nobuhisa] Natl Hosp Org, Yokohama Med Ctr, Kanagawa, Japan; [Ii, Masaaki] Osaka Med Coll, Grp Translat Stem Cell Res, Dept Pharmacol, Osaka, Japan; [Asahara, Takayuki] Tokai Univ, Kanagawa 2591100, Japan	Institute for Biomedical Research & Innovation (IBRI); RIKEN; Tokyo Women's Medical University; Osaka Medical College; Tokai University	Sekiguchi, H (corresponding author), RIKEN Ctr Dev Biol, Grp Vasc Regenerat Res, Inst Biomed Res & Innovat, Kobe, Hyogo, Japan.	masa0331@mac.com; asa777@is.icc.u-tokai.ac.jp			Ministry of Health, Labor and Welfare Organization in Japan; Foundation of Biomedical Research and Innovation of Kobe	Ministry of Health, Labor and Welfare Organization in Japan; Foundation of Biomedical Research and Innovation of Kobe	This work was supported by funding from the Ministry of Health, Labor and Welfare Organization in Japan and by the Foundation of Biomedical Research and Innovation of Kobe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; HOSENPUD JD, 1989, J HEART TRANSPLANT, V8, P460; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Kahler CM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-50; Kamei N, 2010, STEM CELLS, V28, P365, DOI 10.1002/stem.243; Kawabe-Yako R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024646; Krenning G, 2009, J CELL MOL MED, V13, P2521, DOI 10.1111/j.1582-4934.2008.00479.x; Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Kwon SM, 2009, CIRC RES, V104, P969, DOI 10.1161/CIRCRESAHA.108.192856; Nakajima M, 2006, CELL BIOL INT, V30, P239, DOI 10.1016/j.cellbi.2005.11.003; Patschan D, 2006, AM J PHYSIOL-RENAL, V291, pF176, DOI 10.1152/ajprenal.00454.2005; Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072; Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tanaka R, 2008, PLAST RECONSTR SURG, V121, P1929, DOI 10.1097/PRS.0b013e3181715218; Wang CH, 2006, J MOL CELL CARDIOL, V41, P34, DOI 10.1016/j.yjmcc.2006.03.006; Yamada Y, 2006, J EXP MED, V203, P1055, DOI 10.1084/jem.20050373; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433	25	28	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28639	10.1371/journal.pone.0028639	http://dx.doi.org/10.1371/journal.pone.0028639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216102	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300008
J	Kalis, M; Bolmeson, C; Esguerra, JLS; Gupta, S; Edlund, A; Tormo-Badia, N; Speidel, D; Holmberg, D; Mayans, S; Khoo, NKS; Wendt, A; Eliasson, L; Cilio, CM				Kalis, Martins; Bolmeson, Caroline; Esguerra, Jonathan L. S.; Gupta, Shashank; Edlund, Anna; Tormo-Badia, Neivis; Speidel, Dina; Holmberg, Dan; Mayans, Sofia; Khoo, Nelson K. S.; Wendt, Anna; Eliasson, Lena; Cilio, Corrado M.			Beta-Cell Specific Deletion of Dicer1 Leads to Defective Insulin Secretion and Diabetes Mellitus	PLOS ONE			English	Article							MICRORNA EXPRESSION; GENE-EXPRESSION; DIFFERENTIATION; QUANTIFICATION; IDENTIFICATION; PATHWAY; DRIVEN	Mature microRNAs (miRNAs), derived through cleavage of pre-miRNAs by the Dicer1 enzyme, regulate protein expression in many cell-types including cells in the pancreatic islets of Langerhans. To investigate the importance of miRNAs in mouse insulin secreting beta-cells, we have generated mice with a beta-cells specific disruption of the Dicer1 gene using the Cre-lox system controlled by the rat insulin promoter (RIP). In contrast to their normoglycaemic control littermates (RIP-Cre(+/-) Dicer1(Delta/wt)), RIP-Cre(+/-) Dicer1(flox/flox) mice (RIP-Cre Dicer1(Delta/Delta)) developed progressive hyperglycaemia and full-blown diabetes mellitus in adulthood that recapitulated the natural history of the spontaneous disease in mice. Reduced insulin gene expression and concomitant reduced insulin secretion preceded the hyperglycaemic state and diabetes development. Immunohistochemical, flow cytometric and ultrastructural analyses revealed altered islet morphology, marked decreased beta-cell mass, reduced numbers of granules within the beta-cells and reduced granule docking in adult RIP-Cre Dicer1(Delta/Delta) mice. beta-cell specific Dicer1 deletion did not appear to disrupt fetal and neonatal beta-cell development as 2-week old RIP-Cre Dicer1(Delta/Delta) mice showed ultrastructurally normal beta-cells and intact insulin secretion. In conclusion, we have demonstrated that a beta-cell specific disruption of the miRNAs network, although allowing for apparently normal beta-cell development, leads to progressive impairment of insulin secretion, glucose homeostasis and diabetes development.	[Kalis, Martins; Bolmeson, Caroline; Tormo-Badia, Neivis; Khoo, Nelson K. S.; Cilio, Corrado M.] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit,Lund Univ Diabet Ctr, Malmo, Sweden; [Holmberg, Dan; Mayans, Sofia] Umea Univ, Dept Med Genet, Umea, Sweden; [Gupta, Shashank; Holmberg, Dan; Mayans, Sofia] Univ Copenhagen, Fac Life Sci, Dept Dis Biol, Copenhagen, Denmark	Lund University; Skane University Hospital; Umea University; University of Copenhagen	Kalis, M (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit,Lund Univ Diabet Ctr, Malmo, Sweden.	lena.eliasson@med.lu.se; corrado.cilio@med.lu.se	Esguerra, Jonathan/M-2366-2014; Eliasson, Lena/E-9294-2012	Esguerra, Jonathan/0000-0001-8454-6606; Eliasson, Lena/0000-0002-6467-5029; Mayans, Sofia/0000-0002-9912-8252; Wendt, Anna/0000-0001-8807-5979	Swedish Research Council; Linneus grant; EFSD-MSD; Knut and Alice Wallenberg Foundation; Marianne and Marcus Wallenberg Foundation; Novo Nordisk Foundation; Swedish Diabetes Foundation; Albert Pahlssons Foundation; Magnus Bergwall Foundation; Royal Physiographic Society in Lund; Lars Hiertas Minne Foundation; UMAS foundation; O. E. and Edla Johanssons Scientific Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linneus grant; EFSD-MSD; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Marianne and Marcus Wallenberg Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Foundation; Albert Pahlssons Foundation; Magnus Bergwall Foundation; Royal Physiographic Society in Lund; Lars Hiertas Minne Foundation; UMAS foundation; O. E. and Edla Johanssons Scientific Foundation	This work was supported by the Swedish Research Council (project grants (LE and CC), collaboration grant (LE coordinator), CC and AW(PI:s)), Linneus grant to Lund University Diabetes Center (coordinator Leif Groop; LE and CC (PI: s), (JE co-PI)), EFSD-MSD, The Knut and Alice Wallenberg Foundation, The Marianne and Marcus Wallenberg Foundation, Novo Nordisk Foundation, The Swedish Diabetes Foundation, Albert Pahlssons Foundation, Magnus Bergwall Foundation, The Royal Physiographic Society in Lund, Lars Hiertas Minne Foundation, UMAS foundation and O. E. and Edla Johanssons Scientific Foundation. LE has a Senior Research position supported by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alanentalo T, 2010, DIABETES, V59, P1756, DOI 10.2337/db09-1400; Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; El Ouaamari A, 2008, DIABETES; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Esguerra JLS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018613; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; GITTES GK, 1992, P NATL ACAD SCI USA, V89, P1128, DOI 10.1073/pnas.89.3.1128; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; Groop L, 2000, INT J CLIN PRACT, P3; Hennessy Erica, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000781; Herrera PL, 2000, DEVELOPMENT, V127, P2317; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-210; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Lee EK, 2010, ENDOCRINOLOGY, V151, P1403, DOI 10.1210/en.2009-1123; Lovis P, 2008, DIABETES, V57, P2728, DOI 10.2337/db07-1252; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Salehi A, 1999, ENDOCRINOLOGY, V140, P3045, DOI 10.1210/en.140.7.3045; SCHNELL AH, 1988, CELL TISSUE RES, V252, P9; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Vikman J, 2009, FASEB J, V23, P58, DOI 10.1096/fj.08-105734; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200	42	99	101	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29166	10.1371/journal.pone.0029166	http://dx.doi.org/10.1371/journal.pone.0029166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216196	Green Published, Green Submitted, gold			2022-12-25	WOS:000300674900019
J	Mulder, IE; Schmidt, B; Lewis, M; Delday, M; Stokes, CR; Bailey, M; Aminov, RI; Gill, BP; Pluske, JR; Mayer, CD; Kelly, D				Mulder, Imke E.; Schmidt, Bettina; Lewis, Marie; Delday, Margaret; Stokes, Christopher R.; Bailey, Mick; Aminov, Rustam I.; Gill, Bhupinder P.; Pluske, John R.; Mayer, Claus-Dieter; Kelly, Denise			Restricting Microbial Exposure in Early Life Negates the Immune Benefits Associated with Gut Colonization in Environments of High Microbial Diversity	PLOS ONE			English	Article							COMMENSAL INTESTINAL BACTERIA; RESPONSES; SYSTEM; CELLS; FLORA; ACQUISITION; EXPRESSION; MULTIPLE; DELIVERY; ECOLOGY	Background: Acquisition of the intestinal microbiota in early life corresponds with the development of the mucosal immune system. Recent work on caesarean-delivered infants revealed that early microbial composition is influenced by birthing method and environment. Furthermore, we have confirmed that early-life environment strongly influences both the adult gut microbiota and development of the gut immune system. Here, we address the impact of limiting microbial exposure after initial colonization on the development of adult gut immunity. Methodology/Principal Findings: Piglets were born in indoor or outdoor rearing units, allowing natural colonization in the immediate period after birth, prior to transfer to high-health status isolators. Strikingly, gut closure and morphological development were strongly affected by isolator-rearing, independent of indoor or outdoor origins of piglets. Isolator-reared animals showed extensive vacuolation and disorganization of the gut epithelium, inferring that normal gut closure requires maturation factors present in maternal milk. Although morphological maturation and gut closure were delayed in isolator-reared animals, these hard-wired events occurred later in development. Type I IFN, IL-22, IL-23 and Th17 pathways were increased in indoor-isolator compared to outdoor-isolator animals during early life, indicating greater immune activation in pigs originating from indoor environments reflecting differences in the early microbiota. This difference was less apparent later in development due to enhanced immune activation and convergence of the microbiota in all isolator-reared animals. This correlated with elevation of Type I IFN pathways in both groups, although T cell pathways were still more affected in indoor-reared animals. Conclusions/Significance: Environmental factors, in particular microbial exposure, influence expression of a large number of immune-related genes. However, the homeostatic effects of microbial colonization in outdoor environments require sustained microbial exposure throughout development. Gut development in high-hygiene environments negatively impacts on normal succession of the gut microbiota and promotes innate immune activation which may impair immune homeostasis.	[Mulder, Imke E.; Schmidt, Bettina; Delday, Margaret; Aminov, Rustam I.; Kelly, Denise] Univ Aberdeen, Rowett Inst Nutr & Hlth, Gut Immunol Grp, Aberdeen, Scotland; [Lewis, Marie; Stokes, Christopher R.; Bailey, Mick] Univ Bristol, Sch Clin Vet Sci, Bristol, Avon, England; [Gill, Bhupinder P.] Agr & Hort Dev Board, Milton Keynes, Bucks, England; [Pluske, John R.] Murdoch Univ, Sch Vet & Biomed Sci, Murdoch, WA 6150, Australia	University of Aberdeen; University of Bristol; Agriculture & Horticulture Development Board (AHDB); Murdoch University	Mulder, IE (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Gut Immunol Grp, Aberdeen, Scotland.	D.Kelly@abdn.ac.uk	Pluske, John/D-3635-2013; Aminov, Rustam/C-8764-2016; Aminov, Rustam/AAF-9052-2019; Mayer, Claus-Dieter/L-9353-2013	Pluske, John/0000-0002-7194-2164; Aminov, Rustam/0000-0002-5811-8322; Lewis, Marie/0000-0001-6042-0865; Mayer, Claus-Dieter/0000-0001-8788-3149	Department for Environment, Food and Rural Affairs [LS3658/CSA 6738]; Meat and Livestock Commission [LS3658/CSA 6738]; Rural and Environmental Science and Analytical Services	Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Meat and Livestock Commission(Meat and Livestock Australia); Rural and Environmental Science and Analytical Services	This work was supported by a joint grant from the Department for Environment, Food and Rural Affairs and the Meat and Livestock Commission to IM and BS (LS3658/CSA 6738), and the Rural and Environmental Science and Analytical Services to DK and RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER TJ, 1969, CANADIAN VET J, V10, P98; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cooper PJ, 2006, BMC PULM MED, V6, P1; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Ishikawa H, 2008, CLIN EXP IMMUNOL, V153, P127, DOI 10.1111/j.1365-2249.2008.03668.x; Jensen AR, 2001, J NUTR, V131, P3259, DOI 10.1093/jn/131.12.3259; Jin H, 2007, ONCOGENE, V26, P7490, DOI 10.1038/sj.onc.1210559; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Migliore E, 2007, ALLERGY, V62, P293, DOI 10.1111/j.1398-9995.2007.01238.x; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ohnmacht C, 2011, CELL MICROBIOL, V13, P653, DOI 10.1111/j.1462-5822.2011.01577.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pinsk V, 2007, AM J GASTROENTEROL, V102, P1077, DOI 10.1111/j.1572-0241.2007.01124.x; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Tannock GW, 2007, SEMIN IMMUNOL, V19, P94, DOI 10.1016/j.smim.2006.09.001; Teran R, 2011, CLIN IMMUNOL, V138, P299, DOI 10.1016/j.clim.2010.12.011; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Wagner RD, 2008, ADV EXP MED BIOL, V635, P41, DOI 10.1007/978-0-387-09550-9_4; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336	43	96	98	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28279	10.1371/journal.pone.0028279	http://dx.doi.org/10.1371/journal.pone.0028279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216092	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000299684700005
J	Xu, YM; Xin, YQ; Diao, Y; Lu, CY; Fu, J; Luo, L; Yin, ZM				Xu, Yimiao; Xin, Yinqiang; Diao, Ying; Lu, Changyan; Fu, Jin; Luo, Lan; Yin, Zhimin			Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; STRESS-INDUCED APOPTOSIS; HUMAN TUMOR-CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; REACTIVE OXYGEN; CASPASE-2 ACTIVATION; GLUCOSE DEPRIVATION; SPECIES GENERATION; MITOCHONDRIAL	Background: It was well known that the clinical use of chemotherapeutic drugs is restricted by severe adverse reactions and drug resistances. Thus it is necessary to figure out a strategy to increase the specific anti-tumor efficiency of chemotherapeutic drugs. Apigenin, a kind of flavonoids, has been reported to possess anticancer activities with very low cytotoxicity to normal tissue. Methodology/Principal Findings: Our results from cell viability assay, western-blots and TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay demonstrated the synergistic pro-apoptotic effects of a low dose of apigenin and paclitaxel in human cancer cell lines. To analyze the underlying mechanism, we examined reactive oxygen species (ROS) staining after cells were treated with a combination of apigenin and paclitaxel, or each of them alone. Data from flow-cytometry showed that superoxides but not reduction of peroxides accumulated in HeLa cells treated with apigenin or a combination of apigenin and paclitaxel. Apigenin and paclitaxel-induced HeLa cell apoptosis was related to the level of ROS in cells. We further evaluated activity and protein level of superoxide dismutase (SOD). Apigenin significantly inhibited SOD activity but did not alter the SOD protein level suggesting that apigenin promoted ROS accumulation through suppressing enzyme activity of SOD. Addition of Zn2+, Cu2+ and Mn2+ to cell lysates inhibited apigenin's effects on SOD activity. At the same time, data from caspase-2 over-expression and knocked-down experiments demonstrated that caspase-2 participated in apigenin and paclitaxel-induced HeLa cell apoptosis. Conclusions/Significance: Taken together, our study demonstrated that apigenin can sensitize cancer cells to paclitaxel induced apoptosis through suppressing SOD activity, which then led to accumulation of ROS and cleavage of caspase-2, suggesting that the combined use of apigenin and paclitaxel was an effective way to decrease the dose of paclitaxel taken.	[Xu, Yimiao; Xin, Yinqiang; Diao, Ying; Lu, Changyan; Fu, Jin; Yin, Zhimin] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Luo, Lan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing University	Xu, YM (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	lanluo@nju.edu.cn; yinzhimin@njnu.edu.cn			National Nature Science Foundation of China [81072433, 31071000]; Jiangsu Major Nature Science Foundation of High Education [07KJA18026]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Major Nature Science Foundation of High Education; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Nature Science Foundation of China (Nos. 81072433 and 31071000), Jiangsu Major Nature Science Foundation of High Education (No. 07KJA18026) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; AJANI JA, 1994, J NATL CANCER I, V86, P51, DOI 10.1093/jnci/86.1.51; Akashi M, 1996, INT J CANCER, V68, P384, DOI 10.1002/(SICI)1097-0215(19961104)68:3<384::AID-IJC18>3.0.CO;2-8; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Blackburn RV, 1999, FREE RADICAL BIO MED, V26, P419, DOI 10.1016/S0891-5849(98)00217-2; Braga M, 2008, APOPTOSIS, V13, P822, DOI 10.1007/s10495-008-0216-7; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen WJ, 2008, J AGR FOOD CHEM, V56, P2996, DOI 10.1021/jf0730744; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; CHOU TC, 1991, MEDIAN EFFECT PRINCI, P61; Crespo I, 2008, FOOD CHEM TOXICOL, V46, P1555, DOI 10.1016/j.fct.2007.12.014; Das KC, 1998, J BIOL CHEM, V273, P34639, DOI 10.1074/jbc.273.51.34639; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dziadyk JM, 2004, ANTICANCER RES, V24, P27; Ferret Pierre-Jacques, 2002, BMC Immunol, V3, P3; Gao YH, 2010, APOPTOSIS, V15, P822, DOI 10.1007/s10495-010-0495-7; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Itoh Y, 2004, AM J RESP CRIT CARE, V169, P113, DOI 10.1164/rccm.200307-901OC; Ju W, 2007, MOL PHARMACOL, V71, P1381, DOI 10.1124/mol.106.032185; Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kobayashi T, 2002, CANCER LETT, V176, P17, DOI 10.1016/S0304-3835(01)00738-8; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Miyoshi N, 2007, ARCH BIOCHEM BIOPHYS, V466, P274, DOI 10.1016/j.abb.2007.07.026; Noel S, 2006, TOXICOL IN VITRO, V20, P1168, DOI 10.1016/j.tiv.2006.03.007; OBERLEY LW, 1981, MED HYPOTHESES, V7, P21, DOI 10.1016/0306-9877(81)90018-9; Olsson M, 2009, ONCOGENE, V28, P1949, DOI 10.1038/onc.2009.36; Patel D, 2007, INT J ONCOL, V30, P233; PATRICE L, 2002, SCIENCE, V297, P1352; Prasad V, 2006, FREE RADICAL BIO MED, V41, P431, DOI 10.1016/j.freeradbiomed.2006.03.009; Ria F, 2001, BRIT J CANCER, V84, P529, DOI 10.1054/bjoc.2000.1594; Safra T, 2009, GYNECOL ONCOL, V114, P215, DOI 10.1016/j.ygyno.2009.04.008; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Su DM, 2009, MOL CANCER THER, V8, P1292, DOI 10.1158/1535-7163.MCT-08-1030; Tamm C, 2008, APOPTOSIS, V13, P354, DOI 10.1007/s10495-007-0172-7; Wang WQ, 2000, MOL CARCINOGEN, V28, P102; Wang XM, 2005, CELL PHYSIOL BIOCHEM, V16, P147, DOI 10.1159/000089840; Way TD, 2004, J BIOL CHEM, V279, P4479, DOI 10.1074/jbc.M305529200; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; WILLIAMS R, MINERALS HUMAN LIFE; Wilson CR, 2001, TOXICON, V39, P175, DOI 10.1016/S0041-0101(00)00146-X; Wrighton KH, 2009, NAT REV MOL CELL BIO, V10, P739, DOI 10.1038/nrm2788; Yu YS, 2009, J AGR FOOD CHEM, V57, P7673, DOI 10.1021/jf901327g; Zhang JM, 2005, J MASS SPECTROM, V40, P350, DOI 10.1002/jms.793; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030	51	89	94	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29169	10.1371/journal.pone.0029169	http://dx.doi.org/10.1371/journal.pone.0029169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216199	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600063
J	Cambien, B; Richard-Fiardo, P; Karimdjee, BF; Martini, V; Ferrua, B; Pitard, B; Schmid-Antomarchi, H; Schmid-Alliana, A				Cambien, Beatrice; Richard-Fiardo, Peggy; Karimdjee, Babou F.; Martini, Violette; Ferrua, Bernard; Pitard, Bruno; Schmid-Antomarchi, Heidy; Schmid-Alliana, Annie			CCL5 Neutralization Restricts Cancer Growth and Potentiates the Targeting of PDGFR beta in Colorectal Carcinoma	PLOS ONE			English	Article							FACTOR RECEPTOR; TUMOR STROMA; TYROSINE KINASES; CCR5 ANTAGONIST; GASTRIC-CANCER; RANTES LEVELS; EXPRESSION; BREAST; COLON; CELLS	Increased CCL5 levels are markers of an unfavourable outcome in patients with melanoma, breast, cervical, prostate, gastric or pancreatic cancer. Here, we have assessed the role played by CCL5/CCR5 interactions in the development of colon cancer. To do so, we have examined a number of human colorectal carcinoma clinical specimens and found CCL5 and its receptors over-expressed within primary as well as liver and pulmonary metastases of patients compared to healthy tissues. In vitro, CCL5 increased the growth and migratory responses of colon cancer cells from both human and mouse origins. In addition, systemic treatment of mice with CCL5-directed antibodies reduced the extent of development of subcutaneous colon tumors, of liver metastases and of peritoneal carcinosis. Consistently, we found increased numbers of CD45-immunoreactive cells within the stroma of the remaining lesions as well as at the interface with the healthy tissue. In contrast, selective targeting of CCR5 through administration of TAK-779, a CCR5 antagonist, only partially compromised colon cancer progression. Furthermore, CCL5 neutralization rendered the tumors more sensitive to a PDGFR beta-directed strategy in mice, this combination regimen offering the greatest protection against liver metastases and suppressing macroscopic peritoneal carcinosis. Collectively, our data demonstrate the involvement of CCL5 in the pathogenesis of colorectal carcinoma and point to its potential value as a therapeutic target.	[Cambien, Beatrice; Richard-Fiardo, Peggy; Karimdjee, Babou F.; Martini, Violette; Schmid-Antomarchi, Heidy; Schmid-Alliana, Annie] Univ Nice Sophia Antipolis, UFR Med, Nice, France; [Cambien, Beatrice; Richard-Fiardo, Peggy; Karimdjee, Babou F.; Martini, Violette; Schmid-Antomarchi, Heidy; Schmid-Alliana, Annie] Fac Med Nice, INSERM, UMR 576, F-06034 Nice, France; [Karimdjee, Babou F.] Clin St Jean, Cagnes Sur Mer, France; [Ferrua, Bernard] Fac Med Nice, INSERM, U895, F-06034 Nice, France; [Pitard, Bruno] INSERM, U915, Nantes, France; [Pitard, Bruno] In Cell Art, Nantes, France	UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm)	Cambien, B (corresponding author), Univ Nice Sophia Antipolis, UFR Med, Nice, France.	cambien@unice.fr	SCHMID-ALLIANA, Annie/P-4366-2016; Pitard, Bruno F/K-9270-2015; Cambien, Béatrice/AAD-8973-2021	SCHMID-ALLIANA, Annie/0000-0003-2321-7408; Cambien, Béatrice/0000-0002-6914-0525	Institut National de la Sante et de la Recherche Medicale; Association pour la Recherche sur le Cancer [3707]	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported in part by the Institut National de la Sante et de la Recherche Medicale and by the Association pour la Recherche sur le Cancer (Grant 3707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Bailey C, 2007, CLIN EXP METASTAS, V24, P121, DOI 10.1007/s10585-007-9060-3; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bhardwaj B, 1996, CLIN CANCER RES, V2, P773; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Cambien B, 2009, BRIT J CANCER, V100, P1755, DOI 10.1038/sj.bjc.6605078; Cany J, 2011, J HEPATOL, V54, P115, DOI 10.1016/j.jhep.2010.06.027; COLTRERA MD, 1995, CANCER RES, V55, P2703; De Jong KP, 1998, HEPATOLOGY, V28, P971, DOI 10.1002/hep.510280411; Duell EJ, 2006, CANCER EPIDEM BIOMAR, V15, P726, DOI 10.1158/1055-9965.EPI-05-0797; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Erreni M, 2009, METHOD ENZYMOL, V460, P105, DOI 10.1016/S0076-6879(09)05205-7; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; HEMMING AW, 1992, J SURG ONCOL, V51, P147, DOI 10.1002/jso.2930510304; Horst D, 2009, CANCER-AM CANCER SOC, V115, P4946, DOI 10.1002/cncr.24564; ITO M, 1990, VIRCHOWS ARCH B, V59, P173, DOI 10.1007/BF02899402; Kaplan CD, 2006, VACCINE, V24, P6994, DOI 10.1016/j.vaccine.2006.04.071; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kawai T, 1997, LAB INVEST, V77, P431; Kim HK, 2003, EUR J CANCER, V39, P184, DOI 10.1016/S0959-8049(02)00596-8; Kim R, 2005, CANCER-AM CANCER SOC, V103, P1800, DOI 10.1002/cncr.20973; Kitadai Y, 2006, AM J PATHOL, V169, P2054, DOI 10.2353/ajpath.2006.060653; Kuwai T, 2003, INT J CANCER, V105, P176, DOI 10.1002/ijc.11068; Kuwai T, 2008, CLIN EXP METASTAS, V25, P477, DOI 10.1007/s10585-008-9153-7; Luboshits G, 1999, CANCER RES, V59, P4681; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Marella M, 2004, J NEUROSCI, V24, P620, DOI 10.1523/JNEUROSCI.4303-03.2004; McIlroy D, 2009, MOL THER, V17, P1473, DOI 10.1038/mt.2009.84; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Ostman A, 2001, ADV CANCER RES, V80, P1, DOI 10.1016/S0065-230X(01)80010-5; Pradelli E, 2009, INT J CANCER, V125, P2586, DOI 10.1002/ijc.24665; Risau W, 1992, GROWTH FACTORS, V7, P261, DOI 10.3109/08977199209046408; Singer CF, 2004, ENDOCR-RELAT CANCER, V11, P861, DOI 10.1677/erc.1.00801; Sugasawa H, 2008, INT J CANCER, V122, P2535, DOI 10.1002/ijc.23401; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tsukishiro S, 2006, GYNECOL ONCOL, V102, P542, DOI 10.1016/j.ygyno.2006.01.029; Vaday GG, 2006, PROSTATE, V66, P124, DOI 10.1002/pros.20306; Vitale S, 2007, GUT, V56, P365, DOI 10.1136/gut.2005.088989; Wehler TC, 2008, ONCOL REP, V19, P697; Yaal-Hahoshen N, 2006, CLIN CANCER RES, V12, P4474, DOI 10.1158/1078-0432.CCR-06-0074; Zhang XP, 2010, BIOORG MED CHEM LETT, V20, P4627, DOI 10.1016/j.bmcl.2010.06.003	48	87	93	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28842	10.1371/journal.pone.0028842	http://dx.doi.org/10.1371/journal.pone.0028842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205974	gold, Green Published, Green Submitted			2022-12-25	WOS:000298666200012
J	Kodama, T; Togawa, T; Tsukimura, T; Kawashima, I; Matsuoka, K; Kitakaze, K; Tsuji, D; Itoh, K; Ishida, Y; Suzuki, M; Suzuki, T; Sakuraba, H				Kodama, Takashi; Togawa, Tadayasu; Tsukimura, Takahiro; Kawashima, Ikuo; Matsuoka, Kazuhiko; Kitakaze, Keisuke; Tsuji, Daisuke; Itoh, Kohji; Ishida, Yo-ichi; Suzuki, Minoru; Suzuki, Toshihiro; Sakuraba, Hitoshi			Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease	PLOS ONE			English	Article							GM2 GANGLIOSIDOSIS; JAPANESE PATIENT; INFANTILE; GENE; LYSOSPHINGOLIPIDS; ACCUMULATION; THERAPY; BRAIN; MODEL; MICE	To find a new biomarker of Tay-Sachs disease and Sandhoff disease. The lyso-GM2 ganglioside (lyso-GM2) levels in the brain and plasma in Sandhoff mice were measured by means of high performance liquid chromatography and the effect of a modified hexosaminidase (Hex) B exhibiting Hex A-like activity was examined. Then, the lyso-GM2 concentrations in human plasma samples were determined. The lyso-GM2 levels in the brain and plasma in Sandhoff mice were apparently increased compared with those in wild-type mice, and they decreased on intracerebroventricular administration of the modified Hex B. The lyso-GM2 levels in plasma of patients with Tay-Sachs disease and Sandhoff disease were increased, and the increase in lyso-GM2 was associated with a decrease in Hex A activity. Lyso-GM2 is expected to be a potential biomarker of Tay-Sachs disease and Sandhoff disease.	[Kodama, Takashi; Togawa, Tadayasu; Tsukimura, Takahiro; Suzuki, Toshihiro; Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Analyt Biochem, Tokyo, Japan; [Kawashima, Ikuo; Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan; [Kawashima, Ikuo] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Tokyo 113, Japan; [Matsuoka, Kazuhiko; Kitakaze, Keisuke; Tsuji, Daisuke; Itoh, Kohji] Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Med Res, Dept Med Biotechnol, Tokushima 770, Japan; [Ishida, Yo-ichi] Meiji Pharmaceut Univ, Dept Mol Biochem, Tokyo, Japan; [Suzuki, Minoru] RIKEN, Syst Glycobiol Res Grp, Dis Glyc Team, Saitama, Japan	Meiji Pharmaceutical University; Meiji Pharmaceutical University; Tokyo Metropolitan Institute of Medical Science; Tokushima University; Meiji Pharmaceutical University; RIKEN	Kodama, T (corresponding author), Meiji Pharmaceut Univ, Dept Analyt Biochem, Tokyo, Japan.	sakuraba@my-pharm.ac.jp	Kitakaze, Keisuke/AAL-4069-2020; Matsuoka, Kazuhiko/H-7750-2015; Tsuji, Daisuke/F-7085-2013	Kitakaze, Keisuke/0000-0002-4852-1257; Matsuoka, Kazuhiko/0000-0003-1502-8009; Tsuji, Daisuke/0000-0002-1528-7820; Matsuoka, Kazuhiko/0000-0001-8982-5399	Japan Society for the Promotion of Science [23659527, 21390314]; National Institute of Biomedical Innovation [09-15]; Program for Research on Intractable Diseases of Health and Labor Science Research Grants; JAPS Asia/Africa; Ministry of Education, Culture, Sports, Science and Technology of Japan [S0801043]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Program for Research on Intractable Diseases of Health and Labor Science Research Grants; JAPS Asia/Africa; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by grants from the Japan Society for the Promotion of Science (ID: 23659527 and 21390314, HS); the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (ID: 09-15, HS); the Program for Research on Intractable Diseases of Health and Labor Science Research Grants (HS); the JAPS Asia/Africa Scientific Platform Program (HS); and the High-Tech Research Center Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan (ID: S0801043, HS). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Cachon-Gonzalez MB, 2006, P NATL ACAD SCI USA, V103, P10373, DOI 10.1073/pnas.0603765103; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Hara A, 1998, J NEUROL SCI, V155, P86, DOI 10.1016/S0022-510X(97)00299-2; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Jeyakumar M, 2001, BLOOD, V97, P327, DOI 10.1182/blood.V97.1.327; KOBAYASHI T, 1991, BIOCHIM BIOPHYS ACTA, V1081, P159, DOI 10.1016/0005-2760(91)90021-9; KOBAYASHI T, 1992, J NEUROCHEM, V59, P1452, DOI 10.1111/j.1471-4159.1992.tb08460.x; KOBAYASHI T, 1988, ANN NEUROL, V24, P517, DOI 10.1002/ana.410240407; KOTANI M, 1992, BIOCHIM BIOPHYS ACTA, V1117, P97, DOI 10.1016/0304-4165(92)90168-T; KUROKI Y, 1995, BIOCHEM BIOPH RES CO, V212, P564, DOI 10.1006/bbrc.1995.2007; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Matsuoka K, 2011, MOL THER, V19, P1017, DOI 10.1038/mt.2011.27; Matsuoka K, 2010, MOL THER, V18, P1519, DOI 10.1038/mt.2010.113; NEUENHOFER S, 1986, BIOL CHEM H-S, V367, P241, DOI 10.1515/bchm3.1986.367.1.241; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; ROSENGREN B, 1987, J NEUROCHEM, V49, P834, DOI 10.1111/j.1471-4159.1987.tb00969.x; Sakuraba H, 1999, NEUROLOGY, V52, P372, DOI 10.1212/WNL.52.2.372; Shapiro BE, 2009, GENET MED, V11, P425, DOI 10.1097/GIM.0b013e3181a1b5c5; Sueyoshi N, 2001, J LIPID RES, V42, P1197; Togawa T, 2010, BIOCHEM BIOPH RES CO, V399, P716, DOI 10.1016/j.bbrc.2010.08.006; Togawa T, 2010, MOL GENET METAB, V100, P257, DOI 10.1016/j.ymgme.2010.03.020; Tsuji D, 2011, ANN NEUROL, V69, P691, DOI 10.1002/ana.22262	22	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e29074	10.1371/journal.pone.0029074	http://dx.doi.org/10.1371/journal.pone.0029074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205997	Green Submitted, Green Published, gold			2022-12-25	WOS:000298666200018
J	Faust, U; Hampe, N; Rubner, W; Kirchgessner, N; Safran, S; Hoffmann, B; Merkel, R				Faust, Uta; Hampe, Nico; Rubner, Wolfgang; Kirchgessner, Norbert; Safran, Sam; Hoffmann, Bernd; Merkel, Rudolf			Cyclic Stress at mHz Frequencies Aligns Fibroblasts in Direction of Zero Strain	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; FOCAL ADHESIONS; DYNAMIC REORIENTATION; MATRIX ADHESIONS; STEM-CELLS; STRETCH; ORIENTATION; FORCE; SUBSTRATE; FIBERS	Recognition of external mechanical signals is vital for mammalian cells. Cyclic stretch, e. g. around blood vessels, is one such signal that induces cell reorientation from parallel to almost perpendicular to the direction of stretch. Here, we present quantitative analyses of both, cell and cytoskeletal reorientation of umbilical cord fibroblasts. Cyclic strain of preset amplitudes was applied at mHz frequencies. Elastomeric chambers were specifically designed and characterized to distinguish between zero strain and minimal stress directions and to allow accurate theoretical modeling. Reorientation was only induced when the applied stretch exceeded a specific amplitude, suggesting a non-linear response. However, on very soft substrates no mechanoresponse occurs even for high strain. For all stretch amplitudes, the angular distributions of reoriented cells are in very good agreement with a theory modeling stretched cells as active force dipoles. Cyclic stretch increases the number of stress fibers and the coupling to adhesions. We show that changes in cell shape follow cytoskeletal reorientation with a significant temporal delay. Our data identify the importance of environmental stiffness for cell reorientation, here in direction of zero strain. These in vitro experiments on cultured cells argue for the necessity of rather stiff environmental conditions to induce cellular reorientation in mammalian tissues.	[Faust, Uta; Hampe, Nico; Rubner, Wolfgang; Kirchgessner, Norbert; Merkel, Rudolf] Forschungszentrum Julich, Inst Complex Syst, D-52425 Julich, Germany; [Safran, Sam; Hoffmann, Bernd] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel	Helmholtz Association; Research Center Julich; Weizmann Institute of Science	Faust, U (corresponding author), Forschungszentrum Julich, Inst Complex Syst, ICS 7, D-52425 Julich, Germany.	b.hoffmann@fz-juelich.de	Merkel, Rudolf/G-3647-2013; Safran, Samuel/K-1504-2012; Hoffmann, Bernd/I-7237-2013	Merkel, Rudolf/0000-0003-3178-3282; Safran, Samuel/0000-0002-0798-1492; Hampe, Nico/0000-0002-0316-3302; Hoffmann, Bernd/0000-0002-3803-8835	Isreal Science Foundation [54/08]	Isreal Science Foundation	The work by Samuel Safran was funded by a grant from the Isreal Science Foundation (grant number 54/08). The URL of the foundation is http://www.isf.org.il/english/. No further third party funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigun J., 1987, OPTIMAL ORIENTATION; Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100; Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; Cesa CM, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2712870; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Collinsworth AM, 2000, CELL TISSUE RES, V302, P243, DOI 10.1007/s004410000224; Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DARTSCH PC, 1986, ACTA ANAT, V125, P108; De R, 2008, BIOPHYS J, V94, pL29, DOI 10.1529/biophysj.107.126060; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; De R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031923; DELVOYE P, 1991, J INVEST DERMATOL, V97, P898, DOI 10.1111/1523-1747.ep12491651; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fereol S, 2008, RESP PHYSIOL NEUROBI, V163, P3, DOI 10.1016/j.resp.2008.04.018; Freyman TM, 2002, EXP CELL RES, V272, P153, DOI 10.1006/excr.2001.5408; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Hayakawa K, 2000, ZOOL SCI, V17, P617, DOI 10.2108/zsj.15.617; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Irgens F., 2008, CONTINUUM MECH; Jahne B., 2005, DIGITAL IMAGE PROCES; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Landau L. D., 1986, THEORETICAL PHYS, V7; Liu B, 2008, BIOPHYS J, V94, P1497, DOI 10.1529/biophysj.106.098574; Mark JE, 2007, RUBBERLIKE ELASTICITY: A MOLECULAR PRIMER, 2ND EDITION, P1, DOI 10.1017/CBO9780511541322; MCNEILL H, 1993, J CELL BIOL, V120, P1217, DOI 10.1083/jcb.120.5.1217; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Mohl CC, 2009, CELL MOTIL CYTOSKEL, V66, P350, DOI 10.1002/cm.20375; Naruse K, 1998, FEBS LETT, V441, P111, DOI 10.1016/S0014-5793(98)01528-2; Neidlinger-Wilke C, 2002, J ORTHOPAED RES, V20, P953, DOI 10.1016/S0736-0266(02)00024-4; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PEPPELENBOSCH MP, 1995, CELL, V81, P849, DOI 10.1016/0092-8674(95)90005-5; Popov E P, 1998, ENG MECH SOLIDS; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; Safran SA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.060901; Sai XR, 1999, J CELL SCI, V112, P1365; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Schwartz MA, 2001, J CELL SCI, V114, P2553; Schwarz US, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.048102; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; STAMENOVIC D, 1990, J APPL PHYSIOL, V69, P973, DOI 10.1152/jappl.1990.69.3.973; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6; Wang JHC, 2000, ANN BIOMED ENG, V28, P1165, DOI 10.1114/1.1317528; WHITE GE, 1983, J CELL BIOL, V97, P416, DOI 10.1083/jcb.97.2.416; WONG AJ, 1983, SCIENCE, V219, P867, DOI 10.1126/science.6681677; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Yoshigi M, 2003, CYTOM PART A, V55A, P109, DOI 10.1002/cyto.a.10076; Zamir E, 2001, J CELL SCI, V114, P3583; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264	69	101	102	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28963	10.1371/journal.pone.0028963	http://dx.doi.org/10.1371/journal.pone.0028963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194961	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400028
J	Rabang, CF; Bartlett, EL				Rabang, Cal F.; Bartlett, Edward L.			A Computational Model of Cellular Mechanisms of Temporal Coding in the Medial Geniculate Body (MGB)	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; THALAMIC NUCLEI ADJACENT; INFERIOR COLLICULUS; AUDITORY THALAMUS; RESPONSE PROPERTIES; SYNAPTIC PROPERTIES; ELECTROPHYSIOLOGICAL PROPERTIES; NEURAL REPRESENTATIONS; ELECTRICAL-STIMULATION; DISTINGUISHING DRIVERS	Acoustic stimuli are often represented in the early auditory pathway as patterns of neural activity synchronized to time-varying features. This phase-locking predominates until the level of the medial geniculate body (MGB), where previous studies have identified two main, largely segregated response types: Stimulus-synchronized responses faithfully preserve the temporal coding from its afferent inputs, and Non-synchronized responses, which are not phase locked to the inputs, represent changes in temporal modulation by a rate code. The cellular mechanisms underlying this transformation from phase-locked to rate code are not well understood. We use a computational model of a MGB thalamocortical neuron to test the hypothesis that these response classes arise from inferior colliculus (IC) excitatory afferents with divergent properties similar to those observed in brain slice studies. Large-conductance inputs exhibiting synaptic depression preserved input synchrony as short as 12.5 ms interclick intervals, while maintaining low firing rates and low-pass filtering responses. By contrast, small-conductance inputs with Mixed plasticity (depression of AMPA-receptor component and facilitation of NMDA-receptor component) desynchronized afferent inputs, generated a click-rate dependent increase in firing rate, and high-pass filtered the inputs. Synaptic inputs with facilitation often permitted band-pass synchrony along with band-pass rate tuning. These responses could be tuned by changes in membrane potential, strength of the NMDA component, and characteristics of synaptic plasticity. These results demonstrate how the same synchronized input spike trains from the inferior colliculus can be transformed into different representations of temporal modulation by divergent synaptic properties.	[Rabang, Cal F.; Bartlett, Edward L.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Bartlett, Edward L.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rabang, CF (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	ebartle@purdue.edu		Bartlett, Edward/0000-0002-9387-1854	National Science Foundation [0801119]; Deafness Research Foundation	National Science Foundation(National Science Foundation (NSF)); Deafness Research Foundation	This work was supported in part by National Science Foundation award #0801119 and funds from the Deafness Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Anderson LA, 2006, EUR J NEUROSCI, V24, P491, DOI 10.1111/j.1460-9568.2006.04930.x; Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Arsenault D, 2006, J PHYSIOL-LONDON, V573, P121, DOI 10.1113/jphysiol.2006.106542; Atzori M, 2001, NAT NEUROSCI, V4, P1230, DOI 10.1038/nn760; Bauerle P, 2011, J NEUROSCI, V31, P9708, DOI 10.1523/JNEUROSCI.5814-10.2011; Bartlett EL, 2007, J NEUROPHYSIOL, V97, P1005, DOI 10.1152/jn.00593.2006; Bartlett EL, 2011, J NEUROPHYSIOL, V105, P2647, DOI 10.1152/jn.00238.2010; Bartlett EL, 1999, J NEUROPHYSIOL, V81, P1999, DOI 10.1152/jn.1999.81.5.1999; Bartlett EL, 2002, NEUROSCIENCE, V113, P957, DOI 10.1016/S0306-4522(02)00240-3; Bartlett EL, 2000, NEUROSCIENCE, V100, P811, DOI 10.1016/S0306-4522(00)00340-7; BATRA R, 1989, J NEUROPHYSIOL, V61, P257, DOI 10.1152/jn.1989.61.2.257; Blitz DM, 2003, J NEUROPHYSIOL, V90, P2438, DOI 10.1152/jn.00562.2003; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; Brecht M, 2002, J PHYSIOL-LONDON, V538, P495, DOI 10.1113/jphysiol.2001.012334; Briska AM, 2003, EUR J NEUROSCI, V17, P1531, DOI 10.1046/j.1460-9568.2003.02579.x; CALFORD MB, 1983, J NEUROSCI, V3, P2350; Carnevale NT, 2006, NEURON BOOK; Castro-Alamancos MA, 2002, J NEUROPHYSIOL, V87, P946, DOI 10.1152/jn.00426.2001; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V539, P567, DOI 10.1113/jphysiol.2001.013283; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Deschenes M, 2003, J NEUROSCI, V23, P6778; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Donishi T, 2006, NEUROSCIENCE, V141, P1553, DOI 10.1016/j.neuroscience.2006.04.037; HEGGELUND P, 1990, J NEUROPHYSIOL, V63, P1347, DOI 10.1152/jn.1990.63.6.1347; HU B, 1994, J PHYSIOL-LONDON, V479, P217, DOI 10.1113/jphysiol.1994.sp020290; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1304, DOI 10.1152/jn.1991.66.4.1304; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; KALTWASSER MT, 1990, J COMP PSYCHOL, V104, P227, DOI 10.1037/0735-7036.104.3.227; Kammermeier PJ, 1998, J NEUROPHYSIOL, V79, P410, DOI 10.1152/jn.1998.79.1.410; Kimura A, 2003, NEUROSCIENCE, V117, P1003, DOI 10.1016/S0306-4522(02)00949-1; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255, DOI 10.1152/jn.2000.84.1.255; LANGNER G, 1988, J NEUROPHYSIOL, V60, P1799, DOI 10.1152/jn.1988.60.6.1799; Lee CC, 2008, J NEUROPHYSIOL, V100, P317, DOI 10.1152/jn.90391.2008; Lee CC, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.014.2010; Lee CC, 2010, P NATL ACAD SCI USA, V107, P372, DOI 10.1073/pnas.0907873107; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Lim HH, 2007, J NEUROSCI, V27, P8733, DOI 10.1523/JNEUROSCI.5127-06.2007; Llano DA, 2000, BIOL CYBERN, V83, P419, DOI 10.1007/s004220000174; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Lumani A, 2010, BRAIN RES, V1351, P115, DOI 10.1016/j.brainres.2010.06.066; Mardia K. V., 2000, DIRECTIONAL STAT; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Miyata M, 2006, J PHYSIOL-LONDON, V575, P161, DOI 10.1113/jphysiol.2006.114413; Neubig M., 2001, Thalamus & Related Systems, V1, P39, DOI 10.1016/S1472-9288(01)00005-X; Palombi PS, 2001, HEARING RES, V153, P174, DOI 10.1016/S0378-5955(00)00264-1; Parri HR, 1998, J PHYSIOL-LONDON, V506P, p150P; Philibert B, 2005, HEARING RES, V209, P97, DOI 10.1016/j.heares.2005.07.004; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; Rennaker RL, 2007, NEUROSCIENCE, V145, P357, DOI 10.1016/j.neuroscience.2006.11.043; RODRIGUESDAGAEFF C, 1989, HEARING RES, V39, P103, DOI 10.1016/0378-5955(89)90085-3; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; ROUILLER E, 1981, HEARING RES, V5, P81, DOI 10.1016/0378-5955(81)90028-9; ROUILLER E, 1982, EXP BRAIN RES, V48, P323, DOI 10.1007/BF00238607; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Sirota MG, 2005, J NEUROSCI, V25, P5915, DOI 10.1523/JNEUROSCI.0489-05.2005; Smith PH, 2006, J COMP NEUROL, V496, P314, DOI 10.1002/cne.20913; Smith PH, 2007, J NEUROPHYSIOL, V98, P681, DOI 10.1152/jn.00235.2007; Tennigkeit F, 1996, J NEUROPHYSIOL, V76, P3597, DOI 10.1152/jn.1996.76.6.3597; Varela JA, 1997, J NEUROSCI, V17, P7926; Vollmer M, 2005, J NEUROPHYSIOL, V93, P3339, DOI 10.1152/jn.00900.2004; Vollmer M, 1999, J NEUROPHYSIOL, V82, P2883, DOI 10.1152/jn.1999.82.6.2883; WALLENSTEIN GV, 1994, BIOPHYS J, V66, P978, DOI 10.1016/S0006-3495(94)80879-3; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; Wu SH, 2004, J NEUROSCI, V24, P4625, DOI 10.1523/JNEUROSCI.0318-04.2004; Yu YQ, 2004, J PHYSIOL-LONDON, V560, P191, DOI 10.1113/jphysiol.2004.067678; Zhang HM, 2003, J NEUROPHYSIOL, V90, P477, DOI 10.1152/jn.01084.2002; Zheng Y, 2008, J NEUROSCI, V28, P14230, DOI 10.1523/JNEUROSCI.2882-08.2008	72	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29375	10.1371/journal.pone.0029375	http://dx.doi.org/10.1371/journal.pone.0029375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195049	gold, Green Submitted, Green Published			2022-12-25	WOS:000298664400050
J	van Dis, I; Kromhout, D; Boer, JMA; Geleijnse, JM; Verschuren, WMM				van Dis, Ineke; Kromhout, Daan; Boer, Jolanda M. A.; Geleijnse, Johanna M.; Verschuren, W. M. Monique			Paternal and Maternal History of Myocardial Infarction and Cardiovascular Diseases Incidence in a Dutch Cohort of Middle-Aged Persons	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INDEPENDENT RISK-FACTOR; PARENTAL HISTORY; FAMILY-HISTORY; ARTERY DISEASE; FOLLOW-UP; SCORE; MEN; CALCIFICATION; CHOLESTEROL	Background: A positive parental history of myocardial infarction (MI) is an independent risk factor for cardiovascular diseases (CVD). However, different definitions of parental history have been used. We evaluated the impact of parental gender and age of onset of MI on CVD incidence. Methods: Baseline data were collected between 1993 and 1997 in 10 524 respondents aged 40-65 years. CVD events were obtained from the National Hospital Discharge Register and Statistics Netherlands. We used proportional hazard models to calculate hazard ratios (HR) and 95% confidence intervals (CI) for CVD incidence and adjusted for lifestyle and biological risk factors. Results: At baseline, 36% had a parental history of MI. During 10-year follow-up, 914 CVD events occurred. The age and gender adjusted HR was 1.3 (95% CI 1.1-1.5) for those with a paternal MI, 1.5 (1.2-1.8) for those with a maternal MI and 1.6 (1.2-2.2) for those with both parents with an MI. With decreasing parental age of MI, HR increased from 1.2 (1.0-1.6) for age >= 70 years to 1.5 (1.2-1.8) for age <60 years for a paternal MI and from 1.1 (0.9-1.5) to 2.2 (1.6-3.0) for a maternal MI. The impact of having a mother with MI before age 60 significantly differed in women [(2.9 (1.8-4.6)] and men [1.5 (0.9-2.6)]. Adjustment only slightly influenced HRs for maternal MI. Conclusions: Respondents with a parental history of MI have an increased CVD incidence, in particular with parental onset of MI before age 70. A maternal history of MI before age 60 was the strongest predictor of CVD incidence.	[van Dis, Ineke] Netherlands Heart Fdn, The Hague, Netherlands; [van Dis, Ineke; Kromhout, Daan; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [van Dis, Ineke; Boer, Jolanda M. A.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	van Dis, I (corresponding author), Netherlands Heart Fdn, The Hague, Netherlands.	i.van.dis@hartstichting.nl	Kromhout, Daan/A-8566-2014; Geleijnse, Johanna Marianna M/B-5749-2012	Geleijnse, Johanna Marianna M/0000-0001-7638-0589	Netherlands Heart Foundation; Ministry of Health, Welfare and Sport of the Netherlands; National Institute for Public Health and the Environment, Bilthoven, The Netherlands	Netherlands Heart Foundation(Netherlands Heart Foundation); Ministry of Health, Welfare and Sport of the Netherlands; National Institute for Public Health and the Environment, Bilthoven, The Netherlands(Netherlands Government)	Ineke van Dis was supported by the Netherlands Heart Foundation, but data were analyzed and reported independently from this organisation. The other authors report no financial disclosures. The Monitoring Project on Risk Factors and Chronic Diseases in the Netherlands (MORGEN) study was supported by the Ministry of Health, Welfare and Sport of the Netherlands, and the National Institute for Public Health and the Environment, Bilthoven, The Netherlands. The funders had no role in study design, data selection and analysis, decision to publish, or preparation of the manuscript.	Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; CAMBIEN F, 1980, REV EPIDEMIOL SANTE, V28, P21; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P48, DOI 10.1093/oxfordjournals.aje.a114223; COLDITZ GA, 1991, AM J CARDIOL, V67, P933, DOI 10.1016/0002-9149(91)90163-F; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; DEUTSCHER S, 1970, AM J EPIDEMIOL, V91, P233, DOI 10.1093/oxfordjournals.aje.a121133; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harteloh P, 2010, EUR J EPIDEMIOL, V25, P531, DOI 10.1007/s10654-010-9445-5; Hoevenaar-Blom MP, 2011, EUR J CARDIOV PREV R, V18, P41, DOI 10.1097/HJR.0b013e32833bfc87; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; Jousilahti P, 1996, J CLIN EPIDEMIOL, V49, P497, DOI 10.1016/0895-4356(95)00581-1; Jousilahti P, 1997, STROKE, V28, P1361, DOI 10.1161/01.STR.28.7.1361; KATTERMANN R, 1984, J CLIN CHEM CLIN BIO, V22, P245; KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528; Kinra S, 2003, HEART, V89, P834, DOI 10.1136/heart.89.8.834; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Mainous AG, 2007, AM J CARDIOL, V99, P1236, DOI 10.1016/j.amjcard.2006.12.035; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; MYERS RH, 1990, AM HEART J, V120, P963, DOI 10.1016/0002-8703(90)90216-K; Nasir K, 2007, CIRCULATION, V116, P619, DOI 10.1161/CIRCULATIONAHA.107.688739; NYBOE J, 1989, EUR HEART J, V10, P910, DOI 10.1093/oxfordjournals.eurheartj.a059401; Parikh NI, 2007, CIRCULATION, V116, P1473, DOI 10.1161/CIRCULATIONAHA.107.705202; PHILLIPS AN, 1988, EUR HEART J, V9, P243, DOI 10.1093/oxfordjournals.eurheartj.a062492; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rosengren A, 2002, J INTERN MED, V251, P258, DOI 10.1046/j.1365-2796.2002.00954.x; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; SHOLTZ RI, 1975, AM J EPIDEMIOL, V102, P350, DOI 10.1093/oxfordjournals.aje.a112171; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1133; van Dis I, 2009, EUR J CARDIOV PREV R, V16, P729, DOI 10.1097/HJR.0b013e328331dfc0; Watt G, 2000, J EPIDEMIOL COMMUN H, V54, P859, DOI 10.1136/jech.54.11.859; Wilhelmsen L, 2004, J INTERN MED, V256, P298, DOI 10.1111/j.1365-2796.2004.01372.x	33	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28697	10.1371/journal.pone.0028697	http://dx.doi.org/10.1371/journal.pone.0028697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194890	Green Published, gold, Green Submitted			2022-12-25	WOS:000298664400016
J	Capuano, M; Iaffaldano, L; Tinto, N; Montanaro, D; Capobianco, V; Izzo, V; Tucci, F; Troncone, G; Greco, L; Sacchetti, L				Capuano, Marina; Iaffaldano, Laura; Tinto, Nadia; Montanaro, Donatella; Capobianco, Valentina; Izzo, Valentina; Tucci, Francesca; Troncone, Giancarlo; Greco, Luigi; Sacchetti, Lucia			MicroRNA-449a Overexpression, Reduced NOTCH1 Signals and Scarce Goblet Cells Characterize the Small Intestine of Celiac Patients	PLOS ONE			English	Article							EPITHELIAL DIFFERENTIATION; GENE-EXPRESSION; DISEASE; PROLIFERATION; ACTIVATION; CHILDHOOD; PATHOLOGY; PATHWAY; TARGETS; BARRIER	MiRNAs play a relevant role in regulating gene expression in a variety of physiological and pathological conditions including autoimmune disorders. MiRNAs are also important in the differentiation and function of the mouse intestinal epithelium. Our study was aimed to look for miRNA-based modulation of gene expression in celiac small intestine, and particularly for genes involved in cell intestinal differentiation/proliferation mechanisms. A cohort of 40 children (20 with active CD, 9 on a gluten-free diet (GFD), and 11 controls), were recruited at the Paediatrics Department (University of Naples Federico II). The expression of 365 human miRNAs was quantified by TaqMan low-density arrays. We used bioinformatics to predict putative target genes of miRNAs and to select biological pathways. The presence of NOTCH1, HES1, KLF4, MUC-2, Ki67 and beta-catenin proteins in the small intestine of CD and control children was tested by immunohistochemistry. The expression of about 20% of the miRNAs tested differed between CD and control children. We found that high miR-449a levels targeted and reduced both NOTCH1 and KLF4 in HEK-293 cells. NOTCH1, KLF4 signals and the number of goblet cells were lower in small intestine of children with active CD and in those on a GFD than in controls, whereas more nuclear beta-catenin staining, as a sign of the WNT pathway activation, and more Ki67 staining, as sign of proliferation, were present in crypts from CD patients than in controls. In conclusion we first demonstrate a miRNA mediated gene regulation in small intestine of CD patients. We also highlighted a reduced NOTCH1 pathway in our patients, irrespective of whether the disease was active or not. We suggest that NOTCH pathway could be constitutively altered in the celiac small intestine and could drive the increased proliferation and the decreased differentiation of intestinal cells towards the secretory goblet cell lineage.	[Capuano, Marina; Iaffaldano, Laura; Tinto, Nadia; Montanaro, Donatella; Troncone, Giancarlo; Sacchetti, Lucia] SCARI, CEINGE Ctr Ingn Genet Adv Biotechnol, Naples, Italy; [Capuano, Marina; Iaffaldano, Laura; Tinto, Nadia; Sacchetti, Lucia] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy; [Capobianco, Valentina] Fdn IRCSS SDN, Ist Ric Diagnost Nucl, Ist Ricovero & Cura Carattere Sci, Naples, Italy; [Izzo, Valentina; Tucci, Francesca; Greco, Luigi] Univ Naples Federico II, Dept Paediat, Naples, Italy; [Izzo, Valentina; Tucci, Francesca; Greco, Luigi] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Troncone, Giancarlo] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Capuano, M (corresponding author), SCARI, CEINGE Ctr Ingn Genet Adv Biotechnol, Naples, Italy.	sacchett@unina.it	Iaffaldano, Laura/AAL-6083-2021; capuano, marina/GLT-0659-2022; Tucci, Francesca/AAB-2184-2022	Iaffaldano, Laura/0000-0001-7673-5503; Tucci, Francesca/0000-0001-8798-8987; Capobianco, Valentina/0000-0002-9161-1581	European community (PREVENT CD) [036383]	European community (PREVENT CD)	Study supported from European community (PREVENT CD project: EU-FP6-2005-FOOD4B-contract no. 036383). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciacci C, 2002, CLIN EXP IMMUNOL, V130, P526, DOI 10.1046/j.1365-2249.2002.02011.x; Ciccocioppo R, 2006, AM J CLIN PATHOL, V125, P502, DOI 10.1309/DTYRA91G8R0KTM8M; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Diosdado B, 2004, GUT, V53, P944, DOI 10.1136/gut.2003.018374; Festen Eleonora A. M., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P199; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624; Hunt KA, 2009, GUT, V58, P473, DOI 10.1136/gut.2008.155879; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Juuti-Uusitalo K, 2007, CLIN EXP IMMUNOL, V150, P294, DOI 10.1111/j.1365-2249.2007.03500.x; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pauley KM, 2008, ANN NY ACAD SCI, V1143, P226, DOI 10.1196/annals.1443.009; Sacchetti L, 1998, CLIN CHEM, V44, P1755; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yin L, 2010, BIOCHEM PHARMACOL, V80, P690, DOI 10.1016/j.bcp.2010.03.026; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	42	73	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29094	10.1371/journal.pone.0029094	http://dx.doi.org/10.1371/journal.pone.0029094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194996	Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400030
J	Innes-Brown, H; Marozeau, J; Blamey, P				Innes-Brown, Hamish; Marozeau, Jeremy; Blamey, Peter			The Effect of Visual Cues on Difficulty Ratings for Segregation of Musical Streams in Listeners with Impaired Hearing	PLOS ONE			English	Article							TONE SEQUENCES; MULTISENSORY INTEGRATION; TEMPORAL DISCRIMINATION; MELODY RECOGNITION; COCHLEAR IMPLANTS; NORMALLY HEARING; FREQUENCY; PERCEPTION; SPEECH; PITCH	Background: Enjoyment of music is an important part of life that may be degraded for people with hearing impairments, especially those using cochlear implants. The ability to follow separate lines of melody is an important factor in music appreciation. This ability relies on effective auditory streaming, which is much reduced in people with hearing impairment, contributing to difficulties in music appreciation. The aim of this study was to assess whether visual cues could reduce the subjective difficulty of segregating a melody from interleaved background notes in normally hearing listeners, those using hearing aids, and those using cochlear implants. Methodology/Principal Findings: Normally hearing listeners (N = 20), hearing aid users (N = 10), and cochlear implant users (N = 11) were asked to rate the difficulty of segregating a repeating four-note melody from random interleaved distracter notes. The pitch of the background notes was gradually increased or decreased throughout blocks, providing a range of difficulty from easy (with a large pitch separation between melody and distracter) to impossible (with the melody and distracter completely overlapping). Visual cues were provided on half the blocks, and difficulty ratings for blocks with and without visual cues were compared between groups. Visual cues reduced the subjective difficulty of extracting the melody from the distracter notes for normally hearing listeners and cochlear implant users, but not hearing aid users. Conclusion/Significance: Simple visual cues may improve the ability of cochlear implant users to segregate lines of music, thus potentially increasing their enjoyment of music. More research is needed to determine what type of acoustic cues to encode visually in order to optimise the benefits they may provide.	[Innes-Brown, Hamish; Marozeau, Jeremy; Blamey, Peter] Bionics Inst, Melbourne, Vic, Australia; [Blamey, Peter] Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia	Bionics Institute; University of Melbourne	Innes-Brown, H (corresponding author), Bionics Inst, Melbourne, Vic, Australia.	hinnes-brown@bionicsinstitute.org	Marozeau, Jeremy/L-2915-2019; Marozeau, Jeremy/AAA-1880-2021; Marozeau, Jeremy/E-9329-2017; Innes-Brown, Hamish/H-3298-2019	Marozeau, Jeremy/0000-0002-4505-135X; Innes-Brown, Hamish/0000-0002-1512-2823; Blamey, Peter/0000-0002-7579-2255	Jack Brockhoff Foundation; Goldman Sachs JBWere Foundation; Mr. Robert Albert AO RFD RD; Miss Betty Amsden OAM; Frederick and Winnifred Grassick Memorial Fund; Victorian Government	Jack Brockhoff Foundation; Goldman Sachs JBWere Foundation; Mr. Robert Albert AO RFD RD; Miss Betty Amsden OAM; Frederick and Winnifred Grassick Memorial Fund; Victorian Government	Financial support was provided by the Jack Brockhoff Foundation, Goldman Sachs JBWere Foundation, Mr. Robert Albert AO RFD RD, Miss Betty Amsden OAM, Bruce Parncutt and Robin Campbell, and The Frederick and Winnifred Grassick Memorial Fund. The Bionic Ear Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; ANSI, 2007, S342007 ANSI; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; BLAMEY P, 2010, HEARING AID BENEFIT; Boehnke SE, 2005, PERCEPT PSYCHOPHYS, V67, P1088, DOI 10.3758/BF03193634; Bregman A.S., 1994, AUDITORY SCENE ANAL; BROADBENT DE, 1959, J ACOUST SOC AM, V31, P1539, DOI 10.1121/1.1907662; Carlyon RP, 2003, PERCEPTION, V32, P1393, DOI 10.1068/p5035; Carlyon RP, 2001, J EXP PSYCHOL HUMAN, V27, P115, DOI 10.1037/0096-1523.27.1.115; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Chasin Marshall, 2004, Trends Amplif, V8, P35, DOI 10.1177/108471380400800202; Chatterjee M, 2006, HEARING RES, V222, P100, DOI 10.1016/j.heares.2006.09.001; Cooper HR, 2007, HEARING RES, V225, P11, DOI 10.1016/j.heares.2006.11.010; Cooper HR, 2009, J ACOUST SOC AM, V126, P1975, DOI 10.1121/1.3203210; Cusack R, 2004, J EXP PSYCHOL HUMAN, V30, P643, DOI 10.1037/0096-1523.30.4.643; Cusack R, 2000, PERCEPT PSYCHOPHYS, V62, P1112, DOI 10.3758/BF03212092; DELAAT JAPM, 1985, J ACOUST SOC AM, V78, P1574, DOI 10.1121/1.392794; Devergie A, 2011, J ACOUST SOC AM, V130, P283, DOI 10.1121/1.3592223; DOWLING WJ, 1973, COGNITIVE PSYCHOL, V5, P322, DOI 10.1016/0010-0285(73)90040-6; Fort A, 2002, COGNITIVE BRAIN RES, V14, P20, DOI 10.1016/S0926-6410(02)00058-7; GIELEN SCAM, 1983, PERCEPT PSYCHOPHYS, V34, P161, DOI 10.3758/BF03211343; Grant KW, 1998, J ACOUST SOC AM, V104, P2438, DOI 10.1121/1.423751; Grimault N, 2001, BRIT J AUDIOL, V35, P173, DOI 10.1080/00305364.2001.11745235; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; Hong RS, 2006, J ACOUST SOC AM, V120, P360, DOI 10.1121/1.2204450; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; Kochkin S., 2010, HEAR J, V63, P19, DOI [10.1097/01.HJ.0000366912.40173.76, DOI 10.1097/01.HJ.0000366912.40173.76]; Lovelace CT, 2003, COGNITIVE BRAIN RES, V17, P447, DOI 10.1016/S0926-6410(03)00160-5; Marozeau J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011297; McDermott HJ, 1997, J ACOUST SOC AM, V101, P1622, DOI 10.1121/1.418177; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Micheyl C, 2010, JARO-J ASSOC RES OTO, V11, P709, DOI 10.1007/s10162-010-0227-2; Moore BCJ, 2002, ACTA ACUST UNITED AC, V88, P320; Moore BCJ, 2005, SPR HDB AUD, V24, P234; Musacchia G, 2008, HEARING RES, V241, P34, DOI 10.1016/j.heares.2008.04.013; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Musacchia G, 2009, EAR HEARING, V30, P505, DOI 10.1097/AUD.0b013e3181a7f5b7; NELSON DA, 1995, J ACOUST SOC AM, V98, P1987, DOI 10.1121/1.413317; Odgaard EC, 2004, COGN AFFECT BEHAV NE, V4, P127, DOI 10.3758/CABN.4.2.127; Oxenham AJ, 2004, P NATL ACAD SCI USA, V101, P1421, DOI 10.1073/pnas.0306958101; Rahne T, 2007, BRAIN RES, V1144, P127, DOI 10.1016/j.brainres.2007.01.074; Roberts B, 2002, J ACOUST SOC AM, V112, P2074, DOI 10.1121/1.1508784; Rose MM, 2000, J ACOUST SOC AM, V108, P1209, DOI 10.1121/1.1287708; Rose MM, 1997, J ACOUST SOC AM, V102, P1768, DOI 10.1121/1.420108; Rose MM, 2005, HEARING RES, V204, P16, DOI 10.1016/j.heares.2004.12.004; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; Singh S, 2009, EAR HEARING, V30, P160, DOI 10.1097/AUD.0b013e31819342b9; Snyder JS, 2008, J EXP PSYCHOL HUMAN, V34, P1007, DOI 10.1037/0096-1523.34.4.1007; Snyder JS, 2009, PSYCHOPHYSIOLOGY, V46, P1208, DOI 10.1111/j.1469-8986.2009.00870.x; Stainsby TH, 2004, HEARING RES, V192, P119, DOI 10.1016/j.heares.2004.02.003; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; THOMPSON SK, 2011, J EXPT PSYCHOL HUMAN; TONG YC, 1982, J ACOUST SOC AM, V71, P153, DOI 10.1121/1.387342; TONG YC, 1983, SCIENCE, V219, P993, DOI 10.1126/science.6823564; Tremblay C, 2010, RESTOR NEUROL NEUROS, V28, P283, DOI 10.3233/RNN-2010-0498; van Noorden LPAS, 1975, TEMPORAL COHERENCE P; Vliegen J, 1999, J ACOUST SOC AM, V106, P938, DOI 10.1121/1.427140; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Zatorre RJ, 2001, NEURON, V31, P13, DOI 10.1016/S0896-6273(01)00347-6	61	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29327	10.1371/journal.pone.0029327	http://dx.doi.org/10.1371/journal.pone.0029327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195046	Green Published, gold			2022-12-25	WOS:000298370400050
J	Spijkers, LJA; Janssen, BJA; Nelissen, J; Meens, MJPMT; Wijesinghe, D; Chalfant, CE; De Mey, JGR; Alewijnse, AE; Peters, SLM				Spijkers, Leon J. A.; Janssen, Ben J. A.; Nelissen, Jelly; Meens, Merlijn J. P. M. T.; Wijesinghe, Dayanjan; Chalfant, Charles E.; De Mey, Jo G. R.; Alewijnse, Astrid E.; Peters, Stephan L. M.			Antihypertensive Treatment Differentially Affects Vascular Sphingolipid Biology in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL DYSFUNCTION; SPHINGOSINE 1-PHOSPHATE; ANGIOTENSIN-II; UP-REGULATION; CERAMIDE; KINASE; ACTIVATION; ARTERIES	Background: We have previously shown that essential hypertension in humans and spontaneously hypertensive rats (SHR), is associated with increased levels of ceramide and marked alterations in sphingolipid biology. Pharmacological elevation of ceramide in isolated carotid arteries of SHR leads to vasoconstriction via a calcium-independent phospholipase A(2), cyclooxygenase-1 and thromboxane synthase-dependent release of thromboxane A(2). This phenomenon is almost absent in vessels from normotensive Wistar Kyoto (WKY) rats. Here we investigated whether lowering of blood pressure can reverse elevated ceramide levels and reduce ceramide-mediated contractions in SHR. Methods and Findings: For this purpose SHR were treated for 4 weeks with the angiotensin II type 1 receptor antagonist losartan or the vasodilator hydralazine. Both drugs decreased blood pressure equally (SBP untreated SHR: 191 +/- 7 mmHg, losartan: 125 +/- 5 mmHg and hydralazine: 113 +/- 14 mmHg). The blood pressure lowering was associated with a 20-25% reduction in vascular ceramide levels and improved endothelial function of isolated carotid arteries in both groups. Interestingly, losartan, but not hydralazine treatment, markedly reduced sphingomyelinase-induced contractions. While both drugs lowered cyclooxygenase-1 expression, only losartan and not hydralazine, reduced the endothelial expression of calcium-independent phospholipase A(2). The latter finding may explain the effect of losartan treatment on sphingomyelinase-induced vascular contraction. Conclusion: In summary, this study corroborates the importance of sphingolipid biology in blood pressure control and specifically shows that blood pressure lowering reduces vascular ceramide levels in SHR and that losartan treatment, but not blood pressure lowering per se, reduces ceramide-mediated arterial contractions.	[Spijkers, Leon J. A.; Alewijnse, Astrid E.; Peters, Stephan L. M.] Univ Amsterdam, Acad Med Ctr, Dept Pharmacol & Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands; [Janssen, Ben J. A.; Nelissen, Jelly; Meens, Merlijn J. P. M. T.; De Mey, Jo G. R.] Maastricht Univ, Dept Pharmacol, Maastricht, Netherlands; [Wijesinghe, Dayanjan; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA USA	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Virginia Commonwealth University	Spijkers, LJA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pharmacol & Pharmacotherapy, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.l.peters@amc.uva.nl		De Mey, Jo G. R./0000-0001-6274-8071	Top Institute Pharma [T2-108]; Veteran's Administration (VA) [CDA1]; National Institutes of Health [HL072925, CA117950]; NATIONAL CANCER INSTITUTE [R01CA154314, R01CA117950] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER	Top Institute Pharma; Veteran's Administration (VA)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was performed within the framework of Top Institute Pharma project T2-108. CEC and DSW acknowledge support by grants from the Veteran's Administration (VA Merit Review I to CEC, a Research Career Scientist Award to CEC and a CDA1 to DSW), from the National Institutes of Health (HL072925) (CEC), CA117950 (CEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba S, 1999, J BIOL CHEM, V274, P19906, DOI 10.1074/jbc.274.28.19906; Aulakh GK, 2007, LIFE SCI, V81, P615, DOI 10.1016/j.lfs.2007.06.007; Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Boini KM, 2010, J PHARMACOL EXP THER, V334, P839, DOI 10.1124/jpet.110.168815; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523, DOI 10.1161/01.ATV.18.10.1523; Czarny M, 2004, AM J PHYSIOL-HEART C, V287, pH1344, DOI 10.1152/ajpheart.00222.2004; Dantas APV, 2003, AM J PHYSIOL-HEART C, V284, pH2045, DOI 10.1152/ajpheart.01089.2002; Demirci B, 2005, J HYPERTENS, V23, P2219, DOI 10.1097/01.hjh.0000191906.03983.ee; DOHI Y, 1994, J CARDIOVASC PHARM, V24, P372, DOI 10.1097/00005344-199409000-00004; Fenger M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-44; Gulbins E, 2003, PHARMACOL RES, V47, P393, DOI 10.1016/S1043-6618(03)00052-5; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hu ZP, 2010, INT HEART J, V51, P252, DOI 10.1536/ihj.51.252; Li P, 1998, J CARDIOVASC PHARM, V32, P198, DOI 10.1097/00005344-199808000-00005; Matsumoto T, 2010, PHARMACOL RES, V62, P271, DOI 10.1016/j.phrs.2010.03.003; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Modena MG, 2002, J AM COLL CARDIOL, V40, P505, DOI 10.1016/S0735-1097(02)01976-9; Mulders ACM, 2006, ARTERIOSCL THROM VAS, V26, P2043, DOI 10.1161/01.ATV.0000237569.95046.b9; Mulders ACM, 2009, BASIC RES CARDIOL, V104, P50, DOI 10.1007/s00395-008-0744-x; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Ruschitzka F, 1999, J CARDIOVASC PHARM, V34, pS3, DOI 10.1097/00005344-199906341-00002; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021817; Taddei S, 1998, CURR OPIN NEPHROL HY, V7, P203, DOI 10.1097/00041552-199803000-00010; TSCHUDI MR, 1994, CIRCULATION, V89, P2212, DOI 10.1161/01.CIR.89.5.2212; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Yogi A, 2011, HYPERTENSION, V57, P809, DOI 10.1161/HYPERTENSIONAHA.110.162719	31	25	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29222	10.1371/journal.pone.0029222	http://dx.doi.org/10.1371/journal.pone.0029222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195025	gold, Green Published, Green Submitted			2022-12-25	WOS:000298370400040
J	Krasileva, KV; Zheng, C; Leonelli, L; Goritschnig, S; Dahlbeck, D; Staskawicz, BJ				Krasileva, Ksenia V.; Zheng, Connie; Leonelli, Lauriebeth; Goritschnig, Sandra; Dahlbeck, Douglas; Staskawicz, Brian J.			Global Analysis of Arabidopsis/Downy Mildew Interactions Reveals Prevalence of Incomplete Resistance and Rapid Evolution of Pathogen Recognition	PLOS ONE			English	Article							HYALOPERONOSPORA-ARABIDOPSIDIS; PERONOSPORA-PARASITICA; ASSOCIATION; THALIANA; OOMYCETE; EFFECTOR; PROTEIN; LOCUS; ATR1	Interactions between Arabidopsis thaliana and its native obligate oomycete pathogen Hyaloperonospora arabidopsidis (Hpa) represent a model system to study evolution of natural variation in a host/pathogen interaction. Both Arabidopsis and Hpa genomes are sequenced and collections of different sub-species are available. We analyzed similar to 400 interactions between different Arabidopsis accessions and five strains of Hpa. We examined the pathogen's overall ability to reproduce on a given host, and performed detailed cytological staining to assay for pathogen growth and hypersensitive cell death response in the host. We demonstrate that intermediate levels of resistance are prevalent among Arabidopsis populations and correlate strongly with host developmental stage. In addition to looking at plant responses to challenge by whole pathogen inoculations, we investigated the Arabidopsis resistance attributed to recognition of the individual Hpa effectors, ATR1 and ATR13. Our results suggest that recognition of these effectors is evolutionarily dynamic and does not form a single clade in overall Arabidopsis phylogeny for either effector. Furthermore, we show that the ultimate outcome of the interactions can be modified by the pathogen, despite a defined gene-for-gene resistance in the host. These data indicate that the outcome of disease and disease resistance depends on genome-for-genome interactions between the host and its pathogen, rather than single gene pairs as thought previously.	[Krasileva, Ksenia V.; Zheng, Connie; Leonelli, Lauriebeth; Goritschnig, Sandra; Dahlbeck, Douglas; Staskawicz, Brian J.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Krasileva, KV (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	stask@berkeley.edu	Goritschnig, Sandra/AAC-6983-2020; Leonelli, Lauriebeth/GYU-8762-2022	Leonelli, Lauriebeth/0000-0001-7536-523X; Krasileva, Ksenia/0000-0002-1679-0700; Goritschnig, Sandra/0000-0001-6542-6297	National Science Foundation [NSF 2010 0726229]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant NSF 2010 0726229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2008, MOL PLANT PATHOL, V9, P511, DOI 10.1111/J.1364-3703.2008.00481.X; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bailey K, 2011, MOL PLANT MICROBE IN, V24, P827, DOI 10.1094/MPMI-12-10-0278; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bittner-Eddy PD, 2000, PLANT J, V21, P177, DOI 10.1046/j.1365-313x.2000.00664.x; Botella MA, 1998, PLANT CELL, V10, P1847, DOI 10.1105/tpc.10.11.1847; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Chou S, 2011, P NATL ACAD SCI USA, V108, P13323, DOI 10.1073/pnas.1109791108; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; Felsenstein J, 2005, PHILOS T R SOC B, V360, P1427, DOI 10.1098/rstb.2005.1669; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Hall SA, 2009, MOL PLANT PATHOL, V10, P449, DOI [10.1111/j.1364-3703.2009.00544.x, 10.1111/J.1364-3703.2009.00544.X]; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Holub EB, 2008, EUR J PLANT PATHOL, V122, P91, DOI 10.1007/s10658-008-9286-1; KATAGIRI F, 2002, ARABIDOPSIS BOOK, DOI DOI 10.1199/TAB.0039; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; McDowell JM, 2005, MOL PLANT MICROBE IN, V18, P1226, DOI 10.1094/MPMI-18-1226; Nemri A, 2010, P NATL ACAD SCI USA, V107, P10302, DOI 10.1073/pnas.0913160107; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rehmany AP, 2003, FUNGAL GENET BIOL, V38, P33, DOI 10.1016/S1087-1845(02)00515-7; Rentel MC, 2008, P NATL ACAD SCI USA, V105, P1091, DOI 10.1073/pnas.0711215105; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Thomas WJ, 2009, PLANT J, V60, P919, DOI 10.1111/j.1365-313X.2009.03998.x; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Van der Hoorn RAL, 2002, TRENDS PLANT SCI, V7, P67, DOI 10.1016/S1360-1385(01)02188-4; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037	34	21	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28765	10.1371/journal.pone.0028765	http://dx.doi.org/10.1371/journal.pone.0028765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194907	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100094
J	Li, QF; Tainsky, MA				Li, Qunfang; Tainsky, Michael A.			Epigenetic Silencing of IRF7 and/or IRF5 in Lung Cancer Cells Leads to Increased Sensitivity to Oncolytic Viruses	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; NEWCASTLE-DISEASE VIRUS; INTERFERON REGULATORY FACTORS; TUMOR-SPECIFIC DEFECTS; CELLULAR IMMORTALIZATION; EPITHELIAL-CELLS; DNA METHYLATION; IFN-BETA; INFECTION; EXPRESSION	Defective IFN signaling results in loss of innate immunity and sensitizes cells to enhanced cytolytic killing after Vesticular Stomatitis Virus (VSV) infection. Examination of the innate immunity status of normal human bronchial epithelial cells Beas2B and 7 lung cancer cells revealed that the abrogation of IFN signaling in cancer cells is associated with greater sensitivity to VSV infection. The disruption of the IFN pathway in lung cancer cell lines and primary tumor tissues is caused by epigenetic silencing of critical interferon responsive transcription factors IRF7 and/or IRF5. Although 5-aza-2'-deoxycytidine treatment fails to reactivate IRF7 and IRF5 expression or protect cells from VSV infection, manipulating IFN signaling by altering IRF expression changes the viral susceptibility of these cells. Lung cancer cells can be partially protected from viral killing using IRF5+IRF7 overexpression, whereas IFN pathway disruption by transfection of siRNAs to IRF5+IRF7 increases cells' vulnerability to viral infection. Therefore, IRF5 and IRF7 are key transcription factors in IFN pathway that determine viral sensitivity of lung cancer cells; the epigenetically impaired IFN pathway in lung cancer tissues provides potential biomarkers for successful selective killing of cancer cells by oncolytic viral therapy.	[Li, Qunfang; Tainsky, Michael A.] Barbara Ann Karmanos Canc Inst, Program Mol Biol & Genet, Detroit, MI USA; [Li, Qunfang; Tainsky, Michael A.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Li, QF (corresponding author), Barbara Ann Karmanos Canc Inst, Program Mol Biol & Genet, Detroit, MI USA.	tainskym@karmanos.org		Tainsky, Michael/0000-0002-0261-831X	Barbara and Fred Erb Endowed Chair in Cancer Genetics; Karmanos Cancer Institute; Molecular Medicine and Genetics Applied Genomics Technology Center at Wayne State University; Genomics and Biostatistics Cores of the Karmanos Cancer Institute [P30CA022453]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Barbara and Fred Erb Endowed Chair in Cancer Genetics; Karmanos Cancer Institute; Molecular Medicine and Genetics Applied Genomics Technology Center at Wayne State University; Genomics and Biostatistics Cores of the Karmanos Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Barbara and Fred Erb Endowed Chair in Cancer Genetics to Dr. Tainsky, funds from the Karmanos Cancer Institute, the Molecular Medicine and Genetics Applied Genomics Technology Center at Wayne State University, and the Genomics and Biostatistics Cores of the Karmanos Cancer Institute, P30CA022453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain T, 2010, P NATL ACAD SCI USA, V107, P1576, DOI 10.1073/pnas.0912344107; Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Do Jee C, 2009, EUR J CANCER, V45, P1282, DOI 10.1016/j.ejca.2008.12.027; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Fridman AL, 2006, J GERONTOL A-BIOL, V61, P879, DOI 10.1093/gerona/61.9.879; Fukasawa M, 2006, J HUM GENET, V51, P368, DOI 10.1007/s10038-005-0355-4; Hotte SJ, 2007, CLIN CANCER RES, V13, P977, DOI 10.1158/1078-0432.CCR-06-1817; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jaspers I, 2010, AM J RESP CELL MOL, V43, P368, DOI 10.1165/rcmb.2009-0254OC; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Kulaeva OI, 2003, ONCOGENE, V22, P4118, DOI 10.1038/sj.onc.1206594; Kumagai T, 2009, INT J CANCER, V124, P827, DOI 10.1002/ijc.23994; Li QF, 2008, MOL CANCER RES, V6, P770, DOI 10.1158/1541-7786.MCR-07-0114; Muster T, 2004, INT J CANCER, V110, P15, DOI 10.1002/ijc.20078; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Obuchi M, 2003, J VIROL, V77, P8843, DOI 10.1128/JVI.77.16.8843-8856.2003; Pecora AL, 2002, J CLIN ONCOL, V20, P2251, DOI 10.1200/JCO.2002.08.042; Picaud S, 2002, J INTERF CYTOK RES, V22, P457, DOI 10.1089/10799900252952244; Rowan K, 2010, J NATL CANCER I, V102, P590, DOI 10.1093/jnci/djq165; Sanceau J, 2000, ONCOGENE, V19, P3372, DOI 10.1038/sj.onc.1203670; Shin SH, 2010, J KOREAN MED SCI, V25, P1152, DOI 10.3346/jkms.2010.25.8.1152; Singal R, 2001, BLOOD, V98, P3441, DOI 10.1182/blood.V98.12.3441; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Uno K, 2007, J INTERF CYTOK RES, V27, P1013, DOI 10.1089/jir.2007.0047; Wilden H, 2009, INT J ONCOL, V34, P971, DOI 10.3892/ijo_00000223; Wollmann G, 2007, J VIROL, V81, P1479, DOI 10.1128/JVI.01861-06; Wong HH, 2010, VIRUSES-BASEL, V2, P78, DOI 10.3390/v2010078; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; Yamashita M, 2010, CANCER SCI, V101, P1708, DOI 10.1111/j.1349-7006.2010.01581.x; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177; Zamarin D, 2009, MOL THER, V17, P697, DOI 10.1038/mt.2008.286; Zhang KX, 2010, INT J CANCER, V127, P830, DOI 10.1002/ijc.25088	39	51	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28683	10.1371/journal.pone.0028683	http://dx.doi.org/10.1371/journal.pone.0028683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194884	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100077
J	Smit, JJ; Willemsen, K; Hassing, I; Fiechter, D; Storm, G; van Bloois, L; Leusen, JHW; Pennings, M; Zaiss, D; Pieters, RHH				Smit, Joost J.; Willemsen, Karina; Hassing, Ine; Fiechter, Danielle; Storm, Gert; van Bloois, Louis; Leusen, Jeanette H. W.; Pennings, Maarten; Zaiss, Dietmar; Pieters, Raymond H. H.			Contribution of Classic and Alternative Effector Pathways in Peanut-Induced Anaphylactic Responses	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; FOOD ALLERGY; MAST-CELLS; MICE; NEUTROPHILS; ANTIBODIES; MEDIATOR; MOUSE; PAF	Food allergy affects approximately 5% of children and is the leading cause of hospitalization for anaphylactic reactions in westernized countries. However, the pathways of anaphylaxis in food allergy are still relatively unknown. We investigated the effector pathways of allergic and anaphylactic responses of different strains of mice in a clinical relevant model of peanut allergy. C3H/HeOuJ, C57BL/6 and BALB/c mice were sensitized by intragastric peanut extract and challenged by intragastric or intraperitoneal injection of peanut. Peanut-specific T cell responses, IgE, IgG1 and IgG2a and mucosal mast cell degranulation were induced to different extent in C3H/HeOuJ, C57BL/6 and BALB/c mice. Interestingly, anaphylactic symptoms after systemic challenge were highest in C3H/HeOuJ followed by C57BL/6 but were absent in BALB/c mice. Mechanistic studies showed that the food allergic systemic anaphylaxis was dependent on platelets, FcR gamma and mast cells, and partially dependent on platelet activating factor and monocytes/macrophages, depending on mouse strain. These data demonstrate that in three mouse strains, components of the classic and alternative anaphylactic cascade are differently expressed, leading to differential outcomes in parameters of allergic disease and food induced systemic anaphylaxis.	[Smit, Joost J.; Willemsen, Karina; Hassing, Ine; Fiechter, Danielle; Pieters, Raymond H. H.] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Smit, Joost J.; Pennings, Maarten] Utrecht Ctr Food Allergy, Utrecht, Netherlands; [Storm, Gert; van Bloois, Louis] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Utrecht, Netherlands; [Leusen, Jeanette H. W.; Pennings, Maarten] Univ Utrecht, Med Ctr, Utrecht, Netherlands; [Zaiss, Dietmar] Univ Utrecht, Fac Vet Sci, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University	Smit, JJ (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.	j.j.smit@uu.nl	Storm, Gerrit/O-8696-2016; , Jeanette/AAG-3736-2019; Leusen, Jeanette/I-9010-2014	Zaiss, Dietmar M.W./0000-0003-3596-7062; Leusen, Jeanette/0000-0003-4982-6914; Smit, Joost/0000-0003-4612-4036				Arias K, 2011, J ALLERGY CLIN IMMUN, V127, P1552, DOI 10.1016/j.jaci.2011.03.044; Arias K, 2009, J ALLERGY CLIN IMMUN, V124, P307, DOI 10.1016/j.jaci.2009.03.012; Berin MC, 2009, MUCOSAL IMMUNOL, V2, P24, DOI 10.1038/mi.2008.72; Berin MC, 2006, ALLERGY, V61, P64, DOI 10.1111/j.1398-9995.2006.01012.x; BOLSCHOENMAKERS M, 2011, REGULATION INTESTINA, V66, P331; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Burks AW, 2008, LANCET, V371, P1538, DOI 10.1016/S0140-6736(08)60659-5; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Eigenmann PA, 2008, CLIN EXP IMMUNOL, V151, P546, DOI 10.1111/j.1365-2249.2007.03582.x; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Fujimi S, 2006, BLOOD, V107, P4399, DOI 10.1182/blood-2005-09-3776; Jonsson F, 2011, J CLIN INVEST, V121, P1484, DOI 10.1172/JCI45232; Karasuyama H., 2011, ANN REV IMMUNOL; Kasperska-Zajac A, 2008, INFLAMMATION, V31, P112, DOI 10.1007/s10753-007-9056-9; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Knoops L, 2005, J IMMUNOL, V175, P335, DOI 10.4049/jimmunol.175.1.335; Kumar V, 2010, MOL IMMUNOL, V48, P14, DOI 10.1016/j.molimm.2010.07.009; McManus LM, 2000, CRIT REV ORAL BIOL M, V11, P240, DOI 10.1177/10454411000110020701; MILLER HRP, 1988, IMMUNOLOGY, V65, P559; Morafo V, 2003, J ALLERGY CLIN IMMUN, V111, P1122, DOI 10.1067/mai.2003.1463; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; PARISH WE, 1970, LANCET, V2, P591; Ring Johannes, 2002, Curr Allergy Asthma Rep, V2, P40, DOI 10.1007/s11882-002-0036-8; Ross MP, 2008, J ALLERGY CLIN IMMUN, V121, P166, DOI 10.1016/j.jaci.2007.10.012; Rozemuller H, 2004, EXP HEMATOL, V32, P1118, DOI 10.1016/j.exphem.2004.08.002; Schouten B, 2008, INT ARCH ALLERGY IMM, V147, P125, DOI 10.1159/000135699; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Srivastava KD, 2009, J ALLERGY CLIN IMMUN, V123, P443, DOI 10.1016/j.jaci.2008.12.1107; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; STRAIT RT, 2011, J ALLERGY CLIN IMMUN; Sun JF, 2007, J IMMUNOL, V179, P6696, DOI 10.4049/jimmunol.179.10.6696; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; van Wijk F, 2005, J IMMUNOL, V174, P174, DOI 10.4049/jimmunol.174.1.174	34	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28917	10.1371/journal.pone.0028917	http://dx.doi.org/10.1371/journal.pone.0028917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194949	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100125
J	Ukil, A; Kar, S; Srivastav, S; Ghosh, K; Das, PK				Ukil, Anindita; Kar, Susanta; Srivastav, Supriya; Ghosh, Kuntal; Das, Pijush K.			Curative Effect of 18 beta-Glycyrrhetinic Acid in Experimental Visceral Leishmaniasis Depends on Phosphatase-Dependent Modulation of Cellular MAP Kinases	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE PRODUCTION; DONOVANI INFECTION; UP-REGULATION; MACROPHAGES; ACTIVATION; GLYCYRRHIZIN; EXPRESSION; SHP-1; INDUCTION	We earlier showed that 18 beta-glycyrrhetinic acid (GRA), a pentacyclic triterpenoid from licorice root, could completely cure visceral leishmaniasis in BALB/c mouse model. This was associated with induction of nitric oxide and proinflammatory cytokine production through the up regulation of NF-kappa B. In the present study we tried to decipher the underlying cellular mechanisms of the curative effect of GRA. Analysis of MAP kinase pathways revealed that GRA caused strong activation of p38 and to a lesser extent, ERK in bone marrow-derived macrophages (BMDM). Almost complete abrogation of GRA-induced cytokine production in presence of specific inhibitors of p38 and ERK1/2 confirmed the involvement of these MAP kinases in GRA-mediated responses. GRA induced mitogen-and stress-activated protein kinase (MSK1) activity in a time-dependent manner suggested that GRA-mediated NF-kappa B transactivation is mediated by p38, ERK and MSK1 pathway. As kinase/phosphatase balance plays an important role in modulating infection, the effect of GRA on MAPK directed phosphatases (MKP) was studied. GRA markedly reduced the expression and activities of three phosphatases, MKP1, MKP3 and protein phosphatase 2A (PP2A) along with a substantial reduction of p38 and ERK dephosphorylation in infected BMDM. Similarly in the in vivo situation, GRA treatment of L. donovani-infected BALB/c mice caused marked reduction of spleen parasite burden associated with concomitant decrease of individual phosphatase levels. However, activation of kinases also played an important role as the protective effect of GRA was significantly abrogated by pharmacological inhibition of p38 and ERK pathway. Curative effect of GRA may, therefore, be associated with restoration of proper cellular kinase/phosphatase balance, rather than modulation of either kinases or phosphatases.	[Ukil, Anindita; Ghosh, Kuntal] Univ Calcutta, Dept Biochem, Kolkata, India; [Kar, Susanta; Srivastav, Supriya; Das, Pijush K.] Indian Inst Chem Biol, Mol Cell Biol Lab, Infect Dis & Immunol Div, Kolkata, India	University of Calcutta; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ukil, A (corresponding author), Univ Calcutta, Dept Biochem, Kolkata, India.	pijushdas@iicb.res.in			Council of Scientific and Industrial Research, Government of India [SIP007, NWP 0038]; Department of Biotechnology, India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by the Network Project (NWP 0038), Supra Institutional Project (SIP007) grant of the Council of Scientific and Industrial Research, Government of India, and Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE N, 1982, MICROBIOL IMMUNOL, V26, P535, DOI 10.1111/j.1348-0421.1982.tb00207.x; Abu-Dayyeh I, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000305; Awasthi A, 2003, J EXP MED, V197, P1037, DOI 10.1084/jem.20022033; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Banerjee A, 2008, J IMMUNOL, V181, P1386, DOI 10.4049/jimmunol.181.2.1386; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Blanchette J, 2009, IMMUNOLOGY, V127, P123, DOI 10.1111/j.1365-2567.2008.02929.x; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; Chandra D, 2008, CLIN EXP IMMUNOL, V154, P224, DOI 10.1111/j.1365-2249.2008.03741.x; Chung WT, 2001, CYTOTECHNOLOGY, V37, P55, DOI 10.1023/A:1016111713056; Dai JH, 2001, IMMUNOLOGY, V103, P235, DOI 10.1046/j.1365-2567.2001.01224.x; Das L, 2001, J IMMUNOL, V166, P4020, DOI 10.4049/jimmunol.166.6.4020; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dey R, 2007, INFECT IMMUN, V75, P2136, DOI 10.1128/IAI.01589-06; Fiore C, 2005, J ETHNOPHARMACOL, V99, P317, DOI 10.1016/j.jep.2005.04.015; Forget G, 2005, EUR J IMMUNOL, V35, P1906, DOI 10.1002/eji.200526037; Forget G, 2006, INFECT IMMUN, V74, P6272, DOI 10.1128/IAI.00853-05; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Hawn TR, 2002, MICROBES INFECT, V4, P763, DOI 10.1016/S1286-4579(02)01596-4; Jeong HG, 2002, FEBS LETT, V513, P208, DOI 10.1016/S0014-5793(02)02311-6; Junghae M, 2002, INFECT IMMUN, V70, P5026, DOI 10.1128/IAI.70.9.5026-5035.2002; Kar S, 2010, J LEUKOCYTE BIOL, V88, P9, DOI 10.1189/jlb.0909644; Kar S, 2009, EUR J IMMUNOL, V39, P741, DOI 10.1002/eji.200838465; Klotz C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001248; KRAHENBUHL S, 1994, J CLIN ENDOCR METAB, V78, P581, DOI 10.1210/jc.78.3.581; Krishna MT, 2011, CLIN EXP IMMUNOL, V163, P131, DOI 10.1111/j.1365-2249.2010.04296.x; Lee SJ, 2010, J ALLERGY CLIN IMMUN, V125, pS314, DOI 10.1016/j.jaci.2009.08.018; Lee T, 2003, J CELL PHYSIOL, V194, P349, DOI 10.1002/jcp.10211; Mise-Omata S, 2009, J IMMUNOL, V182, P4910, DOI 10.4049/jimmunol.0800967; Moro T, 2008, LIFE SCI, V83, P531, DOI 10.1016/j.lfs.2008.07.023; Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237; Murray HW, 2008, INFECT IMMUN, V76, P4088, DOI 10.1128/IAI.00490-08; MURRAY HW, 1993, J IMMUNOL, V151, P929; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Phillips R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000813; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Prive C, 2000, EUR J IMMUNOL, V30, P2235, DOI 10.1002/1521-4141(2000)30:8&lt;2235::AID-IMMU2235&gt;3.0.CO;2-9; Rossi T, 2003, ANTICANCER RES, V23, P3813; SHARMA S, 1994, CANCER RES, V54, P5848; Takahashi H, 2004, J PHARM PHARMACOL, V56, P437, DOI 10.1211/0022357023132; Ukil A, 2005, J IMMUNOL, V175, P1161, DOI 10.4049/jimmunol.175.2.1161; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139	43	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29062	10.1371/journal.pone.0029062	http://dx.doi.org/10.1371/journal.pone.0029062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194991	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100150
J	Zuco, V; De Cesare, M; Cincinelli, R; Nannei, R; Pisano, C; Zaffaroni, N; Zunino, F				Zuco, Valentina; De Cesare, Michelandrea; Cincinelli, Raffaella; Nannei, Raffaella; Pisano, Claudio; Zaffaroni, Nadia; Zunino, Franco			Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; OVARIAN-CARCINOMA CELLS; RETINOID ST1926; STRAND BREAKS; TUMOR-CELLS; ACETYLATION; APOPTOSIS; DAMAGE; SENSITIZATION; TRANSCRIPTION	Preclinical studies support the therapeutic potential of histone deacetylases inhibitors (HDACi) in combination with taxanes. The efficacy of combination has been mainly ascribed to a cooperative effect on microtubule stabilization following tubulin acetylation. In the present study we investigated the effect of paclitaxel in combination with two novel HDACi, ST2782 or ST3595, able to induce p53 and tubulin hyperacetylation. A synergistic effect of the paclitaxel/ST2782 (or ST3595) combination was found in wild-type p53 ovarian carcinoma cells, but not in a p53 mutant subline, in spite of a marked tubulin acetylation. Such a synergistic interaction was confirmed in additional human solid tumor cell lines harboring wildtype p53 but not in those expressing mutant or null p53. In addition, a synergistic cytotoxic effect was found when ST2782 was combined with the depolymerising agent vinorelbine. In contrast to SAHA, which was substantially less effective in sensitizing cells to paclitaxel-induced apoptosis, ST2782 prevented up-regulation of p21(WAF1/Cip1) by paclitaxel, which has a protective role in response to taxanes, and caused p53 down-regulation, acetylation and mitochondrial localization of acetylated p53. The synergistic antitumor effects of the paclitaxel/ST3595 combination were confirmed in two tumor xenograft models. Our results support the relevance of p53 modulation as a major determinant of the synergistic interaction observed between paclitaxel and novel HDACi and emphasize the therapeutic interest of this combination.	[Zuco, Valentina; De Cesare, Michelandrea; Cincinelli, Raffaella; Zaffaroni, Nadia; Zunino, Franco] Ist Nazl Tumori, Fdn Ist Ricovero Cura Carattere Sci IRCCS, Mol Pharmacol Unit, I-20133 Milan, Italy; [Nannei, Raffaella] Univ Milan, Dipartimento Sci Mol Agroalimentari, Milan, Italy; [Pisano, Claudio] Sigma Tau Pharmaceut Co, Oncol Area Res & Dev, Pomezia, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; Leadiant Biosciences	Zuco, V (corresponding author), Ist Nazl Tumori, Fdn Ist Ricovero Cura Carattere Sci IRCCS, Mol Pharmacol Unit, Via Venezian 1, I-20133 Milan, Italy.	valentina.zuco@istitutotumori.mi.it	Zuco, Valentina/O-7262-2019; Zaffaroni, Nadia/J-8178-2016; De Cesare, Michelandrea/M-6667-2017	Zuco, Valentina/0000-0001-7882-9095; Zaffaroni, Nadia/0000-0002-4669-0890; De Cesare, Michelandrea/0000-0001-9687-0753; pisano, claudio/0000-0001-8624-2980	Associazione Italiana Ricerca sul Cancro, Milan; Fondazione Italo Monzino, Milan; Alleanza Contro Cancro, Rome, Italy	Associazione Italiana Ricerca sul Cancro, Milan(Fondazione AIRC per la ricerca sul cancro); Fondazione Italo Monzino, Milan; Alleanza Contro Cancro, Rome, Italy	This study was partially supported by the Associazione Italiana Ricerca sul Cancro, Milan, by the Fondazione Italo Monzino, Milan and by the Alleanza Contro Cancro, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2009, CANCER LETT, V280, P211, DOI 10.1016/j.canlet.2009.02.013; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Blagosklonny MV, 1997, CANCER RES, V57, P130; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bots M, 2009, CLIN CANCER RES, V15, P3970, DOI 10.1158/1078-0432.CCR-08-2786; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Cassinelli G, 2001, INT J CANCER, V92, P738, DOI 10.1002/1097-0215(20010601)92:5<738::AID-IJC1249>3.0.CO;2-2; Chen CS, 2007, CANCER RES, V67, P5318, DOI 10.1158/0008-5472.CAN-06-3996; Chinnaiyan P, 2008, CLIN CANCER RES, V14, P5410, DOI 10.1158/1078-0432.CCR-08-0643; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cooper AL, 2007, GYNECOL ONCOL, V104, P596, DOI 10.1016/j.ygyno.2006.09.011; Dallavalle S, 2009, EUR J MED CHEM, V44, P1900, DOI 10.1016/j.ejmech.2008.11.005; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dietrich CS, 2010, GYNECOL ONCOL, V116, P126, DOI 10.1016/j.ygyno.2009.09.039; Dowdy SC, 2006, MOL CANCER THER, V5, P2767, DOI 10.1158/1535-7163.MCT-06-0209; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Gatti L, 2002, CELL DEATH DIFFER, V9, P1352, DOI 10.1038/sj.cdd.4401109; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Johnstone RW, 2003, CANCER CELL, V4, P13, DOI 10.1016/S1535-6108(03)00165-X; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Kekatpure VD, 2009, J BIOL CHEM, V284, P7436, DOI 10.1074/jbc.M808999200; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lanzi C, 2001, PROSTATE, V48, P254, DOI 10.1002/pros.1105; Milli A, 2008, BBA-PROTEINS PROTEOM, V1784, P1702, DOI 10.1016/j.bbapap.2008.04.022; Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088; Munshi A, 2006, MOL CANCER THER, V5, P1967, DOI 10.1158/1535-7163.MCT-06-0022; Owonikoko TK, 2010, INT J CANCER, V126, P743, DOI 10.1002/ijc.24759; Perego P, 1998, ANN ONCOL, V9, P423, DOI 10.1023/A:1008265012435; Pisano C, 2007, ANN ONCOL, V18, P1500, DOI 10.1093/annonc/mdm195; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Rao R, 2008, BLOOD, V112, P1886, DOI 10.1182/blood-2008-03-143644; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Vaseva AV, 2009, CELL CYCLE, V8, P1711, DOI 10.4161/cc.8.11.8596; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813; Zuco V, 2005, NEOPLASIA, V7, P667, DOI 10.1593/neo.05127; Zuco V, 2004, CELL DEATH DIFFER, V11, P280, DOI 10.1038/sj.cdd.4401304; Zuco V, 2008, NEOPLASIA, V10, P587, DOI 10.1593/neo.08262; Zuco V, 2010, INT J CANCER, V126, P1246, DOI 10.1002/ijc.24819	43	48	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29085	10.1371/journal.pone.0029085	http://dx.doi.org/10.1371/journal.pone.0029085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194993	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100151
J	Zuo, DM; Yu, XF; Guo, CQ; Yi, HF; Chen, X; Conrad, DH; Guo, TL; Chen, ZL; Fisher, PB; Subjeck, JR; Wang, XY				Zuo, Daming; Yu, Xiaofei; Guo, Chunqing; Yi, Huanfa; Chen, Xing; Conrad, Daniel H.; Guo, Tai L.; Chen, Zhengliang; Fisher, Paul B.; Subjeck, John R.; Wang, Xiang-Yang			Molecular chaperoning by glucose-regulated protein 170 in the extracellular milieu promotes macrophage-mediated pathogen sensing and innate immunity	FASEB JOURNAL			English	Article						TLR9; endocytosis; CpG-ODN	HEAT-SHOCK PROTEINS; TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; ENDOPLASMIC-RETICULUM; BACTERIAL-DNA; LISTERIA-MONOCYTOGENES; HSP70 SUPERFAMILY; MAMMALIAN-CELLS; STRESS-PROTEINS; NITRIC-OXIDE	Recognition of pathogen-associated molecular patterns by innate immune receptors is essential for host defense responses. Although extracellular stress proteins are considered as indicators of the stressful conditions (e. g., infection or cell injury), the exact roles of these molecules in the extracellular milieu remain less defined. We found that glucose-regulated protein 170 (Grp170), the largest stress protein and molecular chaperone, is highly efficient in binding CpG oligodeoxynucleotides (CpG-ODN), the microbial DNA mimetic sensed by toll-like receptor 9 (TLR9). Extracellular Grp170 markedly potentiates the endocytosis and internalization of CpG-ODN by mouse bone marrow-derived macrophages and directly interacts with endosomal TLR9 on cell entry. These molecular collaborations result in the synergistic activation of the MyD88-dependent signaling and enhanced production of proinflammatory cytokines and nitric oxide in mouse primary macrophages as well as human THP-1 monocyte-derived macrophages, suggesting that Grp170 released from injured cells facilitates the sensing of pathogen-associated "danger" signals by intracellular receptors. This CpG-ODN chaperone complex-promoted innate immunity confers increased resistance in mice to infection of Listeria monocytogenes compared with CpG-ODN treatment alone. Our studies reveal a previously unrecognized attribute of Grp170 as a superior DNA-binding chaperone capable of amplifying TLR9 activation on pathogen recognition, which provides a conceptual advance in understanding the dynamics of ancient chaperoning functions inside and outside the cell.-Zuo, D., Yu, X., Guo, C., Yi, H., Chen, X., Conrad, D. H., Guo, T. L., Chen, Z., Fisher, P. B., Subjeck, J. R., Wang, X.-Y. Molecular chaperoning by glucose-regulated protein 170 in the extracellular milieu promotes macrophage-mediated pathogen sensing and innate immunity. FASEB J. 26, 1493-1505 (2012). www.fasebj.org	[Zuo, Daming; Yu, Xiaofei; Guo, Chunqing; Yi, Huanfa; Fisher, Paul B.; Wang, Xiang-Yang] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Conrad, Daniel H.] Virginia Commonwealth Univ, Sch Med, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Guo, Tai L.] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Zuo, Daming; Yu, Xiaofei; Guo, Chunqing; Yi, Huanfa; Fisher, Paul B.; Wang, Xiang-Yang] Virginia Commonwealth Univ, Sch Med, Inst Mol Med, Richmond, VA 23298 USA; [Zuo, Daming; Yu, Xiaofei; Guo, Chunqing; Yi, Huanfa; Fisher, Paul B.; Wang, Xiang-Yang] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA; [Zuo, Daming; Chen, Zhengliang] So Med Univ, Dept Immunol, Guangzhou, Guangdong, Peoples R China; [Chen, Xing; Subjeck, John R.] Roswell Pk Canc Inst, Dept Cellular Stress Biol, Buffalo, NY 14263 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Southern Medical University - China; Roswell Park Cancer Institute	Wang, XY (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, POB 980033, Richmond, VA 23298 USA.	xywang@vcu.edu	GUO, CHUNQING/F-4524-2014; Yu, Xiaofei/N-7860-2013; Zuo, Daming/AAO-8461-2021; Yu, Xiaofei/C-2893-2014	Yu, Xiaofei/0000-0003-3119-4920; Yu, Xiaofei/0000-0002-4944-1865; chen, zhengliang/0000-0002-2657-7970	U.S. National Institutes of Health (NIH) [CA-154708, CA-129111]; American Cancer Society; NIH [CA-099326, CA-097318, N01ES5538]; U.S. National Cancer Institute Cancer Center [P30 CA-16059]; NATIONAL CANCER INSTITUTE [P30CA016059, R01CA097318, R01CA129111, R01CA154708, R01CA099326] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Cancer Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by U.S. National Institutes of Health (NIH) grants CA-154708 and CA-129111 and an American Cancer Society Scholarship (to X.Y.W), NIH grant CA-099326 (to J.R.S), NIH grant CA-097318 (to P. B. F.), and NIH grant N01ES5538 and U.S. National Cancer Institute Cancer Center support grant P30 CA-16059 to Virginia Commonwealth University Massey Cancer Center. X.Y.W is a Harrison Endowed Scholar. P. B. F holds the Thelma New-meyer Corman Endowed Chair at the Virginia Commonwealth University Massey Cancer Center. Author contributions were as follows: D.Z. and X.Y.W. designed research; D.Z., X.Y., H.Y., C. G., X. C., D. H. C., and T. L. G. performed experiments; D.Z., D. H. C., T. L. G., P. B. F., J.R.S., and X.Y.W. analyzed data; X.Y. W., P. B. F., J.R.S., and D.Z. wrote the manuscript. The authors declare no competing financial interests.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Berwin B, 2001, J BIOL CHEM, V276, P21083, DOI 10.1074/jbc.M101836200; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Calderwood SK, 2007, ANN NY ACAD SCI, V1113, P28, DOI 10.1196/annals.1391.019; Clarke AR, 1996, CURR OPIN STRUC BIOL, V6, P43, DOI 10.1016/S0959-440X(96)80093-5; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Facciponte JG, 2007, EUR J IMMUNOL, V37, P2268, DOI 10.1002/eji.200737127; Gong JL, 2009, J IMMUNOL, V183, P3092, DOI 10.4049/jimmunol.0901235; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; HIGHTOWER LE, 1989, J CELL PHYSIOL, V138, P257, DOI 10.1002/jcp.1041380206; Ito S, 2005, INFECT IMMUN, V73, P3803, DOI 10.1128/IAI.73.6.3803-3805.2005; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 1998, J IMMUNOL, V161, P2428; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; Park JE, 2006, CANCER RES, V66, P1161, DOI 10.1158/0008-5472.CAN-05-2609; Prescott J, 2006, CANCER LETT, V231, P12, DOI 10.1016/j.canlet.2004.12.037; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; Spee P, 1999, BIOCHEMISTRY-US, V38, P10559, DOI 10.1021/bi990321r; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; SUBJECK JR, 1986, AM J PHYSIOL, V250, pC1, DOI 10.1152/ajpcell.1986.250.1.C1; Theriault JR, 2006, J IMMUNOL, V177, P8604, DOI 10.4049/jimmunol.177.12.8604; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Wang X.-Y., 2007, PROTEIN REV, V7; Wang XY, 2006, J IMMUNOL, V177, P1543, DOI 10.4049/jimmunol.177.3.1543; Wang XY, 2010, J IMMUNOL, V184, P6309, DOI 10.4049/jimmunol.0903891; Wang XY, 2003, CANCER RES, V63, P2553; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	48	15	15	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1493	1505		10.1096/fj.11-197707	http://dx.doi.org/10.1096/fj.11-197707			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22207611	Green Published			2022-12-25	WOS:000302359700012
J	Arnosti, C; Steen, AD; Ziervogel, K; Ghobrial, S; Jeffrey, WH				Arnosti, Carol; Steen, Andrew D.; Ziervogel, Kai; Ghobrial, Sherif; Jeffrey, Wade H.			Latitudinal Gradients in Degradation of Marine Dissolved Organic Carbon	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; ENZYME-ACTIVITIES; DIVERSITY; BACTERIAL; PATTERNS; MATTER; ASSEMBLAGES; HYDROLYSIS; ABUNDANCE; PACIFIC	Heterotrophic microbial communities cycle nearly half of net primary productivity in the ocean, and play a particularly important role in transformations of dissolved organic carbon (DOC). The specific means by which these communities mediate the transformations of organic carbon are largely unknown, since the vast majority of marine bacteria have not been isolated in culture, and most measurements of DOC degradation rates have focused on uptake and metabolism of either bulk DOC or of simple model compounds (e. g. specific amino acids or sugars). Genomic investigations provide information about the potential capabilities of organisms and communities but not the extent to which such potential is expressed. We tested directly the capabilities of heterotrophic microbial communities in surface ocean waters at 32 stations spanning latitudes from 76 degrees S to 79 degrees N to hydrolyze a range of high molecular weight organic substrates and thereby initiate organic matter degradation. These data demonstrate the existence of a latitudinal gradient in the range of complex substrates available to heterotrophic microbial communities, paralleling the global gradient in bacterial species richness. As changing climate increasingly affects the marine environment, changes in the spectrum of substrates accessible by microbial communities may lead to shifts in the location and rate at which marine DOC is respired. Since the inventory of DOC in the ocean is comparable in magnitude to the atmospheric CO2 reservoir, such a change could profoundly affect the global carbon cycle.	[Arnosti, Carol; Steen, Andrew D.; Ziervogel, Kai; Ghobrial, Sherif] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Jeffrey, Wade H.] Univ W Florida, Ctr Environm Diagnost & Bioremediat, Pensacola, FL 32514 USA	University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of West Florida	Arnosti, C (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA.	arnosti@email.unc.edu		Steen, Andrew/0000-0003-4297-4332; Ziervogel, Kai/0000-0002-4734-1369	National Science Foundation; EPA; Deutsche Forschungsgemeinschaft; Directorate For Geosciences [0848703] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); EPA(United States Environmental Protection Agency); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation (Dr. Arnosti, Dr. Jeffrey), EPA Graduate Fellowship (Dr. Steen), and the Deutsche Forschungsgemeinschaft Postdoctoral Fellowship (Dr. Ziervogel). The authors are also grateful to the Max-Planck Institute for Marine Microbiology (Bremen) for supporting the work on Svalbard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderkamp AC, 2007, FEMS MICROBIOL ECOL, V59, P108, DOI 10.1111/j.1574-6941.2006.00219.x; Amon RMW, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P83; Arnosti C, 1996, ORG GEOCHEM, V25, P105, DOI 10.1016/S0146-6380(96)00112-X; Arnosti C, 2004, MAR CHEM, V92, P263, DOI 10.1016/j.marchem.2004.06.030; Arnosti C, 2005, AQUAT MICROB ECOL, V38, P135, DOI 10.3354/ame038135; Arnosti C, 2003, J CHROMATOGR B, V793, P181, DOI 10.1016/S1570-0232(03)00375-1; Arnosti C, 2008, FEMS MICROBIOL ECOL, V66, P343, DOI 10.1111/j.1574-6941.2008.00587.x; Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; Arrieta JM, 2002, LIMNOL OCEANOGR, V47, P594, DOI 10.4319/lo.2002.47.2.0594; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Baldwin AJ, 2005, AQUAT MICROB ECOL, V41, P91, DOI 10.3354/ame041091; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; BAUER JE, 1992, NATURE, V357, P667, DOI 10.1038/357667a0; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Benner R, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002398; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; Benner R., 2002, BIOGEOCHEMISTRY MARI, P5990, DOI DOI 10.1016/B978-012323841-2/50005-1; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carlson C., 2002, BIOGEOCHEMISTRY MARI, P91, DOI DOI 10.1016/B978-012323841-2/50006-3; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; Elifantz H, 2008, FEMS MICROBIOL ECOL, V63, P316, DOI 10.1111/j.1574-6941.2007.00429.x; Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Goldberg SJ, 2010, MAR CHEM, V119, P9, DOI 10.1016/j.marchem.2009.12.002; Hansell DA, 2002, BIOGEOCHEMISTRY DISS; Hedges J. I., 2002, BIOGEOCHEMISTRY MARI, P1, DOI DOI 10.1016/B978-012323841-2/50003-8; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Kan JJ, 2006, LIMNOL OCEANOGR, V51, P2157, DOI 10.4319/lo.2006.51.5.2157; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Malmstrom RR, 2007, AQUAT MICROB ECOL, V47, P45, DOI 10.3354/ame047045; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McCarren J, 2010, PNAS; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Painter T.J., 1983, POLYSACCHARIDES, P196, DOI DOI 10.1016/B978-0-12-065602-8.50009-1; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Steen AD, 2010, ORG GEOCHEM, V41, P1019, DOI 10.1016/j.orggeochem.2010.05.012; Stein R, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P315; Stocker TF, 2005, NATURE, V434, P830, DOI 10.1038/434830a; Vezina AF, 2008, MAR ECOL PROG SER, V373, P199, DOI 10.3354/meps07868; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Wietz M, 2010, AQUAT MICROB ECOL, V61, P179, DOI 10.3354/ame01443	53	64	65	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28900	10.1371/journal.pone.0028900	http://dx.doi.org/10.1371/journal.pone.0028900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216139	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300016
J	Roberts, AC; Reichl, J; Song, MY; Dearinger, AD; Moridzadeh, N; Lu, ED; Pearce, K; Esdin, J; Glanzman, DL				Roberts, Adam C.; Reichl, Jun; Song, Monica Y.; Dearinger, Amanda D.; Moridzadeh, Naseem; Lu, Elaine D.; Pearce, Kaycey; Esdin, Joseph; Glanzman, David L.			Habituation of the C-Start Response in Larval Zebrafish Exhibits Several Distinct Phases and Sensitivity to NMDA Receptor Blockade	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MAUTHNER CELL; BEHAVIORAL-CHARACTERISTICS; ELECTRICAL SYNAPSE; NEURONAL CIRCUITS; ESCAPE BEHAVIOR; NEURAL CIRCUITS; MIXED SYNAPSES; MEMORY; SYSTEM	The zebrafish larva has been a valuable model system for genetic and molecular studies of development. More recently, biologists have begun to exploit the surprisingly rich behavioral repertoire of zebrafish larvae to investigate behavior. One prominent behavior exhibited by zebrafish early in development is a rapid escape reflex (the C-start). This reflex is mediated by a relatively simple neural circuit, and is therefore an attractive model behavior for neurobiological investigations of simple forms of learning and memory. Here, we describe two forms of short-lived habituation of the C-start in response to brief pulses of auditory stimuli. A rapid form, persisting for >= 1 min but <15 min, was induced by 120 pulses delivered at 0.5-2.0 Hz. A more extended form (termed "short-term habituation" here), which persisted for >= 25 min but <1 h, was induced by spaced training. The spaced training consisted of 10 blocks of auditory pulses delivered at 1 Hz (5 min interblock interval, 900 pulses per block). We found that these two temporally distinguishable forms of habituation are mediated by different cellular mechanisms. The short-term form depends on activation of N-methyl-D-aspartate receptors (NMDARs), whereas the rapid form does not.	[Roberts, Adam C.; Dearinger, Amanda D.; Pearce, Kaycey; Esdin, Joseph; Glanzman, David L.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Reichl, Jun; Song, Monica Y.; Lu, Elaine D.] Univ Calif Los Angeles, Undergrad Interdept Neurosci Program, Los Angeles, CA USA; [Moridzadeh, Naseem] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Glanzman, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Glanzman, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Roberts, AC (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	dglanzman@physci.ucla.edu		Song, Monica/0000-0002-3320-5550; Roberts, Adam/0000-0001-8596-8552	National Science Foundation [0923143]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (0923143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg M, 2011, J NEUROSCI, V31, P8708, DOI 10.1523/JNEUROSCI.6565-10.2011; BAUX G, 1978, P NATL ACAD SCI USA, V75, P4577, DOI 10.1073/pnas.75.9.4577; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Best JD, 2008, NEUROPSYCHOPHARMACOL, V33, P1206, DOI 10.1038/sj.npp.1301489; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; COLE BJ, 1993, PSYCHOPHARMACOLOGY, V111, P465, DOI 10.1007/BF02253537; Davis RC, 1934, J EXP PSYCHOL, V17, P504, DOI 10.1037/h0074305; DEVRIES SH, 1989, J PHYSIOL-LONDON, V414, P351, DOI 10.1113/jphysiol.1989.sp017692; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Dzeban D A, 2004, Neurosci Behav Physiol, V34, P627, DOI 10.1023/B:NEAB.0000028296.59664.df; EATON RC, 1977, J NEUROBIOL, V8, P151, DOI 10.1002/neu.480080207; Ezzeddine Y, 2003, J NEUROSCI, V23, P9585; Fetcho JR, 2008, BRAIN RES REV, V57, P86, DOI 10.1016/j.brainresrev.2007.06.018; Fetcho JR, 2004, CURR OPIN NEUROBIOL, V14, P707, DOI 10.1016/j.conb.2004.10.008; Fetcho JR, 1998, ANN NY ACAD SCI, V860, P333, DOI 10.1111/j.1749-6632.1998.tb09060.x; Fetcho JR, 1997, CURR OPIN NEUROBIOL, V7, P832, DOI 10.1016/S0959-4388(97)80143-2; FRICKE RA, 1984, BRAIN RES, V322, P139, DOI 10.1016/0006-8993(84)91193-4; Friedrich RW, 2010, CURR BIOL, V20, pR371, DOI 10.1016/j.cub.2010.02.039; Glanzman DL, 2009, NEUROBIOL LEARN MEM, V92, P147, DOI 10.1016/j.nlm.2009.03.005; Goldsmith P, 2004, CURR OPIN PHARMACOL, V4, P504, DOI 10.1016/j.coph.2004.04.005; Guo S, 2004, GENES BRAIN BEHAV, V3, P63, DOI 10.1046/j.1601-183X.2003.00053.x; Hatta K, 1998, J COMP NEUROL, V395, P493; Issa FA, 2011, J EXP BIOL, V214, P1028, DOI 10.1242/jeb.048876; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; KIMMEL CB, 1990, NEURON, V4, P535, DOI 10.1016/0896-6273(90)90111-R; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; KORN H, 1975, J NEUROPHYSIOL, V38, P452, DOI 10.1152/jn.1975.38.2.452; Lekven AC, 2000, PHYSIOL GENOMICS, V2, P37, DOI 10.1152/physiolgenomics.2000.2.2.37; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Miklosi A, 2006, ZEBRAFISH, V3, P227, DOI 10.1089/zeb.2006.3.227; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Oda Y, 1998, NATURE, V394, P182, DOI 10.1038/28172; ODA Y, 1995, J NEUROPHYSIOL, V74, P1056, DOI 10.1152/jn.1995.74.3.1056; Pereda A, 2003, J NEUROSCI, V23, P7489; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; RAYPORT SG, 1980, J NEUROPHYSIOL, V44, P555, DOI 10.1152/jn.1980.44.3.555; Rose JK, 2002, LEARN MEMORY, V9, P130, DOI 10.1101/lm.46802; RUSHFORTH NB, 1965, AM ZOOL, V5, P505; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Takahashi M, 2002, J NEUROSCI, V22, P3929, DOI 10.1523/JNEUROSCI.22-10-03929.2002; Tanimoto M, 2009, J NEUROSCI, V29, P2762, DOI 10.1523/JNEUROSCI.5530-08.2009; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Thompson RF, 2009, NEUROBIOL LEARN MEM, V92, P127, DOI 10.1016/j.nlm.2008.07.011; Wang Y, 1997, J NEUROPHYSIOL, V78, P439, DOI 10.1152/jn.1997.78.1.439; Weiss SA, 2008, P NATL ACAD SCI USA, V105, P18047, DOI 10.1073/pnas.0806145105; Wolman MA, 2011, P NATL ACAD SCI USA, V108, P15468, DOI 10.1073/pnas.1107156108; YANG XD, 1990, NATURE, V348, P542, DOI 10.1038/348542a0; YANG XD, 1991, P NATL ACAD SCI USA, V88, P4299, DOI 10.1073/pnas.88.10.4299; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; Zhu PX, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.021.2009	57	42	42	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29132	10.1371/journal.pone.0029132	http://dx.doi.org/10.1371/journal.pone.0029132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216183	gold, Green Published, Green Submitted			2022-12-25	WOS:000300676300029
J	Kho, MF; Bellier, A; Balasubramani, V; Hu, Y; Hsu, WN; Nielsen-LeRoux, C; McGillivray, SM; Nizet, V; Aroian, RV				Kho, Melanie F.; Bellier, Audrey; Balasubramani, Venkatasamy; Hu, Yan; Hsu, Wayne; Nielsen-LeRoux, Christina; McGillivray, Shauna M.; Nizet, Victor; Aroian, Raffi V.			The Pore-Forming Protein Cry5B Elicits the Pathogenicity of Bacillus sp against Caenorhabditis elegans	PLOS ONE			English	Article							VIRULENCE FACTORS; THURINGIENSIS; CEREUS; ANTHRACIS; TOXIN; RESISTANCE; MODEL; HOST; IDENTIFICATION; GERMINATION	The soil bacterium Bacillus thuringiensis is a pathogen of insects and nematodes and is very closely related to, if not the same species as, Bacillus cereus and Bacillus anthracis. The defining characteristic of B. thuringiensis that sets it apart from B. cereus and B. anthracis is the production of crystal (Cry) proteins, which are pore-forming toxins or pore-forming proteins (PFPs). Although it is known that PFPs are important virulence factors since their elimination results in reduced virulence of many pathogenic bacteria, the functions by which PFPs promote virulence are incompletely understood. Here we study the effect of Cry proteins in B. thuringiensis pathogenesis of the nematode Caenorhabditis elegans. We find that whereas B. thuringiensis on its own is not able to infect C. elegans, the addition of the PFP Cry protein, Cry5B, results in a robust lethal infection that consumes the nematode host in 1-2 days, leading to a "Bob'' or bag-of-bacteria phenotype. Unlike other infections of C. elegans characterized to date, the infection by B. thuringiensis shows dose-dependency based on bacterial inoculum size and based on PFP concentration. Although the infection process takes 1-2 days, the PFP-instigated infection process is irreversibly established within 15 minutes of initial exposure. Remarkably, treatment of C. elegans with Cry5B PFP is able to instigate many other Bacillus species, including B. anthracis and even "non-pathogenic'' Bacillus subtilis, to become lethal and infectious agents to C. elegans. Co-culturing of Cry5B-expressing B. thuringiensis with B. anthracis can result in lethal infection of C. elegans by B. anthracis. Our data demonstrate that one potential property of PFPs is to sensitize the host to bacterial infection and further that C. elegans and probably other roundworms can be common hosts for B. cereus-group bacteria, findings with important ecological and research implications.	[Kho, Melanie F.; Bellier, Audrey; Balasubramani, Venkatasamy; Hu, Yan; Hsu, Wayne; Aroian, Raffi V.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [McGillivray, Shauna M.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Nielsen-LeRoux, Christina] INRA, UMR MICALIS 1319, Guyancourt, France; [McGillivray, Shauna M.] Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; INRAE; Texas Christian University	Kho, MF (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	raroian@ucsd.edu	Hu, Yan/A-3299-2013; Nizet, Victor/AAF-3190-2019; McGillivray, Shauna/AAN-3074-2021; Nielsen-Leroux, Christina/GRS-3334-2022; bellier, audrey/D-7649-2015	McGillivray, Shauna/0000-0002-8863-1522; bellier, audrey/0000-0002-3106-4547; Nizet, Victor/0000-0003-3847-0422; Venkatasamy, Balasubramani/0000-0001-6797-3016	National Institutes of Health [NIAID R01 AI056189, NIAID R21 AI065993]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065993, R01AI056189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this project was provided by National Institutes of Health grants to RVA (NIAID R01 AI056189) and to RVA/VN (NIAID R21 AI065993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; Blackburn JK, 2010, J WILDLIFE DIS, V46, P918, DOI 10.7589/0090-3558-46.3.918; BORGONIE G, 1995, J INVERTEBR PATHOL, V65, P61, DOI 10.1006/jipa.1995.1008; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Cappello M, 2006, P NATL ACAD SCI USA, V103, P15154, DOI 10.1073/pnas.0607002103; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Fedhila S, 2010, J INVERTEBR PATHOL, V103, P24, DOI 10.1016/j.jip.2009.09.005; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Griffitts JS, 2005, BIOESSAYS, V27, P614, DOI 10.1002/bies.20239; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hu Y, 2010, P NATL ACAD SCI USA, V107, P5955, DOI 10.1073/pnas.0912327107; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Los FCO, 2011, CELL HOST MICROBE, V9, P147, DOI 10.1016/j.chom.2011.01.005; Marroquin LD, 2000, GENETICS, V155, P1693; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Regoes RR, 2002, P ROY SOC B-BIOL SCI, V269, P271, DOI 10.1098/rspb.2001.1816; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schuch R, 2010, APPL ENVIRON MICROB, V76, P2286, DOI 10.1128/AEM.02518-09; Schulenburg H, 2004, PARASITOLOGY, V128, P433, DOI 10.1017/S003118200300461X; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Steichen CT, 2007, MOL MICROBIOL, V64, P359, DOI 10.1111/j.1365-2958.2007.05658.x; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029	39	36	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29122	10.1371/journal.pone.0029122	http://dx.doi.org/10.1371/journal.pone.0029122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216181	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700031
J	Ponnapalli, SP; Saunders, MA; Van Loan, CF; Alter, O				Ponnapalli, Sri Priya; Saunders, Michael A.; Van Loan, Charles F.; Alter, Orly			A Higher-Order Generalized Singular Value Decomposition for Comparison of Global mRNA Expression from Multiple Organisms	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; DNA MICROARRAY DATA; CELL-CYCLE; FISSION YEAST; INTEGRATIVE ANALYSIS; GENE-EXPRESSION; PHASE; IDENTIFICATION; TRANSCRIPTION; REPLICATION	The number of high-dimensional datasets recording multiple aspects of a single phenomenon is increasing in many areas of science, accompanied by a need for mathematical frameworks that can compare multiple large-scale matrices with different row dimensions. The only such framework to date, the generalized singular value decomposition (GSVD), is limited to two matrices. We mathematically define a higher-order GSVD (HO GSVD) for N >= 2 matrices D-i is an element of R-mi x n, each with full column rank. Each matrix is exactly factored as Di = U-i Sigma V-i(T), where V, identical in all factorizations, is obtained from the eigensystem SV = V Lambda of the arithmetic mean S of all pairwise quotients A(i)A(j)(-1) of the matrices A(i) = D-i(T) D-u i not equal j. We prove that this decomposition extends to higher orders almost all of the mathematical properties of the GSVD. The matrix S is nondefective with V and L real. Its eigenvalues satisfy lambda(k) >= 1. Equality holds if and only if the corresponding eigenvector v(k) is a right basis vector of equal significance in all matrices D-i and D-j, that is sigma(i,k)/sigma(j,k) = 1 for all i and j, and the corresponding left basis vector u(i), k is orthogonal to all other vectors in U-i for all i. The eigenvalues lambda(k) = 1, therefore, define the "common HO GSVD subspace." We illustrate the HO GSVD with a comparison of genome-scale cell-cycle mRNA expression from S. pombe, S. cerevisiae and human. Unlike existing algorithms, a mapping among the genes of these disparate organisms is not required. We find that the approximately common HO GSVD subspace represents the cell-cycle mRNA expression oscillations, which are similar among the datasets. Simultaneous reconstruction in the common subspace, therefore, removes the experimental artifacts, which are dissimilar, from the datasets. In the simultaneous sequence-independent classification of the genes of the three organisms in this common subspace, genes of highly conserved sequences but significantly different cell-cycle peak times are correctly classified.	[Ponnapalli, Sri Priya] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA; [Saunders, Michael A.] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Van Loan, Charles F.] Cornell Univ, Dept Comp Sci, Ithaca, NY 14853 USA; [Alter, Orly] Univ Utah, Sci Comp & Imaging SCI Inst, Salt Lake City, UT USA; [Alter, Orly] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Alter, Orly] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	University of Texas System; University of Texas Austin; Stanford University; Cornell University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ponnapalli, SP (corresponding author), Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA.	orly@sci.utah.edu	Saunders, Michael A/D-1083-2012	Saunders, Michael/0000-0003-3800-4982; Alter, Orly/0000-0002-0418-1078	Office of Naval Research [N00014-02-1-0076]; National Science Foundation [DMS-1016284, DMS-0847173]; Utah Science Technology and Research (USTAR) Initiative, National Human Genome Research Institute [HG-004302]; Direct For Mathematical & Physical Scien [0847173] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004302] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Utah Science Technology and Research (USTAR) Initiative, National Human Genome Research Institute; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by Office of Naval Research Grant N00014-02-1-0076 (to MAS), National Science Foundation Grant DMS-1016284 (to CFVL), as well as the Utah Science Technology and Research (USTAR) Initiative, National Human Genome Research Institute R01 Grant HG-004302 and National Science Foundation CAREER Award DMS-0847173 (to OA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2005, P NATL ACAD SCI USA, V102, P17559, DOI 10.1073/pnas.0509033102; Alter O, 2004, P NATL ACAD SCI USA, V101, P16577, DOI 10.1073/pnas.0406767101; Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Alter O, 2006, P NATL ACAD SCI USA, V103, P16063, DOI 10.1073/pnas.0607650103; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu MT, 1997, SIAM J MATRIX ANAL A, V18, P1082, DOI 10.1137/S0895479895287079; De Lathauwer L, 2000, SIAM J MATRIX ANAL A, V21, P1253, DOI 10.1137/S0895479896305696; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Gauthier NP, 2010, NUCLEIC ACIDS RES, V38, pD699, DOI 10.1093/nar/gkp1044; Golub GH., 2013, MATRIX COMPUTATIONS; Hlavacek O, 2009, FEBS LETT, V583, P1107, DOI 10.1016/j.febslet.2009.02.030; Horn RA., 1985, MATRIX ANAL; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; LEE KS, 1994, J BIOL CHEM, V269, P19725; Lu Y, 2009, BIOINFORMATICS, V25, P1476, DOI 10.1093/bioinformatics/btp247; Mahe Y, 1996, MOL MICROBIOL, V20, P109, DOI 10.1111/j.1365-2958.1996.tb02493.x; Mamnun YM, 2004, FEBS LETT, V559, P111, DOI 10.1016/S0014-5793(04)00046-8; Martin-Castellanos C, 1996, EMBO J, V15, P839, DOI 10.1002/j.1460-2075.1996.tb00419.x; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Olkin, 1990, AEQUATIONES MATH, V40, P89, DOI DOI 10.1007/BF02112284; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Omberg L, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.70; PAIGE CC, 1981, SIAM J NUMER ANAL, V18, P398, DOI 10.1137/0718026; PAIGE CC, 1985, LINEAR ALGEBRA APPL, V70, P269, DOI 10.1016/0024-3795(85)90059-X; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rao C.R, 1973, LINEAR STAT INFERENC, V2; Rao C.R, 1984, WG COCHRANS IMPACT S, P191; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vandewalle J., 2003, P ECCTD 03 EUR C CIR, P389; VANLOAN CF, 1976, SIAM J NUMER ANAL, V13, P76, DOI 10.1137/0713009; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wolfger H, 1997, FEBS LETT, V418, P269, DOI 10.1016/S0014-5793(97)01382-3	39	72	73	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28072	10.1371/journal.pone.0028072	http://dx.doi.org/10.1371/journal.pone.0028072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216090	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700003
J	Rotstein, B; Molnar, D; Adryan, B; Llimargas, M				Rotstein, Barbara; Molnar, David; Adryan, Boris; Llimargas, Marta			Tramtrack Is Genetically Upstream of Genes Controlling Tracheal Tube Size in Drosophila	PLOS ONE			English	Article							DAUGHTER CELL FATES; BRANCHING MORPHOGENESIS; NOTCH; REPRESSION; EXPRESSION; FUSION; PROTEIN; SYSTEM; ACTIVATION; DIVISION	The Drosophila transcription factor Tramtrack (Ttk) is involved in a wide range of developmental decisions, ranging from early embryonic patterning to differentiation processes in organogenesis. Given the wide spectrum of functions and pleiotropic effects that hinder a comprehensive characterisation, many of the tissue specific functions of this transcription factor are only poorly understood. We recently discovered multiple roles of Ttk in the development of the tracheal system on the morphogenetic level. Here, we sought to identify some of the underlying genetic components that are responsible for the tracheal phenotypes of Ttk mutants. We therefore profiled gene expression changes after Ttk loss-and gain-of-function in whole embryos and cell populations enriched for tracheal cells. The analysis of the transcriptomes revealed widespread changes in gene expression. Interestingly, one of the most prominent gene classes that showed significant opposing responses to loss-and gain-of-function was annotated with functions in chitin metabolism, along with additional genes that are linked to cellular responses, which are impaired in ttk mutants. The expression changes of these genes were validated by quantitative real-time PCR and further functional analysis of these candidate genes and other genes also expected to control tracheal tube size revealed at least a partial explanation of Ttk's role in tube size regulation. The computational analysis of our tissue-specific gene expression data highlighted the sensitivity of the approach and revealed an interesting set of novel putatively tracheal genes.	[Rotstein, Barbara; Llimargas, Marta] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain; [Molnar, David; Adryan, Boris] Univ Cambridge, Dept Genet, Cambridge Syst Biol Ctr, Cambridge CB2 3EH, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Cambridge	Rotstein, B (corresponding author), CSIC, Inst Biol Mol Barcelona, Barcelona, Spain.	adryan@sysbiol.cam.ac.uk; mlcbmc@ibmb.csic.es		Adryan, Boris/0000-0003-4588-7867	German National Merit Foundation; Royal Society URF; Wellcome Trust [087522/Z/08/Z]; Programme Consolider [CSD2007-00008]; Ministerio de Educacion y Ciencia [BFU2009-09041/BMC, PIE200720I019]; Agaur [2009-SGR 1333]	German National Merit Foundation; Royal Society URF(Royal Society of London); Wellcome Trust(Wellcome Trust); Programme Consolider; Ministerio de Educacion y Ciencia(Spanish Government); Agaur(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	DM was supported by a scholarship from the German National Merit Foundation. BA is a Royal Society URF and acknowledges Wellcome Trust grant support (087522/Z/08/Z) that contributed to this project. BR is supported by funds from the Programme Consolider 2007(CSD2007-00008) project. ML acknowledges funds from the Ministerio de Educacion y Ciencia (BFU2009-09041/BMC, PIE200720I019), from Agaur (2009-SGR 1333) and from the Programme Consolider 2007(CSD2007-00008) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althauser C, 2005, DEV DYNAM, V232, P1013, DOI 10.1002/dvdy.20361; Araujo SJ, 2007, DEVELOPMENT, V134, P3665, DOI 10.1242/dev.007328; Audibert A, 2005, DEVELOPMENT, V132, P2287, DOI 10.1242/dev.01797; Badenhorst P, 2001, DEVELOPMENT, V128, P4093; Baonza A, 2002, NAT CELL BIOL, V4, P976, DOI 10.1038/ncb887; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bauer DC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-366; Boyle MJ, 2009, DEVELOPMENT, V136, P4187, DOI 10.1242/dev.042770; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodu V, 2010, DEV CELL, V18, P790, DOI [10.1016/j.devcel.2010.03.015, 10.1016/j.devce1.2010.03.015]; BROWN JL, 1991, EMBO J, V10, P665, DOI 10.1002/j.1460-2075.1991.tb07995.x; BROWN JL, 1993, DEVELOPMENT, V117, P45; Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008; Cela C, 2006, DEVELOPMENT, V133, P3115, DOI 10.1242/dev.02482; Chen YJ, 2002, MECH DEVELOP, V116, P75, DOI 10.1016/S0925-4773(02)00143-0; Choi WS, 2011, MOL BIOL CELL, V22, P2010, DOI 10.1091/mbc.E10-12-1014; Chung S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000746; French RL, 2003, DEV BIOL, V253, P18, DOI 10.1006/dbio.2002.0856; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gervais L, 2010, CURR BIOL, V20, P359, DOI 10.1016/j.cub.2009.12.043; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; Ikeya T, 1999, DEVELOPMENT, V126, P4455; Jiang L, 2007, DEV BIOL, V311, P487, DOI 10.1016/j.ydbio.2007.08.049; Jiang L, 2010, MECH DEVELOP, V127, P265, DOI 10.1016/j.mod.2010.03.003; Jordan KC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-16; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; Lai ZC, 1999, GENETICS, V152, P299; Laprise P, 2010, CURR BIOL, V20, P55, DOI 10.1016/j.cub.2009.11.017; Lee M, 2003, DEVELOPMENT, V130, P5989, DOI 10.1242/dev.00806; Llimargas M, 1999, DEVELOPMENT, V126, P2355; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Massarwa R, 2009, DEV CELL, V16, P877, DOI 10.1016/j.devcel.2009.04.010; Mourikis P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-107; Ohshiro T, 1997, DEVELOPMENT, V124, P3975; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; Reddy BA, 2010, MOL CELL BIOL, V30, P5234, DOI 10.1128/MCB.00266-10; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016; Siddall NA, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-64; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4; Steneberg P, 1998, GENE DEV, V12, P956, DOI 10.1101/gad.12.7.956; Sun JJ, 2008, J CELL BIOL, V182, P885, DOI 10.1083/jcb.200802084; Swanson LE, 2006, CURR BIOL, V16, pR51, DOI 10.1016/j.cub.2006.01.008; TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Wang PL, 2002, BIOINFORMATICS, V18, P488, DOI 10.1093/bioinformatics/18.3.488; Ward EJ, 2006, DEV BIOL, V297, P461, DOI 10.1016/j.ydbio.2006.05.021; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008	57	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28985	10.1371/journal.pone.0028985	http://dx.doi.org/10.1371/journal.pone.0028985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216153	Green Published, gold			2022-12-25	WOS:000299684700022
J	Girard-Misguich, F; Cognie, J; Delgado-Ortega, M; Berthon, P; Rossignol, C; Larcher, T; Melo, S; Bruel, T; Guibon, R; Cherel, Y; Sarradin, P; Salmon, H; Guillen, N; Meurens, F				Girard-Misguich, Fabienne; Cognie, Juliette; Delgado-Ortega, Mario; Berthon, Patricia; Rossignol, Christelle; Larcher, Thibaut; Melo, Sandrine; Bruel, Timothee; Guibon, Roseline; Cherel, Yan; Sarradin, Pierre; Salmon, Henri; Guillen, Nancy; Meurens, Francois			Towards the Establishment of a Porcine Model to Study Human Amebiasis	PLOS ONE			English	Article							ENTAMOEBA-HISTOLYTICA INFECTION; PAPUA-NEW-GUINEA; INTESTINAL PROTOZOA; TREPONEMA-HYODYSENTERIAE; MERIONES-UNGUICULATUS; EPITHELIAL-CELLS; MOUSE MODEL; IN-VIVO; PATHOGENESIS; POLECKI	Background: Entamoeba histolytica is an important parasite of the human intestine. Its life cycle is monoxenous with two stages: (i) the trophozoite, growing in the intestine and (ii) the cyst corresponding to the dissemination stage. The trophozoite in the intestine can live as a commensal leading to asymptomatic infection or as a tissue invasive form producing mucosal ulcers and liver abscesses. There is no animal model mimicking the whole disease cycle. Most of the biological information on E. histolytica has been obtained from trophozoite adapted to axenic culture. The reproduction of intestinal amebiasis in an animal model is difficult while for liver amebiasis there are well-described rodent models. During this study, we worked on the assessment of pigs as a new potential model to study amebiasis. Methodology/Principal Findings: We first co-cultured trophozoites of E. histolytica with porcine colonic fragments and observed a disruption of the mucosal architecture. Then, we showed that outbred pigs can be used to reproduce some lesions associated with human amebiasis. A detailed analysis was performed using a washed closed-jejunal loops model. In loops inoculated with virulent amebas a severe acute ulcerative jejunitis was observed with large hemorrhagic lesions 14 days post-inoculation associated with the presence of the trophozoites in the depth of the mucosa in two out four animals. Furthermore, typical large sized hepatic abscesses were observed in the liver of one animal 7 days post-injection in the portal vein and the liver parenchyma. Conclusions: The pig model could help with simultaneously studying intestinal and extraintestinal lesion development.	[Girard-Misguich, Fabienne; Guillen, Nancy] Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France; [Girard-Misguich, Fabienne; Guillen, Nancy] INSERM, U786, Paris, France; [Girard-Misguich, Fabienne] Univ Versailles St Quentin En Yvelines, Dept Biol, Versailles, France; [Cognie, Juliette] INRA, UMR 85, F-37380 Nouzilly, France; [Cognie, Juliette] CNRS, UMR 6175, Nouzilly, France; [Cognie, Juliette] Univ Tours, Tours, France; [Cognie, Juliette] IFCE, Nouzilly, France; [Delgado-Ortega, Mario; Berthon, Patricia; Rossignol, Christelle; Melo, Sandrine; Bruel, Timothee; Guibon, Roseline; Salmon, Henri; Meurens, Francois] INRA, UR 1282, F-37380 Nouzilly, France; [Larcher, Thibaut; Cherel, Yan] Ecole Natl Vet Agroalimentaire & Alimentat Nantes, INRA, UMR 703, Nantes, France; [Sarradin, Pierre] INRA, UE 1277, F-37380 Nouzilly, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; INRAE	Girard-Misguich, F (corresponding author), Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France.	Francois.Meurens@tours.inra.fr	Meurens, Francois JMA/J-3829-2019; Misguich, Fabienne/F-2741-2018; Bruel, Timothée/AAI-4632-2020; Larcher, Thibaut/X-8500-2019; Larcher, Thibaut/M-9160-2013	Meurens, Francois JMA/0000-0002-0353-4871; Misguich, Fabienne/0000-0002-7571-6519; Larcher, Thibaut/0000-0002-0396-3190; Juliette, Cognie/0000-0003-0908-9833; Delgado-Ortega, Mario/0000-0002-6921-2920; Bruel, Timothee/0000-0002-3952-4261	transversal research program INRA-Pasteur [PTR-291]; "Conseil Regional du Centre" (France)	transversal research program INRA-Pasteur; "Conseil Regional du Centre" (France)(Region Centre-Val de Loire)	This work was supported in part by the transversal research program INRA-Pasteur PTR-291: Development of an immuno-pathologic porcine model for intestinal human amebiasis and by the "Conseil Regional du Centre" (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAYAVELAZQUEZ F, 1985, AM J TROP MED HYG, V34, P723, DOI 10.4269/ajtmh.1985.34.723; Bansal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000551; BOLES JM, 1986, MAYO CLIN PROC, V61, P226, DOI 10.1016/S0025-6196(12)61855-2; Bruel T, 2010, DEV COMP IMMUNOL, V34, P562, DOI 10.1016/j.dci.2009.12.017; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CHADEE K, 1985, AM J TROP MED HYG, V34, P283, DOI 10.4269/ajtmh.1985.34.283; CIESLAK PR, 1992, J EXP MED, V176, P1605, DOI 10.1084/jem.176.6.1605; DESOWITZ RS, 1986, ANN TROP MED PARASIT, V80, P399, DOI 10.1080/00034983.1986.11812040; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; DIAMOND LS, 1978, ARCH INVEST MED, V9, P223; Duggal P, 2004, J INFECT DIS, V189, P520, DOI 10.1086/381272; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Faust E. C., 1932, American Journal of Tropical Medicine, V12, P37; Feagins LA, 2009, GASTROINTEST ENDOSC, V69, P1184, DOI 10.1016/j.gie.2008.06.063; GATHIRAM V, 1987, S AFR MED J, V72, P669; Gerdts V, 2001, J IMMUNOL METHODS, V256, P19, DOI 10.1016/S0022-1759(01)00429-X; GIBODA M, 1988, FOLIA PARASIT, V35, P11; Houpt ER, 2002, J IMMUNOL, V169, P4496, DOI 10.4049/jimmunol.169.8.4496; HUGHES R, 1975, AM J VET RES, V36, P971; Jorgensen FG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-2; Kim CJ, 2009, BBA-GEN SUBJECTS, V1790, P1161, DOI 10.1016/j.bbagen.2009.05.018; Meurens F, TRENDS MICR IN PRESS; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; Meurens F, 2009, VET RES, V40, DOI 10.1051/vetres:2008043; Mortimer L, 2010, EXP PARASITOL, V126, P366, DOI 10.1016/j.exppara.2010.03.005; Owen IL, 2005, J HELMINTHOL, V79, P1, DOI 10.1079/JOH2004266; PAKANDL M, 1994, VET MED-CZECH, V39, P377; Petri WA, 2009, NUTR REV, V67, pS207, DOI 10.1111/j.1753-4887.2009.00242.x; Rees CW, 1929, ARCH PATHOL, V7, P1; REINERTSON JW, 1951, P SOC EXP BIOL MED, V76, P518, DOI 10.3181/00379727-76-18541; RIGOTHIER MC, 1989, ANN PARASIT HUM COMP, V64, P185, DOI 10.1051/parasite/1989643185; Santi-Rocca J, 2008, CELL MICROBIOL, V10, P202, DOI 10.1111/j.1462-5822.2007.01030.x; Schauser K, 2004, J MED MICROBIOL, V53, P691, DOI 10.1099/jmm.0.45582-0; Seydel KB, 1997, INFECT IMMUN, V65, P1631, DOI 10.1128/IAI.65.5.1631-1639.1997; Shibayama M, 1997, PARASITOL RES, V83, P170, DOI 10.1007/s004360050228; SHIBAYAMASALAS M, 1992, ARCHIVES OF MEDICAL RESEARCH, VOL 23, NO 2, P187; Solaymani-Mohammadi S, 2004, J WILDLIFE DIS, V40, P801, DOI 10.7589/0090-3558-40.4.801; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Stedman NL, 2003, VET PATHOL, V40, P340, DOI 10.1354/vp.40-3-340; Swartzwelder JC, 1939, AM J HYG, V29, P89, DOI 10.1093/oxfordjournals.aje.a118498; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Variyam EP, 2000, ARCH MED RES, V31, pS245, DOI 10.1016/S0188-4409(00)00144-2; WHIPP SC, 1978, AM J VET RES, V39, P1293; Zanello G, 2011, PLOS ONE IN PRESS	44	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28795	10.1371/journal.pone.0028795	http://dx.doi.org/10.1371/journal.pone.0028795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205970	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600034
J	Normanno, N; Pinto, C; Castiglione, F; Bardelli, A; Gambacorta, M; Botti, G; Nappi, O; Siena, S; Ciardiello, F; Taddei, G; Marchetti, A				Normanno, Nicola; Pinto, Carmine; Castiglione, Francesca; Bardelli, Alberto; Gambacorta, Marcello; Botti, Gerardo; Nappi, Oscar; Siena, Salvatore; Ciardiello, Fortunato; Taddei, GianLuigi; Marchetti, Antonio			KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment	PLOS ONE			English	Article							1ST-LINE TREATMENT; PHASE-III; CANCER; CETUXIMAB; FLUOROURACIL; LEUCOVORIN; PANITUMUMAB; OXALIPLATIN; IRINOTECAN; EFFICACY	Background: Monoclonal antibodies directed against the epidermal growth factor receptor (EGFR) have been approved for the treatment of patients with metastatic colorectal carcinoma (mCRC) that do not carry KRAS mutations. Therefore, KRAS testing has become mandatory to chose the most appropriate therapy for these patients. Methodology/Principal Findings: In order to guarantee the possibility for mCRC patients to receive an high quality KRAS testing in every Italian region, the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pathology and Cytopathology -Italian division of the International Academy of Pathology (SIAPEC-IAP) started a program to improve KRAS testing. AIOM and SIAPEC identified a large panel of Italian medical oncologists, pathologists and molecular biologists that outlined guidelines for KRAS testing in mCRC patients. These guidelines include specific information on the target patient population, the biological material for molecular analysis, the extraction of DNA, and the methods for the mutational analysis that are summarized in this paper. Following the publication of the guidelines, the scientific societies started an external quality assessment scheme for KRAS testing. Five CRC specimens with known KRAS mutation status were sent to the 59 centers that participated to the program. The samples were validated by three referral laboratories. The participating laboratories were allowed to use their own preferred method for DNA extraction and mutational analysis and were asked to report the results within 4 weeks. The limit to pass the quality assessment was set at 100% of true responses. In the first round, only two centers did not pass (3%). The two centers were offered to participate to a second round and both centers failed again to pass. Conclusions: The results of this first Italian quality assessment for KRAS testing suggest that KRAS mutational analysis is performed with good quality in the majority of Italian centers.	[Normanno, Nicola] INT Fdn G Pascale, Cell Biol & Biotherapy Unit, Naples, Italy; [Normanno, Nicola] CROM Ctr Ric Oncol Mercogliano, Pharmacogen Lab, Avellino, Italy; [Pinto, Carmine] St Orsola Marcello Malpighi Hosp, Bologna, Italy; [Castiglione, Francesca; Taddei, GianLuigi] Univ Florence, Dept Human Pathol & Oncol, Florence, Italy; [Bardelli, Alberto] Univ Turin, Inst Canc Res & Treatment, Turin, Italy; [Gambacorta, Marcello] Osped Niguarda Ca Granda, Div Pathol, Milan, Italy; [Botti, Gerardo] INT Fdn G Pascale, Surg Pathol Unit, Naples, Italy; [Nappi, Oscar] Antonio Cardarelli Hosp, Naples, Italy; [Siena, Salvatore] Osped Niguarda Ca Granda, Dept Oncol, Falck Div Med Oncol, Milan, Italy; [Ciardiello, Fortunato] Univ Naples 2, Dept Expt & Clin Med & Surg F Magrassi & A Lanzar, Naples, Italy; [Marchetti, Antonio] Univ Fdn, Ctr Excellence Aging, Ctr Predict Mol Med, Chieti, Italy	IRCCS Fondazione Pascale; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Florence; University of Turin; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Fondazione Pascale; Antonio Cardarelli Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Universita della Campania Vanvitelli	Normanno, N (corresponding author), INT Fdn G Pascale, Cell Biol & Biotherapy Unit, Naples, Italy.	nicnorm@yahoo.com	Pinto, Carmine/AAC-2184-2020; SIENA, SALVATORE/AAC-5806-2019; Normanno, Nicola/AAT-1107-2021; BARDELLI, Alberto/J-9721-2018	Pinto, Carmine/0000-0002-3159-5268; SIENA, SALVATORE/0000-0002-2681-2846; Botti, Gerardo/0000-0002-6287-733X; Normanno, Nicola/0000-0002-7158-2605; BARDELLI, Alberto/0000-0003-1647-5070; Ciardiello, Fortunato/0000-0002-3369-4841	Italian division of Merck; Italian division of Amgen	Italian division of Merck; Italian division of Amgen	The external quality assessment was funded by the Italian divisions of Merck and Amgen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Bellon E, 2011, ONCOLOGIST, V16, P467, DOI 10.1634/theoncologist.2010-0429; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Carotenuto P, 2010, PHARMACOGENOMICS, V11, P1169, DOI 10.2217/PGS.10.86; Ciardiello F, 2011, TARGET ONCOL, V6, P133, DOI 10.1007/s11523-011-0181-x; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; JUNG A, 2009, J CLIN ONCOL S, V27, pS15; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Santini D, 2008, ONCOLOGIST, V13, P1270, DOI 10.1634/theoncologist.2008-0181; TIE J, 2011, CLIN CANC RES   0118, P1122; Tol J, 2010, J CELL MOL MED, V14, P2122, DOI 10.1111/j.1582-4934.2009.00788.x; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y	19	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29146	10.1371/journal.pone.0029146	http://dx.doi.org/10.1371/journal.pone.0029146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216189	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600058
J	Giacoia-Gripp, CBW; Sales, AM; Nery, JAD; Santos-Oliveira, JR; de Oliveira, AL; Sarno, EN; Margado, MG				Wagner Giacoia-Gripp, Carmem Beatriz; Sales, Anna Maria; da Costa Nery, Jose Augusto; Santos-Oliveira, Joanna Reis; de Oliveira, Ariane Leite; Sarno, Euzenir Nunes; Margado, Mariza Goncalves			Evaluation of Cellular Phenotypes Implicated in Immunopathogenesis and Monitoring Immune Reconstitution Inflammatory Syndrome in HIV/Leprosy Cases	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; CD8(+) T-LYMPHOCYTES; MYCOBACTERIUM-LEPRAE; RESTORATION SYNDROME; PROTEASE INHIBITORS; TUBERCULOID LEPROSY; CD38 EXPRESSION; AIDS	Background: It is now evident that HAART-associated immunological improvement often leads to a variety of new clinical manifestations, collectively termed immune reconstitution inflammatory syndrome, or IRIS. This phenomenon has already been described in cases of HIV coinfection with Mycobacterium leprae, most of them belonging to the tuberculoid spectrum of leprosy disease, as observed in leprosy reversal reaction (RR). However, the events related to the pathogenesis of this association need to be clarified. This study investigated the immunological profile of HIV/leprosy patients, with special attention to the cellular activation status, to better understand the mechanisms related to IRIS/RR immunopathogenesis, identifying any potential biomarkers for IRIS/RR intercurrence. Methods/Principal Findings: Eighty-five individuals were assessed in this study: HIV/leprosy and HIV-monoinfected patients, grouped according to HIV-viral load levels, leprosy patients without HIV coinfection, and healthy controls. Phenotypes were evaluated by flow cytometry for T cell subsets and immune differentiation/activation markers. As expected, absolute counts of the CD4+ and CD8+ T cells from the HIV-infected individuals changed in relation to those of the leprosy patients and controls. However, there were no significant differences among the groups, whether in the expression of cellular differentiation phenotypes or cellular activation, as reflected by the expression of CD38 and HLA-DR. Six HIV/leprosy patients identified as IRIS/RR were analyzed during IRIS/RR episodes and after prednisone treatment. These patients presented high cellular activation levels regarding the expression of CD38 in CD8+ cells T during IRIS/RR (median: 77,15%), dropping significantly (p < 0,05) during post-IRIS/RR moments (median: 29,7%). Furthermore, an increase of cellular activation seems to occur prior to IRIS/RR. Conclusion/Significance: These data suggest CD38 expression in CD8+ T cells interesting tool identifying HIV/leprosy individuals at risk for IRIS/RR. So, a comparative investigation to leprosy patients at RR should be conducted.	[Wagner Giacoia-Gripp, Carmem Beatriz; Margado, Mariza Goncalves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Mol Immunol, Rio De Janeiro, Brazil; [Sales, Anna Maria; da Costa Nery, Jose Augusto; de Oliveira, Ariane Leite; Sarno, Euzenir Nunes] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Leprosy Lab, Rio De Janeiro, Brazil; [Santos-Oliveira, Joanna Reis] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinary Med Res, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Giacoia-Gripp, CBW (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Mol Immunol, Rio De Janeiro, Brazil.	carmembg@ioc.fiocruz.br		Nunes Sarno, Euzenir/0000-0003-0129-2159	Oswaldo Cruz Foundation/Brazilian Ministry of Health	Oswaldo Cruz Foundation/Brazilian Ministry of Health	This project was supported by the Oswaldo Cruz Foundation Integrated AIDS Program/Brazilian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Benito DM, 2005, JAIDS-J ACQ IMM DEF, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2; Benito JM, 2004, AIDS RES HUM RETROV, V20, P227, DOI 10.1089/088922204773004950; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Carr A, 1997, LANCET, V349, P995, DOI 10.1016/S0140-6736(05)62892-9; Carvalho KI, 2008, IMMUNOLOGY, V124, P206, DOI 10.1111/j.1365-2567.2007.02756.x; Cheng VCC, 2002, EUR J CLIN MICROBIOL, V21, P803, DOI 10.1007/s10096-002-0821-2; Couppie P, 2004, ARCH DERMATOL, V140, P997, DOI 10.1001/archderm.140.8.997; Decrion AZ, 2007, IMMUNOLOGY, V121, P405, DOI 10.1111/j.1365-2567.2007.02589.x; French M A, 2000, HIV Med, V1, P107, DOI 10.1046/j.1468-1293.2000.00012.x; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Jehle AW, 2004, CLIN INFECT DIS, V38, pE32, DOI 10.1086/381441; Jevtovic D, 2005, HIV MED, V6, P140, DOI 10.1111/j.1468-1293.2005.00277.x; Kaushik S, 2006, CLIN IMMUNOL, V119, P330, DOI 10.1016/j.clim.2005.12.014; Kharkar V, 2007, INDIAN J DERMATOL VE, V73, P253, DOI 10.4103/0378-6323.33637; Koval CE, 2002, CLIN INFECT DIS, V35, P491, DOI 10.1086/341974; Lawn SD, 2003, CLIN INFECT DIS, V36, pE5, DOI 10.1086/344446; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Lockwood DNJ, 2011, DERMATOL CLIN, V29, P125, DOI 10.1016/j.det.2010.08.016; Martinez E, 1998, CLIN INFECT DIS, V27, P1510, DOI 10.1086/515019; Marziali M, 2006, AIDS, V20, P2033, DOI 10.1097/01.aids.0000247588.69438.fd; Massone C, 2008, BRIT J DERMATOL, V165, P321; Massone C, 2011, EXPERT REV ANTI-INFE, V9, P701, DOI [10.1586/eri.11.44, 10.1586/ERI.11.44]; Menezes VM, 2009, AIDS, V23, P641, DOI 10.1097/QAD.0b013e3283291405; Murdoch David M, 2007, AIDS Res Ther, V4, P9, DOI 10.1186/1742-6405-4-9; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pignataro P, 2004, EUR J CLIN MICROBIOL, V23, P408, DOI 10.1007/s10096-004-1131-7; Race EM, 1998, LANCET, V351, P252, DOI 10.1016/S0140-6736(97)04352-3; Rutschmann OT, 1998, J INFECT DIS, V177, P783, DOI 10.1086/517808; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; SAMPAIO EP, 1995, INFECT IMMUN, V63, P1848, DOI 10.1128/IAI.63.5.1848-1854.1995; Santos-Oliveira JR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-358; Sarno EN, 2008, PUBLIC HEALTH REP, V123, P206, DOI 10.1177/003335490812300213; Sasaki S, 2001, MICROBIOL IMMUNOL, V45, P729, DOI 10.1111/j.1348-0421.2001.tb01308.x; Schluger NW, 2002, CHEST, V122, P597, DOI 10.1378/chest.122.2.597; SCOLLARD DM, 1994, INT J LEPROSY, V62, P559; Shelburne SA, 2002, MEDICINE, V81, P213, DOI 10.1097/00005792-200205000-00005; Talhari C, 2010, J INFECT DIS, V202, P345, DOI 10.1086/653839; Visco-Comandini U, 2004, SCAND J INFECT DIS, V36, P881, DOI 10.1080/00365540410025357; Woods TC, 1997, BLOOD, V89, P1635, DOI 10.1182/blood.V89.5.1635.1635_1635_1641	42	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28735	10.1371/journal.pone.0028735	http://dx.doi.org/10.1371/journal.pone.0028735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205964	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600028
J	Aguer, C; Foretz, M; Lantier, L; Hebrard, S; Viollet, B; Mercier, J; Kitzmann, M				Aguer, Celine; Foretz, Marc; Lantier, Louise; Hebrard, Sophie; Viollet, Benoit; Mercier, Jacques; Kitzmann, Magali			Increased FAT/CD36 Cycling and Lipid Accumulation in Myotubes Derived from Obese Type 2 Diabetic Patients	PLOS ONE			English	Article							FATTY-ACID UPTAKE; SKELETAL-MUSCLE CELLS; BLOOD LACTATE REMOVAL; TRIACYLGLYCEROL ACCUMULATION; SUPRAMAXIMAL EXERCISE; GLYCOGEN-SYNTHASE; FATIGUE INDEXES; PLASMA-MEMBRANE; OXIDATION; TRANSPORT	Background: Permanent fatty acid translocase (FAT/)CD36 relocation has previously been shown to be related to abnormal lipid accumulation in the skeletal muscle of type 2 diabetic patients, however mechanisms responsible for the regulation of FAT/CD36 expression and localization are not well characterized in human skeletal muscle. Methodology/Principal Findings: Primary muscle cells derived from obese type 2 diabetic patients (OBT2D) and from healthy subjects (Control) were used to examine the regulation of FAT/CD36. We showed that compared to Control myotubes, FAT/CD36 was continuously cycling between intracellular compartments and the cell surface in OBT2D myotubes, independently of lipid raft association, leading to increased cell surface FAT/CD36 localization and lipid accumulation. Moreover, we showed that FAT/CD36 cycling and lipid accumulation were specific to myotubes and were not observed in reserve cells. However, in Control myotubes, the induction of FAT/CD36 membrane translocation by the activation of (AMP)-activated protein kinase (AMPK) pathway did not increase lipid accumulation. This result can be explained by the fact that pharmacological activation of AMPK leads to increased mitochondrial beta-oxidation in Control cells. Conclusion/Significance: Lipid accumulation in myotubes derived from obese type 2 diabetic patients arises from abnormal FAT/CD36 cycling while lipid accumulation in Control cells results from an equilibrium between lipid uptake and oxidation. As such, inhibiting FAT/CD36 cycling in the skeletal muscle of obese type 2 diabetic patients should be sufficient to diminish lipid accumulation.	[Aguer, Celine; Mercier, Jacques; Kitzmann, Magali] INSERM, Physiol & Med Expt Coeur & Muscles U1046, Montpellier, France; [Aguer, Celine; Mercier, Jacques; Kitzmann, Magali] Univ Montpellier 2, Univ Montpellier 1, Montpellier, France; [Foretz, Marc; Lantier, Louise; Hebrard, Sophie; Viollet, Benoit] Inst Cochin, INSERM, U1016, Paris, France; [Foretz, Marc; Lantier, Louise; Hebrard, Sophie] CNRS, UMR8104, Paris, France; [Foretz, Marc; Lantier, Louise; Hebrard, Sophie; Viollet, Benoit] Univ Paris 05, Paris, France; [Mercier, Jacques] CHRU Montpellier, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier	Aguer, C (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Mitochondrial Bioenerget Lab, Ottawa, ON, Canada.	magali.kitzmann@igh.cnrs.fr	Viollet, Benoit/N-2397-2019; Aguer, Celine/U-7848-2019; FORETZ, Marc/O-7334-2017; Aguer, Celine/K-4444-2012; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Aguer, Celine/0000-0001-8828-8472; FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224	Association Francaise contre les Myopathies (AFM) [MNM2 2005, 11330]; Institut National de Sante et de la Recherche Medicale (INSERM) [ERI25]; Languedoc Roussillon Region, University of Montpellier [1 (EA4202)]; CHU of Montpellier; Centre de Recherche National Scientifique (CNRS); EMO International	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Institut National de Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Languedoc Roussillon Region, University of Montpellier(Region Occitanie); CHU of Montpellier; Centre de Recherche National Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); EMO International	This work was supported by grants from Association Francaise contre les Myopathies (AFM, MNM2 2005, no11330), Institut National de Sante et de la Recherche Medicale (INSERM, ERI25), Languedoc Roussillon Region, University of Montpellier 1 (EA4202) and CHU of Montpellier. The authors are grateful to the Centre de Recherche National Scientifique (CNRS) for its support to M. Kitzmann and to AFM and EMO International for their fellowships to C. Aguer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2010, DIABETOLOGIA, V53, P1151, DOI 10.1007/s00125-010-1708-x; Aguer C, 2010, MOL CELL ENDOCRINOL, V315, P225, DOI 10.1016/j.mce.2009.10.017; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Chabowski A, 2007, PROSTAG LEUKOTR ESS, V77, P345, DOI 10.1016/j.plefa.2007.10.017; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; Costford SR, 2009, DIABETOLOGIA, V52, P2405, DOI 10.1007/s00125-009-1480-y; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Gaster M, 2006, BBA-MOL CELL BIOL L, V1761, P100, DOI 10.1016/j.bbalip.2005.12.003; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Glatz JFC, 1997, PROSTAG LEUKOTR ESS, V57, P3, DOI 10.1016/S0952-3278(97)90485-3; Glatz JFC, 2001, CURR OPIN LIPIDOL, V12, P267, DOI 10.1097/00041433-200106000-00005; Han XX, 2007, AM J PHYSIOL-ENDOC M, V293, pE566, DOI 10.1152/ajpendo.00106.2007; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Jackson S, 2000, DIABETES, V49, P1169, DOI 10.2337/diabetes.49.7.1169; Keizer HA, 2004, HISTOCHEM CELL BIOL, V121, P101, DOI 10.1007/s00418-003-0615-3; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kitzmann M, 2006, J CELL PHYSIOL, V208, P538, DOI 10.1002/jcp.20688; Kitzmann M, 2011, BBA-MOL BASIS DIS, V1812, P423, DOI 10.1016/j.bbadis.2010.12.007; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; MACEY RI, 1970, BIOCHIM BIOPHYS ACTA, V211, P104, DOI 10.1016/0005-2736(70)90130-6; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Newsom SA, 2011, METABOLISM, V60, P852, DOI 10.1016/j.metabol.2010.08.004; Nikoulina SE, 2001, J CLIN ENDOCR METAB, V86, P4307, DOI 10.1210/jc.86.9.4307; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Norheim F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1013, DOI 10.1152/ajpendo.00326.2011; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Schenk S, 2006, AM J PHYSIOL-ENDOC M, V291, pE254, DOI 10.1152/ajpendo.00051.2006; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Sfeir Z, 1999, MOL CELL BIOCHEM, V192, P3, DOI 10.1023/A:1006811300125; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Thomas C, 2004, J APPL PHYSIOL, V97, P2132, DOI 10.1152/japplphysiol.00387.2004; Thomas C, 2005, J APPL PHYSIOL, V98, P804, DOI 10.1152/japplphysiol.01057.2004; Tsukahara T, 2011, BIOCHEM BIOPH RES CO, V406, P558, DOI 10.1016/j.bbrc.2011.02.090; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; Wood DR, 2005, J BIOL CHEM, V280, P6663, DOI 10.1074/jbc.M410332200; Yoon JH, 2011, J PROTEOME RES	44	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28981	10.1371/journal.pone.0028981	http://dx.doi.org/10.1371/journal.pone.0028981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194967	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400030
J	Mitroulis, I; Kambas, K; Chrysanthopoulou, A; Skendros, P; Apostolidou, E; Kourtzelis, I; Drosos, GI; Boumpas, DT; Ritis, K				Mitroulis, Ioannis; Kambas, Konstantinos; Chrysanthopoulou, Akrivi; Skendros, Panagiotis; Apostolidou, Eirini; Kourtzelis, Ioannis; Drosos, Georgios I.; Boumpas, Dimitrios T.; Ritis, Konstantinos			Neutrophil Extracellular Trap Formation Is Associated with IL-1 beta and Autophagy-Related Signaling in Gout	PLOS ONE			English	Article							MONOSODIUM URATE CRYSTALS; PHOSPHATIDYLINOSITOL 3-KINASE; INFLAMMATION; ACTIVATION; ARTHRITIS; EXPRESSION; MECHANISM; ANAKINRA; RELEASE; INDUCE	Background: Gout is a prevalent inflammatory arthritis affecting 1-2% of adults characterized by activation of innate immune cells by monosodium urate (MSU) crystals resulting in the secretion of interleukin-1 beta (IL-1 beta). Since neutrophils play a major role in gout we sought to determine whether their activation may involve the formation of proinflammatory neutrophil extracellular traps (NETs) in relation to autophagy and IL-1 beta. Methodology/Principal Findings: Synovial fluid neutrophils from six patients with gout crisis and peripheral blood neutrophils from six patients with acute gout and six control subjects were isolated. MSU crystals, as well as synovial fluid or serum obtained from patients with acute gout, were used for the treatment of control neutrophils. NET formation was assessed using immunofluorescence microscopy. MSU crystals or synovial fluid or serum from patients induced NET formation in control neutrophils. Importantly, NET production was observed in neutrophils isolated from synovial fluid or peripheral blood from patients with acute gout. NETs contained the alarmin high mobility group box 1 (HMGB1) supporting their pro-inflammatory potential. Inhibition of phosphatidylinositol 3-kinase signaling or phagolysosomal fusion prevented NET formation, implicating autophagy in this process. NET formation was driven at least in part by IL-1 beta as demonstrated by experiments involving IL-1 beta and its inhibitor anakinra. Conclusions/Significance: These findings document for the first time that activation of neutrophils in gout is associated with the formation of proinflammatory NETs and links this process to both autophagy and IL-1 beta. Modulation of the autophagic machinery may represent an additional therapeutic study in crystalline arthritides.	[Mitroulis, Ioannis; Kambas, Konstantinos; Chrysanthopoulou, Akrivi; Skendros, Panagiotis; Apostolidou, Eirini; Kourtzelis, Ioannis; Ritis, Konstantinos] Democritus Univ Thrace, Univ Gen Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece; [Drosos, Georgios I.] Democritus Univ Thrace, Univ Gen Hosp Alexandroupolis, Dept Orthopaed Surg, Alexandroupolis, Greece; [Boumpas, Dimitrios T.] Univ Crete, Dept Rheumatol Clin Immunol & Allergy, Univ Hosp, Sch Med, Iraklion, Greece	Democritus University of Thrace; Democritus University of Thrace; University of Crete; University of Patras	Mitroulis, I (corresponding author), Democritus Univ Thrace, Univ Gen Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.	ritis2@otenet.gr	Kourtzelis, Ioannis/G-1767-2012; Mitroulis, Ioannis/AAB-7915-2021	Kourtzelis, Ioannis/0000-0002-7292-5745; Mitroulis, Ioannis/0000-0002-9991-2362; Chrysanthopoulou, Akrivi/0000-0002-0325-6146; Skendros, Panagiotis/0000-0003-0456-7015; Kourtzelis, Ioannis/0000-0003-3006-8885	Hellenic Ministry of Education; General Secretariat for Research and Technology (ESPA) [898]	Hellenic Ministry of Education; General Secretariat for Research and Technology (ESPA)(Greek Ministry of Development-GSRT)	This study was supported by the Hellenic Ministry of Education and General Secretariat for Research and Technology (ESPA project/No 898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V., 2010, JOVE-J VIS EXP, V36, P1724, DOI [10.3791/1724, DOI 10.3791/1724/J0VE.C0M/VIDE0/1724]; Castiglioni A, 2011, CELL TISSUE RES, V343, P189, DOI 10.1007/s00441-010-1033-1; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Dworski R, 2011, J ALLERGY CLIN IMMUN, V127, P1260, DOI 10.1016/j.jaci.2010.12.1103; El Kebir D, 2009, J IMMUNOL, V182, P4386, DOI 10.4049/jimmunol.0803044; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Jackson JK, 1997, J RHEUMATOL, V24, P341; Kambas K, 2008, J IMMUNOL, V180, P7368, DOI 10.4049/jimmunol.180.11.7368; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Martin WJ, 2009, ARTHRITIS RHEUM-US, V60, P281, DOI 10.1002/art.24185; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McGonagle D, 2007, ANN RHEUM DIS, V66, P1683, DOI 10.1136/ard.2007.073759; Mitroulis I, 2010, EUR J INTERN MED, V21, P157, DOI 10.1016/j.ejim.2010.03.005; Mitroulis I, 2010, EUR J IMMUNOL, V40, P1461, DOI 10.1002/eji.200940025; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Popa-Nita O, 2007, J LEUKOCYTE BIOL, V82, P763, DOI 10.1189/jlb.0307174; Popa-Nita O, 2010, IMMUNOL CELL BIOL, V88, P32, DOI 10.1038/icb.2009.98; Popa-Nita O, 2009, J IMMUNOL, V183, P2104, DOI 10.4049/jimmunol.0900906; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Ryckman C, 2004, J LEUKOCYTE BIOL, V76, P433, DOI 10.1189/jlb.0603294; Savchenko AS, 2011, PATHOL INT, V61, P290, DOI 10.1111/j.1440-1827.2011.02651.x; Scott P, 2006, J IMMUNOL, V177, P6370, DOI 10.4049/jimmunol.177.9.6370; Shacka JJ, 2006, AUTOPHAGY, V2, P228, DOI 10.4161/auto.2703; SHIRAHAMA T, 1974, AM J PATHOL, V76, P501; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; So A, 2010, ARTHRITIS RHEUM-US, V62, P3064, DOI 10.1002/art.27600; So A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2509; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Terkeltaub R, 2009, ANN RHEUM DIS, V68, P1613, DOI 10.1136/ard.2009.108936; Torres R, 2009, ANN RHEUM DIS, V68, P1602, DOI 10.1136/ard.2009.109355; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450	38	268	284	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29318	10.1371/journal.pone.0029318	http://dx.doi.org/10.1371/journal.pone.0029318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195044	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400047
J	Stoltz, M; Sundstrom, KB; Hidmark, A; Tolf, C; Vene, S; Ahlm, C; Lindberg, AM; Lundkvist, A; Klingstrom, J				Stoltz, Malin; Sundstrom, Karin B.; Hidmark, Asa; Tolf, Conny; Vene, Sirkka; Ahlm, Clas; Lindberg, A. Michael; Lundkvist, Ake; Klingstrom, Jonas			A Model System for In Vitro Studies of Bank Vole Borne Viruses	PLOS ONE			English	Article							CELL-CULTURE; PUUMALA HANTAVIRUS; LJUNGAN VIRUS; ENCEPHALITIS-VIRUS; FRUIT BAT; INTERFERON; ADAPTATION; INDUCTION; PROTEIN; EXPRESSION	The bank vole (Myodes glareolus) is a common small mammal in Europe and a natural host for several important emerging zoonotic viruses, e. g. Puumala hantavirus (PUUV) that causes hemorrhagic fever with renal syndrome (HFRS). Hantaviruses are known to interfere with several signaling pathways in infected human cells, and HFRS is considered an immunemediated disease. There is no in vitro-model available for infectious experiments in bank vole cells, nor tools for analyses of bank vole immune activation and responses. Consequently, it is not known if there are any differences in the regulation of virus induced responses in humans compared to natural hosts during infection. We here present an in vitro-model for studies of bank vole borne viruses and their interactions with natural host cell innate immune responses. Bank vole embryonic fibroblasts (VEFs) were isolated and shown to be susceptible for PUUV-infection, including a wild-type PUUV strain (only passaged in bank voles). The significance of VEFs as a model system for bank vole associated viruses was further established by infection studies showing that these cells are also susceptible to tick borne encephalitis, cowpox and Ljungan virus. The genes encoding bank vole IFN-beta and Mx2 were partially sequenced and protocols for semi-quantitative RT-PCR were developed. Interestingly, PUUV did not induce an increased IFN-beta or Mx2 mRNA expression. Corresponding infections with CPXV and LV induced IFN-beta but not Mx2, while TBEV induced both IFN-beta and Mx2. In conclusion, VEFs together with protocols developed for detection of bank vole innate immune activation provide valuable tools for future studies of how PUUV and other zoonotic viruses affect cells derived from bank voles compared to human cells. Notably, wild-type PUUV which has been difficult to cultivate in vitro readily infected VEFs, suggesting that embryonic fibroblasts from natural hosts might be valuable for isolation of wild-type hantaviruses.	[Stoltz, Malin; Sundstrom, Karin B.; Lundkvist, Ake; Klingstrom, Jonas] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Stoltz, Malin; Sundstrom, Karin B.; Vene, Sirkka; Klingstrom, Jonas] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden; [Hidmark, Asa] Heidelberg Univ, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany; [Tolf, Conny; Lindberg, A. Michael] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden; [Ahlm, Clas] Umea Univ, Dept Clin Microbiol Infect Dis, Umea, Sweden; [Lundkvist, Ake] Swedish Inst Communicable Dis Control, Dept Epidemiol, Solna, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Ruprecht Karls University Heidelberg; Linnaeus University; Umea University; Swedish Institute for Infectious Disease Control	Stoltz, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Malin.Stoltz@smi.se	Lindberg, A. Michael/B-8465-2013	Lindberg, A. Michael/0000-0003-3841-4826; Klingstrom, Jonas/0000-0001-9076-1441	Ake Wibergs stiftelse; Magn. Bergvalls stiftelse; Jeanssons stiftelse; Stiftelsen Clas Groschinskys minnesfond; Royal Swedish Academy of Sciences; Swedish Medical Research Council; Carl Trygger Foundation; The County Council of Vasterbotten; Medical Faculty Umea University; County Councils of Northern Sweden	Ake Wibergs stiftelse; Magn. Bergvalls stiftelse; Jeanssons stiftelse; Stiftelsen Clas Groschinskys minnesfond; Royal Swedish Academy of Sciences; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Carl Trygger Foundation; The County Council of Vasterbotten; Medical Faculty Umea University; County Councils of Northern Sweden	This work was supported by Ake Wibergs stiftelse, Magn. Bergvalls stiftelse, Jeanssons stiftelse, Stiftelsen Clas Groschinskys minnesfond, the Royal Swedish Academy of Sciences, the Swedish Medical Research Council, Carl Trygger Foundation, The County Council of Vasterbotten, the Medical Faculty Umea University, and the County Councils of Northern Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amori G, 2008, IUCN 2008 IUCN RED L; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; Easterbrook JD, 2007, P NATL ACAD SCI USA, V104, P15502, DOI 10.1073/pnas.0707453104; Easterbrook JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000172; Ekstrom JO, 2007, VIRUS RES, V130, P129, DOI 10.1016/j.virusres.2007.06.004; Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Haglund M, 2003, J MED VIROL, V71, P610, DOI 10.1002/jmv.10497; Hardestam J, 2008, EMERG INFECT DIS, V14, P1209, DOI 10.3201/eid1408.080221; Herbst MM, 2002, CYTOKINE, V17, P203, DOI 10.1006/cyto.2001.0998; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Johansson ES, 2004, BIOCHEM BIOPH RES CO, V317, P1023, DOI 10.1016/j.bbrc.2004.03.145; Jordan I, 2009, VIRUS RES, V145, P54, DOI 10.1016/j.virusres.2009.06.007; Juto P, 1997, J MED VIROL, V53, P150, DOI 10.1002/(SICI)1096-9071(199710)53:2<150::AID-JMV7>3.0.CO;2-8; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Klingstrom J, 2011, EXPERT REV ANTI-INFE, V9, P33, DOI 10.1586/ERI.10.157; Krahling V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000802; Krous HF, 2010, BIRTH DEFECTS RES A, V88, P947, DOI 10.1002/bdra.20728; Lundkvist A, 1997, J VIROL, V71, P9515, DOI 10.1128/JVI.71.12.9515-9523.1997; Mackow ER, 2009, THROMB HAEMOSTASIS, V102, P1030, DOI 10.1160/TH09-09-0640; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; Nemirov K, 2003, J VIROL, V77, P8793, DOI 10.1128/JVI.77.16.8793-8800.2003; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Schonrich G, 2008, IMMUNOL REV, V225, P163, DOI 10.1111/j.1600-065X.2008.00694.x; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Schountz Tony, 2004, BMC Immunology, V5; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Stoltz M, 2007, J VIROL, V81, P8685, DOI 10.1128/JVI.00415-07; Stoltz M, 2010, J VIROL, V84, P9140, DOI 10.1128/JVI.00717-10; Sundstrom KB, 2011, J VIROL, V85, P1747, DOI 10.1128/JVI.01428-10; Suss J, 2003, VACCINE, V21, pS19, DOI 10.1016/S0264-410X(02)00812-5; Tolf C, 2008, J VIROL METHODS, V150, P34, DOI 10.1016/j.jviromet.2008.02.012; Tolf C, 2009, ARCH VIROL, V154, P1271, DOI 10.1007/s00705-009-0417-6; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6	37	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28992	10.1371/journal.pone.0028992	http://dx.doi.org/10.1371/journal.pone.0028992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194969	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400032
J	Zhang, YG; Huang, JH; Hu, XY; Sheng, QS; Zhao, W; Luo, ZJ				Zhang, Yong-Guang; Huang, Jing-Hui; Hu, Xue-Yu; Sheng, Qing-Song; Zhao, Wei; Luo, Zhuo-Jing			Omentum-Wrapped Scaffold with Longitudinally Oriented Micro-Channels Promotes Axonal Regeneration and Motor Functional Recovery in Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PERIPHERAL-NERVE REGENERATION; ANGIOGENIC FACTOR; GREATER OMENTUM; NEOVASCULARIZATION; CELLS; MODEL; GRAFT; VEGF; RECONSTRUCTION	Background: Tissue-engineered nerve scaffolds hold great potential in bridging large peripheral nerve defects. However, insufficient vascularization of nerve scaffolds limited neural tissues survival and regeneration, which hampered the successful implantation and clinical application of nerve scaffolds. The omentum possesses a high vascularization capacity and enhances regeneration and maturation of tissues and constructs to which it is applied. However, combined application of nerve scaffolds and omentum on axonal regeneration and functional recovery in the treatment of large peripheral nerve defects has rarely been investigated thus far. Methods: In the present study, an omentum-wrapped collagen-chitosan scaffold was used to bridge a 15-mm-long sciatic nerve defect in rats. Rats that received nerve autografts or scaffolds alone were served as positive control or negative control, respectively. The axonal regeneration and functional recovery were examined by a combination of walking track analysis, electrophysiological assessment, Fluoro-Gold (FG) retrograde tracing, as well as morphometric analyses to both regenerated nerves and target muscles. Findings: The results demonstrated that axonal regeneration and functional recovery were in the similar range between the omentum-wrapping group and the autograft group, which were significantly better than those in the scaffold alone group. Further investigation showed that the protein levels of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) were significantly higher in the omentum-wrapping group than those in the scaffold alone group in the early weeks after surgery. Conclusion: These findings indicate that the omentum-wrapped scaffold is capable of enhancing axonal regeneration and functional recovery, which might be served as a potent alternative to nerve autografts. The beneficial effect of omentum-wrapping on nerve regeneration might be related with the proteins produced by omentum.	[Zhang, Yong-Guang; Huang, Jing-Hui; Hu, Xue-Yu; Luo, Zhuo-Jing] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China; [Zhang, Yong-Guang] Fuzhou Gen Hosp, Clin Div 476, Fuzhou, Peoples R China; [Sheng, Qing-Song] Fourth Mil Med Univ, Xijing Hosp, Dept Obstet & Gynecol, Xian 710032, Peoples R China; [Zhao, Wei] Ningxia Med Univ, Basic Med Sci Coll, Dept Biochem & Mol Biol, Yinchuan, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Ningxia Medical University	Zhang, YG (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China.	zjluo@fmmu.edu.cn		Huang, Jinghui/0000-0002-0991-0591	National Natural Science Foundation of China [30770571]; National Hi-Tech Research and Development Program of China (863) [2002AA216101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China (863)(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (Grants No. 30770571) and the National Hi-Tech Research and Development Program of China (863) (Grant No. 2002AA216101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarturk TO, 2004, ANN PLAS SURG, V53, P210, DOI 10.1097/01.sap.0000116285.98328.f7; Agner C, 2001, NEUROL RES, V23, P7, DOI 10.1179/016164101101198226; Alluin O, 2009, BIOMATERIALS, V30, P363, DOI 10.1016/j.biomaterials.2008.09.043; Baumert H, 2007, EUR UROL, V52, P884, DOI 10.1016/j.eururo.2006.11.044; Baumert H, 2007, EUR UROL, V52, P1492, DOI 10.1016/j.eururo.2007.04.098; CHAMORRO M, 1993, BRIT J PLAST SURG, V46, P426, DOI 10.1016/0007-1226(93)90050-L; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Collins D, 2009, J GASTROINTEST SURG, V13, P1138, DOI 10.1007/s11605-009-0855-1; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Goitz RJ, 2005, PLAST RECONSTR SURG, V115, P163, DOI 10.1097/01.PRS.0000138808.77038.D7; Goldsmith HS, 2007, J AM COLL SURGEONS, V205, P800, DOI 10.1016/j.jamcollsurg.2007.06.294; Goldsmith HS, 2009, J AM COLL SURGEONS, V208, P289, DOI 10.1016/j.jamcollsurg.2008.10.021; GOLDSMITH HS, 1984, JAMA-J AM MED ASSOC, V252, P2034, DOI 10.1001/jama.252.15.2034; HARE GMT, 1992, PLAST RECONSTR SURG, V89, P251, DOI 10.1097/00006534-199202000-00009; Horie H, 2004, J NEUROSCI, V24, P1873, DOI 10.1523/JNEUROSCI.4483-03.2004; Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI [10.1089/ten.tea.2009.0017, 10.1089/ten.TEA.2009.0017]; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hultman CS, 2001, ANN PLAS SURG, V46, P242, DOI 10.1097/00000637-200103000-00007; Johnson PJ, 2011, J RECONSTR MICROSURG, V27, P83, DOI 10.1055/s-0030-1267834; KANAYA F, 1992, PLAST RECONSTR SURG, V89, P924, DOI 10.1097/00006534-199205000-00024; Kemp SWP, 2009, TISSUE ENG PT A, V15, P1975, DOI 10.1089/ten.tea.2008.0338; Litbarg NO, 2007, CELL TISSUE RES, V328, P487, DOI 10.1007/s00441-006-0356-4; Luk HW, 2003, J NEUROSCI RES, V73, P644, DOI 10.1002/jnr.10701; Maloney CT, 2003, PLAST RECONSTR SURG, V111, P1899, DOI 10.1097/01.PRS.0000056874.31920.7D; Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889; Mitsuma N, 2004, NEUROSCIENCE, V129, P109, DOI 10.1016/j.neuroscience.2004.06.083; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; PODHAJSKY RJ, 1995, J NEUROSCI METH, V60, P79, DOI 10.1016/0165-0270(94)00222-3; PODHAJSKY RJ, 1994, BRAIN RES, V662, P88, DOI 10.1016/0006-8993(94)90799-4; Pola R, 2004, NEUROBIOL AGING, V25, P1361, DOI 10.1016/j.neurobiolaging.2004.02.028; Saifzadeh S, 2009, J INVEST SURG, V22, P129, DOI 10.1080/08941930802566730; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Shrager JB, 2003, J THORAC CARDIOV SUR, V125, P526, DOI 10.1067/mtc.2003.12; Singh AK, 2008, CELL TISSUE RES, V332, P81, DOI 10.1007/s00441-007-0560-x; Sondell M, 1999, BRAIN RES, V846, P219, DOI 10.1016/S0006-8993(99)02056-9; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Suh S, 2004, ASAIO J, V50, P464, DOI 10.1097/01.MAT.0000138016.83837.8A; Tark KC, 2001, J RECONSTR MICROSURG, V17, P109; Vargel I, 2009, J RECONSTR MICROSURG, V25, P243, DOI 10.1055/s-0028-1104557; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983	42	15	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29184	10.1371/journal.pone.0029184	http://dx.doi.org/10.1371/journal.pone.0029184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195018	Green Submitted, Green Published, gold			2022-12-25	WOS:000298664400040
J	Parra, M; Derrick, SC; Yang, A; Tian, JH; Kolibab, K; Oakley, M; Perera, LP; Jacobs, WR; Kumar, S; Morris, SL				Parra, Marcela; Derrick, Steven C.; Yang, Amy; Tian, JinHua; Kolibab, Kristopher; Oakley, Miranda; Perera, Liyanage P.; Jacobs, William R.; Kumar, Sanjai; Morris, Sheldon L.			Malaria Infections Do Not Compromise Vaccine-Induced Immunity against Tuberculosis in Mice	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE IMMUNITY; BOVIS BCG; ENVIRONMENTAL MYCOBACTERIA; PLASMODIUM-YOELII; IN-VITRO; TGF-BETA; CELLS; HIV; IMMUNIZATION	Background: Given the considerable geographic overlap in the endemic regions for malaria and tuberculosis, it is probable that co-infections with Mycobacterium tuberculosis and Plasmodium species are prevalent. Thus, it is quite likely that both malaria and TB vaccines may be used in the same populations in endemic areas. While novel vaccines are currently being developed and tested individually against each of these pathogens, the efficacy of these vaccines has not been evaluated in co-infection models. To further assess the effectiveness of these new immunization strategies, we investigated whether co-infection with malaria would impact the anti-tuberculosis protection induced by four different types of TB vaccines in a mouse model of pulmonary tuberculosis. Principal Findings: Here we show that the anti-tuberculosis protective immunity induced by four different tuberculosis vaccines was not impacted by a concurrent infection with Plasmodium yoelii NL, a nonlethal form of murine malaria. After an aerogenic challenge with virulent M. tuberculosis, the lung bacterial burdens of vaccinated animals were not statistically different in malaria infected and malaria naive mice. Multi-parameter flow cytometric analysis showed that the frequency and the median fluorescence intensities (MFI) for specific multifunctional T (MFT) cells expressing IFN-gamma, TNF-alpha, and/or IL-2 were suppressed by the presence of malaria parasites at 2 weeks following the malaria infection but was not affected after parasite clearance at 7 and 10 weeks post-challenge with P. yoelii NL. Conclusions: Our data indicate that the effectiveness of novel TB vaccines in protecting against tuberculosis was unaffected by a primary malaria co-infection in a mouse model of pulmonary tuberculosis. While the activities of specific MFT cell subsets were reduced at elevated levels of malaria parasitemia, the T cell suppression was short-lived. Our findings have important relevance in developing strategies for the deployment of new TB vaccines in malaria endemic areas.	[Parra, Marcela; Derrick, Steven C.; Yang, Amy; Tian, JinHua; Kolibab, Kristopher; Oakley, Miranda; Morris, Sheldon L.] US FDA, Off Vaccines Res & Review, Ctr Biol Evaluat & Review, Bethesda, MD 20014 USA; [Perera, Liyanage P.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Jacobs, William R.] Yeshiva Univ Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA; [Jacobs, William R.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Kumar, Sanjai] US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Review, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; US Food & Drug Administration (FDA)	Parra, M (corresponding author), US FDA, Off Vaccines Res & Review, Ctr Biol Evaluat & Review, Bethesda, MD 20014 USA.	steven.derrick@fda.hhs.gov		Jacobs, William/0000-0003-3321-3080	FDA	FDA(United States Department of Health & Human Services)	Annual lab budget allocation from the FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; Azzopardi P, 2009, INT J TUBERC LUNG D, V13, P1331; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Beresford B, 2010, CLIN INFECT DIS, V50, pS178, DOI 10.1086/651489; BRADLEYMOORE AM, 1985, ANN TROP MED PARASIT, V79, P563, DOI 10.1080/00034983.1985.11811963; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Buddle BM, 2002, VACCINE, V20, P1126, DOI 10.1016/S0264-410X(01)00436-4; Caruso AM, 1999, J IMMUNOL, V162, P5407; COLDITZ GA, 1995, PEDIATRICS, V96, P29; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Derrick SC, 2004, VACCINE, V23, P780, DOI 10.1016/j.vaccine.2004.07.036; Derrick SC, 2004, INFECT IMMUN, V72, P1685, DOI 10.1128/IAI.72.3.1685-1692.2004; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Dharmadhikari AS, 2008, AM J RESP CELL MOL, V39, P503, DOI 10.1165/rcmb.2008-0154TR; Elias D, 2005, VACCINE, V23, P1326, DOI 10.1016/j.vaccine.2004.09.038; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; Hawkes M, 2010, MICROBES INFECT, V12, P864, DOI 10.1016/j.micinf.2010.05.013; Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953; Hinchey J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015857; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Kolibab K, 2010, CLIN VACCINE IMMUNOL, V17, P793, DOI 10.1128/CVI.00006-10; Lambert PH, 2009, CLIN CHEST MED, V30, P811, DOI 10.1016/j.ccm.2009.08.014; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Mansoor N, 2009, J INFECT DIS, V199, P982, DOI 10.1086/597304; Matsumoto S, 2000, VACCINE, V19, P779, DOI 10.1016/S0264-410X(00)00257-7; Ocana-Morgner C, 2007, EUR J IMMUNOL, V37, P1562, DOI 10.1002/eji.200737068; Parida SK, 2010, CURR OPIN IMMUNOL, V22, P374, DOI 10.1016/j.coi.2010.04.006; Parra M, 2009, CLIN VACCINE IMMUNOL, V16, P1025, DOI 10.1128/CVI.00067-09; Perera PY, 2009, VACCINE, V27, P2121, DOI 10.1016/j.vaccine.2009.01.132; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Pouniotis DS, 2005, J IMMUNOL, V175, P3525, DOI 10.4049/jimmunol.175.6.3525; Range N, 2007, ANN TROP MED PARASIT, V101, P343, DOI 10.1179/136485907X176373; SCHELL RF, 1974, J RETICULOENDOTH SOC, V16, P131; Scott CP, 2004, AM J TROP MED HYG, V70, P144, DOI 10.4269/ajtmh.2004.70.144; SMRKOVSKI LL, 1978, J IMMUNOL, V121, P1257; SROUR EF, 1988, J PROTOZOOL, V35, P441, DOI 10.1111/j.1550-7408.1988.tb04127.x; Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107; Thapa R, 2010, INT J INFECT DIS, V14, pE254, DOI 10.1016/j.ijid.2009.04.005; von Reyn CF, 2006, CLIN INFECT DIS, V42, P559, DOI 10.1086/499959; WHITTLE HC, 1984, NATURE, V312, P449, DOI 10.1038/312449a0; WILLIAMSON WA, 1978, LANCET, V1, P1328; World Health Organization, 2010, GLOB TUB CONTR WHO R	44	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28164	10.1371/journal.pone.0028164	http://dx.doi.org/10.1371/journal.pone.0028164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205939	Green Submitted, Green Published, gold			2022-12-25	WOS:000298665600004
J	Daftary, GS; Lomberk, GA; Buttar, NS; Allen, TW; Grzenda, A; Zhang, JS; Zheng, Y; Mathison, AJ; Gada, RP; Calvo, E; Iovanna, JL; Billadeau, DD; Prendergast, FG; Urrutia, R				Daftary, Gaurang S.; Lomberk, Gwen A.; Buttar, Navtej S.; Allen, Thomas W.; Grzenda, Adrienne; Zhang, Jinsan; Zheng, Ye; Mathison, Angela J.; Gada, Ravi P.; Calvo, Ezequiel; Iovanna, Juan L.; Billadeau, Daniel D.; Prendergast, Franklyn G.; Urrutia, Raul			Detailed Structural-Functional Analysis of the Kruppel-like Factor 16 (KLF16) Transcription Factor Reveals Novel Mechanisms for Silencing Sp/KLF Sites Involved in Metabolism and Endocrinology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIAL STROMAL CELLS; IN-VITRO DECIDUALIZATION; ESTROGEN-RECEPTOR; REPRESSOR DOMAINS; PAH2 DOMAIN; SRC KINASE; 3 FINGERS; BINDING; PROTEIN; GROWTH	Kruppel-like factor (KLF) proteins have elicited significant attention due to their emerging key role in metabolic and endocrine diseases. Here, we extend this knowledge through the biochemical characterization of KLF16, unveiling novel mechanisms regulating expression of genes involved in reproductive endocrinology. We found that KLF16 selectively binds three distinct KLF-binding sites (GC, CA, and BTE boxes). KLF16 also regulated the expression of several genes essential for metabolic and endocrine processes in sex steroid-sensitive uterine cells. Mechanistically, we determined that KLF16 possesses an activation domain that couples to histone acetyltransferase-mediated pathways, as well as a repression domain that interacts with the histone deacetylase chromatin-remodeling system via all three Sin3 isoforms, suggesting a higher level of plasticity in chromatin cofactor selection. Molecular modeling combined with molecular dynamic simulations of the Sin3a-KLF16 complex revealed important insights into how this interaction occurs at an atomic resolution level, predicting that phosphorylation of Tyr-10 may modulate KLF16 function. Phosphorylation of KLF16 was confirmed by in vivo P-32 incorporation and controlled by a Y10F site-directed mutant. Inhibition of Src-type tyrosine kinase signaling as well as the nonphosphorylatable Y10F mutation disrupted KLF16-mediated gene silencing, demonstrating that its function is regulatable rather than constitutive. Subcellular localization studies revealed that signal-induced nuclear translocation and euchromatic compartmentalization constitute an additional mechanism for regulating KLF16 function. Thus, this study lends insights on key biochemical mechanisms for regulating KLF sites involved in reproductive biology. These data also contribute to the new functional information that is applicable to understanding KLF16 and other highly related KLF proteins.	[Daftary, Gaurang S.; Zheng, Ye; Gada, Ravi P.] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA; [Lomberk, Gwen A.; Buttar, Navtej S.; Grzenda, Adrienne; Mathison, Angela J.; Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Lomberk, Gwen A.; Allen, Thomas W.; Prendergast, Franklyn G.; Urrutia, Raul] Mayo Clin, Dept Biol & Mol Biol, Rochester, MN 55905 USA; [Zhang, Jinsan; Billadeau, Daniel D.] Mayo Clin, Dept Oncol Res, Rochester, MN 55905 USA; [Calvo, Ezequiel] CHUL Res Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Iovanna, Juan L.] INSERM, U624, F-13276 Marseille, France	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Daftary, GS (corresponding author), Mayo Clin, Dept Obstet & Gynecol, Guggenheim 10,200 1st St SW, Rochester, MN 55905 USA.	daftary.gaurang@mayo.edu; urrutia.raul@mayo.edu	Grzenda, Adrienne L/K-4421-2019; Lomberk, Gwen/AAL-8490-2020; Iovanna, Juan/M-9805-2017	Grzenda, Adrienne L/0000-0001-5952-6953; Lomberk, Gwen/0000-0001-5463-789X; Iovanna, Juan/0000-0003-1822-2237; Mathison, Angela/0000-0002-6763-2710; Allen, Thomas/0000-0002-1107-1416	National Institutes of Health [DK52913]; Mayo Foundation; NATIONAL CANCER INSTITUTE [T32CA148073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R56DK052913, R01DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK52913 (to R. U.). This work was also supported by the Mayo Foundation	Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Brubaker K, 2000, CELL, V103, P655, DOI 10.1016/S0092-8674(00)00168-9; Buttar NS, 2010, J BIOL CHEM, V285, P11433, DOI 10.1074/jbc.M109.077065; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; CUMMINGS AM, 1995, FUND APPL TOXICOL, V27, P287, DOI 10.1006/faat.1995.1135; CUMMINGS AM, 1995, REPROD TOXICOL, V9, P233, DOI 10.1016/0890-6238(95)00004-T; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; FUJIIKURIYAMA Y, 1992, FASEB J, V6, P706, DOI 10.1096/fasebj.6.2.1537460; Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Gutierrez-Aguilar R, 2008, J CLIN ENDOCR METAB, V93, P3128, DOI 10.1210/jc.2007-2504; Hadfield RM, 2001, MOL HUM REPROD, V7, P1073, DOI 10.1093/molehr/7.11.1073; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Johnson KL, 1997, ENVIRON HEALTH PERSP, V105, P750, DOI 10.1289/ehp.97105750; Kaczynski J, 2001, J BIOL CHEM, V276, P36749, DOI 10.1074/jbc.M105831200; KORACH KS, 1994, SCIENCE, V266, P1524, DOI 10.1126/science.7985022; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Maruyama T, 1999, ENDOCRINOLOGY, V140, P2632, DOI 10.1210/en.140.6.2632; Maruyama T, 1999, ENDOCRINOLOGY, V140, P5982, DOI 10.1210/endo.140.12.7184; Mayani A, 1997, HUM REPROD, V12, P373, DOI 10.1093/humrep/12.2.373; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; Pang YP, 2003, FEBS LETT, V548, P108, DOI 10.1016/S0014-5793(03)00749-X; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Shah YM, 2005, MOL ENDOCRINOL, V19, P732, DOI 10.1210/me.2004-0298; Shimizu A, 2005, BIOL REPROD, V73, P1219, DOI 10.1095/biolreprod.105.041616; Shiozawa T, 2003, J CLIN ENDOCR METAB, V88, P871, DOI 10.1210/jc.2002-020946; Simmen RCM, 2004, J BIOL CHEM, V279, P29286, DOI 10.1074/jbc.M403139200; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; Tsuchiya Y, 2005, CANCER LETT, V227, P115, DOI 10.1016/j.canlet.2004.10.007; Vermeulen M, 2006, MOL CELL BIOL, V26, P5226, DOI 10.1128/MCB.00440-06; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Yager JD, 1996, ANNU REV PHARMACOL, V36, P203, DOI 10.1146/annurev.pa.36.040196.001223; Zhang DY, 2002, ENDOCRINOLOGY, V143, P62, DOI 10.1210/en.143.1.62; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	46	32	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7010	7025		10.1074/jbc.M111.266007	http://dx.doi.org/10.1074/jbc.M111.266007			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22203677	Green Published, hybrid			2022-12-25	WOS:000301060200007
J	Antigny, F; Girardin, N; Frieden, M				Antigny, Fabrice; Girardin, Nathalie; Frieden, Maud			Transient Receptor Potential Canonical Channels Are Required for in Vitro Endothelial Tube Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES CRAC CHANNELS; PERMANENT CELL-LINE; CA2+ ENTRY; ENDOPLASMIC-RETICULUM; ION CHANNELS; STORE; ANGIOGENESIS; STIM1; ORAI1; PROLIFERATION	In endothelial cells Ca2+ entry is an essential component of the Ca2+ signal that takes place during processes such as cell proliferation or angiogenesis. Ca2+ influx occurs via the store-operated Ca2+ entry pathway, involving stromal interaction molecule-1 (STIM1) and Orai1, but also through channels gated by second messengers like the transient receptor potential canonical (TRPC) channels. The human umbilical vein-derived endothelial cell line EA.hy926 expressed STIM1 and Orai1 as well as several TRPC channels. By invalidating each of these molecules, we showed that TRPC3, TRPC4, and TRPC5 are essential for the formation of tubular structures observed after EA.hy926 cells were plated on Matrigel. On the contrary, the silencing of STIM1 or Orai1 did not prevent tubulogenesis. Soon after being plated on Matrigel, the cells displayed spontaneous Ca2+ oscillations that were strongly reduced by treatment with siRNA against TRPC3, TRPC4, or TRPC5, but not siRNA against STIM1 or Orai1. Furthermore, we showed that cell proliferation was reduced upon siRNA treatment against TRPC3, TRPC5, and Orai1 channels, whereas the knockdown of STIM1 had no effect. On primary human umbilical vein endothelial cells, TRPC1, TRPC4, and STIM1 are involved in tube formation, whereas Orai1 has no effect. These data showed that TRPC channels are essential for in vitro tubulogenesis, both on endothelial cell line and on primary endothelial cells.	[Antigny, Fabrice; Girardin, Nathalie; Frieden, Maud] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva	Frieden, M (corresponding author), Ctr Med Univ Geneva, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	maud.frieden@unige.ch	Antigny, Fabrice/Q-3999-2018	Antigny, Fabrice/0000-0002-9515-6571; Frieden, Maud/0000-0001-7135-0874	Swiss National Science Foundation [31000-120186/1]; Carlos and Elsie de Reuter Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Carlos and Elsie de Reuter Foundation	This work was supported by the Swiss National Science Foundation Grant 31000-120186/1 and by the Carlos and Elsie de Reuter Foundation.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Alessandro R, 1998, BIOCHEM BIOPH RES CO, V248, P635, DOI 10.1006/bbrc.1998.8705; Antigny F, 2011, CELL CALCIUM, V49, P115, DOI 10.1016/j.ceca.2010.12.001; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Capiod T, 2011, BIOCHIMIE, V93, P2075, DOI 10.1016/j.biochi.2011.07.015; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; El Boustany C, 2010, CELL CALCIUM, V47, P350, DOI 10.1016/j.ceca.2010.01.006; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Ge RL, 2009, CANCER LETT, V283, P43, DOI 10.1016/j.canlet.2009.03.023; Girardin NC, 2010, PFLUG ARCH EUR J PHY, V460, P109, DOI 10.1007/s00424-010-0825-1; Hamdollah Zadeh MA, 2008, MICROCIRCULATION, V15, P605, DOI 10.1080/10739680802220323; Jousset H, 2008, CELL CALCIUM, V43, P83, DOI 10.1016/j.ceca.2007.04.006; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Munaron L, 2009, CURR MED CHEM, V16, P4691, DOI 10.2174/092986709789878210; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shuttleworth Trevor J, 2004, Sci STKE, V2004, ppe40, DOI 10.1126/stke.2432004pe40; Tapia V, 2011, GYNECOL ONCOL, V121, P13, DOI 10.1016/j.ygyno.2010.12.341; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang YJ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3148pe42; Wong CO, 2011, ADV EXP MED BIOL, V704, P759, DOI 10.1007/978-94-007-0265-3_40; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yu PC, 2010, CIRC RES, V106, P1221, DOI 10.1161/CIRCRESAHA.109.207670; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	41	76	77	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5917	5927		10.1074/jbc.M111.295733	http://dx.doi.org/10.1074/jbc.M111.295733			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203682	Green Published, hybrid			2022-12-25	WOS:000300638000066
J	Naeeni, AR; Conte, MR; Bayfield, MA				Naeeni, Amir R.; Conte, Maria R.; Bayfield, Mark A.			RNA Chaperone Activity of Human La Protein Is Mediated by Variant RNA Recognition Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR TRANSFER-RNAS; DROSOPHILA-MELANOGASTER; STRUCTURAL-ANALYSIS; MESSENGER-RNA; IN-VITRO; BINDING; TRANSLATION; MATURATION; AUTOANTIGEN; ANTIGEN	La proteins are conserved factors in eukaryotes that bind and protect the 3' trailers of pre-tRNAs from exonuclease digestion via sequence-specific recognition of UUU-3'OH. La has also been hypothesized to assist pre-tRNAs in attaining their native fold through RNA chaperone activity. In addition to binding polymerase III transcripts, human La has also been shown to enhance the translation of several internal ribosome entry sites and upstream ORF-containing mRNA targets, also potentially through RNA chaperone activity. Using in vitro FRET-based assays, we show that human and Schizosaccharomyces pombe La proteins harbor RNA chaperone activity by enhancing RNA strand annealing and strand dissociation. We use various RNA substrates and La mutants to show that UUU-3'OH-dependent La-RNA binding is not required for this function, and we map RNA chaperone activity to its RRM1 motif including a noncanonical alpha 3-helix. We validate the importance of this alpha 3-helix by appending it to the RRM of the unrelated U1A protein and show that this fusion protein acquires significant strand annealing activity. Finally, we show that residues required for La-mediated RNA chaperone activity in vitro are required for La-dependent rescue of tRNA-mediated suppression via a mutated suppressor tRNA in vivo. This work delineates the structural elements required for La-mediated RNA chaperone activity and provides a basis for understanding how La can enhance the folding of its various RNA targets.	[Naeeni, Amir R.; Bayfield, Mark A.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Conte, Maria R.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	York University - Canada; University of London; King's College London	Bayfield, MA (corresponding author), York Univ, Dept Biol, 4700 Keele St,Life Sci Bldg 327E, Toronto, ON M3J 1P3, Canada.	bayfield@yorku.ca	Conte, Maria R/C-4102-2008; Conte, Maria/W-3088-2019	Conte, Maria R/0000-0001-8558-2051; Conte, Maria/0000-0001-8558-2051; Bayfield, Mark/0000-0002-8971-7598	Banting Research Foundation; Natural Sciences and Engineering Research Council of Canada; Wellcome Trust; Canadian Institutes of Health Research	Banting Research Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Banting Research Foundation and the Natural Sciences and Engineering Research Council of Canada (to M. A. B.), as well as The Wellcome Trust (to M. R. C.).; Supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Master's Award.	Alfano C, 2004, NAT STRUCT MOL BIOL, V11, P323, DOI 10.1038/nsmb747; Ali N, 2000, J BIOL CHEM, V275, P27531; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Bai CY, 2000, NUCLEIC ACIDS RES, V28, P1078, DOI 10.1093/nar/28.5.1078; Bayfield MA, 2007, MOL CELL BIOL, V27, P3303, DOI 10.1128/MCB.00026-07; Bayfield MA, 2010, BBA-GENE REGUL MECH, V1799, P365, DOI 10.1016/j.bbagrm.2010.01.011; Bayfield MA, 2009, NAT STRUCT MOL BIOL, V16, P430, DOI 10.1038/nsmb.1573; Belisova A, 2005, RNA, V11, P1084, DOI 10.1261/rna.7263905; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Bousquet-Antonelli C, 2009, RNA, V15, P750, DOI 10.1261/rna.1478709; Chakshusmathi G, 2003, EMBO J, V22, P6562, DOI 10.1093/emboj/cdg625; Copela LA, 2006, RNA, V12, P644, DOI 10.1261/rna.2307206; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Dong G, 2004, EMBO J, V23, P1000, DOI 10.1038/sj.emboj.7600115; Fan H, 1998, MOL CELL BIOL, V18, P3201, DOI 10.1128/MCB.18.6.3201; Goodier JL, 1997, MOL CELL BIOL, V17, P5823, DOI 10.1128/MCB.17.10.5823; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Horke S, 2002, J BIOL CHEM, V277, P34949, DOI 10.1074/jbc.M201911200; Huang Y, 2006, NAT STRUCT MOL BIOL, V13, P611, DOI 10.1038/nsmb1110; Intine RV, 2003, MOL CELL, V12, P1301, DOI 10.1016/S1097-2765(03)00429-5; Intine RV, 2002, MOL CELL, V9, P1113, DOI 10.1016/S1097-2765(02)00533-6; Intine RVA, 2000, MOL CELL, V6, P339, DOI 10.1016/S1097-2765(00)00034-4; Jacks A, 2003, STRUCTURE, V11, P833, DOI 10.1016/S0969-2126(03)00121-7; Johansson MJO, 2002, RNA, V8, P324, DOI 10.1017/S1355838202027851; Katzman S, 2008, BIOINFORMATICS, V24, P2453, DOI 10.1093/bioinformatics/btn438; Kotik-Kogan O, 2008, STRUCTURE, V16, P852, DOI 10.1016/j.str.2008.02.021; Kucera NJ, 2011, P NATL ACAD SCI USA, V108, P1308, DOI 10.1073/pnas.1017085108; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martino L., 2011, NUCL ACIDS IN PRESS; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Pudi R, 2004, J BIOL CHEM, V279, P29879, DOI 10.1074/jbc.M403417200; Rajkowitsch L, 2005, BIOCHEM SOC T, V33, P450, DOI 10.1042/BST0330450; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Rajkowitsch L, 2007, RNA, V13, P2053, DOI 10.1261/rna.671807; Rupert PB, 2003, ACTA CRYSTALLOGR D, V59, P1521, DOI 10.1107/S0907444903011338; Schwartz EI, 2004, MOL CELL BIOL, V24, P9580, DOI 10.1128/MCB.24.21.9580-9591.2004; Sommer G, 2011, ONCOGENE, V30, P434, DOI 10.1038/onc.2010.425; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; SVITKIN YV, 1994, J VIROL, V68, P7001, DOI 10.1128/JVI.68.11.7001-7007.1994; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Van Horn DJ, 1997, RNA, V3, P1434; Woodson SA, 2010, RNA BIOL, V7, P677, DOI 10.4161/rna.7.6.13615; Xue DH, 2000, EMBO J, V19, P1650, DOI 10.1093/emboj/19.7.1650; YOO CJ, 1994, MOL CELL BIOL, V14, P5412, DOI 10.1128/MCB.14.8.5412; Yoo CJ, 1997, CELL, V89, P393, DOI 10.1016/S0092-8674(00)80220-2	48	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5472	5482		10.1074/jbc.M111.276071	http://dx.doi.org/10.1074/jbc.M111.276071			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203678	hybrid, Green Published			2022-12-25	WOS:000300638000027
J	Wei, CX; Ding, SM; You, HH; Zhang, YR; Wang, Y; Yang, X; Yuan, JL				Wei, Chenxi; Ding, Shumao; You, Huihui; Zhang, Yaran; Wang, Yao; Yang, Xu; Yuan, Junlin			An Immunoassay for Dibutyl Phthalate Based on Direct Hapten Linkage to the Polystyrene Surface of Microtiter Plates	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; MONOCLONAL-ANTIBODY; SENSITIVE IMMUNOASSAY; RESIDUES; ELISA; PURIFICATION; GENERATION; HERBICIDE; ACID	Background: Dibutyl phthalate (DBP) is predominantly used as a plasticizer inplastics to make them flexible. Extensive use of phthalates in both industrial processes and other consumer products has resulted in the ubiquitous presence of phthalates in the environment. In order to better determine the level of pollution in the environment and evaluate the potential adverse effects of exposure to DBP, immunoassay for DBP was developed. Methodology/Principal Findings: A monoclonal antibody specific to DBP was produced from a stable hybridoma cell line generated by lymphocyte hybridoma technique. An indirect competitive enzyme-linked immunosorbent assay (icELISA) employing direct coating of hapten on polystyrene microtiter plates was established for the detection of DBP. Polystyrene surface was first oxidized by permanganate in dilute sulfuric acid to generate carboxyl groups. Then dibutyl 4-aminophthalate, which is an analogue of DBP, was covalently linked to the carboxyl groups of polystyrene surface with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC). Compared with conjugate coated format (IC50 = 106 ng/mL), the direct hapten coated format (IC50 = 14.6 ng/mL) improved assay sensitivity after careful optimization of assay conditions. The average recovery of DBP from spiked water sample was 104.4% and the average coefficient of variation was 9.95%. Good agreement of the results obtained by the hapten coated icELISA and gas chromatography-mass spectrometry further confirmed the reliability and accuracy of the icELISA for the detection of DBP in certain plastic and cosmetic samples. Conclusions/Significance: The stable and efficient hybridoma cell line obtained is an unlimited source of sensitive and specific antibody to DBP. The hapten coated format is proposed as generally applicable because the carboxyl groups on modified microtiter plate surface enables stable immobilization of aminated or hydroxylated hapten with EDC. The developed hapten coated icELISA can be used as a convenient quantitative tool for the sensitive and accurate monitoring DBP in water, plastic and cosmetic samples.	[Wei, Chenxi; Ding, Shumao; You, Huihui; Zhang, Yaran; Yang, Xu; Yuan, Junlin] Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Wang, Yao] Fudan Univ, Coll Life Sci, Shanghai 200433, Peoples R China	Central China Normal University; Fudan University	Wei, CX (corresponding author), Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	yangxu@mail.ccnu.edu.cn; yuanjl@mail.ccnu.edu.cn	Wei, Chenxi/C-8630-2016	Wei, Chenxi/0000-0002-3837-1881	National Science Foundation of China [51076079, 51136002]; Huazhong Normal University [2009029]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong Normal University	This work was supported by the National Science Foundation of China (51076079; 51136002) and the Graduate Independent Research Project of Huazhong Normal University (2009029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KC, 2004, J AGR FOOD CHEM, V52, P4583, DOI 10.1021/jf049646r; ATSDR, 2001, TOX PROF DI N BUT PH; Brun EM, 2004, J IMMUNOL METHODS, V295, P21, DOI 10.1016/j.jim.2004.08.014; Crowther J.R., 2001, ELISA GUIDEBOOK, P1; Estevez MC, 2005, ANAL CHEM, V77, P5283, DOI 10.1021/ac0502910; Feng Y, 2009, TALANTA, V80, P803, DOI 10.1016/j.talanta.2009.07.070; Holthues H, 2001, FRESEN J ANAL CHEM, V371, P897, DOI 10.1007/s002160101050; Hu YX, 2002, CELL RES, V12, P157, DOI 10.1038/sj.cr.7290122; James W.G., 1995, MONOCLONAL ANTIBODIE, P141; Jen JF, 2006, J CHROMATOGR A, V1130, P28, DOI 10.1016/j.chroma.2006.06.029; Kaur J, 2004, ANAL CHIM ACTA, V506, P133, DOI 10.1016/j.aca.2003.11.009; Kim KO, 2002, J AGR FOOD CHEM, V50, P6675, DOI 10.1021/jf025703+; Kramer PM, 2004, J AGR FOOD CHEM, V52, P2462, DOI 10.1021/jf035498d; Lee JK, 2002, J AGR FOOD CHEM, V50, P1791, DOI 10.1021/jf011150b; Lei HT, 2010, ANAL CHIM ACTA, V665, P84, DOI 10.1016/j.aca.2010.03.007; Lei HY, 2010, AFR J BIOTECHNOL, V9, P3026; Manclus JJ, 1996, J AGR FOOD CHEM, V44, P4052, DOI 10.1021/jf960144q; Mercader JV, 2008, J AGR FOOD CHEM, V56, P2581, DOI 10.1021/jf800157s; Moon JK, 2007, J AGR FOOD CHEM, V55, P5416, DOI 10.1021/jf070358f; Nakata M, 2001, PEST MANAG SCI, V57, P269, DOI 10.1002/ps.286; NTP-CERHR, 2003, NTP CERHR MON; Pastor-Navarro N, 2007, ANAL CHIM ACTA, V594, P211, DOI 10.1016/j.aca.2007.05.045; Plaza G, 2000, POL J ENVIRON STUD, V9, P231; Ramon-Azcon J, 2009, J AGR FOOD CHEM, V57, P375, DOI 10.1021/jf802821n; REIK LM, 1987, J IMMUNOL METHODS, V100, P123, DOI 10.1016/0022-1759(87)90180-3; Serodio P, 2006, WATER RES, V40, P2572, DOI 10.1016/j.watres.2006.05.002; Sugawara Y, 1998, ANAL CHEM, V70, P1092, DOI 10.1021/ac9708203; TEMPONI M, 1989, HYBRIDOMA, V8, P85, DOI 10.1089/hyb.1989.8.85; van Wezel AP, 2000, ECOTOX ENVIRON SAFE, V46, P305, DOI 10.1006/eesa.2000.1930; Wang ZH, 2007, ANAL CHEM, V79, P4471, DOI 10.1021/ac070064t; Watanabe E, 2002, J AGR FOOD CHEM, V50, P3637, DOI 10.1021/jf0114684; Xu T, 2007, J AGR FOOD CHEM, V55, P3764, DOI 10.1021/jf063287d; Yanaihara N, 2002, US patent, Patent No. [6.399.318, 6399318]; Yang ZY, 2006, J AGR FOOD CHEM, V54, P4551, DOI 10.1021/jf0606196; Zammatteo N, 1996, ANAL BIOCHEM, V236, P85, DOI 10.1006/abio.1996.0135; Zeravik J, 2004, ANAL CHEM, V76, P1021, DOI 10.1021/ac030217m; Zhang K, 2008, FOOD ADDIT CONTAM A, V25, P1416, DOI 10.1080/02652030802163380; Zhang MC, 2006, ANAL BIOANAL CHEM, V386, P1401, DOI 10.1007/s00216-006-0703-z; Zhou SX, 2005, CHINESE J PESTICIDES, V44, P337	39	28	33	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29196	10.1371/journal.pone.0029196	http://dx.doi.org/10.1371/journal.pone.0029196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216208	gold, Green Published, Green Submitted			2022-12-25	WOS:000300674900020
J	Chepelev, NL; Bennitz, JD; Huang, T; McBride, S; Willmore, WG				Chepelev, Nikolai L.; Bennitz, Joshua D.; Huang, Ting; McBride, Skye; Willmore, William G.			The Nrf1 CNC-bZIP Protein Is Regulated by the Proteasome and Activated by Hypoxia	PLOS ONE			English	Article							ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF1; ENDOPLASMIC-RETICULUM MEMBRANE; N-TERMINAL DOMAIN; OXIDATIVE STRESS; GENE-EXPRESSION; HEME OXYGENASE-1; PATHWAY; CELLS; DEGRADATION	Background: Nrf1 (nuclear factor-erythroid 2 p45 subunit-related factor 1) is a transcription factor mediating cellular responses to xenobiotic and pro-oxidant stress. Nrf1 regulates the transcription of many stress-related genes through the electrophile response elements (EpREs) located in their promoter regions. Despite its potential importance in human health, the mechanisms controlling Nrf1 have not been addressed fully. Principal Findings: We found that proteasomal inhibitors MG-132 and clasto-lactacystin-b-lactone stabilized the protein expression of full-length Nrf1 in both COS7 and WFF2002 cells. Concomitantly, proteasomal inhibition decreased the expression of a smaller, N-terminal Nrf1 fragment, with an approximate molecular weight of 23 kDa. The EpRE-luciferase reporter assays revealed that proteasomal inhibition markedly inhibited the Nrf1 transactivational activity. These results support earlier hypotheses that the 26 S proteasome processes Nrf1 into its active form by removing its inhibitory N-terminal domain anchoring Nrf1 to the endoplasmic reticulum. Immunoprecipitation demonstrated that Nrf1 is ubiquitinated and that proteasomal inhibition increased the degree of Nrf1 ubiquitination. Furthermore, Nrf1 protein had a half-life of approximately 5 hours in COS7 cells. In contrast, hypoxia (1% O-2) significantly increased the luciferase reporter activity of exogenous Nrf1 protein, while decreasing the protein expression of p65, a shorter form of Nrf1, known to act as a repressor of EpRE-controlled gene expression. Finally, the protein phosphatase inhibitor okadaic acid activated Nrf1 reporter activity, while the latter was repressed by the PKC inhibitor staurosporine. Conclusions: Collectively, our data suggests that Nrf1 is controlled by several post-translational mechanisms, including ubiquitination, proteolytic processing and proteasomal-mediated degradation as well as by its phosphorylation status.	[Chepelev, Nikolai L.; Bennitz, Joshua D.; Huang, Ting; McBride, Skye; Willmore, William G.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Willmore, William G.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada	Carleton University; Carleton University	Chepelev, NL (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	Bill_Willmore@carleton.ca		Bennitz, Joshua/0000-0003-3475-7848	Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada to WGW and an NSERC Canada Graduate Scholarship to NLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Dickinson DA, 2003, FASEB J, V17, P473, DOI 10.1096/fj.02-0566fje; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Magnani M., 2000, Current Drug Targets, V1, P387, DOI 10.2174/1389450003349056; Mera K, 2010, BIOCHEM BIOPH RES CO, V397, P350, DOI 10.1016/j.bbrc.2010.05.128; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; NIKI E, 1990, METHOD ENZYMOL, V186, P100; Nouhi Z, 2007, FEBS LETT, V581, P5401, DOI 10.1016/j.febslet.2007.10.041; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Satoh T, 2009, BIOCHEM BIOPH RES CO, V380, P298, DOI 10.1016/j.bbrc.2009.01.063; SCHNEIDERPOETSC.T, 2010, CHEM BIOL, V6, P209; Schultz Michelle A, 2010, Cancers (Basel), V2, P1354, DOI 10.3390/cancers2021354; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tanaka K, 2001, BIOCHIMIE, V83, P351, DOI 10.1016/S0300-9084(01)01237-8; TERAO K, 1986, Journal of Free Radicals in Biology and Medicine, V2, P193; Waleh NS, 1998, CARCINOGENESIS, V19, P1333, DOI 10.1093/carcin/19.8.1333; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Yamasaki M, 2007, ONCOL REP, V18, P1145; Zhang H, 2008, AM J RESP CELL MOL, V38, P483, DOI 10.1165/rcmb.2007-0260OC; Zhang HQ, 2010, BBA-GENE REGUL MECH, V1799, P496, DOI 10.1016/j.bbagrm.2010.05.003; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2010, BIOCHEM J, V430, P497, DOI 10.1042/BJ20100471; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhao R, 2011, ENVIRON HEALTH PERSP, V119, P56, DOI 10.1289/ehp.1002304; Zhu M, 2001, BIOCHEM BIOPH RES CO, V289, P212, DOI 10.1006/bbrc.2001.5944	50	28	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29167	10.1371/journal.pone.0029167	http://dx.doi.org/10.1371/journal.pone.0029167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216197	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600062
J	Thambisetty, M; Simmons, A; Hye, A; Campbell, J; Westman, E; Zhang, Y; Wahlund, LO; Kinsey, A; Causevic, M; Killick, R; Kloszewska, I; Mecocci, P; Soininen, H; Tsolaki, M; Vellas, B; Spenger, C; Lovestone, S				Thambisetty, Madhav; Simmons, Andrew; Hye, Abdul; Campbell, James; Westman, Eric; Zhang, Yi; Wahlund, Lars-Olof; Kinsey, Anna; Causevic, Mirsada; Killick, Richard; Kloszewska, Iwona; Mecocci, Patrizia; Soininen, Hilkka; Tsolaki, Magda; Vellas, Bruno; Spenger, Christian; Lovestone, Simon		AddNeuroMed Consortium	Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID BIOMARKERS; CLUSTERIN CONCENTRATION; COMPLEMENT; DEMENTIA; PROTEINS; PROGRESSION; PREDICTION; TRIALS	Peripheral biomarkers of Alzheimer's disease (AD) reflecting early neuropathological change are critical to the development of treatments for this condition. The most widely used indicator of AD pathology in life at present is neuroimaging evidence of brain atrophy. We therefore performed a proteomic analysis of plasma to derive biomarkers associated with brain atrophy in AD. Using gel based proteomics we previously identified seven plasma proteins that were significantly associated with hippocampal volume in a combined cohort of subjects with AD (N = 27) and MCI (N = 17). In the current report, we validated this finding in a large independent cohort of AD (N = 79), MCI (N = 88) and control (N = 95) subjects using alternative complementary methods-quantitative immunoassays for protein concentrations and estimation of pathology by whole brain volume. We confirmed that plasma concentrations of five proteins, together with age and sex, explained more than 35% of variance in whole brain volume in AD patients. These proteins are complement components C3 and C3a, complement factor-I, gamma-fibrinogen and alpha-1-microglobulin. Our findings suggest that these plasma proteins are strong predictors of in vivo AD pathology. Moreover, these proteins are involved in complement activation and coagulation, providing further evidence for an intrinsic role of these pathways in AD pathogenesis.	[Thambisetty, Madhav; Lovestone, Simon] NIA, Lab Behav Neurosci, NIH, Baltimore, MD 21224 USA; [Simmons, Andrew; Hye, Abdul; Westman, Eric; Kinsey, Anna; Causevic, Mirsada; Killick, Richard] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Campbell, James] Proteome Sci Plc, Cobham, England; [Zhang, Yi; Spenger, Christian] Karolinska Inst, Div Radiol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Wahlund, Lars-Olof] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Sect Clin Geriatr, Stockholm, Sweden; [Kloszewska, Iwona] Med Univ Lodz, Dept Old Age Psychiat & Psychot Disorders, Lodz, Poland; [Mecocci, Patrizia] Univ Perugia, Dept Clin & Expt Med, Sect Gerontol & Geriatr, I-06100 Perugia, Italy; [Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Soininen, Hilkka] Univ Eastern Finland, Dept Neurol, Kuopio, Finland; [Tsolaki, Magda] Aristotle Univ Thessaloniki, Dept Neurol, GR-54006 Thessaloniki, Greece; [Vellas, Bruno] Hop Toulouse, Dept Internal & Geriatr Med, Toulouse, France	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; King's College London; Karolinska Institutet; Karolinska Institutet; Medical University Lodz; University of Perugia; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Aristotle University of Thessaloniki; CHU de Toulouse	Thambisetty, M (corresponding author), NIA, Lab Behav Neurosci, NIH, Baltimore, MD 21224 USA.	thambisettym@mail.nih.gov	Westman, Eric/H-5771-2011; Causevic, Mirsada/AAM-7423-2020; Simmons, Andrew/B-8848-2008; Mecocci, Patrizia/W-2116-2019	Westman, Eric/0000-0002-3115-2977; Causevic, Mirsada/0000-0002-6099-6415; Simmons, Andrew/0000-0003-2306-5811; Mecocci, Patrizia/0000-0003-0729-5246; Lovestone, Simon/0000-0003-0473-4565; Campbell, James/0000-0001-6756-8766; Killick, Richard/0000-0002-8815-3436; Tsolaki, Magda/0000-0002-2072-8010; wahlund, lars-olof/0000-0002-9905-8426; Kinsey, Anna/0000-0001-8987-5353	European Union [FP6-2004-LIFESCIHEALTH-5]; Alzheimer's Society at the Institute of Psychiatry, King's College London; National Institute for Health Research Biomedical Research Centre for Mental Health at South London; Maudsley National Health Service Foundation Trust; Institute of Psychiatry, King's College London.; MRC [G0400061] Funding Source: UKRI; Alzheimers Research UK [ART-PG2000-1, ART-ESG2006-3, ART-PG2010-4] Funding Source: researchfish; Medical Research Council [G0400061] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1045] Funding Source: researchfish	European Union(European Commission); Alzheimer's Society at the Institute of Psychiatry, King's College London; National Institute for Health Research Biomedical Research Centre for Mental Health at South London; Maudsley National Health Service Foundation Trust; Institute of Psychiatry, King's College London.(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by InnoMed (Innovative Medicines in Europe), an Integrated Project funded by the European Union of the Sixth Framework program priority FP6-2004-LIFESCIHEALTH-5, Life Sciences, Genomics and Biotechnology for Health. Madhav Thambisetty held an Alzheimer's Society Research Fellowship at the Institute of Psychiatry, King's College London, and was an Emanoel Lee medical research fellow at St. Cross College, Oxford. AS and SL were supported by funds from the National Institute for Health Research Biomedical Research Centre for Mental Health at South London (www.nihr.ac.uk) and Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; Cummings JL, 2007, NEUROLOGY, V69, P1622, DOI 10.1212/01.wnl.0000295996.54210.69; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Karas G, 2008, AM J NEURORADIOL, V29, P944, DOI 10.3174/ajnr.A0949; Lovestone S, 2007, J NUTR HEALTH AGING, V11, P359; Lyketsos CG, 2004, ALZ DIS ASSOC DIS, V18, P171; MATTILA KM, 1995, APPL THEOR ELECTROPH, V4, P189; Mills S, 2007, BRIT J RADIOL, V80, pS128, DOI 10.1259/bjr/79217686; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; MURPHY DGM, 1993, BIOL PSYCHIAT, V34, P612, DOI 10.1016/0006-3223(93)90153-5; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Shen Y, 2003, PROG NEUROBIOL, V70, P463, DOI 10.1016/j.pneurobio.2003.08.001; Simmons A, 2011, INT J GERIATR PSYCH, V26, P75, DOI 10.1002/gps.2491; Simonsen AH, 2007, ARCH NEUROL-CHICAGO, V64, P366, DOI 10.1001/archneur.64.3.366; Smith SM, 2007, NEUROIMAGE, V36, P1200, DOI 10.1016/j.neuroimage.2007.04.035; Stove S, 1996, CLIN DIAGN LAB IMMUN, V3, P175; Thambisetty M, 2012, NEUROIMAGE, V59, P212, DOI 10.1016/j.neuroimage.2011.07.056; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Thambisetty M, 2008, J NEUROL, V255, P1712, DOI 10.1007/s00415-008-0006-8; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; Wahlund LO, 2003, NEUROSCI LETT, V339, P99, DOI 10.1016/S0304-3940(02)01483-0; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	28	88	93	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28527	10.1371/journal.pone.0028527	http://dx.doi.org/10.1371/journal.pone.0028527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205954	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600021
J	Banno, M; Koide, T; Aleksic, B; Yamada, K; Kikuchi, T; Kohmura, K; Adachi, Y; Kawano, N; Kushima, I; Ikeda, M; Inada, T; Yoshikawa, T; Iwata, N; Ozaki, N				Banno, Masahiro; Koide, Takayoshi; Aleksic, Branko; Yamada, Kazuo; Kikuchi, Tsutomu; Kohmura, Kunihiro; Adachi, Yasunori; Kawano, Naoko; Kushima, Itaru; Ikeda, Masashi; Inada, Toshiya; Yoshikawa, Takeo; Iwata, Nakao; Ozaki, Norio			A Case Control Association Study and Cognitive Function Analysis of Neuropilin and Tolloid-Like 1 Gene and Schizophrenia in the Japanese Population	PLOS ONE			English	Article							NMDA RECEPTORS; EXPRESSION; FAMILIES	Background: Using a knock-out mouse model, it was shown that NETO1 is a critical component of the NMDAR complex, and that loss of Neto1 leads to impaired hippocampal long term potentiation and hippocampal-dependent learning and memory. Moreover, hemizygosity of NETO1 was shown to be associated with autistic-like behavior in humans. Purpose of the Research: We examined the association between schizophrenia and the neuropilin and tolloid-like 1 gene (NETO1). First, we selected eight single nucleotide polymorphisms (SNPs) within the NETO1 locus, based on the Japanese schizophrenia genome wide association study (JGWAS) results and previously conducted association studies. These SNPs were genotyped in the replication sample comprised of 963 schizophrenic patients and 919 healthy controls. We also examined the effect of associated SNPs on scores in the Continuous Performance Test and the Wisconsin Card Sorting Test Keio version (schizophrenic patients 107, healthy controls 104). Results: There were no significant allele-wise and haplotype-wise associations in the replication analysis after Bonferroni correction. However, in meta-analysis (JGWAS and replication dataset) three association signals were observed (rs17795324: p = 0.028, rs8098760: p = 0.017, rs17086492: p = 0.003). These SNPs were followed up but we could not detect the allele-specific effect on cognitive performance measured by the Continuous performance test (CPT) and Wisconsin Card Sorting test (WCST). Major Conclusions: We did not detect evidence for the association of NETO1 with schizophrenia in the Japanese population. Common variants within the NETO1 locus may not increase the genetic risk for schizophrenia in the Japanese population. Additionally, common variants investigated in the current study did not affect cognitive performance, as measured by the CPT and WCST.	[Banno, Masahiro; Koide, Takayoshi; Aleksic, Branko; Kikuchi, Tsutomu; Kohmura, Kunihiro; Adachi, Yasunori; Kawano, Naoko; Kushima, Itaru; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Showa Ku, Nagoya, Aichi, Japan; [Aleksic, Branko; Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Yamada, Kazuo; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan; [Kikuchi, Tsutomu] Matsuzaki Hosp, Miyakojima Ku, Osaka, Japan; [Inada, Toshiya] Seiwa Hosp, Inst Neuropsychiat, Dept Psychiat, Shinjuku Ku, Tokyo, Japan	Nagoya University; Fujita Health University; RIKEN	Banno, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Showa Ku, Nagoya, Aichi, Japan.	branko@med.nagoya-u.ac.jp	KUSHIMA, Itaru/M-8872-2014; Ozaki, Norio/M-8908-2014; Aleksic, Branko/G-1540-2011; Banno, Masahiro/E-5341-2010; Aleksic, Branko/L-7851-2019; Yoshikawa, Takeo/F-9599-2019	Ozaki, Norio/0000-0002-7360-4898; Aleksic, Branko/0000-0001-8982-4580; Banno, Masahiro/0000-0002-2539-1031; Aleksic, Branko/0000-0001-8982-4580; Ikeda, Masashi/0000-0001-6237-2449; Kushima, Itaru/0000-0002-0018-5178; Inada, Toshiya/0000-0002-8427-5639	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Science, Sports and Culture of Japan; Comparative Cognitive Science Institutes; Core Research for Evolutional Science and Technology	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Comparative Cognitive Science Institutes; Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST))	Funding for this study was provided by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare of Japan; Grant-in-Aid for "Integrated Research on Neuropsychiatric Disorders" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan; The Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes; and the Core Research for Evolutional Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksic B, 2010, SCHIZOPHR RES, V118, P113, DOI 10.1016/j.schres.2010.01.014; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; CORNBLATT BA, 1988, PSYCHIAT RES, V26, P223, DOI 10.1016/0165-1781(88)90076-5; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Gao XM, 2000, AM J PSYCHIAT, V157, P1141, DOI 10.1176/appi.ajp.157.7.1141; Heaton, 1981, WISCONSIN CARD SORTI; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hori H, 2006, SCHIZOPHR RES, V86, P138, DOI 10.1016/j.schres.2006.05.004; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; INAGAKI A, 2008, RINSHO SEISHIN YAKUR, P887; INAGAKI A, 2010, RINSHO SEISHIN YAKUR, P1349; Kashima H, 1987, NEUROPSYCHOLOGICAL I; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; O'Donnell L, 2010, HUM GENET, V128, P155, DOI 10.1007/s00439-010-0839-y; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Shi G, 2011, GENET EPIDEMIOL, V35, P111, DOI 10.1002/gepi.20556; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Steinpreis RE, 1996, BEHAV BRAIN RES, V74, P45, DOI 10.1016/0166-4328(95)00162-X; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Stohr H, 2002, GENE, V286, P223, DOI 10.1016/S0378-1119(02)00438-9; STRAUB C, 2011, NETOL NATURE N UNPUB; Suzuki H, 2011, PROG NEURO-PSYCHOPH, V35, P161, DOI 10.1016/j.pnpbp.2010.10.021; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Yamada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020468	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28929	10.1371/journal.pone.0028929	http://dx.doi.org/10.1371/journal.pone.0028929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205981	Green Published, Green Submitted, gold			2022-12-25	WOS:000298666200013
J	Sakaeda, T; Kadoyama, K; Okuno, Y				Sakaeda, Toshiyuki; Kadoyama, Kaori; Okuno, Yasushi			Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SIGNAL-DETECTION; ROSUVASTATIN; SAFETY; ATORVASTATIN; THERAPY; METAANALYSIS; EFFICACY; RISK	Objective: Adverse event reports (AERs) submitted to the US Food and Drug Administration (FDA) were reviewed to assess the muscular and renal adverse events induced by the administration of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) and to attempt to determine the rank-order of the association. Methods: After a revision of arbitrary drug names and the deletion of duplicated submissions, AERs involving pravastatin, simvastatin, atorvastatin, or rosuvastatin were analyzed. Authorized pharmacovigilance tools were used for quantitative detection of signals, i.e., drug-associated adverse events, including the proportional reporting ratio, the reporting odds ratio, the information component given by a Bayesian confidence propagation neural network, and the empirical Bayes geometric mean. Myalgia, rhabdomyolysis and an increase in creatine phosphokinase level were focused on as the muscular adverse events, and acute renal failure, non-acute renal failure, and an increase in blood creatinine level as the renal adverse events. Results: Based on 1,644,220 AERs from 2004 to 2009, signals were detected for 4 statins with respect to myalgia, rhabdomyolysis, and an increase in creatine phosphokinase level, but these signals were stronger for rosuvastatin than pravastatin and atorvastatin. Signals were also detected for acute renal failure, though in the case of atorvastatin, the association was marginal, and furthermore, a signal was not detected for non-acute renal failure or for an increase in blood creatinine level. Conclusions: Data mining of the FDA's adverse event reporting system, AERS, is useful for examining statin-associated muscular and renal adverse events. The data strongly suggest the necessity of well-organized clinical studies with respect to statin-associated adverse events.	[Sakaeda, Toshiyuki; Kadoyama, Kaori] Kyoto Univ, Grad Sch Pharmaceut Sci, Ctr Dev Integrat Educ Pharm & Pharmaceut Sci, Kyoto, Japan; [Okuno, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biosci Drug Discovery, Kyoto, Japan	Kyoto University; Kyoto University	Sakaeda, T (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Ctr Dev Integrat Educ Pharm & Pharmaceut Sci, Kyoto, Japan.	sakaedat@pharm.kyoto-u.ac.jp; okuno@pharm.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almenoff JS, 2007, CLIN PHARMACOL THER, V82, P157, DOI 10.1038/sj.clpt.6100258; Alsheikh-Ali AA, 2005, CIRCULATION, V111, P3051, DOI 10.1161/CIRCULATIONAHA.105.555482; [Anonymous], 2003, LANCET, V362, P1341; Athyros VG, 2004, J CLIN PATHOL, V57, P728, DOI 10.1136/jcp.2003.012989; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Cohen JS, 2004, LANCET, V364, P1579, DOI 10.1016/S0140-6736(04)17304-2; Colhoun HM, 2009, AM J KIDNEY DIS, V54, P810, DOI 10.1053/j.ajkd.2009.03.022; Di Stasi SL, 2010, PHYS THER, V90, P1530, DOI 10.2522/ptj.20090251; Dirks AJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1208, DOI 10.1152/ajpcell.00226.2006; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Florentinus SR, 2004, LANCET, V364, P1577, DOI 10.1016/S0140-6736(04)17301-7; Golomb BA, 2007, DRUG SAFETY, V30, P669, DOI 10.2165/00002018-200730080-00003; Gould AL, 2003, PHARMACOEPIDEM DR S, V12, P559, DOI 10.1002/pds.771; Harper CR, 2010, CURR ATHEROSCLER REP, V12, P322, DOI 10.1007/s11883-010-0120-9; Koren MJ, 2009, AM J KIDNEY DIS, V53, P741, DOI 10.1053/j.ajkd.2008.11.025; Lardizabal JA, 2010, VASC HEALTH RISK MAN, V6, P843, DOI 10.2147/VHRM.S9474; McKillop T, 2003, LANCET, V362, P1498, DOI 10.1016/S0140-6736(03)14698-3; Meyboom RHB, 2004, LANCET, V364, P1997, DOI 10.1016/S0140-6736(04)17525-9; Nicholls SJ, 2010, AM J CARDIOL, V105, P69, DOI 10.1016/j.amjcard.2009.08.651; Okie S, 2005, NEW ENGL J MED, V352, P1173, DOI 10.1056/NEJMp058029; Olsson GO, 2004, LANCET, V364, P135, DOI 10.1016/S0140-6736(04)16616-6; Oskarsson B, 2011, NEUROLOGY, V76, pS14, DOI 10.1212/WNL.0b013e31820c3648; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; Shepherd J, 2007, CLIN J AM SOC NEPHRO, V2, P1131, DOI 10.2215/CJN.04371206; Szarfman A, 2002, DRUG SAFETY, V25, P381, DOI 10.2165/00002018-200225060-00001; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Tomlinson SS, 2005, PHYS THER, V85, P459, DOI 10.1093/ptj/85.5.459; Toth PP, 2010, DRUGS, V70, P1363, DOI 10.2165/10898610-000000000-00000; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; Wolfe SM, 2004, LANCET, V363, P2189, DOI 10.1016/S0140-6736(04)16513-6; Zipes Douglas P, 2006, MedGenMed, V8, P73	35	48	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28124	10.1371/journal.pone.0028124	http://dx.doi.org/10.1371/journal.pone.0028124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205938	Green Submitted, Green Published, gold			2022-12-25	WOS:000298666200004
J	Madera, RF; Wang, JP; Libraty, DH				Madera, Rachel F.; Wang, Jennifer P.; Libraty, Daniel H.			The Combination of Early and Rapid Type I IFN, IL-1 alpha, and IL-1 beta Production Are Essential Mediators of RNA-Like Adjuvant Driven CD4+Th1 Responses	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; CD4 T-CELLS; INFLAMMATORY RESPONSE; ADAPTIVE IMMUNITY; MODIFIER R-848; ACTIVATION; VACCINE; INTERFERON; RECEPTOR; IL-1	There is a growing need for novel vaccine adjuvants that can provide safe and potent T-helper type 1 (Th1) activity. RNA-like immune response modifiers (IRMs) are candidate T-cell adjuvants that skew acquired immune responses towards a Th1 phenotype. We set out to delineate the essential signaling pathways by which the RNA-like IRMs, resiquimod (R-848) and polyinosinic: polycytidylic acid (poly I: C), augment CD4+ T-helper 1 (Th1) responses. Highly purified murine conventional dendritic cells (cDCs) and conventional CD4+ T-cells were co-cultured in allogeneic and MHC congenic mixed leukocyte reactions. The activation of CD4+ Th1 cells was examined utilizing cells from mice deficient in specific RNA-sensing pattern recognition receptors and signaling mediators. R-848 and poly I: C stimulation of Type I interferon production and signaling in cDCs was essential but not sufficient for driving CD4+ Th1 responses. The early and rapid production of IL-1 alpha and IL-1 beta was equally critical for the optimal activation of Th1 CD4+ T-cells. R-848 activation of Toll-like receptor 7/MyD88-dependent signaling in cDCs led to a rapid upregulation of pro-IL-1 alpha and pro-IL-1 beta production compared to poly I: C activation of MyD88-independent signaling pathways. The in vitro data show that CD4+ T-cell adjuvant activity of RNA-like IRMs is mediated by a critical combination of early and rapid Type I interferon, IL-1 alpha and IL-1 beta production. These results provide important insights into the key signaling pathways responsible for RNA-like IRM CD4+ Th1 activation. A better understanding of the critical signaling pathways by which RNA-like IRMs stimulate CD4+ Th1 responses is relevant to the rational design of improved vaccine adjuvants.	[Madera, Rachel F.; Wang, Jennifer P.; Libraty, Daniel H.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Madera, RF (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	daniel.libraty@umassmed.edu		wang, jennifer/0000-0002-2556-9100	National Institutes of Health [NIH U19 AI57319]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH U19 AI57319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen CL, 1999, CELL IMMUNOL, V197, P62, DOI 10.1006/cimm.1999.1555; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Fortier ME, 2004, AM J PHYSIOL-REG I, V287, pR759, DOI 10.1152/ajpregu.00293.2004; Glaccum MB, 1997, J IMMUNOL, V159, P3364; GUARDA G, IMMUNITY, V34, P213; Guo ZH, 2003, BLOOD, V102, P4441, DOI 10.1182/blood-2002-11-3420; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Higgins Sarah C, 2010, Curr Infect Dis Rep, V12, P4, DOI 10.1007/s11908-009-0080-9; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hurgin V, 2007, P NATL ACAD SCI USA, V104, P5044, DOI 10.1073/pnas.0611608104; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Jensen FC, 1998, ADV DRUG DELIV REV, V32, P173; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Luft T, 2002, J IMMUNOL, V168, P713, DOI 10.4049/jimmunol.168.2.713; Luheshi NM, 2009, TRAFFIC, V10, P16, DOI 10.1111/j.1600-0854.2008.00840.x; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; McAleer JP, 2010, TRENDS IMMUNOL, V31, P429, DOI 10.1016/j.it.2010.08.005; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nakae S, 2001, IMMUNOLOGY, V104, P402, DOI 10.1046/j.1365-2567.2001.01337.x; Nambu A, 2006, INT IMMUNOL, V18, P701, DOI 10.1093/intimm/dxl007; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Rajan JV, 2010, FEBS LETT, V584, P4627, DOI 10.1016/j.febslet.2010.10.036; Ramakrishna V, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-5; Re F, 2004, IMMUNOBIOLOGY, V209, P191, DOI 10.1016/j.imbio.2004.03.005; RICHARDTPARGMAN.D, 2010, IMMUNOBIOLOGY; Santini SM, 2002, J INTERF CYTOK RES, V22, P1071, DOI 10.1089/10799900260442494; Spranger S, 2010, J IMMUNOL, V185, P738, DOI 10.4049/jimmunol.1000060; STARUCH MJ, 1983, J IMMUNOL, V130, P2191; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Vasilakos JP, 2000, CELL IMMUNOL, V204, P64, DOI 10.1006/cimm.2000.1689; Wang JP, 2007, J IMMUNOL, V178, P3363, DOI 10.4049/jimmunol.178.6.3363; Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; Wang YM, 2010, J IMMUNOL, V184, P2751, DOI 10.4049/jimmunol.0903201; Zhang WW, 2008, INFECT IMMUN, V76, P3777, DOI 10.1128/IAI.01527-07; Zhou SH, 2009, J VIROL, V83, P1625, DOI 10.1128/JVI.01770-08; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	50	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29412	10.1371/journal.pone.0029412	http://dx.doi.org/10.1371/journal.pone.0029412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206014	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600037
J	Dancyger, AM; King, JJ; Quinlan, MJ; Fifield, H; Tucker, S; Saunders, HL; Berru, M; Magor, BG; Martin, A; Larijani, M				Dancyger, Alex M.; King, Justin J.; Quinlan, Matthew J.; Fifield, Heather; Tucker, Stephanie; Saunders, Holly L.; Berru, Maribel; Magor, Bradley G.; Martin, Alberto; Larijani, Mani			Differences in the enzymatic efficiency of human and bony fish AID are mediated by a single residue in the C terminus modulating single-stranded DNA binding	FASEB JOURNAL			English	Article						antibody diversification; DNA mutating enzymes; mechanisms of enzyme thermosensitivity	INDUCED CYTIDINE DEAMINASE; CLASS-SWITCH RECOMBINATION; ACTIVATION-INDUCED DEAMINASE; APOBEC3G CATALYTIC DOMAIN; CRYSTAL-STRUCTURE; PSYCHROPHILIC ENZYMES; SOMATIC HYPERMUTATION; AID/APOBEC FAMILY; EVOLUTION; ISOTYPE	Activation-induced cytidine deaminase (AID) mediates antibody diversification by deaminating deoxycytidines to deoxyuridine within immunoglobulin genes. However, it also generates genome-wide DNA lesions, leading to transformation. Though the biochemical properties of AID have been described, its 3-dimensional structure has not been determined. Hence, to investigate the relationship between the primary structure and biochemical characteristics of AID, we compared the properties of human and bony fish AID, since these are most divergent in amino acid sequence. We show that AIDs of various species have different catalytic rates that are thermosensitive and optimal at native physiological temperatures. Zebrafish AID is severalfold more catalytically robust than human AID, while catfish AID is least active. This disparity is mediated by a single amino acid difference in the C terminus. Using functional assays supported by models of AID core and surface structure, we show that this residue modulates activity by affecting ssDNA binding. Furthermore, the cold-adapted catalytic rates of fish AID result from increased ssDNA binding affinity at lower temperatures. Our work suggests that AID may generate DNA damage with variable efficiencies in different organisms, identifies residues critical in regulating AID activity, and provides insights into the evolution of the APOBEC family of enzymes.-Dancyger, A. M., King, J. J., Quinlan, M. J., Fifield, H., Tucker, S., Saunders, H. L., Berru, M., Magor, B. G., Martin, A., Larijani, M. Differences in the enzymatic efficiency of human and bony fish AID are mediated by a single residue in the C terminus modulating single-stranded DNA binding. FASEB J. 26, 1517-1525 (2012). www.fasebj.org	[Larijani, Mani] Mem Univ Newfoundland, Hlth Sci Ctr, Fac Med, Program Immunol & Infect Dis,Div Biomed Sci, St John, NF A1B 3V6, Canada; [Saunders, Holly L.; Magor, Bradley G.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Berru, Maribel; Martin, Alberto] Univ Toronto, Dept Immunol, Toronto, ON, Canada	Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Alberta; University of Toronto	Larijani, M (corresponding author), Mem Univ Newfoundland, Hlth Sci Ctr, Fac Med, Program Immunol & Infect Dis,Div Biomed Sci, Rm 1809A, St John, NF A1B 3V6, Canada.	mlarijani@mun.ca	Magor, Bradley/M-6352-2017	Magor, Bradley/0000-0003-4819-8530; Martin, Alberto/0000-0002-0795-0418	Canadian Instiutes of Health Research (CIHR) [MOP111132, MOP66965]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair award	Canadian Instiutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by operating grants from the Canadian Instiutes of Health Research (CIHR) to M. L. (MOP111132) and A. M. (MOP66965), and from the Natural Sciences and Engineering Research Council of Canada to B. M. A. D. is supported by a CIHR fellowship. A. M. is supported by a Canada Research Chair award. M. L. is supported by a CIHR New Investigator award.	Barreto VM, 2011, DEV COMP IMMUNOL, V35, P991, DOI 10.1016/j.dci.2011.02.005; Barreto VM, 2005, J EXP MED, V202, P733, DOI 10.1084/jem.20051378; Barreto VM, 2005, TRENDS IMMUNOL, V26, P90, DOI 10.1016/j.it.2004.12.004; Basu U, 2008, MOL CELL, V32, P285, DOI 10.1016/j.molcel.2008.08.019; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Coker HA, 2007, DNA REPAIR, V6, P235, DOI 10.1016/j.dnarep.2006.10.001; Coker HA, 2006, METHOD ENZYMOL, V408, P156, DOI 10.1016/S0076-6879(06)08010-4; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; D'Amico S, 2002, PHILOS T R SOC B, V357, P917, DOI 10.1098/rstb.2002.1105; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Durandy A, 2006, HUM MUTAT, V27, P1185, DOI 10.1002/humu.20414; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Gerday C, 1997, BBA-PROTEIN STRUCT M, V1342, P119, DOI 10.1016/S0167-4838(97)00093-9; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Ichikawa HT, 2006, J IMMUNOL, V177, P355, DOI 10.4049/jimmunol.177.1.355; Kohli RM, 2010, J BIOL CHEM, V285, P40956, DOI 10.1074/jbc.M110.177402; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Larijani M, 2005, IMMUNOGENETICS, V56, P840, DOI 10.1007/s00251-004-0748-0; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Larijani M, 2007, MOL CELL BIOL, V27, P20, DOI 10.1128/MCB.00824-06; Marshall CJ, 1997, TRENDS BIOTECHNOL, V15, P359, DOI 10.1016/S0167-7799(97)01086-X; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2007, DNA REPAIR, V6, P689, DOI 10.1016/j.dnarep.2007.01.001; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Saunders HL, 2004, DEV COMP IMMUNOL, V28, P657, DOI 10.1016/j.dci.2004.01.002; Saunders HL, 2010, DEV COMP IMMUNOL, V34, P669, DOI 10.1016/j.dci.2010.01.013; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Stavnezer J, 2004, SEMIN IMMUNOL, V16, P257, DOI 10.1016/j.smim.2004.08.005; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Wakae K, 2006, INT IMMUNOL, V18, P41, DOI 10.1093/intimm/dxh347; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Wang M, 2009, NAT STRUCT MOL BIOL, V16, P769, DOI 10.1038/nsmb.1623; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhao YF, 2005, DEV COMP IMMUNOL, V29, P61, DOI 10.1016/j.dci.2004.05.005	49	17	18	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1517	1525		10.1096/fj.11-198135	http://dx.doi.org/10.1096/fj.11-198135			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22198384				2022-12-25	WOS:000302359700014
J	Delley, CL; Striebel, F; Heydenreich, FM; Ozcelik, D; Weber-Ban, E				Delley, Cyrille L.; Striebel, Frank; Heydenreich, Franziska M.; Oezcelik, Dennis; Weber-Ban, Eilika			Activity of the Mycobacterial Proteasomal ATPase Mpa Is Reversibly Regulated by Pupylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; AAA PLUS PROTEIN; TUBERCULOSIS; PUP; IDENTIFICATION; TERMINI; PATHWAY; GATE; DOP	Pupylation is a bacterial post-translational modification of target proteins on lysine residues with prokaryotic ubiquitin-like protein Pup. Pup-tagged substrates are recognized by a proteasome-interacting ATPase termed Mpa in Mycobacterium tuberculosis. Mpa unfolds pupylated substrates and threads them into the proteasome core particle for degradation. Interestingly, Mpa itself is also a pupylation target. Here, we show that the Pup ligase PafA predominantly produces monopupylated Mpa modified homogeneously on a single lysine residue within its C-terminal region. We demonstrate that this modification renders Mpa functionally inactive. Pupylated Mpa can no longer support Pup-mediated proteasomal degradation due to its inability to associate with the proteasome core. Mpa is further inactivated by rapid Pup-and ATPase-driven deoligomerization of the hexameric Mpa ring. We show that pupylation of Mpa is chemically and functionally reversible. Mpa regains its enzymatic activity upon depupylation by the depupylase Dop, affording a rapid and reversible activity control over Mpa function.	[Delley, Cyrille L.; Striebel, Frank; Heydenreich, Franziska M.; Oezcelik, Dennis; Weber-Ban, Eilika] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), ETH, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	eilika@mol.biol.ethz.ch	Heydenreich, Franziska M/N-6314-2015; Özcelik, Dennis/M-9961-2019	Heydenreich, Franziska M/0000-0002-8049-4383; Özcelik, Dennis/0000-0002-7185-4690; Weber-Ban, Eilika/0000-0002-5773-9274	Swiss National Science Foundation; National Center for Excellence in Research Structural Biology of the Swiss National Science Foundation; ETH; Kekule fellowship by the "Fonds der Chemischen Industrie"	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Excellence in Research Structural Biology of the Swiss National Science Foundation; ETH(ETH Zurich); Kekule fellowship by the "Fonds der Chemischen Industrie"	This work was supported by the Swiss National Science Foundation, the National Center for Excellence in Research Structural Biology program of the Swiss National Science Foundation, an ETH research grant, and a Kekule fellowship by the "Fonds der Chemischen Industrie" (to F. S.).	BAIS R, 1975, ANAL BIOCHEM, V63, P271, DOI 10.1016/0003-2697(75)90215-8; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; Burns KE, 2010, J BACTERIOL, V192, P2933, DOI 10.1128/JB.01639-09; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Imkamp F, 2010, MOL MICROBIOL, V75, P744, DOI 10.1111/j.1365-2958.2009.07013.x; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Poulsen C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.39; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Summer H, 2006, J STRUCT BIOL, V156, P120, DOI 10.1016/j.jsb.2006.01.010; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Wang T, 2009, STRUCTURE, V17, P1377, DOI 10.1016/j.str.2009.08.010; Watrous J, 2010, MOL BIOSYST, V6, P376, DOI 10.1039/b916104j; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589	27	30	31	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7907	7914		10.1074/jbc.M111.331124	http://dx.doi.org/10.1074/jbc.M111.331124			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22210775	hybrid, Green Published			2022-12-25	WOS:000301349400007
J	Nelson, C; Glitsch, MD				Nelson, Charmaine; Glitsch, Maike D.			Lack of Kinase Regulation of Canonical Transient Receptor Potential 3 (TRPC3) Channel-dependent Currents in Cerebellar Purkinje Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE-RECEPTOR; PHOSPHOLIPASE-C; PHOSPHORYLATION; DIACYLGLYCEROL; TRAFFICKING; ACTIVATION; INHIBITION; EXPRESSION; INDUCTION	Canonical transient receptor potential (TRPC) channels are widely expressed in the brain and play several roles in development and normal neuronal function. In the cerebellum, Purkinje cell TRPC3 channels underlie the slow excitatory postsynaptic potential observed after parallel fiber stimulation. In these cells TRPC3 channel opening requires stimulation of metabotropic glutamate receptor 1, activation of which can also lead to the induction of long term depression (LTD), which underlies cerebellar motor learning. LTD induction requires protein kinase C (PKC) and protein kinase G (PKG) activation, and although PKC phosphorylation targets are well established, virtually nothing is known about PKG targets in LTD. Because TRPC3 channels are inhibited after phosphorylation by PKC and PKG in expression systems, we examined whether native TRPC3 channels in Purkinje cells are a target for PKG or PKC, thereby contributing to cerebellar LTD. We find that in Purkinje cells, activation of TRPC3-dependent currents is not inhibited by conventional PKC or PKG to any significant extent and that inhibition of these kinases does not significantly impact on TRPC3-mediated currents either. Based on these and previous findings, we propose that TRPC3-dependent currents may differ significantly in their regulation from those overexpressed in expression systems.	[Nelson, Charmaine; Glitsch, Maike D.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Glitsch, MD (corresponding author), Univ Oxford, DPAG, Sherrington Bldg,Parks Rd, Oxford OX1 3OT, England.	maike.glitsch@dpag.ox.ac.uk		Glitsch, Maike/0000-0003-0723-3117				Albert AP, 2006, J PHYSIOL-LONDON, V571, P361, DOI 10.1113/jphysiol.2005.102780; Albert AP, 2005, J PHYSIOL-LONDON, V566, P769, DOI 10.1113/jphysiol.2005.090852; Amaral MD, 2007, PHARMACOL THERAPEUT, V113, P394, DOI 10.1016/j.pharmthera.2006.09.005; Ambudkar I.S., 2004, NOVART FDN SYMP, V258; Ambudkar I.S., 2004, NOVART FDN SYMP, V258, P98; Ambudkar I.S., 2004, NOVART FDN SYMP, V258; Ambudkar Indu S, 2004, Novartis Found Symp, V258, P63; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Belmeguenai A, 2005, J NEUROSCI, V25, P10768, DOI 10.1523/JNEUROSCI.2876-05.2005; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Bollimuntha S, 2011, ADV EXP MED BIOL, V704, P573, DOI 10.1007/978-94-007-0265-3_31; Canepari M, 2006, J PHYSIOL-LONDON, V573, P65, DOI 10.1113/jphysiol.2005.103770; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; Glitsch MD, 2010, FASEB J, V24, P318, DOI 10.1096/fj.09-134973; Hartmann J, 2009, ACTA PHYSIOL, V195, P79, DOI 10.1111/j.1748-1716.2008.01923.x; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Harvey VL, 2004, EUR J NEUROSCI, V20, P684, DOI 10.1111/j.1460-9568.2004.03505.x; Hirono M, 2001, J BIOL CHEM, V276, P45236, DOI 10.1074/jbc.M105413200; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Huang WC, 2007, CELL CALCIUM, V42, P1, DOI 10.1016/j.ceca.2006.11.002; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kamouchi M, 1999, J PHYSIOL-LONDON, V518, P345, DOI 10.1111/j.1469-7793.1999.0345p.x; Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270; Kiselyov K, 2010, VITAM HORM, V83, P197, DOI 10.1016/S0083-6729(10)83008-0; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kondo T, 2005, EUR J NEUROSCI, V22, P1817, DOI 10.1111/j.1460-9568.2005.04319.x; Kwan HY, 2009, EUR J PHARMACOL, V602, P181, DOI 10.1016/j.ejphar.2008.10.054; Kwan HY, 2006, J CELL PHYSIOL, V207, P315, DOI 10.1002/jcp.20567; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lu W., 2011, CURR OPIN NEUROBIOL, V22, P1; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Remillard CV, 2006, MOL PHARMACOL, V70, P1151, DOI 10.1124/mol.106.029280; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Selvaraj S, 2010, CNS NEUROL DISORD-DR, V9, P94, DOI 10.2174/187152710790966650; Song MY, 2010, ADV EXP MED BIOL, V661, P99, DOI 10.1007/978-1-60761-500-2_6; Tai YL, 2009, PFLUG ARCH EUR J PHY, V458, P283, DOI 10.1007/s00424-008-0618-y; Trebak M., 2007, V179, P593; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Vazquez G, 2010, CHANNELS, V4, P232, DOI 10.4161/chan.4.3.12058; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Winklhofer A, 2003, NEUROPHARMACOLOGY, V44, P829, DOI 10.1016/S0028-3908(03)00070-4; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	51	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6326	6335		10.1074/jbc.M111.246553	http://dx.doi.org/10.1074/jbc.M111.246553			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207762	Green Published, hybrid			2022-12-25	WOS:000300791800025
J	Levic, S; Lv, P; Yamoah, EN				Levic, Snezana; Lv, Ping; Yamoah, Ebenezer N.			The Activity of Spontaneous Action Potentials in Developing Hair Cells Is Regulated by Ca2+-Dependence of a Transient K+ Current	PLOS ONE			English	Article							ACTIVITY-DEPENDENT DEVELOPMENT; PRENATAL AUDITORY ENRICHMENT; POTASSIUM CURRENTS; DEVELOPMENTAL-CHANGES; GENE-EXPRESSION; OUTWARD CURRENT; PROTEIN-KINASE; CALCIUM WAVES; INNER-EAR; CHANNEL	Spontaneous action potentials have been described in developing sensory systems. These rhythmic activities may have instructional roles for the functional development of synaptic connections. The importance of spontaneous action potentials in the developing auditory system is underpinned by the stark correlation between the time of auditory system functional maturity, and the cessation of spontaneous action potentials. A prominent K+ current that regulates patterning of action potentials is I-A. This current undergoes marked changes in expression during chicken hair cell development. Although the properties of I-A are not normally classified as Ca2+-dependent, we demonstrate that throughout the development of chicken hair cells, I-A is greatly reduced by acute alterations of intracellular Ca2+. As determinants of spike timing and firing frequency, intracellular Ca2+ buffers shift the activation and inactivation properties of the current to more positive potentials. Our findings provide evidence to demonstrate that the kinetics and functional expression of I-A are tightly regulated by intracellular Ca2+. Such feedback mechanism between the functional expression of I-A and intracellular Ca2+ may shape the activity of spontaneous action potentials, thus potentially sculpting synaptic connections in an activity-dependent manner in the developing cochlea.	[Levic, Snezana; Lv, Ping; Yamoah, Ebenezer N.] Univ Calif Davis, Sch Med, Dept Anesthesiol & Pain Med, Program Commun Sci, Davis, CA 95616 USA; [Lv, Ping] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China	University of California System; University of California Davis; Hebei Medical University	Levic, S (corresponding author), Univ Calif Davis, Sch Med, Dept Anesthesiol & Pain Med, Program Commun Sci, Davis, CA 95616 USA.	enyamoah@ucdavis.edu		Levic, Snezana/0000-0002-6171-896X	National Institutes of Health (NIH) [DC003826]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010917, R01DC003826] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (NIH) DC003826. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol I, 1999, EMBO J, V18, P4137, DOI 10.1093/emboj/18.15.4137; Alladi PA, 2005, INT J DEV NEUROSCI, V23, P363, DOI 10.1016/j.ijdevneu.2004.12.009; Alladi PA, 2005, J NEUROBIOL, V62, P92, DOI 10.1002/neu.20071; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Baxter D A, 1991, Curr Opin Neurobiol, V1, P105, DOI 10.1016/0959-4388(91)90017-2; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; BORN DE, 1985, J COMP NEUROL, V231, P435, DOI 10.1002/cne.902310403; Brandt N, 2007, J NEUROSCI, V27, P3174, DOI 10.1523/JNEUROSCI.3965-06.2007; Cai SQ, 2007, CURR PHARM DESIGN, V13, P3178, DOI 10.2174/138161207782341286; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; DUKES ID, 1991, J PHYSIOL-LONDON, V435, P395, DOI 10.1113/jphysiol.1991.sp018516; Dupont G, 2004, J CELL SCI, V117, P4313, DOI 10.1242/jcs.01278; Duzhyy DE, 2004, MOL BRAIN RES, V121, P70, DOI 10.1016/j.molbrainres.2003.10.022; Fields RD, 1996, TRENDS NEUROSCI, V19, P473, DOI 10.1016/S0166-2236(96)30013-1; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Griguer C, 1996, J NEUROPHYSIOL, V75, P508, DOI 10.1152/jn.1996.75.1.508; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; Hiel H, 2002, JARO-J ASSOC RES OTO, V3, P1, DOI 10.1007/s101620010071; Hofer T, 2002, J NEUROSCI, V22, P4850, DOI 10.1523/JNEUROSCI.22-12-04850.2002; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Housley GD, 2006, J MEMBRANE BIOL, V209, P89, DOI 10.1007/s00232-005-0835-7; JAHN H, 1988, EUR J BIOCHEM, V178, P535, DOI 10.1111/j.1432-1033.1988.tb14480.x; Johnson SL, 2007, J PHYSIOL-LONDON, V583, P631, DOI 10.1113/jphysiol.2007.136630; Johnson SL, 2011, NAT NEUROSCI, V14, P711, DOI 10.1038/nn.2803; Jones TA, 2001, J NEUROSCI, V21, P8129, DOI 10.1523/JNEUROSCI.21-20-08129.2001; Jones TA, 2006, J NEUROPHYSIOL, V96, P128, DOI 10.1152/jn.00599.2005; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kennedy HJ, 2002, J PHYSIOL-LONDON, V539, P15, DOI 10.1113/jphysiol.2001.013171; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Levic S, 2007, P NATL ACAD SCI USA, V104, P19108, DOI 10.1073/pnas.0705927104; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Marcotti W, 2004, J PHYSIOL-LONDON, V557, P613, DOI 10.1113/jphysiol.2003.060137; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Moser T, 2006, CELL TISSUE RES, V326, P347, DOI 10.1007/s00441-006-0276-3; MURROW BW, 1994, J PHYSIOL-LONDON, V480, P247, DOI 10.1113/jphysiol.1994.sp020357; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Park SY, 2003, MOL CELLS, V16, P256; Peretz A, 1999, J PHYSIOL-LONDON, V519, P373, DOI 10.1111/j.1469-7793.1999.0373m.x; Perrier E, 2004, J BIOL CHEM, V279, P40634, DOI 10.1074/jbc.M407470200; Rajeevan MS, 1999, MOL BRAIN RES, V66, P83, DOI 10.1016/S0169-328X(99)00012-1; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Saunders JC, 1998, J COMP NEUROL, V390, P412; Schrader LA, 2009, BIOCHEM J, V417, P705, DOI 10.1042/BJ20081213; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; Sokolowski BHA, 2004, J NEUROSCI, V24, P6265, DOI 10.1523/JNEUROSCI.1291-04.2004; Spitzer NC, 2002, J PHYSIOLOGY-PARIS, V96, P73, DOI 10.1016/S0928-4257(01)00082-1; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Venance L, 1997, J NEUROSCI, V17, P1981; Wagner J, 2004, CELL CALCIUM, V35, P433, DOI 10.1016/j.ceca.2003.10.009; Wang L, 1997, CIRC RES, V81, P120, DOI 10.1161/01.RES.81.1.120; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Zhang LI, 2001, NAT NEUROSCI	66	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29005	10.1371/journal.pone.0029005	http://dx.doi.org/10.1371/journal.pone.0029005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216155	Green Submitted, Green Published, gold			2022-12-25	WOS:000299684700023
J	Thomas, M; Wrzosek, L; Ben-Yahia, L; Noordine, ML; Gitton, C; Chevret, D; Langella, P; Mayeur, C; Cherbuy, C; Rul, F				Thomas, Muriel; Wrzosek, Laura; Ben-Yahia, Leila; Noordine, Marie-Louise; Gitton, Christophe; Chevret, Didier; Langella, Philippe; Mayeur, Camille; Cherbuy, Claire; Rul, Francoise			Carbohydrate Metabolism Is Essential for the Colonization of Streptococcus thermophilus in the Digestive Tract of Gnotobiotic Rats	PLOS ONE			English	Article							BETA-GALACTOSIDASE ACTIVITY; LACTOSE-INTOLERANCE; COMPARATIVE GENOMICS; ESCHERICHIA-COLI; TRANSPORT-SYSTEM; ADAPTATION; BACTERIA; YOGURT; MICROBIOTA; BUTYRATE	Streptococcus thermophilus is the archetype of lactose-adapted bacterium and so far, its sugar metabolism has been mainly investigated in vitro. The objective of this work was to study the impact of lactose and lactose permease on S. thermophilus physiology in the gastrointestinal tract (GIT) of gnotobiotic rats. We used rats mono-associated with LMD-9 strain and receiving 4.5% lactose. This model allowed the analysis of colonization curves of LMD-9, its metabolic profile, its production of lactate and its interaction with the colon epithelium. Lactose induced a rapid and high level of S. thermophilus in the GIT, where its activity led to 49 mM of intra-luminal L-lactate that was related to the induction of mono-carboxylic transporter mRNAs (SLC16A1 and SLC5A8) and p27(Kip1) cell cycle arrest protein in epithelial cells. In the presence of a continuous lactose supply, S. thermophilus recruited proteins involved in glycolysis and induced the metabolism of alternative sugars as sucrose, galactose, and glycogen. Moreover, inactivation of the lactose transporter, LacS, delayed S. thermophilus colonization. Our results show i/that lactose constitutes a limiting factor for colonization of S. thermophilus, ii/that activation of enzymes involved in carbohydrate metabolism constitutes the metabolic signature of S. thermophilus in the GIT, iii/that the production of lactate settles the dialogue with colon epithelium. We propose a metabolic model of management of carbohydrate resources by S. thermophilus in the GIT. Our results are in accord with the rationale that nutritional allegation via consumption of yogurt alleviates the symptoms of lactose intolerance.	[Thomas, Muriel; Wrzosek, Laura; Ben-Yahia, Leila; Noordine, Marie-Louise; Langella, Philippe; Mayeur, Camille; Cherbuy, Claire] INRA, Commensal & Probiot Host Interact Lab, Micalis UMR1319, Jouy En Josas, France; [Gitton, Christophe; Rul, Francoise] INRA, Peptides & Bacterial Commun Lab, Micalis UMR1319, Jouy En Josas, France; [Chevret, Didier] INRA, PAPPSO Plateforme Anal Prote Paris Sud Ouest Prot, Micalis UMR1319, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Thomas, M (corresponding author), INRA, Commensal & Probiot Host Interact Lab, Micalis UMR1319, Jouy En Josas, France.	muriel.thomas@jouy.inra.fr; francoise.rul@jouy.inra.fr	thomas, muriel/HDO-3887-2022; Langella, Philippe/N-8368-2017; Thomas, Muriel/D-9164-2015	Langella, Philippe/0000-0001-5960-4341; Thomas, Muriel/0000-0002-7608-3274; Rul, Francoise/0000-0002-7093-3098	Syndifrais-CNIEL (Syndicat National des Fabricants de Produits Frais/Centre National Interprofessionnel de l'Economie Laitiere) (Paris, France)	Syndifrais-CNIEL (Syndicat National des Fabricants de Produits Frais/Centre National Interprofessionnel de l'Economie Laitiere) (Paris, France)	This work was financially supported by Syndifrais-CNIEL (Syndicat National des Fabricants de Produits Frais/Centre National Interprofessionnel de l'Economie Laitiere) (Paris, France) (http://www.cniel.com/quifait/Syndicat/SYNDIFRAI/syndifr.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding has been received for this study.	Adolfsson O, 2004, AM J CLIN NUTR, V80, P245, DOI 10.1093/ajcn/80.2.245; Alonso-Casajus N, 2006, J BACTERIOL, V188, P5266, DOI 10.1128/JB.01566-05; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Bourassa L, 2009, MOL MICROBIOL, V72, P124, DOI 10.1111/j.1365-2958.2009.06629.x; Campbell Anthony K., 2005, Science Progress, V88, P157, DOI 10.3184/003685005783238408; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Cherbuy C, 2004, EUR J BIOCHEM, V271, P87, DOI 10.1046/j.1432-1033.2003.03908.x; CHERBUY C, 1995, GASTROENTEROLOGY, V109, P1890, DOI 10.1016/0016-5085(95)90756-4; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Delorme C, 2008, INT J FOOD MICROBIOL, V126, P274, DOI 10.1016/j.ijfoodmicro.2007.08.014; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Derzelle S, 2005, APPL ENVIRON MICROB, V71, P8597, DOI 10.1128/AEM.71.12.8597-8605.2005; Drouault S, 2002, APPL ENVIRON MICROB, V68, P938, DOI 10.1128/AEM.68.2.938-941.2002; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; FOUCAUD C, 1992, J BIOL CHEM, V267, P22087; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gardan R, 2009, J BACTERIOL, V191, P4647, DOI 10.1128/JB.00257-09; Guarner F, 2005, BRIT J NUTR, V93, P783, DOI 10.1079/BJN20051428; He T, 2008, J APPL MICROBIOL, V104, P595, DOI 10.1111/j.1365-2672.2007.03579.x; Hertzler SR, 1996, J AM DIET ASSOC, V96, P243, DOI 10.1016/S0002-8223(96)00074-0; Hertzler SR, 1996, AM J CLIN NUTR, V64, P232, DOI 10.1093/ajcn/64.2.232; Herve-Jimenez L, 2008, PROTEOMICS, V8, P4273, DOI 10.1002/pmic.200700489; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; HOVE H, 1995, DIGEST DIS SCI, V40, P320, DOI 10.1007/BF02065417; HOVE H, 1993, GUT, V34, P625, DOI 10.1136/gut.34.5.625; Joly F, 2009, AM J PHYSIOL-GASTR L, V297, pG116, DOI 10.1152/ajpgi.90657.2008; Lomer MCE, 2008, ALIMENT PHARM THER, V27, P93, DOI 10.1111/j.1365-2036.2007.03557.x; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Mater DDG, 2006, BRIT J NUTR, V96, P177, DOI 10.1079/BJN20061724; Munoz-Tamayo R, 2011, FEMS MICROBIOL ECOL, V76, P615, DOI 10.1111/j.1574-6941.2011.01085.x; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; POCHART P, 1989, AM J CLIN NUTR, V49, P828, DOI 10.1093/ajcn/49.5.828; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roy K, 2008, PROTEOMICS, V8, P1661, DOI 10.1002/pmic.200700698; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; Saavedra JM, 2004, AM J CLIN NUTR, V79, P261; Seibold GM, 2007, MICROBIOL-SGM, V153, P2212, DOI 10.1099/mic.0.2006/005181-0; Szilagyi A, 2002, ALIMENT PHARM THER, V16, P1591, DOI 10.1046/j.1365-2036.2002.01321.x; Turpin W, 2010, INT J FOOD MICROBIOL, V143, P87, DOI 10.1016/j.ijfoodmicro.2010.07.032; van den Bogaard PTC, 2000, J BACTERIOL, V182, P5982, DOI 10.1128/JB.182.21.5982-5989.2000; Veiga P, 2010, P NATL ACAD SCI USA, V107, P18132, DOI 10.1073/pnas.1011737107; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x	44	24	28	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28789	10.1371/journal.pone.0028789	http://dx.doi.org/10.1371/journal.pone.0028789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216112	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700011
J	Kavanagh, K; Robertson, C; McMenamin, J				Kavanagh, Kimberley; Robertson, Chris; McMenamin, Jim			Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach	PLOS ONE			English	Article								Background: Estimation of Influenza vaccine effectiveness (VE) varies with study design, clinical outcome considered and statistical methodology used. By estimating VE using differing outcomes and statistical methods on the same cohort of individuals the variability in the estimates produced can be better understood. The Pandemic Influenza Primary Care Reporting (PIPeR) cohort of approximately 193,000 individuals was used to estimate pandemic VE in Scotland during season 2009-10. VE results for three outcomes; influenza related consultations, virological confirmed influenza and death were considered. Use of individualised records allowed all models to be adjusted for age, sex, deprivation, risk status relating to chronic illnesses, seasonal vaccination status and a marker of the individual's propensity to consult. For the consultation and death outcomes, VE was calculated by comparing consultation rates in the unvaccinated and vaccinated groups, adjusted for the listed factors, using both Cox and Poisson regression models. For the consultation outcome, the unvaccinated group was split into individuals before vaccination and those never vaccinated to allow for potential differences in the health seeking behaviour of these groups. For the virology outcome estimates were calculated using a generalised additive logistic regression model. All models were adjusted for time. Vaccine effect was demonstrated for the influenza-like illness consultation outcome using the Cox model (VE = 49% 95% CI (19%, 67%)) with lower estimates from the model splitting the before and never vaccinated groups (VE = 34.2% with 95% CI (20.5%, 58.9%)). Vaccine effect was also illustrated for overall mortality (VE = 40% (95% CI 18%, 56%)) and a virological confirmed subset of symptomatic individuals (VE = 60% (95% CI -38%, 89%)). Conclusions: This study illustrates positive point estimates of Influenza VE across methodology and outcome for a single cohort of individuals during season 2009-10. Understanding of potential differences between approaches aids interpretation of VE results in future seasons.	[Kavanagh, Kimberley; Robertson, Chris] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Robertson, Chris; McMenamin, Jim] Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Robertson, Chris] Int Prevent Res Inst, Lyon, France	University of Strathclyde	Kavanagh, K (corresponding author), Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland.	kim.kavanagh@strath.ac.uk		Kavanagh, Kimberley/0000-0002-2679-5409	ECDC through Epiconcept (Paris); Scottish Government Department of Health and Wellbeing	ECDC through Epiconcept (Paris); Scottish Government Department of Health and Wellbeing	This work was funded by ECDC through Epiconcept (Paris) with additional support provided by Scottish Government Department of Health and Wellbeing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COX DR, 1972, J R STAT SOC B, V34, P187; ECDC, 2009, PROT CLUST INV MEAS; ECOSS (The Electronic Communication of Surveillance in Scotland), HLTH PROT SCOTL; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; FROME EL, 1973, J AM STAT ASSOC, V68, P935, DOI 10.2307/2284525; Hardelid P, 2011, EURO SURVEILL, V16; ISD, GEN PRACT PRACT TEAM; McLoone P, CARSTAIRS SCORES; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Wichmann O, 2010, EURO SURVEILL, V15; Wood SN, 2006, GEN ADD MOD INTRO R	14	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28743	10.1371/journal.pone.0028743	http://dx.doi.org/10.1371/journal.pone.0028743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216108	Green Published, Green Accepted, gold			2022-12-25	WOS:000299113600029
J	Yang, L; Agarwal, P				Yang, Lun; Agarwal, Pankaj			Systematic Drug Repositioning Based on Clinical Side-Effects	PLOS ONE			English	Article							BLOOD-PRESSURE; THERAPY; DISEASE; GLUCOSE; STROKE; MECHANISMS; DISCOVERY; TRIAL; RAT	Drug repositioning helps fully explore indications for marketed drugs and clinical candidates. Here we show that the clinical side-effects (SEs) provide a human phenotypic profile for the drug, and this profile can suggest additional disease indications. We extracted 3,175 SE-disease relationships by combining the SE-drug relationships from drug labels and the drug-disease relationships from PharmGKB. Many relationships provide explicit repositioning hypotheses, such as drugs causing hypoglycemia are potential candidates for diabetes. We built Naive Bayes models to predict indications for 145 diseases using the SEs as features. The AUC was above 0.8 in 92% of these models. The method was extended to predict indications for clinical compounds, 36% of the models achieved AUC above 0.7. This suggests that closer attention should be paid to the SEs observed in trials not just to evaluate the harmful effects, but also to rationally explore the repositioning potential based on this "clinical phenotypic assay''.	[Yang, Lun; Agarwal, Pankaj] GlaxoSmithKline, Computat Biol, Quantitat Sci, Med Discovery & Dev, Philadelphia, PA USA	GlaxoSmithKline	Yang, L (corresponding author), GlaxoSmithKline, Computat Biol, Quantitat Sci, Med Discovery & Dev, Philadelphia, PA USA.	Lun.Yang@gmail.com	Agarwal, Pankaj/N-2147-2019; Yang, Lun/B-4859-2012	Agarwal, Pankaj/0000-0002-4165-9990				Abolfazli R, 2011, DEPRESS ANXIETY, V28, P297, DOI 10.1002/da.20801; Albayram S, 2002, AM J NEURORADIOL, V23, P618; Altman RB, 2007, NAT GENET, V39, P426, DOI 10.1038/ng0407-426; Andersson C, 1999, J INTERN MED, V245, P193, DOI 10.1046/j.1365-2796.1999.0448e.x; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Blazer-Yost BL, 2010, PPAR RES, V2010, DOI [10.1155/2010/785369, 10.1155/2010/274376]; Bosch J, 2002, BMJ-BRIT MED J, V324, P699, DOI 10.1136/bmj.324.7339.699; Buchan NS, 2011, DRUG DISCOV TODAY, V16, P426, DOI 10.1016/j.drudis.2011.03.002; Burnett AL, 2006, UROLOGY, V67, P1043, DOI 10.1016/j.urology.2005.11.045; Burns P, 2003, BMJ-BRIT MED J, V326, P584, DOI 10.1136/bmj.326.7389.584; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Capers Q, 1997, CIRC RES, V80, P838; Chiang AP, 2009, CLIN PHARMACOL THER, V86, P507, DOI 10.1038/clpt.2009.103; Chiba S, 2010, PSYCHOPHARMACOLOGY, V211, P291, DOI 10.1007/s00213-010-1894-8; Dechanet J, 1999, J INFECT DIS, V179, P1, DOI 10.1086/314568; DOCHERTY JR, 1988, N-S ARCH PHARMACOL, V337, P1; Ekins Sean, 2005, Expert Opin Drug Metab Toxicol, V1, P303, DOI 10.1517/17425255.1.2.303; FELEKE E, 1983, ACTA MED SCAND, V213, P381; Fernandez HH, 2003, NEUROLOGIST, V9, P16, DOI 10.1097/01.nrl.0000038585.58012.97; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Gross U, 2000, J INHERIT METAB DIS, V23, P641, DOI 10.1023/A:1005645624262; Hall M, 2009, SIGKDD EXPL; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Ibarra-Lara L, 2010, EUR J PHARMACOL, V627, P185, DOI 10.1016/j.ejphar.2009.10.039; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kendig EL, 2008, BIOCHEM PHARMACOL, V76, P216, DOI 10.1016/j.bcp.2008.05.001; Kernohan AFB, 2007, CLIN ENDOCRINOL, V66, P27, DOI 10.1111/j.1365-2265.2006.02679.x; Landriscina M, 2009, PROSTATE, V69, P744, DOI 10.1002/pros.20923; Luo H, 2011, NUCL ACIDS RES; Mallat Z, 2009, CIRC RES, V105, P827, DOI 10.1161/CIRCRESAHA.109.208595; Nemets B, 2005, J CLIN PSYCHIAT, V66, P586, DOI 10.4088/JCP.v66n0507; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Nijland HMJ, 2006, CLIN INFECT DIS, V43, P848, DOI 10.1086/507543; O'Regan C, 2008, AM J MED, V121, P24, DOI 10.1016/j.amjmed.2007.06.033; Ong C S, 2000, Australas J Dermatol, V41, P242, DOI 10.1046/j.1440-0960.2000.00445.x; Pouliot Y, 2011, CLIN PHARMACOL THER, V90, P90, DOI 10.1038/clpt.2011.81; Quan MN, 2011, NEUROSCIENCE, V182, P88, DOI 10.1016/j.neuroscience.2011.03.026; Sardana D, 2011, BRIEF BIOINFORM; SCHWARTZ E, 1988, CLIN CARDIOL, V11, P53, DOI 10.1002/clc.4960110118; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; STEVENSON JG, 1984, DRUG INTEL CLIN PHAR, V18, P113, DOI 10.1177/106002808401800204; Sun RCF, 2008, THESCIENTIFICWORLDJO, V8, P1063, DOI 10.1100/tsw.2008.126; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Terasmaa A, 2011, J PHYSL BIOCH; van Dokkum RPE, 2002, J HYPERTENS, V20, P2351, DOI 10.1097/00004872-200212000-00010; Vogelgesang A, 2011, J NEUROIMMUNOL, V231, P105, DOI 10.1016/j.jneuroim.2010.09.023; Wallach I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012063; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; YALOURIS AG, 1987, BRIT MED J, V295, P1237, DOI 10.1136/bmj.295.6608.1237-a; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Yang L, 2009, BIOINFORMATICS, V25, P2244, DOI 10.1093/bioinformatics/btp369; Yang L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000441; Yang L, 2009, NUCLEIC ACIDS RES, V37, pW406, DOI 10.1093/nar/gkp312	56	161	167	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28025	10.1371/journal.pone.0028025	http://dx.doi.org/10.1371/journal.pone.0028025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205936	Green Submitted, Green Published, gold			2022-12-25	WOS:000299113600008
J	Ahmad, S; Mizuguchi, K				Ahmad, Shandar; Mizuguchi, Kenji			Partner-Aware Prediction of Interacting Residues in Protein-Protein Complexes from Sequence Data	PLOS ONE			English	Article							BINDING-SITES PREDICTION; INTERFACES; PROFILE; IDENTIFICATION; POTENTIALS; DOCKING	Computational prediction of residues that participate in protein-protein interactions is a difficult task, and state of the art methods have shown only limited success in this arena. One possible problem with these methods is that they try to predict interacting residues without incorporating information about the partner protein, although it is unclear how much partner information could enhance prediction performance. To address this issue, the two following comparisons are of crucial significance: (a) comparison between the predictability of inter-protein residue pairs, i.e., predicting exactly which residue pairs interact with each other given two protein sequences; this can be achieved by either combining conventional single-protein predictions or making predictions using a new model trained directly on the residue pairs, and the performance of these two approaches may be compared: (b) comparison between the predictability of the interacting residues in a single protein (irrespective of the partner residue or protein) from conventional methods and predictions converted from the pair-wise trained model. Using these two streams of training and validation procedures and employing similar two-stage neural networks, we showed that the models trained on pair-wise contacts outperformed the partner-unaware models in predicting both interacting pairs and interacting single-protein residues. Prediction performance decreased with the size of the conformational change upon complex formation; this trend is similar to docking, even though no structural information was used in our prediction. An example application that predicts two partner-specific interfaces of a protein was shown to be effective, highlighting the potential of the proposed approach. Finally, a preliminary attempt was made to score docking decoy poses using prediction of interacting residue pairs; this analysis produced an encouraging result.	[Ahmad, Shandar; Mizuguchi, Kenji] Natl Inst Biomed Innovat, Osaka, Japan	National Institute of Health Sciences - Japan	Ahmad, S (corresponding author), Natl Inst Biomed Innovat, Osaka, Japan.	shandar@nibio.go.jp	Mizuguchi, Kenji/GVS-5857-2022	Mizuguchi, Kenji/0000-0003-3021-7078; Ahmad, Shandar/0000-0002-7287-305X	Japan Society for Promotion of Science of Japan [22500277]; New Energy and Industrial Technology Development Organization of Japan	Japan Society for Promotion of Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work has been supported by a grants-in-aid (kaken-hi #22500277) program of Japan Society for Promotion of Science of Japan to SA and a grant from the Industrial Technology Research Grant Program in 2007 from New Energy and Industrial Technology Development Organization of Japan to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amos-Binks A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-225; Andrabi M, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-30; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; Bonsor DA, 2011, J MOL BIOL, V411, P321, DOI 10.1016/j.jmb.2011.06.009; Bradford JR, 2006, J MOL BIOL, V362, P365, DOI 10.1016/j.jmb.2006.07.028; Bui QC, 2011, BIOINFORMATICS, V27, P259, DOI 10.1093/bioinformatics/btq620; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Chen P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-402; Chen XW, 2005, BIOINFORMATICS, V21, P4394, DOI 10.1093/bioinformatics/bti721; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Dong QW, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-147; Fariselli P, 2002, EUR J BIOCHEM, V269, P1356, DOI 10.1046/j.1432-1033.2002.02767.x; Fitzpatrick AW, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002169; Geppert T, 2011, CHEM BIOL, V18, P344, DOI 10.1016/j.chembiol.2011.01.005; Gilmore JM, 2008, BIOINFORMATICS, V24, P1554, DOI 10.1093/bioinformatics/btn238; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; HAKES L, 2008, NAT BIOTECHNOL, P69; Hamer R, 2010, PROTEINS, V78, P2781, DOI 10.1002/prot.22792; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kelly WP, 2008, CURR OPIN BIOTECH, V19, P396, DOI 10.1016/j.copbio.2008.06.010; Knisley D, 2011, COMPUT BIOL CHEM, V35, P108, DOI 10.1016/j.compbiolchem.2011.03.003; Koike A, 2004, PROTEIN ENG DES SEL, V17, P165, DOI 10.1093/protein/gzh020; Konc J, 2007, J CHEM INF MODEL, V47, P940, DOI 10.1021/ci6005257; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Leung CCY, 2011, J BIOL CHEM, V286, P4292, DOI 10.1074/jbc.M110.189555; Li N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-553; Malik A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-1; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Murakami Y, 2010, BIOINFORMATICS, V26, P1841, DOI 10.1093/bioinformatics/btq302; Najafabadi HS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r87; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Qian N, 1988, J MOL BIOL, V202, P865, DOI 10.1016/0022-2836(88)90564-5; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Rashid M, 2010, CURR PROTEIN PEPT SC, V11, P589, DOI 10.2174/138920310794109120; Reddy Boojala V. B., 2005, Journal of Bioinformatics and Computational Biology, V3, P1137, DOI 10.1142/S0219720005001429; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Soong TT, 2008, BIOINFORMATICS, V24, P2608, DOI 10.1093/bioinformatics/btn498; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Wang B, 2010, PROTEIN PEPTIDE LETT, V17, P1111, DOI 10.2174/092986610791760397; Wang CS, 2009, PROTEIN J, V28, P111, DOI 10.1007/s10930-009-9170-7; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhou HX, 2001, PROTEINS, V44, P336, DOI 10.1002/prot.1099	53	55	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29104	10.1371/journal.pone.0029104	http://dx.doi.org/10.1371/journal.pone.0029104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194998	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100155
J	Gosal, G; Kochut, KJ; Kannan, N				Gosal, Gurinder; Kochut, Krys J.; Kannan, Natarajan			ProKinO: An Ontology for Integrative Analysis of Protein Kinases in Cancer	PLOS ONE			English	Article							MUTATIONS; REPRESENTATION; UNIFICATION; MECHANISMS; RESOURCE; DATABASE; TOOL	Background: Protein kinases are a large and diverse family of enzymes that are genomically altered in many human cancers. Targeted cancer genome sequencing efforts have unveiled the mutational profiles of protein kinase genes from many different cancer types. While mutational data on protein kinases is currently catalogued in various databases, integration of mutation data with other forms of data on protein kinases such as sequence, structure, function and pathway is necessary to identify and characterize key cancer causing mutations. Integrative analysis of protein kinase data, however, is a challenge because of the disparate nature of protein kinase data sources and data formats. Results: Here, we describe ProKinO, a protein kinase-specific ontology, which provides a controlled vocabulary of terms, their hierarchy, and relationships unifying sequence, structure, function, mutation and pathway information on protein kinases. The conceptual representation of such diverse forms of information in one place not only allows rapid discovery of significant information related to a specific protein kinase, but also enables large-scale integrative analysis of protein kinase data in ways not possible through other kinase-specific resources. We have performed several integrative analyses of ProKinO data and, as an example, found that a large number of somatic mutations (similar to 288 distinct mutations) associated with the haematopoietic neoplasm cancer type map to only 8 kinases in the human kinome. This is in contrast to glioma, where the mutations are spread over 82 distinct kinases. We also provide examples of how ontology-based data analysis can be used to generate testable hypotheses regarding cancer mutations. Conclusion: We present an integrated framework for large-scale integrative analysis of protein kinase data. Navigation and analysis of ontology data can be performed using the ontology browser available at: http://vulcan.cs.uga.edu/prokino.	[Gosal, Gurinder; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Kochut, Krys J.] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA; [Kochut, Krys J.; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Gosal, G (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	kochut@cs.uga.edu; kannan@bmb.uga.edu			American Cancer Society [RSG-10-188-01-TBE]; Georgia Cancer Coalition (GCC)	American Cancer Society(American Cancer Society); Georgia Cancer Coalition (GCC)	Funding for this work was provided by the American Cancer Society (RSG-10-188-01-TBE) and the Georgia Cancer Coalition (GCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fonseca F, 2007, J ASSOC INF SYST, V8, P129, DOI 10.17705/1jais.00114; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gruber TR, 1995, INT J HUM-COMPUT ST, V43, P907, DOI 10.1006/ijhc.1995.1081; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Jensen LJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000374; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Krupa A, 2004, NUCLEIC ACIDS RES, V32, pD153, DOI 10.1093/nar/gkh019; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Montecchi-Palazzi L, 2008, NAT BIOTECHNOL, V26, P864, DOI 10.1038/nbt0808-864; Natale DA, 2011, NUCLEIC ACIDS RES, V39, pD539, DOI 10.1093/nar/gkq907; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Ortutay C, 2005, HUM MUTAT, V25, P435, DOI 10.1002/humu.20166; Pilato CM, 2008, OREILLY; Richardson CJ, 2009, NUCLEIC ACIDS RES, V37, pD824, DOI 10.1093/nar/gkn832; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Rubin DL, 2008, BRIEF BIOINFORM, V9, P75, DOI 10.1093/bib/bbm059; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Taketani T, 2010, LEUKEMIA, V24, P1975, DOI 10.1038/leu.2010.207; Toffalini F, 2010, BLOOD, V116, P2429, DOI 10.1182/blood-2010-04-279752; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Torkamani A, 2009, METHODS MOL BIOL, V563, P289, DOI 10.1007/978-1-60761-175-2_16; Wolstencroft K, 2005, BIOINFORMATICS, V21, P1685, DOI 10.1093/bioinformatics/bti158	32	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28782	10.1371/journal.pone.0028782	http://dx.doi.org/10.1371/journal.pone.0028782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194913	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100098
J	Wu, Y; Xiao, YZ; Ding, XF; Zhuo, YM; Ren, P; Zhou, C; Zhou, JL				Wu, Yuan; Xiao, Yuzhong; Ding, Xiaofeng; Zhuo, Yiming; Ren, Peng; Zhou, Chang; Zhou, Jianlin			A miR-200b/200c/429-Binding Site Polymorphism in the 3 ' Untranslated Region of the AP-2 alpha Gene Is Associated with Cisplatin Resistance	PLOS ONE			English	Article							ACTIVATOR PROTEIN 2-ALPHA; TRANSCRIPTION FACTOR; CANCER-CELLS; APOPTOSIS INDUCTION; E-CADHERIN; GROWTH; EXPRESSION; FAMILY; AP-2; TUMORIGENICITY	The transcription factor AP-2 alpha functions as a tumor suppressor by regulating various genes that are involved in cell proliferation and apoptosis. Chemotherapeutic drugs including cisplatin induce post-transcriptionally endogenous AP-2 alpha, which contributes to chemosensitivity by enhancing therapy-induced apoptosis. microRNAs (miRNAs) miR-200b, miR-200c and miR-429 (miR-200b/200c/429) are up-regulated in endometrial and esophageal cancers, and their overexpression correlates with resistance to cisplatin treatment. Using computational programs, we predicted that the 3' untranslated region (UTR) of AP-2 alpha gene contains a potential miRNA response element (MRE) for the miR-200b/200c/429 family, and the single nucleotide polymorphism (SNP) site rs1045385 (A or C allele) resided within the predicted MRE. Luciferase assays and Western blot analysis demonstrated that the miR-200b/200c/429 family recognized the MRE in the 3' UTR of AP-2 alpha gene and negatively regulated the expression of endogenous AP-2 alpha proteins. SNP rs1045385 A. C variation enhanced AP-2 alpha expression by disrupting the binding of the miR-200b/200c/429 family to the 3' UTR of AP-2 alpha. The effects of the two polymorphic variants on cisplatin sensitivity were determined by clonogenic assay. The overexpression of AP-2 alpha with mutant 3' UTR (C allele) in the endometrial cancer cell line HEC-1A, which has high levels of endogenous miR-200b/200c/429 and low levels of AP-2 alpha protein, significantly increased cisplatin sensitivity, but overexpression of A allele of AP-2 alpha has no significant effects, compared with mock transfection. We concluded that miR-200b/200c/429 induced cisplatin resistance by repressing AP-2 alpha expression in endometrial cancer cells. The SNP (rs1045385) A. C variation decreased the binding of miR-200b/200c/429 to the 3' UTR of AP-2 alpha, which upregulated AP-2 alpha protein expression and increased cisplatin sensitivity. Our results suggest that SNP (rs1045385) may be a potential prognostic marker for cisplatin treatment.	[Wu, Yuan; Xiao, Yuzhong; Ding, Xiaofeng; Zhuo, Yiming; Ren, Peng; Zhou, Chang; Zhou, Jianlin] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China	Hunan Normal University	Wu, Y (corresponding author), Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China.	zhouchang1972@126.com; jlzhou@hunnu.edu.cn	Zhou, Jianlin/R-1304-2019	Zhou, Jianlin/0000-0001-8640-5364; Zhou, Chang/0000-0002-3744-2940	National Natural Science Foundation of China [81071656, 81071696, 30900827]; Hunan Provincial Innovation Foundation For Postgraduate [CX2010B227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Innovation Foundation For Postgraduate	This work was supported by National Natural Science Foundation of China (Grant Nos. 81071656, 81071696 and 30900827) and Hunan Provincial Innovation Foundation For Postgraduate (Grant No. CX2010B227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila MA, 2000, BRIT J CANCER, V82, P1974; Brewer S, 2002, MECH DEVELOP, V110, P139, DOI 10.1016/S0925-4773(01)00579-2; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Choi HJ, 2008, GLYCOBIOLOGY, V18, P395, DOI 10.1093/glycob/cwn016; Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Fauquette V, 2007, CARCINOGENESIS, V28, P2305, DOI 10.1093/carcin/bgm158; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Heimberger AB, 2005, CLIN CANCER RES, V11, P267; HU X, MOL BIOL REP; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jonckheere N, 2009, BRIT J CANCER, V101, P637, DOI 10.1038/sj.bjc.6605190; Karjalainen JM, 1998, J CLIN ONCOL, V16, P3584, DOI 10.1200/JCO.1998.16.11.3584; Lee JW, 2011, GYNECOL ONCOL, V120, P56, DOI 10.1016/j.ygyno.2010.09.022; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Ruiz M, 2004, CANCER RES, V64, P631, DOI 10.1158/0008-5472.CAN-03-2751; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Schwartz B, 2007, ONCOGENE, V26, P4049, DOI 10.1038/sj.onc.1210193; Wajapeyee N, 2005, CANCER RES, V65, P8628, DOI 10.1158/0008-5472.CAN-05-1059; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; West-Mays JA, 1999, DEV BIOL, V206, P46, DOI 10.1006/dbio.1998.9132; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhou JL, 2005, FEBS LETT, V579, P1715, DOI 10.1016/j.febslet.2005.02.027	31	61	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29043	10.1371/journal.pone.0029043	http://dx.doi.org/10.1371/journal.pone.0029043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194984	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100146
J	Zhao, JK; Lama, M; Sarkar, S; Atun, R				Zhao, Jinkou; Lama, Marcel; Sarkar, Swarup; Atun, Rifat			Indicators Measuring the Performance of Malaria Programs Supported by the Global Fund in Asia, Progress and the Way Forward	PLOS ONE			English	Article								Introduction: In 2010, the Global Fund provided more than 75% of external international financing for malaria control. The Global Fund uses performance based funding in the grants it finances. This paper analyses the indicators used to measure the performance of Global Fund supported malaria grants in Asia. Methods: Indicators used in the performance frameworks for all Global Fund supported malaria grants in Asia were retrieved from grant database and grouped into impact, outcome, output and input categories and categorized by service delivery areas. Indicators of each group were compared over rounds. Indicators used in performance frameworks were compared with internationally adopted indicators included in the Monitoring and Evaluation Toolkit developed by the Global Fund and international technical agencies. Results: Between 2002 and 2010, 1,434 indicators were included in the performance frameworks of the 48 malaria grants awarded in Asia, including 229 impact and 227 outcome indicators, 437 output and 541 input indicators, with an average of 29.9 indicators per grant. The proportion of impact and outcome indicators increased over rounds, with that of input indicators declining from 44.1% in Round 1 to 22.7% in Round 9. Conclusions: Input indicators, which have predominated the performance frameworks of the Global Fund supported malaria programs in Asia have declined between Rounds 1 and 9. However, increased alignment with internationally adopted indicators included in the Monitoring and Evaluation Toolkit is needed to improve the validity of reported results.	[Zhao, Jinkou; Lama, Marcel; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Zhao, Jinkou] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Sarkar, Swarup] United Nations Programme HIV AIDS, Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England	Jiangsu Provincial Center for Disease Control & Prevention; Imperial College London	Zhao, JK (corresponding author), Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.	jinkou.zhao@theglobalfund.org	Atun, Rifat/AAH-5537-2021	Zhao, Jinkou/0000-0001-9184-3385; Atun, Rifat/0000-0002-1531-5983				*GLOB FUND, PERF FRAM; *GLOB FUND, 2009, MON EV TOOLK; *GLOB FUND, GRANT PERF RAT DISB, P177; Low-Beer D, 2007, PLOS MED, V4, P1308, DOI 10.1371/journal.pmed.0040219; Roll Back Malaria, 2008, GLOB MAL ACT PLAN FR; Snow RW, 2010, LANCET, V376, P1409, DOI 10.1016/S0140-6736(10)61340-2; The Global Fund, MON EV TOOLK; The Global Fund, GRANT PORTF; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Worrall E, 2007, TROP MED INT HEALTH, V12, P75, DOI 10.1111/j.1365-3156.2006.01772.x; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	11	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28932	10.1371/journal.pone.0028932	http://dx.doi.org/10.1371/journal.pone.0028932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205982	gold, Green Submitted, Green Published			2022-12-25	WOS:000298665600016
J	Ueta, T; Inoue, T; Furukawa, T; Tamaki, Y; Nakagawa, Y; Imai, H; Yanagi, Y				Ueta, Takashi; Inoue, Tatsuya; Furukawa, Takahisa; Tamaki, Yasuhiro; Nakagawa, Yasuhito; Imai, Hirotaka; Yanagi, Yasuo			Glutathione Peroxidase 4 Is Required for Maturation of Photoreceptor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; INCREASED EXPRESSION; OXIDATIVE DAMAGE; LIPID-PEROXIDATION; ROD PHOTORECEPTORS; DEATH; MOUSE; GENE; MICE	Oxidative stress is implicated in the pathologies of photoreceptor cells, and the protective role of antioxidant enzymes for photoreceptor cells have been well understood. However, their essentiality has remained unknown. In this study we generated photoreceptor-specific conditional knock-out (CKO) mice of glutathione peroxidase 4 (GPx4) and showed the critical role of GPx4 for photoreceptor cells. In the wild-type retina the dominant GPx4 expression was in the mitochondria, indicating the mitochondrial variant was the major GPx4 in the retina. In the GPx4-CKO mice, although photoreceptor cells developed and differentiated into rod and cone cells by P12, they rapidly underwent drastic degeneration and completely disappeared by P21. The photoreceptor cell death in the GPx4-CKO mice was associated with the nuclear translocation of apoptosis-inducing factor (AIF) and TUNEL-positive cells. Photoreceptor cells before undergoing apoptosis (P11) exhibited decreased mitochondrial biomass, decreased number of connecting cilia, as well as disorganized structure of outer segments. These findings indicate that GPx4 is a critical antioxidant enzyme for the maturation and survival of photoreceptor cells.	[Ueta, Takashi] Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138655, Japan; [Furukawa, Takahisa] JST, CREST, Osaka 5650874, Japan; [Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka 5650874, Japan; [Nakagawa, Yasuhito; Imai, Hirotaka] Kitasato Univ, Sch Pharmaceut Sci, Tokyo 1088641, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kitasato University	Ueta, T (corresponding author), Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ueta-tky@umin.ac.jp	Yanagi, Yasuo/AAF-2670-2020; Yanagi, Yasuo/AAA-5441-2022	Yanagi, Yasuo/0000-0002-0362-7285	Japan Society for the Promotion of Science [21791669, 20390446, 23659806]; Grants-in-Aid for Scientific Research [10J06326] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (21791669) ( to Y. Y.), and (20390446 and 23659806) (to Y. T.).	Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; Dong A, 2007, J NEUROCHEM, V103, P1041, DOI 10.1111/j.1471-4159.2007.04839.x; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Gosbell AD, 2006, INVEST OPHTH VIS SCI, V47, P2613, DOI 10.1167/iovs.05-0962; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674; Imai H, 2010, J CLIN BIOCHEM NUTR, V46, P1, DOI 10.3164/jcbn.09-94R; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Lu LL, 2009, ANTIOXID REDOX SIGN, V11, P715, DOI [10.1089/ars.2008.2171, 10.1089/ARS.2008.2171]; Maiorino M, 2003, J BIOL CHEM, V278, P34286, DOI 10.1074/jbc.M305327200; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Okoye G, 2003, J NEUROSCI, V23, P4164; Osborne NN, 2004, INVEST OPHTH VIS SCI, V45, P3787, DOI 10.1167/iovs.04-0147; Ramamurthy V, 2009, CLIN GENET, V76, P137, DOI 10.1111/j.1399-0004.2009.01240.x; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Ross CA, 2006, NAT MED, V12, P1239, DOI 10.1038/nm1106-1239; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Tanito M, 2002, INVEST OPHTH VIS SCI, V43, P1162; Tanito M, 2005, J NEUROSCI, V25, P2396, DOI 10.1523/JNEUROSCI.4866-04.2005; THOMAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1045, P252, DOI 10.1016/0005-2760(90)90128-K; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; Usui S, 2009, MOL THER, V17, P778, DOI 10.1038/mt.2009.47; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Zhang M, 2009, CURR EYE RES, V34, P791, DOI 10.1080/02713680903086018	33	76	79	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7675	7682		10.1074/jbc.M111.335174	http://dx.doi.org/10.1074/jbc.M111.335174			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22207760	Green Published, hybrid			2022-12-25	WOS:000301060200066
J	Ota, A; Wang, YB				Ota, Asuka; Wang, Yibin			Cdc37/Hsp90 Protein-mediated Regulation of IRE1 alpha Protein Activity in Endoplasmic Reticulum Stress Response and Insulin Synthesis in INS-1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER STRESS; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; INDUCED APOPTOSIS; KINASE IRE1; BETA-CELL; ATF6; ACTIVATION; TRANSCRIPTION; INDUCTION	IRE1 alpha is an endoplasmic reticulum (ER) localized signaling molecule critical for unfolded protein response. During ER stress, IRE1 alpha activation is induced by oligomerization and autophosphorylation in its cytosolic domain, a process triggered by dissociation of an ER luminal chaperone, binding immunoglobulin-protein (BiP), from IRE1 alpha. In addition, inhibition of a cytosolic chaperone protein Hsp90 also induces IRE1 alpha oligomerization and activation in the absence of an ER stressor. Here, we report that the Hsp90 cochaperone Cdc37 directly interacts with IRE1 alpha through a highly conserved cytosolic motif of IRE1 alpha. Cdc37 knockdown or disruption of Cdc37 interaction with IRE1 alpha significantly increased basal IRE1 alpha activity. In INS-1 cells, Hsp90 inhibition and disruption of IRE1 alpha-Cdc37 interaction both induced an ER stress response and impaired insulin synthesis and secretion. These data suggest that Cdc37-mediated direct interaction between Hsp90/Cdc37 and an IRE1 alpha cytosolic motif is important to maintain basal IRE1 alpha activity and contributes to normal protein homeostasis and unfolded protein response under physiological stimulation.	[Ota, Asuka; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Ota, Asuka; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Physiol, Los Angeles, CA 90095 USA; [Ota, Asuka; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Med, Los Angeles, CA 90095 USA; [Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol, BH 569,CHS,650 Charles E Young Dr, Los Angeles, CA 90095 USA.	yibinwang@mednet.ucla.edu		Wang, Yibin/0000-0003-0852-0767	National Institutes of Health [F31AG032163, HL070079, 088640]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported, in whole or in part, by National Institutes of Health Pre-doctoral Individual Fellowship Award F31AG032163 (to A. O.) and Grants HL070079 and 088640 (to Y. W.). This work was also supported by an American Heart Association Established Investigator award (to Y. W.).	Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Fonseca SG, 2010, ISLETS, V2, P1, DOI 10.4161/isl.2.1.10456; Fonseca V, 2010, CURR MED RES OPIN, V26, P1621, DOI 10.1185/03007995.2010.485087; Guo J, 2006, EMBO REP, V7, P1124, DOI 10.1038/sj.embor.7400813; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hartley T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-59; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lai MT, 2003, CELL SIGNAL, V15, P585, DOI 10.1016/S0898-6568(03)00004-4; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sommer T, 2002, DEV CELL, V3, P1, DOI 10.1016/S1534-5807(02)00210-1; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Taiyab A, 2009, BIOCHEM PHARMACOL, V78, P142, DOI 10.1016/j.bcp.2009.04.001; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	31	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6266	6274		10.1074/jbc.M111.331264	http://dx.doi.org/10.1074/jbc.M111.331264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22199355	hybrid, Green Published			2022-12-25	WOS:000300791800019
J	Ulsamer, A; Wei, Y; Kim, KK; Tan, K; Wheeler, S; Xi, Y; Thies, RS; Chapman, HA				Ulsamer, Arnau; Wei, Ying; Kim, Kevin K.; Tan, Kevin; Wheeler, Sarah; Xi, Ying; Thies, R. Scott; Chapman, Harold A.			Axin Pathway Activity Regulates in Vivo pY654-beta-catenin Accumulation and Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOPLASMIC-RETICULUM STRESS; BETA-CATENIN; TYROSINE PHOSPHORYLATION; GROWTH-FACTOR; E-CADHERIN; BINDING-PROTEIN; LIVER FIBROSIS; CELL-ADHESION; SRC	Epithelial to mesenchymal transition (EMT) and pulmonary fibrogenesis require epithelial integrin alpha 3 beta 1-mediated crosstalk between TGF beta 1 and Wnt signaling pathways. One hallmark of this cross-talk is pY654-beta-catenin accumulation, but whether pY654-beta-catenin is a biomarker of fibrogenesis or functionally important is unknown. To clarify further the role of beta-catenin in fibrosis, we explored pY654-beta-catenin generation and function. alpha 3 beta 1 was required for TGF beta 1-mediated activation of Src family kinases, and Src inhibition blocked both pY654 and EMT in primary alveolar epithelial cells (AECs). TGF beta 1 stimulated beta-catenin/Lef1-dependent promoter activity comparably in immortalized AECs stably expressing WT beta-catenin as well as Y654E or Y654F beta-catenin point mutants. But EMT was abrogated in the Tyr to Phe mutant. pY654-beta-catenin was sensitive to the axin beta-catenin turnover pathway as inhibition of tankyrase 1 led to high AEC axin levels, loss of pY654-beta-catenin, and inhibition of EMT ex vivo. Mice given a tankyrase inhibitor (50 mg/kg orally) daily for 7 days beginning 10 days after intratracheal bleomycin had improved survival over controls. Treated mice developed raised axin levels in the lung that abrogated pY654-beta-catenin and attenuated lung Snail1, Twist1, alpha-smooth muscle actin, and type I collagen accumulation. Total beta-catenin levels were unaltered. These findings identify Src kinase(s) as a mediator of TGF beta 1-induced pY654-beta-catenin, provide evidence that pY654-beta-catenin levels are a critical determinant of EMT and fibrogenesis, and suggest regulation of axin levels as a novel therapeutic approach to fibrotic disorders.	[Ulsamer, Arnau; Wei, Ying; Kim, Kevin K.; Tan, Kevin; Wheeler, Sarah; Xi, Ying; Chapman, Harold A.] Univ Calif San Francisco, Pulm & Crit Care Div, Dept Med, San Francisco, CA 94143 USA; [Ulsamer, Arnau; Wei, Ying; Kim, Kevin K.; Tan, Kevin; Wheeler, Sarah; Xi, Ying; Chapman, Harold A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Thies, R. Scott] Fate Therapeut Inc, San Diego, CA 92121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chapman, HA (corresponding author), Univ Calif San Francisco, Pulm & Crit Care Div, Dept Med, 513 Parnassus Ave, San Francisco, CA 94143 USA.	hal.chapman@ucsf.edu	Ulsamer, A/H-7994-2014	Ulsamer, A/0000-0001-7808-1005	National Institutes of Health [HL 44712, K08HL085290]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085290, R01HL044712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 44712 (to H. A. C.) and K08HL085290 (to K. K. K.).	Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Bergmann C, 2011, ANN RHEUM DIS, V70, P2191, DOI 10.1136/ard.2010.147140; Boyer B, 1997, EMBO J, V16, P5904, DOI 10.1093/emboj/16.19.5904; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jayachandran A, 2009, THORAX, V64, P1053, DOI 10.1136/thx.2009.121798; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Minami Y, 2008, P NATL ACAD SCI USA, V105, P17967, DOI 10.1073/pnas.0808303105; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; Simoneau M, 2011, CELL SIGNAL, V23, P269, DOI 10.1016/j.cellsig.2010.09.011; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Zhang F, 2003, J CELL BIOL, V163, P177, DOI 10.1083/jcb.200304065; Zhong Q, 2011, AM J RESP CELL MOL, V45, P498, DOI 10.1165/rcmb.2010-0347OC	48	71	74	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5164	5172		10.1074/jbc.M111.322123	http://dx.doi.org/10.1074/jbc.M111.322123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22203675	Green Published, hybrid			2022-12-25	WOS:000300608500074
J	Jacobi, D; Caille, A; Borys, JM; Lommez, A; Couet, C; Charles, MA; Oppert, JM				Jacobi, David; Caille, Agnes; Borys, Jean-Michel; Lommez, Agnes; Couet, Charles; Charles, Marie-Aline; Oppert, Jean-Michel		FLVS Study Grp	Parent-Offspring Correlations in Pedometer-Assessed Physical Activity	PLOS ONE			English	Article							FAMILIAL AGGREGATION; UNITED-STATES; RESEMBLANCE; YOUTH; EXERCISE; CHILDREN; FITNESS; GIRLS; AGE	Background: Physical activity is a major component of a healthy lifestyle in youth and adults. To identify determinants of this complex behavior is an important research objective in the process of designing interventions to promote physical activity at population level. In addition to individual determinants, there is evidence documenting familial influences on physical activity. However, the few studies that have addressed this issue with objective measures did not provide data on parent-offspring physical activity relationships throughout childhood and adolescence. The purpose of this study was to assess familial correlations in pedometer-assessed physical activity. Methods: We measured ambulatory activity in 286 French nuclear families (283 mothers, 237 fathers, and 631 children aged 8-18 years) by pedometer recordings (Yamax Digiwalker DW 450) over a week. Correlations were computed with their 95% confidence intervals (CI) for spouse pairs, siblings, mother-offspring, and father-offspring. Data were expressed as steps per day and computed both for the full recording period and separately for weekdays and weekends. Results: The correlations were the highest between siblings (r = 0.28, 95% CI: 0.17-0.38). Parent-offspring correlations were significant in mothers (r = 0.21, 95% CI: 0.12-0.30), especially between mothers and daughters (r = 0.24, 95% CI: 0.12-0.36 vs. r = 0.18, 95% CI: 0.05-0.31 for sons), but were almost nonexistent in fathers. Correlations were generally higher on weekend days compared to weekdays. Mother-offspring correlations did not decrease with increasing age of children (r = 0.17, 95% CI: 0.00-0.34 in 8-11-year-olds, r = 0.20, 95% CI: 0.07-0.33 in 12-15-year-olds, and r = 0.25, 95% CI: 0.07-0.39 in >= 16-year-olds). Finally, between-spouse correlations were significant only during weekend days (r = 0.14, 95% CI: 0.01-0.27). Conclusion: Ambulatory activity correlated within families, with a possible mother effect. Mother-offspring correlations remained significant through the transition from childhood to adolescence. Further studies are required to better understand the respective influences of shared activities, parental modeling and support as well as genetic factors on the familial aggregation of physical activity.	[Jacobi, David; Couet, Charles] Ctr Hosp Reg Univ CHRU Tours, Serv Med Interne Nutr, Tours, France; [Jacobi, David; Couet, Charles] Univ Tours, INSERM, U921, Tours, France; [Caille, Agnes] Univ Tours, INSERM, Ctr Invest Clin CIC 202, Tours, France; [Borys, Jean-Michel; Lommez, Agnes] Fleurbaix Laventie Assoc, Laventie, France; [Charles, Marie-Aline] Ctr Rech Epidemiol & Sante Populat CESP, Team Lifelong Epidemiol Obes Diabet & Renal Dis, INSERM, U1018, Villejuif, France; [Charles, Marie-Aline] Univ Paris 11, Le Kremlin Bicetre, France; [Oppert, Jean-Michel] Hop La Pitie Salpetriere, AP HP, Serv Nutr, Paris, France; [Oppert, Jean-Michel] Univ Paris 06, Ctr Rech Nutr Humaine Ile de France CRNH IdF, Paris, France	CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Jacobi, D (corresponding author), Ctr Hosp Reg Univ CHRU Tours, Serv Med Interne Nutr, Tours, France.	jean-michel.oppert@psl.aphp.fr	Caille, Agnès/K-6628-2012; Charles, Marie Aline/F-8567-2017; jacobi, david/N-8553-2017; Charles, Marie Aline/S-1866-2019; caille, agnes/L-9011-2015; Heude, Barbara/G-3095-2016; Oppert, Jean-Michel/F-2810-2017; FROGUEL, Philippe/O-6799-2017; jacobi, david/J-1322-2014	Charles, Marie Aline/0000-0003-4025-4390; jacobi, david/0000-0001-8674-223X; Charles, Marie Aline/0000-0003-4025-4390; Heude, Barbara/0000-0002-1565-1629; FROGUEL, Philippe/0000-0003-2972-0784; Caille, Agnes/0000-0003-4715-6144	Cedus; Roche; Lesieur; Nestle'France; French Ministry of Health-National Nutrition and Health [PNNS-2002]	Cedus; Roche(Roche Holding); Lesieur; Nestle'France; French Ministry of Health-National Nutrition and Health	Cedus (www.lesucre.com), Roche (www.roche.fr), Lesieur (www.lesieur.fr), and Nestle'France (www.nestle.fr) financially supported the Fleurbaix-Laventie Ville-Sante'study. This project was supported by a research-action grant from the French Ministry of Health-National Nutrition and Health Program (PNNS-2002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beets MW, 2007, SEX ROLES, V56, P125, DOI 10.1007/s11199-006-9154-4; Beydoun MA, 2009, SOC SCI MED, V68, P2137, DOI 10.1016/j.socscimed.2009.03.029; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; CDC, 2005, MMWR-MORBID MORTAL W, V55, P1; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Edwardson CL, 2010, PSYCHOL SPORT EXERC, V11, P522, DOI 10.1016/j.psychsport.2010.05.001; ELIASZIW M, 1991, ANN HUM GENET, V55, P77, DOI 10.1111/j.1469-1809.1991.tb00400.x; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; FREEDSON PS, 1991, RES Q EXERCISE SPORT, V62, P384, DOI 10.1080/02701367.1991.10607538; Fuemmeler BF, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-17; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Jago R, 2010, BMC PUBLIC HEALTH, V15, P10, DOI DOI 10.1186/1471-2458-1110-1194; Kettaneh A, 2005, INT J OBESITY, V29, P586, DOI 10.1038/sj.ijo.0802992; Loucaides Constantinos A, 2006, J Phys Act Health, V3, P267, DOI 10.1123/jpah.3.3.267; MOORE LL, 1991, J PEDIATR-US, V118, P215, DOI 10.1016/S0022-3476(05)80485-8; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Oliver M, 2010, J SCI MED SPORT, V13, P403, DOI 10.1016/j.jsams.2009.05.008; PATTERSON TL, 1987, PREV MED, V16, P616, DOI 10.1016/0091-7435(87)90045-4; PERUSSE L, 1988, AM J CLIN NUTR, V47, P629, DOI 10.1093/ajcn/47.4.629; PERUSSE L, 1989, AM J EPIDEMIOL, V129, P1012, DOI 10.1093/oxfordjournals.aje.a115205; PERUSSE L, 1987, PREV MED, V16, P607, DOI 10.1016/0091-7435(87)90044-2; Physical Activity Guidelines Advisory Committee (PAGAC), 2008, PHYS ACT GUID ADV CO; Rankinen T, 2010, MED SCI SPORT EXER, V42, P835, DOI 10.1249/MSS.0b013e3181d86cec; Romon M, 2004, INT J OBESITY, V28, P1227, DOI 10.1038/sj.ijo.0802725; Rosner B, 1977, APPL STATIST, V26, P179; Seabra AF, 2008, EUR J EPIDEMIOL, V23, P205, DOI 10.1007/s10654-008-9222-x; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Thompson JL, 2010, CHILD CARE HLTH DEV, V36, P265, DOI 10.1111/j.1365-2214.2009.01051.x; Treuth MS, 2001, AM J CLIN NUTR, V74, P529; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tudor-Locke C, 2004, SPORTS MED, V34, P281, DOI 10.2165/00007256-200434050-00001; Tudor-Locke C, 2010, MED SCI SPORT EXER, V42, P2244, DOI 10.1249/MSS.0b013e3181e32d7f; Ukoumunne OC, 2002, STAT MED, V21, P3757, DOI 10.1002/sim.1330; Van Domelen DR, 2011, AM J PREV MED, V41, P136, DOI 10.1016/j.amepre.2011.03.019	37	53	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29195	10.1371/journal.pone.0029195	http://dx.doi.org/10.1371/journal.pone.0029195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216207	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300035
J	Wang, FK; Hu, S; Liu, WX; Qiao, ZJ; Gao, YZ; Bu, ZG				Wang, Fangkun; Hu, Sen; Liu, Wenxing; Qiao, Zujian; Gao, Yuzhe; Bu, Zhigao			Deep-Sequencing Analysis of the Mouse Transcriptome Response to Infection with Brucella melitensis Strains of Differing Virulence	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; B KINASE ALPHA; CELL-DEATH; GENE-EXPRESSION; OMP25/OMP31 FAMILY; ABORTUS INFECTION; PHOSPHATASE SHP-1; APOPTOSIS; MACROPHAGES; PATHWAY	Brucella melitensis is an important zoonotic pathogen that causes brucellosis, a disease that affects sheep, cattle and occasionally humans. B. melitensis strain M5-90, a live attenuated vaccine cultured from B. melitensis strain M28, has been used as an effective tool in the control of brucellosis in goats and sheep in China. However, the molecular changes leading to attenuated virulence and pathogenicity in B. melitensis remain poorly understood. In this study we employed the Illumina Genome Analyzer platform to perform genome-wide digital gene expression (DGE) analysis of mouse peritoneal macrophage responses to B. melitensis infection. Many parallel changes in gene expression profiles were observed in M28and M5-90-infected macrophages, suggesting that they employ similar survival strategies, notably the induction of antiinflammatory and antiapoptotic factors. Moreover, 1019 differentially expressed macrophage transcripts were identified 4 h after infection with the different B. melitensis strains, and these differential transcripts notably identified genes involved in the lysosome and mitogen-activated protein kinase (MAPK) pathways. Further analysis employed gene ontology (GO) analysis: high-enrichment GOs identified endocytosis, inflammatory, apoptosis, and transport pathways. Path-Net and Signal-Net analysis highlighted the MAPK pathway as the key regulatory pathway. Moreover, the key differentially expressed genes of the significant pathways were apoptosis-related. These findings demonstrate previously unrecognized changes in gene transcription that are associated with B. melitensis infection of macrophages, and the central signaling pathways identified here merit further investigation. Our data provide new insights into the molecular attenuation mechanism of strain M5-90 and will facilitate the generation of new attenuated vaccine strains with enhanced efficacy.	[Wang, Fangkun; Hu, Sen; Liu, Wenxing; Qiao, Zujian; Gao, Yuzhe; Bu, Zhigao] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China; [Wang, Fangkun; Hu, Sen; Liu, Wenxing; Qiao, Zujian; Gao, Yuzhe; Bu, Zhigao] Chinese Acad Agr Sci, Zoonosis Lab, Minist Agr, Harbin Vet Res Inst, Harbin, Heilongjiang, Peoples R China; [Wang, Fangkun] Shandong Agr Univ, Dept Vet Prevent Med, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Shandong Agricultural University	Wang, FK (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China.	zgbu@yahoo.com			Ministry of Agriculture of China [200803018, 200903027]; Natural Science Foundation of China [31001068]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Animal Infectious Disease Control Research Program of the Ministry of Agriculture of China (200803018; 200903027) and Natural Science Foundation of China (31001068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2003, J INFECT DIS, V187, pS340, DOI 10.1086/374747; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barrionuevo P, 2008, INFECT IMMUN, V76, P250, DOI 10.1128/IAI.00949-07; Benjamini Y, 2001, ANN STAT, V29, P1165; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bohme L, 2009, MICROBES INFECT, V11, P1063, DOI 10.1016/j.micinf.2009.08.014; BOWDEN RA, 1995, INFECT IMMUN, V63, P3945, DOI 10.1128/IAI.63.10.3945-3952.1995; Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004; Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chen F, 2011, INFECT IMMUN, V79, P2460, DOI 10.1128/IAI.00050-11; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Chin JContEndDis, 1991, CHINESE J CONTROL EN, V65-68; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Covert J, 2009, EXP BIOL MED, V234, P1450, DOI 10.3181/0904-RM-124; de Bagues MPJ, 2005, CLIN IMMUNOL, V114, P227, DOI 10.1016/j.clim.2004.07.010; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Descargues P, 2008, EMBO J, V27, P2639, DOI 10.1038/emboj.2008.196; Dornand J, 2002, VET MICROBIOL, V90, P383, DOI 10.1016/S0378-1135(02)00223-7; Edmonds MD, 2002, RES VET SCI, V72, P235, DOI 10.1053/rvsc.2002.0555; Edmonds MD, 2002, VET MICROBIOL, V88, P205, DOI 10.1016/S0378-1135(02)00110-4; Edmonds MD, 2001, AM J VET RES, V62, P1461, DOI 10.2460/ajvr.2001.62.1461; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erbay Ebru, 2007, Curr Atheroscler Rep, V9, P222, DOI 10.1007/s11883-007-0023-6; Cariaga-Martinez AE, 2009, ADV UROL, V2009, DOI 10.1155/2009/723831; Eskra L, 2003, INFECT IMMUN, V71, P1125, DOI 10.1128/IAI.71.3.1125-1133.2003; Ferjoux G, 2000, J PHYSIOLOGY-PARIS, V94, P205, DOI 10.1016/S0928-4257(00)00206-0; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Fernandez-Prada CM, 2003, INFECT IMMUN, V71, P2110, DOI 10.1128/IAI.71.4.2110-2119.2003; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Fugier Emilie, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000543; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Gouaze V, 2002, J BIOL CHEM, V277, P42867, DOI 10.1074/jbc.M203067200; Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000; Guerin S, 2002, EUR J IMMUNOL, V32, P1; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Hamilton TA, 1999, PATHOBIOLOGY, V67, P241, DOI 10.1159/000028101; He YQ, 2006, INFECT IMMUN, V74, P5035, DOI 10.1128/IAI.01998-05; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hughes JP, 2003, J NEUROCHEM, V86, P25, DOI 10.1046/j.1471-4159.2003.01830.x; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; JONES SM, 1992, INFECT IMMUN, V60, P3011, DOI 10.1128/IAI.60.7.3011-3014.1992; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; Kim JG, 1997, J LIPID RES, V38, P2207; Liu BG, 2006, P NATL ACAD SCI USA, V103, P17202, DOI 10.1073/pnas.0604481103; Luo FJ, 2010, J PATHOL, V220, P542, DOI 10.1002/path.2672; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Martin-Martin AI, 2009, VET MICROBIOL, V137, P74, DOI 10.1016/j.vetmic.2008.12.003; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oliveira SC, 2008, MICROBES INFECT, V10, P1005, DOI 10.1016/j.micinf.2008.07.005; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Roberg K, 2001, LAB INVEST, V81, P149, DOI 10.1038/labinvest.3780222; Roberts Lewis R., 1999, Cell Biochemistry and Biophysics, V30, P71, DOI 10.1007/BF02737885; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sapra R, 2006, MICROB PATHOGENESIS, V41, P157, DOI 10.1016/j.micpath.2006.07.002; Seleem MN, 2008, FEMS MICROBIOL LETT, V288, P211, DOI 10.1111/j.1574-6968.2008.01358.x; Seleem MN, 2008, VET MICROBIOL, V129, P1, DOI 10.1016/j.vetmic.2007.11.023; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thakur N, 2009, FUTURE ONCOL, V5, P1, DOI 10.2217/14796694.5.1.1; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30; Zang Y, 2001, CELL DEATH DIFFER, V8, P477, DOI 10.1038/sj.cdd.4400843; Zapata P D, 2004, Actas Urol Esp, V28, P269; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhu F, 2009, HISTOL HISTOPATHOL, V24, P265, DOI 10.14670/HH-24.265; Zhu Xiangping, 2003, J Biomol Tech, V14, P298; Zwerdling A, 2008, MICROBES INFECT, V10, P1346, DOI 10.1016/j.micinf.2008.07.035	85	23	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28485	10.1371/journal.pone.0028485	http://dx.doi.org/10.1371/journal.pone.0028485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216095	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300004
J	Canuti, M; Eis-Huebinger, AM; Deijs, M; de Vries, M; Drexler, JF; Oppong, SK; Muller, MA; Klose, SM; Wellinghausen, N; Cottontail, VM; Kalko, EKV; Drosten, C; van der Hoek, L				Canuti, Marta; Eis-Huebinger, Anna Maria; Deijs, Martin; de Vries, Michel; Drexler, Jan Felix; Oppong, Samuel K.; Mueller, Marcel A.; Klose, Stefan M.; Wellinghausen, Nele; Cottontail, Veronika M.; Kalko, Elisabeth K. V.; Drosten, Christian; van der Hoek, Lia			Two Novel Parvoviruses in Frugivorous New and Old World Bats	PLOS ONE			English	Article							GENETIC DIVERSITY; FRUIT BATS; VIRUS; IDENTIFICATION; INFECTION; FRAGMENTATION; PREVALENCE; RESERVOIRS; EVOLUTION; TYPE-1	Bats, a globally distributed group of mammals with high ecological importance, are increasingly recognized as natural reservoir hosts for viral agents of significance to human and animal health. In the present study, we evaluated pools of blood samples obtained from two phylogenetically distant bat families, in particular from flying foxes (Pteropodidae), Eidolon helvum in West Africa, and from two species of New World leaf-nosed fruit bats (Phyllostomidae), Artibeus jamaicensis and Artibeus lituratus in Central America. A sequence-independent virus discovery technique (VIDISCA) was used in combination with high throughput sequencing to detect two novel parvoviruses: a PARV4-like virus named Eh-BtPV-1 in Eidolon helvum from Ghana and the first member of a putative new genus in Artibeus jamaicensis from Panama (Aj-BtPV-1). Those viruses were circulating in the corresponding bat colony at rates of 7-8%. Aj-BtPV-1 was also found in Artibeus lituratus (5.5%). Both viruses were detected in the blood of infected animals at high concentrations: up to 10E8 and to 10E10 copies/ml for Aj-BtPV-1 and Eh-BtPV-1 respectively. Eh-BtPV-1 was additionally detected in all organs collected from bats (brain, lungs, liver, spleen, kidneys and intestine) and spleen and kidneys were identified as the most likely sites where viral replication takes place. Our study shows that bat parvoviruses share common ancestors with known parvoviruses of humans and livestock. We also provide evidence that a variety of Parvovirinae are able to cause active infection in bats and that they are widely distributed in these animals with different geographic origin, ecologies and climatic ranges.	[Canuti, Marta; Deijs, Martin; de Vries, Michel; van der Hoek, Lia] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Eis-Huebinger, Anna Maria; Drexler, Jan Felix; Mueller, Marcel A.; Klose, Stefan M.; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Oppong, Samuel K.] Kwame Nkrumah Univ Sci & Technol, Dept Wildlife & Range Management, Kumasi, Ghana; [Klose, Stefan M.; Cottontail, Veronika M.; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Wellinghausen, Nele] Gaertner & Collegues Lab, Ravensburg, Germany; [Cottontail, Veronika M.] Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama	University of Amsterdam; Academic Medical Center Amsterdam; University of Bonn; Kwame Nkrumah University Science & Technology; Ulm University; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Canuti, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun CINIMA, NL-1105 AZ Amsterdam, Netherlands.	c.m.vanderhoek@amc.uva.nl	Drexler, Jan Felix/C-1004-2014; Müller, Marcel A./O-2425-2019; Canuti, Marta/I-3145-2019; van der Hoek, Lia/Y-6412-2019; Drexler, Jan Felix/GMW-5098-2022	Müller, Marcel A./0000-0003-2242-5117; Canuti, Marta/0000-0002-9959-128X; Drexler, Jan Felix/0000-0002-3509-0232	European Community; VIDI from the Netherlands Organization for Scientific Research (NWO) [016.066.318]; Arthur von Gwinner Foundation (Max Planck Society); Boehringer Ingelheim Fonds for Basic Research in Medicine (BIF); Smithsonian Tropical Reserarch Institute (STRI); German Ministry of Education and Research (BMBF) [01KIO701]; German Research Foundation (DFG) [DR 772/3-1 KA 1241/18-1]; EC grant [223498]	European Community(European Commission); VIDI from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Arthur von Gwinner Foundation (Max Planck Society); Boehringer Ingelheim Fonds for Basic Research in Medicine (BIF)(Boehringer Ingelheim); Smithsonian Tropical Reserarch Institute (STRI); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); EC grant	This study was supported by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project EMPERIE, EC grant agreement number 223498, VIDI grant 016.066.318 from the Netherlands Organization for Scientific Research (NWO). Grants from the Arthur von Gwinner Foundation (Max Planck Society), the Boehringer Ingelheim Fonds for Basic Research in Medicine (BIF) and trust funds from the Smithsonian Tropical Reserarch Institute (STRI) contributed to field work in Panama. Work in Ghana was supported by grants from the German Ministry of Education and Research (BMBF) (01KIO701) and the German Research Foundation (DFG) (DR 772/3-1 KA 1241/18-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON MJ, 1985, J INFECT DIS, V152, P257, DOI 10.1093/infdis/152.2.257; ASIBEY E O A, 1974, Biological Conservation, V6, P32, DOI 10.1016/0006-3207(74)90039-1; Breed AC, 2010, ECOHEALTH, V7, P204, DOI 10.1007/s10393-010-0332-z; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cottontail VM, 2009, PARASITOLOGY, V136, P1133, DOI 10.1017/S0031182009990485; de Vries M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016118; Drummond A, 2010, GENEIOUS V5 1; Epstein Jonathan H, 2006, Curr Infect Dis Rep, V8, P59, DOI 10.1007/s11908-006-0036-2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Handley, 1991, DEMOGRAPHY NATURAL H; Hoek L. van der, 2004, Nature Medicine, V10, P368, DOI 10.1038/nm1024; Jakava-Viljanen M, 2010, EPIDEMIOL INFECT, V138, P1581, DOI 10.1017/S0950268810000373; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klose SM, 2006, J COMP PHYSIOL A, V192, P341, DOI 10.1007/s00359-005-0067-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Lau SKP, 2010, VIROLOGY, V404, P106, DOI 10.1016/j.virol.2010.03.049; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Y, 2010, J GEN VIROL, V91, P2601, DOI 10.1099/vir.0.020032-0; Li Y, 2010, J VIROL, V84, P3889, DOI 10.1128/JVI.02497-09; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; Meyer CFJ, 2008, J APPL ECOL, V45, P381, DOI 10.1111/j.1365-2664.2007.01389.x; Mickleburgh S, 2009, ORYX, V43, P217, DOI 10.1017/S0030605308000938; Misra V, 2009, J GEN VIROL, V90, P2015, DOI 10.1099/vir.0.010694-0; Moore PR, 2010, ANN TROP MED PARASIT, V104, P613, DOI 10.1179/136485910X12851868779948; Norja P, 2008, J VIROL, V82, P6427, DOI 10.1128/JVI.00471-08; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Szelei J, 2010, EMERG INFECT DIS, V16, P561, DOI [10.3210/eid1603.090746, 10.3201/eid1603.090746]; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Turmelle AS, 2009, ECOHEALTH, V6, P522, DOI 10.1007/s10393-009-0263-8; Wibbelt G, 2007, J GEN VIROL, V88, P2651, DOI 10.1099/vir.0.83045-0; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Zhu HC, 2009, J GEN VIROL, V90, P883, DOI 10.1099/vir.0.007732-0; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	52	51	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29140	10.1371/journal.pone.0029140	http://dx.doi.org/10.1371/journal.pone.0029140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216187	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900016
J	Neumann, F; Borchert, S; Schmidt, C; Reimer, R; Hohenberg, H; Fischer, N; Grundhoff, A				Neumann, Friederike; Borchert, Sophie; Schmidt, Claudia; Reimer, Rudolph; Hohenberg, Heinrich; Fischer, Nicole; Grundhoff, Adam			Replication, Gene Expression and Particle Production by a Consensus Merkel Cell Polyomavirus (MCPyV) Genome	PLOS ONE			English	Article							T-ANTIGEN; SIMIAN VIRUS-40; SIMIAN-VIRUS-40; LINES; DNA; CARCINOMA; PROTEINS; IDENTIFICATION; CULTIVATION; ACTIVATION	Merkel Cell Polyomavirus (MCPyV) genomes are clonally integrated in tumor tissues of approximately 85% of all Merkel cell carcinoma (MCC) cases, a highly aggressive tumor of the skin which predominantly afflicts elderly and immunosuppressed patients. All integrated viral genomes recovered from MCC tissue or MCC cell lines harbor signature mutations in the early gene transcript encoding for the large T-Antigen (LT-Ag). These mutations selectively abrogate the ability of LT-Ag to support viral replication while still maintaining its Rb-binding activity, suggesting a continuous requirement for LT-Ag mediated cell cycle deregulation during MCC pathogenesis. To gain a better understanding of MCPyV biology, in vitro MCPyV replication systems are required. We have generated a synthetic MCPyV genomic clone (MCVSyn) based on the consensus sequence of MCC-derived sequences deposited in the NCBI database. Here, we demonstrate that transfection of recircularized MCVSyn DNA into some human cell lines recapitulates efficient replication of the viral genome, early and late gene expression together with virus particle formation. However, serial transmission of infectious virus was not observed. This in vitro culturing system allows the study of viral replication and will facilitate the molecular dissection of important aspects of the MCPyV lifecycle.	[Neumann, Friederike; Borchert, Sophie; Schmidt, Claudia; Fischer, Nicole] Univ Med Ctr Eppendorf, Inst Microbiol & Virol, Hamburg, Germany; [Borchert, Sophie; Reimer, Rudolph; Hohenberg, Heinrich; Grundhoff, Adam] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute	Neumann, F (corresponding author), Univ Med Ctr Eppendorf, Inst Microbiol & Virol, Hamburg, Germany.	nfischer@uke.de; adam.grundhoff@hpi.uni-hamburg.de		Grundhoff, Adam/0000-0003-0940-7045	Graduate School for Structure and Dynamics in Infection (SDI); Federal State Hamburg, Germany; Free and Hanseatic City of Hamburg; Federal Ministry of Health	Graduate School for Structure and Dynamics in Infection (SDI); Federal State Hamburg, Germany; Free and Hanseatic City of Hamburg; Federal Ministry of Health	N.F., S. B., and A. G. are supported by the Graduate School for Structure and Dynamics in Infection (SDI), funded by the Federal State Hamburg, Germany. The Heinrich-Pette Institute is a member of the Leibniz Gemeinschaft (WGL) and is supported by the Free and Hanseatic City of Hamburg and the Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; BIEDLER JL, 1978, CANCER RES, V38, P3751; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRADY J, 1984, P NATL ACAD SCI-BIOL, V81, P2040, DOI 10.1073/pnas.81.7.2040; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; CARSWELL S, 1986, J VIROL, V60, P1055, DOI 10.1128/JVI.60.3.1055-1061.1986; CLAYSON ET, 1989, J VIROL, V63, P2278, DOI 10.1128/JVI.63.5.2278-2288.1989; Daniels R, 2006, J VIROL, V80, P6575, DOI 10.1128/JVI.00347-06; Erickson KD, 2009, J VIROL, V83, P10275, DOI 10.1128/JVI.00949-09; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022468; Fischer N, CELLULAR TRANS UNPUB; Fischer N, 2010, INT J CANCER, V126, P2133, DOI 10.1002/ijc.24877; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Foulongne V, 2008, EMERG INFECT DIS, V14, P1491, DOI 10.3201/eid1409.080651; GALLO GJ, 1990, J VIROL, V64, P173, DOI 10.1128/JVI.64.1.173-184.1990; GARDNER SD, 1971, LANCET, V1, P1253; Garneski KM, 2009, J INVEST DERMATOL, V129, P246, DOI 10.1038/jid.2008.229; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grundhoff A, 2003, J VIROL, V77, P2779, DOI 10.1128/JVI.77.4.2779-2783.2003; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HOHENBERG H, 1994, J MICROSC-OXFORD, V175, P34, DOI 10.1111/j.1365-2818.1994.tb04785.x; Imperiale MJ, 2000, VIROLOGY, V267, P1, DOI 10.1006/viro.1999.0092; Jul-Larsen A, 2004, EXP CELL RES, V298, P58, DOI 10.1016/j.yexcr.2004.03.045; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Katano H, 2009, J MED VIROL, V81, P1951, DOI 10.1002/jmv.21608; KELLER JM, 1984, CELL, V36, P381, DOI 10.1016/0092-8674(84)90231-9; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; MITSUDOMI T, 1992, ONCOGENE, V7, P171; NORKIN LC, 1976, J VIROL, V18, P48, DOI 10.1128/JVI.18.1.48-57.1976; PADGETT BL, 1971, LANCET, V1, P1257; Pastrana DV, 2010, VIROLOGY, V405, P20, DOI 10.1016/j.virol.2010.06.022; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; RESNICK J, 1986, J VIROL, V60, P1098, DOI 10.1128/JVI.60.3.1098-1106.1986; Sauvage V, 2011, EMERG INFECT DIS, V17, P1364, DOI 10.3201/eid1708.110278; Schowalter RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002161; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; SEEGER RC, 1977, CANCER RES, V37, P1364; Seo GJ, 2009, VIROLOGY, V383, P183, DOI 10.1016/j.virol.2008.11.001; Shishido-Hara Y, 2004, J VIROL, V78, P9890, DOI 10.1128/JVI.78.18.9890-9903.2004; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Tremblay JD, 2001, METH MOL B, V165, P1; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; WACHTER M, 1985, J VIROL, V56, P520, DOI 10.1128/JVI.56.2.520-526.1985; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575	53	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29112	10.1371/journal.pone.0029112	http://dx.doi.org/10.1371/journal.pone.0029112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216177	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900013
J	Yamauchi, Y; Izumi, Y; Inoue, M; Sugiura, H; Goto, T; Anraku, M; Ohtsuka, T; Kohno, M; Soejima, K; Nomori, H				Yamauchi, Yoshikane; Izumi, Yotaro; Inoue, Masanori; Sugiura, Hiroaki; Goto, Taichiro; Anraku, Masaki; Ohtsuka, Takashi; Kohno, Mitsutomo; Soejima, Kenzo; Nomori, Hiroaki			Safety of Postoperative Administration of Human Urinary Trypsin Inhibitor in Lung Cancer Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							ULINASTATIN; CYTOKINES; INJURY	Background: Patients with idiopathic pulmonary fibrosis (IPF) undergoing pulmonary resection for lung cancer carry risks of acute exacerbations of IPF (AE) postoperatively. Currently, agents which may attenuate AE are actively sought. Urinary trypsin inhibitor, ulinastatin, is a synthetic glycoprotein which may potentially inhibit various inflammatory factors associated with the development and progression of IPF. The present study was done to evaluate the effects of administration of high dose ulinastatin in lung cancer patients with IPF immediately following lung resection. Methods: Patients with IPFs radiologically diagnosed on high resolution CT, and histologically diagnosed resectable lung cancers, were eligible for the study. The effects of escalating doses of ulinastatin 3 x 10(5), 6 x 10(5), and 9 x 10(5) units/body/day, administered postoperatively for 3 days were evaluated. The endpoints were safety and feasibility. Results: Nine patients were evaluated, in cohorts of 3 patients per dosage. Postoperative follow up ranged from 3 to 12 months (median 9 months). The postoperative courses were uneventful in all patients. No subjective adverse events such as abdominal symptoms or skin rashes, or objective adverse events as per serum laboratory tests, such as liver or kidney dysfunctions potentially attributable to ulinastatin administration were observed. AE was seen in one patient at 3 months after surgery, but since this occurred shortly after administration of chemotherapy, it was considered to be attributable to the chemotherapy rather than surgery. Discussion: Ulinastatin administration after lung resection in lung cancer patients with IPF was considered to be safe and feasible. Further study is planned at the highest dose of this study to evaluate efficacy.	[Yamauchi, Yoshikane; Izumi, Yotaro; Goto, Taichiro; Anraku, Masaki; Ohtsuka, Takashi; Kohno, Mitsutomo; Nomori, Hiroaki] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Inoue, Masanori; Sugiura, Hiroaki] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo, Japan; [Soejima, Kenzo] Keio Univ, Sch Med, Dept Pulm Med, Tokyo, Japan	Keio University; Keio University; Keio University	Yamauchi, Y (corresponding author), Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.	yotaroizumi@a2.keio.jp	Goto, Taichiro/AAM-5276-2020; Soejima, Kenzo/T-9878-2019; OHTSUKA, TAKASHI/I-3988-2019; Yamauchi, Yoshikane/I-1952-2019; Anraku, Masaki/Y-1246-2018	Goto, Taichiro/0000-0002-2560-3639; Soejima, Kenzo/0000-0001-9749-995X; OHTSUKA, TAKASHI/0000-0002-8039-9159; Yamauchi, Yoshikane/0000-0002-3374-2399; Anraku, Masaki/0000-0002-2710-3486	Japanese Ministry of Education, Culture, Sports, Science and Technology [22791321]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by grant in aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology (No. 22791321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bao PT, 2009, EUR J PHARMACOL, V603, P114, DOI 10.1016/j.ejphar.2008.12.007; CAI M, 1994, CIRC SHOCK, V43, P71; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Ebina M, 2011, PULM MED, V2011, DOI 10.1155/2011/916486; ENDO S, 1990, CLIN THER, V12, P323; Fujimoto T, 2003, ANN THORAC SURG, V76, P1674, DOI 10.1016/S0003-4975(03)00966-4; Hanibuchi M, 2001, JPN J LUNG CANC, V41, P281, DOI DOI 10.2482/HAIGAN.41.281; Hoshikawa Yasushi, 2004, Nihon Geka Gakkai Zasshi, V105, P757; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5, DOI 10.1164/ajrccm.161.1.9906062; Katoh H, 2010, J RADIAT RES, V51, P325, DOI 10.1269/jrr.09108; Kawamura T, 1996, CAN J ANAESTH, V43, P456, DOI 10.1007/BF03018106; Kondo D, 1993, Kyobu Geka, V46, P922; Kumar P, 2003, J THORAC CARDIOV SUR, V125, P1321, DOI 10.1016/S0022-5223(03)00028-X; Le Jeune I, 2007, RESP MED, V101, P2534, DOI 10.1016/j.rmed.2007.07.012; Minegishi Y, 2011, LUNG CANCER, V71, P70, DOI 10.1016/j.lungcan.2010.04.014; Miyamoto Atsushi, 2011, Nihon Kokyuki Gakkai Zasshi, V49, P148; OHNISHI H, 1984, DIGEST DIS SCI, V29, P26, DOI 10.1007/BF01296858; OHNISHI H, 1985, JPN J PHARMACOL, V39, P137, DOI 10.1254/jjp.39.137; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Samet JM, 2000, AM J RESP CRIT CARE, V161, P1; Sensaki K, 1993, JPN J LUNG CANC, V33, P61; Takeda A, 2008, RADIAT MED, V26, P504, DOI 10.1007/s11604-008-0261-8; Takenaka K, 1999, JPN J LUNG CANC, V39, P955; The Japan Lung Cancer Society, 2010, GEN RUL CLIN PATH RE; The Japanese Respiratory Society, 2004, ID INT PNEUM DIAGN T; Tsujimura S, 2008, RHEUMATOLOGY, V47, P907, DOI 10.1093/rheumatology/ken067; Tsujimura Shizuyo, 2005, Mod Rheumatol, V15, P374; Watanabe A, 2008, J THORAC CARDIOV SUR, V136, P1357, DOI 10.1016/j.jtcvs.2008.07.016; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6	29	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29053	10.1371/journal.pone.0029053	http://dx.doi.org/10.1371/journal.pone.0029053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216165	gold, Green Submitted, Green Published			2022-12-25	WOS:000299684700026
J	Cox, CM; Goodin, K; Fisher, E; Dawood, FS; Hamilton, JJ; Leparc, GF; Gray, M; Nelson, L; Borse, RH; Singleton, JA; Reed, C; Balish, AL; Katz, JM; Hopkins, RS; Fry, AM				Cox, Chad M.; Goodin, Kate; Fisher, Emily; Dawood, Fatimah S.; Hamilton, Janet J.; Leparc, German F.; Gray, Monica; Nelson, Linda; Borse, Rebekah H.; Singleton, James A.; Reed, Carrie; Balish, Amanda L.; Katz, Jacqueline M.; Hopkins, Richard S.; Fry, Alicia M.			Prevalence of 2009 Pandemic Influenza A (H1N1) Virus Antibodies, Tampa Bay Florida - November-December, 2009	PLOS ONE			English	Article							RISK-FACTORS; ATTACK RATE; INFECTION; SEROCONVERSION; CHILDREN; VACCINE	Background: In 2009, a novel influenza virus (2009 pandemic influenza A (H1N1) virus (pH1N1)) caused significant disease in the United States. Most states, including Florida, experienced a large fall wave of disease from September through November, after which disease activity decreased substantially. We determined the prevalence of antibodies due to the pH1N1 virus in Florida after influenza activity had peaked and estimated the proportion of the population infected with pH1N1 virus during the pandemic. Methods: During November-December 2009, we collected leftover serum from a blood bank, a pediatric children's hospital and a pediatric outpatient clinic in Tampa Bay Florida. Serum was tested for pH1N1 virus antibodies using the hemagglutination-inhibition (HI) assay. HI titers >= 40 were considered seropositive. We adjusted seroprevalence results to account for previously established HI assay specificity and sensitivity and employed a simple statistical model to estimate the proportion of seropositivity due to pH1N1 virus infection and vaccination. Results: During the study time period, the overall seroprevalence in Tampa Bay, Florida was 25%, increasing to 30% after adjusting for HI assay sensitivity and specificity. We estimated that 5.9% of the population had vaccine-induced seropositivity while 25% had seropositivity secondary to pH1N1 virus infection. The highest cumulative incidence of pH1N1 virus infection was among children aged 5-17 years (53%) and young adults aged 18-24 years (47%), while adults aged >= 50 years had the lowest cumulative incidence (11-13%) of pH1N1 virus infection. Conclusions: After the peak of the fall wave of the pandemic, an estimated one quarter of the Tampa Bay population had been infected with the pH1N1 virus. Consistent with epidemiologic trends observed during the pandemic, the highest burdens of disease were among school-aged children and young adults.	[Cox, Chad M.] Ctr Dis Control & Prevent CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Cox, Chad M.; Dawood, Fatimah S.; Singleton, James A.; Reed, Carrie; Balish, Amanda L.; Katz, Jacqueline M.; Fry, Alicia M.] Natl Ctr Immunizat & Resp Dis NCIRD, Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Goodin, Kate; Hamilton, Janet J.; Hopkins, Richard S.] Florida Dept Hlth & Rehabil Serv, Bur Epidemiol, Tallahassee, FL 32399 USA; [Leparc, German F.] Florida Blood Serv, St Petersburg, FL USA; [Gray, Monica] Univ S Florida, All Childrens Hosp, St Petersburg, FL 33701 USA; [Nelson, Linda] Univ S Florida, Pediat Clin, Tampa, FL USA; [Borse, Rebekah H.] Natl Ctr Emerging & Zoonot Infect Dis, Ctr Dis Control & Prevent CDC, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Florida Department of Health; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Centers for Disease Control & Prevention - USA	Cox, CM (corresponding author), Ctr Dis Control & Prevent CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	cyv5@cdc.gov			Juvaris, Inc; Nobilon-Merck Sharp; Dohme; GlaxoSmithKline	Juvaris, Inc; Nobilon-Merck Sharp; Dohme; GlaxoSmithKline(GlaxoSmithKline)	JMK received support for research studies not related to the work described in this manuscript from Juvaris, Inc, Nobilon-Merck Sharp and Dohme and GlaxoSmithKline in the previous 3 years. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.	Adamson WE, 2010, EUROSURVEILLANCE, V15; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P229; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; *CDCP, 2009, INFL VACC COV; *CDCP, 2010, FIN EST 2009 10 SEAS; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dowse GK, 2011, MED J AUSTRALIA, V194, P68, DOI 10.5694/j.1326-5377.2011.tb04170.x; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Grills N, 2010, AUST NZ J PUBL HEAL, V34, P228, DOI 10.1111/j.1753-6405.2010.00518.x; Gurav YK, 2010, INDIAN J MED RES, V132, P67; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Jordan H. T., 2009, Morbidity and Mortality Weekly Report, V58, P470; Khan Laura Kettel, 2009, Morbidity and Mortality Weekly Report, V58, P1; Lim WY, 2011, EMERG INFECT DIS, V17, P1455, DOI 10.3201/eid1708.101270; Lu P. J., 2010, Morbidity and Mortality Weekly Report, V59, P363; Mak GC, 2010, J MED VIROL, V82, P1809, DOI 10.1002/jmv.21895; McVernon J, 2010, EURO SURVEILL, V15, pii; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Singleton J. A., 2010, Morbidity and Mortality Weekly Report, V59, P44; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; TIAN LL, 2010, PREV MED; VEGUILLA V, 2011, J CLIN MICROBIOL; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Organization, MAN LAB DIAGN VIR SU; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; [No title captured]	39	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e29301	10.1371/journal.pone.0029301	http://dx.doi.org/10.1371/journal.pone.0029301			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22206008	Green Submitted, gold, Green Published			2022-12-25	WOS:000298666200022
J	Lasithiotaki, I; Antoniou, KM; Vlahava, VM; Karagiannis, K; Spandidos, DA; Siafakas, NM; Sourvinos, G				Lasithiotaki, Ismini; Antoniou, Katerina M.; Vlahava, Virginia-Maria; Karagiannis, Konstantinos; Spandidos, Demetrios A.; Siafakas, Nikolaos M.; Sourvinos, George			Detection of Herpes Simplex Virus Type-1 in Patients with Fibrotic Lung Diseases	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IDIOPATHIC PULMONARY-FIBROSIS; TOLL-LIKE RECEPTORS; DNA; EBV; EXACERBATION; PATHOGENESIS; INFLAMMATION; EXPRESSION; INFECTION	The current study intends to investigate i) the incidence of herpes viruses including Herpes Simplex Virus type-1 (HSV-1), Cytomegalovirus (CMV) and Human Herpes Virus -6, -7, -8 (HHV6, HHV7, HHV8) in two biological samples, bronchoalveolar lavage fluid (BALF) and lung tissue biopsy, in different forms of pulmonary fibrosis, and ii) the induction of molecular pathways involved in fibrosis by herpesvirus infection in primary cell cultures. PCR was employed for the detection of CMV, HHV6-8 and HSV-1 DNA in lung specimens (4 controls and 11 IPF specimens) and BALF pellet [6 controls and 20 fibrotic Idiopathic Intestitial Pneumonias (f-IIPs) samples: 13 idiopathic pulmonary fibrosis (IPF) and 7 nonspecific idiopathic interstitial pneumonia (NSIP)] samples. Among all herpesviruses tested, HSV-1 was detected in 1/11 (9%) specimens from IPF lung tissue and in 2/20 (10%) samples of f-IIPs BALF whereas the control group was negative. Primary cell cultures from BALF of patients with IPF and healthy controls were infected in vitro with wild-type HSV-1 virus and Real Time PCR was employed for the detection of gene transcription of specific axes implicated in lung fibrosis. Primary cell cultures were permissive to HSV-1, resulting in an upregulation of the fibrotic growth factors TGF beta 1 and FGF, the angiogenetic markers SDF1a, SDF1b, VEGF, FGF and the regulators of tissue wound healing MMP9 and CCR7. Downregulation was noted for the CXCR4 and MMP2 genes, while a different response has been detected in healthy donors regarding the expression of the aforementioned markers. These results implicate for the first time the HSV-1 with Fibrotic Idiopathic Interstitial Pneumonias since the virus presented similar incidence in two different biological samples.	[Lasithiotaki, Ismini; Antoniou, Katerina M.; Karagiannis, Konstantinos] Univ Crete, Sch Med, Lab Mol & Cellular Pulmonol, Iraklion, Crete, Greece; [Lasithiotaki, Ismini; Vlahava, Virginia-Maria; Spandidos, Demetrios A.; Sourvinos, George] Univ Crete, Sch Med, Virol Lab, Iraklion, Crete, Greece; [Antoniou, Katerina M.; Siafakas, Nikolaos M.] Univ Crete, Sch Med, Dept Thorac Med, Iraklion, Crete, Greece	University of Crete; University of Crete; University of Crete	Lasithiotaki, I (corresponding author), Univ Crete, Sch Med, Lab Mol & Cellular Pulmonol, Iraklion, Crete, Greece.	lasithiotaki_ismini@yahoo.gr; katerinaantoniou@yahoo.gr; sourvino@med.uoc.gr	Siafakas, Nikolas/AAI-3324-2020; Karagiannis, Konstantinos/H-4798-2013; Vlachava, Virginia-Maria/R-1933-2018; Lasithiotaki, Ismini/B-4847-2017	Vlachava, Virginia-Maria/0000-0003-4233-7739; Lasithiotaki, Ismini/0000-0001-5089-7547; Spandidos, Demetrios/0000-0002-1146-931X; Karagiannis, Konstantinos/0000-0003-1893-9916	University of Crete; NSRF; European Union; National Resources	University of Crete; NSRF; European Union(European Commission); National Resources	This work was supported by the project "IRAKLITOS II - University of Crete" of the Operational Programme for Education and Lifelong Learning 2007-2013 (E.P.E.D.V.M.) of the NSRF (2007-2013), which is co-funded by the European Union (European Social Fund) and National Resources. V.-M.V. is a PhD student of the Graduate Program "Molecular Basis of Human Disease" at the Medical School, University of Crete. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Antomou KM, 2007, PULM PHARMACOL THER, V20, P453, DOI 10.1016/j.pupt.2006.01.002; Antoniou KM, 2008, AM J RESP CRIT CARE, V177, P190, DOI 10.1164/rccm.200612-1759OC; Antoniou KM, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/537929; Antoniou KM, 2010, CONNECT TISSUE RES, V51, P71, DOI 10.3109/03008200903056150; Center DM, 2007, AM J RESP CRIT CARE, V175, P1101, DOI 10.1164/rccm.200704-547ED; Choi ES, 2006, J CLIN PATHOL, V59, P28, DOI 10.1136/jcp.2005.026872; Economidou F, 2010, J RECEPT SIG TRANSD, V30, P154, DOI 10.3109/10799891003671147; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1365, DOI 10.1099/0022-1317-71-6-1365; Gargano LM, 2009, J VIROL, V83, P1474, DOI 10.1128/JVI.01717-08; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Guenther JF, 2010, AM J PHYSIOL-LUNG C, V299, pL771, DOI 10.1152/ajplung.00408.2009; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; Krug LT, 2010, AM J PATHOL, V177, P608, DOI 10.2353/ajpath.2010.091122; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lanone S, 2002, J CLIN INVEST, V110, P463, DOI 10.1172/JCI200214136; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lok SS, 2002, EUR RESPIR J, V20, P1228, DOI 10.1183/09031936.02.00272902; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; Malizia AP, 2009, EXP CELL RES, V315, P1819, DOI 10.1016/j.yexcr.2009.04.001; Margaritopoulos GA, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-20; Marzouk K, 2005, CURR OPIN PULM MED, V11, P456, DOI 10.1097/01.mcp.0000176678.38539.9a; McMillan TR, 2008, AM J RESP CRIT CARE, V177, P771, DOI 10.1164/rccm.200708-1184OC; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moore PS, 2000, NEW ENGL J MED, V343, P1411, DOI 10.1056/NEJM200011093431912; Mora AL, 2005, AM J PHYSIOL-LUNG C, V289, pL711, DOI 10.1152/ajplung.00007.2005; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Neofytou E, 2009, FERTILITY STERILITY, V91; Panagiotakis SH, 2007, AIDS RES HUM RETROV, V23, P10, DOI 10.1089/aid.2006.0083; Rudd BD, 2006, J IMMUNOL, V176, P1937, DOI 10.4049/jimmunol.176.3.1937; Selman M, 2010, SEMIN RESP CRIT CARE, V31, P607, DOI 10.1055/s-0030-1265901; Sides MD, 2010, AM J RESP CELL MOL B; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Stoolman JS, 2010, AM J PHYSL LUNG CELL; Suga M, 2000, AM J RESP CRIT CARE, V162, P1949, DOI 10.1164/ajrccm.162.5.9906096; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Vannella KM, 2010, AM J RESP CRIT CARE, V181, P465, DOI 10.1164/rccm.200905-0798OC; Vannella KM, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-2; Wangoo A, 1997, THORAX, V52, P888, DOI 10.1136/thx.52.10.888; Zamo A, 2005, SARCOIDOSIS VASC DIF, V22, P123	44	36	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e27800	10.1371/journal.pone.0027800	http://dx.doi.org/10.1371/journal.pone.0027800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205929	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000298666200002
J	Vynne, C; Keim, JL; Machado, RB; Marinho, J; Silveira, L; Groom, MJ; Wasser, SK				Vynne, Carly; Keim, Jonah L.; Machado, Ricardo B.; Marinho-Filho, Jader; Silveira, Leandro; Groom, Martha J.; Wasser, Samuel K.			Resource Selection and Its Implications for Wide-Ranging Mammals of the Brazilian Cerrado	PLOS ONE			English	Article							CHRYSOCYON-BRACHYURUS; NATIONAL-PARK; MANED WOLVES; HOME-RANGE; CONSERVATION; HABITAT; MODEL; SCALE	Conserving animals beyond protected areas is critical because even the largest reserves may be too small to maintain viable populations for many wide-ranging species. Identification of landscape features that will promote persistence of a diverse array of species is a high priority, particularly, for protected areas that reside in regions of otherwise extensive habitat loss. This is the case for Emas National Park, a small but important protected area located in the Brazilian Cerrado, the world's most biologically diverse savanna. Emas Park is a large-mammal global conservation priority area but is too small to protect wide-ranging mammals for the long-term and conserving these populations will depend on the landscape surrounding the park. We employed novel, noninvasive methods to determine the relative importance of resources found within the park, as well as identify landscape features that promote persistence of wide-ranging mammals outside reserve borders. We used scat detection dogs to survey for five large mammals of conservation concern: giant armadillo (Priodontes maximus), giant anteater (Myrmecophaga tridactyla), maned wolf (Chrysocyon brachyurus), jaguar (Panthera onca), and puma (Puma concolor). We estimated resource selection probability functions for each species from 1,572 scat locations and 434 giant armadillo burrow locations. Results indicate that giant armadillos and jaguars are highly selective of natural habitats, which makes both species sensitive to landscape change from agricultural development. Due to the high amount of such development outside of the Emas Park boundary, the park provides rare resource conditions that are particularly important for these two species. We also reveal that both woodland and forest vegetation remnants enable use of the agricultural landscape as a whole for maned wolves, pumas, and giant anteaters. We identify those features and their landscape compositions that should be prioritized for conservation, arguing that a multi-faceted approach is required to protect these species.	[Vynne, Carly; Groom, Martha J.; Wasser, Samuel K.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Vynne, Carly] Natl Fish & Wildlife Fdn, Washington, DC USA; [Keim, Jonah L.] Matrix Solut Inc, Edmonton, AB, Canada; [Machado, Ricardo B.; Marinho-Filho, Jader] Univ Brasilia, Dept Zool, Brasilia, DF, Brazil; [Silveira, Leandro] Jaguar Conservat Fund, Mineiros, Goias, Brazil; [Groom, Martha J.] Univ Washington Bothell, Bothell, WA USA	University of Washington; University of Washington Seattle; Universidade de Brasilia; University of Washington; University of Washington Bothell	Vynne, C (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	Carly.Vynne@nfwf.org	Marinho-Filho, Jader/AAD-6438-2019; Machado, Ricardo/GXM-8198-2022; Wasser, Samuel K/I-5542-2015; Machado, Ricardo Bomfim/J-5894-2012; Groom, Martha/AAF-4483-2021	Marinho-Filho, Jader/0000-0002-4333-0304; Machado, Ricardo Bomfim/0000-0002-6508-9005; 	Gordon and Betty Moore Foundation; Morris Animal Foundation [63-1335]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Morris Animal Foundation	The National Science Foundation (www.nsf.gov), National Security Education Program (www.iie.org/nsep), and the TEAM Network of Conservation International (www.teamnetwork.org), funded by the Gordon and Betty Moore Foundation (www.moore.org), supported C. Vynne with Graduate Fellowships. Project funding was provided by the Morris Animal Foundation (www.morrisanimalfoundation.org, grant 63-1335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Astrup R, 2008, FOREST ECOL MANAG, V256, P1659, DOI 10.1016/j.foreco.2008.07.016; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; Burnham K. P., 1998, MODEL SELECTION INFE; CALVALCANCI RB, 2002, CERRADOS BRAZIL, P351; Camilo-Alves CD, 2006, BIOTROPICA, V38, P52, DOI 10.1111/j.1744-7429.2006.00106.x; CARTER TS, 1983, J MAMMAL, V64, P103, DOI 10.2307/1380755; Chame M, 2003, MEM I OSWALDO CRUZ, V98, P71, DOI 10.1590/S0074-02762003000900014; Coelho CM, 2007, APPL ANIM BEHAV SCI, V105, P259, DOI 10.1016/j.applanim.2006.04.024; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; CONDE DA, 2010, BIOL CONSERV, V2413, P180; Costa LP, 2005, CONSERV BIOL, V19, P672, DOI 10.1111/j.1523-1739.2005.00666.x; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Jacomo ATD, 2009, J MAMMAL, V90, P150, DOI 10.1644/07-MAMM-A-380.1; de Miranda Guilherme H.B., 2006, Endangered Species Update, V23, P96; DIETZ JM, 1984, SMITHSON CONTRIB ZOO, V392, P1; Dinerstein E, 2003, RETURN UNICORNS; Eisenberg J.F., 1999, MAMMALS NEOTROPICS C, V3; Emmons Louise H., 2004, Edentata, V6, P41, DOI 10.1896/1413-4411.6.1.41; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Silva MMFP, 2008, GENET MOL BIOL, V31, P800, DOI 10.1590/S1415-47572008000400030; Ferreira LG, 2003, REMOTE SENS ENVIRON, V87, P534, DOI 10.1016/j.rse.2002.09.003; Grim T, 2006, WILSON J ORNITHOL, V118, P109, DOI 10.1676/04-129.1; *ICMBIO, I CHIC MEND; IUCN, 2014, IUCN RED LIST THREAT; Jacomo ATDA, 2004, J ZOOL, V262, P99; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Keim JL, 2011, ECOL APPL, V21, P1011, DOI 10.1890/10-0949.1; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Lele SR, 2006, ECOLOGY, V87, P3021, DOI 10.1890/0012-9658(2006)87[3021:WDAEOR]2.0.CO;2; Lele SR, 2009, J WILDLIFE MANAGE, V73, P122, DOI 10.2193/2007-535; MacKay Paula, 2008, P183; Manly B.F.J., 2002, RESOURCE SELECTION A; Mcloughlin PD, 2007, ECOLOGY, V88, P3192, DOI 10.1890/06-1974.1; Mittermeier RA, 2004, HOTSPOTS REVISITED; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Mourao G, 2007, J ZOOL, V271, P187, DOI 10.1111/j.1469-7998.2006.00198.x; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; OLIVIERA PS, 2002, CERRADOS BRAZIL ECOL; Panzacchi M, 2009, J ANIM ECOL, V78, P1124, DOI 10.1111/j.1365-2656.2009.01584.x; Raffalovich LE, 2008, J APPL STAT, V35, P1093, DOI 10.1080/03081070802203959; REDFORD KH, 1986, BIOTROPICA, V18, P126, DOI 10.2307/2388755; Rodden M, 2004, CANIDS FOXES WOLVES, P38; Rosner B., 2011, FUNDAMENTALS BIOSTAT; SILVA JMC, 2002, BIOSCIENCE, V52, P225, DOI DOI 10.1641/0006-3568(2002)052[; Silveira L, 1999, ORYX, V33, P108, DOI 10.1017/S0030605300030362; Silveira L., 2004, THESIS U BRASILIA BR; Silveira L, 2009, J WILDLIFE MANAGE, V73, P68, DOI 10.2193/2008-051; Silveira Leandro, 2009, Edentata, V8-10, P25; SOLLMAN R, 2010, J ZOOL, DOI DOI 10.1111/J.1469-7998.2010.00727; Taper ML, 2004, NATURE OF SCIENTIFIC EVIDENCE, P488; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; *UNEP, 2010, CITES SPEC DAT; Vynne C, 2012, ANIM CONSERV, V15, P184, DOI 10.1111/j.1469-1795.2011.00503.x; Vynne C., 2010, LANDSCAPE USE WIDE R; Vynne C, 2011, CONSERV BIOL, V25, P154, DOI 10.1111/j.1523-1739.2010.01581.x; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wolf M, 2009, J MAMMAL, V90, P604, DOI 10.1644/08-MAMM-A-002R1.1; Woodroffe R, 2001, CONSERV BIOL SER, V5, P61	62	43	46	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28939	10.1371/journal.pone.0028939	http://dx.doi.org/10.1371/journal.pone.0028939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205984	gold, Green Submitted, Green Published			2022-12-25	WOS:000298666200014
J	Showmaker, K; Lawrence, GW; Lu, SE; Balbalian, C; Klink, VP				Showmaker, Kurt; Lawrence, Gary W.; Lu, Shien; Balbalian, Clarissa; Klink, Vincent P.			Quantitative Field Testing Rotylenchulus reniformis DNA from Metagenomic Samples Isolated Directly from Soil	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; AMPLIFIED POLYMORPHIC DNA; PARASITIC NEMATODES; MOLECULAR DIAGNOSTICS; MELOIDOGYNE-INCOGNITA; MAJOR MELOIDOGYNE; IDENTIFICATION; COTTON; PCR; QUANTIFICATION	A quantitative PCR procedure targeting the beta-tubulin gene determined the number of Rotylenchulus reniformis Linford & Oliveira 1940 in metagenomic DNA samples isolated from soil. Of note, this outcome was in the presence of other soil-dwelling plant parasitic nematodes including its sister genus Helicotylenchus Steiner, 1945. The methodology provides a framework for molecular diagnostics of nematodes from metagenomic DNA isolated directly from soil.	[Showmaker, Kurt; Balbalian, Clarissa] Mississippi State Univ, Dept Biochem, Bost Extens Ctr, Mississippi State, MS 39762 USA; [Klink, Vincent P.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University	Showmaker, K (corresponding author), Mississippi State Univ, Dept Biochem, Bost Extens Ctr, Mississippi State, MS 39762 USA.	vklink@biology.msstate.edu		Showmaker, Kurt/0000-0002-6317-9402	Department of Biological Sciences	Department of Biological Sciences	Work was supported by start-up funds from the Department of Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Agudelo P, 2005, J NEMATOL, V37, P105; Alkharouf NW, 2007, EXP PARASITOL, V115, P247, DOI 10.1016/j.exppara.2006.09.009; Arzanlou M, 2007, PHYTOPATHOLOGY, V97, P1112, DOI 10.1094/PHYTO-97-9-1112; Atallah ZK, 2006, PHYTOPATHOLOGY, V96, P1037, DOI 10.1094/PHYTO-96-1037; Berry SD, 2008, MOL CELL PROBE, V22, P168, DOI 10.1016/j.mcp.2008.01.003; Blasingame D, 2006, P BELTW COTT C JAN 3, P155; Blok VC, 2005, CAN J PLANT PATHOL, V27, P176; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CENIS JL, 1993, PHYTOPATHOLOGY, V83, P76, DOI 10.1094/Phyto-83-76; DASGUPTA DR, 1968, P HELM SOC WASH, V35, P169; ELGAWAD AMM, 1997, INT J NEMATOL, V7, P103; Finetti-Sialer MM, 2005, PHYTOPATHOLOGY, V95, P262, DOI 10.1094/PHYTO-95-0262; Gao X, 2004, PLANT DIS, V88, P1372, DOI 10.1094/PDIS.2004.88.12.1372; Gasser RB, 1997, MOL CELL PROBE, V11, P201, DOI 10.1006/mcpr.1997.0106; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; GILMAN DF, 1978, LA AGR, V21, P10; Hankins G.W., 1997, Proceedings Beltwide Cotton Conferences, V1, P100; HARRIS TS, 1990, J NEMATOL, V22, P518; HUSSEY RS, 1972, J NEMATOL, V4, P183; Lawrence G. W., 1999, SOYBEAN PRODUCTION M, P291; Lawrence KS, 2005, J NEMATOL, V37, P272; LINFORD M. B., 1940, PROC HELMINTHOL SOC WASHINGTON, V7, P35; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QY, 2011, J CLIN MICROBIOL, V49, P960, DOI 10.1128/JCM.01813-10; Okubara PA, 2008, PHYTOPATHOLOGY, V98, P837, DOI 10.1094/PHYTO-98-7-0837; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Palanisamy S., 1983, Nematologia Mediterranea, V11, P201; Patel R. R., 2004, Indian Journal of Nematology, V34, P106; POWERS TO, 1993, J NEMATOL, V25, P1; Robinson AF, 2007, ANNU REV PHYTOPATHOL, V45, P263, DOI 10.1146/annurev.phyto.45.011107.143949; Robinson AF, 1997, NEMATROPICA, V27, P127; ROOSIEN J, 1993, PARASITOLOGY, V107, P567, DOI 10.1017/S0031182000068153; Semblat JP, 1998, MOL ECOL, V7, P119, DOI 10.1046/j.1365-294x.1998.00326.x; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Stokes DE, 1982, 91 FLA DEP AGR CONS; SUD U C, 1984, Indian Journal of Nematology, V14, P148; THAMES WH, 1974, PLANT DIS REP, V58, P337; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; WILLIAMS J. R., 1960, MAURITIUS SUGAR INDUST RES INST OCCAS PAPER, V4, P1; Winterrowd CA, 2003, VET PARASITOL, V117, P161, DOI 10.1016/j.vetpar.2003.09.001; Wubben MJ, 2010, MOL BIOCHEM PARASIT, V172, P31, DOI 10.1016/j.molbiopara.2010.03.011	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28954	10.1371/journal.pone.0028954	http://dx.doi.org/10.1371/journal.pone.0028954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194958	Green Published, gold, Green Submitted			2022-12-25	WOS:000298664400026
J	Goodier, SAM; Cotterill, FPD; O'Ryan, C; Skelton, PH; de Wit, MJ				Goodier, Sarah A. M.; Cotterill, Fenton P. D.; O'Ryan, Colleen; Skelton, Paul H.; de Wit, Maarten J.			Cryptic Diversity of African Tigerfish (Genus Hydrocynus) Reveals Palaeogeographic Signatures of Linked Neogene Geotectonic Events	PLOS ONE			English	Article							MAIN ETHIOPIAN RIFT; FRESH-WATER FISH; POPULATION-GROWTH; DRAINAGE EVOLUTION; STATISTICAL TESTS; MALAWI RIFT; DNA; DIVERSIFICATION; BIOGEOGRAPHY; ECOLOGY	The geobiotic history of landscapes can exhibit controls by tectonics over biotic evolution. This causal relationship positions ecologically specialized species as biotic indicators to decipher details of landscape evolution. Phylogeographic statistics that reconstruct spatio-temporal details of evolutionary histories of aquatic species, including fishes, can reveal key events of drainage evolution, notably where geochronological resolution is insufficient. Where geochronological resolution is insufficient, phylogeographic statistics that reconstruct spatio-temporal details of evolutionary histories of aquatic species, notably fishes, can reveal key events of drainage evolution. This study evaluates paleo-environmental causes of mitochondrial DNA (mtDNA) based phylogeographic records of tigerfishes, genus Hydrocynus, in order to reconstruct their evolutionary history in relation to landscape evolution across Africa. Strong geographical structuring in a cytochrome b (cyt-b) gene phylogeny confirms the established morphological diversity of Hydrocynus and reveals the existence of five previously unknown lineages, with Hydrocynus tanzaniae sister to a clade comprising three previously unknown lineages (Groups B, C and D) and H. vittatus. The dated phylogeny constrains the principal cladogenic events that have structured Hydrocynus diversity from the late Miocene to the Plio-Pleistocene (ca. 0-16 Ma). Phylogeographic tests reveal that the diversity and distribution of Hydrocynus reflects a complex history of vicariance and dispersals, whereby range expansions in particular species testify to changes to drainage basins. Principal divergence events in Hydrocynus have interfaced closely with evolving drainage systems across tropical Africa. Tigerfish evolution is attributed to dominant control by pulses of geotectonism across the African plate. Phylogenetic relationships and divergence estimates among the ten mtDNA lineages illustrates where and when local tectonic events modified Africa's Neogene drainage. Haplotypes shared amongst extant Hydrocynus populations across northern Africa testify to recent dispersals that were facilitated by late Neogene connections across the Nilo-Sahelian drainage. These events in tigerfish evolution concur broadly with available geological evidence and reveal prominent control by the African Rift System, evident in the formative events archived in phylogeographic records of tigerfish.	[Goodier, Sarah A. M.; Cotterill, Fenton P. D.; O'Ryan, Colleen] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa; [Goodier, Sarah A. M.; Cotterill, Fenton P. D.; de Wit, Maarten J.] Univ Cape Town, AEON, ZA-7925 Cape Town, South Africa; [Skelton, Paul H.] SAIAB, Grahamstown, South Africa; [de Wit, Maarten J.] Nelson Mandela Metropolitan Univ, AEON, Port Elizabeth, South Africa	University of Cape Town; University of Cape Town; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Nelson Mandela University	Goodier, SAM (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa.	fcotterill@gmail.com		O'Ryan, Colleen/0000-0003-3719-4657; Cotterill, Fenton/0000-0003-4561-018X; Goodier, Sarah/0000-0002-5272-7549	InkabayeAfrica; National Research Foundation; Ellerman Foundation; ERANDA Foundation; Tourette Fishing Safaris; BRC-DiamondCore; Nxamaseri; Guma Camp; National Geographical Society; Ndola Fisheries; Microsoft Corporation; Drotsky Camp	InkabayeAfrica; National Research Foundation; Ellerman Foundation; ERANDA Foundation; Tourette Fishing Safaris; BRC-DiamondCore; Nxamaseri; Guma Camp; National Geographical Society; Ndola Fisheries; Microsoft Corporation(Microsoft); Drotsky Camp	The authors gratefully acknowledge funding by InkabayeAfrica, the National Research Foundation, the Ellerman Foundation and the ERANDA Foundation. The study also received support from Tourette Fishing Safaris, BRC-DiamondCore, Nxamaseri, Guma and Drotsky's Camps and the National Geographical Society and Ndola Fisheries. Shimano and Fred Tucker's are gratefully thanked for sponsorship of angling equipment. Part of this work was carried out by using the resources of the Computational Biology Service Unit from Cornell University which is partially funded by Microsoft Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interests: The authors' are grateful for logistical support from Keith Clover of Tourette Fishing Safaris, Mike de Wit and colleagues of BRC-DiamondCore; Robin Hartle, and guides and staff at Nxamaseri, Guma and Drotsky's Camps; as well as the National Geographical Society and Ndola Fisheries. Shimano and Fred Tucker's are gratefully thanked for sponsorship of angling equipment. Part of this work was carried out by using the resources of the Computational Biology Service Unit from Cornell University which is partially funded by Microsoft Corporation. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abebe T, 2010, TERRA NOVA, V22, P470, DOI 10.1111/j.1365-3121.2010.00968.x; Arroyave J, 2011, MOL PHYLOGENET EVOL, V60, P385, DOI 10.1016/j.ympev.2011.04.016; Badgley C, 2010, ECOGRAPHY, V33, P220, DOI 10.1111/j.1600-0587.2010.06282.x; BALON EK, 1974, COPEIA, P643; Bauer FU, 2010, INT J EARTH SCI, V99, P1575, DOI 10.1007/s00531-010-0549-7; Bazinet A.L., GENEALOGICAL S UNPUB; BELL-CROSS G, 1972, Arnoldia (Rhodesia), V5, P1; Bell-Cross G, 1965, FISH REASERCH B, V4, P3; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Berendzen PB, 2008, J FISH BIOL, V73, P2021, DOI 10.1111/j.1095-8649.2008.02046.x; Berra TM, 2007, FRESHWATER FISH DIST; Brewster B., 1986, Bulletin of the British Museum (Natural History) Zoology, V50, P163; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; BROWN KJ, 2010, BMC EVOL BIOL, V10, pNIL1, DOI DOI 10.1186/1471-2148-10-188; Bruhn RL, 2011, J AFR EARTH SCI, V59, P295, DOI 10.1016/j.jafrearsci.2010.12.002; Burridge CP, 2008, EVOLUTION, V62, P1484, DOI 10.1111/j.1558-5646.2008.00377.x; Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; Cotterill F.P.D., 2003, P11; Cotterill FPD, 2011, S AFR J GEOL, V114, P489, DOI 10.2113/gssajg.114.3-4.489; COTTERILL FPD, 2009, AFRICAN FISHERMAN, V20, P37; CRACRAFT J, 1992, SYSTEMATICS, ECOLOGY, AND THE BIODIVERSITY CRISIS, P59; CRACRAFT J, 1985, ANN MO BOT GARD, V72, P794, DOI 10.2307/2399222; Craw D, 2008, GEOLOGY, V36, P19, DOI 10.1130/G24126A.1; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Day JJ, 2009, J EVOLUTION BIOL, V22, P805, DOI 10.1111/j.1420-9101.2009.01691.x; de Wit M, 2006, SCIENCE, V311, P1917, DOI 10.1126/science.1119929; Delvaux D, 2001, MEM MUS NAT HIST NAT, V186, P545; Dixey F., 1943, S AFR GEOGR J, V25, P20; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Du Toit A. L., 1933, S AFR GEOGR J, V16, P3; Ebinger CJ, 2000, GEOL SOC AM BULL, V112, P163, DOI 10.1130/0016-7606(2000)112<163:RDMAPL>2.0.CO;2; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAIRHEAD JD, 1969, NATURE, V221, P1018, DOI 10.1038/2211018a0; FAIRHEAD JD, 1989, J AFR EARTH SCI, V8, P231, DOI 10.1016/S0899-5362(89)80027-2; Faulkes CG, 2011, J ZOOL, V285, P324, DOI 10.1111/j.1469-7998.2011.00863.x; Faulkes CG, 2010, BIOL J LINN SOC, V100, P337, DOI 10.1111/j.1095-8312.2010.01418.x; Fu YX, 1996, GENETICS, V143, P557; Fu YX, 1997, GENETICS, V147, P915; GOODIER SAM, 2010, THESIS U CAPE TOWN; Goudie AS, 2005, GEOMORPHOLOGY, V67, P437, DOI 10.1016/j.geomorph.2004.11.008; Griffin DL, 2006, J GEOL SOC LONDON, V163, P905, DOI 10.1144/0016-76492005-049; GUIRAUD R, 1992, TECTONOPHYSICS, V213, P153, DOI 10.1016/0040-1951(92)90256-6; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hekkala E, 2011, MOL ECOL, V20, P4199, DOI 10.1111/j.1365-294X.2011.05245.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hrbek T, 2004, MOL PHYLOGENET EVOL, V32, P297, DOI 10.1016/j.ympev.2003.12.017; Hunn CA, 2001, SYST BIOL, V50, P391, DOI 10.1080/713849647; Jackson P. B. N., 1961, Proceedings of the Zoological Society of London, V136, P603; JACKSON PBN, 1986, ECOLOGY RIVER SYSTEM, P269; Jarvis A., 2008, EOS T AGU, V89, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; JUBB R. A., 1952, S AFRICAN JOUR SCI, V49, P50; JUBB RA, 1977, COPEIA, V1, P198; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kinabo BD, 2008, TECTONICS, V27, DOI 10.1029/2007TC002154; Leveque C., 1997, BIODIVERSITY DYNAMIC; LI WH, 1977, GENETICS, V85, P331; Marijnissen SAE, 2006, MOL PHYLOGENET EVOL, V40, P628, DOI 10.1016/j.ympev.2006.03.025; MERRON GS, 1995, ENVIRON BIOL FISH, V43, P109, DOI 10.1007/BF00002478; Modisi MP, 2000, J AFR EARTH SCI, V30, P569, DOI 10.1016/S0899-5362(00)00039-7; Moodley Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000454; Moore A.E., 2007, LARGE RIVERS GEOMORP, P311, DOI DOI 10.1002/9780470723722.CH15; Moore AE, 2001, S AFR J GEOL, V104, P47, DOI 10.2113/104.1.47; MOORE AE, 2011, PALAEOGEOGR IN PRESS; Nagaoka S, 2005, PALAEOGEOGR PALAEOCL, V216, P333, DOI 10.1016/j.palaeo.2004.11.008; NJOME MS, 2011, EARTH SCI R IN PRESS; Njonfang E, 2011, GEOL SOC AM SPEC PAP, V478, P173, DOI 10.1130/2011.2478(09); Otero O, 2011, GEOLOGY, V39, P435, DOI 10.1130/G31212.1; Otero O, 2009, J AFR EARTH SCI, V54, P62, DOI 10.1016/j.jafrearsci.2009.03.004; Otero O, 2009, PALAEOGEOGR PALAEOCL, V274, P134, DOI 10.1016/j.palaeo.2009.01.005; PAUGY D, 1989, Revue d'Hydrobiologie Tropicale, V22, P63; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POSADA D, 1999, COLLAPSE VERSION 1 1; REEVES CV, 1972, NATURE, V237, P95, DOI 10.1038/237095a0; Regnoult J.M., 1986, SYNTHESE GEOLOGIQUE; REID JM, 1996, P ROY SOC EDINB B, V104, P285; RING U, 1995, J HUM EVOL, V28, P7, DOI 10.1006/jhev.1995.1003; ROBERTS TR, 1975, ZOOL J LINN SOC-LOND, V57, P249, DOI 10.1111/j.1096-3642.1975.tb01893.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roller S, 2010, INT J EARTH SCI, V99, P1643, DOI 10.1007/s00531-010-0560-z; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHOLZ CH, 1976, GEOPHYS J ROY ASTR S, V44, P135, DOI 10.1111/j.1365-246X.1976.tb00278.x; Skelton P. H, 2001, COMPLETE GUTIDE FRES; SKELTON PH, 1994, ANN MUS R AFR CENTR, V275, P95; Smedmark JEE, 2010, J BIOGEOGR, V37, P2260, DOI 10.1111/j.1365-2699.2010.02366.x; Sokal RR, 1963, PRINCIPLES NUMERICAL; Speigel C, 2010, GEOLOGY, V35, P427, DOI [10.1130/G23108A, DOI 10.1130/G23108A]; Stankiewicz J, 2006, J AFR EARTH SCI, V44, P75, DOI 10.1016/j.jafrearsci.2005.11.008; Stewart KM, 2001, FISH FISH, V2, P177, DOI 10.1046/j.1467-2960.2001.00052.x; Stewart KM, 2009, MONOGR BIOL, V89, P677; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TAJIMA F, 1989, GENETICS, V123, P585; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; *TECHN PTY LTD, 2006, CHROM 2 13; Teugels G.G., 1994, ANN MUSEE R DAFRIQUE, V275, P67; Teugels G.G., 2003, FRESH BRACKISH WATER; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WINEMILLER KO, 1994, J FISH BIOL, V45, P211; WoldeGabriel G, 2005, J VOLCANOL GEOTH RES, V147, P81, DOI 10.1016/j.jvolgeores.2005.03.008; WRIGHT S, 1951, ANN EUGENIC, V15, P323	107	68	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28775	10.1371/journal.pone.0028775	http://dx.doi.org/10.1371/journal.pone.0028775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194910	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100097
J	van Tienen, C; van der Loeff, MS; Peterson, I; Cotten, M; Andersson, S; Holmgren, B; Vincent, T; de Silva, T; Rowland-Jones, S; Aaby, P; Whittle, H				van Tienen, Carla; van der Loeff, Maarten Schim; Peterson, Ingrid; Cotten, Matthew; Andersson, Soren; Holmgren, Birgitta; Vincent, Tim; de Silva, Thushan; Rowland-Jones, Sarah; Aaby, Peter; Whittle, Hilton			HTLV-1 and HIV-2 Infection Are Associated with Increased Mortality in a Rural West African Community	PLOS ONE			English	Article							VIRUS TYPE-1 HTLV-1; PLASMA VIRAL LOAD; GUINEA-BISSAU; INCREASED PREVALENCE; DUAL INFECTIONS; NORMAL SURVIVAL; PROVIRUS LOAD; RISK-FACTORS; OLDER WOMEN; POPULATION	Background: Survival of people with HIV-2 and HTLV-1 infection is better than that of HIV-1 infected people, but long-term follow-up data are rare. We compared mortality rates of HIV-1, HIV-2, and HTLV-1 infected subjects with those of retrovirus-uninfected people in a rural community in Guinea-Bissau. Methods: In 1990, 1997 and 2007, adult residents (aged >= 15 years) were interviewed, a blood sample was drawn and retroviral status was determined. An annual census was used to ascertain the vital status of all subjects. Cox regression analysis was used to estimate mortality hazard ratios (HR), comparing retrovirus-infected versus uninfected people. Results: A total of 5376 subjects were included; 197 with HIV-1, 424 with HIV-2 and 325 with HTLV-1 infection. The median follow-up time was 10.9 years (range 0.0-20.3). The crude mortality rates were 9.6 per 100 person-years of observation (95% confidence interval 7.1-12.9) for HIV-1, 4.1 (3.4-5.0) for HIV-2, 3.6 (2.9-4.6) for HTLV-1, and 1.6 (1.5-1.8) for retrovirus-negative subjects. The HR comparing the mortality rate of infected to that of uninfected subjects varied significantly with age. The adjusted HR for HIV-1 infection varied from 4.0 in the oldest age group (>= 60 years) to 12.7 in the youngest (15-29 years). The HR for HIV-2 infection varied from 1.2 (oldest) to 9.1 (youngest), and for HTLV-1 infection from 1.2 (oldest) to 3.8 (youngest). Conclusions: HTLV-1 infection is associated with significantly increased mortality. The mortality rate of HIV-2 infection, although lower than that of HIV-1 infection, is also increased, especially among young people.	[van Tienen, Carla; Peterson, Ingrid; Cotten, Matthew; Vincent, Tim; de Silva, Thushan; Whittle, Hilton] MRC, Fajara, Gambia; [van der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Andersson, Soren] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Holmgren, Birgitta] Lund Univ, Lund, Sweden; [Holmgren, Birgitta] Dept Lab Med, Malmo, Sweden; [de Silva, Thushan] UCL, Ctr Med Mol Virol, Div Infect & Immun, London, England; [Rowland-Jones, Sarah] John Radcliffe Hosp, Weatherall Inst Mol Med, Human Immunol Unit, Oxford OX3 9DU, England; [Aaby, Peter] Indepth Network, Proj Saude Bandim, Bissau, Guinea Bissau; [van der Loeff, Maarten Schim] Municipal Hlth Serv, Amsterdam, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Swedish Institute for Infectious Disease Control; Lund University; University of London; University College London; University of Oxford	van Tienen, C (corresponding author), MRC, Fajara, Gambia.	mschim@ggd.amsterdam.nl	de Silva, Thushan/AAT-4820-2020; van Tienen, Carla/A-1119-2012	de Silva, Thushan/0000-0002-6498-9212; Aaby, Peter/0000-0001-8331-1389; Cotten, Matthew/0000-0002-3361-3351	Medical Research Council, United Kingdom; MRC [MC_U190081997] Funding Source: UKRI; Medical Research Council [MC_U190081997] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding provided by the Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 1996, AIDS, V10, P1585, DOI 10.1097/00002030-199611000-00019; Alabi AS, 2003, AIDS, V17, P1513, DOI 10.1097/00002030-200307040-00012; Ariyoshi K, 2003, J INFECT DIS, V188, P1648, DOI 10.1086/379780; Ariyoshi K, 1996, J INFECT DIS, V173, P245, DOI 10.1093/infdis/173.1.245; Berry N, 2002, AIDS RES HUM RETROV, V18, P1167, DOI 10.1089/08892220260387904; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Brites C, 2009, AIDS REV, V11, P8; Cooke FJ, 2005, J MED VIROL, V76, P143, DOI 10.1002/jmv.20336; Cooper S, 2009, J NEUROL NEUROSUR PS, V80, P66, DOI 10.1136/jnnp.2008.152819; DASILVA ZJ, 2009, AIDS; de Silva Thushan I., 2010, HIV Therapy, V4, P305, DOI 10.2217/HIV.10.26; GABBAI AA, 1993, AM J TROP MED HYG, V49, P664, DOI 10.4269/ajtmh.1993.49.664; GESKUS R, 2009, 13 INT WORKSH HIV OB; Holmgren B, 1999, SCAND J INFECT DIS, V31, P459, DOI 10.1080/00365549950163978; Holmgren B, 2003, AIDS, V17, P241, DOI 10.1097/00002030-200301240-00015; Holmgren B, 2002, J ACQ IMMUN DEF SYND, V30, P342, DOI [10.1097/01.QAI.0000013943.86473.3E, 10.1097/00126334-200207010-00011]; Holmgren B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-85; IWATA K, 1994, JPN J CANCER RES, V85, P231, DOI 10.1111/j.1349-7006.1994.tb02087.x; Krook A, 1997, J ACQ IMMUN DEF SYND, V15, P381, DOI 10.1097/00042560-199708150-00009; Larsen O, 2000, J ACQ IMMUN DEF SYND, V25, P157, DOI 10.1097/00126334-200010010-00010; Marinho J, 2005, JAIDS-J ACQ IMM DEF, V40, P625, DOI 10.1097/01.qai.0000174252.73516.7a; Melbye M, 1998, INT J CANCER, V76, P293, DOI 10.1002/(SICI)1097-0215(19980504)76:3&lt;293::AID-IJC1&gt;3.0.CO;2-Q; NORRGREN H, 2010, INT J INFECT DIS; Norrgren HR, 2008, JAIDS-J ACQ IMM DEF, V48, P607, DOI 10.1097/QAI.0b013e31817efb83; Oliveira I, 2010, AIDS, V24, P783, DOI 10.1097/QAD.0b013e328335cead; Orland Jennie R, 2004, Retrovirology, V1, P4, DOI 10.1186/1742-4690-1-4; Poulsen AG, 1997, LANCET, V349, P911, DOI 10.1016/S0140-6736(96)04402-9; RICARD D, 1994, AIDS, V8, P977, DOI 10.1097/00002030-199407000-00016; Seng R, 2002, AIDS, V16, P1059, DOI 10.1097/00002030-200205030-00013; Todd J, 1997, AIDS, V11, P801, DOI 10.1097/00002030-199706000-00013; van der Loeff MFS, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-46; van der Loeff MFS, 2002, AIDS, V16, P1775, DOI 10.1097/00002030-200209060-00010; van der Loeff MFS, 2001, AIDS, V15, P2303, DOI 10.1097/00002030-200111230-00012; van Tienen C, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-50; van Tienen C, 2010, JAIDS-J ACQ IMM DEF, V53, P640, DOI 10.1097/QAI.0b013e3181bf1a25; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Zehender G, 2004, J MED VIROL, V74, P207, DOI 10.1002/jmv.20165	38	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29026	10.1371/journal.pone.0029026	http://dx.doi.org/10.1371/journal.pone.0029026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194980	Green Published, gold, Green Accepted			2022-12-25	WOS:000298369100143
J	Wernegreen, JJ				Wernegreen, Jennifer J.			Reduced Selective Constraint in Endosymbionts: Elevation in Radical Amino Acid Replacements Occurs Genome-Wide	PLOS ONE			English	Article							DELETERIOUS MUTATIONS; POPULATION-SIZE; GENETIC DRIFT; MOLECULAR EVOLUTION; SEQUENCE EVOLUTION; RATES; SUBSTITUTIONS; BUCHNERA; BACTERIA; GROEL	As predicted by the nearly neutral model of evolution, numerous studies have shown that reduced N-e accelerates the accumulation of slightly deleterious changes under genetic drift. While such studies have mostly focused on eukaryotes, bacteria also offer excellent models to explore the effects of N-e. Most notably, the genomes of host-dependent bacteria with small N-e show signatures of genetic drift, including elevated K-a/K-s. Here, I explore the utility of an alternative measure of selective constraint: the per-site rate of radical and conservative amino acid substitutions (D-r/D-c). I test the hypothesis that purifying selection against radical amino acid changes is less effective in two insect endosymbiont groups (Blochmannia of ants and Buchnera of aphids), compared to related gamma-Proteobacteria. Genome comparisons demonstrate a significant elevation in D-r/D-c in endosymbionts that affects the majority (66-79%) of shared orthologs examined. The elevation of D-r/D-c in endosymbionts affects all functional categories examined. Simulations indicate that D-r/D-c estimates are sensitive to codon frequencies and mutational parameters; however, estimation biases occur in the opposite direction as the patterns observed in genome comparisons, thereby making the inference of elevated D-r/D-c more conservative. Increased D-r/D-c and other signatures of genome degradation in endosymbionts are consistent with strong effects of genetic drift in their small populations, as well as linkage to selected sites in these asexual bacteria. While relaxed selection against radical substitutions may contribute, genome-wide processes such as genetic drift and linkage best explain the pervasive elevation in D-r/D-c across diverse functional categories that include basic cellular processes. Although the current study focuses on a few bacterial lineages, it suggests D-r/D-c is a useful gauge of selective constraint and may provide a valuable alternative to K-a/K-s when high sequence divergences preclude estimates of K-s. Broader application of D-r/D-c will benefit from approaches less prone to estimation biases.	[Wernegreen, Jennifer J.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Wernegreen, Jennifer J.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University; Duke University	Wernegreen, JJ (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	j.wernegreen@duke.edu			National Science Foundation [MCB-1103113]; National Institutes of Health [R01GM062626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062626] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by grants from the National Science Foundation (MCB-1103113) and National Institutes of Health (R01GM062626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot P, 2002, MOL ECOL, V11, P2649, DOI 10.1046/j.1365-294X.2002.01646.x; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bastolla U, 2004, J MOL BIOL, V343, P1451, DOI 10.1016/j.jmb.2004.08.086; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Eyre-Walker A, 2002, MOL BIOL EVOL, V19, P2142, DOI 10.1093/oxfordjournals.molbev.a004039; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Fares MA, 2004, TRENDS GENET, V20, P413, DOI 10.1016/j.tig.2004.07.001; Fares MA, 2002, MOL BIOL EVOL, V19, P1162, DOI 10.1093/oxfordjournals.molbev.a004174; Funk DJ, 2001, GENETICS, V157, P477; Gerrard DT, 2005, MOL BIOL EVOL, V22, P1423, DOI 10.1093/molbev/msi128; Gillespie JH, 2001, EVOLUTION, V55, P2161; Gillespie JH, 2000, GENE, V261, P11, DOI 10.1016/S0378-1119(00)00485-6; Gillespie JH, 1999, THEOR POPUL BIOL, V55, P145, DOI 10.1006/tpbi.1998.1391; Goto H, 2004, GENES GENET SYST, V79, P19, DOI 10.1266/ggs.79.19; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; Hudson RR, 2003, EVOLUTION, V57, P182; Hughes AL, 2009, GENE, V440, P50, DOI 10.1016/j.gene.2009.03.012; ISHIKAWA H, 1984, BIOSYSTEMS, V17, P127, DOI 10.1016/0303-2647(84)90004-2; Johnson KP, 2001, MOL BIOL EVOL, V18, P874, DOI 10.1093/oxfordjournals.molbev.a003869; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; Li W.H., 1997, MOL EVOLUTION, P487; LI WH, 1987, J MOL EVOL, V25, P330, DOI 10.1007/BF02603118; Lockhart P, 2006, MOL BIOL EVOL, V23, P40, DOI 10.1093/molbev/msj005; Lu J, 2006, TRENDS GENET, V22, P126, DOI 10.1016/j.tig.2006.01.004; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; NACHMAN MW, 1994, P NATL ACAD SCI USA, V91, P6364, DOI 10.1073/pnas.91.14.6364; Ohta T, 1972, J Mol Evol, V1, P150, DOI 10.1007/BF01659161; OHTA T, 1995, J MOL EVOL, V40, P56, DOI 10.1007/BF00166595; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; OHTA T, 1976, THEOR POPUL BIOL, V10, P254, DOI 10.1016/0040-5809(76)90019-8; Ota T, 1971, J Mol Evol, V1, P18, DOI 10.1007/BF01659391; Pupko T, 2003, GENE, V319, P127, DOI 10.1016/S0378-1119(03)00802-3; Raineri E, 2010, BIOINFORMATICS, V26, P1685, DOI 10.1093/bioinformatics/btq287; Rand DM, 2000, GENE, V261, P115, DOI 10.1016/S0378-1119(00)00483-2; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Serres Margrethe Hauge, 2000, Microbial and Comparative Genomics, V5, P205, DOI 10.1089/mcg.2000.5.205; Serres MH, 2004, NUCLEIC ACIDS RES, V32, pD300, DOI 10.1093/nar/gkh087; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smith NGC, 2003, J MOL EVOL, V57, P467, DOI 10.1007/s00239-003-2500-z; Toft C, 2010, MOL BIOL EVOL, V27, P2375, DOI 10.1093/molbev/msq123; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Warnecke T, 2011, MOL BIOL EVOL, V28, P2339, DOI 10.1093/molbev/msr054; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P83, DOI 10.1093/oxfordjournals.molbev.a026040; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Williams TA, 2010, GENOME BIOL EVOL, V2, P609, DOI 10.1093/gbe/evq045; Woolfit M, 2005, P ROY SOC B-BIOL SCI, V272, P2277, DOI 10.1098/rspb.2005.3217; Woolfit M, 2003, MOL BIOL EVOL, V20, P1545, DOI 10.1093/molbev/msg167; Xu JP, 2004, GENOME, V47, P775, DOI 10.1139/G04-037; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	73	25	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28905	10.1371/journal.pone.0028905	http://dx.doi.org/10.1371/journal.pone.0028905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194947	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100123
J	Lavelle, TA; Meltzer, MI; Gebremariam, A; Lamarand, K; Fiore, AE; Prosser, LA				Lavelle, Tara A.; Meltzer, Martin I.; Gebremariam, Achamyeleh; Lamarand, Kara; Fiore, Anthony E.; Prosser, Lisa A.			Community-Based Values for 2009 Pandemic Influenza A H1N1 Illnesses and Vaccination-Related Adverse Events	PLOS ONE			English	Article							VALUING HEALTH; PREFERENCES; SCORES; LIFE	Objective: To evaluate community-based values for avoiding pandemic influenza (A) H1N1 (pH1N1) illness and vaccination-related adverse events in adults and children. Methods: Adult community members were randomly selected from a nationally representative research panel to complete an internet survey (response rate = 65%; n = 718). Respondents answered a series of time trade-off questions to value four hypothetical health state scenarios for varying ages (1, 8, 35, or 70 years): uncomplicated pH1N1 illness, pH1N1 illness-related hospitalization, severe allergic reaction to the pH1N1 vaccine, and Guillain-Barre syndrome. We calculated descriptive statistics for time trade-off amounts and derived quality adjusted life year losses for these events. Multivariate regression analyses evaluated the effect of scenario age, as well as respondent socio-demographic and health characteristics on time trade-off amounts. Results: Respondents were willing to trade more time to avoid the more severe outcomes, hospitalization and Guillain-Barre syndrome. In our adjusted and unadjusted analyses, age of the patient in the scenario was significantly associated with time trade-off amounts (p-value<0.05), with respondents willing to trade more time to prevent outcomes in children versus adults. Persons who had received the pH1N1 vaccination were willing to trade significantly more time to avoid hospitalization, severe allergic reaction, and Guillain-Barre syndrome, controlling for other variables in adjusted analyses.(p-value<0.05) Conclusions: Community members placed the highest value on preventing outcomes in children, compared with adults, and the time trade-off values reported were consistent with the severity of the outcomes presented. Considering these public values along with other decision-making factors may help policy makers improve the allocation of pandemic vaccine resources.	[Lavelle, Tara A.] Harvard Univ, PhD Program Hlth Policy, Cambridge, MA 02138 USA; [Lavelle, Tara A.] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Meltzer, Martin I.; Fiore, Anthony E.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Gebremariam, Achamyeleh; Lamarand, Kara; Prosser, Lisa A.] Univ Michigan Hlth Syst, Child Hlth Evaluat & Res Unit, Div Gen Pediat, Ann Arbor, MI USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan	Lavelle, TA (corresponding author), Harvard Univ, PhD Program Hlth Policy, Cambridge, MA 02138 USA.	tlavelle@fas.harvard.edu	Meltzer, Martin/AAT-3235-2021; Fiore, Anthony/AAO-8956-2020	Meltzer, Martin/0000-0002-7250-0472; 	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, RESPONDENT INCENTIVE; Attema AE, 2010, VALUE HEALTH, V13, P879, DOI 10.1111/j.1524-4733.2010.00773.x; Baron J, 2003, MED DECIS MAKING, V23, P422, DOI 10.1177/0272989X03257277; Brazier J, 2011, SOC SCI MED, V73, P245, DOI 10.1016/j.socscimed.2011.05.026; Dennis JM, 2010, KNOWLEDGEPANELH DESI; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Eisenberg D, 2007, HEALTH AFFAIR, V26, P345, DOI 10.1377/hlthaff.26.2.345; Eisenberg D, 2011, APPL HEALTH ECON HEA, V9, P149, DOI 10.2165/11587340-000000000-00000; Gaskin DJ, 2007, J NATL MED ASSOC, V99, P22; Gold MR, 1996, COST EFFECTIVENESS H; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Johannesson Magnus, 1996, THEORY METHODS EC EV; Johnston SS, 2010, AM J MANAG CARE, V16, pE205; Lillie-Blanton M, 2001, Yale J Health Policy Law Ethics, V1, P15; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Prosser LA, 2003, MULT SCLER J, V9, P311, DOI 10.1191/1352458503ms903oa; Prosser Lisa A, 2005, Health Qual Life Outcomes, V3, P18, DOI 10.1186/1477-7525-3-18; Prosser LA, 2011, VALUE HEALTH, V14, P135, DOI 10.1016/j.jval.2010.10.026; SteelFisher Gillian K, 2010, N Engl J Med, V362, pe65, DOI 10.1056/NEJMp1005102; U.S. Department of Health and Human Services USDoHS, 2008, GUID ALL TARG PAND I; Ubel PA, 2003, QUAL LIFE RES, V12, P599, DOI 10.1023/A:1025119931010; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030; Weinstein MC, 2009, VALUE HEALTH, V12, pS5, DOI 10.1111/j.1524-4733.2009.00515.x; Wittenberg E, 2006, QUAL LIFE RES, V15, P645, DOI 10.1007/s11136-005-3514-3	25	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27777	10.1371/journal.pone.0027777	http://dx.doi.org/10.1371/journal.pone.0027777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	870JO	22205927	Green Published, gold, Green Submitted			2022-12-25	WOS:000298665600002
J	Blumbach, K; Niehoff, A; Belgardt, BF; Ehlen, HWA; Schmitz, M; Hallinger, R; Schulz, JN; Bruning, JC; Krieg, T; Schubert, M; Gullberg, D; Eckes, B				Blumbach, Katrin; Niehoff, Anja; Belgardt, Bengt F.; Ehlen, Harald W. A.; Schmitz, Markus; Hallinger, Ralf; Schulz, Jan-Niklas; Bruening, Jens C.; Krieg, Thomas; Schubert, Markus; Gullberg, Donald; Eckes, Beate			Dwarfism in Mice Lacking Collagen-binding Integrins alpha 2 beta 1 and alpha 11 beta 1 Is Caused by Severely Diminished IGF-1 Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; EXTRACELLULAR-MATRIX; STRUCTURAL BASIS; GENE-EXPRESSION; TRANSGENIC MICE; BONE; RECEPTOR; FIBROBLASTS; HORMONE; MOUSE	Mice with a combined deficiency in the alpha 2 beta 1 and alpha 11 beta 1 integrins lack the major receptors for collagen I. These mutants are born with inconspicuous differences in size but develop dwarfism within the first 4 weeks of life. Dwarfism correlates with shorter, less mineralized and functionally weaker bones that do not result from growth plate abnormalities or osteoblast dysfunction. Besides skeletal dwarfism, internal organs are correspondingly smaller, indicating proportional dwarfism and suggesting a systemic cause for the overall size reduction. In accordance with a critical role of insulin-like growth factor (IGF)-1 in growth control and bone mineralization, circulating IGF-1 levels in the sera of mice lacking either alpha 2 beta 1 or alpha 11 beta 1 or both integrins were sharply reduced by 39%, 64%, or 81% of normal levels, respectively. Low hepatic IGF-1 production resulted from diminished growth hormone-releasing hormone expression in the hypothalamus and, subsequently, reduced growth hormone expression in the pituitary glands of these mice. These findings point out a novel role of collagen-binding integrin receptors in the control of growth hormone/IGF-1-dependent biological activities. Thus, coupling hormone secretion to extracellular matrix signaling via integrins represents a novel concept in the control of endocrine homeostasis.	[Blumbach, Katrin; Schmitz, Markus; Hallinger, Ralf; Schulz, Jan-Niklas; Krieg, Thomas; Eckes, Beate] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Niehoff, Anja] German Sport Univ Cologne, Inst Biomech & Orthopaed, D-50933 Cologne, Germany; [Belgardt, Bengt F.; Bruening, Jens C.] Univ Cologne, Inst Mouse Genet & Metab, D-50674 Cologne, Germany; [Belgardt, Bengt F.; Bruening, Jens C.; Krieg, Thomas; Schubert, Markus] Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Belgardt, Bengt F.; Bruening, Jens C.; Krieg, Thomas; Schubert, Markus] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany; [Ehlen, Harald W. A.] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Ehlen, Harald W. A.] Univ Duisburg Essen, Ctr Med Biotechnol ZMB Biol & Geog, Inst Dev Biol 1, D-45117 Essen, Germany; [Bruening, Jens C.; Schubert, Markus] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50937 Cologne, Germany; [Bruening, Jens C.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Gullberg, Donald] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	University of Cologne; German Sport University Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Duisburg Essen; University of Cologne; Max Planck Society; University of Bergen	Schubert, M (corresponding author), Univ Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Kerpener Str 62, D-50937 Cologne, Germany.	markus.schubert@uk-koeln.de; beate.eckes@uni-koeln.de	Gullberg, Donald/H-2495-2016; Schubert, Markus/F-5150-2010; Niehoff, Anja/K-6626-2015	Gullberg, Donald/0000-0002-7245-4437; Niehoff, Anja/0000-0002-4165-0929; Schulz, Jan-Niklas/0000-0001-9286-206X; Belgardt, Bengt-Frederik/0000-0003-4537-9002	Deutsche Forschungsgemeinschaft [SFB 829, BR1492/7-1]; Research Council of Norway [1823258/S10, 197066/V40]; Norwegian Cancer Association [536711-2010]; Else Kroner-Fresenius-Stiftung [2010_A93]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Council of Norway(Research Council of Norway); Norwegian Cancer Association; Else Kroner-Fresenius-Stiftung	This project was supported in part by Deutsche Forschungsgemeinschaft Grant SFB 829 (to B.E. and T.K.) and BR1492/7-1 (to J.C.B.), by Research Council of Norway Grants 1823258/S10 and 197066/V40 (to D.G.), by Norwegian Cancer Association Grant 536711-2010 (to D.G.), and by Else Kroner-Fresenius-Stiftung Grant 2010_A93 (to M.S.).	Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Baur A, 2011, FREE RADICAL RES, V45, P550, DOI 10.3109/10715762.2011.555483; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Bikle DD, 2008, OSTEOPOROSIS INT, V19, P1237, DOI 10.1007/s00198-008-0597-z; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Eckes B, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-4; Ekholm E, 2002, AM J PATHOL, V160, P1779, DOI 10.1016/S0002-9440(10)61124-8; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; GLUCKMAN PD, 1981, ENDOCR REV, V2, P363, DOI 10.1210/edrv-2-4-363; Goel HL, 2004, J CELL BIOL, V166, P407, DOI 10.1083/jcb.200403003; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gruner S, 2004, CIRCULATION, V110, P2946, DOI 10.1161/01.CIR.0000146341.63677.3C; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; He JN, 2006, BONE, V38, P826, DOI 10.1016/j.bone.2005.11.021; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long RK, 2007, CLIN REV BONE MINER, V5, P222, DOI 10.1007/s12018-008-9009-3; Nakayamada S, 2003, J BIOL CHEM, V278, P45368, DOI 10.1074/jbc.M308786200; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Phillips JA, 2008, MATRIX BIOL, V27, P609, DOI 10.1016/j.matbio.2008.05.003; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Romero CJ, 2010, MOL ENDOCRINOL, V24, P1077, DOI 10.1210/me.2009-0393; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Schmitz M, 2008, MATRIX BIOL, V27, P67, DOI 10.1016/j.matbio.2007.08.001; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Takahashi Y, 1996, NEW ENGL J MED, V334, P432, DOI 10.1056/NEJM199602153340704; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; Wickstrom S., 2011, EXTRACELLULAR MATRIX, P223; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; WU JE, 1994, DEV DYNAM, V199, P292, DOI 10.1002/aja.1001990405; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2009, J BONE MINER RES, V24, P1481, DOI [10.1359/JBMR.090226, 10.1359/jbmr.090226]; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	68	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6431	6440		10.1074/jbc.M111.283119	http://dx.doi.org/10.1074/jbc.M111.283119			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22210772	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000300791800033
J	Neve, EPA; Nordling, A; Andersson, TB; Hellman, U; Diczfalusy, U; Johansson, I; Ingelman-Sundberg, M				Neve, Etienne P. A.; Nordling, Asa; Andersson, Tommy B.; Hellman, Ulf; Diczfalusy, Ulf; Johansson, Inger; Ingelman-Sundberg, Magnus			Amidoxime Reductase System Containing Cytochrome b(5) Type B (CYB5B) and MOSC2 Is of Importance for Lipid Synthesis in Adipocyte Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT THROMBIN INHIBITOR; RAT-LIVER; OUTER MITOCHONDRIAL; PROTEIN; PRODRUG; IDENTIFICATION; DETOXIFICATION; INVOLVEMENT; ABSORPTION; ACID	Reduction of hydroxylamines and amidoximes is important for drug activation and detoxification of aromatic and heterocyclic amines. Such a reductase system was previously found to be of high activity in adipose tissue and liver, and furthermore, in vitro studies using recombinant truncated and purified enzymes suggested the participation of cytochrome b(5) reductase (CYB5R), cytochrome b(5) (CYB5), and molybdenum cofactor sulfurase C-terminal containing 1 and 2 (MOSC1 and -2). Here, we show that purified rat liver outer mitochondrial membrane contains high amidoxime reductase activity and that MOSC2 is exclusively localized to these membranes. Moreover, using the same membrane fraction, we could show direct binding of a radiolabeled benzamidoxime substrate to MOSC2. Following differentiation of murine 3T3-L1 cells into mature adipocytes, the MOSC2 levels as well as the amidoxime reductase activity were increased, indicating that the enzyme is highly regulated under lipogenic conditions. siRNA-mediated down-regulation of MOSC2 and the mitochondrial form of cytochrome b(5) type B (CYB5B) significantly inhibited the reductase activity in the differentiated adipocytes, whereas down-regulation of MOSC1, cytochrome b(5) type A (CYB5A), CYB5R1, CYB5R2, or CYB5R3 had no effect. Down-regulation of MOSC2 caused impaired lipid synthesis. These results demonstrate for the first time the direct involvement of MOSC2 and CYB5B in the amidoxime reductase activity in an intact cell system. We postulate the presence of a novel reductive enzyme system of importance for lipid synthesis that is exclusively localized to the outer mitochondrial membrane and is composed of CYB5B, MOSC2, and a third unknown component (a CYB5B reductase).	[Neve, Etienne P. A.; Nordling, Asa; Andersson, Tommy B.; Johansson, Inger; Ingelman-Sundberg, Magnus] Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, SE-17177 Stockholm, Sweden; [Andersson, Tommy B.] AstraZeneca Res & Dev, SE-43183 Molndal, Sweden; [Hellman, Ulf] Ludwig Inst Canc Res Ltd, Uppsala Branch, SE-75123 Uppsala, Sweden; [Diczfalusy, Ulf] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Clin Chem, Dept Lab Med, SE-14186 Huddinge, Sweden	Karolinska Institutet; AstraZeneca; Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska University Hospital	Neve, EPA (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, SE-17177 Stockholm, Sweden.	etienne.neve@ki.se	Ingelman-Sundberg, Magnus/ABD-9302-2021; Diczfalusy, Ulf/A-5336-2008	Diczfalusy, Ulf/0000-0001-6643-3763	AstraZeneca; Swedish Research Council	AstraZeneca(AstraZeneca); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from AstraZeneca and from the Swedish Research Council.	Altuve A, 2004, BIOCHEM BIOPH RES CO, V314, P602, DOI 10.1016/j.bbrc.2003.12.138; Anantharaman V, 2002, FEMS MICROBIOL LETT, V207, P55, DOI 10.1016/S0378-1097(01)00515-8; Andersson AM, 1998, J VIROL, V72, P9585, DOI 10.1128/JVI.72.12.9585-9596.1998; Andersson S, 2005, DRUG METAB DISPOS, V33, P570, DOI 10.1124/dmd.104.002972; BERNHEIM ML, 1968, ARCH BIOCHEM BIOPHYS, V124, P436, DOI 10.1016/0003-9861(68)90349-4; Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501; CARLSEN J, 1995, CELL BIOL INT, V19, P759, DOI 10.1006/cbir.1995.1127; Clement B, 1997, J BIOL CHEM, V272, P19615, DOI 10.1074/jbc.272.31.19615; COUGHLAN MP, 1980, J BIOL CHEM, V255, P2694; Deinum J, 2009, THROMB HAEMOSTASIS, V101, P1051, DOI 10.1160/TH08-09-0586; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Eriksson UG, 2003, DRUG METAB DISPOS, V31, P294, DOI 10.1124/dmd.31.3.294; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; Gustafsson D, 2001, THROMB RES, V101, P171, DOI 10.1016/S0049-3848(00)00399-6; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Hellman U, 2000, EXS, V88, P43; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; ITO A, 1981, BIOCHEM BIOPH RES CO, V101, P591, DOI 10.1016/0006-291X(81)91300-0; Johansson S, 2011, INT J CLIN PHARM TH, V49, P258, DOI 10.5414/CP201465; KADLUBAR FF, 1974, ARCH BIOCHEM BIOPHYS, V162, P83, DOI 10.1016/0003-9861(74)90107-6; KARIYA K, 1984, LIFE SCI, V35, P2327, DOI 10.1016/0024-3205(84)90524-1; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; King RS, 1999, CANCER LETT, V143, P167, DOI 10.1016/S0304-3835(99)00119-6; Kozmin SG, 2008, MOL MICROBIOL, V68, P51, DOI 10.1111/j.1365-2958.2008.06128.x; Kurian JR, 2006, CHEM RES TOXICOL, V19, P1366, DOI 10.1021/tx060106t; Kurian JR, 2004, J PHARMACOL EXP THER, V311, P1171, DOI 10.1124/jpet.104.072389; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malik AN, 2007, BIOCHEM BIOPH RES CO, V357, P237, DOI 10.1016/j.bbrc.2007.03.132; Mikula M, 2011, FUNCT INTEGR GENOMIC, V11, P215, DOI 10.1007/s10142-010-0200-5; Mkrtchian S, 1998, EUR J BIOCHEM, V251, P304, DOI 10.1046/j.1432-1327.1998.2510304.x; Murphy D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-14; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Ogishima T, 2003, J BIOL CHEM, V278, P21204, DOI 10.1074/jbc.M301698200; Pinski J, 2011, PROSTATE, V71, P892, DOI 10.1002/pros.21305; Reh R, 2008, XENOBIOTICA, V38, P1177, DOI [10.1080/00498250802109199, 10.1080/00498250802109199 ]; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sivertsson L, 2010, DRUG METAB DISPOS, V38, P995, DOI 10.1124/dmd.110.032367; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Timm U, 1997, J CHROMATOGR B, V691, P397, DOI 10.1016/S0378-4347(96)00477-X; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051	41	44	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6307	6317		10.1074/jbc.M111.328237	http://dx.doi.org/10.1074/jbc.M111.328237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22203676	Green Published, hybrid			2022-12-25	WOS:000300791800023
J	Fritsch, C; Sawala, A; Harris, R; Maartens, A; Sutcliffe, C; Ashe, HL; Ray, RP				Fritsch, Cornelia; Sawala, Annick; Harris, Robin; Maartens, Aidan; Sutcliffe, Catherine; Ashe, Hilary L.; Ray, Robert P.			Different Requirements for Proteolytic Processing of Bone Morphogenetic Protein 5/6/7/8 Ligands in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE ENCODES; PRO-DOMAINS; ACTIVATION; PRODOMAIN; COMPLEX; DPP; PROPROTEIN; CLEAVAGE; EMBRYO; FAMILY	Bone morphogenetic proteins (BMPs) are synthesized as proproteins that undergo proteolytic processing by furin/subtilisin proprotein convertases to release the active ligand. Here we study processing of BMP5/6/7/8 proteins, including the Drosophila orthologs Glass Bottom Boat (Gbb) and Screw (Scw) and human BMP7. Gbb and Scw have three functional furin/subtilisin proprotein convertase cleavage sites; two between the prodomain and ligand domain, which we call the Main and Shadow sites, and one within the prodomain, which we call the Pro site. In Gbb each site can be cleaved independently, although efficient cleavage at the Shadow site requires cleavage at the Main site, and remarkably, none of the sites is essential for Gbb function. Rather, Gbb must be processed at either the Pro or Main site to produce a functional ligand. Like Gbb, the Pro and Main sites in Scw can be cleaved independently, but cleavage at the Shadow site is dependent on cleavage at the Main site. However, both Pro and Main sites are essential for Scw function. Thus, Gbb and Scw have different processing requirements. The BMP7 ligand rescues gbb mutants in Drosophila, but full-length BMP7 cannot, showing that functional differences in the prodomain limit the BMP7 activity in flies. Furthermore, unlike Gbb, cleavage-resistant BMP7, although non-functional in rescue assays, activates the downstream signaling cascade and thus retains some functionality. Our data show that cleavage requirements evolve rapidly, supporting the notion that changes in post-translational processing are used to create functional diversity between BMPs within and between species.	[Sawala, Annick; Harris, Robin; Sutcliffe, Catherine; Ashe, Hilary L.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Fritsch, Cornelia; Maartens, Aidan; Ray, Robert P.] Univ Sussex, Sch Life Sci, Falmer Brighton BN1 9QG, England	University of Manchester; University of Sussex	Ashe, HL (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	Hilary.Ashe@manchester.ac.uk; r.ray@sussex.ac.uk	Harris, Robin/ABA-6788-2020	Harris, Robin/0000-0001-6945-6741; Maartens, Aidan/0000-0001-7112-819X; Sawala, Annick/0000-0002-3845-4206	Wellcome Trust Studentship [083271/Z/07/Z]; Medical Research Council [G0500916]; Biotechnology and Biological Sciences Research Council [BB/C508050/1, G19755]; MRC [G0500916] Funding Source: UKRI	Wellcome Trust Studentship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Studentship 083271/Z/07/Z (to A. S. and H. L. A.), Medical Research Council Grant G0500916 (to R. P. R.), and Biotechnology and Biological Sciences Research Council Grants BB/C508050/1 and G19755 (to R. P. R. and H. L. A.), respectively.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Bergeron F, 2000, J MOL ENDOCRINOL, V24, P1, DOI 10.1677/jme.0.0240001; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Chen YJ, 1998, DEVELOPMENT, V125, P1759; Christoforou CP, 2008, DEV BIOL, V313, P519, DOI 10.1016/j.ydbio.2007.09.044; Conley CA, 2000, DEVELOPMENT, V127, P3947; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cui YZ, 2001, GENE DEV, V15, P2797; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Fritsch C, 2010, DEV GENES EVOL, V220, P235, DOI 10.1007/s00427-010-0341-5; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Harris RE, 2011, EMBO REP, V12, P519, DOI 10.1038/embor.2011.80; Hashimoto O, 2005, P NATL ACAD SCI USA, V102, P5426, DOI 10.1073/pnas.0409533102; Hauburger A, 2009, FEBS J, V276, P6386, DOI 10.1111/j.1742-4658.2009.07361.x; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007; Ho DM, 2010, MECH DEVELOP, V127, P485, DOI 10.1016/j.mod.2010.08.004; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; Kunnapuu J, 2009, P NATL ACAD SCI USA, V106, P8501, DOI 10.1073/pnas.0809885106; LOPEZ AR, 1992, MOL CELL BIOL, V12, P1674, DOI 10.1128/MCB.12.4.1674; McGuire S. E., 2004, SCI STKE, V2004, pp16, DOI DOI 10.1125/STKE.2202004P16; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Pirrotta V, 1988, Biotechnology, V10, P437; Ray RP, 2001, DEVELOPMENT, V128, P3913; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shimmi O, 2005, DEV BIOL, V282, P70, DOI 10.1016/j.ydbio.2005.02.029; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Simpson P, 2008, ADV GENET, V61, P67, DOI 10.1016/S0065-2660(07)00003-X; Sopory S, 2010, DEV BIOL, V346, P102, DOI 10.1016/j.ydbio.2010.07.019; Wharton KA, 1999, GENETICS, V152, P629; WITTBRODT J, 1994, GENE DEV, V8, P1448, DOI 10.1101/gad.8.12.1448; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100	46	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5942	5953		10.1074/jbc.M111.316745	http://dx.doi.org/10.1074/jbc.M111.316745			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22199351	Green Published, hybrid			2022-12-25	WOS:000300638000068
J	Kim, MY; Mo, JS; Ann, EJ; Yoon, JH; Park, HS				Kim, Mi-Yeon; Mo, Jung-Soon; Ann, Eun-Jung; Yoon, Ji-Hye; Park, Hee-Sae			Dual Regulation of Notch1 Signaling Pathway by Adaptor Protein Fe65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; E3 UBIQUITIN LIGASE; INTRACELLULAR DOMAIN; MAMMALIAN NUMB; DOWN-REGULATION; CELL FATE; DEGRADATION; RECEPTOR; APP; TRANSCRIPTION	Notch1 receptor functions as a critical controller of cell fate decisions and also as a key regulator of cell growth, differentiation, and proliferation in invertebrates and vertebrates. In this study, we have demonstrated that the adaptor protein Fe65 attenuates Notch1 signaling via the accelerated degradation of the membrane-tethered Notch1 in the cytoplasm. Fe65 also suppresses Notch1 transcriptional activity via the dissociation of the Notch1-IC-recombining binding protein suppressor of hairless (RBP)-Jk complex within the nucleus. Fe65 is capable of forming a trimeric complex with Itch and membrane-tethered Notch1, and Fe65 enhances the protein degradation of membrane-tethered Notch1 via an Itch-dependent proteasomal pathway. Collectively, our results demonstrate that Fe65 carries out different functions depending on its location in the regulation of Notch1 signaling.	[Kim, Mi-Yeon; Mo, Jung-Soon; Ann, Eun-Jung; Yoon, Ji-Hye; Park, Hee-Sae] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea	Chonnam National University	Park, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	proteome@jnu.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0071386, 2011-0014796]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by Ministry of Education, Science and Technology Grants 2009-0071386 and 2011-0014796.	ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cornell M, 1999, GENETICS, V152, P567; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Dievart A, 1999, ONCOGENE, V18, P5973, DOI 10.1038/sj.onc.1202991; Egan SE, 1998, CURR TOP MICROBIOL, V228, P273; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kesavapany S, 2002, NEUROSCIENCE, V115, P951, DOI 10.1016/S0306-4522(02)00422-0; Kim MY, 2007, MOL CELL BIOL, V27, P6506, DOI 10.1128/MCB.01515-06; Kim SY, 2007, BBA-MOL CELL RES, V1773, P736, DOI 10.1016/j.bbamcr.2007.02.001; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Liu YC, 2007, SEMIN IMMUNOL, V19, P197, DOI 10.1016/j.smim.2007.02.003; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; Mo JS, 2007, MOL CELL BIOL, V27, P5565, DOI 10.1128/MCB.02372-06; Mo JS, 2011, J CELL SCI, V124, P100, DOI 10.1242/jcs.073924; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Weinmaster G, 1998, CURR OPIN GENET DEV, V8, P436, DOI 10.1016/S0959-437X(98)80115-9; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001	49	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4690	4701		10.1074/jbc.M111.289637	http://dx.doi.org/10.1074/jbc.M111.289637			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22199353	hybrid, Green Published			2022-12-25	WOS:000300608500031
J	Dosanjh, DPS; Bakir, M; Millington, KA; Soysal, A; Aslan, Y; Efee, S; Deeks, JJ; Lalvani, A				Dosanjh, Davinder P. S.; Bakir, Mustafa; Millington, Kerry A.; Soysal, Ahmet; Aslan, Yasemin; Efee, Serpil; Deeks, Jonathan J.; Lalvani, Ajit			Novel M tuberculosis Antigen-Specific T-Cells Are Early Markers of Infection and Disease Progression	PLOS ONE			English	Article							PREDICTIVE-VALUE; IMMUNE-RESPONSES; ESAT-6 ANTIGEN; GENE-PRODUCTS; RD1 REGION; DIAGNOSIS; PROTEIN; ASSAY; BCG; EPITOPES	Background: Mycobacterium tuberculosis Region-of-Difference-1 gene products present opportunities for specific diagnosis of M. tuberculosis infection, yet immune responses to only two gene-products, Early Secretory Antigenic Target-6 (ESAT-6) and Culture Filtrate Protein-10 (CFP-10), have been comprehensively investigated. Methods: T-cell responses to Rv3873, Rv3878 and Rv3879c were quantified by IFN-c-enzyme-linked-immunospot (ELISpot) in 846 children with recent household tuberculosis exposure and correlated with kinetics of tuberculin skin test (TST) and ESAT-6/CFP-10-ELISpot conversion over six months and clinical outcome over two years. Results: Responses to Rv3873, Rv3878, and Rv3879c were present in 20-25% of contacts at enrolment. Rv3873 and Rv3879c responses were associated with and preceded TST conversion (P = 0.02 and P = 0.04 respectively), identifying these antigens as early targets of cell-mediated immunity following M. tuberculosis exposure. Responses to Rv3873 were additionally associated with subsequent ESAT-6/CFP-10-ELISpot conversion (P = 0.04). Responses to Rv3873 and Rv3878 predicted progression to active disease (adjusted incidence rate ratio [95% CI] 3.06 [1.05,8.95; P = 0.04], and 3.32 [1.14,9.71; P = 0.03], respectively). Presence of a BCG-vaccination scar was associated with a 67% (P = 0.03) relative risk reduction for progression to active tuberculosis. Conclusions: These RD1-derived antigens are early targets of cellular immunity following tuberculosis exposure and T-cells specific for these antigens predict progression to active tuberculosis suggesting diagnostic and prognostic utility.	[Dosanjh, Davinder P. S.; Millington, Kerry A.; Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, TB Res Unit, London, England; [Bakir, Mustafa; Soysal, Ahmet; Aslan, Yasemin; Efee, Serpil] Marmara Univ, Sch Med, Dept Paediat, Istanbul, Turkey; [Deeks, Jonathan J.] Univ Birmingham, Sch Populat Hlth & Sci, Unit Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England	Imperial College London; Marmara University; University of Birmingham	Dosanjh, DPS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, TB Res Unit, London, England.	a.lalvani@imperial.ac.uk	ASLAN, YASEMİN/AAP-7409-2020; Dosanjh, Davinder/ABD-8895-2021; Deeks, Jon/AAV-5745-2020; Aslan, Yasemin/AAP-7713-2020	Dosanjh, Davinder/0000-0002-9169-5607; Deeks, Jon/0000-0002-8850-1971; Aslan, Yasemin/0000-0001-6292-2332; Lalvani, Ajit/0000-0002-2396-246X	Wellcome Trust Funding Source: Medline; Department of Health Funding Source: Medline	Wellcome Trust(Wellcome Trust); Department of Health		Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Bakir M, 2009, CLIN INFECT DIS, V48, P302, DOI 10.1086/595847; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brandt L, 1996, J IMMUNOL, V157, P3527; Brock I, 2004, J CLIN MICROBIOL, V42, P2379, DOI 10.1128/JCM.42.6.2379-2387.2004; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Brusasca PN, 2001, SCAND J IMMUNOL, V54, P448, DOI 10.1046/j.1365-3083.2001.00975.x; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Deb DK, 2002, TUBERCULOSIS, V82, P175, DOI 10.1054/tube.2002.0337; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Demangel C, 2004, INFECT IMMUN, V72, P2170, DOI 10.1128/IAI.72.4.2170-2176.2004; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; HASLOV K, 1995, INFECT IMMUN, V63, P804; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Leung CC, 2010, AM J RESP CRIT CARE; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Liu XQ, 2004, INFECT IMMUN, V72, P2574, DOI 10.1128/IAI.72.5.2574-2581.2004; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Marais BJ, 2009, CLIN CHEST MED, V30, P827, DOI 10.1016/j.ccm.2009.08.012; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Mustafa AS, 2002, CLIN EXP IMMUNOL, V130, P37, DOI 10.1046/j.1365-2249.2002.01937.x; Okkels LM, 2003, INFECT IMMUN, V71, P6116, DOI 10.1128/IAI.71.11.6116-6123.2003; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pollock JM, 1997, INFECT IMMUN, V65, P2587, DOI 10.1128/IAI.65.7.2587-2592.1997; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Turkish Ministry of Health Website, 2005, REP CAS CARR AIDS DI; Turkiye Cumhuriyeti Saglik Bakanligi Ankara Website, 2003, TURK TUB KONTR IC BA; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; WHO, 2006, STOP TB STRAT; World Health Organization Website, 2005, IMM PROF TURK; Zellweger JP, 2005, INT J TUBERC LUNG D, V9, P1242	50	18	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28754	10.1371/journal.pone.0028754	http://dx.doi.org/10.1371/journal.pone.0028754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216109	Green Submitted, Green Published, gold			2022-12-25	WOS:000300676300011
J	Vanderkooi, OG; Church, DL; MacDonald, J; Zucol, F; Kellner, JD				Vanderkooi, Otto G.; Church, Deirdre L.; MacDonald, Judy; Zucol, Franziska; Kellner, James D.			Community-Based Outbreaks in Vulnerable Populations of Invasive Infections Caused by Streptococcus pneumoniae Serotypes 5 and 8 in Calgary, Canada	PLOS ONE			English	Article							PNEUMOCOCCAL DISEASE; CHILDREN; RESISTANT; VACCINE; CLONE; HOME	Background: Outbreaks of invasive pneumococcal disease (IPD) typically occur within institutions. Beginning in 2005, we detected an increase in serotype (ST) 5 and ST8 IPD cases, predominantly in homeless persons living in an open community. Methodology/Principal Findings: CASPER (Calgary Area S. pneumoniae Epidemiology Research) surveillance study of all IPD (sterile site isolates) in our region (pop,1,100,000). Interviews and chart reviews of all cases and all isolates phenotypically analyzed and selected isolated tested by multi-locus sequence typing (MLST). Conclusions/Significance: During 2005-2007, 162 cases of ST5 IPD and 45 cases of ST8 IPD were identified. The isolates demonstrated phenotypic and genotypic clonality. The ST5 isolates were sequence type (ST) 289 and demonstrated intermediate susceptibility to TMP-SMX. The ST8 isolates were predominantly ST1268, with a susceptible antimicrobial susceptibility profile. Individuals with ST5 IPD were more likely to be middle aged (OR 2.6), homeless (OR 4.4), using illicit drugs(OR 4.8), and asthmatic(OR 2.6). Those with ST8 were more likely to be male (OR 4.4), homeless (OR 2.6), aboriginal (OR7.3), and a current smoker (OR 2.5). Overlapping outbreaks of ST5 and ST8 IPD occurred in an open community in Calgary, Canada and homelessness was a predominant risk factor. Homelessness represents a unique community in which pneumococcal outbreaks can occur.	[Vanderkooi, Otto G.; Church, Deirdre L.; MacDonald, Judy; Kellner, James D.] Univ Calgary, Calgary, AB, Canada; [Vanderkooi, Otto G.; Zucol, Franziska; Kellner, James D.] Alberta Childrens Prov Gen Hosp, Alberta Hlth Serv, Calgary, AB, Canada; [Vanderkooi, Otto G.; Church, Deirdre L.] Calgary Lab Serv, Calgary, AB, Canada; [MacDonald, Judy] Publ Hlth Portfolio, Alberta Hlth Serv Calgary Zone, Calgary, AB, Canada	University of Calgary; Alberta Childrens Hospital; Alberta Health Services (AHS); University of Calgary; University of Calgary; Alberta Health Services (AHS)	Vanderkooi, OG (corresponding author), Univ Calgary, Calgary, AB, Canada.	ovanderk@ucalgary.ca	Kellner, James Duncan/D-6358-2011	Kellner, James Duncan/0000-0002-9083-2980; MacDonald, Judy/0000-0001-9774-7220	Alberta Children's Hospital Foundation; Pfizer, Inc.; Wyeth (Pfizer); GSK	Alberta Children's Hospital Foundation; Pfizer, Inc.(Pfizer); Wyeth (Pfizer)(WyethPfizer); GSK(GlaxoSmithKline)	Alberta Children's Hospital Foundation (operating grant) and Wyeth Canada (now Pfizer, Inc., an unrestricted, investigator-initiated, grant-in-aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JDK has served as a consultant to Wyeth (Pfizer) and GlaxoSmithKline and has received research grants from Wyeth (Pfizer) for Surveillance and Vaccine Evaluation Projects and from Wyeth (Pfizer) and GSK for vaccine clinical trials. OGV has received research grants from Wyeth (Pfizer) and GSK for vaccine clinical trials. He has participated in an expert panel meeting for GSK and Novartis. JM, FZ and DLC declare no conflicts of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2008, PREV PNEUM 7 VAL CON; Ansaldi F, 2005, J INT MED RES, V33, P490, DOI 10.1177/147323000503300503; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; CHERIAN T, 1994, JAMA-J AM MED ASSOC, V271, P695, DOI 10.1001/jama.271.9.695; *CLIN LAB STAND I, 2009, M100S19 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI, V8; Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7; DEMARIA A, 1980, JAMA-J AM MED ASSOC, V244, P1446, DOI 10.1001/jama.244.13.1446; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Fiore AE, 1998, J AM GERIATR SOC, V46, P1112, DOI 10.1111/j.1532-5415.1998.tb06649.x; Firacative C, 2009, REV PANAM SALUD PUBL, V25, P337, DOI 10.1590/S1020-49892009000400008; Foundation CH, 2009, CALG TRIAG ASS SURV; Gleich S, 2000, INFECT CONT HOSP EP, V21, P711, DOI 10.1086/501717; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; Kellner JD, 2008, PEDIATR INFECT DIS J, V27, P526, DOI 10.1097/INF.0b013e3181658c5c; Kellner JD, 2009, CLIN INFECT DIS, V49, P205, DOI 10.1086/599827; Kellner JD, 2006, OUTBREAKS SEROTYPES; Kellner JD, 2008, SEROTYPE 5 INVASIVE; Lovgren M, 2008, ALB PROV LAB PUBL HL; Mattew A, 2006, M2A9 CLSI; MERCAT A, 1991, CHEST, V99, P147, DOI 10.1378/chest.99.1.147; Merck and Co I, 1986, PNEUM 23 PNEUM VACC; Merck and Co I, 2007, PNEUM 23 PNEUM VACC; National Advisory Committee on Immunization (NACI), 2008, Can Commun Dis Rep, V34, P1; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Plevneshi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007255; Romney MG, 2008, CLIN INFECT DIS, V47, P768, DOI 10.1086/591128; Shouval DS, 2009, PEDIATR INFECT DIS J, V28, P277, DOI 10.1097/INF.0b013e31818e0e2e; Stroick SM, 2008, COMMUNITY NEIGHBOURH; Tamayo M, 1999, J CLIN MICROBIOL, V37, P2337, DOI 10.1128/JCM.37.7.2337-2342.1999; Vanderkooi OG, 2007, LARGE OUTBREAK SEROT; Wenger JD, 2009, PEDIATR INFECT DIS J	34	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e28547	10.1371/journal.pone.0028547	http://dx.doi.org/10.1371/journal.pone.0028547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216100	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900001
J	Hung, JH; Teng, YN; Wang, LHC; Su, IJ; Wang, CCC; Huang, WY; Lee, KH; Lu, KY; Wang, LH				Hung, Jui-Hsiang; Teng, Yen-Ni; Wang, Lily Hui-Ching; Su, Ih-Jen; Wang, Clay C. C.; Huang, Wenya; Lee, Kuan-Han; Lu, Kuan-Ying; Wang, Lyu-Han			Induction of Bcl-2 Expression by Hepatitis B Virus Pre-S2 Mutant Large Surface Protein Resistance to 5-Fluorouracil Treatment in Huh-7 Cells	PLOS ONE			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; HUMAN HEPATOCELLULAR-CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; GROUND GLASS HEPATOCYTES; ADVANCED LIVER-DISEASE; CANCER-CELLS; MOLECULAR PATHOGENESIS; HIGH PREVALENCE; S DELETION	Background: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with poor prognosis due to resistance to conventional chemotherapy and limited efficacy of radiotherapy. Our previous studies have indicated that expression of Hepatitis B virus pre-S2 large mutant surface antigen (HBV pre-S2 Delta) is associated with a significant risk of developing HCC. However, the relationship between HBV pre-S2 Delta protein and the resistance of chemotherapeutic drug treatment is still unclear. Methodology/Principal Findings: Here, we show that the expression of HBV pre-S2 Delta mutant surface protein in Huh-7 cell significantly promoted cell growth and colony formation. Furthermore, HBV pre-S2 Delta protein increased both mRNA (2.7 +/- 0.5-fold vs. vehicle, p = 0.05) and protein (3.2 +/- 0.3-fold vs. vehicle, p = 0.01) levels of Bcl-2 in Huh-7 cells. HBV pre-S2 Delta protein also enhances Bcl-2 family, Bcl-xL and Mcl-1, expression in Huh-7 cells. Meanwhile, induction of NF-kappa B p65, ERK, and Akt phosphorylation, and GRP78 expression, an unfolded protein response chaperone, were observed in HBV pre-S2 Delta and HBV pre-S-expressing cells. Induction of Bcl-2 expression by HBV pre-S2 Delta protein resulted in resistance to 5-fluorouracil treatment in colony formation, caspase-3 assay, and cell apoptosis, and can enhance cell death by co-incubation with Bcl-2 inhibitor. Similarly, transgenic mice showed higher expression of Bcl-2 in liver tissue expressing HBV pre-S2 Delta large surface protein in vivo. Conclusion/Significance: Our result demonstrates that HBV pre-S2 Delta increased Bcl-2 expression which plays an important role in resistance to 5-fluorouracil-caused cell death. Therefore, these data provide an important chemotherapeutic strategy in HBV pre-S2 Delta-associated tumor.	[Hung, Jui-Hsiang] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Teng, Yen-Ni] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan; [Wang, Lily Hui-Ching; Lu, Kuan-Ying; Wang, Lyu-Han] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Su, Ih-Jen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Wang, Clay C. C.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [Huang, Wenya] Natl Cheng Kung Univ, Coll Med, Dept Med Technol, Tainan 70101, Taiwan; [Lee, Kuan-Han] Chia Nan Univ Pharm & Sci, Inst Pharmaceut Sci, Tainan, Taiwan	Chia Nan University of Pharmacy & Science; National University Tainan; National Tsing Hua University; National Health Research Institutes - Taiwan; University of Southern California; National Cheng Kung University; Chia Nan University of Pharmacy & Science	Hung, JH (corresponding author), Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan.	hung86@mail.chna.edu.tw	LEE, KH/AAP-8972-2021; Huang, Wenya/G-9115-2011; Su, Ih-Jen/B-2655-2010; Wang, Clay/ABG-9056-2021; Wang, Lily Hui-Ching/D-1967-2011	LEE, KH/0000-0003-2693-4496; Hung, Jui-Hsiang/0000-0002-7649-4823; Wang, Clay/0000-0003-2955-7569; Wang, Lily Hui-Ching/0000-0003-0659-0139; TENG, YEN-NI/0000-0002-3340-8577	National Science Council on Taiwan [NSC 100-2320-B-041-007]; Chia-Nan University of Pharmacy & Science, Tainan, Taiwan [CN9911]	National Science Council on Taiwan; Chia-Nan University of Pharmacy & Science, Tainan, Taiwan	This work has been supported by a research grant from the National Science Council on Taiwan (NSC 100-2320-B-041-007), and in part by grant CN9911 to J-HH from Chia-Nan University of Pharmacy & Science, Tainan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2009, CANCER SCI, V100, P2249, DOI 10.1111/j.1349-7006.2009.01309.x; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Arbuthnot P, 2001, INT J EXP PATHOL, V82, P77, DOI 10.1111/j.1365-2613.2001.iep178.x; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Chang YS, 2011, J CELL BIOCHEM, V112, P881, DOI 10.1002/jcb.22996; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 1996, HEPATOLOGY, V24, P38, DOI 10.1002/hep.510240108; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; Fan YF, 2000, J GASTROEN HEPATOL, V15, P519, DOI 10.1046/j.1440-1746.2000.02187.x; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; FISHER TC, 1993, CANCER RES, V53, P3321; Gavrielides MV, 2004, CURR DRUG TARGETS, V5, P431, DOI 10.2174/1389450043345380; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; Hisaka T, 1999, INT J ONCOL, V14, P453; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Hsieh YH, 2007, MOL CANCER RES, V5, P1063, DOI 10.1158/1541-7786.MCR-07-0098; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Huang S, 2000, CANCER RES, V60, P5334; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Hung JH, 2010, HEPATOL RES, V40, P633, DOI 10.1111/j.1872-034X.2010.00645.x; Huy TTT, 2003, J CLIN MICROBIOL, V41, P5449, DOI 10.1128/JCM.41.12.5449-5455.2003; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kanda T, 2006, CANCER LETT, V234, P143, DOI 10.1016/j.canlet.2005.03.030; Kaneko M, 2004, BIOL PHARM BULL, V27, P1202, DOI 10.1248/bpb.27.1202; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Kao JH, 2005, LIVER INT, V25, P696, DOI 10.1111/j.1478-3231.2005.01139.x; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Motola-Kuba Daniel, 2006, Ann Hepatol, V5, P16; Nakopoulou L, 1999, PATHOL RES PRACT, V195, P19, DOI 10.1016/S0344-0338(99)80089-2; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Parkin DM, 1993, INT J CANCER, V53, P919; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ravi R, 2004, DRUG RESIST UPDATE, V7, P53, DOI 10.1016/j.drup.2004.01.003; Ross JS, 1999, AM J CLIN PATHOL, V112, pS53; Sugauchi F, 2003, J MED VIROL, V70, P537, DOI 10.1002/jmv.10428; SUZUKI K, 1994, HEPATOLOGY, V20, P1231; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Wang WG, 2004, CANCER RES, V64, P8167, DOI 10.1158/0008-5472.CAN-04-0970; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Watanabe J, 2002, INT J ONCOL, V21, P515; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yang JC, 2009, HEPATOLOGY, V49, P1962, DOI 10.1002/hep.22889; Yeo W, 2004, J CLIN ONCOL, V22, P927, DOI 10.1200/JCO.2004.05.161; Yeo W, 2007, HEPATOLOGY, V45, P1382, DOI 10.1002/hep.21572	55	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28977	10.1371/journal.pone.0028977	http://dx.doi.org/10.1371/journal.pone.0028977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216150	Green Submitted, Green Published, gold			2022-12-25	WOS:000299684700021
J	Sakai, M; Wang, D; Wang, KX; Li, SH; Akamatsu, T				Sakai, Mai; Wang, Ding; Wang, Kexiong; Li, Songhai; Akamatsu, Tomonari			Do Porpoises Choose Their Associates? A New Method for Analyzing Social Relationships among Cetaceans	PLOS ONE			English	Article							NEOPHOCAENA-PHOCAENOIDES-ASIAEORIENTALIS; YANGTZE FINLESS PORPOISE; BEHAVIOR; PENGUINS; POPULATION; DOLPHINS	Background: Observing and monitoring the underwater social interactions of cetaceans is challenging. Therefore, previous cetacean studies have monitored these interactions by surface observations. However, because cetaceans spend most of their time underwater, it is important that their underwater behavior is also continuously monitored to better understand their social relationships and social structure. The finless porpoise is small and has no dorsal fin. It is difficult to observe this species in the wild, and little is known of its sociality. Methodology/Principal Findings: The swim depths of 6 free-ranging finless porpoises were simultaneously recorded using a time-synchronized bio-logging system. Synchronous diving was used as an index of association. Two pairs, # 27 (an immature female estimated to be 3.5 years old) and # 32 (an adult male), # 28 (a juvenile male estimated to be 2 years old) and # 29 (an adult male), tended to participate in long periods of synchronized diving more frequently than 13 other possible pairs, indicating that the 4 porpoises chose their social partners. The adult males (# 32, # 29) tended to follow the immature female (# 27) and juvenile male (# 28), respectively. However, during synchronized diving, the role of an initiator often changed within the pair, and their body movements appeared to be non-agonistic, e. g., rubbing of bodies against one another instead of that on one-side, as observed with chasing and escaping behaviors. Conclusions/Significance: The present study employed a time-synchronized bio-logging method to observe the social relationships of free-ranging aquatic animals based on swimming depth. The results suggest that certain individuals form associations even if they are not a mother and calf pair. Long synchronized dives occurred when particular members were reunited, and this suggests that the synchronized dives were not a by-product of opportunistic aggregation.	[Sakai, Mai] Univ Tokyo, Ocean Res Inst, Ctr Int Cooperat, Tokyo, Japan; [Sakai, Mai] Univ Tokyo, Life Sci Network, Tokyo, Japan; [Wang, Ding; Wang, Kexiong; Li, Songhai] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China; [Akamatsu, Tomonari] Fisheries Res Agcy, Natl Res Inst Fisheries Engn, Ibaraki, Japan	University of Tokyo; University of Tokyo; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Japan Fisheries Research & Education Agency (FRA)	Sakai, M (corresponding author), Univ Tokyo, Ocean Res Inst, Ctr Int Cooperat, Tokyo, Japan.	wangd@ihb.ac.cn	Li, Songhai/A-2652-2012	Li, Songhai/0000-0003-4977-1722	Chinese National Natural Science Foundation [30730018]; Research and Development program for New Bio-industry Initiatives; ministry of Education, Science and Culture, Japan [B09450172]; "Bio-Logging Science of the University of Tokyo (UTBLS)'' program; Grants-in-Aid for Scientific Research [23700308] Funding Source: KAKEN	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Research and Development program for New Bio-industry Initiatives; ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Bio-Logging Science of the University of Tokyo (UTBLS)'' program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by grants from the Chinese National Natural Science Foundation (30730018) and the Research and Development program for New Bio-industry Initiatives, Grant-in-aid for scientific Research (B) from the ministry of Education, Science and Culture, Japan (B09450172). M. Sakai was supported by the "Bio-Logging Science of the University of Tokyo (UTBLS)'' program led by Nobuyuki Miyazaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Amano M, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P437; Baird RW, 2000, CETACEAN SOCIETIES, P127; Bjorge A, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P530; BYGOTT JD, 1979, NATURE, V282, P839, DOI 10.1038/282839a0; Chen DQ, 2006, MAR FRESHW BEHAV PHY, V39, P163, DOI 10.1080/10236340600563396; Connor RC, 2000, CETACEAN SOCIETIES, P91; Gilchrist JS, 2004, BEHAV ECOL, V15, P952, DOI 10.1093/beheco/arh071; Hao YJ, 2007, THERIOGENOLOGY, V67, P673, DOI 10.1016/j.theriogenology.2006.06.014; Herzing Denise L., 1996, Aquatic Mammals, V22, P61; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Kasuya T., 1999, HDB MARINE MAMMALS, P411; Nishida Toshisada, 1996, P114, DOI 10.1017/CBO9780511752414.011; Sakai M, 2006, MAR MAMMAL SCI, V22, P966, DOI 10.1111/j.1748-7692.2006.00082.x; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Takahashi A, 2004, J ETHOL, V22, P5, DOI 10.1007/s10164-003-0111-1; Tremblay Y, 1999, CONDOR, V101, P179, DOI 10.2307/1370462; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang KX, 2011, J ETHOL, V29, P343, DOI 10.1007/s10164-011-0266-0; Whitehead H, 2000, CETACEAN SOCIETIES, P154; Whitehead H, 2000, CETACEAN SOCIETIES, P65; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; WILSON RP, 1986, ETHOLOGY, V72, P338; WIRTZ P, 1982, Z TIERPSYCHOL, V58, P277; Wu HP, 2010, THERIOGENOLOGY, V74, P1467, DOI 10.1016/j.theriogenology.2010.06.018; Xian YJ, 2010, MAR FRESHW BEHAV PHY, V43, P221, DOI 10.1080/10236244.2010.487300	27	12	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28836	10.1371/journal.pone.0028836	http://dx.doi.org/10.1371/journal.pone.0028836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216123	Green Published, gold			2022-12-25	WOS:000299113600042
J	Cardoso, SC; Stelling, MP; Paulsen, BS; Rehen, SK				Cardoso, Simone C.; Stelling, Mariana P.; Paulsen, Bruna S.; Rehen, Stevens K.			Synchrotron Radiation X-Ray Microfluorescence Reveals Polarized Distribution of Atomic Elements during Differentiation of Pluripotent Stem Cells	PLOS ONE			English	Article							FLUORESCENCE; CAVITATION	The mechanisms underlying pluripotency and differentiation in embryonic and reprogrammed stem cells are unclear. In this work, we characterized the pluripotent state towards neural differentiated state through analysis of trace elements distribution using the Synchrotron Radiation X-ray Fluorescence Spectroscopy. Naive and neural-stimulated embryoid bodies (EB) derived from embryonic and induced pluripotent stem (ES and iPS) cells were irradiated with a spatial resolution of 20 mu m to make elemental maps and qualitative chemical analyses. Results show that these embryo-like aggregates exhibit self-organization at the atomic level. Metallic elements content rises and consistent elemental polarization pattern of P and S in both mouse and human pluripotent stem cells were observed, indicating that neural differentiation and elemental polarization are strongly correlated.	[Cardoso, Simone C.] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil; [Stelling, Mariana P.; Paulsen, Bruna S.; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Stelling, Mariana P.; Paulsen, Bruna S.; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Cardoso, SC (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil.	srehen@lance-ufrj.org	Cardoso, Simone/AAH-4274-2021; Rehen, Stevens/J-5874-2012; Cardoso, Simone/V-2514-2019	Rehen, Stevens/0000-0003-4216-9501; cardoso, simone/0000-0001-6216-202X	Research Foundation of the State of Rio de Janeiro; National Research Council; Brazilian Synchrotron Light Laboratory	Research Foundation of the State of Rio de Janeiro; National Research Council; Brazilian Synchrotron Light Laboratory	This work was supported by the Research Foundation of the State of Rio de Janeiro, the National Research Council, and the Brazilian Synchrotron Light Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharvand H, 2007, INT J DEV BIOL, V51, P371, DOI 10.1387/ijdb.072280hb; Bernasconi MV, 2000, MOL PHYLOGENET EVOL, V16, P308, DOI 10.1006/mpev.2000.0825; Bratt-Leal AM, 2009, BIOTECHNOL PROGR, V25, P43, DOI 10.1002/btpr.139; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chwiej J, 2011, J BIOL INORG CHEM, V16, P275, DOI 10.1007/s00775-010-0724-0; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Dodani SC, 2011, P NATL ACAD SCI USA, V108, P5980, DOI 10.1073/pnas.1009932108; Gh Popescu BF, 2011, CNS NEUROSCI THER; Golosio B, 2003, J APPL PHYS, V94, P145, DOI 10.1063/1.1578176; Grasso EJ, 2011, TOXICOLOGY, V284, P26, DOI 10.1016/j.tox.2011.03.009; Guerra CD, 2010, APPL RADIAT ISOTOPES, V68, P71, DOI 10.1016/j.apradiso.2009.08.005; James SA, 2011, ANAL BIOANAL CHEM; Kemner KM, 2004, SCIENCE, V306, P686, DOI 10.1126/science.1103524; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; Marinho PAN, 2010, BIOTECHNOL PROGR, V26, P548, DOI 10.1002/btpr.328; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakazawa E, 2011, J ENV MONIT; Nunez-Milland DR, 2010, J SYNCHROTRON RADIAT, V17, P560, DOI 10.1107/S0909049510014020; Paulsen BS, 2011, STEM CELLS DEV; Perez CA, 1999, X-RAY SPECTROM, V28, P320, DOI 10.1002/(SICI)1097-4539(199909/10)28:5<320::AID-XRS359>3.0.CO;2-1; Pushie MJ, 2011, METALLOMICS, V3, P206, DOI 10.1039/c0mt00037j; Qin J, 2009, BIOLOGICALS, V37, P235, DOI 10.1016/j.biologicals.2009.03.001; Qin Z, 2011, METALLOMICS; Smith A, 2005, CELL, V123, P757, DOI 10.1016/j.cell.2005.11.012; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ueki T, 2002, ZOOL SCI, V19, P27, DOI 10.2108/zsj.19.27; Wolford JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012308; Zhang HF, 2010, METALLOMICS, V2, P806, DOI 10.1039/c0mt00059k	33	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29244	10.1371/journal.pone.0029244	http://dx.doi.org/10.1371/journal.pone.0029244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195032	gold, Green Submitted, Green Published			2022-12-25	WOS:000298664400043
J	Stekler, JD; Ellis, GM; Carlsson, J; Eilers, B; Holte, S; Maenza, J; Stevens, CE; Collier, AC; Frenkel, LM				Stekler, Joanne D.; Ellis, Giovanina M.; Carlsson, Jacquelyn; Eilers, Braiden; Holte, Sarah; Maenza, Janine; Stevens, Claire E.; Collier, Ann C.; Frenkel, Lisa M.			Prevalence and Impact of Minority Variant Drug Resistance Mutations in Primary HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; OLIGONUCLEOTIDE LIGATION ASSAY; TREATMENT-NAIVE PATIENTS; ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; LOW-FREQUENCY; POPULATIONS; TRANSMISSION; NEVIRAPINE; FAILURE	Objective: To evaluate minority variant drug resistance mutations detected by the oligonucleotide ligation assay (OLA) but not consensus sequencing among subjects with primary HIV-1 infection. Design/Methods: Observational, longitudinal cohort study. Consensus sequencing and OLA were performed on the first available specimens from 99 subjects enrolled after 1996. Survival analyses, adjusted for HIV-1 RNA levels at the start of antiretroviral (ARV) therapy, evaluated the time to virologic suppression (HIV-1 RNA<50 copies/mL) among subjects with minority variants conferring intermediate or high-level resistance. Results: Consensus sequencing and OLA detected resistance mutations in 5% and 27% of subjects, respectively, in specimens obtained a median of 30 days after infection. Median time to virologic suppression was 110 (IQR 62-147) days for 63 treated subjects without detectable mutations, 84 (IQR 56-109) days for ten subjects with minority variant mutations treated with >= 3 active ARVs, and 104 (IQR 60-162) days for nine subjects with minority variant mutations treated with <3 active ARVs (p = .9). Compared to subjects without mutations, time to virologic suppression was similar for subjects with minority variant mutations treated with >= 3 active ARVs (aHR 1.2, 95% CI 0.6-2.4, p = .6) and subjects with minority variant mutations treated with <3 active ARVs (aHR 1.0, 95% CI 0.4-2.4, p = .9). Two subjects with drug resistance and two subjects without detectable resistance experienced virologic failure. Conclusions: Consensus sequencing significantly underestimated the prevalence of drug resistance mutations in ARV-naive subjects with primary HIV-1 infection. Minority variants were not associated with impaired ARV response, possibly due to the small sample size. It is also possible that, with highly-potent ARVs, minority variant mutations may be relevant only at certain critical codons.	[Stekler, Joanne D.; Eilers, Braiden; Maenza, Janine; Stevens, Claire E.; Collier, Ann C.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Frenkel, Lisa M.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Stekler, Joanne D.; Holte, Sarah; Collier, Ann C.; Frenkel, Lisa M.] Univ Washington, Ctr AIDS & STDs, Seattle, WA 98195 USA; [Ellis, Giovanina M.; Carlsson, Jacquelyn] Seattle Childrens Hosp & Res Inst, Seattle, WA USA; [Holte, Sarah; Frenkel, Lisa M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Fred Hutchinson Cancer Center	Stekler, JD (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	jstekler@uw.edu		Frenkel, Lisa M/0000-0001-9566-8959	NIH [K23 AI-65243]; University of Washington CFAR [AI-27757]; Seattle Primary Infection Program [P01 AI-57005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065243, P30AI027757, P01AI057005] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington CFAR; Seattle Primary Infection Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by NIH K23 AI-65243, University of Washington CFAR grant AI-27757, and Seattle Primary Infection Program P01 AI-57005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammaranond P, 2003, AIDS, V17, P264, DOI 10.1097/00002030-200301240-00020; Balduin M, 2009, J CLIN VIROL, V45, P34, DOI 10.1016/j.jcv.2009.03.002; Barbour JD, 2004, AIDS, V18, P1683, DOI 10.1097/01.aids.0000131391.91468.ff; Beck I, 2011, QUANTIFICATION DYNAM; Beck IA, 2008, JAIDS-J ACQ IMM DEF, V48, P418, DOI 10.1097/QAI.0b013e31817ed7d7; Beek IA, 2002, J CLIN MICROBIOL, V40, P1413, DOI 10.1128/JCM.40.4.1413-1419.2002; Berrey MM, 2001, J INFECT DIS, V183, P1466, DOI 10.1086/320189; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Chaix ML, 2003, AIDS, V17, P2635, DOI 10.1097/00002030-200312050-00011; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Edelstein RE, 1998, J CLIN MICROBIOL, V36, P569, DOI 10.1128/JCM.36.2.569-572.1998; Ellis GM, 2004, J CLIN MICROBIOL, V42, P3670, DOI [10.1128/JCM.42.8.3670-3674.2004, 10.1128/jcm.42.8.3670-3674.2004]; Geretti AM, 2009, JAIDS-J ACQ IMM DEF, V52, P569, DOI 10.1097/QAI.0b013e3181ba11e8; Goodman DD, 2009, ANTIVIR THER, V14, pA43; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; HIV/AIDS Epidemiology Unit Public Health-Seattle & King County and the Infectious Disease and Reproductive Health Assessment Unit Washington State Department of Health., 2009, HIV AIDS EP REP, V75; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Jourdain G, 2010, CLIN INFECT DIS, V50, P1397, DOI 10.1086/652148; Kassutto S, 2006, CLIN INFECT DIS, V42, P1024, DOI 10.1086/500410; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; LEITNER T, 1993, BIOTECHNIQUES, V15, P120; Li CC, 2005, J CLIN MICROBIOL, V43, P3901, DOI 10.1128/JCM.43.8.3901-3905.2005; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Mei Y, 2008, STAT MED, V27, P121, DOI 10.1002/sim.3038; Metzner Karin J, 2006, J HIV Ther, V11, P74; Metzner KJ, 2007, AIDS, V21, P703, DOI 10.1097/QAD.0b013e3280121ac6; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Micek MA, 2010, CLIN INFECT DIS, V50, P1405, DOI 10.1086/652151; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2009, GUIDELINES USE ANTIR; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Porter K, 2001, BRIT MED J, V322, P1087, DOI 10.1136/bmj.322.7294.1087; Salomon H, 2000, AIDS, V14, pF17, DOI 10.1097/00002030-200001280-00003; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; Seattle Children's Hospital Research Institute, 2007, GEN KITS DET HIV 1 P; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stanford University, STANF U HIV DRUG RES; Stekler J, COLLIER AC CLIN OUTC; Tamalet C, 2000, J MED VIROL, V61, P181, DOI 10.1002/(SICI)1096-9071(200006)61:2&lt;181::AID-JMV2&gt;3.0.CO;2-T; Van Laethem K, 1999, J ACQ IMMUN DEF SYND, V22, P107; Van Laethem K, 2007, J CLIN VIROL, V39, P43, DOI 10.1016/j.jcv.2007.02.003; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6	63	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28952	10.1371/journal.pone.0028952	http://dx.doi.org/10.1371/journal.pone.0028952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194957	Green Published, gold, Green Submitted			2022-12-25	WOS:000298664400025
J	Amarir-Bouhram, J; Goin, M; Petit, MA				Amarir-Bouhram, Jihane; Goin, Melodie; Petit, Marie-Agnes			Low Efficiency of Homology-Facilitated Illegitimate Recombination during Conjugation in Escherichia coli	PLOS ONE			English	Article							FOREIGN DNA; REPLICATION FORKS; PLASMIDS; UVRD; TRANSFORMATION; INTEGRATION; MECHANISMS; HELICASE	Homology-facilitated illegitimate recombination has been described in three naturally competent bacterial species. It permits integration of small linear DNA molecules into the chromosome by homologous recombination at one end of the linear DNA substrate, and illegitimate recombination at the other end. We report that homology-facilitated illegitimate recombination also occurs in Escherichia coli during conjugation with small non-replicative plasmids, but at a low frequency of 3x10(-10) per recipient cell. The fate of linear DNA in E. coli is either RecBCD-dependent degradation, or circularisation by ligation, and integration into the chromosome by single crossing-over. We also report that the observed single crossing-overs are recA-dependent, but essentially recBCD, and recFOR independent. This suggests that other, still unknown, proteins may act as mediator for the loading of RecA on DNA during single crossing-over recombination in E. coli.	[Amarir-Bouhram, Jihane; Goin, Melodie; Petit, Marie-Agnes] INRA, UMR 1319, Jouy En Josas, France; [Amarir-Bouhram, Jihane; Goin, Melodie; Petit, Marie-Agnes] AgroParisTech, UMR 1319, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Amarir-Bouhram, J (corresponding author), INRA, UMR 1319, Jouy En Josas, France.	marie-agnes.petit@jouy.inra.fr			French Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	Dr. Amarir-Bouhram PhD grant is funded by the French Ministry of Research. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; de Vries J, 2002, P NATL ACAD SCI USA, V99, P2094, DOI 10.1073/pnas.042263399; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Harms K, 2007, MOL MICROBIOL, V64, P691, DOI 10.1111/j.1365-2958.2007.05692.x; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; Loenen WAM, 2003, NUCLEIC ACIDS RES, V31, P7059, DOI 10.1093/nar/gkg944; LOVETT ST, 1991, J BACTERIOL, V173, P353, DOI 10.1128/jb.173.1.353-364.1991; Lovett ST, 2002, GENETICS, V160, P851; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; Meier P, 2003, MOL MICROBIOL, V48, P1107, DOI 10.1046/j.1365-2958.2003.03498.x; Persky NS, 2008, CRIT REV BIOCHEM MOL, V43, P347, DOI [10.1080/10409230802485358, 10.1080/10409230802485358 ]; Prudhomme M, 2002, P NATL ACAD SCI USA, V99, P2100, DOI 10.1073/pnas.032262999; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; Touzain F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r45; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485	17	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28876	10.1371/journal.pone.0028876	http://dx.doi.org/10.1371/journal.pone.0028876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194937	Green Published, gold, Green Submitted			2022-12-25	WOS:000298370400023
J	Couradeau, E; Benzerara, K; Moreira, D; Gerard, E; Kazmierczak, J; Tavera, R; Lopez-Garcia, P				Couradeau, Estelle; Benzerara, Karim; Moreira, David; Gerard, Emmanuelle; Kazmierczak, Jozef; Tavera, Rosaluz; Lopez-Garcia, Purificacion			Prokaryotic and Eukaryotic Community Structure in Field and Cultured Microbialites from the Alkaline Lake Alchichica (Mexico)	PLOS ONE			English	Article							SATONDA CRATER LAKE; GLOEOBACTER-VIOLACEUS PCC-7421; MODERN MARINE STROMATOLITES; LITHIFIED MICRITIC LAMINAE; SULFATE-REDUCING BACTERIA; HIGHBORNE CAY; SHARK BAY; PHYLOGENETIC-RELATIONSHIPS; GEN. NOV.; DIVERSITY	The geomicrobiology of crater lake microbialites remains largely unknown despite their evolutionary interest due to their resemblance to some Archaean analogs in the dominance of in situ carbonate precipitation over accretion. Here, we studied the diversity of archaea, bacteria and protists in microbialites of the alkaline Lake Alchichica from both field samples collected along a depth gradient (0-14 m depth) and long-term-maintained laboratory aquaria. Using small subunit (SSU) rRNA gene libraries and fingerprinting methods, we detected a wide diversity of bacteria and protists contrasting with a minor fraction of archaea. Oxygenic photosynthesizers were dominated by cyanobacteria, green algae and diatoms. Cyanobacterial diversity varied with depth, Oscillatoriales dominating shallow and intermediate microbialites and Pleurocapsales the deepest samples. The early-branching Gloeobacterales represented significant proportions in aquaria microbialites. Anoxygenic photosynthesizers were also diverse, comprising members of Alphaproteobacteria and Chloroflexi. Although photosynthetic microorganisms dominated in biomass, heterotrophic lineages were more diverse. We detected members of up to 21 bacterial phyla or candidate divisions, including lineages possibly involved in microbialite formation, such as sulfate-reducing Deltaproteobacteria but also Firmicutes and very diverse taxa likely able to degrade complex polymeric substances, such as Planctomycetales, Bacteroidetes and Verrucomicrobia. Heterotrophic eukaryotes were dominated by Fungi (including members of the basal Rozellida or Cryptomycota), Choanoflagellida, Nucleariida, Amoebozoa, Alveolata and Stramenopiles. The diversity and relative abundance of many eukaryotic lineages suggest an unforeseen role for protists in microbialite ecology. Many lineages from lake microbialites were successfully maintained in aquaria. Interestingly, the diversity detected in aquarium microbialites was higher than in field samples, possibly due to more stable and favorable laboratory conditions. The maintenance of highly diverse natural microbialites in laboratory aquaria holds promise to study the role of different metabolisms in the formation of these structures under controlled conditions.	[Couradeau, Estelle; Moreira, David; Lopez-Garcia, Purificacion] Univ Paris 11, CNRS UMR 8079, Unite Ecol Systemat & Evolut, Orsay, France; [Couradeau, Estelle; Benzerara, Karim] Univ Paris 06, CNRS UMR 7590, Inst Mineral & Phys Milieux Condenses, Paris, France; [Couradeau, Estelle; Gerard, Emmanuelle] Univ Paris Diderot, CNRS UMR 7154, Inst Phys Globe Paris, Paris, France; [Kazmierczak, Jozef] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland; [Tavera, Rosaluz] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; Universidad Nacional Autonoma de Mexico	Couradeau, E (corresponding author), Univ Paris 11, CNRS UMR 8079, Unite Ecol Systemat & Evolut, Orsay, France.	puri.lopez@u-psud.fr	Moreira, David/F-7445-2012; Lopez-Garcia, Purificacion/B-6775-2012; GERARD, Emmanuelle/A-3828-2013; Benzerara, Karim/J-1532-2016; Couradeau, Estelle/Q-6874-2018	Moreira, David/0000-0002-2064-5354; Lopez-Garcia, Purificacion/0000-0002-0927-0651; GERARD, Emmanuelle/0000-0002-4910-747X; Benzerara, Karim/0000-0002-0553-0137; Couradeau, Estelle/0000-0002-3947-2529	French Centre National de la Recherche Scientifique - CNRS; Institut National des Sciences de l'Univers - INSU; Polish Ministry of Science and Higher Education [N307019]	French Centre National de la Recherche Scientifique - CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National des Sciences de l'Univers - INSU; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This project was financed by the French Centre National de la Recherche Scientifique - CNRS Interdisciplinary program "Origines des planetes et de la vie" (PID OPV) and Institut National des Sciences de l'Univers - INSU program "InteractionsTerre/Vie" (InterrVie), and the Polish Ministry of Science and Higher Education grant N307019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qassab S, 2002, ACTA PROTOZOOL, V41, P91; Allen MA, 2009, GEOBIOLOGY, V7, P82, DOI 10.1111/j.1472-4669.2008.00187.x; Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; ALTERMANN, 2006, GEOBIOLOGY; Altermann W., 2004, PRECAMBRIAN EARTH TE, P564; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andres MS, 2006, SEDIMENT GEOL, V185, P319, DOI 10.1016/j.sedgeo.2005.12.020; Armienta MA, 2008, J VOLCANOL GEOTH RES, V178, P249, DOI 10.1016/j.jvolgeores.2008.06.019; Arp G, 1999, SEDIMENT GEOL, V126, P159, DOI 10.1016/S0037-0738(99)00038-X; Arp G, 2004, J SEDIMENT RES, V74, P318, DOI 10.1306/081503740318; Arp G, 2001, SCIENCE, V292, P1701, DOI 10.1126/science.1057204; AWRAMIK SM, 1988, P NATL ACAD SCI USA, V85, P1327, DOI 10.1073/pnas.85.5.1327; AWRAMIK SM, 1971, SCIENCE, V174, P825, DOI 10.1126/science.174.4011.825; Awramik SM, 2009, PRECAMBRIAN RES, V174, P215, DOI 10.1016/j.precamres.2009.07.005; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; BAULD J, SKYRING GWP PRIMARY; Baumgartner LK, 2009, ENVIRON MICROBIOL, V11, P2710, DOI 10.1111/j.1462-2920.2009.01998.x; Baumgartner LK, 2006, SEDIMENT GEOL, V185, P131, DOI 10.1016/j.sedgeo.2005.12.008; Benzerara K, 2010, GEOL SOC SPEC PUBL, V336, P211, DOI 10.1144/SP336.10; BERNARDET JF, 1989, INT J SYST BACTERIOL, V39, P346, DOI 10.1099/00207713-39-3-346; Bosak T, 2007, GEOBIOLOGY, V5, P119, DOI 10.1111/j.1472-4669.2007.00104.x; Bower SM, 2004, J EUKARYOT MICROBIOL, V51, P325, DOI 10.1111/j.1550-7408.2004.tb00574.x; Braissant O, 2007, GEOBIOLOGY, V5, P401, DOI 10.1111/j.1472-4669.2007.00117.x; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Buick R, 2008, PHILOS T R SOC B, V363, P2731, DOI 10.1098/rstb.2008.0041; BURNE R V, 1987, Palaios, V2, P241, DOI 10.2307/3514674; Burns BP, 2004, ENVIRON MICROBIOL, V6, P1096, DOI 10.1111/j.1462-2920.2004.00651.x; Caballero M., 2003, GEOFIS INT, V42, P529; Chen M, 2002, J PORPHYR PHTHALOCYA, V6, P763, DOI 10.1142/S1088424602000889; Choo KS, 2002, J PHYCOL, V38, P493, DOI 10.1046/j.1529-8817.2002.t01-1-01083.x; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Ferreira AC, 1999, EXTREMOPHILES, V3, P235, DOI 10.1007/s007920050121; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P1045, DOI 10.1128/AEM.62.3.1045-1050.1996; Foster JS, 2009, ISME J, V3, P573, DOI 10.1038/ismej.2008.129; Freytet P, 1998, SEDIMENTOLOGY, V45, P535, DOI 10.1046/j.1365-3091.1998.00155.x; Goh F, 2009, ISME J, V3, P383, DOI 10.1038/ismej.2008.114; Golubic S, 2005, TRENDS MICROBIOL, V13, P229, DOI 10.1016/j.tim.2005.03.007; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; Guiry M.D., 2011, ALGAEBASE WORLD WIDE; Gupta RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-24; Havemann SA, 2008, APPL ENVIRON MICROB, V74, P7410, DOI 10.1128/AEM.01710-08; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P241, DOI DOI 10.5169/SEALS-266440; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; JONES MDM, 2011, NATURE ADV ONLINE PU; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kazmierczak J, 2006, NATURWISSENSCHAFTEN, V93, P119, DOI 10.1007/s00114-005-0066-x; KAZMIERCZAK J, 2011, FACIES, P1; KEMPE S, 1990, CHEM GEOL, V81, P299, DOI 10.1016/0009-2541(90)90052-9; Kempe S., 1993, FACIES, V28, P1; Krieg N. R., 2010, BERGEYS MANUAL SYSTE; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lepere C, 2006, APPL ENVIRON MICROB, V72, P2971, DOI 10.1128/AEM.72.4.2971-2981.2006; Lepot K, 2008, NAT GEOSCI, V1, P118, DOI 10.1038/ngeo107; Lopez-Garcia P, 2005, EXTREMOPHILES, V9, P263, DOI 10.1007/s00792-005-0457-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Macek M, 2008, HIDROBIOLOGICA, V18, P25; Madigan MT, 2009, BROCK BIOL MICROORGA; Mimuro M, 2010, PHOTOCHEM PHOTOBIOL, V86, P62, DOI 10.1111/j.1751-1097.2009.00619.x; MOBBERLEY JM, 2011, ENV MICROBIOLOGY; Morin N, 2010, J MICROBIOL METH, V80, P148, DOI 10.1016/j.mimet.2009.11.012; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Myshrall KL, 2010, GEOBIOLOGY, V8, P337, DOI 10.1111/j.1472-4669.2010.00245.x; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Paerl HW, 2001, ENVIRON MICROBIOL, V3, P123, DOI 10.1046/j.1462-2920.2001.00168.x; Papineau D, 2005, APPL ENVIRON MICROB, V71, P4822, DOI 10.1128/AEM.71.8.4822-4832.2005; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rambaut A., 2018, FIGTREE; Reid RP, 2003, FACIES, V49, P299; RIDING R, 1991, GEOL MAG, V128, P227, DOI 10.1017/S001675680002207X; Riding R, 2000, SEDIMENTOLOGY, V47, P179, DOI 10.1046/j.1365-3091.2000.00003.x; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; Santos F, 2010, SYST APPL MICROBIOL, V33, P209, DOI 10.1016/j.syapm.2010.02.006; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Souza-Egipsy V, 2006, INT REV HYDROBIOL, V91, P222, DOI 10.1002/iroh.200510845; Spadafora A, 2010, SEDIMENTOLOGY, V57, P27, DOI 10.1111/j.1365-3091.2009.01083.x; Tsuchiya T, 2005, FEBS LETT, V579, P2125, DOI 10.1016/j.febslet.2005.02.066; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Valenzuela-Encinas C, 2009, EXTREMOPHILES, V13, P609, DOI 10.1007/s00792-009-0244-4; van der Grinten E, 2005, HYDROBIOLOGIA, V548, P267, DOI 10.1007/s10750-005-5324-6; Van Kranendonk MJ, 2008, PRECAMBRIAN RES, V167, P93, DOI 10.1016/j.precamres.2008.07.003; Visscher PT, 2000, GEOLOGY, V28, P919, DOI 10.1130/0091-7613(2000)028<0919:MOOSRC>2.3.CO;2; Visscher PT, 1998, AM MINERAL, V83, P1482, DOI 10.2138/am-1998-11-1236; Wen AM, 1999, INT J SYST BACTERIOL, V49, P567, DOI 10.1099/00207713-49-2-567; WINSBOROUGH BM, 1987, J PHYCOL, V23, P195; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	95	93	96	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28767	10.1371/journal.pone.0028767	http://dx.doi.org/10.1371/journal.pone.0028767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194908	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100095
J	Hifumi, E; Honjo, E; Fujimoto, N; Arakawa, M; Nishizono, A; Uda, T				Hifumi, Emi; Honjo, Eijiro; Fujimoto, Naoko; Arakawa, Mitsue; Nishizono, Akira; Uda, Taizo			Highly efficient method of preparing human catalytic antibody light chains and their biological characteristics	FASEB JOURNAL			English	Article						germline gene; rabies virus; infection	MONOCLONAL-ANTIBODIES; ABILITY; HYDROLYSIS; SUBUNITS; PEPTIDE; HIV-1; GP41	The ultimate goal of catalytic antibody research is to develop new patient therapies that use the advantages offered by human catalytic antibodies. The establishment of a high-throughput method for obtaining valuable candidate catalytic antibodies must be accelerated to achieve this objective. In this study, based on our concept that we can find antibody light chains with a high probability of success if they include a serine protease-like catalytic triad composed of Ser, His, and Asp on a variable region of the antibody structure, we amplified and cloned DNAs encoding human antibody light chains from germline genes of subgroup II by seminested PCR using two primer sets designed for this purpose. Seven DNA fragments encoding light chains in 17 clones were derived from germline gene A18b, 6 DNA fragments from A3/A19, 2 DNA fragments from A17, and a clone DNA fragment from A5 and O11/O1. All light chains expressed in Escherichia coli and highly purified under nondenaturing conditions exhibited amidolytic activity against synthetic peptides. Some of the light chains exhibited unique features that suppressed the infectious activity of the rabies virus. Furthermore, the survival rate of mice in which a lethal level of the rabies virus was coinoculated directly into the brain with light chain 18 was significantly improved. In the case of humans, these results demonstrate that high-throughput selection of light chains possessing catalytic functions and specificity for a target molecule can be attained from a light-chain DNA library amplified from germline genes belonging to subgroup II.-Hifumi, E., Honjo, E., Fujimoto, N., Arakawa, M., Nishizono, A., Uda, T. Highly efficient method of preparing human catalytic antibody light chains and their biological characteristics. FASEB J. 26, 1607-1615 (2012). www.fasebj.org	[Honjo, Eijiro; Fujimoto, Naoko; Uda, Taizo] Oita Univ, Fac Engn, Dept Appl Biochem, Oita 8701192, Japan; [Hifumi, Emi] Oita Univ, Res Ctr Appl Med Engn, Oita 8701192, Japan; [Honjo, Eijiro; Fujimoto, Naoko; Uda, Taizo] Oita Univ, Fac Med, Dept Nursing, Yufu, Japan; [Nishizono, Akira] Oita Univ, Fac Med, Dept Microbiol, Yufu, Japan; [Hifumi, Emi; Honjo, Eijiro; Fujimoto, Naoko; Arakawa, Mitsue; Nishizono, Akira; Uda, Taizo] Japan Sci & Technol Agcy Core Res Evolut Sci & Te, Kawaguchi, Saitama, Japan	Oita University; Oita University; Oita University; Oita University; Japan Science & Technology Agency (JST)	Uda, T (corresponding author), Oita Univ, Fac Engn, Dept Appl Biochem, 700 Dan Noharu, Oita 8701192, Japan.	uda@oita-u.ac.jp		Uda, Taizo/0000-0001-8146-7902	Japan Science and Technology Agency (Core Research for Evolutional Science and Technology, Establishment of Innovative Manufacturing Technology Based on Nanoscience)	Japan Science and Technology Agency (Core Research for Evolutional Science and Technology, Establishment of Innovative Manufacturing Technology Based on Nanoscience)	This study was supported by the Japan Science and Technology Agency (Core Research for Evolutional Science and Technology, Establishment of Innovative Manufacturing Technology Based on Nanoscience). The authors thank Mr. Masashi Kanda and Mr. Hiroyuki Sakata for their assistance with this study.	ANCHIN JM, 1994, J MOL GRAPHICS, V12, P257, DOI 10.1016/0263-7855(94)80102-9; GAO QS, 1994, J BIOL CHEM, V269, P32389; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gololobov G, 1999, MOL IMMUNOL, V36, P1215, DOI 10.1016/S0161-5890(99)00141-8; Hatiuchi K, 2003, IMMUNOL LETT, V86, P249, DOI 10.1016/S0165-2478(03)00030-0; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Hifumi E, 2000, APPL BIOCHEM BIOTECH, V83, P209, DOI 10.1385/ABAB:83:1-3:209; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2010, FEBS J, V277, P3823, DOI 10.1111/j.1742-4658.2010.07785.x; Hollfelder F, 1996, NATURE, V383, P60, DOI 10.1038/383060a0; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; LAUTNERRIESKE A, 1992, EUR J IMMUNOL, V22, P1023, DOI 10.1002/eji.1830220422; LERNER RA, 1991, SCIENCE, V252, P659, DOI 10.1126/science.2024118; Matsumoto T, 2010, MICROBIOL IMMUNOL, V54, P673, DOI 10.1111/j.1348-0421.2010.00262.x; MEI S, 1991, J BIOL CHEM, V266, P15571; Mitsuda Y, 2004, BIOTECHNOL BIOENG, V86, P217, DOI 10.1002/bit.20031; Okochi N, 2007, APPL MICROBIOL BIOT, V77, P597, DOI 10.1007/s00253-007-1197-0; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Paul S, 2010, J CLIN IMMUNOL, V30, pS43, DOI 10.1007/s10875-010-9414-5; Planque S, 2008, AUTOIMMUN REV, V7, P473, DOI 10.1016/j.autrev.2008.04.002; Ramsland R. A., 2006, BIOCHEM J, V396, P473; Sharma V, 2009, J BIOL CHEM, V284, P33079, DOI 10.1074/jbc.M109.036087; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535; SUN M, 1994, J IMMUNOL, V153, P5121; Uda T, 2004, J BIOSCI BIOENG, V97, P143, DOI 10.1016/S1389-1723(04)70183-8	27	25	26	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1607	1615		10.1096/fj.11-195339	http://dx.doi.org/10.1096/fj.11-195339			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22205784				2022-12-25	WOS:000302359700022
J	Zhang, HL; Limphong, P; Pieper, J; Liu, Q; Rodesch, CK; Christians, E; Benjamin, IJ				Zhang, Huali; Limphong, Pattraranee; Pieper, Joel; Liu, Qiang; Rodesch, Christopher K.; Christians, Elisabeth; Benjamin, Ivor J.			Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity	FASEB JOURNAL			English	Article						redox potential; thioredoxin; roGFPs; reactive oxygen species	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; FLUORESCENT PROTEIN INDICATORS; REDOX STATE; SACCHAROMYCES-CEREVISIAE; THIOREDOXIN SYSTEMS; N-ACETYLCYSTEINE; CARCINOMA-CELLS; APOPTOSIS; INVOLVEMENT; RESISTANCE	To investigate the effects of the predominant nonprotein thiol, glutathione (GSH), on redox homeostasis, we employed complementary pharmacological and genetic strategies to determine the consequences of both loss-and gain-of-function GSH content in vitro. We monitored the redox events in the cytosol and mitochondria using reduction-oxidation sensitive green fluorescent protein (roGFP) probes and the level of reduced/oxidized thioredoxins (Trxs). Either H2O2 or the Trx reductase inhibitor 1-chloro-2,4-dinitrobenzene (DNCB), in embryonic rat heart (H9c2) cells, evoked 8 or 50 mV more oxidizing glutathione redox potential, E-hc (GSSG/2GSH), respectively. In contrast, N-acetyl-L-cysteine (NAC) treatment in H9c2 cells, or overexpression of either the glutamate cysteine ligase (GCL) catalytic subunit (GCLC) or GCL modifier subunit (GCLM) in human embryonic kidney 293 T (HEK293T) cells, led to 3- to 4-fold increase of GSH and caused 7 or 12 mV more reducing Ehc, respectively. This condition paradoxically increased the level of mitochondrial oxidation, as demonstrated by redox shifts in mitochondrial roGFP and Trx2. Lastly, either NAC treatment (EC50 4 mM) or either GCLC or GCLM overexpression exhibited increased cytotoxicity and the susceptibility to the more reducing milieu was achieved at decreased levels of ROS. Taken together, our findings reveal a novel mechanism by which GSH-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.-Zhang, H., Limphong, P., Pieper, J., Liu, Q., Rodesch, C. K., Christians, E., Benjamin, I. J. Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. FASEB J. 26, 1442-1451 (2012). www.fasebj.org	[Zhang, Huali; Limphong, Pattraranee; Pieper, Joel; Liu, Qiang; Christians, Elisabeth; Benjamin, Ivor J.] Univ Utah, Sch Med, Lab Cardiac Dis Redox Signaling & Cell Regenerat, Div Cardiol, Salt Lake City, UT 84132 USA; [Rodesch, Christopher K.] Univ Utah, Sch Med, Cell Imaging Lab, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Benjamin, IJ (corresponding author), Univ Utah, Sch Med, Dept Internal Med, 30 N 1900 E,Rm 4A100, Salt Lake City, UT 84132 USA.	ivor.benjamin@hsc.utah.edu			U.S. National Heart, Lung, and Blood Institute (NHLBI) [2 R01 HL063834-06, 5R01HL074370-03]; U.S. National Institutes of Health [NIH 5DP1OD006438-02]; NIH [1RO1HL66701]; Leducq Transatlantic Network of Excellence; American Heart Association [09POST2251058]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074370, R01HL063834, DP1HL117650] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006438] Funding Source: NIH RePORTER	U.S. National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Transatlantic Network of Excellence; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the U.S. National Heart, Lung, and Blood Institute (NHLBI; ARRA award 2 R01 HL063834-06 and grant 5R01HL074370-03 to I.J.B.), a 2009 U.S. National Institutes of Health Director's Pioneer (NIH 5DP1OD006438-02), Veterans Affairs Merit Review award (NIH 1RO1HL66701 I.J.B.), and the Leducq Transatlantic Network of Excellence. H.Z. was supported by an American Heart Association postdoctoral fellowship (09POST2251058).	Adeyemo D, 2001, CANCER LETT, V164, P77, DOI 10.1016/S0304-3835(00)00720-5; Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; BAILEY HH, 1992, CANCER RES, V52, P5115; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Chen Y, 2002, J BIOL CHEM, V277, P33242, DOI 10.1074/jbc.M202026200; Chen ZF, 1998, J PHARMACOL EXP THER, V285, P608; Damdimopoulos AE, 2002, J BIOL CHEM, V277, P33249, DOI 10.1074/jbc.M203036200; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Garrido EO, 2002, MOL MICROBIOL, V43, P993, DOI 10.1046/j.1365-2958.2002.02795.x; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Halvey PJ, 2005, BIOCHEM J, V386, P215, DOI 10.1042/BJ20041829; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; HUANG CS, 1993, J BIOL CHEM, V268, P20578; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jones DP, 2006, CHEM-BIOL INTERACT, V163, P38, DOI 10.1016/j.cbi.2006.07.008; Linke K, 2003, ANTIOXID REDOX SIGN, V5, P425, DOI 10.1089/152308603768295168; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Menon SG, 2007, CANCER RES, V67, P6392, DOI 10.1158/0008-5472.CAN-07-0225; Merten KE, 2006, J PHARMACOL EXP THER, V319, P934, DOI 10.1124/jpet.106.108845; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Qanungo S, 2004, J BIOL CHEM, V279, P50455, DOI 10.1074/jbc.M406749200; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Tanaka T, 2002, EMBO J, V21, P1695, DOI 10.1093/emboj/21.7.1695; Tipnis SR, 1999, BIOCHEM J, V337, P559, DOI 10.1042/0264-6021:3370559; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Trotter EW, 2002, MOL MICROBIOL, V46, P869, DOI 10.1046/j.1365-2958.2002.03216.x; Tsai JC, 1996, J BIOL CHEM, V271, P3667; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhang X, 2010, HYPERTENSION, V55, P1412, DOI 10.1161/HYPERTENSIONAHA.109.147066	42	117	124	1	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1442	1451		10.1096/fj.11-199869	http://dx.doi.org/10.1096/fj.11-199869			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22202674	Green Published			2022-12-25	WOS:000302359700007
J	Zhang, LP; Dong, YJ; Dong, YL; Cheng, JZ; Du, J				Zhang, Liping; Dong, Yanjun; Dong, Yanlan; Cheng, Jizhong; Du, Jie			Role of Integrin-beta 3 Protein in Macrophage Polarization and Regeneration of Injured Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; FIBROSIS; EXPRESSION; MICE; ACTIVATION; MECHANISMS; ATROPHY; CELLS	Following injury, skeletal muscle achieves repair by a highly coordinated, dynamic process resulting from interplay among numerous inflammatory, growth factors and myogenic regulators. To identify genes involved in muscle regeneration, we used a microarray analysis; there was a significant increase in the expression of a group of integrin genes. To verify these results, we used RT-PCR and Western blotting and found that 12 integrins were up-regulated from 3 h to 15 days following injury. Following muscle injury, integrin-beta 3 was initially expressed, mainly in macrophages. In integrin-beta 3 global KO mice, the expression of myogenic genes was decreased and muscle regeneration was impaired, whereas fibrosis was enhanced versus events in wild type (WT) mice. The mechanism for these responses in integrin-beta 3 KO mice included an infiltration of macrophages that were polarized into the M2 phenotype. These macrophages produced more TGF-beta 1 and increased TGF-beta 1/Smad signaling. In vitro, we confirmed that M2 macrophages lacking integrin-beta 3 produced more TGF-beta 1. Furthermore, transplantation of bone marrow cells from integrin-beta 3 KO mice into WT mice led to suppression of the infiltration and accumulation of macrophages into injured muscles. There was also impaired muscle regeneration with an increase in muscle fibrosis. Our results demonstrate that integrin-beta 3 plays a fundamental role in muscle regeneration through a regulation of macrophage infiltration and polarization leading to suppressed TGF-beta 1 production. This promotes efficient muscle regeneration. Thus, an improvement in integrin-beta 3 function could stimulate muscle regeneration.	[Zhang, Liping; Dong, Yanjun; Dong, Yanlan; Cheng, Jizhong] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Du, Jie] Capital Med Univ, Minist Educ, Beijing Anzhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Beijing 100029, Peoples R China	Baylor College of Medicine; Capital Medical University	Zhang, LP (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA.	lipingz@bcm.edu		Dong, Yanjun/0000-0001-6396-8949	National Institutes of Health [R37 DK37175]; Satellite Health; American Diabetic Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Satellite Health; American Diabetic Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 DK37175 (to W. E. Mitch). This work was also supported by a Norman S. Coplon extramural research grant from the Satellite Health and American Diabetic Association (to L. Z.) and by the generous support of Dr. and Mrs. Harold Selzman.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bastos KRB, 2002, J LEUKOCYTE BIOL, V71, P271; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Dumont N, 2010, AM J PATHOL, V176, P2228, DOI 10.2353/ajpath.2010.090884; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Liu HJ, 2011, FASEB J, V25, P1914, DOI 10.1096/fj.10-170449; Longbrake EE, 2007, J NEUROCHEM, V102, P1083, DOI 10.1111/j.1471-4159.2007.04617.x; Marino JS, 2008, AM J PHYSIOL-CELL PH, V295, pC1026, DOI 10.1152/ajpcell.212.2008; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; RIEU P, 1993, J LEUKOCYTE BIOL, V53, P576, DOI 10.1002/jlb.53.5.576; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; Sorokin LM, 2000, EXP CELL RES, V256, P500, DOI 10.1006/excr.2000.4842; Taverna D, 1998, J CELL BIOL, V143, P849, DOI 10.1083/jcb.143.3.849; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	25	28	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6177	6186		10.1074/jbc.M111.292649	http://dx.doi.org/10.1074/jbc.M111.292649			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22210777	Green Published, hybrid			2022-12-25	WOS:000300791800011
J	Bonente, G; Pippa, S; Castellano, S; Bassi, R; Ballottari, M				Bonente, Giulia; Pippa, Sara; Castellano, Stefania; Bassi, Roberto; Ballottari, Matteo			Acclimation of Chlamydomonas reinhardtii to Different Growth Irradiances	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEXES; PHOTOSYSTEM-II ANTENNA; NONPHOTOCHEMICAL ENERGY-DISSIPATION; CHLOROPHYLL-A/B PROTEINS; CYCLIC ELECTRON FLOW; PHOTOSYNTHETIC APPARATUS; STATE TRANSITIONS; LESS MUTANT; IN-VIVO; CHLOROPLAST	We report on the changes the photosynthetic apparatus of Chlamydomonas reinhardtii undergoes upon acclimation to different light intensity. When grown in high light, cells had a faster growth rate and higher biomass production compared with low and control light conditions. However, cells acclimated to low light intensity are indeed able to produce more biomass per photon available as compared with high light-acclimated cells, which dissipate as heat a large part of light absorbed, thus reducing their photosynthetic efficiency. This dissipative state is strictly dependent on the accumulation of LhcSR3, a protein related to light-harvesting complexes, responsible for nonphotochemical quenching in microalgae. Other changes induced in the composition of the photosynthetic apparatus upon high light acclimation consist of an increase of carotenoid content on a chlorophyll basis, particularly zeaxanthin, and a major down-regulation of light absorption capacity by decreasing the chlorophyll content per cell. Surprisingly, the antenna size of both photosystem I and II is not modulated by acclimation; rather, the regulation affects the PSI/PSII ratio. Major effects of the acclimation to low light consist of increased activity of state 1 and 2 transitions and increased contributions of cyclic electron flow.	[Bonente, Giulia; Pippa, Sara; Castellano, Stefania; Bassi, Roberto; Ballottari, Matteo] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy; [Bassi, Roberto] KFA Julich GmbH, Inst Bio & Geowissensch IBG 2, D-52425 Julich, Germany	University of Verona; Helmholtz Association; Research Center Julich	Bassi, R (corresponding author), Univ Verona, Dipartimento Biotecnol, CaVignal 1,Str Grazie 15, I-37134 Verona, Italy.	roberto.bassi@univr.it	Ballottari, Matteo/N-1916-2019	Ballottari, Matteo/0000-0001-8410-3397; bassi, roberto/0000-0002-4140-8446	European Union [245070]	European Union(European Commission)	This work was supported by European Union Project 245070 FP7-KBBE-2009-3 SUNBIOPATH.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; ALLEN KD, 1994, PLANTA, V194, P42; Alric J, 2010, PHOTOSYNTH RES, V106, P47, DOI 10.1007/s11120-010-9566-4; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; Aluru MR, 2006, J EXP BOT, V57, P1871, DOI 10.1093/jxb/erj008; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Bailleul B, 2010, PHOTOSYNTH RES, V106, P179, DOI 10.1007/s11120-010-9579-z; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; BASSI R, 1991, PLANTA, V183, P423, DOI 10.1007/BF00197742; BASSI R, 1992, J BIOL CHEM, V267, P25714; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Betterle N, 2010, ARCH BIOCHEM BIOPHYS, V504, P67, DOI 10.1016/j.abb.2010.05.016; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Cournac L, 2000, PHILOS T ROY SOC B, V355, P1447, DOI 10.1098/rstb.2000.0705; Cruz JA, 2005, PHOTOSYNTH RES, V85, P221, DOI 10.1007/s11120-005-4731-x; DAINESE P, 1990, PHOTOCHEM PHOTOBIOL, V51, P693, DOI 10.1111/php.1990.51.6.693; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2007, J BIOL CHEM, V282, P35056, DOI 10.1074/jbc.M704729200; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; DEMMIGADAMS B, 1990, PLANT PHYSIOL, V92, P293, DOI 10.1104/pp.92.2.293; DEMMIGADAMS B, 1995, AUST J PLANT PHYSIOL, V22, P249, DOI 10.1071/PP9950249; DEVITRY C, 1984, BIOCHIM BIOPHYS ACTA, V767, P415, DOI 10.1016/0005-2728(84)90039-2; Diaz M, 2007, PLANT CELL ENVIRON, V30, P1578, DOI 10.1111/j.1365-3040.2007.01735.x; DINER BA, 1980, EUR J BIOCHEM, V110, P521, DOI 10.1111/j.1432-1033.1980.tb04894.x; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; Durnford DG, 2003, PHYSIOL PLANTARUM, V118, P193, DOI 10.1034/j.1399-3054.2003.00078.x; FALK S, 1992, PHOTOSYNTH RES, V31, P31, DOI 10.1007/BF00049534; FALKOWSKI PG, 1980, PLANT PHYSIOL, V66, P592, DOI 10.1104/pp.66.4.592; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; Gordillo FJL, 2001, PHOTOSYNTH RES, V68, P225, DOI 10.1023/A:1012969324756; Grossman AR, 2010, PHOTOSYNTH RES, V106, P3, DOI 10.1007/s11120-010-9555-7; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Holub O, 2007, J MICROSC-OXFORD, V226, P90, DOI 10.1111/j.1365-2818.2007.01763.x; Ibanez H, 2010, J PLANT PHYSIOL, V167, P732, DOI 10.1016/j.jplph.2009.12.013; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Joliot P, 2005, P NATL ACAD SCI USA, V102, P4913, DOI 10.1073/pnas.0501268102; Josse EM, 2000, PLANT PHYSIOL, V123, P1427, DOI 10.1104/pp.123.4.1427; Lambrev PH, 2010, PLANT PHYSIOL, V152, P1611, DOI 10.1104/pp.109.148213; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Lucinski R, 2007, PHOTOSYNTH RES, V91, P214; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Melis A, 1998, J APPL PHYCOL, V10, P515, DOI 10.1023/A:1008076231267; MERCHANT S, 1984, PLANT PHYSIOL, V75, P781, DOI 10.1104/pp.75.3.781; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mozzo M, 2010, BBA-BIOENERGETICS, V1797, P212, DOI 10.1016/j.bbabio.2009.10.005; Mussgnug JH, 2010, J BIOTECHNOL, V150, P51, DOI 10.1016/j.jbiotec.2010.07.030; Nandha B, 2007, BBA-BIOENERGETICS, V1767, P1252, DOI 10.1016/j.bbabio.2007.07.007; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Peltier G, 2010, PHOTOSYNTH RES, V106, P19, DOI 10.1007/s11120-010-9575-3; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Pesaresi P, 2009, PLANT CELL, V21, P2402, DOI 10.1105/tpc.108.064964; Polle JEW, 2000, PLANTA, V211, P335, DOI 10.1007/s004250000279; RAVENEL J, 1994, PLANTA, V193, P251; ROCHAIX JD, 1989, EMBO J, V8, P1013, DOI 10.1002/j.1460-2075.1989.tb03468.x; Ruban AV, 2010, ARCH BIOCHEM BIOPHYS, V504, P78, DOI 10.1016/j.abb.2010.06.034; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; SMITH BM, 1990, PLANT PHYSIOL, V93, P1433, DOI 10.1104/pp.93.4.1433; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623	80	147	153	4	82	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5833	5847		10.1074/jbc.M111.304279	http://dx.doi.org/10.1074/jbc.M111.304279			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22205699	hybrid, Green Published			2022-12-25	WOS:000300638000058
J	Jin, YY; Dong, L; Lu, Y; Wu, WQ; Hao, Q; Zhou, ZC; Jiang, J; Zhao, Y; Zhang, L				Jin, Yunyun; Dong, Liang; Lu, Yi; Wu, Wenqing; Hao, Qian; Zhou, Zhaocai; Jiang, Jin; Zhao, Yun; Zhang, Lei			Dimerization and Cytoplasmic Localization Regulate Hippo Kinase Signaling Activity in Organ Size Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PATHWAY; CELL-CYCLE EXIT; DROSOPHILA HOMOLOG; PROMOTES APOPTOSIS; TEAD/TEF FAMILY; PROTEIN-KINASE; MST1 KINASE; GROWTH; PROLIFERATION; ACTIVATION	The Hippo (Hpo) signaling pathway controls organ size by regulating the balance between cell proliferation and apoptosis. Although the Hpo function is conserved, little is known about the mechanism of how its kinase activity is regulated. Based on structural information, we performed mutation-function analysis and provided in vitro and in vivo evidence that Hpo activation requires proper dimerization of its N-terminal kinase domain as well as the C-terminal SARAH domain. Hpo carrying point mutation M242E can still dimerize, yet the dimers formed between intermolecular kinase domains were altered in conformation. As a result, autophosphorylation of Hpo at Thr-195 was blocked, and its kinase activity was abolished. In contrast, Hpo carrying I634D, a single mutation introduced in the Hpo C-terminal SARAH domain, disrupted the dimerization of the SARAH domain, leading to reduced Hippo activity. We also find that the Hpo C-terminal half contains two nuclear export signals that promote cytoplasmic localization and activity of Hpo. Taken together, our results suggest that dimerization and nucleocytoplasmic translocation of Hpo are crucial for its biological function and indicate that a proper dimer conformation of the kinase domain is essential for Hpo autophosphorylation and kinase activity.	[Jin, Yunyun; Dong, Liang; Lu, Yi; Wu, Wenqing; Hao, Qian; Zhou, Zhaocai; Zhao, Yun; Zhang, Lei] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Jiang, Jin] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhao, Y (corresponding author), Chinese Acad Sci, Hundred Talents Program, Beijing 100864, Peoples R China.	yunzhao@sibs.ac.cn; rayzhang@sibs.ac.cn	jin, yun/GQZ-6618-2022		National Basic Research Program of China 973 Program [2010CB912101, 2012CB945001, 2011CB943902]; National Natural Science Foundation of China [30971646, 30971647, 31171394, 31171414]; Shanghai Pujiang Program [09PJ1410900]; National Key Basic Research and Development Program of China [2011CB915502]; Chinese Academy of Sciences [XDA01010405, XDA01010406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061269, R01GM067045] Funding Source: NIH RePORTER	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National Key Basic Research and Development Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program of China 973 Program Grants 2010CB912101, 2012CB945001, and 2011CB943902; National Natural Science Foundation of China Grants 30971646, 30971647, 31171394, and 31171414; Shanghai Pujiang Program Grant 09PJ1410900; National Key Basic Research and Development Program of China Grant 2011CB915502; and "Strategic Priority Research Program" of the Chinese Academy of Sciences Grants XDA01010405 and XDA01010406.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Baena-Lopez LA, 2008, P NATL ACAD SCI USA, V105, P9645, DOI 10.1073/pnas.0803747105; Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Centonze Victoria E., 2004, Biol Proced Online, V6, P78, DOI 10.1251/bpo75; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Colombani J, 2006, CURR BIOL, V16, P1453, DOI 10.1016/j.cub.2006.05.059; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee KK, 2002, J BIOL CHEM, V277, P12351, DOI 10.1074/jbc.M108138200; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Record CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011905; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yin MX, 2011, J GENET GENOMICS, V38, P471, DOI 10.1016/j.jgg.2011.09.009; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang L, 2009, FLY, V3, P68, DOI 10.4161/fly.3.1.7788; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	67	34	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5784	5796		10.1074/jbc.M111.310334	http://dx.doi.org/10.1074/jbc.M111.310334			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215676	hybrid, Green Published			2022-12-25	WOS:000300638000054
J	Yan, BX; Boyd, D; Kaschak, T; Tsukuda, J; Shen, A; Lin, YW; Chung, S; Gupta, P; Kamath, A; Wong, A; Vernes, JM; Meng, GY; Totpal, K; Schaefer, G; Jiang, GY; Nogal, B; Emery, C; Vanderlaan, M; Carter, P; Harris, R; Amanullah, A				Yan, Boxu; Boyd, Daniel; Kaschak, Timothy; Tsukuda, Joni; Shen, Amy; Lin, Yuwen; Chung, Shan; Gupta, Priyanka; Kamath, Amrita; Wong, Anne; Vernes, Jean-Michel; Meng, Gloria Y.; Totpal, Klara; Schaefer, Gabriele; Jiang, Guoying; Nogal, Bartek; Emery, Craig; Vanderlaan, Martin; Carter, Paul; Harris, Reed; Amanullah, Ashraf			Engineering Upper Hinge Improves Stability and Effector Function of a Human IgG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL FC-RECEPTOR; THERAPEUTIC ANTIBODIES; MONOCLONAL-ANTIBODIES; DEVELOPMENT TRENDS; ELECTRON-TRANSFER; GAMMA-RI; VARIANTS; PROTEINS; MECHANISMS; AFFINITY	Upper hinge is vulnerable to radical attacks that result in breakage of the heavy-light chain linkage and cleavage of the hinge of an IgG1. To further explore mechanisms responsible for the radical induced hinge degradation, nine mutants were designed to determine the roles that the upper hinge Asp and His play in the radical reactions. The observation that none of these substitutions could inhibit the breakage of the heavy-light chain linkage suggests that the breakage may result from electron transfer from Cys(231) directly to the heavy-light chain linkage upon radical attacks, and implies a pathway separate from His(229)-mediated hinge cleavage. On the other hand, the substitution of His(229) with Tyr showed promising advantages over the native antibody and other substitutions in improving the stability and function of the IgG1. This substitution inhibited the hinge cleavage by 98% and suggests that the redox active nature of Tyr did not enable it to replicate the ability of His to facilitate radical induced degradation. We propose that the lower redox potential of Tyr, a residue that may be the ultimate sink for oxidizing equivalents in proteins, is responsible for the inhibition. More importantly, the substitution increased the antibody's binding to Fc gamma RIII receptors by 2-3-fold, and improved ADCC activity by 2-fold, while maintaining a similar pharmacokinetic profile with respect to the wild type. Implications of these observations for antibody engineering and development are discussed.	[Yan, Boxu; Boyd, Daniel; Kaschak, Timothy; Nogal, Bartek; Emery, Craig; Amanullah, Ashraf] Genentech Inc, Dept Pharma Tech Dev, Oceanside, CA 92056 USA; [Tsukuda, Joni; Shen, Amy] Genentech Inc, Dept Early Stage Cell Culture, San Francisco, CA 94080 USA; [Lin, Yuwen; Chung, Shan] Genentech Inc, Dept Bioanalyt Sci, San Francisco, CA 94080 USA; [Gupta, Priyanka; Kamath, Amrita] Genentech Inc, Dept Pharmacokinet & Pharmacodynam, San Francisco, CA 94080 USA; [Wong, Anne; Vernes, Jean-Michel; Meng, Gloria Y.] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Totpal, Klara; Schaefer, Gabriele] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Jiang, Guoying; Vanderlaan, Martin; Harris, Reed] Genentech Inc, Dept Analyt Dev & Qual Control, San Francisco, CA 94080 USA; [Carter, Paul] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Yan, BX (corresponding author), Genentech Inc, Dept Pharma Tech Dev, Oceanside, CA 92056 USA.	byan1027@gmail.com	Shen, Amy/GVT-6125-2022; Chung, Shan/AAK-5790-2021	Schaefer, Gabriele/0000-0001-9727-3555				Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; Davies M. J., 1997, RADICAL MEDIATED PRO, P50; Ducry L, 2010, BIOCONJUGATE CHEM, V21, P5, DOI 10.1021/bc9002019; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Goldmacher VS, 2011, THER DELIV, V2, P397, DOI 10.4155/TDE.10.98; HORNE C, 1982, J IMMUNOL, V129, P660; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Kirby JP, 1997, J AM CHEM SOC, V119, P9230, DOI 10.1021/ja970176+; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Lu YM, 2011, J IMMUNOL METHODS, V365, P132, DOI 10.1016/j.jim.2010.12.014; Mohammad R., 2007, J AM CHEM SOC, V129, P15060; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Oganesyan V, 2008, MOL IMMUNOL, V45, P1872, DOI 10.1016/j.molimm.2007.10.042; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Schneider CK, 2008, NAT BIOTECHNOL, V26, P985, DOI 10.1038/nbt0908-985; Seyedsayamdost MR, 2006, J AM CHEM SOC, V128, P1562, DOI 10.1021/ja055927j; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Stewart R, 2011, PROTEIN ENG DES SEL, V24, P671, DOI 10.1093/protein/gzr015; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Yan BX, 2011, J BIOL CHEM, V286, P24674, DOI 10.1074/jbc.M111.255026; Yan BX, 2009, J BIOL CHEM, V284, P35390, DOI 10.1074/jbc.M109.064147; Yates Z, 2010, J BIOL CHEM, V285, P18662, DOI 10.1074/jbc.M110.108597; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182	35	18	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5891	5897		10.1074/jbc.M111.311811	http://dx.doi.org/10.1074/jbc.M111.311811			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203673	hybrid, Green Published			2022-12-25	WOS:000300638000063
J	Huang, HL; Chen, YC; Huang, YC; Yang, KC; Pan, HY; Shih, SP; Chen, YJ				Huang, Huey-Lan; Chen, Yu-Chieh; Huang, Yu-Chuen; Yang, Kai-Chien; Pan, Hsin Yi; Shih, Shou-Ping; Chen, Yu-Jen			Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells	PLOS ONE			English	Article							TYROSINE-KINASE-INHIBITOR; ACUTE MYELOID-LEUKEMIA; GROWTH-FACTOR RECEPTOR; MULTIVESICULAR BODIES; CANCER CELLS; IN-VITRO; GEFITINIB; DEATH; ERLOTINIB; GW572016	Lapatinib is an oral, small-molecule, dual tyrosine kinase inhibitor of epidermal growth factor receptors (EGFR, or ErbB/Her) in solid tumors. Little is known about the effect of lapatinib on leukemia. Using human chronic myelogenous leukemia (CML) K562 cells as an experimental model, we found that lapatinib simultaneously induced morphological changes resembling apoptosis, autophagy, and megakaryocytic differentiation. Lapatinib-induced apoptosis was accompanied by a decrease in mitochondrial transmembrane potential and was attenuated by the pancaspase inhibitor z-VAD-fmk, indicating a mitochondria-mediated and caspase-dependent pathway. Lapatinib-induced autophagic cell death was verified by LC3-II conversion, and upregulation of Beclin-1. Further, autophagy inhibitor 3-methyladenine as well as autophagy-related proteins Beclin-1 (ATG6), ATG7, and ATG5 shRNA knockdown rescued the cells from lapatinib-induced growth inhibition. A moderate number of lapatinib-treated K562 cells exhibited features of megakaryocytic differentiation. In summary, lapatinib inhibited viability and induced multiple cellular events including apoptosis, autophagic cell death, and megakaryocytic differentiation in human CML K562 cells. This distinct activity of lapatinib against CML cells suggests potential for lapatinib as a therapeutic agent for treatment of CML. Further validation of lapatinib activity in vivo is warranted.	[Huang, Huey-Lan; Chen, Yu-Chieh; Pan, Hsin Yi; Shih, Shou-Ping] Chang Jung Christian Univ, Coll Hlth Sci, Dept Biosci Technol, Tainan, Taiwan; [Huang, Yu-Chuen] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Huang, Yu-Chuen] China Med Univ, Coll Chinese Med, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Yang, Kai-Chien; Chen, Yu-Jen] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Chen, Yu-Jen] Mackay Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chen, Yu-Jen] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Chen, Yu-Jen] Taipei Med Univ, Inst Pharmacol, Taipei, Taiwan	Chang Jung Christian University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Mackay Memorial Hospital; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Medical University	Huang, HL (corresponding author), Chang Jung Christian Univ, Coll Hlth Sci, Dept Biosci Technol, Tainan, Taiwan.	chenmdphd@yahoo.com		Shih, Shou-Ping/0000-0001-8989-5979	Mackay Memorial Hospital [MMH-9900-01]; National Science Council of Taiwan, ROC [NSC 98-2314-B-195-005-MY3, NSC 97-2314-B-309-003-, NSC 100-2314-B-309-004-]	Mackay Memorial Hospital; National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grant MMH-9900-01 from Mackay Memorial Hospital, and grants NSC 98-2314-B-195-005-MY3, NSC 97-2314-B-309-003- and NSC 100-2314-B-309-004- from the National Science Council of Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN H, 1990, BIOCHEM J, V271, P785, DOI 10.1042/bj2710785; Bekaii-Saab T, 2009, CLIN CANCER RES, V15, P5895, DOI 10.1158/1078-0432.CCR-09-0465; Bell BD, 2009, AUTOPHAGY, V5, P238, DOI 10.4161/auto.5.2.7512; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; Boehrer S, 2008, BLOOD, V111, P2170, DOI 10.1182/blood-2007-07-100362; Boehrer S, 2008, BIOCHEM PHARMACOL, V76, P1417, DOI 10.1016/j.bcp.2008.05.024; BUHRING HJ, 1995, BLOOD, V86, P1916, DOI 10.1182/blood.V86.5.1916.bloodjournal8651916; Chan G, 2007, BLOOD, V110, P1079, DOI 10.1182/blood-2007-01-069856; Chen YJ, 2009, AUTOPHAGY, V5, P173, DOI 10.4161/auto.5.2.7360; Colosetti P, 2009, AUTOPHAGY, V5, P1092, DOI 10.4161/auto.5.8.9889; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Djavaheri-Mergny M, 2007, AUTOPHAGY, V3, P390, DOI 10.4161/auto.4248; Ennishi D, 2006, INT J HEMATOL, V84, P284, DOI 10.1532/IJH97.06149; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; HONMA Y, 1995, INT J CANCER, V60, P685, DOI 10.1002/ijc.2910600519; Huang YC, 2009, TOXICOL IN VITRO, V23, P979, DOI 10.1016/j.tiv.2009.06.027; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Ito Yoshinori, 2007, Breast Cancer, V14, P156, DOI 10.2325/jbcs.971; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Kopper L, 2008, PATHOL ONCOL RES, V14, P1, DOI 10.1007/s12253-008-9018-z; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lakshmikuttyamma A, 2008, ONCOGENE, V27, P3831, DOI 10.1038/onc.2008.8; Lindhagen E, 2008, EUR J HAEMATOL, V81, P344, DOI 10.1111/j.1600-0609.2008.01120.x; Martin AP, 2009, CANCER BIOL THER, V8, P2084; Miranda MB, 2008, LEUKEMIA, V22, P1624, DOI 10.1038/leu.2008.28; Morceau F, 2000, LEUKEMIA, V14, P1589, DOI 10.1038/sj.leu.2401890; Muller MR, 2003, CLIN CANCER RES, V9, P3448; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2007, MOL CANCER THER, V6, P667, DOI 10.1158/1535-7163.MCT-06-0423; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Noguchi K, 2009, CANCER SCI, V100, P1701, DOI 10.1111/j.1349-7006.2009.01213.x; Olaussen KA, 2009, ONCOGENE, V28, P4249, DOI 10.1038/onc.2009.277; Pitini V, 2008, J CLIN ONCOL, V26, P3645, DOI 10.1200/JCO.2008.17.0357; Ramanathan RK, 2009, CANCER CHEMOTH PHARM, V64, P777, DOI 10.1007/s00280-009-0927-7; Ravindranathan M, 2007, LEUKEMIA, V21, P2546, DOI 10.1038/sj.leu.2404851; Rusnak DW, 2007, CELL PROLIFERAT, V40, P580, DOI 10.1111/j.1365-2184.2007.00455.x; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Spengeman JD, 2005, CELL CYCLE, V4, P483, DOI 10.4161/cc.4.3.1533; Spira AI, 2003, CURR OPIN PHARMACOL, V3, P338, DOI 10.1016/S1471-4892(03)00081-X; Steeghs N, 2007, ANN SURG ONCOL, V14, P942, DOI 10.1245/s10434-006-9227-1; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Swanton C, 2006, CLIN CANCER RES, V12, p4377S, DOI 10.1158/1078-0432.CCR-06-0115; Takigawa N, 2005, ANTICANCER RES, V25, P2579; Tazzari PL, 2007, LEUKEMIA, V21, P886, DOI 10.1038/sj.leu.2404643; TETTEROO PAT, 1984, LEUKEMIA RES, V8, P197, DOI 10.1016/0145-2126(84)90143-7; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhou YF, 2006, CANCER RES, V66, P404, DOI 10.1158/0008-5472.CAN-05-2506	53	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29014	10.1371/journal.pone.0029014	http://dx.doi.org/10.1371/journal.pone.0029014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216158	gold, Green Published, Green Submitted			2022-12-25	WOS:000299684700024
J	Menter, DG; Ramsauer, VP; Harirforoosh, S; Chakraborty, K; Yang, PY; Hsi, L; Newman, RA; Krishnan, K				Menter, David G.; Ramsauer, Victoria P.; Harirforoosh, Sam; Chakraborty, Kanishka; Yang, Peiying; Hsi, Linda; Newman, Robert A.; Krishnan, Koyamangalath			Differential Effects of Pravastatin and Simvastatin on the Growth of Tumor Cells from Different Organ Sites	PLOS ONE			English	Article							COENZYME-A REDUCTASE; ANION TRANSPORTING POLYPEPTIDES; CHOLESTEROL-LOWERING DRUGS; COA REDUCTASE; IN-VIVO; CANCER-CELLS; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; CORONARY EVENTS; STATINS	3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors, commonly known as statins, may possess cancer preventive and therapeutic properties. Statins are effective suppressors of cholesterol synthesis with a well-established risk-benefit ratio in cardiovascular disease prevention. Mechanistically, targeting HMGCR activity primarily influences cholesterol biosynthesis and prenylation of signaling proteins. Pravastatin is a hydrophilic statin that is selectively taken up by a sodium-independent organic anion transporter protein-1B1 (OATP1B1) exclusively expressed in liver. Simvastatin is a hydrophobic statin that enters cells by other mechanisms. Poorly-differentiated and well-differentiated cancer cell lines were selected from various tissues and examined for their response to these two statins. Simvastatin inhibited the growth of most tumor cell lines more effectively than pravastatin in a dose dependent manner. Poorly-differentiated cancer cells were generally more responsive to simvastatin than well-differentiated cancer cells, and the levels of HMGCR expression did not consistently correlate with response to statin treatment. Pravastatin had a significant effect on normal hepatocytes due to facilitated uptake and a lesser effect on prostate PC3 and colon Caco-2 cancer cells since the OATP1B1 mRNA and protein were only found in the normal liver and hepatocytes. The inhibition of cell growth was accompanied by distinct alterations in mitochondrial networks and dramatic changes in cellular morphology related to cofilin regulation and loss of p-caveolin. Both statins, hydrophilic pravastatin and hypdrophobic simvastatin caused redistribution of OATP1B1 and HMGCR to perinuclear sites. In conclusion, the specific chemical properties of different classes of statins dictate mechanistic properties which may be relevant when evaluating biological responses to statins.	[Menter, David G.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Ramsauer, Victoria P.; Harirforoosh, Sam] E Tennessee State Univ, Bill Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA; [Yang, Peiying; Newman, Robert A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Hsi, Linda] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44106 USA; [Hsi, Linda] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevention, Houston, TX 77030 USA; [Ramsauer, Victoria P.; Chakraborty, Kanishka; Krishnan, Koyamangalath] E Tennessee State Univ, Dept Internal Med, Div Hematol Oncol, Johnson City, TN 37614 USA	University of Texas System; UTMD Anderson Cancer Center; East Tennessee State University; University of Texas System; UTMD Anderson Cancer Center; Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center; East Tennessee State University	Menter, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	krishnak@etsu.edu	Harirforoosh, Sam/J-9493-2013; Palau, Victoria E/F-3520-2012	Harirforoosh, Sam/0000-0002-2631-3756; Palau, Victoria E/0000-0003-2761-7003	American Cancer Society [TPRN-99-240-01-CNE-1]; National Cancer Institute [R21 CA-10241, R21 CA-102145]; Dishner Chair of Excellence Endowment Funds; NATIONAL CANCER INSTITUTE [R21CA102145] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dishner Chair of Excellence Endowment Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant TPRN-99-240-01-CNE-1 from the American Cancer Society, and by National Cancer Institute grants R21 CA-10241 and R21 CA-102145, and the Dishner Chair of Excellence Endowment Funds. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Chang CC, 2011, PROSTATE; COHEN LH, 1993, BIOCHEM PHARMACOL, V45, P2203, DOI 10.1016/0006-2952(93)90190-8; Cui YH, 2003, LAB INVEST, V83, P527, DOI 10.1097/01.LAB.0000065015.02412.48; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Duncan RE, 2004, J BIOL CHEM, V279, P33079, DOI 10.1074/jbc.M400732200; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Farwell WR, 2011, JNCI-J NATL CANCER I, V103, P885, DOI 10.1093/jnci/djr108; FENTON RG, 1992, J CELL BIOL, V117, P347, DOI 10.1083/jcb.117.2.347; Fowke JH, 2011, CANCER CAUSE CONTROL, V22, P417, DOI 10.1007/s10552-010-9713-4; Generaux GT, 2011, XENOBIOTICA; GERMERSHAUSEN JI, 1989, BIOCHEM BIOPH RES CO, V158, P667, DOI 10.1016/0006-291X(89)92773-3; Guruswamy S, 2009, INT J ONCOL, V35, P1037, DOI 10.3892/ijo_00000418; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; ISHIGAMI M, 1995, PHARMACEUT RES, V12, P1741, DOI 10.1023/A:1016226024587; Jacobs EJ, 2006, J NATL CANCER I, V98, P69, DOI 10.1093/jnci/djj006; Kawabata K, 2005, J CHROMATOGR B, V816, P73, DOI 10.1016/j.jchromb.2004.11.014; Kim K, 2006, J CLIN ONCOL, V24, P4796, DOI 10.1200/JCO.2006.07.9673; KOGA T, 1990, BIOCHIM BIOPHYS ACTA, V1045, P115, DOI 10.1016/0005-2760(90)90139-O; KOKOGLU E, 1992, CANCER LETT, V65, P169, DOI 10.1016/0304-3835(92)90162-O; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156, DOI 10.1152/ajpgi.2000.278.1.G156; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005; Li SW, 1996, J BIOL CHEM, V271, P3863; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Mady EA, 2000, J STEROID BIOCHEM, V75, P323, DOI 10.1016/S0960-0760(00)00183-7; Manzoni M, 2002, APPL MICROBIOL BIOT, V58, P555, DOI 10.1007/s00253-002-0932-9; McLaughlin J, 2006, J NATL CANCER I, V98, P4, DOI 10.1093/jnci/djj023; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; Moorman PG, 2007, EPIDEMIOLOGY, V18, P194, DOI 10.1097/01.ede.0000254699.31405.e2; Murtola TJ, 2009, PROSTATE, V69, P1017, DOI 10.1002/pros.20951; Nygren C, 1997, BRIT J NEUROSURG, V11, P216, DOI 10.1080/02688699746276; Papadopoulos G, 2011, EUR J CANCER, V47, P819, DOI 10.1016/j.ejca.2011.01.005; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2000, AM J CARDIOL, V86, P257, DOI 10.1016/S0002-9149(00)00910-3; PETERSON C, 1985, MED ONCOL TUMOR PHAR, V2, P143; Plenz GAM, 2004, CIRCULATION, V109, pE7, DOI 10.1161/01.CIR.0000111128.83347.7A; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Rao S, 1999, P NATL ACAD SCI USA, V96, P7797, DOI 10.1073/pnas.96.14.7797; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Shannon J, 2005, AM J EPIDEMIOL, V162, P318, DOI 10.1093/aje/kwi203; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shimoyama S, 2011, CANCER CHEMOTH PHARM, V67, P729, DOI 10.1007/s00280-011-1583-2; Subbarayan V, 2001, CANCER RES, V61, P2720; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Tan N, 2011, J UROLOGY, V186, P86, DOI 10.1016/j.juro.2011.03.004; Uray IP, 2011, RECENT RESULTS CANC, V188, P147, DOI 10.1007/978-3-642-10858-7_13; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Zhuang LY, 2005, J CLIN INVEST, V115, P959; ZIEGLER K, 1994, BBA-MOL CELL RES, V1223, P195, DOI 10.1016/0167-4889(94)90226-7; ZIEGLER K, 1992, BIOCHIM BIOPHYS ACTA, V1139, P203; Zollner G, 2005, LIVER INT, V25, P367, DOI 10.1111/j.1478-3231.2005.01033.x	59	57	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28813	10.1371/journal.pone.0028813	http://dx.doi.org/10.1371/journal.pone.0028813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216116	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700013
J	Vazquez, MC; del Pozo, T; Robledo, FA; Carrasco, G; Pavez, L; Olivares, F; Gonzalez, M; Zanlungo, S				Vazquez, Mary C.; del Pozo, Talia; Robledo, Fermin A.; Carrasco, Gonzalo; Pavez, Leonardo; Olivares, Felipe; Gonzalez, Mauricio; Zanlungo, Silvana			Alteration of Gene Expression Profile in Niemann-Pick Type C Mice Correlates with Tissue Damage and Oxidative Stress	PLOS ONE			English	Article							DISEASE TYPE-C; CHOLESTEROL; COPPER; METABOLISM; PROTEIN; MODEL; NPC1; PCR; CERULOPLASMIN; GLUTATHIONE	Background: Niemann-Pick type C disease (NPC) is a neurovisceral lipid storage disorder mainly characterized by unesterified cholesterol accumulation in lysosomal/late endosomal compartments, although there is also an important storage for several other kind of lipids. The main tissues affected by the disease are the liver and the cerebellum. Oxidative stress has been described in various NPC cells and tissues, such as liver and cerebellum. Although considerable alterations occur in the liver, the pathological mechanisms involved in hepatocyte damage and death have not been clearly defined. Here, we assessed hepatic tissue integrity, biochemical and oxidative stress parameters of wild-type control (Npc1(+/+); WT) and homozygous-mutant (Npc1(-/-); NPC) mice. In addition, the mRNA abundance of genes encoding proteins associated with oxidative stress, copper metabolism, fibrosis, inflammation and cholesterol metabolism were analyzed in livers and cerebella of WT and NPC mice. Methodology/Principal Findings: We analyzed various oxidative stress parameters in the liver and hepatic and cerebellum gene expression in 7-week-old NPC1-deficient mice compared with control animals. We found signs of inflammation and fibrosis in NPC livers upon histological examination. These signs were correlated with increased levels of carbonylated proteins, diminished total glutathione content and significantly increased total copper levels in liver tissue. Finally, we analyzed liver and cerebellum gene expression patterns by qPCR and microarray assays. We found a correlation between fibrotic tissue and differential expression of hepatic as well as cerebellar genes associated with oxidative stress, fibrosis and inflammation in NPC mice. Conclusions/Significance: In NPC mice, liver disease is characterized by an increase in fibrosis and in markers associated with oxidative stress. NPC is also correlated with altered gene expression, mainly of genes involved in oxidative stress and fibrosis. These findings correlate with similar parameters in cerebellum, as has been previously reported in the NPC mice model.	[Vazquez, Mary C.; Robledo, Fermin A.; Zanlungo, Silvana] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago, Chile; [del Pozo, Talia; Pavez, Leonardo; Olivares, Felipe; Gonzalez, Mauricio] Univ Chile, INTA, Lab Bioinformat & Expres Genica, Santiago, Chile; [Carrasco, Gonzalo] Fdn Hosp Parroquial San Bernardo, Santiago, Chile; [Gonzalez, Mauricio] Univ Chile, CMM, Lab Bioinformat & Matemat Genoma, Fac Ciencias Fis & Matemat, Santiago, Chile; [del Pozo, Talia; Gonzalez, Mauricio; Zanlungo, Silvana] FONDAP Ctr Genome Regulat CGR, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile	Vazquez, MC (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Alameda 340, Santiago, Chile.	silvana@med.puc.cl	Gonzalez, Mauricio/I-2772-2013	del Pozo, Talia/0000-0002-9169-2529; Olivares Vera, Felipe/0000-0002-4798-8680; Zanlungo, Silvana/0000-0001-8383-9829; Pavez, Leonardo/0000-0003-1093-8134; Carrasco-Avino, Gonzalo/0000-0003-2415-5413; Gonzalez Canales, Mauricio Alejandro/0000-0002-1592-9758	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [3100026, 1110310, 1110427]; Fondo Nacional de Desarrollo de Areas Prioritarias (FONDAP) [15090007]; Abraham Stekel (Nestle Chile-INTA)	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo Nacional de Desarrollo de Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Abraham Stekel (Nestle Chile-INTA)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT Grants # 3100026 (MCV), 1110310 (SZ) and 1110427 (MG)) and Fondo Nacional de Desarrollo de Areas Prioritarias (FONDAP Grant # 15090007). TDP is a recipient of FONDAP and Abraham Stekel (Nestle Chile-INTA) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Amigo L, 2002, HEPATOLOGY, V36, P819, DOI 10.1053/jhep.2002.35617; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Beltroy EP, 2005, HEPATOLOGY, V42, P886, DOI 10.1002/hep.20868; De Windt A, 2007, DNA CELL BIOL, V26, P665, DOI 10.1089/dna.2006.0570; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Fu R, 2010, MOL GENET METAB; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Guo JY, 2003, J MAGN RESON IMAGING, V18, P321, DOI 10.1002/jmri.10404; Harada N, 2003, GASTROENTEROLOGY, V125, P1911, DOI 10.1053/S0016-5085(03)01591-9; Jevon GP, 1998, PEDIATR DEVEL PATHOL, V1, P179, DOI 10.1007/s100249900026; Klein A, 2011, NEUROBIOL DIS, V41, P209, DOI 10.1016/j.nbd.2010.09.008; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liao GH, 2010, BRAIN RES, V1325, P128, DOI 10.1016/j.brainres.2010.02.019; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P1, DOI 10.1016/j.bbalip.2004.08.004; Liscum L, 1998, CURR OPIN LIPIDOL, V9, P131, DOI 10.1097/00041433-199804000-00009; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Nitti M, 2008, MOL ASPECTS MED, V29, P36, DOI 10.1016/j.mam.2007.09.001; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Patterson M., 2001, METABOLIC MOL BASIS; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Rimkunas VM, 2008, HEPATOLOGY, V47, P1504, DOI 10.1002/hep.22327; Schedin S, 1997, J BIOL CHEM, V272, P6245, DOI 10.1074/jbc.272.10.6245; Sedeek M, 2009, CURR OPIN NEPHROL HY, V18, P122, DOI 10.1097/MNH.0b013e32832923c3; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Suazo M, 2008, J NUTR BIOCHEM, V19, P269, DOI 10.1016/j.jnutbio.2007.04.003; Tatsumi K, 2008, BIOCHEM BIOPH RES CO, V374, P106, DOI 10.1016/j.bbrc.2008.06.103; Tint GS, 1998, J INHERIT METAB DIS, V21, P853, DOI 10.1023/A:1005474803278; Uauy R, 1998, AM J CLIN NUTR, V67, p952S, DOI 10.1093/ajcn/67.5.952S; Ulatowski L, 2011, J LIPID RES, V52, P1400, DOI 10.1194/jlr.M015560; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Wang X, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.15.e75; West EC, 2004, EXP BIOL MED, V229, P756, DOI 10.1177/153537020422900807; Wraith JE, 2009, MOL GENET METAB, V98, P152, DOI 10.1016/j.ymgme.2009.06.008; Yanagimoto C, 2011, HEPATOL RES, V41, P484, DOI 10.1111/j.1872-034X.2011.00788.x; Yanagimoto C, 2009, EXP CELL RES, V315, P119, DOI 10.1016/j.yexcr.2008.10.022; Yerushalmi B, 2002, J PEDIATR GASTR NUTR, V35, P44, DOI 10.1097/00005176-200207000-00011; Yevenes LF, 2011, BIOCHIM BIOPHYS ACTA, DOI [DOI: 10.1016/j.bbadis.2011.1011.1009, DOI 10.1016/J.BBADIS.2011.1011.1009]; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200; ZAMPIERI S, 2008, J CELL MOL MED; Zhang JR, 2008, J CLIN INVEST, V118, P2281, DOI [10.1172/JCI32561, 10.1172/JC132561]	53	51	53	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28777	10.1371/journal.pone.0028777	http://dx.doi.org/10.1371/journal.pone.0028777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216111	gold, Green Submitted, Green Published			2022-12-25	WOS:000299684700010
J	Haun, DBM; Nawroth, C; Call, J				Haun, Daniel B. M.; Nawroth, Christian; Call, Josep			Great Apes' Risk-Taking Strategies in a Decision Making Task	PLOS ONE			English	Article							GORILLA-GORILLA PERFORM; PONGO-PYGMAEUS; PAN-TROGLODYTES; CONTINGENCY TASK; MACACA-MULATTA; TOOL USE; CHIMPANZEES; QUANTITY; RESPONSES; PANISCUS	We investigate decision-making behaviour in all four non-human great ape species. Apes chose between a safe and a risky option across trials of varying expected values. All species chose the safe option more often with decreasing probability of success. While all species were risk-seeking, orangutans and chimpanzees chose the risky option more often than gorillas and bonobos. Hence all four species' preferences were ordered in a manner consistent with normative dictates of expected value, but varied predictably in their willingness to take risks.	[Haun, Daniel B. M.] Max Planck Inst Evolutionary Anthropol, Max Planck Res Grp Comparat Cognit Anthropol, Leipzig, Germany; [Haun, Daniel B. M.] Max Planck Inst Psycholinguist, Max Planck Res Grp Comparat Cognit Anthropol, Nijmegen, Netherlands; [Haun, Daniel B. M.] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England; [Nawroth, Christian; Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany	Max Planck Society; Max Planck Society; University of Portsmouth; Max Planck Society	Haun, DBM (corresponding author), Max Planck Inst Evolutionary Anthropol, Max Planck Res Grp Comparat Cognit Anthropol, Leipzig, Germany.	haun@eva.mpg.de	Nawroth, Christian/C-4017-2018	Nawroth, Christian/0000-0003-4582-4057; Call Balaguer, Josep/0000-0002-8597-8336	Max Planck Society for the Advancement of Science	Max Planck Society for the Advancement of Science(Max Planck SocietyEuropean Commission)	This research was funded by the Max Planck Society for the Advancement of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; BOYSEN ST, 1995, J EXP PSYCHOL ANIM B, V21, P82, DOI 10.1037/0097-7403.21.1.82; Call J., 2001, ANIM COGN, V3, P207, DOI [10.1007/s100710100078, DOI 10.1007/S100710100078]; Call J, 2010, ANIM COGN, V13, P689, DOI 10.1007/s10071-010-0317-x; Conklin-Brittain Nancy L., 2001, P167; Fox EA, 2004, AM J PHYS ANTHROPOL, V125, P162, DOI 10.1002/ajpa.10386; Gilby IC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1771, DOI 10.1007/s00265-007-0410-6; Hampton RR, 2004, ANIM COGN, V7, P239, DOI 10.1007/s10071-004-0215-1; Haun DBM, 2010, TRENDS COGN SCI, V14, P552, DOI 10.1016/j.tics.2010.09.006; Hayden BY, 2007, CURR BIOL, V17, P49, DOI 10.1016/j.cub.2006.10.055; Heilbronner SR, 2008, BIOL LETTERS, V4, P246, DOI 10.1098/rsbl.2008.0081; InoueNakamura N, 1997, J COMP PSYCHOL, V111, P159, DOI 10.1037/0735-7036.111.2.159; Kacelnik A, 1996, AM ZOOL, V36, P402; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D, 2000, CHOICES VALUES FRAME; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Murray EA, 2005, ANIM BEHAV, V69, P991, DOI 10.1016/j.anbehav.2004.06.034; Nishimura T, 2003, PRIMATES, V44, P199, DOI 10.1007/s10329-002-0018-4; Smith JD, 2009, TRENDS COGN SCI, V13, P389, DOI 10.1016/j.tics.2009.06.009; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Suda-King C, 2008, ANIM COGN, V11, P21, DOI 10.1007/s10071-007-0082-7; SUMITA K, 1985, Primates, V26, P168, DOI 10.1007/BF02382016; Suzuki A, 1994, INT C OR NEGL AP; Uher J, 2008, J COMP PSYCHOL, V122, P204, DOI 10.1037/0735-7036.122.2.204; Van Schaik CP, 2001, AM J PHYS ANTHROPOL, V114, P331, DOI 10.1002/ajpa.1045; Vlamings PHJM, 2006, J EXP PSYCHOL-ANIM B, V32, P60, DOI 10.1037/0097-7403.32.1.60; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; Wrangham RW, 1996, GREAT APE SOC	29	59	59	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28801	10.1371/journal.pone.0028801	http://dx.doi.org/10.1371/journal.pone.0028801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216113	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600036
J	Hosni-Ahmed, A; Barnes, JD; Wan, J; Jones, TS				Hosni-Ahmed, Amira; Barnes, Joseph D.; Wan, Jim; Jones, Terreia S.			Thiopurine Methyltransferase Predicts the Extent of Cytotoxicty and DNA Damage in Astroglial Cells after Thioguanine Exposure	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INFLAMMATORY-BOWEL-DISEASE; SECONDARY BRAIN-TUMORS; S-METHYLTRANSFERASE; BIOCHEMICAL-PROPERTIES; MOLECULAR-MECHANISMS; TRANSPLANT RECIPIENT; MALIGNANT NEOPLASMS; MISMATCH REPAIR; AZATHIOPRINE	Thiopurine methyltransferase (Tpmt) is the primary enzyme responsible for deactivating thiopurine drugs. Thiopurine drugs (i.e., thioguanine [TG], mercaptopurine, azathioprine) are commonly used for the treatment of cancer, organ transplant, and autoimmune disorders. Chronic thiopurine therapy has been linked to the development of brain cancer (most commonly astrocytomas), and Tpmt status has been associated with this risk. Therefore, we investigated whether the level of Tpmt protein activity could predict TG-associated cytotoxicity and DNA damage in astrocytic cells. We found that TG induced cytotoxicity in a dose-dependent manner in Tpmt(+/+), Tpmt(+/-) and Tpmt(-/-) primary mouse astrocytes and that a low Tpmt phenotype predicted significantly higher sensitivity to TG than did a high Tpmt phenotype. We also found that TG exposure induced significantly more DNA damage in the form of single strand breaks (SSBs) and double strand breaks (DSBs) in primary astrocytes with low Tpmt versus high Tpmt. More interestingly, we found that Tpmt(+/-) astrocytes had the highest degree of cytotoxicity and genotoxicity (i.e., IC50, SSBs and DSBs) after TG exposure. We then used human glioma cell lines as model astroglial cells to represent high (T98) and low (A172) Tpmt expressers and found that A172 had the highest degree of cytoxicity and SSBs after TG exposure. When we over-expressed Tpmt in the A172 cell line, we found that TG IC50 was significantly higher and SSB's were significantly lower as compared to mock transfected cells. This study shows that low Tpmt can lead to greater sensitivity to thiopurine therapy in astroglial cells. When Tpmt deactivation at the germ-line is considered, this study also suggests that heterozygosity may be subject to the greatest genotoxic effects of thiopurine therapy.	[Hosni-Ahmed, Amira; Jones, Terreia S.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Barnes, Joseph D.; Jones, Terreia S.] Univ Tennessee, Hlth Sci Ctr, Dept Clin Pharm, Memphis, TN USA; [Jones, Terreia S.] Univ Tennessee, Hlth Sci Ctr, Dept Neurosurg, Memphis, TN USA; [Wan, Jim] Univ Tennessee, Hlth Sci Ctr, Div Biostat & Epidemiol, Memphis, TN USA; [Hosni-Ahmed, Amira] Fayoum Univ, Coll Sci, Dept Chem, Al Fayyum, Egypt	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Fayoum University	Hosni-Ahmed, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	tjones@uthsc.edu			Center for Translational Science Institute, University of Tennessee Health Science Center	Center for Translational Science Institute, University of Tennessee Health Science Center	The work was funded by the Center for Translational Science Institute, University of Tennessee Health Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalastanis A, 2010, J NATL CANCER I, V102, P1731, DOI 10.1093/jnci/djq389; CHRISTIE NT, 1984, CANCER RES, V44, P3665; Cooley N, 2010, TOXICOLOGY, V268, P111, DOI 10.1016/j.tox.2009.12.008; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; EVANS WE, 1991, J PEDIATR-US, V119, P985, DOI 10.1016/S0022-3476(05)83063-X; Guenova E, 2009, MELANOMA RES, V19, P271, DOI 10.1097/CMR.0b013e32831bc44a; Hartford C, 2007, CANCER RES, V67, P4965, DOI 10.1158/0008-5472.CAN-06-3508; HIESSE C, 1995, TRANSPLANT P, V27, P2450; Hijiya N, 2007, JAMA-J AM MED ASSOC, V297, P1207, DOI 10.1001/jama.297.11.1207; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kinsella TJ, 2009, CLIN CANCER RES, V15, P1853, DOI 10.1158/1078-0432.CCR-08-1307; Krynetski EY, 1996, PHARMACOGENETICS, V6, P279, DOI 10.1097/00008571-199608000-00001; MCLEOD HL, 1995, BLOOD, V85, P1897, DOI 10.1182/blood.V85.7.1897.bloodjournal8571897; NYGAARD R, 1991, ACTA PAEDIATR SCAND, V80, P1220, DOI 10.1111/j.1651-2227.1991.tb11812.x; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Otterness D, 1997, CLIN PHARMACOL THER, V62, P60, DOI 10.1016/S0009-9236(97)90152-1; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; PENN I, 1993, J HEART LUNG TRANSPL, V12, pS328; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; REMY CN, 1963, J BIOL CHEM, V238, P1078; ROSSO P, 1994, INT J CANCER, V59, P451, DOI 10.1002/ijc.2910590402; Schaeffeler E, 2004, PHARMACOGENETICS, V14, P407, DOI 10.1097/01.fpc.0000114745.08559.db; SCHUTZ E, 1993, LANCET, V341, P436, DOI 10.1016/0140-6736(93)93028-Y; Smith MA, 2010, ALIMENT PHARM THER, V32, P119, DOI 10.1111/j.1365-2036.2010.04330.x; Snanoudj R, 2003, TRANSPLANTATION, V76, P930, DOI 10.1097/01.TP.0000079253.06061.52; Stanulla M, 2009, BLOOD, V114, P1314, DOI 10.1182/blood-2008-12-193250; SZUMLANSKI CL, 1992, PHARMACOGENETICS, V2, P148, DOI 10.1097/00008571-199208000-00002; Tai HL, 1996, AM J HUM GENET, V58, P694; Tassaneeyakul W, 2003, TRANSPLANTATION, V76, P265, DOI 10.1097/01.TP.0000070521.22024.F1; Thomsen JB, 1999, CANCER-AM CANCER SOC, V86, P1080, DOI 10.1002/(SICI)1097-0142(19990915)86:6<1080::AID-CNCR26>3.0.CO;2-5; TIDD DM, 1974, CANCER RES, V34, P738; Vancura RW, 2006, SURG NEUROL, V65, P490, DOI 10.1016/j.surneu.2005.06.047; VANLOON JA, 1982, BIOCHEM GENET, V20, P637, DOI 10.1007/BF00483962; VANLOON JA, 1992, BIOCHEM PHARMACOL, V44, P775, DOI 10.1016/0006-2952(92)90416-G; Walter AW, 1998, J CLIN ONCOL, V16, P3761, DOI 10.1200/JCO.1998.16.12.3761; WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651; WEINSHILBOUM RM, 1978, CLIN CHIM ACTA, V85, P323, DOI 10.1016/0009-8981(78)90311-X; Yan T, 2003, CLIN CANCER RES, V9, P2327; Yuan BF, 2008, J BIOL CHEM, V283, P23665, DOI 10.1074/jbc.M804047200; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b; Yue JM, 2010, BIOCHEM BIOPH RES CO, V394, P667, DOI 10.1016/j.bbrc.2010.03.047	45	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29163	10.1371/journal.pone.0029163	http://dx.doi.org/10.1371/journal.pone.0029163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216194	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600061
J	Huang, MB; Xu, H; Xie, SJ; Zhou, H; Qu, LH				Huang, Mian-Bo; Xu, Hui; Xie, Shu-Juan; Zhou, Hui; Qu, Liang-Hu			Insulin-Like Growth Factor-1 Receptor Is Regulated by microRNA-133 during Skeletal Myogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; MUSCLE HYPERTROPHY; SIGNALING PATHWAYS; EXPRESSION; DIFFERENTIATION; TARGETS; PROLIFERATION; HORMONE	Background: The insulin-like growth factor (IGF) signaling pathway has long been established as playing critical roles in skeletal muscle development. However, the underlying regulatory mechanism is poorly understood. Recently, a large family of small RNAs, named microRNAs (miRNAs), has been identified as key regulators for many developmental processes. Because miRNAs participate in the regulation of various signaling pathways, we hypothesized that miRNAs may be involved in the regulation of IGF signaling in skeletal myogenesis. Methodology/Principal Findings: In the present study, we determined that the cell-surface receptor IGF-1R is directly regulated by a muscle-specific miRNA, microRNA-133 (miR-133). A conserved and functional binding site for miR-133 was identified in the 3'untranslated region (3'UTR) of IGF-1R. During differentiation of C2C12 myoblasts, IGF-1R protein, but not messenger RNA (mRNA) expression, was gradually reduced, concurrent with the upregulation of miR-133. Overexpression of miR-133 in C2C12 cells significantly suppressed IGF-1R expression at the posttranscriptional level. We also demonstrated that both overexpression of miR-133 and knockdown of IGF-1R downregulated the phosphorylation of Akt, the central mediator of the PI3K/Akt signaling pathway. Furthermore, upregulation of miR-133 during C2C12 differentiation was significantly accelerated by the addition of IGF-1. Mechanistically, we found that the expression of myogenin, a myogenic transcription factor reported to transactivate miR-133, was increased by IGF-1 stimulation. Conclusion/Significance: Our results elucidate a negative feedback circuit in which IGF-1-stimulated miR-133 in turn represses IGF-1R expression to modulate the IGF-1R signaling pathway during skeletal myogenesis. These findings also suggest that miR-133 may be a potential therapeutic target in muscle diseases.	[Huang, Mian-Bo; Xu, Hui; Xie, Shu-Juan; Zhou, Hui; Qu, Liang-Hu] Sun Yat Sen Univ, State Key Lab Biocontrol, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Huang, MB (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China.	lssqlh@mail.sysu.edu.cn	Huang, Mianbo/K-5256-2018	Huang, Mianbo/0000-0001-7193-4255; Zhou, Hui/0000-0001-9157-3792; Xie, Shujuan/0000-0002-0867-7273; Xu, Hui/0000-0003-3424-1219; Qu, Liang-Hu/0000-0003-3657-2863	National Natural Science Foundation of China [30830066, 81070589, 30870530]; Ministry of Science and Technology of China [2011CB811300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by grants from the National Natural Science Foundation of China (No. 30830066, 81070589 and 30870530) and the National Basic Research Program (No. 2011CB811300) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen X, 2009, J BIOL CHEM, V284, P5362, DOI 10.1074/jbc.M807523200; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hill DJ, 1998, DIABETES CARE, V21, pB60; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Lee EK, 2010, ENDOCRINOLOGY, V151, P1403, DOI 10.1210/en.2009-1123; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; Ning HX, 2009, DIFFERENTIATION, V78, P253, DOI 10.1016/j.diff.2009.07.009; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; Quinn LS, 2007, AM J PHYSIOL-ENDOC M, V293, pE1538, DOI 10.1152/ajpendo.00160.2007; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rao PK, 2010, FASEB J, V24, P3427, DOI 10.1096/fj.09-150698; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Werner H, 2006, TRENDS ENDOCRIN MET, V17, P236, DOI 10.1016/j.tem.2006.06.007; Wu MZ, 2011, J CELL PHYSIOL, V226, P29, DOI 10.1002/jcp.22353; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Yoshiko Y, 2002, AM J PHYSIOL-CELL PH, V283, pC1278, DOI 10.1152/ajpcell.00168.2002; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	42	112	124	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29173	10.1371/journal.pone.0029173	http://dx.doi.org/10.1371/journal.pone.0029173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195016	gold, Green Submitted, Green Published			2022-12-25	WOS:000298370400036
J	Kuo, MW; Wang, CH; Wu, HC; Chang, SJ; Chuang, YJ				Kuo, Meng-Wei; Wang, Chian-Huei; Wu, Hsiao-Chun; Chang, Shing-Jyh; Chuang, Yung-Jen			Soluble THSD7A Is an N-Glycoprotein That Promotes Endothelial Cell Migration and Tube Formation in Angiogenesis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; P38 MAP KINASE; ACTIVATED PROTEIN-KINASE; LATENT-TGF-BETA; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; TIP CELLS; VEGF-C; THROMBOSPONDIN; INTEGRINS	Background: Thrombospondin type I domain containing 7A (THSD7A) is a novel neural protein that is known to affect endothelial migration and vascular patterning during development. To further understand the role of THSD7A in angiogenesis, we investigated the post-translational modification scheme of THS7DA and to reveal the underlying mechanisms by which this protein regulates blood vessel growth. Methodology/Principal Findings: Full-length THSD7A was overexpressed in human embryonic kidney 293T (HEK293T) cells and was found to be membrane associated and N-glycosylated. The soluble form of THSD7A, which is released into the cultured medium, was harvested for further angiogenic assays. We found that soluble THSD7A promotes human umbilical vein endothelial cell (HUVEC) migration and tube formation. HUVEC sprouts and zebrafish subintestinal vessel (SIV) angiogenic assays further revealed that soluble THSD7A increases the number of branching points of new vessels. Interestingly, we found that soluble THSD7A increased the formation of filopodia in HUVEC. The distribution patterns of vinculin and phosphorylated focal adhesion kinase (FAK) were also affected, which implies a role for THSD7A in focal adhesion assembly. Moreover, soluble THSD7A increased FAK phosphorylation in HUVEC, suggesting that THSD7A is involved in regulating cytoskeleton reorganization. Conclusions/Significance: Taken together, our results indicate that THSD7A is a membrane-associated N-glycoprotein with a soluble form. Soluble THSD7A promotes endothelial cell migration during angiogenesis via a FAK-dependent mechanism and thus may be a novel neuroangiogenic factor.	[Kuo, Meng-Wei; Wang, Chian-Huei; Wu, Hsiao-Chun; Chuang, Yung-Jen] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Kuo, Meng-Wei; Wang, Chian-Huei; Wu, Hsiao-Chun; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chang, Shing-Jyh] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; Mackay Memorial Hospital	Kuo, MW (corresponding author), Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.	yjchuang@life.nthu.edu.tw	Xiao, Yang/B-5668-2012; Chuang, Yung-Jen/D-2362-2013	Chuang, Yung-Jen/0000-0002-6022-0107	National Science Council, Taiwan [NSC 98-2311-B-007-012-MY3]; Taiwan Zebrafish Core Facility at NTHU; NHRI	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Zebrafish Core Facility at NTHU; NHRI(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council, Taiwan (NSC 98-2311-B-007-012-MY3 to YJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Taiwan Zebrafish Core Facility at NTHU and NHRI for providing critical experimental materials and instrumentation support for this study.	Adams JC, 2000, DEV DYNAM, V218, P280; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Benest AV, 2008, CARDIOVASC RES, V78, P315, DOI 10.1093/cvr/cvm094; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Davis GE, 2006, J INVEST DERM SYMP P, V11, P44, DOI 10.1038/sj.jidsymp.5650008; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hodivala-Dilke KM, 2003, CELL TISSUE RES, V314, P131, DOI 10.1007/s00441-003-0774-5; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lawrence DA, 2001, MOL CELL BIOCHEM, V219, P163, DOI 10.1023/A:1010819716023; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Masson-Gadais B, 2003, CELL STRESS CHAPERON, V8, P37, DOI 10.1379/1466-1268(2003)8<37:IVRFVA>2.0.CO;2; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nicoli S, 2009, J CELL MOL MED, V13, P2061, DOI 10.1111/j.1582-4934.2008.00432.x; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Park JA, 2003, BIOCHEM BIOPH RES CO, V311, P247, DOI 10.1016/j.bbrc.2003.09.129; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Roy RS, 2010, P NATL ACAD SCI USA, V107, P13608, DOI 10.1073/pnas.1006007107; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; SIPES JM, 1993, J CELL BIOL, V121, P469, DOI 10.1083/jcb.121.2.469; Sipes JM, 1999, J BIOL CHEM, V274, P22755, DOI 10.1074/jbc.274.32.22755; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tangkijvanich P, 2002, J CELL PHYSIOL, V191, P351, DOI 10.1002/jcp.10112; Vainionpaa N, 2006, AM J PHYSIOL-CELL PH, V290, pC764, DOI 10.1152/ajpcell.00285.2005; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang CH, 2011, DEV DYNAM, V240, P1412, DOI 10.1002/dvdy.22641; Wang CH, 2010, J CELL PHYSIOL, V222, P685, DOI 10.1002/jcp.21990; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200	53	49	54	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29000	10.1371/journal.pone.0029000	http://dx.doi.org/10.1371/journal.pone.0029000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194972	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100137
J	Guo, Y; Jose, PA				Guo, Yan; Jose, Pedro A.			C-Terminal Di-leucine Motif of Dopamine D-1 Receptor Plays an Important Role in Its Plasma Membrane Trafficking	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ENDOPLASMIC-RETICULUM; CELLS; ENDOCYTOSIS; HYPERTENSION; D1; GLYCOSYLATION; MECHANISMS; TRANSPORT; SIGNAL	The dopamine D-1 receptor (D1R), a G protein-coupled receptor, plays a critical role in regulating blood pressure through its actions on renal hemodynamics and epithelial ion transport, which are highly linked to its intracellular trafficking. In this study, we generated a series of C-terminal mutants of D1R that were tagged with or without enhanced yellow fluorescent protein, and analyzed the consequences of these mutants on the plasma membrane trafficking of D1R and cyclic AMP response to D1R stimulation. D1R with mutations within the endocytic recycling signal (amino acid residues 360-382) continued to be functional, albeit decreased relative to wild-type D1R. Mutation of the palmitoylation site (347C>S) of D1R did not impair its trafficking to the plasma membrane, but abolished its ability to increase cyclic AMP accumulation. In contrast, replacement of di-leucines (344-345L>A) by alanines resulted in the retention of D1R in the early endosome, decreased its glycosylation, and prevented its targeting to the plasma membrane. Our studies suggest that di-L motif at the C-terminus of D1R is critical for the glycosylation and cell surface targeting of D1R.	[Guo, Yan; Jose, Pedro A.] Childrens Natl Med Ctr, Ctr Mol Physiol Res, Washington, DC 20010 USA	Children's National Health System	Guo, Y (corresponding author), Childrens Natl Med Ctr, Ctr Mol Physiol Res, Washington, DC 20010 USA.	gygq@yahoo.com			National Institute of Diabetes and Digestive and Kidney Diseases [DK39308]; National Heart, Lung and Blood Institute [HL092196]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039308] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the National Institute of Diabetes and Digestive and Kidney Diseases, DK39308 and National Heart, Lung and Blood Institute, HL092196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht FE, 1996, J CLIN INVEST, V97, P2283, DOI 10.1172/JCI118670; Asico LD, 1998, J CLIN INVEST, V102, P493, DOI 10.1172/JCI3685; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Furman CA, 2009, NEUROSCI LETT, V463, P78, DOI 10.1016/j.neulet.2009.07.049; Gabilondo AM, 1997, P NATL ACAD SCI USA, V94, P12285, DOI 10.1073/pnas.94.23.12285; Huang LP, 2007, FEBS J, V274, P3986, DOI 10.1111/j.1742-4658.2007.05933.x; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; JENSEN AA, 1995, J NEUROCHEM, V65, P1325, DOI 10.1046/j.1471-4159.1995.65031325.x; Jin H, 1999, EUR J PHARMACOL, V386, P305, DOI 10.1016/S0014-2999(99)00727-X; Karpa KD, 1999, MOL PHARMACOL, V56, P1071, DOI 10.1124/mol.56.5.1071; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lane C, 2004, BIOMETALS, V17, P87, DOI 10.1023/A:1024413631537; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; MCDONALD RH, 1964, J CLIN INVEST, V43, P1116, DOI 10.1172/JCI104996; Nisar S, 2010, TRAFFIC, V11, P508, DOI 10.1111/j.1600-0854.2010.01035.x; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Sanada H, 1999, HYPERTENSION, V33, P1036, DOI 10.1161/01.HYP.33.4.1036; Sibley DR, 1999, ANNU REV PHARMACOL, V39, P313, DOI 10.1146/annurev.pharmtox.39.1.313; SIBLEY DR, 1992, NEUROCHEM INT, V20, pS17; Tower-Gilchrist C, 2011, BIOCHEM BIOPH RES CO, V413, P555, DOI 10.1016/j.bbrc.2011.08.137; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Yang ZW, 2006, AM J PHYSIOL-REG I, V290, pR96, DOI 10.1152/ajpregu.00434.2005; Yu PY, 2004, KIDNEY INT, V66, P2167, DOI 10.1111/j.1523-1755.2004.66007.x	33	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29204	10.1371/journal.pone.0029204	http://dx.doi.org/10.1371/journal.pone.0029204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206002	Green Published, Green Submitted, gold			2022-12-25	WOS:000298665600030
J	Yamashita, T; Fujimiya, M; Nagaishi, K; Ataka, K; Tanaka, M; Yoshida, H; Tsuchihashi, K; Shimamoto, K; Miura, T				Yamashita, Tomohisa; Fujimiya, Mineko; Nagaishi, Kanna; Ataka, Koji; Tanaka, Marenao; Yoshida, Hideaki; Tsuchihashi, Kazufumi; Shimamoto, Kazuaki; Miura, Tetsuji			Fusion of bone marrow-derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy	FASEB JOURNAL			English	Article						mice; TNF-alpha; streptozotocin; high-fat diet	MULTIPOTENT STROMAL CELLS; NECROSIS-FACTOR-ALPHA; EPITHELIAL-CELLS; TNF-ALPHA; STEM-CELLS; ALBUMIN; GLOMERULI; PATHWAY; MICE; RATS	Although diabetic nephropathy (DN) is a major cause of end-stage renal disease, the mechanism of dysfunction has not yet been clarified. We previously reported that in diabetes proinsulin-producing bone marrow-derived cells (BMDCs) fuse with hepatocytes and neurons. Fusion cells are polyploidy and produce tumor necrosis factor (TNF)-alpha, ultimately causing diabetic complications. In this study, we assessed whether the same mechanism is involved in DN. We performed bone marrow transplantation from male GFP-Tg mice to female C57BL/6J mice and produced diabetes by streptozotocin (STZ) or a high-fat diet. In diabetic kidneys, massive infiltration of BMDCs and tubulointerstitial injury were prominent. BMDCs and damaged tubular epithelial cells were positively stained with proinsulin and TNF-alpha. Cell fusion between BMDCs and renal tubules was confirmed by the presence of Y chromosome. Of tubular epithelial cells, 15.4% contain Y chromosomes in STZ-diabetic mice, 8.6% in HFD-diabetic mice, but only 1.5% in nondiabetic mice. Fusion cells primarily expressed TNF-alpha and caspase-3 in diabetic kidney. These in vivo findings were confirmed by in vitro coculture experiments between isolated renal tubular cells and BMDCs. It was concluded that cell fusion between BMDCs and renal tubular epithelial cells plays a crucial role in DN.-Yamashita, T. Fujimiya, M., Nagaishi, K., Ataka, K., Tanaka, M., Yoshida, H., Tsuchihashi, K., Shimamoto, K., Miura, T. Fusion of bone marrow-derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy. FASEB J. 26, 1559-1568 (2012). www.fasebj.org	[Fujimiya, Mineko; Nagaishi, Kanna; Ataka, Koji] Sapporo Med Univ, Sch Med, Dept Anat 2, Sapporo, Hokkaido 0608543, Japan; [Yamashita, Tomohisa; Tanaka, Marenao; Yoshida, Hideaki; Tsuchihashi, Kazufumi; Shimamoto, Kazuaki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido 0608543, Japan	Sapporo Medical University; Sapporo Medical University	Fujimiya, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Anat 2, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	fujimiya@sapmed.ac.jp	Yamashita, Tomohisa/AAU-9554-2020; Marenao, Tanaka/ABA-4054-2020	Yamashita, Tomohisa/0000-0001-9808-7623; Ataka, Koji/0000-0002-2572-5572; Tanaka, Marenao/0000-0002-6575-9996	Ministry of Education, Culture, Sports, Science, and Technology, Japan [21390054]; Akiyama Life Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Akiyama Life Science Foundation	The authors are thankful for the help of Dr. Sugaya (CIMIC Co., Ltd., Tokyo, Japan) in mProx24 cell culture and for technical assistance of Ms. Asami Ogawa. This work was supported by a Grant-in-Aid for Scientific Research 21390054 (to M. F.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan and by Akiyama Life Science Foundation (to M.F.).	Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; BOHLE A, 1991, PATHOL RES PRACT, V187, P251; Camargo FD, 2004, J CLIN INVEST, V113, P1266, DOI 10.1172/JCI200421301; Cameron NE, 2008, CURR DRUG TARGETS, V9, P60, DOI 10.2174/138945008783431718; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Curril IM, 2010, FASEB J, V24, P4856, DOI 10.1096/fj.09-152991; Dong X, 2007, KIDNEY INT, V71, P619, DOI 10.1038/sj.ki.5002132; Ezquer F, 2009, BIOL BLOOD MARROW TR, V15, P1354, DOI 10.1016/j.bbmt.2009.07.022; Fujimiya M, 2007, P NATL ACAD SCI USA, V104, P4030, DOI 10.1073/pnas.0700220104; Guo GJ, 1999, AM J PHYSIOL-RENAL, V277, pF766, DOI 10.1152/ajprenal.1999.277.5.F766; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; JEVNIKAR AM, 1991, KIDNEY INT, V40, P203, DOI 10.1038/ki.1991.201; Joussen AM, 2009, MOL VIS, V15, P1418; Kalantarinia K, 2003, KIDNEY INT, V64, P1208, DOI 10.1046/j.1523-1755.2003.00237.x; Kamijo A, 2002, KIDNEY INT, V62, P1628, DOI 10.1046/j.1523-1755.2002.00618.x; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Li L, 2007, J AM SOC NEPHROL, V18, P3067, DOI 10.1681/ASN.2007030284; Meldrum KK, 2007, AM J PHYSIOL-REG I, V292, pR1456, DOI 10.1152/ajpregu.00620.2005; Munusamy S, 2009, FREE RADICAL BIO MED, V46, P1149, DOI 10.1016/j.freeradbiomed.2009.01.022; NAKAMURA T, 1993, DIABETES, V42, P450, DOI 10.2337/diabetes.42.3.450; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Peti-Peterdi J, 2009, AM J PHYSIOL-RENAL, V296, pF1255, DOI 10.1152/ajprenal.00144.2009; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976; Russo LM, 2009, J AM SOC NEPHROL, V20, P489, DOI 10.1681/ASN.2008050503; Saito A, 2005, NEPHROLOGY, V10, pS26, DOI 10.1111/j.1440-1797.2005.00453.x; Satoh Jo, 2003, Exp Diabesity Res, V4, P65, DOI 10.1155/EDR.2003.65; Striker G E, 1970, Hum Pathol, V1, P615, DOI 10.1016/S0046-8177(70)80060-0; Sugimoto H, 1999, DIABETOLOGIA, V42, P878, DOI 10.1007/s001250051241; Takaya K, 2003, AM J PHYSIOL-RENAL, V284, pF1037, DOI 10.1152/ajprenal.00230.2002; Tanaka M, 2008, INFLAMM RES, V57, P593, DOI 10.1007/s00011-008-7171-1; Tanner GA, 2009, AM J PHYSIOL-RENAL, V296, pF1258, DOI 10.1152/ajprenal.90638.2008; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; U.S. Renal Data System, 2010, ANN DAT REP 2010; WHO, 2006, WORLD HLTH REPORT 20; Zhang B, 2007, KIDNEY INT, V72, P37, DOI 10.1038/sj.ki.5002242; Zheng F, 2004, DIABETES, V53, P2420, DOI 10.2337/diabetes.53.9.2420; Zhou H, 2009, CHINESE MED J-PEKING, V122, P2573, DOI 10.3760/cma.j.issn.0366-6999.2009.21.009	42	15	17	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1559	1568		10.1096/fj.11-183194	http://dx.doi.org/10.1096/fj.11-183194			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22198389				2022-12-25	WOS:000302359700018
J	Derache, C; Meudal, H; Aucagne, V; Mark, KJ; Cadene, M; Delmas, AF; Lalmanach, AC; Landon, C				Derache, Chrystelle; Meudal, Herve; Aucagne, Vincent; Mark, Kevin J.; Cadene, Martine; Delmas, Agnes F.; Lalmanach, Anne-Christine; Landon, Celine			Initial Insights into Structure-Activity Relationships of Avian Defensins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; MAMMALIAN DEFENSINS; BETA-DEFENSINS; PREVENTION; MECHANISM; APIDAECIN; PROGRAM	Numerous beta-defensins have been identified in birds, and the potential use of these peptides as alternatives to antibiotics has been proposed, in particular to fight antibiotic-resistant and zoonotic bacterial species. Little is known about the mechanism of antibacterial activity of avian beta-defensins, and this study was carried out to obtain initial insights into the involvement of structural features or specific residues in the antimicrobial activity of chicken AvBD2. Chicken AvBD2 and its enantiomeric counterpart were chemically synthesized. Peptide elongation and oxidative folding were both optimized. The similar antimicrobial activity measured for both L-and D-proteins clearly indicates that there is no chiral partner. Therefore, the bacterial membrane is in all likelihood the primary target. Moreover, this work indicates that the three-dimensional fold is required for an optimal antimicrobial activity, in particular for Gram-positive bacterial strains. The three-dimensional NMR structure of chicken AvBD2 defensin displays the structural three-stranded antiparallel beta-sheet characteristic of beta-defensins. The surface of the molecule does not display any amphipathic character. In light of this new structure and of the king penguin AvBD103b defensin structure, the consensus sequence of the avian beta-defensin family was analyzed. Well conserved residues were highlighted, and the potential strategic role of the lysine 31 residue of AvBD2 was emphasized. The synthetic AvBD2-K31A variant displayed substantial N-terminal structural modifications and a dramatic decrease in activity. Taken together, these results demonstrate the structural as well as the functional role of the critical lysine 31 residue in antimicrobial activity.	[Lalmanach, Anne-Christine] INRA, UR1282, Ctr Rech Tours, Unite Infectiol Anim & Sante Publ, F-37380 Nouzilly, France; [Derache, Chrystelle; Meudal, Herve; Aucagne, Vincent; Mark, Kevin J.; Cadene, Martine; Delmas, Agnes F.; Landon, Celine] CNRS, UPR4301, Ctr Biophys Mol, F-45071 Orleans, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Lalmanach, AC (corresponding author), INRA, UR1282, Ctr Rech Tours, Unite Infectiol Anim & Sante Publ, F-37380 Nouzilly, France.	Anne-Christine.Lalmanach@tours.inra.fr; celine.landon@cnrs-orleans.fr	Meudal, Hervé/B-5851-2016; Aucagne, Vincent/AAB-1856-2019	Meudal, Hervé/0000-0002-9642-3643; Lalmanach, Anne-Christine/0000-0002-2666-4839; Cadene, Martine/0000-0003-4936-2662; Aucagne, Vincent/0000-0002-2647-0188	Region Centre, France [3200068]; Institut National de la Recherche Agronomique and Region Centre; CNRS; TGE RMN THC [Fr3050]	Region Centre, France(Region Centre-Val de Loire); Institut National de la Recherche Agronomique and Region Centre(Region Centre-Val de Loire); CNRS(Centre National de la Recherche Scientifique (CNRS)); TGE RMN THC	The work was supported by "Biotechnocentre" Grant 3200068 from the Region Centre, France, by a doctoral fellowship from Institut National de la Recherche Agronomique and Region Centre, by a postdoctoral fellowship from CNRS. Financial support from the TGE RMN THC Fr3050 for conducting the research is gratefully acknowledged.	Boisbouvier J, 2000, J BIOMOL NMR, V16, P197, DOI 10.1023/A:1008354007926; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cadene M, 2000, ANAL CHEM, V72, P5655, DOI 10.1021/ac000811l; CASTEELS P, 1994, BIOCHEM BIOPH RES CO, V199, P339, DOI 10.1006/bbrc.1994.1234; Castle M, 1999, J BIOL CHEM, V274, P32555, DOI 10.1074/jbc.274.46.32555; Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.3.CO;2-B; Cremer GA, 2006, J PEPT SCI, V12, P437, DOI 10.1002/psc.746; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derache C, 2009, ANTIMICROB AGENTS CH, V53, P4647, DOI 10.1128/AAC.00301-09; Derache C, 2009, DEV COMP IMMUNOL, V33, P959, DOI 10.1016/j.dci.2009.03.005; EFSA, 2007, EFSA J, P97, DOI DOI 10.2903/J.EFSA.2007.98R; Epand R, 2003, BIOPOLYMERS, V71, P2, DOI 10.1002/bip.10372; Gabant G, 2008, METHODS, V46, P54, DOI 10.1016/j.ymeth.2008.10.021; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Hubbard SJ, 1993, NACCESS COMPUTER PRO; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Landon C, 2004, PROTEIN SCI, V13, P703, DOI 10.1110/ps.03404404; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Marcos JF, 2009, EXPERT OPIN DRUG DIS, V4, P659, DOI 10.1517/17460440902992888; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Pag U, 2008, J ANTIMICROB CHEMOTH, V61, P341, DOI 10.1093/jac/dkm479; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; Paquet F, 2010, FEBS J, V277, P5133, DOI 10.1111/j.1742-4658.2010.07927.x; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Raetz C. R. H., 1987, ESCHERICHIA COLI SAL, P498; Sadeyen JR, 2006, MICROBES INFECT, V8, P1308, DOI 10.1016/j.micinf.2005.12.014; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Sugiarto H, 2007, FEMS MICROBIOL LETT, V270, P195, DOI 10.1111/j.1574-6968.2007.00642.x; Thouzeau C, 2003, J BIOL CHEM, V278, P51053, DOI 10.1074/jbc.M306839200; van Dijk A, 2008, VET IMMUNOL IMMUNOP, V124, P1, DOI 10.1016/j.vetimm.2007.12.006; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543	48	25	26	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7746	7755		10.1074/jbc.M111.312108	http://dx.doi.org/10.1074/jbc.M111.312108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22205704	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000301060200073
J	Xiong, H; Hong, J; Du, W; Lin, YW; Ren, LL; Wang, YC; Su, WY; Wang, JL; Cui, Y; Wang, ZH; Fang, JY				Xiong, Hua; Hong, Jie; Du, Wan; Lin, Yan-wei; Ren, Lin-lin; Wang, Ying-chao; Su, Wen-yu; Wang, Ji-lin; Cui, Yun; Wang, Zhen-hua; Fang, Jing-Yuan			Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; COLON-CANCER; SIGNALING PATHWAY; TUMOR PROGRESSION; CARCINOMA-CELLS; EXPRESSION; PROMOTES; GROWTH; SNAIL; MIGRATION	The progression of colorectal carcinoma (CRC) to invasive and metastatic disease may involve localized occurrences of epithelial-mesenchymal transition (EMT). However, mechanisms of the EMT process in CRC progression are not fully understood. We previously showed that knockdown of signal transducer and activator of transcription 3 (STAT3) up-regulated E-cadherin (a key component in EMT progression) in CRC. In this study, we examined the roles of STAT3 in CRC EMT and ZEB1, an EMT inducer, in STAT3-induced down-regulation of E-cadherin. Knockdown of STAT3 significantly increased E-cadherin and decreased N-cadherin and vimentin expressions in highly invasive LoVo CRC cells. Meanwhile, overexpression of STAT3 significantly reduced E-cadherin and enhanced N-cadherin and vimentin expressions in weakly invasive SW1116 CRC cells. Activation of STAT3 significantly increased CRC cell invasiveness and resistance to apoptosis. Knockdown of STAT3 dramatically enhanced chemosensitivity of CRC cells to fluorouracil. STAT3 regulated ZEB1 expression in CRC cells, and the STAT3-induced decrease in E-cadherin and cell invasion depended on activation of ZEB1 in CRC cells. Additionally, pSTAT3Tyr-(705) and ZEB1 expressions were significantly correlated with TNM (tumor, lymph node, and metastasis stages) (p < 0.01). In conclusion, STAT3 may directly mediate EMT progression and regulate ZEB1 expression in CRC. ZEB1 may participate in STAT3-induced cell invasion and E-cadherin down-regulation in CRC cells. The expressions of pSTAT3Tyr-(705) and ZEB1 may be positively associated with CRC metastasis. Our data may provide potential targets to prevent and/ or treat CRC invasion and metastasis.	[Xiong, Hua; Hong, Jie; Du, Wan; Lin, Yan-wei; Ren, Lin-lin; Wang, Ying-chao; Su, Wen-yu; Wang, Ji-lin; Cui, Yun; Wang, Zhen-hua; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Gastrointestinal Div,State Key Lab Oncogenes & Ge, Sch Med,Shanghai Inst Digest Dis,Minist Hlth, Renji Hosp,Key Lab Gastroenterol & Hepatol, Shanghai 200001, Peoples R China	Shanghai Jiao Tong University	Hong, J (corresponding author), Shanghai Jiao Tong Univ, Gastrointestinal Div,State Key Lab Oncogenes & Ge, Sch Med,Shanghai Inst Digest Dis,Minist Hlth, Renji Hosp,Key Lab Gastroenterol & Hepatol, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China.	jiehong97@gmail.com; jingyuanfang@yahoo.com	wang, yingying/GRS-3058-2022		National Natural Science Foundation of China [30900757, 91129724]; "Chen Guang" Project [09CG13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Chen Guang" Project	This work was supported by National Natural Science Foundation of China Grant 30900757 (to F. J. Y.), National Natural Science Foundation of China Grant 91129724 (to J. H.), and "Chen Guang" Project Grant 09CG13 (to J. H.).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Bates RC, 2005, CANCER BIOL THER, V4, P365; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blaschuk OW, 2009, EUR J PHARMACOL, V625, P195, DOI 10.1016/j.ejphar.2009.05.033; Cavallaro U, 2006, EXP CELL RES, V312, P659, DOI 10.1016/j.yexcr.2005.09.019; Chen YL, 2011, HEPATOLOGY, V53, P1708, DOI 10.1002/hep.24254; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Ellenrieder V, 2001, CANCER RES, V61, P4222; Ferrand A, 2004, EXP CELL RES, V301, P128, DOI 10.1016/j.yexcr.2004.07.037; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hay ED, 1995, ACTA ANAT, V154, P8; Hecht M, 2004, CANCER RES, V64, P6109, DOI 10.1158/0008-5472.CAN-04-1014; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Joyce T, 2009, CLIN EXP METASTAS, V26, P569, DOI 10.1007/s10585-009-9256-9; Kalogeropoulou M, 2010, MOL CANCER RES, V8, P554, DOI 10.1158/1541-7786.MCR-09-0159; Kusaba T, 2006, ONCOL REP, V15, P1445; Lassmann S, 2007, J CLIN PATHOL, V60, P173, DOI 10.1136/jcp.2005.035113; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Markowitz SD, 2002, CANCER CELL, V1, P233, DOI 10.1016/S1535-6108(02)00053-3; Morita Y, 2000, P NATL ACAD SCI USA, V97, P5405, DOI 10.1073/pnas.090084797; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Papageorgis P, 2010, CANCER RES, V70, P968, DOI 10.1158/0008-5472.CAN-09-1872; Paschos KA, 2009, CELL SIGNAL, V21, P665, DOI 10.1016/j.cellsig.2009.01.006; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Spano JP, 2006, EUR J CANCER, V42, P2668, DOI 10.1016/j.ejca.2006.07.006; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158	50	226	238	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5819	5832		10.1074/jbc.M111.295964	http://dx.doi.org/10.1074/jbc.M111.295964			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22205702	hybrid, Green Published			2022-12-25	WOS:000300638000057
J	Meng, XB; Zhu, DL; Yang, SJ; Wang, XJ; Xiong, Z; Zhang, YP; Brachova, P; Leslie, KK				Meng, Xiangbing; Zhu, Danlin; Yang, Shujie; Wang, Xinjun; Xiong, Zhi; Zhang, Yuping; Brachova, Pavla; Leslie, Kimberly K.			Cytoplasmic Metadherin (MTDH) Provides Survival Advantage under Conditions of Stress by Acting as RNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASTROCYTE ELEVATED GENE-1; GRANULE SEQUESTRATION; ENDOMETRIAL-CANCER; BREAST-CANCER; METASTASIS; LYRIC/AEG-1; ACTIVATION; EXPRESSION; ASTROCYTE-ELEVATED-GENE-1; CHEMORESISTANCE	Overexpression of metadherin (MTDH) has been documented in many solid tumors and is implicated in metastasis and chemoresistance. MTDH has been detected at the plasma membrane as well as in the cytoplasm and nucleus, and the function of MTDH in these locales remains under investigation. In the nucleus, MTDH acts as a transcription co-factor to induce expression of chemoresistance-associated genes. However, MTDH is predominantly cytoplasmic in prostate tumors, and this localization correlates with poor prognosis. Herein, we used endometrial cancer cells as a model system to define a new role for MTDH in the cytoplasm. First, MTDH was primarily localized to the cytoplasm in endometrial cancer cells, and the N-terminal region of MTDH was required to maintain cytoplasmic localization. Next, we identified novel binding partners for cytoplasmic MTDH, including RNA-binding proteins and components of the RNA-induced silencing complex. Nucleic acids were required for the association of MTDH with these cytoplasmic proteins. Furthermore, MTDH interacted with and regulated protein expression of multiple mRNAs, such as PDCD10 and KDM6A. Depletion of cytoplasmic MTDH was associated with increased stress granule formation, reduced survival in response to chemotherapy and the tyrosine kinase inhibitor BIBF1120, Rad51 nuclear accumulation, and cell cycle arrest at G(2)/M. Finally, in vivo tumor formation was abrogated with knockdown of cytoplasmic MTDH. Taken together, our data identify a novel function for cytoplasmic MTDH as an RNA-binding protein. Our findings implicate cytoplasmic MTDH in cell survival and broad drug resistance via association with RNA and RNA-binding proteins.	[Meng, Xiangbing; Zhu, Danlin; Yang, Shujie; Wang, Xinjun; Xiong, Zhi; Zhang, Yuping; Brachova, Pavla; Leslie, Kimberly K.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Meng, Xiangbing; Leslie, Kimberly K.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Meng, XB (corresponding author), Univ Iowa, Dept Obstet & Gynecol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	xiangbing-meng@uiowa.edu	Brachova, Pavla/AAA-1477-2021	Wang, Xinjun/0000-0002-5062-4765; Brachova, Pavla/0000-0002-9014-132X; Yang, Shujie/0000-0003-1753-3068; meng, xiangbing/0000-0002-9612-6438; Leslie, Kimberly/0000-0002-2704-8990	National Institutes of Health [R01CA99908-7]; Department of Obstetrics and Gynecology from American Cancer Society [IRG-77-004-31]; NATIONAL CANCER INSTITUTE [R01CA099908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology from American Cancer Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA99908-7 (to K. K. L.). This work was also supported by the Department of Obstetrics and Gynecology Research Development Fund and Institutional Research Grant IRG-77-004-31 from the American Cancer Society (to X. M.), administered through the Holden Comprehensive Cancer Center at the University of Iowa.	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Dai DH, 2005, CANCER RES, V65, P9517, DOI 10.1158/0008-5472.CAN-05-1613; DOWNLOADED F, ISI THOMSON SCI; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Gao XJ, 2010, FEBS LETT, V584, P3525, DOI 10.1016/j.febslet.2010.07.022; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Li C, 2011, INT J GYNECOL CANCER, V21, P602, DOI 10.1097/IGC.0b013e3182145561; Liu HY, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-19; Meng FL, 2011, INT J GYNECOL PATHOL, V30, P145, DOI 10.1097/PGP.0b013e3181ffd2f7; Meng XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020920; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Park S, 2006, BREAST CANCER RES TR, V99, P9, DOI 10.1007/s10549-006-9175-2; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Song HT, 2010, INT J GYNECOL CANCER, V20, P1188, DOI 10.1111/IGC.0b013e3181ef8e21; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Thirkettle HJ, 2009, ONCOGENE, V28, P3663, DOI 10.1038/onc.2009.223; Thirkettle HJ, 2009, CLIN CANCER RES, V15, P3003, DOI 10.1158/1078-0432.CCR-08-2046; Unsworth H, 2010, FASEB J, V24, P3370, DOI 10.1096/fj.09-151142; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Xiang Hua, 2011, Chinese Journal of Pathology, V40, P94, DOI 10.3760/cma.j.issn.0529-5807.2011.02.006; Yague E, 2010, BIOCHEM SOC T, V38, P1537, DOI 10.1042/BST0381537; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yoo BK, 2011, PHARMACOL THERAPEUT, V130, P1, DOI 10.1016/j.pharmthera.2011.01.008; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Zong XY, 2011, RNA BIOL, V8, P968, DOI 10.4161/rna.8.6.17606	32	44	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4485	4491		10.1074/jbc.C111.291518	http://dx.doi.org/10.1074/jbc.C111.291518			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22199357	Green Published, hybrid			2022-12-25	WOS:000300608500012
J	Kadri, S; Hinman, VF; Benos, PV				Kadri, Sabah; Hinman, Veronica F.; Benos, Panayiotis V.			RNA Deep Sequencing Reveals Differential MicroRNA Expression during Development of Sea Urchin and Sea Star	PLOS ONE			English	Article							INTERFERENCE; EVOLUTION; NETWORK; GENOME; GENES; DICER	microRNAs (miRNAs) are small (20-23 nt), non-coding single stranded RNA molecules that act as post-transcriptional regulators of mRNA gene expression. They have been implicated in regulation of developmental processes in diverse organisms. The echinoderms, Strongylocentrotus purpuratus (sea urchin) and Patiria miniata (sea star) are excellent model organisms for studying development with well-characterized transcriptional networks. However, to date, nothing is known about the role of miRNAs during development in these organisms, except that the genes that are involved in the miRNA biogenesis pathway are expressed during their developmental stages. In this paper, we used Illumina Genome Analyzer (Illumina, Inc.) to sequence small RNA libraries in mixed stage population of embryos from one to three days after fertilization of sea urchin and sea star (total of 22,670,000 reads). Analysis of these data revealed the miRNA populations in these two species. We found that 47 and 38 known miRNAs are expressed in sea urchin and sea star, respectively, during early development (32 in common). We also found 13 potentially novel miRNAs in the sea urchin embryonic library. miRNA expression is generally conserved between the two species during development, but 7 miRNAs are highly expressed in only one species. We expect that our two datasets will be a valuable resource for everyone working in the field of developmental biology and the regulatory networks that affect it. The computational pipeline to analyze Illumina reads is available at http://www.benoslab.pitt.edu/services.html.	[Kadri, Sabah] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Hinman, Veronica F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Benos, Panayiotis V.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kadri, S (corresponding author), Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	benos@pitt.edu		Kadri, Sabah/0000-0003-0365-6550; Benos, Panayiotis/0000-0003-3172-3132	National Institutes of Health [R01LM007994, R01LM009657]; National Science Foundation [IOS 1024811]; NATIONAL LIBRARY OF MEDICINE [R01LM009657, R01LM007994] Funding Source: NIH RePORTER; Direct For Biological Sciences [1024811] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health grants R01LM007994, and R01LM009657 (PVB), and National Science Foundation grant IOS 1024811. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Davidson EH, 2009, CURR OPIN GENET DEV, V19, P535, DOI 10.1016/j.gde.2009.10.007; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Hinman VF, 2003, MECH DEVELOP, V120, P1165, DOI 10.1016/j.mod.2003.08.002; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Oliveri P, 2002, DEV BIOL, V246, P209, DOI 10.1006/dbio.2002.0627; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Song JL, 2007, DEV DYNAM, V236, P3180, DOI 10.1002/dvdy.21353; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; WADA H, 1994, J MOL EVOL, V38, P41; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911	40	19	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29217	10.1371/journal.pone.0029217	http://dx.doi.org/10.1371/journal.pone.0029217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216218	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000300676300038
J	Rigor, RR; Damoc, C; Phinney, BS; Cala, PM				Rigor, Robert R.; Damoc, Catalina; Phinney, Brett S.; Cala, Peter M.			Phosphorylation and Activation of the Plasma Membrane Na+/H+ Exchanger (NHE1) during Osmotic Cell Shrinkage	PLOS ONE			English	Article							RED-BLOOD-CELLS; AMINO-ACIDS SER(770); VOLUME REGULATION; DEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; STATISTICAL-MODEL; MASS-SPECTROMETRY; GROWTH-FACTORS; OKADAIC ACID; ERM PROTEINS	The Na+/H+ Exchanger isoform 1 (NHE1) is a highly versatile, broadly distributed and precisely controlled transport protein that mediates volume and pH regulation in most cell types. NHE1 phosphorylation contributes to Na+/H+ exchange activity in response to phorbol esters, growth factors or protein phosphatase inhibitors, but has not been observed during activation by osmotic cell shrinkage (OCS). We examined the role of NHE1 phosphorylation during activation by OCS, using an ideal model system, the Amphiuma tridactylum red blood cell (atRBC). Na+/H+ exchange in atRBCs is mediated by an NHE1 homolog (atNHE1) that is 79% identical to human NHE1 at the amino acid level. NHE1 activity in atRBCs is exceptionally robust in that transport activity can increase more than 2 orders of magnitude from rest to full activation. Michaelis-Menten transport kinetics indicates that either OCS or treatment with the phosphatase inhibitor calyculin-A (CLA) increase Na+ transport capacity without affecting transport affinity (K-m = 44 mM) in atRBCs. CLA and OCS act non-additively to activate atNHE1, indicating convergent, phosphorylation-dependent signaling in atNHE1 activation. In situ P-32 labeling and immunoprecipitation demonstrates that the net phosphorylation of atNHE1 is increased 4-fold during OCS coinciding with a more than 2-order increase in Na+ transport activity. This is the first reported evidence of increased NHE1 phosphorylation during OCS in any vertebrate cell type. Finally, liquid chromatography and mass spectrometry (LC-MS/MS) analysis of atNHE1 immunoprecipitated from atRBC membranes reveals 9 phosphorylated serine/threonine residues, suggesting that activation of atNHE1 involves multiple phosphorylation and/or dephosphorylation events.	[Rigor, Robert R.; Cala, Peter M.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Damoc, Catalina; Phinney, Brett S.] Univ Calif Davis, Genome Ctr, Prote Core Facil, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Rigor, RR (corresponding author), Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA.	robrigor@ucdavis.edu	Phinney, Brett/S-6404-2016	Phinney, Brett/0000-0003-3870-3302; Rigor, Robert/0000-0001-6234-1992	National Institutes of Health [R01 HL 21179]; American Heart Association Western States Affiliate; American Heart Association [AHA 0315035Y]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021179, R37HL021179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Western States Affiliate(American Heart Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health research grant (NHLBI) R01 HL 21179 (to PMC). RRR was supported by the Joel Drillings Award for Excellence in Cardiovascular Disease Research from the American Heart Association Western States Affiliate, and an American Heart Association Predoctoral Fellowship (#AHA 0315035Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; BIANCHINI L, 1995, AM J PHYSIOL-CELL PH, V269, pC998, DOI 10.1152/ajpcell.1995.269.4.C998; Bianchini L, 1997, J BIOL CHEM, V272, P271; BIANCHINI L, 1991, J BIOL CHEM, V266, P15406; CALA PM, 1983, MOL PHYSIOL, V4, P33; CALA PM, 1994, J GEN PHYSIOL, V103, P1035, DOI 10.1085/jgp.103.6.1035; CALA PM, 1985, FED PROC, V44, P2500; CALA PM, 1980, J GEN PHYSIOL, V76, P683, DOI 10.1085/jgp.76.6.683; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; Grenier AL, 2008, AM J PHYSIOL-CELL PH, V295, pC883, DOI 10.1152/ajpcell.00574.2007; GRINSTEIN S, 1992, J BIOL CHEM, V267, P23823; Grinstein Sergio, 1992, News in Physiological Sciences, V7, P232; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; Hoffmann EK, 2010, ACTA PHYSL OXF; Hoffmann EK, 2006, CONTRIB NEPHROL, V152, P54, DOI 10.1159/000096318; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holt MEV, 2006, CELL BIOCHEM BIOPHYS, V45, P1, DOI 10.1385/CBB:45:1:1; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Koster S, 2011, J BIOL CHEM IN PRESS; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lehoux S, 2001, J BIOL CHEM, V276, P15794, DOI 10.1074/jbc.M100410200; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Liu HZ, 2004, ANAL CHEM, V76, P4223, DOI 10.1021/ac035231d; LIVNE AA, 1991, FEBS LETT, V284, P219, DOI 10.1016/0014-5793(91)80689-Z; Lytle C, 1997, J BIOL CHEM, V272, P15069, DOI 10.1074/jbc.272.24.15069; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; McLean LA, 1999, AM J PHYSIOL-CELL PH, V276, pC1025, DOI 10.1152/ajpcell.1999.276.5.C1025; McSwine RL, 1996, J CELL PHYSIOL, V168, P8; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; Musch MW, 1999, J BIOL CHEM, V274, P7923, DOI 10.1074/jbc.274.12.7923; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ortiz-Acevedo A, 2010, AM J PHYSL CELL PHYS; Ortiz-Acevedo A, 2008, AM J PHYSIOL-CELL PH, V295, pC1316, DOI 10.1152/ajpcell.00160.2008; Pedersen SF, 2006, AM J PHYSIOL-REG I, V291, pR1, DOI 10.1152/ajpregu.00782.2005; Pedersen SF, 2004, J EXP ZOOL PART A, V301A, P569, DOI 10.1002/jez.a.47; Pedersen SF, 2001, COMP BIOCHEM PHYS A, V130, P385, DOI 10.1016/S1095-6433(01)00429-9; Pedersen SF, 2006, PFLUG ARCH EUR J PHY, V452, P249, DOI 10.1007/s00424-006-0044-y; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rasmussen M, 2008, AM J PHYSIOL-CELL PH, V294, pC197, DOI 10.1152/ajpcell.00268.2007; Rowley A, 2000, METHODS, V20, P383, DOI 10.1006/meth.2000.0951; SARDET C, 1991, J BIOL CHEM, V266, P19166; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200	51	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29210	10.1371/journal.pone.0029210	http://dx.doi.org/10.1371/journal.pone.0029210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216214	gold, Green Published, Green Submitted			2022-12-25	WOS:000300676300037
J	Sridevi, P; Dutta-Gupta, A; Senthilkumaran, B				Sridevi, Parikipandla; Dutta-Gupta, Aparna; Senthilkumaran, Balasubramanian			Molecular Cloning and Expression Analysis of fushi tarazu Factor 1 in the Brain of Air-Breathing Catfish, Clarias gariepinus	PLOS ONE			English	Article							FTZ-F1-RELATED ORPHAN RECEPTORS; CHAR SALVELINUS-ALPINUS; STEROIDOGENIC FACTOR-I; ZEBRAFISH DANIO-RERIO; FTZ-F1 HOMOLOG; OVARIAN-FOLLICLES; NUCLEAR RECEPTOR; GENE-EXPRESSION; RAINBOW-TROUT; MESSENGER-RNA	Background: Fushi tarazu factor 1 (FTZ-F1) encodes an orphan nuclear receptor belonging to the nuclear receptor family 5A (NR5A) which includes adrenal 4-binding protein or steroidogenic factor-1 (Ad4BP/ SF-1) and liver receptor homologue 1 (LRH-1) and plays a pivotal role in the regulation of aromatases. Methodology/Principal Findings: Present study was aimed to understand the importance of FTZ-F1 in relation to brain aromatase (cyp19a1b) during development, recrudescence and after human chorionic gonadotropin (hCG) induction. Initially, we cloned FTZ-F1 from the brain of air-breathing catfish, Clarias gariepinus through degenerate primer RT-PCR and RACE. Its sequence analysis revealed high homology with other NR5A1 group members Ad4BP/SF-1 and LRH-1, and also analogous to the spatial expression pattern of the latter. In order to draw functional correlation of cyp19a1b and FTZ-F1, we analyzed the expression pattern of the latter in brain during gonadal ontogeny, which revealed early expression during gonadal differentiation. The tissue distribution both at transcript and protein levels revealed its prominent expression in brain along with liver, kidney and testis. The expression pattern of brain FTZ-F1 during reproductive cycle and after hCG induction, in vivo was analogous to that of cyp19a1b shown in our earlier study indicating its involvement in recrudescence. Conclusions/Significance: Based on our previous results on cyp19a1b and the present data, it is plausible to implicate potential roles for brain FTZ-F1 in ovarian differentiation and recrudescence process probably through regulation of cyp19a1b in teleosts. Nevertheless, these interactions would require primary coordinated response from ovarian aromatase and its related transcription factors.	[Sridevi, Parikipandla; Dutta-Gupta, Aparna; Senthilkumaran, Balasubramanian] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Ctr Adv Studies, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Sridevi, P (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Ctr Adv Studies, Hyderabad 500134, Andhra Pradesh, India.	bsksl@uohyd.ernet.in		Sridevi, Parikipandla/0000-0002-0479-6419	Council for Scientific and Industrial Research, India [37 (1208)/04/EMR-II]; University Grants Commission (UGC), India; DST- PURSE	Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), India(University Grants Commission, India); DST- PURSE	Grant from Council for Scientific and Industrial Research (Nos: 37 (1208)/04/EMR-II), India awarded to BS are gratefully acknowledged. PS is thankful to University Grants Commission (UGC), India for a senior research fellowship. The authors also acknowledge DST- FIST, DBT- CREBB and CAS programs for the instrumentation facility. Financial support from DST- PURSE grant is also appreciated. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai C, 2000, MECH DEVELOP, V91, P421, DOI 10.1016/S0925-4773(99)00312-3; Chan SM, 1999, FEBS LETT, V454, P109, DOI 10.1016/S0014-5793(99)00787-5; ELLINGERZIEGELBAUER H, 1994, MOL CELL BIOL, V14, P2786, DOI 10.1128/MCB.14.4.2786; Galarneau L, 1996, MOL CELL BIOL, V16, P3853; Govoroun M, 2001, ENDOCRINOLOGY, V142, P1841, DOI 10.1210/en.142.5.1841; Hammer GD, 1999, FRONT NEUROENDOCRIN, V20, P199, DOI 10.1006/frne.1999.0182; Higa M, 2001, COMP BIOCHEM PHYS B, V129, P503, DOI 10.1016/S1096-4959(01)00348-7; HONDA S, 1993, J BIOL CHEM, V268, P7494; IKEDA Y, 1993, MOL ENDOCRINOL, V7, P852, DOI 10.1210/me.7.7.852; Ito M, 1998, BBA-GENE STRUCT EXPR, V1395, P271, DOI 10.1016/S0167-4781(97)00158-9; Kagawa H, 2003, BIOL REPROD, V68, P1562, DOI 10.1095/biolreprod.102.008219; Kanda H, 2006, J STEROID BIOCHEM, V99, P85, DOI 10.1016/j.jsbmb.2005.12.005; Kudo T, 1997, GENE, V197, P261, DOI 10.1016/S0378-1119(97)00270-9; Kuo MW, 2005, BIOCHEM J, V389, P19, DOI 10.1042/BJ20050005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; Lin WW, 2000, BIOCHEM J, V348, P439, DOI 10.1042/0264-6021:3480439; Liu D, 1997, MOL ENDOCRINOL, V11, P877, DOI 10.1210/me.11.7.877; Liu XS, 2004, GEN COMP ENDOCR, V138, P247, DOI 10.1016/j.ygcen.2004.04.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller WL, 1998, BAILLIERE CLIN ENDOC, V12, P67, DOI 10.1016/S0950-351X(98)80461-8; Nakajima T, 2000, GENE, V248, P203, DOI 10.1016/S0378-1119(00)00119-0; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; NOMURA M, 1995, J BIOL CHEM, V270, P7453, DOI 10.1074/jbc.270.13.7453; Oba K, 1996, BIOCHEM BIOPH RES CO, V226, P261, DOI 10.1006/bbrc.1996.1343; Ohmuro-Matsuyama Y, 2007, MOL REPROD DEV, V74, P1065, DOI 10.1002/mrd.20497; OHNO CK, 1994, MOL CELL BIOL, V14, P3166, DOI 10.1128/MCB.14.5.3166; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Raghuveer K, 2011, SEX DEV, V5, P213, DOI 10.1159/000328823; Rasheeda MK, 2010, GEN COMP ENDOCR, V167, P234, DOI 10.1016/j.ygcen.2010.03.009; Senthilkumaran B, 2004, MOL CELL ENDOCRINOL, V215, P11, DOI 10.1016/j.mce.2003.11.012; Senthilkumaran B, 2011, FRONT BIOSCI-LANDMRK, V16, P1898, DOI 10.2741/3829; Sreenivasulu G, 2009, GEN COMP ENDOCR, V163, P259, DOI 10.1016/j.ygcen.2009.04.022; Sridevi P, 2012, BBA-GENE REGUL MECH, V1819, P57, DOI 10.1016/j.bbagrm.2011.10.003; Sridevi P, 2011, GEN COMP ENDOCR, V174, P259, DOI 10.1016/j.ygcen.2011.08.015; SUN GC, 1994, DEV BIOL, V162, P426, DOI 10.1006/dbio.1994.1099; TALBOT PJ, 1984, J IMMUNOL METHODS, V73, P177, DOI 10.1016/0022-1759(84)90043-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UEDA H, 1990, NUCLEIC ACIDS RES, V18, P7229, DOI 10.1093/nar/18.24.7229; von Hofsten J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-63; von Hofsten J, 2003, GEN COMP ENDOCR, V132, P96, DOI 10.1016/S0016-6480(03)00034-0; von Hofsten J, 2002, BIOL REPROD, V67, P1297, DOI 10.1095/biolreprod67.4.1297; von Hofsten J, 2001, GEN COMP ENDOCR, V121, P146, DOI 10.1006/gcen.2000.7582; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Watanabe M, 1999, MOL CELL ENDOCRINOL, V149, P221, DOI 10.1016/S0303-7207(99)00006-4; Yoshiura Y, 2003, BIOL REPROD, V68, P1545, DOI 10.1095/biolreprod.102.010843; Zhang WM, 2004, J EXP ZOOL PART A, V301A, P691, DOI 10.1002/jez.a.74	48	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28867	10.1371/journal.pone.0028867	http://dx.doi.org/10.1371/journal.pone.0028867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216130	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300014
J	Bernaudat, F; Frelet-Barrand, A; Pochon, N; Dementin, S; Hivin, P; Boutigny, S; Rioux, JB; Salvi, D; Seigneurin-Berny, D; Richaud, P; Joyard, J; Pignol, D; Sabaty, M; Desnos, T; Pebay-Peyroula, E; Darrouzet, E; Vernet, T; Rolland, N				Bernaudat, Florent; Frelet-Barrand, Annie; Pochon, Nathalie; Dementin, Sebastien; Hivin, Patrick; Boutigny, Sylvain; Rioux, Jean-Baptiste; Salvi, Daniel; Seigneurin-Berny, Daphne; Richaud, Pierre; Joyard, Jacques; Pignol, David; Sabaty, Monique; Desnos, Thierry; Pebay-Peyroula, Eva; Darrouzet, Elisabeth; Vernet, Thierry; Rolland, Norbert			Heterologous Expression of Membrane Proteins: Choosing the Appropriate Host	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; HIGH-THROUGHPUT CLONING; LARGE-SCALE PRODUCTION; HIGH-LEVEL EXPRESSION; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; BACTERIAL EXPRESSION; NICOTIANA-BENTHAMIANA; FUNCTIONAL EXPRESSION; ENABLING TECHNOLOGIES	Background: Membrane proteins are the targets of 50% of drugs, although they only represent 1% of total cellular proteins. The first major bottleneck on the route to their functional and structural characterisation is their overexpression; and simply choosing the right system can involve many months of trial and error. This work is intended as a guide to where to start when faced with heterologous expression of a membrane protein. Methodology/Principal Findings: The expression of 20 membrane proteins, both peripheral and integral, in three prokaryotic (E. coli, L. lactis, R. sphaeroides) and three eukaryotic (A. thaliana, N. benthamiana, Sf9 insect cells) hosts was tested. The proteins tested were of various origins (bacteria, plants and mammals), functions (transporters, receptors, enzymes) and topologies (between 0 and 13 transmembrane segments). The Gateway system was used to clone all 20 genes into appropriate vectors for the hosts to be tested. Culture conditions were optimised for each host, and specific strategies were tested, such as the use of Mistic fusions in E. coli. 17 of the 20 proteins were produced at adequate yields for functional and, in some cases, structural studies. We have formulated general recommendations to assist with choosing an appropriate system based on our observations of protein behaviour in the different hosts. Conclusions/Significance: Most of the methods presented here can be quite easily implemented in other laboratories. The results highlight certain factors that should be considered when selecting an expression host. The decision aide provided should help both newcomers and old-hands to select the best system for their favourite membrane protein.	[Bernaudat, Florent; Pebay-Peyroula, Eva; Vernet, Thierry] CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Bernaudat, Florent; Pebay-Peyroula, Eva; Vernet, Thierry] CNRS, UMR 5075, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Bernaudat, Florent; Pebay-Peyroula, Eva; Vernet, Thierry] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Salvi, Daniel; Seigneurin-Berny, Daphne; Joyard, Jacques; Rolland, Norbert] CEA, DSV, iRTSV, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Salvi, Daniel; Seigneurin-Berny, Daphne; Joyard, Jacques; Rolland, Norbert] CNRS, UMR 5168, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Salvi, Daniel; Seigneurin-Berny, Daphne; Joyard, Jacques; Rolland, Norbert] INRA, UMR 1200, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Salvi, Daniel; Seigneurin-Berny, Daphne; Joyard, Jacques; Rolland, Norbert] Univ Grenoble 1, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Pochon, Nathalie; Desnos, Thierry] CEA, DSV, iBEB, Lab Biol Dev Plantes,SBVME, St Paul Les Durance, France; [Pochon, Nathalie; Desnos, Thierry] CNRS, UMR 6191, Lab Biol Dev Plantes, St Paul Les Durance, France; [Pochon, Nathalie; Desnos, Thierry] Univ Aix Marseille, Lab Biol Dev Plantes, St Paul Les Durance, France; [Dementin, Sebastien; Rioux, Jean-Baptiste; Pignol, David; Sabaty, Monique] CEA, DSV, iBEB, Lab Bioenerget Cellulaire,SBVME, St Paul Les Durance, France; [Dementin, Sebastien; Rioux, Jean-Baptiste; Pignol, David; Sabaty, Monique] CNRS, UMR 6191, Lab Bioenerget Cellulaire, St Paul Les Durance, France; [Dementin, Sebastien; Rioux, Jean-Baptiste; Pignol, David; Sabaty, Monique] Univ Aix Marseille, Lab Bioenerget Cellulaire, St Paul Les Durance, France; [Hivin, Patrick] CEA, DSV, iBEB, Lab Ingn Cellulaire & Biotechnol,SBTN, Bagnols Sur Ceze, France; [Richaud, Pierre] CEA, DSV, iBEB, Lab Echanges Membranaires & Signalisat,SBVME, St Paul Les Durance, France; [Richaud, Pierre] CNRS, UMR 6191, Lab Echanges Membranaires & Signalisat, St Paul Les Durance, France; [Richaud, Pierre] Univ Aix Marseille, Lab Echanges Membranaires & Signalisat, St Paul Les Durance, France; [Darrouzet, Elisabeth] CEA, DSV, iBEB,SBTN, Lab Transporteurs Imagerie & Radiotherapie Oncol,, Bagnols Sur Ceze, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA	Bernaudat, F (corresponding author), CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France.	florent.bernaudat@ibs.fr	Vernet, Thierry/G-1118-2012; frelet barrand, annie/E-5479-2015; FRELET-BARRAND, Annie/AFX-2878-2022; ROLLAND, Norbert/B-4405-2012; Frelet-Barrand, Annie/S-1951-2017; sabaty, monique/K-4244-2013; SEIGNEURIN-BERNY, Daphne/C-8412-2017	FRELET-BARRAND, Annie/0000-0002-0849-9040; ROLLAND, Norbert/0000-0003-1959-6636; SEIGNEURIN-BERNY, Daphne/0000-0002-7436-9885; sabaty, monique/0000-0002-1399-6922; PIGNOL, David/0000-0002-8070-0319; DESNOS, Thierry/0000-0002-6585-1362; Dementin, Sebastien/0000-0001-6168-5371	CEA (Commissariat a l'Energie Atomique et aux Energies Alternatives); CNRS (Centre National de la Recherche Scientifique); University of Grenoble; European grant [LSMH-CT-EUR-INTAFAR 2004-512138]	CEA (Commissariat a l'Energie Atomique et aux Energies Alternatives)(French Atomic Energy Commission); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); University of Grenoble; European grant	This work has been supported by the CEA (Commissariat a l'Energie Atomique et aux Energies Alternatives, funding of the CEA-PM project and PostDoc fellowships to F. Bernaudat, A. Frelet-Barrand, P. Hivin and S. Dementin), by the CNRS (Centre National de la Recherche Scientifique, Post-Doc fellowship to A. Frelet-Barrand) and by the University of Grenoble 1. This work was partly supported by the European grant LSMH-CT-EUR-INTAFAR 2004-512138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bechtel S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-399; Bensmihen S, 2004, FEBS LETT, V561, P127, DOI 10.1016/S0014-5793(04)00148-6; Berne C, 2007, APPL MICROBIOL BIOT, V77, P135, DOI 10.1007/s00253-007-1140-4; BLAIN KY, 2010, BIOCHEMISTRY; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bonander N, 2005, PROTEIN SCI, V14, P1729, DOI 10.1110/ps.051435705; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Brugiere S, 2004, PHYTOCHEMISTRY, V65, P1693, DOI 10.1016/j.phytochem.2004.03.028; Carvalho LC, 2008, J PLANT PHYSIOL, V165, P1300, DOI 10.1016/j.jplph.2007.04.009; Catty P, 2011, J BIOL CHEM, V286, P36188, DOI 10.1074/jbc.M111.241034; CLAYTON RK, 1960, BIOCHIM BIOPHYS ACTA, V37, P503, DOI 10.1016/0006-3002(60)90507-2; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Condreay JP, 2007, CURR DRUG TARGETS, V8, P1126, DOI 10.2174/138945007782151351; Dahlroth SL, 2009, PROTEIN EXPRES PURIF, V68, P121, DOI 10.1016/j.pep.2009.07.010; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; del Rio B, 2010, VACCINE, V28, P6714, DOI 10.1016/j.vaccine.2010.07.084; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Deniaud A, 2011, BBA-BIOMEMBRANES, V1808, P2059, DOI 10.1016/j.bbamem.2011.04.011; Dobrovetsky Elena, 2005, Journal of Structural and Functional Genomics, V6, P33, DOI 10.1007/s10969-005-1363-5; DOUILLARD FP, 2011, PLASMID; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Dvir H, 2009, PROTEIN EXPRES PURIF, V68, P28, DOI 10.1016/j.pep.2009.06.007; Eifler N, 2007, J STRUCT BIOL, V159, P179, DOI 10.1016/j.jsb.2007.01.014; Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Freigassner M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-69; Frelet-Barrand A, 2010, METHODS MOL BIOL, V601, P67, DOI 10.1007/978-1-60761-344-2_5; Frelet-Barrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008746; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; Griffith DA, 2003, FEBS LETT, V553, P45, DOI 10.1016/S0014-5793(03)00952-9; Haferkamp I, 2002, EUR J BIOCHEM, V269, P3172, DOI 10.1046/j.1432-1033.2002.02991.x; Hartley JL, 2006, CURR OPIN BIOTECH, V17, P359, DOI 10.1016/j.copbio.2006.06.011; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Huc-Brandt S, 2011, BBA-BIOMEMBRANES, V1808, P65, DOI 10.1016/j.bbamem.2010.08.013; Hunt I, 2005, PROTEIN EXPRES PURIF, V40, P1, DOI 10.1016/j.pep.2004.10.018; JARVIS DL, 1995, VIROLOGY, V212, P500, DOI 10.1006/viro.1995.1508; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; Keech O, 2005, PHYSIOL PLANTARUM, V124, P403, DOI 10.1111/j.1399-3054.2005.00521.x; Kefala Georgia, 2007, Journal of Structural and Functional Genomics, V8, P167, DOI 10.1007/s10969-007-9033-4; KILEY PJ, 1988, MICROBIOL REV, V52, P50, DOI 10.1128/MMBR.52.1.50-69.1988; Koehn Jim, 2009, V498, P1, DOI 10.1007/978-1-59745-196-3_1; Korepanova A, 2005, PROTEIN SCI, V14, P148, DOI 10.1110/ps.041022305; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krammer EM, 2009, BIOPHYS J, V97, pL25, DOI 10.1016/j.bpj.2009.08.047; Kunji ERS, 2005, CURR OPIN BIOTECH, V16, P546, DOI 10.1016/j.copbio.2005.08.006; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Laage R, 2001, TRAFFIC, V2, P99, DOI 10.1034/j.1600-0854.2001.020204.x; Lacapere JJ, 2007, TRENDS BIOCHEM SCI, V32, P259, DOI 10.1016/j.tibs.2007.04.001; Laible Philip D., 2004, Journal of Structural and Functional Genomics, V5, P167, DOI 10.1023/B:JSFG.0000029201.33710.46; Le Loir Y, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-2; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Lee Min Woo, 2006, V323, P225; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Lesley SA, 2009, METHOD ENZYMOL, V463, P767, DOI 10.1016/S0076-6879(09)63041-X; Leviatan S, 2010, J BIOL CHEM, V285, P23548, DOI 10.1074/jbc.M110.125492; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Linares DM, 2010, J MOL BIOL, V401, P45, DOI 10.1016/j.jmb.2010.06.002; Liu HP, 1999, BIOSCI BIOTECH BIOCH, V63, P530, DOI 10.1271/bbb.63.530; Liu XJ, 2008, BBA-PROTEINS PROTEOM, V1784, P1742, DOI 10.1016/j.bbapap.2008.06.018; Lundstrom K, 2003, BBA-BIOMEMBRANES, V1610, P90, DOI 10.1016/S0005-2736(02)00721-6; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Marreddy RKR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010317; Matsuyama A, 2009, METHODS MOL BIOL, V577, P11, DOI 10.1007/978-1-60761-232-2_2; McLuskey K, 2010, EUR BIOPHYS J BIOPHY, V39, P723, DOI 10.1007/s00249-009-0546-6; Midgett CR, 2007, J STRUCT BIOL, V160, P265, DOI 10.1016/j.jsb.2007.07.001; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-16; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Miras S, 2002, J BIOL CHEM, V277, P47770, DOI 10.1074/jbc.M207477200; Miras S, 2007, J BIOL CHEM, V282, P29482, DOI 10.1074/jbc.M611112200; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Mizutani K, 2011, PROTEIN EXPRES PURIF, V77, P1, DOI 10.1016/j.pep.2010.12.009; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; NEKRASOVA OV, 2010, J BIOTECHNOL; Neuhaus HE, 1997, PLANT J, V11, P73, DOI 10.1046/j.1365-313X.1997.11010073.x; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Panneels V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018478; Pellet J, 2010, NUCLEIC ACIDS RES, V38, pD371, DOI 10.1093/nar/gkp1000; Petrovskaya LE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P881, DOI 10.1134/S0006297910070102; Porter RK, 2008, J BIOENERG BIOMEMBR, V40, P457, DOI 10.1007/s10863-008-9172-8; Possee RD, 1997, CURR OPIN BIOTECH, V8, P569, DOI 10.1016/S0958-1669(97)80030-4; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Psakis G, 2007, PROTEIN SCI, V16, P2667, DOI 10.1110/ps.073104707; Rahman M, 2007, MOL MEMBR BIOL, V24, P407, DOI 10.1080/09687860701243998; Rajagopala SV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-470; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; Riedel C, 2001, TRENDS BIOCHEM SCI, V26, P490, DOI 10.1016/S0968-0004(01)01904-1; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Sabaty M, 2001, APPL ENVIRON MICROB, V67, P5122, DOI 10.1128/AEM.67.11.5122-5126.2001; Sahdev S, 2008, MOL CELL BIOCHEM, V307, P249, DOI 10.1007/s11010-007-9603-6; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Sorensen HP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-27; STEEN A, 2010, MOL CELL PROTEOMICS; Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; von Heijne G, 2007, J INTERN MED, V261, P543, DOI 10.1111/j.1365-2796.2007.01792.x; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Wise AA, 2006, METH MOL B, V343, P43; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Yashiroda Y, 2008, CURR OPIN CHEM BIOL, V12, P55, DOI 10.1016/j.cbpa.2008.01.024; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhou XX, 2006, BIOTECHNOL ADV, V24, P285, DOI 10.1016/j.biotechadv.2005.11.001	129	90	94	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29191	10.1371/journal.pone.0029191	http://dx.doi.org/10.1371/journal.pone.0029191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216205	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600065
J	Daly, GM; Bexfield, N; Heaney, J; Stubbs, S; Mayer, AP; Palser, A; Kellam, P; Drou, N; Caccamo, M; Tiley, L; Alexander, GJM; Bernal, W; Heeney, JL				Daly, Gordon M.; Bexfield, Nick; Heaney, Judith; Stubbs, Sam; Mayer, Antonia P.; Palser, Anne; Kellam, Paul; Drou, Nizar; Caccamo, Mario; Tiley, Laurence; Alexander, Graeme J. M.; Bernal, William; Heeney, Jonathan L.			A Viral Discovery Methodology for Clinical Biopsy Samples Utilising Massively Parallel Next Generation Sequencing	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; C VIRUS; GENOME; IDENTIFICATION; AMPLIFICATION; PCR; INFECTION; CARCINOMA; FRAGMENT; DISEASES	Here we describe a virus discovery protocol for a range of different virus genera, that can be applied to biopsy-sized tissue samples. Our viral enrichment procedure, validated using canine and human liver samples, significantly improves viral read copy number and increases the length of viral contigs that can be generated by de novo assembly. This in turn enables the Illumina next generation sequencing (NGS) platform to be used as an effective tool for viral discovery from tissue samples.	[Daly, Gordon M.; Bexfield, Nick; Heaney, Judith; Stubbs, Sam; Mayer, Antonia P.; Tiley, Laurence; Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Palser, Anne; Kellam, Paul] Wellcome Trust Sanger Inst, Cambridge, England; [Drou, Nizar; Caccamo, Mario] Genome Anal Ctr, Norwich, Norfolk, England; [Alexander, Graeme J. M.] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Dept Hepatol, Cambridge, England; [Bernal, William] Kings Coll London, Sch Med, Kings Coll Hosp, Inst Liver Studies, London WC2R 2LS, England	University of Cambridge; Wellcome Trust Sanger Institute; The Genome Analysis Centre (TGAC); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Daly, GM (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	jlh66@cam.ac.uk		Heeney, Jonathan/0000-0003-2702-1621; Kellam, Paul/0000-0003-3166-4734; Stubbs, Sam/0000-0003-4175-6464; Bexfield, Nicholas/0000-0001-6830-8296	Wellcome Trust; European Community; EC [223498]	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	GD, NB, SS and AM are funded by the Wellcome Trust. AP and PK are funded by the Wellcome Trust and part of this work is supported by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project EMPERIE, EC grant agreement number 223498'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Ambrose HE, 2006, REV MED VIROL, V16, P365, DOI 10.1002/rmv.515; Candotti D, 2004, J VIROL METHODS, V118, P39, DOI 10.1016/j.jviromet.2004.01.017; Castillo I, 2004, J INFECT DIS, V189, P7, DOI 10.1086/380202; De Marco L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008128; de Vries M, 2008, J CLIN MICROBIOL, V46, P759, DOI 10.1128/JCM.02009-07; de Vries M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016118; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07; Hsia CC, 2006, TRANSFUSION, V46, P1829, DOI 10.1111/j.1537-2995.2006.00974.x; Tan LV, 2011, J INFECT DEV COUNTR, V5, P142, DOI 10.3855/jidc.1087; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luna LKDS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-26; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Pyrc Krzysztof, 2008, V454, P73, DOI 10.1007/978-1-59745-181-9_7; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Weber G, 2002, NAT GENET, V30, P141, DOI 10.1038/ng818; Weinberger KM, 2000, J GEN VIROL, V81, P1165, DOI 10.1099/0022-1317-81-5-1165	28	58	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28879	10.1371/journal.pone.0028879	http://dx.doi.org/10.1371/journal.pone.0028879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216131	Green Submitted, Green Published, gold			2022-12-25	WOS:000299113600046
J	Wang, YF; Cai, JP; Wang, YD; Dong, H; Hao, W; Jiang, LX; Long, J; Chan, CM; Woo, PCY; Lau, SKP; Yuen, KY; Che, XY				Wang, Yan-Fang; Cai, Jian-Piao; Wang, Ya-Di; Dong, Hui; Hao, Wei; Jiang, Ling-Xiao; Long, Jun; Chan, Cheman; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung; Che, Xiao-Yan			Immunoassays Based on Penicillium marneffei Mp1p Derived from Pichia pastoris Expression System for Diagnosis of Penicilliosis	PLOS ONE			English	Article							CELL-WALL MANNOPROTEIN; MONOCLONAL-ANTIBODIES; INFECTION; ANTIGEN; EPIDEMIOLOGY; TESTS	Background: Penicillium marneffei is a dimorphic fungus endemic in Southeast Asia. It can cause fatal penicilliosis in humans, particularly in HIV-infected people. Diagnosis of this infection is difficult because its clinical manifestations are not distinctive. Specialized laboratory tests are necessary to establish a definitive diagnosis for successful management. We have demonstrated previously that a cell wall mannoprotein Mp1p, abundant in P. marneffei, is a potential biomarker for diagnosis of P. marneffei infections. In the present study, we describe immunoassays based on Mp1p derived from the yeast Pichia pastoris expression system. Methodology/Principal Findings: We generated monoclonal antibodies (MAbs) and rabbit polyclonal antibodies (PAbs) against Mp1p expressed in P. pastoris. Subsequently, we developed two Mp1p antigen capture ELISAs which employed MAbs for both the capture and detecting antibodies (MAb-MAb pair) or PAbs and MAbs as the capture and detecting antibodies (PAbs-MAb pair) respectively. The two Mp1p antigen ELISAs detected Mp1p specifically in cultures of P. marneffei yeast phase at 37-40 degrees C and had no cross-reaction with other tested pathogenic fungi. The sensitivities and specificities of the two antigen assays were found to be 55% (11/20) and 99.6% (538/540) for MAb-MAb Mp1p ELISA, and 75% (15/20) and 99.4% (537/540) for PAbs-MAb Mp1p ELISA performed using 20 sera with culture-confirmed penicilliosis, and 540 control sera from 15 other mycosis patients and 525 healthy donors. Meanwhile, we also developed an anti-Mp1p IgG antibody ELISA with an evaluated sensitivity of 30% (6/20) and a specificity of 98.5% (532/540) using the same sera. Furthermore, combining the results of Mp1p antigen and antibody detection improved the sensitivity of diagnosis to 100% (20/20). Conclusions/Significance: Simultaneous detection of antigen and antibody using the immunoassays based on Mp1p derived from P. pastoris greatly improves detection sensitivity. The procedures should be useful for the routine diagnosis of penicilliosis.	[Wang, Yan-Fang; Cai, Jian-Piao; Wang, Ya-Di; Hao, Wei; Jiang, Ling-Xiao; Long, Jun; Che, Xiao-Yan] So Med Univ, Zhujiang Hosp, Ctr Clin Lab, Guangzhou, Guangdong, Peoples R China; [Dong, Hui] Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Chan, Cheman; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; University of Hong Kong	Wang, YF (corresponding author), So Med Univ, Zhujiang Hosp, Ctr Clin Lab, Guangzhou, Guangdong, Peoples R China.	kyyuen@hkucc.hku.hk; chexiaoyan@126.com	CAI, Jian-Piao/HCI-0096-2022; CAI, Jian-piao/GYD-5763-2022; Lau, Susanna Kar Pui/AAJ-6848-2020; Woo, Patrick Chiu Yat/C-4449-2009	CAI, Jian-piao/0000-0003-4077-3852; Lau, Susanna Kar Pui/0000-0002-1383-7374; Yuen, Kwok-yung/0000-0002-2083-1552; Wang, Yanfang/0000-0001-7722-8597; Woo, Patrick Chiu Yat/0000-0001-9401-1832	Ted Sun Foundation, Hong Kong; Research and Development Project of Guang Dong Province [2010B090400498]	Ted Sun Foundation, Hong Kong; Research and Development Project of Guang Dong Province	This work was supported by the Ted Sun Foundation, Hong Kong and the Research and Development Project of Guang Dong Province (No. 2010B090400498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao L, 1998, INFECT IMMUN, V66, P966, DOI 10.1128/IAI.66.3.966-973.1998; Cao L, 1998, J CLIN MICROBIOL, V36, P3028, DOI 10.1128/JCM.36.10.3028-3031.1998; Cao L, 1999, J CLIN MICROBIOL, V37, P981, DOI 10.1128/JCM.37.4.981-986.1999; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Desakorn V, 2002, J CLIN MICROBIOL, V40, P3179, DOI 10.1128/JCM.40.9.3179-3183.2002; Devi Khuraijam Ranjana, 2007, Indian J Pathol Microbiol, V50, P674; Duong TA, 1996, CLIN INFECT DIS, V23, P125, DOI 10.1093/clinids/23.1.125; Hao W, 2008, CLIN VACCINE IMMUNOL, V15, P194, DOI 10.1128/CVI.00362-07; Kaufman L, 1996, J CLIN MICROBIOL, V34, P2503, DOI 10.1128/JCM.34.10.2503-2505.1996; KAUFMAN L, 1995, J CLIN MICROBIOL, V33, P2136, DOI 10.1128/JCM.33.8.2136-2138.1995; Kaufman L, 1998, MYCOPATHOLOGIA, V143, P3, DOI 10.1023/A:1006958027581; Mootsikapun P, 2006, INT J INFECT DIS, V10, P66, DOI 10.1016/j.ijid.2004.10.006; Panichakul T, 2002, AM J TROP MED HYG, V67, P443, DOI 10.4269/ajtmh.2002.67.443; Qiu Li-wen, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P38; Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08; Rinaldi MG, 1996, INT J ANTIMICROB AG, V6, P131, DOI 10.1016/0924-8579(95)00047-X; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Wong SSY, 2001, J CLIN MICROBIOL, V39, P4535, DOI 10.1128/JCM.39.12.4535-4540.2001	18	23	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28796	10.1371/journal.pone.0028796	http://dx.doi.org/10.1371/journal.pone.0028796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205971	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600035
J	Geng, LY; Huehls, AM; Wagner, JM; Huntoon, CJ; Karnitz, LM				Geng, Liyi; Huehls, Amelia M.; Wagner, Jill M.; Huntoon, Catherine J.; Karnitz, Larry M.			Checkpoint Signaling, Base Excision Repair, and PARP Promote Survival of Colon Cancer Cells Treated with 5-Fluorodeoxyuridine but Not 5-Fluorouracil	PLOS ONE			English	Article							DNA MISMATCH REPAIR; SINGLE-STRANDED-DNA; MICROSATELLITE INSTABILITY; OVARIAN-CANCER; POLY(ADP-RIBOSE) POLYMERASE; COLORECTAL-CANCER; CELLULAR-SENSITIVITY; THYMIDYLATE SYNTHASE; DAMAGING AGENTS; MESSENGER-RNA	The fluoropyrimidines 5-fluorouracil (5-FU) and FdUrd (5-fluorodeoxyuridine; floxuridine) are the backbone of chemotherapy regimens for colon cancer and other tumors. Despite their widespread use, it remains unclear how these agents kill tumor cells. Here, we have analyzed the checkpoint and DNA repair pathways that affect colon tumor responses to 5-FU and FdUrd. These studies demonstrate that both FdUrd and 5-FU activate the ATR and ATM checkpoint signaling pathways, indicating that they cause genotoxic damage. Notably, however, depletion of ATM or ATR does not sensitize colon cancer cells to 5-FU, whereas these checkpoint pathways promote the survival of cells treated with FdUrd, suggesting that FdUrd exerts cytotoxicity by disrupting DNA replication and/or inducing DNA damage, whereas 5-FU does not. We also found that disabling the base excision (BER) repair pathway by depleting XRCC1 or APE1 sensitized colon cancer cells to FdUrd but not 5-FU. Consistent with a role for the BER pathway, we show that small molecule poly(ADP-ribose) polymerase 1/2 (PARP) inhibitors, AZD2281 and ABT-888, remarkably sensitized both mismatch repair (MMR)-proficient and -deficient colon cancer cell lines to FdUrd but not to 5-FU. Taken together, these studies demonstrate that the roles of genotoxin-induced checkpoint signaling and DNA repair differ significantly for these agents and also suggest a novel approach to colon cancer therapy in which FdUrd is combined with a small molecule PARP inhibitor.	[Geng, Liyi; Huehls, Amelia M.; Wagner, Jill M.; Huntoon, Catherine J.; Karnitz, Larry M.] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA; [Huehls, Amelia M.; Karnitz, Larry M.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Karnitz, Larry M.] Mayo Clin, Coll Med, Dept Radiat Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Geng, LY (corresponding author), Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA.	karnitz.larry@mayo.edu			National Institutes of Health [R01-CA084321, P50-CA136393, GT32-M072474]; Mayo Clinic; NATIONAL CANCER INSTITUTE [P50CA136393, R01CA084321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-CA084321 (LK), P50-CA136393 (LK), GT32-M072474 (AH), a Mayo Clinic Eagles Pilot Project Award, and the Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; An Q, 2007, CANCER RES, V67, P940, DOI 10.1158/0008-5472.CAN-06-2960; Andersen S, 2005, CARCINOGENESIS, V26, P547, DOI 10.1093/carcin/bgh347; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Baker D, 2002, CHEM RES TOXICOL, V15, P33, DOI 10.1021/tx010113b; Bast RC, 2010, J CLIN ONCOL, V28, P3545, DOI 10.1200/JCO.2010.28.5791; Berger SH, 2008, BIOCHEM PHARMACOL, V76, P697, DOI 10.1016/j.bcp.2008.05.019; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bracht K, 2010, BRIT J CANCER, V103, P340, DOI 10.1038/sj.bjc.6605780; Brody JR, 2009, CANCER RES, V69, P984, DOI 10.1158/0008-5472.CAN-08-3610; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cao DL, 2004, DRUG TODAY, V40, P431, DOI 10.1358/dot.2004.40.5.850491; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Casper AM, 2004, AM J HUM GENET, V75, P654, DOI 10.1086/422701; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; El-Awady RA, 2010, ANTI-CANCER DRUG, V21, P277, DOI 10.1097/CAD.0b013e328334b0ae; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fischer F, 2007, GASTROENTEROLOGY, V133, P1858, DOI 10.1053/j.gastro.2007.09.003; Fischer JA, 2006, CANCER RES, V66, P8829, DOI 10.1158/0008-5472.CAN-06-0540; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; GHOSHAL K, 1994, CANCER RES, V54, P632; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Grogan BC, 2011, BIOCHEMISTRY-US, V50, P618, DOI 10.1021/bi102046h; Gustavsson M, 2008, RNA, V14, P666, DOI 10.1261/rna.966208; HAWN MT, 1995, CANCER RES, V55, P3721; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huehls AM, 2011, CANCER RES, V71, P4944, DOI 10.1158/0008-5472.CAN-11-0814; Humeniuk R, 2009, MOL CANCER THER, V8, P1037, DOI 10.1158/1535-7163.MCT-08-0716; Huntoon CJ, 2010, CANCER RES, V70, P8642, DOI 10.1158/0008-5472.CAN-10-1345; INGRAHAM HA, 1980, CANCER RES, V40, P998; ISRAEL VK, 1995, CANCER CHEMOTH PHARM, V37, P32; Jardim MJ, 2009, MOL BIOL CELL, V20, P3801, DOI 10.1091/mbc.E09-04-0303; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kammler S, 2008, MOL CANCER RES, V6, P990, DOI 10.1158/1541-7786.MCR-07-2217; KAMPHUIS JT, 1995, CANCER CHEMOTH PHARM, V37, P190; Karnitz LM, 2005, MOL PHARMACOL, V68, P1636, DOI 10.1124/mol.105.012716; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; KOI M, 1994, CANCER RES, V54, P4308; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Li HR, 2004, CANCER RES, V64, P4760, DOI 10.1158/0008-5472.CAN-04-0975; Li L, 2004, MOL CANCER THER, V3, P747; Liu A, 2008, J CELL BIOCHEM, V105, P245, DOI 10.1002/jcb.21824; Liu XS, 2008, MOL CANCER RES, V6, P1621, DOI 10.1158/1541-7786.MCR-08-0240; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Luo Y, 2008, DNA REPAIR, V7, P162, DOI 10.1016/j.dnarep.2007.09.001; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Matuo R, 2009, J APPL TOXICOL, V29, P308, DOI 10.1002/jat.1411; MAURO DJ, 1993, MOL PHARMACOL, V43, P854; McNeill DR, 2009, MOL CANCER RES, V7, P897, DOI 10.1158/1541-7786.MCR-08-0519; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Meyers M, 2005, J BIOL CHEM, V280, P5516, DOI 10.1074/jbc.M412105200; Meyers M, 2004, ENVIRON MOL MUTAGEN, V44, P249, DOI 10.1002/em.20056; Meyers M, 2001, CANCER RES, V61, P5193; Morgan MA, 2006, CELL CYCLE, V5, P1983, DOI 10.4161/cc.5.17.3184; MORGAN RJ, 1995, GYNECOL ONCOL, V58, P79, DOI 10.1006/gyno.1995.1187; Muggia FM, 1996, GYNECOL ONCOL, V61, P395, DOI 10.1006/gyno.1996.0163; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; Parsels LA, 2004, CANCER RES, V64, P6588, DOI 10.1158/0008-5472.CAN-03-3040; PATTON JR, 1993, BIOCHEMISTRY-US, V32, P8939, DOI 10.1021/bi00085a027; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; PETERS GJ, 1991, CANCER, V68, P1903, DOI 10.1002/1097-0142(19911101)68:9<1903::AID-CNCR2820680910>3.0.CO;2-9; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Petronzelli F, 2000, J CELL PHYSIOL, V185, P473, DOI 10.1002/1097-4652(200012)185:3<473::AID-JCP19>3.0.CO;2-#; Pettersen HS, 2011, NUCLEIC ACIDS RES, V39, P8430, DOI 10.1093/nar/gkr563; PIZZORNO G, 1995, BIOCHEM PHARMACOL, V49, P553, DOI 10.1016/0006-2952(94)00444-Q; Power DG, 2009, MOL CANCER THER, V8, P1015, DOI 10.1158/1535-7163.MCT-08-0709; Robinson HMR, 2006, ONCOGENE, V25, P5359, DOI 10.1038/sj.onc.1209532; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; SAMUELSSON T, 1991, NUCLEIC ACIDS RES, V19, P6139, DOI 10.1093/nar/19.22.6139; Sansom OJ, 2003, ONCOGENE, V22, P7130, DOI 10.1038/sj.onc.1206850; Silverstein RA, 2011, MOL CANCER RES, V9, P332, DOI 10.1158/1541-7786.MCR-10-0084; Sinicrope FA, 2009, CURR OPIN ONCOL, V21, P369, DOI 10.1097/CCO.0b013e32832c94bd; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Turner DP, 2006, CANCER RES, V66, P7686, DOI 10.1158/0008-5472.CAN-05-4488; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Welsh SJ, 2003, EUR J CANCER, V39, P378, DOI 10.1016/S0959-8049(02)00610-X; Wilsker D, 2007, MOL CANCER THER, V6, P1406, DOI 10.1158/1535-7163.MCT-06-0679; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5; Xiao Z, 2005, ONCOGENE, V24, P1403, DOI 10.1038/sj.onc.1208309; Xiao Z, 2006, MOL CANCER THER, V5, P1935, DOI 10.1158/1535-7163.MCT-06-0077; YIN MB, 1991, CANCER COMMUN, V3, P45; Zhao XL, 2007, NUCLEIC ACIDS RES, V35, P550, DOI 10.1093/nar/gkl1084	89	29	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28862	10.1371/journal.pone.0028862	http://dx.doi.org/10.1371/journal.pone.0028862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194930	gold, Green Published, Green Submitted			2022-12-25	WOS:000298370400022
J	Sun, HB; Jia, Z; Cao, D; Jiang, BJ; Wu, CX; Hou, WS; Liu, YK; Fei, ZH; Zhao, DZ; Han, TF				Sun, Hongbo; Jia, Zhen; Cao, Dong; Jiang, Bingjun; Wu, Cunxiang; Hou, Wensheng; Liu, Yike; Fei, Zhihong; Zhao, Dazhong; Han, Tianfu			GmFT2a, a Soybean Homolog of FLOWERING LOCUS T, Is Involved in Flowering Transition and Maintenance	PLOS ONE			English	Article							GRAFT-TRANSMISSIBLE ACTION; FLORAL INDUCTION; LONG-DISTANCE; FT PROTEIN; AMBIENT-TEMPERATURE; ARABIDOPSIS; TIME; EXPRESSION; CONSTANS; GENE	Background: Flowering reversion can be induced in soybean (Glycine max L. Merr.), a typical short-day (SD) dicot, by switching from SD to long-day (LD) photoperiods. This process may involve florigen, putatively encoded by FLOWERING LOCUS T (FT) in Arabidopsis thaliana. However, little is known about the potential function of soybean FT homologs in flowering reversion. Methods: A photoperiod-responsive FT homologue GmFT (renamed as GmFT2a hereafter) was cloned from the photoperiod-sensitive cultivar Zigongdongdou. GmFT2a gene expression under different photoperiods was analyzed by real-time quantitative PCR. In situ hybridization showed direct evidence for its expression during flowering-related processes. GmFT2a was shown to promote flowering using transgenic studies in Arabidopsis and soybean. The effects of photoperiod and temperature on GmFT2a expression were also analyzed in two cultivars with different photoperiod-sensitivities. Results: GmFT2a expression is regulated by photoperiod. Analyses of GmFT2a transcripts revealed a strong correlation between GmFT2a expression and flowering maintenance. GmFT2a transcripts were observed continuously within the vascular tissue up to the shoot apex during flowering. By contrast, transcripts decreased to undetectable levels during flowering reversion. In grafting experiments, the early-flowering, photoperiod-insensitive stock Heihe27 promotes the appearance of GmFT2a transcripts in the shoot apex of scion Zigongdongdou under noninductive LD conditions. The photothermal effects of GmFT2a expression diversity in cultivars with different photoperiod-sensitivities and a hypothesis is proposed. Conclusion: GmFT2a expression is associated with flowering induction and maintenance. Therefore, GmFT2a is a potential target gene for soybean breeding, with the aim of increasing geographic adaptation of this crop.	[Sun, Hongbo; Jia, Zhen; Cao, Dong; Jiang, Bingjun; Wu, Cunxiang; Hou, Wensheng; Liu, Yike; Fei, Zhihong; Han, Tianfu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Sun, Hongbo; Jia, Zhen; Cao, Dong; Jiang, Bingjun; Wu, Cunxiang; Hou, Wensheng; Liu, Yike; Fei, Zhihong; Han, Tianfu] Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Sun, Hongbo] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China; [Zhao, Dazhong] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Minzu University of China; University of Wisconsin System; University of Wisconsin Milwaukee	Sun, HB (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	tianfuhan@hotmail.com	Jiang, Bingjun/GWQ-4354-2022; /CAH-4560-2022	Liu, Yike/0000-0003-2155-3328	National High Technology Research and Development Program of China [2007AA10Z133]; State Key Basic Research and Development Plan of China [2009CB118404]; National Natural Science Foundation of China [30070456, 30471054]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Basic Research and Development Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China (http://www.863.gov.cn; grant no. 2007AA10Z133), the State Key Basic Research and Development Plan of China (http://www.973.gov.cn; grant no. 2009CB118404), and the National Natural Science Foundation of China (http://www.nsfc.gov.cn; grant no. 30070456 and 30471054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adrian J, 2009, MOL PLANT, V2, P628, DOI 10.1093/mp/ssp031; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; BATTEY NH, 1990, BOT REV, V56, P162, DOI 10.1007/BF02858534; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Chen NZ, 2007, J BIOCHEM MOL BIOL, V40, P1083; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Fei ZhiHong, 2009, Acta Agronomica Sinica, V35, P1525, DOI 10.3724/SP.J.1006.2009.01525; Flores T, 2008, TRANSGENIC RES, V17, P839, DOI 10.1007/s11248-008-9167-6; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; HAN T, 1995, ACTA AGRON SIN, P168; Han TF, 2006, ENVIRON EXP BOT, V55, P120, DOI 10.1016/j.envexpbot.2004.10.006; Han TianFu, 1995, Soybean Science, V14, P283; Han TianFu, 1998, Acta Agronomica Sinica, V24, P168; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim SK, 2008, PLANTA, V228, P355, DOI 10.1007/s00425-008-0742-0; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; KONG F, 2010, PLANT PHYSIOL, V110; Lee JH, 2008, J PLANT BIOL, V51, P321, DOI 10.1007/BF03036133; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li CY, 2009, J VIROL, V83, P3540, DOI 10.1128/JVI.02346-08; LI X, 2005, ACTA AGRON SIN, P1437; Lifschitz E, 2006, J EXP BOT, V57, P3405, DOI 10.1093/jxb/erl106; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Mimida N, 2011, PLANT CELL REP, V30, P1485, DOI 10.1007/s00299-011-1057-3; Molinero-Rosales N, 2004, PLANTA, V218, P427, DOI 10.1007/s00425-003-1109-1; Nishikawa F, 2007, J EXP BOT, V58, P3915, DOI 10.1093/jxb/erm246; Notaguchi M, 2008, PLANT CELL PHYSIOL, V49, P1645, DOI 10.1093/pcp/pcn154; Notaguchi M, 2009, PLANT SIGNAL BEHAV, V4, P123, DOI 10.4161/psb.4.2.7558; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Vickers CE, 2007, BIOTECHNOL LETT, V29, P1793, DOI 10.1007/s10529-007-9467-6; Washburn CF, 2000, AM J BOT, V87, P1425, DOI 10.2307/2656869; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wu CX, 2006, PLANTA, V223, P725, DOI 10.1007/s00425-005-0130-y; [徐云远 Xu Yunyuan], 2002, [植物学通报, Chinese Bulletin of Botany], V19, P234; YAN H, 2003, NEW HIGH QUALITY YIE; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yu H, 2002, P NATL ACAD SCI USA, V99, P16336, DOI 10.1073/pnas.212624599; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009; Zhang QZ, 2008, P NATL ACAD SCI USA, V105, P21028, DOI 10.1073/pnas.0810585105	62	78	101	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29238	10.1371/journal.pone.0029238	http://dx.doi.org/10.1371/journal.pone.0029238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195028	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100168
J	Nickerson, CA; Ott, CM; Castro, SL; Garcia, VM; Molina, TC; Briggler, JT; Pitt, AL; Tavano, JJ; Byram, JK; Barrila, J; Nickerson, MA				Nickerson, Cheryl A.; Ott, C. Mark; Castro, Sarah L.; Garcia, Veronica M.; Molina, Thomas C.; Briggler, Jeffrey T.; Pitt, Amber L.; Tavano, Joseph J.; Byram, J. Kelly; Barrila, Jennifer; Nickerson, Max A.			Evaluation of Microorganisms Cultured from Injured and Repressed Tissue Regeneration Sites in Endangered Giant Aquatic Ozark Hellbender Salamanders	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE DEFENSES; FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; CRYPTOBRANCHUS-ALLEGANIENSIS; GRANULICATELLA-ADIACENS; CUTANEOUS BACTERIA; INFECTIOUS-DISEASE; LIMB REGENERATION; ESCHERICHIA-COLI; POPULATIONS; FROG	Investigation into the causes underlying the rapid, global amphibian decline provides critical insight into the effects of changing ecosystems. Hypothesized and confirmed links between amphibian declines, disease, and environmental changes are increasingly represented in published literature. However, there are few long-term amphibian studies that include data on population size, abnormality/injury rates, disease, and habitat variables to adequately assess changes through time. We cultured and identified microorganisms isolated from abnormal/injured and repressed tissue regeneration sites of the endangered Ozark Hellbender, Cryptobranchus alleganiensis bishopi, to discover potential causative agents responsible for their significant decline in health and population. This organism and our study site were chosen because the population and habitat of C. a. bishopi have been intensively studied from 1969-2009, and the abnormality/injury rate and apparent lack of regeneration were established. Although many bacterial and fungal isolates recovered were common environmental organisms, several opportunistic pathogens were identified in association with only the injured tissues of C. a. bishopi. Bacterial isolates included Aeromonas hydrophila, a known amphibian pathogen, Granulicetella adiacens, Gordonai terrae, Stenotrophomonas maltophilia, Aerococcus viridans, Streptococcus pneumoniae and a variety of Pseudomonads, including Pseudomonas aeruginosa, P. stutzeri, and P. alcaligenes. Fungal isolates included species in the genera Penicillium, Acremonium, Cladosporium, Curvularia, Fusarium, Streptomycetes, and the Class Hyphomycetes. Many of the opportunistic pathogens identified are known to form biofilms. Lack of isolation of the same organism from all wounds suggests that the etiological agent responsible for the damage to C. a. bishopi may not be a single organism. To our knowledge, this is the first study to profile the external microbial consortia cultured from a Cryptobranchid salamander. The incidence of abnormalities/injury and retarded regeneration in C. a. bishopi may have many contributing factors including disease and habitat degradation. Results from this study may provide insight into other amphibian population declines.	[Nickerson, Cheryl A.; Barrila, Jennifer] Arizona State Univ, Sch Life Sci, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Ott, C. Mark] NASA, Lyndon B Johnson Space Ctr, Habitabil & Environm Factors Div, Houston, TX 77058 USA; [Castro, Sarah L.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Garcia, Veronica M.; Molina, Thomas C.] Wyle Labs, EASI, Houston, TX USA; [Briggler, Jeffrey T.] Missouri Dept Conservat, Jefferson City, MO USA; [Pitt, Amber L.; Tavano, Joseph J.; Byram, J. Kelly; Nickerson, Max A.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of Florida	Nickerson, CA (corresponding author), Arizona State Univ, Sch Life Sci, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA.	maxn@flmnh.ufl.edu		Barrila, Jennifer/0000-0002-6597-3001; Ott, Mark/0000-0002-3101-4806	NASA [NNX07AM16G, NCC2-1362]; St. Louis Zoological Park; Reptile and Amphibian Conservation Corps	NASA(National Aeronautics & Space Administration (NASA)); St. Louis Zoological Park; Reptile and Amphibian Conservation Corps	NASA student grant NNX07AM16G, NASA grant NCC2-1362, The St. Louis Zoological Park, and The Reptile and Amphibian Conservation Corps. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barribeau SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002692; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Bodinof CM, 2011, DIS AQUAT ORGAN, V96, P1, DOI 10.3354/dao02380; Briggler J., 2007, HELLBENDER POPULATIO; Briggler Jeffrey T., 2008, Herpetological Review, V39, P443; Briggler Jeffrey T., 2007, Herpetological Review, V38, P174; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; BYRAM J, 2008, THESIS U FLORIDA GAI; BYRAM JK, 2009, REPTILE AMPHIBIAN CO, P1; Caramujo MJ, 2008, HYDROBIOLOGIA, V598, P77, DOI 10.1007/s10750-007-9141-y; Castro VA, 2004, MICROB ECOL, V47, P119, DOI 10.1007/s00248-003-1030-y; CATTANEO A, 1987, CAN J FISH AQUAT SCI, V44, P296, DOI 10.1139/f87-038; Chetelat J, 1999, CAN J FISH AQUAT SCI, V56, P560, DOI 10.1139/cjfas-56-4-560; Collins J.P., 2009, EXTINCTION OUR TIMES; *COMM DIS CTR, 2011, HARMF ALG BLOOMS; Cooper H. R., 1975, THESIS ARKANSAS STAT; CROCE G, 1973, TOXICON, V11, P99, DOI 10.1016/0041-0101(73)90159-1; CSORDAS A, 1969, TOXICON, V7, P103, DOI 10.1016/0041-0101(69)90072-5; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; De Lucca Anthony J., 2007, Revista Iberoamericana de Micologia, V24, P3; del Pozo JL, 2008, DIAGN MICR INFEC DIS, V61, P58, DOI 10.1016/j.diagmicrobio.2007.12.009; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Englebert ET, 2008, SCI TOTAL ENVIRON, V404, P10, DOI 10.1016/j.scitotenv.2008.05.025; Erspamer Vittorio, 1994, P178; Fedewa Luke A., 2005, Journal of Herpetological Medicine and Surgery, V15, P13; Gall BG, 2010, ETHOLOGY, V116, P47, DOI 10.1111/j.1439-0310.2009.01718.x; GIBBS EL, 1971, BIOSCIENCE, V21, P1027, DOI 10.2307/1296057; Goncalves Ana B., 2006, Revista Iberoamericana de Micologia, V23, P194; Greenbaum Eli, 2008, Herpetological Review, V39, P70; Halliday T, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P3; Harshbarger J.C., 2002, P 6 INT S PATH REPT, P43; HEATWOLE H, AMPHIBIAN BIOL, V1; Hiler Waylon R., 2005, Journal of the Arkansas Academy of Science, V59, P88; HUTCHISON JA, 1970, MYCOLOGIA, V62, P585, DOI 10.2307/3757531; Manresa MJ, 2009, PEDIATR DERMATOL, V26, P601, DOI 10.1111/j.1525-1470.2009.00993.x; Kimber KR, 2000, J ZOO WILDLIFE MED, V31, P452, DOI 10.1638/1042-7260(2000)031[0452:IAPDAC]2.0.CO;2; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Lauer A, 2008, ISME J, V2, P145, DOI 10.1038/ismej.2007.110; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; LOW J, 1996, PROBLEMS PROVIDE MEA; Ma ESK, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-60; MAUGH TH, 1972, SCIENCE, V178, P388, DOI 10.1126/science.178.4059.388; Miller BT, 2005, SOUTHEAST NAT, V4, P513, DOI 10.1656/1528-7092(2005)004[0513:POPAIE]2.0.CO;2; *MO DEP CONS TROUT, 2003, PLAN MISS TROUT FISH; *NAT AC SCI, 1974, AMPH GUID BREED CAR; NICKERSON M A, 1973, Milwaukee Public Museum Publications in Biology and Geology, V1, P1; Nickerson MA, 2003, SOUTHEAST NAT, V2, P619, DOI 10.1656/1528-7092(2003)002[0619:HDAACD]2.0.CO;2; NICKERSON MA, 1973, ECOLOGY, V54, P1164, DOI 10.2307/1935586; NICKERSON MA, 1971, AM MIDL NAT, V86, P500, DOI 10.2307/2423642; NICKERSON MA, 1973, SW NATURALIST, V18, P93; NICKERSON MA, 2009, DECLINE OZARK HELLBE; Nickerson Max A., 2007, APPLIED HERPETOLOGY, V4, P207, DOI 10.1163/157075407781268354; Nickerson Max A., 2007, Salamandra, V43, P111; PETERSON CL, 1979, AGE GROWTH OZARK HEL; PFINGSTEN R A, 1990, Herpetological Review, V21, P48; PITT AL, 2008, COLIFORM BACTERIAL C; QUINLAN EL, 2007, PRELIMINARY INVESTIG; Reeves Mari K., 2008, Herpetological Review, V39, P68; REICHENBACHKLIN.H, 1965, PRINCIPLE DIS LOWER, P209; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P63, DOI 10.1016/S0145-305X(01)00041-6; Rumbaugh KP, 1999, J HOSP INFECT, V43, P211, DOI 10.1053/jhin.1999.0252; SCADDING SR, 1977, J EXP ZOOL, V202, P57, DOI 10.1002/jez.1402020108; SCHAUBLE MK, 1972, J EXP ZOOL, V181, P281, DOI 10.1002/jez.1401810215; Sheafor B, 2008, J WILDLIFE DIS, V44, P226, DOI 10.7589/0090-3558-44.2.226; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Siqueira JF, 2006, ORAL SURG ORAL MED O, V102, P259, DOI 10.1016/j.tripleo.2005.09.021; SMITH BG, 1911, B WISCONSIN NATURAL, V9, P64; Solis ME, 2007, ARCH ENVIRON CON TOX, V53, P426, DOI 10.1007/s00244-006-0208-y; Solis ME, 2007, HERPETOLOGICA, V63, P285, DOI 10.1655/0018-0831(2007)63[285:HASCOO]2.0.CO;2; Suihko ML, 2007, SYST APPL MICROBIOL, V30, P494, DOI 10.1016/j.syapm.2007.05.001; SUN Y, 2009, INVEST OPHTH VIS SCI, V51, P1511; Taylor Sharon K., 2001, P181; TILLS D W, 1977, Transactions of the Kansas Academy of Science, V80, P75, DOI 10.2307/3627512; Trauth S. E., 2004, AMPHIBIANS REPTILES, VFirst; Trauth Stanley E., 2002, Journal of the Arkansas Academy of Science, V56, P190; VALENSTEIN P, 1983, AM J CLIN PATHOL, V79, P245, DOI 10.1093/ajcp/79.2.245; Wheeler B.A., 2002, J ARKANSAS ACAD SCI, V56, P250, DOI DOI 10.1371/J0URNAL.P0NE.0028906; Whitman RL, 2003, APPL ENVIRON MICROB, V69, P4714, DOI 10.1128/AEM.69.8.4714-4719.2003; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Woodhams Douglas C., 2008, Herpetological Review, V39, P66; YOUNG HE, 1983, ANAT RECORD, V206, P289, DOI 10.1002/ar.1092060307; Yu CY, 2008, AVIAN PATHOL, V37, P273, DOI 10.1080/03079450802056546; 1973, MODERN MED, V41, P20	88	20	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28906	10.1371/journal.pone.0028906	http://dx.doi.org/10.1371/journal.pone.0028906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205979	Green Published, gold, Green Submitted			2022-12-25	WOS:000298665600014
J	Hwang, SY; Putney, JW				Hwang, Sung-Yong; Putney, James W.			Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1	FASEB JOURNAL			English	Article						store-operated channels; bone remodeling; osteoporosis; receptor activator of nuclear factor kappa B ligand; tartrate-resistant acid phosphatase	KAPPA-B LIGAND; T-CELLS C1; BONE-RESORPTION; GENE-EXPRESSION; TERMINAL DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; RECEPTOR ACTIVATOR; SIGNALING PATHWAY; PROTEIN-KINASE; NUCLEAR FACTOR	Bone diseases such as postmenopausal osteoporosis are primarily caused by excessive formation and activity of osteoclasts (OCLs). Receptor activator of nuclear factor-kappa B ligand (RANKL) is a key initiating cytokine for OCL differentiation and function. RANKL induces calcium (Ca2+) oscillations, resulting in selective and robust induction of nuclear factor of activated T cells c1 (NFATc1), a Ca2+-responsive transcription factor that drives osteoclastogenesis. Store-operated Ca2+ entry (SOCE) is a major Ca2+ influx pathway in most nonexcitable cell types and is activated by any stimulus that depletes Ca2+ stores in the endoplasmic reticulum. Although the role of Orai1, a SOCE channel in the plasma membrane, in maintaining Ca2+ oscillations and transactivation of NFAT in other cell types is well known, its contribution to osteoclastogenesis remains unclear. We show here that silencing of the Orai1 gene with viral delivery of shRNA reduces SOCE and inhibits RANKL-induced osteoclastogenesis of RAW264.7 cells, a murine monocyte/macrophage cell line, by suppressing the induction of NFATc1. This was accompanied by defective induction of OCL-specific genes, such as tartrate-resistant acid phosphatase and immunoreceptor OCL-associated receptor, which are known to be direct transcriptional targets of NFATc1 during osteoclastogenesis. In addition, maturation of OCLs was abrogated by defective cell fusion of pre-OCLs depleted of Orai1, consistent with defective RANKL-mediated induction of d2 isoform of vacuolar ATPase V-o domain that is involved in cell fusion of pre-OCLs. We found that the functional bone resorbing capacity was severely impaired in OCLs depleted of Orai1, potentially related to the observed decrease in the induction of cathepsin K, a major bone matrix degrading protease. Our results indicate that Orai1 plays a critical role in the differentiation and function of OCLs, suggesting that Orai1 might be a potential therapeutic target for the treatment or prevention of bone loss caused by OCLs.-Hwang, S.-Y., Putney, J. W. Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1. FASEB J. 26, 1484 -1492 (2012). www.fasebj.org	[Hwang, Sung-Yong; Putney, James W.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hwang, SY (corresponding author), NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	hwangs3@niehs.nih.gov	Putney, James W/F-7247-2019	Putney, James W/0000-0002-3379-4789	U.S. National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090087] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the U.S. National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS). The authors thank Dr. Xiaoling Li and Dr. Robert Oakley for helpful comments. The authors thank Dr. Gary Bird for technical advice and helpful discussion. The authors also thank Dr. Charles Romeo and Dr. Negin Martin (Viral Vector Core, NIEHS) for lentivirus preparations.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; Blair H. C., 2007, V45, P539; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; FALLON MD, 1983, LAB INVEST, V49, P159; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fujikawa Y, 1996, BRIT J RHEUMATOL, V35, P213; Gelb BD, 1996, BIOCHEM MOL MED, V59, P200, DOI 10.1006/bmme.1996.0088; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hwang SY, 2011, BBA-MOL CELL RES, V1813, P979, DOI 10.1016/j.bbamcr.2010.11.002; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lin JT, 2004, CLIN ORTHOP RELAT R, P126, DOI 10.1097/01.blo.0000132404.30139.f2; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Mentaverri R, 2003, CELL CALCIUM, V34, P169, DOI 10.1016/S0143-4160(03)00080-0; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mohamed SGK, 2005, BIOCHEM BIOPH RES CO, V329, P839, DOI 10.1016/j.bbrc.2005.02.049; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Romas E, 2000, ARTHRITIS RHEUM, V43, P821, DOI 10.1002/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T; Romas E, 2002, BONE, V30, P340, DOI 10.1016/S8756-3282(01)00682-2; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhou YD, 2011, J CELL PHYSIOL, V226, P1082, DOI 10.1002/jcp.22423	48	48	49	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1484	1492		10.1096/fj.11-194399	http://dx.doi.org/10.1096/fj.11-194399			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22198385	Green Published			2022-12-25	WOS:000302359700011
J	Dhar, S; Thota, A; Rao, MRS				Dhar, Surbhi; Thota, Anusha; Rao, Manchanahalli Rangaswamy Satyanarayana			Insights into Role of Bromodomain, Testis-specific (Brdt) in Acetylated Histone H4-dependent Chromatin Remodeling in Mammalian Spermiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; MOUSE SPERMATOGENESIS; PROTEIN INTERACTIONS; SWI/SNF SUBUNIT; TOPOISOMERASE-I; SPLICING FACTOR; BASIC-PROTEINS; RAINBOW-TROUT; DNA; HYPERACETYLATION	Mammalian spermiogenesis is of considerable biological interest especially due to the unique chromatin remodeling events that take place during spermatid maturation. Here, we have studied the expression of chromatin remodeling factors in different spermatogenic stages and narrowed it down to bromodomain, testis-specific (Brdt) as a key molecule participating in chromatin remodeling during rat spermiogenesis. Our immunocytochemistry experiments reveal that Brdt colocalizes with acetylated H4 in elongating spermatids. Remodeling assays showed an acetylation-dependent but ATP-independent chromatin reorganization property of Brdt in haploid round spermatids. Furthermore, Brdt interacts with Smarce1, a member of the SWI/SNF family. We have studied the genomic organization of smarce1 and identified that it has two splice variants expressed during spermatogenesis. The N terminus of Brdt is involved in the recognition of Smarce1 as well as in the reorganization of hyperacetylated round spermatid chromatin. Interestingly, the interaction between Smarce1 and Brdt increases dramatically upon histone hyperacetylation both in vitro and in vivo. Thus, our results indicate this interaction to be a vital step in the chromatin remodeling process during mammalian spermiogenesis.	[Dhar, Surbhi; Thota, Anusha; Rao, Manchanahalli Rangaswamy Satyanarayana] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Rao, MRS (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	mrsrao@jncasr.ac.in			Department of Biotechnology, New Delhi, India; Council of Scientific and Industrial Research; Department of Science and Technology	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	This work was supported in part by the Department of Biotechnology, New Delhi, India.; Recipient of fellowship support from the Council of Scientific and Industrial Research.; Recipient of a J. C. Bose fellowship from the Department of Science and Technology. To whom correspondence should be addressed. Tel.: 91-80-2208-2864; Fax: 91-80-2362-2762; E-mail: mrsrao@jncasr.ac.in.	Aslam I, 1998, HUM REPROD, V13, P634, DOI 10.1093/humrep/13.3.634; Awe S, 2010, SYST BIOL REPROD MED, V56, P44, DOI 10.3109/19396360903490790; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barda S, 2012, FERTIL STERIL, V97, P46, DOI 10.1016/j.fertnstert.2011.10.010; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Bladen CL, 2005, J BIOL CHEM, V280, P5205, DOI 10.1074/jbc.M412758200; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Boussouar F, 2008, CELL CYCLE, V7, P3499, DOI 10.4161/cc.7.22.6975; Carrell DT, 2010, MOL HUM REPROD, V16, P37, DOI 10.1093/molehr/gap090; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Chichiarelli S, 2010, ARCH BIOCHEM BIOPHYS, V494, P178, DOI 10.1016/j.abb.2009.12.004; Chichiarelli S, 2007, J CELL PHYSIOL, V210, P343, DOI 10.1002/jcp.20824; CHRISTENSEN ME, 1984, NUCLEIC ACIDS RES, V12, P4575, DOI 10.1093/nar/12.11.4575; CHRISTENSEN ME, 1982, DEV BIOL, V93, P404, DOI 10.1016/0012-1606(82)90127-0; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dehnugara T, 2012, MOL REPROD DEV, V79, P19, DOI 10.1002/mrd.21396; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Durand-Dubief M, 2010, EMBO J, V29, P2126, DOI 10.1038/emboj.2010.109; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Faure AK, 2003, MOL HUM REPROD, V9, P757, DOI 10.1093/molehr/gag101; Fischle W, 2008, GENE DEV, V22, P3375, DOI 10.1101/gad.1759708; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; GERTON GL, 1984, J CELL BIOL, V98, P619, DOI 10.1083/jcb.98.2.619; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; GRIMES SR, 1984, EXP CELL RES, V152, P91, DOI 10.1016/0014-4827(84)90232-5; GRUPPI CM, 1993, DEV GENET, V14, P119, DOI 10.1002/dvg.1020140206; Hah N, 2010, CANCER RES, V70, P4402, DOI 10.1158/0008-5472.CAN-09-2767; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KADURA SN, 1983, COMP BIOCHEM PHYS B, V74, P343, DOI 10.1016/0305-0491(83)90023-8; Kazantseva A, 2009, J NEUROCHEM, V109, P807, DOI 10.1111/j.1471-4159.2009.06005.x; KENNEDY BP, 1980, J BIOL CHEM, V255, P2533; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Kolthur-Seetharam U, 2009, J HISTOCHEM CYTOCHEM, V57, P951, DOI 10.1369/jhc.2009.953414; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krynetskaia NF, 2009, MOL CANCER THER, V8, P864, DOI 10.1158/1535-7163.MCT-08-0695; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Lewis JD, 2003, BIOCHEM CELL BIOL, V81, P131, DOI 10.1139/o03-045; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Chi MN, 2011, MOL BIOL CELL, V22, P2875, DOI 10.1091/mbc.E11-03-0212; Meetei AR, 2002, BIOCHEMISTRY-US, V41, P185, DOI 10.1021/bi0117652; MEISTRICH ML, 1992, MOL REPROD DEV, V31, P170, DOI 10.1002/mrd.1080310303; Montellier E., 2011, BIOESSAYS       1215, DOI [10.1002/ bies.201100141, DOI 10.1002/BIES.201100141]; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; OLIVA R, 1982, NUCLEIC ACIDS RES, V10, P8049, DOI 10.1093/nar/10.24.8049; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Pradeepa MM, 2008, MOL CELL BIOL, V28, P4331, DOI 10.1128/MCB.00519-07; Pradeepa MM, 2009, J BIOL CHEM, V284, P29956, DOI 10.1074/jbc.M109.052043; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Shipra A, 2006, BIOINFORMATICS, V22, P2940, DOI 10.1093/bioinformatics/btl509; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4; Straub T, 2000, BIOCHEMISTRY-US, V39, P7552, DOI 10.1021/bi992898e; SUDHAKAR L, 1990, J BIOL CHEM, V265, P22526; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m; Yu JK, 2009, J BIOL CHEM, V284, P1505, DOI 10.1074/jbc.M805113200; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	76	49	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6387	6405		10.1074/jbc.M111.288167	http://dx.doi.org/10.1074/jbc.M111.288167			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215678	hybrid, Green Published			2022-12-25	WOS:000300791800030
J	Rafiq, K; Guo, JF; Vlasenko, L; Guo, XJ; Kolpakov, MA; Sanjay, A; Houser, SR; Sabri, A				Rafiq, Khadija; Guo, Jianfen; Vlasenko, Liudmila; Guo, Xinji; Kolpakov, Mikhail A.; Sanjay, Archana; Houser, Steven R.; Sabri, Abdelkarim			c-Cbl Ubiquitin Ligase Regulates Focal Adhesion Protein Turnover and Myofibril Degeneration Induced by Neutrophil Protease Cathepsin G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL REGULATION; CARDIOMYOCYTE SURVIVAL; MYOCARDIAL-INFARCTION; DOWN-REGULATION; QUALITY CONTROL; HEART-FAILURE; KINASE; HYPERTROPHY; RECEPTOR; PATHWAY	The neutrophil-derived serine protease, cathepsin G (Cat. G), has been shown to induce myocyte detachment and apoptosis by anoikis through down-regulation of focal adhesion (FA) signaling. However, the mechanisms that control FA protein stability and turnover in myocytes are not well understood. Here, we have shown that the Casitas b-lineage lymphoma (c-Cbl), adaptor protein with an intrinsic E3 ubiquitin ligase activity, is involved in FA and myofibrillar protein stability and turnover in myocytes. Cat. G treatment induced c-Cbl activation and its interaction with FA proteins. Deletion of c-Cbl using c-Cbl knock-out derived myocytes or inhibition of c-Cbl ligase activity significantly reduced FA protein degradation, myofibrillar degeneration, and myocyte apoptosis induced by Cat. G. We also found that inhibition of the proteasome activity, but not the lysosome or the calpain activity, markedly attenuated FA and myofibrillar protein degradation induced by Cat. G. Interestingly, c-Cbl activation induced by Cat. G was mediated through epidermal growth factor receptor (EGFR) transactivation as inhibition of EGFR kinase activity markedly attenuated c-Cbl phosphorylation and FA protein degradation induced by Cat. G. These findings support a model in which neutrophil protease Cat. G promotes c-Cbl interaction with FA proteins, resulting in enhanced c-Cbl-mediated FA protein ubiquitination and degradation, myofibril degradation, and subsequent down-regulation of myocyte survival signaling.	[Rafiq, Khadija; Guo, Jianfen; Vlasenko, Liudmila; Guo, Xinji; Kolpakov, Mikhail A.; Sanjay, Archana; Houser, Steven R.; Sabri, Abdelkarim] Temple Univ, Cardiovasc Res Ctr, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sabri, A (corresponding author), Temple Univ, Cardiovasc Res Ctr, Dept Physiol, Sch Med, MERB 1045,3500 N Broad St, Philadelphia, PA 19140 USA.	sabri@temple.edu			National Institutes of Health [HL360338, HL 360343]; American Heart Association [240052]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grants HL360338 and HL 360343.; Recipient of an American Heart Association award (240052).	Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Balasubramanian S, 2006, J MOL CELL CARDIOL, V41, P669, DOI 10.1016/j.yjmcc.2006.04.022; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Ciechanover A, 2000, J CELL BIOCHEM, P40; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Friedman J, 2004, DEV CELL, V6, P460, DOI 10.1016/S1534-5807(04)00104-2; Hakim ZS, 2009, J MOL CELL CARDIOL, V46, P241, DOI 10.1016/j.yjmcc.2008.10.017; HANSEN PR, 1995, CIRCULATION, V91, P1872, DOI 10.1161/01.CIR.91.6.1872; IACOVIELLO L, 1995, ARTERIOSCL THROM VAS, V15, P2037, DOI 10.1161/01.ATV.15.11.2037; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Le Y, 2007, IMMUNITY, V27, P811, DOI 10.1016/j.immuni.2007.09.011; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; MOLINO M, 1995, J BIOL CHEM, V270, P11168, DOI 10.1074/jbc.270.19.11168; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Pfister R, 2007, BASIC RES CARDIOL, V102, P257, DOI 10.1007/s00395-006-0640-1; Rafiq K, 2006, J BIOL CHEM, V281, P19781, DOI 10.1074/jbc.M513040200; Sabri A, 2003, J BIOL CHEM, V278, P23944, DOI 10.1074/jbc.M302718200; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tidball JG, 2002, J PHYSIOL-LONDON, V545, P819, DOI 10.1113/jphysiol.2002.024935; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Vadlamudi RK, 2002, J CELL PHYSIOL, V190, P189, DOI 10.1002/JCP.10054; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004	36	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5327	5339		10.1074/jbc.M111.307009	http://dx.doi.org/10.1074/jbc.M111.307009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203672	Green Published, hybrid			2022-12-25	WOS:000300638000015
J	Sandstrom, A; Scharf, L; McRae, G; Hawk, AJ; Meredith, SC; Adams, EJ				Sandstrom, Andrew; Scharf, Louise; McRae, Gabrielle; Hawk, Andrew J.; Meredith, Stephen C.; Adams, Erin J.			gamma delta T Cell Receptors Recognize the Non-classical Major Histocompatibility Complex (MHC) Molecule T22 via Conserved Anchor Residues in a MHC Peptide-like Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPEPTIDE ANTIGENS; ALPHA-BETA; SPECIFICITY; PRODUCT; T10	The molecular mechanisms by which gamma delta T cells recognize ligand remain a mystery. The non-classical MHC molecule T22 represents the best characterized ligand for murine gamma delta T cells, with a motif (W ... EGYEL) present in the gamma delta T cell receptor complementary-determining region 3 delta (CDR3 delta) loop mediating gamma delta T cell recognition of this molecule. Produced through V(D)J recombination, this loop is quite diverse, with different numbers and chemical types of amino acids between Trp and EGYEL, which have unknown functional consequences for T22 recognition. We have investigated the biophysical and structural effects of CDR3 delta loop diversity, revealing a range of affinities for T22 but a common thermodynamic pattern. Mutagenesis of these CDR3 delta loops defines the key anchor residues involved in T22 recognition as W ... EGYEL, similar to those found for the G8 CDR3 delta loop, and demonstrates that spacer residues modulate but are not required for T22 recognition. Comparison of the location of these residues in the T22 interface reveals a striking similarity to peptide anchor residues in classically presented MHC peptides, with the key Trp residue of the CDR3 delta motif completing the deficient peptide-binding groove of T22. This suggests that gamma delta T cell recognition of T22 utilizes the conserved ligand-presenting nature of the MHC fold.	[Sandstrom, Andrew; Scharf, Louise; McRae, Gabrielle; Meredith, Stephen C.; Adams, Erin J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Hawk, Andrew J.; Meredith, Stephen C.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Adams, Erin J.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Adams, EJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St,GCIS W236, Chicago, IL 60637 USA.	ejadams@uchicago.edu		Sandstrom, Andrew/0000-0002-8629-9087	National Institutes of Health [R01 AI073922]; Kinship Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinship Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI073922. This work was also supported by the Kinship Foundation Searle Scholars Award (to E. J. A.).	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Adams EJ, 2008, NAT IMMUNOL, V9, P777, DOI 10.1038/ni.1620; BLUESTONE JA, 1988, J EXP MED, V168, P1899, DOI 10.1084/jem.168.5.1899; BONNEVILLE M, 1989, P NATL ACAD SCI USA, V86, P5928, DOI 10.1073/pnas.86.15.5928; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; ITO K, 1990, CELL, V62, P549, DOI 10.1016/0092-8674(90)90019-B; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kazen AR, 2011, P NATL ACAD SCI USA, V108, pE332, DOI 10.1073/pnas.1105105108; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Mishra R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000924; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rock E. P., 1994, J EXP MED, V179, P323; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Wingren C, 2000, SCIENCE, V287, P310, DOI 10.1126/science.287.5451.310	25	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6035	6043		10.1074/jbc.M111.333153	http://dx.doi.org/10.1074/jbc.M111.333153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215668	hybrid, Green Published			2022-12-25	WOS:000300638000076
J	Ranta, F; Leveringhaus, J; Theilig, D; Schulz-Raffelt, G; Hennige, AM; Hildebrand, DG; Handrick, R; Jendrossek, V; Bosch, F; Schulze-Osthoff, K; Haring, HU; Ullrich, S				Ranta, Felicia; Leveringhaus, Johannes; Theilig, Dorothea; Schulz-Raffelt, Gabriele; Hennige, Anita M.; Hildebrand, Dominic G.; Handrick, Rene; Jendrossek, Verena; Bosch, Fatima; Schulze-Osthoff, Klaus; Haering, Hans-Ulrich; Ullrich, Susanne			Protein Kinase C Delta (PKC delta) Affects Proliferation of Insulin-Secreting Cells by Promoting Nuclear Extrusion of the Cell Cycle Inhibitor p21(Cip1/WAF1)	PLOS ONE			English	Article							PANCREATIC BETA-CELL; ENDOPLASMIC-RETICULUM STRESS; FUNCTION IN-VIVO; INDUCED APOPTOSIS; FATTY-ACIDS; ACTIVATION; PHOSPHORYLATION; DEATH; P21; IDENTIFICATION	Background: High fat diet-induced hyperglycemia and palmitate-stimulated apoptosis was prevented by specific inhibition of protein kinase C delta (PKC delta) in beta-cells. To understand the role of PKC delta in more detail the impact of changes in PKC delta activity on proliferation and survival of insulin-secreting cells was analyzed under stress-free conditions. Methodology and Principal Findings: Using genetic and pharmacological approaches, the effect of reduced and increased PKC delta activity on proliferation, apoptosis and cell cycle regulation of insulin secreting cells was examined. Proteins were analyzed by Western blotting and by confocal laser scanning microscopy. Increased expression of wild type PKC delta (PKC delta WT) significantly stimulated proliferation of INS-1E cells with concomitant reduced expression and cytosolic retraction of the cell cycle inhibitor p21(Cip1/WAF1). This nuclear extrusion was mediated by PKC delta-dependent phosphorylation of p21(Cip1/WAF1) at Ser146. In kinase dead PKC delta (PKC delta KN) overexpressing cells and after inhibition of endogenous PKC delta activity by rottlerin or RNA interference phosphorylation of p21(Cip1/WAF1) was reduced, which favored its nuclear accumulation and apoptotic cell death of INS-1E cells. Human and mouse islet cells express p21(Cip1/WAF1) with strong nuclear accumulation, while in islet cells of PKC delta WT transgenic mice the inhibitor resides cytosolic. Conclusions and Significance: These observations disclose PKC delta as negative regulator of p21(Cip1/WAF1), which facilitates proliferation of insulin secreting cells under stress-free conditions and suggest that additional stress-induced changes push PKC delta into its known pro-apoptotic role.	[Ranta, Felicia; Leveringhaus, Johannes; Theilig, Dorothea; Schulz-Raffelt, Gabriele; Hennige, Anita M.; Haering, Hans-Ulrich; Ullrich, Susanne] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, D-7400 Tubingen, Germany; [Hildebrand, Dominic G.; Schulze-Osthoff, Klaus] Univ Tubingen, Interfac Inst Biochem IFIB, Tubingen, Germany; [Handrick, Rene] Biberach Univ Appl Sci, Inst Pharmaceut Biotechnol, Biberach, Germany; [Jendrossek, Verena] Univ Essen Gesamthsch, Inst Cell Biol, Essen, Germany; [Bosch, Fatima] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Bellaterra, Spain; [Bosch, Fatima] CIBER Diabet & Enfermedades Metab Asociad CIBERDE, Barcelona, Spain	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Duisburg Essen; Autonomous University of Barcelona	Ranta, F (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, D-7400 Tubingen, Germany.	susanne.ullrich@med.uni-tuebingen.de	Jendrossek, Verena/AAH-4967-2019; Schulze-Osthoff, Klaus/N-9025-2013	Jendrossek, Verena/0000-0003-1058-2107; Schulze-Osthoff, Klaus/0000-0003-1443-2720; BOSCH, FATIMA/0000-0002-7705-5515	German Federal Ministry of Education and Research (BMBF); DFG [GRK1302/1, UL140/7-1, UL140/7-2]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This study was financially supported for consumables/material expenses by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.) and by financial supports of DFG grants (GRK1302/1, UL140/7-1 and UL140/7-2) for consumables/material expenses and staff appropriations. Human islets were provided through JDRF Award 31-2008-413 (ECIT Islet for Basic Research Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Basu A, 2010, THESCIENTIFICWORLDJO, V10, P2272, DOI 10.1100/tsw.2010.214; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Cantley J, 2011, DIABETOLOGIA, V54, P380, DOI 10.1007/s00125-010-1962-y; Carpenter L, 2002, DIABETES, V51, P317, DOI 10.2337/diabetes.51.2.317; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cozar-Castellano I, 2006, DIABETES, V55, P3271, DOI 10.2337/db06-0627; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fiaschi-Taesch N, 2009, DIABETES, V58, P882, DOI 10.2337/db08-0631; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Heinzelmann I, 2010, THESIS U TUBINGEN; Hennige AM, 2010, DIABETES, V59, P119, DOI 10.2337/db09-0512; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Janicke RU, 2007, CELL CYCLE, V6, P407; Kaneto H, 1999, DIABETOLOGIA, V42, P1093, DOI 10.1007/s001250051276; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; KNUTSON KL, 1994, ENDOCRINOLOGY, V135, P881, DOI 10.1210/en.135.3.881; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Markou T, 2006, J BIOL CHEM, V281, P8321, DOI 10.1074/jbc.M508398200; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Mauro LV, 2010, PANCREAS, V39, pE31, DOI 10.1097/MPA.0b013e3181bce796; Oh YT, 2007, APOPTOSIS, V12, P1339, DOI 10.1007/s10495-007-0066-8; Qi X, 2008, J CELL SCI, V121, P804, DOI 10.1242/jcs.024653; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rodriguez-Vilarrupla A, 2002, FEBS LETT, V531, P319, DOI 10.1016/S0014-5793(02)03549-4; Rossig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200; Schneider L, 2008, ONCOGENE, V27, P116, DOI 10.1038/sj.onc.1210628; Schulthess FT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004394; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Scott MT, 2002, EMBO J, V21, P6771, DOI 10.1093/emboj/cdf684; Tavana O, 2010, DIABETES, V59, P135, DOI 10.2337/db09-0792; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Walker JL, 2006, J BIOL CHEM, V281, P38127, DOI 10.1074/jbc.M609622200; Yang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008344; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Ziegler WH, 1999, CURR BIOL, V9, P522, DOI 10.1016/S0960-9822(99)80236-X	53	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e28828	10.1371/journal.pone.0028828	http://dx.doi.org/10.1371/journal.pone.0028828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216119	Green Submitted, gold, Green Published			2022-12-25	WOS:000300674900004
J	Vegran, F; Boidot, R; Solary, E; Lizard-Nacol, S				Vegran, Frederique; Boidot, Romain; Solary, Eric; Lizard-Nacol, Sarab			A Short Caspase-3 Isoform Inhibits Chemotherapy-Induced Apoptosis by Blocking Apoptosome Assembly	PLOS ONE			English	Article							BREAST-CANCER CELLS; CISPLATIN-INDUCED APOPTOSIS; TAXOL-INDUCED APOPTOSIS; CYTOCHROME-C; HL-60 CELLS; OVARIAN; ACTIVATION; PACLITAXEL; PATHWAYS; VARIANT	Aternative splicing of caspase-3 produces a short isoform caspase-3s that antagonizes caspase-3 apoptotic activity. However, the mechanism of apoptosis inhibition by caspase-3s remains unknown. Here we show that exogenous caspase-3 sensitizes MCF-7 and HBL100 breast cancers cells to chemotherapeutic treatments such as etoposide and methotrexate whereas co-transfection with caspase-3s strongly inhibits etoposide and methotrexate-induced apoptosis underlying thus the anti-apoptotic role of caspase-3s. In caspase-3 transfected cells, lamin-A and alpha-fodrin were cleaved when caspase-3 was activated by etoposide or methotrexate. When caspase-3s was co-transfected, this cleavage was strongly reduced. Depletion of caspase-3 by RNA interference in HBL100 containing endogenous caspase-3s caused reduction in etoposide and methotrexate-induced apoptosis, whereas the depletion of caspase-3s sensitized cells to chemotherapy. In the presence of caspase-3s, a lack of interaction between caspase-3 and caspase-9 was observed. Immunoprecipitation assays showed that caspase-3s binds the pro-forms of caspase-3. This result suggested that the absence of interaction with caspase-9 when both variants of caspase-3 are present contribute to block the apoptosome assembly and inhibit apoptosis. These data support that caspases-3s negatively interferes with caspase-3 activation and apoptosis in breast cancer, and that it can play key roles in the modulation of response to chemotherapeutic treatments.	[Vegran, Frederique; Boidot, Romain; Lizard-Nacol, Sarab] Ctr Georges Francois Leclerc, Mol Biol Unit, Dijon, France; [Vegran, Frederique; Boidot, Romain; Solary, Eric; Lizard-Nacol, Sarab] Univ Burgundy, Federat Inst Res IFR Sante STIC, Dijon, France; [Vegran, Frederique; Solary, Eric] UMR INSERM U866, Dijon, France	UNICANCER; Centre Georges-Francois Leclerc; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Vegran, F (corresponding author), Ctr Georges Francois Leclerc, Mol Biol Unit, Dijon, France.	Slizard@cgfl.fr	VEGRAN, Frederique/O-9986-2018; VEGRAN, Frédérique/H-4792-2017	VEGRAN, Frederique/0000-0002-4377-1441; Solary, Eric/0000-0002-8629-1341				Bellarosa D, 2001, J PHARMACOL EXP THER, V296, P276; Blanc C, 2000, CANCER RES, V60, P4386; Bose K, 2003, BIOCHEMISTRY-US, V42, P12298, DOI 10.1021/bi034998x; Chen T, 2005, MOL CANCER THER, V4, P217; Cummings BS, 2002, J PHARMACOL EXP THER, V302, P8, DOI 10.1124/jpet.302.1.8; Hattangadi DK, 2004, BIOCHEM PHARMACOL, V68, P1699, DOI 10.1016/j.bcp.2004.06.033; Henkels KM, 1999, CANCER RES, V59, P3077; HORVITZ HR, 1983, COLD SPRING HARB SYM, V48, P453, DOI 10.1101/SQB.1983.048.01.050; Huang YH, 2001, BIOCHEM BIOPH RES CO, V283, P762, DOI 10.1006/bbrc.2001.4871; Ibrado AM, 1998, LEUKEMIA, V12, P1930, DOI 10.1038/sj.leu.2401218; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kishimoto S, 2005, BIOL PHARM BULL, V28, P1954, DOI 10.1248/bpb.28.1954; Kivinen K, 2005, EXP CELL RES, V311, P62, DOI 10.1016/j.yexcr.2005.08.006; Kojima H, 1998, J BIOL CHEM, V273, P16647, DOI 10.1074/jbc.273.27.16647; Kottke TJ, 1999, J BIOL CHEM, V274, P15927, DOI 10.1074/jbc.274.22.15927; Kwon KB, 2002, EXP MOL MED, V34, P32, DOI 10.1038/emm.2002.5; Mercatante D, 2000, PHARMACOL THERAPEUT, V85, P237, DOI 10.1016/S0163-7258(99)00067-4; Mohr A, 2005, ONCOGENE, V24, P2421, DOI 10.1038/sj.onc.1208432; Ofir R, 2002, CELL DEATH DIFFER, V9, P636, DOI 10.1038/sj.cdd.4401012; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rozalski M, 2005, PHARMACOL REP, V57, P360; Samejima K, 1999, J BIOL CHEM, V274, P4335, DOI 10.1074/jbc.274.7.4335; Seol DW, 1999, J BIOL CHEM, V274, P2072, DOI 10.1074/jbc.274.4.2072; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Tenev T, 2001, CELL DEATH DIFFER, V8, P256, DOI 10.1038/sj.cdd.4400808; Wang PZ, 2006, LIFE SCI, V79, P934, DOI 10.1016/j.lfs.2006.04.026; Wegran F, 2006, CLIN CANCER RES, V12, P5794, DOI 10.1158/1078-0432.CCR-06-0725; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; Weigel TL, 2000, J THORAC CARDIOV SUR, V119, P795, DOI 10.1016/S0022-5223(00)70016-X; Yang SH, 2007, BBA-MOL CELL RES, V1773, P903, DOI 10.1016/j.bbamcr.2007.03.021; Yang XH, 2001, CANCER RES, V61, P348	33	28	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29058	10.1371/journal.pone.0029058	http://dx.doi.org/10.1371/journal.pone.0029058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216167	Green Published, gold, Green Submitted			2022-12-25	WOS:000299684700027
J	dos Santos, JI; Cardoso, FF; Soares, AM; Silva, MDP; Gallacci, M; Fontes, MRM				dos Santos, Juliana I.; Cardoso, Fabio F.; Soares, Andreimar M.; Silva, Maeli dal Pai; Gallacci, Marcia; Fontes, Marcos R. M.			Structural and Functional Studies of a Bothropic Myotoxin Complexed to Rosmarinic Acid: New Insights into Lys49-PLA(2) Inhibition	PLOS ONE			English	Article							LYS49 PHOSPHOLIPASE A(2); CASEARIA-SYLVESTRIS FLACOURTIACEAE; MEMBRANE-DAMAGING ACTIVITIES; SNAKE-VENOM; AQUEOUS EXTRACT; CRYSTAL-STRUCTURE; LYS(49)-PHOSPHOLIPASE A(2); LYS49-PHOSPHOLIPASE A(2); ANTIOPHIDIAN PROPERTIES; BROMOPHENACYL BROMIDE	Snakebite envenoming is an important public health problem in many tropical and subtropical countries, and is considered a neglected tropical disease by the World Health Organization. Most severe cases are inflicted by species of the families Elapidae and Viperidae, and lead to a number of systemic and local effects in the victim. One of the main problems regarding viperidic accidents is prominent local tissue damage whose pathogenesis is complex and involves the combined actions of a variety of venom components. Phospholipases A(2) (PLA(2)s) are the most abundant muscle-damaging components of these venoms. Herein, we report functional and structural studies of PrTX-I, a Lys49-PLA(2) from Bothops pirajai snake venom, and the influence of rosmarinic acid (RA) upon this toxin's activities. RA is a known active component of some plant extracts and has been reported as presenting anti-myotoxic properties related to bothopic envenomation. The myotoxic activity of Lys49-PLA(2)s is well established in the literature and although no in vivo neurotoxicity has been observed among these toxins, in vitro neuromuscular blockade has been reported for some of these proteins. Our in vitro studies show that RA drastically reduces both the muscle damage and the neuromuscular blockade exerted by PrTX-I on mice neuromuscular preparations (by,80% and,90%, respectively). These results support the hypothesis that the two effects are closely related and lead us to suggest that they are consequences of the muscle membrane-destabilizing activity of the Lys49-PLA(2). Although the C-terminal region of these proteins has been reported to comprise the myotoxic site, we demonstrate by X-ray crystallographic studies that RA interacts with PrTX-I in a different region. Consequently, a new mode of Lys49-PLA(2) inhibition is proposed. Comparison of our results with others in the literature suggests possible new ways to inhibit bothropic snake venom myotoxins and improve serum therapy.	[dos Santos, Juliana I.; Fontes, Marcos R. M.] Univ Estadual Paulista, Dept Fis & Biofis, Inst Biociencias, Botucatu, SP, Brazil; [dos Santos, Juliana I.; Fontes, Marcos R. M.] Conselho Nacl Desenvolvimento Cient & Tecnol, Inst Nacl Ciencia & Tecnol Toxinas, Botucatu, SP, Brazil; [Cardoso, Fabio F.; Gallacci, Marcia] Univ Estadual Paulista, Inst Biociencias, Dept Farmacol, Botucatu, SP, Brazil; [Soares, Andreimar M.] Univ Fed Rondonia, Fundacao Oswaldo Cruz Rondonia, Porto Velho, Rondonia, Brazil; [Soares, Andreimar M.] Univ Fed Rondonia, Ctr Estudos Biomol Aplicadas, Porto Velho, Rondonia, Brazil; [Silva, Maeli dal Pai] Univ Estadual Paulista, Inst Biociencias, Dept Morfol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Rondonia; Universidade Federal de Rondonia; Universidade Estadual Paulista	dos Santos, JI (corresponding author), Univ Estadual Paulista, Dept Fis & Biofis, Inst Biociencias, Botucatu, SP, Brazil.	gallacci@ibb.unesp.br; fontes@ibb.unesp.br	Fontes, Marcos Roberto/B-1941-2009; Gallacci, Márcia/C-8479-2013; Soares, Andreimar/AAE-4657-2021; Soares, Andrei/ABG-3545-2020; Dal-Pai-Silva, Maeli/GLR-1413-2022; Cardoso, Fábio/G-2265-2016; Soares, Andreimar M/K-5556-2014; dos Santos, Juliana/A-4906-2013	Fontes, Marcos Roberto/0000-0002-4634-6221; Gallacci, Márcia/0000-0001-6149-4030; Cardoso, Fábio/0000-0003-2779-9564; Dal Pai, Maeli/0000-0001-7269-9197; Soares, Andreimar/0000-0003-1032-2188	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil; Coordenadacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Instituto Nacional de Ciencia e Tecnologia em Toxinas	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Toxinas	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil, Coordenadacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil and Instituto Nacional de Ciencia e Tecnologia em Toxinas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio ALB, 2005, J BIOL CHEM, V280, P7326, DOI 10.1074/jbc.M410588200; Angulo Y, 2005, TOXICON, V46, P291, DOI 10.1016/j.toxicon.2005.03.025; [Anonymous], AVOGADRO OPEN SOURCE; Aragao EA, 2009, INT J BIOCHEM CELL B, V41, P2588, DOI 10.1016/j.biocel.2009.08.016; ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455; Aung HT, 2011, BIOORGAN MED CHEM, V19, P2392, DOI 10.1016/j.bmc.2011.02.013; Bancroft JD, 1990, THEORY PRACTICE OH H; Biondo R, 2004, PLANT CELL REP, V22, P549, DOI 10.1007/s00299-003-0722-6; Biondo R, 2003, BIOCHIMIE, V85, P1017, DOI 10.1016/S0300-9084(03)00138-X; Borges MH, 2000, COMP BIOCHEM PHYS B, V127, P21, DOI 10.1016/S0305-0491(00)00237-6; Borges MH, 2001, TOXICON, V39, P1863, DOI 10.1016/S0041-0101(01)00169-6; Brasil, 2001, MAN DIAGN TRAT AC AN, P120; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARDOSO JLC, 1993, Q J MED, V86, P315; Cavalcante WLG, 2007, J ETHNOPHARMACOL, V112, P490, DOI 10.1016/j.jep.2007.04.002; Cavalcante WLG, 2005, CHEM-BIOL INTERACT, V151, P95, DOI 10.1016/j.cbi.2004.12.001; Chioato L, 2002, BIOCHEM J, V366, P971, DOI 10.1042/BJ20020092; Chioato L, 2007, BBA-BIOMEMBRANES, V1768, P1247, DOI 10.1016/j.bbamem.2007.01.023; da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I; da Silva JO, 2005, J ETHNOPHARMACOL, V100, P145, DOI 10.1016/j.jep.2005.01.063; de Oliveira M, 2003, TOXICON, V42, P373, DOI 10.1016/S0041-0101(03)00166-1; de Oliveira RCW, 2009, EPIDEMIOLOGIA ACIDEN; DIAZ C, 1993, TOXICON, V31, P1202, DOI 10.1016/0041-0101(93)90136-7; DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6; Doley R, 2009, CELL MOL LIFE SCI, V66, P2851, DOI 10.1007/s00018-009-0050-2; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; dos Santos JI, 2010, ACTA CRYSTALLOGR F, V66, P699, DOI 10.1107/S1744309110013709; dos Santos JI, 2009, PROTEIN PEPTIDE LETT, V16, P887, DOI 10.2174/092986609788923310; dos Santos JI, 2009, J STRUCT BIOL, V167, P106, DOI 10.1016/j.jsb.2009.04.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fale PL, 2009, FOOD CHEM, V114, P798, DOI 10.1016/j.foodchem.2008.10.015; Fan H.W., 1995, HDB CLIN TOXICOLOGY, P667; Fernandes CA, 2011, J STRUCT BIOL; Gallacci M, 2010, TOXICON, V55, P1, DOI 10.1016/j.toxicon.2009.10.025; Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; Gutierrez JM, 2002, REV BIOL TROP, V50, P377; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; Gutierrez JM, 2008, TOXICON, V51, P80, DOI 10.1016/j.toxicon.2007.08.007; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Gutierrez JM, 2009, J PROTEOMICS, V72, P165, DOI 10.1016/j.jprot.2009.01.008; Halgren TA, 1996, J COMPUT CHEM, V17, P587, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<587::AID-JCC4>3.0.CO;2-Q; HELUANY NF, 1992, TOXICON, V30, P1203, DOI 10.1016/0041-0101(92)90436-9; Januario AH, 2004, CHEM-BIOL INTERACT, V150, P243, DOI 10.1016/j.cbi.2004.09.016; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Lalloo DG, 2003, J TOXICOL-CLIN TOXIC, V41, P277, DOI 10.1081/CLT-120021113; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee WH, 2001, BIOCHEMISTRY-US, V40, P28, DOI 10.1021/bi0010470; LOMONTE B, 1987, TOXICON, V25, P443, DOI 10.1016/0041-0101(87)90078-X; Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008; Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1; LOMONTE B, 1994, J BIOL CHEM, V269, P29867; LOMONTE B, 1992, TOXICON, V30, P239, DOI 10.1016/0041-0101(92)90866-4; Lomonte B, 2009, TOXICON, V54, P1012, DOI 10.1016/j.toxicon.2009.03.015; Lomonte B, 2009, PROTEIN PEPTIDE LETT, V16, P860, DOI 10.2174/092986609788923356; Maiorano VA, 2005, J ETHNOPHARMACOL, V102, P364, DOI 10.1016/j.jep.2005.06.039; MANCUSO LC, 1995, TOXICON, V33, P615, DOI 10.1016/0041-0101(95)00012-B; Marchi-Salvador DP, 2009, BBA-PROTEINS PROTEOM, V1794, P1583, DOI 10.1016/j.bbapap.2009.07.005; Marcussi S, 2007, CURR TOP MED CHEM, V7, P743, DOI 10.2174/156802607780487614; Gutierrez JM, 2010, J PROTEOME RES, V9, P564, DOI 10.1021/pr9009518; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McPherson A., 1999, CRYSTALLIZATION BIOL; Melo PA, 1999, TOXICON, V37, P199, DOI 10.1016/S0041-0101(98)00183-4; MouradaSilva AM, 1996, EUR J IMMUNOL, V26, P2000, DOI 10.1002/eji.1830260905; MOURADASILVA AM, 1991, TOXICON, V29, P1471, DOI 10.1016/0041-0101(91)90003-A; Murakami MT, 2007, TOXICON, V49, P378, DOI 10.1016/j.toxicon.2006.10.011; Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIOKA SD, 1992, AM J TROP MED HYG, V47, P805, DOI 10.4269/ajtmh.1992.47.805; Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6; Oliveira CZ, 2005, J ETHNOPHARMACOL, V98, P213, DOI 10.1016/j.jep.2004.12.028; Orhan I, 2008, FOOD CHEM, V108, P663, DOI 10.1016/j.foodchem.2007.11.023; Otero R, 2000, J ETHNOPHARMACOL, V73, P233, DOI 10.1016/S0378-8741(00)00321-4; Otero R, 2000, J ETHNOPHARMACOL, V71, P505, DOI 10.1016/S0378-8741(99)00197-X; Otero R, 2002, TOXICON, V40, P1107, DOI 10.1016/S0041-0101(02)00104-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7; Ramos OHP, 2006, COMP BIOCHEM PHYS C, V142, P328, DOI 10.1016/j.cbpc.2005.11.005; RENETSEDER R, 1988, J MOL BIOL, V200, P181, DOI 10.1016/0022-2836(88)90342-7; RODRIGUESSIMIONI L, 1983, NEUROSCIENCE, V10, P475, DOI 10.1016/0306-4522(83)90147-1; RODRIGUESSIMIONI L, 1995, TOXICON, V33, P1479, DOI 10.1016/0041-0101(95)00089-5; Rosenberg P, 1990, HDB TOXINOLOGY; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; Soares AM, 2000, ARCH BIOCHEM BIOPHYS, V378, P201, DOI 10.1006/abbi.2000.1790; Soares AM, 2005, CURR MED CHEM, V12, P2625, DOI 10.2174/092986705774370655; Soares AM, 2004, CURR ORG CHEM, V8, P1677, DOI 10.2174/1385272043369610; Theakston RDG, 2003, TOXICON, V41, P541, DOI 10.1016/S0041-0101(02)00393-8; Theakston RDG, 2000, LANCET, V356, P2104, DOI 10.1016/S0140-6736(05)74319-1; Ticli FK, 2005, TOXICON, V46, P318, DOI 10.1016/j.toxicon.2005.04.023; Trento EP, 2001, BIOCHEM PHARMACOL, V62, P1521, DOI 10.1016/S0006-2952(01)00800-0; VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538; Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089; Ward RJ, 1998, PROTEIN ENG, V11, P285, DOI 10.1093/protein/11.4.285; Warrell D., 1992, RECENT ADV TOXINOLOG, V1, P121; Warrell D.A., 1996, ENVENOMINGS THEIR TR, P63; Watanabe L, 2005, BIOCHIMIE, V87, P161, DOI 10.1016/j.biochi.2004.11.005	98	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28521	10.1371/journal.pone.0028521	http://dx.doi.org/10.1371/journal.pone.0028521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205953	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600019
J	Huang, WX; Febbraio, M; Silverstein, RL				Huang, Wenxin; Febbraio, Maria; Silverstein, Roy L.			CD9 Tetraspanin Interacts with CD36 on the Surface of Macrophages: A Possible Regulatory Influence on Uptake of Oxidized Low Density Lipoprotein	PLOS ONE			English	Article							FOAM CELL-FORMATION; APOPTOTIC CELLS; T-LYMPHOCYTES; FATTY-ACIDS; RECEPTOR; PHAGOCYTOSIS; MEMBRANE; IDENTIFICATION; GLYCOPROTEIN; ANGIOGENESIS	CD36 is a type 2 scavenger receptor with multiple functions. CD36 binding to oxidized LDL triggers signaling cascades that are required for macrophage foam cell formation, but the mechanisms by which CD36 signals remain incompletely understood. Mass spectrometry analysis of anti-CD36 immuno-precipitates from macrophages identified the tetraspanin CD9 as a CD36 interacting protein. Western blot showed that CD9 was precipitated from mouse macrophages by anti-CD36 monoclonal antibody and CD36 was likewise precipitated by anti-CD9, confirming the mass spectrometry results. Macrophages from cd36 null mice were used to demonstrate specificity. Membrane associations of the two proteins on intact cells was analyzed by confocal immunofluorescence microscopy and by a novel cross linking assay that detects proteins in close proximity (< 40 nm). Functional significance was determined by assessing lipid accumulation, foam cell formation and JNK activation in wt, cd9 null and cd36 null macrophages exposed to oxLDL. OxLDL uptake, lipid accumulation, foam cell formation, and JNK phosphorylation were partially impaired in cd9 null macrophages. The present study demonstrates that CD9 associates with CD36 on the macrophage surface and may participate in macrophage signaling in response to oxidized LDL.	[Huang, Wenxin; Silverstein, Roy L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [Febbraio, Maria] Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH USA; [Febbraio, Maria; Silverstein, Roy L.] Western Reserve Univ, Cleveland Clin, Lerner Coll Med Case, Dept Mol Med, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Huang, WX (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA.	rsilverstein@mcw.edu			NHLBI [P01 HL087018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by a grant from NHLBI - P01 HL087018 - to Roy L. Silverstein. The funders had no role in study design, data colleciton and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; CHEN K, 2011, BLOOD; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Delaguillaumie A, 2002, J CELL SCI, V115, P433; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; GHOSH A, 2011, BLOOD; Ghosh A, 2008, J CLIN INVEST, V118, P1934, DOI 10.1172/JCI34904; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kazerounian S, 2011, BLOOD, V117, P4658, DOI 10.1182/blood-2010-09-305284; KNOWLES DM, 1984, J IMMUNOL, V132, P2170; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; Miao WM, 2001, BLOOD, V97, P1689, DOI 10.1182/blood.V97.6.1689; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Primo L, 2005, FASEB J, V19, P1713, DOI 10.1096/fj.05-3697fje; Quesada AJ, 2005, CELL DEATH DIFFER, V12, P649, DOI 10.1038/sj.cdd.4401615; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rege TA, 2009, J CELL PHYSIOL, V218, P94, DOI 10.1002/jcp.21570; RhinehartJones T, 1996, ARCH BIOCHEM BIOPHYS, V326, P115, DOI 10.1006/abbi.1996.0054; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Ryeom SW, 1996, J CELL SCI, V109, P387; SILVERSTEIN RL, 1992, J BIOL CHEM, V267, P16607; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Takahashi Y, 2001, MOL BIOL CELL, V12, P809, DOI 10.1091/mbc.12.4.809; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Waterhouse R, 2002, J EXP MED, V195, P277, DOI 10.1084/jem.20011741; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Zhang F, 2009, CARDIOVASC RES, V83, P7, DOI 10.1093/cvr/cvp080	42	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29092	10.1371/journal.pone.0029092	http://dx.doi.org/10.1371/journal.pone.0029092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216174	Green Submitted, gold, Green Published			2022-12-25	WOS:000299113600056
J	Karim, S; Singh, P; Ribeiro, JMC				Karim, Shahid; Singh, Parul; Ribeiro, Jose M. C.			A Deep Insight into the Sialotranscriptome of the Gulf Coast Tick, Amblyomma maculatum	PLOS ONE			English	Article							HEPATOZOON-AMERICANUM APICOMPLEXA; PLATELET-AGGREGATION INHIBITORS; NATURALLY-OCCURRING ANTAGONISTS; SERINE PROTEINASE-INHIBITORS; SALIVARY-GLAND HYALURONIDASE; THYROGLOBULIN TYPE-1 DOMAINS; FIBRINOGEN-RELATED PROTEINS; HISTAMINE-BINDING PROTEINS; RICH SECRETORY PROTEINS; IXODES-PACIFICUS ACARI	Background: Saliva of blood sucking arthropods contains compounds that antagonize their hosts' hemostasis, which include platelet aggregation, vasoconstriction and blood clotting; saliva of these organisms also has anti-inflammatory and immunomodullatory properties. Perhaps because hosts mount an active immune response against these compounds, the diversity of these compounds is large even among related blood sucking species. Because of these properties, saliva helps blood feeding as well as help the establishment of pathogens that can be transmitted during blood feeding. Methodology/Principal Findings: We have obtained 1,626,969 reads by pyrosequencing a salivary gland cDNA library from adult females Amblyomma maculatum ticks at different times of feeding. Assembly of this data produced 72,441 sequences larger than 149 nucleotides from which 15,914 coding sequences were extracted. Of these, 5,353 had>75% coverage to their best match in the non-redundant database from the National Center for Biotechnology information, allowing for the deposition of 4,850 sequences to GenBank. The annotated data sets are available as hyperlinked spreadsheets. Putative secreted proteins were classified in 133 families, most of which have no known function. Conclusions/Significance: This data set of proteins constitutes a mining platform for novel pharmacologically active proteins and for uncovering vaccine targets against A. maculatum and the diseases they carry.	[Karim, Shahid; Singh, Parul] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Ribeiro, Jose M. C.] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD USA	University of Southern Mississippi; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Karim, S (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	jribeiro@niaid.nih.gov	Ribeiro, Jose/J-7011-2015	Karim, Shahid/0000-0001-5596-3304; Ribeiro, Jose/0000-0002-9107-0818	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) [2007-35607-20200]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Institutes of Health-National Center for Research Resources [P20RR016476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)(United States Department of Agriculture (USDA)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) award (# 2007-35607-20200) to SK. The Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, to JMCR and the National Institutes of Health-National Center for Research Resources award (P20RR016476) to the MS-INBRE facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Chaidez FJ, 2007, INSECT BIOCHEM MOLEC, V37, P48, DOI 10.1016/j.ibmb.2006.10.002; Alim MA, 2008, J INSECT PHYSIOL, V54, P573, DOI 10.1016/j.jinsphys.2007.12.006; Alim MA, 2007, INSECT BIOCHEM MOLEC, V37, P911, DOI 10.1016/j.ibmb.2007.04.010; Alim MA, 2008, J VET MED SCI, V70, P1363, DOI 10.1292/jvms.70.1363; Alim MA, 2009, INT J PARASITOL, V39, P97, DOI 10.1016/j.ijpara.2008.06.012; Aljamali MN, 2009, INSECT MOL BIOL, V18, P129, DOI 10.1111/j.1365-2583.2009.00863.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ameri M, 2008, J MED ENTOMOL, V45, P94, DOI 10.1603/0022-2585(2008)45[94:AIBPAO]2.0.CO;2; Anatriello E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-450; Andersen JF, 2004, BIOCHEMISTRY-US, V43, P6987, DOI 10.1021/bi049655t; Andersen JF, 2009, J PROTEOME RES, V8, P1474, DOI 10.1021/pr8008429; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; Arolas JL, 2005, J MOL BIOL, V350, P489, DOI 10.1016/j.jmb.2005.05.015; Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Batista IFC, 2008, TOXICON, V51, P823, DOI 10.1016/j.toxicon.2007.12.011; Bergman DK, 1998, J MED ENTOMOL, V35, P505, DOI 10.1093/jmedent/35.4.505; Bergman DK, 2000, J PARASITOL, V86, P516, DOI 10.1645/0022-3395(2000)086[0516:IAMCOA]2.0.CO;2; Bishop R, 2002, INT J PARASITOL, V32, P833, DOI 10.1016/S0020-7519(02)00027-9; Bishopp FC, 1936, J ECON ENTOMOL, V29, P1068, DOI 10.1093/jee/29.6.1068; Boisbouvier J, 1998, J MOL BIOL, V283, P205, DOI 10.1006/jmbi.1998.2057; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; BROWN SJ, 1984, J IMMUNOL, V133, P3319; Calvete JJ, 2007, CURR PHARM DESIGN, V13, P2853, DOI 10.2174/138161207782023766; Calvo E, 2006, J EXP BIOL, V209, P2651, DOI 10.1242/jeb.02267; Calvo E, 2010, J MED ENTOMOL, V47, P376, DOI 10.1603/ME09226; Campbell CL, 2005, INSECT MOL BIOL, V14, P121, DOI 10.1111/j.1365-2583.2004.00537.x; Castaneda O, 2009, TOXICON, V54, P1119, DOI 10.1016/j.toxicon.2009.02.032; Cavassani KA, 2005, IMMUNOLOGY, V114, P235, DOI 10.1111/j.1365-2567.2004.02079.x; Cerna P, 2002, INSECT BIOCHEM MOLEC, V32, P1691, DOI 10.1016/S0965-1748(02)00109-1; CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694; CHINERY WA, 1973, J MED ENTOMOL, V10, P355, DOI 10.1093/jmedent/10.4.355; Chmelar J, 2011, BLOOD, V117, P736, DOI 10.1182/blood-2010-06-293241; Chmelar J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-233; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Espinoza-Gomez F, 2011, VECTOR-BORNE ZOONOT, V11, P945, DOI 10.1089/vbz.2010.0154; Ewing SA, 2002, VET PARASITOL, V103, P43, DOI 10.1016/S0304-4017(01)00572-6; Faudry E, 2004, J BIOL CHEM, V279, P19607, DOI 10.1074/jbc.M401681200; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Fogaca AC, 2006, PEPTIDES, V27, P667, DOI 10.1016/j.peptides.2005.07.013; Francischetti IMB, 2005, INSECT BIOCHEM MOLEC, V35, P1142, DOI 10.1016/j.ibmb.2005.05.007; Francischetti IMB, 2005, THROMB HAEMOSTASIS, V94, P167, DOI 10.1160/TH04-09-0566; Francischetti IMB, 2003, BIOCHEM BIOPH RES CO, V305, P869, DOI 10.1016/S0006-291X(03)00857-X; Francischetti IMB, 2008, INSECT BIOCHEM MOLEC, V38, P1, DOI 10.1016/j.ibmb.2007.09.009; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Francischetti IMB, 2008, J PROTEOMICS, V71, P493, DOI 10.1016/j.jprot.2008.07.006; Francischetti NMB, 2004, THROMB HAEMOSTASIS, V91, P886, DOI 10.1160/TH03-11-0715; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Galesa K, 2003, FEBS LETT, V539, P120, DOI 10.1016/S0014-5793(03)00215-1; Garg R, 2006, J IMMUNOL, V177, P6579, DOI 10.4049/jimmunol.177.10.6579; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gong HY, 2007, J INSECT PHYSIOL, V53, P1079, DOI 10.1016/j.jinsphys.2007.06.008; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Harnnoi T, 2007, COMP BIOCHEM PHYS B, V147, P93, DOI 10.1016/j.cbpb.2006.12.008; Harvey AL, 1997, GEN PHARMACOL-VASC S, V28, P7, DOI 10.1016/S0306-3623(96)00173-5; Hengst U, 2001, J BIOL CHEM, V276, P535, DOI 10.1074/jbc.M002524200; HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V92, P707, DOI 10.1016/0091-6749(93)90014-7; Hojgaard A, 2009, J MED ENTOMOL, V46, P1458, DOI 10.1603/033.046.0631; Horackova J, 2010, J VECTOR ECOL, V35, P410, DOI 10.1111/j.1948-7134.2010.00100.x; Horn M, 2009, CHEM BIOL, V16, P1053, DOI 10.1016/j.chembiol.2009.09.009; HUANG TF, 1994, J TOXICOL-TOXIN REV, V13, P253, DOI 10.3109/15569549409089964; HUANG XQ, 1992, GENOMICS, V14, P18, DOI 10.1016/S0888-7543(05)80277-0; Imamura S, 2005, VACCINE, V23, P1301, DOI 10.1016/j.vaccine.2004.08.041; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JONES LD, 1992, EXP APPL ACAROL, V13, P241, DOI 10.1007/BF01195081; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Juncadella IJ, 2007, FEMS IMMUNOL MED MIC, V49, P433, DOI 10.1111/j.1574-695X.2007.00223.x; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; KAUFMAN W, 1976, J EXP BIOL, V64, P727; Kisilevsky R, 2008, CURR OPIN INVEST DR, V9, P265; Kopacek P, 2010, ADV EXP MED BIOL, V708, P137; Kotsyfakis M, 2008, J IMMUNOL, V181, P5209, DOI 10.4049/jimmunol.181.8.5209; Kotsyfakis M, 2006, J BIOL CHEM, V281, P26298, DOI 10.1074/jbc.M513010200; Kovar L, 2004, FOLIA MICROBIOL, V49, P327, DOI 10.1007/BF02931051; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KWONG PD, 1995, STRUCTURE, V3, P1109, DOI 10.1016/S0969-2126(01)00246-5; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Leboulle G, 2002, J BIOL CHEM, V277, P10083, DOI 10.1074/jbc.M111391200; Lenarcic B, 1997, J BIOL CHEM, V272, P13899; Lenarcic B, 1999, J BIOL CHEM, V274, P563, DOI 10.1074/jbc.274.2.563; Lewis S, 2000, CURR OPIN STRUC BIOL, V10, P349, DOI 10.1016/S0959-440X(00)00095-6; Li KC, 2011, NEURON, V69, P974, DOI 10.1016/j.neuron.2011.01.022; Li WF, 2006, PEPTIDES, V27, P2350, DOI 10.1016/j.peptides.2006.03.016; Little SE, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S5; LUCCHESI KJ, 1991, J GEN PHYSIOL, V97, P1295, DOI 10.1085/jgp.97.6.1295; Ma D, THROMB HAEMOST, V105, P1032; Ma DY, 2009, MOL CELL PROTEOMICS, V8, P2071, DOI 10.1074/mcp.M900186-MCP200; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P22, DOI 10.1016/j.ibmb.2007.09.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Mans BJ, 2002, MOL BIOL EVOL, V19, P1695, DOI 10.1093/oxfordjournals.molbev.a003992; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Mathew JS, 1999, J PARASITOL, V85, P1023, DOI 10.2307/3285663; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mima J, 2003, J BIOL CHEM, V278, P29792, DOI 10.1074/jbc.M301859200; MISUMI Y, 1990, EUR J BIOCHEM, V191, P563, DOI 10.1111/j.1432-1033.1990.tb19158.x; Monteiro RQ, 2008, PROTEIN SCI, V17, P146, DOI 10.1110/ps.073016308; Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738; Mulenga A, 2001, J VET MED SCI, V63, P1063, DOI 10.1292/jvms.63.1063; Narasimhan S, 2002, INSECT MOL BIOL, V11, P641, DOI 10.1046/j.1365-2583.2002.00375.x; Nazareth RA, 2006, THROMB HAEMOSTASIS, V96, P7, DOI 10.1160/TH06-02-0105; NEITZ AWH, 1978, ONDERSTEPOORT J VET, V45, P235; Nene V, 2002, INT J PARASITOL, V32, P1447, DOI 10.1016/S0020-7519(02)00159-5; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; NIEWIAROWSKI S, 1994, SEMIN HEMATOL, V31, P289; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; Nuttall PA, 2006, PARASITE IMMUNOL, V28, P155, DOI 10.1111/j.1365-3024.2006.00806.x; OGATA S, 1990, BIOCHEMISTRY-US, V29, P7923, DOI 10.1021/bi00486a021; Paesen GA, 2000, BBA-PROTEIN STRUCT M, V1482, P92, DOI 10.1016/S0167-4838(00)00168-0; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Paesen GC, 2009, J MOL BIOL, V389, P734, DOI 10.1016/j.jmb.2009.04.045; PAFFENBARGER R S Jr, 1951, New Orleans Med Surg J, V103, P329; PATRICK CD, 1975, J MED ENTOMOL, V12, P389, DOI 10.1093/jmedent/12.3.389; Pichu S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-32; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; Prevot PP, 2007, VACCINE, V25, P3284, DOI 10.1016/j.vaccine.2007.01.008; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rego ROM, 2006, INSECT BIOCHEM MOLEC, V36, P291, DOI 10.1016/j.ibmb.2006.01.008; Rego ROM, 2005, INSECT BIOCHEM MOLEC, V35, P991, DOI 10.1016/j.ibmb.2005.04.001; Ribeiro JMC, 1998, EXP PARASITOL, V89, P213, DOI 10.1006/expr.1998.4296; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Ribeiro JMC, 2000, J MED ENTOMOL, V37, P743, DOI 10.1603/0022-2585-37.5.743; Ribeiro JMC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-136; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Rubbo H, 2009, ARCH BIOCHEM BIOPHYS, V484, P167, DOI 10.1016/j.abb.2008.11.007; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; Santos IKFD, 2004, ANN NY ACAD SCI, V1026, P242, DOI 10.1196/annals.1307.037; Sasaki SD, 2008, EXP PARASITOL, V118, P214, DOI 10.1016/j.exppara.2007.08.003; SCHMIDT SP, 1982, COMP BIOCHEM PHYS C, V72, P9, DOI 10.1016/0306-4492(82)90197-6; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schwarz A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000532; Sojka D, 2007, INT J PARASITOL, V37, P713, DOI 10.1016/j.ijpara.2006.12.020; Sojka D, 2011, ADV EXP MED BIOL, V712, P177, DOI 10.1007/978-1-4419-8414-2_11; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sterba J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-127; STEVENSON KJ, 1982, THROMB RES, V26, P341, DOI 10.1016/0049-3848(82)90252-3; Stutzer C, 2009, EXP PARASITOL, V122, P318, DOI 10.1016/j.exppara.2009.04.007; Sumner JW, 2007, EMERG INFECT DIS, V13, P751, DOI 10.3201/eid1305.061468; Sun DF, 2006, PLATELETS, V17, P178, DOI 10.1080/09537100500460234; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Trimnell AR, 2005, VACCINE, V23, P4329, DOI 10.1016/j.vaccine.2005.03.041; Turner AJ, 2000, ADV EXP MED BIOL, V477, P229; Udby L, 2004, BIOCHEMISTRY-US, V43, P12877, DOI 10.1021/bi048823e; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Valenzuela JG, 2004, PARASITOLOGY, V129, pS83, DOI 10.1017/S0031182004005189; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Volfova V, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000294; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF; Wang XY, 2009, INSECT BIOCHEM MOLEC, V39, P607, DOI 10.1016/j.ibmb.2009.06.004; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Watanabe RMO, 2010, BIOCHIMIE, V92, P933, DOI 10.1016/j.biochi.2010.03.024; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Wilson AD, 2008, VET IMMUNOL IMMUNOP, V122, P94, DOI 10.1016/j.vetimm.2007.10.011; Xu XQ, 2008, MOL CELL PROTEOMICS, V7, P582, DOI 10.1074/mcp.M700497-MCP200; Yalcin EB, 2011, ACS CHEM BIOL, V6, P176, DOI 10.1021/cb100266g; Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023; Yamazaki Y, 2003, ARCH BIOCHEM BIOPHYS, V412, P133, DOI 10.1016/S0003-9861(03)00028-6; YANG XF, 1994, ARCH BIOCHEM BIOPHYS, V315, P382, DOI 10.1006/abbi.1994.1514; Zhou JL, 2006, GENE, V372, P191, DOI 10.1016/j.gene.2005.12.020	169	149	153	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28525	10.1371/journal.pone.0028525	http://dx.doi.org/10.1371/journal.pone.0028525			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216098	gold, Green Submitted, Green Published			2022-12-25	WOS:000299113600020
J	Nakamura, TJ; Ebihara, S; Shinohara, K				Nakamura, Takahiro J.; Ebihara, Shizufumi; Shinohara, Kazuyuki			Reduced Light Response of Neuronal Firing Activity in the Suprachiasmatic Nucleus and Optic Nerve of Cryptochrome-Deficient Mice	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; GANGLION-CELLS; OCULAR PHOTORECEPTORS; RETINAL DEGENERATION; MAMMALIAN RETINA; NON-CONE; NON-ROD; MELANOPSIN; PACEMAKER; MOUSE	To examine roles of the Cryptochromes (Cry1 and Cry2) in mammalian circadian photoreception, we recorded single-unit neuronal firing activity in the suprachiasmatic nucleus (SCN), a primary circadian oscillator, and optic nerve fibers in vivo after retinal illumination in anesthetized Cry1 and Cry2 double-knockout (Cry-deficient) mice. In wild-type mice, most SCN neurons increased their firing frequency in response to retinal illumination at night, whereas only 17% of SCN neurons responded during the daytime. However, 40% of SCN neurons responded to light during the daytime, and 31% of SCN neurons responded at night in Cry-deficient mice. The magnitude of the photic response in SCN neurons at night was significantly lower (1.3-fold of spontaneous firing) in Cry-deficient mice than in wild-type mice (4.0-fold of spontaneous firing). In the optic nerve near the SCN, no difference in the proportion of light-responsive fibers was observed between daytime and nighttime in both genotypes. However, the response magnitude in the light-activated fibers (ON fibers) was high during the nighttime and low during the daytime in wild-type mice, whereas this day-night difference was not observed in Cry-deficient mice. In addition, we observed day-night differences in the spontaneous firing rates in the SCN in both genotypes and in the fibers of wild-type, but not Cry-deficient mice. We conclude that the low photo response in the SCN of Cry-deficient mice is caused by a circadian gating defect in the retina, suggesting that Cryptochromes are required for appropriate temporal photoreception in mammals.	[Nakamura, Takahiro J.; Shinohara, Kazuyuki] Nagasaki Univ, Div Neurobiol & Behav, Dept Translat Med Sci, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Nakamura, Takahiro J.; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan; [Nakamura, Takahiro J.] Teikyo Heisei Univ, Fac Pharmaceut Sci, Ichihara, Chiba, Japan	Nagasaki University; Nagoya University	Nakamura, TJ (corresponding author), Nagasaki Univ, Div Neurobiol & Behav, Dept Translat Med Sci, Grad Sch Biomed Sci, Nagasaki 852, Japan.	t.nakamura@thu.ac.jp	Nakamura, Takahiro J./W-5316-2019		Japanese Ministry of Education, Science and Culture [14011687]	Japanese Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for the Promotion of Science for Young Scientists from Japanese Ministry of Education, Science and Culture 14011687 (to TJN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Baba K, MOL VIS, V16, P2605; BARLOW RB, 1977, SCIENCE, V197, P86, DOI 10.1126/science.867057; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Bisti S, 1998, J NEUROSCI, V18, P5019; BLOCK GD, 1993, INT REV CYTOL, V146, P83, DOI 10.1016/S0074-7696(08)60381-2; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; INOUYE SIT, 1994, NEUROSCI RES, V20, P109, DOI 10.1016/0168-0102(94)90029-9; LAVAIL MM, 1978, INVEST OPHTH VIS SCI, V17, P1189; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; MEIJER JH, 1992, BRAIN RES, V598, P257, DOI 10.1016/0006-8993(92)90191-B; Meijer JH, 1998, J NEUROSCI, V18, P9078; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Miyamoto Y, 1999, MOL BRAIN RES, V71, P238, DOI 10.1016/S0169-328X(99)00192-8; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; Mrosovsky N, 2001, CHRONOBIOL INT, V18, P613, DOI 10.1081/CBI-100106076; Nakamura TJ, 2004, NEUROSCI LETT, V371, P244, DOI 10.1016/j.neulet.2004.09.005; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; TERMAN M, 1985, ANN NY ACAD SCI, V453, P147, DOI 10.1111/j.1749-6632.1985.tb11807.x; Thompson CL, 2004, MOL BRAIN RES, V122, P158, DOI 10.1016/j.molbrainres.2003.12.006; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Van Gelder RN, 2002, J NEUROGENET, V16, P181, DOI 10.1080/01677060215306; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; Yoshimura T, 1998, BRAIN RES, V779, P188, DOI 10.1016/S0006-8993(97)01122-0	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28726	10.1371/journal.pone.0028726	http://dx.doi.org/10.1371/journal.pone.0028726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216107	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600027
J	Chen, JC; Brunzell, DH; Jackson, K; van der Vaart, A; Ma, JZ; Payne, TJ; Sherva, R; Farrer, LA; Gejman, P; Levinson, DF; Holmans, P; Aggen, SH; Damaj, I; Kuo, PH; Webb, BT; Anton, R; Kranzler, HR; Gelernter, J; Li, MD; Kendler, KS; Chen, XN				Chen, Jingchun; Brunzell, Darlene H.; Jackson, Kia; van der Vaart, Andrew; Ma, Jennie Z.; Payne, Thomas J.; Sherva, Richard; Farrer, Lindsay A.; Gejman, Pablo; Levinson, Douglas F.; Holmans, Peter; Aggen, Steven H.; Damaj, Imad; Kuo, Po-Hsiu; Webb, Bradley T.; Anton, Raymond; Kranzler, Henry R.; Gelernter, Joel; Li, Ming D.; Kendler, Kenneth S.; Chen, Xiangning			ACSL6 Is Associated with the Number of Cigarettes Smoked and Its Expression Is Altered by Chronic Nicotine Exposure	PLOS ONE			English	Article							CANNABINOID RECEPTOR GENE; GENOME-WIDE ASSOCIATION; NEUROTROPHIC FACTOR; AFRICAN-AMERICAN; ENDOCANNABINOID SYSTEM; CNR1 POLYMORPHISM; WORKING-MEMORY; LUNG-CANCER; DEPENDENCE; SCHIZOPHRENIA	Individuals with schizophrenia tend to be heavy smokers and are at high risk for tobacco dependence. However, the nature of the comorbidity is not entirely clear. We previously reported evidence for association of schizophrenia with SNPs and SNP haplotypes in a region of chromosome 5q containing the SPEC2, PDZ-GEF2 and ACSL6 genes. In this current study, analysis of the control subjects of the Molecular Genetics of Schizophrenia (MGS) sample showed similar pattern of association with number of cigarettes smoked per day (numCIG) for the same region. To further test if this locus is associated with tobacco smoking as measured by numCIG and FTND, we conducted replication and meta-analysis in 12 independent samples (n>16,000) for two markers in ACSL6 reported in our previous schizophrenia study. In the meta-analysis of the replication samples, we found that rs667437 and rs477084 were significantly associated with numCIG (p = 0.00038 and 0.00136 respectively) but not with FTND scores. We then used in vitro and in vivo techniques to test if nicotine exposure influences the expression of ACSL6 in brain. Primary cortical culture studies showed that chronic (5-day) exposure to nicotine stimulated ACSL6 mRNA expression. Fourteen days of nicotine administration via osmotic mini pump also increased ACSL6 protein levels in the prefrontal cortex and hippocampus of mice. These increases were suppressed by injection of the nicotinic receptor antagonist mecamylamine, suggesting that elevated expression of ACSL6 requires nicotinic receptor activation. These findings suggest that variations in the ACSL6 gene may contribute to the quantity of cigarettes smoked. The independent associations of this locus with schizophrenia and with numCIG in non-schizophrenic subjects suggest that this locus may be a common liability to both conditions.	[Chen, Jingchun; Jackson, Kia; Aggen, Steven H.; Webb, Bradley T.; Kendler, Kenneth S.; Chen, Xiangning] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23284 USA; [Chen, Jingchun; Jackson, Kia; Aggen, Steven H.; Webb, Bradley T.; Kendler, Kenneth S.; Chen, Xiangning] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Brunzell, Darlene H.; Damaj, Imad] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Brunzell, Darlene H.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA; [Brunzell, Darlene H.] Virginia Commonwealth Univ, Interdisciplinary Neurosci Program, Richmond, VA USA; [van der Vaart, Andrew; Li, Ming D.] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA; [Ma, Jennie Z.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Payne, Thomas J.] Univ Mississippi, Med Ctr, Dept Otolaryngol & Communicat Sci, Jackson, MS 39216 USA; [Sherva, Richard; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA; [Gejman, Pablo] NorthShore Univ HealthSyst Res Inst, Ctr Psychiat Genet, Evanston, IL USA; [Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Holmans, Peter] Cardiff Univ, Sch Med, Med Resource Council,& Neurol,Biostat & Bioinform, Ctr Neuropsychiat Genet & Genom,Dept Psychol Med, Cardiff, S Glam, Wales; [Kuo, Po-Hsiu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Anton, Raymond] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Kranzler, Henry R.] Univ Penn, Dept Psychiat, Treatment Res Ctr, Sch Med 3900, Philadelphia, PA 19104 USA; [Kranzler, Henry R.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Gelernter, Joel] Vet Affairs Connecticut Healthcare Ctr, West Haven, CT USA; [Kendler, Kenneth S.; Chen, Xiangning] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Virginia; University of Virginia; University of Mississippi; University of Mississippi Medical Center; Boston University; NorthShore University Health System; Stanford University; Cardiff University; National Taiwan University; Medical University of South Carolina; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Virginia Commonwealth University	Chen, JC (corresponding author), Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23284 USA.	xchen@vcu.edu	Farrer, Lindsay/AAS-1035-2020; Webb, Bradley T/B-1459-2009; Payne, Thomas/R-4290-2019; kranzler, henry/AAS-1113-2020; Holmans, Peter/F-4518-2015; Kendler, Kenneth/AAF-2876-2019	Webb, Bradley T/0000-0002-0576-5366; Payne, Thomas/0000-0002-9839-6255; kranzler, henry/0000-0002-1018-0450; Holmans, Peter/0000-0003-0870-9412; Gelernter, Joel/0000-0002-4067-1859; Chen, Jingchun/0000-0001-9408-0117; Farrer, Lindsay/0000-0001-5533-4225; Kuo, Po-Hsiu/0000-0003-0365-3587; Sherva, Richard/0000-0003-2133-1493	National Institutes of Health [DA019498, DA011287]; Virginia Tobacco Settlement Foundation [5100004ST]; Virginia Foundation for Healthy Youth [8520667]; Medical Research Council [G0801418B] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011287, K01DA019498, R01DA012844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tobacco Settlement Foundation; Virginia Foundation for Healthy Youth; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants DA019498 to XC and DA011287 to KSK from the National Institutes of Health, by funds from the Virginia Tobacco Settlement Foundation through the Virginia Youth Tobacco Project to Virginia Commonwealth University (subcontracted to KSK, #5100004ST) and by a grant from Virginia Foundation for Healthy Youth 8520667 to DHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JC, 2005, PHARMACOL BIOCHEM BE, V81, P396, DOI 10.1016/j.pbb.2005.02.015; Arnold OH, 1999, NEUROPSYCHOBIOLOGY, V40, P21, DOI 10.1159/000026593; Batel P, 2000, EUR PSYCHIAT, V15, P115, DOI 10.1016/S0924-9338(00)00203-0; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Beuten J, 2005, AM J MED GENET B, V139B, P73, DOI 10.1002/ajmg.b.30231; Bierut LJ, 2008, DRUG ALCOHOL DEPEN, V95, P14, DOI 10.1016/j.drugalcdep.2007.11.023; Bierut LJ, 2002, ALCOHOL RES HEALTH, V26, P208; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Chavarria-Siles I, 2008, AM J MED GENET B, V147B, P279, DOI 10.1002/ajmg.b.30592; Chen T, 2004, J NEUROTRAUM, V21, P271, DOI 10.1089/089771504322972068; Chen XN, 2008, ARCH GEN PSYCHIAT, V65, P816, DOI 10.1001/archpsyc.65.7.816; Chen XN, 2006, HUM MOL GENET, V15, P3329, DOI 10.1093/hmg/ddl409; Colombo G, 2005, PHARMACOL BIOCHEM BE, V81, P369, DOI 10.1016/j.pbb.2005.01.022; Comings DE, 1997, MOL PSYCHIATR, V2, P161, DOI 10.1038/sj.mp.4000247; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; De Luca V, 2004, NEUROPSYCHOPHARMACOL, V29, P1522, DOI 10.1038/sj.npp.1300466; De Luca V, 2006, EXP BRAIN RES, V174, P292, DOI 10.1007/s00221-006-0458-y; Di Matteo V, 2007, CURR PHARM DESIGN, V13, P1269, DOI 10.2174/138161207780618920; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Fattore L, 2008, MOL CELL ENDOCRINOL, V286, pS97, DOI 10.1016/j.mce.2008.02.006; Fattore Liana, 2004, Critical Reviews in Neurobiology, V16, P147, DOI 10.1615/CritRevNeurobiol.v16.i12.160; Feltenstein MW, 2008, BRIT J PHARMACOL, V154, P261, DOI 10.1038/bjp.2008.51; Fernandez-Espejo E, 2009, PSYCHOPHARMACOLOGY, V206, P531, DOI 10.1007/s00213-009-1612-6; Forget B, 2005, PSYCHOPHARMACOLOGY, V181, P722, DOI 10.1007/s00213-005-0015-6; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Goonawardena AV, 2010, LEARN MEMORY, V17, P502, DOI 10.1101/lm.1893710; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Ho BC, 2007, AM J PSYCHIAT, V164, P1890, DOI 10.1176/appi.ajp.2007.05111903; Huang WH, 2009, NEUROPSYCHOPHARMACOL, V34, P319, DOI 10.1038/npp.2008.37; Jackson KJ, 2008, J PHARMACOL EXP THER, V325, P302, DOI 10.1124/jpet.107.132977; Jackson KJ, 2011, PHARMACOGENOMICS J, V11, P251, DOI 10.1038/tpj.2010.41; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Jackson KJ, 2009, NEUROPHARMACOLOGY, V57, P347, DOI 10.1016/j.neuropharm.2009.07.020; Jacobsen LK, 2004, BIOL PSYCHIAT, V55, P850, DOI 10.1016/j.biopsych.2003.12.023; Kendler K.S., 2007, GENES ENV PSYCHOPATH; Kendler KS, 1999, PSYCHOL MED, V29, P299, DOI 10.1017/S0033291798008022; Kumari V, 2005, NEUROSCI BIOBEHAV R, V29, P1021, DOI 10.1016/j.neubiorev.2005.02.006; Landi MT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-203; Le Foll Bernard, 2009, Handb Exp Pharmacol, P335, DOI 10.1007/978-3-540-69248-5_12; Leonard Sherry, 2007, J Dual Diagn, V3, P43, DOI 10.1300/J374v03n03_05; Li MD, 2007, MOL PSYCHIATR, V12, P462, DOI 10.1038/sj.mp.4001933; Li MD, 2005, HUM MOL GENET, V14, P1211, DOI 10.1093/hmg/ddi132; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupica CR, 2004, BRIT J PHARMACOL, V143, P227, DOI 10.1038/sj.bjp.0705931; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Mansvelder HD, 2009, SEMIN CELL DEV BIOL, V20, P432, DOI 10.1016/j.semcdb.2009.01.007; Martinez-Gras I, 2006, EUR ARCH PSY CLIN N, V256, P437, DOI 10.1007/s00406-006-0665-3; McClernon FJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2148, DOI 10.1038/sj.npp.1301618; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Merritt LL, 2008, J PHARMACOL EXP THER, V326, P483, DOI 10.1124/jpet.108.138321; Moss TG, 2009, DRUG ALCOHOL DEPEN, V104, P94, DOI 10.1016/j.drugalcdep.2009.04.005; Neves-Pereira M, 2005, MOL PSYCHIATR, V10, P208, DOI 10.1038/sj.mp.4001575; Pattij T, 2008, EUR J PHARMACOL, V585, P458, DOI 10.1016/j.ejphar.2008.02.099; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian L, 2007, BIOCHEM BIOPH RES CO, V353, P738, DOI 10.1016/j.bbrc.2006.12.121; Racz I, 2003, J NEUROSCI, V23, P2453; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; Robinson L, 2010, BEHAV BRAIN RES, V208, P584, DOI 10.1016/j.bbr.2010.01.004; Sacco KA, 2005, ARCH GEN PSYCHIAT, V62, P649, DOI 10.1001/archpsyc.62.6.649; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Salin-Pascual RJ, 2003, REV INVEST CLIN, V55, P677; Schmidt LG, 2002, DRUG ALCOHOL DEPEN, V65, P221, DOI 10.1016/S0376-8716(01)00164-8; Sherva R, 2010, NEUROPSYCHOPHARMACOL, V35, P1921, DOI 10.1038/npp.2010.64; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shoaib M, 2008, NEUROPHARMACOLOGY, V54, P438, DOI 10.1016/j.neuropharm.2007.10.011; Simpson NK, 2000, CONTROL CLIN TRIALS, V21, p356S, DOI 10.1016/S0197-2456(00)00102-1; Solowij Nadia, 2008, Curr Drug Abuse Rev, V1, P81; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; Tamminga CA, 2010, AM J PSYCHIAT, V167, P1178, DOI 10.1176/appi.ajp.2010.09081187; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Tsai SJ, 2000, PSYCHIATR GENET, V10, P149, DOI 10.1097/00041444-200010030-00008; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; van Erp TGM, 2008, PSYCHIAT RES, V159, P271, DOI 10.1016/j.psychres.2007.03.003; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Voineskos S, 2007, J PSYCHIATR NEUROSCI, V32, P412; Wang J, 2009, PROSTAG OTH LIPID M, V89, P112, DOI 10.1016/j.prostaglandins.2008.12.002; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560; Zintzaras E, 2007, PSYCHIAT GENET, V17, P69, DOI 10.1097/YPG.0b013e32801119da; Zuo LJ, 2007, BIOL PSYCHIAT, V62, P616, DOI 10.1016/j.biopsych.2006.12.004	86	9	9	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28790	10.1371/journal.pone.0028790	http://dx.doi.org/10.1371/journal.pone.0028790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205969	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000298666200011
J	Vella, JB; Thompson, SD; Bucsek, MJ; Song, MJ; Huard, J				Vella, Joseph B.; Thompson, Seth D.; Bucsek, Mark J.; Song, Minjung; Huard, Johnny			Murine and Human Myogenic Cells Identified by Elevated Aldehyde Dehydrogenase Activity: Implications for Muscle Regeneration and Repair	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO3A; BONE MORPHOGENETIC PROTEIN; SKELETAL-MUSCLE; STEM-CELLS; PROGENITOR CELLS; MUSCULAR-DYSTROPHY; ENDOTHELIAL-CELLS; DIFFERENTIATION; TRANSPLANTATION; SURVIVAL	Background: Despite the initial promise of myoblast transfer therapy to restore dystrophin in Duchenne muscular dystrophy patients, clinical efficacy has been limited, primarily by poor cell survival post-transplantation. Murine muscle derived stem cells (MDSCs) isolated from slowly adhering cells (SACs) via the preplate technique, induce greater muscle regeneration than murine myoblasts, primarily due to improved post-transplantation survival, which is conferred by their increased stress resistance capacity. Aldehyde dehydrogenase (ALDH) represents a family of enzymes with important morphogenic as well as oxidative damage mitigating roles and has been found to be a marker of stem cells in both normal and malignant tissue. In this study, we hypothesized that elevated ALDH levels could identify murine and human muscle derived cell (hMDC) progenitors, endowed with enhanced stress resistance and muscle regeneration capacity. Methodology/Principal Findings: Skeletal muscle progenitors were isolated from murine and human skeletal muscle by a modified preplate technique and unfractionated enzymatic digestion, respectively. ALDH(hi) subpopulations isolated by fluorescence activate cell sorting demonstrated increased proliferation and myogenic differentiation capacities compared to their ALDH(lo) counterparts when cultivated in oxidative and inflammatory stress media conditions. This behavior correlated with increased intracellular levels of reduced glutathione and superoxide dismutase. ALDH(hi) murine myoblasts were observed to exhibit an increased muscle regenerative potential compared to ALDH(lo) myoblasts, undergo multipotent differentiation (osteogenic and chondrogenic), and were found predominately in the SAC fraction, characteristics that are also observed in murine MDSCs. Likewise, human ALDH(hi) hMDCs demonstrated superior muscle regenerative capacity compared to ALDH(lo) hMDCs. Conclusions: The methodology of isolating myogenic cells on the basis of elevated ALDH activity yielded cells with increased stress resistance, a behavior that conferred increased regenerative capacity of dystrophic murine skeletal muscle. This result demonstrates the critical role of stress resistance in myogenic cell therapy as well as confirms the role of ALDH as a marker for rapid isolation of murine and human myogenic progenitors for cell therapy.	[Vella, Joseph B.; Thompson, Seth D.; Bucsek, Mark J.; Song, Minjung; Huard, Johnny] Childrens Hosp Pittsburgh, Stem Cell Res Ctr, Dept Orthoped Surg, Pittsburgh, PA 15213 USA; [Vella, Joseph B.; Bucsek, Mark J.; Huard, Johnny] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Huard, Johnny] Univ Pittsburgh, McGowen Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vella, JB (corresponding author), Childrens Hosp Pittsburgh, Stem Cell Res Ctr, Dept Orthoped Surg, Pittsburgh, PA 15213 USA.	jhuard@pitt.edu	Vella, Joe/AFG-8321-2022; Vella, Joe/AAF-1801-2022	Thompson, Seth/0000-0002-6769-6941	Nation Institutes of Health (NIH) [T32 EB001026, NIH RO1 DE013420-10]; Department of Defense [W81XWH-09-1-0658]; University of Pittsburgh; Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013420] Funding Source: NIH RePORTER	Nation Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University of Pittsburgh(University of Pittsburgh); Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the Nation Institutes of Health (NIH T32 EB001026 and NIH RO1 DE013420-10), the Department of Defense (Contract #:W81XWH-09-1-0658) the Henry J. Mankin Endowed Chair at the University of Pittsburgh and the William F. and Jean W. Donaldson Endowed Chair at the Children's Hospital of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bahnson A, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-19; Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613; BEAUCHAMP JR, 1994, MUSCLE NERVE       S, V4, P261; Bottino R, 2002, DIABETES, V51, P2561, DOI 10.2337/diabetes.51.8.2561; Bouchentouf M, 2007, CURR OPIN ORGAN TRAN, V12, P664, DOI 10.1097/MOT.0b013e3282f19f20; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Cai H, 2006, BIOCHEM BIOPH RES CO, V350, P364, DOI 10.1016/j.bbrc.2006.09.046; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; Capoccia BJ, 2009, BLOOD, V113, P5340, DOI 10.1182/blood-2008-04-154567; Cash DE, 1997, J CELL BIOL, V136, P445, DOI 10.1083/jcb.136.2.445; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cerletti M, 2006, J CELL SCI, V119, P3117, DOI 10.1242/jcs.03056; Chen HL, 2010, MOL CELL ENDOCRINOL, V323, P147, DOI 10.1016/j.mce.2010.02.034; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Deasy BM, 2002, STEM CELLS, V20, P50, DOI 10.1634/stemcells.20-1-50; Deasy BM, 2007, M S-MED SCI, V23, P798, DOI 10.1051/medsci/20072310798; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Douville J, 2009, STEM CELLS DEV, V18, P17, DOI 10.1089/scd.2008.0055; Drowley L, 2010, MOL THER, V18, P1865, DOI 10.1038/mt.2010.160; EDWARDS MKS, 1983, DEV BIOL, V98, P187, DOI 10.1016/0012-1606(83)90348-2; Fink MP, 2007, CRIT CARE MED, V35, pS461, DOI 10.1097/01.CCM.0000279192.96303.E7; Froeschle A, 1998, ONCOGENE, V16, P3369, DOI 10.1038/sj.onc.1201894; Fulle S, 2005, EXP GERONTOL, V40, P189, DOI 10.1016/j.exger.2004.11.006; Gazit D, 1999, J GENE MED, V1, P121, DOI 10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J; GAZIT D, 1993, MOL ENDOCRINOL, V7, P189, DOI 10.1210/me.7.2.189; Gentry T, 2007, CYTOTHERAPY, V9, P259, DOI 10.1080/14653240701218516; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ginestier C, 2009, CELL CYCLE, V8, P3297, DOI 10.4161/cc.8.20.9761; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Guerette B, 1997, J IMMUNOL, V159, P2522; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; HALEVY O, 1993, J CELL PHYSIOL, V154, P566, DOI 10.1002/jcp.1041540315; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; HUARD J, 1994, HUM GENE THER, V5, P949, DOI 10.1089/hum.1994.5.8-949; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jankowski RJ, 2002, J CELL SCI, V115, P4361, DOI 10.1242/jcs.00110; Jankowski RJ, 2001, HUM GENE THER, V12, P619, DOI 10.1089/104303401300057306; Jean E, 2011, J CELL MOL MED, V15, P119, DOI 10.1111/j.1582-4934.2009.00942.x; Jiang JF, 2008, INT J RADIAT ONCOL, V70, P816, DOI 10.1016/j.ijrobp.2007.10.047; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; KUMAR V, 2005, ROBBINS COTRAN PATHO, P48; Lassen N, 2007, J BIOL CHEM, V282, P25668, DOI 10.1074/jbc.M702076200; Li YP, 1998, FASEB J, V12, P871, DOI 10.1096/fasebj.12.10.871; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Macias CA, 2007, ANN SURG, V245, P305, DOI 10.1097/01.sla.0000236626.57752.8e; Makia NL, 2011, CHEM-BIOL INTERACT, V191, P278, DOI 10.1016/j.cbi.2011.01.013; Meng JH, 2011, NEUROMUSCULAR DISORD, V21, P4, DOI 10.1016/j.nmd.2010.10.004; MITCHELL JB, 1983, RADIAT RES, V96, P422, DOI 10.2307/3576226; Nagano M, 2007, BLOOD, V110, P151, DOI 10.1182/blood-2006-10-047092; Ogasawara MA, 2009, ANTIOXID REDOX SIGN, V11, P1107, DOI [10.1089/ars.2008.2308, 10.1089/ARS.2008.2308]; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Qu Z, 2000, GENE THER, V7, P428, DOI 10.1038/sj.gt.3301103; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; RICHLER C, 1970, DEV BIOL, V23, P1, DOI 10.1016/S0012-1606(70)80004-5; RYAN T, 2011, STEM CELL REV REP, P1; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Skuk D, 2003, J NEUROPATH EXP NEUR, V62, P951, DOI 10.1093/jnen/62.9.951; Skuk D, 2007, TRANSPLANTATION, V84, P1307, DOI 10.1097/01.tp.0000288322.94252.22; Skuk D, 2011, EXPERT OPIN BIOL TH, V11, P359, DOI 10.1517/14712598.2011.548800; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Storms RW, 2005, BLOOD, V106, P95, DOI 10.1182/blood-2004-09-3652; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; van den Brink MRM, 2002, NAT REV IMMUNOL, V2, P273, DOI 10.1038/nri775; Vauchez K, 2009, MOL THER, V17, P1948, DOI 10.1038/mt.2009.204; VONSCHROEDER HP, 1994, TERATOLOGY, V50, P54, DOI 10.1002/tera.1420500108; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	85	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29226	10.1371/journal.pone.0029226	http://dx.doi.org/10.1371/journal.pone.0029226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195027	Green Published, gold			2022-12-25	WOS:000298370400041
J	Watkins, AJ; Lucas, ES; Wilkins, A; Cagampang, FRA; Fleming, TP				Watkins, Adam J.; Lucas, Emma S.; Wilkins, Adrian; Cagampang, Felino R. A.; Fleming, Tom P.			Maternal Periconceptional and Gestational Low Protein Diet Affects Mouse Offspring Growth, Cardiovascular and Adipose Phenotype at 1 Year of Age	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; CATCH-UP GROWTH; BETA-CELL MASS; INSULIN-RESISTANCE; GENE-EXPRESSION; PRENATAL EXPOSURE; RESTRICTION LEADS; IN-UTERO; MALE-RAT; GLUCOSE-TOLERANCE	Human and animal studies have revealed a strong association between periconceptional environmental factors, such as poor maternal diet, and an increased propensity for cardiovascular and metabolic disease in adult offspring. Previously, we reported cardiovascular and physiological effects of maternal low protein diet (LPD) fed during discrete periods of periconceptional development on 6-month-old mouse offspring. Here, we extend the analysis in 1 year aging offspring, evaluating mechanisms regulating growth and adiposity. Isocaloric LPD (9% casein) or normal protein diet (18% casein; NPD) was fed to female MF-1 mice either exclusively during oocyte maturation (for 3.5 days prior to mating; Egg-LPD, Egg-NPD, respectively), throughout gestation (LPD, NPD) or exclusively during preimplantation development (for 3.5 days post mating; Emb-LPD). LPD and Emb-LPD female offspring were significantly lighter and heavier than NPD females respectively for up to 52 weeks. Egg-LPD, LPD and Emb-LPD offspring displayed significantly elevated systolic blood pressure at 52 weeks compared to respective controls (Egg-NPD, NPD). LPD females had significantly reduced inguinal and retroperitoneal fat pad: body weight ratios compared to NPD females. Expression of the insulin receptor (Insr) and insulin-like growth factor I receptor (Igf1r) in retroperitoneal fat was significantly elevated in Emb-LPD females (P<0.05), whilst Emb-LPD males displayed significantly decreased expression of the mitochondrial uncoupling protein 1 (Ucp1) gene compared to NPD offspring. LPD females displayed significantly increased expression of Ucp1 in interscapular brown adipose tissue when compared to NPD offspring. Our results demonstrate that aging offspring body weight, cardiovascular and adiposity homeostasis can be programmed by maternal periconceptional nutrition. These adverse outcomes further exemplify the criticality of dietary behaviour around the time of conception on long-term offspring health.	[Watkins, Adam J.; Lucas, Emma S.; Fleming, Tom P.] Univ Southampton, Southampton Gen Hosp, Sch Biol Sci, Southampton, Hants, England; [Watkins, Adam J.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Wilkins, Adrian; Cagampang, Felino R. A.] Univ Southampton, Fac Med, Southampton Gen Hosp, Human Dev & Hlth Unit,Inst Dev Sci, Southampton SO9 5NH, Hants, England	University of Southampton; University of Nottingham; University of Southampton	Watkins, AJ (corresponding author), Univ Southampton, Southampton Gen Hosp, Sch Biol Sci, Southampton, Hants, England.	adam.watkins@nottingham.ac.uk	Lucas, Emma S/I-2719-2013; Cagampang, Felino/AAG-5141-2019; Watkins, Adam J/J-4839-2013; Watkins, Adam/AAH-9401-2021	Lucas, Emma S/0000-0002-8571-8921; Cagampang, Felino/0000-0003-4404-9853; Watkins, Adam J/0000-0002-0842-1251; Watkins, Adam/0000-0002-0842-1251	Biotechnology and Biological Sciences Research Council [BBF007450]; National Institutes of Health, USA as part of the NICHD [U01 HD04435]; Gerald Kerkut Charitable Trust; COST Action [FA0702]; Biotechnology and Biological Sciences Research Council [BB/I001840/1, BB/F007450/1] Funding Source: researchfish; BBSRC [BB/F007450/1, BB/I001840/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health, USA as part of the NICHD; Gerald Kerkut Charitable Trust; COST Action(European Cooperation in Science and Technology (COST)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council [grant number BBF007450], the National Institutes of Health, USA as part of the NICHD National Cooperative Program on Female Health and Egg Quality under cooperative agreement [grant number U01 HD04435] and the Gerald Kerkut Charitable Trust. In addition, we acknowledge the support of the COST Action FA0702 'GEMINI' for the opportunity to discuss and share research ideas amongst scientists within this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2005, J PHYSIOL-LONDON, V565, P171, DOI 10.1113/jphysiol.2005.084947; Augustyniak RA, 2010, AM J PHYSIOL-REG I, V298, pR1375, DOI 10.1152/ajpregu.00848.2009; Battista MC, 2002, AM J PHYSIOL-ENDOC M, V283, pE124, DOI 10.1152/ajpendo.00004.2001; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Berney DM, 1997, J PATHOL, V183, P109; Bertin E, 2002, AM J PHYSIOL-REG I, V283, pR623, DOI 10.1152/ajpregu.00037.2002; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bol VV, 2009, AM J PHYSIOL-REG I, V297, pR291, DOI 10.1152/ajpregu.90497.2008; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004950; Cleal JK, 2007, P NATL ACAD SCI USA, V104, P9529, DOI 10.1073/pnas.0610373104; Delahaye F, 2010, AM J PHYSIOL-REG I, V299, pR101, DOI 10.1152/ajpregu.00604.2009; Edwards LJ, 2002, AM J PHYSIOL-REG I, V283, pR669, DOI 10.1152/ajpregu.00736.2001; Elahi MM, 2008, HYPERTENSION, V51, P939, DOI 10.1161/HYPERTENSIONAHA.107.100982; Elmes MJ, 2007, BRIT J NUTR, V98, P93, DOI 10.1017/S000711450769182X; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Fagundes ATS, 2009, HORM METAB RES, V41, P866, DOI 10.1055/s-0029-1233457; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Garofano A, 1999, DIABETOLOGIA, V42, P711, DOI 10.1007/s001250051219; Garofano A, 1997, DIABETOLOGIA, V40, P1231, DOI 10.1007/s001250050812; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Guan HY, 2005, AM J PHYSIOL-ENDOC M, V288, pE663, DOI 10.1152/ajpendo.00461.2004; Hanson MA, 2008, BASIC CLIN PHARMACOL, V102, P90, DOI 10.1111/j.1742-7843.2007.00186.x; Kwong WY, 2000, DEVELOPMENT, V127, P4195; LANGLEY SC, 1994, COMP BIOCHEM PHYS A, V109, P223, DOI 10.1016/0300-9629(94)90124-4; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; LangleyEvans SC, 1996, J REPROD FERTIL, V106, P307, DOI 10.1530/jrf.0.1060307; Lucas ES, 2011, THERIOGENOLOGY, V76, P558, DOI 10.1016/j.theriogenology.2011.03.008; Maloney CA, 2011, J NUTR, V141, P95, DOI 10.3945/jn.109.119453; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; Mortensen ELK, 2010, INT J OBESITY, V34, P1618, DOI 10.1038/ijo.2010.91; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Reckelhoff JF, 1998, HYPERTENSION, V31, P435, DOI 10.1161/01.HYP.31.1.435; Robinson S, 2007, GENES NUTR, V2, P31, DOI 10.1007/s12263-007-0004-y; SAKEMI T, 1995, NEPHRON, V69, P159, DOI 10.1159/000188433; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Sugden MC, 2002, J ENDOCRINOL, V175, P757, DOI 10.1677/joe.0.1750757; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Theys N, 2009, AM J PHYSIOL-REG I, V297, pR1516, DOI 10.1152/ajpregu.00280.2009; Todd SE, 2009, PEDIATR RES, V65, P409, DOI 10.1203/PDR.0b013e3181975efa; Torrens C, 2009, BRIT J NUTR, V101, P27, DOI 10.1017/S0007114508988760; Torrens C, 2009, EXP PHYSIOL, V94, P1024, DOI 10.1113/expphysiol.2009.047340; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vickers MH, 2001, ENDOCRINOLOGY, V142, P3964, DOI 10.1210/en.142.9.3964; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Watkins AJ, 2010, J DEV ORIG HLTH DIS, V1, P87, DOI 10.1017/S2040174409990195; Watkins AJ, 2008, J PHYSIOL-LONDON, V586, P2231, DOI 10.1113/jphysiol.2007.149229; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Watkins AJ, 2010, BRIT J NUTR, V103, P1762, DOI 10.1017/S0007114509993783	56	87	89	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28745	10.1371/journal.pone.0028745	http://dx.doi.org/10.1371/journal.pone.0028745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194901	gold, Green Accepted, Green Published			2022-12-25	WOS:000298370400018
J	Hammond, AS; Dumont, ER; McCarthy, RC				Hammond, Ashley S.; Dumont, Elizabeth R.; McCarthy, Robert C.			The Effect of Unerupted Permanent Tooth Crowns on the Distribution of Masticatory Stress in Children	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; BITE FORCE; LIFE-HISTORY; AUSTRALOPITHECUS-AFRICANUS; MECHANICAL-PROPERTIES; FEEDING BIOMECHANICS; BRIEF COMMUNICATION; DENTAL DEVELOPMENT; FACIAL SKELETON; EVOLUTION	Human mothers wean their children from breast milk at an earlier developmental stage than do ape mothers, resulting in human children chewing solid and semi-solid foods using the deciduous dentition. Mechanical forces generated by chewing solid foods during the post-weaning period travel through not only the deciduous teeth, but also the enamel caps of the developing permanent teeth within the maxilla and mandible, which are not present in the adult face. The effects of mechanical stress propagating through these very stiff structures have yet to be examined. Based on a heuristic model, we predicted that the enamel of the embedded developing teeth would act to reduce stresses in the surrounding bony elements of the juvenile face. We tested this hypothesis by simulating occlusal loading in a finite element (FE) model of a child's cranium with a complete set of deciduous teeth and the first permanent molars embedded in the bony crypt in the maxilla. We modeled bone and enamel with appropriate material properties and assessed the effect of embedding high-stiffness enamel structures on stress distribution in the juvenile face. Against expectation, the presence of unerupted enamel caps does not affect the magnitude or location of stresses in the juvenile face. Our results do not support the hypothesis that the unerupted secondary teeth act to moderate stresses in the juvenile face.	[Hammond, Ashley S.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Hammond, Ashley S.; McCarthy, Robert C.] Florida Atlantic Univ, Dept Anthropol, Boca Raton, FL 33431 USA; [Dumont, Elizabeth R.] Univ Massachusetts, Dept Organismal & Evolutionary Biol, Amherst, MA 01003 USA; [McCarthy, Robert C.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA	University of Missouri System; University of Missouri Columbia; State University System of Florida; Florida Atlantic University; University of Massachusetts System; University of Massachusetts Amherst; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Hammond, AS (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	ashammond@mail.mizzou.edu	D, Betsy/ABD-1855-2020; Hammond, Ashley S./G-2158-2012	Hammond, Ashley S./0000-0001-8444-0553	National Science Foundation [DBI-0743460]; Direct For Biological Sciences [0743460] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation Grant number DBI-0743460 to E.R. Dumont and I.R. Grosse supported teaching author ASH the methods to be employed in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1991, J HUM EVOL, V21, P397, DOI 10.1016/0047-2484(91)90114-B; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; BHASKAR SN, 1976, ENAMEL ORBANS ORAL H, P45; Bogin B., 1999, PATTERNS HUMAN GROWT, V2nd ed.; CABANA T, 1993, AM J HUM BIOL, V5, P93, DOI 10.1002/ajhb.1310050113; Castelo PM, 2007, EUR J ORTHODONT, V29, P149, DOI 10.1093/ejo/cjl089; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Cobb SN, 2011, J ANAT, V218, P96, DOI 10.1111/j.1469-7580.2010.01321.x; Couly G, 1975, Rev Stomatol Chir Maxillofac, V76, P607; DAEGLING DJ, 1991, AM J PHYS ANTHROPOL, V86, P321, DOI 10.1002/ajpa.1330860302; DETTWYLER KA, 1992, ANNU REV ANTHROPOL, V21, P171; Dettwyler Katherine A., 1995, BREASTFEEDING BIOCUL; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Endo B., 1966, J FS U TOKYO, V3, P1; Gavião Maria Beatriz Duarte, 2007, Braz. oral res., V21, P146, DOI 10.1590/S1806-83242007000200009; Gross MD, 2001, J ORAL REHABIL, V28, P684, DOI 10.1046/j.1365-2842.2001.00711.x; Grosse IR, 2007, ANAT REC, V290, P1069, DOI 10.1002/ar.20568; Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3; HILLSON S, 1996, DENTAL ANTHR; Huang HM, 2006, J DENT, V34, P261, DOI 10.1016/j.jdent.2005.06.007; Kamegai T, 2005, EUR J ORTHODONT, V27, P53, DOI 10.1093/ejo/cjh090; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kelley J, 2010, P NATL ACAD SCI USA, V107, P1035, DOI 10.1073/pnas.0906206107; Kennedy GE, 2005, J HUM EVOL, V48, P123, DOI 10.1016/j.jhevol.2004.09.005; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972; Lieberman DE, 2008, EVOL ANTHROPOL, V17, P55, DOI 10.1002/evan.20154; Lieberman DE, 2004, J HUM EVOL, V46, P655, DOI 10.1016/j.jhevol.2004.03.005; Liversidge HM, 2009, FRONT ORAL BIOL, V13, P153, DOI 10.1159/000242409; Lucas PW, 2009, AM J PHYS ANTHROPOL, V140, P643, DOI 10.1002/ajpa.21026; MANSON PN, 1980, PLAST RECONSTR SURG, V66, P54, DOI 10.1097/00006534-198007000-00010; Marinescu R, 2005, ANAT REC PART A, V283A, P300, DOI 10.1002/ar.a.20166; Marlowe FW, 2003, EVOL HUM BEHAV, V24, P217, DOI 10.1016/S1090-5138(03)00014-X; Osborn JW, 1996, J BIOMECH, V29, P589, DOI 10.1016/0021-9290(95)00117-4; Peterson J, 2006, ANAT REC PART A, V288A, P962, DOI 10.1002/ar.a.20358; Ravosa MJ, 2007, J EXP BIOL, V210, P628, DOI 10.1242/jeb.02683; Rentes AM, 2002, J ORAL REHABIL, V29, P1174, DOI 10.1046/j.1365-2842.2002.00957.x; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; Shapiro D, 1997, AM J PHYS ANTHROPOL, V103, P415, DOI 10.1002/(SICI)1096-8644(199707)103:3<415::AID-AJPA11>3.3.CO;2-J; Smith B. Holly, 1994, Yearbook of Physical Anthropology, V37, P177; SMITH BH, 1991, AM J PHYS ANTHROPOL, V86, P157, DOI 10.1002/ajpa.1330860206; Smith BH, 1992, EVOL ANTHROPOL, V1, P134, DOI DOI 10.1002/EVAN.1360010406; SPENCER MA, 1993, AM J PHYS ANTHROPOL, V91, P1, DOI 10.1002/ajpa.1330910102; Strait DS, 2010, ANAT REC, V293, P583, DOI 10.1002/ar.21122; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Sugarman M, 1995, CLIN PEDIATR, V34, P642, DOI 10.1177/000992289503401203; Ubelaker D.H., 1989, HUMAN SKELETAL REMAI, V3rd; Wang Q, 2010, ANAT REC, V293, P607, DOI 10.1002/ar.21123; Wise GE, 2007, CLIN ANAT, V20, P632, DOI 10.1002/ca.20495; Wroe S, 2007, ANAT REC, V290, P1248, DOI 10.1002/ar.20594; Wroe S, 2010, P ROY SOC B-BIOL SCI, V277, P3579, DOI 10.1098/rspb.2010.0509	53	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29121	10.1371/journal.pone.0029121	http://dx.doi.org/10.1371/journal.pone.0029121			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195003	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100157
J	Sun, W; Grassi, P; Engstrom, A; Sooriyaarachchi, S; Ubhayasekera, W; Hreinsson, J; Wanggren, K; Clark, GF; Dell, A; Schedin-Weiss, S				Sun, Wei; Grassi, Paola; Engstrom, Ake; Sooriyaarachchi, Sanjeewani; Ubhayasekera, Wimal; Hreinsson, Julius; Wanggren, Kjell; Clark, Gary F.; Dell, Anne; Schedin-Weiss, Sophia			N-glycans of Human Protein C Inhibitor: Tissue-Specific Expression and Function	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; SEMINAL PLASMA; BINDING; SERPIN; COMPLEXES; MECHANISM; CELLS; SEMEN	Protein C inhibitor (PCI) is a serpin type of serine protease inhibitor that is found in many tissues and fluids in human, including blood plasma, seminal plasma and urine. This inhibitor displays an unusually broad protease specificity compared with other serpins. Previous studies have shown that the N-glycan(s) and the NH2-terminus affect some blood-related functions of PCI. In this study, we have for the first time determined the N-glycan profile of seminal plasma PCI, by mass spectrometry. The N-glycan structures differed markedly compared with those of both blood-derived and urinary PCI, providing evidence that the N-glycans of PCI are expressed in a tissue-specific manner. The most abundant structure (m/z 2592.9) had a composition of Fuc(3)Hex(5)HexNAc(4), consistent with a core fucosylated bi-antennary glycan with terminal Lewis x. A major serine protease in semen, prostate specific antigen (PSA), was used to evaluate the effects of N-glycans and the NH2-terminus on a PCI function related to the reproductive tract. Second-order rate constants for PSA inhibition by PCI were 4.3 +/- 0.2 and 4.1 +/- 0.5 M-1 s(-1) for the natural full-length PCI and a form lacking six amino acids at the NH2-terminus, respectively, whereas these constants were 4.8 +/- 0.1 and 29 +/- 7 M-1 s(-1) for the corresponding PNGase F-treated forms. The 7-8-fold higher rate constants obtained when both the N-glycans and the NH(2-)terminus had been removed suggest that these structures jointly affect the rate of PSA inhibition, presumably by together hindering conformational changes of PCI required to bind to the catalytic pocket of PSA.	[Sun, Wei; Engstrom, Ake; Ubhayasekera, Wimal; Schedin-Weiss, Sophia] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Grassi, Paola; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England; [Sooriyaarachchi, Sanjeewani] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [Hreinsson, Julius; Wanggren, Kjell] Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Clark, Gary F.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO USA	Uppsala University; Imperial College London; Uppsala University; Uppsala University; Uppsala University Hospital; University of Missouri System; University of Missouri Columbia	Sun, W (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	sophia.schedin.weiss@ki.se		Schedin Weiss, Sophia/0000-0003-2143-7052; Dell, Anne/0000-0003-1380-2347	Swedish Research Council [2005-6412]; Magnus Bergvall foundation; Biotechnology and Biological Sciences Research Council [BBF0083091, B19088]; Marie Curie Initial Training Network	Swedish Research Council(Swedish Research CouncilEuropean Commission); Magnus Bergvall foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Initial Training Network(European Commission)	This work was supported by Swedish Research Council grant 2005-6412 and by the Magnus Bergvall foundation (to S.S.W.), by the Biotechnology and Biological Sciences Research Council (BBF0083091 and B19088) and by the Marie Curie Initial Training Network, EuroglycoArrays Project, part of the FP7 People Programme (to A.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren G, 1995, J ANDROL, V16, P491; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; CHRISTENSSON A, 1994, EUR J BIOCHEM, V220, P45, DOI 10.1111/j.1432-1033.1994.tb18597.x; CLARK GF, 2011, MOL CELL PROTEOMICS; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Elisen MGLM, 1996, THROMB HAEMOSTASIS, V75, P760; ESPANA F, 1991, THROMB RES, V64, P309, DOI 10.1016/0049-3848(91)90002-E; Espana F, 1999, ANDROLOGIA, V31, P217, DOI 10.1046/j.1439-0272.1999.00282.x; ESPANA F, 1993, THROMB HAEMOSTASIS, V70, P989; ESPANA F, 1995, EUR J BIOCHEM, V234, P641, DOI 10.1111/j.1432-1033.1995.641_b.x; Fujita M, 2002, THROMB RES, V105, P95, DOI 10.1016/S0049-3848(01)00398-X; Garcia-Vallejo JJ, 2009, IMMUNOL REV, V230, P22, DOI 10.1111/j.1600-065X.2009.00786.x; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; He SP, 1999, MOL HUM REPROD, V5, P513, DOI 10.1093/molehr/5.6.513; HERMANS JM, 1994, BIOCHEMISTRY-US, V33, P5440, DOI 10.1021/bi00184a012; Izutani W, 2001, THROMB RES, V104, P65, DOI 10.1016/S0049-3848(01)00342-5; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURELL M, 1992, J CLIN INVEST, V89, P1094, DOI 10.1172/JCI115689; LI W, 2007, J BIOL CHEM; LUNDWALL A, 1987, FEBS LETT, V214, P317, DOI 10.1016/0014-5793(87)80078-9; MACDONALD RJ, 1988, BIOCHEM J, V253, P313, DOI 10.1042/bj2530313; Meinhardt A, 2011, MOL CELL ENDOCRINOL, V335, P60, DOI 10.1016/j.mce.2010.03.022; Menez R, 2008, J MOL BIOL, V376, P1021, DOI 10.1016/j.jmb.2007.11.052; MOORE A, 1993, MOL REPROD DEV, V34, P280, DOI 10.1002/mrd.1080340308; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Pang PC, 2009, J PROTEOME RES, V8, P4906, DOI 10.1021/pr9001756; RADTKE KP, 1988, BIOL CHEM H-S, V369, P965, DOI 10.1515/bchm3.1988.369.2.965; RADTKE KP, 1994, J CLIN INVEST, V94, P2117, DOI 10.1172/JCI117566; Sun W, 2008, J BIOL CHEM, V283, P18601, DOI 10.1074/jbc.M800608200; Sun W, 2010, BIOCHEM BIOPH RES CO, V403, P198, DOI 10.1016/j.bbrc.2010.11.005; Sun W, 2009, BIOCHEMISTRY-US, V48, P1094, DOI 10.1021/bi802138m; Suzuki K, 2008, J THROMB HAEMOST, V6, P2017, DOI 10.1111/j.1538-7836.2008.03181.x; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; Uhrin P, 2000, J CLIN INVEST, V106, P1531, DOI 10.1172/JCI10768; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979	41	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29011	10.1371/journal.pone.0029011	http://dx.doi.org/10.1371/journal.pone.0029011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205989	gold, Green Submitted, Green Published			2022-12-25	WOS:000298665600021
J	Tan, SX; Ng, Y; Meoli, CC; Kumar, A; Khoo, PS; Fazakerley, DJ; Junutula, JR; Vali, S; James, DE; Stockli, J				Tan, Shi-Xiong; Ng, Yvonne; Meoli, Christopher C.; Kumar, Ansu; Khoo, Poh-Sim; Fazakerley, Daniel J.; Junutula, Jagath R.; Vali, Shireen; James, David E.; Stoeckli, Jacqueline			Amplification and Demultiplexing in Insulin-regulated Akt Protein Kinase Pathway in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3T3-L1 ADIPOCYTES; RECEPTOR SUBSTRATE-1; GLUT4 TRANSLOCATION; GLUCOSE-TRANSPORT; RAPAMYCIN PATHWAY; PLASMA-MEMBRANE; MICE LACKING; PHOSPHORYLATION; ACTIVATION; RESISTANCE	Akt plays a major role in insulin regulation of metabolism in muscle, fat, and liver. Here, we show that in 3T3-L1 adipocytes, Akt operates optimally over a limited dynamic range. This indicates that Akt is a highly sensitive amplification step in the pathway. With robust insulin stimulation, substantial changes in Akt phosphorylation using either pharmacologic or genetic manipulations had relatively little effect on Akt activity. By integrating these data we observed that half-maximal Akt activity was achieved at a threshold level of Akt phosphorylation corresponding to 5-22% of its full dynamic range. This behavior was also associated with lack of concordance or demultiplexing in the behavior of downstream components. Most notably, FoxO1 phosphorylation was more sensitive to insulin and did not exhibit a change in its rate of phosphorylation between 1 and 100 nM insulin compared with other substrates (AS160, TSC2, GSK3). Similar differences were observed between various insulin-regulated pathways such as GLUT4 translocation and protein synthesis. These data indicate that Akt itself is a major amplification switch in the insulin signaling pathway and that features of the pathway enable the insulin signal to be split or demultiplexed into discrete outputs. This has important implications for the role of this pathway in disease.	[Tan, Shi-Xiong; Ng, Yvonne; Meoli, Christopher C.; Fazakerley, Daniel J.; James, David E.; Stoeckli, Jacqueline] St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW 2010, Australia; [James, David E.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2050, Australia; [Kumar, Ansu; Vali, Shireen] Cellworks Grp Inc, Saratoga, CA 95070 USA; [Khoo, Poh-Sim; Junutula, Jagath R.] Genentech Inc, San Francisco, CA 94080 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; Roche Holding; Genentech	James, DE (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Res Program, 384 Victoria St, Sydney, NSW 2010, Australia.	d.james@garvan.org.au	Stoeckli, Jacqueline/D-7053-2016; Fazakerley, Daniel/J-2652-2019; Stoeckli, Jacqueline/Z-4443-2019; Tan, Shi-Xiong/Y-3728-2019; Junutula, Jagath Reddy/ABD-4753-2020	Stoeckli, Jacqueline/0000-0002-6446-7350; Fazakerley, Daniel/0000-0001-8241-2903; Stoeckli, Jacqueline/0000-0002-6446-7350; Junutula, Jagath Reddy/0000-0002-5942-4428; Tan, Shi-Xiong/0000-0002-0020-2572; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia.	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; CHANEY LK, 1983, J BIOL CHEM, V258, P62; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cirstea D, 2010, MOL CANCER THER, V9, P963, DOI 10.1158/1535-7163.MCT-09-0763; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; KAHN CR, 1978, METABOLISM, V27, P1893; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Kazi AA, 2010, MOL MED, V16, P359, DOI 10.2119/molmed.2009.00168; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Ng Y, 2010, J BIOL CHEM, V285, P2255, DOI 10.1074/jbc.M109.060236; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; RICE KM, 1993, BIOCHEM BIOPH RES CO, V190, P961, DOI 10.1006/bbrc.1993.1143; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shanmugam MK, 2011, J MOL MED, V89, P713, DOI 10.1007/s00109-011-0746-2; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tan SX, 2010, BIOCHEM J, V432, P191, DOI 10.1042/BJ20100750; Tan SX, 2011, BIOCHEM J, V435, P539, DOI 10.1042/BJ20110040; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Vali Shireen, 2010, Syst Synth Biol, V4, P25, DOI 10.1007/s11693-009-9046-3; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8	44	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6128	6138		10.1074/jbc.M111.318238	http://dx.doi.org/10.1074/jbc.M111.318238			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207758	Green Published, hybrid			2022-12-25	WOS:000300791800006
J	Loh, PR; Tucker, G; Berger, B				Loh, Po-Ru; Tucker, George; Berger, Bonnie			Phenotype Prediction Using Regularized Regression on Genetic Data in the DREAM5 Systems Genetics B Challenge	PLOS ONE			English	Article							PERSONALIZED MEDICINE; GENOMIC DATA; EXPRESSION; DISCOVERY; DISEASE; ASSOCIATIONS; SELECTION; BIOLOGY; CANCER; MODELS	A major goal of large-scale genomics projects is to enable the use of data from high-throughput experimental methods to predict complex phenotypes such as disease susceptibility. The DREAM5 Systems Genetics B Challenge solicited algorithms to predict soybean plant resistance to the pathogen Phytophthora sojae from training sets including phenotype, genotype, and gene expression data. The challenge test set was divided into three subcategories, one requiring prediction based on only genotype data, another on only gene expression data, and the third on both genotype and gene expression data. Here we present our approach, primarily using regularized regression, which received the best-performer award for subchallenge B2 (gene expression only). We found that despite the availability of 941 genotype markers and 28,395 gene expression features, optimal models determined by cross-validation experiments typically used fewer than ten predictors, underscoring the importance of strong regularization in noisy datasets with far more features than samples. We also present substantial analysis of the training and test setup of the challenge, identifying high variance in performance on the gold standard test sets.	[Loh, Po-Ru] MIT, Dept Math & Comp Sci, Cambridge, MA 02139 USA; MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Loh, PR (corresponding author), MIT, Dept Math & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bab@mit.edu			National Science Foundation; National Defense Science and Engineering Graduate fellowship	National Science Foundation(National Science Foundation (NSF)); National Defense Science and Engineering Graduate fellowship	P-RL was supported by an National Science Foundation graduate fellowship. GT was supported by an National Defense Science and Engineering Graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chen BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.69; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Roses AD, 2004, NAT REV GENET, V5, P645, DOI 10.1038/nrg1432; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2006, GENOME RES, V16, P559, DOI 10.1101/gr.3851306; Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693; Zhou LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-49; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	23	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29095	10.1371/journal.pone.0029095	http://dx.doi.org/10.1371/journal.pone.0029095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216175	Green Published, gold			2022-12-25	WOS:000300676300027
J	Durand, N; Carot-Sans, G; Bozzolan, F; Rosell, G; Siaussat, D; Debernard, S; Chertemps, T; Maibeche-Coisne, M				Durand, Nicolas; Carot-Sans, Gerard; Bozzolan, Francoise; Rosell, Gloria; Siaussat, David; Debernard, Stephane; Chertemps, Thomas; Maibeche-Coisne, Martine			Degradation of Pheromone and Plant Volatile Components by a Same Odorant-Degrading Enzyme in the Cotton Leafworm, Spodoptera littoralis	PLOS ONE			English	Article							SEX-PHEROMONE; ESTERASE; ANTENNAE; BINDING; FEMALE; INACTIVATION; PROTEINS; MOTHS	Background: Odorant-Degrading Enzymes (ODEs) are supposed to be involved in the signal inactivation step within the olfactory sensilla of insects by quickly removing odorant molecules from the vicinity of the olfactory receptors. Only three ODEs have been both identified at the molecular level and functionally characterized: two were specialized in the degradation of pheromone compounds and the last one was shown to degrade a plant odorant. Methodology: Previous work has shown that the antennae of the cotton leafworm Spodoptera littoralis, a worldwide pest of agricultural crops, express numerous candidate ODEs. We focused on an esterase overexpressed in males antennae, namely SlCXE7. We studied its expression patterns and tested its catalytic properties towards three odorants, i.e. the two female sex pheromone components and a green leaf volatile emitted by host plants. Conclusion: SlCXE7 expression was concomitant during development with male responsiveness to odorants and during adult scotophase with the period of male most active sexual behaviour. Furthermore, SlCXE7 transcription could be induced by male exposure to the main pheromone component, suggesting a role of Pheromone-Degrading Enzyme. Interestingly, recombinant SlCXE7 was able to efficiently hydrolyze the pheromone compounds but also the plant volatile, with a higher affinity for the pheromone than for the plant compound. In male antennae, SlCXE7 expression was associated with both long and short sensilla, tuned to sex pheromones or plant odours, respectively. Our results thus suggested that a same ODE could have a dual function depending of it sensillar localisation. Within the pheromone-sensitive sensilla, SlCXE7 may play a role in pheromone signal termination and in reduction of odorant background noise, whereas it could be involved in plant odorant inactivation within the short sensilla.	[Durand, Nicolas; Bozzolan, Francoise; Siaussat, David; Debernard, Stephane; Chertemps, Thomas; Maibeche-Coisne, Martine] Univ Paris 06, UMR Physiol Insecte Signalisat & Commun A 1272, INRA, Paris, France; [Durand, Nicolas; Bozzolan, Francoise; Siaussat, David; Debernard, Stephane; Chertemps, Thomas; Maibeche-Coisne, Martine] Univ Paris 06, UMR Physiol Insecte Signalisat & Commun A 1272, INRA, Versailles, France; [Carot-Sans, Gerard] Spanish Council Sci Res, Inst Adv Chem Catalonia, Dept Biol Chem & Mol Modeling, Barcelona, Spain; [Rosell, Gloria] Univ Barcelona, Fac Pharm, Unit Med Chem Associated, Spanish Council Sci Res, Barcelona, Spain	INRAE; UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Barcelona	Durand, N (corresponding author), Univ Paris 06, UMR Physiol Insecte Signalisat & Commun A 1272, INRA, Paris, France.	martine.maibeche@snv.jussieu.fr	Durand, Nicolas F./D-3035-2011	Durand, Nicolas F./0000-0002-3613-2609	Universite Pierre et Marie Curie (UPMC); INRA; Research Ministry;  [ANR-09-BLAN-0239-01]	Universite Pierre et Marie Curie (UPMC); INRA; Research Ministry; 	This work was supported by Universite Pierre et Marie Curie (UPMC), INRA, ANR-09-BLAN-0239-01 funding and a fellowship from the Research Ministry to N. Durand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON P, 1995, PHYSIOL ENTOMOL, V20, P189, DOI 10.1111/j.1365-3032.1995.tb00001.x; Carlsson MA, 1999, J CHEM ECOL, V25, P2445, DOI 10.1023/A:1020865922827; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; DUNKELBLUM E, 1987, ENTOMOL EXP APPL, V44, P241, DOI 10.1007/BF00369185; Durand N, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00939.x; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gu YQ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000321; GYORGYI TK, 1988, P NATL ACAD SCI USA, V85, P9851, DOI 10.1073/pnas.85.24.9851; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Jacquin-Joly E., 2009, SHORT VIEWS INSECT M, V1, P147; Jonsson M, 1999, PHYSIOL ENTOMOL, V24, P377, DOI 10.1046/j.1365-3032.1999.00154.x; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kasang G., 1971, GUSTATION OLFACTION, P245; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Kostal L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000053; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Merlin C, 2007, INSECT MOL BIOL, V16, P73, DOI [10.1111/j.1365-2583.2006.00702.x, 10.1111/1365-2583.2006.00702.x]; Oakeshott J.G, 2005, COMPREHENSIVE MOL IN, V5, P309, DOI [DOI 10.1016/B0-44-451924-6/00073-9, 10.1016/B0-44-451924-6/00073-9]; Quero C, 1996, J CHEM ECOL, V22, P1087, DOI 10.1007/BF02027947; Quero C, 2003, BIOORGAN MED CHEM, V11, P1047, DOI 10.1016/S0968-0896(02)00467-4; Silvegren G, 2005, J INSECT PHYSIOL, V51, P277, DOI 10.1016/j.jinsphys.2004.11.013; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Teese MG, 2010, INSECT BIOCHEM MOLEC, V40, P1, DOI 10.1016/j.ibmb.2009.12.002; Tsubota T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-377; Vogt R.G., 2005, P753; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1989, J NEUROSCI, V9, P3332; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5	34	68	79	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29147	10.1371/journal.pone.0029147	http://dx.doi.org/10.1371/journal.pone.0029147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216190	Green Submitted, Green Published, gold			2022-12-25	WOS:000300674900017
J	Gupta, MK; Walthall, JM; Venkataraman, R; Crowder, SW; Jung, DK; Yu, SS; Feaster, TK; Wang, XT; Giorgio, TD; Hong, CC; Baudenbacher, FJ; Hatzopoulos, AK; Sung, HJ				Gupta, Mukesh K.; Walthall, Joel M.; Venkataraman, Raghav; Crowder, Spencer W.; Jung, Dae Kwang; Yu, Shann S.; Feaster, Tromondae K.; Wang, Xintong; Giorgio, Todd D.; Hong, Charles C.; Baudenbacher, Franz J.; Hatzopoulos, Antonis K.; Sung, Hak-Joon			Combinatorial Polymer Electrospun Matrices Promote Physiologically-Relevant Cardiomyogenic Stem Cell Differentiation	PLOS ONE			English	Article							IN-VITRO; EPSILON-CAPROLACTONE; INFARCTED MYOCARDIUM; RAT CARDIOMYOCYTES; ADULT MYOCARDIUM; MAMMALIAN HEART; TISSUE; ANGIOGENESIS; REPAIR; TRANSPLANTATION	Myocardial infarction results in extensive cardiomyocyte death which can lead to fatal arrhythmias or congestive heart failure. Delivery of stem cells to repopulate damaged cardiac tissue may be an attractive and innovative solution for repairing the damaged heart. Instructive polymer scaffolds with a wide range of properties have been used extensively to direct the differentiation of stem cells. In this study, we have optimized the chemical and mechanical properties of an electrospun polymer mesh for directed differentiation of embryonic stem cells (ESCs) towards a cardiomyogenic lineage. A combinatorial polymer library was prepared by copolymerizing three distinct subunits at varying molar ratios to tune the physicochemical properties of the resulting polymer: hydrophilic polyethylene glycol (PEG), hydrophobic poly(epsilon-caprolactone) (PCL), and negatively-charged, carboxylated PCL (CPCL). Murine ESCs were cultured on electrospun polymeric scaffolds and their differentiation to cardiomyocytes was assessed through measurements of viability, intracellular reactive oxygen species (ROS), alpha-myosin heavy chain expression (alpha-MHC), and intracellular Ca2+ signaling dynamics. Interestingly, ESCs on the most compliant substrate, 4% PEG-86% PCL-10% CPCL, exhibited the highest alpha-MHC expression as well as the most mature Ca2+ signaling dynamics. To investigate the role of scaffold modulus in ESC differentiation, the scaffold fiber density was reduced by altering the electrospinning parameters. The reduced modulus was found to enhance alpha-MHC gene expression, and promote maturation of myocyte Ca2+ handling. These data indicate that ESC-derived cardiomyocyte differentiation and maturation can be promoted by tuning the mechanical and chemical properties of polymer scaffold via copolymerization and electrospinning techniques.	[Gupta, Mukesh K.; Venkataraman, Raghav; Crowder, Spencer W.; Jung, Dae Kwang; Yu, Shann S.; Wang, Xintong; Giorgio, Todd D.; Baudenbacher, Franz J.; Sung, Hak-Joon] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Gupta, Mukesh K.; Walthall, Joel M.; Crowder, Spencer W.; Jung, Dae Kwang; Yu, Shann S.; Feaster, Tromondae K.; Wang, Xintong; Hong, Charles C.; Hatzopoulos, Antonis K.; Sung, Hak-Joon] Vanderbilt Univ, Ctr Stem Cell Biol, Nashville, TN USA; [Walthall, Joel M.; Feaster, Tromondae K.; Hong, Charles C.; Hatzopoulos, Antonis K.] Vanderbilt Univ, Dept Med, Div Cardiovasc Med, Nashville, TN USA; [Feaster, Tromondae K.; Hong, Charles C.; Hatzopoulos, Antonis K.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Gupta, MK (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	hak-joon.sung@vanderbilt.edu	Wang, Xintong/I-8169-2013; Hatzopoulos, Antonis/X-2043-2019; Hatzopoulos, Antonis/D-2049-2010; Yu, Shann S/D-2586-2011; Gupta, Mukesh/B-4180-2016	Hatzopoulos, Antonis/0000-0001-5610-0017; Yu, Shann S/0000-0002-4461-793X; Gupta, Mukesh/0000-0002-9571-3454; Feaster, Tromondae/0000-0003-2102-8742	VIIBRE; Vanderbilt startup; National Institutes of Health [HL091465]; Vanderbilt Internal Discovery Grant [4-48-999-9132]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040, R21HL091465] Funding Source: NIH RePORTER	VIIBRE; Vanderbilt startup; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Internal Discovery Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	VIIBRE, Vanderbilt startup, National Institutes of Health grant HL091465, Vanderbilt Internal Discovery Grant (#4-48-999-9132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper J, 2009, NAT BIOTECHNOL, V27, P213, DOI 10.1038/nbt0309-213a; Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647; Chandra P, 2010, BIOINTERPHASES, V5, P53, DOI 10.1116/1.3438080; Crespo FL, 2010, STEM CELLS, V28, P1132, DOI 10.1002/stem.441; DELCARPIO JB, 1995, ANN NY ACAD SCI, V752, P267, DOI 10.1111/j.1749-6632.1995.tb17437.x; Ding L, 2008, STEM CELLS DEV, V17, P751, DOI 10.1089/scd.2007.0206; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Etzion S, 2001, J MOL CELL CARDIOL, V33, P1321, DOI 10.1006/jmcc.2000.1391; Forte G, 2008, STEM CELLS, V26, P2093, DOI 10.1634/stemcells.2008-0061; Gimenez S, 2001, J BIOACT COMPAT POL, V16, P32, DOI 10.1106/MF92-TCJC-KC2X-J0FB; Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646; Gu QA, 2010, EUR J CLIN PHARMACOL, V66, P1217, DOI 10.1007/s00228-010-0863-9; Hakuno D, 2005, J BIOL CHEM, V280, P39534, DOI 10.1074/jbc.M505575200; Hammon M, 2011, J CELL MOL MED, V15, P1582, DOI 10.1111/j.1582-4934.2010.01146.x; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004; Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Krause C, INT J BIOCH CELL BIO, V43, P478; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Leor J, 2000, CIRCULATION, V102, P56; Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003; Li R, 2008, C12N500200601 ORG WI; Li RK, 1996, CIRC RES, V78, P283, DOI 10.1161/01.RES.78.2.283; Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Min JY, 2002, J APPL PHYSIOL, V92, P288, DOI 10.1152/jappl.2002.92.1.288; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ou DB, 2011, J CELL BIOCH; Ou DB, 2011, J CELL BIOCHEM, V112, P3555, DOI 10.1002/jcb.23283; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P251, DOI 10.1006/jmcc.2001.1494; Reinecke H, 2000, CARDIOVASC PATHOL, V9, P337, DOI 10.1016/S1054-8807(00)00055-7; Sauer H, 2005, ANTIOXID REDOX SIGN, V7, P1423, DOI 10.1089/ars.2005.7.1423; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044; Strauss S, 2010, NAT BIOTECHNOL, V28, P989, DOI 10.1038/nbt1010-989; Sung FJ, 2005, BIOMATERIALS, V26, P4557, DOI 10.1016/j.biomaterials.2004.11.034; Sung HJ, 2007, AM J PHYSIOL-CELL PH, V293, pC87, DOI 10.1152/ajpcell.00585.2006; Sung HJ, 2010, SOFT MATTER, V6, P5196, DOI 10.1039/c0sm00172d; Sung HJ, 2009, J CELL PHYSIOL, V218, P549, DOI 10.1002/jcp.21629; Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066; Taylor DA, 2004, INT J CARDIOL, V95, pS8, DOI 10.1016/S0167-5273(04)90003-4; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Wang F, 2010, ADV DRUG DELIVER REV, V62, P784, DOI 10.1016/j.addr.2010.03.001; Wang YC, 2009, MACROMOLECULES, V42, P3026, DOI 10.1021/ma900288t; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367	59	43	43	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e28935	10.1371/journal.pone.0028935	http://dx.doi.org/10.1371/journal.pone.0028935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216144	Green Published, gold, Green Submitted			2022-12-25	WOS:000300674900006
J	Roff, G; Ledlie, MH; Ortiz, JC; Mumby, PJ				Roff, George; Ledlie, Mary H.; Ortiz, Juan C.; Mumby, Peter J.			Spatial Patterns of Parrotfish Corallivory in the Caribbean: The Importance of Coral Taxa, Density and Size	PLOS ONE			English	Article							REEF-BUILDING CORALS; LIVE CORAL; FORAGING ACTIVITY; SPARISOMA-VIRIDE; EASTERN BRAZIL; PREDATION; DISEASE; PORITES; REGENERATION; MORTALITY	The past few decades have seen an increase in the frequency and intensity of disturbance on coral reefs, resulting in shifts in size and composition of coral populations. These changes have lead to a renewed focus on processes that influence demographic rates in corals, such as corallivory. While previous research indicates selective corallivory among coral taxa, the importance of coral size and the density of coral colonies in influencing corallivory are unknown. We surveyed the size, taxonomy and number of bites by parrotfish per colony of corals and the abundance of three main corallivorous parrotfish (Sparisoma viride, Sparisoma aurofrenatum, Scarus vetula) at multiple spatial scales (reefs within islands: 1-100 km, and between islands: >100 km) within the Bahamas Archipelago. We used a linear mixed model to determine the influence of coral taxa, colony size, colony density, and parrotfish abundance on the intensity of corallivory (bites per m 2 of coral tissue). While the effect of colony density was significant in determining the intensity of corallivory, we found no significant influence of colony size or parrotfish abundance (density, biomass or community structure). Parrotfish bites were most frequently observed on the dominant species of reef building corals (Montastraea annularis, Montastraea faveolata and Porites astreoides), yet our results indicate that when the confounding effects of colony density and size were removed, selective corallivory existed only for the less dominant Porites porites. As changes in disturbance regimes result in the decline of dominant frame-work building corals such as Montastraea spp., the projected success of P. porites on Caribbean reefs through high reproductive output, resistance to disease and rapid growth rates may be attenuated through selective corallivory by parrotfish.	[Roff, George; Ledlie, Mary H.; Ortiz, Juan C.; Mumby, Peter J.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia, Qld, Australia; [Ledlie, Mary H.] Nat Seychelles, Roche Caiman, Mahe, Seychelles	University of Queensland	Roff, G (corresponding author), Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia, Qld, Australia.	g.roff@uq.edu.au	Roff, George/C-8766-2015; Mumby, Peter/F-9914-2010; Ortiz Cuellar, Juan carlos/GQZ-3899-2022; Roff, George/ABB-4406-2021	Roff, George/0000-0002-2823-0575; Mumby, Peter/0000-0002-6297-9053; Roff, George/0000-0002-2823-0575	NERC [NE/E00606X/1, NE/G017344/1] Funding Source: UKRI; Natural Environment Research Council [NE/E00606X/1, NE/G017344/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Bohnsack JA, LENGTH WEIGHT RELATI; Bonaldo RM, 2006, MAR BIOL, V149, P423, DOI 10.1007/s00227-005-0233-9; Bruckner AW, 1998, CORAL REEFS, V17, P350, DOI 10.1007/s003380050138; Bruckner AW, 2000, CORAL REEFS, V19, P50, DOI 10.1007/s003380050225; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V112, P51, DOI 10.3354/meps112051; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V106, P41, DOI 10.3354/meps106041; Burkepile DE, 2011, CORAL REEFS; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Bythell JC, INITIAL RESULTS LONG, P171; DAVIES PS, 1990, MAR POLLUT BULL, V21, P346; DUSTAN P, 1977, ENVIRON GEOL, V2, P51, DOI 10.1007/BF02430665; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Fisher EM, 2007, MAR ECOL PROG SER, V339, P61, DOI 10.3354/meps339061; Francini RB, 2008, NEOTROP ICHTHYOL, V6, P191, DOI 10.1590/S1679-62252008000200006; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; FRYDL P, 1979, INT REV GES HYDROBIO, V64, P737, DOI 10.1002/iroh.19790640603; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Garzon-Ferreira Jaime, 2001, Boletin de Investigaciones Marinas y Costeras, V30, P133; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Goreau TJ, 1951, BLEACHING REEF COMMU, P683; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Greenstein BJ, 1998, CORAL REEFS, V17, P249, DOI 10.1007/s003380050125; Harborne AR, 2008, J APPL ECOL, V45, P1010, DOI 10.1111/j.1365-2664.2008.01490.x; HUGHES TP, 1987, MAR ECOL PROG SER, V35, P259, DOI 10.3354/meps035259; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Jaap WC, CORAL REEF RESTORATI, P345; Knowlton N, FUTURE CORAL REEFS, P5419; Kramer PA, 2003, STATUS CORAL REEFS W, P76; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Lewis JB, COMP GROWTH RATES SO; LITTLER MM, 1989, OECOLOGIA, V80, P331, DOI 10.1007/BF00379034; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MAH AJ, 1986, CORAL REEFS, V4, P169, DOI 10.1007/BF00427938; Meesters EH, 1997, MAR ECOL PROG SER, V146, P91, DOI 10.3354/meps146091; Meesters EH, 1996, B MAR SCI, V58, P838; Miller J, 2006, CORAL REEFS, V25, P418, DOI 10.1007/s00338-006-0125-6; Miller J, MONITORING CORAL DIS, P47; Miller MW, 1998, OECOLOGIA, V113, P231, DOI 10.1007/s004420050373; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Nagelkerken I, 1999, J EXP MAR BIOL ECOL, V234, P29, DOI 10.1016/S0022-0981(98)00147-6; Ostrander GK, 2000, P NATL ACAD SCI USA, V97, P5297, DOI 10.1073/pnas.090104897; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Reyes-Nivia MC, 2004, REV BIOL TROP, V52, P883; Rogers CS, 1999, CORAL REEFS, V18, P254, DOI 10.1007/s003380050189; Rotjan RD, 2006, J EXP MAR BIOL ECOL, V335, P292, DOI 10.1016/j.jembe.2006.03.015; Rotjan RD, 2005, MAR ECOL PROG SER, V305, P193, DOI 10.3354/meps305193; Sanchez JA, 2004, CORAL REEFS, V23, P578, DOI 10.1007/s00338-004-0419-5; Whelan KRT, 2007, CORAL REEFS, V26, P689, DOI 10.1007/s00338-007-0241-y; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Yakob L, 2011, P NATL ACAD SCI USA, V108, P1967, DOI 10.1073/pnas.1015443108	56	16	16	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29133	10.1371/journal.pone.0029133	http://dx.doi.org/10.1371/journal.pone.0029133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216184	Green Published, Green Submitted, gold			2022-12-25	WOS:000300674900015
J	Dinamarca, J; Shlyk-Kerner, O; Kaftan, D; Goldberg, E; Dulebo, A; Gidekel, M; Gutierrez, A; Scherz, A				Dinamarca, Jorge; Shlyk-Kerner, Oksana; Kaftan, David; Goldberg, Eran; Dulebo, Alexander; Gidekel, Manuel; Gutierrez, Ana; Scherz, Avigdor			Double Mutation in Photosystem II Reaction Centers and Elevated CO2 Grant Thermotolerance to Mesophilic Cyanobacterium	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; D1 PROTEIN; CARBOXYLASE OXYGENASE; ELECTRON-TRANSPORT; GROWTH TEMPERATURE; MEMBRANE-LIPIDS; FORCE-FIELD; HEAT-STRESS; PCC 6803; PHOTOSYNTHESIS	Photosynthetic biomass production rapidly declines in mesophilic cyanobacteria grown above their physiological temperatures largely due to the imbalance between degradation and repair of the D1 protein subunit of the heat susceptible Photosystem II reaction centers (PSIIRC). Here we show that simultaneous replacement of two conserved residues in the D1 protein of the mesophilic Synechocystis sp. PCC 6803, by the analogue residues present in the thermophilic Thermosynechococcus elongatus, enables photosynthetic growth, extensive biomass production and markedly enhanced stability and repair rate of PSIIRC for seven days even at 43 degrees C but only at elevated CO2 (1%). Under the same conditions, the Synechocystis control strain initially presented very slow growth followed by a decline after 3 days. Change in the thylakoid membrane lipids, namely the saturation of the fatty acids is observed upon incubation for the different strains, but only the double mutant shows a concomitant major change of the enthalpy and entropy for the light activated Q(A)(-)-> Q(B) electron transfer, rendering them similar to those of the thermophilic strain. Following these findings, computational chemistry and protein dynamics simulations we propose that the D1 double mutation increases the folding stability of the PSIIRC at elevated temperatures. This, together with the decreased impairment of D1 protein repair under increased CO2 concentrations result in the observed photothermal tolerance of the photosynthetic machinery in the double mutant	[Dinamarca, Jorge; Shlyk-Kerner, Oksana; Goldberg, Eran; Scherz, Avigdor] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Kaftan, David; Dulebo, Alexander] Univ S Bohemia Ceske Budejovice, Inst Phys Biol, Nove Hrady, Czech Republic; [Dinamarca, Jorge; Gidekel, Manuel] Univ La Frontera, Dept Agr Prod, Temuco, Chile; [Gidekel, Manuel; Gutierrez, Ana] Univ Adolfo Ibanez, VentureLab, Knowledge Ctr Business, Santiago, Chile	Weizmann Institute of Science; University of South Bohemia Ceske Budejovice; Universidad de La Frontera; Universidad Adolfo Ibanez	Dinamarca, J (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	kaftan@ufb.jcu.cz; avigdor.scherz@weizmann.ac.il	Gutiérrez, Ana/V-5129-2019; Kaftan, David/N-6799-2019; dinamarca, jorge/T-7065-2017; Kaftan, David/J-5790-2017	Gutiérrez, Ana/0000-0002-5460-4139; Kaftan, David/0000-0003-0932-0986; Gidekel, Manuel/0000-0002-6770-4630	Avron-Minerva Foundation for Photosynthesis [7105640201]; "Alternative Energy Resources Initiative" of the Weizmann Institute [7204880101]; Conicyt, Chile [PBCT CTE-06]; FONDEF, Chile [D03I-1079]; Ministry of Education, Youth, and Sports of the Czech Republic [MSM6007665808]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA608170901]; South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses [CZ.1.05/2.1.00/01.0024]	Avron-Minerva Foundation for Photosynthesis; "Alternative Energy Resources Initiative" of the Weizmann Institute; Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDEF, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses	This work was supported by the Avron-Minerva Foundation for Photosynthesis (7105640201) and the "Alternative Energy Resources Initiative" of the Weizmann Institute (7204880101). J.D. was also supported by the Programa Bicentenario-Banco Mundial, Conicyt, Chile (PBCT CTE-06) and FONDEF, Chile (D03I-1079). D.K. was also supported by the Ministry of Education, Youth, and Sports of the Czech Republic (MSM6007665808), the Grant Agency of the Academy of Sciences of the Czech Republic (IAA608170901) and South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses (CZ.1.05/2.1.00/01.0024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A.S. is the incumbent of the Robert and Yaddele Sklare Professorial Chair in Biochemistry. J.D. was supported by a fellowship from the Programa Bicentenario-Banco Mundial, Conicyt, Chile. This program has no commercial interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Balogi Z, 2005, ARCH BIOCHEM BIOPHYS, V436, P346, DOI 10.1016/j.abb.2005.02.018; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Behrenfeld MJ, 1998, PHOTOSYNTH RES, V58, P259, DOI 10.1023/A:1006138630573; Beney L, 2001, APPL MICROBIOL BIOT, V57, P34; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; BIRD IF, 1982, J EXP BOT, V33, P1004, DOI 10.1093/jxb/33.5.1004; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; CHEN Z, 1992, INT J COMP INTEG M, V5, P2, DOI 10.1080/095119X9208547560; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crabbe MJC, 2008, COMPUT BIOL CHEM, V32, P311, DOI 10.1016/j.compbiolchem.2008.04.001; Cser K, 2007, BBA-BIOENERGETICS, V1767, P233, DOI 10.1016/j.bbabio.2007.01.022; CUNNINGHAM FX, 1989, PLANT PHYSIOL, V91, P1179, DOI 10.1104/pp.91.3.1179; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Edelman M, 2008, PHOTOSYNTH RES, V98, P609, DOI 10.1007/s11120-008-9342-x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frisch MJ, 2006, CHEM LISTY, V100, pA9; GOMBOS Z, 1994, PLANT PHYSIOL, V104, P563, DOI 10.1104/pp.104.2.563; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hao MH, 2006, J CHEM THEORY COMPUT, V2, P863, DOI 10.1021/ct0600262; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; HORVATH G, 1987, BIOCHIM BIOPHYS ACTA, V891, P68, DOI 10.1016/0005-2728(87)90084-3; Horvath I, 1998, P NATL ACAD SCI USA, V95, P3513, DOI 10.1073/pnas.95.7.3513; Huner NPA, 1996, PHYSIOL PLANTARUM, V98, P358, DOI 10.1034/j.1399-3054.1996.980218.x; Inoue N, 2001, PLANT CELL PHYSIOL, V42, P1140, DOI 10.1093/pcp/pce147; JORDAN DB, 1984, PLANTA, V161, P308, DOI 10.1007/BF00398720; Kakani VG, 2008, PHOTOSYNTHETICA, V46, P420, DOI 10.1007/s11099-008-0074-0; Kana R, 2002, PHOTOSYNTH RES, V72, P271, DOI 10.1023/A:1019894720789; Kim K, 2004, FEBS LETT, V571, P124, DOI 10.1016/j.febslet.2004.06.064; Kim KM, 2006, PHOTOSYNTH RES, V87, P195, DOI 10.1007/s11120-005-8386-4; KLESS H, 1994, BIOCHEMISTRY-US, V33, P10501, DOI 10.1021/bi00200a035; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Laczko-Dobos H, 2009, BIOCHEMISTRY-US, V48, P10120, DOI 10.1021/bi9011034; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LICHTENTHALER H. K., 1983, BIOCHEM SOC T, V11, P591, DOI [DOI 10.1042/BST0110591, 10.1042/BST0110591]; Lilley RM, 2010, PLANT CELL ENVIRON, V33, P995, DOI 10.1111/j.1365-3040.2010.02121.x; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; MAMEDOV M, 1993, BIOCHIM BIOPHYS ACTA, V1142, P1, DOI 10.1016/0005-2728(93)90077-S; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; MORRISON WR, 1964, J LIPID RES, V5, P600; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nanjo Y, 2010, BBA-BIOENERGETICS, V1797, P1483, DOI 10.1016/j.bbabio.2010.03.014; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; PEARCY RW, 1978, PLANT PHYSIOL, V61, P484, DOI 10.1104/pp.61.4.484; Rader AJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016002; RAVNIKAR PD, 1989, NUCLEIC ACIDS RES, V17, P3991, DOI 10.1093/nar/17.10.3991; Sakurai I, 2006, J BIOCHEM, V140, P201, DOI 10.1093/jb/mvj141; SANTARIUS KA, 1976, J THERM BIOL, V1, P101, DOI 10.1016/0306-4565(76)90028-0; Schmidt CW, 2008, ENVIRON HEALTH PERSP, V116, pA292, DOI 10.1289/ehp.116-a292; Shlyk-Kerner O, 2006, NATURE, V442, P827, DOI 10.1038/nature04947; Singh M, 2005, J PLANT PHYSIOL, V162, P1246, DOI 10.1016/j.jplph.2004.12.008; SOMERO GN, 1978, ANNU REV ECOL SYST, V9, P1, DOI 10.1146/annurev.es.09.110178.000245; Szilard A, 2005, PHOTOSYNTH RES, V84, P15, DOI 10.1007/s11120-004-7161-2; Takahashi S, 2006, BBA-BIOENERGETICS, V1757, P198, DOI 10.1016/j.bbabio.2006.02.002; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2009, P NATL ACAD SCI USA, V106, P3237, DOI 10.1073/pnas.0808363106; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANWALRAVEN HS, 1984, EUR J BIOCHEM, V144, P563; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; Vreven T, 2006, J CHEM THEORY COMPUT, V2, P815, DOI 10.1021/ct050289g; WADA H, 1990, PLANT PHYSIOL, V92, P1062, DOI 10.1104/pp.92.4.1062; Wen XG, 2005, PLANT PHYSIOL BIOCH, V43, P389, DOI 10.1016/j.plaphy.2005.03.001; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; YAMAOKA T, 1978, PLANT CELL PHYSIOL, V19, P943, DOI 10.1093/oxfordjournals.pcp.a075684; Yamasaki T, 2002, PLANT PHYSIOL, V128, P1087, DOI 10.1104/pp.010919	74	8	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28389	10.1371/journal.pone.0028389	http://dx.doi.org/10.1371/journal.pone.0028389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216094	gold, Green Published, Green Submitted			2022-12-25	WOS:000299684700007
J	Ryan, SJ; Walsh, PD				Ryan, Sadie J.; Walsh, Peter D.			Consequences of Non-Intervention for Infectious Disease in African Great Apes	PLOS ONE			English	Article							GORILLA-GORILLA-BERINGEI; SYNCYTIAL VIRUS-INFECTION; MARBURG HEMORRHAGIC-FEVER; MOUNTAIN GORILLAS; EBOLA-VIRUS; NONHUMAN-PRIMATES; NATIONAL-PARK; CHIMPANZEES; VACCINE; METAPNEUMOVIRUS	Infectious disease has recently joined poaching and habitat loss as a major threat to African apes. Both "naturally" occurring pathogens, such as Ebola and Simian Immunodeficiency Virus (SIV), and respiratory pathogens transmitted from humans, have been confirmed as important sources of mortality in wild gorillas and chimpanzees. While awareness of the threat has increased, interventions such as vaccination and treatment remain controversial. Here we explore both the risk of disease to African apes, and the status of potential responses. Through synthesis of published data, we summarize prior disease impact on African apes. We then use a simple demographic model to illustrate the resilience of a well-known gorilla population to disease, modeled on prior documented outbreaks. We found that the predicted recovery time for this specific gorilla population from a single outbreak ranged from 5 years for a low mortality (4%) respiratory outbreak, to 131 years for an Ebola outbreak that killed 96% of the population. This shows that mortality rates comparable to those recently reported for disease outbreaks in wild populations are not sustainable. This is particularly troubling given the rising pathogen risk created by increasing habituation of wild apes for tourism, and the growth of human populations surrounding protected areas. We assess potential future disease spillover risk in terms of vaccination rates amongst humans that may come into contact with wild apes, and the availability of vaccines against potentially threatening diseases. We discuss and evaluate non-interventionist responses such as limiting tourist access to apes, community health programs, and safety, logistic, and cost issues that constrain the potential of vaccination.	[Ryan, Sadie J.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Walsh, Peter D.] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; University of Cambridge	Ryan, SJ (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.	sjryan@esf.edu	Ryan, Sadie Jane/H-7488-2019; Ryan, Sadie/H-1595-2012	Ryan, Sadie Jane/0000-0002-4308-6321; 	National Center for Ecological Analysis and Synthesis; National Science Foundation (NSF) [EF-0553768]; University of California, Santa Barbara; State of California	National Center for Ecological Analysis and Synthesis; National Science Foundation (NSF)(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California	This work was conducted as part of the Efficient Wildlife Vaccination Working Group supported by the National Center for Ecological Analysis and Synthesis, a Center funded by the National Science Foundation (NSF) (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. Additional support was also provided for Dr. Ryan by the National Center for Ecological Analysis and Synthesis (NCEAS) Postdoctoral Associate in the Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevshatian L, 2007, B WORLD HEALTH ORGAN, V85, P449, DOI 10.2471/BLT.06.031526; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Boesch C, 2008, AM J PRIMATOL, V70, P722, DOI 10.1002/ajp.20571; Boivin G, 2003, EMERG INFECT DIS, V9, P634; BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0; Broussard SR, 1997, VIROLOGY, V237, P349, DOI 10.1006/viro.1997.8797; Burgess DC, 2006, VACCINE, V24, P3921, DOI 10.1016/j.vaccine.2006.02.033; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Centers for Disease Control and Prevention, 2009, VACC PREV DIS; Colebunders R, 2007, J INFECT DIS, V196, pS148, DOI 10.1086/520543; Cranfield M., 2007, International Zoo Yearbook, V41, P110, DOI 10.1111/j.1748-1090.2007.00021.x; Dabbagh A, 2008, JAMA-J AM MED ASSOC, V299, P400; Luna LKD, 2007, J INFECT DIS, V195, P675, DOI 10.1086/511432; Gallo RC, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S2-I3; Glezen W Paul, 2004, Pediatr Infect Dis J, V23, pS202, DOI 10.1097/01.inf.0000144662.86396.07; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; Graczyk TK, 2001, PARASITOL RES, V87, P1024; Guerrera W, 2003, INT J PRIMATOL, V24, P197, DOI 10.1023/A:1021410931928; Hanamura S, 2008, PRIMATES, V49, P77, DOI 10.1007/s10329-007-0054-1; Hartter J, 2011, LANDSCAPE ECOL, V26, P877, DOI 10.1007/s10980-011-9616-0; Hartter J, 2010, LAND USE POLICY, V27, P815, DOI 10.1016/j.landusepol.2009.11.001; Hartter J, 2009, LANDSCAPE ECOL, V24, P643, DOI 10.1007/s10980-009-9339-7; Hastings BE, 2001, P AM ASS ZOOLOGICAL, P198; Hayden FG, 2006, ANTIVIR RES, V71, P372, DOI 10.1016/j.antiviral.2006.05.016; Herfst S, 2008, J CLIN VIROL, V41, P45, DOI 10.1016/j.jcv.2007.10.022; Homsy J., 1999, APE TOURISM HUMAN DI; HOSAKA K, 1995, PAN AFR NEWS, V2, P3; Infuso A, 2006, EUROSURVEILLANCE, V11, P604; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Katz SL, 2006, J CLIN VIROL, V36, P163, DOI 10.1016/j.jcv.2006.03.003; Kaur T, 2008, AM J PRIMATOL, V70, P755, DOI 10.1002/ajp.20565; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kuehl HS, 2009, BIOL CONSERV, V142, P1500, DOI 10.1016/j.biocon.2009.02.032; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; Lusebrink J, 2009, EXPERT REV ANTI-INFE, V7, P1125, DOI [10.1586/eri.09.90, 10.1586/ERI.09.90]; Makuwa M, 2007, J GEN VIROL, V88, P2679, DOI 10.1099/vir.0.82992-0; Matsuzawa T, 2006, PAN AFRICAN NEWS, V13, P2; Matsuzawa Tetsuro, 2004, Primate Research, V20, P45, DOI 10.2354/psj.20.45; Meyer G, 2008, COMP IMMUNOL MICROB, V31, P191, DOI 10.1016/j.cimid.2007.07.008; Muehlenbein MP, 2008, ECOHEALTH, V5, P371, DOI 10.1007/s10393-008-0192-y; Nakamura M., 2009, PRIMATE CONSERV, V24, P85, DOI DOI 10.1896/052.024.0106; Nakazibwe C, 2007, B WORLD HEALTH ORGAN, V85, P654; Ndayimirije N, 2005, NEW ENGL J MED, V352, P2155, DOI 10.1056/NEJMp058115; Okware SI, 2002, TROP MED INT HEALTH, V7, P1068, DOI 10.1046/j.1365-3156.2002.00944.x; Olszewska W, 2009, EXPERT OPIN EMERG DR, V14, P207, DOI 10.1517/14728210902946399; Palacios G, 2011, EMERG INFECT DIS, V17, P711, DOI 10.3201/eid1704.100883; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Roy S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000503; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Sandbrook C, 2006, ORYX, V40, P428, DOI 10.1017/S0030605306001323; Sleeman JM, 2000, J ZOO WILDLIFE MED, V31, P9, DOI 10.1638/1042-7260(2000)031[0009:FAOFLM]2.0.CO;2; Sugiyama Y, 2004, AM J PHYS ANTHROPOL, V124, P154, DOI 10.1002/ajpa.10345; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; WERIKHE S, 1997, CAN MOUNTAIN GORILLA; Whittier AC, 2001, EFFECTS HAND REARING, P232; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Woodford MH, 2002, ORYX, V36, P153, DOI 10.1017/S0030605302000224; World Health Organization T, 2009, WORLD HLTH STAT 2009; World Health Organization (WHO) T United Nations Children's Fund (UNICEF) T, 2009, IMM SUMM STAT REF CO	71	68	69	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29030	10.1371/journal.pone.0029030	http://dx.doi.org/10.1371/journal.pone.0029030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216162	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700025
J	Rillich, J; Stevenson, PA				Rillich, Jan; Stevenson, Paul Anthony			Winning Fights Induces Hyperaggression via the Action of the Biogenic Amine Octopamine in Crickets	PLOS ONE			English	Article							CHALLENGE HYPOTHESIS; GRYLLUS-BIMACULATUS; AGGRESSIVE-BEHAVIOR; AGONISTIC BEHAVIOR; REWARD SYSTEM; DUM NEURONS; EXPERIENCE; WINNERS; TESTOSTERONE; MECHANISMS	Winning an agonistic interaction against a conspecific is known to heighten aggressiveness, but the underlying events and mechanism are poorly understood. We quantified the effect of experiencing successive wins on aggression in adult male crickets (Gryllus bimaculatus) by staging knockout tournaments and investigated its dependence on biogenic amines by treatment with amine receptor antagonists. For an inter-fight interval of 5 min, fights between winners escalated to higher levels of aggression and lasted significantly longer than the preceding round. This winner effect is transient, and no longer evident for an inter-fight interval of 20 min, indicating that it does not result from selecting individuals that were hyperaggressive from the outset. A winner effect was also evident in crickets that experienced wins without physical exertion, or that engaged in fights that were interrupted before a win was experienced. Finally, the winner effect was abolished by prior treatment with epinastine, a highly selective octopamine receptor blocker, but not by propranolol, a beta-adrenergic receptor antagonist, nor by yohimbine, an insect tyramine receptor blocker nor by fluphenazine an insect dopamine-receptor blocker. Taken together our study in the cricket indicates that the physical exertion of fighting, together with some rewarding aspect of the actual winning experience, leads to a transient increase in aggressive motivation via activation of the octopaminergic system, the invertebrate equivalent to the adrenergic system of vertebrates.	[Rillich, Jan] Free Univ Berlin, Inst Neurobiol, Berlin, Germany; [Stevenson, Paul Anthony] Univ Leipzig, Inst Biol, Leipzig, Germany	Free University of Berlin; Leipzig University	Rillich, J (corresponding author), Free Univ Berlin, Inst Neurobiol, Berlin, Germany.	stevenson@rz.uni-leipzig.de	Stevenson, Paul A/A-2048-2010	Stevenson, Paul Anthony/0000-0002-3232-5155	Deutsche Forschungsgemeinschaft (DFG Research group) [1363, STE 714/4-1]	Deutsche Forschungsgemeinschaft (DFG Research group)(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (DFG Research group 1363, project STE 714/4-1). URL: http://www.dfg.de/en/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1995, J EXP BIOL, V198, P1691; ADAMO SA, 1994, J INSECT PHYSIOL, V40, P439, DOI 10.1016/0022-1910(94)90162-7; ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Barron AB, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00163; Bondar NP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004190; Caramaschi D, 2008, BEHAV BRAIN RES, V189, P263, DOI 10.1016/j.bbr.2008.01.003; Carre JM, 2010, PSYCHONEUROENDOCRINO, V35, P475, DOI 10.1016/j.psyneuen.2009.09.011; CHASE ID, 1994, ANIM BEHAV, V48, P393, DOI 10.1006/anbe.1994.1253; Couppis MH, 2008, PSYCHOPHARMACOLOGY, V197, P449, DOI 10.1007/s00213-007-1054-y; Duch C, 1999, J COMP NEUROL, V403, P119, DOI 10.1002/(SICI)1096-9861(19990105)403:1<119::AID-CNE9>3.0.CO;2-F; Dugatkin LA, 2004, P ROY SOC LOND B BIO, V271, P488; Evans PD, 1985, OCTOPAMINE COMPREHEN, P499; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Fuxjager MJ, 2010, P NATL ACAD SCI USA, V107, P12393, DOI 10.1073/pnas.1001394107; Haller J, 1998, NEUROSCI BIOBEHAV R, V22, P85; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Hsu YY, 2009, BEHAV ECOL SOCIOBIOL, V63, P1247, DOI 10.1007/s00265-009-0791-9; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Iwasaki M, 2006, ZOOL SCI, V23, P863, DOI 10.2108/zsj.23.863; JACKSON WM, 1991, BEHAV ECOL SOCIOBIOL, V28, P271; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Kasumovic MM, 2010, BEHAV ECOL, V21, P404, DOI 10.1093/beheco/arp204; Khazraie K, 1999, BEHAV PROCESS, V44, P341, DOI 10.1016/S0376-6357(98)00058-8; Kou R, 2008, HORM BEHAV, V54, P521, DOI 10.1016/j.yhbeh.2008.05.011; MOORE A J, 1988, Journal of Insect Behavior, V1, P157, DOI 10.1007/BF01052235; Morris OT, 1999, J EXP BIOL, V202, P3555; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; Oliveira RF, 2009, P ROY SOC B-BIOL SCI, V276, P2249, DOI 10.1098/rspb.2009.0132; OTRONEN M, 1990, ANIM BEHAV, V40, P980, DOI 10.1016/S0003-3472(05)81000-0; Pfluger HJ, 2005, ARTHROPOD STRUCT DEV, V34, P379, DOI 10.1016/j.asd.2005.04.004; Rillich J, 2007, ANIM BEHAV, V74, P823, DOI 10.1016/j.anbehav.2006.11.022; Rillich J, 2011, P ROY SOC B-BIOL SCI, V278, P1873, DOI 10.1098/rspb.2010.2099; Rillich J, 2009, ANIM BEHAV, V77, P737, DOI 10.1016/j.anbehav.2008.12.009; Roeder T, 1998, EUR J PHARMACOL, V349, P171, DOI 10.1016/S0014-2999(98)00192-7; ROEDER T, 1995, BRIT J PHARMACOL, V114, P210, DOI 10.1111/j.1476-5381.1995.tb14927.x; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Schroeter U, 2007, CELL TISSUE RES, V327, P647, DOI 10.1007/s00441-006-0197-1; Scott MP, 2006, HORM BEHAV, V49, P276, DOI 10.1016/j.yhbeh.2005.07.003; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; STEVENSON PA, 1995, COMP BIOCHEM PHYS A, V110, P203, DOI 10.1016/0300-9629(94)00152-J; Tibbetts EA, 2010, AM NAT, V176, P123, DOI 10.1086/653664; Trainor BC, 2004, HORM BEHAV, V45, P115, DOI 10.1016/j.yhbeh.2003.09.006; Trumbo ST, 2007, HORM BEHAV, V51, P281, DOI 10.1016/j.yhbeh.2006.11.002; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Van Wilgenburg E, 2010, BIOL LETTERS, V6, P152, DOI 10.1098/rsbl.2009.0616; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Whitehouse MEA, 1997, ANIM BEHAV, V53, P913, DOI 10.1006/anbe.1996.0313; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	54	51	51	2	193	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28891	10.1371/journal.pone.0028891	http://dx.doi.org/10.1371/journal.pone.0028891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216137	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600050
J	Zhao, YH; Kong, XL; Li, XY; Yan, S; Yuan, CZ; Hu, WW; Yang, QF				Zhao, Yuhan; Kong, Xiaoli; Li, Xiaoyan; Yan, Shi; Yuan, Cunzhong; Hu, Wenwei; Yang, Qifeng			Metadherin Mediates Lipopolysaccharide-Induced Migration and Invasion of Breast Cancer Cells	PLOS ONE			English	Article							ASTROCYTE-ELEVATED GENE-1; KAPPA-B ACTIVATION; TUMOR; AEG-1; INFLAMMATION; PROGRESSION; METASTASIS; HALLMARKS; PROTEIN; GROWTH	Background: Breast cancer is the most prevalent cancer in women worldwide and metastatic breast cancer has very poor prognosis. Inflammation has been implicated in migration and metastasis of breast cancer, although the exact molecular mechanism remains elusive. Principal Findings: We show that the pro-inflammatory endotoxin Lipopolysaccharide (LPS) upregulates the expression of Metadherin (MTDH), a recently identified oncogene, in a number of breast cancer lines. Stable knockdown of MTDH by shRNA in human breast MDA-MB-231 cells abolishes LPS-induced cell migration and invasion as determined by several in vitro assays. In addition, knockdown of MTDH diminishes Nuclear Factor-kappa B (NF-kappa B) activation by LPS and inhibited LPS-induced IL-8 and MMP-9 production. Conclusions: These results strongly suggest that MTDH is a pivotal molecule in inflammation-mediated tumor metastasis. Since NF-kappa B, IL-8 and MMP-9 play roles in LPS-induced invasion or metastasis, the mechanism of MTDH-promoted invasion and metastasis may be through the activation of NF-kappa B, IL-8 and MMP-9, also suggesting a role of MTDH in regulating both inflammatory responses and inflammation-associated tumor invasion. These findings indicate that MTDH is involved in inflammation-induced tumor progression, and support that MTDH targeting therapy may hold promising prospects in treating breast cancer.	[Zhao, Yuhan; Kong, Xiaoli; Li, Xiaoyan; Yang, Qifeng] Shandong Univ, Sch Med, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Yan, Shi; Yuan, Cunzhong] Shandong Univ, Sch Med, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Hu, Wenwei] Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ USA	Shandong University; Shandong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Zhao, YH (corresponding author), Shandong Univ, Sch Med, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	huw1@umndj.edu; qifengy@gmail.com	yang, qiang/GYJ-0971-2022	Yuan, Cunzhong/0000-0002-8785-2139; Yang, Qifeng/0000-0003-0576-8513; Zhao, Yuhan/0000-0001-5529-1907	Chinese Ministry of Education [108080]; National Natural Science Foundation of China [30772133, 81072150]; Independent Innovation Foundation of Shandong University (IIFSDU) [2009JQ007]; Program for New Century Excellent Talents in University	Chinese Ministry of Education(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University (IIFSDU); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This project is supported by Program for New Century Excellent Talents in University, Key Project of Chinese Ministry of Education (No. 108080), National Natural Science Foundation of China (No. 30772133; No. 81072150) and Independent Innovation Foundation of Shandong University (IIFSDU, No. 2009JQ007) to Prof. Yang Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Brunn GJ, 2005, FASEB J, V19, P872, DOI 10.1096/fj.04-3211fje; Chen W, 2010, NEOPLASMA, V57, P522, DOI 10.4149/neo_2010_06_522; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Connelly L, 2011, ONCOGENE, V30, P1402, DOI 10.1038/onc.2010.521; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Emdad L, 2007, PHARMACOL THERAPEUT, V114, P155, DOI 10.1016/j.pharmthera.2007.01.010; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Gonzalez-Reyes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-665; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harmey JH, 2002, INT J CANCER, V101, P415, DOI 10.1002/ijc.10632; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Khuda IIE, 2009, IMMUNOLOGY, V128, pe700, DOI 10.1111/j.1365-2567.2009.03063.x; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li C, 2011, J SURG ONCOL, V103, P184, DOI 10.1002/jso.21788; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Liu XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017582; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Pidgeon GP, 1999, BRIT J CANCER, V81, P1311, DOI 10.1038/sj.bjc.6694369; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Qian BJ, 2011, CANC IMMUNOL IMMUNOT; Rahim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019343; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Song HT, 2010, INT J COLORECTAL DIS, V25, P1201, DOI 10.1007/s00384-010-1009-3; Su P, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-38; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209	38	50	54	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29363	10.1371/journal.pone.0029363	http://dx.doi.org/10.1371/journal.pone.0029363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195048	gold, Green Published, Green Submitted			2022-12-25	WOS:000298664400049
J	Kvitt, H; Rosenfeld, H; Zandbank, K; Tchernov, D				Kvitt, Hagit; Rosenfeld, Hanna; Zandbank, Keren; Tchernov, Dan			Regulation of Apoptotic Pathways by Stylophora pistillata (Anthozoa, Pocilloporidae) to Survive Thermal Stress and Bleaching	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; GREAT-BARRIER-REEF; CELL-DEATH; OXIDATIVE STRESS; GENE-EXPRESSION; CASPASE FAMILY; CLIMATE-CHANGE; SEA-ANEMONE; CORALS; TEMPERATURE	Elevated seawater temperatures are associated with coral bleaching events and related mortality. Nevertheless, some coral species are able to survive bleaching and recover. The apoptotic responses associated to this ability were studied over 3 years in the coral Stylophora pistillata from the Gulf of Eilat subjected to long term thermal stress. These include caspase activity and the expression profiles of the S. pistillata caspase and Bcl-2 genes (StyCasp and StyBcl-2-like) cloned in this study. In corals exposed to thermal stress (32 or 34 degrees C), caspase activity and the expression levels of the StyBcl-2-like gene increased over time (6-48 h) and declined to basal levels within 72 h of thermal stress. Distinct transcript levels were obtained for the StyCasp gene, with stimulated expression from 6 to 48 h of 34 degrees C thermal stress, coinciding with the onset of bleaching. Increased cell death was detected in situ only between 6 to 48 h of stress and was limited to the gastroderm. The bleached corals survived up to one month at 32 degrees C, and recovered back symbionts when placed at 24 degrees C. These results point to a two-stage response in corals that withstand thermal stress: (i) the onset of apoptosis, accompanied by rapid activation of antioxidant/anti-apoptotic mediators that block the progression of apoptosis to other cells and (ii) acclimatization of the coral to the chronic thermal stress alongside the completion of symbiosis breakdown. Accordingly, the coral's ability to rapidly curb apoptosis appears to be the most important trait affecting the coral's thermotolerance and survival.	[Kvitt, Hagit; Tchernov, Dan] Univ Haifa, Dept Marine Biol, Leon H Charney Sch Marine Sci, IL-31999 Haifa, Israel; [Kvitt, Hagit; Zandbank, Keren; Tchernov, Dan] Interuniv Inst Eilat, Elat, Israel; [Kvitt, Hagit; Rosenfeld, Hanna] Natl Ctr Mariculture, Elat, Israel	University of Haifa	Kvitt, H (corresponding author), Univ Haifa, Dept Marine Biol, Leon H Charney Sch Marine Sci, IL-31999 Haifa, Israel.	hagit.kvitt@mail.huji.ac.il	Tchernov, Dan/AAE-2545-2021	Tchernov, Dan/0000-0003-1135-8270	Israeli Science Foundation [981/05]; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung-BMBF, Israeli Ministry of Science and Technology MOST), BMBF-MOST [GR-1941]	Israeli Science Foundation(Israel Science Foundation); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung-BMBF, Israeli Ministry of Science and Technology MOST), BMBF-MOST	This research was supported by the Israeli Science Foundation grant no. 981/05 and a German-Israeli scientific and technological cooperation grant from the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung-BMBF, Israeli Ministry of Science and Technology MOST), BMBF-MOST grant GR-1941. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Dunn SR, 2007, BIOL BULL-US, V212, P250, DOI 10.2307/25066607; Dunn SR, 2006, J MOL EVOL, V63, P95, DOI 10.1007/s00239-005-0236-7; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Lasi M, 2010, CELL RES, V20, P812, DOI 10.1038/cr.2010.66; Lasi M, 2010, APOPTOSIS, V15, P269, DOI 10.1007/s10495-009-0442-7; Lauber K, 2001, J BIOL CHEM, V276, P29772, DOI 10.1074/jbc.M101524200; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; LOTEM J, 1993, CELL GROWTH DIFFER, V4, P41; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Piana S, 2003, BIOCHEMISTRY-US, V42, P8720, DOI 10.1021/bi034032l; Polato NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011221; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Richier S, 2008, COMP BIOCHEM PHYS D, V3, P283, DOI 10.1016/j.cbd.2008.08.001; Rodriguez-Lanetty M, 2008, J BIOCHEM BIOPH METH, V70, P985, DOI 10.1016/j.jbbm.2007.08.005; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; STRYCHAR KB, 2008, P 11 INT COR REEF S; Strychar KB, 2009, J EXP MAR BIOL ECOL, V369, P31, DOI 10.1016/j.jembe.2008.10.021; Susnow N, 2009, SEMIN CANCER BIOL, V19, P42, DOI 10.1016/j.semcancer.2008.12.002; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wiens M, 2003, BBA-MOL CELL RES, V1593, P179, DOI 10.1016/S0167-4889(02)00388-9; Wiens M, 2001, CELL DEATH DIFFER, V8, P887, DOI 10.1038/sj.cdd.4400906; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zmasek CM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r226	56	48	49	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28665	10.1371/journal.pone.0028665	http://dx.doi.org/10.1371/journal.pone.0028665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194880	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100074
J	Annibaldi, A; Dousse, A; Martin, S; Tazi, J; Widmann, C				Annibaldi, Alessandro; Dousse, Aline; Martin, Sophie; Tazi, Jamal; Widmann, Christian			Revisiting G3BP1 as a RasGAP Binding Protein: Sensitization of Tumor Cells to Chemotherapy by the RasGAP 317-326 Sequence Does Not Involve G3BP1	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; MYC MESSENGER-RNA; ENDORIBONUCLEASE G3BP; STRESS GRANULES; BCL-2 FAMILY; PHOSPHORYLATION; APOPTOSIS; PEPTIDE; PUMA; BIM	RasGAP is a multifunctional protein that controls Ras activity and that is found in chromosomal passenger complexes. It also negatively or positively regulates apoptosis depending on the extent of its cleavage by caspase-3. RasGAP has been reported to bind to G3BP1 (RasGAP SH3-domain-binding protein 1), a protein regulating mRNA stability and stress granule formation. The region of RasGAP (amino acids 317-326) thought to bind to G3BP1 corresponds exactly to the sequence within fragment N2, a caspase-3-generated fragment of RasGAP, that mediates sensitization of tumor cells to genotoxins. While assessing the contribution of G3BP1 in the anti-cancer function of a cell-permeable peptide containing the 317-326 sequence of RasGAP (TAT-RasGAP(317-326)), we found that, in conditions where G3BP1 and RasGAP bind to known partners, no interaction between G3BP1 and RasGAP could be detected. TAT-RasGAP(317-326) did not modulate binding of G3BP1 to USP10, stress granule formation or c-myc mRNA levels. Finally, TAT-RasGAP(317-326) was able to sensitize G3BP1 knock-out cells to cisplatin-induced apoptosis. Collectively these results indicate that G3BP1 and its putative RasGAP binding region have no functional influence on each other. Importantly, our data provide arguments against G3BP1 being a genuine RasGAP-binding partner. Hence, G3BP1-mediated signaling may not involve RasGAP.	[Annibaldi, Alessandro; Dousse, Aline; Widmann, Christian] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Martin, Sophie; Tazi, Jamal] CNRS, Inst Genet Mol Montpellier UMR 5535, IFR 122, Montpellier, France	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Annibaldi, A (corresponding author), Univ Lausanne, Dept Physiol, Lausanne, Switzerland.	Christian.Widmann@unil.ch	Widmann, Christian/N-9851-2013	Widmann, Christian/0000-0002-6881-0363; Annibaldi, Alessandro/0000-0002-0346-4340; Martin, Sophie/0000-0002-4458-7582; Tazi, Jamal/0000-0002-1949-8748	Swiss National Science Foundation [31003A_119876]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation grant 31003A_119876 (to CW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Backer MV, 2003, J CONTROL RELEASE, V89, P499, DOI 10.1016/S0168-3659(03)00150-0; Boulkroun S, 2008, AM J PHYSIOL-RENAL, V295, pF889, DOI 10.1152/ajprenal.00001.2008; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; French J, 2002, HISTOCHEM J, V34, P223, DOI 10.1023/A:1021737413055; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Gilmanshin R, 1996, J PHYS CHEM-US, V100, P16754, DOI 10.1021/jp9611941; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; HERRICK DJ, 1994, MOL CELL BIOL, V14, P2119, DOI 10.1128/MCB.14.3.2119; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Ivanov PA, 2006, MOL BIOL+, V40, P844, DOI 10.1134/S0026893306060021; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kennedy D, 2002, J CELL BIOCHEM, V84, P173, DOI 10.1002/jcb.1277; Li KQ, 2005, J BIOL CHEM, V280, P29176, DOI 10.1074/jbc.M502975200; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Michod D, 2004, ONCOGENE, V23, P8971, DOI 10.1038/sj.onc.1207999; Michod D, 2007, MOL CANCER RES, V5, P497, DOI 10.1158/1541-7786.MCR-06-0257; Michod D, 2009, JNCI-J NATL CANCER I, V101, P828, DOI 10.1093/jnci/djp100; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Parker F, 1996, MOL CELL BIOL, V16, P2561; Pittet O, 2007, J PHOTOCH PHOTOBIO B, V88, P29, DOI 10.1016/j.jphotobiol.2007.04.009; Ross B, 2007, BIOCHEM BIOPH RES CO, V353, P463, DOI 10.1016/j.bbrc.2006.12.044; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Stark LA, 2005, MOL CELL BIOL, V25, P5985, DOI 10.1128/MCB.25.14.5985-6004.2005; Strasser A, 2000, ANN NY ACAD SCI, V917, P541; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; WALDMAN T, 1995, CANCER RES, V55, P5187; Yang JY, 2005, MOL BIOL CELL, V16, P3511, DOI 10.1091/mbc.E05-01-0080; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; Yeilding NM, 1996, MOL CELL BIOL, V16, P3511; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zekri L, 2005, MOL CELL BIOL, V25, P8703, DOI 10.1128/MCB.25.19.8703-8716.2005	42	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29024	10.1371/journal.pone.0029024	http://dx.doi.org/10.1371/journal.pone.0029024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205990	gold, Green Published			2022-12-25	WOS:000298665600022
J	Halder, P; Chen, YC; Brauckhoff, J; Hofbauer, A; Dabauvalle, MC; Lewandrowski, U; Winkler, C; Sickmann, A; Buchner, E				Halder, Partho; Chen, Yi-chun; Brauckhoff, Janine; Hofbauer, Alois; Dabauvalle, Marie-Christine; Lewandrowski, Urs; Winkler, Christiane; Sickmann, Albert; Buchner, Erich			Identification of Eps15 as Antigen Recognized by the Monoclonal Antibodies aa2 and ab52 of the Wuerzburg Hybridoma Library against Drosophila Brain	PLOS ONE			English	Article							POLYACRYLAMIDE GELS; EH DOMAIN; PROTEIN; MELANOGASTER; THERAPEUTICS; GENE; BRUCHPILOT; HOMOLOGY; THERAPY; ASCITES	The Wuerzburg Hybridoma Library against the Drosophila brain represents a collection of around 200 monoclonal antibodies that bind to specific structures in the Drosophila brain. Here we describe the immunohistochemical staining patterns, the Western blot signals of one- and two-dimensional electrophoretic separation, and the mass spectrometric characterization of the target protein candidates recognized by the monoclonal antibodies aa2 and ab52 from the library. Analysis of a mutant of a candidate gene identified the Drosophila homolog of the Epidermal growth factor receptor Pathway Substrate clone 15 (Eps15) as the antigen for these two antibodies.	[Halder, Partho; Chen, Yi-chun; Brauckhoff, Janine; Buchner, Erich] Univ Wurzburg, Dept Neurobiol & Genet, Theodor Boveri Inst, Wurzburg, Germany; [Halder, Partho; Buchner, Erich] Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany; [Hofbauer, Alois] Univ Regensburg, Inst Zool, Dept Dev Biol, D-8400 Regensburg, Germany; [Dabauvalle, Marie-Christine] Univ Wurzburg, Div Electron Microscopy, Theodor Boveri Inst, Wurzburg, Germany; [Lewandrowski, Urs; Winkler, Christiane; Sickmann, Albert] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Lewandrowski, Urs; Sickmann, Albert] Leibniz Inst Analyt Wissensch ISAS eV, Dortmund, Germany; [Sickmann, Albert] Univ Bochum, Med Proteom Ctr, Bochum, Germany	University of Wurzburg; University of Wurzburg; University of Regensburg; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Ruhr University Bochum	Halder, P (corresponding author), Univ Wurzburg, Dept Neurobiol & Genet, Theodor Boveri Inst, Wurzburg, Germany.	buchner@biozentrum.uni-wuerzburg.de	Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265	German Research Foundation (DFG); University of Wuerzburg; German Excellence Initiative; DFG [SFB481, SFB554]; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; Bundesministerium fur Bildung und Forschung	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; German Excellence Initiative; DFG(German Research Foundation (DFG)); Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. PH is a PhD fellow supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg. The work was supported by DFG grants to EB (SFB481 and SFB554) and by the "Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen" and the "Bundesministerium fur Bildung und Forschung." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht H, 2009, DRUG TODAY, V45, P199, DOI 10.1358/dot.2009.45.3.1341343; BRODEUR BR, 1986, J IMMUNOL METHODS, V86, P239, DOI 10.1016/0022-1759(86)90459-X; BUCHNER E, 1986, CELL TISSUE RES, V246, P57; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; Cuesta AM, 2010, TRENDS BIOTECHNOL, V28, P355, DOI 10.1016/j.tibtech.2010.03.007; da Silva FA, 2008, BIODRUGS, V22, P301, DOI 10.2165/00063030-200822050-00003; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; DIEZEL W, 1972, ANAL BIOCHEM, V48, P617, DOI 10.1016/0003-2697(72)90117-0; ElBakri A, 2010, HUM IMMUNOL, V71, P1243, DOI 10.1016/j.humimm.2010.09.007; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; FUJITA SC, 1988, ANNU REV ENTOMOL, V33, P1, DOI 10.1146/annurev.en.33.010188.000245; Groves DJ, 2000, HYBRIDOMA, V19, P201, DOI 10.1089/02724570050109602; Hofbauer A, 1991, THESIS U WUERZBURG G; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; KOHLER G, 1976, EUR J IMMUNOL, V6, P511, DOI 10.1002/eji.1830060713; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KUO CH, 1982, EXP CELL RES, V142, P141, DOI 10.1016/0014-4827(82)90418-9; KUSHNER PD, 1984, J NEUROCHEM, V43, P775, DOI 10.1111/j.1471-4159.1984.tb12799.x; Lachmann P, 2009, VACCINE, V27, pG33, DOI 10.1016/j.vaccine.2009.09.137; Li J, 2010, ACTA PHARMACOL SIN, V31, P1198, DOI 10.1038/aps.2010.120; Li L, 2010, COCHRANE DB SYST REV, V8; Lipman NS, 1998, RES IMMUNOL, V149, P571, DOI 10.1016/S0923-2494(98)80008-4; Majumdar A, 2006, EXP CELL RES, V312, P2288, DOI 10.1016/j.yexcr.2006.03.030; Majumder R, 2010, J NEUROGENET, V24, P146, DOI 10.3109/01677063.2010.506229; Montesinos ML, 2005, BRAIN RES REV, V49, P416, DOI 10.1016/j.brainresrev.2005.06.002; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nieratschker V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000700; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; REICHMUTH C, 1995, MOL BRAIN RES, V32, P45, DOI 10.1016/0169-328X(95)00058-Z; REIFEGERSTE R, 1993, J NEUROSCI, V13, P2186; Salcini AE, 1999, INT J BIOCHEM CELL B, V31, P805, DOI 10.1016/S1357-2725(99)00042-4; SAUMWEBER H, 1980, CHROMOSOMA, V80, P253, DOI 10.1007/BF00292684; Schachter EN, 2009, DRUG TODAY, V45, P533, DOI 10.1358/dot.2009.45.7.1395290; SCHINDELIN J, 2008, P IM US DEV C LUX; Schmid B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-274; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29352	10.1371/journal.pone.0029352	http://dx.doi.org/10.1371/journal.pone.0029352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206011	Green Published, gold			2022-12-25	WOS:000298665600035
J	Schwindinger, WF; Mirshahi, UL; Baylor, KA; Sheridan, KM; Stauffer, AM; Usefof, S; Stecker, MM; Mirshahi, T; Robishaw, JD				Schwindinger, William F.; Mirshahi, Uyenlinh L.; Baylor, Kelly A.; Sheridan, Kathleen M.; Stauffer, Anna M.; Usefof, Stephanie; Stecker, Mark M.; Mirshahi, Tooraj; Robishaw, Janet D.			Synergistic Roles for G-protein gamma(3) and gamma(7) Subtypes in Seizure Susceptibility as Revealed in Double Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE D1 RECEPTOR; KETOGENIC DIET; IMMUNOHISTOCHEMICAL LOCALIZATION; GABA(B) RECEPTORS; EEG COHERENCE; BRAIN-INJURY; ADENOSINE; LACKING; SUBUNITS; NEURONS	The functions of differentG-protein alpha beta gamma subunit combinations are traditionally ascribed to their various alpha components. However, the discovery of similarly diverse gamma subtypes raises the possibility that they may also contribute to specificity. To test this possibility, we used a gene targeting approach to determine whether the closely related gamma(3) and gamma(7) subunits can perform functionally interchangeable roles in mice. In contrast to single knock-out mice that show normal survival, Gng3(-/-) Gng7(-/-) double knock-out mice display a progressive seizure disorder that dramatically reduces their median life span to only 75 days. Biochemical analyses reveal that the severe phenotype is not due to redundant roles for the two gamma subunits in the same signaling pathway but rather is attributed to their unique actions in different signaling pathways. The results suggest that the gamma(3) subunit is a component of a G(i/o) protein that is required for gamma-aminobutyric acid, type B, receptor-regulated neuronal excitability, whereas the gamma(7) subunit is a component of a G(olf) protein that is responsible for A(2A) adenosine or D-1 dopamine receptor-induced neuro-protective response. The development of this mouse model offers a novel experimental framework for exploring how signaling pathways integrate to produce normal brain function and how their combined dysfunction leads to spontaneous seizures and premature death. The results underscore the critical role of the gamma subunit in this process.	[Schwindinger, William F.; Mirshahi, Uyenlinh L.; Baylor, Kelly A.; Sheridan, Kathleen M.; Stauffer, Anna M.; Usefof, Stephanie; Stecker, Mark M.; Mirshahi, Tooraj; Robishaw, Janet D.] Geisinger Med Clin, Weis Ctr Res, Danville, PA 17822 USA	Geisinger Medical Center	Robishaw, JD (corresponding author), 100 N Acad Ave, Danville, PA 17822 USA.	jrobishaw@geisinger.edu		Stecker, Mark/0000-0002-9632-168X	National Institutes of Health [GM039867]; American Heart Association [0765275U]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039867, R29GM039867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM039867 (to J. D. R.). This work was also supported by American Heart Association-Great Rivers Affiliate Beginning Grant-in-aid 0765275U (to T.M.).	ANDERSON KD, 1991, BRAIN RES, V568, P235, DOI 10.1016/0006-8993(91)91403-N; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bernacer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001174; Bertran-Gonzalez J, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00136; CALABRESI P, 1991, J PHYSIOL-LONDON, V440, P581, DOI 10.1113/jphysiol.1991.sp018726; Charara A, 2000, NEUROSCIENCE, V95, P127; Charles KJ, 2001, NEUROSCIENCE, V106, P447, DOI 10.1016/S0306-4522(01)00296-2; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Cross JH, 2010, ARCH DIS CHILD, V95, P550, DOI 10.1136/adc.2009.159848; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; Eder DN, 2003, J PSYCHIAT RES, V37, P305, DOI 10.1016/S0022-3956(03)00007-4; Gantois I, 2007, P NATL ACAD SCI USA, V104, P4182, DOI 10.1073/pnas.0611625104; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Hartman AL, 2007, PEDIATR NEUROL, V36, P281, DOI 10.1016/j.pediatrneurol.2007.02.008; Hildebrandt JD, 1997, BIOCHEM PHARMACOL, V54, P325, DOI 10.1016/S0006-2952(97)00269-4; Isler JR, 2010, CLIN NEUROPHYSIOL, V121, P2035, DOI 10.1016/j.clinph.2010.05.004; Jones PA, 1998, NEUROSCIENCE, V85, P229, DOI 10.1016/S0306-4522(97)00613-1; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kitaoka K, 2011, BRAIN RES, V1423, P10, DOI 10.1016/j.brainres.2011.09.023; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; LI Y, 1994, J BIOL CHEM, V269, P27589; Lopez-Meraz ML, 2010, NEUROBIOL DIS, V37, P394, DOI 10.1016/j.nbd.2009.10.019; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Mantis John G, 2004, Nutr Metab (Lond), V1, P11, DOI 10.1186/1743-7075-1-11; Miskovic V, 2010, DEV PSYCHOPATHOL, V22, P419, DOI 10.1017/S0954579410000155; Neal EG, 2010, J HUM NUTR DIET, V23, P113, DOI 10.1111/j.1365-277X.2010.01043.x; Nylen K, 2008, EXP NEUROL, V210, P449, DOI 10.1016/j.expneurol.2007.11.015; Oldenburg IA, 2011, CURR OPIN NEUROBIOL, V21, P425, DOI 10.1016/j.conb.2011.04.004; Padgett CL, 2010, ADV PHARMACOL, V58, P123, DOI 10.1016/S1054-3589(10)58006-2; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Robishaw J. D., 2009, HDB CELL SIGNALING, P623; ROBISHAW JD, 1994, METHOD ENZYMOL, V237, P498; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/MCB.24.17.7758-7768.2004; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Schwindinger WF, 2010, J BIOL CHEM, V285, P29787, DOI 10.1074/jbc.M110.142620; Schwindinger WF, 2009, AM J PHYSIOL-REG I, V297, pR1494, DOI 10.1152/ajpregu.00308.2009; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; So EL, 2010, J CLIN NEUROPHYSIOL, V27, P227, DOI 10.1097/WNP.0b013e3181eaa60e; Sodickson DL, 1998, J NEUROSCI, V18, P8153; Stone Trevor W, 2009, Handb Exp Pharmacol, P535, DOI 10.1007/978-3-540-89615-9_17; Styer AM, 2010, J BIOL CHEM, V285, P41290, DOI 10.1074/jbc.M110.178541; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Winterer G, 2001, SCHIZOPHR RES, V49, P129, DOI 10.1016/S0920-9964(00)00128-6; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; Yang WL, 2006, CELL SIGNAL, V18, P194, DOI 10.1016/j.cellsig.2005.04.011; Zimmermann G, 1998, J BIOL CHEM, V273, P19650, DOI 10.1074/jbc.273.31.19650	61	32	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7121	7133		10.1074/jbc.M111.308395	http://dx.doi.org/10.1074/jbc.M111.308395			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22207761	Green Published, hybrid			2022-12-25	WOS:000301060200016
J	Perriches, T; Singleton, MR				Perriches, Thibaud; Singleton, Martin R.			Structure of Yeast Kinetochore Ndc10 DNA-binding Domain Reveals Unexpected Evolutionary Relationship to Tyrosine Recombinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROMERIC DNA; TOPOISOMERASE-I; CBF3; COMPLEX; SPINDLE; COMPONENT; INSIGHTS; SKP1P; SGT1P	We have solved the x-ray structure of the N-terminal half of the yeast kinetochore protein Ndc10 at 1.9 angstrom resolution. This essential protein is a key constituent of the budding yeast centromere and is essential for the recruitment of the centromeric nucleosome and establishment of the kinetochore. The fold of the protein shows unexpected similarities to the tyrosine recombinase/lambda-integrase family of proteins, most notably Cre, with some variation in the relative position of the subdomains. This finding offers new insights into kinetochore evolution and the adaptation of a well studied protein fold to a novel role. By comparison with tyrosine recombinases and mutagenesis studies, we have been able to define some of the key DNA-binding motifs.	[Perriches, Thibaud; Singleton, Martin R.] Canc Res UK London Res Inst, Macromol Struct & Funct Lab, London WC2A 3LY, England	Cancer Research UK	Singleton, MR (corresponding author), Canc Res UK London Res Inst, Macromol Struct & Funct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	Martin.Singleton@cancer.org.uk		Singleton, Martin/0000-0001-5716-7715	Cancer Research UK; Cancer Research UK [15656] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by a grant from Cancer Research UK.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER RE, 1989, J BIOL CHEM, V264, P10843; Bellizzi JJ, 2007, STRUCTURE, V15, P1422, DOI 10.1016/j.str.2007.09.008; Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; CARBON J, 1984, J CELL SCI, P43; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Cho US, 2012, NAT STRUCT MOL BIOL, V19, P48, DOI 10.1038/nsmb.2178; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espelin CW, 1997, J CELL BIOL, V139, P1383, DOI 10.1083/jcb.139.6.1383; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Ghosh K, 2005, J BIOL CHEM, V280, P8290, DOI 10.1074/jbc.M411668200; Gibb B, 2010, NUCLEIC ACIDS RES, V38, P5817, DOI 10.1093/nar/gkq384; Gillis AN, 2005, J CELL BIOL, V171, P773, DOI 10.1083/jcb.200507017; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JIANG WD, 1993, J CELL BIOL, V121, P513, DOI 10.1083/jcb.121.3.513; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nunes-Duby SE, 2002, J BACTERIOL, V184, P1385, DOI 10.1128/JB.184.5.1385-1394.2002; Peng YT, 2011, MOL BIOL CELL, V22, P2680, DOI 10.1091/mbc.E10-11-0915; Pietrasanta LI, 1999, P NATL ACAD SCI USA, V96, P3757, DOI 10.1073/pnas.96.7.3757; Purvis A, 2008, EMBO REP, V9, P56, DOI 10.1038/sj.embor.7401139; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Rodrigo-Brenni MC, 2004, MOL BIOL CELL, V15, P3366, DOI 10.1091/mbc.E03-12-0887; Romao M, 2008, J STRUCT BIOL, V163, P18, DOI 10.1016/j.jsb.2008.03.015; Russell ID, 1999, J CELL BIOL, V145, P933, DOI 10.1083/jcb.145.5.933; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; Widlund PO, 2006, MOL BIOL CELL, V17, P1065, DOI 10.1091/mbc.E05-07-0640	43	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5173	5179		10.1074/jbc.C111.318501	http://dx.doi.org/10.1074/jbc.C111.318501			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22215672	hybrid, Green Published			2022-12-25	WOS:000300608500075
J	Qin, HY; Suzuki, K; Nakata, M; Chikuma, S; Izumi, N; Huong, LT; Maruya, M; Fagarasan, S; Busslinger, M; Honjo, T; Nagaoka, H				Qin, Hongyan; Suzuki, Keiichiro; Nakata, Mikiyo; Chikuma, Shunsuke; Izumi, Nakako; Le Thi Huong; Maruya, Mikako; Fagarasan, Sidonia; Busslinger, Meinrad; Honjo, Tasuku; Nagaoka, Hitoshi			Activation-Induced Cytidine Deaminase Expression in CD4(+) T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; IMMUNOGLOBULIN-A GENERATION; HYPER-IGM SYNDROME; NF-KAPPA-B; SOMATIC HYPERMUTATION; EFFECTOR FUNCTIONS; AID EXPRESSION; CONSTITUTIVE EXPRESSION; GERMINAL-CENTERS; CUTTING EDGE	Activation-induced cytidine deaminase (AID), produced by the Aicda gene, is essential for the immunoglobulin gene (Ig) alterations that form immune memory. Using a Cre-mediated genetic system, we unexpectedly found CD4(+) T cells that had expressed Aicda (exAID cells) as well as B cells. ExAID cells increased with age, reaching up to 25% of the CD4(+) and B220(+) cell populations. ExAID B cells remained IgM(+), suggesting that class-switched memory B cells do not accumulate in the spleen. In T cells, AID was expressed in a subset that produced IFN-gamma and IL-10 but little IL-4 or IL-17, and showed no evidence of genetic mutation. Interestingly, the endogenous Aicda expression in T cells was enhanced in the absence of B cells, indicating that the process is independent from the germinal center reaction. These results suggest that in addition to its roles in B cells, AID may have previously unappreciated roles in T-cell function or tumorigenesis.	[Qin, Hongyan; Nakata, Mikiyo; Chikuma, Shunsuke; Izumi, Nakako; Le Thi Huong; Honjo, Tasuku; Nagaoka, Hitoshi] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan; [Suzuki, Keiichiro; Maruya, Mikako; Fagarasan, Sidonia] RIKEN, Lab Mucosal Immun, Yokohama, Kanagawa, Japan; [Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria	Kyoto University; RIKEN; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Qin, HY (corresponding author), Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China.	honjo@mfour.med.kyoto-u.ac.jp; nagaokh@gifu-u.ac.jp	Busslinger, Meinrad J./J-1249-2016; Fagarasan, Sidonia/A-5258-2016; Honjo, Tasuku/N-4470-2016; Chikuma, Shunsuke/Y-1016-2019	Busslinger, Meinrad J./0000-0002-9111-9351; Fagarasan, Sidonia/0000-0003-2086-6402; Qin, Hongyan/0000-0003-1038-7037	Ministry of Education, Science, Sports and Culture [20590277, 17002015]; Boehringer Ingelheim; Grants-in-Aid for Scientific Research [23659151] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Boehringer Ingelheim(Boehringer Ingelheim); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Education, Science, Sports and Culture by a Grant-in-Aid for Scientific Research (20590277) and a Grant-in-Aid for Specially-Promoted Research (17002015). Busslinger's research was supported by Boehringer Ingelheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fan J, 2010, J VIROL, V84, P7278, DOI 10.1128/JVI.02239-09; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Han JH, 2007, IMMUNITY, V27, P64, DOI 10.1016/j.immuni.2007.05.018; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715; Ishikawa C, 2011, CARCINOGENESIS, V32, P110, DOI 10.1093/carcin/bgq222; JAMIESON C, 1991, J IMMUNOL, V147, P416; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kuraoka M, 2011, P NATL ACAD SCI USA, V108, P11560, DOI 10.1073/pnas.1102571108; Kuraoka M, 2009, J IMMUNOL, V183, P3237, DOI 10.4049/jimmunol.0901548; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Lee WT, 1998, CELL IMMUNOL, V188, P1, DOI 10.1006/cimm.1998.1341; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084/jem.20091442; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Meyers G, 2011, P NATL ACAD SCI USA, V108, P11554, DOI 10.1073/pnas.1102600108; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Morisawa T, 2008, INT J CANCER, V123, P2735, DOI 10.1002/ijc.23853; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rucci F, 2006, GENE, V377, P150, DOI 10.1016/j.gene.2006.03.024; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Schreck S, 2006, J PATHOL, V210, P26, DOI 10.1002/path.2014; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x; ZHENG B, 1994, NATURE, V372, P556, DOI 10.1038/372556a0	63	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29141	10.1371/journal.pone.0029141	http://dx.doi.org/10.1371/journal.pone.0029141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216188	Green Submitted, gold, Green Published			2022-12-25	WOS:000300676300030
J	Calabrese, JM; Brunner, JL; Ostfeld, RS				Calabrese, Justin M.; Brunner, Jesse L.; Ostfeld, Richard S.			Partitioning the Aggregation of Parasites on Hosts into Intrinsic and Extrinsic Components via an Extended Poisson-Gamma Mixture Model	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; PEROMYSCUS-LEUCOPUS; TICK; IXODIDAE; POPULATIONS; TRANSMISSION; INFECTION; ABUNDANCE; PATTERNS; DAMMINI	It is well known that parasites are often highly aggregated on their hosts such that relatively few individuals host the large majority of parasites. When the parasites are vectors of infectious disease, a key consequence of this aggregation can be increased disease transmission rates. The cause of this aggregation, however, is much less clear, especially for parasites such as arthropod vectors, which generally spend only a short time on their hosts. Regression-based analyses of ticks on various hosts have focused almost exclusively on identifying the intrinsic host characteristics associated with large burdens, but these efforts have had mixed results; most host traits examined have some small influence, but none are key. An alternative approach, the Poisson-gamma mixture distribution, has often been used to describe aggregated parasite distributions in a range of host/macroparasite systems, but lacks a clear mechanistic basis. Here, we extend this framework by linking it to a general model of parasite accumulation. Then, focusing on blacklegged ticks (Ixodes scapularis) on mice (Peromyscus leucopus), we fit the extended model to the best currently available larval tick burden datasets via hierarchical Bayesian methods, and use it to explore the relative contributions of intrinsic and extrinsic factors on observed tick burdens. Our results suggest that simple bad luck-inhabiting a home range with high vector density-may play a much larger role in determining parasite burdens than is currently appreciated.	[Calabrese, Justin M.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Calabrese, Justin M.] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany; [Brunner, Jesse L.; Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Brunner, Jesse L.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Cary Institute of Ecosystem Studies; Washington State University	Calabrese, JM (corresponding author), Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA.	CalabreseJ@si.edu	Brunner, Jesse L./B-1692-2013; Calabrese, Justin/B-9131-2012	Brunner, Jesse L./0000-0003-4894-8274; Calabrese, Justin/0000-0003-0575-6408; Ostfeld, Richard/0000-0002-3707-9301	NSF [DEB 0075277, DEB 0444585]; NIH [R01 AI40076]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040076] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data collection for this research was supported by NSF grants DEB 0075277 and DEB 0444585, and NIH grant R01 AI40076 (www.nsf.gov,www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1982, PARASITOLOGY, V85, P373, DOI 10.1017/S0031182000055347; Boswell M., 1970, RANDOM COUNTS SCI WO, V1, P3; Boyer N, 2010, J ANIM ECOL, V79, P538, DOI 10.1111/j.1365-2656.2010.01659.x; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; BUSH AO, 1993, CAN J ZOOL, V71, P1358, DOI 10.1139/z93-186; Case T, 2000, ILLUSTRATED GUIDE TH, V44; Clark J. S, 2007, MODELS ECOLOGICAL DA; CROFTON HD, 1971, PARASITOLOGY, V62, P179, DOI 10.1017/S0031182000071420; FALCO RC, 1991, J MED ENTOMOL, V28, P726, DOI 10.1093/jmedent/28.5.726; FALCO RC, 1992, EXP APPL ACAROL, V14, P165, DOI 10.1007/BF01219108; Fish Durland, 1993, P25; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Hilborn Ray, 1997, V28; Hubbard A, 2002, PARASITOLOGY, V125, P221, DOI 10.1017/S003118200200207X; JANOVY J, 1988, J THEOR BIOL, V134, P391, DOI 10.1016/S0022-5193(88)80069-9; JONES LD, 1987, SCIENCE, V237, P775, DOI 10.1126/science.3616608; KEYMER AE, 1979, PARASITOLOGY, V79, P195, DOI 10.1017/S0031182000053282; Kiffner C, 2011, MED VET ENTOMOL, V25, P39, DOI 10.1111/j.1365-2915.2010.00929.x; Kiffner C, 2011, PARASITOL RES, V108, P323, DOI 10.1007/s00436-010-2065-x; LABUDA M, 1993, J MED ENTOMOL, V30, P295, DOI 10.1093/jmedent/30.1.295; Lindsay LR, 1998, J MED ENTOMOL, V35, P189, DOI 10.1093/jmedent/35.3.189; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Markowski D, 1997, J PARASITOL, V83, P207, DOI 10.2307/3284440; Mouchet J, 1996, LANCET, V348, P1735, DOI 10.1016/S0140-6736(05)65860-6; Paterson S, 2003, TRENDS PARASITOL, V19, P370, DOI 10.1016/S1471-4922(03)00149-1; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; PETNEY TN, 1990, ONDERSTEPOORT J VET, V57, P123; SCHAD GA, 1985, SCIENCE, V228, P1537, DOI 10.1126/science.4012307; Schmidt KA, 1999, J MED ENTOMOL, V36, P749, DOI 10.1093/jmedent/36.6.749; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Wilson K, 2002, ECOLOGY WILDLIFE DIS, P644; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	36	42	42	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29215	10.1371/journal.pone.0029215	http://dx.doi.org/10.1371/journal.pone.0029215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216216	Green Submitted, gold, Green Published			2022-12-25	WOS:000299684700041
J	Wang, SX; Hackett, A; Jia, N; Zhang, CH; Zhang, L; Parker, C; Zhou, A; Li, J; Cao, WC; Huang, ZH; Li, Y; Lu, S				Wang, Shixia; Hackett, Anthony; Jia, Na; Zhang, Chunhua; Zhang, Lu; Parker, Chris; Zhou, An; Li, Jun; Cao, Wu-Chun; Huang, Zuhu; Li, Yan; Lu, Shan			Polyvalent DNA Vaccines Expressing HA Antigens of H5N1 Influenza Viruses with an Optimized Leader Sequence Elicit Cross-Protective Antibody Responses	PLOS ONE			English	Article							RELATIVE IMMUNOGENICITY; INACTIVATED VACCINES; IMMUNE-RESPONSES; RECEPTOR-BINDING; MDCK CELLS; HEMAGGLUTININ; INFECTION; VACCINATION; CANDIDATE; CHICKENS	Highly pathogenic avian influenza A (HPAI) H5N1 viruses are circulating among poultry populations in parts of Asia, Africa, and the Middle East, and have caused human infections with a high mortality rate. H5 subtype hemagglutinin (HA) has evolved into phylogenetically distinct clades and subclades based on viruses isolated from various avian species. Since 1997, humans have been infected by HPAI H5N1 viruses from several clades. It is, therefore, important to develop strategies to produce protective antibody responses against H5N1 viruses from multiple clades or antigenic groups. In the current study, we optimized the signal peptide design of DNA vaccines expressing HA antigens from H5N1 viruses. Cross reactivity analysis using sera from immunized rabbits showed that antibody responses elicited by a polyvalent formulation, including HA antigens from different clades, was able to elicit broad protective antibody responses against multiple key representative H5N1 viruses across different clades. Data presented in this report support the development of a polyvalent DNA vaccine strategy against the threat of a potential H5N1 influenza pandemic.	[Wang, Shixia; Zhang, Chunhua; Zhang, Lu; Li, Jun; Huang, Zuhu; Lu, Shan] Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Zhang, Chunhua; Zhang, Lu; Li, Jun; Huang, Zuhu; Lu, Shan] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Key Lab Infect Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Chunhua; Zhang, Lu; Li, Jun; Huang, Zuhu] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Jia, Na; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Jia, Na; Cao, Wu-Chun] State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Li, Yan] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Wang, Shixia; Hackett, Anthony; Parker, Chris; Zhou, An; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Beijing Institute of Microbiology & Epidemiology; Public Health Agency of Canada; University of Massachusetts System; University of Massachusetts Worcester	Wang, SX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China.	shan.lu@umassmed.edu			China Special Grant for the Prevention and Control of Infection Diseases [2008ZX10004-006]; National Natural Science Foundation of China [30800976]; Jiangsu Province Key Laboratory in Infectious Diseases [200707]; Jiangsu Natural Science Foundation [BK2006728]; National Institutes of Health NIAID [U01AI078073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078073] Funding Source: NIH RePORTER	China Special Grant for the Prevention and Control of Infection Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Key Laboratory in Infectious Diseases; Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	1) China Special Grant for the Prevention and Control of Infection Diseases (2008ZX10004-006); 2) National Natural Science Foundation of China (30800976); 3) Jiangsu Province Key Laboratory in Infectious Diseases grant (200707); 4) Jiangsu Natural Science Foundation Major Grant (BK2006728); 5) National Institutes of Health NIAID U01AI078073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Baras B, 2006, PLOS MED, V3, pe360; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Desheva JA, 2006, VACCINE, V24, P6859, DOI 10.1016/j.vaccine.2006.06.023; Dong J, 2009, INFLUENZA OTHER RESP, V3, P287, DOI 10.1111/j.1750-2659.2009.00104.x; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; FDA, 2007, GUID IND CLIN DAT NE; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Jia N, 2008, J VIROL METHODS, V153, P43, DOI 10.1016/j.jviromet.2008.06.016; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kendal AP, 1982, WHO COLLABORATING CT, pB17; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; Li CJ, 2008, BIOCHEM BIOPH RES CO, V372, P293, DOI 10.1016/j.bbrc.2008.05.057; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Lu S, 1999, METHODS MOL MED DNA, P355; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Lu XH, 2006, VACCINE, V24, P6588, DOI 10.1016/j.vaccine.2006.05.039; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Murakami S, 2008, J VIROL, V82, P10502, DOI 10.1128/JVI.00970-08; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suguitan AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021942; Swayne DE, 2006, AVIAN PATHOL, V35, P141, DOI 10.1080/03079450600597956; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P23, DOI 10.1007/BF02123574; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tsai CG, 2009, VACCINE, V27, P6777, DOI 10.1016/j.vaccine.2009.08.056; Wang S, 2004, GENE DELIVERY MAMMAL; Wang SX, 2008, VACCINE, V26, P2100, DOI 10.1016/j.vaccine.2008.02.033; Wang S, 2008, VACCINE, V26, P3626, DOI 10.1016/j.vaccine.2008.04.073; Wang SX, 2008, VACCINE, V26, P1664, DOI 10.1016/j.vaccine.2008.01.024; Wang SX, 2006, J VIROL, V80, P11628, DOI 10.1128/JVI.01065-06; Wang SX, 2005, J VIROL, V79, P1906, DOI 10.1128/JVI.79.3.1906-1910.2005; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; Wang W, 2004, J VIROL, V84; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; Xing YP, 2008, VACCINE, V26, P5145, DOI 10.1016/j.vaccine.2008.03.072; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165	55	24	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28757	10.1371/journal.pone.0028757	http://dx.doi.org/10.1371/journal.pone.0028757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205966	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600032
J	Watson, JT; El Bushra, H; Lebo, EJ; Bwire, G; Kiyengo, J; Emukule, G; Omballa, V; Tole, J; Zuberi, M; Breiman, RF; Katz, MA				Watson, John T.; El Bushra, Hassan; Lebo, Emmaculate J.; Bwire, Godfrey; Kiyengo, James; Emukule, Gideon; Omballa, Victor; Tole, John; Zuberi, Muvunyi; Breiman, Robert F.; Katz, Mark A.			Outbreak of Beriberi among African Union Troops in Mogadishu, Somalia	PLOS ONE			English	Article							THIAMINE-DEFICIENCY; MARANHAO; BRAZIL; STATE	Context and Objectives: In July 2009, WHO and partners were notified of a large outbreak of unknown illness, including deaths, among African Union (AU) soldiers in Mogadishu. Illnesses were characterized by peripheral edema, dyspnea, palpitations, and fever. Our objectives were to determine the cause of the outbreak, and to design and recommend control strategies. Design, Setting, and Participants: The illness was defined as acute onset of lower limb edema, with dyspnea, chest pain, palpitations, nausea, vomiting, abdominal pain, or headache. Investigations in Nairobi and Mogadishu included clinical, epidemiologic, environmental, and laboratory studies. A case-control study was performed to identify risk factors for illness. Results: From April 26, 2009 to May 1, 2010, 241 AU soldiers had lower limb edema and at least one additional symptom; four patients died. At least 52 soldiers were airlifted to hospitals in Kenya and Uganda. Four of 31 hospitalized patients in Kenya had right-sided heart failure with pulmonary hypertension. Initial laboratory investigations did not reveal hematologic, metabolic, infectious or toxicological abnormalities. Illness was associated with exclusive consumption of food provided to troops (not eating locally acquired foods) and a high level of insecurity (e.g., being exposed to enemy fire on a daily basis). Because the syndrome was clinically compatible with wet beriberi, thiamine was administered to ill soldiers, resulting in rapid and dramatic resolution. Blood samples taken from 16 cases prior to treatment showed increased levels of erythrocyte transketolase activation coefficient, consistent with thiamine deficiency. With mass thiamine supplementation for healthy troops, the number of subsequent beriberi cases decreased with no further deaths reported. Conclusions: An outbreak of wet beriberi caused by thiamine deficiency due to restricted diet occurred among soldiers in a modern, well-equipped army. Vigilance to ensure adequate micronutrient intake must be a priority in populations completely dependent upon nutritional support from external sources.	[Watson, John T.] WHO, CH-1211 Geneva, Switzerland; [El Bushra, Hassan] WHO, Reg Off Eastern Mediterranean, Cairo, Egypt; [Lebo, Emmaculate J.; Emukule, Gideon; Omballa, Victor; Breiman, Robert F.; Katz, Mark A.] Ctr Dis Control & Prevent, Nairobi, Kenya; [Bwire, Godfrey; Kiyengo, James] Uganda Def Force UDPF, Entebbe, Uganda; [Omballa, Victor] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Tole, John] Aga Khan Univ Hosp, Nairobi, Kenya; [Zuberi, Muvunyi] African Union Headquarters, Addis Ababa, Ethiopia	World Health Organization; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Kenya Medical Research Institute; African Union (AU)	Watson, JT (corresponding author), WHO, CH-1211 Geneva, Switzerland.	watsonj@who.int	Bwire, Godfrey/J-7715-2019	Bwire, Godfrey/0000-0002-8376-2857				Ahoua L, 2007, FOOD NUTR BULL, V28, P283, DOI 10.1177/156482650702800304; Lima HCAV, 2010, TROP DOCT, V40, P95, DOI 10.1258/td.2009.090439; [Anonymous], 2009, UN RADIO; [Anonymous], 2009, REUTERS; BAYOUMI RA, 1976, CLIN CHEM, V22, P327; BHUVANESWARAN C, 1962, ANN NY ACAD SCI, V98, P576, DOI 10.1111/j.1749-6632.1962.tb30580.x; Bowman BA, 1996, AM J CLIN NUTR, V64, P383, DOI 10.1093/ajcn/64.3.383; CAMPBELL CH, 1984, LANCET, V2, P446; Charters A. D., 1943, TRANS ROY SOC TROP MED AND HYG, V37, P55, DOI 10.1016/S0035-9203(43)90010-0; Chen KT, 2003, PUBLIC HEALTH REP, V118, P59, DOI 10.1016/S0033-3549(04)50217-0; ENGBERS JG, 1984, BRIT HEART J, V51, P581, DOI 10.1136/hrt.51.5.581; Fozi K, 2006, Med J Malaysia, V61, P519; Prinzo ZW, 2002, P NUTR SOC, V61, P251, DOI 10.1079/PNS2002151; Rosa CAR, 2010, FOOD ADDIT CONTAM A, V27, P241, DOI 10.1080/19440040903289712; Sharma BD, 1999, POSTGRAD MED J, V75, P657, DOI 10.1136/pgmj.75.889.657; Udagawa Shun-ichi, 2004, Yakushigaku Zasshi, V39, P321; UNPOS United Nations Political Office for Somalia, SEC BRIEF; VIMOKESANT S, 1982, ANN NY ACAD SCI, V378, P123, DOI 10.1111/j.1749-6632.1982.tb31191.x; World Health Organization, 1999, THIAM DEF ITS PREV C	19	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28345	10.1371/journal.pone.0028345	http://dx.doi.org/10.1371/journal.pone.0028345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205947	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600015
J	Zheng, HQ; Jia, HW; Shankar, A; Heneine, W; Switzer, WM				Zheng, HaoQiang; Jia, Hongwei; Shankar, Anupama; Heneine, Walid; Switzer, William M.			Detection of Murine Leukemia Virus or Mouse DNA in Commercial RT-PCR Reagents and Human DNAs	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; NO ASSOCIATION; XMRV; CONTAMINATION; RETROVIRUS; SEQUENCES; FAILURE; ABSENCE; BLOOD	The xenotropic murine leukemia virus (MLV)-related viruses (XMRV) have been reported in persons with prostate cancer, chronic fatigue syndrome, and less frequently in blood donors. Polytropic MLVs have also been described in persons with CFS and blood donors. However, many studies have failed to confirm these findings, raising the possibility of contamination as a source of the positive results. One PCR reagent, Platinum Taq polymerase (pol) has been reported to contain mouse DNA that produces false-positive MLV PCR results. We report here the finding of a large number of PCR reagents that have low levels of MLV sequences. We found that recombinant reverse-transcriptase (RT) enzymes from six companies derived from either MLV or avian myeloblastosis virus contained MLV pol DNA sequences but not gag or mouse DNA sequences. Sequence and phylogenetic analysis showed high relatedness to Moloney MLV, suggesting residual contamination with an RT-containing plasmid. In addition, we identified contamination with mouse DNA and a variety of MLV sequences in commercially available human DNAs from leukocytes, brain tissues, and cell lines. These results identify new sources of MLV contamination and highlight the importance of careful pre-screening of commercial specimens and diagnostic reagents to avoid false-positive MLV PCR results.	[Zheng, HaoQiang] Natl Ctr HIV AIDS, Branch Lab, Div HIV AIDS Prevent, STD, Atlanta, GA USA; Ctr Dis Control & Prevent, TB Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Zheng, HQ (corresponding author), Natl Ctr HIV AIDS, Branch Lab, Div HIV AIDS Prevent, STD, Atlanta, GA USA.	bswitzer@cdc.gov			U.S. Congress through the Centers for Disease Control and Prevention	U.S. Congress through the Centers for Disease Control and Prevention	The U.S. Congress funded work through the Centers for Disease Control and Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes E, 2010, J INFECT DIS, V202, P1482, DOI 10.1086/657167; Cornelissen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012040; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katzourakis A, 2011, J VIROL, V85, P10909, DOI 10.1128/JVI.00827-11; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lintas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016609; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Raisch KP, 2003, VIROLOGY, V308, P83, DOI 10.1016/S0042-6822(02)00074-0; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Silverman RH, 2010, NAT REV UROL, V7, P392, DOI 10.1038/nrurol.2010.77; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; SWITZER W, 2011, RETROVIROLOGY, V8, pA232; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255	30	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e29050	10.1371/journal.pone.0029050	http://dx.doi.org/10.1371/journal.pone.0029050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205995	Green Published, gold			2022-12-25	WOS:000298666200017
J	Heermann, S; Schmucker, J; Hinz, U; Rickmann, M; Unterbarnscheidt, T; Schwab, MH; Krieglstein, K				Heermann, Stephan; Schmuecker, Julia; Hinz, Ursula; Rickmann, Michael; Unterbarnscheidt, Tilmann; Schwab, Markus H.; Krieglstein, Kerstin			Neuregulin 1 Type III/ErbB Signaling Is Crucial for Schwann Cell Colonization of Sympathetic Axons	PLOS ONE			English	Article							GLIAL GROWTH-FACTOR; PROLIFERATION; MOTILITY; REGENERATION; PURIFICATION; MYELINATION; MIGRATION; SURVIVAL; ERBB2	Analysis of Schwann cell (SC) development has been hampered by the lack of growing axons in many commonly used in vitro assays. As a consequence, the molecular signals and cellular dynamics of SC development along peripheral axons are still only poorly understood. Here we use a superior cervical ganglion (SCG) explant assay, in which axons elongate after treatment with nerve growth factor (NGF). Migration as well as proliferation and apoptosis of endogenous SCG-derived SCs along sympathetic axons were studied in these cultures using pharmacological interference and time-lapse imaging. Inhibition of ErbB receptor tyrosine kinases leads to reduced SC proliferation, increased apoptosis and thereby severely interfered with SC migration to distal axonal sections and colonization of axons. Furthermore we demonstrate that SC colonization of axons is also strongly impaired in a specific null mutant of an ErbB receptor ligand, Neuregulin 1 (NRG1) type III. Taken together, using a novel SC development assay, we demonstrate that NRG1 type III serves as a critical axonal signal for glial ErbB receptors that drives SC development along sympathetic axons.	[Heermann, Stephan; Hinz, Ursula] Heidelberg Univ, Dept Neuroanat, Heidelberg, Germany; [Schmuecker, Julia; Rickmann, Michael] Univ Gottingen, Dept Neuroanat, Gottingen, Germany; [Unterbarnscheidt, Tilmann; Schwab, Markus H.] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Heermann, Stephan; Krieglstein, Kerstin] Univ Freiburg, Inst Anat & Cell Biol, Dept Mol Embryol, D-79106 Freiburg, Germany; [Krieglstein, Kerstin] Univ Freiburg, FRIAS, D-79106 Freiburg, Germany	Ruprecht Karls University Heidelberg; University of Gottingen; Max Planck Society; University of Freiburg; University of Freiburg	Heermann, S (corresponding author), Heidelberg Univ, Dept Neuroanat, Heidelberg, Germany.	stephan.heermann@cos.uni-heidelberg.de	Heermann, Stephan/J-8586-2015		Deutsche Forschungsgemeinschaft [592-TPA22]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029071] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Deutsche Forschungsgemeinschaft, SFB 592-TPA22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; BROCKES JP, 1980, J BIOL CHEM, V255, P8374; Cheng HL, 2000, MOL CELL ENDOCRINOL, V170, P211, DOI 10.1016/S0303-7207(00)00324-5; Cornejo M, 2010, NEUROCHEM RES, V35, P1643, DOI 10.1007/s11064-010-0225-0; D'Antonio M, 2006, J NEUROSCI, V26, P8417, DOI 10.1523/JNEUROSCI.1578-06.2006; Day WA, 2003, EXP NEUROL, V184, P857, DOI 10.1016/S0014-4886(03)00308-X; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Ebendal T, 1989, NERVE GROWTH FACTORS, V12, P81; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Grinspan JB, 1996, J NEUROSCI, V16, P6107; Gumy LF, 2008, MOL CELL NEUROSCI, V37, P298, DOI 10.1016/j.mcn.2007.10.004; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Klutchko SR, 2006, J MED CHEM, V49, P1475, DOI 10.1021/jm050936o; Lai C, 2005, CURR BIOL, V15, pR332, DOI 10.1016/j.cub.2005.04.024; LEMKE GE, 1984, J NEUROSCI, V4, P75; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P373, DOI 10.1073/pnas.46.3.373; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Meyer D, 1997, DEVELOPMENT, V124, P3575; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Zhang LQ, 2009, GLIA, V57, P1178, DOI 10.1002/glia.20840; Zuo Y, 2004, J NEUROSCI, V24, P10999, DOI 10.1523/JNEUROSCI.3934-04.2004	27	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28692	10.1371/journal.pone.0028692	http://dx.doi.org/10.1371/journal.pone.0028692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194888	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400015
J	Fitzpatrick, DA; O'Brien, J; Moran, C; Hasin, N; Kenny, E; Cormican, P; Gates, A; Morris, DW; Jones, GW				Fitzpatrick, David A.; O'Brien, Jennifer; Moran, Ciara; Hasin, Naushaba; Kenny, Elaine; Cormican, Paul; Gates, Amy; Morris, Derek W.; Jones, Gary W.			Assessment of Inactivating Stop Codon Mutations in Forty Saccharomyces cerevisiae Strains: Implications for [PSI+] Prion-Mediated Phenotypes	PLOS ONE			English	Article							DE-NOVO FORMATION; YEAST PRION; ANTAGONISTIC INTERACTIONS; ENVIRONMENTAL-STRESS; GENETIC-VARIATION; CELL-GROWTH; PROPAGATION; HSP70; PROTEIN; MECHANISM	The yeast prion [PSI+] has been implicated in the generation of novel phenotypes by a mechanism involving a reduction in translation fidelity causing readthrough of naturally occurring stop codons. Some [PSI+] associated phenotypes may also be generated due to readthrough of inactivating stop codon mutations (ISCMs). Using next generation sequencing we have sequenced the genomes of two Saccharomyces cerevisiae strains that are commonly used for the study of the yeast [PSI+] prion. We have identified approximately 26,000 and 6,500 single nucleotide polymorphisms (SNPs) in strains 74-D694 and G600 respectively, compared to reference strain S288C. In addition to SNPs that produce non-synonymous amino acid changes we have also identified a number of SNPs that cause potential ISCMs in these strains, one of which we show is associated with a [PSI+]-dependent stress resistance phenotype in strain G600. We identified twenty-two potential ISCMs in strain 74-D694, present in genes involved in a variety of cellular processes including nitrogen metabolism, signal transduction and oxidative stress response. The presence of ISCMs in a subset of these genes provides possible explanations for previously identified [PSI+]-associated phenotypes in this strain. A comparison of ISCMs in strains G600 and 74-D694 with S. cerevisiae strains sequenced as part of the Saccharomyces Genome Resequencing Project (SGRP) shows much variation in the generation of strain-specific ISCMs and suggests this process is possible under complex genetic control. Additionally we have identified a major difference in the abilities of strains G600 and 74-D694 to grow at elevated temperatures. However, this difference appears unrelated to novel SNPs identified in strain 74-D694 present in proteins involved in the heat shock response, but may be attributed to other SNP differences in genes previously identified as playing a role in high temperature growth.	[Fitzpatrick, David A.] Natl Univ Ireland Maynooth, Genome Evolut Lab, Dept Biol, Maynooth, Kildare, Ireland; [O'Brien, Jennifer; Moran, Ciara; Hasin, Naushaba; Jones, Gary W.] Natl Univ Ireland Maynooth, Yeast Genet Lab, Dept Biol, Maynooth, Kildare, Ireland; [Kenny, Elaine; Cormican, Paul; Gates, Amy; Morris, Derek W.] Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland; [Kenny, Elaine; Cormican, Paul; Gates, Amy; Morris, Derek W.] Trinity Coll Dublin, Trinity Genome Sequencing Lab, Inst Mol Med, Dublin, Ireland	Maynooth University; Maynooth University; Trinity College Dublin; Trinity College Dublin	Fitzpatrick, DA (corresponding author), Natl Univ Ireland Maynooth, Genome Evolut Lab, Dept Biol, Maynooth, Kildare, Ireland.	gary.jones@nuim.ie	Morris, Derek/AAW-8343-2021; Kenny, Elaine/D-1644-2014	Morris, Derek/0000-0002-3413-570X; Jones, Gary/0000-0002-7565-934X; Fitzpatrick, David/0000-0001-7345-6998; Kenny, Elaine/0000-0003-4676-3436; Lafont, Amy/0000-0001-8396-4216	Science Foundation Ireland [08/BMT/1439]; Irish Health Research Board; IRCSET; NUI	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Health Research Board; IRCSET(Irish Research Council for Science, Engineering and Technology); NUI	This work was supported by a Science Foundation Ireland (www.sfi.ie) Research Frontiers grant (08/BMT/1439) awarded to GWJ. DAF acknowledges support of the Irish Health Research Board (www.hrb.ie). CM was supported by an IRCSET (www.ircset.ie) postgraduate scholarship and NH is supported by a NUI Maynooth John and Pat Hume postgraduate scholarship. The Trinity Genome Sequencing Laboratory is supported by Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Cubillos FA, 2009, FEMS YEAST RES, V9, P1217, DOI 10.1111/j.1567-1364.2009.00583.x; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Giacomelli MG, 2007, MOL BIOL EVOL, V24, P457, DOI 10.1093/molbev/msl172; Griswold CK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000517; Gu ZL, 2005, P NATL ACAD SCI USA, V102, P1092, DOI 10.1073/pnas.0409159102; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrison LB, 2007, J MOL BIOL, V368, P273, DOI 10.1016/j.jmb.2007.01.070; Jones G, 2004, MOL CELL BIOL, V24, P3928, DOI 10.1128/MCB.24.9.3928-3937.2004; Jones GW, 2005, BIOESSAYS, V27, P823, DOI 10.1002/bies.20267; Jones GW, 2003, GENETICS, V163, P495; Jonson L, 2004, EUR J BIOCHEM, V271, P4788, DOI 10.1111/j.1432-1033.2004.04443.x; Jung G, 2000, GENETICS, V156, P559; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lindquist S, 2009, COLD SH Q B, V74, P103, DOI 10.1101/sqb.2009.74.043; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Loovers HM, 2007, GENETICS, V175, P621, DOI 10.1534/genetics.106.066019; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Namy O, 2008, NAT CELL BIOL, V10, P1069, DOI 10.1038/ncb1766; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; Sideri TC, 2010, P NATL ACAD SCI USA, V107, P6394, DOI 10.1073/pnas.1000347107; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; True HL, 2006, TRENDS GENET, V22, P110, DOI 10.1016/j.tig.2005.12.004; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2007, METHOD MICROBIOL, V36, P491, DOI 10.1016/S0580-9517(06)36020-5; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2010, FEMS YEAST RES, V10, P980, DOI 10.1111/j.1567-1364.2010.00666.x; Wilson MA, 2005, P NATL ACAD SCI USA, V102, P10244, DOI 10.1073/pnas.0504557102	45	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28684	10.1371/journal.pone.0028684	http://dx.doi.org/10.1371/journal.pone.0028684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194885	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400017
J	Hsu, FC; Chou, MY; Peng, HP; Chou, SJ; Shih, MC				Hsu, Fu-Chiun; Chou, Mei-Yi; Peng, Hsiao-Ping; Chou, Shu-Jen; Shih, Ming-Che			Insights into Hypoxic Systemic Responses Based on Analyses of Transcriptional Regulation in Arabidopsis	PLOS ONE			English	Article							FLOODED TOMATO PLANTS; GENE-EXPRESSION; ABSCISIC-ACID; LOW-OXYGEN; GLYOXYLATE CYCLE; SUBMERGENCE TOLERANCE; PROLINE ACCUMULATION; STOMATAL CLOSURE; SALT TOLERANCE; ROOT-FORMATION	We have adopted a hypoxic treatment system in which only roots were under hypoxic conditions. Through analyzing global transcriptional changes in both shoots and roots, we found that systemic signals may be transduced from roots to trigger responses in tissues not directly subjected to hypoxia. The molecular mechanisms of such systemic responses under flooding are currently largely unknown. Using ontological categorization for regulated genes, a systemic managing program of carbohydrate metabolism was observed, providing an example of how systemic responses might facilitate the survival of plants under flooding. Moreover, a proportion of gene expressions that regulated in shoots by flooding was affected in an ethylene signaling mutation, ein2-5. Many systemic-responsive genes involved in the systemic carbohydrate managing program, hormone responses and metabolism, ubiquitin-dependent protein degradation were also affected in ein2-5. These results suggested an important role of ethylene in mediation of hypoxic systemic responses. Genes associated with abscisic acid (ABA) biosynthesis are upregulated in shoots and down regulated in roots. An ABA signaling mutation, abi4-1, affects expression of several systemic responsive genes. These results suggested that regulation of ABA biosynthesis could be required for systemic responses. The implications of these results for the systemic responses of root-flooded Arabidopsis are discussed.	[Hsu, Fu-Chiun; Chou, Mei-Yi; Peng, Hsiao-Ping; Shih, Ming-Che] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Hsu, Fu-Chiun] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Chou, Shu-Jen] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan; University of Iowa; Academia Sinica - Taiwan	Hsu, FC (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	mcshih@gate.sinica.edu.tw	Hsu, Fu-Chiun/AAV-2927-2021; Shih, Ming-Che/V-1816-2019	Hsu, Fu-Chiun/0000-0003-2871-1990	National Science Council [98-2321-B-001-027-MY3]; Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was funded by a grant (#98-2321-B-001-027-MY3) from the National Science Council (http://web1.nsc.gov.tw/mp.aspx?mp=7), and Academia Sinica (www.sinica.edu.tw/main_e.shtml), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbona V, 2008, J PLANT GROWTH REGUL, V27, P241, DOI 10.1007/s00344-008-9051-x; Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Atkinson CJ, 2008, ENVIRON EXP BOT, V64, P196, DOI 10.1016/j.envexpbot.2008.02.001; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Benschop JJ, 2005, PLANT J, V44, P756, DOI 10.1111/j.1365-313X.2005.02563.x; BRADFORD KJ, 1980, PLANT PHYSIOL, V65, P322, DOI 10.1104/pp.65.2.322; BRADFORD KJ, 1982, PLANT PHYSIOL, V70, P1503, DOI 10.1104/pp.70.5.1503; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; Christianson JA, 2010, PLANT SIGNAL BEHAV, V5, P1006, DOI [10.4161/psb.5.8.12231, 10.1093/pcp/pcp163]; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Christianson JA, 2009, PLANT PHYSIOL, V149, P1724, DOI 10.1104/pp.108.131912; Clark DG, 1999, PLANT PHYSIOL, V121, P53, DOI 10.1104/pp.121.1.53; Cornah JE, 2004, J BIOL CHEM, V279, P42916, DOI 10.1074/jbc.M407380200; Eastmond PJ, 2000, P NATL ACAD SCI USA, V97, P5669, DOI 10.1073/pnas.97.10.5669; Eastmond PJ, 2001, TRENDS PLANT SCI, V6, P72, DOI 10.1016/S1360-1385(00)01835-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellis MH, 1999, PLANT PHYSIOL, V119, P57, DOI 10.1104/pp.119.1.57; Else MA, 1996, PLANT PHYSIOL, V112, P239, DOI 10.1104/pp.112.1.239; FOSTER R, 1994, FASEB J, V8, P192, DOI 10.1096/fasebj.8.2.8119490; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Gil PM, 2009, PLANT SIGNAL BEHAV, V4, P100, DOI 10.4161/psb.4.2.7872; Gonzali S, 2005, ANN BOT-LONDON, V96, P661, DOI 10.1093/aob/mci218; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Hoeren FU, 1998, GENETICS, V149, P479; HOFFMANNBENNING S, 1992, PLANT PHYSIOL, V99, P1156, DOI 10.1104/pp.99.3.1156; Hoth S, 2002, J CELL SCI, V115, P4891, DOI 10.1242/jcs.00175; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Klok EJ, 2002, PLANT CELL, V14, P2481, DOI 10.1105/tpc.004747; Komatsu S, 2010, AMINO ACIDS, V38, P729, DOI 10.1007/s00726-009-0277-0; Kreuzwieser J, 2001, PHYSIOL PLANTARUM, V113, P41, DOI 10.1034/j.1399-3054.2001.1130106.x; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Lasanthi-Kudahettige R, 2007, PLANT PHYSIOL, V144, P218, DOI 10.1104/pp.106.093997; Licausi F, 2011, NEW PHYTOL, V190, P442, DOI 10.1111/j.1469-8137.2010.03451.x; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Loreti E, 2005, PLANT PHYSIOL, V137, P1130, DOI 10.1104/pp.104.057299; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Negi S, 2010, PLANT J, V61, P3, DOI 10.1111/j.1365-313X.2009.04027.x; NEUMAN DS, 1991, J EXP BOT, V42, P1499, DOI 10.1093/jxb/42.12.1499; Pracharoenwattana I, 2005, PLANT CELL, V17, P2037, DOI 10.1105/tpc.105.031856; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Robinson MF, 1997, ANN BOT-LONDON, V80, P387, DOI 10.1006/anbo.1996.0435; Saika H, 2007, PLANT CELL PHYSIOL, V48, P287, DOI 10.1093/pcp/pcm003; Shingaki-Wells RN, 2011, PLANT PHYSIOL, V156, P1706, DOI 10.1104/pp.111.175570; Strizhov N, 1997, PLANT J, V12, P557, DOI 10.1046/j.1365-313X.1997.00557.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; TREJO CL, 1991, J EXP BOT, V42, P1507, DOI 10.1093/jxb/42.12.1507; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; van Dongen JT, 2009, ANN BOT-LONDON, V103, P269, DOI 10.1093/aob/mcn126; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Vidoz ML, 2010, PLANT J, V63, P551, DOI 10.1111/j.1365-313X.2010.04262.x; Voesenek LACJ, 2003, ANN BOT-LONDON, V91, P205, DOI 10.1093/aob/mcf116; Welsch R, 2007, PLANT PHYSIOL, V145, P1073, DOI 10.1104/pp.107.104828; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V238, P17, DOI 10.1007/BF00279525; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Yoshiba Y, 1999, BIOCHEM BIOPH RES CO, V261, P766, DOI 10.1006/bbrc.1999.1112; Zhang HW, 2004, PLANTA, V220, P262, DOI 10.1007/s00425-004-1347-x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	72	65	65	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28888	10.1371/journal.pone.0028888	http://dx.doi.org/10.1371/journal.pone.0028888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194941	Green Published, gold, Green Submitted			2022-12-25	WOS:000298370400024
J	Magnusson, C; Bengtsson, AM; Liu, M; Liu, J; Ceder, Y; Ehrnstrom, R; Sjolander, A				Magnusson, Cecilia; Bengtsson, Astrid M.; Liu, Minghui; Liu, Jian; Ceder, Yvonne; Ehrnstrom, Roy; Sjolander, Anita			Regulation of Cysteinyl Leukotriene Receptor 2 Expression-A Potential Anti-Tumor Mechanism	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ENDOTHELIAL-CELLS; COLORECTAL ADENOCARCINOMAS; PROSTAGLANDIN E-2; SIGNALING NETWORK; CYSLT(1) RECEPTOR; INTERFERON-ALPHA; GENE-EXPRESSION; UP-REGULATION; CACO-2 CELLS	Background: The cysteinyl leukotrienes receptors (CysLTRs) are implicated in many different pathological conditions, such as inflammation and cancer. We have previously shown that colon cancer patients with high CysLT(1)R and low CysLT(2)R expression demonstrate poor prognosis. Therefore, we wanted to investigate ways for the transcriptional regulation of CysLT(2)R, which still remains to be poorly understood. Methodology/Principal Findings: We investigated the potential role of the anti-tumorigenic interferon alpha (IFN-alpha) and the mitogenic epidermal growth factor (EGF) on CysLT(2)R regulation using non-transformed intestinal epithelial cell lines and colon cancer cells to elucidate the effects on the CysLT(2)R expression and regulation. This was done using Western blot, qPCR, luciferase reporter assay and a colon cancer patient array. We found a binding site for the transcription factor IRF-7 in the putative promoter region of CysLT(2)R. This site was involved in the IFN-alpha induced activity of the CysLT(2)R luciferase reporter assay. In addition, IFN-alpha induced the activity of the differentiation marker alkaline phosphatase along with the expression of mucin-2, which protects the epithelial layer from damage. Interestingly, EGF suppressed both the expression and promoter activity of the CysLT(2)R. E-boxes present in the CysLT(2)R putative promoter region were involved in the suppressing effect. CysLT(2)R signaling was able to suppress cell migration that was induced by EGF signaling. Conclusions/Significance: The patient array showed that aggressive tumors generally expressed less IFN-alpha receptor and more EGFR. Interestingly, there was a negative correlation between CysLT(2)R and EGFR expression. Our data strengthens the idea that there is a protective role against tumor progression for CysLT(2)R and that it highlights new possibilities to regulate the CysLT(2)R.	[Magnusson, Cecilia; Bengtsson, Astrid M.; Liu, Minghui; Liu, Jian; Ceder, Yvonne; Ehrnstrom, Roy; Sjolander, Anita] Lund Univ, Skanes Univ Hosp, Dept Lab Med, Malmo, Sweden	Lund University	Magnusson, C (corresponding author), Lund Univ, Skanes Univ Hosp, Dept Lab Med, Malmo, Sweden.	anita.sjolander@med.lu.se		Ceder, Yvonne/0000-0002-8705-8293	Swedish Cancer Foundation; Swedish Medical Research Council; Foundations at Skanes University Hospital; Osterlund Foundation; Royal Physiographic Society in Lund; Gunnar Nilsson Foundation	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Foundations at Skanes University Hospital; Osterlund Foundation; Royal Physiographic Society in Lund; Gunnar Nilsson Foundation	This work was supported by grants for AS from the Swedish Cancer Foundation (www.cancerfonden.se), the Swedish Medical Research Council (www.vr.se), the Foundations at Skanes University Hospital, Gunnar Nilsson Foundation (www.cancerstiftelsen.com), the Osterlund Foundation (www.medmicro.se/stiftelse.htm), and for CM and AMB from the Royal Physiographic Society in Lund (www.fysiografen.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augenlicht L, 2003, ONCOGENE, V22, P4983, DOI 10.1038/sj.onc.1206521; Back M, 2006, ANN MED, V38, P493, DOI 10.1080/07853890600982737; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dukes CE, 1932, J PATHOL BACTERIOL, V35, P323, DOI 10.1002/path.1700350303; Early SB, 2007, AM J RESP CELL MOL, V36, P715, DOI 10.1165/rcmb.2006-0252OC; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fujii M, 2005, CHEST, V128, P3148, DOI 10.1378/chest.128.5.3148; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; HENLE G, 1957, J IMMUNOL, V79, P54; HO SB, 1993, CANCER RES, V53, P641; Hossain Z, 2006, CELL BIOCHEM FUNCT, V24, P159, DOI 10.1002/cbf.1202; Hui YQ, 2004, CIRCULATION, V110, P3360, DOI 10.1161/01.CIR.0000147775.50954.AA; Jiang Y, 2007, BLOOD, V110, P3263, DOI 10.1182/blood-2007-07-100453; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lotzer K, 2003, ARTERIOSCL THROM VAS, V23, pE32, DOI 10.1161/01.ATV.0000082690.23131.CB; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Lynch KR, 1999, NATURE, V399, P789; MAGNUSSON C, INT J CANC; MAGNUSSON C, EUR J CANC, V46, P826; Magnusson C, 2007, CANCER RES, V67, P9190, DOI 10.1158/0008-5472.CAN-07-0771; Mann JR, 2006, CANCER RES, V66, P6649, DOI 10.1158/0008-5472.CAN-06-1787; Massoumi R, 2003, EXP CELL RES, V289, P342, DOI 10.1016/S0014-4827(03)00285-4; Negus RPM, 1997, AM J PATHOL, V150, P1723; Nielsen CK, 2005, CANCER RES, V65, P732; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; Paruchuri S, 2003, J BIOL CHEM, V278, P45577, DOI 10.1074/jbc.M302881200; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; PETERSON MD, 1992, J CELL SCI, V102, P581; Pfeffer LM, 1998, CANCER RES, V58, P2489; REGO RL, BR J CANC, V102, P165; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P1592, DOI 10.1053/gast.2002.33426; Shirasaki H, 2007, ANN ALLERG ASTHMA IM, V99, P340, DOI 10.1016/S1081-1206(10)60550-9; Sjostrom M, 2003, ARTERIOSCL THROM VAS, V23, pE37, DOI 10.1161/01.ATV.0000082689.46538.DF; Solis M, 2006, BIOCHEM PHARMACOL, V72, P1469, DOI 10.1016/j.bcp.2006.06.002; STENSON WF, 1990, SCAND J GASTROENTERO, V25, P13, DOI 10.3109/00365529009091903; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Thompson C, 2008, J BIOL CHEM, V283, P1974, DOI 10.1074/jbc.M608197200; Tilg H, 1997, GASTROENTEROLOGY, V112, P1017, DOI 10.1053/gast.1997.v112.pm9041265; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; Woszczek G, 2007, J IMMUNOL, V178, P5262, DOI 10.4049/jimmunol.178.8.5262; Yudina Y, 2008, PROSTAG LEUKOTR ESS, V79, P223, DOI 10.1016/j.plefa.2008.09.024	54	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29060	10.1371/journal.pone.0029060	http://dx.doi.org/10.1371/journal.pone.0029060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194989	Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400029
J	Terhune, DB; Brugger, P				Terhune, Devin Blair; Brugger, Peter			Doing Better by Getting Worse: Posthypnotic Amnesia Improves Random Number Generation	PLOS ONE			English	Article							HYPNOTIC-SUSCEPTIBILITY; HYPNOTIZABILITY; MEMORIES; HYPNOSIS; SCALE	Although forgetting is often regarded as a deficit that we need to control to optimize cognitive functioning, it can have beneficial effects in a number of contexts. We examined whether disrupting memory for previous numerical responses would attenuate repetition avoidance (the tendency to avoid repeating the same number) during random number generation and thereby improve the randomness of responses. Low suggestible and low dissociative and high dissociative highly suggestible individuals completed a random number generation task in a control condition, following a posthypnotic amnesia suggestion to forget previous numerical responses, and in a second control condition following the cancellation of the suggestion. High dissociative highly suggestible participants displayed a selective increase in repetitions during posthypnotic amnesia, with equivalent repetition frequency to a random system, whereas the other two groups exhibited repetition avoidance across conditions. Our results demonstrate that temporarily disrupting memory for previous numerical responses improves random number generation.	[Terhune, Devin Blair] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Brugger, Peter] Univ Zurich, Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Brugger, Peter] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	University of Oxford; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Terhune, DB (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	devin.terhune@psy.ox.ac.uk	Terhune, Devin B./GNM-6644-2022	Terhune, Devin/0000-0002-6792-4975	Bial Foundation [54/06]; Cogito Foundation	Bial Foundation(Bial Foundation); Cogito Foundation	The research was supported by research grant 54/06 from the Bial Foundation and a postdoctoral fellowship from the Cogito Foundation, both to DBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2009, CURR DIR PSYCHOL SCI, V18, P189, DOI 10.1111/j.1467-8721.2009.01634.x; Barnier AJ, 2002, PSYCHOL SCI, V13, P232, DOI 10.1111/1467-9280.00443; Bowers KS, 1998, INT J CLIN EXP HYP, V46, P250, DOI 10.1080/00207149808410006; Brugger P, 1997, PERCEPT MOTOR SKILL, V84, P627, DOI 10.2466/pms.1997.84.2.627; Bryant RA, 2001, AM J PSYCHIAT, V158, P600, DOI 10.1176/appi.ajp.158.4.600; Chiu CD, 2009, J ABNORM PSYCHOL, V118, P214, DOI 10.1037/a0014654; CRAWFORD HJ, 1993, J ABNORM PSYCHOL, V102, P534, DOI 10.1037/0021-843X.102.4.534; Falk R, 1997, PSYCHOL REV, V104, P301, DOI 10.1037/0033-295X.104.2.301; FREEMAN WB, 1990, INT J CLIN EXP HYP, V38, P10, DOI 10.1080/00207149008414494; FRISCHHOLZ EJ, 1992, AM J CLIN HYPN, V35, P29, DOI 10.1080/00029157.1992.10402980; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; GEISELMAN RE, 1983, J EXP PSYCHOL GEN, V112, P58, DOI 10.1037/0096-3445.112.1.58; GRAHAM C, 1977, J ABNORM PSYCHOL, V86, P631, DOI 10.1037/0021-843X.86.6.631; Heuer H, 2010, Q J EXP PSYCHOL, V63, P465, DOI 10.1080/17470210902974138; Kihlstrom JF, 1998, PSYCHOL BULL, V123, P186, DOI 10.1037/0033-2909.123.2.186; King BJ, 1998, INT J CLIN EXP HYP, V46, P295, DOI 10.1080/00207149808410009; Knoch D, 2005, CEREB CORTEX, V15, P885, DOI 10.1093/cercor/bhh196; Korlin D, 2007, NORD J PSYCHIAT, V61, P126, DOI 10.1080/08039480701226112; Mendelsohn A, 2008, NEURON, V57, P159, DOI 10.1016/j.neuron.2007.11.022; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; NADON R, 1987, J PERS SOC PSYCHOL, V53, P948; Oakley DA, 2009, TRENDS COGN SCI, V13, P264, DOI 10.1016/j.tics.2009.03.004; Terhune DB, 2011, CONSCIOUS COGN, V20, P727, DOI 10.1016/j.concog.2010.11.005; Terhune DB, 2011, COGN NEUROPSYCHIATRY, V16, P113, DOI 10.1080/13546805.2010.503048; Weitzenhoffer A. M., 1967, REVISED STANFORD PRO	25	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29206	10.1371/journal.pone.0029206	http://dx.doi.org/10.1371/journal.pone.0029206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866HE	22195022	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000298370400038
J	De Paiva, CS; Volpe, EA; Gandhi, NB; Zhang, XB; Zheng, XF; Pitcher, JD; Farley, WJ; Stern, ME; Niederkorn, JY; Li, DQ; Flavell, RA; Pflugfelder, SC				De Paiva, Cintia S.; Volpe, Eugene A.; Gandhi, Niral B.; Zhang, Xiaobo; Zheng, Xiaofen; Pitcher, John D., III; Farley, William J.; Stern, Michael E.; Niederkorn, Jerry Y.; Li, De-Quan; Flavell, Richard A.; Pflugfelder, Stephen C.			Disruption of TGF-beta Signaling Improves Ocular Surface Epithelial Disease in Experimental Autoimmune Keratoconjunctivitis Sicca	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL DRY EYE; REGULATORY T-CELLS; SJOGRENS-SYNDROME; DESICCATING STRESS; SALIVARY-GLANDS; TEAR FLUID; CORNEAL EPITHELIUM; BARRIER DISRUPTION; INTERFERON-GAMMA	Background: TGF-beta is a pleiotropic cytokine that can have pro- or anti-inflammatory effects depending on the context. Elevated levels of bioactive TGF-beta 1 in tears and elevated TGF-beta 1mRNA transcripts in conjunctiva and minor salivary glands of human Sjogren's Syndrome patients has also been reported. The purpose of this study was to evaluate the response to desiccating stress (DS), an experimental model of dry eye, in dominant-negative TGF-beta type II receptor (CD4-DNTGF beta RII) mice. These mice have a truncated TGF-beta receptor in CD4(+) T cells, rendering them unresponsive to TGF-beta. Methodology/Principal Findings: DS was induced by subcutaneous injection of scopolamine and exposure to a drafty low humidity environment in CD4-DNTGF beta RII and wild-type (WT) mice, aged 14 weeks, for 5 days. Nonstressed (NS) mice served as controls. Parameters of ocular surface disease included corneal smoothness, corneal barrier function and conjunctival goblet cell density. NS CD4-DNTGF beta RII at 14 weeks of age mice exhibited a spontaneous dry eye phenotype; however, DS improved their corneal barrier function and corneal surface irregularity, increased their number of PAS+ GC, and lowered CD4(+) T cell infiltration in conjunctiva. In contrast to WT, CD4-DNTGF beta RII mice did not generate a Th-17 and Th-1 response, and they failed to upregulate MMP-9, IL-23, IL-17A, ROR gamma T, IFN-gamma and T-bet mRNA transcripts in conjunctiva. RAG1KO recipients of adoptively transferred CD4+T cells isolated from DS5 CD4-DNTGF beta RII showed milder dry eye phenotype and less conjunctival inflammation than recipients of WT control. Conclusions/Significance: Our results showed that disruption of TGF-beta signaling in CD4(+) T cells causes paradoxical improvement of dry eye disease in mice subjected to desiccating stress.	[De Paiva, Cintia S.; Volpe, Eugene A.; Gandhi, Niral B.; Zhang, Xiaobo; Zheng, Xiaofen; Pitcher, John D., III; Farley, William J.; Stern, Michael E.; Li, De-Quan; Pflugfelder, Stephen C.] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Zheng, Xiaofen] Shanxi Eye Hosp, Taiyuan, Peoples R China; [Niederkorn, Jerry Y.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Baylor College of Medicine; Shanxi Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Yale University; Yale University	De Paiva, CS (corresponding author), Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA.	cintiadp@bcm.tmc.edu	Volpe, Eugene A./D-2000-2012; De Paiva, Cintia/AAH-8354-2021	Volpe, Eugene A./0000-0002-9128-754X; De Paiva, Cintia/0000-0002-9057-5494	National Institutes of Health (NIH) [EY018090, EY11915, EY018888, P30-EY002520]; Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; Hamill Foundation; NATIONAL EYE INSTITUTE [P30EY002520, R01EY011915, R01EY018090, R21EY018888] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oshman Foundation; William Stamps Farish Fund; Hamill Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grants EY018090 (to SCP, MES, JYN) EY11915 (to SCP), NIH Grant EY018888 (to CSDP), Research to Prevent Blindness, NIH Core Grant P30-EY002520, Oshman Foundation, William Stamps Farish Fund, and the Hamill Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chotikavanich S, 2009, INVEST OPHTH VIS SCI, V50, P3203, DOI 10.1167/iovs.08-2476; COHEN MS, 1992, OPHTHALMIC PLAST REC, V8, P183, DOI 10.1097/00002341-199209000-00005; Corrales RM, 2006, INVEST OPHTH VIS SCI, V47, P3293, DOI 10.1167/iovs.05-1382; Cox CA, 2008, J IMMUNOL, V180, P7414, DOI 10.4049/jimmunol.180.11.7414; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; De Paiva CS, 2006, INVEST OPHTH VIS SCI, V47, P2847, DOI 10.1167/iovs.05-1281; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; De Paiva CS, 2010, RHEUMATOLOGY, V49, P246, DOI 10.1093/rheumatology/kep357; De Paiva CS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1625, DOI 10.1001/archophthalmol.2009.316; Ecoiffier T, 2008, ARCH OPHTHALMOL-CHIC, V126, P1695, DOI 10.1001/archopht.126.12.1695; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; GAO J, 2008, INVEST OPHTHALMOL VI, V49; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gupta A, 1996, CURR EYE RES, V15, P605, DOI 10.3109/02713689609008900; LAM H, 2008, AM J OPHTHALMOL 1105; LEE HS, 2011, CORNEA; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McCartneyFrancis NL, 1997, AM J PATHOL, V151, P1281; McCartneyFrancis NL, 1996, J IMMUNOL, V157, P1306; Nandula SR, 2007, ARTHRITIS RHEUM-US, V56, P1798, DOI 10.1002/art.22715; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Rahimy E, 2010, AM J PATHOL, V177, P744, DOI 10.2353/ajpath.2010.091116; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Sun D, 1998, AUTOIMMUNITY, V28, P125, DOI 10.3109/08916939808996281; Turpie B, 2009, AM J PATHOL, V175, P1136, DOI 10.2353/ajpath.2009.081058; van Blokland SCA, 2002, CLIN IMMUNOL, V103, P111, DOI 10.1006/clim.2002.5189; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Yoshino K, 1996, CURR EYE RES, V15, P615, DOI 10.3109/02713689609008901; Zhang XB, 2011, AM J PATHOL, V179, P1807, DOI 10.1016/j.ajpath.2011.06.030; Zhang XB, 2011, INVEST OPHTH VIS SCI, V52, P6279, DOI 10.1167/iovs.10-7081; Zheng XF, 2010, CORNEA, V29, P1048, DOI 10.1097/ICO.0b013e3181cf98ff	43	41	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29017	10.1371/journal.pone.0029017	http://dx.doi.org/10.1371/journal.pone.0029017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194977	Green Submitted, gold, Green Published			2022-12-25	WOS:000298369100141
J	Poteat, T; Diouf, D; Drame, FM; Ndaw, M; Traore, C; Dhaliwal, M; Beyrer, C; Baral, S				Poteat, Tonia; Diouf, Daouda; Drame, Fatou Maria; Ndaw, Marieme; Traore, Cheikh; Dhaliwal, Mandeep; Beyrer, Chris; Baral, Stefan			HIV Risk among MSM in Senegal: A Qualitative Rapid Assessment of the Impact of Enforcing Laws That Criminalize Same Sex Practices	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; SOUTH-AFRICA; HEALTH-CARE; YOUNG MEN; PREVENTION; TRANSMISSION; PREVALENCE; COMMUNITY; HIV/AIDS; NETWORKS	Men who have sex with men (MSM) are at high risk for HIV in Senegal, with a prevalence of 21.5%. In December 2008, nine male HIV prevention workers were imprisoned for "acts against nature" prohibited by Senegalese law. This qualitative study assessed the impact of these arrests on HIV prevention efforts. A purposive sample of MSM in six regions of Senegal was recruited by network referral. 26 in-depth interviews (IDIs) and 6 focus group discussions (FGDs) were conducted in July-August 2009. 14 key informants were also interviewed. All participants reported pervasive fear and hiding among MSM as a result of the December 2008 arrests and publicity. Service providers suspended HIV prevention work with MSM out of fear for their own safety. Those who continued to provide services noticed a sharp decline in MSM participation. An effective response to the HIV epidemic in Senegal should include active work to decrease enforcement of this law.	[Poteat, Tonia] Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Diouf, Daouda; Ndaw, Marieme] Enda Sante, Dakar, Senegal; [Drame, Fatou Maria] Gaston Berger Univ, St Louis, Senegal; [Traore, Cheikh; Dhaliwal, Mandeep] United Nations Dev Program, New York, NY USA; [Beyrer, Chris; Baral, Stefan] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Beyrer, Chris; Baral, Stefan] Johns Hopkins Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Poteat, T (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.	tpoteat@jhsph.edu	Baral, Stefan/D-2930-2013; Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419; Poteat, Tonia/0000-0001-6541-3787	HIV directorate of the United Nations Development Program (UNDP); Center for Global Health (CGH) at Johns Hopkins University	HIV directorate of the United Nations Development Program (UNDP); Center for Global Health (CGH) at Johns Hopkins University	The HIV directorate of the United Nations Development Program (UNDP) provided financial support for this work. In addition, UNDP provided input to the design of the study instruments and encouraged the development of a report describing the work and conclusions. The UNDP played no role in the decision to publish these data in a peer-reviewed manuscript. Additional funding was provided by the Frameworks Award of the Center for Global Health (CGH) at Johns Hopkins University. CGH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhanian YA, 2005, AIDS, V19, P1897, DOI 10.1097/01.aids.0000189867.74806.fb; [Anonymous], 2008, EP FACT SHEET HIV AI; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Becker S, 2010, AIDS BEHAV, V14, P558, DOI 10.1007/s10461-009-9607-1; BEEBE J, 1995, HUM ORGAN, V54, P42, DOI 10.17730/humo.54.1.k84tv883mr2756l3; Beyrer C, 2007, CLIN INFECT DIS, V44, P981, DOI 10.1086/512371; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Bhattacharya G, 2005, AIDS EDUC PREV, V17, P555, DOI 10.1521/aeap.2005.17.6.555; Campbell C, 2002, AIDS CARE, V14, P41, DOI 10.1080/09540120220097928; *CONS NAT LUTT SID, 2008, REP SEN PLAN STRAT L; CRABTREE B, DOING QUALITATIVE RE; DIENG M, 2008, GOORJIGEEN SE MARIEN; Epprecht M, 2001, REV CAN ETUD DEV, V22, P1089; Friedman SR, 2007, AM J PREV MED, V32, pS160, DOI 10.1016/j.amepre.2007.02.005; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P570, DOI 10.1097/OLQ.0b013e3181a866b8; HANSON C, 2010, SO AFRICA HIV AIDS I, V16, P9; Hendriksen ES, 2009, AIDS BEHAV, V13, P1213, DOI 10.1007/s10461-009-9608-0; *INT GAY LESB HUM, WORDS HAT CLIM FEAR; Johnson Cary A., 2007, OFF MAP HIV AIDS PRO; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Krishna A., 1999, C PAP C SOC CAP POV; Lindstrom M, 2004, SCAND J PUBLIC HEALT, V32, P243, DOI 10.1080/14034910310019227; Lovell AM, 2002, SOC SCI MED, V55, P803, DOI 10.1016/S0277-9536(01)00204-0; Macinko J, 2001, MILBANK Q, V79, P387, DOI 10.1111/1468-0009.00213; Maxwell J., 2004, QUALITATIVE RES DESI, DOI DOI 10.1177/1094428106290193; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V51, P340, DOI 10.1097/QAI.0b013e3181a24b38; MOREAU A, 2007, IMPLEMENTING STI HIV; NIANG C, 2001, M SEXUAL HLTH NEEDS; Niang CI, 2003, CULT HEALTH SEX, V5, P499, DOI 10.1080/1369105031000152715; Pinto RM, 2008, J GAY LESBIAN SOC SE, V20, P203, DOI 10.1080/10538720802235179; Pisani E, 1999, ACTING EARLY PREVENT; Reid E, 2000, Dev Bull, P21; Salomon EA, 2009, AIDS BEHAV, V13, P811, DOI 10.1007/s10461-008-9439-4; Sharma A, 2008, SEX TRANSM DIS, V35, P352, DOI 10.1097/OLQ.0b013e31815e6320; Shoko T, 2010, J HOMOSEXUAL, V57, P634, DOI 10.1080/00918361003712087; Sivaram S, 2009, AIDS EDUC PREV, V21, P233, DOI 10.1521/aeap.2009.21.3.233; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Smith RA, 2009, AIDS BEHAV, V13, P133, DOI 10.1007/s10461-008-9476-z; Sundquist K, 2007, HEALTH PLACE, V13, P324, DOI 10.1016/j.healthplace.2006.02.002; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; Takahashi LM, 2008, HEALTH PLACE, V14, P182, DOI 10.1016/j.healthplace.2007.06.002; Teunis N., 2001, AIDS BEHAV, V5, P173, DOI DOI 10.1023/A:1011335129358; van Griensven F, 2008, SEX TRANSM DIS, V35, P355, DOI 10.1097/OLQ.0b013e31816bf64c; van Griensven F, 2007, AIDS, V21, P1361, DOI 10.1097/QAD.0b013e328017f868; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Wade AS, 2010, AIDS CARE, V22, P409, DOI 10.1080/09540120903253973; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07; Wouters E, 2009, AIDS CARE, V21, P411, DOI 10.1080/09540120802242077	49	85	85	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28760	10.1371/journal.pone.0028760	http://dx.doi.org/10.1371/journal.pone.0028760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GS	22194906	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100093
J	Ran-Ressler, RR; Khailova, L; Arganbright, KM; Adkins-Rieck, CK; Jouni, ZE; Koren, O; Ley, RE; Brenna, JT; Dvorak, B				Ran-Ressler, Rinat R.; Khailova, Ludmila; Arganbright, Kelly M.; Adkins-Rieck, Camille K.; Jouni, Zeina E.; Koren, Omry; Ley, Ruth E.; Brenna, J. Thomas; Dvorak, Bohuslav			Branched Chain Fatty Acids Reduce the Incidence of Necrotizing Enterocolitis and Alter Gastrointestinal Microbial Ecology in a Neonatal Rat Model	PLOS ONE			English	Article							AMNIOTIC-FLUID; PSEUDOMONAS-AERUGINOSA; VERNIX CASEOSA; PRETERM INFANTS; HUMAN-MILK; GUT; CYTOKINES; BIFIDOBACTERIUM; SUPPLEMENTATION; INTESTINE	Introduction: Branched chain fatty acids (BCFA) are found in the normal term human newborn's gut, deposited as major components of vernix caseosa ingested during late fetal life. We tested the hypothesis that premature infants' lack of exposure to gastrointestinal (GI) BCFA is associated with their microbiota and risk for necrotizing enterocolitis (NEC) using a neonatal rat model. Methods: Pups were collected one day before scheduled birth. The pups were exposed to asphyxia and cold stress to induce NEC. Pups were assigned to one of three experimental treatments. DF (dam-fed); Control, hand-fed rat milk substitute; BCFA, hand-fed rat milk substitute with 20% w/w BCFA. Total fat was equivalent (11%wt) for both the Control and BCFA groups. Cecal microbiota were characterized by 16S rRNA gene pyrosequencing, and intestinal injury, ileal cytokine and mucin gene expression, interleukin-10 (IL-10) peptide immunohistochemistry, and BCFA uptake in ileum phospholipids, serum and liver were assessed. Results: NEC incidence was reduced by over 50% in the BCFA group compared to the Control group as assessed in ileal tissue; microbiota differed among all groups. BCFA-fed pups harbored greater levels of BCFA-associated Bacillus subtilis and Pseudomonas aeruginosa compared to Controls. Bacillus subtilis levels were five-fold greater in healthy pups compared to pups with NEC. BCFA were selectively incorporated into ileal phospholipids, serum and liver tissue. IL-10 expression increased three-fold in the BCFA group versus Controls and no other inflammatory or mucosal mRNA markers changed. Conclusion: At constant dietary fat level, BCFA reduce NEC incidence and alter microbiota composition. BCFA are also incorporated into pup ileum where they are associated with enhanced IL-10 and may exert other specific effects.	[Ran-Ressler, Rinat R.; Brenna, J. Thomas] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Khailova, Ludmila; Arganbright, Kelly M.; Adkins-Rieck, Camille K.; Dvorak, Bohuslav] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Jouni, Zeina E.] Mead Johnson Nutr, Evansville, IN USA; [Koren, Omry; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Cornell University; University of Arizona; Cornell University	Ran-Ressler, RR (corresponding author), Cornell Univ, Div Nutr Sci, Savage Hall, Ithaca, NY 14853 USA.	jtb4@cornell.edu; dvorakb@peds.arizona.edu	Koren, Omry/A-5222-2016; Ley, Ruth E/M-8542-2014	Koren, Omry/0000-0002-7738-1337; Ley, Ruth E/0000-0002-9087-1672; Brenna, James Thomas/0000-0001-9494-4245	United States National Institutes of Health (NIH) [HD039657]; NIH Human Microbiome Project Data Analysis and Coordination center; NIH [HD064604]; Mead Johnson Nutrition; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD064604, R01HD039657] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Human Microbiome Project Data Analysis and Coordination center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mead Johnson Nutrition; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the United States National Institutes of Health (NIH) grant HD039657 (to BD), NIH Human Microbiome Project Data Analysis and Coordination center (to REL), NIH grant HD064604 (to JTB), and a gift from Mead Johnson Nutrition (to BD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD) or the NIH. The funders had no role in data collection and analysis, preparation of the manuscript or decision to publish. ZEJ, an employee of Mean Johnson Nutrition, contributed to study design and final approval of the manuscript.	Baguma-Nibasheka M, 1999, BIOL REPROD, V60, P698, DOI 10.1095/biolreprod60.3.698; BEEBY PJ, 1992, ARCH DIS CHILD-FETAL, V67, P432, DOI 10.1136/adc.67.4_Spec_No.432; Bezirtzoglou E, 2006, COMP IMMUNOL MICROB, V29, P345, DOI 10.1016/j.cimid.2006.09.002; BEZIRTZOGLOU E, 2011, ANAEROBE        0416; BIEZENSK.JJ, 1968, AM J OBSTET GYNECOL, V102, P853, DOI 10.1016/0002-9378(68)90514-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CAMPEOTTO F, 2011, BR J NUTR, P1; CAPLAN MS, 1990, J PEDIATR-US, V116, P960, DOI 10.1016/S0022-3476(05)80661-4; Caplan MS, 2001, PEDIATR RES, V49, P647, DOI 10.1203/00006450-200105000-00007; Caplan MS, 2001, CURR OPIN PEDIATR, V13, P111, DOI 10.1097/00008480-200104000-00004; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlson SE, 1998, PEDIATR RES, V44, P491, DOI 10.1203/00006450-199810000-00005; Chao J, 2010, CAN J MICROBIOL, V56, P1028, DOI 10.1139/W10-093; Cilieborg MS, 2011, J NUTR, V141, P223, DOI 10.3945/jn.110.128561; Cilieborg MS, 2011, JPEN-PARENTER ENTER, V35, P32, DOI 10.1177/0148607110377206; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; CONRAD RS, 1981, J BACTERIOL, V148, P487, DOI 10.1128/JB.148.2.487-497.1981; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dvorak B, 2000, J PEDIATR GASTR NUTR, V31, P162, DOI 10.1097/00005176-200008000-00013; Dvorak B, 2003, PEDIATR RES, V53, P426, DOI 10.1203/01.PDR.0000050657.56817.E0; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EGGE H, 1972, CHEM PHYS LIPIDS, V8, P42, DOI 10.1016/0009-3084(72)90042-4; Ford H, 1997, J PEDIATR SURG, V32, P275, DOI 10.1016/S0022-3468(97)90194-9; Frost BL, 2011, CURR OPIN PEDIATR, V23, P151, DOI 10.1097/MOP.0b013e328343d65f; GIBSON RA, 1981, AM J CLIN NUTR, V34, P252, DOI 10.1093/ajcn/34.2.252; Grave GD, 2007, PEDIATR RES, V62, P510, DOI 10.1203/PDR.0b013e318142580a; GUPTA AK, 1993, J TROP PEDIATRICS, V39, P32, DOI 10.1093/tropej/39.1.32; HALL MA, 1990, ARCH DIS CHILD, V65, P185, DOI 10.1136/adc.65.2.185; Halpern MD, 2003, J PEDIATR GASTR NUTR, V36, P126, DOI 10.1097/00005176-200301000-00024; Halpern MD, 2002, PEDIATR RES, V51, P733, DOI 10.1023/01.PDR.0000017480.64723.56; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Huang JM, 2008, FEMS IMMUNOL MED MIC, V53, P195, DOI 10.1111/j.1574-695X.2008.00415.x; Inoue T, 2008, FEMS MICROBIOL LETT, V281, P81, DOI 10.1111/j.1574-6968.2008.01089.x; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Liu YY, 2009, AM J PHYSIOL-GASTR L, V297, pG442, DOI 10.1152/ajpgi.00182.2009; Lu J, 2007, PEDIATR RES, V61, P427, DOI 10.1203/pdr.0b013e3180332ca5; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Magne F, 2005, J PEDIATR GASTR NUTR, V41, P386, DOI 10.1097/01.mpg.0000179855.38543.85; McGuire W, 2003, ARCH DIS CHILD-FETAL, V88, P11; MIETTINE.TA, 1968, ACTA CHEM SCAND, V22, P2603, DOI 10.3891/acta.chem.scand.22-2603; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Narendran V, 2000, PEDIATR RES, V48, P120, DOI 10.1203/00006450-200007000-00021; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; NICOLAIDES N, 1965, J AM OIL CHEM SOC, V42, P702, DOI 10.1007/BF02540043; Ozturk H, 2002, J PEDIATR SURG, V37, P1330, DOI 10.1053/jpsu.2002.35002; Patterson JK, 2010, J NUTR, V140, P2158, DOI 10.3945/jn.110.130302; Pickens WL, 2000, J INVEST DERMATOL, V115, P875, DOI 10.1046/j.1523-1747.2000.00134.x; PRITCHARD JA, 1966, OBSTET GYNECOL, V28, P606; Ran-Ressler RR, 2011, LIPIDS, V46, P569, DOI 10.1007/s11745-011-3530-8; Ran-Ressler RR, 2008, PEDIATR RES, V64, P605, DOI 10.1203/PDR.0b013e318184d2e6; RAVUSSIN Y, 2011, OBESITY SIL IN PRESS; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rennick DM, 2000, AM J PHYSIOL-GASTR L, V278, pG829, DOI 10.1152/ajpgi.2000.278.6.G829; Rissmann R, 2006, J INVEST DERMATOL, V126, P1823, DOI 10.1038/sj.jid.5700305; Selvam R, 2009, INDIAN J BIOCHEM BIO, V46, P79; Sharma R, 2007, J PEDIATR SURG, V42, P454, DOI 10.1016/j.jpedsurg.2006.10.038; Siggers RH, 2008, J NUTR, V138, P1437, DOI 10.1093/jn/138.8.1437; Sun P, 2010, J DAIRY SCI, V93, P5851, DOI 10.3168/jds.2010-3263; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; VEERKAMP JH, 1971, J BACTERIOL, V108, P861, DOI 10.1128/JB.108.2.861-867.1971; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Young Christopher M, 2011, J Pediatr, V158, pe25, DOI 10.1016/j.jpeds.2010.11.009; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	72	119	130	6	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29032	10.1371/journal.pone.0029032	http://dx.doi.org/10.1371/journal.pone.0029032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194981	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100144
J	Schoni-Affolter, F; Keiser, O; Mwango, A; Stringer, J; Ledergerber, B; Mulenga, L; Bucher, HC; Westfall, AO; Calmy, A; Boulle, A; Chintu, N; Egger, M; Chi, BH				Schoeni-Affolter, Franziska; Keiser, Olivia; Mwango, Albert; Stringer, Jeffrey; Ledergerber, Bruno; Mulenga, Lloyd; Bucher, Heiner C.; Westfall, Andrew O.; Calmy, Alexandra; Boulle, Andrew; Chintu, Namwinga; Egger, Matthias; Chi, Benjamin H.		Swiss HIV Cohort Study IeDEA So	Estimating Loss to Follow-Up in HIV-Infected Patients on Antiretroviral Therapy: The Effect of the Competing Risk of Death in Zambia and Switzerland	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; TREATMENT PROGRAMS; MORTALITY; IMPACT; COHORT; ADULTS; COUNTRIES; SURVIVAL; OUTCOMES; FAILURE	Background: Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality is a competing risk (CR) for LTFU; however, it is often overlooked in cohort analyses. We examined how the CR of death affected LTFU estimates in Zambia and Switzerland. Methods and Findings: HIV-infected patients aged >= 18 years who started ART 2004-2008 in observational cohorts in Zambia and Switzerland were included. We compared standard Kaplan-Meier curves with CR cumulative incidence. We calculated hazard ratios for LTFU across CD4 cell count strata using cause-specific Cox models, or Fine and Gray subdistribution models, adjusting for age, gender, body mass index and clinical stage. 89,339 patients from Zambia and 1,860 patients from Switzerland were included. 12,237 patients (13.7%) in Zambia and 129 patients (6.9%) in Switzerland were LTFU and 8,498 (9.5%) and 29 patients (1.6%), respectively, died. In Zambia, the probability of LTFU was overestimated in Kaplan-Meier curves: estimates at 3.5 years were 29.3% for patients starting ART with CD4 cells <100 cells/mu l and 15.4% among patients starting with >= 350 cells/mu L. The estimates from CR cumulative incidence were 22.9% and 13.6%, respectively. Little difference was found between naive and CR analyses in Switzerland since only few patients died. The results from Cox and Fine and Gray models were similar: in Zambia the risk of loss to follow-up and death increased with decreasing CD4 counts at the start of ART, whereas in Switzerland there was a trend in the opposite direction, with patients with higher CD4 cell counts more likely to be lost to follow-up. Conclusions: In ART programmes in low-income settings the competing risk of death can substantially bias standard analyses of LTFU. The CD4 cell count and other prognostic factors may be differentially associated with LTFU in low-income and high-income settings.	[Schoeni-Affolter, Franziska; Keiser, Olivia; Egger, Matthias] Univ Bern, Div Int & Environm Hlth, Inst Social & Prevent Med ISPM, Bern, Switzerland; [Schoeni-Affolter, Franziska] Univ Lausanne Hosp, Ctr Data, Swiss HIV Cohort Study, Lausanne, Switzerland; [Mwango, Albert] Zambian Minist Hlth, Lusaka, Zambia; [Stringer, Jeffrey; Mulenga, Lloyd; Westfall, Andrew O.; Chintu, Namwinga; Chi, Benjamin H.] Ctr Infect Dis Res Zambia CIDRZ, Lusaka, Zambia; [Stringer, Jeffrey; Westfall, Andrew O.; Chintu, Namwinga; Chi, Benjamin H.] Univ Alabama, Sch Med, Birmingham, AL USA; [Stringer, Jeffrey; Westfall, Andrew O.; Chintu, Namwinga; Chi, Benjamin H.] Univ Alabama, Sch Publ Hlth, Birmingham, AL 35294 USA; [Ledergerber, Bruno] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Zurich Hosp, Zurich, Switzerland; [Bucher, Heiner C.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Calmy, Alexandra] Univ Hosp Geneva, HIV Aids Unit, Div Infect Dis, Dept Internal Med, Geneva, Switzerland; [Boulle, Andrew; Egger, Matthias] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Zurich; University Zurich Hospital; University of Basel; University of Geneva; University of Cape Town	Schoni-Affolter, F (corresponding author), Univ Bern, Div Int & Environm Hlth, Inst Social & Prevent Med ISPM, Bern, Switzerland.	egger@ispm.unibe.ch	Ledergerber, Bruno/B-5656-2009; Stringer, Jeffrey S. A./AAU-2342-2021; Boulle, Andrew/C-1413-2008; Pantaleo, Giuseppe/K-6163-2016	Ledergerber, Bruno/0000-0002-6881-4401; Boulle, Andrew/0000-0002-7713-8062; Westfall, Andrew/0000-0002-0468-4695; Keiser, Olivia/0000-0001-8191-2789; Egger, Matthias/0000-0001-7462-5132	National Institute of Allergy and Infectious Diseases [1 U01AI069924-01]; Swiss HIV Cohort Study, through the Swiss National Science Foundation; Swiss National Science Foundation [3233B_131629]; Zambian Ministry of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swiss HIV Cohort Study, through the Swiss National Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Zambian Ministry of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Allergy and Infectious Diseases (grant 1 U01AI069924-01) and by the Swiss HIV Cohort Study, through the Swiss National Science Foundation. OK was funded by a Program for Social Medicine, Preventive and Epidemiological Research (PROSPER) fellowship from the Swiss National Science Foundation (grant no. 3233B_131629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all patients and staff at the clinics included in this analysis and to the staff at the data centres in Lusaka and Lausanne. We also thank the Zambian Ministry of Health for its continued support for outcomes and operations research.	[Anonymous], HIV GUID ZAMB GUID; Arici Claudio, 2002, HIV Clin Trials, V3, P52; Bakoyannis G, 2011, STAT METHODS MED RES; Berry SD, 2010, J AM GERIATR SOC, V58, P783, DOI 10.1111/j.1532-5415.2010.02767.x; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014149; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chi BH, 2010, AM J EPIDEMIOL, V171, P924, DOI 10.1093/aje/kwq008; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gebhardt M, 1998, AIDS, V12, P1195, DOI 10.1097/00002030-199810000-00012; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Goldman JD, 2008, AIDS RES HUM RETROV, V24, P1031, DOI 10.1089/aid.2008.0035; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Hessol NA, 2001, AM J EPIDEMIOL, V154, P563, DOI 10.1093/aje/154.6.563; Hill T, 2010, J CLIN EPIDEMIOL, V63, P1101, DOI 10.1016/j.jclinepi.2009.12.007; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Krebs DW, 2008, AIDS CARE, V20, P311, DOI 10.1080/09540120701594776; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lebouche B, 2006, HIV MED, V7, P140, DOI 10.1111/j.1468-1293.2006.00357.x; LEDERGERBER B, 1994, SOZ PRAVENTIV MED, V39, P387, DOI 10.1007/BF01299670; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, P681; Pintilie M, 2006, COMPETING RISKS PRAC; Pintilie M, 2007, STAT MED, V26, P1360, DOI 10.1002/sim.2655; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Scrucca L, 2010, BONE MARROW TRANSPL, V45, P1388, DOI 10.1038/bmt.2009.359; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Weber R, 2009, HIV MED, V10, P407, DOI 10.1111/j.1468-1293.2009.00701.x; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	39	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27919	10.1371/journal.pone.0027919	http://dx.doi.org/10.1371/journal.pone.0027919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205933	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000298665600003
J	Dickhout, JG; Carlisle, RE; Jerome, DE; Mohammed-Ali, Z; Jiang, H; Yang, GD; Mani, S; Garg, SK; Banerjee, R; Kaufman, RJ; Maclean, KN; Wang, R; Austin, RC				Dickhout, Jeffrey G.; Carlisle, Rachel E.; Jerome, Danielle E.; Mohammed-Ali, Zahraa; Jiang, Hua; Yang, Guangdong; Mani, Sarathi; Garg, Sanjay K.; Banerjee, Ruma; Kaufman, Randal J.; Maclean, Kenneth N.; Wang, Rui; Austin, Richard C.			Integrated Stress Response Modulates Cellular Redox State via Induction of Cystathionine gamma-Lyase CROSS-TALK BETWEEN INTEGRATED STRESS RESPONSE AND THIOL METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BETA-SYNTHASE; OXIDATIVE STRESS; PLASMA HOMOCYSTEINE; TRANSSULFURATION PATHWAY; CARDIOVASCULAR-DISEASE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FOLIC-ACID; ER STRESS	The integrated stress response mediated by eukaryotic translation initiation factor 2 alpha (eIF2 alpha) phosphorylation maintains cellular homeostasis under endoplasmic reticulum (ER) stress. eIF2 alpha phosphorylation induces activating transcription factor 4 (ATF4), a basic leucine zipper transcription factor that regulates the expression of genes responsible for amino acid metabolism, cellular redox state, and anti-stress responses. Cystathionine gamma-lyase (CSE) and cystathionine beta-synthase are critical enzymes in the transsulfuration pathway, which also regulate cellular redox status by modulating glutathione (GSH) levels. To determine the link between the integrated stress response and the transsulfuration pathway, we used homocysteine (Hcy) as an inducer of eIF2 alpha phosphorylation and ATF4 gene induction. Mouse embryonic fibroblasts (MEFs) lacking ATF4 (ATF4(-/-)) had reduced GSH levels and increased reactive oxygen species and were susceptible to apoptotic cell death under normal culture conditions. Further, ATF4(-/-) MEFs were more sensitive to Hcy-induced cytotoxicity and showed significantly reduced intracellular GSH levels associated with apoptosis. ATF4(-/-) MEFs could be rescued from L-Hcy-induced apoptosis by beta-mercaptoethanol medium supplementation that increases cysteine levels and restores GSH synthesis. ATF4(-/-) MEFs showed little or no CSE protein but did express cystathionine beta-synthase. Further, ER stress-inducing agents, including tunicamycin and thapsigargin, induced the expression of CSE in ATF4(-/-) MEFs. Consistent with ATF4(-/-) MEFs, CSE-/- MEFs showed significantly greater apoptosis when treated with tunicamycin, thapsigargin, and L-Hcy, compared with CSE-/- MEFs. Liver and kidney GSH levels were also reduced in CSE-/- mice, suggesting that CSE is a critical factor in GSH synthesis and may act to protect the liver and kidney from a variety of conditions that cause ER stress.	[Austin, Richard C.] St Josephs Hosp, Hamilton Ctr Kidney Res, Hamilton, ON L8N 4A6, Canada; [Austin, Richard C.] McMaster Univ, St Josephs Healthcare Hamilton, Div Nephrol, Dept Med, Hamilton, ON L8N 4A6, Canada; [Jiang, Hua; Maclean, Kenneth N.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Mani, Sarathi; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Yang, Guangdong] Lakehead Univ, Sch Kinesiol, Thunder Bay, ON P7B 5E1, Canada; [Garg, Sanjay K.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Garg, Sanjay K.] Univ Michigan, Med Ctr, Dept Internal Med Geriatr Med, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Sanford Burnham Med Res Inst, Neurosci Aging & Stem Cell Res Ctr, La Jolla, CA 92037 USA	McGill University; McMaster University; McMaster University; University of Colorado System; University of Colorado Anschutz Medical Campus; Lakehead University; Lakehead University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sanford Burnham Prebys Medical Discovery Institute	Austin, RC (corresponding author), St Josephs Hosp, Hamilton Ctr Kidney Res, 50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	raustin@thrombosis.hhscr.org	Dickhout, Jeffrey/R-2606-2019; Yang, Guangdong/G-4129-2011; Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620; MANI, SARATHI/0000-0001-8383-4788	National Institutes of Health [P01HL057346, R37DK042394, R01DK088227, R01HL052173, HL58984]; Heart and Stroke Foundation of Ontario [T-5385]; Canadian Institutes of Health Research [MOP-74477, MOP-86708]; St. Joseph's Healthcare Hamilton; Jerome Lejeune Foundation; Special Products U.K; William R. Hummel Homocystinuria Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL052173, R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088227, R37DK042394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); St. Joseph's Healthcare Hamilton; Jerome Lejeune Foundation; Special Products U.K; William R. Hummel Homocystinuria Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL057346, R37DK042394, R01DK088227, and R01HL052173 (to R. J. K.) and HL58984 (to R. B.). This work was also supported in part by Heart and Stroke Foundation of Ontario Grant T-5385 (to R. C. A.) and Canadian Institutes of Health Research Grant MOP-74477 (to R. C. A.). This work was also supported by St. Joseph's Healthcare Hamilton.; Supported by the Jerome Lejeune Foundation, Special Products U.K., and the William R. Hummel Homocystinuria Research Fund.; Supported by Canadian Institutes of Health Research operating Grant MOP-86708.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; de Koning ABL, 2003, CLIN BIOCHEM, V36, P431, DOI 10.1016/S0009-9120(03)00062-6; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dickhout JG, 2007, ANTIOXID REDOX SIGN, V9, P1863, DOI 10.1089/ars.2007.1780; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Dickhout JG, 2002, CIRC RES, V91, P487, DOI 10.1161/01.RES.0000035243.66189.92; Dombroski BA, 2010, AM J HUM GENET, V86, P719, DOI 10.1016/j.ajhg.2010.03.017; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Espinos C, 2010, CLIN GENET, V78, P554, DOI 10.1111/j.1399-0004.2010.01431.x; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Garg SK, 2010, METHODS IN REDOX SIGNALING, P7; Handy DE, 2005, J BIOL CHEM, V280, P15518, DOI 10.1074/jbc.M501452200; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; ISHII T, 1981, J BIOL CHEM, V256, P2387; Jakubowski H, 2003, CLIN CHEM LAB MED, V41, P1462, DOI 10.1515/CCLM.2003.224; Jakubowski H, 2008, FASEB J, V22, P4071, DOI 10.1096/fj.08-112086; Kraus JP, 2009, MOL GENET METAB, V97, P250, DOI 10.1016/j.ymgme.2009.04.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Maclean KN, 2004, J BIOL CHEM, V279, P8558, DOI 10.1074/jbc.M310211200; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Martin J. A., 2007, CELL MOL BIOL S, V53; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; O'Brien M, 2000, J PHARMACOL EXP THER, V294, P480; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Patel H, 2003, J BIOL CHEM, V278, P19436, DOI 10.1074/jbc.M301718200; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Shastry S, 2007, KIDNEY INT, V71, P304, DOI 10.1038/sj.ki.5002031; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Wang J, 2004, CLIN GENET, V65, P483, DOI 10.1111/j.1399-0004.2004.00250.x; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yap S, 2001, ARTERIOSCL THROM VAS, V21, P2080, DOI 10.1161/hq1201.100225; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97; Zhou J, 2003, ATHEROSCLEROSIS, V168, P255, DOI 10.1016/S0021-9150(03)00138-2; Zhou J, 2001, ARTERIOSCL THROM VAS, V21, P1470, DOI 10.1161/hq0901.096582; Zhou J, 2008, FASEB J, V22, P2569, DOI 10.1096/fj.07-105353; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	62	81	87	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7603	7614		10.1074/jbc.M111.304576	http://dx.doi.org/10.1074/jbc.M111.304576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22215680	hybrid, Green Published			2022-12-25	WOS:000301060200060
J	Challa, TD; Beaton, N; Arnold, M; Rudofsky, G; Langhans, W; Wolfrum, C				Challa, Tenagne Delessa; Beaton, Nigel; Arnold, Myrtha; Rudofsky, Gottfried; Langhans, Wolfgang; Wolfrum, Christian			Regulation of Adipocyte Formation by GLP-1/GLP-1R Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; ADIPOSE-TISSUE; INSULIN SENSITIVITY; BODY-WEIGHT; RECEPTOR; DIFFERENTIATION; PROLIFERATION; LIRAGLUTIDE; OBESITY	Increased nutrient intake leads to excessive adipose tissue accumulation, obesity, and the development of associated metabolic disorders. How the intestine signals to adipose tissue to adapt to increased nutrient intake, however, is still not completely understood. We show here, that the gut peptide GLP-1 or its long-lasting analog liraglutide, function as intestinally derived signals to induce adipocyte formation, both in vitro and in vivo. GLP-1 and liraglutide activate the GLP-1R, thereby promoting pre-adipocyte proliferation and inhibition of apoptosis. This is achieved at least partly through activation of ERK, PKC, and AKT signaling pathways. In contrast, loss of GLP-1R expression causes reduction in adipogenesis, through induction of apoptosis in pre-adipocytes, by inhibition of the above mentioned pathways. Because GLP-1 and liraglutide are used for the treatment of type 2 diabetes, these findings implicate GLP-1 as a regulator of adipogenesis, which could be an alternate pathway leading to improved lipid homeostasis and controlled downstream insulin signaling.	[Challa, Tenagne Delessa; Beaton, Nigel; Arnold, Myrtha; Langhans, Wolfgang; Wolfrum, Christian] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Swiss Fed Inst Technol, CH-8603 Schwerzenbach, Switzerland; [Rudofsky, Gottfried] Heidelberg Univ, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg	Wolfrum, C (corresponding author), Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Swiss Fed Inst Technol, SLA C92,Schorenstr 16, CH-8603 Schwerzenbach, Switzerland.	Christian-wolfrum@ethz.ch	Langhans, Wolfgang/C-4073-2016	Wolfrum, Christian/0000-0002-3862-6805; Beaton, Nigel/0000-0003-3852-0223; Challa, PhD, Tenagne Delessa/0000-0002-5898-8061	ERC (AdipoDif); SNF	ERC (AdipoDif); SNF	This work was supported by the ERC (AdipoDif) and by the SNF.	Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Bregenbolt S, 2005, BIOCHEM BIOPH RES CO, V330, P577, DOI 10.1016/j.bbrc.2005.03.013; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; CLEMENS MJ, 1992, J CELL SCI, V103, P881; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Davidson LA, 2000, CARCINOGENESIS, V21, P1513, DOI 10.1093/carcin/21.8.1513; Drucker DJ, 2010, NAT REV DRUG DISCOV, V9, P267, DOI 10.1038/nrd3148; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dubuisson O, 2011, ENDOCRINOLOGY, V152, P3648, DOI 10.1210/en.2011-0225; Egan JM, 2003, DIABETES-METAB RES, V19, P115, DOI 10.1002/dmrr.357; EGAN JM, 1994, ENDOCRINOLOGY, V135, P2070, DOI 10.1210/en.135.5.2070; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hayes MR, 2011, OBESITY, V19, P1342, DOI 10.1038/oby.2011.50; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huang Y, 2010, BRIT J PHARMACOL, V159, P237, DOI 10.1111/j.1476-5381.2009.00517.x; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kaplan NM, 1998, J HYPERTENS, V16, pS35; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Korner Antje, 2005, Hormones (Athens), V4, P189; Kortum RL, 2005, MOL CELL BIOL, V25, P7592, DOI 10.1128/MCB.25.17.7592-7604.2005; LACASA D, 1995, BIOCHEM BIOPH RES CO, V217, P123, DOI 10.1006/bbrc.1995.2753; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Lo Yung-Feng, 2009, Chang Gung Med J, V32, P51; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Mari A, 2007, DIABETES CARE, V30, P2032, DOI 10.2337/dc07-0310; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Meissburger B, 2011, EMBO MOL MED, V3, P637, DOI 10.1002/emmm.201100172; MontroseRafizadeh C, 1997, J CELL PHYSIOL, V172, P275, DOI 10.1002/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Rask E, 2001, DIABETES CARE, V24, P1640, DOI 10.2337/diacare.24.9.1640; Sanz C, 2010, AM J PHYSIOL-ENDOC M, V298, pE634, DOI 10.1152/ajpendo.00460.2009; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Tong J, 2010, AM J PHYSIOL-GASTR L, V298, pG474, DOI 10.1152/ajpgi.00367.2009; Verdich C, 2001, INT J OBESITY, V25, P1206, DOI 10.1038/sj.ijo.0801655; von der Weid PY, 2010, ALIMENT PHARM THER, V32, P697, DOI 10.1111/j.1365-2036.2010.04407.x; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zhou YR, 2006, INT J BIOCHEM CELL B, V38, P2151, DOI 10.1016/j.biocel.2006.06.009	52	86	92	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6421	6430		10.1074/jbc.M111.310342	http://dx.doi.org/10.1074/jbc.M111.310342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207759	Green Published, hybrid			2022-12-25	WOS:000300791800032
J	Ferrand, J; Lehours, P; Schmid-Alliana, A; Megraud, F; Varon, C				Ferrand, Jonathan; Lehours, Philippe; Schmid-Alliana, Annie; Megraud, Francis; Varon, Christine			Epithelial Cells in vitro Induces Mesenchymal Stem Cell Migration through an NF-kappa B-Dependent Pathway	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CAG PATHOGENICITY ISLAND; MARROW-DERIVED CELLS; GASTRIC-CANCER; ENDOTHELIAL-CELLS; STROMAL CELLS; IV SECRETION; EXPRESSION; ACTIVATION; REGENERATION	The role of bone marrow-derived mesenchymal stem cells (MSC) in the physiology of the gastrointestinal tract epithelium is currently not well established. These cells can be recruited in response to inflammation due to epithelial damage, home, and participate in tissue repair. In addition, in the case of tissue repair failure, these cells could transform and be at the origin of carcinomas. However, the chemoattractant molecules responsible for MSC recruitment and migration in response to epithelial damage, and particularly to Helicobacter pylori infection, remain unknown although the role of some chemokines has been suggested. This work aimed to get insight into the mechanisms of mouse MSC migration during in vitro infection of mouse gastrointestinal epithelial cells by H. pylori. Using a cell culture insert system, we showed that infection of gastrointestinal epithelial cells by different H. pylori strains is able to stimulate the migration of MSC. This mechanism involves the secretion by infected epithelial cells of multiple cytokines, with a major role of TNFa, mainly via a Nuclear Factor-kappa B-dependent pathway. This study provides the first evidence of the role of H. pylori infection in MSC migration and paves the way to a better understanding of the role of bone marrow-derived stem cells in gastric pathophysiology and carcinogenesis.	[Ferrand, Jonathan; Lehours, Philippe; Megraud, Francis; Varon, Christine] Univ Bordeaux, Dept Bacteriol, Bordeaux, France; [Ferrand, Jonathan; Lehours, Philippe; Megraud, Francis; Varon, Christine] Inst Natl Sante & Rech Med, U853, Bordeaux, France; [Schmid-Alliana, Annie] Univ Nice Sophia Antipolis, Dept Immune & Inflammatory Regulat, Nice, France; [Schmid-Alliana, Annie] Inst Natl Sante & Rech Med, U576, Nice, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ferrand, J (corresponding author), Univ Bordeaux, Dept Bacteriol, Bordeaux, France.	francis.megraud@chu-bordeaux.fr	Ferrand, Jonathan/A-9479-2013; SCHMID-ALLIANA, Annie/P-4366-2016; Lehours, Philippe/I-2780-2014	SCHMID-ALLIANA, Annie/0000-0003-2321-7408; Ferrand, Jonathan/0000-0001-5797-2693; Varon, Christine/0000-0003-4026-2016	Institut de Recherche des Maladies de l'Appareil Digestif; Institut Federatif de Recherche 66 (Universite Victor Segalen, France)	Institut de Recherche des Maladies de l'Appareil Digestif; Institut Federatif de Recherche 66 (Universite Victor Segalen, France)	This project was financially supported by the Institut de Recherche des Maladies de l'Appareil Digestif, the Institut Federatif de Recherche 66 (Universite Victor Segalen Bordeaux 2, France), the Association pour la Recherche contre le Cancer (ARC, project number: 8412) and the Institut National du Cancer (project number: 07/3D1616/IABC-23-12/NC-NG). J. Ferrand is the recipient of fellowships from the French Ministry of Education, Research, and Technologies and the ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2003, J INFECT DIS, V187, P829; Bauer B, 2005, INFECT IMMUN, V73, P4643, DOI 10.1128/IAI.73.8.4643-4652.2005; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Chaouche-Drider N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005396; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019569; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Futagami S, 2003, GUT, V52, P1257, DOI 10.1136/gut.52.9.1257; Goso Y, 1997, J BIOCHEM-TOKYO, V122, P96; Hollande F, 2001, AM J PHYSIOL-GASTR L, V280, pG910, DOI 10.1152/ajpgi.2001.280.5.G910; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Hutchinson L, 2011, STEM CELLS DEV, V20, P11, DOI 10.1089/scd.2010.0139; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Kotarsky K, 2010, MUCOSAL IMMUNOL, V3, P40, DOI 10.1038/mi.2009.115; Kudo T, 2005, INFECT IMMUN, V73, P7602, DOI 10.1128/IAi.73.11.7602-7612.2005; Kuipers EJ, 1999, ALIMENT PHARM THERAP, V13, P3, DOI 10.1046/j.1365-2036.1999.00002.x; Kundu P, 2006, J BIOL CHEM, V281, P34651, DOI 10.1074/jbc.M604574200; Kusugami K, 1999, J GASTROEN HEPATOL, V14, P20, DOI 10.1046/j.1440-1746.1999.01810.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lee SK, 2003, MICROBES INFECT, V5, P1345, DOI 10.1016/j.micinf.2003.09.018; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Matsumoto T, 2005, GASTROENTEROLOGY, V128, P1851, DOI 10.1053/j.gastro.2005.03.085; Mishima Y, 2008, J ORTHOP RES; Okamoto R, 2004, J GASTROENTEROL, V39, P1, DOI 10.1007/s00535-003-1259-8; Park DH, 2008, MED SCI MONITOR, V14, pRA206; Peek RM, 1995, LAB INVEST, V73, P760; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Sarosi G, 2008, DIS ESOPHAGUS, V21, P43, DOI 10.1111/j.1442-2050.2007.00744.x; Secchiero P, 2008, STEM CELLS, V26, P2955, DOI 10.1634/stemcells.2008-0512; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sordi V, 2009, TRANSPLANTATION, V87, pS42, DOI 10.1097/TP.0b013e3181a28533; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Sterzenbach T, 2007, INFECT IMMUN, V75, P2717, DOI 10.1128/IAI.01935-06; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; Suganuma M, 2005, J CANCER RES CLIN, V131, P305, DOI 10.1007/s00432-004-0652-x; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Torok AM, 2005, INFECT IMMUN, V73, P1523, DOI 10.1128/IAI.73.3.1523-1531.2005; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Varon C, 2011, GASTROENTER IN PRESS; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang GH, 2009, CANCER-AM CANCER SOC, V115, P2430, DOI 10.1002/cncr.24255; Wang Lei, 2002, Hematology, V7, P113; Yamaoka Y, 1996, GASTROENTEROLOGY, V110, P1744, DOI 10.1053/gast.1996.v110.pm8964399; Yamaoka Y, 1997, GUT, V41, P442, DOI 10.1136/gut.41.4.442	57	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29007	10.1371/journal.pone.0029007	http://dx.doi.org/10.1371/journal.pone.0029007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216156	gold, Green Published, Green Submitted			2022-12-25	WOS:000300676300021
J	Polato, NR; Vera, JC; Baums, IB				Polato, Nicholas R.; Vera, J. Cristobal; Baums, Iliana B.			Gene Discovery in the Threatened Elkhorn Coral: 454 Sequencing of the Acropora palmata Transcriptome	PLOS ONE			English	Article							CARIBBEAN CORAL; SEA-ANEMONE; NEMATOSTELLA-VECTENSIS; MONTASTRAEA-FAVEOLATA; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; REEF; GENOME; EVOLUTION; CONSERVATION	Background: Cnidarians, including corals and anemones, offer unique insights into metazoan evolution because they harbor genetic similarities with vertebrates beyond that found in model invertebrates and retain genes known only from non-metazoans. Cataloging genes expressed in Acropora palmata, a foundation-species of reefs in the Caribbean and western Atlantic, will advance our understanding of the genetic basis of ecologically important traits in corals and comes at a time when sequencing efforts in other cnidarians allow for multi-species comparisons. Results: A cDNA library from a sample enriched for symbiont free larval tissue was sequenced on the 454 GS-FLX platform. Over 960,000 reads were obtained and assembled into 42,630 contigs. Annotation data was acquired for 57% of the assembled sequences. Analysis of the assembled sequences indicated that 83-100% of all A. palmata transcripts were tagged, and provided a rough estimate of the total number genes expressed in our samples (similar to 18,000-20,000). The coral annotation data contained many of the same molecular components as in the Bilateria, particularly in pathways associated with oxidative stress and DNA damage repair, and provided evidence that homologs of p53, a key player in DNA repair pathways, has experienced selection along the branch separating Cnidaria and Bilateria. Transcriptome wide screens of paralog groups and transition/transversion ratios highlighted genes including: green fluorescent proteins, carbonic anhydrase, and oxidative stress proteins; and functional groups involved in protein and nucleic acid metabolism, and the formation of structural molecules. These results provide a starting point for study of adaptive evolution in corals. Conclusions: Currently available transcriptome data now make comparative studies of the mechanisms underlying coral's evolutionary success possible. Here we identified candidate genes that enable corals to maintain genomic integrity despite considerable exposure to genotoxic stress over long life spans, and showed conservation of important physiological pathways between corals and bilaterians.	[Polato, Nicholas R.; Vera, J. Cristobal; Baums, Iliana B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Polato, NR (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	baums@psu.edu	Baums, Iliana Brigitta/G-6435-2010	Baums, Iliana Brigitta/0000-0001-6463-7308	National Science Foundation (NSF); National Oceanic and Atmospheric Administration; NSF [OCE-0825979, IOS-0950416]; Directorate For Geosciences [0825979] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was made possible with funding from a National Science Foundation (NSF) Graduate Research Fellowship Program grant to NP, National Oceanic and Atmospheric Administration Coral Ree462 to IB, NSF grant OCE-0825979 to IB and JV was supported by NSF grant IOS-0950416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aronson R, 2008, IUCN 2010 IUCN RED L; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baruch R, 2005, J EXP BIOL, V208, P843, DOI 10.1242/jeb.01496; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Belyi VA, 2010, COLD SPRING HARBOR P, V2, DOI 10.1101/cshperspect.a001198; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Bessat F, 2001, PALAEOGEOGR PALAEOCL, V175, P381, DOI 10.1016/S0031-0182(01)00381-9; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chapman RW, 2001, DEV COMP IMMUNOL, V25, P549, DOI 10.1016/S0145-305X(01)00045-3; Chung JY, 2002, J CELL SCI, V115, P679; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Foster N, MOL ECOLOGY IN PRESS; Foster NL, 2007, J ANIM ECOL, V76, P384, DOI 10.1111/j.1365-2656.2006.01207.x; Fusaoka E, 2006, GENES CELLS, V11, P541, DOI 10.1111/j.1365-2443.2006.00962.x; Gelfand Y, 2006, NUCL ACIDS RES; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Goldstein DB, 1999, MICROSATELLITES EVOL, P11; Grech A, 2000, MOL IMMUNOL, V37, P721, DOI 10.1016/S0161-5890(00)00098-5; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; HATCHER BG, 1988, TRENDS ECOL EVOL, V3, P106, DOI 10.1016/0169-5347(88)90117-6; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iguchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020140; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Keller I, 2007, PLOS GENET, V3, P185, DOI 10.1371/journal.pgen.0030022; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kohn MH, 2006, TRENDS ECOL EVOL, V21, P629, DOI 10.1016/j.tree.2006.08.001; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Levy O, 2006, J EXP BIOL, V209, P273, DOI 10.1242/jeb.01983; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Nesa B., 2008, P 11 INT COR REEF S, V1, P149; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Pankow S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000782; Petrov DA, 1999, P NATL ACAD SCI USA, V96, P1475, DOI 10.1073/pnas.96.4.1475; PONTKINGDON GA, 1995, NATURE, V375, P109, DOI 10.1038/375109b0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; ROGERS CS, 1981, J EXP MAR BIOL ECOL, V49, P179, DOI 10.1016/0022-0981(81)90069-1; Romanov MN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S10; Rutkowski R, 2010, COLD SPRING HARBOR P, V2; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Shick JM, 1996, GLOBAL CHANGE BIOL, V2, P527, DOI 10.1111/j.1365-2486.1996.tb00065.x; Smith JJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-19; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vollmer SV, 2006, J HEREDITY; Voolstra CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020392; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Walmod PS, 2007, HDB NEUROCHEMISTRY M; Wang S, 2009, J HERED, V100, P329, DOI 10.1093/jhered/esn100; Waterhouse RM, 2011, NUCLEIC ACIDS RES, V39, pD283, DOI 10.1093/nar/gkq930; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Young ET, 2000, GENETICS, V154, P1053; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	88	44	44	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28634	10.1371/journal.pone.0028634	http://dx.doi.org/10.1371/journal.pone.0028634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216101	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300007
J	Qumsieh, RY; Ali, BR; Abdulrazzaq, YM; Osman, O; Akawi, NA; Bastaki, SA				Qumsieh, Rula Y.; Ali, Bassam R.; Abdulrazzaq, Yousef M.; Osman, Ossama; Akawi, Nadia A.; Bastaki, SalimM. A.			Identification of New Alleles and the Determination of Alleles and Genotypes Frequencies at the CYP2D6 Gene in Emiratis	PLOS ONE			English	Article							CYTOCHROME-P450 2D6; EUROPEAN POPULATION; DEBRISOQUINE; METABOLISM; POLYMORPHISMS; ANTIDEPRESSANTS; PHENOTYPE; PHARMACOGENETICS; HYDROXYLATION; INTERMEDIATE	CYP2D6 belongs to the cytochrome P450 superfamily of enzymes and plays an important role in the metabolism of 20-25% of clinically used drugs including antidepressants. It displays inter-individual and inter-ethnic variability in activity ranging from complete absence to excessive activity which causes adverse drug reactions and toxicity or therapy failure even at normal drug doses. This variability is due to genetic polymorphisms which form poor, intermediate, extensive or ultrarapid metaboliser phenotypes. This study aimed to determine CYP2D6 alleles and their frequencies in the United Arab Emirates (UAE) local population. CYP2D6 alleles and genotypes were determined by direct DNA sequencing in 151 Emiratis with the majority being psychiatric patients on antidepressants. Several new alleles have been identified and in total we identified seventeen alleles and 49 genotypes. CYP2D6*1 (wild type) and CYP2D6*2 alleles (extensive metaboliser phenotype) were found with frequencies of 39.1% and 12.2%, respectively. CYP2D6*41 (intermediate metaboliser) occurred in 15.2%. Homozygous CYP2D6*4 allele (poor metaboliser) was found with a frequency of 2% while homozygous and heterozygous CYP2D6*4 occurred with a frequency of 9%. CYP2D6*2xn, caused by gene duplication (ultrarapid metaboliser) had a frequency of 4.3%. CYP2D6 gene duplication/multiduplication occurred in 16% but only 11.2% who carried more than 2 active functional alleles were considered ultrarapid metabolisers. CYP2D6 gene deletion in one copy occurred in 7.5% of the study group. In conclusion, CYP2D6 gene locus is heterogeneous in the UAE national population and no significant differences have been identified between the psychiatric patients and controls.	[Qumsieh, Rula Y.; Bastaki, SalimM. A.] United Arab Emirates Univ, Dept Pharmacol, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Ali, Bassam R.; Akawi, Nadia A.] United Arab Emirates Univ, Dept Pathol, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Abdulrazzaq, Yousef M.] United Arab Emirates Univ, Dept Pediat, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Osman, Ossama] United Arab Emirates Univ, Dept Psychiat, Fac Med & Hlth Sci, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; United Arab Emirates University	Qumsieh, RY (corresponding author), United Arab Emirates Univ, Dept Pharmacol, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	sbastaki@uaeu.ac.ae	Akawi, Nadia/AAX-2650-2020; Abdulrazzaq, Yousef M./G-5069-2017; Ali, Bassam/J-7014-2012	Akawi, Nadia/0000-0001-6311-7028; Abdulrazzaq, Yousef M./0000-0001-5853-6578; Ali, Bassam R/0000-0003-1306-6618	UAE University [02-04-8-11/08]	UAE University	This research has been funded by UAE University through grant no. 02-04-8-11/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441; Bernard S, 2006, ONCOLOGIST, V11, P126, DOI 10.1634/theoncologist.11-2-126; BERTILSSON L, 1995, CLIN PHARMACOKINET, V29, P192, DOI 10.2165/00003088-199529030-00005; Bozina N, 2003, CROAT MED J, V44, P425; Britzi M, 2000, THER DRUG MONIT, V22, P510, DOI 10.1097/00007691-200010000-00002; BROLY F, 1991, DNA CELL BIOL, V10, P545, DOI 10.1089/dna.1991.10.545; Cascorbi I, 2003, EUR J CLIN INVEST, V33, P17, DOI 10.1046/j.1365-2362.33.s2.3.x; DAHL ML, 1993, PHARMACOGENETICS, V3, P61, DOI 10.1097/00008571-199304000-00001; Dahl ML, 1995, COST B1 C VAR SPEC D, P111; DALY AK, 1991, PHARMACOGENETICS, V1, P33, DOI 10.1097/00008571-199110000-00006; De Leon J, 2006, PSYCHOSOMATICS, V47, P75, DOI 10.1176/appi.psy.47.1.75; EICHELBAUM M, 1990, PHARMACOL THERAPEUT, V46, P377, DOI 10.1016/0163-7258(90)90025-W; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Hosono N, 2009, CLIN CHEM, V55, P1546, DOI 10.1373/clinchem.2009.123620; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; JOHANSSON I, 1994, MOL PHARMACOL, V46, P452; Kalow W, 2005, EXPERT OPIN PHARMACO, V6, P1299, DOI 10.1517/14656566.6.8.1299; Kawanishi C, 2004, EUR J CLIN PHARMACOL, V59, P803, DOI 10.1007/s00228-003-0701-4; Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494; Kouhi H, 2009, GENET TEST MOL BIOMA, V13, P665, DOI 10.1089/gtmb.2009.0009; Ma MK, 2002, AM J HEALTH-SYST PH, V59, P2061, DOI 10.1093/ajhp/59.21.2061; Marez D, 1997, PHARMACOGENETICS, V7, P193, DOI 10.1097/00008571-199706000-00004; Masimirembwa C, 1996, BRIT J CLIN PHARMACO, V42, P713, DOI 10.1046/j.1365-2125.1996.00489.x; Matimba Alice, 2009, Human Genomics, V3, P169; McLellan RA, 1997, PHARMACOGENETICS, V7, P187, DOI 10.1097/00008571-199706000-00003; McLellan RA, 1996, 11 INT S MICR DRUG O, P205; Sachse C, 1998, PHARMACOGENETICS, V8, P181; Sistonen J, 2007, PHARMACOGENET GENOM, V17, P93; Toscano C, 2006, PHARMACOGENET GENOM, V16, P755, DOI 10.1097/01.fpc.0000230112.96086.e0; Zanger UM, 2008, ACTA CHIM SLOV, V55, P38; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2	31	20	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28943	10.1371/journal.pone.0028943	http://dx.doi.org/10.1371/journal.pone.0028943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216145	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700018
J	Fears, SC; Scheibel, K; Abaryan, Z; Lee, C; Service, SK; Jorgensen, MJ; Fairbanks, LA; Cantor, RM; Freimer, NB; Woods, RP				Fears, Scott C.; Scheibel, Kevin; Abaryan, Zvart; Lee, Chris; Service, Susan K.; Jorgensen, Matthew J.; Fairbanks, Lynn A.; Cantor, Rita M.; Freimer, Nelson B.; Woods, Roger P.			Anatomic Brain Asymmetry in Vervet Monkeys	PLOS ONE			English	Article							PLANUM TEMPORALE; CORTICAL CONNECTIONS; CEREBRAL ASYMMETRY; NONHUMAN-PRIMATES; AREA; RESONANCE; MACAQUE; HERITABILITY; EVOLUTION; PETALIAS	Asymmetry is a prominent feature of human brains with important functional consequences. Many asymmetric traits show population bias, but little is known about the genetic and environmental sources contributing to inter-individual variance. Anatomic asymmetry has been observed in Old World monkeys, but the evidence for the direction and extent of asymmetry is equivocal and only one study has estimated the genetic contributions to inter-individual variance. In this study we characterize a range of qualitative and quantitative asymmetry measures in structural brain MRIs acquired from an extended pedigree of Old World vervet monkeys (n = 357), and implement variance component methods to estimate the proportion of trait variance attributable to genetic and environmental sources. Four of six asymmetry measures show pedigree- level bias and one of the traits has a significant heritability estimate of about 30%. We also found that environmental variables more significantly influence the width of the right compared to the left prefrontal lobe.	[Fears, Scott C.; Fairbanks, Lynn A.; Freimer, Nelson B.; Woods, Roger P.] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Fears, Scott C.; Service, Susan K.; Fairbanks, Lynn A.; Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Fears, Scott C.; Woods, Roger P.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Scheibel, Kevin; Abaryan, Zvart; Lee, Chris; Woods, Roger P.] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA USA; [Jorgensen, Matthew J.] Wake Forest Univ Hlth Sci, Dept Pathol Comparat Med, Winston Salem, NC USA; [Cantor, Rita M.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Woods, Roger P.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Wake Forest University; Wake Forest University School of Medicine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Fears, SC (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.	sfears@mednet.ucla.edu		Jorgensen, Matthew/0000-0002-0977-6425	Training Grant for Neurobehavioral Genetics [5T32NS048004]; National Institutes of Health [5K08MH086786]; National Institutes of Health Roadmap for Biomedical Research [U54 RR021813]; University of California, Los Angeles Semel Institute [NCRR 2R01RR016300-03, P40RR019963, 5P20RR020750-03]; National Center for Research Resources (NCRR) [RR12169, RR13642, RR00865]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012169, P40RR019963, R01RR016300, M01RR000865, U54RR021813, P41RR013642, P20RR020750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH086786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048004] Funding Source: NIH RePORTER	Training Grant for Neurobehavioral Genetics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Roadmap for Biomedical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Los Angeles Semel Institute; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	SCF was supported by the Training Grant for Neurobehavioral Genetics (5T32NS048004) and a subsequent National Institutes of Health Career Development Award, (5K08MH086786). Funding was provided by the National Institutes of Health Roadmap for Biomedical Research (Grant U54 RR021813); the University of California, Los Angeles Semel Institute (NCRR 2R01RR016300-03; P40RR019963 and 5P20RR020750-03). Support was also provided by Grant Numbers RR12169, RR13642 and RR00865 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Bakola S, 2010, CORTICAL CONNECTIONS; Balzeau A, 2010, J HUM EVOL, V59, P54, DOI 10.1016/j.jhevol.2010.03.013; Barrick TR, 2005, NEUROIMAGE, V24, P678, DOI 10.1016/j.neuroimage.2004.09.003; Breveglieri R, 2008, CEREB CORTEX, V18, P806, DOI 10.1093/cercor/bhm127; Cantalupo C, 2001, NATURE, V414, P505, DOI 10.1038/35107134; Cantalupo C, 2009, EUR J NEUROSCI, V30, P431, DOI 10.1111/j.1460-9568.2009.06830.x; CHEVERUD JM, 1990, J HERED, V81, P51, DOI 10.1093/oxfordjournals.jhered.a110924; CHEVERUD JM, 1990, BRAIN BEHAV EVOLUT, V35, P368, DOI 10.1159/000115881; Corballis MC, 2009, PHILOS T R SOC B, V364, P867, DOI 10.1098/rstb.2008.0232; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; FALK D, 1990, BRAIN RES, V512, P40, DOI 10.1016/0006-8993(90)91167-F; FALK D, 1978, ACTA ANAT, V101, P334; Fears SC, 2009, J NEUROSCI, V29, P2867, DOI 10.1523/JNEUROSCI.5153-08.2009; Gannon PJ, 2005, ANAT REC PART A, V287A, P1128, DOI 10.1002/ar.a.20256; Gannon PJ, 1998, SCIENCE, V279, P220, DOI 10.1126/science.279.5348.220; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; HEILBRONER PL, 1989, AM J PHYS ANTHROPOL, V80, P203, DOI 10.1002/ajpa.1330800208; HEILBRONER PL, 1988, AM J PHYS ANTHROPOL, V76, P39, DOI 10.1002/ajpa.1330760105; Hopkins WD, 2000, NEUROPSYCHOLOGIA, V38, P493, DOI 10.1016/S0028-3932(99)00090-1; Hopkins WD, 2000, BRAIN BEHAV EVOLUT, V56, P293, DOI 10.1159/000047213; Hopkins WD, 2000, BEHAV NEUROSCI, V114, P739, DOI 10.1037//0735-7044.114.4.739; Lyn H, 2011, NEUROPSYCHOLOGIA; Passarelli L, 2011, J NEUROSCI, V31, P1790, DOI 10.1523/JNEUROSCI.4784-10.2011; Phillips KA, 2007, NEUROPSYCHOLOGIA, V45, P2398, DOI 10.1016/j.neuropsychologia.2007.02.021; Pilcher DL, 2001, LATERALITY, V6, P165; Rogers LJ, 2009, PHILOS T R SOC B, V364, P943, DOI 10.1098/rstb.2008.0225; Shipp S, 1998, EUR J NEUROSCI, V10, P3171, DOI 10.1046/j.1460-9568.1998.00327.x; The R Development Team, 2008, LANG ENV STAT COMP; Woods RP, 2011, NEUROIMAGE, V54, P1872, DOI 10.1016/j.neuroimage.2010.09.070; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; YENIKOMSHIAN GH, 1976, SCIENCE, V192, P387, DOI 10.1126/science.816005; Yoon U, 2010, NEUROIMAGE, V53, P1117, DOI 10.1016/j.neuroimage.2010.01.007	33	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28243	10.1371/journal.pone.0028243	http://dx.doi.org/10.1371/journal.pone.0028243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205941	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600011
J	Mazda, M; Nishi, K; Naito, Y; Ui-Tei, K				Mazda, Minami; Nishi, Kenji; Naito, Yuki; Ui-Tei, Kumiko			E-Cadherin Is Transcriptionally Activated via Suppression of ZEB1 Transcriptional Repressor by Small RNA-Mediated Gene Silencing	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; INTERFERING RNAS; CANCER-CELLS; SIRNA; EXPRESSION; METHYLATION; ARGONAUTE; DUPLEX; DETERMINANTS; MICRORNAS	RNA activation has been reported to be induced by small interfering RNAs (siRNAs) that act on the promoters of several genes containing E-cadherin. In this study, we present an alternative mechanism of E-cadherin activation in human PC-3 cells by siRNAs previously reported to possess perfect-complementary sequences to E-cadherin promoter. We found that activation of E-cadherin can be also induced via suppression of ZEB1, which is a transcriptional repressor of E-cadherin, by seed-dependent silencing mechanism of these siRNAs. The functional seed-complementary sites of the siRNAs were found in the coding region in addition to the 39 untranslated region of ZEB1 mRNA. Promoter analyses indicated that E-boxes, which are ZEB1-binding sites, in the upstream promoter region are indispensable for E-cadherin transcription by the siRNAs. Thus, the results caution against ignoring siRNA seed-dependent silencing effects in genome-wide transcriptional regulation. In addition, members of miR-302/372/373/520 family, which have the same seed sequences with one of the siRNAs containing perfect-complementarity to E-cadherin promoter, are also found to activate E-cadherin transcription. Thus, E-cadherin could be upregulated by the suppression of ZEB1 transcriptional repressor by miRNAs in vivo.	[Mazda, Minami; Nishi, Kenji; Naito, Yuki; Ui-Tei, Kumiko] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan	University of Tokyo	Mazda, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan.	ktei@bi.s.u-tokyo.ac.jp		Naito, Yuki/0000-0002-1182-6786	MEXT; Genome Network; Grants-in-Aid for Scientific Research [21310123, 21115004] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Genome Network; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by grants from MEXT, the Genome Network Project, and Cell Innovation Project (MEXT) to KUT. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Moses J, 2010, RNA, V16, P430, DOI 10.1261/rna.1808510; Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Suzuki K, 2008, J BIOL CHEM, V283, P23353, DOI 10.1074/jbc.M709651200; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P7100, DOI 10.1093/nar/gkn902; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Weinberg MS, 2007, NUCLEIC ACIDS RES, V35, P7303, DOI 10.1093/nar/gkm847; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	52	30	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28688	10.1371/journal.pone.0028688	http://dx.doi.org/10.1371/journal.pone.0028688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205962	Green Submitted, Green Published, gold			2022-12-25	WOS:000299113600026
J	Mira, NP; Madeira, A; Moreira, AS; Coutinho, CP; Sa-Correia, I				Mira, Nuno P.; Madeira, Andreia; Moreira, Ana Silvia; Coutinho, Carla P.; Sa-Correia, Isabel			Genomic Expression Analysis Reveals Strategies of Burkholderia cenocepacia to Adapt to Cystic Fibrosis Patients' Airways and Antimicrobial Therapy	PLOS ONE			English	Article							HYPERMUTABLE PSEUDOMONAS-AERUGINOSA; CEPACIA COMPLEX; LUNG INFECTION; EFFLUX PUMP; AMINOGLYCOSIDE RESISTANCE; ANTIBIOTIC-RESISTANCE; ISOCITRATE LYASE; STRUCTURAL BASIS; OUTER-MEMBRANE; VIRULENCE	Pulmonary colonization of cystic fibrosis (CF) patients with Burkholderia cenocepacia or other bacteria of the Burkholderia cepacia complex (Bcc) is associated with worse prognosis and increased risk of death. During colonization, the bacteria may evolve under the stressing selection pressures exerted in the CF lung, in particular, those resulting from challenges of the host immune defenses, antimicrobial therapy, nutrient availability and oxygen limitation. Understanding the adaptive mechanisms that promote successful colonization and long-term survival of B. cenocepacia in the CF lung is essential for an improved therapeutic outcome of chronic infections. To get mechanistic insights into these adaptive strategies a transcriptomic analysis, based on DNA microarrays, was explored in this study. The genomic expression levels in two clonal variants isolated during long-term colonization of a CF patient who died from the cepacia syndrome were compared. One of the isolates examined, IST439, is the first B. cenocepacia isolate retrieved from the patient and the other isolate, IST4113, was obtained three years later and is more resistant to different classes of antimicrobials. Approximately 1000 genes were found to be differently expressed in the two clonal variants reflecting a marked reprogramming of genomic expression. The up-regulated genes in IST4113 include those involved in translation, iron uptake (in particular, in ornibactin biosynthesis), efflux of drugs and in adhesion to epithelial lung tissue and to mucin. Alterations related with adaptation to the nutritional environment of the CF lung and to an oxygen-limited environment are also suggested to be a key feature of transcriptional reprogramming occurring during long-term colonization, antibiotic therapy and the progression of the disease.	[Mira, Nuno P.; Madeira, Andreia; Moreira, Ana Silvia; Coutinho, Carla P.; Sa-Correia, Isabel] Univ Tecn Lisboa, Inst Super Tecn, IBB, Ctr Biol & Chem Engn, P-1096 Lisbon, Portugal; [Mira, Nuno P.; Madeira, Andreia; Sa-Correia, Isabel] Univ Tecn Lisboa, Inst Super Tecn, Dept Bioengn, P-1096 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Mira, NP (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, IBB, Ctr Biol & Chem Engn, P-1096 Lisbon, Portugal.	isacorreia@ist.utl.pt	Coutinho, Carla P./F-7867-2014; Madeira, Andreia S/B-4962-2012; Moreira, Ana/K-5063-2012; Coutinho, Carla P. S./F-5975-2010; Sá-Correia, Isabel/H-4054-2011; Mira, Nuno Pereira/E-2965-2012	Coutinho, Carla P./0000-0002-9222-0339; Coutinho, Carla P. S./0000-0002-9222-0339; Sá-Correia, Isabel/0000-0003-2208-5183; Mira, Nuno Pereira/0000-0001-7556-0385; Moreira, Ana/0000-0002-5531-8505	Fundacao para a Ciencia e a Tecnologia' (FCT, Portugal) [PTDC/SAU-MII/69591/2006, ERA-PTG/SAU/0001/2008, (SFRH/BPD/46982/2008), (SFRH/BD/37012/2007), (SFRH/BD/2729/2006)]; Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) [BA-009-A]	Fundacao para a Ciencia e a Tecnologia' (FCT, Portugal)(Portuguese Foundation for Science and Technology); Cystic Fibrosis Foundation Therapeutics Inc. (CFFT)	This work was supported by Fundacao para a Ciencia e a Tecnologia'' (FCT, Portugal): contracts PTDC/SAU-MII/69591/2006 and ERA-PTG/SAU/0001/2008, this under the EraNet Pathogenomics ADHRES Signature Project, and post-doctoral and PhD fellowships awarded to NPM (SFRH/BPD/46982/2008), AM (SFRH/BD/37012/2007) and CPC (SFRH/BD/2729/2006). The microarray analysis was sponsored by Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) under the scope of the Burkholderia Array project (contract BA-009-A). This research is also performed under the COST Action BM1003 "Microbial Cell Surface Determinants of Virulence as Targets for New Theraputics in Cystic Fibrosis.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoli K, 2006, J BACTERIOL, V188, P3631, DOI 10.1128/JB.188.10.3631-3644.2006; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; ARONOFF SC, 1988, ANTIMICROB AGENTS CH, V32, P1636, DOI 10.1128/AAC.32.11.1636; Baldwin A, 2005, J CLIN MICROBIOL, V43, P4665, DOI 10.1128/JCM.43.9.4665-4673.2005; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Barth AL, 1996, J MED MICROBIOL, V45, P110, DOI 10.1099/00222615-45-2-110; Bazzini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018902; Bernier SP, 2005, J BACTERIOL, V187, P5278, DOI 10.1128/JB.187.15.5278-5291.2005; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; BRYAN LE, 1984, ANTIMICROB AGENTS CH, V26, P250, DOI 10.1128/AAC.26.2.250; Burns JL, 2007, BUKHOLDERIA MOL MICR; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; CANTIN AM, 1994, J CLIN INVEST, V93, P606, DOI 10.1172/JCI117013; Coenye T, 2011, ANTIMICROB AGENTS CH, V55, P1912, DOI 10.1128/AAC.01571-10; Coutinho CP, 2011, INFECT IMMUN, V79, P2950, DOI 10.1128/IAI.01366-10; Cunha MV, 2007, J CLIN MICROBIOL, V45, P1628, DOI 10.1128/JCM.00234-07; Cunha MV, 2003, J CLIN MICROBIOL, V41, P4113, DOI 10.1128/JCM.41.9.4113-4120.2003; Cunningham L, 1997, MOL MICROBIOL, V24, P579, DOI 10.1046/j.1365-2958.1997.3561728.x; Doring G, 2011, FEMS MICROBIOL REV, V35, P124, DOI 10.1111/j.1574-6976.2010.00237.x; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Drevinek P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-121; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P1145, DOI 10.1128/AAC.48.4.1145-1150.2004; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Evans E, 1999, J MED MICROBIOL, V48, P825, DOI 10.1099/00222615-48-9-825; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Guglierame P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-66; Hagins JM, 2010, MICROBIOL-SGM, V156, P1201, DOI 10.1099/mic.0.033381-0; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Itoh Y, 2004, PSEUDOMONAS BIOSYNTH; JAFFE A, 1982, ANTIMICROB AGENTS CH, V22, P942, DOI 10.1128/AAC.22.6.942; Jain M, 2008, TRANSL RES, V152, P257, DOI 10.1016/j.trsl.2008.10.003; Jansen HJ, 1999, J MED MICROBIOL, V48, P551, DOI 10.1099/00222615-48-6-551; Jeannot K, 2005, J BACTERIOL, V187, P5341, DOI 10.1128/JB.187.15.5341-5346.2005; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Kida Y, 2011, INFECT IMMUN, V79, P211, DOI 10.1128/IAI.01053-10; Lameignere E, 2008, BIOCHEM J, V411, P307, DOI [10.1042/BJ20071276, 10.1042/bj20071276]; Lameignere E, 2010, GLYCOBIOLOGY, V20, P87, DOI 10.1093/glycob/cwp151; Leitao JH, 2008, EUR J CLIN MICROBIOL, V27, P1101, DOI 10.1007/s10096-008-0552-0; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Madeira A, 2011, PROTEOMICS, V11, P1313, DOI 10.1002/pmic.201000457; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Malott RJ, 2005, INFECT IMMUN, V73, P4982, DOI 10.1128/IAI.73.8.4982-4992.2005; Martins M, 2006, IN VIVO, V20, P657; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P2242, DOI 10.1128/AAC.44.9.2242-2246.2000; Menard A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-308; Mil-Homens D, 2010, MICROBIOL-SGM, V156, P1084, DOI 10.1099/mic.0.032623-0; MOORE RA, 1986, ANTIMICROB AGENTS CH, V30, P923, DOI 10.1128/AAC.30.6.923; O'Grady EP, 2011, J BACTERIOL, V193, P163, DOI 10.1128/JB.00852-10; O'Grady EP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-441; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Saldias MS, 2009, J MED MICROBIOL, V58, P1542, DOI 10.1099/jmm.0.013235-0; Saldias MS, 2009, MICROBIOL-SGM, V155, P2809, DOI 10.1099/mic.0.031344-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; Sulak O, 2010, STRUCTURE, V18, P59, DOI 10.1016/j.str.2009.10.021; Thomas SR, 2000, THORAX, V55, P795, DOI 10.1136/thorax.55.9.795; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Urban TA, 2005, INFECT IMMUN, V73, P5426, DOI 10.1128/IAI.73.9.5426-5437.2005; Visser MB, 2004, INFECT IMMUN, V72, P2850, DOI 10.1128/IAI.72.5.2850-2857.2004; Whitby PW, 2006, J MED MICROBIOL, V55, P661, DOI 10.1099/jmm.0.46199-0; Xia BY, 2005, GLYCOBIOLOGY, V15, P747, DOI 10.1093/glycob/cwi061; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	75	53	53	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28831	10.1371/journal.pone.0028831	http://dx.doi.org/10.1371/journal.pone.0028831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216120	gold, Green Submitted, Green Published			2022-12-25	WOS:000299113600039
J	Dai, CY; Zhao, N; Wang, WJ; Lin, CT; Gao, B; Yang, XJ; Zhang, ZW; Lei, FM				Dai, Chuanyin; Zhao, Na; Wang, Wenjuan; Lin, Congtian; Gao, Bin; Yang, Xiaojun; Zhang, Zhengwang; Lei, Fumin			Profound Climatic Effects on Two East Asian Black-Throated Tits (Ave: Aegithalidae), Revealed by Ecological Niche Models and Phylogeographic Analysis	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; NUCLEOTIDE SUBSTITUTION; SPECIES DISTRIBUTIONS; GENETIC CONSEQUENCES; ALCIPPE-MORRISONIA; PLEISTOCENE; BIRDS; DIVERGENCE; SPECIATION	Although a number of studies have assessed the effects of geological and climatic changes on species distributions in East Asian, we still have limited knowledge of how these changes have impacted avian species in south-western and southern China. Here, we aim to study paleo-climatic effects on an East Asian bird, two subspecies of black-throated tit (A. c. talifuensis-concinnus) with the combined analysis of phylogeography and Ecological Niche Models (ENMs). We sequenced three mitochondrial DNA markers from 32 populations (203 individuals) and used phylogenetic inferences to reconstruct the intra-specific relationships among haplotypes. Population genetic analyses were undertaken to gain insight into the demographic history of these populations. We used ENMs to predict the distribution of target species during three periods; last inter-glacial (LIG), last glacial maximum (LGM) and present. We found three highly supported, monophyletic MtDNA lineages and different historical demography among lineages in A. c. talifuensis-concinnus. These lineages formed a narrowly circumscribed intra-specific contact zone. The estimated times of lineage divergences were about 2.4 Ma and 0.32 Ma respectively. ENMs predictions were similar between present and LGM but substantially reduced during LIG. ENMs reconstructions and molecular dating suggest that Pleistocene climate changes had triggered and shaped the genetic structure of black-throated tit. Interestingly, in contrast to profound impacts of other glacial cycles, ENMs and phylogeographic analysis suggest that LGM had limited effect on these two subspecies. ENMs also suggest that Pleistocene climatic oscillations enabled the formation of the contact zone and thus support the refuge theory.	[Dai, Chuanyin; Zhao, Na; Wang, Wenjuan; Lin, Congtian; Gao, Bin; Lei, Fumin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Yang, Xiaojun] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhang, Zhengwang] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China; [Dai, Chuanyin; Wang, Wenjuan; Gao, Bin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Beijing Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dai, CY (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	leifm@ioz.ac.cn		Zhang, Zhengwang/0000-0003-1063-7198	National Science Fund for Distinguished Young Scientists [17 30925008]; NSFC [30870270, J0930004]; Major International (Regional) Joint Research Project [(31010103901) 18]	National Science Fund for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NSFC(National Natural Science Foundation of China (NSFC)); Major International (Regional) Joint Research Project	This work was supported by the National Science Fund for Distinguished Young Scientists (No. 17 30925008), NSFC (30870270) and Major International (Regional) Joint Research Project (No: 31010103901) 18 to F. M. Lei, and by a NSFC program grant (J0930004) to C. Y. Dai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Aliabadian M, 2005, BIOL LETTERS, V1, P21, DOI 10.1098/rsbl.2004.0258; Alstrom P, 2010, IBIS, V152, P145, DOI 10.1111/j.1474-919X.2009.00990.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; CHENG J, 2001, GEOSCIENCE, V15, P290; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Conroy CJ, 2000, MOL ECOL, V9, P165, DOI 10.1046/j.1365-294x.2000.00846.x; Dai Chuanyin, 2010, Chinese Birds, V1, P112; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; Diniz JAF, 2008, GLOBAL ECOL BIOGEOGR, V17, P11, DOI 10.1111/j.1466-8238.2007.00339.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Eck S., 2006, Zoologische Mededelingen (Leiden), V80, P1; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fedorov VB, 2001, P ROY SOC B-BIOL SCI, V268, P809, DOI 10.1098/rspb.2001.1584; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Fu YX, 1997, GENETICS, V147, P915; Fuchs J, 2008, J BIOGEOGR, V35, P565, DOI 10.1111/j.1365-2699.2007.01811.x; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gill FB, 2005, AUK, V122, P121, DOI 10.1642/0004-8038(2005)122[0121:POTPIS]2.0.CO;2; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAFFER J, 1989, J ORNITHOL, V130, P475, DOI 10.1007/BF01918466; Haffer J, 2001, AMAZONIANA, V16, P579; Haffer Jurgen, 1997, Ornithological Monographs, V48, P281; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hope G, 2004, QUATERN INT, V118, P103, DOI 10.1016/S1040-6182(03)00133-2; Huang ZH, 2010, MOL PHYLOGENET EVOL, V56, P273, DOI 10.1016/j.ympev.2010.01.028; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Lei FM, 2003, BIODIVERS CONSERV, V12, P239, DOI 10.1023/A:1021928801558; Li G, 1982, CHINESE FAUNA SINICA, V13, P54; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Nielsen R, 2001, GENETICS, V158, P885; Nylander JAA, 2004, MRMODELTEST VER 2; Olsson U, 2004, ZOOL SCR, V33, P501, DOI 10.1111/j.0300-3256.2004.00166.x; Olsson U, 2006, MOL PHYLOGENET EVOL, V41, P556, DOI 10.1016/j.ympev.2006.05.009; Packert M, 2007, MOL PHYLOGENET EVOL, V44, P1, DOI 10.1016/j.ympev.2007.03.006; Packert M, 2010, MOL PHYLOGENET EVOL, V55, P952, DOI 10.1016/j.ympev.2010.01.024; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Posada D, 2001, MOL BIOL EVOL, V18, P897, DOI 10.1093/oxfordjournals.molbev.a003890; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schneider S, 1999, GENETICS, V152, P1079; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Sun BN, 2011, PALAEOGEOGR PALAEOCL, V304, P328, DOI 10.1016/j.palaeo.2010.09.023; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tietze DT, 2006, IBIS, V148, P477, DOI 10.1111/j.1474-919X.2006.00547.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; WANG WT, 1992, ACTA PHYTOTAXON SIN, V30, P1, DOI DOI 10.4324/9780429500190-1; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Williams M., 1998, QUATERNARY ENV; Yang SJ, 2006, MOL PHYLOGENET EVOL, V41, P257, DOI 10.1016/j.ympev.2006.06.003; Zhang Rong-Zu, 2004, Acta Zoologica Sinica, V50, P841; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zou FH, 2007, MOL PHYLOGENET EVOL, V44, P165, DOI 10.1016/j.ympev.2006.12.004	80	46	50	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29329	10.1371/journal.pone.0029329	http://dx.doi.org/10.1371/journal.pone.0029329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195047	Green Submitted, gold, Green Published			2022-12-25	WOS:000298664400048
J	Jongsma, M; Matas-Rico, E; Rzadkowski, A; Jalink, K; Moolenaar, WH				Jongsma, Maikel; Matas-Rico, Elisa; Rzadkowski, Adrian; Jalink, Kees; Moolenaar, Wouter H.			LPA Is a Chemorepellent for B16 Melanoma Cells: Action through the cAMP-Elevating LPA(5) Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR; PLECKSTRIN-HOMOLOGY DOMAINS; KINASE-A; AXON GUIDANCE; LEADING-EDGE; MIGRATION; AUTOTAXIN; ACTIVATION; EPAC	Lysophosphatidic acid (LPA), a lipid mediator enriched in serum, stimulates cell migration, proliferation and other functions in many cell types. LPA acts on six known G protein-coupled receptors, termed LPA(1-6), showing both overlapping and distinct signaling properties. Here we show that, unexpectedly, LPA and serum almost completely inhibit the transwell migration of B16 melanoma cells, with alkyl-LPA(18:1) being 10-fold more potent than acyl-LPA(18:1). The anti-migratory response to LPA is highly polarized and dependent on protein kinase A (PKA) but not Rho kinase activity; it is associated with a rapid increase in intracellular cAMP levels and PIP3 depletion from the plasma membrane. B16 cells express LPA(2), LPA(5) and LPA(6) receptors. We show that LPA-induced chemorepulsion is mediated specifically by the alkyl-LPA-preferring LPA(5) receptor (GPR92), which raises intracellular cAMP via a noncanonical pathway. Our results define LPA(5) as an antimigratory receptor and they implicate the cAMP-PKA pathway, along with reduced PIP3 signaling, as an effector of chemorepulsion in B16 melanoma cells.	[Jongsma, Maikel; Matas-Rico, Elisa; Rzadkowski, Adrian; Jalink, Kees; Moolenaar, Wouter H.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Netherlands Cancer Institute	Jongsma, M (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	w.moolenaar@nki.nl	Matas-Rico, Elisa/B-3390-2017	Matas-Rico, Elisa/0000-0003-0640-5511; Jalink, Kees/0000-0001-7019-3440	Dutch Cancer Society	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Arikawa K, 2003, J BIOL CHEM, V278, P32841, DOI 10.1074/jbc.M305024200; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Gaetano CG, 2009, MOL CARCINOGEN, V48, P801, DOI 10.1002/mc.20524; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; HOUBEN AJ, 2011, CANC METASTASIS REV; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Khandoga AL, 2011, CARDIOVASC RES, V90, P157, DOI 10.1093/cvr/cvq369; Kim A, 2009, EXP CELL RES, V315, P3325, DOI 10.1016/j.yexcr.2009.05.024; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee Z, 2008, MOL BIOL CELL, V19, P5435, DOI 10.1091/mbc.E08-03-0316; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Lorenowicz MJ, 2007, ARTERIOSCL THROM VAS, V27, P1014, DOI 10.1161/ATVBAHA.106.132282; Lundequist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018192; Melnikova VO, 2004, ONCOGENE, V23, P2347, DOI 10.1038/sj.onc.1207405; Murray AJ, 2009, J NEUROSCI, V29, P15434, DOI 10.1523/JNEUROSCI.3071-09.2009; Nam SW, 2001, CANCER RES, V61, P6938; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Taghavi P, 2008, ONCOGENE, V27, P6806, DOI 10.1038/onc.2008.294; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194; Wolff SC, 2005, AM J PHYSIOL-CELL PH, V288, pC624, DOI 10.1152/ajpcell.00338.2004; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	48	56	58	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29260	10.1371/journal.pone.0029260	http://dx.doi.org/10.1371/journal.pone.0029260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195035	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100171
J	Wei, SS; Gao, XW; Du, J; Su, JF; Xu, ZP				Wei, Saisai; Gao, Xiangwei; Du, Juan; Su, Jinfeng; Xu, Zhengping			Angiogenin Enhances Cell Migration by Regulating Stress Fiber Assembly and Focal Adhesion Dynamics	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; NUCLEAR TRANSLOCATION; BINDING; ACTIN; PROLIFERATION; PROTEIN; KINASE; CYTOSKELETAL; ACTIVATION; MECHANISMS	Angiogenin (ANG) acts on both vascular endothelial cells and cancer cells, but the underlying mechanism remains elusive. In this study, we carried out a co-immunoprecipitation assay in HeLa cells and identified 14 potential ANG-interacting proteins. Among these proteins, beta-actin, alpha-actinin 4, and non-muscle myosin heavy chain 9 are stress fiber components and involved in cytoskeleton organization and movement, which prompted us to investigate the mechanism of action of ANG in cell migration. Upon confirmation of the interactions between ANG and the three proteins, further studies revealed that ANG co-localized with beta-actin and alpha-actinin 4 at the leading edge of migrating cells. Down-regulation of ANG resulted in fewer but thicker stress fibers with less dynamics, which was associated with the enlargements of focal adhesions. The focal adhesion kinase activity and cell migration capacity were significantly decreased in ANG-deficient cells. Taken together, our data demonstrated that the existence of ANG in the cytoplasm optimizes stress fiber assembly and focal adhesion formation to accommodate cell migration. The finding that ANG promoted cancer cell migration might provide new clues for tumor metastasis research.	[Wei, Saisai; Gao, Xiangwei; Su, Jinfeng; Xu, Zhengping] Zhejiang Univ, Sch Med, Inst Environm Med, Hangzhou 310003, Zhejiang, Peoples R China; [Du, Juan] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wei, SS (corresponding author), Zhejiang Univ, Sch Med, Inst Environm Med, Hangzhou 310003, Zhejiang, Peoples R China.	zpxu@zju.edu.cn	Gao, Xiangwei/J-3026-2015	Gao, Xiangwei/0000-0002-8358-6320	National Natural Science Foundation of China [30171035, 31170721]; Ministry of Education [NCET-05-0521]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This work was supported by grants from the National Natural Science Foundation of China (30171035 & 31170721). Zhengping Xu is sponsored by the Program for New Century Excellent Talents in University, Ministry of Education (NCET-05-0521) and the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; BADET J, 1989, P NATL ACAD SCI USA, V86, P8427, DOI 10.1073/pnas.86.21.8427; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Campo L, 2005, J PATHOL, V205, P585, DOI 10.1002/path.1740; Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; HU GF, 1994, P NATL ACAD SCI USA, V91, P12096, DOI 10.1073/pnas.91.25.12096; HU GF, 1993, P NATL ACAD SCI USA, V90, P1217, DOI 10.1073/pnas.90.4.1217; Hu HJ, 2005, BIOCHEM BIOPH RES CO, V329, P661, DOI 10.1016/j.bbrc.2005.01.158; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Kim HM, 2007, BIOCHEM BIOPH RES CO, V352, P509, DOI 10.1016/j.bbrc.2006.11.047; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; LEE FS, 1993, PROG NUCLEIC ACID RE, V44, P1, DOI 10.1016/S0079-6603(08)60215-9; Li Shuping, 2010, Int J Biochem Mol Biol, V1, P26; Liu SM, 2001, BIOCHEM BIOPH RES CO, V287, P305, DOI 10.1006/bbrc.2001.5568; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; Pyatibratov MG, 2010, ARCH BIOCHEM BIOPHYS, V495, P74, DOI 10.1016/j.abb.2009.12.024; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sadagopan S, 2011, J VIROL, V85, P2666, DOI 10.1128/JVI.01532-10; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; SONCIN F, 1992, P NATL ACAD SCI USA, V89, P2232, DOI 10.1073/pnas.89.6.2232; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5; Xu ZP, 2001, BIOCHEM BIOPH RES CO, V285, P909, DOI 10.1006/bbrc.2001.5255; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103	33	29	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28797	10.1371/journal.pone.0028797	http://dx.doi.org/10.1371/journal.pone.0028797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194915	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100100
J	Khaperskyy, DA; Hatchette, TF; McCormick, C				Khaperskyy, Denys A.; Hatchette, Todd F.; McCormick, Craig			Influenza A virus inhibits cytoplasmic stress granule formation	FASEB JOURNAL			English	Article						PKR; interferon; translation; NS1; live imaging	DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; NS1 PROTEIN; INFECTED-CELLS; MESSENGER-RNA; RIG-I; BINDING; PHOSPHORYLATION; TRANSLATION; ACTIVATION	An important component of the mammalian stress response is the reprogramming of translation. A variety of stresses trigger abrupt polysome disassembly and the accumulation of stalled translation preinitiation complexes. These complexes nucleate cytoplasmic stress granules (SGs), sites of mRNA triage in which mRNAs from disassembling polysomes are sorted and the fates of individual transcripts are determined. Here, we demonstrate that influenza A virus (IAV) actively suppresses SG formation during infection, thereby allowing translation of viral mRNAs. Complete inhibition of SG formation is dependent on the function of the viral nonstructural protein 1 (NS1); at late times postinfection, cells infected with NS1-mutant viruses formed SGs in a double-stranded RNA-activated protein kinase (PKR)-dependent fashion. In these cells, SG formation correlated with inhibited viral protein synthesis. Together, these experiments demonstrate the antiviral potential of SGs and reveal a viral countermeasure that limits SG formation.-Khaperskyy, D. A., Hatchette, T. F., McCormick, C. Influenza A virus inhibits cytoplasmic stress granule formation. FASEB J. 26, 1629-1639 (2012). www.fasebj.org	[Khaperskyy, Denys A.; Hatchette, Todd F.; McCormick, Craig] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4R2, Canada; [Hatchette, Todd F.] Queen Elizabeth 2 Hlth Sci Ctr, Dept Pathol & Lab Med, Halifax, NS, Canada; [McCormick, Craig] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada	Dalhousie University; Queen Elizabeth II Health Sciences Centre	McCormick, C (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, 5850 Coll St,Rm 7F,POB 15000, Halifax, NS B3H 4R2, Canada.	mccormick@dal.ca	McCormick, Craig/AAH-9069-2019	McCormick, Craig/0000-0003-2794-3722; Hatchette, Todd/0000-0002-5377-2528; Khaperskyy, Denys/0000-0003-0583-7179	Canadian Institutes of Health Research; Nova Scotia Health Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation	The authors thank members of the C. M. laboratory for helpful discussions and critical manuscript review. The authors thank Dr. Paul Anderson (Harvard Medical School, Boston, MA, USA), Dr. John Bell (Ottawa Hospital Research Institute, Ottawa, ON, Canada), Dr. Adolfo Garcia-Sastre (Mount Sinai School of Medicine, New York, NY, USA), Dr. Garry Nolan (Stanford University, Stanford, CA, USA), Dr. Chris Richardson (Dalhousie University, Halifax, NS, Canada), and Dr. Richard Webby (St. Jude Children's Research Hospital, Memphis, TN, USA) for reagents. The authors thank Steven Whitefield for technical assistance with live fluorescence microscopy This work was supported by grants from the Canadian Institutes of Health Research and the Nova Scotia Health Research Foundation (to C.M.).	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Detzer A, 2011, NUCLEIC ACIDS RES, V39, P2727, DOI 10.1093/nar/gkq1216; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Egorov A, 1998, J VIROL, V72, P6437, DOI 10.1128/JVI.72.8.6437-6441.1998; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hatada E, 1999, J VIROL, V73, P2425, DOI 10.1128/JVI.73.3.2425-2433.1999; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Kakugawa S, 2009, J VIROL, V83, P2510, DOI 10.1128/JVI.02416-08; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; LEE TG, 1994, MOL CELL BIOL, V14, P2331, DOI 10.1128/MCB.14.4.2331; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Luig C, 2010, FASEB J, V24, P4068, DOI 10.1096/fj.10-158766; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Montero H, 2008, J VIROL, V82, P1496, DOI 10.1128/JVI.01779-07; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Smith JA, 2006, J VIROL, V80, P2019, DOI 10.1128/JVI.80.4.2019-2033.2006; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013	32	97	100	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1629	1639		10.1096/fj.11-196915	http://dx.doi.org/10.1096/fj.11-196915			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22202676				2022-12-25	WOS:000302359700024
J	Mirakaj, V; Jennewein, C; Konig, K; Granja, T; Rosenberger, P				Mirakaj, Valbona; Jennewein, Carla; Koenig, Klemens; Granja, Tiago; Rosenberger, Peter			The guidance receptor neogenin promotes pulmonary inflammation during lung injury	FASEB JOURNAL			English	Article						axonal guidance; cytokine; neutrophil	INHIBITS LEUKOCYTE MIGRATION; ENDOTHELIAL-CELLS; IN-VIVO; NETRIN-1; MOLECULE; EXPRESSION; HYPOXIA; PROTEIN; MOUSE; ACTIVATION	Lung injury is marked by a persistent self-propagating inflammation within the pulmonary tissue that is initiated by the migration of leukocytes into the alveolar space. Recent work has demonstrated that neuronal guidance proteins are involved into the orchestration of leukocyte migration. Neogenin is a crucial guidance receptor for axonal migration, yet its role during leukocyte migration and acute inflammation is to date unknown. Here, we report that neogenin influences neutrophil migration across endothelial HMEC-1 and alveolar A549 monolayers in vitro. In vivo, Neo1(-/-) mice demonstrated 59% reduced cell count, 41% reduced TNF-alpha, and 76% reduced IL-6 levels within the alveolar space during lung injury. In studies employing chimeric animals, the presence of Neo1(-/-) bone marrow was associated with a 42% reduction of cell count and reduced inflammatory changes within pulmonary tissue during lung injury. The functional inhibition of neogenin through antibody injection confirmed these results and the role of neogenin for the inflammatory changes within the alveolar space. Previously unappreciated, the guidance receptor neogenin has a significant effect on the orchestration of leukocyte migration and the control of acute inflammation.-Mirakaj, V., Jennewein, C., Konig, K., Granja, T., Rosenberger, P. The guidance receptor neogenin promotes pulmonary inflammation during lung injury. FASEB J. 26, 1549-1558 (2012). www.fasebj.org	[Mirakaj, Valbona; Koenig, Klemens; Rosenberger, Peter] Univ Tubingen, Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, D-72076 Tubingen, Germany; [Mirakaj, Valbona; Jennewein, Carla; Koenig, Klemens; Granja, Tiago; Rosenberger, Peter] Goethe Univ Frankfurt, Univ Hosp, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Rosenberger, P (corresponding author), Univ Tubingen, Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	peter.rosenberger@medizin.uni-tuebingen.de	Granja, Tiago/O-2597-2019; Jennewein, Carla/C-2199-2013	Granja, Tiago/0000-0002-8137-1449; Mirakaj, Valbona/0000-0002-6907-6455	Deutsche Forschungsgemeinschaft (DFG) [DFG-RO 3671/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank Stefanie Laucher and Dr. David Kohler for technical assistance during bone marrow transplantation. The authors thank Dr. Alexander Schaub for help with the performing experiments. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) DFG-RO 3671/5-1 to P.R.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Bae GU, 2009, MOL BIOL CELL, V20, P4920, DOI 10.1091/mbc.E09-06-0491; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Conrad S, 2007, J BIOL CHEM, V282, P16423, DOI 10.1074/jbc.M610901200; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH569, DOI 10.1152/ajpheart.00180.2008; Eckle T, 2008, AM J PHYSIOL-LUNG C, V295, pL718, DOI 10.1152/ajplung.90298.2008; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fitzgerald DP, 2006, DEV DYNAM, V235, P1720, DOI 10.1002/dvdy.20744; Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Grenz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014812; Hagihara M, 2011, J BIOL CHEM, V286, P5157, DOI 10.1074/jbc.M110.180919; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Henes J, 2009, FASEB J, V23, P4244, DOI 10.1096/fj.09-138693; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Nick JA, 1999, CHEST, V116, p54S, DOI 10.1378/chest.116.suppl_1.54S; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Tsuchiya A, 2007, BRAIN RES, V1159, P1, DOI 10.1016/j.brainres.2006.12.096; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wang WW, 2009, AM J NEPHROL, V30, P186, DOI 10.1159/000213503; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yamashita R, 2006, NUCLEIC ACIDS RES, V34, pD86, DOI 10.1093/nar/gkj129; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Zhou Z, 2008, J BONE MINER RES, V23, pS273; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	41	21	24	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1549	1558		10.1096/fj.11-200063	http://dx.doi.org/10.1096/fj.11-200063			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22198383				2022-12-25	WOS:000302359700017
J	Qi, Q; He, KY; Yoo, MH; Chan, CB; Liu, X; Zhang, ZB; Olson, JJ; Xiao, G; Wang, LY; Mao, H; Fu, HA; Tao, H; Ramalingam, SS; Sun, SY; Mischel, PS; Ye, KQ				Qi, Qi; He, Kunyan; Yoo, Min-Heui; Chan, Chi-Bun; Liu, Xia; Zhang, Zhaobin; Olson, Jeffrey J.; Xiao, Ge; Wang, Liya; Mao, Hui; Fu, Haian; Tao, Hui; Ramalingam, Suresh S.; Sun, Shi-Yong; Mischel, Paul S.; Ye, Keqiang			Acridine Yellow G Blocks Glioblastoma Growth via Dual Inhibition of Epidermal Growth Factor Receptor and Protein Kinase C Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOMA CELL-LINES; TOPOISOMERASE-II; INDUCE APOPTOSIS; TYROSINE KINASE; LUNG-CANCER; TUMOR-CELLS; GEFITINIB; GENE; PROLIFERATION; SUPPRESSION	Amplification of the epidermal growth factor receptor (EGFR), frequently expressed as a constitutively active deletion mutant (EGFRvIII), occurs commonly in glioblastoma multiformes (GBM). However, blockade of EGFR is therapeutically disappointing for gliomas with PTEN deletion. To search for small molecules treating this aggressive cancer, we have established a cell-based screening and successfully identified acridine yellow G that preferentially blocks cell proliferation of the most malignant U87MG/EGFRvIII cells over the less malignant U87MG/PTEN cells. Oral administration of this compound markedly diminishes the brain tumor volumes in both subcutaneous and intracranial models. It directly inhibits EGFR and PKCs with IC50 values of similar to 7.5 and 5 mu M, respectively. It dually inhibits EGFR and PKCs, resulting in a blockade of mammalian target of rapamycin signaling and cell cycle arrest in the G(1) phase, which leads to activation of apoptosis in the tumors. Hence, combinatorial inhibition of EGFR and PKCs might provide proof of concept in developing therapeutic agents for treating malignant glioma and other human cancers.	[Qi, Qi; He, Kunyan; Yoo, Min-Heui; Chan, Chi-Bun; Liu, Xia; Ye, Keqiang] Emory Univ, Sch Med, Ctr Syst Imaging, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Zhang, Zhaobin; Olson, Jeffrey J.] Emory Univ, Sch Med, Ctr Syst Imaging, Dept Neurol Surg, Atlanta, GA 30322 USA; [Wang, Liya; Mao, Hui] Emory Univ, Sch Med, Ctr Syst Imaging, Dept Radiol, Atlanta, GA 30322 USA; [Fu, Haian] Emory Univ, Sch Med, Winship Canc Inst, Dept Pharmacol, Atlanta, GA 30322 USA; [Tao, Hui; Ramalingam, Suresh S.; Sun, Shi-Yong] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Xiao, Ge] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Pharmacol, Los Angeles, CA 90095 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Centers for Disease Control & Prevention - USA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ye, KQ (corresponding author), 615 Michael St, Atlanta, GA 30300 USA.	kye@emory.edu	Qi, Qi/J-3508-2013; Ramalingam, Suresh/AAV-7478-2020	Qi, Qi/0000-0003-4460-0713; 	National Institutes of Health [RO1 CA127119]; NATIONAL CANCER INSTITUTE [R01CA127119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA127119 (to K. Y.).	Akhavan D, 2010, NEURO-ONCOLOGY, V12, P882, DOI 10.1093/neuonc/noq052; BALTUCH GH, 1993, NEUROSURGERY, V33, P495; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Capranico G, 1998, J BIOL CHEM, V273, P12732, DOI 10.1074/jbc.273.21.12732; Cho KK, 1999, INT J DEV NEUROSCI, V17, P447, DOI 10.1016/S0736-5748(99)00054-4; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; CORNFORD EM, 1992, CANCER CHEMOTH PHARM, V29, P439, DOI 10.1007/BF00684844; COULDWELL WT, 1994, FEBS LETT, V345, P43, DOI 10.1016/0014-5793(94)00415-3; COULDWELL WT, 1990, J NEUROSURG, V73, P594, DOI 10.3171/jns.1990.73.4.0594; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Ferguson LR, 2007, MUTAT RES-FUND MOL M, V623, P14, DOI 10.1016/j.mrfmmm.2007.03.014; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Ghosh R., MOL CELL BIOCH; Goodell JR, 2008, J MED CHEM, V51, P179, DOI 10.1021/jm701228e; Haas-Kogan DA, 2005, JNCI-J NATL CANCER I, V97, P880, DOI 10.1093/jnci/dji161; HANNUN YA, 1988, J BIOL CHEM, V263, P5124; HERMAN RK, 1971, J BACTERIOL, V106, P543, DOI 10.1128/JB.106.2.543-550.1971; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Kreisl TN, 2009, J NEURO-ONCOL, V92, P99, DOI 10.1007/s11060-008-9741-z; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MASUI H, 1984, CANCER RES, V44, P1002; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; WEI Z, 1992, NEUROSURGERY, V31, P725; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; Zhang W., 1992, NEUROSURGERY, V31, P729; ZWELLING LA, 1989, J BIOL CHEM, V264, P16411	36	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6113	6127		10.1074/jbc.M111.293605	http://dx.doi.org/10.1074/jbc.M111.293605			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215664	Green Published, hybrid			2022-12-25	WOS:000300791800005
J	Frampton, R; Aggio, RBM; Villas-Boas, SG; Arcus, VL; Cook, GM				Frampton, Rebekah; Aggio, Raphael B. M.; Villas-Boas, Silas G.; Arcus, Vickery L.; Cook, Gregory M.			Toxin-Antitoxin Systems of Mycobacterium smegmatis Are Essential for Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN AMINO-ACIDS; MESSENGER-RNA INTERFERASES; ESCHERICHIA-COLI; F-PLASMID; STATIONARY-PHASE; MICROBIAL-CELLS; PIN-DOMAIN; TUBERCULOSIS; OPERON; LOCI	The role of chromosomal toxin-antitoxin (TA) modules in bacterial physiology remains enigmatic despite their abundance in the genomes of many bacteria. Mycobacterium smegmatis contains three putative TA systems, VapBC, MazEF, and Phd/Doc, and previous work from our group has shown VapBC to be a bona fide TA system. In this study, we show that MazEF and Phd/Doc are also TA systems that are constitutively expressed, transcribed as leaderless transcripts, and subject to autoregulation, and expression of the toxin component leads to growth inhibition that can be rescued by the cognate antitoxin. No phenotype was identified for deletions of the individual TA systems, but a triple deletion strain (Delta vapBC, mazEF, phd/doc), designated Delta TA(triple), exhibited a survival defect in complex growth medium demonstrating an essential role for these TA modules in mycobacterial survival. Transcriptomic analysis revealed no significant differences in gene expression between wild type and the Delta TA(triple) mutant under these conditions suggesting that the growth defect was not at a transcriptional level. Metabolomic analysis demonstrated that in response to starvation in complex medium, both the wild type and Delta TA(triple) mutant consumed a wide range of amino acids from the external milieu. Analysis of intracellular metabolites revealed a significant difference in the levels of branched-chain amino acids between the wild type and Delta TA(triple) mutant, which are proposed to play essential roles in monitoring the nutritional supply and physiological state of the cell and linking catabolic with anabolic reactions. Disruption of this balance in the Delta TA(triple) mutant may explain the survival defect in complex growth medium.	[Frampton, Rebekah; Cook, Gregory M.] Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, Dunedin 9054, New Zealand; [Aggio, Raphael B. M.; Villas-Boas, Silas G.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Arcus, Vickery L.] Univ Waikato, Dept Biol Sci, Hamilton 3240, New Zealand	University of Otago; University of Auckland; University of Waikato	Cook, GM (corresponding author), Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, POB 56, Dunedin 9054, New Zealand.	gregory.cook@otago.ac.nz	Villas-Boas, Silas/AAS-5888-2020; Villas-Boas, Silas/AAR-6748-2020; Frampton, Rebekah A/M-7719-2017; Cook, Gregory/E-5665-2011	Villas-Boas, Silas/0000-0003-0148-5882; Frampton, Rebekah A/0000-0001-5283-2878; 	Health Research Council New Zealand; University of Otago	Health Research Council New Zealand(Health Research Council of New Zealand); University of Otago	This work was supported in part by the Health Research Council New Zealand.; Supported by Ph.D. scholarships from the University of Otago.	Aggio RBM, 2010, BIOINFORMATICS, V26, P2969, DOI 10.1093/bioinformatics/btq567; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; BLUM PH, 1988, J BACTERIOL, V170, P5125, DOI 10.1128/jb.170.11.5125-5133.1988; Bull TJ, 2000, MICROBIOL-SGM, V146, P2185, DOI 10.1099/00221287-146-9-2185; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2004, MOL MICROBIOL, V53, P587, DOI 10.1111/j.1365-2958.2004.04127.x; Christensen-Dalsgaard M, 2008, NUCLEIC ACIDS RES, V36, P6472, DOI 10.1093/nar/gkn667; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Fu ZB, 2007, J BACTERIOL, V189, P8871, DOI 10.1128/JB.01272-07; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Han JS, 2010, BIOCHEM BIOPH RES CO, V400, P293, DOI 10.1016/j.bbrc.2010.08.023; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; HIRAGA S, 1989, J BACTERIOL, V171, P1496, DOI 10.1128/jb.171.3.1496-1505.1989; Hopper S, 2000, INFECT IMMUN, V68, P896, DOI 10.1128/IAI.68.2.896-905.2000; HORN DB, 1966, CLIN CHIM ACTA, V14, P185, DOI 10.1016/0009-8981(66)90085-4; JAFFE A, 1985, J BACTERIOL, V163, P841; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Korch SB, 2009, J BACTERIOL, V191, P1618, DOI 10.1128/JB.01318-08; LARSSON CM, 1979, PLANT CELL PHYSIOL, V20, P145; Lemos JAC, 2005, FEMS MICROBIOL LETT, V253, P251, DOI 10.1016/j.femsle.2005.09.045; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; LUNDIN A, 1975, ANAL BIOCHEM, V66, P47, DOI 10.1016/0003-2697(75)90723-X; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; MAKI S, 1992, J BIOL CHEM, V267, P12244; Mantovani HC, 2002, MICROBIOL-SGM, V148, P3347, DOI 10.1099/00221287-148-11-3347; MENARD R, 1993, J BACTERIOL, V175, P5899; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; MONK BC, 1991, J BACTERIOL, V173, P6826, DOI 10.1128/jb.173.21.6826-6836.1991; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; RUSCETTI FW, 1972, J BACTERIOL, V11, P142, DOI 10.1128/JB.111.1.142-151.1972; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; Singh R, 2010, J BACTERIOL, V192, P1279, DOI 10.1128/JB.01285-09; Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Syed MA, 2011, J BACTERIOL, V193, P1122, DOI 10.1128/JB.01114-10; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Tojo S, 2005, MOL MICROBIOL, V56, P1560, DOI 10.1111/j.1365-2958.2005.04635.x; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; UCHIDA T, 1970, BIOCHEM BIOPH RES CO, V41, P1048, DOI 10.1016/0006-291X(70)90191-9; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Villas-Boas SG, 2007, ANAL BIOCHEM, V370, P87, DOI 10.1016/j.ab.2007.06.028; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624; Zhao LX, 2008, FEBS LETT, V582, P710, DOI 10.1016/j.febslet.2008.01.045; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; ZILBERSTEIN D, 1982, J BIOL CHEM, V257, P3687	78	50	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5340	5356		10.1074/jbc.M111.286856	http://dx.doi.org/10.1074/jbc.M111.286856			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22199354	hybrid, Green Published			2022-12-25	WOS:000300638000016
J	Boehm-Sturm, P; Mengler, L; Wecker, S; Hoehn, M; Kallur, T				Boehm-Sturm, Philipp; Mengler, Luam; Wecker, Stefan; Hoehn, Mathias; Kallur, Therese			In Vivo Tracking of Human Neural Stem Cells with F-19 Magnetic Resonance Imaging	PLOS ONE			English	Article							MR TRACKING; MIGRATION; STROKE; DIFFERENTIATION; TRANSPLANTATION; SURVIVAL	Background: Magnetic resonance imaging (MRI) is a promising tool for monitoring stem cell- based therapy. Conventionally, cells loaded with ironoxide nanoparticles appear hypointense on MR images. However, the contrast generated by ironoxide labeled cells is neither specific due to ambiguous background nor quantitative. A strategy to overcome these drawbacks is F-19 MRI of cells labeled with perfluorocarbons. We show here for the first time that human neural stem cells (NSCs), a promising candidate for clinical translation of stem cell- based therapy of the brain, can be labeled with F-19 as well as detected and quantified in vitro and after brain implantation. Methodology/Principal Findings: Human NSCs were labeled with perfluoropolyether (PFPE). Labeling efficacy was assessed with F-19 MR spectroscopy, influence of the label on cell phenotypes studied by immunocytochemistry. For in vitro MRI, NSCs were suspended in gelatin at varying densities. For in vivo experiments, labeled NSCs were implanted into the striatum of mice. A decrease of cell viability was observed directly after incubation with PFPE, which re-normalized after 7 days in culture of the replated cells. No label-related changes in the numbers of Ki67, nestin, GFAP, or bIII-tubulin+ cells were detected, both in vitro and on histological sections. We found that 1,000 NSCs were needed to accumulate in one image voxel to generate significant signal-to-noise ratio in vitro. A detection limit of similar to 10,000 cells was found in vivo. The location and density of human cells (hunu+) on histological sections correlated well with observations in the F-19 MR images. Conclusion/Significance: Our results show that NSCs can be efficiently labeled with (19)Fwith little effects on viability or proliferation and differentiation capacity. We show for the first time that F-19 MRI can be utilized for tracking human NSCs in brain implantation studies, which ultimately aim for restoring loss of function after acute and neurodegenerative disorders.	[Boehm-Sturm, Philipp; Mengler, Luam; Hoehn, Mathias; Kallur, Therese] Max Planck Inst Neurol Res, In Vivo NMR Lab, D-50931 Cologne, Germany; [Wecker, Stefan] Medres Med Res GmbH, Cologne, Germany	Max Planck Society	Boehm-Sturm, P (corresponding author), Max Planck Inst Neurol Res, In Vivo NMR Lab, Gleueler Str 50, D-50931 Cologne, Germany.	mathias@nf.mpg.de		Boehm-Sturm, Philipp/0000-0001-8777-4823	EU [HEALTH-F5-2008-201842, LSHBCT-2006-037526]; German Federal Ministry of Education and Research [BMBF-0314104]	EU(European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Financial support from the EU grants HEALTH-F5-2008-201842 (ENCITE) and LSHBCT-2006-037526 (StemStroke), and by funds from the German Federal Ministry of Education and Research (BMBF-0314104) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Bonetto F, 2011, INT J CANCER, V129, P365, DOI 10.1002/ijc.25672; Bulte JWM, 2005, NAT BIOTECHNOL, V23, P945, DOI 10.1038/nbt0805-945; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; Darsalia V, 2007, EUR J NEUROSCI, V26, P605, DOI 10.1111/j.1460-9568.2007.05702.x; Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Helfer BM, 2010, CYTOTHERAPY, V12, P238, DOI 10.3109/14653240903446902; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Himmelreich Uwe, 2005, Mol Imaging, V4, P104; Himmelreich U, 2009, METHODS, V48, P112, DOI 10.1016/j.ymeth.2009.03.020; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Janjic JM, 2009, WIRES NANOMED NANOBI, V1, P492, DOI 10.1002/wnan.35; Kadayakkara DKK, 2010, MAGN RESON MED, V64, P1252, DOI 10.1002/mrm.22506; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; Kallur T, 2011, EUR J NEUROSCI, V34, P382, DOI 10.1111/j.1460-9568.2011.07759.x; Koch P, 2009, LANCET NEUROL, V8, P819, DOI 10.1016/S1474-4422(09)70202-9; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Maki J, 2007, BIOMATERIALS, V28, P434, DOI 10.1016/j.biomaterials.2006.08.050; Masuda C, 2006, NEUROSCI RES, V56, P224, DOI 10.1016/j.neures.2006.06.011; Modo M, 2004, NEUROIMAGE, V21, P311, DOI 10.1016/j.neuroimage.2003.08.030; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Ruiz-Cabello J, 2011, NMR BIOMED, V24, P114, DOI 10.1002/nbm.1570; Ruiz-Cabello J, 2008, MAGN RESON MED, V60, P1506, DOI 10.1002/mrm.21783; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; Srinivas M, 2010, TRENDS BIOTECHNOL, V28, P363, DOI 10.1016/j.tibtech.2010.04.002; Srinivas M, 2009, MAGN RESON MED, V62, P747, DOI 10.1002/mrm.22063; Waiczies H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021981	31	87	88	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29040	10.1371/journal.pone.0029040	http://dx.doi.org/10.1371/journal.pone.0029040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216163	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300024
J	Kaczensky, P; Ganbataar, O; Altansukh, N; Enkhsaikhan, N; Stauffer, C; Walzer, C				Kaczensky, Petra; Ganbataar, Oyunsaikhan; Altansukh, Nanjid; Enkhsaikhan, Namtar; Stauffer, Christian; Walzer, Chris			The Danger of Having All Your Eggs in One Basket-Winter Crash of the Re-Introduced Przewalski's Horses in the Mongolian Gobi	PLOS ONE			English	Article							POPULATION-DYNAMICS; NONEQUILIBRIUM; MORTALITY; LIVESTOCK; DISASTER; MODEL	Large mammals re-introduced into harsh and unpredictable environments are vulnerable to stochastic effects, particularly in times of global climate change. The Mongolian Gobi is home to several rare large ungulates such as re-introduced Przewalski's horses (Equus ferus przewalskii) and Asiatic wild asses (Equus hemionus), but also to a millennium-old seminomadic livestock herding culture. The Gobi is prone to large inter-annual environmental fluctuations, but the winter 2009/ 2010 was particularly severe. Millions of livestock died and the Przewalski's horse population in the Gobi crashed. We used spatially explicit livestock loss statistics, ranger survey data and GPS telemetry to provide insight into the effect of a catastrophic climate event on the two sympatric wild equid species and the livestock population in light of their different space use strategies. Herders in and around the Great Gobi B Strictly Protected Area lost on average 67% of their livestock. Snow depth varied locally, resulting in livestock losses following an east-west gradient. Herders had few possibilities for evasion, as competition for available winter camps was high. Przewalski's horses used three different winter ranges, two in the east and one in the west. Losses averaged 60%, but differed hugely between east and west. Space use of Przewalski's horses was extremely conservative, as groups did not attempt to venture beyond their known home ranges. Asiatic wild asses seemed to have suffered few losses by shifting their range westwards. The catastrophic winter 2009/ 2010 provided a textbook example for how vulnerable small and spatially confined populations are in an environment prone to environmental fluctuations and catastrophes. This highlights the need for disaster planning by local herders, multiple reintroduction sites with spatially dispersed populations for re-introduced Przewalski's horses, and a landscape-level approach beyond protected area boundaries to allow for migratory or nomadic movements in Asiatic wild asses.	[Kaczensky, Petra; Walzer, Chris] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria; [Ganbataar, Oyunsaikhan] Great Gobi B Strictly Protected Area Adm, Takhin Tal, Gobi Altai Prov, Mongolia; [Enkhsaikhan, Namtar] Natl Univ Mongolia, Dept Zool, Fac Biol, Ulaanbaatar, Mongolia; [Stauffer, Christian] Int Takhi Grp Mongolia, Ulaanbaatar, Mongolia; [Stauffer, Christian] Int Takhi Grp Switzerland, Sihlwald, Switzerland	University of Veterinary Medicine Vienna; National University of Mongolia	Kaczensky, P (corresponding author), Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria.	petra.kaczensky@fiwi.at		Walzer, Chris/0000-0002-0437-5147; Kaczensky, Petra/0000-0001-5428-1176	Austrian Science Foundation FWF [P14992, P18624]; University of Veterinary Sciences in Vienna; Mohammed bin Zayed Species Conservation Fund [11251783]	Austrian Science Foundation FWF(Austrian Science Fund (FWF)); University of Veterinary Sciences in Vienna; Mohammed bin Zayed Species Conservation Fund	No specific funding was obtained for the explicit analyses contained in this manuscript. Rather it is a by-product built on data being collected by a range of ongoing projects funded by several sources. Main funding was provided by the Austrian Science Foundation FWF project P14992 and P18624 (http://www.fwf.ac.at/en/index.asp). Additional funding and resources came from the Great Gobi B SPA administration, the International Takhi Group, the University of Veterinary Sciences in Vienna, and the Mohammed bin Zayed Species Conservation Fund, project no. 11251783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbjornsen EJ, 2005, J ANIM ECOL, V74, P612, DOI 10.1111/j.1365-2656.2005.00946.x; BARRETT MW, 1982, J WILDLIFE MANAGE, V46, P991, DOI 10.2307/3808232; Begzsuren S, 2004, J ARID ENVIRON, V59, P785, DOI 10.1016/j.jaridenv.2004.02.001; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Boyd L, 2011, IUCN 2011 IUCN RED L; Bryson J, 2009, 10 EUR C ART LIF ECA; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Calcagno V, 2010, J STAT SOFTW, V34, P1; Fernandez-Gimenez ME, 1999, J APPL ECOL, V36, P871, DOI 10.1046/j.1365-2664.1999.00447.x; Fernandez-Gimenez ME, 1999, GEOGR REV, V89, P315, DOI 10.2307/216154; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Goodman D., 1987, P11, DOI 10.1017/CBO9780511623400.003; Hall D. K., 2006, MODIS TERRA SNOW COV, DOI 10.5067/ACYTYZB9BEOS; Kaczensky P, 2008, J APPL ECOL, V45, P1762, DOI 10.1111/j.1365-2664.2008.01565.x; Kaczensky P., 2010, WINTER DISASTER DZUN; Kaczensky Petra, 2007, Erforschung Biologischer Ressourcen der Mongolei, V10, P99; Kaczensky Petra, 2010, Wildlife Biology in Practice, V6, P108; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; Lacy Robert C., 2000, Ecological Bulletins, V48, P39; Mallon D.P., 2008, IUCN 2010 IUCN RED L; Mallon DP, 2009, J APPL ECOL, V46, P516, DOI 10.1111/j.1365-2664.2009.01654.x; Milner-Gulland EJ, 1998, J APPL ECOL, V35, P240, DOI 10.1046/j.1365-2664.1998.00293.x; Parry M. L., 2007, CLIMATE CHANGE 2007; R Development Core Team, 2007, R LANG ENV STAT COMP; REIMERS E, 1982, ARCTIC ALPINE RES, V14, P295, DOI 10.2307/1550792; Robert N, 2005, J ZOO WILDLIFE MED, V36, P273, DOI 10.1638/03-035.1; Saether BE, 2002, ECOLOGY, V83, P3457, DOI 10.2307/3072094; Saltz D, 2006, CONSERV BIOL, V20, P1402, DOI 10.1111/j.1523-1739.2006.00486.x; Scharf Katie M., 2010, P312, DOI 10.1002/9781444317091.ch12; Singh NJ, 2011, ORYX, V45, P38, DOI 10.1017/S0030605310000839; Slotta-Bachmayr L, 2004, J WILDLIFE MANAGE, V68, P790, DOI 10.2193/0022-541X(2004)068[0790:UOPVAT]2.0.CO;2; Sternberg T, 2010, NOMAD PEOPLES, V14, P72, DOI 10.3167/np.2010.140105; Sundaresan SR, 2007, OECOLOGIA, V151, P140, DOI 10.1007/s00442-006-0553-6; Tachiiri K, 2008, J ARID ENVIRON, V72, P2251, DOI 10.1016/j.jaridenv.2008.06.015; UN Mongolia Country Team, 2010, MONG DZUD APP; VanDierendonck MC, 1996, CONSERV BIOL, V10, P728, DOI 10.1046/j.1523-1739.1996.10030728.x; Vetter S, 2005, J ARID ENVIRON, V62, P321, DOI 10.1016/j.jaridenv.2004.11.015; von Wehrden H, 2007, Basic Appl Dryland Res, V1, P100; von Wehrden Henrik, 2006, Mongolian Journal of Biological Sciences, V4, P3; Wit Piet, 2006, TALE PRZEWALSKIS HOR; Zhirnov L.V., 1986, GREAT GOBI NATL PARK	41	39	41	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28057	10.1371/journal.pone.0028057	http://dx.doi.org/10.1371/journal.pone.0028057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216089	gold, Green Published, Green Submitted			2022-12-25	WOS:000300676300003
J	Tao, SJ; Witte, M; Bryson-Richardson, RJ; Currie, PD; Hogan, BM; Schulte-Merker, S				Tao, Shijie; Witte, Merlijn; Bryson-Richardson, Robert J.; Currie, Peter D.; Hogan, Benjamin M.; Schulte-Merker, Stefan			Zebrafish prox1b Mutants Develop a Lymphatic Vasculature, and prox1b Does Not Specifically Mark Lymphatic Endothelial Cells	PLOS ONE			English	Article							COUP-TFII; REDUNDANT ROLES; XENOPUS-LAEVIS; SOX18; GENE; LYMPHANGIOGENESIS; IDENTITY; SYSTEM; MAINTENANCE; ARTERIES	Background: The expression of the Prospero homeodomain transcription factor (Prox1) in a subset of cardinal venous cells specifies the lymphatic lineage in mice. Prox1 is also indispensible for the maintenance of lymphatic cell fate, and is therefore considered a master control gene for lymphangiogenesis in mammals. In zebrafish, there are two prox1 paralogues, the previously described prox1 (also known as prox1a) and the newly identified prox1b. Principal Findings: To investigate the role of the prox1b gene in zebrafish lymphangiogenesis, we knocked-down prox1b and found that depletion of prox1b mRNA did not cause lymphatic defects. We also generated two different prox1b mutant alleles, and maternal-zygotic homozygous mutant embryos were viable and did not show any lymphatic defects. Furthermore, the expression of prox1b was not restricted to lymphatic vessels during zebrafish development. Conclusion: We conclude that Prox1b activity is not essential for embryonic lymphatic development in zebrafish.	[Tao, Shijie; Witte, Merlijn; Hogan, Benjamin M.; Schulte-Merker, Stefan] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Tao, Shijie; Witte, Merlijn; Hogan, Benjamin M.; Schulte-Merker, Stefan] Univ Med Ctr, Utrecht, Netherlands; [Bryson-Richardson, Robert J.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Currie, Peter D.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Currie, Peter D.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Schulte-Merker, Stefan] Wageningen Univ, EZO, Dept Anim Sci, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Monash University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Australian Regenerative Medicine Institute; Monash University; Wageningen University & Research	Tao, SJ (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.	s.schulte@hubrecht.eu	Hogan, Benjamin M/J-1807-2014; Hogan, Benjamin/AAD-7410-2022; Bryson-Richardson, Robert/B-7556-2008	Hogan, Benjamin M/0000-0002-0651-7065; Hogan, Benjamin/0000-0002-0651-7065; Bryson-Richardson, Robert/0000-0002-9501-8208; Currie, Peter/0000-0001-8874-8862	Koninklijke Nederlandse Akademie van Wetenschappen	Koninklijke Nederlandse Akademie van Wetenschappen	The study was financed by the Koninklijke Nederlandse Akademie van Wetenschappen (http://www.knaw.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Aranguren XL, 2011, BIOCHEM BIOPH RES CO, V410, P121, DOI 10.1016/j.bbrc.2011.05.117; Aselli G., 1627, LACTEIBUS SIVE LACTE; Bos FL, 2011, CIRC RES; Bussmann J, 2011, DEVELOPMENT, V138, P4327, DOI 10.1242/dev.068080; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; Del Giacco L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013170; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Geudens I, 2010, ARTERIOSCL THROM VAS, V30, P1695, DOI 10.1161/ATVBAHA.110.203034; Herpers R, 2008, CIRC RES, V102, P12, DOI 10.1161/CIRCRESAHA.107.166066; Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Isogai S, 2009, ANAT SCI INT, V84, P102, DOI 10.1007/s12565-009-0024-3; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lee S, 2009, BLOOD, V113, P1856, DOI 10.1182/blood-2008-03-145789; Liao W, 1997, DEVELOPMENT, V124, P381; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Oliver G, 2005, ANNU REV CELL DEV BI, V21, P457, DOI 10.1146/annurev.cellbio.21.012704.132338; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; Oliver G, 2010, DEVELOPMENT, V137, P363, DOI 10.1242/dev.035360; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Schulte-Merker Stefan, 2002, P39; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yamazaki T, 2009, GENES CELLS, V14, P425, DOI 10.1111/j.1365-2443.2008.01279.x; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Yousef M, 2005, STRUCTURE, V13, P601, DOI 10.1016/j.str.2005.01.023	38	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28934	10.1371/journal.pone.0028934	http://dx.doi.org/10.1371/journal.pone.0028934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216143	Green Published, gold, Green Submitted			2022-12-25	WOS:000300676300017
J	Hu, PZ; Chu, GCY; Zhu, GD; Yang, H; Luthringer, D; Prins, G; Habib, F; Wang, YZ; Wang, RX; Chung, LWK; Zhau, HY				Hu, Peizhen; Chu, Gina C. -Y.; Zhu, Guodong; Yang, Hua; Luthringer, Daniel; Prins, Gail; Habib, Fouad; Wang, Yuzhuo; Wang, Ruoxiang; Chung, Leland W. K.; Zhau, Haiyen E.			Multiplexed Quantum Dot Labeling of Activated c-Met Signaling in Castration-Resistant Human Prostate Cancer	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; PROTEIN EXPRESSION; ANDROGEN RECEPTOR; CELLS; IMMUNOHISTOCHEMISTRY; MODEL; PROGRESSION; METASTASIS; MICROARRAY; BIOMARKERS	The potential application of multiplexed quantum dot labeling (MQDL) for cancer detection and prognosis and monitoring therapeutic responses has attracted the interests of bioengineers, pathologists and cancer biologists. Many published studies claim that MQDL is effective for cancer biomarker detection and useful in cancer diagnosis and prognosis, these studies have not been standardized against quantitative biochemical and molecular determinations. In the present study, we used a molecularly characterized human prostate cancer cell model exhibiting activated c-Met signaling with epithelial to mesenchymal transition (EMT) and lethal metastatic progression to bone and soft tissues as the gold standard, and compared the c-Met cell signaling network in this model, in clinical human prostate cancer tissue specimens and in a castration-resistant human prostate cancer xenograft model. We observed c-Met signaling network activation, manifested by increased phosphorylated c-Met in all three. The downstream survival signaling network was mediated by NF-kappa B and Mcl-1 and EMT was driven by receptor activator of NF-kappa B ligand (RANKL), at the single cell level in clinical prostate cancer specimens and the xenograft model. Results were confirmed by real-time RT-PCR and western blots in a human prostate cancer cell model. MQDL is a powerful tool for assessing biomarker expression and it offers molecular insights into cancer progression at both the cell and tissue level with high degree of sensitivity.	[Hu, Peizhen; Chu, Gina C. -Y.; Wang, Ruoxiang; Chung, Leland W. K.; Zhau, Haiyen E.] Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA; [Hu, Peizhen] Fourth Mil Univ, Dept Pathol, Xijing Hosp, Xian, Peoples R China; [Zhu, Guodong] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Urol, Xian 710049, Peoples R China; [Yang, Hua] Jilin Univ, Dept Pathol, Changchun 130023, Peoples R China; [Luthringer, Daniel] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA; [Prins, Gail] Univ Illinois, Dept Physiol, Chicago, IL USA; [Habib, Fouad] Univ Edinburgh, Dept Surg, Edinburgh, Midlothian, Scotland; [Wang, Yuzhuo] BC Canc, Dept Expt Therapeut, Vancouver, BC, Canada	Cedars Sinai Medical Center; Air Force Military Medical University; Xi'an Jiaotong University; Jilin University; Cedars Sinai Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Edinburgh	Hu, PZ (corresponding author), Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA.	Haiyen.zhau@cshs.org	Zhu, Guangshan/E-2024-2013	Wang, Yuzhuo/0000-0002-9749-8591	National Institutes of Health/National Cancer Institute [2PO1CA098912, 1RO1CA122602]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA122602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040890] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by research grants 2PO1CA098912 and 1RO1CA122602 of the National Institutes of Health/National Cancer Institute, and Prostate Cancer Foundation Challenge Award (LWK Chung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Bailey VJ, 2009, IEEE ENG MED BIO, P4089, DOI 10.1109/IEMBS.2009.5334553; Chu GCY, 2010, AUTOCRINE PARACRINE; CHUNG LWK, 1992, J CELL BIOCHEM, P99; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; Ghazani AA, 2006, NANO LETT, V6, P2881, DOI 10.1021/nl062111n; Hu M, 2010, ACS NANO, V4, P488, DOI 10.1021/nn901404h; Huynh H, 2009, J CELL MOL MED, V13, P2673, DOI 10.1111/j.1582-4934.2009.00692.x; Kong XL, 2010, CLIN CHEM LAB MED, V48, P279, DOI 10.1515/CCLM.2010.041; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Leung K, 2004, QUANTUM DOT 800 PROS, P591; Li RL, 2009, CLIN CANCER RES, V15, P3568, DOI 10.1158/1078-0432.CCR-08-0826; Liang RQ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni019; Liu J, 2010, ACS NANO, V4, P2755, DOI 10.1021/nn100213v; Odero-Marah VA, 2008, CELL RES, V18, P858, DOI 10.1038/cr.2008.84; PISTERS LL, 1995, J UROLOGY, V154, P293, DOI 10.1016/S0022-5347(01)67297-5; PRINS GS, 1991, ENDOCRINOLOGY, V129, P3187, DOI 10.1210/endo-129-6-3187; Shi C, 2008, EUR J HISTOCHEM, V52, P127; Smith DC, 2010, EORTC, p406a; Sweeney E, 2008, BIOCHEM BIOPH RES CO, V374, P181, DOI 10.1016/j.bbrc.2008.06.127; THALMANN GN, 1994, CANCER RES, V54, P2577; Thalmann GN, 2000, PROSTATE, V44, P91; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Torres KE, 2011, CLIN CANCER RES, V17, P3943, DOI 10.1158/1078-0432.CCR-11-0193; van Leenders GJLH, 2003, AM J PATHOL, V162, P1529, DOI 10.1016/S0002-9440(10)64286-1; Wagner MK, 2010, ANAL BIOANAL CHEM, V397, P3213, DOI 10.1007/s00216-010-3847-9; Xing Y, 2007, NAT PROTOC, V2, P1152, DOI 10.1038/nprot.2007.107; Yurube T, 2011, J ORTHOP RES, V29, P1284, DOI 10.1002/jor.21406; Zhang S, 2011, ONCOGENE; Zhang SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-9; Zhang Y, 2010, IDRUGS, V13, P112; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhou AX, 2011, INT J CANCER, V128, P839, DOI 10.1002/ijc.25417	33	36	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28670	10.1371/journal.pone.0028670	http://dx.doi.org/10.1371/journal.pone.0028670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205960	Green Published, gold			2022-12-25	WOS:000299113600025
J	Ellefson, WM; Lakner, AM; Hamilton, A; McKillop, IH; Bonkovsky, HL; Steuerwald, NM; Huet, YM; Schrum, LW				Ellefson, Whitney M.; Lakner, Ashley M.; Hamilton, Alicia; McKillop, Iain H.; Bonkovsky, Herbert L.; Steuerwald, Nury M.; Huet, Yvette M.; Schrum, Laura W.			Neonatal Androgenization Exacerbates Alcohol-Induced Liver Injury in Adult Rats, an Effect Abrogated by Estrogen	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; STELLATE CELL ACTIVATION; ETHANOL OXIDIZING SYSTEM; PITUITARY-GONADAL AXIS; HEPATITIS-C VIRUS; NF-KAPPA-B; OXIDATIVE STRESS; FEMALE RATS; SEX-DIFFERENCES; BISPHENOL-A	Alcoholic liver disease (ALD) affects millions of people worldwide and is a major cause of morbidity and mortality. However, fewer than 10% of heavy drinkers progress to later stages of injury, suggesting other factors in ALD development, including environmental exposures and genetics. Females display greater susceptibility to the early damaging effects of ethanol. Estrogen (E2) and ethanol metabolizing enzymes (cytochrome P450, CYP450) are implicated in sex differences of ALD. Sex steroid hormones are developmentally regulated by the hypothalamic-pituitary-gonadal (HPG) axis, which controls sex-specific cycling of gonadal steroid production and expression of hepatic enzymes. The aim of this study was to determine if early postnatal inhibition of adult cyclic E2 alters ethanol metabolizing enzyme expression contributing to the development of ALD in adulthood. An androgenized rat model was used to inhibit cyclic E2 production. Control females (Ctrl), androgenized females (Andro) and Andro females with E2 implants were administered either an ethanol or isocalorically-matched control Lieber-DeCarli diet for four weeks and liver injury and CYP450 expression assessed. Androgenization exacerbated the deleterious effects of ethanol demonstrated by increased steatosis, lipid peroxidation, profibrotic gene expression and decreased antioxidant defenses compared to Ctrl. Additionally, CYP2E1 expression was down-regulated in Andro animals on both diets. No change was observed in CYP1A2 protein expression. Further, continuous exogenous administration of E2 to Andro in adulthood attenuated these effects, suggesting that E2 has protective effects in the androgenized animal. Therefore, early postnatal inhibition of cyclic E2 modulates development and progression of ALD in adulthood.	[Ellefson, Whitney M.; Lakner, Ashley M.; McKillop, Iain H.; Bonkovsky, Herbert L.; Huet, Yvette M.; Schrum, Laura W.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Hamilton, Alicia; Steuerwald, Nury M.] Carolinas Med Ctr, Mol Biol Core Facil, Charlotte, NC 28203 USA; [McKillop, Iain H.] Carolinas Med Ctr, Dept Gen Surg, Charlotte, NC 28203 USA; [Bonkovsky, Herbert L.; Schrum, Laura W.] Carolinas Med Ctr, Dept Internal Med, Charlotte, NC 28203 USA; [McKillop, Iain H.; Bonkovsky, Herbert L.; Steuerwald, Nury M.; Schrum, Laura W.] Carolinas Med Ctr, Liver Biliary Pancreat Ctr, Charlotte, NC 28203 USA	University of North Carolina; University of North Carolina Charlotte; Carolinas Medical Center; Carolinas Medical Center; Carolinas Medical Center; Carolinas Medical Center	Ellefson, WM (corresponding author), Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA.	laura.schrum@carolinashealthcare.org	Bonkovsky, Herbert L./AAH-1892-2021; Huet, Yvette/J-4901-2013	Bonkovsky, Herbert L./0000-0001-7387-3230; Huet, Yvette/0000-0002-8783-8679	National Institutes of Health [DK38825, AA014891]; Carolinas Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carolinas Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Grants from National Institutes of Health (DK38825, HLB; AA014891, LWS) and by institutional funds from Carolinas Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteel GE, 2010, DIGEST DIS, V28, P729, DOI 10.1159/000324280; Asai H, 1996, J PHARMACOL EXP THER, V277, P1004; Beier JI, 2010, BIOL CHEM, V391, P1249, DOI 10.1515/BC.2010.137; BELL H, 1995, EUR J ENDOCRINOL, V132, P444, DOI 10.1530/eje.0.1320444; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Choi SY, 2011, BIOCHEM PHARMACOL, V81, P777, DOI 10.1016/j.bcp.2010.12.019; CHRISTAKOS S, 1976, BRIT J CANCER, V34, P58, DOI 10.1038/bjc.1976.122; CSABA G, 1987, HORM METAB RES, V19, P493, DOI 10.1055/s-2007-1011861; Davidge ST, 2001, AM J PHYSIOL-REG I, V280, pR904, DOI 10.1152/ajpregu.2001.280.3.R904; Day CP, 2006, LIVER INT, V26, P1021, DOI 10.1111/j.1478-3231.2006.01323.x; DEGAWA M, 1989, CARCINOGENESIS, V10, P1119, DOI 10.1093/carcin/10.6.1119; Doi SAR, 2005, EUR J OBSTET GYN R B, V118, P4, DOI 10.1016/j.ejogrb.2004.06.024; EAGON PK, 1981, ARCH BIOCHEM BIOPHYS, V211, P48, DOI 10.1016/0003-9861(81)90428-8; EDWARDS DA, 1971, PHYSIOL BEHAV, V6, P223, DOI 10.1016/0031-9384(71)90030-8; Fernandez M, 2010, ENVIRON HEALTH PERSP, V118, P1217, DOI 10.1289/ehp.0901257; GORDON GG, 1979, METABOLISM, V28, P20, DOI 10.1016/0026-0495(79)90163-X; Gramenzi A, 2006, ALIMENT PHARM THER, V24, P1151, DOI 10.1111/j.1365-2036.2006.03110.x; GUSTAFSSON JA, 1981, ENVIRON HEALTH PERSP, V38, P129, DOI 10.2307/3429371; GUSTAFSSON JA, 1974, J BIOL CHEM, V249, P711; Hayashida K, 2010, MICROBIOL IMMUNOL, V54, P684, DOI 10.1111/j.1348-0421.2010.00268.x; HONG J, 2011, INT J ONCOL; Iba MM, 1999, ARCH TOXICOL, V73, P208, DOI 10.1007/s002040050608; Inoue H, 2003, DIGEST DIS SCI, V48, P570, DOI 10.1023/A:1022553119715; Jarvelainen HA, 2001, J HEPATOL, V35, P46, DOI 10.1016/S0168-8278(01)00050-2; Karaa A, 2008, SHOCK, V30, P197, DOI [10.1097/SHK.0b013e318160f417, 10.1097/shk.0b013e318160f417]; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; Kono H, 2000, AM J PHYSIOL-GASTR L, V278, pG652, DOI 10.1152/ajpgi.2000.278.4.G652; Kostic N, 1989, Srp Arh Celok Lek, V117, P767; LACORT M, 1995, LIPIDS, V30, P141, DOI 10.1007/BF02538267; Lakner AM, 2011, LIVER INT, V31, P42, DOI 10.1111/j.1478-3231.2010.02356.x; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; McKillop IH, 2009, SEMIN LIVER DIS, V29, P222, DOI 10.1055/s-0029-1214377; MIZUKAMI S, 1982, ENDOKRINOLOGIE, V79, P1; Nanji AA, 2001, AM J PHYSIOL-GASTR L, V281, pG1348, DOI 10.1152/ajpgi.2001.281.6.G1348; Omoya T, 2001, LIVER, V21, P183, DOI 10.1034/j.1600-0676.2001.021003183.x; PINILLA L, 1993, J REPROD FERTIL, V97, P13, DOI 10.1530/jrf.0.0970013; Ramos JG, 2003, ENDOCRINOLOGY, V144, P3206, DOI 10.1210/en.2002-0198; Sener G, 2005, J SURG RES, V128, P70, DOI 10.1016/j.jss.2005.02.019; Shayya R, 2010, BJOG-INT J OBSTET GY, V117, P150, DOI 10.1111/j.1471-0528.2009.02421.x; Shimizu I, 2003, LIVER INT, V23, P63, DOI 10.1034/j.1600-0676.2003.00811.x; Steuerwald NM, 2010, LIVER INT, V30, P1490, DOI 10.1111/j.1478-3231.2010.02321.x; Tadic SD, 2002, J APPL PHYSIOL, V93, P1057, DOI 10.1152/japplphysiol.00568.2001; VANTHIEL DH, 1990, ALCOHOL CLIN EXP RES, V14, P478; Vassilatou E, 2010, HUM REPROD, V25, P212, DOI 10.1093/humrep/dep380; Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307; Yin M, 2000, HEPATOLOGY, V31, P117, DOI 10.1002/hep.510310119	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e29463	10.1371/journal.pone.0029463	http://dx.doi.org/10.1371/journal.pone.0029463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22206017	Green Published, Green Submitted, gold			2022-12-25	WOS:000298666200025
J	MacNamara, KC; Jones, M; Martin, O; Winslow, GM				MacNamara, Katherine C.; Jones, Maura; Martin, Olga; Winslow, Gary M.			Transient Activation of Hematopoietic Stem and Progenitor Cells by IFN gamma during Acute Bacterial Infection	PLOS ONE			English	Article							SELF-RENEWAL; BONE-MARROW; COMPARTMENT; PROLIFERATION; MAINTENANCE; RECEPTORS; EXPANSION; INNATE; NICHE	How hematopoietic stem cells (HSCs) respond to inflammatory signals during infections is not well understood. Our studies have used a murine model of ehrlichiosis, an emerging tick-born disease, to address how infection impacts hematopoietic function. Infection of C57BL/6 mice with the intracellular bacterium, Ehrlichia muris, results in anemia and thrombocytopenia, similar to what is observed in human ehrlichiosis patients. In the mouse, infection promotes myelopoiesis, a process that is critically dependent on interferon gamma (IFN gamma) signaling. In the present study, we demonstrate that E. muris infection also drives the transient proliferation and expansion of bone marrow Lin-negative Sca-1(+) cKit(+) (LSK) cells, a population of progenitor cells that contains HSCs. Expansion of the LSK population in the bone marrow was associated with a loss of dormant, long-term repopulating HSCs, reduced engraftment, and a bias towards myeloid lineage differentiation within that population. The reduced engraftment and myeloid bias of the infection-induced LSK cells was transient, and was most pronounced on day 8 post-infection. The infection-induced changes were accompanied by an expansion of more differentiated multipotent progenitor cells, and required IFN gamma signaling. Thus, in response to inflammatory signals elicited during acute infection, HSCs can undergo a rapid, IFN gamma-dependent, transient shift from dormancy to activity, ostensibly, to provide the host with additional or better-armed innate cells for host defense. Similar changes in hematopoietic function likely underlie many different infections of public health importance.	[MacNamara, Katherine C.; Jones, Maura; Martin, Olga; Winslow, Gary M.] New York State Dept Hlth, Immunol Lab, Div Infect Dis, Wadsworth Ctr, Albany, NY USA; [Winslow, Gary M.] SUNY Albany, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	MacNamara, KC (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	gary.winslow@wadsworth.org		MacNamara, Katherine/0000-0001-6202-4700	U.S. Public Health Service [R01AI064678, F32AI077242]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077242, R01AI064678] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. Public Health Service grant R01AI064678 to GMW, and F32AI077242 to KCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; ESPLIN BL, 2011, J IMMUNOLOGY; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; MacNamara KC, 2011, J IMMUNOL, V186, P1032, DOI 10.4049/jimmunol.1001893; MacNamara KC, 2009, INFECT IMMUN, V77, P4061, DOI 10.1128/IAI.01550-08; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Singh P, 2008, STEM CELLS, V26, P1009, DOI 10.1634/stemcells.2007-0461; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Welner RS, 2008, BLOOD, V112, P3753, DOI 10.1182/blood-2008-04-151506; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yanez A, 2009, MICROBES INFECT, V11, P531, DOI 10.1016/j.micinf.2009.01.011; Zhang P, 2008, STEM CELLS, V26, P1778, DOI 10.1634/stemcells.2007-1027; Zhao X, 2010, STEM CELLS, V28, P122, DOI 10.1002/stem.252	29	62	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28669	10.1371/journal.pone.0028669	http://dx.doi.org/10.1371/journal.pone.0028669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194881	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100075
J	Sweiss, NJ; Zhang, W; Franek, BS; Kariuki, SN; Moller, DR; Patterson, KC; Bennett, P; Girijala, LR; Nair, V; Baughman, RP; Garcia, JGN; Niewold, TB				Sweiss, Nadera J.; Zhang, Wei; Franek, Beverly S.; Kariuki, Silvia N.; Moller, David R.; Patterson, Karen C.; Bennett, Peggy; Girijala, Lakshmi R.; Nair, Vaisak; Baughman, Robert P.; Garcia, Joe G. N.; Niewold, Timothy B.			Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHRONIC HEPATITIS-C; REFRACTORY SARCOIDOSIS; PULMONARY SARCOIDOSIS; ALVEOLAR MACROPHAGES; INFLIXIMAB THERAPY; SJOGRENS-SYNDROME; FACTOR INHIBITION; VIRUS-INFECTION	Background: Both type I interferon (IFN), also known as IFN-alpha and tumor necrosis factor alpha (TNF-alpha) have been implicated in the pathogenesis of sarcoidosis. We investigated serum levels of these cytokines in a large multi-ancestral sarcoidosis population to determine correlations between cytokine levels and disease phenotypes. Methods: We studied serum samples from 98 patients with sarcoidosis, including 71 patients of African-American ancestry and 27 patients of European-American ancestry. Serum type I IFN was measured using a sensitive reporter cell assay and serum TNF-alpha was measured using a commercial ELISA kit. Clinical data including presence or absence of neurologic, cardiac, and severe pulmonary manifestations of sarcoidosis were abstracted from medical records. Twenty age-matched non-autoimmune controls were also studied from each ancestral background. Differences in cytokine levels between groups were analyzed with Mann-Whitney U test, and correlations were assessed using Spearman's rho. Multivariate logistic regression models were used to detect associations between cytokines and clinical manifestations. Results: Significant differences in cytokine levels were observed between African-and European-American patients with sarcoidosis. In African-Americans, serum TNF-alpha levels were significantly higher relative to matched controls (P=0.039), and patients with neurologic disease had significantly higher TNF-alpha than patients lacking this manifestation (P=0.022). In European-Americans, serum type I IFN activity was higher in sarcoidosis cases as compared to matched controls, and patients with extra-pulmonary disease represented a high serum IFN subgroup (P=0.0032). None of the associations observed were shared between the two ancestral groups. Conclusions: Our data indicate that significant associations between serum levels of TNF-alpha and type I IFN and clinical manifestations exist in a sarcoidosis cohort that differ significantly by self-reported ancestry. In each ancestral background, the cytokine elevated in patients with sarcoidosis was also associated with a particular disease phenotype. These findings may relate to ancestral differences in the molecular pathogenesis of this heterogeneous disease.	[Sweiss, Nadera J.; Franek, Beverly S.; Kariuki, Silvia N.; Niewold, Timothy B.] Univ Illinois, Dept Med, Rheumatol Sect, Chicago, IL 60607 USA; [Sweiss, Nadera J.; Garcia, Joe G. N.] Univ Illinois, Dept Med, Sect Pulm Crit Care & Sleep Med, Chicago, IL USA; [Sweiss, Nadera J.; Garcia, Joe G. N.] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA; [Zhang, Wei] Univ Illinois, Dept Pediat, Chicago, IL USA; [Zhang, Wei] Univ Illinois, Inst Human Genet, Chicago, IL USA; [Franek, Beverly S.; Kariuki, Silvia N.; Niewold, Timothy B.] Univ Illinois, Gwen Knapp Ctr Lupus Res, Chicago, IL USA; [Moller, David R.] Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Patterson, Karen C.; Bennett, Peggy] Univ Illinois, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL USA; [Girijala, Lakshmi R.] IIT, Chicago, IL 60616 USA; [Nair, Vaisak] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Baughman, Robert P.] Univ Cincinnati, Div Pulm & Crit Care, Cincinnati, OH USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Illinois Institute of Technology; Johns Hopkins University; University System of Ohio; University of Cincinnati	Sweiss, NJ (corresponding author), Univ Illinois, Dept Med, Rheumatol Sect, Chicago, IL 60607 USA.	nsweiss@uic.edu	; Niewold, Timothy/D-2669-2018	Patterson, Karen/0000-0002-5596-6801; Sweiss, Nadera/0000-0003-2215-0221; Kariuki, Silvia/0000-0003-0801-5285; Niewold, Timothy/0000-0003-3532-6660	A Foundation for Sarcoidosis Research Young Investigators Award	A Foundation for Sarcoidosis Research Young Investigators Award	A Foundation for Sarcoidosis Research Young Investigators Award given to Nadera J. Sweiss was used to fund this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSASSI S, ARTHRITIS RHEUM, V62, P589; Baughman RP, 2006, AM J RESP CRIT CARE, V174, P795, DOI 10.1164/rccm.200603-402OC; BAUGHMAN RP, 1990, J LAB CLIN MED, V115, P36; Bave U, 2005, ARTHRITIS RHEUM-US, V52, P1185, DOI 10.1002/art.20998; Bozkaya H, 2000, HEPATO-GASTROENTEROL, V47, P1675; Daien CI, 2009, RHEUMATOLOGY, V48, P883, DOI 10.1093/rheumatology/kep046; Dhaille F, 2010, DERMATOLOGY, V220, P234, DOI 10.1159/000275676; Doyle MK, 2006, JCR-J CLIN RHEUMATOL, V12, P241, DOI 10.1097/01.rhu.0000240035.67652.9d; Fantini F, 2009, DERMATOL THER, V22, pS1, DOI 10.1111/j.1529-8019.2009.01263.x; Faurie P, 2010, EUR J GASTROEN HEPAT, V22, P967, DOI 10.1097/MEG.0b013e32833834bc; Garg S, 2008, JCR-J CLIN RHEUMATOL, V14, P238, DOI 10.1097/RHU.0b013e318181b45a; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Josse S, 2009, JOINT BONE SPINE, V76, P718, DOI 10.1016/j.jbspin.2009.02.003; Kariuki SN, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3101; Kariuki SN, 2010, TRANSL RES, V155, P109, DOI 10.1016/j.trsl.2009.08.012; Koon H, 2006, NEW ENGL J MED, V354, P758, DOI 10.1056/NEJMe058307; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Massara A, 2010, SEMIN ARTHRITIS RHEU, V39, P313, DOI 10.1016/j.semarthrit.2008.11.003; Mavragani CP, 2007, ARTHRITIS RHEUM, V56, P3995, DOI 10.1002/art.23062; Moravan M, 2009, NEUROLOGY, V72, P337, DOI 10.1212/01.wnl.0000341278.26993.22; Niewold TB, 2007, GENES IMMUN, V8, P492, DOI 10.1038/sj.gene.6364408; Niewold TB, 2005, CLIN RHEUMATOL, V24, P178, DOI 10.1007/s10067-004-1024-2; Niewold TB, 2008, JCR-J CLIN RHEUMATOL, V14, P131, DOI 10.1097/RHU.0b013e318177627d; Niewold TB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/948364; Niewold TB, 2009, ARTHRITIS RHEUM, V60, P1815, DOI 10.1002/art.24555; Niewold TR, 2008, ARTHRITIS RHEUM, V58, P541, DOI 10.1002/art.23191; O'Shea FD, 2006, ARTHRIT RHEUM-ARTHR, V55, P978, DOI 10.1002/art.22351; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; PETEREIT HF, 2010, J NEUROL, V17, P17; Ramos-Casals M, 2005, CURR OPIN RHEUMATOL, V17, P447; RODRIGUEZLOJO R, 2010, C DERMATOL RES PRACT; Rossman MD, 2006, SARCOIDOSIS VASC DIF, V23, P201; Salloum R, 2010, ARTHRITIS RHEUM-US, V62, P553, DOI 10.1002/art.27182; Sharma OP, 2008, CLIN CHEST MED, V29, P357, DOI 10.1016/j.ccm.2008.03.013; Shinohara MM, 2009, J DRUGS DERMATOL, V8, P870; STEFFEN M, 1993, J ALLERGY CLIN IMMUN, V91, P939, DOI 10.1016/0091-6749(93)90352-G; Sweiss NJ, 2007, J RHEUMATOL, V34, P2129; Sweiss NJ, 2007, CLIN DERMATOL, V25, P341, DOI 10.1016/j.clindermatol.2007.03.012; Sweiss NJ, 2010, SEMIN RESP CRIT CARE, V31, P463, DOI 10.1055/s-0030-1262214; Sweiss NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009088; Sweiss NJ, 2005, ARTHRIT RHEUM-ARTHR, V53, P788, DOI 10.1002/art.21468; Sweiss NJ, 2010, AM THOR SOC 2010 INT; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842	44	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29126	10.1371/journal.pone.0029126	http://dx.doi.org/10.1371/journal.pone.0029126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195005	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100159
J	Uddin, M; Sturge, M; Peddle, L; O'Rielly, DD; Rahman, P				Uddin, Mohammed; Sturge, Mitch; Peddle, Lynette; O'Rielly, Darren D.; Rahman, Proton			Genome-Wide Signatures of 'Rearrangement Hotspots' within Segmental Duplications in Humans	PLOS ONE			English	Article							COPY NUMBER VARIATION; MICRODELETION; EVOLUTION; DELETIONS; MICRODUPLICATION; CHROMOSOME; DIVERSITY; MECHANISM; DISCOVERY; VARIANTS	The primary objective of this study was to create a genome-wide high resolution map (i.e., >100 bp) of 'rearrangement hotspots' which can facilitate the identification of regions capable of mediating de novo deletions or duplications in humans. A hierarchical method was employed to fragment segmental duplications (SDs) into multiple smaller SD units. Combining an end space free pairwise alignment algorithm with a 'seed and extend' approach, we have exhaustively searched 409 million alignments to detect complex structural rearrangements within the reference-guided assembly of the NA18507 human genome (186 coverage), including the previously identified novel 4.8 Mb sequence from de novo assembly within this genome. We have identified 1,963 rearrangement hotspots within SDs which encompass 166 genes and display an enrichment of duplicated gene nucleotide variants (DNVs). These regions are correlated with increased nonallelic homologous recombination (NAHR) event frequency which presumably represents the origin of copy number variations (CNVs) and pathogenic duplications/deletions. Analysis revealed that 20% of the detected hotspots are clustered within the proximal and distal SD breakpoints flanked by the pathogenic deletions/duplications that have been mapped for 24 NAHR-mediated genomic disorders. FISH Validation of selected complex regions revealed 94% concordance with in silico localization of the highly homologous derivatives. Other results from this study indicate that intra-chromosomal recombination is enhanced in genic compared with agenic duplicated regions, and that gene desert regions comprising SDs may represent reservoirs for creation of novel genes. The generation of genome-wide signatures of 'rearrangement hotspots', which likely serve as templates for NAHR, may provide a powerful approach towards understanding the underlying mutational mechanism(s) for development of constitutional and acquired diseases.	[Uddin, Mohammed; Sturge, Mitch; Peddle, Lynette; O'Rielly, Darren D.; Rahman, Proton] Mem Univ, Discipline Med & Genet, Fac Med, St John, NF, Canada	Memorial University Newfoundland	Uddin, M (corresponding author), Mem Univ, Discipline Med & Genet, Fac Med, St John, NF, Canada.	prahman@mun.ca	O'Rielly, Darren D./AAA-1687-2020	O'Rielly, Darren D./0000-0002-4287-8589	Atlantic Innovation Foundation; Arthritis Society of Canada	Atlantic Innovation Foundation; Arthritis Society of Canada	This project was funded by the Atlantic Innovation Foundation and Arthritis Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Ho MR, 2011, NUCLEIC ACIDS RES, V39, pD920, DOI 10.1093/nar/gkq1197; Huang XS, 2010, EUR J MED GENET, V53, P153, DOI 10.1016/j.ejmg.2010.03.004; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Koscinski I, 2011, AM J HUM GENET, V88, P344, DOI 10.1016/j.ajhg.2011.01.018; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; LIHENG, 2008, GENOME RES, V18, P1851; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nagamani SCS, 2011, EUR J HUM GENET, V19, P280, DOI 10.1038/ejhg.2010.184; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Shaikh TH, 2007, GENOME RES, V17, P482, DOI 10.1101/gr.5986507; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tokutomi T, 2009, AM J MED GENET A, V149A, P2560, DOI 10.1002/ajmg.a.33049; Tucker T, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-25; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; YANOVSKY V, 2008, WORKSH ALG BIOINF WA; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; DECIPHER GENOMIC ABE	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28853	10.1371/journal.pone.0028853	http://dx.doi.org/10.1371/journal.pone.0028853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194928	Green Accepted, gold, Green Published			2022-12-25	WOS:000298369100111
J	Camp, ND; James, RG; Dawson, DW; Yan, F; Davison, JM; Houck, SA; Tang, XB; Zheng, N; Major, MB; Moon, RT				Camp, Nathan D.; James, Richard G.; Dawson, David W.; Yan, Feng; Davison, James M.; Houck, Scott A.; Tang, Xiaobo; Zheng, Ning; Major, Michael B.; Moon, Randall T.			Wilms Tumor Gene on X Chromosome (WTX) Inhibits Degradation of NRF2 Protein through Competitive Binding to KEAP1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; CUL3-BASED E3 LIGASE; SUPPRESSOR WTX; BETA-CATENIN; MUTATIONS; ACTIVATION; ADAPTER; INACTIVATION; PROTEOMICS; INTERFACE	WTX is a tumor suppressor protein that is lost or mutated in up to 30% of cases of Wilms tumor. Among its known functions, WTX interacts with the beta-transducin repeat containing family of ubiquitin ligase adaptors and promotes the ubiquitination and degradation of the transcription factor beta-catenin, a key control point in the WNT/beta-catenin signaling pathway. Here, we report that WTX interacts with a second ubiquitin ligase adaptor, KEAP1, which functions to regulate the ubiquitination of the transcription factor NRF2, a key control point in the antioxidant response. Surprisingly, we find that unlike its ability to promote the ubiquitination of beta-catenin, WTX inhibits the ubiquitination of NRF2. WTX and NRF2 compete for binding to KEAP1, and thus loss of WTX leads to rapid ubiquitination and degradation of NRF2 and a reduced response to cytotoxic insult. These results expand our understanding of the molecular mechanisms of WTX and reveal a novel regulatory mechanism governing the antioxidant response.	[Camp, Nathan D.; James, Richard G.; Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Sch Med, Dept Pharmacol,Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Dawson, David W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Yan, Feng; Davison, James M.; Houck, Scott A.; Major, Michael B.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Major, MB (corresponding author), 450 West Dr,Rm 31-351, Chapel Hill, NC 27599 USA.	ben_major@med.unc.edu; rtmoon@uw.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014; Dawson, David/I-5917-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Major, Michael/0000-0002-6753-8513; james, richard/0000-0002-2302-7367	National Institutes of Health from USPHS [T32 GM07270]; NRSA; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 GM07270 from USPHS and NRSA (to N.D.C.).; Supported by a National Institutes of Health Directors New Innovator Award and a Sidney Kimmel Scholar Award. To whom correspondence may be addressed: 450 West Dr., Rm. 31-351, Chapel Hill, NC 27599. Tel.: 919-259-2695; E-mail: ben_major@med.unc.edu.	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim MKH, 2011, ONCOGENE, V30, P832, DOI 10.1038/onc.2010.452; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Moisan A, 2011, DEV CELL, V20, P583, DOI 10.1016/j.devcel.2011.03.013; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Owen C, 2008, HAEMATOLOGICA, V93, P947, DOI 10.3324/haematol.12509; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Perdu B, 2010, J BONE MINER RES, V25, P82, DOI 10.1359/jbmr.090707; Perotti D, 2008, ONCOGENE, V27, P4625, DOI 10.1038/onc.2008.93; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	44	78	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6539	6550		10.1074/jbc.M111.316471	http://dx.doi.org/10.1074/jbc.M111.316471			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215675	hybrid, Green Published			2022-12-25	WOS:000300791800042
J	Heinhuis, B; Koenders, MI; van den Berg, WB; Netea, MG; Dinarello, CA; Joosten, LAB				Heinhuis, Bas; Koenders, Marije I.; van den Berg, Wim B.; Netea, Mihai G.; Dinarello, Charles A.; Joosten, Leo A. B.			Interleukin 32 (IL-32) Contains a Typical alpha-Helix Bundle Structure That Resembles Focal Adhesion Targeting Region of Focal Adhesion Kinase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; INDUCED CELL-DEATH; A VIRUS-INFECTION; RHEUMATOID-ARTHRITIS; PROINFLAMMATORY CYTOKINE; INTEGRIN ALPHA-V-BETA-3; TYROSINE KINASE; RGD-PEPTIDES; CROSS-TALK; I-TASSER	IL-32 can be expressed in several isoforms. The amino acid sequences of the major IL-32 isoforms were used to predict the secondary and tertiary protein structure by I-TASSER software. The secondary protein structure revealed coils and alpha-helixes, but no beta sheets. Furthermore, IL-32 contains an RGD motif, which potentially activates procaspase-3 intracellular and or binds to integrins. Mutation of the RGD motif did not result in inhibition of the IL-32 beta- or IL-32 gamma-induced cytotoxicity mediated through caspase-3. Although IL-32 alpha interacted with the extracellular part of alpha V beta 3 and alpha V beta 6 integrins, only the alpha V beta 3 binding was inhibited by small RGD peptides. Additionally, IL-32 beta was able to bind to alpha V beta 3 integrins, whereas this binding was not inhibited by small RGD peptides. In addition to the IL-32/integrin interactions, we observed that IL-32 is also able to interact with intracellular proteins that are involved in integrin and focal adhesion signaling. Modeling of IL-32 revealed a distinct alpha-helix protein resembling the focal adhesion targeting region of focal adhesion kinase (FAK). Inhibition of FAK resulted in modulation of the IL-32 beta- or IL-32 gamma-induced cytotoxicity. Interestingly, IL-32 alpha binds to paxillin without the RGD motif being involved. Finally, FAK inhibited IL-32 alpha/paxillin binding, whereas FAK also could interact with IL-32 alpha, demonstrating that IL-32 is a member of the focal adhesion protein complex. This study demonstrates for the first time that IL-32 binds to the extracellular domain of integrins and to intracellular proteins like paxillin and FAK, suggesting a dual role for IL-32 in integrin signaling.	[Netea, Mihai G.; Dinarello, Charles A.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HB Nijmegen, Netherlands; [Heinhuis, Bas; Koenders, Marije I.; van den Berg, Wim B.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Joosten, LAB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.	l.joosten@aig.umcn.nl	Dinarello, Charles/C-8524-2013; Netea, Mihai/N-5155-2014; Heinhuis, Bas/G-6076-2016; Joosten, Leo AB/H-3138-2015; van den Berg, W.B./H-8010-2014; Koenders, Marije I/A-1341-2012	Joosten, Leo AB/0000-0001-6166-9830; Koenders, Marije I/0000-0001-5845-8362	National Institutes of Health [AI-15614]; Dutch Arthritis Association [06-1-301]; Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015614, R01AI015614, R56AI015614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Arthritis Association; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-15614 (to C. A. D.).; Supported by Dutch Arthritis Association Grant 06-1-301.; Supported by a Vici grant from The Netherlands Organization for Scientific Research.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Aguzzi MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-84; Bai XY, 2010, J IMMUNOL, V184, P3830, DOI 10.4049/jimmunol.0901913; Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Broxterman HJ, 1999, DRUG RESIST UPDATE, V2, P139, DOI 10.1054/drup.1999.0081; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Cagnard N, 2005, EUR CYTOKINE NETW, V16, P289; Calabrese F, 2008, AM J RESP CRIT CARE, V178, P894, DOI 10.1164/rccm.200804-646OC; DAHL CA, 1992, J IMMUNOL, V148, P597; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hasegawa H, 2011, CYTOKINE, V53, P74, DOI 10.1016/j.cyto.2010.09.002; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9; Heinhuis B, 2011, P NATL ACAD SCI USA, V108, P4962, DOI 10.1073/pnas.1016005108; Heinhuis B, 2011, ANN RHEUM DIS, V70, P660, DOI 10.1136/ard.2010.139196; Heinhuis B, 2010, ANN RHEUM DIS, V69, P1866, DOI 10.1136/ard.2009.127399; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kim S, 2008, BMB REP, V41, P814, DOI 10.5483/BMBRep.2008.41.11.814; Kim YG, 2010, ARTHRITIS RHEUM-US, V62, P515, DOI 10.1002/art.27197; Li W, 2010, J IMMUNOL, V185, P5056, DOI 10.4049/jimmunol.0902667; Li W, 2009, EUR J IMMUNOL, V39, P1019, DOI 10.1002/eji.200838885; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mabilleau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004173; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Matsuki K, 2008, J ORTHOP SCI, V13, P524, DOI 10.1007/s00776-008-1281-z; Millard M, 2011, THERANOSTICS, V1, P154, DOI 10.7150/thno/v01p0154; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Mun SH, 2009, ARTHRITIS RHEUM-US, V60, P678, DOI 10.1002/art.24299; Neff L, 2003, J BIOL CHEM, V278, P27721, DOI 10.1074/jbc.M212065200; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Nolan K, 1999, MOL CELL BIOL, V19, P6120; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Nold-Petry CA, 2009, P NATL ACAD SCI USA, V106, P3883, DOI 10.1073/pnas.0813334106; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Porter AG, 2006, NAT CHEM BIOL, V2, P509, DOI 10.1038/nchembio1006-509; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; Rasool ST, 2008, IMMUNOL LETT, V117, P161, DOI 10.1016/j.imlet.2008.01.007; Richards S, 2008, TISSUE ENG PT C-METH, V14, P221, DOI 10.1089/ten.tec.2007.0428; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Semaan N, 2008, J IMMUNOL, V180, P3485, DOI 10.4049/jimmunol.180.5.3485; Seo EH, 2008, J MICROBIOL BIOTECHN, V18, P1606; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Shoda H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2074; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sorrentino C, 2009, AM J RESP CRIT CARE, V180, P769, DOI 10.1164/rccm.200903-0400OC; Stupp R, 2007, J CLIN ONCOL, V25, P1637, DOI 10.1200/JCO.2006.09.8376; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wilder RL, 2002, ANN RHEUM DIS, V61, P96, DOI 10.1136/ard.61.suppl_2.ii96; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Zeisel MB, 2005, J IMMUNOL, V174, P7393, DOI 10.4049/jimmunol.174.11.7393; Zepp JA, 2011, J IMMUNOL, V186, P4110, DOI 10.4049/jimmunol.1000081; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	74	62	64	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5733	5743		10.1074/jbc.M111.288290	http://dx.doi.org/10.1074/jbc.M111.288290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203669	hybrid, Green Published			2022-12-25	WOS:000300638000049
J	Rittiner, JE; Korboukh, I; Hull-Ryde, EA; Jin, J; Janzen, WP; Frye, SV; Zylka, MJ				Rittiner, Joseph E.; Korboukh, Ilia; Hull-Ryde, Emily A.; Jin, Jian; Janzen, William P.; Frye, Stephen V.; Zylka, Mark J.			AMP Is an Adenosine A(1) Receptor Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDES; HETEROMERIC ASSOCIATION; DORSAL HORN; ATP; ACTIVATION; CELLS; DERIVATIVES; CONVERSION; NEUROTRANSMISSION; IDENTIFICATION	Numerous receptors for ATP, ADP, and adenosine exist; however, it is currently unknown whether a receptor for the related nucleotide adenosine 5'-monophosphate (AMP) exists. Using a novel cell-based assay to visualize adenosine receptor activation in real time, we found that AMP and a non-hydrolyzable AMP analog (deoxyadenosine 5'-monophosphonate, ACP) directly activated the adenosine A(1) receptor (A(1)R). In contrast, AMP only activated the adenosine A(2B) receptor (A(2B)R) after hydrolysis to adenosine by ecto-5'-nucleotidase (NT5E, CD73) or prostatic acid phosphatase (PAP, ACPP). Adenosine and AMP were equipotent human A(1)R agonists in our real-time assay and in a cAMP accumulation assay. ACP also depressed cAMP levels in mouse cortical neurons through activation of endogenous A(1)R. Non-selective purinergic receptor antagonists (pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid and suramin) did not block adenosine-or AMP-evoked activation. Moreover, mutation of His-251 in the human A(1)R ligand binding pocket reduced AMP potency without affecting adenosine potency. In contrast, mutation of a different binding pocket residue (His-278) eliminated responses to AMP and to adenosine. Taken together, our study indicates that the physiologically relevant nucleotide AMP is a full agonist of A(1)R. In addition, our study suggests that some of the physiological effects of AMP may be direct, and not indirect through ectonucleotidases that hydrolyze this nucleotide to adenosine.	[Zylka, Mark J.] Univ N Carolina, Dept Cell & Mol Physiol, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Korboukh, Ilia; Hull-Ryde, Emily A.; Jin, Jian; Janzen, William P.; Frye, Stephen V.] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Ctr Neurosci, 5109A NRB,CB 7545, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu			National Institutes of Health from the NINDS [R01NS060725, R01NS067688]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060725, R01NS067688] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS060725 and R01NS067688 from the NINDS (to M. J. Z.).	Abbracchio MP, 2005, TRENDS PHARMACOL SCI, V26, P8, DOI 10.1016/j.tips.2004.10.010; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Ashton TD, 2008, BIOORGAN MED CHEM, V16, P1861, DOI 10.1016/j.bmc.2007.11.010; Boyer JL, 1996, BRIT J PHARMACOL, V118, P1959, DOI 10.1111/j.1476-5381.1996.tb15630.x; BRUNS RF, 1980, N-S ARCH PHARMACOL, V315, P5, DOI 10.1007/BF00504224; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cappellacci L, 2008, BIOORGAN MED CHEM, V16, P336, DOI 10.1016/j.bmc.2007.09.035; Cooper J, 1997, BRIT J PHARMACOL, V122, P546, DOI 10.1038/sj.bjp.0701401; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Dalpiaz A, 2001, PHARM RES-DORDR, V18, P531, DOI 10.1023/A:1011018730459; Daniels IS, 2010, J BIOL CHEM, V285, P20716, DOI 10.1074/jbc.M109.090845; Dulla CG, 2005, NEURON, V48, P1011, DOI 10.1016/j.neuron.2005.11.009; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; El-Tayeb A, 2009, J MED CHEM, V52, P7669, DOI 10.1021/jm900538v; Elzein E, 2008, EXPERT OPIN INV DRUG, V17, P1901, DOI [10.1517/13543780802497284, 10.1517/13543780802497284 ]; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gao N, 2007, AM J PHYSIOL-GASTR L, V292, pG492, DOI 10.1152/ajpgi.00257.2006; GERWINS P, 1990, MOL PHARMACOL, V38, P660; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Inbe H, 2004, J BIOL CHEM, V279, P19790, DOI 10.1074/jbc.M400360200; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Kumar TS, 2010, J MED CHEM, V53, P2562, DOI 10.1021/jm9018542; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; LEE KS, 1981, NEUROSCI LETT, V23, P309, DOI 10.1016/0304-3940(81)90016-1; MAILLARD MC, 1994, J PHARM SCI, V83, P46, DOI 10.1002/jps.2600830112; MOODY CJ, 1984, EUR J PHARMACOL, V97, P47, DOI 10.1016/0014-2999(84)90511-9; Mustafa SJ, 2007, J PHARMACOL EXP THER, V320, P1246, DOI 10.1124/jpet.106.112250; NAITO Y, 1985, BIOCHEM J, V226, P645, DOI 10.1042/bj2260645; Nakata H, 2005, J MOL NEUROSCI, V26, P233, DOI 10.1385/JMN:26:2-3:233; Ohkubo S, 2000, BRIT J PHARMACOL, V131, P1667, DOI 10.1038/sj.bjp.0703750; OLAH ME, 1992, J BIOL CHEM, V267, P10764; Patterson SL, 2001, J NEUROCHEM, V76, P234, DOI 10.1046/j.1471-4159.2001.00016.x; PIROTTON S, 1993, EUR J PHARMACOL, V241, P55, DOI 10.1016/0014-2999(93)90932-8; Qi Ai-Dong, 2004, Purinergic Signal, V1, P67, DOI 10.1007/s11302-004-5069-0; RAGAZZI E, 1991, CIRC RES, V68, P1035, DOI 10.1161/01.RES.68.4.1035; SALTER MW, 1985, NEUROSCIENCE, V15, P815, DOI 10.1016/0306-4522(85)90080-6; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Schenone S, 2010, CURR TOP MED CHEM, V10, P878, DOI 10.2174/156802610791268729; Sowa NA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-20; Street SE, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-80; Suzuki T, 2006, BIOCHEM BIOPH RES CO, V351, P559, DOI 10.1016/j.bbrc.2006.10.075; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yoshioka K, 2001, P NATL ACAD SCI USA, V98, P7617, DOI 10.1073/pnas.121587098; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; Zhang JY, 2003, EUR J PHARMACOL, V472, P33, DOI 10.1016/S0014-2999(03)01855-7; Zhou SY, 2010, J PHARMACOL EXP THER, V333, P920, DOI 10.1124/jpet.109.164376; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024; Zylka MJ, 2011, TRENDS MOL MED, V17, P188, DOI 10.1016/j.molmed.2010.12.006	49	98	104	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5301	5309		10.1074/jbc.M111.291666	http://dx.doi.org/10.1074/jbc.M111.291666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215671	Green Published, hybrid			2022-12-25	WOS:000300638000012
J	Saha, D; Khandelia, P; O'Keefe, RT; Vijayraghavan, U				Saha, Debjani; Khandelia, Piyush; O'Keefe, Raymond T.; Vijayraghavan, Usha			Saccharomyces cerevisiae NineTeen Complex (NTC)-associated Factor Bud31/Ycr063w Assembles on Precatalytic Spliceosomes and Improves First and Second Step Pre-mRNA Splicing Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRP19P-ASSOCIATED COMPLEX; MASS-SPECTROMETRY; SNRNP ADDITION; YEAST; PROTEIN; COMPONENTS; U5; IDENTIFICATION; ACTIVATION; INTERACTS	Pre-mRNA splicing occurs in spliceosomes whose assembly and activation are critical for splice site selection and catalysis. The highly conserved NineTeen complex protein complex stabilizes various snRNA and protein interactions early in the spliceosome assembly pathway. Among several NineTeen complex-associated proteins is the nonessential protein Bud31/Ycr063w, which is also a component of the Cef1p subcomplex. A role for Bud31 in pre-mRNA splicing is implicated by virtue of its association with splicing factors, but its specific functions and spliceosome interactions are uncharacterized. Here, using in vitro splicing assays with extracts from a strain lacking Bud31, we illustrate its role in efficient progression to the first catalytic step and its requirement for the second catalytic step in reactions at higher temperatures. Immunoprecipitation of functional epitope-tagged Bud31 from in vitro reactions showed that its earliest association is with precatalytic B complex and that the interaction continues in catalytically active complexes with stably bound U2, U5, and U6 small nuclear ribonucleoproteins. In complementary experiments, wherein precatalytic spliceosomes are selected from splicing reactions, we detect the occurrence of Bud31. Cross-linking of proteins to pre-mRNAs with a site-specific 4-thio uridine residue at the -3 position of exon 1 was tested in reactions with WT and bud31 null extracts. The data suggest an altered interaction between a similar to 25-kDa protein and this exonic residue of pre-mRNAs in the arrested bud31 null spliceosomes. These results demonstrate the early spliceosomal association of Bud31 and provide plausible functions for this factor in stabilizing protein interactions with the pre-mRNA.	[Saha, Debjani; Khandelia, Piyush; Vijayraghavan, Usha] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [O'Keefe, Raymond T.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Indian Institute of Science (IISC) - Bangalore; University of Manchester	Vijayraghavan, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	uvr@mcbl.iisc.ernet.in			Department of Biotechnology; Council of Scientific and Industrial Research, Government of India; International Relations Cell, IISc; Biotechnology and Biological Sciences Research Council (courtesy of The University of Manchester) for the stay in Manchester	Department of Biotechnology; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); International Relations Cell, IISc; Biotechnology and Biological Sciences Research Council (courtesy of The University of Manchester) for the stay in Manchester(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an infrastructure grant to the Indian Institute of Science (IISc) from the Department of Biotechnology (to U. V.); by scholarships (to D. S. and P. K.) from the Council of Scientific and Industrial Research, Government of India; and by a short term travel fellowship by the International Relations Cell, IISc, and funding from the Biotechnology and Biological Sciences Research Council (courtesy of The University of Manchester) for the stay in Manchester (to D. S.), which facilitated the UV cross-linking experiments.	ABOVICH N, 1994, GENE DEV, V8, P843, DOI 10.1101/gad.8.7.843; Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; Caspary F, 1998, EMBO J, V17, P6348, DOI 10.1093/emboj/17.21.6348; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Chen CH, 2001, J BIOL CHEM, V276, P488, DOI 10.1074/jbc.M006958200; Chen HR, 1999, P NATL ACAD SCI USA, V96, P5406, DOI 10.1073/pnas.96.10.5406; Chen HR, 1998, MOL CELL BIOL, V18, P2196, DOI 10.1128/MCB.18.4.2196; CHENG SC, 1994, NUCLEIC ACIDS RES, V22, P1548, DOI 10.1093/nar/22.9.1548; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; Chiu YF, 2009, MOL CELL BIOL, V29, P5671, DOI 10.1128/MCB.00773-09; Chung SY, 1999, RNA, V5, P1042, DOI 10.1017/S1355838299990635; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; HLA T, 1995, BBA-GENE STRUCT EXPR, V1260, P227, DOI 10.1016/0167-4781(94)00219-S; Hogg R, 2010, BIOCHEM SOC T, V38, P1110, DOI 10.1042/BST0381110; James SA, 2002, RNA, V8, P1068, DOI 10.1017/S1355838202022033; JONES MH, 1995, P NATL ACAD SCI USA, V92, P9687, DOI 10.1073/pnas.92.21.9687; Masciadri B, 2004, BIOCHEM BIOPH RES CO, V320, P1342, DOI 10.1016/j.bbrc.2004.05.228; McGrail JC, 2008, NUCLEIC ACIDS RES, V36, P814, DOI 10.1093/nar/gkm1098; McGrail JC, 2009, NUCLEIC ACIDS RES, V37, P4205, DOI 10.1093/nar/gkp341; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; McPheeters DS, 2003, MOL CELL BIOL, V23, P4174, DOI 10.1128/MCB.23.12.4174-4186.2003; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; NEWMAN AJ, 1985, CELL, V42, P335, DOI 10.1016/S0092-8674(85)80129-X; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Sapra AK, 2008, BIOCHEM J, V416, P365, DOI 10.1042/BJ20081195; Seshadri V, 1996, GENETICS, V143, P45; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; Stevens SW, 2000, METHOD ENZYMOL, V318, P385; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; TEIGELKAMP S, 1995, EMBO J, V14, P2602, DOI 10.1002/j.1460-2075.1995.tb07258.x; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; VIJAYRAGHAVAN U, 1990, MOL CELL BIOL, V10, P324, DOI 10.1128/MCB.10.1.324; VIJAYRAGHAVAN U, 1986, EMBO J, V5, P1683, DOI 10.1002/j.1460-2075.1986.tb04412.x; Wang Q, 2005, MOL CELL BIOL, V25, P10745, DOI 10.1128/MCB.25.24.10745-10754.2005; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	41	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5390	5399		10.1074/jbc.M111.298547	http://dx.doi.org/10.1074/jbc.M111.298547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215661	Green Published, hybrid			2022-12-25	WOS:000300638000020
J	Wei, GZ; Yin, Y; Li, WM; Bito, H; She, H; Mao, ZX				Wei, Gengze; Yin, Yue; Li, Wenming; Bito, Haruhiko; She, Hua; Mao, Zixu			Calpain-mediated Degradation of Myocyte Enhancer Factor 2D Contributes to Excitotoxicity by Activation of Extrasynaptic N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE NEURONS; TRANSCRIPTION FACTOR MEF2; NMDA RECEPTORS; CELL-DEATH; HIPPOCAMPAL-NEURONS; SURVIVAL; NEURODEGENERATION; APOPTOSIS; BLOCKADE; CLEAVAGE	Synaptic and extrasynaptic NMDA receptors (NMDARs) appear to play opposite roles in neuronal survival and death. Here we report the new findings on the dysregulation of survival factor, myocyte enhancer factor 2D (MEF2D), by extrasynaptic NMDARs. Excitotoxicity led to the NMDAR-dependent degradation of MEF2D protein and inhibition of its transactivation activity in mature cortical neurons. The activation of extrasynaptic NMDARs alone was sufficient for degradation of MEF2D. Calpain directly cleaved MEF2D in vitro and blocking this protease activity greatly attenuated NMDAR signaled degradation of MEF2D in neurons. Consistently, inhibition of calpain protected cortical neurons from NMDA-induced excitotoxicity. Furthermore, knockdown of MEF2D sensitized neurons to NMDA-induced excitotoxicity, which was not protected by calpain inhibition. Collectively, these findings suggest that dysregulation of MEF2D by calpain may mediate excitotoxicity via an extrasynaptic NMDAR-dependent manner.	[Wei, Gengze; Li, Wenming; She, Hua; Mao, Zixu] Emory Univ, Dept Pharmacol, Sch Med, Atlanta, GA 30322 USA; [Wei, Gengze; Li, Wenming; She, Hua; Mao, Zixu] Emory Univ, Dept Neurol, Sch Med, Atlanta, GA 30322 USA; [Bito, Haruhiko] Univ Tokyo, Dept Neurochem, Grad Sch Med, Tokyo 1130033, Japan; [Yin, Yue] Fourth Mil Med Univ, Xian 710032, Shaanxi, Peoples R China	Emory University; Emory University; University of Tokyo; Air Force Military Medical University	Mao, ZX (corresponding author), Emory Univ, Dept Pharmacol, Sch Med, Whitehead Bldg Rm505L,615 Michael St, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu	Bito, Haruhiko/A-8635-2008; Wei, Gengze/B-3572-2014	Bito, Haruhiko/0000-0001-6315-9594	National Institutes of Health [AG023695, NS048254, ES015317, ES016731-002]; Michael J. Fox Foundation; Grants-in-Aid for Scientific Research [20670002] Funding Source: KAKEN; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731, R01ES015317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants AG023695, NS048254, ES015317, and ES016731-002 (to Z. M.). This work was also supported by the Michael J. Fox Foundation (to Z. M.).	Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Battaglia F, 2003, J MOL NEUROSCI, V20, P357, DOI 10.1385/JMN:20:3:357; Bevers MB, 2009, J NEUROCHEM, V108, P1237, DOI 10.1111/j.1471-4159.2008.05860.x; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Heidenreich KA, 2004, MOL NEUROBIOL, V29, P155, DOI 10.1385/MN:29:2:155; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Monti B, 2000, EUR J NEUROSCI, V12, P3117, DOI 10.1046/j.1460-9568.2000.00189.x; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Scholzke MN, 2003, EUR J NEUROSCI, V18, P3305, DOI 10.1111/j.1460-9568.2003.03079.x; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wiedmann M, 2005, J NEUROSCI RES, V81, P226, DOI 10.1002/jnr.20556; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yang QA, 2010, APOPTOSIS, V15, P1410, DOI 10.1007/s10495-010-0475-y; Yang Q, 2009, CELL CYCLE, V8, P1304, DOI 10.4161/cc.8.9.8363; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783	40	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5797	5805		10.1074/jbc.M111.260109	http://dx.doi.org/10.1074/jbc.M111.260109			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215669	Green Published, hybrid			2022-12-25	WOS:000300638000055
J	Wu, YN; Wang, S; Farooq, SM; Castelvetere, MP; Hou, YN; Gao, JL; Navarro, JV; Oupicky, D; Sun, F; Li, CY				Wu, Yanning; Wang, Shuo; Farooq, Shukkur M.; Castelvetere, Marcello P.; Hou, Yuning; Gao, Ji-Liang; Navarro, Javier V.; Oupicky, David; Sun, Fei; Li, Chunying			A Chemokine Receptor CXCR2 Macromolecular Complex Regulates Neutrophil Functions in Inflammatory Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PHOSPHOLIPASE-C-BETA; CYSTIC-FIBROSIS; PDZ DOMAINS; PROTEIN; MIGRATION; ROLES; CFTR; INTERLEUKIN-8; BINDING	Inflammation plays an important role in a wide range of human diseases such as ischemia-reperfusion injury, arteriosclerosis, cystic fibrosis, inflammatory bowel disease, etc. Neutrophilic accumulation in the inflamed tissues is an essential component of normal host defense against infection, but uncontrolled neutrophilic infiltration can cause progressive damage to the tissue epithelium. The CXC chemokine receptor CXCR2 and its specific ligands have been reported to play critical roles in the pathophysiology of various inflammatory diseases. However, it is unclear how CXCR2 is coupled specifically to its downstream signaling molecules and modulates cellular functions of neutrophils. Here we show that the PDZ scaffold protein NHERF1 couples CXCR2 to its downstream effector phospholipase C( PLC)beta 2, forming a macromolecular complex, through a PDZ-based interaction. We assembled a macromolecular complex of CXCR2.NHERF1.PLC-beta 2 in vitro, and we also detected such a complex in neutrophils by co-immunoprecipitation. We further observed that the CXCR2-containing macromolecular complex is critical for the CXCR2-mediated intracellular calcium mobilization and the resultant migration and infiltration of neutrophils, as disrupting the complex with a cell permeant CXCR2-specific peptide (containing the PDZ motif) inhibited intracellular calcium mobilization, chemotaxis, and transepithelial migration of neutrophils. Taken together, our data demonstrate a critical role of the PDZ-dependent CXCR2 macromolecular signaling complex in regulating neutrophil functions and suggest that targeting the CXCR2 multiprotein complex may represent a novel therapeutic strategy for certain inflammatory diseases.	[Wu, Yanning; Wang, Shuo; Farooq, Shukkur M.; Castelvetere, Marcello P.; Hou, Yuning; Li, Chunying] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Li, Chunying] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA; [Li, Chunying] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Sun, Fei] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Oupicky, David] Wayne State Univ, Sch Med, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Gao, Ji-Liang] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Navarro, Javier V.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Medical Branch Galveston	Li, CY (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield,5312 Scott Hall, Detroit, MI 48201 USA.	cl@med.wayne.edu	Gao, Ji-Liang/Y-4397-2019; Oupicky, David/AAR-1655-2021	Hou, Yuning/0000-0001-9894-3821; Oupicky, David/0000-0003-4710-861X; Navarro, Javier/0000-0001-7098-4373	American Heart Association [0765185B]; Elsa U. Pardee Foundation; Wayne State University; Cardiovascular Research Institute Isis Initiative; National Institutes of Health [HL096800]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Elsa U. Pardee Foundation; Wayne State University; Cardiovascular Research Institute Isis Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by American Heart Association (Greater SE Affiliate) Beginning Grant-in-aid 0765185B (to C. L.), an Elsa U. Pardee Foundation research grant (to C. L.), Wayne State University intramural startup fund and a Cardiovascular Research Institute Isis Initiative award (to C. L.), and National Institutes of Health Grant HL096800 (to F. S.).	Ajuebor MN, 2004, EXP MOL PATHOL, V76, P1, DOI 10.1016/j.yexmp.2003.08.004; BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Baugher PJ, 2008, J BIOL CHEM, V283, P30868, DOI 10.1074/jbc.M804054200; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Bezprozvanny I, 2001, P NATL ACAD SCI USA, V98, P787, DOI 10.1073/pnas.98.3.787; Bizzarri C, 2006, PHARMACOL THERAPEUT, V112, P139, DOI 10.1016/j.pharmthera.2006.04.002; Buanne P, 2007, J LEUKOCYTE BIOL, V82, P1239, DOI 10.1189/jlb.0207118; Carrigan SO, 2005, IMMUNOLOGY, V115, P108, DOI 10.1111/j.1365-2567.2005.02131.x; Choi JW, 2010, CELL SIGNAL, V22, P1153, DOI 10.1016/j.cellsig.2010.03.010; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302; COLLINS SJ, 1987, BLOOD, V70, P1233; Donowitz M, 2010, PHYSIOL GENOMICS, V42A, P200, DOI 10.1152/physiolgenomics.00001.2010; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Farooq SM, 2009, J PHARMACOL EXP THER, V329, P123, DOI 10.1124/jpet.108.145862; Geng JG, 2001, CELL RES, V11, P85, DOI 10.1038/sj.cr.7290071; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Hess DJ, 2002, J SURG RES, V104, P88, DOI 10.1006/jsre.2002.6417; Hirst Robert A, 2006, Methods Mol Biol, V312, P37; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Lee WY, 2006, METH MOL B, V341, P205; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2011, METHODS MOL BIOL, V741, P255, DOI 10.1007/978-1-61779-117-8_17; Li CY, 2010, CANCER LETT, V292, P246, DOI 10.1016/j.canlet.2009.12.009; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liu Y, 2004, J IMMUNOL, V172, P7, DOI 10.4049/jimmunol.172.1.7; Matzer SP, 2004, IMMUNOBIOLOGY, V209, P225, DOI 10.1016/j.imbio.2004.02.009; McColl SR, 1999, J IMMUNOL, V163, P2829; Murphy CT, 2010, CLIN EXP IMMUNOL, V162, P188, DOI 10.1111/j.1365-2249.2010.04234.x; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neel NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023813; Neel NF, 2009, J CELL SCI, V122, P1882, DOI 10.1242/jcs.039057; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Pease James E, 2002, Am J Respir Med, V1, P19; Pizurki L, 2000, AM J PATHOL, V156, P1407, DOI 10.1016/S0002-9440(10)65009-2; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; Raman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010050; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; THOMAS KM, 1990, J BIOL CHEM, V265, P20061; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Wu DQ, 2000, J CELL SCI, V113, P2935; Xu L, 2005, CANCER RES, V65, P5711, DOI 10.1158/0008-5472.CAN-04-4313	63	51	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5744	5755		10.1074/jbc.M111.315762	http://dx.doi.org/10.1074/jbc.M111.315762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203670	Green Published, hybrid			2022-12-25	WOS:000300638000050
J	Dor, R; Lovette, IJ; Safran, RJ; Billerman, SM; Huber, GH; Vortman, Y; Lotem, A; McGowan, A; Evans, MR; Cooper, CB; Winkler, DW				Dor, Roi; Lovette, Irby J.; Safran, Rebecca J.; Billerman, Shawn M.; Huber, Gernot H.; Vortman, Yoni; Lotem, Arnon; McGowan, Andrew; Evans, Matthew R.; Cooper, Caren B.; Winkler, David W.			Low Variation in the Polymorphic Clock Gene Poly-Q Region Despite Population Genetic Structure across Barn Swallow (Hirundo rustica) Populations	PLOS ONE			English	Article							MICROSATELLITE LOCI; CIRCADIAN-RHYTHMS; LATITUDINAL CLINE; PHYLOGENY; SOFTWARE; SEARCH; AVES	Recent studies of several species have reported a latitudinal cline in the circadian clock gene, Clock, which influences rhythms in both physiology and behavior. Latitudinal variation in this gene may hence reflect local adaptation to seasonal variation. In some bird populations, there is also an among-individual association between Clock poly-Q genotype and clutch initiation date and incubation period. We examined Clock poly-Q allele variation in the Barn Swallow (Hirundo rustica), a species with a cosmopolitan geographic distribution and considerable variation in life-history traits that may be influenced by the circadian clock. We genotyped Barn Swallows from five populations (from three subspecies) and compared variation at the Clock locus to that at microsatellite loci and mitochondrial DNA (mtDNA). We found very low variation in the Clock poly-Q region, as >96% of individuals were homozygous, and the two other alleles at this locus were globally rare. Genetic differentiation based on the Clock poly-Q locus was not correlated with genetic differentiation based on either microsatellite loci or mtDNA sequences. Our results show that high diversity in Clock poly-Q is not general across avian species. The low Clock variation in the background of heterogeneity in microsatellite and mtDNA loci in Barn Swallows may be an outcome of stabilizing selection on the Clock locus.	[Dor, Roi; Lovette, Irby J.; Winkler, David W.] Cornell Univ, Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY 14850 USA; [Lovette, Irby J.; Winkler, David W.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Dor, Roi; Safran, Rebecca J.; Huber, Gernot H.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Billerman, Shawn M.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Vortman, Yoni; Lotem, Arnon] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [McGowan, Andrew; Evans, Matthew R.] Univ Exeter, Sch Biosci, Exeter, Devon, England	Cornell University; Cornell University; University of Colorado System; University of Colorado Boulder; University of Wyoming; Tel Aviv University; University of Exeter	Dor, R (corresponding author), Cornell Univ, Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY 14850 USA.	roi.dor@colorado.edu	Lovette, Irby/P-3477-2014	Dor, Roi/0000-0002-8743-9387; Cooper, Caren/0000-0001-6263-8892; Evans, Matthew/0000-0002-5630-7621	Cornell Lab of Ornithology; NSF [IOS-0717421, OISE-0730180]	Cornell Lab of Ornithology; NSF(National Science Foundation (NSF))	Funded by the Cornell Lab of Ornithology and NSF grants IOS-0717421 to RJS and OISE-0730180 to DWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avivi A, 2001, P NATL ACAD SCI USA, V98, P13751, DOI 10.1073/pnas.181484498; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bensch S, 1997, MOL ECOL, V6, P91, DOI 10.1046/j.1365-294X.1997.00150.x; Billerman SM, 2011, AUK, V128, P506, DOI 10.1525/auk.2011.10252; Christie DA, 2004, HDB BIRDS WORLD, P602; Cramp S., 1988, BIRDS W PALEARCTIC, V5; Dickinson E.C., 2001, Zoologische Verhandelingen (Leiden), V335, P85; Dor R, 2012, ECOL EVOL, V2, P95, DOI 10.1002/ece3.73; Dor R, 2012, J HERED, V103, P55, DOI 10.1093/jhered/esr114; Dor R, 2010, MOL PHYLOGENET EVOL, V56, P409, DOI 10.1016/j.ympev.2010.02.008; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fidler AE, 2003, COMP BIOCHEM PHYS B, V136, P861, DOI 10.1016/S1096-4959(03)00276-8; HANOTTE O, 1994, MOL ECOL, V3, P529, DOI 10.1111/j.1365-294X.1994.tb00133.x; Hayasaka N, 2002, J NEUROSCI, V22, P1600, DOI 10.1523/JNEUROSCI.22-05-01600.2002; Hunt JS, 2001, AUK, V118, P35, DOI 10.1642/0004-8038(2001)118[0035:MSABOA]2.0.CO;2; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Liedvogel M, 2010, J AVIAN BIOL, V41, P543, DOI 10.1111/j.1600-048X.2010.05055.x; Liedvogel M, 2009, MOL ECOL, V18, P2444, DOI 10.1111/j.1365-294X.2009.04204.x; MARTINEZ M M, 1983, Neotropica (La Plata), V29, P83; MCDONALD DB, 1994, SCIENCE, V266, P1030, DOI 10.1126/science.7973654; MOLLER AP, 1988, NATURE, V332, P640, DOI 10.1038/332640a0; Moller AP., 1994, SEXUAL SELECTION BAR; Nei M., 2000, MOL EVOLUTION PHYLOG; O'Malley KG, 2008, P ROY SOC B-BIOL SCI, V275, P2813, DOI 10.1098/rspb.2008.0524; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Peters J.L., 1960, CHECK LIST BIRDS WOR, V9, P80; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Saleem Q, 2001, HUM GENET, V109, P136, DOI 10.1007/s004390100550; Sheldon FH, 2005, MOL PHYLOGENET EVOL, V35, P254, DOI 10.1016/j.ympev.2004.11.008; Steeves TDL, 1999, GENOMICS, V57, P189, DOI 10.1006/geno.1998.5675; Steinmeyer C, 2009, GENETICA, V136, P109, DOI 10.1007/s10709-008-9318-y; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Tauber E, 2005, METHOD ENZYMOL, V393, P797, DOI 10.1016/S0076-6879(05)93042-5; Tsyusko OV, 2007, MOL ECOL NOTES, V7, P833, DOI 10.1111/j.1471-8286.2007.01719.x; Turner A., 1989, SWALLOWS MARTINS IDE; Turner A., 2006, BARN SWALLOW; Visser ME, 2010, PHILOS T R SOC B, V365, P3113, DOI 10.1098/rstb.2010.0111; Vortman Y, 2011, BEHAV ECOL, V22, P1344, DOI 10.1093/beheco/arr139; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	43	23	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28843	10.1371/journal.pone.0028843	http://dx.doi.org/10.1371/journal.pone.0028843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216124	Green Published, gold			2022-12-25	WOS:000299113600043
J	Rantala, A; Jaakkola, JJK; Jaakkola, MS				Rantala, Aino; Jaakkola, Jouni J. K.; Jaakkola, Maritta S.			Respiratory Infections Precede Adult-Onset Asthma	PLOS ONE			English	Article							VIRAL-INFECTIONS; ATOPY; RISK; EXACERBATIONS; ASSOCIATION; MOLDS	Background: Respiratory infections in early life are associated with an increased risk of developing asthma but there is little evidence on the role of infections for onset of asthma in adults. The objective of this study was to assess the relation of the occurrence of respiratory infections in the past 12 months to adult-onset asthma in a population-based incident case-control study of adults 21-63 years of age. Methods/PrincipalFindings: We recruited all new clinically diagnosed cases of asthma (n = 521) during a 2.5-year study period and randomly selected controls (n = 932) in a geographically defined area in South Finland. Information on respiratory infections was collected by a self-administered questionnaire. The diagnosis of asthma was based on symptoms and reversible airflow obstruction in lung function measurements. The risk of asthma onset was strongly increased in subjects who had experienced in the preceding 12 months lower respiratory tract infections (including acute bronchitis and pneumonia) with an adjusted odds ratio (OR) 7.18 (95% confidence interval [CI] 5.16-9.99), or upper respiratory tract infections (including common cold, sinusitis, tonsillitis, and otitis media) with an adjusted OR 2.26 (95% CI 1.72-2.97). Individuals with personal atopy and/or parental atopy were more susceptible to the effects of respiratory infections on asthma onset than non-atopic persons. Conclusions/Significance: This study provides new evidence that recently experienced respiratory infections are a strong determinant for adult-onset asthma. Reducing such infections might prevent onset of asthma in adulthood, especially in individuals with atopy or hereditary propensity to it.	[Rantala, Aino; Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Jaakkola, Maritta S.] Univ Oulu, Resp Med Unit, Inst Clin Med, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Jaakkola, Maritta S.] Oulu Univ Hosp, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Rantala, A (corresponding author), Univ Oulu, Inst Hlth Sci, Ctr Environm & Resp Hlth Res, Oulu, Finland.	jouni.jaakkola@oulu.fi	Rantala, Aino/AAZ-7578-2020; Jaakkola, Jouni J.K./G-4314-2012	Rantala, Aino/0000-0002-4845-076X; Jaakkola, Maritta S./0000-0003-1373-7784; Jaakkola, Jouni/0000-0003-4168-4683	Academy of Finland [129419, 138691]; National Institute for Health and Welfare [240100]	Academy of Finland(Academy of Finland); National Institute for Health and Welfare	This work was supported by Academy of Finland (grant no. 129419 and 138691), and the Finnish Health Promotion Funding, National Institute for Health and Welfare(grant no. 240100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRA L, 1994, EUR RESPIR J, V7, P2165, DOI 10.1183/09031936.94.07122165; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Asthma Program, 2004, PUBL MIN SOC AFF HLT; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Global Initiative for Asthma (GINA), 2010, GLOB STRAT ASTH MAN; Guilbert Theresa W, 2010, Expert Rev Respir Med, V4, P71, DOI 10.1586/ers.09.60; Hahn DL, 1996, EPIDEMIOL INFECT, V117, P513, DOI 10.1017/S0950268800059197; HAHN DL, 1991, JAMA-J AM MED ASSOC, V266, P225, DOI 10.1001/jama.266.2.225; Holt PG, 2011, CHEST, V139, P1165, DOI 10.1378/chest.10-2397; Holt PG, 2010, J ALLERGY CLIN IMMUN, V125, P653, DOI 10.1016/j.jaci.2009.12.018; JAAKKOLA JJK, 1995, AM J EPIDEMIOL, V141, P755, DOI 10.1093/oxfordjournals.aje.a117498; Jaakkola JJK, 2002, J ALLERGY CLIN IMMUN, V109, P784, DOI 10.1067/mai.2002.123870; Jaakkola JJK, 2003, AM J EPIDEMIOL, V158, P981, DOI 10.1093/aje/kwg238; Jaakkola JJK, 2006, AM J EPIDEMIOL, V164, P742, DOI 10.1093/aje/kwj249; Jaakkola MS, 2007, ENVIRON HEALTH PERSP, V115, P1007, DOI 10.1289/ehp.9875; Jaakkola MS, 1999, AM J EPIDEMIOL, V150, P1223; Jaakkola MS, 2006, J ALLERGY CLIN IMMUN, V117, P642, DOI 10.1016/j.jaci.2005.11.003; Jaakkola MS, 2003, AM J PUBLIC HEALTH, V93, P2055, DOI 10.2105/AJPH.93.12.2055; Jaakkola MS, 2002, ENVIRON HEALTH PERSP, V110, P543, DOI 10.1289/ehp.02110543; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kraft M, 2000, CLIN CHEST MED, V21, P301, DOI 10.1016/S0272-5231(05)70268-9; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lemanske RF, 2002, PEDIAT ALLERG IMM-UK, V13, P38, DOI 10.1034/j.1399-3038.13.s.15.8.x; Moorman Jeanne E., 2011, Morbidity and Mortality Weekly Report, V60, P84; Nafstad P, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e38; Piipari R, 2004, EUR RESPIR J, V24, P734, DOI 10.1183/09031936.04.00116903; Sly PD, 2011, CURR OPIN ALLERGY CL, V11, P127, DOI 10.1097/ACI.0b013e32834487c6; VILJANEN AA, 1982, SCAND J CLIN LAB INV, V42, P5	30	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e27912	10.1371/journal.pone.0027912	http://dx.doi.org/10.1371/journal.pone.0027912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205932	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600005
J	Alais, D; Apthorp, D; Karmann, A; Cass, J				Alais, David; Apthorp, Deborah; Karmann, Anna; Cass, John			Temporal Integration of Movement: The Time-Course of Motion Streaks Revealed by Masking	PLOS ONE			English	Article							CROSS-ORIENTATION SUPPRESSION; INDUCED BLINDNESS; HUMAN-VISION; SUMMATION; BACKWARD; CAT; VISIBILITY; DYNAMICS	Temporal integration in the visual system causes fast-moving objects to leave oriented 'motion streaks' in their wake, which could be used to facilitate motion direction perception. Temporal integration is thought to occur over similar to 100 ms in early cortex, although this has never been tested for motion streaks. Here we compare the ability of fast-moving ('streaky') and slow-moving fields of dots to mask briefly flashed gratings either parallel or orthogonal to the motion trajectory. Gratings were presented at various asynchronies relative to motion onset (from -200 to +700 ms) to sample the time-course of the accumulating streaks. Predictions were that masking would be strongest for the fast parallel condition, and would be weak at early asynchronies and strengthen over time as integration rendered the translating dots more streaky and grating-like. The asynchrony where the masking function reached a plateau would correspond to the temporal integration period. As expected, fast-moving dots caused greater masking of parallel gratings than orthogonal gratings, and slow motion produced only modest masking of either grating orientation. Masking strength in the fast, parallel condition increased with time and reached a plateau after 77 ms, providing an estimate of the temporal integration period for mechanisms encoding motion streaks. Interestingly, the greater masking by fast motion of parallel compared with orthogonal gratings first reached significance at 48 ms before motion onset, indicating an effect of backward masking by motion streaks.	[Alais, David; Apthorp, Deborah] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Karmann, Anna] Univ Regensburg, Regensburg, Germany; [Cass, John] Univ Western Sydney, Sch Psychol, Sydney, NSW, Australia	University of Sydney; University of Regensburg; Western Sydney University	Alais, D (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	deborah.apthorp@sydney.edu.au	Apthorp, Deborah/N-5623-2014; Cass, John/AAC-7505-2021	Apthorp, Deborah/0000-0001-5785-024X; 	Australian Research Council [DP0774697, DP0878371]	Australian Research Council(Australian Research Council)	Author John Cass was supported by a Discovery Project (DP0774697) awarded by the Australian Research Council. Author David Alais was supported by a Discovery Project (DP0878371) awarded by the Australian Research Council. Author Anna Karmann's visit to Australia was supported by Universitat Regensburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JD, 2001, VISUAL NEUROSCI, V18, P941, DOI 10.1017/S0952523801186116; ANDERSON SJ, 1985, VISION RES, V25, P1147, DOI 10.1016/0042-6989(85)90104-X; Apthorp D, 2009, J VISION, V9, P101; Apthorp D, 2009, J VISION, V9, P271; Apthorp D, 2011, J VISION, V11, DOI 10.1167/11.7.17; Apthorp D, 2010, J VISION, V10, DOI 10.1167/10.10.11; Badcock David R, 2009, Vision Res, V49, P407, DOI 10.1016/j.visres.2008.11.009; BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; Bloch A.-M., 1885, CR HEBD ACAD SCI, V37, P493; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breitmeyer B., 2006, OXFORD PSYCHOL SERIE; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; Bridgeman B, 1998, DURATIONS STIMULI DI; BURBECK CA, 1981, J OPT SOC AM, V71, P1335, DOI 10.1364/JOSA.71.001335; BURR D, 1980, NATURE, V284, P164, DOI 10.1038/284164a0; BURR DC, 1981, PROC R SOC SER B-BIO, V211, P321, DOI 10.1098/rspb.1981.0010; Burr DC, 2002, J NEUROSCI, V22, P8661; BURR DC, 1993, J OPT SOC AM A, V10, P1706, DOI 10.1364/JOSAA.10.001706; Cass J, 2009, J VISION, V9, P121; Cass J, 2006, VISION RES, V46, P2859, DOI 10.1016/j.visres.2006.02.015; Cass J, 2009, J VISION, V9, DOI 10.1167/9.12.17; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Dickinson JE, 2010, J VISION, V10, P201; Francis G, 1997, PSYCHOL REV, V104, P572, DOI 10.1037/0033-295X.104.3.572; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; Geisler WS, 2001, VISUAL NEUROSCI, V18, P501, DOI 10.1017/S0952523801184014; Geremek A, 2008, PERCEPTION, V37, P740, DOI 10.1068/p5947; Graham CH, 1935, AM J PHYSIOL, V113, P299, DOI 10.1152/ajplegacy.1935.113.2.299; HESS RF, 1992, VISION RES, V32, P47, DOI 10.1016/0042-6989(92)90112-V; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; Kanai R, 2005, VISION RES, V45, P3109, DOI 10.1016/j.visres.2005.05.014; Krekelberg B, 2005, J NEUROPHYSIOL, V94, P4373, DOI 10.1152/jn.00690.2005; KULIKOWSKI JJ, 1973, J PHYSIOL-LONDON, V232, P149, DOI 10.1113/jphysiol.1973.sp010261; LEGGE GE, 1978, VISION RES, V18, P69, DOI 10.1016/0042-6989(78)90079-2; Li BW, 2006, J NEUROPHYSIOL, V96, P1755, DOI 10.1152/jn.00425.2006; Macknik SL, 2000, P NATL ACAD SCI USA, V97, P7556, DOI 10.1073/pnas.110142097; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Macknik Stephen L, 2008, Adv Cogn Psychol, V3, P125, DOI 10.2478/v10053-008-0020-5; Manahilov V, 2003, VISION RES, V43, P1855, DOI 10.1016/S0042-6989(03)00275-X; Meese TS, 2007, P ROY SOC B-BIOL SCI, V274, P127, DOI 10.1098/rspb.2006.3697; Meese TS, 2010, J VISION, V10, P91; Motoyoshi I, 2010, J VISION, V10, P161; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Roach NW, 2009, J NEUROPHYSIOL, V102, P3619, DOI 10.1152/jn.00548.2009; ROGOWITZ BE, 1983, VISION RES, V23, P1057, DOI 10.1016/0042-6989(83)90017-2; Ross J, 2000, CURR BIOL, V10, P679, DOI 10.1016/S0960-9822(00)00524-8; ROUFS JAJ, 1972, VISION RES, V12, P261, DOI 10.1016/0042-6989(72)90117-4; Saarela TP, 2008, J VISION, V8, DOI 10.1167/8.3.23; SNOWDEN RJ, 1991, VISION RES, V31, P907, DOI 10.1016/0042-6989(91)90156-Y; Wallis TSA, 2009, CURR BIOL, V19, P325, DOI 10.1016/j.cub.2008.12.053; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6	54	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28675	10.1371/journal.pone.0028675	http://dx.doi.org/10.1371/journal.pone.0028675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205961	Green Published, gold, Green Submitted			2022-12-25	WOS:000298666200009
J	Alonso-Perez, E; Suarez-Gestal, M; Calaza, M; Witte, T; Papasteriades, C; Marchini, M; Migliaresi, S; Kovacs, A; Ordi-Ros, J; Bijl, M; Santos, MJ; Ruzickova, S; Pullmann, R; Carreira, P; Skopouli, FN; D'Alfonso, S; Sebastiani, GD; Suarez, A; Blanco, FJ; Gomez-Reino, JJ; Gonzalez, A				Alonso-Perez, Elisa; Suarez-Gestal, Marian; Calaza, Manuel; Witte, Torsten; Papasteriades, Chryssa; Marchini, Maurizio; Migliaresi, Sergio; Kovacs, Attila; Ordi-Ros, Josep; Bijl, Marc; Santos, Maria Jose; Ruzickova, Sarka; Pullmann, Rudolf; Carreira, Patricia; Skopouli, Fotini N.; D'Alfonso, Sandra; Sebastiani, Gian Domenico; Suarez, Ana; Blanco, Francisco J.; Gomez-Reino, Juan J.; Gonzalez, Antonio		European Consortium SLE DNA	Association of Systemic Lupus Erythematosus Clinical Features with European Population Genetic Substructure	PLOS ONE			English	Article							MULTIETHNIC COHORT; ETHNIC-GROUPS; RNA HELICASE; AUTOANTIBODIES; SUSCEPTIBILITY; ANTIBODIES; ANCESTRY; LUMINA; RISK; SLE	Systemic Lupus Erythematosus (SLE) is an autoimmune disease with a very varied spectrum of clinical manifestations that could be partly determined by genetic factors. We aimed to determine the relationship between prevalence of 11 clinical features and age of disease onset with European population genetic substructure. Data from 1413 patients of European ancestry recruited in nine countries was tested for association with genotypes of top ancestry informative markers. This analysis was done with logistic regression between phenotypes and genotypes or principal components extracted from them. We used a genetic additive model and adjusted for gender and disease duration. Three clinical features showed association with ancestry informative markers: autoantibody production defined as immunologic disorder (P = 6.8x10(-4)), oral ulcers (P = 6.9x10(-4)) and photosensitivity (P = 0.002). Immunologic disorder was associated with genotypes more common in Southern European ancestries, whereas the opposite trend was observed for photosensitivity. Oral ulcers were specifically more common in patients of Spanish and Portuguese self-reported ancestry. These results should be taken into account in future research and suggest new hypotheses and possible underlying mechanisms to be investigated. A first hypothesis linking photosensitivity with variation in skin pigmentation is suggested.	[Alonso-Perez, Elisa; Suarez-Gestal, Marian; Calaza, Manuel; Gomez-Reino, Juan J.; Gonzalez, Antonio] Univ Santiago, Lab Invest, Inst Invest Sanitaria, Hosp Clin Santiago de Compostela, Santiago De Compostela, Spain; [Witte, Torsten] Hannover Med Sch, Dept Internal Med, Div Clin Immunol & Rheumatol, D-3000 Hannover, Germany; [Papasteriades, Chryssa] Evangelismos Med Ctr, Dept Histocompatibil & Immunol, Athens, Greece; [Marchini, Maurizio] Univ Milan, Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Milan, Italy; [Migliaresi, Sergio] Univ Naples 2, Rheumatol Unit, Naples, Italy; [Kovacs, Attila] Hosp Hungarian Railways, Dept Rheumatol, Szolnok, Hungary; [Ordi-Ros, Josep] Hosp Valle De Hebron, Internal Med Res Lab Autoimmune Dis, Barcelona, Spain; [Bijl, Marc] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 AV Groningen, Netherlands; [Santos, Maria Jose] Inst Mol Med, Rheumatol Res Unit, Lisbon, Portugal; [Santos, Maria Jose] Hosp Garcia de Orta, Dept Rheumatol, Lisbon, Portugal; [Ruzickova, Sarka] Acad Sci Czech Republic, Inst Biotechnol, Prague, Czech Republic; [Pullmann, Rudolf] Martin Fac Hosp, Jessenius Med Fac, Inst Clin Biochem, Martin, Slovakia; [Carreira, Patricia] Hosp 12 Octubre, Dept Rheumatol, E-28041 Madrid, Spain; [Skopouli, Fotini N.] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece; [D'Alfonso, Sandra] Eastern Piedmont Univ, Dept Med Sci, Novara, Italy; [D'Alfonso, Sandra] Eastern Piedmont Univ, IRCAD, Novara, Italy; [Sebastiani, Gian Domenico] Osped S Camillo Forlanini, Unita Operat Complessa Reumatol, Rome, Italy; [Suarez, Ana] Univ Oviedo, Dept Funct Biol, Oviedo, Spain; [Blanco, Francisco J.] Complejo Hosp Univ A Coruna, Serv Reumatol, Lab Invest Osteoarticular & Envejecimiento, La Coruna, Spain; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Hannover Medical School; Evangelismos Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Universita della Campania Vanvitelli; Hospital Universitari Vall d'Hebron; University of Groningen; Universidade de Lisboa; Hospital Garcia de Orta; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Comenius University Bratislava; Hospital Universitario 12 de Octubre; Athens Medical School; National & Kapodistrian University of Athens; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera San Camillo-Forlanini; University of Oviedo; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Universidade de Santiago de Compostela	Alonso-Perez, E (corresponding author), Univ Santiago, Lab Invest, Inst Invest Sanitaria, Hosp Clin Santiago de Compostela, Santiago De Compostela, Spain.	antonio.gonzalez.martinez-pedrayo@sergas.es	Blanco, Francisco J./C-3192-2014; Rego-Pérez, Ignacio/B-1665-2012; Santos, Maria Jose/N-6913-2014; Witte, Torsten/B-5783-2016; Suarez, Ana/F-4492-2015; Carreira, Patricia E/D-4429-2018; Gomez-Reino, Juan/ABI-2853-2020; Gonzalez, Antonio/C-4444-2008; D'Alfonso, Sandra/K-7295-2014	Blanco, Francisco J./0000-0001-9821-7635; Rego-Pérez, Ignacio/0000-0003-1754-1164; Santos, Maria Jose/0000-0002-7946-1365; Suarez, Ana/0000-0002-4452-7539; Carreira, Patricia E/0000-0001-8279-3806; Gonzalez, Antonio/0000-0002-2624-0606; D'Alfonso, Sandra/0000-0002-3983-9925; Sebastiani, Gian Domenico/0000-0003-2969-6649; Calaza Cabanas, Manuel/0000-0003-3082-525X; Rapa, Anna/0000-0002-5523-5224; Gomez-Reino, Juan/0000-0001-5229-6294	Instituto de Salud Carlos III [[06/0620, 08/0744]; RETICS [RD08/0075 (RIER)]; European Union; Xunta de Galicia; Spanish Ministry of Education;  [DFG WI 1031/6-1]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); RETICS; European Union(European Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish Ministry of Education(Spanish Government); 	This work was supported by the Instituto de Salud Carlos III (grants [06/0620, 08/0744),by the RETICS Program (RD08/0075 (RIER)) which is partially financed by the European Regional Development Fund program of the European Union, and by grants from the Xunta de Galicia and by (DFG WI 1031/6-1) awarded to TW. EA-P is the recipient of a pre-doctoral bursary of the Instituto de Salud Carlos III. MS-G is the recipient of a FPU pre-doctoral bursary of the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon GS, 2006, ANN RHEUM DIS, V65, P1168, DOI 10.1136/ard.200X.046896; Alarcon GS, 2006, LUPUS, V15, P26, DOI 10.1191/0961203306lu2260oa; Arnett FC, 1996, ARTHRITIS RHEUM, V39, P1833, DOI 10.1002/art.1780391109; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Cervera R, 2006, AUTOIMMUN REV, V5, P180, DOI 10.1016/j.autrev.2005.06.004; Chung SA, 2009, ARTHRITIS RHEUM-US, V60, P2448, DOI 10.1002/art.24707; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Ferreiros-Vidal I, 2007, GENES IMMUN, V8, P138, DOI 10.1038/sj.gene.6364370; Ferreiros-Vidal I, 2004, ARTHRITIS RHEUM-US, V50, P2590, DOI 10.1002/art.20436; Galeazzi M, 2000, LUPUS, V9, P47, DOI 10.1177/096120330000900109; Garcia CO, 1996, LUPUS, V5, P602, DOI 10.1177/096120339600500608; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Nan HM, 2009, INT J CANCER, V125, P909, DOI 10.1002/ijc.24327; Richman IB, 2010, GENES IMMUN, V11, P515, DOI 10.1038/gene.2009.80; Santos MJ, 2007, ACTA REUMATOL PORT, V32, P153; Seldin MF, 2008, GENES IMMUN, V9, P389, DOI 10.1038/gene.2008.25; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Sestak AL, 2008, LUPUS, V17, P1004, DOI 10.1177/0961203308091969; Smikle M F, 1996, J Assoc Acad Minor Phys, V7, P53; Suarez-Gestal M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2698; SUTEJ PG, 1989, BRIT J RHEUMATOL, V28, P321; Taylor KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001311; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Tikly M, 1996, CLIN RHEUMATOL, V15, P261, DOI 10.1007/BF02229704; Tikly M, 2008, BEST PRACT RES CL RH, V22, P643, DOI 10.1016/j.berh.2008.05.003; To CH, 2005, ARTHRITIS RHEUM-US, V52, P4003, DOI 10.1002/art.21414; Vazquez-Del Mercado M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2905; Wallace D, 2007, DUBOIS LUPUS ERYTHEM, V7th; Yamasaki Y, 2007, ARTHRITIS RHEUM-US, V56, P596, DOI 10.1002/art.22329; 2006, REUMATOL CLIN, V2, P131	35	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29033	10.1371/journal.pone.0029033	http://dx.doi.org/10.1371/journal.pone.0029033			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194982	Green Published, gold			2022-12-25	WOS:000298369100145
J	Fontaine, A; Pascual, A; Orlandi-Pradines, E; Diouf, I; Remoue, F; Pages, F; Fusai, T; Rogier, C; Almeras, L				Fontaine, Albin; Pascual, Aurelie; Orlandi-Pradines, Eve; Diouf, Ibrahima; Remoue, Franck; Pages, Frederic; Fusai, Thierry; Rogier, Christophe; Almeras, Lionel			Relationship between Exposure to Vector Bites and Antibody Responses to Mosquito Salivary Gland Extracts	PLOS ONE			English	Article							WEST-NILE-VIRUS; ANOPHELES-GAMBIAE; CULEX-PIPIENS; AEDES-AEGYPTI; PLASMODIUM-FALCIPARUM; POTENTIAL MALARIA; EQUATORIAL-GUINEA; TRANSMISSION; PROTEINS; ANTIGENS	Mosquito-borne diseases are major health problems worldwide. Serological responses to mosquito saliva proteins may be useful in estimating individual exposure to bites from mosquitoes transmitting these diseases. However, the relationships between the levels of these IgG responses and mosquito density as well as IgG response specificity at the genus and/or species level need to be clarified prior to develop new immunological markers to assess human/vector contact. To this end, a kinetic study of antibody levels against several mosquito salivary gland extracts from southeastern French individuals living in three areas with distinct ecological environments and, by implication, distinct Aedes caspius mosquito densities were compared using ELISA. A positive association was observed between the average levels of IgG responses against Ae. caspius salivary gland extracts and spatial Ae. caspius densities. Additionally, the average level of IgG responses increased significantly during the peak exposure to Ae. caspius at each site and returned to baseline four months later, suggesting short-lived IgG responses. The species-specificity of IgG antibody responses was determined by testing antibody responses to salivary gland extracts from Cx. pipiens, a mosquito that is present at these three sites at different density levels, and from two other Aedes species not present in the study area (Ae. aegypti and Ae. albopictus). The IgG responses observed against these mosquito salivary gland extracts contrasted with those observed against Ae. caspius salivary gland extracts, supporting the existence of species-specific serological responses. By considering different populations and densities of mosquitoes linked to environmental factors, this study shows, for the first time, that specific IgG antibody responses against Ae. caspius salivary gland extracts may be related to the seasonal and geographical variations in Ae. caspius density. Characterisation of such immunological-markers may allow the evaluation of the effectiveness of vector-control strategies or estimation of the risk of vector-borne disease transmission.	[Fontaine, Albin; Pascual, Aurelie; Diouf, Ibrahima; Fusai, Thierry; Rogier, Christophe; Almeras, Lionel] Antenne Marseille Inst Rech Biomed Armees IRBA, Unite Parasitol, Marseille, France; [Orlandi-Pradines, Eve; Pages, Frederic] Antenne Marseille Inst Rech Biomed Armees IRBA, Unite Entomol Med, Marseille, France; [Remoue, Franck] IRD, Montpellier, France; [Rogier, Christophe] Inst Pasteur Madagascar, Antananarivo, Madagascar	Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Fontaine, A (corresponding author), Antenne Marseille Inst Rech Biomed Armees IRBA, Unite Parasitol, Marseille, France.	almerasl@imtssa.fr	ROGIER, Christophe/C-2550-2008; Fontaine, Albin/K-4345-2019	Fontaine, Albin/0000-0001-6869-6516; ALMERAS, Lionel/0000-0003-0490-5774	French Armed Forces Medical Service; Delegation Generale pour l'Armement (DGA) [07CO406, 10CO401]	French Armed Forces Medical Service; Delegation Generale pour l'Armement (DGA)	This study was supported by the French Armed Forces Medical Service and the Delegation Generale pour l'Armement (DGA, SALIVAPULS project, Grant 07CO406 and ARTHROSER project, Grant 10CO401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeras L, 2004, PROTEOMICS, V4, P2184, DOI 10.1002/pmic.200300732; Almeras L, 2010, VECTOR-BORNE ZOONOT, V10, P391, DOI 10.1089/vbz.2009.0042; Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251; Balenghien T, 2006, J MED ENTOMOL, V43, P936, DOI 10.1603/0022-2585(2006)43[936:HBAHBA]2.0.CO;2; Balenghien T, 2010, B ENTOMOL RES, V100, P247, DOI 10.1017/S0007485309990745; Bellini R, 1997, J AM MOSQUITO CONTR, V13, P356; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Billingsley PF, 2006, PARASITE IMMUNOL, V28, P143, DOI 10.1111/j.1365-3024.2006.00805.x; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; BrummerKorvenkontio H, 1997, INT ARCH ALLERGY IMM, V112, P169, DOI 10.1159/000237450; Byrne K, 1999, HEREDITY, V82, P7, DOI 10.1038/sj.hdy.6884120; Campbell GL, 2001, ANN NY ACAD SCI, V951, P94; Cancrini G, 2006, J MED ENTOMOL, V43, P574, DOI 10.1603/0022-2585(2006)43[574:NVODIR]2.0.CO;2; Cano J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-21; Cano J, 2004, J MED ENTOMOL, V41, P158, DOI 10.1603/0022-2585-41.2.158; Chastel C, 2009, B ACAD NAT MED PARIS, V193, P485, DOI 10.1016/S0001-4079(19)32598-1; Chevalier V, 2010, EUROSURVEILLANCE, V15, P18; Chevillon C, 1998, MOL ECOL, V7, P197, DOI 10.1046/j.1365-294x.1998.00338.x; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684; EID, 2011, HIST VEILL SURV AED; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-33; Fontaine A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-276; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Kurkela S, 2005, J INFECT DIS, V191, P1820, DOI 10.1086/430007; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Mihalyi F, 1965, WHO VECTOR CONTROL, V25, P33; MOUCHET J, 1970, ANN I PASTEUR PARIS, V118, P839; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; Mussi ADH, 2007, ACTA TROP, V104, P108, DOI 10.1016/j.actatropica.2007.07.011; Nascimento RJ, 2001, AM J TROP MED HYG, V65, P219, DOI 10.4269/ajtmh.2001.65.219; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Orlandi-Pradines E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-171; Palosuo K, 1997, INT ARCH ALLERGY IMM, V114, P367, DOI 10.1159/000237696; Peng ZK, 2002, J ALLERGY CLIN IMMUN, V110, P816, DOI 10.1067/mai.2002.128736; PENNEYS NS, 1988, J AM ACAD DERMATOL, V18, P87, DOI 10.1016/S0190-9622(88)70013-4; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poncon N, 2007, EMERG INFECT DIS, V13, P1810, DOI 10.3201/eid1312.070730; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Rageau J., 1967, CAH ORSTOM EM, V5, P263; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; RIOUX JA, 1968, MOSQ NEWS, V28, P572; Rizzo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017980; Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4; Schafer ML, 2006, WETLANDS, V26, P57, DOI 10.1672/0277-5212(2006)26[57:IOLSOM]2.0.CO;2; SCHWARTZ BS, 1991, AM J EPIDEMIOL, V134, P86, DOI 10.1093/oxfordjournals.aje.a115996; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Shaukat AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-122; Teixeira C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000638; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; Trevejo RT, 2005, J AM MOSQUITO CONTR, V21, P39, DOI 10.2987/8756-971X(2005)21[39:DOCATM]2.0.CO;2; Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009; Vinogradova Elena B., 2003, Acta Societatis Zoologicae Bohemicae, V67, P41; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626; WHEELER CM, 1991, J PARASITOL, V77, P965, DOI 10.2307/3282751	65	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29107	10.1371/journal.pone.0029107	http://dx.doi.org/10.1371/journal.pone.0029107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195000	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100156
J	Park, JH; Kwon, JY				Park, Jeong-Ho; Kwon, Jae Young			Heterogeneous Expression of Drosophila Gustatory Receptors in Enteroendocrine Cells	PLOS ONE			English	Article							VERTEBRATE TACHYKININ FAMILY; CANDIDATE TASTE RECEPTORS; STEM-CELLS; INSECT NEUROPEPTIDES; GLUCOSE-ABSORPTION; CAFFEINE RESPONSE; GENE-EXPRESSION; BITTER TASTE; MIDGUT; SYSTEM	The gastrointestinal tract is emerging as a major site of chemosensation in mammalian studies. Enteroendocrine cells are chemosensory cells in the gut which produce regulatory peptides in response to luminal contents to regulate gut physiology, food intake, and glucose homeostasis, among other possible functions. Increasing evidence shows that mammalian taste receptors and taste signaling molecules are expressed in enteroendocrine cells in the gut. Invertebrate models such as Drosophila can provide a simple and genetically tractable system to study the chemosensory functions of enteroendocrine cells in vivo. To establish Drosophila enteroendocrine cells as a model for studying gut chemosensation, we used the GAL4/UAS system to examine the expression of all 68 Gustatory receptors (Grs) in the intestine. We find that 12 Gr-GAL4 drivers label subsets of enteroendocrine cells in the midgut, and examine colocalization of these drivers with the regulatory peptides neuropeptide F (NPF), locustatachykinin (LTK), and diuretic hormone 31 (DH31). RT-PCR analysis provides additional evidence for the presence of Gr transcripts in the gut. Our results suggest that the Drosophila Grs have chemosensory roles in the intestine to regulate physiological functions such as food uptake, nutrient absorption, or sugar homeostasis.	[Park, Jeong-Ho; Kwon, Jae Young] Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU)	Park, JH (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea.	jykwon@skku.edu			Sungkyunkwan University	Sungkyunkwan University	This research was supported by the Faculty Research Fund, Sungkyunkwan University (2008) to JYK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAND AH, 1993, DEVELOPMENT, V118, P401; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chen MC, 2006, AM J PHYSIOL-CELL PH, V291, pC726, DOI 10.1152/ajpcell.00003.2006; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Dubreuil RR, 2004, INT J BIOCHEM CELL B, V36, P745, DOI 10.1016/j.biocel.2003.07.004; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Dyer J, 2007, BIOCHEM SOC T, V35, P1191, DOI 10.1042/BST0351191; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Hartenstein V, 2010, GEN COMP ENDOCR, V166, P462, DOI 10.1016/j.ygcen.2009.12.002; Isono K, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00020; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kokrashvili Z, 2009, AM J CLIN NUTR, V90, p822S, DOI 10.3945/ajcn.2009.27462T; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Kwon JY, 2011, J NEUROSCI, V31, P15300, DOI 10.1523/JNEUROSCI.3363-11.2011; LaJeunesse Dennis R., 2010, BMC Physiology, V10, P14, DOI 10.1186/1472-6793-10-14; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Park JH, 2011, MOL CELLS, V32, P375, DOI 10.1007/s10059-011-0128-1; Raybould HE, 2010, AUTON NEUROSCI-BASIC, V153, P41, DOI 10.1016/j.autneu.2009.07.007; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; SCHOOFS L, 1990, FEBS LETT, V261, P397, DOI 10.1016/0014-5793(90)80601-E; SCHOOFS L, 1990, REGUL PEPTIDES, V31, P199, DOI 10.1016/0167-0115(90)90006-I; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Skaer Helen, 1993, P941; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Stainier DYR, 2005, SCIENCE, V307, P1902, DOI 10.1126/science.1108709; STEINERT RE, 2011, PHYSL BEHAV IN PRESS; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576	47	65	67	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29022	10.1371/journal.pone.0029022	http://dx.doi.org/10.1371/journal.pone.0029022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194978	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100142
J	Wu, J; Xia, J; Lei, W; Wang, BP				Wu, Jun; Xia, Jun; Lei, Wei; Wang, Baoping			Facile Synthesis of Three-Dimensional ZnO Nanostructure: Realization of a Multifunctional Stable Superhydrophobic Surface	PLOS ONE			English	Article							FILMS; FABRICATE	Background: After comprehensive study of various superhydrophobic phenomena in nature, it is no longer a puzzle for researchers to realize such fetching surfaces. However, the different types of artificial surfaces may get wetted and lose its water repellence if there exist defects or the liquid is under pressure. With respect to the industry applications, in which the resistance of wetting transition is critical important, new nanostructure satisfied a certain geometric criterion should be designed to hold a stable gas film at the base area to avoid the wet transition. Methodology: A thermal deposition method was utilized to produce a thin ZnO seeds membrane on the aluminum foil. And then a chemical self-assemble technology was developed in present work to fabricate three-dimensional (3D) hierarchical dune-like ZnO architecture based on the prepared seeds membrane. Results: Hierarchical ZnO with micro scale dune-like structure and core-sharing nanosheets was generated. The characterization results showed that there exist plenty of gaps and interfaces among the micro-dune and nanosheets, and thus the surface area was enlarged by such a unique morphology. Benefited from this unique 3D ZnO hierarchical nanostructure, the obtained surface exhibited stable water repellency after modification with Teflon, and furthermore, based on solid theory analysis, such 3D ZnO nanostructure would exhibit excellent sensing performance.	[Wu, Jun; Xia, Jun; Lei, Wei; Wang, Baoping] Southeast Univ, Sch Elect Sci & Engn, Nanjing, Peoples R China	Southeast University - China	Wu, J (corresponding author), Southeast Univ, Sch Elect Sci & Engn, Nanjing, Peoples R China.	xiajun@seu.edu.cn	Xia, Jun/A-1240-2011		National Basic Research Program of China [2010CB327705]	National Basic Research Program of China(National Basic Research Program of China)	This work is supported by the National Basic Research Program of China (2010CB327705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barona D, 2011, LAB CHIP, V11, P936, DOI [10.1039/c0lc00335b, 10.1039/c01c00335b]; Han JT, 2005, J PHYS CHEM B, V109, P20773, DOI 10.1021/jp052691x; Hikita M, 2005, LANGMUIR, V21, P7299, DOI 10.1021/la050901r; Huang L, 2005, J PHYS CHEM B, V109, P7746, DOI 10.1021/jp046549s; Korhonen JT, 2011, ACS APPL MATER INTER, V3, P1813, DOI 10.1021/am200475b; Lee C, 2009, LANGMUIR, V25, P12812, DOI 10.1021/la901824d; Li XH, 2006, POLYMER, V47, P506, DOI 10.1016/j.polymer.2005.08.097; Liu XH, 2011, J MATER CHEM, V21, P349, DOI 10.1039/c0jm01800g; Ma M, 2008, J ADHES SCI TECHNOL, V11, P193; Marmur A, 2006, SOFT MATTER, V2, P12, DOI 10.1039/b514811c; Mertaniemi H, 2011, ADV MATER, V23, P2911, DOI 10.1002/adma.201100461; Ming W, 2005, NANO LETT, V5, P2298, DOI 10.1021/nl0517363; Nakajima A, 2001, MONATSH CHEM, V132, P31, DOI 10.1007/s007060170142; Sarkar DK, 2008, MATER LETT, V62, P1226, DOI 10.1016/j.matlet.2007.08.051; Wang CH, 2006, SURF SCI, V600, pL38, DOI 10.1016/j.susc.2005.12.013; Wu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014475; Wu J, 2011, MATER LETT, V65, P477, DOI 10.1016/j.matlet.2010.10.029; Wu J, 2010, MATER LETT, V64, P1251, DOI 10.1016/j.matlet.2010.02.060; Wu J, 2010, PHYSICA E, V42, P1325, DOI 10.1016/j.physe.2009.10.063; Xu CX, 2004, APPL PHYS LETT, V85, P3878, DOI 10.1063/1.1811380; Zhang J, 2009, CRYST GROWTH DES, V9, P3532, DOI 10.1021/cg900269a; Zhang X, 2008, J MATER CHEM, V18, P621, DOI 10.1039/b711226b; Zhao J, 2006, J EUR CERAM SOC, V26, P3745, DOI 10.1016/j.jeurceramsoc.2006.01.006	23	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29047	10.1371/journal.pone.0029047	http://dx.doi.org/10.1371/journal.pone.0029047			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194987	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100149
J	Morris, M; Koyama, A; Masliah, E; Mucke, L				Morris, Meaghan; Koyama, Akihiko; Masliah, Eliezer; Mucke, Lennart			Tau Reduction Does Not Prevent Motor Deficits in Two Mouse Models of Parkinson's Disease	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PROTEIN-TAU; LEWY BODIES; MICE; DEMENTIA; PHOSPHORYLATION; FIBRILLIZATION; ASSOCIATION	Many neurodegenerative diseases are increasing in prevalence and cannot be prevented or cured. If they shared common pathogenic mechanisms, treatments targeting such mechanisms might be of benefit in multiple conditions. The tau protein has been implicated in the pathogenesis of diverse neurodegenerative disorders, including Alzheimer's disease (AD) and Parkinson's disease (PD). Tau reduction prevents cognitive deficits, behavioral abnormalities and other pathological changes in multiple AD mouse models. Here we examined whether tau reduction also prevents motor deficits and pathological alterations in two mouse models of PD, generated by unilateral striatal injection of 6-hydroxydopamine (6-OHDA) or transgene-mediated neuronal expression of human wildtype alpha-synuclein. Both models were evaluated on Tau(+/+), Tau(+/-) and Tau(-/-) backgrounds in a variety of motor tests. Tau reduction did not prevent motor deficits caused by 6-OHDA and slightly worsened one of them. Tau reduction also did not prevent 6-OHDA-induced loss of dopaminergic terminals in the striatum. Similarly, tau reduction did not prevent motor deficits in alpha-synuclein transgenic mice. Our results suggest that tau has distinct roles in the pathogeneses of AD and PD and that tau reduction may not be of benefit in the latter condition.	[Morris, Meaghan; Koyama, Akihiko; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Morris, Meaghan] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Biochem Cellular & Mol Biol Grad Program, Baltimore, MD 21205 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Mucke, Lennart] Univ Calif San Diego, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Johns Hopkins University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Morris, M (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	lmucke@gladstone.ucsf.edu		Morris, Meaghan/0000-0001-5340-148X	National Institutes of Health [AG011385, AG022074, NS065780, AG18440]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, R37AG018440, R01AG011385, R01AG018440, R37AG011385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG011385, AG022074 and NS065780 to LM and AG18440 to EM and by a gift from the S.D. Bechtel Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BOLLER F, 1980, ANN NEUROL, V7, P329, DOI 10.1002/ana.410070408; Dawson HN, 2001, J CELL SCI, V114, P1179; DITTER SM, 1987, NEUROLOGY, V37, P754, DOI 10.1212/WNL.37.5.754; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Elbaz A, 2011, ANN NEUROL, V69, P778, DOI 10.1002/ana.22321; Fernagut PO, 2007, SYNAPSE, V61, P991, DOI 10.1002/syn.20456; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fleming SM, 2006, NEUROSCIENCE, V142, P1245, DOI 10.1016/j.neuroscience.2006.07.005; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gittis AH, 2011, NEURON, V71, P858, DOI 10.1016/j.neuron.2011.06.035; Golbe LI, 2001, MOVEMENT DISORD, V16, P442, DOI 10.1002/mds.1087; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guyenet S.J., 2010, J VIS EXP; Haggerty T, 2011, EUR J NEUROSCI, V33, P1598, DOI 10.1111/j.1460-9568.2011.07660.x; HAKIM AM, 1979, NEUROLOGY, V29, P1209, DOI 10.1212/WNL.29.9_Part_1.1209; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; HOFMAN A, 1989, NEUROLOGY, V39, P1589, DOI 10.1212/WNL.39.12.1589; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEVERENZ J, 1986, ARCH NEUROL-CHICAGO, V43, P662, DOI 10.1001/archneur.1986.00520070020010; LIEBERMAN A, 1979, ANN NEUROL, V6, P355, DOI 10.1002/ana.410060409; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Martin ER, 2001, JAMA-J AM MED ASSOC, V286, P2245, DOI 10.1001/jama.286.18.2245; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; MAYEUX R, 1988, ARCH NEUROL-CHICAGO, V45, P260, DOI 10.1001/archneur.1988.00520270034017; Mikolaenko I, 2005, J NEUROPATH EXP NEUR, V64, P156, DOI 10.1093/jnen/64.2.156; Pastor P, 2000, ANN NEUROL, V47, P242; PEARCE J, 1974, EUR NEUROL, V12, P94, DOI 10.1159/000114608; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Wills J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017953; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040	52	37	37	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29257	10.1371/journal.pone.0029257	http://dx.doi.org/10.1371/journal.pone.0029257			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206005	Green Published, gold, Green Submitted			2022-12-25	WOS:000298665600032
J	Rivers, J; Hughes, C; McKenna, T; Woolerton, Y; Vissers, JPC; Langridge, JI; Beynon, RJ				Rivers, Jenny; Hughes, Chris; McKenna, Therese; Woolerton, Yvonne; Vissers, Johannes P. C.; Langridge, James I.; Beynon, Robert J.			Asymmetric Proteome Equalization of the Skeletal Muscle Proteome Using a Combinatorial Hexapeptide Library	PLOS ONE			English	Article							PEPTIDE LIGAND LIBRARIES; MULTIPLEXED ABSOLUTE QUANTIFICATION; CONCATENATED SIGNATURE PEPTIDES; HIGH-ABUNDANCE PROTEINS; HUMAN PLASMA PROTEOME; IN-DEPTH EXPLORATION; QUANTITATIVE-ANALYSIS; CEREBROSPINAL-FLUID; CONCENTRATION RANGE; EXPRESSION	Immobilized combinatorial peptide libraries have been advocated as a strategy for equalization of the dynamic range of a typical proteome. The technology has been applied predominantly to blood plasma and other biological fluids such as urine, but has not been used extensively to address the issue of dynamic range in tissue samples. Here, we have applied the combinatorial library approach to the equalization of a tissue where there is also a dramatic asymmetry in the range of abundances of proteins; namely, the soluble fraction of skeletal muscle. We have applied QconCAT and label-free methodology to the quantification of the proteins that bind to the beads as the loading is progressively increased. Although some equalization is achieved, and the most abundant proteins no longer dominate the proteome analysis, at high protein loadings a new asymmetry of protein expression is reached, consistent with the formation of complex assembles of heat shock proteins, cytoskeletal elements and other proteins on the beads. Loading at different ionic strength values leads to capture of different subpopulations of proteins, but does not completely eliminate the bias in protein accumulation. These assemblies may impair the broader utility of combinatorial library approaches to the equalization of tissue proteomes. However, the asymmetry in equalization is manifest at either low and high ionic strength values but manipulation of the solvent conditions may extend the capacity of the method.	[Rivers, Jenny; Woolerton, Yvonne; Beynon, Robert J.] Univ Liverpool, Prot Funct Grp, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Hughes, Chris; McKenna, Therese; Vissers, Johannes P. C.; Langridge, James I.] Waters Corp MS Technol Ctr, Manchester, Lancs, England	University of Liverpool; Waters Corporation	Rivers, J (corresponding author), Univ Liverpool, Prot Funct Grp, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	r.beynon@liv.ac.uk	Beynon, Robert J/K-1408-2014	Beynon, Robert J/0000-0003-0857-495X	Genus plc; University of Liverpool; Biotechnology and Biological Sciences Research Council (BBSRC) [IIP/1008/001]; BBSRC/Genus plc; BBSRC/Waters plc; Genus	Genus plc; University of Liverpool; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC/Genus plc(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC/Waters plc(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Genus	This work has been supported in part by a Knowledge Transfer Partnership Fellowship between Genus plc and the University of Liverpool awarded to RJB/JR, a Biotechnology and Biological Sciences Research Council (BBSRC) Industrial Interchange Award (IIP/1008/001) to RJB and JIL, a BBSRC/Genus plc Industrial Cooperative Award in Science and Engineering (CASE) Award to JR and a BBSRC/Waters plc Industrial CASE award to YW. Waters provided training and advice to RJB during a sabbatical period. Genus was the sponsor of a studentship to JR and supported her during her subsequent training fellowship. As authors JIL, CH and TM are employees of Waters Corp, the funders Waters Corp did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding for this study.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Beynon RJ, 2005, NAT METHODS, V2, P587, DOI 10.1038/NMETH774; Boschetti E, 2009, J CHROMATOGR A, V1216, P1215, DOI 10.1016/j.chroma.2008.11.098; Brownridge P, 2011, PROTEOMICS, V11, P2957, DOI 10.1002/pmic.201100039; Candiano G, 2009, ELECTROPHORESIS, V30, P2405, DOI 10.1002/elps.200800762; Capitanio D, 2009, PROTEOMICS, V9, P2004, DOI 10.1002/pmic.200701162; Castagna A, 2005, J PROTEOME RES, V4, P1917, DOI 10.1021/pr050153r; Cereda A, 2010, J PROTEOMICS, V73, P1732, DOI 10.1016/j.jprot.2010.05.010; D'Amato A, 2011, J PROTEOME RES, V10, P3789, DOI 10.1021/pr200266w; D'Amato A, 2009, J PROTEOME RES, V8, P3925, DOI 10.1021/pr900221x; Desrosiers RR, 2007, CELL BIOCHEM BIOPHYS, V49, P182, DOI 10.1007/s12013-007-0048-z; Doherty MK, 2005, PROTEOMICS, V5, P522, DOI 10.1002/pmic.200400959; Doherty MK, 2004, PROTEOMICS, V4, P2082, DOI 10.1002/pmic.200300716; Doran P, 2007, EUR J CELL BIOL, V86, P629, DOI 10.1016/j.ejcb.2007.07.003; Doran P, 2007, INT J MOL MED, V19, P547; Farinazzo A, 2009, J CHROMATOGR A, V1216, P1241, DOI 10.1016/j.chroma.2008.11.051; Fasoli E, 2011, J PROTEOMICS, V74, P127, DOI 10.1016/j.jprot.2010.10.009; Fasoli E, 2010, J PROTEOMICS, V73, P733, DOI 10.1016/j.jprot.2009.10.008; Fasoli E, 2009, J PROTEOMICS, V72, P501, DOI 10.1016/j.jprot.2009.01.013; Gelfi C, 2011, J PROTEOMICS, V74, P774, DOI 10.1016/j.jprot.2011.02.028; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gronwall Caroline, 2007, Biotechnology Journal, V2, P1389, DOI 10.1002/biot.200700053; Guerrier L, 2006, J CHROMATOGR B, V833, P33, DOI 10.1016/j.jchromb.2005.12.048; Guerrier L, 2008, NAT PROTOC, V3, P883, DOI 10.1038/nprot.2008.59; Hughes MA, 2006, J PROTEOME RES, V5, P54, DOI 10.1021/pr050248t; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Liu T, 2006, MOL CELL PROTEOMICS, V5, P2167, DOI 10.1074/mcp.T600039-MCP200; Maughan DW, 2005, MOL CELL PROTEOMICS, V4, P1541, DOI 10.1074/mcp.M500053-MCP200; McLean L, 2007, PROTEOMICS, V7, P2667, DOI 10.1002/pmic.200601004; Mouton-Barbosa E, 2010, MOL CELL PROTEOMICS, V9, P1006, DOI 10.1074/mcp.M900513-MCP200; Plavina T, 2007, J PROTEOME RES, V6, P662, DOI 10.1021/pr060413k; Pratt JM, 2006, NAT PROTOC, V1, P1029, DOI 10.1038/nprot.2006.129; Ramstrom M, 2009, BIOTECHNOL APPL BIOC, V52, P159, DOI [10.1042/BA20080028, 10.1042/BA20080015]; Righetti PG, 2005, ELECTROPHORESIS, V26, P297, DOI 10.1002/elps.200406189; RIGHETTI PG, 2011, CURR PHARM BIOTECHNO; Righetti PG, 2007, FEBS J, V274, P897, DOI 10.1111/j.1742-4658.2007.05648.x; Righetti PG, 2006, PROTEOMICS, V6, P3980, DOI 10.1002/pmic.200500904; Righetti PG, 2010, EXPERT REV PROTEOMIC, V7, P373, DOI [10.1586/epr.10.25, 10.1586/EPR.10.25]; Righetti PG, 2010, J CHROMATOGR A, V1217, P893, DOI 10.1016/j.chroma.2009.08.070; Rivers J, 2007, MOL CELL PROTEOMICS, V6, P1416, DOI 10.1074/mcp.M600456-MCP200; Sennels L, 2007, J PROTEOME RES, V6, P4055, DOI 10.1021/pr070339l; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Zhang H, 2007, MOL CELL PROTEOMICS, V6, P64, DOI 10.1074/mcp.M600160-MCP200; Zolotarjova N, 2005, PROTEOMICS, V5, P3304, DOI 10.1002/pmic.200402021	48	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28902	10.1371/journal.pone.0028902	http://dx.doi.org/10.1371/journal.pone.0028902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205978	gold, Green Published, Green Submitted			2022-12-25	WOS:000298665600013
J	Rodley, CDM; Pai, DA; Mills, TA; Engelke, DR; O'Sullivan, JM				Rodley, Chris D. M.; Pai, Dave A.; Mills, Tyrone A.; Engelke, David R.; O'Sullivan, Justin M.			tRNA Gene Identity Affects Nuclear Positioning	PLOS ONE			English	Article							POLYMERASE-III; TRANSCRIPTION COMPLEXES; SACCHAROMYCES-CEREVISIAE; NUCLEOLAR LOCALIZATION; YEAST GENOME; CONDENSIN; RDNA; ASSOCIATION; INITIATION; CHROMATIN	The three-dimensional organization of genomes is dynamic and plays a critical role in the regulation of cellular development and phenotypes. Here we use proximity-based ligation methods (i.e. chromosome conformation capture [3C] and circularized chromosome confrmation capture [4C]) to explore the spatial organization of tRNA genes and their locus-specific interactions with the ribosomal DNA. Directed replacement of one lysine and two leucine tRNA loci shows that tRNA spatial organization depends on both tRNA coding sequence identity and the surrounding chromosomal loci. These observations support a model whereby the three-dimensional, spatial organization of tRNA loci within the nucleus utilizes tRNA gene-specific signals to affect local interactions, though broader organization of chromosomal regions are determined by factors outside the tRNA genes themselves.	[Rodley, Chris D. M.; Mills, Tyrone A.; O'Sullivan, Justin M.] Massey Univ, Inst Nat Sci, Auckland, New Zealand; [Pai, Dave A.; Engelke, David R.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Massey University; University of Michigan System; University of Michigan	Rodley, CDM (corresponding author), Massey Univ, Inst Nat Sci, Auckland, New Zealand.	j.m.osullivan@massey.ac.nz	O'Sullivan, Justin/HDO-1639-2022	O'Sullivan, Justin/0000-0003-2927-450X	Marsden Fund [MAU1004]; Auckland Medical Research Foundation; Massey University; Maurice & Phyllis Paykel Trust; HRC; National Institutes of Health [GM082875]; National Institutes of Health University of Michigan [T32 GM07544]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544, R01GM082875] Funding Source: NIH RePORTER	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Auckland Medical Research Foundation; Massey University; Maurice & Phyllis Paykel Trust; HRC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health University of Michigan(University of Michigan SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in JMO's laboratory is funded by the Marsden Fund (MAU1004), Auckland Medical Research Foundation, Massey University Research Fund and Maurice & Phyllis Paykel Trust. CDMR was funded by an HRC Ph.D. scholarship. DRE was funded by National Institutes of Health grant GM082875. DAP was funded by an National Institutes of Health University of Michigan Genetics Predoctoral Training Grant (T32 GM07544). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Ganley ARD, 2009, MOL CELL, V35, P683, DOI 10.1016/j.molcel.2009.07.012; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; IWASAKI O, 2010, GLOBAL GENOME ORG ME; Iwasaki O, 2010, MOL BIOL CELL, V21, P254, DOI 10.1091/mbc.E09-09-0790; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Kendall A, 2000, P NATL ACAD SCI USA, V97, P13108, DOI 10.1073/pnas.240454997; KURJAN J, 1980, CELL, V20, P701, DOI 10.1016/0092-8674(80)90316-5; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Machin F, 2004, CURR BIOL, V14, P125, DOI 10.1016/j.cub.2004.01.001; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; O'Sullivan JM, 2009, YEAST, V26, P125, DOI 10.1002/yea.1657; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Rodley CDM, 2009, FUNGAL GENET BIOL, V46, P879, DOI 10.1016/j.fgb.2009.07.006; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Tsang CK, 2007, EMBO J, V26, P448, DOI 10.1038/sj.emboj.7601488; Wang BD, 2008, PLASMID, V59, P45, DOI 10.1016/j.plasmid.2007.09.003; Wang L, 2005, J BIOL CHEM, V280, P8637, DOI 10.1074/jbc.C500017200	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29267	10.1371/journal.pone.0029267	http://dx.doi.org/10.1371/journal.pone.0029267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206006	gold, Green Published, Green Submitted			2022-12-25	WOS:000298665600033
J	Durgadoss, L; Nidadavolu, P; Valli, RK; Saeed, U; Mishra, M; Seth, P; Ravindranath, V				Durgadoss, Lalitha; Nidadavolu, Prakash; Valli, Rupanagudi Khader; Saeed, Uzma; Mishra, Mamata; Seth, Pankaj; Ravindranath, Vijayalakshmi			Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down-regulation of pAkt	FASEB JOURNAL			English	Article						protein thiol; glutaredoxin; thiol antioxidants; protein phosphatase 2A	PROTEIN-KINASE; OXIDATIVE STRESS; CELL-SURVIVAL; PARKINSONS-DISEASE; NEGATIVE REGULATOR; ACTIVATION; APOPTOSIS; DEATH; PHOSPHORYLATION; GLUTAREDOXIN	Impairment of Akt phosphorylation, a critical survival signal, has been implicated in the degeneration of dopaminergic neurons in Parkinson's disease. However, the mechanism underlying pAkt loss is unclear. In the current study, we demonstrate pAkt loss in ventral midbrain of mice treated with dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), when compared to ventral midbrain of control mice treated with vehicle alone. Thiol residues of the critical cysteines in Akt are oxidized to a greater degree in mice treated with MPTP, which is reflected as a 40% loss of reduced Akt. Association of oxidatively modified Akt with the phosphatase PP2A, which can lead to enhanced dephosphorylation of pAkt, was significantly stronger after MPTP treatment. Maintaining the protein thiol homeostasis by thiol antioxidants prevented loss of reduced Akt, decreased association with PP2A, and maintained pAkt levels. Overexpression of glutaredoxin, a protein disulfide oxidoreductase, in human primary neurons helped sustain reduced state of Akt and abolished MPP+-mediated pAkt loss. We demonstrate for the first time the selective loss of Akt activity, in vivo, due to oxidative modification of Akt and provide mechanistic insight into oxidative stress-induced down-regulation of cell survival pathway in mouse midbrain following exposure to MPTP.-Durgadoss, L., Nidadavolu, P., Khader Valli, R., Saeed, U., Mishra, M., Seth, P., Ravindranath, R. Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down-regulation of pAkt. FASEB J. 26, 1473-1483 (2012). www.fasebj.org	[Nidadavolu, Prakash; Ravindranath, Vijayalakshmi] Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India; [Durgadoss, Lalitha; Nidadavolu, Prakash; Valli, Rupanagudi Khader; Saeed, Uzma; Mishra, Mamata; Seth, Pankaj; Ravindranath, Vijayalakshmi] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Nainwal Mode, Manesar, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Ravindranath, V (corresponding author), Indian Inst Sci, Ctr Neurosci, CV Raman Ave, Bangalore 560012, Karnataka, India.	viji@cns.iisc.ernet.in	MISHRA, MAMATA/AAL-4321-2021	MISHRA, MAMATA/0000-0003-3797-7133; Seth, Pankaj/0000-0003-1021-7839	Department of Science and Technology, India; National Brain Research Centre (NBRC), India; Council of Scientific and Industrial Research, India	Department of Science and Technology, India(Department of Science & Technology (India)); National Brain Research Centre (NBRC), India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Science and Technology, India to V. R. and a core grant of the National Brain Research Centre (NBRC), India. L. D. was supported by the Council of Scientific and Industrial Research, India. The authors also thank Ms. Neha Sehgal and Mr. Ajit Ray for their help with some experiments.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bruhn MA, 2010, GROWTH FACTORS, V28, P394, DOI 10.3109/08977194.2010.518616; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Cheng HC, 2011, J NEUROSCI, V31, P2125, DOI 10.1523/JNEUROSCI.5519-10.2011; Chung CY, 2007, J NEUROSCI, V27, P8314, DOI 10.1523/JNEUROSCI.1972-07.2007; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; D'Astous M, 2006, MOL PHARMACOL, V69, P1492, DOI 10.1124/mol.105.018671; D'Astous M, 2005, NEUROENDOCRINOLOGY, V82, P111, DOI 10.1159/000091206; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Doo AR, 2010, J ETHNOPHARMACOL, V131, P433, DOI 10.1016/j.jep.2010.07.008; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com; Karunakaran S, 2008, J NEUROSCI, V28, P12500, DOI 10.1523/JNEUROSCI.4511-08.2008; Kenchappa RS, 2004, FASEB J, V18, P1102, DOI 10.1096/fj.03-1075fje; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Koh H, 2000, J BIOL CHEM, V275, P34451, DOI 10.1074/jbc.M001753200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Leak RK, 2006, J NEUROCHEM, V99, P1151, DOI 10.1111/j.1471-4159.2006.04149.x; Li M, 1998, METH MOL B, V93, P59; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Malagelada C, 2008, J NEUROSCI, V28, P14363, DOI 10.1523/JNEUROSCI.3928-08.2008; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Panigrahi M, 1996, BRAIN RES, V717, P184, DOI 10.1016/0006-8993(96)00009-1; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Quesada A, 2008, DEV NEUROBIOL, V68, P632, DOI 10.1002/dneu.20609; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Rodriguez-Blanco J, 2008, J NEUROCHEM, V107, P127, DOI 10.1111/j.1471-4159.2008.05588.x; Saeed U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002459; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schoenebeck B, 2005, MOL CELL NEUROSCI, V30, P249, DOI 10.1016/j.mcn.2005.07.017; SIM ATR, 1991, MOL NEUROBIOL, V5, P229, DOI 10.1007/BF02935548; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tasaki Y, 2010, BRAIN RES, V1344, P25, DOI 10.1016/j.brainres.2010.04.085; Timmons S, 2009, NEUROSCI LETT, V467, P30, DOI 10.1016/j.neulet.2009.09.055; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Urata Y, 2006, J BIOL CHEM, V281, P13092, DOI 10.1074/jbc.M601984200; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004; Zhang J, 2007, CELL SIGNAL, V19, P2194, DOI 10.1016/j.cellsig.2007.06.022	57	36	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1473	1483		10.1096/fj.11-194100	http://dx.doi.org/10.1096/fj.11-194100			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22198382				2022-12-25	WOS:000302359700010
J	Engel, T; Gomez-Villafuertes, R; Tanaka, K; Mesuret, G; Sanz-Rodriguez, A; Garcia-Huerta, P; Miras-Portugal, MT; Henshall, DC; Diaz-Hernandez, M				Engel, Tobias; Gomez-Villafuertes, Rosa; Tanaka, Katsuhiro; Mesuret, Guillaume; Sanz-Rodriguez, Amaya; Garcia-Huerta, Paula; Teresa Miras-Portugal, M.; Henshall, David C.; Diaz-Hernandez, Miguel			Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice	FASEB JOURNAL			English	Article						anticonvulsant; ATP; pharmacoresistance; temporal lobe epilepsy	TEMPORAL-LOBE EPILEPSY; C-FOS EXPRESSION; P2X(7) RECEPTORS; MICROGLIAL ACTIVATION; GLUTAMATE RELEASE; ATP; HIPPOCAMPUS; RAT; PATHOPHYSIOLOGY; INHIBITION	Prolonged seizures [status epilepticus (SE)] constitute a neurological emergency that can permanently damage the brain. SE results from a failure of the normal mechanisms to terminate seizures; in particular, gamma-amino butyric acid-mediated inhibition, and benzodiazepine anticonvulsants are often incompletely effective. ATP acts as a fast neurotransmitter via ionotropic ligand-gated P2X receptors. Here we report that SE induced by intra-amygdala kainic acid in mice selectively increased hippocampal levels of P2X7 receptors relative to other P2X receptors. Using transgenic P2X7 reporter mice expressing enhanced green fluorescent protein, we identify dentate granule neurons as the major cell population transcribing the P2X7 receptor after SE. Pretreatment of mice with an intracerebroventricular microinjection of 1.75 nmol A438079, a P2X7 receptor antagonist, reduced seizure duration by 58% and reduced seizure-induced neuronal death by 61%. Injection of brilliant blue G (1 pmol), another selective antagonist, reduced seizure duration by 48% and was also neuroprotective. A438079 was seizure-suppressive when injected shortly after induction of SE, and coinjection of A438079 with lorazepam 60 min after triggering SE, when electrographic seizure-responsiveness to lorazepam had decreased, also terminated SE. Our results suggest that P2X7 receptor antagonists may be a promising class of drug for seizure abrogation and neuroprotection in SE.-Engel, T., Gomez-Villafuertes, R., Tanaka, K., Mesuret, G., SanzRodriguez, A., Garcia-Huerta, P., Miras-Portugal, M. T., Henshall, D. C., Diaz-Hernandez, M. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice. FASEB J. 26, 1616-1628 (2012). www.fasebj.org	[Engel, Tobias; Tanaka, Katsuhiro; Mesuret, Guillaume; Sanz-Rodriguez, Amaya; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Gomez-Villafuertes, Rosa; Garcia-Huerta, Paula; Teresa Miras-Portugal, M.; Diaz-Hernandez, Miguel] Univ Complutense Madrid, Fac Vet, Dept Biochem & Mol Biol 4, Madrid, Spain; [Gomez-Villafuertes, Rosa; Garcia-Huerta, Paula; Teresa Miras-Portugal, M.; Diaz-Hernandez, Miguel] Univ Complutense Madrid, Inst Neuroquim UCM, Madrid, Spain; [Gomez-Villafuertes, Rosa; Garcia-Huerta, Paula; Teresa Miras-Portugal, M.; Diaz-Hernandez, Miguel] Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Madrid, Spain; [Tanaka, Katsuhiro] Mie Univ, Sch Med, Dept Neurosurg, Tsu, Mie 514, Japan	Royal College of Surgeons - Ireland; Complutense University of Madrid; Complutense University of Madrid; Mie University	Henshall, DC (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, 123 St Stephens Green, Dublin 2, Ireland.	dhenshall@rcsi.ie	Miras-Portugal, Maria Teresa/L-7137-2014; Gomez-Villafuertes, Rosa/L-7181-2014	Gomez-Villafuertes, Rosa/0000-0002-7064-0906; Pintor, Jesus/0000-0002-9191-7679; Diaz-Hernandez, Miguel/0000-0002-1952-4600; Henshall, David/0000-0001-6237-9632; Engel, Tobias/0000-0001-9137-0637	Health Research Board Ireland [HRA_POR/2010/123, PD/2009/31]; Science Foundation Ireland [08/IN1/B1875]; Comunidad de Madrid [S-SAL-0253-2006]; Spanish Ministry of Science and Education [BFU2008-02699]; Fundacion Marcelino Botin; Consolider SICI Spanish Ion Channel Initiative [CSD2008-00005]; UCM-Santander Central Hispano Bank [911585-670]	Health Research Board Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); Spanish Ministry of Science and Education(Spanish Government); Fundacion Marcelino Botin; Consolider SICI Spanish Ion Channel Initiative; UCM-Santander Central Hispano Bank	The authors thank Dr. Maiken Nedergaard (University of Rochester, Rochester, NY, USA) for kindly providing the P2rx7-EGFP mice. This work was supported by grants from Health Research Board Ireland (HRA_POR/2010/123 and PD/2009/31), Science Foundation Ireland (08/IN1/B1875), Comunidad de Madrid (S-SAL-0253-2006), Spanish Ministry of Science and Education (BFU2008-02699), Fundacion Marcelino Botin, Consolider SICI Spanish Ion Channel Initiative (CSD2008-00005), and a grant from UCM-Santander Central Hispano Bank (911585-670).	Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Atkinson L, 2004, NEUROSCIENCE, V123, P761, DOI 10.1016/j.neuroscience.2003.08.065; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; BENARI Y, 1980, NEUROSCIENCE, V5, P515, DOI 10.1016/0306-4522(80)90049-4; Bernardino L, 2008, J NEUROCHEM, V106, P271, DOI 10.1111/j.1471-4159.2008.05387.x; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Chen JWY, 2006, LANCET NEUROL, V5, P246, DOI 10.1016/S1474-4422(06)70374-X; Cho JH, 2010, NEUROREPORT, V21, P865, DOI 10.1097/WNR.0b013e32833d9142; Choi HK, 2012, NEUROL SCI, V33, P515, DOI 10.1007/s10072-011-0740-z; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Csolle C, 2010, J NEUROIMMUNOL, V219, P38, DOI 10.1016/j.jneuroim.2009.11.011; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; DELORENZO RJ, 2006, STATUS EPILEPTICUS M, P17; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Diaz-Hernandez M, 2001, EUR J NEUROSCI, V14, P918, DOI 10.1046/j.0953-816x.2001.01703.x; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Diez-Zaera M, 2011, MOL BIOL CELL, V22, P1014, DOI 10.1091/mbc.E10-09-0740; Dona F, 2009, EPILEPSY RES, V83, P157, DOI 10.1016/j.eplepsyres.2008.10.008; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; Fabene PF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001105; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; FOLBERGROVA J, 1981, J NEUROCHEM, V37, P1228, DOI 10.1111/j.1471-4159.1981.tb04673.x; Gomez-Villafuertes R, 2009, FEBS J, V276, P5307, DOI 10.1111/j.1742-4658.2009.07228.x; Green SM, 2009, ANN EMERG MED, V54, P181, DOI 10.1016/j.annemergmed.2008.10.003; Gualix J, 2003, J NEUROCHEM, V87, P160, DOI 10.1046/j.1471-4159.2003.01975.x; Harvey BD, 2005, J COMP NEUROL, V488, P442, DOI 10.1002/cne.20594; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Jun DJ, 2007, J BIOL CHEM, V282, P37350, DOI 10.1074/jbc.M707915200; Kapur J, 1995, ANN NEUROL, V38, P893, DOI 10.1002/ana.410380609; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2003, J NEUROSCI, V23, P7426; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Labrousse VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006006; Le Feuvre RA, 2003, J CEREBR BLOOD F MET, V23, P381, DOI 10.1097/01.WCB.0000048519.34839.97; Lowenstein DH, 2005, CURR OPIN PHARMACOL, V5, P334, DOI 10.1016/j.coph.2005.04.003; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Mazarati AM, 1999, NEUROSCI LETT, V265, P187, DOI 10.1016/S0304-3940(99)00238-4; Monif M, 2010, INT J BIOCHEM CELL B, V42, P1753, DOI 10.1016/j.biocel.2010.06.021; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Murphy BM, 2010, CELL DEATH DIFFER, V17, P459, DOI 10.1038/cdd.2009.134; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Pankratov Y, 1998, EUR J NEUROSCI, V10, P3898, DOI 10.1046/j.1460-9568.1998.00419.x; Papp L, 2004, NEUROREPORT, V15, P2387, DOI 10.1097/00001756-200410250-00017; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Rappold PM, 2006, BRAIN RES, V1089, P171, DOI 10.1016/j.brainres.2006.03.040; Ravizza T, 2006, EPILEPSIA, V47, P1160, DOI 10.1111/j.1528-1167.2006.00590.x; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Sanchez-Nogueiro J, 2005, FEBS LETT, V579, P3783, DOI 10.1016/j.febslet.2005.05.073; Sloviter RS, 2007, EPILEPSIA, V48, P6, DOI 10.1111/j.1528-1167.2007.01335.x; Sloviter RS, 2005, CR BIOL, V328, P143, DOI 10.1016/j.crvi.2004.10.010; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Ubogu EE, 2003, EPILEPSY BEHAV, V4, P70, DOI 10.1016/S1525-5050(02)00643-1; Vezzani A, 1999, J NEUROSCI, V19, P5054; Vianna EPM, 2002, EPILEPSIA, V43, P227, DOI 10.1046/j.1528-1157.43.s.5.26.x; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; WASTERLAIN CG, 2006, STATUS EPILEPTICUS M, P11; Wasterlain CG, 2009, EPILEPSIA, V50, P16, DOI 10.1111/j.1528-1167.2009.02375.x; Wasterlain CG, 2008, EPILEPSIA, V49, P63, DOI 10.1111/j.1528-1167.2008.01928.x; WIERASZKO A, 1989, BRAIN RES, V485, P244, DOI 10.1016/0006-8993(89)90567-2; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	67	143	157	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1616	1628		10.1096/fj.11-196089	http://dx.doi.org/10.1096/fj.11-196089			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22198387	Bronze			2022-12-25	WOS:000302359700023
J	Kemaladewi, DU; de Gorter, DJJ; Aartsma-Rus, A; van Ommen, GJ; ten Dijke, P; 't Hoen, PAC; Hoogaars, WM				Kemaladewi, Dwi U.; de Gorter, David J. J.; Aartsma-Rus, Annemieke; van Ommen, Gert-Jan; ten Dijke, Peter; 't Hoen, Peter A. C.; Hoogaars, Willem M.			Cell-type specific regulation of myostatin signaling	FASEB JOURNAL			English	Article						myoblast; TGF-beta signaling; ALK4; ALK5; coreceptor	TRANSFORMING-GROWTH-FACTOR; GROSS MUSCLE HYPERTROPHY; TGF-BETA; ACTIVIN; GENE; CRIPTO; DIFFERENTIATION; MICE; MASS; TRANSDUCTION	The transforming growth factor (TGF)-beta family member myostatin is an important regulator of myoblast, adipocyte, and fibroblast growth and differentiation, but the signaling mechanisms remain to be established. We therefore determined the contribution of myostatin type I receptors activin receptor-like kinase-4 (ALK4) and -5 (ALK5) and different coreceptors in C2C12 myoblasts, C3H10T1/2 mesenchymal stem cells, and 3T3-L1 fibroblasts, as well as in primary myoblast and fibroblasts. We performed siRNA-mediated knockdown of each receptor and measured signaling activity using Smad3-dependent luciferase and Smad2 phosphorylation assays with nontargeting siRNA as control. We find that myostatin utilizes ALK4 in myoblasts, whereas it has a preference for ALK5 in nonmyogenic cells. Notably, our results show that coreceptor Cripto is expressed in myoblasts but not in the nonmyogenic cells and that it regulates myostatin activity. More specifically, myostatin requires Cripto in myoblasts, whereas Cripto represses activin activity and TGF-beta signaling is Cripto independent. Cripto-mediated myostatin signaling is dependent on both epidermal growth factor (EGF)-like and Cripto-FRL1-cryptic (CFC) domains, whereas activin signaling is solely conferred by the CFC domain. Furthermore, Cripto down-regulation enhances myoblast differentiation, showing its importance in myostatin signaling. Together, our results identify a molecular mechanism that explains the cell-type specific aspects of signaling by myostatin and other TGF-beta family members.-Kemaladewi, D. U., de Gorter, D. J. J., Aartsma-Rus, A., van Ommen, G.-J. ten Dijke, P., 't Hoen, P. A., Hoogaars, W. M. Cell-type specific regulation of myostatin signaling. FASEB J. 26, 1462-1472 (2012). www.fasebj.org	[Kemaladewi, Dwi U.; Aartsma-Rus, Annemieke; van Ommen, Gert-Jan; 't Hoen, Peter A. C.; Hoogaars, Willem M.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2300 RC Leiden, Netherlands; [Kemaladewi, Dwi U.; de Gorter, David J. J.; ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol & Cell Biol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	't Hoen, PAC (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Postzone S4-P,POB 9600, NL-2300 RC Leiden, Netherlands.	p.a.c.hoen@lumc.nl	Hoen, Peter A 't/D-3950-2018; Hoogaars, Willem/AAL-1657-2021; Dijke, Peter ten/AAG-4660-2021	Hoen, Peter A 't/0000-0003-4450-3112; Dijke, Peter ten/0000-0002-7234-342X; Hoogaars, Willem/0000-0001-6061-2576; Aartsma-Rus, Annemieke/0000-0003-1565-654X; Kemaladewi, Dwi/0000-0002-0747-4589	Dutch Duchenne Parent's Project; Netherlands Organization for Scientific Research; Centre for Biomedical Genetics	Dutch Duchenne Parent's Project; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Biomedical Genetics	The authors thank Dr. Peter C. Gray (Salk Institute for Biological Studies, La Jolla, CA, USA) for providing the Cripto plasmids and the Cripto antibody. The authors are grateful to Maarten van Dinther, Midory Thorikay, and Long Zhang (Molecular Cell Biology Department, Leiden University Medical Center) for the expert technical assistance. This study is supported by the Dutch Duchenne Parent's Project (to W. M. H. H and P. A. C. H), the Netherlands Organization for Scientific Research (to P. T. D), and the Centre for Biomedical Genetics (to P. T. D and G.J.V.O).	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Andersson O, 2007, DEV BIOL, V311, P500, DOI 10.1016/j.ydbio.2007.08.060; Artaza JN, 2008, J ENDOCRINOL, V196, P235, DOI 10.1677/JOE-07-0408; Bianco C, 2010, EXPERT OPIN THER PAT, V20, P1739, DOI 10.1517/13543776.2010.530659; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; Ciarmela P, 2011, J CLIN ENDOCR METAB, V96, P755, DOI 10.1210/jc.2010-0501; Ciarmela P, 2009, ENDOCRINOLOGY, V150, P906, DOI 10.1210/en.2008-0880; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dumonceaux J, 2010, MOL THER, V18, P881, DOI 10.1038/mt.2009.322; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Kang JK, 2011, MOL THER, V19, P159, DOI 10.1038/mt.2010.212; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200; Liu CM, 2008, GENE THER, V15, P155, DOI 10.1038/sj.gt.3303016; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lopez-Casillas F, 2003, J BIOL CHEM, V278, P382, DOI 10.1074/jbc.M208520200; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Magee TR, 2006, J GENE MED, V8, P1171, DOI 10.1002/jgm.946; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; Moustakas A, 2001, J CELL SCI, V114, P4359; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shelton GD, 2007, NEUROMUSCULAR DISORD, V17, P721, DOI 10.1016/j.nmd.2007.06.008; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Watanabe K, 2007, J BIOL CHEM, V282, P35772, DOI 10.1074/jbc.M707351200; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	49	48	49	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1462	1472		10.1096/fj.11-191189	http://dx.doi.org/10.1096/fj.11-191189			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22202673				2022-12-25	WOS:000302359700009
J	Fukushima, N; Matsuura, K; Akazawa, H; Honda, A; Nagai, T; Takahashi, T; Seki, A; Murasaki, KM; Shimizu, T; Okano, T; Hagiwara, N; Komuro, I				Fukushima, Noritoshi; Matsuura, Katsuhisa; Akazawa, Hiroshi; Honda, Atsushi; Nagai, Toshio; Takahashi, Toshinao; Seki, Akiko; Murasaki, Kagari M.; Shimizu, Tatsuya; Okano, Teruo; Hagiwara, Nobuhisa; Komuro, Issei			A Crucial Role of Activin A-Mediated Growth Hormone Suppression in Mouse and Human Heart Failure	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; DILATED CARDIOMYOPATHY; TRANSGENIC MICE; STEM-CELLS; TRANSCRIPTION FACTOR; CARDIAC-HYPERTROPHY; SIGNAL TRANSDUCER; PROGENITOR CELLS; ANGIOTENSIN-II; ISCHEMIC-HEART	Infusion of bone marrow-derived mononuclear cells (BMMNC) has been reported to ameliorate cardiac dysfunction after acute myocardial infarction. In this study, we investigated whether infusion of BMMNC is also effective for non-ischemic heart failure model mice and the underlying mechanisms. Intravenous infusion of BMMNC showed transient cardioprotective effects on animal models with dilated cardiomyopathy (DCM) without their engraftment in heart, suggesting that BMMNC infusion improves cardiac function via humoral factors rather than their differentiation into cardiomyocytes. Using conditioned media from sorted BMMNC, we found that the cardioprotective effects were mediated by growth hormone (GH) secreted from myeloid (Gr-1(+)) cells and the effects was partially mediated by signal transducer and activator of transcription 3 in cardiomyocytes. On the other hand, the GH expression in Gr-1(+) cells was significantly downregulated in DCM mice compared with that in healthy control, suggesting that the environmental cue in heart failure might suppress the Gr-1(+) cells function. Activin A was upregulated in the serum of DCM models and induced downregulation of GH levels in Gr-1(+) cells and serum. Furthermore, humoral factors upregulated in heart failure including angiotensin II upregulated activin A in peripheral blood mononuclear cells (PBMNC) via activation of NFkB. Similarly, serum activin A levels were also significantly higher in DCM patients with heart failure than in healthy subjects and the GH levels in conditioned medium from PBMNC of DCM patients were lower than that in healthy subjects. Inhibition of activin A increased serum GH levels and improved cardiac function of DCM model mice. These results suggest that activin A causes heart failure by suppressing GH activity and that inhibition of activin A might become a novel strategy for the treatment of heart failure.	[Fukushima, Noritoshi; Matsuura, Katsuhisa; Honda, Atsushi; Seki, Akiko; Murasaki, Kagari M.; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Fukushima, Noritoshi; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Global Ctr Excellence GCOE Program, Tokyo, Japan; [Matsuura, Katsuhisa; Shimizu, Tatsuya; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Akazawa, Hiroshi; Komuro, Issei] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Nagai, Toshio; Takahashi, Toshinao] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Osaka, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University; Osaka University	Fukushima, N (corresponding author), Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan.	kmatsuura@abmes.twmu.ac.jp; komuro-tky@umin.ac.jp	Okano, Teruo/J-4028-2012; Tatsuya, Shimizu/AAN-5675-2021	Akazawa, Hiroshi/0000-0002-3574-9607	Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM); Japanese Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [23390213] Funding Source: KAKEN	Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by: The Global Centers of Excellence (COE) Program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to N. Fukushima); a Grant-in-Aid for Scientific Research, Developmental Scientific Research, and Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Uehara Memorial Research Grant (to KM); Grants from the Japanese Ministry of Education, Culture, Sports, Science and Culture and Health and Labor Sciences Research Grants (to HA); and a Grant-in-Aid for Scientific Research on Priority Areas and for Exploratory Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to IK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 1997, CIRCULATION, V96, P526; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Cicoira M, 2003, J CARD FAIL, V9, P219, DOI 10.1054/jcaf.2003.23; Colao A, 2004, EUR J ENDOCRINOL, V151, pS93, DOI 10.1530/eje.0.151S093; Colao A, 2008, CLIN ENDOCRINOL, V69, P347, DOI 10.1111/j.1365-2265.2008.03292.x; Colligan PB, 2002, J ENDOCRINOL, V173, P257, DOI 10.1677/joe.0.1730257; Donndorf P, 2011, J THORAC CARDIOVASC; Funamoto M, 2000, J BIOL CHEM, V275, P10561, DOI 10.1074/jbc.275.14.10561; GADDYKURTEN D, 1995, J BIOL CHEM, V270, P28733, DOI 10.1074/jbc.270.48.28733; Gao LR, 2006, AM J CARDIOL, V98, P597, DOI 10.1016/j.amjcard.2006.03.034; Giustina A, 1996, AM HEART J, V131, P620, DOI 10.1016/S0002-8703(96)90552-9; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Honda A, 2009, ATHEROSCLEROSIS, V205, P376, DOI 10.1016/j.atherosclerosis.2008.12.036; Ikeda K, 2000, LIFE SCI, V67, P2991, DOI 10.1016/S0024-3205(00)00879-1; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Le Corvoisier P, 2007, J CLIN ENDOCR METAB, V92, P180, DOI 10.1210/jc.2006-1313; Marleau S, 2006, CARDIOVASC RES, V69, P26, DOI 10.1016/j.cardiores.2005.08.022; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Matsuura K, 2004, J CELL BIOL, V167, P351, DOI 10.1083/jcb.200312111; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Muller AF, 2004, J CLIN ENDOCR METAB, V89, P1503, DOI 10.1210/jc.2002-022049; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Perez EA, 2004, J CLIN ONCOL, V22, P322, DOI 10.1200/JCO.2004.01.120; REDEMANN N, 1992, MOL CELL BIOL, V12, P491, DOI 10.1128/MCB.12.2.491; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Seidman A, 2002, J CLIN ONCOL, V20, P1215, DOI 10.1200/JCO.20.5.1215; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sirotkin AV, 2005, VET J, V170, P307, DOI 10.1016/j.tvjl.2004.05.014; Tajima M, 1999, CIRCULATION, V99, P127, DOI 10.1161/01.CIR.99.1.127; Takahashi M, 2008, AM J PHYSIOL-HEART C, V294, pH2879, DOI 10.1152/ajpheart.91406.2007; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685; Welch S, 2002, CIRC RES, V90, P641, DOI 10.1161/01.RES.0000013780.77774.75; Yndestad A, 2004, CIRCULATION, V109, P1379, DOI 10.1161/01.CIR.0000120704.97934.41; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	47	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e27901	10.1371/journal.pone.0027901	http://dx.doi.org/10.1371/journal.pone.0027901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216087	Green Published, Green Submitted, gold			2022-12-25	WOS:000300676300002
J	Sjeklocha, LM; Park, CW; Wong, PYP; Roney, MJ; Belcher, JD; Kaufman, DS; Vercellotti, GM; Hebbel, RP; Steer, CJ				Sjeklocha, Lucas M.; Park, Chang-Won; Wong, Phillip Y-P; Roney, Mark J.; Belcher, John D.; Kaufman, Dan S.; Vercellotti, Gregory M.; Hebbel, Robert P.; Steer, Clifford J.			Erythroid-Specific Expression of beta-globin from Sleeping Beauty-Transduced Human Hematopoietic Progenitor Cells	PLOS ONE			English	Article							STABLE GENE-TRANSFER; EX-VIVO GENERATION; RED-BLOOD-CELLS; STEM-CELLS; DNA METHYLATION; RETROVIRAL VECTORS; TRANSPOSON SYSTEM; NONVIRAL VECTORS; MOUSE GENOME; THERAPY	Gene therapy for sickle cell disease will require efficient delivery of a tightly regulated and stably expressed gene product to provide an effective therapy. In this study we utilized the non-viral Sleeping Beauty (SB) transposon system using the SB100X hyperactive transposase to transduce human cord blood CD34(+) cells with DsRed and a hybrid IHK-beta-globin transgene. IHK transduced cells were successfully differentiated into multiple lineages which all showed transgene integration. The mature erythroid cells had an increased beta-globin to gamma-globin ratio from 0.66 +/- 0.08 to 1.05 +/- 0.12 (p = 0.05), indicating expression of beta-globin from the integrated SB transgene. IHK-beta-globin mRNA was found in non-erythroid cell types, similar to native beta-globin mRNA that was also expressed at low levels. Additional studies in the hematopoietic K562 cell line confirmed the ability of cHS4 insulator elements to protect DsRed and IHK-beta-globin transgenes from silencing in long-term culture studies. Insulated transgenes had statistically significant improvement in the maintenance of long term expression, while preserving transgene regulation. These results support the use of Sleeping Beauty vectors in carrying an insulated IHK-beta-globin transgene for gene therapy of sickle cell disease.	[Sjeklocha, Lucas M.; Park, Chang-Won; Wong, Phillip Y-P; Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Roney, Mark J.; Belcher, John D.; Vercellotti, Gregory M.; Hebbel, Robert P.] Univ Minnesota, Sch Med, Vasc Biol Ctr, Minneapolis, MN 55455 USA; [Roney, Mark J.; Belcher, John D.; Kaufman, Dan S.; Vercellotti, Gregory M.; Hebbel, Robert P.] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; [Kaufman, Dan S.] Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sjeklocha, LM (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Minneapolis, MN 55455 USA.	steer001@umn.edu		Kaufman, Dan/0000-0002-2003-2494; Sjeklocha, Lucas/0000-0003-0658-3377	NIH [P30 CA77598, R21 HL096469-01, P01 HL55552]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL096469, P01HL055552] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Carol Bruzzone for technical advice and Alexander Swart for technical assistance. The cHS4 chromatin insulator plasmid DNA construct, pJC13-1 was kindly provided by Dr. Gary Felsenfeld, NIH. We would also like to acknowledge the Flow Cytometry Core Facility of the Masonic Cancer Center, an NCI designated comprehensive cancer center funded in part by NIH grant P30 CA77598.; These studies were supported by National Institutes of Health (NIH) grants R21 HL096469-01 to RPH and CJS and P01 HL55552 to RPH (NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addya S, 2004, PHYSIOL GENOMICS, V19, P117, DOI 10.1152/physiolgenomics.00028.2004; Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Arumugam P, 2010, HEMATOL-AM SOC HEMAT, P445, DOI 10.1182/asheducation-2010.1.445; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Biffi A, 2008, CURR GENE THER, V8, P135, DOI 10.2174/156652308784049381; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Collier LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S15; Dalsgaard T, 2009, MOL THER, V17, P121, DOI 10.1038/mt.2008.224; Daniel R, 2008, HUM GENE THER, V19, P557, DOI 10.1089/hum.2007.148; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Douay Luc, 2009, V482, P127, DOI 10.1007/978-1-59745-060-7_8; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Gaines Peter, 2005, Curr Protoc Immunol, VChapter 22, DOI 10.1002/0471142735.im22f05s67; Garrison BS, 2007, MOL CELL BIOL, V27, P8824, DOI 10.1128/MCB.00498-07; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Giebel B, 2008, BIOL CHEM, V389, P813, DOI 10.1515/BC.2008.092; Gresch O, 2004, METHODS, V33, P151, DOI 10.1016/j.ymeth.2003.11.009; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Huang X, 2010, HUM GENE THER, V21, P1577, DOI 10.1089/hum.2009.138; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2000, J MOL BIOL, V302, P93, DOI 10.1006/jmbi.2000.4047; Izsvak Z, 2010, BIOESSAYS, V32, P756, DOI 10.1002/bies.201000027; Jackson DA, 2006, MOL THER, V14, P613, DOI 10.1016/j.ymthe.2006.03.026; Johnson SE, 2005, J IMMUNOL, V175, P7325, DOI 10.4049/jimmunol.175.11.7325; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Li CL, 2008, GENE THER, V15, P49, DOI 10.1038/sj.gt.3303009; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Moreau-Gaudry F, 2001, BLOOD, V98, P2664, DOI 10.1182/blood.V98.9.2664; Nienhuis AW, 2008, BLOOD, V111, P4431, DOI 10.1182/blood-2007-11-078121; Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Papapetrou EP, 2005, GENE THER, V12, pS118, DOI 10.1038/sj.gt.3302626; Park CW, 2006, GENOMICS, V88, P204, DOI 10.1016/j.ygeno.2006.04.007; Park CW, 2005, GENES CELLS, V10, P763, DOI 10.1111/j.1365-2443.2005.00875.x; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; SHELTON JB, 1984, J LIQ CHROMATOGR, V7, P1969, DOI 10.1080/01483918408068849; Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008; Walisko O, 2008, MOL THER, V16, P359, DOI 10.1038/sj.mt.6300366; Xue XK, 2009, BLOOD, V114, P1319, DOI 10.1182/blood-2009-03-210005; Zhu JH, 2007, BIOCHEMISTRY-US, V46, P6844, DOI 10.1021/bi6024484; Zhu JH, 2010, BIOCHEMISTRY-US, V49, P1507, DOI 10.1021/bi9016846; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	48	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29110	10.1371/journal.pone.0029110	http://dx.doi.org/10.1371/journal.pone.0029110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216176	gold, Green Published, Green Submitted			2022-12-25	WOS:000300676300028
J	Wang, Z; Zhang, H; Shen, XH; Jin, KL; Ye, GF; Qian, L; Li, B; Zhang, YH; Shi, GP				Wang, Zhen; Zhang, Hong; Shen, Xu-Hui; Jin, Kui-Li; Ye, Guo-fen; Qian, Li; Li, Bo; Zhang, Yong-Hong; Shi, Guo-Ping			Immunoglobulin E and Mast Cell Proteases Are Potential Risk Factors of Human Pre-Diabetes and Diabetes Mellitus	PLOS ONE			English	Article							C-REACTIVE PROTEIN; IMPAIRED FASTING GLUCOSE; INSULIN-RESISTANCE; ELEVATED LEVELS; INFLAMMATION; DEFICIENCY; TOLERANCE; MARKERS; OBESITY; PATHOGENESIS	Background: Recent studies have suggested that mast-cell activation and inflammation are important in obesity and diabetes. Plasma levels of mast cell proteases and the mast cell activator immunoglobulin E (IgE) may serve as novel inflammatory markers that associate with the risk of pre-diabetes and diabetes mellitus. Methods and Results: A total of 340 subjects 55 to 75 years of age were grouped according to the American Diabetes Association 2003 criteria of normal glucose tolerance, pre-diabetes, and diabetes mellitus. The Kruskal-Wallis test demonstrated significant differences in plasma IgE levels (P = 0.008) among groups with different glucose tolerance status. Linear regression analysis revealed significant correlations between plasma levels of chymase (P = 0.030) or IgE (P = 0.022) and diabetes mellitus. Ordinal logistic regression analysis showed that IgE was a significant risk factor of pre-diabetes and diabetes mellitus (odds ratio [OR]: 1.674, P = 0.034). After adjustment for common diabetes risk factors, including age, sex, hypertension, body-mass index, cholesterol, homeostatic model assessment (HOMA) index, high-sensitivity C-reactive protein (hs-CRP), and mast cell chymase and tryptase, IgE remained a significant risk factor (OR: 1.866, P = 0.015). Two-variable ordinal logistic analysis indicated that interactions between hs-CRP and IgE, or between IgE and chymase, increased further the risks of developing pre-diabetes and diabetes mellitus before (OR: 2.204, P = 0.044; OR: 2.479, P = 0.033) and after (OR: 2.251, P = 0.040; OR: 2.594, P = 0.026) adjustment for common diabetes risk factors. Conclusions: Both IgE and chymase associate with diabetes status. While IgE and hs-CRP are individual risk factors of prediabetes and diabetes mellitus, interactions of IgE with hs-CRP or with chymase further increased the risk of pre-diabetes and diabetes mellitus.	[Wang, Zhen] Huzhou Teachers Coll, Sch Med, Dept Clin Med, Huzhou, Zhejiang, Peoples R China; [Zhang, Hong; Shen, Xu-Hui] Huzhou Teachers Coll, Sch Med, Dept Nursing Med, Huzhou, Zhejiang, Peoples R China; [Jin, Kui-Li] Huzhou Ctr Dis Prevent & Control, Huzhou, Zhejiang, Peoples R China; [Ye, Guo-fen] Aishan St Community Hlth Ctr, Huzhou, Zhejiang, Peoples R China; [Qian, Li] Longquan St Community Hlth Ctr, Huzhou, Zhejiang, Peoples R China; [Li, Bo] Huanzhu Rural Hosp, Huzhou, Zhejiang, Peoples R China; [Zhang, Yong-Hong] Soochow Univ, Sch Radiat Med & Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China; [Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Shi, Guo-Ping] Harvard Univ, Sch Med, Boston, MA USA	Huzhou University; Huzhou University; Soochow University - China; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wang, Z (corresponding author), Huzhou Teachers Coll, Sch Med, Dept Clin Med, Huzhou, Zhejiang, Peoples R China.	gshi@rics.bwh.harvard.edu			Huzhou Municipal Science and Technology Agency [2008GS09]; Zhejiang Province Department of Health [2008B178]; Zhejiang Province Department of Education [20070470]; National Institutes of Health [HL60942, HL81090, HL88547]; EIA from the American Heart Association [0840118N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060942, R01HL088547, R01HL081090] Funding Source: NIH RePORTER	Huzhou Municipal Science and Technology Agency; Zhejiang Province Department of Health; Zhejiang Province Department of Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EIA from the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by awards from the Huzhou Municipal Science and Technology Agency (2008GS09) (HZ), the Zhejiang Province Department of Health (2008B178) (ZW), and the Zhejiang Province Department of Education (20070470) (X-HS); by grants from the National Institutes of Health, HL60942, HL81090, HL88547 (G-PS); and by EIA award 0840118N from the American Heart Association (G-PS). The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; Bock G, 2006, DIABETES, V55, P3536, DOI 10.2337/db06-0319; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Erdogan O, 2003, JPN HEART J, V44, P593, DOI 10.1536/jhj.44.593; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; GRUBER B, 1989, MONOGR ALLERGY, V26, P120; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Haffner SM, 2003, DIABETES RES CLIN PR, V61, pS9, DOI 10.1016/S0168-8227(03)00122-0; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Ikeoka D, 2010, REV ASSOC MED BRAS, V56, P116, DOI 10.1590/S0104-42302010000100026; Kim Jason K, 2010, Korean Diabetes J, V34, P137, DOI 10.4093/kdj.2010.34.3.137; Kovanen PT, 1998, ARCH INTERN MED, V158, P1434, DOI 10.1001/archinte.158.13.1434; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Macglashan Donald Jr., 1998, Frontiers in Bioscience, V3, pD746; Mayor S, 2007, INT J CLIN PRACT, V61, P1773, DOI 10.1111/j.1742-1241.2007.01547.x; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Ndumele Chiadi E, 2006, J Cardiometab Syndr, V1, P190; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Retnakaran R, 2003, J CLIN ENDOCR METAB, V88, P3507, DOI 10.1210/jc.2003-030186; Sabanayagam C, 2011, DIABETOLOGIA, V54, P767, DOI 10.1007/s00125-011-2052-5; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Schulze MB, 2005, AM J CLIN NUTR, V82, P675, DOI 10.1093/ajcn/82.3.675; Shahzad F, 2010, IRAN J IMMUNOL, V7, P109, DOI IJIv7i2A6; Sommer Peter, 2010, Korean Diabetes J, V34, P71, DOI 10.4093/kdj.2010.34.2.71; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Sun JS, 2009, CIRCULATION, V120, P973, DOI 10.1161/CIRCULATIONAHA.109.849679; Theoharides TC, 2006, ANN NY ACAD SCI, V1088, P78, DOI 10.1196/annals.1366.025; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Wang J, 2011, J CLIN INVEST, V121, P3564, DOI 10.1172/JCI46028; Wasada T, 2004, DIABETOLOGIA, V47, P759, DOI 10.1007/s00125-004-1339-1; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Xiang MX, 2011, ATHEROSCLEROSIS, V215, P494, DOI 10.1016/j.atherosclerosis.2011.01.006; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang M, 2008, ARTERIOSCL THROM VAS, V28, P2202, DOI 10.1161/ATVBAHA.108.172320; Yang M, 2007, NAT CELL BIOL, V9, P970, DOI 10.1038/ncb1623; Zhang J, 2011, CIRC RES, V108, P1316, DOI 10.1161/CIRCRESAHA.111.243758; [张普洪 ZHANG Puhong], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P1162	44	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28962	10.1371/journal.pone.0028962	http://dx.doi.org/10.1371/journal.pone.0028962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194960	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400027
J	Varnum, SM; Webb-Robertson, BJM; Hessol, NA; Smith, RD; Zangar, RC				Varnum, Susan M.; Webb-Robertson, Bobbie-Jo M.; Hessol, Nancy A.; Smith, Richard D.; Zangar, Richard C.			Plasma Biomarkers for Detecting Hodgkin's Lymphoma in HIV Patients	PLOS ONE			English	Article							THROUGHPUT; PROTEIN; CANCER; VIRUS	The lifespan of people with human immunodeficiency virus (HIV) infection has increased as a result of effective antiretroviral therapy, and the incidences of the AIDS-defining cancers, non-Hodgkin's lymphoma and Kaposi sarcoma, have declined. Even so, HIV-infected individuals are now at greater risk of other cancers, including Hodgkin's lymphoma (HL). To identify candidate biomarkers for the early detection of HL, we undertook an accurate mass and elution time tag proteomics analysis of individual plasma samples from either HIV-infected patients without HL (controls; n = 14) and from HIV-infected patient samples with HL (n = 22). This analysis identified 60 proteins that were statistically (p < 0.05) altered and at least 1.5-fold different between the two groups. At least three of these proteins have previously been reported to be altered in the blood of HL patients that were not known to be HIV positive, suggesting that these markers may be broadly useful for detecting HL. Ingenuity Pathway Analysis software identified "inflammatory response" and "cancer" as the top two biological functions associated with these proteins. Overall, this study validated three plasma proteins as candidate biomarkers for detecting HL, and identified 57 novel candidate biomarkers that remain to be validated. The relationship of these novel candidate biomarkers with cancer and inflammation suggests that they are truly associated with HL and therefore may be useful for the early detection of this cancer in susceptible populations.	[Varnum, Susan M.; Zangar, Richard C.] Pacific NW Natl Lab, Dept Cell Biol & Biochem, Richland, WA 99352 USA; [Webb-Robertson, Bobbie-Jo M.] Pacific NW Natl Lab, Dept Computat Biol & Bioinformat, Richland, WA 99352 USA; [Smith, Richard D.] Pacific NW Natl Lab, Dept Biol Sci Div, Richland, WA 99352 USA; [Hessol, Nancy A.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of California System; University of California San Francisco	Varnum, SM (corresponding author), Pacific NW Natl Lab, Dept Cell Biol & Biochem, Richland, WA 99352 USA.	richard.zangar@pnnl.gov	Webb-Robertson, Bobbie-Jo/K-8230-2019; Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349; Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397	National Cancer Institute's Early Detection Research Network [U01 CA117378]; Department of Energy's Office of Biological and Environmental Research; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA117378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	National Cancer Institute's Early Detection Research Network; Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (U01 CA117378) from the National Cancer Institute's Early Detection Research Network. Some work was performed in the PNNL's Environmental Molecular Science Laboratory, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albitar M, 2007, LEUKEMIA RES, V31, P139, DOI 10.1016/j.leukres.2006.02.013; Armitage JO, 2010, NEW ENGL J MED, V363, P653, DOI 10.1056/NEJMra1003733; Banerjee Diponkar, 2011, Adv Hematol, V2011, P439456, DOI 10.1155/2011/439456; Bien E, 2009, SCAND J IMMUNOL, V70, P490, DOI 10.1111/j.1365-3083.2009.02313.x; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Hessol NA, 2007, AM J EPIDEMIOL, V165, P1143, DOI 10.1093/aje/kwm017; Khan G, 2006, EXP HEMATOL, V34, P399, DOI 10.1016/j.exphem.2005.11.008; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oberg AL, 2009, J PROTEOME RES, V8, P2144, DOI 10.1021/pr8010099; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2010, J PROTEOME RES, V9, P4779, DOI 10.1021/pr1005026; Rana GSJB, 2010, ANAL BIOANAL CHEM, V397, P1809, DOI 10.1007/s00216-010-3742-4; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Webb-Robertson BJM, 2010, J PROTEOME RES, V9, P5748, DOI 10.1021/pr1005247	19	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29263	10.1371/journal.pone.0029263	http://dx.doi.org/10.1371/journal.pone.0029263			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195036	Green Submitted, gold, Green Published			2022-12-25	WOS:000298370400045
J	Zhu, L; Li, YH; Li, SH; Li, HD; Qiu, ZX; Lee, CC; Lu, HR; Lin, XF; Zhao, R; Chen, L; Wu, JZ; Tang, GZ; Yang, WG				Zhu, Lei; Li, Yuhuan; Li, Shaohua; Li, Haodong; Qiu, Zongxing; Lee, Chichang; Lu, Henry; Lin, Xianfeng; Zhao, Rong; Chen, Li; Wu, Jim Z.; Tang, Guozhi; Yang, Wengang			Inhibition of Influenza A Virus (H1N1) Fusion by Benzenesulfonamide Derivatives Targeting Viral Hemagglutinin	PLOS ONE			English	Article							CONFORMATIONAL-CHANGE; MEMBRANE-FUSION; PH; IDENTIFICATION; REPLICATION; MORTALITY; MECHANISM; COMPOUND; RESIDUES; ARBIDOL	Hemagglutinin (HA) of the influenza virus plays a crucial role in the early stage of the viral life cycle by binding to sialic acid on the surface of host epithelial cells and mediating fusion between virus envelope and endosome membrane for the release of viral genomes into the cytoplasm. To initiate virus fusion, endosome pH is lowered by acidification causing an irreversible conformational change of HA, which in turn results in a fusogenic HA. In this study, we describe characterization of an HA inhibitor of influenza H1N1 viruses, RO5464466. One-cycle time course study in MDCK cells showed that this compound acted at an early step of influenza virus replication. Results from HA-mediated hemolysis of chicken red blood cells and trypsin sensitivity assay of isolated HA clearly showed that RO5464466 targeted HA. In cell-based assays involving multiple rounds of virus infection and replication, RO5464466 inhibited an established influenza infection. The overall production of progeny viruses, as a result of the compound's inhibitory effect on fusion, was dramatically reduced by 8 log units when compared with a negative control. Furthermore, RO5487624, a close analogue of RO5464466, with pharmacokinetic properties suitable for in vivo efficacy studies displayed a protective effect on mice that were lethally challenged with influenza H1N1 virus. These results might benefit further characterization and development of novel anti-influenza agents by targeting viral hemagglutinin.	[Zhu, Lei; Qiu, Zongxing; Lin, Xianfeng; Zhao, Rong; Chen, Li; Wu, Jim Z.; Tang, Guozhi; Yang, Wengang] Roche Pharma Res & Early Dev, Shanghai, Peoples R China; [Li, Shaohua; Li, Haodong; Lee, Chichang; Lu, Henry] WuXi AppTec Co Ltd, Shanghai, Peoples R China; [Li, Yuhuan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS	Zhu, L (corresponding author), Roche Pharma Res & Early Dev, Shanghai, Peoples R China.	wengang.yang@roche.com		Tang, Guozhi/0000-0002-7131-4678	Roche Pharma Research and Early Development	Roche Pharma Research and Early Development	Roche Pharma Research and Early Development supports this study but had no role in direct design, data collection, and preparation of the manuscript. Roche does make a decision to support the submission of the manuscript for publication.	[Anonymous], FIELDS VIROLOGY; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; BODIAN DL, 1993, BIOCHEMISTRY-US, V32, P2967, DOI 10.1021/bi00063a007; BOMMAKANTI G, 2010, P NATL ACAD SCI US; Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Cianci C, 1999, J VIROL, V73, P1785, DOI 10.1128/JVI.73.3.1785-1794.1999; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; *FOOD DRUG ADM, 2009, EM US AUTH PER FACT; GHENDON Y, 1986, J GEN VIROL, V67, P1115, DOI 10.1099/0022-1317-67-6-1115; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Hoffman LR, 1997, J VIROL, V71, P8808, DOI 10.1128/JVI.71.11.8808-8820.1997; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Komar N, 2008, EMERG INFECT DIS, V14, P1176, DOI 10.3201/eid1407.080161; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Leneva IA, 2009, ANTIVIR RES, V81, P132, DOI 10.1016/j.antiviral.2008.10.009; Lindstrom SE, 2004, VIROLOGY, V328, P101, DOI 10.1016/j.virol.2004.06.009; Luo GX, 1997, J VIROL, V71, P4062, DOI 10.1128/JVI.71.5.4062-4070.1997; Luo GX, 1996, VIROLOGY, V226, P66, DOI 10.1006/viro.1996.0628; Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39; Plotch SJ, 1999, J VIROL, V73, P140, DOI 10.1128/JVI.73.1.140-151.1999; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Staschke KA, 1998, VIROLOGY, V248, P264, DOI 10.1006/viro.1998.9273; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tang GZ, 2011, ACS MED CHEM LETT, V2, P603, DOI 10.1021/ml2000627; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Yoshimoto J, 1999, ARCH VIROL, V144, P865, DOI 10.1007/s007050050552	33	37	39	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29120	10.1371/journal.pone.0029120	http://dx.doi.org/10.1371/journal.pone.0029120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195002	Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400033
J	Arnold, SN; Steneck, RS				Arnold, Suzanne N.; Steneck, Robert S.			Settling into an Increasingly Hostile World: The Rapidly Closing "Recruitment Window" for Corals	PLOS ONE			English	Article							REGION-WIDE DECLINES; CARIBBEAN CORAL; ACROPORA-PALMATA; LIFE-HISTORIES; FLORIDA-KEYS; SETTLEMENT; REEFS; COMMUNITY; ABUNDANCE; SURVIVAL	Free space is necessary for larval recruitment in all marine benthic communities. Settling corals, with limited energy to invest in competitive interactions, are particularly vulnerable during settlement into well-developed coral reef communities. This situation may be exacerbated for corals settling into coral-depauperate reefs where succession in nursery microhabitats moves rapidly toward heterotrophic organisms inhospitable to settling corals. To study effects of benthic organisms (at millimeter to centimeter scales) on newly settled corals and their survivorship we deployed terra-cotta coral settlement plates at 10 m depth on the Mesoamerican Barrier Reef in Belize and monitored them for 38 mo. During the second and third years, annual recruitment rates declined by over 50% from the previous year. Invertebrate crusts (primarily sponges) were absent at the start of the experiment but increased in abundance annually from 39, 60, to 73% of the plate undersides by year three. Subsequently, substrates hospitable to coral recruitment, including crustose coralline algae, biofilmed terra-cotta and polychaete tubes, declined. With succession, substrates upon which spat settled shifted toward organisms inimical to survivorship. Over 50% of spat mortality was due to overgrowth by sponges alone. This result suggests that when a disturbance creates primary substrate a "recruitment window" for settling corals exists from approximately 9 to 14 mo following the disturbance. During the window, early-succession, facilitating species are most abundant. The window closes as organisms hostile to coral settlement and survivorship overgrow nursery microhabitats.	[Arnold, Suzanne N.; Steneck, Robert S.] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA	University of Maine System; University of Maine Orono	Arnold, SN (corresponding author), Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA.	Suzanne.Arnold@maine.edu			Smithsonian Marine Science Network; Connectivity Working Group of the Global Environment Fund's Coral Reef Targeted Research and Capacity Building Project	Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); Connectivity Working Group of the Global Environment Fund's Coral Reef Targeted Research and Capacity Building Project	Funding for the research was provided by the Smithsonian Marine Science Network and the Connectivity Working Group of the Global Environment Fund's Coral Reef Targeted Research and Capacity Building Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEY W H, 1975, Phycologia, V14, P55, DOI 10.2216/i0031-8884-14-2-55.1; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; BABCOCK RC, 1985, P 5 INT COR REEF S, V4, P355; Baird AH, 2000, CORAL REEFS, V19, P179, DOI 10.1007/PL00006955; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Birkeland C, 1977, P 3 INT COR REEF S, V1, P15; BUSS LW, 1981, MECH COMPETITION ONY; CARLETON JH, 1987, B MAR SCI, V40, P85; Carlon DB, 2001, B MAR SCI, V68, P525; CHO LL, 2000, P 9 INT COR REEF S, P23; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; DENLEY EJ, 1979, J EXP MAR BIOL ECOL, V36, P269, DOI 10.1016/0022-0981(79)90122-9; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; English S., 1997, SURVEY MANUAL TROPIC; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; HARRIOTT VJ, 1987, MAR ECOL PROG SER, V37, P201, DOI 10.3354/meps037201; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; MAIDA M, 1994, J EXP MAR BIOL ECOL, V180, P189, DOI 10.1016/0022-0981(94)90066-3; MILLER MW, 2002, P CAR ACR WORKSH POT, P59; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pawlik JR, 2007, LIMNOL OCEANOGR, V52, P907, DOI 10.4319/lo.2007.52.2.0907; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; Raimondi PT, 2000, ECOLOGY, V81, P3193, DOI 10.1890/0012-9658(2000)081[3193:TCOCLB]2.0.CO;2; RAIMONDI PT, 1988, ECOLOGY, V69, P400, DOI 10.2307/1940438; Raymundo LJ, 2004, ECOL APPL, V14, P281, DOI 10.1890/02-5373; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; RYLAARSDAM KW, 1983, MAR ECOL PROG SER, V13, P249, DOI 10.3354/meps013249; Sammarco PW, 1985, P 5 INT COR REEF C, V4, P391; Shearer TL, 2006, MAR ECOL PROG SER, V306, P133, DOI 10.3354/meps306133; STENECK RS, 1991, ECOLOGY, V72, P938, DOI 10.2307/1940595; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; Williams DE, 2008, CORAL REEFS, V27, P697, DOI 10.1007/s00338-008-0386-3	49	71	72	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28681	10.1371/journal.pone.0028681	http://dx.doi.org/10.1371/journal.pone.0028681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194883	gold, Green Submitted, Green Published			2022-12-25	WOS:000298369100076
J	Atefi, M; von Euw, E; Attar, N; Ng, C; Chu, C; Guo, DL; Nazarian, R; Chmielowski, B; Glaspy, JA; Comin-Anduix, B; Mischel, PS; Lo, RS; Ribas, A				Atefi, Mohammad; von Euw, Erika; Attar, Narsis; Ng, Charles; Chu, Connie; Guo, Deliang; Nazarian, Ramin; Chmielowski, Bartosz; Glaspy, John A.; Comin-Anduix, Begonya; Mischel, Paul S.; Lo, Roger S.; Ribas, Antoni			Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; CUTANEOUS MELANOMA; SIGNALING PATHWAYS; CELL-LINES; ACTIVATION; MUTATIONS; THERAPY; CANCER; OVERCOME; BIOLOGY	Background: The sustained clinical activity of the BRAF inhibitor vemurafenib (PLX4032/RG7204) in patients with BRAF(V600) mutant melanoma is limited primarily by the development of acquired resistance leading to tumor progression. Clinical trials are in progress using MEK inhibitors following disease progression in patients receiving BRAF inhibitors. However, the PI3K/AKT pathway can also induce resistance to the inhibitors of MAPK pathway. Methodology/Principal Findings: The sensitivity to vemurafenib or the MEK inhibitor AZD6244 was tested in sensitive and resistant human melanoma cell lines exploring differences in activation-associated phosphorylation levels of major signaling molecules, leading to the testing of co-inhibition of the AKT/mTOR pathway genetically and pharmacologically. There was a high degree of cross-resistance to vemurafenib and AZD6244, except in two vemurafenib-resistant cell lines that acquired a secondary mutation in NRAS. In other cell lines, acquired resistance to both drugs was associated with persistence or increase in activity of AKT pathway. siRNA-mediated gene silencing and combination therapy with an AKT inhibitor or rapamycin partially or completely reversed the resistance. Conclusions/Significance: Primary and acquired resistance to vemurafenib in these in vitro models results in frequent cross resistance to MEK inhibitors, except when the resistance is the result of a secondary NRAS mutation. Resistance to BRAF or MEK inhibitors is associated with the induction or persistence of activity within the AKT pathway in the presence of these drugs. This resistance can be potentially reversed by the combination of a RAF or MEK inhibitor with an AKT or mTOR inhibitor. These combinations should be available for clinical testing in patients progressing on BRAF inhibitors.	[Atefi, Mohammad; von Euw, Erika; Attar, Narsis; Ng, Charles; Chu, Connie; Chmielowski, Bartosz; Glaspy, John A.; Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Guo, Deliang; Mischel, Paul S.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Nazarian, Ramin; Lo, Roger S.] Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90024 USA; [Glaspy, John A.; Comin-Anduix, Begonya; Mischel, Paul S.; Lo, Roger S.; Ribas, Antoni] Univ Calif Los Angeles, Dept Surg, Div Surg Oncol, Los Angeles, CA 90024 USA; [Comin-Anduix, Begonya; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Atefi, M (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA.	aribas@mednet.ucla.edu	Guo, Deliang/I-3735-2014	Guo, Deliang/0000-0002-8359-390X; Chmielowski, Bartosz/0000-0002-2374-3320	Seaver Institute; Melanoma Research Foundation; Melanoma Research Alliance; Louise Belley and Richard Schnarr Fund; Caltech-University of California, Los Angeles Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE [K22CA151638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073831] Funding Source: NIH RePORTER	Seaver Institute; Melanoma Research Foundation; Melanoma Research Alliance; Louise Belley and Richard Schnarr Fund; Caltech-University of California, Los Angeles Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by The Seaver Institute, the Melanoma Research Foundation, the Melanoma Research Alliance, the Louise Belley and Richard Schnarr Fund, and the Caltech-University of California, Los Angeles Joint Center for Translational Medicine (all to A.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Jiang CC, 2010, CLIN CANC RES; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kefford R, 2010, J CLIN ONCOL S, V28, p611s; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2010, BRIT J CANCER, V102, P1724, DOI 10.1038/sj.bjc.6605714; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Rexer BN, 2009, CLIN CANCER RES, V15, P4518, DOI 10.1158/1078-0432.CCR-09-0872; RIBAS A, 2011, J CLIN ONCOLOGY, V29; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOLOGY OFFI; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558	30	170	181	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28973	10.1371/journal.pone.0028973	http://dx.doi.org/10.1371/journal.pone.0028973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194965	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100135
J	Chiang, CLL; Hagemann, AR; Leskowitz, R; Mick, R; Garrabrant, T; Czerniecki, BJ; Kandalaft, LE; Powell, DJ; Coukos, G				Chiang, Cheryl Lai-Lai; Hagemann, Andrea R.; Leskowitz, Rachel; Mick, Rosemarie; Garrabrant, Thomas; Czerniecki, Brian J.; Kandalaft, Lana E.; Powell, Daniel J., Jr.; Coukos, George			Day-4 Myeloid Dendritic Cells Pulsed with Whole Tumor Lysate Are Highly Immunogenic and Elicit Potent Anti-Tumor Responses	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; CD4(+) T-CELLS; PHASE-I; CLINICAL-APPLICATION; MELANOMA PATIENTS; SCALE GENERATION; HUMAN MONOCYTES; MATURE; IMMUNOTHERAPY; VACCINATION	"Day-7" myeloid DCs are commonly used in the clinic. However, there is a strong need to develop DCs faster that have the same potent immunostimulatory capacity as "Day-7" myeloid DCs and at the same time minimizing time, labor and cost of DC preparations. Although "2 days" DCs can elicit peptide-specific responses, they have not been demonstrated to engulf, process and present complex whole tumor lysates, which could be more convenient and personalized source of tumor antigens than defined peptides. In this preclinical study, we evaluated the T-cell stimulatory capacity of Day-2, Day-4, and Day-7 cultured monocyte-derived DCs loaded with SKOV3 cell whole lysate prepared by freeze-thaw or by UVB-irradiation followed by freeze-thaw, and matured with lipopolysaccharide (LPS) and interferon (IFN)-gamma. DCs were evaluated for antigen uptake, and following maturation with LPS and IFN-gamma, DCs were assessed for expression of CD80, CD40, CD86, ICAM-1 and CCR7, production of IL-12p70 and IP-10, and induction of tumor-specific T-cell responses. Day-4 and Day-7 DCs exhibited similar phagocytic abilities, which were superior to Day-2 DCs. Mature Day-7 DCs expressed the highest CD40 and ICAM-1, but mature Day-4 DCs produced the most IL-12p70 and IP-10. Importantly, Day-4 and Day-7 DCs derived from ovarian cancer patients stimulated equally strongly tumor-specific T-cell responses. This is the first study demonstrating the highly immunogenic and strong T-cell stimulatory properties of Day-4 myeloid DCs, and provided important preclinical data for rapid development of potent whole tumor lysate-loaded DC vaccines that are applicable to many tumor types.	[Chiang, Cheryl Lai-Lai; Hagemann, Andrea R.; Leskowitz, Rachel; Garrabrant, Thomas; Kandalaft, Lana E.; Powell, Daniel J., Jr.; Coukos, George] Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Mick, Rosemarie] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Czerniecki, Brian J.] Univ Penn, Rena Rowan Breast Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Chiang, CLL (corresponding author), Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA.	gcks@mail.med.upenn.edu	Coukos, George/ABG-7389-2020; Kandalaft, Lana/AAP-8104-2020; CHIANG, Cheryl Lai Lai/AAA-2997-2022	CHIANG, Cheryl Lai Lai/0000-0002-0444-3357; Coukos, George/0000-0001-8813-7367; Kandalaft, Lana/0000-0002-1575-6674	National Cancer Institute (NCI) [P01-CA83638]; Ovarian Cancer Research Fund (OCRF); Immunotherapy Initiative for Ovarian Cancer (ITI-OC); University of Pennsylvania Abramson Cancer Center [P30-CA-016520]; NATIONAL CANCER INSTITUTE [P50CA083638, P30CA016520] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund (OCRF); Immunotherapy Initiative for Ovarian Cancer (ITI-OC); University of Pennsylvania Abramson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (NCI) P01-CA83638 Ovarian Specialized Program of Research Excellence (SPORE); the Ovarian Cancer Research Fund (OCRF) (GC); the Immunotherapy Initiative for Ovarian Cancer (ITI-OC) (GC); and the University of Pennsylvania Abramson Cancer Center Core Support Grant P30-CA-016520 (RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NCI (http://www.cancer.gov), University of Pennsylvania (http://www.upenn.edu).	Ardavin Carlos, 2004, Immunity, V20, P17, DOI 10.1016/S1074-7613(03)00352-2; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Berger TG, 2005, J IMMUNOL METHODS, V298, P61, DOI 10.1016/j.jim.2005.01.005; Berger TG, 2002, J IMMUNOL METHODS, V268, P131, DOI 10.1016/S0022-1759(02)00189-8; Chiang CLL, 2006, CANCER IMMUNOL IMMUN, V55, P1384, DOI 10.1007/s00262-006-0127-9; Chiang CLL, 2010, SEMIN IMMUNOL, V22, P132, DOI 10.1016/j.smim.2010.02.004; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Dauer M, 2008, J IMMUNOL METHODS, V337, P97, DOI 10.1016/j.jim.2008.07.003; Fay JW, 2006, CANCER IMMUNOL IMMUN, V55, P1209, DOI 10.1007/s00262-005-0106-6; Gangur V, 1998, FASEB J, V12, P705, DOI 10.1096/fasebj.12.9.705; Gitlitz BJ, 2003, J IMMUNOTHER, V26, P412, DOI 10.1097/00002371-200309000-00004; HAYES MP, 1995, BLOOD, V86, P646, DOI 10.1182/blood.V86.2.646.bloodjournal862646; Hernando JJ, 2002, CANCER IMMUNOL IMMUN, V51, P45, DOI 10.1007/s00262-001-0255-1; Iwashita Y, 2003, CANCER IMMUNOL IMMUN, V52, P155, DOI 10.1007/s00262-002-0360-9; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kvistborg P, 2009, CELL IMMUNOL, V260, P56, DOI 10.1016/j.cellimm.2009.09.003; Liu AH, 2002, J IMMUNOL METHODS, V261, P49, DOI 10.1016/S0022-1759(01)00545-2; Loudovaris M, 2001, J HEMATOTH STEM CELL, V10, P569, DOI 10.1089/15258160152509172; Maier T, 2003, BLOOD, V102, P2338, DOI 10.1182/blood-2002-08-2455; Marten A, 2003, HUM GENE THER, V14, P483, DOI 10.1089/104303403321467243; Nagayama H, 2003, MELANOMA RES, V13, P521, DOI 10.1097/00008390-200310000-00011; Neller MA, 2008, SEMIN IMMUNOL, V20, P286, DOI 10.1016/j.smim.2008.09.006; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Pandha HS, 2004, BJU INT, V94, P412, DOI 10.1111/j.1464-410X.2004.04922.x; Rad AN, 2003, CANCER RES, V63, P5143; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Tschoep K, 2003, J LEUKOCYTE BIOL, V74, P69, DOI 10.1189/jlb.0702352; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; Wiechen K, 1999, BRIT J CANCER, V81, P790, DOI 10.1038/sj.bjc.6690765; YU DH, 1993, CANCER RES, V53, P891	35	42	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28732	10.1371/journal.pone.0028732	http://dx.doi.org/10.1371/journal.pone.0028732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194898	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100087
J	Dong, ZJ; Ge, JC; Li, K; Xu, ZQ; Liang, D; Li, JY; Li, JB; Jia, WS; Li, YH; Dong, XH; Cao, SS; Wang, XX; Pan, JL; Zhao, QS				Dong, Zhangji; Ge, Jiachun; Li, Kui; Xu, Zhiqiang; Liang, Dong; Li, Jingyun; Li, Junbo; Jia, Wenshuang; Li, Yuehua; Dong, Xiaohua; Cao, Shasha; Wang, Xiaoxiao; Pan, Jianlin; Zhao, Qingshun			Heritable Targeted Inactivation of Myostatin Gene in Yellow Catfish (Pelteobagrus fulvidraco) Using Engineered Zinc Finger Nucleases	PLOS ONE			English	Article							KNOCKOUT RATS; HOMOLOGOUS RECOMBINATION; EMBRYO MICROINJECTION; ZEBRAFISH; GENOME; MICE; MUTAGENESIS; DISRUPTION; GENERATION; CLONING	Yellow catfish (Pelteobagrus fulvidraco) is one of the most important freshwater aquaculture species in China. However, its small size and lower meat yield limit its edible value. Myostatin (MSTN) is a negative regulator of mammalian muscle growth. But, the function of Mstn in fish remains elusive. To explore roles of mstn gene in fish growth and create a strain of yellow catfish with high amount of muscle mass, we performed targeted disruption of mstn in yellow catfish using engineered zinc-finger nucleases (ZFNs). Employing zebrafish embryos as a screening system to identify ZFN activity, we obtained one pair of ZFNs that can edit mstn in yellow catfish genome. Using the ZFNs, we successfully obtained two founders (Founder July29-7 and Founder July29-8) carrying mutated mstn gene in their germ cells. The mutated mstn allele inherited from Founder July29-7 was a null allele (mstn(nju6)) containing a 4 bp insertion, predicted to encode function null Mstn. The mutated mstn inherited from Founder July29-8 was a complex type of mutation (mstn(nju7)), predicted to encode a protein lacking two amino acids in the N-terminal secretory signal of Mstn. Totally, we obtained 6 mstn(nju6/+) and 14 mstn(nju7/+) yellow catfish. To our best knowledge, this is the first endogenous gene knockout in aquaculture fish. Our result will help in understanding the roles of mstn gene in fish.	[Dong, Zhangji; Li, Kui; Liang, Dong; Li, Jingyun; Li, Junbo; Jia, Wenshuang; Dong, Xiaohua; Cao, Shasha; Wang, Xiaoxiao; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Peoples R China; [Zhao, Qingshun] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China; [Ge, Jiachun; Xu, Zhiqiang; Li, Yuehua; Pan, Jianlin] Freshwater Fisheries Res Inst Jiangsu Prov, Nanjing, Peoples R China; [Ge, Jiachun; Xu, Zhiqiang] Nanjing Normal Univ, Coll Life Sci, Nanjing, Peoples R China	Nanjing University; Wenzhou Medical University; Nanjing Normal University	Dong, ZJ (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Peoples R China.	qingshun@nju.edu.cn	LI, Yue/GRS-8071-2022		Fund for Independent Innovation on Agriculture Science and Technology of Jiangsu Province [CX(11)1036]; National Natural Science Foundation of China [30871439]; Natural Science Foundation of Jiangsu Province [BK2008484]; Fundamental Research Funds for the Central Universities [1114090302]	Fund for Independent Innovation on Agriculture Science and Technology of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Fund for Independent Innovation on Agriculture Science and Technology of Jiangsu Province [CX(11)1036], the National Natural Science Foundation of China (30871439), the Natural Science Foundation of Jiangsu Province (BK2008484), and the Fundamental Research Funds for the Central Universities (1114090302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2002, GENETICS, V161, P1169; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Lee CY, 2009, BIOCHEM BIOPH RES CO, V387, P766, DOI 10.1016/j.bbrc.2009.07.110; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Medeiros EF, 2009, AM J PHYSIOL-REG I, V297, pR235, DOI 10.1152/ajpregu.91020.2008; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Pan JL, 2007, DNA SEQUENCE, V18, P279, DOI 10.1080/10425170701243492; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Stinckens A, 2011, ANIM GENET, V42, P229, DOI 10.1111/j.1365-2052.2010.02144.x; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108	27	59	69	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28897	10.1371/journal.pone.0028897	http://dx.doi.org/10.1371/journal.pone.0028897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194943	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100120
J	Du, HJ; Massiah, MA				Du, Haijuan; Massiah, Michael A.			NMR Studies of the C-Terminus of alpha4 Reveal Possible Mechanism of Its Interaction with MID1 and Protein Phosphatase 2A	PLOS ONE			English	Article							SENSITIVE SIGNAL-TRANSDUCTION; SYNDROME GENE-PRODUCT; CHEMICAL-SHIFT INDEX; OPITZ G/BBB SYNDROME; REGULATORY SUBUNIT; CATALYTIC SUBUNIT; INTRINSIC FLEXIBILITY; UBIQUITIN LIGASE; CELL-DIVISION; RAPAMYCIN	Alpha4 is a regulatory subunit of the protein phosphatase family of enzymes and plays an essential role in regulating the catalytic subunit of PP2A (PP2Ac) within the rapamycin-sensitive signaling pathway. Alpha4 also interacts with MID1, a microtubule-associated ubiquitin E3 ligase that appears to regulate the function of PP2A. The C-terminal region of alpha4 plays a key role in the binding interaction of PP2Ac and MID1. Here we report on the solution structure of a 45-amino acid region derived from the C-terminus of alpha4 (alpha45) that binds tightly to MID1. In aqueous solution, alpha45 has properties of an intrinsically unstructured peptide although chemical shift index and dihedral angle estimation based on chemical shifts of backbone atoms indicate the presence of a transient alpha-helix. Alpha45 adopts a helix-turn-helix HEAT-like structure in 1% SDS micelles, which may mimic a negatively charged surface for which alpha45 could bind. Alpha45 binds tightly to the Bbox1 domain of MID1 in aqueous solution and adopts a structure consistent with the helix-turn-helix structure observed in 1% SDS. The structure of alpha45 reveals two distinct surfaces, one that can interact with a negatively charged surface, which is present on PP2A, and one that interacts with the Bbox1 domain of MID1.	[Du, Haijuan; Massiah, Michael A.] George Washington Univ, Dept Chem, Washington, DC 20052 USA	George Washington University	Du, HJ (corresponding author), George Washington Univ, Dept Chem, Washington, DC 20052 USA.	massiah@gwu.edu			Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR09-065]; National Science Foundation [0546506]; Direct For Biological Sciences [1052520] Funding Source: National Science Foundation	Oklahoma Center for the Advancement of Science and Technology (OCAST); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by funds from The Oklahoma Center for the Advancement of Science and Technology (OCAST) (HR09-065) and the National Science Foundation (#0546506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN NH, 1992, BIOCHEM BIOPH RES CO, V184, P1008, DOI 10.1016/0006-291X(92)90691-D; Aranda-Orgilles B, 2008, HUM GENET, V123, P163, DOI 10.1007/s00439-007-0456-6; Bystrom R, 2008, CELL BIOCHEM BIOPHYS, V52, P175, DOI 10.1007/s12013-008-9033-4; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Smetana JHC, 2006, BBA-PROTEINS PROTEOM, V1764, P724, DOI 10.1016/j.bbapap.2006.01.018; Cox TC, 2000, HUM MOL GENET, V9, P2553, DOI 10.1093/hmg/9.17.2553; Cox TC, 2004, CLIN GENET, V65, P163, DOI 10.1111/j.0009-9163.2004.00225.x; Cygnar KD, 2005, GENETICS, V170, P733, DOI 10.1534/genetics.104.039909; DANCHECK B, 2008, BIOCHEMISTRY; De Falco F, 2003, AM J MED GENET A, V120A, P222, DOI 10.1002/ajmg.a.10265; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dutcher Janice P, 2004, Curr Oncol Rep, V6, P111, DOI 10.1007/s11912-004-0022-5; Everett AD, 2002, DEV DYNAM, V224, P461, DOI 10.1002/dvdy.10125; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Galea CA, 2008, J MOL BIOL, V376, P827, DOI 10.1016/j.jmb.2007.12.016; Gaudenz K, 1998, AM J HUM GENET, V63, P703, DOI 10.1086/302010; Goddard T.D., SPARKY 3; Graham JM, 2003, AM J MED GENET A, V123A, P37, DOI 10.1002/ajmg.a.20504; Granata A, 2003, DEV BIOL, V258, P397, DOI 10.1016/S0012-1606(03)00131-3; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Han XF, 2011, J MOL BIOL, V407, P505, DOI 10.1016/j.jmb.2011.01.048; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; INUI S, 1995, J IMMUNOL, V154, P2714; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE MS, 1992, J BIOMOL NMR, V2, P307, DOI 10.1007/BF01874810; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Massiah MA, 2006, J MOL BIOL, V358, P532, DOI 10.1016/j.jmb.2006.02.009; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; Mita Monica M, 2003, Clin Breast Cancer, V4, P126, DOI 10.3816/CBC.2003.n.018; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Onda M, 1997, GENOMICS, V46, P373, DOI 10.1006/geno.1997.5048; PARKER W, 1992, BIOPHYS J, V61, P1435, DOI 10.1016/S0006-3495(92)81949-5; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Rao RD, 2004, CURR CANCER DRUG TAR, V4, P621, DOI 10.2174/1568009043332718; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Schweiger S, 1999, P NATL ACAD SCI USA, V96, P2794, DOI 10.1073/pnas.96.6.2794; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Short KM, 2006, J BIOL CHEM; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tao H, 2008, BIOCHEMISTRY-US, V47, P2450, DOI 10.1021/bi7018496; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Turowski P, 1997, EUR J BIOCHEM, V248, P200, DOI 10.1111/j.1432-1033.1997.t01-1-00200.x; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WISHART DS, 1994, J BIOMOL NMR, V222, P311; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118	57	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28877	10.1371/journal.pone.0028877	http://dx.doi.org/10.1371/journal.pone.0028877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194938	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100116
J	Riordan, P; Delahay, RJ; Cheeseman, C; Johnson, PJ; Macdonald, DW				Riordan, Philip; Delahay, Richard John; Cheeseman, Chris; Johnson, Paul James; Macdonald, David Whyte			Culling-Induced Changes in Badger (Meles meles) Behaviour, Social Organisation and the Epidemiology of Bovine Tuberculosis	PLOS ONE			English	Article							HIGH-DENSITY POPULATION; MYCOBACTERIUM-BOVIS; EUROPEAN BADGER; SPATIAL-ORGANIZATION; EURASIAN BADGERS; DYNAMICS; DISEASE; CATTLE; MOVEMENT; TRANSMISSION	In the UK, attempts since the 1970s to control the incidence of bovine tuberculosis (bTB) in cattle by culling a wildlife host, the European badger (Meles meles), have produced equivocal results. Culling-induced social perturbation of badger populations may lead to unexpected outcomes. We test predictions from the 'perturbation hypothesis', determining the impact of culling operations on badger populations, movement of surviving individuals and the influence on the epidemiology of bTB in badgers using data dervied from two study areas within the UK Government's Randomised Badger Culling Trial (RBCT). Culling operations did not remove all individuals from setts, with between 34-43% of badgers removed from targeted social groups. After culling, bTB prevalence increased in badger social groups neighbouring removals, particularly amongst cubs. Seventy individual adult badgers were fitted with radio-collars, yielding 8,311 locational fixes from both sites between November 2001 and December 2003. Home range areas of animals surviving within removed groups increased by 43.5% in response to culling. Overlap between summer ranges of individuals from Neighbouring social groups in the treatment population increased by 73.3% in response to culling. The movement rate of individuals between social groups was low, but increased after culling, in Removed and Neighbouring social groups. Increased bTB prevalence in Neighbouring groups was associated with badger movements both into and out of these groups, although none of the moving individuals themselves tested positive for bTB. Significant increases in both the frequency of individual badger movements between groups and the emergence of bTB were observed in response to culling. However, no direct evidence was found to link the two phenomena. We hypothesise that the social disruption caused by culling may not only increase direct contact and thus disease transmission between surviving badgers, but may also increase social stress within the surviving population, causing immunosuppression and enhancing the expression of disease.	[Riordan, Philip; Johnson, Paul James; Macdonald, David Whyte] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England; [Delahay, Richard John; Cheeseman, Chris] Food & Environm Res Agcy, York, N Yorkshire, England	University of Oxford; Food & Environment Research Agency	Riordan, P (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, S Parks Rd, Oxford OX1 3PS, England.	philip.riordan@zoo.ox.ac.uk	Delahay, Richard/GSI-4663-2022; Delahay, Richard/J-2261-2014; Riordan, Philip/AAY-6420-2020	Riordan, Philip/0000-0001-6285-8596	Defra [SE3108]; People's Trust for Endangered Species (WildCRU)	Defra(Department for Environment, Food & Rural Affairs (DEFRA)); People's Trust for Endangered Species (WildCRU)	Funding was provided by Defra (project SE3108) and the People's Trust for Endangered Species (WildCRU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDERSON RM, 1981, NATURE, V289, P765, DOI 10.1038/289765a0; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Anwar MA, 2000, PARASITOLOGY, V120, P255, DOI 10.1017/S0031182099005491; BARNARD CJ, 1993, PARASITOLOGY, V107, P183, DOI 10.1017/S0031182000067299; Blundell GM, 2001, ECOL MONOGR, V71, P469, DOI 10.1890/0012-9615(2001)071[0469:LHREOS]2.0.CO;2; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Bohm M, 2008, J ANIM ECOL, V77, P735, DOI 10.1111/j.1365-2656.2008.01377.x; BOURNE FJ, 1998, 1 MAFF IND SCI GROUP; Bourne J, 2005, CATTLE PRACT, V13, P289; CARTER SP, 2009, MANAGEMENT DIS WILD, pCH7; Chambers MA, 2002, VET MICROBIOL, V86, P183, DOI 10.1016/S0378-1135(02)00012-3; Cheeseman C.L., 1993, P78; CHEESEMAN CL, 1988, MAMMAL REV, V18, P61, DOI 10.1111/j.1365-2907.1988.tb00073.x; CHEESEMAN CL, 1988, MAMMAL REV, V18, P51, DOI 10.1111/j.1365-2907.1988.tb00071.x; CHEESEMAN CL, 1981, J APPL ECOL, V18, P795, DOI 10.2307/2402370; CHEESEMAN CL, 1982, J ZOOL, V197, P289; CHRISTIAN SF, 1994, Z SAUGETIERKD, V59, P218; CLIFTONHADLEY RS, 1993, EPIDEMIOL INFECT, V111, P9, DOI 10.1017/S0950268800056624; Conner MM, 2004, ECOL APPL, V14, P1870, DOI 10.1890/03-5309; Corner LAL, 2003, NEW ZEAL VET J, V51, P73, DOI 10.1080/00480169.2003.36343; Courtenay O, 2006, BIOL LETT-UK, V2, P460, DOI 10.1098/rsbl.2006.0468; CRESSWELL WJ, 1992, PHILOS T ROY SOC B, V338, P393, DOI 10.1098/rstb.1992.0157; de Leeuw ANS, 2004, VET J, V167, P186, DOI 10.1016/S1090-0233(03)00113-8; de Lisle GW, 2001, REV SCI TECH OIE, V20, P86, DOI 10.20506/rst.20.1.1262; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Delahay RJ, 2006, ANIM BEHAV, V71, P1047, DOI 10.1016/j.anbehav.2005.07.018; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Drewe JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011196; Dugdale HL, 2007, MOL ECOL, V16, P5294, DOI 10.1111/j.1365-294X.2007.03571.x; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Hemson G, 2005, J ANIM ECOL, V74, P455, DOI 10.1111/j.1365-2656.2005.00944.x; Jenkins HE, 2008, INT J INFECT DIS, V12, P457, DOI 10.1016/j.ijid.2008.04.001; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; KENWARD RE, MANUAL WILDLIFE RADI; Krebs J., 1997, PB3423 HMSO; KRUUK H, 1978, J ZOOL, V184, P1; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Macdonald David, 1995, P33; Macdonald DW, 2008, J MAMMAL, V89, P1077, DOI 10.1644/07-MAMM-A-185.1; MacDonald DW, 2006, BIOL CONSERV, V131, P268, DOI 10.1016/j.biocon.2006.05.006; MacDonald DW, 2004, ANIM BEHAV, V67, P745, DOI 10.1016/j.anbehav.2003.08.021; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; Mian Rubina, 2005, P61; Montes I, 2011, J ZOOL, V284, P114, DOI 10.1111/j.1469-7998.2010.00787.x; Moore JAH, 2003, MAMMAL REV, V33, P308, DOI 10.1046/j.1365-2907.2003.00021.x; MUIRHEAD RH, 1974, VET REC, V95, P552, DOI 10.1136/vr.95.24.552; Olsson GE, 1996, WILDLIFE BIOL, V2, P11, DOI 10.2981/wlb.1996.003; Pope LC, 2007, MOL ECOL, V16, P4919, DOI 10.1111/j.1365-294X.2007.03553.x; RIORDAN P, 2007, KEY TOPICS CONSERVAT; Rogers LM, 1998, P ROY SOC B-BIOL SCI, V265, P1269, DOI 10.1098/rspb.1998.0429; SAS Institute Inc, 1997, SAS STAT SOFTW CHANG; South AB, 2002, DISPERSAL ECOLOGY, P327; Swinton J, 1997, PHILOS T R SOC B, V352, P619, DOI 10.1098/rstb.1997.0042; Tuyttens F. A. M., 2000, BEHAV CONSERVATION; Tuyttens FAM, 2000, J ANIM ECOL, V69, P567, DOI 10.1046/j.1365-2656.2000.00419.x; Tuyttens FAM, 2000, J ANIM ECOL, V69, P815, DOI 10.1046/j.1365-2656.2000.00437.x; Vicente J, 2007, J ANIM ECOL, V76, P348, DOI 10.1111/j.1365-2656.2006.01199.x; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; WOODROFFE R, 1995, J ZOOL, V237, P227, DOI 10.1111/j.1469-7998.1995.tb02760.x; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003	71	40	41	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28904	10.1371/journal.pone.0028904	http://dx.doi.org/10.1371/journal.pone.0028904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194946	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100122
J	Yang, XL; Jin, HY; Liu, K; Gu, Q; Xu, X				Yang, Xiaolu; Jin, Huiyi; Liu, Kun; Gu, Qing; Xu, Xun			A Novel Peptide Derived from Human Pancreatitis-Associated Protein Inhibits Inflammation In Vivo and In Vitro and Blocks NF-Kappa B Signaling Pathway	PLOS ONE			English	Article							ENDOTOXIN-INDUCED UVEITIS; OCULAR INFLAMMATION; INTRAVITREAL INJECTION; GENE-EXPRESSION; MECHANISM; ADHESION; MODEL; RATS; ANTIBACTERIAL; ACTIVATION	Background: Pancreatitis-associated protein (PAP) is a pancreatic secretory protein belongs to the group VII of C-type lectin family. Emerging evidence suggests that PAP plays a protective effect in inflammatory diseases. In the present study, we newly identified a 16-amino-acid peptide (named PAPep) derived from C-type lectin-like domain (CTLD) of human PAP with potent anti-inflammatory activity using both in vivo and in vitro assays. Methodology/Principal Findings: We assessed the anti-inflammatory effect of PAPep on endotoxin-induced uveitis (EIU) in rats and demonstrated that intravitreal pretreatment of PAPep concentration-dependently attenuated clinical manifestation of EIU rats, reduced protein leakage and cell infiltration into the aqueous humor (AqH), suppressed tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein (MCP)-1 production in ocular tissues, and improved histopathologic manifestation of EIU. Furthermore, PAPep suppressed the LPS-induced mRNA expression of TNF-alpha and IL-6 in RAW 264.7 cells, inhibited protein expression of ICAM-1 in TNF-alpha-stimulated human umbilical vein endothelial cells (HUVECs) as well as U937 cells adhesion to HUVECs. Western blot analysis in ocular tissues and different cell lines revealed that the possible mechanism for this anti-inflammatory effect of PAPep may depend on its ability to inhibit the activation of NF-kB signaling pathway. Conclusions/Significance: Our studies provide the first evidence that the sequence of PAPep is within the critically active region for the anti-inflammatory function of PAP and the peptide may be a promising candidate for the management of ocular inflammatory diseases.	[Yang, Xiaolu; Jin, Huiyi; Liu, Kun; Gu, Qing; Xu, Xun] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai, Peoples R China; [Yang, Xiaolu; Jin, Huiyi; Liu, Kun; Gu, Qing; Xu, Xun] Shanghai Key Lab Fundus Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University	Yang, XL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai, Peoples R China.	drxuxun@sjtu.edu.cn			National Natural Science Foundation of China [30930097, 30872827]; National Science and Technology Major Project [20112X09302-007-02]; Medicine-Industry Interdisciplinary Foundation of Shanghai Jiaotong University [YG2010ZD206]; Shanghai Jiaotong University [BXJ201134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Medicine-Industry Interdisciplinary Foundation of Shanghai Jiaotong University; Shanghai Jiaotong University	This work was sponsored by Key Program (No. 30930097) and General Program (No. 30872827) of National Natural Science Foundation of China, http://www.nsfc.gov.cn/Portal0/default152.htm; National Science and Technology Major Project (20112X09302-007-02), http://www.nmp.gov.cn/zxjs/zdxy/201012/t20101208_2128.htm; Medicine-Industry Interdisciplinary Foundation of Shanghai Jiaotong University (YG2010ZD206), http://www.sjtu.edu.cn/info/news/kjw/content_kj/10854.htm; Doctoral Innovation Fund of Shanghai Jiaotong University (BXJ201134), http://yjsy.shsmu.edu.cn//cxjh/485.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo D, 2006, POSTGRAD MED J, V82, P186, DOI 10.1136/pgmj.2005.039586; Behar-Cohen FF, 1998, INVEST OPHTH VIS SCI, V39, P897; BHATTACHERJEE P, 1983, INVEST OPHTH VIS SCI, V24, P196; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Chang JHM, 2002, OCUL IMMUNOL INFLAMM, V10, P263, DOI 10.1076/ocii.10.4.263.15592; Chekmenev EY, 2006, BBA-BIOMEMBRANES, V1758, P1359, DOI 10.1016/j.bbamem.2006.03.034; Cheng LY, 2010, INVEST OPHTH VIS SCI, V51, P474, DOI 10.1167/iovs.09-3672; Christa L, 1996, AM J PHYSIOL-GASTR L, V271, pG993, DOI 10.1152/ajpgi.1996.271.6.G993; CHRISTIAN W, 1995, CIRCULATION, V91, P1914; Closa D, 2007, WORLD J GASTROENTERO, V13, P170, DOI 10.3748/wjg.v13.i2.170; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P1100; Ferres-Maso M, 2009, CELL MOL LIFE SCI, V66, P2195, DOI 10.1007/s00018-009-0040-4; FitzGerald GA, 2004, JCR-J CLIN RHEUMATOL, V10, pS12, DOI 10.1097/01.rhu.0000130685.73681.8b; Folch-Puy E, 2006, J IMMUNOL, V176, P3774, DOI 10.4049/jimmunol.176.6.3774; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gironella M, 2005, GUT, V54, P1244, DOI 10.1136/gut.2004.056309; Granado M, 2005, AM J PHYSIOL-ENDOC M, V288, pE486, DOI 10.1152/ajpendo.00196.2004; Hafezi-Moghadam A, 2007, FASEB J, V21, P464, DOI 10.1096/fj.06-6390com; Heller A, 1999, ANESTHESIOLOGY, V91, P1408, DOI 10.1097/00000542-199911000-00034; Hernandez-Ledesma B, 2009, BIOCHEM BIOPH RES CO, V390, P803, DOI 10.1016/j.bbrc.2009.10.053; Iovanna JL, 2005, BBA-GEN SUBJECTS, V1723, P8, DOI 10.1016/j.bbagen.2005.01.002; KEIM V, 1984, DIGESTION, V29, P242, DOI 10.1159/000199041; Kolusheva S, 2008, PEPTIDES, V29, P1620, DOI 10.1016/j.peptides.2008.05.012; Kubota S, 2009, INVEST OPHTH VIS SCI, V50, P3512, DOI 10.1167/iovs.08-2666; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lajavardi L, 2007, INVEST OPHTH VIS SCI, V48, P3230, DOI 10.1167/iovs.06-1305; Li S, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/748218; Li X, 2008, INT J PHARMACEUT, V363, P177, DOI 10.1016/j.ijpharm.2008.07.017; Lin CP, 2011, J SCI FOOD AGR, V91, P1751, DOI 10.1002/jsfa.4371; Miyahara S, 2004, INVEST OPHTH VIS SCI, V45, P4197, DOI 10.1167/iovs.04-0192; Miyazaki A, 2008, GRAEF ARCH CLIN EXP, V246, P747, DOI 10.1007/s00417-007-0730-2; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Noda K, 2008, FASEB J, V22, P1094, DOI 10.1096/fj.07-9377com; Novotny NM, 2008, CYTOKINE, V43, P215, DOI 10.1016/j.cyto.2008.05.015; Ooi KGJ, 2006, CLIN MED RES, V4, P294, DOI 10.3121/cmr.4.4.294; Pan LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019766; Park KH, 2009, BBA-BIOMEMBRANES, V1788, P1193, DOI 10.1016/j.bbamem.2009.02.020; Planck SR, 2008, INFLAMMATION, V31, P105, DOI 10.1007/s10753-007-9055-x; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Samudre SS, 2004, J OCUL PHARMACOL TH, V20, P533, DOI 10.1089/jop.2004.20.533; Satofuka S, 2006, INVEST OPHTH VIS SCI, V47, P2686, DOI 10.1167/iovs.05-1458; Song YM, 2005, BIOCHEMISTRY-US, V44, P12094, DOI 10.1021/bi050765p; Suhler EB, 2008, AM J OPHTHALMOL, V146, P890, DOI 10.1016/j.ajo.2008.09.014; Tellier Z, 2007, ANN NY ACAD SCI, V1110, P337, DOI 10.1196/annals.1423.036; Touchard E, 2010, INVEST OPHTH VIS SCI, V51, P4683, DOI 10.1167/iovs.09-4733; Tuaillon N, 2002, INVEST OPHTH VIS SCI, V43, P1493; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Valery C, 2001, J INVEST DERMATOL, V116, P426, DOI 10.1046/j.1523-1747.2001.01278.x; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Viterbo D, 2009, J PANCREAS, V10, P15; Wang YP, 2000, KIDNEY INT, V57, P2011, DOI 10.1046/j.1523-1755.2000.00051.x; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; WHITCUP SM, 1995, EXP EYE RES, V60, P597, DOI 10.1016/S0014-4835(05)80001-6; Xie D, 2010, ANTIMICROB AGENTS CH, V54, P191, DOI 10.1128/AAC.00976-09; Yadav UCS, 2009, INVEST OPHTH VIS SCI, V50, P2276, DOI 10.1167/iovs.08-2816; Zhang H, 2004, SCAND J GASTROENTERO, V39, P870, DOI 10.1080/00365520410006477; Zhang R, 2010, INVEST OPHTH VIS SCI, V51, P3575, DOI 10.1167/iovs.09-4373	61	20	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29155	10.1371/journal.pone.0029155	http://dx.doi.org/10.1371/journal.pone.0029155			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195011	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100163
J	Gu, DY; Wang, ML; Wang, SZ; Zhang, ZD; Chen, JF				Gu, Dongying; Wang, Meilin; Wang, Shizhi; Zhang, Zhengdong; Chen, Jinfei			The DNA Repair Gene APE1 T1349G Polymorphism and Risk of Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							BASE EXCISION-REPAIR; ACID SUBSTITUTION VARIANTS; LUNG-CANCER; EPIDEMIOLOGY; MECHANISMS; XRCC1	Background: Apurinic/apyrimidinic endonuclease 1 (APE1) has a central role in the repair of apurinic apyrimidic sites through both its endonuclease and its phosphodiesterase activities. A common APE1 polymorphism, T1349G (rs3136820), was previously shown to be associated with the risk of cancers. Objective: We hypothesized that the APE1 T1349G polymorphism is also associated with risk of gastric cancer. Methods: In a hospital-based case-control study of 338 case patients with newly diagnosed gastric cancer and 362 cancer-free controls frequency-matched by age and sex, we genotyped the T1349G polymorphism and assessed its associations with risk of gastric cancer. Results: Compared with the APE1 TT genotype, individuals with the variant TG/GG genotypes had a significantly increased risk of gastric cancer (odds ratio = 1.69, 95% confidence interval = 1.19-2.40), which was more pronounced among subgroups of aged <= 60 years, male, ever smokers, and ever drinkers. Further analyses revealed that the variant genotypes were associated with an increased risk for diffuse-type, low depth of tumor infiltration (T1 and T2), and lymph node metastasis gastric cancer. Conclusions: The APE1 T1349G polymorphism may be a marker for the development of gastric cancer in the Chinese population. Larger studies are required to validate these findings in diverse populations.	[Gu, Dongying; Chen, Jinfei] Nanjing Med Univ, Dept Oncol, Affiliated Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Wang, Shizhi; Zhang, Zhengdong] Nanjing Med Univ, Dept Mol & Genet Toxicol, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Gu, DY (corresponding author), Nanjing Med Univ, Dept Oncol, Affiliated Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	jinfeichen@sohu.com	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [81071641]; Natural Science Foundation of Jiangsu Province [BK2010120]; Science Project and Program of Nanjing [201001099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Science Project and Program of Nanjing	This study was partly supported by the National Natural Science Foundation of China (81071641), the Natural Science Foundation of Jiangsu Province (BK2010120), and the Science Project and Program of Nanjing (201001099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canbay E, 2010, ANTICANCER RES, V30, P1359; Christmann M, 2003, TOXICOLOGY, V193, P3, DOI 10.1016/S0300-483X(03)00287-7; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Crew KD, 2004, SEMIN ONCOL, V31, P450, DOI 10.1053/j.seminoncol.2004.04.021; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Gu DY, 2009, MUTAGENESIS, V24, P507, DOI 10.1093/mutage/gep036; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hecht SS, 2002, ENVIRON MOL MUTAGEN, V39, P119, DOI 10.1002/em.10071; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu JJ, 2001, CARCINOGENESIS, V22, P917, DOI 10.1093/carcin/22.6.917; Izumi T, 2000, CARCINOGENESIS, V21, P1329, DOI 10.1093/carcin/21.7.1329; Kelley MR, 2001, CLIN CANCER RES, V7, P824; Li WQ, 2009, CARCINOGENESIS, V30, P500, DOI 10.1093/carcin/bgp018; Li ZX, 2009, GASTRIC CANCER, V12, P52, DOI 10.1007/s10120-008-0495-2; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Misra RR, 2003, CANCER LETT, V191, P171, DOI 10.1016/S0304-3835(02)00638-9; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Popanda O, 2004, CARCINOGENESIS, V25, P2433, DOI 10.1093/carcin/bgh264; Ramos-De la Medina A, 2004, J GASTROINTEST SURG, V8, P240, DOI 10.1016/j.gassur.2003.12.009; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu DM, 2009, CANCER SCI, V100, P1688, DOI 10.1111/j.1349-7006.2009.01229.x; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhao QH, 2011, CANCER SCI, V102, P1293, DOI 10.1111/j.1349-7006.2011.01959.x; Zhu HJ, 2006, CARCINOGENESIS, V27, P2491, DOI 10.1093/carcin/bgl121	29	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28971	10.1371/journal.pone.0028971	http://dx.doi.org/10.1371/journal.pone.0028971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205985	Green Published, gold, Green Submitted			2022-12-25	WOS:000298665600018
J	Bosmann, M; Sarma, JV; Atefi, G; Zetoune, FS; Ward, PA				Bosmann, Markus; Sarma, J. Vidya; Atefi, Gelareh; Zetoune, Firas S.; Ward, Peter A.			Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis	FASEB JOURNAL			English	Article						macrophages; interleukin-10; C5L2; endotoxic shock	CELL-DIFFERENTIATION; ESCHERICHIA-COLI; IL-17 PRODUCTION; DENDRITIC CELLS; REGULATORY ROLE; IFN-GAMMA; RECEPTOR; COMPLEMENT; ANAPHYLATOXIN; DRIVES	There is growing evidence that the complement activation product C5a positively or negatively regulates inflammatory functions. The studies presented here report that C5a exerts anti-inflammatory effects by altering production of the cytokines IL-17A and IL-23 during endotoxic shock in young adult male C57BL/6J mice and has similar effects on macrophages from the same mice. IL-17A and IL-23 both appeared in plasma during endotoxemia, and their neutralization improved survival. The relevant sources of IL-17A during endotoxemia were not CD4(+) cells, gamma delta T cells, or NK cells but CD11b(+)F4/80(+) macrophages. The addition in vitro of C5a to lipopolysaccharide-activated peritoneal macrophages dose dependently antagonized the production of IL-17A (IC50, 50-100 nM C5a) and IL-23 (IC50, 10 nM C5a). This suppression required the receptor C5aR, but was independent of the second C5a receptor, C5L2. Genetic absence of C5aR was associated with much higher levels of IL-17A and IL-23 during endotoxic shock. Mechanistically, C5a mediated its effects on the IL-17A/IL-23 axis in a 2-step process. C5a caused activation of the PI3K-Akt and MEK1/2-ERK1/2 pathways, resulting in induction of IL-10, which powerfully inhibited production of IL-17A and IL-23. These data identify previously unknown mechanisms by which the anaphylatoxin C5a limits acute inflammation and antagonizes the IL-17A/IL-23 axis.-Bosmann, M., Sarma, J. V., Atefi, G., Zetoune, F. S., Ward, P. A. Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis. FASEB J. 26, 1640-1651 (2012). www.fasebj.org	[Bosmann, Markus; Sarma, J. Vidya; Atefi, Gelareh; Zetoune, Firas S.; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd, Ann Arbor, MI 48109 USA.	pward@umich.edu		Bosmann, Markus/0000-0003-2773-1033	U.S. National Institutes of Health [GM-29507, GM-61656]; Deutsche Forschungsgemeinschaft [571701, BO 3482/1-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029507, R01GM061656, R37GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health, grants GM-29507 and GM-61656 (to P. A. W.), along with the Deutsche Forschungsgemeinschaft, project 571701, BO 3482/1-1 (to M. B.). The authors cordially thank Beverly Schumann, Sue Scott, and Robin Kunkel for assistance in the preparation of the manuscript.	Atefi G, 2011, FASEB J, V25, P2500, DOI 10.1096/fj.11-183236; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bosmann M, 2011, FASEB J, V25, P4222, DOI 10.1096/fj.11-191205; Bosmann M, 2011, SHOCK, V36, P396, DOI 10.1097/SHK.0b013e3182295f5f; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Guo RF, 2006, J LEUKOCYTE BIOL, V80, P1575, DOI 10.1189/jlb.0106065; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hollmann TJ, 2008, MOL IMMUNOL, V45, P1907, DOI 10.1016/j.molimm.2007.10.037; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lalli PN, 2008, BLOOD, V112, P1759, DOI 10.1182/blood-2008-04-151068; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu JB, 2008, J IMMUNOL, V180, P5882, DOI 10.4049/jimmunol.180.9.5882; Liu XKK, 2005, MOL CELLS, V20, P339; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Peerschke EI, 2010, MOL IMMUNOL, V47, P2170, DOI 10.1016/j.molimm.2010.05.009; Ramos TN, 2009, NEUROSCI LETT, V467, P234, DOI 10.1016/j.neulet.2009.10.045; Reiman R, 2002, EUR J IMMUNOL, V32, P1157, DOI 10.1002/1521-4141(200204)32:4<1157::AID-IMMU1157>3.3.CO;2-D; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Takahashi N, 2008, J EXP MED, V205, P1755, DOI 10.1084/jem.20080588; Taylor FB, 2001, CRIT CARE MED, V29, pS78, DOI 10.1097/00003246-200107001-00026; Taylor FB, 2006, ADV EXP MED BIOL, V586, P203; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Wittmann M, 1999, J IMMUNOL, V162, P6763; Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636	50	55	56	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1640	1651		10.1096/fj.11-199216	http://dx.doi.org/10.1096/fj.11-199216			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22202675	Green Published, Green Submitted			2022-12-25	WOS:000302359700025
J	Auldridge, ME; Satyshur, KA; Anstrom, DM; Forest, KT				Auldridge, Michele E.; Satyshur, Kenneth A.; Anstrom, David M.; Forest, Katrina T.			Structure-guided Engineering Enhances a Phytochrome-based Infrared Fluorescent Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; CHROMOPHORE-BINDING DOMAIN; RAMAN-SPECTROSCOPY; CRYSTAL-STRUCTURE; QUANTUM YIELD; GROUND-STATE; PHOTOCONVERSION; LIGHT; REFINEMENT; PFR	Phytochrome is a multidomain dimeric red light photoreceptor that utilizes a chromophore-binding domain (CBD), a PHY domain, and an output module to induce cellular changes in response to light. A promising biotechnology tool emerged when a structure-based substitution at Asp-207 was shown to be an infrared fluorophore that uses a biologically available tetrapyrrole chromophore. We report multiple crystal structures of this D207H variant of the Deinococcus radiodurans CBD, in which His-207 is observed to form a hydrogen bond with either the tetrapyrrole A-ring oxygen or the Tyr-263 hydroxyl. Based on the implications of this duality for fluorescence properties, Y263F was introduced and shown to have stronger fluorescence than the original D207H template. Our structures are consistent with the model that the Y263F change prevents a red light-induced far-red light absorbing phytochrome chromophore configuration. With the goal of decreasing size and thereby facilitating use as a fluorescent tag in vivo, we also engineered a monomeric form of the CBD. Unexpectedly, photoconversion was observed in the monomer despite the lack of a PHY domain. This observation underscores an interplay between dimerization and the photochemical properties of phytochrome and suggests that the monomeric CBD could be used for further studies of the photocycle. The D207H substitution on its own in the monomer did not result in fluorescence, whereas Y263F did. Combined, the D207H and Y263F substitutions in the monomeric CBD lead to the brightest of our variants, designated Wisconsin infrared phytofluor (Wi-Phy).	[Auldridge, Michele E.; Satyshur, Kenneth A.; Anstrom, David M.; Forest, Katrina T.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Forest, KT (corresponding author), Univ Wisconsin, Dept Bacteriol, 6552 Microbial Sci Bldg,1550 Linden Dr, Madison, WI 53706 USA.	forest@bact.wisc.edu		Satyshur, Kenneth/0000-0001-9371-2493	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corp; Michigan Technology Tri-Corridor [085P1000817]; National Science Foundation [BIR-9512577, MCB0424062, MCB07191530]; National Institutes of Health [S10 RR13790, GM59721]; University of Wisconsin-Madison Graduate School; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059721] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corp; Michigan Technology Tri-Corridor; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison Graduate School; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Robert Landick and Jorge Escalante-Semerena for use of equipment, Dr. Darrell McCaslin for carrying out analytical centrifugation experiments, Dr. Roger Tsien for the gift of an IFP1.4-expressing plasmid, and Shyamosree Bhattacharya for purification of IFP1.4. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817). Analytical centrifugation data were obtained at the University of Wisconsin-Madison Biophysics Instrumentation Facility, which is supported by National Science Foundation Grant BIR-9512577 and National Institutes of Health Grant S10 RR13790.; This work was supported, in whole or in part, by National Institutes of Health Grant GM59721 (to K. T. F.). This work was also supported by a grant from the University of Wisconsin-Madison Graduate School (to K. T. F.) and National Science Foundation Grants MCB0424062 and MCB07191530 (to R. D. Vierstra and K. T. F.).	Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Murphy JT, 1997, CURR BIOL, V7, P870, DOI 10.1016/S0960-9822(06)00375-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PRATT LH, 1973, PLANT PHYSIOL, V51, P203, DOI 10.1104/pp.51.1.203; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Rohmer T, 2010, J AM CHEM SOC, V132, P4431, DOI 10.1021/ja9108616; Samma AA, 2010, J PHYS CHEM B, V114, P15362, DOI 10.1021/jp107119q; Schumann C, 2007, CHEMPHYSCHEM, V8, P1657, DOI 10.1002/cphc.200700210; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Toh KC, 2011, PHYS CHEM CHEM PHYS, V13, P11985, DOI 10.1039/c1cp00050k; Toh KC, 2010, P NATL ACAD SCI USA, V107, P9170, DOI 10.1073/pnas.0911535107; von Stetten D, 2008, ANGEW CHEM INT EDIT, V47, P4753, DOI 10.1002/anie.200705716; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Zienicke B, 2011, J BIOL CHEM, V286, P1103, DOI 10.1074/jbc.M110.155143	34	99	104	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7000	7009		10.1074/jbc.M111.295121	http://dx.doi.org/10.1074/jbc.M111.295121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22210774	Green Published, hybrid			2022-12-25	WOS:000301060200006
J	Chattopadhyay, S; Tchesnokova, V; McVeigh, A; Kisiela, DI; Dori, K; Navarro, A; Sokurenko, EV; Savarino, SJ				Chattopadhyay, Sujay; Tchesnokova, Veronika; McVeigh, Annette; Kisiela, Dagmara I.; Dori, Kathleen; Navarro, Armando; Sokurenko, Evgeni V.; Savarino, Stephen J.			Adaptive Evolution of Class 5 Fimbrial Genes in Enterotoxigenic Escherichia coli and Its Functional Consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR ANTIGEN-I; COLONIZATION FACTOR; FIMH ADHESIN; BINDING SPECIFICITIES; BACTERIAL ADHESION; CFA/I FIMBRIAE; MUTATIONS; DIARRHEA; DIVERSITY; VIRULENCE	Class 5 fimbriae of enterotoxigenic Escherichia coli (ETEC) comprise eight serologically discrete colonization factors that mediate small intestinal adhesion. Their differentiation has been attributed to the pressure imposed by host adaptive immunity. We sequenced the major pilin and minor adhesin subunit genes of a geographically diverse population of ETEC elaborating CFA/I (n = 31), CS17 (n = 20), and CS2 (n = 18) and elucidated the functional effect of microevolutionary processes. Between the fimbrial types, the pairwise nucleotide diversity for the pilin or adhesin genes ranged from 35-43%. Within each fimbrial type, there were 17 non-synonymous and 1 synonymous point mutations among all pilin or adhesin gene copies, implying that each fimbrial type was acquired by ETEC strains very recently, consistent with a recent origin of this E. coli pathotype. The 17 non-synonymous allelic differences occurred in the CFA/I pilin gene cfaB (two changes) and adhesin gene cfaE (three changes), and CS17 adhesin gene csbD (12 changes). All but one amino acid change in the adhesins clustered around the predicted ligand-binding pocket. Functionally, these changes conferred an increase in cell adhesion in a flow chamber assay. In contrast, the two mutations in the non-adhesive CfaB subunit localized to the intersubunit interface and significantly reduced fimbrial adhesion in this assay. In conclusion, naturally occurring mutations in the ETEC adhesive and non-adhesive subunits altered function, were acquired under positive selection, and are predicted to impact bacteria-host interactions.	[Chattopadhyay, Sujay; Tchesnokova, Veronika; Kisiela, Dagmara I.; Sokurenko, Evgeni V.] Univ Washington, Dept Microbiol, Sch Med, Seattle, WA 98195 USA; [McVeigh, Annette; Dori, Kathleen; Savarino, Stephen J.] USN, Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA; [Navarro, Armando] Univ Nacl Autonoma Mexico, Fac Med, Dept Salud Publ, Mexico City 04510, DF, Mexico; [Savarino, Stephen J.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA	University of Washington; University of Washington Seattle; United States Department of Defense; United States Navy; Universidad Nacional Autonoma de Mexico; Uniformed Services University of the Health Sciences - USA	Sokurenko, EV (corresponding author), Univ Washington, Dept Microbiol, Sch Med, Room E309,Hlth Sci Bldg,Campus Box 357242, Seattle, WA 98195 USA.	evs@u.washington.edu; stephen.savarino@med.navy.mil	NAVARRO, ARMANDO/AAO-7368-2020; Navarro, Armando/AAE-3832-2022; Chattopadhyay, Sujay/AAA-5772-2022	NAVARRO, ARMANDO/0000-0002-6693-7168; Chattopadhyay, Sujay/0000-0003-1785-2683	U.S. Army Medical Research and Materiel Command Award [6000 RAD1 DA2 A0307]; Henry M. Jackson Foundation for the Advancement of Military Medicine [G1876KI]	U.S. Army Medical Research and Materiel Command Award(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine	This work was supported by the U.S. Army Medical Research and Materiel Command Award 6000 RAD1 DA2 A0307 (to S. J. S.) and the Henry M. Jackson Foundation for the Advancement of Military Medicine Grant G1876KI (to S. J. S.).	Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P97; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; Baker KK, 2009, CELL MICROBIOL, V11, P742, DOI 10.1111/j.1462-5822.2009.01287.x; BARTUS H, 1985, J CLIN MICROBIOL, V21, P951, DOI 10.1128/JCM.21.6.951-954.1985; BLACK RE, 1990, REV INFECT DIS, V12, pS73; Bullitt E, 1998, BIOPHYS J, V74, P623, DOI 10.1016/S0006-3495(98)77821-X; Chattopadhyay S, 2007, J MOL EVOL, V64, P204, DOI 10.1007/s00239-006-0063-5; Chattopadhyay S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-187; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; EVANS DG, 1979, INFECT IMMUN, V25, P738, DOI 10.1128/IAI.25.2.738-748.1979; EVANS DG, 1975, INFECT IMMUN, V12, P656, DOI 10.1128/IAI.12.3.656-667.1975; EVANS DG, 1977, INFECT IMMUN, V18, P330, DOI 10.1128/IAI.18.2.330-337.1977; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Fleckenstein JM, 2010, MICROBES INFECT, V12, P89, DOI 10.1016/j.micinf.2009.10.002; Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298; Fussenegger M, 1997, GENE, V192, P125, DOI 10.1016/S0378-1119(97)00038-3; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Gomez-Duarte OG, 2007, J BACTERIOL, V189, P9145, DOI 10.1128/JB.00722-07; Grewal HMS, 1997, INFECT IMMUN, V65, P507, DOI 10.1128/IAI.65.2.507-513.1997; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUILAN S, 1991, B WORLD HEALTH ORGAN, V69, P549; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khalil S. B., 2000, 100 GEN M AM SOC MIC; Korotkova N, 2007, MOL MICROBIOL, V64, P180, DOI 10.1111/j.1365-2958.2007.05648.x; Li YF, 2007, J BIOL CHEM, V282, P23970, DOI 10.1074/jbc.M700921200; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; MADISON B, 1994, INFECT IMMUN, V62, P843, DOI 10.1128/IAI.62.3.843-848.1994; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NEI M, 1986, MOL BIOL EVOL, V3, P418; Philippe N, 2007, BIOESSAYS, V29, P846, DOI 10.1002/bies.20629; Poole ST, 2007, MOL MICROBIOL, V63, P1372, DOI 10.1111/j.1365-2958.2007.05612.x; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Sokurenko EV, 2004, MOL BIOL EVOL, V21, P1373, DOI 10.1093/molbev/msh136; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; Suzuki Y., 2004, PHYLOGENETIC HDB PRA, P283; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; von Sonnenburg F, 2000, LANCET, V356, P133, DOI 10.1016/S0140-6736(00)02451-X; Weissman SJ, 2007, INFECT IMMUN, V75, P3548, DOI 10.1128/IAI.01963-06; Weissman SJ, 2006, MOL MICROBIOL, V59, P975, DOI 10.1111/j.1365-2958.2005.04985.x; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	49	21	21	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6150	6158		10.1074/jbc.M111.303735	http://dx.doi.org/10.1074/jbc.M111.303735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215679	Green Published, hybrid			2022-12-25	WOS:000300791800008
J	Zhang, QH; Wang, CM; Liu, ZL; Liu, XG; Han, CF; Cao, XT; Li, N				Zhang, Qinghua; Wang, Chunmei; Liu, Zhaolong; Liu, Xingguang; Han, Chaofeng; Cao, Xuetao; Li, Nan			Notch Signal Suppresses Toll-like Receptor-triggered Inflammatory Responses in Macrophages by Inhibiting Extracellular Signal-regulated Kinase 1/2-mediated Nuclear Factor kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; NEGATIVE REGULATION; DEPENDENT PATHWAY; IL-10 PRODUCTION; DENDRITIC CELLS; UP-REGULATION; NITRIC-OXIDE; I INTERFERON; T-CELLS; LIPOPOLYSACCHARIDE	Multiple signaling pathways are involved in the tight regulation of Toll-like receptor (TLR) signaling, which is important for the tailoring of inflammatory response to pathogens in macrophages. It is widely accepted that TLR signaling can activate Notch pathway; however, whether full activation of Notch signaling can feedback modulate TLR signaling pathway so as to control inflammation response remains unclear. Here, we demonstrated that stimulation with TLR ligands up-regulated Notch1 and Notch2 expression in macrophages. The expression of Notch target genes including Hes1 and Hes5 was also induced in macrophages by LPS, suggesting that TLR4 signaling enhances the activation of Notch pathway. Importantly, overexpression of constituted active form of Notch1 (NICD1) and Notch2 (NICD2) suppressed production of TLR4-triggered pro-inflammatory cytokines such as TNF-alpha and IL-6 but promoted production of antiinflammatory cytokine IL-10, which is dependent on the PEST domain of NICD. In addition, NICD1 and NICD2 suppressed TLR-triggered ERK phosphorylation, which is indispensable for Notch-mediated inhibition of TLR4-triggered proinflammatory cytokine production. Furthermore, activation of Notch signaling inhibited NF-kappa B transcription activity by MyD88/TRAF6 and TRIF pathways, which was dependent on ERK activity. Therefore, our results showed that Notch signaling negatively regulates TLR-triggered inflammation responses, revealing a new mechanism for negative regulation of TLR signaling via Notch pathway.	[Zhang, Qinghua; Wang, Chunmei; Liu, Xingguang; Han, Chaofeng; Cao, Xuetao; Li, Nan] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Zhang, Qinghua; Wang, Chunmei; Liu, Xingguang; Han, Chaofeng; Cao, Xuetao; Li, Nan] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Zhang, Qinghua] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China; [Liu, Zhaolong] Peoples Hosp Pudong New Area, Dept Gen Surg, Shanghai 201200, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Ocean University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	caoxt@immunol.org; linan@immunol.org	Zhang, Qinghua/F-3602-2012		National Key Basic Research Program of China [2010CB911903, 2012CB910202]; National Natural Science Foundation of China [81123006, 30801009, 31070789]; Shanghai Committee of Science and Technology [10DZ1910300]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National Key Basic Research Program of China Grants 2010CB911903 and 2012CB910202, National Natural Science Foundation of China Grants 81123006, 30801009, and 31070789, and Shanghai Committee of Science and Technology Grant 10DZ1910300.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Cua DJ, 1997, J IMMUNOL, V159, P5834; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Foldi J, 2010, J IMMUNOL, V185, P5023, DOI 10.4049/jimmunol.1001544; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Heitzler P, 2010, CURR TOP DEV BIOL, V92, P457, DOI 10.1016/S0070-2153(10)92014-0; Hertzog P, 2008, IMMUNITY, V29, P663, DOI 10.1016/j.immuni.2008.10.006; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kassner N, 2010, J IMMUNOL, V184, P550, DOI 10.4049/jimmunol.0903152; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim MY, 2008, J CELL SCI, V121, P1466, DOI 10.1242/jcs.019018; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Okamoto M, 2008, J EXP MED, V205, P1087, DOI 10.1084/jem.20072200; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; RECHSTEINER M, 1988, ADV ENZYME REGUL, V27, P135; Rutz S, 2008, P NATL ACAD SCI USA, V105, P3497, DOI 10.1073/pnas.0712102105; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsao PN, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-56; Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zhang Y, 2011, BLOOD, V117, P299, DOI 10.1182/blood-2010-03-271940	46	102	120	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6208	6217		10.1074/jbc.M111.310375	http://dx.doi.org/10.1074/jbc.M111.310375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22205705	Green Published, hybrid			2022-12-25	WOS:000300791800014
J	Butler, DC; Messer, A				Butler, David C.; Messer, Anne			Bifunctional Anti-Huntingtin Proteasome-Directed Intrabodies Mediate Efficient Degradation of Mutant Huntingtin Exon 1 Protein Fragments	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; IN-VIVO; INTRACELLULAR ANTIBODIES; POLYGLUTAMINE PROTEINS; AGGREGATE FORMATION; MOUSE MODELS; HD MUTATION; DISEASE; EXPRESSION; CELLS	Huntington's disease (HD) is a fatal autosomal dominant neurodegenerative disorder caused by a trinucleotide (CAG)(n) repeat expansion in the coding sequence of the huntingtin gene, and an expanded polyglutamine (>37Q) tract in the protein. This results in misfolding and accumulation of huntingtin protein (htt), formation of neuronal intranuclear and cytoplasmic inclusions, and neuronal dysfunction/degeneration. Single-chain Fv antibodies (scFvs), expressed as intrabodies that bind htt and prevent aggregation, show promise as immunotherapeutics for HD. Intrastriatal delivery of anti-N-terminal htt scFv-C4 using an adeno-associated virus vector (AAV2/1) significantly reduces the size and number of aggregates in HDR6/1 transgenic mice; however, this protective effect diminishes with age and time after injection. We therefore explored enhancing intrabody efficacy via fusions to heterologous functional domains. Proteins containing a PEST motif are often targeted for proteasomal degradation and generally have a short half life. In ST14A cells, fusion of the C-terminal PEST region of mouse ornithine decarboxylase (mODC) to scFv-C4 reduces htt exon 1 protein fragments with 72 glutamine repeats (httex1-72Q) by similar to 80-90% when compared to scFv-C4 alone. Proteasomal targeting was verified by either scrambling the mODC-PEST motif, or via proteasomal inhibition with epoxomicin. For these constructs, the proteasomal degradation of the scFv intrabody proteins themselves was reduced <25% by the addition of the mODC-PEST motif, with or without antigens. The remaining intrabody levels were amply sufficient to target N-terminal httex1-72Q protein fragment turnover. Critically, scFv-C4-PEST prevents aggregation and toxicity of httex1-72Q fragments at significantly lower doses than scFv-C4. Fusion of the mODC-PEST motif to intrabodies is a valuable general approach to specifically target toxic antigens to the proteasome for degradation.	[Butler, David C.; Messer, Anne] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA; [Butler, David C.; Messer, Anne] SUNY Albany, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Butler, DC (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.	messer@wadsworth.org			National Institutes of Health/NINDS, Hereditary Disease Foundation [NS053912, NS 073415, NS061257]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053912, R21NS073415, R21NS061257] Funding Source: NIH RePORTER	National Institutes of Health/NINDS, Hereditary Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health/NINDS NS053912, NS 073415 and NS061257 Hereditary Disease Foundation (http://www.hdfoundation.org/home.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; Barkhordarian H, 2006, PROTEIN ENG DES SEL, V19, P497, DOI 10.1093/protein/gzl036; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; Butler DC, 2011, PROGR NEURO IN PRESS; Cardinale A, 2008, TRENDS MOL MED, V14, P373, DOI 10.1016/j.molmed.2008.07.004; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Greiner ER, NAT CHEM BIOL, V7, P412; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Holt L J, 2000, Nucleic Acids Res, V28, pE72, DOI 10.1093/nar/28.15.e72; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Kvam E, 2010, PROTEIN ENG DES SEL, V23, P489, DOI 10.1093/protein/gzq022; Kvam E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005727; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Leclerc GM, 2000, BIOTECHNIQUES, V29, P590, DOI 10.2144/00293rr02; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; McLear JA, 2008, FASEB J, V22, P2003, DOI 10.1096/fj.07-099689; Melchionna T, 2007, J MOL BIOL, V374, P641, DOI 10.1016/j.jmb.2007.09.053; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Messer A, 2006, BIODRUGS, V20, P327, DOI 10.2165/00063030-200620060-00002; Messer A, 2009, EXPERT OPIN BIOL TH, V9, P1189, DOI 10.1517/14712590903176387; Miller TW, 2005, MOL THER, V12, P394, DOI 10.1016/j.ymthe.2005.04.003; Miller TW, 2005, NEUROBIOL DIS, V19, P47, DOI 10.1016/j.nbd.2004.11.003; Murakami Y, 1999, MOL CELL BIOL, V19, P7216; Murphy RC, 2004, MOL BRAIN RES, V121, P141, DOI 10.1016/j.molbrainres.2003.11.011; Omi K, 2008, NEUROSCI LETT, V431, P45, DOI 10.1016/j.neulet.2007.11.018; Perez-Martinez D, 2010, BIOESSAYS, V32, P589, DOI 10.1002/bies.201000009; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Schiefner A, J MOL BIOL; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Sibler AP, 2005, FEBS J, V272, P2878, DOI 10.1111/j.1742-4658.2005.04709.x; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Snyder-Keller A, J NEUROPATHOL EXP NE, V69, P1078; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tomlinson I, 2000, METHOD ENZYMOL, V326, P461; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	59	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29199	10.1371/journal.pone.0029199	http://dx.doi.org/10.1371/journal.pone.0029199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216210	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700038
J	Gaither, MR; Jones, SA; Kelley, C; Newman, SJ; Sorenson, L; Bowen, BW				Gaither, Michelle R.; Jones, Shelley A.; Kelley, Christopher; Newman, Stephen J.; Sorenson, Laurie; Bowen, Brian W.			High Connectivity in the Deepwater Snapper Pristipomoides filamentosus (Lutjanidae) across the Indo-Pacific with Isolation of the Hawaiian Archipelago	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; CORAL-REEF FISH; POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; GENETIC CONNECTIVITY; COMPARATIVE PHYLOGEOGRAPHY; COALESCENT APPROACH; GENOMIC DNA; CONSERVATION; DIVERSITY	In the tropical Indo-Pacific, most phylogeographic studies have focused on the shallow-water taxa that inhabit reefs to approximately 30 m depth. Little is known about the large predatory fishes, primarily snappers (subfamily Etelinae) and groupers (subfamily Epinephelinae) that occur at 100-400 m. These long-lived, slow-growing species support fisheries across the Indo-Pacific, yet no comprehensive genetic surveys within this group have been conducted. Here we contribute the first range-wide survey of a deepwater Indo-Pacific snapper, Pristipomoides filamentosus, with special focus on Hawai'i. We applied mtDNA cytochrome b and 11 microsatellite loci to 26 samples (N = 1,222) collected across 17,000 km from Hawai'i to the western Indian Ocean. Results indicate that P. filamentosus is a highly dispersive species with low but significant population structure (mtDNA Phi(ST) = 0.029, microsatellite F-ST = 0.029) due entirely to the isolation of Hawai'i. No population structure was detected across 14,000 km of the Indo-Pacific from Tonga in the Central Pacific to the Seychelles in the western Indian Ocean, a pattern rarely observed in reef species. Despite a long pelagic phase (60-180 days), interisland dispersal as adults, and extensive gene flow across the Indo-Pacific, P. filamentosus is unable to maintain population connectivity with Hawai'i. Coalescent analyses indicate that P. filamentosus may have colonized Hawai'i 26 K-52 K y ago against prevailing currents, with dispersal away from Hawai'i dominating migration estimates. P. filamentosus harbors low genetic diversity in Hawai'i, a common pattern in marine fishes, and our data indicate a single archipelago-wide stock. However, like the Hawaiian Grouper, Hyporthodus quernus, this snapper had several significant pairwise comparisons (F-ST) clustered around the middle of the archipelago (St. Rogatien, Brooks Banks, Gardner) indicating that this region may be isolated or (more likely) receives input from Johnston Atoll to the south.	[Gaither, Michelle R.; Bowen, Brian W.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Jones, Shelley A.] Humboldt State Univ, Human Performance Lab, Arcata, CA 95521 USA; [Kelley, Christopher] Univ Hawaii Manoa, Hawaii Undersea Res Lab, Honolulu, HI 96822 USA; [Newman, Stephen J.] Western Australian Fisheries & Marine Res Labs, Dept Fisheries, North Beach, Australia; [Sorenson, Laurie] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of Hawaii System; University of Hawaii Manoa; California State University System; California State Polytechnic University, Humboldt; University of Hawaii System; University of Hawaii Manoa; Western Australian Fisheries & Marine Research Laboratories; University of California System; University of California Los Angeles	Gaither, MR (corresponding author), Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	gaither@hawaii.edu	Gaither, Michelle/J-3137-2015; Newman, Stephen/C-4507-2016	Gaither, Michelle/0000-0002-0371-5621; Newman, Stephen/0000-0002-5324-5568	National Science Foundation [OIA0554657, OCE-0453167, OCE-0929031]; University of Hawai [NA05OAR4171048, UNIHI-SEAGRANT-JC-10-27]; NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies [NA07NOS4780188]; NOAA [NA05OAR4301108, 05-WPC-033]; NOAA Pacific Island Fisheries Science Center [NA10NMF4520121]; Hawai'i Division of Aquatic Resources; Hawai'i Institute of Marine Biology	National Science Foundation(National Science Foundation (NSF)); University of Hawai; NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA Pacific Island Fisheries Science Center; Hawai'i Division of Aquatic Resources; Hawai'i Institute of Marine Biology	This study was supported by the National Science Foundation (http://www.nsf.gov/;grants No. OIA0554657, OCE-0453167, OCE-0929031 to BWB), University of Hawai'i Sea (http://seagrant.soest.hawaii.edu/) Grant No. NA05OAR4171048 (BWB), NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant (http://ccma.nos.noaa.gov/ecosystems/coralreef/coral_grant.aspx) NA07NOS4780188, NOAA Coral Reef Conservation Program and Hawai'i Undersea Research Laboratory (http://www.soest.hawaii.edu/HURL/) Grant NA05OAR4301108, NOAA Pacific Island Fisheries Science Center (http://www.pifsc.noaa.gov/) Grant NA10NMF4520121, NOAA National Marine Sanctuaries Program (http://sanctuaries.noaa.gov/) MOA grant No. 2005-008/66882 (R.J. Toonen), Western Pacific Regional Fisheries Management Council (http://www.wpcouncil.org/; contract No. 05-WPC-033) and the Hawai'i Division of Aquatic Resources (http://hawaii.gov/dlnr/dar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sample collections at the Rowley Shoals were facilitated by a research permit from the Department of Environment and Conservation (Western Australia). We thank Craig Skepper, Ben Rome, Gabby Mitsopoulos, Jerry Jenke, the late Richard Steckis, and the crews of the RV Flinders and RV Naturaliste for assistance with sample collection along the coast of Western Australia. Samples obtained from the Indian Ocean Territories [Cocos (Keeling) and Christmas Island] were facilitated by funding from the Commonwealth Department of Regional Australia, Regional Development and Local Government. We thank the fishermen in the Hawaiian Bottomfish fishery for their assistance in sample collection throughout the Hawaiian Islands. For facilitating this project we thank Sam Pooley, Michael Seki, and Robert Moffitt at the NOAA Pacific Islands Fisheries Science Center, Kitty Simonds and Mark Mitsuyasu at the Western Pacific Regional Fishery Management Council, Aulani Wilhelm and Randall Kosaki at the Papahanaumokuakea Marine National Monument, and the Hawai'i State Division of Aquatic Resources. The views expressed herein are those of the authors and do not necessarily reflect the views of NSF, NOAA or any of their sub-agencies. Special thanks to Matthew Iacchei and Greg Concepcion for sharing unpublished data. Thanks to Kimberly Andrews, Jonathan Puritz, Jennifer Schultz, Derek Skillings, Zoltan Szabo, and especially Robert Toonen and Steve Karl for their intellectual input. We thank the staff of the University of Hawai'i Advanced Studies of Genomics, Proteomics and Bioinformatics sequencing facility for their assistance with DNA sequencing and HIMB EPSCoR core facility for genotyping. Thanks to director Jo-Ann Leong and all the staff at the Hawai'i Institute of Marine Biology for their support throughout this project. We thank Robert Moffitt, Robert Fleischer (editor) and two anonymous reviewers whose comments substantially improved the manuscript. This is contribution #1477 from the Hawai'i Institute of Marine Biology, #8527 from the School of Ocean and Earth Science and Technology, and UNIHI-SEAGRANT-JC-10-27 from the University of Hawai'i Sea Grant.	Allen GR, 1985, INDOPAC FISH, V11, P87; Andrews AH, 2011, H1107 US DEP COMM NO, P82; Andrews K. R., 2011, J MAR BIOL, DOI 0.1155/2011/765353; Andrews KR, 2010, MOL ECOL, V19, P732, DOI 10.1111/j.1365-294X.2010.04521.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bay LK, 2004, MAR BIOL, V144, P757, DOI 10.1007/s00227-003-1224-3; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli Peter, 2009, V17, P42; Benjamini Y, 2001, ANN STAT, V29, P1165; Bowen BW, 2001, EVOLUTION, V55, P1029, DOI 10.1554/0014-3820(2001)055[1029:POTTAR]2.0.CO;2; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Brodziak J, 2009, H0902 US DEP COMM NO; Cannings, 2007, HDB STAT GENETICS, P945; CHAPPELL J, 1981, INT ASS HYDROL SCI P, V131, P411; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clague DA, 1987, VOLCANISM HAWAII, V1350, P5; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Craig MT, 2010, J BIOGEOGR, V37, P2125, DOI 10.1111/j.1365-2699.2010.02358.x; DeMartini EE, 1994, NOAATMNMFSSWFSC199 U; DiBattista J.D., 2011, J MAR BIOL; DiBattista JD, MAR ECOL PR IN PRESS; Duda TF, 1999, MAR BIOL, V134, P705, DOI 10.1007/s002270050586; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Eble JA, 2011, J MAR BIOL; Eble JA, 2011, MAR ECOL PROG SER, V428, P245, DOI 10.3354/meps09083; Eble JA, 2009, MAR BIOL, V156, P689, DOI 10.1007/s00227-008-1119-4; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fitzpatrick JM, 2011, MOL ECOL, V20, P219, DOI 10.1111/j.1365-294X.2010.04942.x; Fleminger A., 1986, UNESCO TECH PAP MAR, V49, P84; Friedlander AM, 2002, J FISH BIOL, V60, P28, DOI 10.1006/jfbi.2001.1808; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Gaither MR, 2010, CONSERV GENET RESOUR, V2, P169, DOI 10.1007/s12686-009-9119-3; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAIGHT WR, 1993, MAR FISH REV, V55, P20; HARPENDING HC, 1994, HUM BIOL, V66, P591; HOLLAND KN, 1993, B MAR SCI, V52, P982; Horne JB, 2008, MOL PHYLOGENET EVOL, V49, P629, DOI 10.1016/j.ympev.2008.08.023; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kikkawa B. S., 1984, P 2 S RES INV NW HAW, V2, P149; Klanten OS, 2007, MAR BIOL, V150, P659, DOI 10.1007/s00227-006-0372-7; Kobayashi DR, 2006, CORAL REEFS, V25, P407, DOI 10.1007/s00338-006-0118-5; Kobayashi DR, 2008, THESIS U HAWAII; LEIS JM, 1994, B MAR SCI, V55, P46; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; MEYER A, 1994, TRENDS ECOL EVOL, V9, P278, DOI 10.1016/0169-5347(94)90028-0; Meyer CG, 2000, ENVIRON BIOL FISH, V59, P235, DOI 10.1023/A:1007664813814; Moffitt R, 2006, H0601 US DEP COMM NO; Moffitt R. B., 1993, NEARSHORE MARINE RES, P73; Moffitt RB, 1996, PAC SCI, V50, P370; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; NEI M, 1978, GENETICS, V89, P583; Ovenden JR, 2002, FISH RES, V59, P57, DOI 10.1016/S0165-7836(01)00415-5; Park SDE, 2001, THESIS U DUBLIN; PARKER RO, 1990, B MAR SCI, V46, P749; Planes S, 2002, EVOLUTION, V56, P378; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POTTS DC, 1983, B MAR SCI, V33, P619; Pritchard JK, 2000, GENETICS, V155, P945; Ralston S, 1981, THESIS U WASHINGTON; Randall JE, 1998, ZOOL STUD, V37, P227; Randall JE., 2007, REEF SHORE FISHES HA; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reece JS, 2011, MAR ECOL PROG SER, V437, P269, DOI 10.3354/meps09248; Reece JS, 2010, MOL PHYLOGENET EVOL, V57, P829, DOI 10.1016/j.ympev.2010.07.013; Reece JS, 2010, J HERED, V101, P391, DOI 10.1093/jhered/esq036; Rivera MAJ, 2004, BIOL J LINN SOC, V81, P449, DOI 10.1111/j.1095-8312.2003.00304.x; Rocha LA, 2007, CORAL REEFS, V26, P501, DOI 10.1007/s00338-007-0261-7; Schneider S. D., 2000, ARLEQUIN VERSION 200; Schultz JK, 2007, MAR BIOL, V151, P167, DOI 10.1007/s00227-006-0471-5; Schultz JK, 2011, CONSERV BIOL, V25, P124, DOI 10.1111/j.1523-1739.2010.01615.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SHAKLEE JB, 1984, FISH B-NOAA, V82, P703; Skillings DJ, 2011, J MAR BIOL; Stepien Carol A., 1994, Pacific Science, V48, P44; Taberlet P, 1992, MOL ECOL, V1, P27, DOI 10.1111/j.1365-294X.1992.tb00152.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Toonen RJ, 2011, J MAR BIOL; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VERON JEN, 1995, CORALS SPACE TIME BI; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; WINANS GA, 1980, EVOLUTION, V34, P558, DOI 10.1111/j.1558-5646.1980.tb04844.x; Winters KL, 2010, MAR BIOL, V157, P1679, DOI 10.1007/s00227-010-1442-4	93	71	71	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28913	10.1371/journal.pone.0028913	http://dx.doi.org/10.1371/journal.pone.0028913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216141	Green Submitted, Green Published, gold			2022-12-25	WOS:000299684700017
J	Chaverri, G; Kunz, TH				Chaverri, Gloriana; Kunz, Thomas H.			Response of a Specialist Bat to the Loss of a Critical Resource	PLOS ONE			English	Article							HOME-RANGE SIZE; LEAF-ROOSTING BAT; THYROPTERA-TRICOLOR; WINGED BAT; SOCIAL-ORGANIZATION; EXTINCTION RISK; GROUP STABILITY; SELECTION; HABITAT; ASSOCIATION	Human activities have negatively impacted many species, particularly those with unique traits that restrict their use of resources and conditions to specific habitats. Unfortunately, few studies have been able to isolate the individual and combined effects of different threats on population persistence in a natural setting, since not all organisms can be associated with discrete habitat features occurring over limited spatial scales. We present the results of a field study that examines the short-term effects of roost loss in a specialist bat using a conspicuous, easily modified resource. We mimicked roost loss in the natural habitat and monitored individuals before and after the perturbation to determine patterns of resource use, spatial movements, and group stability. Our study focused on the disc-winged bat Thyroptera tricolor, a species highly morphologically specialized for roosting in the developing furled leaves of members of the order Zingiberales. We found that the number of species used for roosting increased, that home range size increased (before: mean 0.14 +/- SD 0.08 ha; after: 0.73 +/- 0.68 ha), and that mean association indices decreased (before: 0.95 +/- 0.10; after: 0.77 +/- 0.18) once the roosting habitat was removed. These results demonstrate that the removal of roosting resources is associated with a decrease in roost-site preferences or selectivity, an increase in mobility of individuals, and a decrease in social cohesion. These responses may reduce fitness by potentially increasing energetic expenditure, predator exposure, and a decrease in cooperative interactions. Despite these potential risks, individuals never used roost-sites other than developing furled leaves, suggesting an extreme specialization that could ultimately jeopardize the long-term persistence of this species' local populations.	[Chaverri, Gloriana; Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	Boston University	Chaverri, G (corresponding author), Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, 5 Cummington St, Boston, MA 02215 USA.	gchaverri@upacificosur.org	Chaverri, Gloriana/J-4798-2012	Chaverri, Gloriana/0000-0002-1155-432X	Rufford Small Grant for Nature Conservation; Cleveland Metroparks Zoo; Cleveland Zoological Society	Rufford Small Grant for Nature Conservation; Cleveland Metroparks Zoo; Cleveland Zoological Society	Funding provided by Rufford Small Grant for Nature Conservation, Scott Neotropic Fund of Cleveland Metroparks Zoo and Cleveland Zoological Society. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KEH, 2008, ECOLOGY, V89, P971, DOI 10.1890/07-0711.1; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Baglione V, 2010, P ROY SOC B-BIOL SCI, V277, P3275, DOI 10.1098/rspb.2010.0745; Balsom S, 1996, ALCES N AM, V32, P131; Bancroft JS, 2003, ECOLOGY, V84, P1756, DOI 10.1890/0012-9658(2003)084[1756:AETOFA]2.0.CO;2; Berry F., 1991, HELICONIA IDENTIFICA; Boyles JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000672; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Brunet-Rossinni Anja K., 2009, P315; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chaverri G, 2011, ANIM BEHAV, V82, P1127, DOI 10.1016/j.anbehav.2011.08.007; Chaverri Gloriana, 2010, Communicative & Integrative Biology, V3, P599, DOI 10.4161/cib.3.6.13277; Chaverri G, 2010, BEHAV ECOL SOCIOBIOL, V64, P1619, DOI 10.1007/s00265-010-0975-3; Chaverri G, 2010, BIOL LETTERS, V6, P441, DOI 10.1098/rsbl.2009.0964; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; Crampton LH, 1998, CONSERV BIOL, V12, P1347, DOI 10.1046/j.1523-1739.1998.97209.x; Dechmann DKN, 2006, J MAMMAL, V87, P1013, DOI 10.1644/05-MAMM-A-424R2.1; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Entwistle AC, 2000, J ZOOL, V252, P11, DOI 10.1017/S095283690000902X; FENTON MB, 1994, ANIM BEHAV, V48, P9, DOI 10.1006/anbe.1994.1207; Fenton MB, 1999, CAN J ZOOL, V77, P1891, DOI 10.1139/cjz-77-12-1891; Ferrara FJ, 2005, J MAMMAL, V86, P729, DOI 10.1644/1545-1542(2005)086[0729:COPSBD]2.0.CO;2; Ferriere R, 1996, AM NAT, V147, P692, DOI 10.1086/285875; FINDLEY JS, 1974, J MAMMAL, V55, P562, DOI 10.2307/1379546; Fisher DO, 2000, J ANIM ECOL, V69, P1083, DOI 10.1046/j.1365-2656.2000.00450.x; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; GINSBERG JR, 1992, ANIM BEHAV, V44, P377, DOI 10.1016/0003-3472(92)90042-8; Gotelli NJ, 2010, ECOSIM NULL MODELS S; Hammel BE, MANUAL PLANTAS COSTA; Heg D, 2005, BEHAVIOUR, V142, P1615, DOI 10.1163/156853905774831891; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Hopkins GW, 2002, BIOL CONSERV, V105, P293, DOI 10.1016/S0006-3207(01)00203-8; Johnson CA, 2009, P R SOC B, V276, P3361, DOI 10.1098/rspb.2008.1958; Keeley ATH, 2004, J MAMMAL, V85, P113, DOI 10.1644/BME-004; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Kerth G, 2008, BIOSCIENCE, V58, P737, DOI 10.1641/B580810; Kotler BP, 2007, ISR J ECOL EVOL, V53, P237, DOI 10.1560/IJEE.53.3.237; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Kunz T.H., 1982, P1; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Langer P, 2004, NATURE, V428, P844, DOI 10.1038/nature02431; Lausen CL, 2006, J MAMMAL, V87, P362, DOI 10.1644/05-MAMM-A-127R1.1; LEVEY DJ, 1988, ECOLOGY, V69, P1076, DOI 10.2307/1941263; Lewis SE, 1996, BEHAV ECOL SOCIOBIOL, V39, P335, DOI 10.1007/s002650050298; Linders MJ, 2004, J MAMMAL, V85, P511, DOI 10.1644/1545-1542(2004)085<0511:SVITUO>2.0.CO;2; Lumsden LF, 2002, J ZOOL, V257, P207, DOI 10.1017/S095283690200081X; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Mora C, 2007, P ROY SOC B-BIOL SCI, V274, P1023, DOI 10.1098/rspb.2006.0338; MYERS RA, 1995, SCIENCE, V269, P1106, DOI 10.1126/science.269.5227.1106; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; Panzacchi M, 2009, J ANIM ECOL, V78, P1124, DOI 10.1111/j.1365-2656.2009.01584.x; Parker KL, 1996, CAN J ZOOL, V74, P442, DOI 10.1139/z96-051; Pereira MJR, 2002, ACTA CHIROPTEROL, V4, P183, DOI 10.3161/001.004.0207; PULLIAM HR, 1974, AM NAT, V108, P59, DOI 10.1086/282885; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Racey PA, 2003, BAT ECOLOGY, P680; Racey Paul A., 2009, P249; Ralisata M, 2010, J ZOOL, V282, P130, DOI 10.1111/j.1469-7998.2010.00724.x; Rezsutek MJ, 1998, J MAMMAL, V79, P538, DOI 10.2307/1382984; Riskin DK, 2010, BIOL J LINN SOC, V99, P233; Riskin DK, 2001, CAN J ZOOL, V79, P2261, DOI 10.1139/cjz-79-12-2261; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Rogers WH, 1993, STATA TECHN B, V13, P19; Rogowitz GL, 1996, AM ZOOL, V36, P197; Safi K, 2004, CONSERV BIOL, V18, P1293, DOI 10.1111/j.1523-1739.2004.00155.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schurch R, 2010, ETHOLOGY, V116, P257, DOI 10.1111/j.1439-0310.2009.01738.x; Sedgeley JA, 2004, NEW ZEAL J ECOL, V28, P1; Siffczyk C, 2003, OECOLOGIA, V136, P635, DOI 10.1007/s00442-003-1256-x; SMITH EP, 1993, CAN J FISH AQUAT SCI, V50, P627, DOI 10.1139/f93-072; Sokal R. R., 2012, BIOMETRY; THOMAS SP, 1972, J EXP BIOL, V57, P317; UNDERWOOD AJ, 1991, AUST J MAR FRESH RES, V42, P569, DOI 10.1071/MF9910569; Vonhof MJ, 2004, ANIM BEHAV, V68, P507, DOI 10.1016/j.anbehav.2003.08.025; Vonhof MJ, 2004, J TROP ECOL, V20, P291, DOI 10.1017/S0266467404001403; Wauters LA, 2005, EVOL ECOL, V19, P375, DOI 10.1007/s10682-005-8311-5; Whitehead Hal, 1999, Animal Behaviour Forum, V57, pF26, DOI 10.1006/anbe.1999.1099; WILKINSON GS, 1986, ANIM BEHAV, V34, P1880, DOI 10.1016/S0003-3472(86)80274-3; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILSON D E, 1977, Mammalian Species, V71, P1; Wimmer T, 2004, CAN J ZOOL, V82, P1782, DOI 10.1139/Z04-168; WIMSATT WA, 1966, ANAT REC, V154, P495; Worm B, 2004, NATURE, V429, P15, DOI 10.1038/429015a	90	28	28	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28821	10.1371/journal.pone.0028821	http://dx.doi.org/10.1371/journal.pone.0028821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216118	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600038
J	Jones, PM; Robinson, MW; Dalton, JP; George, AM				Jones, Peter M.; Robinson, Mark W.; Dalton, John P.; George, Anthony M.			The Plasmodium falciparum Malaria M1 Alanyl Aminopeptidase (PfA-M1): Insights of Catalytic Mechanism and Function from MD Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ESCHERICHIA-COLI; HEMOGLOBIN DEGRADATION; CYSTEINE PROTEASES; CHABAUDI CHABAUDI; CRYSTAL-STRUCTURE; NETWORK MODEL; PROTEINS; INHIBITION; SITES	Malaria caused by several species of Plasmodium is major parasitic disease of humans, causing 1-3 million deaths worldwide annually. The widespread resistance of the human parasite to current drug therapies is of major concern making the identification of new drug targets urgent. While the parasite grows and multiplies inside the host erythrocyte it degrades the host cell hemoglobin and utilizes the released amino acids to synthesize its own proteins. The P. falciparum malarial M1 alanyl-aminopeptidase (PfA-M1) is an enzyme involved in the terminal stages of hemoglobin digestion and the generation of an amino acid pool within the parasite. The enzyme has been validated as a potential drug target since inhibitors of the enzyme block parasite growth in vitro and in vivo. In order to gain further understanding of this enzyme, molecular dynamics simulations using data from a recent crystal structure of PfA-M1 were performed. The results elucidate the pentahedral coordination of the catalytic Zn in these metallo-proteases and provide new insights into the roles of this cation and important active site residues in ligand binding and in the hydrolysis of the peptide bond. Based on the data, we propose a two-step catalytic mechanism, in which the conformation of the active site is altered between the Michaelis complex and the transition state. In addition, the simulations identify global changes in the protein in which conformational transitions in the catalytic domain are transmitted at the opening of the N-terminal 8 angstrom-long channel and at the opening of the 30 angstrom-long C-terminal internal chamber that facilitates entry of peptides to the active site and exit of released amino acids. The possible implications of these global changes with regard to enzyme function are discussed.	[Jones, Peter M.; George, Anthony M.] Sch Med & Mol Biosci, Sydney, NSW, Australia; [Jones, Peter M.; Robinson, Mark W.; George, Anthony M.] Univ Technol Sydney, I3 Inst, Sydney, NSW 2007, Australia; [Dalton, John P.] McGill Univ, Inst Parasitol, Montreal, PQ, Canada	University of Technology Sydney; McGill University	Jones, PM (corresponding author), Sch Med & Mol Biosci, Sydney, NSW, Australia.	tony.george@uts.edu.au	Dalton, John/K-4457-2014	Robinson, Mark/0000-0001-7191-0034; George, Anthony/0000-0003-4691-8960	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institute of Health Research, UTS Chancellor's Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addlagatta A, 2006, P NATL ACAD SCI USA, V103, P13339, DOI 10.1073/pnas.0606167103; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BLOMSTER M, 1995, EUR J BIOCHEM, V231, P528, DOI 10.1111/j.1432-1033.1995.tb20728.x; CURLEY GP, 1994, J EUKARYOT MICROBIOL, V41, P119, DOI 10.1111/j.1550-7408.1994.tb01483.x; Dal Peraro MD, 2007, J STRUCT BIOL, V157, P444, DOI 10.1016/j.jsb.2006.10.019; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fournie-Zaluski MC, 2009, ACTA CRYSTALLOGR D, V65, P814, DOI 10.1107/S090744490901779X; Gavigan CS, 2001, MOL BIOCHEM PARASIT, V117, P37, DOI 10.1016/S0166-6851(01)00327-9; HANGAUER DG, 1984, BIOCHEMISTRY-US, V23, P5730, DOI 10.1021/bi00319a011; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Izaguirre JA, 2002, OVERCOMING INSTABILI; JIANG WP, 1992, FEBS LETT, V312, P110, DOI 10.1016/0014-5793(92)80916-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; Lin Jessica T, 2010, Curr Infect Dis Rep, V12, P165, DOI 10.1007/s11908-010-0099-y; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MARTYNA GJ, 1994, PHYS REV E, V50, P3234, DOI 10.1103/PhysRevE.50.3234; McGowan S, 2010, P NATL ACAD SCI USA, V107, P2449, DOI 10.1073/pnas.0911813107; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mezei M, 1997, J COMPUT CHEM, V18, P812, DOI 10.1002/(SICI)1096-987X(19970430)18:6<812::AID-JCC6>3.0.CO;2-V; Nankya-Kitaka MF, 1998, PARASITOL RES, V84, P552, DOI 10.1007/s004360050447; Nocek B, 2008, PROTEINS, V70, P273, DOI 10.1002/prot.21276; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pelmenschikov V, 2002, J BIOL INORG CHEM, V7, P284, DOI 10.1007/s007750100295; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Rosenthal PJ, 2003, J EXP BIOL, V206, P3735, DOI 10.1242/jeb.00589; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; Rudberg PC, 2002, J BIOL CHEM, V277, P1398, DOI 10.1074/jbc.M106577200; Sakharov DV, 2005, J AM CHEM SOC, V127, P4921, DOI 10.1021/ja0429115; Schlitzer M, 2007, CHEMMEDCHEM, V2, P944, DOI 10.1002/cmdc.200600240; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Velmourougane G, 2011, J MED CHEM, V54, P1655, DOI 10.1021/jm101227t; Yang LW, 2005, BIOINFORMATICS, V21, P2978, DOI 10.1093/bioinformatics/bti469	46	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28589	10.1371/journal.pone.0028589	http://dx.doi.org/10.1371/journal.pone.0028589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205955	Green Published, Green Submitted, gold			2022-12-25	WOS:000299113600022
J	Leisher, C; Brouwer, R; Boucher, TM; Vogelij, R; Bainbridge, WR; Sanjayan, M				Leisher, Craig; Brouwer, Roy; Boucher, Timothy M.; Vogelij, Rogier; Bainbridge, W. R.; Sanjayan, M.			Striking a Balance: Socioeconomic Development and Conservation in Grassland through Community-Based Zoning	PLOS ONE			English	Article							PROTECTED AREAS; POVERTY; POLICY	The goal of preserving nature is often in conflict with economic development and the aspirations of the rural poor. Nowhere is this more striking than in native grasslands, which have been extensively converted until a mere fraction of their original extent remains. This is not surprising; grasslands flourish in places coveted by humans, primed for agriculture, plantations, and settlements that nearly always trump conservation efforts. The Umgano grassland conservation and poverty reduction project in KwaZulu-Natal Province, South Africa uses community-based spatial planning to balance the conversion of its lower-conservation value grasslands to a timber plantation, while conserving higher-value grasslands for heritage purposes and managed livestock grazing. Ten years after project launch, we measured the ecological and socioeconomic impacts of the project using Normalized Differential Vegetation Index remote sensing data and over 500 household interviews, as compared with similar non-conserved areas. Zoned management of the Umgano area had resulted in between 9% and 17% greater average peak production in the grassland areas compared to control sites. There was also a 21% gain in incomes for the roughly one hundred people employed by the forestry efforts, when compared to others in their village. Community-based spatial zoning is an overlooked tool for balancing conservation and development but may require, as we found in Umgano, certain critical factors including strong local leadership, an accountable financial management mechanism to distribute income, outside technical expertise for the zoning design, and community support.	[Leisher, Craig; Boucher, Timothy M.; Sanjayan, M.] Nature Conservancy, Cent Sci, Arlington, VA USA; [Brouwer, Roy; Vogelij, Rogier] Vrije Univ Amsterdam, Inst Environm Studies, Dept Environm Econ, Amsterdam, Netherlands; [Bainbridge, W. R.] Umgano Project, Umgano, Kwazulu Natal, South Africa	Nature Conservancy; Vrije Universiteit Amsterdam	Leisher, C (corresponding author), Nature Conservancy, Cent Sci, 1815 N Lynn St, Arlington, VA USA.	cleisher@tnc.org	Brouwer, Roy/M-9437-2013	Brouwer, Roy/0000-0002-0525-2050	Schooner Foundation; HRH Foundation	Schooner Foundation; HRH Foundation	The Schooner Foundation and the HRH Foundation funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 1999, WORLD DEV, V27, P629, DOI 10.1016/S0305-750X(98)00161-2; Ancrenaz M, 2007, PLOS BIOL, V5, P2443, DOI 10.1371/journal.pbio.0050289; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; Babaie-Kafaky Sasan, 2009, American Journal of Environmental Sciences, V5, P714, DOI 10.3844/ajessp.2009.714.721; Bainbridge WR, 2009, INTEGRATED MANAGEMEN; Bainbridge WR, 1997, STREAMLINED ENV IMPA; Barrow E, 1995, INTEGRATING PEOPLE W, P21; Brooks JS, 2006, SYSTEMATIC REV; de Sherbinin A, 2008, ORYX, V42, P26, DOI 10.1017/S0030605308000781; Sabatini MD, 2007, J ENVIRON MANAGE, V83, P198, DOI 10.1016/j.jenvman.2006.02.005; Ebrahimi A, 2010, ECOL MODEL, V221, P900, DOI 10.1016/j.ecolmodel.2009.12.009; EKZNW, 2007, KZN BIOD STEW PROGR; Eriksen SEH, 2009, ENVIRON SCI POLICY, V12, P5, DOI 10.1016/j.envsci.2008.10.009; Geneletti D, 2008, LANDSCAPE URBAN PLAN, V85, P97, DOI 10.1016/j.landurbplan.2007.10.004; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Homewood KM, 2004, ENVIRON SCI POLICY, V7, P125, DOI 10.1016/j.envsci.2003.12.006; Kawamura K, 2005, AGR ECOSYST ENVIRON, V107, P83, DOI 10.1016/j.agee.2004.09.008; Kawamura Kensuke, 2005, Grassland Science, V51, P33, DOI 10.1111/j.1744-697X.2005.00006.x; Leisher C., 2007, NATURES INVESTMENT B; Lipsey MK, 2010, AGR ECOSYST ENVIRON, V137, P133, DOI 10.1016/j.agee.2010.01.013; Marshall GR, 2009, ECOL ECON, V68, P1507, DOI 10.1016/j.ecolecon.2008.10.008; Mehta JN, 2001, ENVIRON MANAGE, V28, P165, DOI 10.1007/s002670010215; Morton DC, 2005, EARTH INTERACT, V9; Murray S., 2000, PILOT ANAL GLOBAL EC; O'Connor TG, 2005, J APPL ECOL, V42, P975, DOI 10.1111/j.1365-2664.2005.01065.x; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P683, DOI 10.1016/S0964-5691(01)00075-8; Pullin AS, 2001, CONSERV BIOL, V15, P50, DOI 10.1046/j.1523-1739.2001.99499.x; Pullin AS, 2004, BIOL CONSERV, V119, P245, DOI 10.1016/j.biocon.2003.11.007; Ravallion M, 2008, HBK ECON, V9, P3787, DOI 10.1016/S1573-4471(07)04059-4; Reyers B., 2001, Diversity and Distributions, V7, P79, DOI 10.1046/j.1472-4642.2001.00098.x; Roe D, 2008, ORYX, V42, P491, DOI 10.1017/S0030605308002032; Sansom AL, 1999, WATER SCI TECHNOL, V39, P85, DOI 10.1016/S0273-1223(99)00322-4; SHLAY AB, 1981, AM SOCIOL REV, V46, P703, DOI 10.2307/2095075; Singh A., 2005, ONE PLANET MANY PEOP; Skelcher B, 2003, J BLACK STUD, V33, P761, DOI 10.1177/0021934703033006003; Spiteri A, 2006, ENVIRON MANAGE, V37, P1, DOI 10.1007/s00267-004-0311-7; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; TUCKER CJ, 1985, SCIENCE, V227, P369, DOI 10.1126/science.227.4685.369; Turner MD, 2011, J DEV STUD, V47, P183, DOI 10.1080/00220381003599352; UNECE, 2007, WYE GROUP HDB RUR HO; Wang J., 2005, GEOCARTO INT, V20, P5, DOI DOI 10.1080/10106040508542350; Wang J, 2008, GEOSC REM SENS S 200, V4, P754; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Wessels KJ, 2006, INT J REMOTE SENS, V27, P951, DOI 10.1080/01431160500169098; Western D, NATURAL CONNECTIONS; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9	48	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28807	10.1371/journal.pone.0028807	http://dx.doi.org/10.1371/journal.pone.0028807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	876NF	22216114	Green Submitted, Green Published, gold			2022-12-25	WOS:000299113600037
J	Zhang, Y; Li, CY; Li, K; Liu, L; Jian, Z; Gao, TW				Zhang, Ying; Li, Chunying; Li, Kai; Liu, Ling; Jian, Zhe; Gao, Tianwen			Analysis of Inducible Nitric Oxide Synthase Gene Polymorphisms in Vitiligo in Han Chinese People	PLOS ONE			English	Article							NORMAL HUMAN MELANOCYTES; AUTOIMMUNE-DISEASES; TETRAHYDROBIOPTERIN; LIPOPOLYSACCHARIDE; CYTOKINES; MALARIA; BIOSYNTHESIS; ASSOCIATION; PROTECTION; MESSENGER	Background: Vitiligo is a chronic depigmented skin disorder with regional melanocytes depletion. The pathogenesis was not completely clarified. Recently, more and more evidence suggested that polymorphisms of some genes are associated with vitiligo risk. Here, we want to examine the association between the inducible nitric oxide synthase (iNOS) gene polymorphisms and the risk of vitiligo in Chinese populations. Methods and Principal Findings: In a hospital-based case-control study of 749 patients with vitiligo and 763 age-and sex-matched healthy controls, three polymorphisms of iNOS gene were genotyped by using the PCR-restriction fragment length polymorphism (PCR-RFLP) and mutagenically separated PCR (MS-PCR) methods, respectively. We found the iNOS-954 polymorphism was associated with a significantly higher risk of vitiligo (adjusted OR = 1.36, 95% CI = 1.02-1.81). Furthermore, this association is more pronounced in vulgaris vitiligo, active vitiligo and vitiligo without other autoimmune diseases in the stratification study. Analysis of haplotypes showed increased risk for the C-1173C-954CEx16+14 (OR = 1.44, 95% CI = 1.01-1.74). In addition, the serum iNOS activity is significantly associated with iNOS-954 combined genotype (GC+CC) and is much higher in vitiligo patients than in the controls (P<0.01). Logistic regression analysis of iNOS activity showed increased risk between higher activity and iNOS-954 G -> C variant genotype carriers (P-trend<0.001). Conclusions and Significance: INOS gene polymorphisms may play an important role in the genetic susceptibility to the development of vitiligo.	[Zhang, Ying; Li, Chunying; Li, Kai; Liu, Ling; Jian, Zhe; Gao, Tianwen] Fourth Mil Med Univ, Dept Dermatol, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University	Zhang, Y (corresponding author), Fourth Mil Med Univ, Dept Dermatol, Xijing Hosp, Xian 710032, Peoples R China.	chylifmmu@yahoo.cn; gaotwfmmu@yahoo.com	Jian, Zhe/AAJ-7339-2020					Aalberts M, 2007, MOL REPROD DEV, V74, P378, DOI 10.1002/mrd.20546; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; Cork RJ, 1998, PROG BRAIN RES, V118, P37; Dave Shriya, 2002, Indian J Dermatol Venereol Leprol, V68, P323; Fecker LF, 2002, J INVEST DERMATOL, V118, P1019, DOI 10.1046/j.1523-1747.2002.01744.x; Ivanova K, 1997, J PATHOL, V183, P469, DOI 10.1002/(SICI)1096-9896(199712)183:4<469::AID-PATH931>3.0.CO;2-T; Johannesen J, 2001, J CLIN ENDOCR METAB, V86, P2792, DOI 10.1210/jc.86.6.2792; Kharitonov Sergei A., 2005, Current Drug Targets - Inflammation and Allergy, V4, P141, DOI 10.2174/1568010053586282; Kim PKM, 2001, INT IMMUNOPHARMACOL, V1, P1421, DOI 10.1016/S1567-5769(01)00088-1; Kolb H, 1998, IMMUNOL TODAY, V19, P556, DOI 10.1016/S0167-5699(98)01366-8; Kun JF, 2001, J INFECT DIS, V184, P330, DOI 10.1086/322037; Kun JFJ, 1998, LANCET, V351, P265, DOI 10.1016/S0140-6736(05)78273-8; Le Poole I C, 1993, Exp Dermatol, V2, P145; Levesque MC, 1999, J INFECT DIS, V180, P1994, DOI 10.1086/315140; Li CY, 2007, CANCER, V109, P1570, DOI 10.1002/cncr.22582; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P132, DOI 10.1016/S1089-8603(02)00127-1; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; Mearin F, 2006, AM J GASTROENTEROL, V101, P1979, DOI 10.1111/j.1572-0241.2006.00762.x; MORELLI JG, 1993, J INVEST DERMATOL, V100, pS191; Prcic Sonja, 2002, Med Pregl, V55, P475, DOI 10.2298/MPNS0212475P; Rocha IM, 2001, ARCH DERMATOL RES, V293, P245; SAKAI N, 1995, J NEUROCHEM, V65, P895; SCHALLREUTER KU, 1994, BBA-MOL BASIS DIS, V1226, P181, DOI 10.1016/0925-4439(94)90027-2; SCHALLREUTER KU, 1994, SCIENCE, V263, P1444, DOI 10.1126/science.8128228; Shen J, 2004, WORLD J GASTROENTERO, V10, P3278, DOI 10.3748/wjg.v10.i22.3278; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Singh VK, 2000, IMMUNOL RES, V22, P1, DOI 10.1385/IR:22:1:1; Stromberg S, 2008, PIGM CELL MELANOMA R, V21, P162, DOI 10.1111/j.1755-148X.2007.00429.x; VODOVOTZ Y, 1994, J IMMUNOL, V152, P4110; Xu WM, 1996, BIOCHEM BIOPH RES CO, V219, P784, DOI 10.1006/bbrc.1996.0311	31	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e27077	10.1371/journal.pone.0027077	http://dx.doi.org/10.1371/journal.pone.0027077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205923	gold, Green Submitted, Green Published			2022-12-25	WOS:000299113600001
J	Koerts, J; Van Beilen, M; Tucha, O; Leenders, KL; Brouwer, WH				Koerts, Janneke; Van Beilen, Marije; Tucha, Oliver; Leenders, Klaus L.; Brouwer, Wiebo H.			Executive Functioning in Daily Life in Parkinson's Disease: Initiative, Planning and Multi-Task Performance	PLOS ONE			English	Article							DUAL-TASK-PERFORMANCE; COGNITIVE DECLINE; NORMATIVE DATA; DEFICITS; MOVEMENT; ABILITY; TESTS	Impairments in executive functioning are frequently observed in Parkinson's disease (PD). However, executive functioning needed in daily life is difficult to measure. Considering this difficulty the Cognitive Effort Test (CET) was recently developed. In this multi-task test the goals are specified but participants are free in their approach. This study applies the CET in PD patients and investigates whether initiative, planning and multi-tasking are associated with aspects of executive functions and psychomotor speed. Thirty-six PD patients with a mild to moderate disease severity and thirty-four healthy participants were included in this study. PD patients planned and demonstrated more sequential task execution, which was associated with a decreased psychomotor speed. Furthermore, patients with a moderate PD planned to execute fewer tasks at the same time than patients with a mild PD. No differences were found between these groups for multi-tasking. In conclusion, PD patients planned and executed the tasks of the CET sequentially rather than in parallel presumably reflecting a compensation strategy for a decreased psychomotor speed. Furthermore, patients with moderate PD appeared to take their impairments into consideration when planning how to engage the tasks of the test. This compensation could not be detected in patients with mild PD.	[Koerts, Janneke; Tucha, Oliver; Brouwer, Wiebo H.] Univ Groningen, Fac Behav & Social Sci, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Koerts, Janneke; Van Beilen, Marije; Leenders, Klaus L.; Brouwer, Wiebo H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen	Koerts, J (corresponding author), Univ Groningen, Fac Behav & Social Sci, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	janneke.koerts@rug.nl	Tucha, Oliver/AAD-1403-2019; van Beilen, Marije/A-7435-2011					Aarsland D, 2004, ARCH NEUROL-CHICAGO, V61, P1906, DOI 10.1001/archneur.61.12.1906; Benton AL, 1976, MULTILINGUAL APHASIA; Bialystok E, 2008, J INT NEUROPSYCH SOC, V14, P257, DOI 10.1017/S1355617708080296; Bleom BR, 2006, J NEUROL SCI, V248, P196, DOI 10.1016/j.jns.2006.05.010; BROWN RG, 1991, BRAIN, V114, P215; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colman KSF, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/213983; Cools R, 2001, BRAIN, V124, P2503, DOI 10.1093/brain/124.12.2503; Drago V, 2009, J NEUROL SCI, V276, P179, DOI 10.1016/j.jns.2008.09.026; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Esselink RAJ, 2004, NEUROLOGY, V62, P201, DOI 10.1212/01.WNL.0000103235.12621.C3; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Farina E, 2000, EUR J NEUROL, V7, P259, DOI 10.1046/j.1468-1331.2000.00066.x; FLOWERS KA, 1985, J NEUROL NEUROSUR PS, V48, P517, DOI 10.1136/jnnp.48.6.517; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067; GEORGIOU N, 1994, J NEUROL NEUROSUR PS, V57, P368, DOI 10.1136/jnnp.57.3.368; Hammes J.G.W., 1978, DE STROOP KLEUR WOOR; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Koerts J, 2011, J NEUROL SCI, V310, P172, DOI 10.1016/j.jns.2011.07.009; Lange KW, 2003, J NEURAL TRANSM, V110, P983, DOI 10.1007/s00702-003-0011-0; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Ma HI, 2009, CLIN REHABIL, V23, P229, DOI 10.1177/0269215508098896; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Muslimovic D, 2007, J INT NEUROPSYCH SOC, V13, P920, DOI 10.1017/S1355617707071160; Muslimovic D, 2009, J INT NEUROPSYCH SOC, V15, P426, DOI 10.1017/S1355617709090614; NORMAN DA, 1986, CONCIOUSSNESS SELF R; Perfetti B, 2010, PARKINSONISM RELAT D, V16, P46, DOI 10.1016/j.parkreldis.2009.07.011; Pomati S, 1996, ITAL J NEUROL SCI, V17, P201, DOI 10.1007/BF01995684; Proud EL, 2010, ARCH PHYS MED REHAB, V91, P794, DOI 10.1016/j.apmr.2010.01.008; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schmand B, 2008, Tijdschr Gerontol Geriatr, V39, P64; Schmand B, 2003, NORMEN STROOP KLEUR; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; Strauss E, 2006, COMPENDIUM NEUROPSYC; van Beilen M, 2005, J PSYCHIATR RES, V39, P585, DOI 10.1016/j.jpsychires.2005.02.001; van Beilen M, 2006, J NEUROL SCI, V248, P68, DOI 10.1016/j.jns.2006.05.033; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; VANBEILEN M, 2008, PARKINSONISM RELAT D, P1353; WECHSLER, 2005, SWETS TEST PUBLISHER; Wechsler D, 1987, WMS R WECHSLER MEMOR; Weintraub D, 2005, DEMENT GERIATR COGN, V20, P140, DOI 10.1159/000087043; Werheid K, 2007, NEUROPSYCHOLOGIA, V45, P273, DOI 10.1016/j.neuropsychologia.2006.07.007; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599	52	26	30	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e29254	10.1371/journal.pone.0029254	http://dx.doi.org/10.1371/journal.pone.0029254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22206004	Green Published, Green Submitted, gold			2022-12-25	WOS:000298666200020
J	Limberger, R; Wickham, SA				Limberger, Romana; Wickham, Stephen A.			Predator Dispersal Determines the Effect of Connectivity on Prey Diversity	PLOS ONE			English	Article							POND METACOMMUNITIES; SPECIES-DIVERSITY; HABITAT CONNECTIVITY; COMMUNITY STRUCTURE; SPATIAL SCALES; ZOOPLANKTON; RICHNESS; CONSEQUENCES; MECHANISMS; SIMILARITY	Linking local communities to a metacommunity can positively affect diversity by enabling immigration of dispersal-limited species and maintenance of sink populations. However, connectivity can also negatively affect diversity by allowing the spread of strong competitors or predators. In a microcosm experiment with five ciliate species as prey and a copepod as an efficient generalist predator, we analysed the effect of connectivity on prey species richness in metacommunities that were either unconnected, connected for the prey, or connected for both prey and predator. Presence and absence of predator dispersal was cross-classified with low and high connectivity. The effect of connectivity on local and regional richness strongly depended on whether corridors were open for the predator. Local richness was initially positively affected by connectivity through rescue of species from stochastic extinctions. With predator dispersal, however, this positive effect soon turned negative as the predator spread over the metacommunity. Regional richness was unaffected by connectivity when local communities were connected only for the prey, while predator dispersal resulted in a pronounced decrease of regional richness. The level of connectivity influenced the speed of richness decline, with regional species extinctions being delayed for one week in weakly connected metacommunities. While connectivity enabled rescue of prey species from stochastic extinctions, deterministic extinctions due to predation were not overcome through reimmigration from predator-free refuges. Prey reimmigrating into these sink habitats appeared to be directly converted into increased predator abundance. Connectivity thus had a positive effect on the predator, even when the predator was not dispersing itself. Our study illustrates that dispersal of a species with strong negative effects on other community members shapes the dispersal-diversity relationship. When connections enable the spread of a generalist predator, positive effects of connectivity on prey species richness are outweighed by regional extinctions through predation.	[Limberger, Romana; Wickham, Stephen A.] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria	Salzburg University	Limberger, R (corresponding author), Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria.	romana.limberger@stud.sbg.ac.at		Limberger, Romana/0000-0002-9421-7520	Austrian Science Fund, FWF [P19117-B17]; University of Salzburg	Austrian Science Fund, FWF(Austrian Science Fund (FWF)); University of Salzburg	This study was funded by the Austrian Science Fund, FWF, grant P19117-B17 to S. Wickham, and a Marie-Andessner scholarship of the University of Salzburg to R. Limberger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadotte MW, 2006, OECOLOGIA, V149, P150, DOI 10.1007/s00442-006-0426-z; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; Cadotte MW, 2006, ECOLOGY, V87, P1008, DOI 10.1890/0012-9658(2006)87[1008:MIOCRA]2.0.CO;2; Cadotte MW, 2005, ECOL LETT, V8, P548, DOI 10.1111/j.1461-0248.2005.00750.x; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Chisholm C, 2011, ECOGRAPHY, V34, P415, DOI 10.1111/j.1600-0587.2010.06588.x; Cohen GM, 2003, OIKOS, V103, P603, DOI 10.1034/j.1600-0706.2003.12660.x; Davies KF, 2009, J ANIM ECOL, V78, P937, DOI 10.1111/j.1365-2656.2009.01559.x; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Forbes AE, 2002, OIKOS, V96, P433, DOI 10.1034/j.1600-0706.2002.960305.x; Gilbert F, 1998, P ROY SOC B-BIOL SCI, V265, P577, DOI 10.1098/rspb.1998.0333; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Howeth JG, 2008, ECOL LETT, V11, P245, DOI 10.1111/j.1461-0248.2007.01143.x; Howeth JG, 2010, ECOLOGY, V91, P2727, DOI 10.1890/09-1004.1; Kneitel JM, 2003, AM NAT, V162, P165, DOI 10.1086/376585; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Limberger R, 2011, OECOLOGIA, V167, P723, DOI 10.1007/s00442-011-2013-1; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; McPeek MA, 1998, ECOL MONOGR, V68, P1, DOI 10.1890/0012-9615(1998)068[0001:TCOCTT]2.0.CO;2; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; Pedruski MT, 2011, OECOLOGIA, V166, P221, DOI 10.1007/s00442-010-1814-y; R Development Core Team, 2009, R FDN STAT COMP; Schoener TW, 1996, NATURE, V381, P691, DOI 10.1038/381691a0; Shurin JB, 2001, ECOLOGY, V82, P3404, DOI 10.2307/2680161; Spiller DA, 1998, ECOLOGY, V79, P503, DOI 10.2307/176949; Staddon P, 2010, ECOL LETT, V13, P543, DOI 10.1111/j.1461-0248.2010.01450.x; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; Warren PH, 1996, OECOLOGIA, V105, P132, DOI 10.1007/BF00328801; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449	34	11	11	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29071	10.1371/journal.pone.0029071	http://dx.doi.org/10.1371/journal.pone.0029071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194992	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400036
J	Tong, SYC; Xie, S; Richardson, LJ; Ballard, SA; Dakh, F; Grabsch, EA; Grayson, ML; Howden, BP; Johnson, PDR; Giffard, PM				Tong, Steven Y. C.; Xie, Shirley; Richardson, Leisha J.; Ballard, Susan A.; Dakh, Farshid; Grabsch, Elizabeth A.; Grayson, M. Lindsay; Howden, Benjamin P.; Johnson, Paul D. R.; Giffard, Philip M.			High-Resolution Melting Genotyping of Enterococcus faecium Based on Multilocus Sequence Typing Derived Single Nucleotide Polymorphisms	PLOS ONE			English	Article							EBURST	We have developed a single nucleotide polymorphism (SNP) nucleated high-resolution melting (HRM) technique to genotype Enterococcus faecium. Eight SNPs were derived from the E. faecium multilocus sequence typing (MLST) database and amplified fragments containing these SNPs were interrogated by HRM. We tested the HRM genotyping scheme on 85 E. faecium bloodstream isolates and compared the results with MLST, pulsed-field gel electrophoresis (PFGE) and an allele specific real-time PCR (AS kinetic PCR) SNP typing method. In silico analysis based on predicted HRM curves according to the G+C content of each fragment for all 567 sequence types (STs) in the MLST database together with empiric data from the 85 isolates demonstrated that HRM analysis resolves E. faecium into 231 "melting types" (MelTs) and provides a Simpson's Index of Diversity (D) of 0.991 with respect to MLST. This is a significant improvement on the AS kinetic PCR SNP typing scheme that resolves 61 SNP types with D of 0.95. The MelTs were concordant with the known ST of the isolates. For the 85 isolates, there were 13 PFGE patterns, 17 STs, 14 MelTs and eight SNP types. There was excellent concordance between PFGE, MLST and MelTs with Adjusted Rand Indices of PFGE to MelT 0.936 and ST to MelT 0.973. In conclusion, this HRM based method appears rapid and reproducible. The results are concordant with MLST and the MLST based population structure.	[Tong, Steven Y. C.; Richardson, Leisha J.; Dakh, Farshid; Giffard, Philip M.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Xie, Shirley; Ballard, Susan A.; Grabsch, Elizabeth A.; Grayson, M. Lindsay; Howden, Benjamin P.; Johnson, Paul D. R.] Austin Hlth, Dept Infect Dis & Microbiol, Heidelberg, Vic, Australia	Charles Darwin University; Menzies School of Health Research; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Tong, SYC (corresponding author), Menzies Sch Hlth Res, Darwin, NT, Australia.	Steven.tong@menzies.edu.au	Tong, Steven/N-2353-2013; Giffard, Philip/N-2293-2013; Richardson, Leisha/C-4135-2012	Tong, Steven/0000-0002-1368-8356; Howden, Benjamin/0000-0003-0237-1473; Dakh, Farshid/0000-0003-4010-1722; Giffard, Phil/0000-0002-3030-9127	Australian National Health and Medical Research Council [508829]; Austin Hospital Department of Pathology	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Austin Hospital Department of Pathology	This work was supported by an Australian National Health and Medical Research Council Postdoctoral Training Fellowship (508829) to ST and by the Austin Hospital Department of Pathology to SX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard SA, 2005, ANTIMICROB AGENTS CH, V49, P1688, DOI 10.1128/AAC.49.5.1688-1694.2005; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Chuang YC, 2010, J CLIN MICROBIOL, V48, P2897, DOI 10.1128/JCM.00136-10; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Hall TA, 2009, J CLIN MICROBIOL, V47, P1733, DOI 10.1128/JCM.02175-08; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huygens F, 2006, J CLIN MICROBIOL, V44, P3712, DOI 10.1128/JCM.00843-06; Johnson PDR, 2010, J INFECT DIS, V202, P1278, DOI 10.1086/656319; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; Price EP, 2006, J MED MICROBIOL, V55, P1061, DOI 10.1099/jmm.0.46460-0; Rathnayake IU, 2011, J CLIN MICROBIOL, V49, P367, DOI 10.1128/JCM.01120-10; Richardson LJ, 2011, CLIN MICROBIOL INFEC, V17, P1426, DOI 10.1111/j.1469-0691.2010.03433.x; Robertson GA, 2004, J MED MICROBIOL, V53, P35, DOI 10.1099/jmm.0.05365-0; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]	17	25	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e29189	10.1371/journal.pone.0029189	http://dx.doi.org/10.1371/journal.pone.0029189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22195020	Green Published, gold			2022-12-25	WOS:000298664400041
J	Xu, LL; Bao, LL; Li, FD; Lv, Q; Ma, YL; Zhou, JF; Xu, YF; Deng, W; Zhan, LJ; Zhu, H; Ma, CM; Shu, YL; Qin, C				Xu, Lili; Bao, Linlin; Li, Fengdi; Lv, Qi; Ma, Yila; Zhou, Jiangfang; Xu, Yanfeng; Deng, Wei; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Shu, Yuelong; Qin, Chuan			Adaption of Seasonal H1N1 Influenza Virus in Mice	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; A VIRUS; INCREASED VIRULENCE; RECEPTOR-BINDING; MOLECULAR-BASIS; H5N1 VIRUS; CYTOKINE RESPONSES; ANTIVIRAL ACTIVITY; EPITHELIAL-CELLS; PROTEIN-CHANGES	The experimental infection of a mouse lung with influenza A virus has proven to be an invaluable model for studying the mechanisms of viral adaptation and virulence. The mouse adaption of human influenza A virus can result in mutations in the HA and other proteins, which is associated with increased virulence in mouse lungs. In this study, a mouse-adapted seasonal H1N1 virus was obtained through serial lung-to-lung passages and had significantly increased virulence and pathogenicity in mice. Genetic analysis indicated that the increased virulence of the mouse-adapted virus was attributed to incremental acquisition of three mutations in the HA protein (T89I, N125T, and D221G). However, the mouse adaption of influenza A virus did not change the specificity and affinity of receptor binding and the pH-dependent membrane fusion of HA, as well as the in vitro replication in MDCK cells. Notably, infection with the mouse adapted virus induced severe lymphopenia and modulated cytokine and chemokine responses in mice. Apparently, mouse adaption of human influenza A virus may change the ability to replicate in mouse lungs, which induces strong immune responses and inflammation in mice. Therefore, our findings may provide new insights into understanding the mechanisms underlying the mouse adaption and pathogenicity of highly virulent influenza viruses.	[Xu, Lili; Bao, Linlin; Li, Fengdi; Lv, Qi; Ma, Yila; Xu, Yanfeng; Deng, Wei; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Xu, Lili; Bao, Linlin; Li, Fengdi; Lv, Qi; Ma, Yila; Xu, Yanfeng; Deng, Wei; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Qin, Chuan] Peking Union Med Collage, Comparat Med Ctr, Beijing, Peoples R China; [Xu, Lili; Bao, Linlin; Li, Fengdi; Lv, Qi; Ma, Yila; Xu, Yanfeng; Deng, Wei; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Qin, Chuan] Minist Hlth, Key Lab Human Dis Comparat Med, Beijing, Peoples R China; [Xu, Lili; Bao, Linlin; Li, Fengdi; Lv, Qi; Ma, Yila; Xu, Yanfeng; Deng, Wei; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Qin, Chuan] State Adm Tradit Chinese Med, Key Lab Anim Model Human Dis, Beijing, Peoples R China; [Zhou, Jiangfang; Shu, Yuelong] China Ctr Dis Control, Natl Inst Viral Dis Control & Prevent, Chinese Natl Influenza Ctr, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, LL (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China.	qinchuan@pumc.edu.cn	Deng, Wei/GWC-9207-2022		National Natural Science Foundation of China [81102286]; China Postdoctoral Science Foundation [20110490323]; Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health [DWS201112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health	This study was supported by grants from the National Natural Science Foundation of China (81102286), China Postdoctoral Science Foundation (20110490323), and the Open Fund of the Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health (DWS201112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Brown EG, 1999, VIRUS RES, V61, P63, DOI 10.1016/S0168-1702(99)00027-1; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; CATE TR, 1987, AM J MED, V82, P15, DOI 10.1016/0002-9343(87)90555-9; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gambaryan AS, 2005, ANTIVIR RES, V68, P116, DOI 10.1016/j.antiviral.2005.07.008; GITELMAN AK, 1984, VIROLOGY, V134, P230, DOI 10.1016/0042-6822(84)90288-5; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Hartley CA, 1997, ARCH VIROL, V142, P75, DOI 10.1007/s007050050060; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; HIRST GK, 1947, J EXP MED, V86, P357, DOI 10.1084/jem.86.5.357; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; KAVERIN NV, 1989, ARCH VIROL, V105, P29, DOI 10.1007/BF01311114; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Liu MT, 2001, J IMMUNOL, V166, P1790, DOI 10.4049/jimmunol.166.3.1790; Mahalingam S, 1999, J VIROL, V73, P1479, DOI 10.1128/JVI.73.2.1479-1491.1999; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Nakajima N, 2010, JPN J INFECT DIS, V63, P67; Narasaraju T, 2009, MICROBES INFECT, V11, P2, DOI 10.1016/j.micinf.2008.09.013; Ning ZY, 2009, VET RES COMMUN, V33, P895, DOI 10.1007/s11259-009-9307-3; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; RAUT S, 1975, J MED MICROBIOL, V8, P127, DOI 10.1099/00222615-8-1-127; RUDNEVA IA, 1986, ARCH VIROL, V90, P237, DOI 10.1007/BF01317373; SCHULMAN JL, 1977, J VIROL, V24, P170, DOI 10.1128/JVI.24.1.170-176.1977; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; SMEENK CA, 1994, J VIROL, V68, P530, DOI 10.1128/JVI.68.1.530-534.1994; Smeenk CA, 1996, VIRUS RES, V44, P79, DOI 10.1016/0168-1702(96)01329-9; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; Speshock JL, 2007, INFECT IMMUN, V75, P3102, DOI 10.1128/IAI.01943-06; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; SWEET C, 1980, MICROBIOL REV, V44, P303, DOI 10.1128/MMBR.44.2.303-330.1980; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Treanor JD, 2007, NEW ENGL J MED, V357, P1439, DOI 10.1056/NEJMe078140; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Ward AC, 1997, VIRUS GENES, V14, P187, DOI 10.1023/A:1007979709403; Whitley RJ, 2006, J INFECT DIS, V194, pS133, DOI 10.1086/507548; Xu LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-325; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06	54	25	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28901	10.1371/journal.pone.0028901	http://dx.doi.org/10.1371/journal.pone.0028901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194944	Green Published, gold, Green Submitted			2022-12-25	WOS:000298664400023
J	Daughdrill, GW; Borcherds, WM; Wu, HW				Daughdrill, Gary W.; Borcherds, Wade M.; Wu, Hongwei			Disorder Predictors Also Predict Backbone Dynamics for a Family of Disordered Proteins	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION DOMAIN; NATIVELY UNFOLDED PROTEINS; INTRINSIC DISORDER; FUNCTIONAL ANTHOLOGY; TRANSACTIVATION DOMAIN; P53; SEQUENCE; BINDING	Several algorithms have been developed that use amino acid sequences to predict whether or not a protein or a region of a protein is disordered. These algorithms make accurate predictions for disordered regions that are 30 amino acids or longer, but it is unclear whether the predictions can be directly related to the backbone dynamics of individual amino acid residues. The nuclear Overhauser effect between the amide nitrogen and hydrogen (NHNOE) provides an unambiguous measure of backbone dynamics at single residue resolution and is an excellent tool for characterizing the dynamic behavior of disordered proteins. In this report, we show that the NHNOE values for several members of a family of disordered proteins are highly correlated with the output from three popular algorithms used to predict disordered regions from amino acid sequence. This is the first test between an experimental measure of residue specific backbone dynamics and disorder predictions. The results suggest that some disorder predictors can accurately estimate the backbone dynamics of individual amino acids in a long disordered region.	[Daughdrill, Gary W.; Borcherds, Wade M.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Daughdrill, Gary W.; Wu, Hongwei] Univ S Florida, Ctr Drug Discovery & Innovat, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Daughdrill, GW (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	gdaughdrill@usf.edu			American Cancer Society [RSG-07-289-01-GMC]; National Science Foundation [MCB-0939014]	American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF))	This work was funded by the American Cancer Society (RSG-07-289-01-GMC; www.acs.org) and the National Science Foundation (MCB-0939014; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2001, CURR OPIN CHEM BIOL, V5, P51, DOI 10.1016/S1367-5931(00)00164-2; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; CHOTHIA C, 1987, COLD SPRING HARB SYM, V52, P399, DOI 10.1101/SQB.1987.052.01.046; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Dawson R, 2003, J MOL BIOL, V332, P1131, DOI 10.1016/j.jmb.2003.08.008; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Dyson HJ, 1998, NAT STRUCT BIOL, V5, P499, DOI 10.1038/739; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; ELIEZER D, 2007, METHODS MOL BIOLOGY, P49; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaustov L, 2006, CELL CYCLE, V5, P489, DOI 10.4161/cc.5.5.2489; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Kutyshenko VP, 2009, BBA-PROTEINS PROTEOM, V1794, P1813, DOI 10.1016/j.bbapap.2009.08.021; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li LW, 2007, J AM CHEM SOC, V129, P15668, DOI 10.1021/ja076046a; Liang SD, 2009, BIOCHEMISTRY-US, V48, P399, DOI 10.1021/bi8017043; Lowry DF, 2008, PROTEINS, V71, P587, DOI 10.1002/prot.21721; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Petsko G., 2004, PROTEIN STRUCTURE FU; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 1998, Pac Symp Biocomput, P437; SIMON I, 2005, J MOL BIOL, V347, P827; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P., 2010, STRUCTURE FUNCTION I; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; [No title captured], DOI DOI 10.1002/9783527619498.CH41	50	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29207	10.1371/journal.pone.0029207	http://dx.doi.org/10.1371/journal.pone.0029207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195023	Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400039
J	Huang, CL; Shu, WY; Tsai, ML; Chiang, CS; Chang, CW; Chang, CT; Hsu, IC				Huang, Ching-Lung; Shu, Wun-Yi; Tsai, Min-Lung; Chiang, Chi-Shiun; Chang, Cheng-Wei; Chang, Chiu-Ting; Hsu, Ian C.			Repeated Small Perturbation Approach Reveals Transcriptomic Steady States	PLOS ONE			English	Article							EXPRESSION MICROARRAY DATA; SYSTEMS BIOLOGY; GENE-EXPRESSION; ANTIPROLIFERATIVE ACTIVITY; SACCHAROMYCES-CEREVISIAE; EPIDERMAL-KERATINOCYTES; METABOLIC NETWORK; CELL-DEATH; PROTEIN; RADIATION	The study of biological systems dynamics requires elucidation of the transitions of steady states. A "small perturbation" approach can provide important information on the "steady state" of a biological system. In our experiments, small perturbations were generated by applying a series of repeating small doses of ultraviolet radiation to a human keratinocyte cell line, HaCaT. The biological response was assessed by monitoring the gene expression profiles using cDNA microarrays. Repeated small doses (10 J/m2) of ultraviolet B (UVB) exposure modulated the expression profiles of two groups of genes in opposite directions. The genes that were up-regulated have functions mainly associated with anti-proliferation/anti-mitogenesis/apoptosis, and the genes that were down-regulated were mainly related to proliferation/mitogenesis/anti-apoptosis. For both groups of genes, repetition of the small doses of UVB caused an immediate response followed by relaxation between successive small perturbations. This cyclic pattern was suppressed when large doses (233 or 582.5 J/m2) of UVB were applied. Our method and results contribute to a foundation for computational systems biology, which implicitly uses the concept of steady state.	[Huang, Ching-Lung; Chiang, Chi-Shiun; Chang, Cheng-Wei; Chang, Chiu-Ting; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Shu, Wun-Yi] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Tsai, Min-Lung] Natl Taiwan Sport Univ, Inst Athlet, Taichung, Taiwan	National Tsing Hua University; National Tsing Hua University	Huang, CL (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	ichsu@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008	Chiang, Chi-Shiun/0000-0002-2581-4129	NSC, Taiwan [NSC 99-2112-M-007-008]	NSC, Taiwan(Ministry of Science and Technology, Taiwan)	NSC 99-2112-M-007-008, NSC, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri AB, 1998, GEN PHARMACOL-VASC S, V31, P741, DOI 10.1016/S0306-3623(98)00111-6; Andersen ME, 2005, REPROD TOXICOL, V19, P327, DOI 10.1016/j.reprotox.2004.12.004; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; BenPorath I, 1996, GENE, V183, P69, DOI 10.1016/S0378-1119(96)00475-1; Berney M, 2006, APPL ENVIRON MICROB, V72, P2586, DOI 10.1128/AEM.72.4.2586-2593.2006; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brandt-Bohne U, 2007, BIOCHEM J, V401, P447, DOI 10.1042/BJ20060691; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cline SD, 2006, DNA REPAIR, V5, P611, DOI 10.1016/j.dnarep.2006.01.007; Friboulet A, 2005, BIOSENS BIOELECTRON, V20, P2404, DOI 10.1016/j.bios.2004.11.014; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Im SB, 1998, CANCER RES, V58, P47; Kerr MK, 2001, GENET RES, V77, P123; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Li H, 2007, P NATL ACAD SCI USA, V104, P20001, DOI 10.1073/pnas.0709986104; Maeda T, 2002, J INVEST DERMATOL, V119, P22, DOI 10.1046/j.1523-1747.2002.01781.x; MAGUCHI M, 1995, BIOCHEM BIOPH RES CO, V217, P238, DOI 10.1006/bbrc.1995.2769; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuda S, 1996, ONCOGENE, V12, P705; MAYTIN EV, 1993, CANCER RES, V53, P4952; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ohta S, 1997, BIOCHEM J, V324, P777, DOI 10.1042/bj3240777; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Sesto A, 2002, P NATL ACAD SCI USA, V99, P2965, DOI 10.1073/pnas.052678999; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Weinstein AM, 2004, B MATH BIOL, V66, P1201, DOI 10.1016/j.bulm.2003.12.002; Wolff T, 1998, J VIROL, V72, P7170, DOI 10.1128/JVI.72.9.7170-7180.1998; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29241	10.1371/journal.pone.0029241	http://dx.doi.org/10.1371/journal.pone.0029241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195030	Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400042
J	Correa-Costa, M; Braga, TT; Semedo, P; Hayashida, CY; Bechara, LRG; Elias, RM; Barreto, CR; Silva-Cunha, C; Hyane, MI; Goncalves, GM; Brum, PC; Fujihara, C; Zatz, R; Pacheco-Silva, A; Zamboni, DS; Camara, NOS				Correa-Costa, Matheus; Braga, Tarcio Teodoro; Semedo, Patricia; Hayashida, Caroline Yuri; Grassmann Bechara, Luiz Roberto; Elias, Rosa Maria; Barreto, Claudiene Rodrigues; Silva-Cunha, Claudia; Hyane, Meire Ioshie; Goncalves, Giselle Martins; Brum, Patricia Chakur; Fujihara, Clarice; Zatz, Roberto; Pacheco-Silva, Alvaro; Zamboni, Dario S.; Saraiva Camara, Niels Olsen			Pivotal Role of Toll-Like Receptors 2 and 4, Its Adaptor Molecule MyD88, and Inflammasome Complex in Experimental Tubule-Interstitial Nephritis	PLOS ONE			English	Article							XANTHINE OXIDOREDUCTASE; KIDNEY-DISEASE; MOUSE MODEL; URIC-ACID; FIBROSIS; DANGER; INJURY; DEHYDROGENASE; OXIDASE	Tubule-interstitial nephritis (TIN) results in decreased renal function and interstitial inflammation, which ultimately leads to fibrosis. Excessive adenine intake can cause TIN because xanthine dehydrogenase (XDH) can convert this purine into an insoluble compound, which precipitates in the tubuli. Innate immune sensors, such as Toll-like receptors (TLR) and inflammasome complex, play a crucial role in the initiation of inflammation. The aim of this study was to evaluate the roles of TLR-2 and -4, Myd88 and inflammasome complex in an experimental model of TIN. Here, we show that wild-type (WT) mice fed adenine-enriched food exhibited significant renal dysfunction and enhanced cellular infiltration accompanied by collagen deposition. They also presented higher gene and protein expression of pro-inflammatory cytokines. In contrast, TLR-2, -4, MyD88, ASC and Caspase-1 KO mice showed renoprotection associated with expression of inflammatory molecules at levels comparable to controls. Furthermore, treatment of WT animals with allopurinol, an XDH inhibitor, led to reduced levels of uric acid, oxidative stress, collagen deposition and a downregulation of the NF-kB signaling pathway. We concluded that MyD88 signaling and inflammasome participate in the development of TIN. Furthermore, inhibition of XDH seems to be a promising way to therapeutically target the developing inflammatory process.	[Correa-Costa, Matheus; Braga, Tarcio Teodoro; Hayashida, Caroline Yuri; Silva-Cunha, Claudia; Hyane, Meire Ioshie; Goncalves, Giselle Martins; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Inst Biomed Sci 4, Dept Immunol, Lab Transplantat Immunobiol, Sao Paulo, Brazil; [Semedo, Patricia; Elias, Rosa Maria; Barreto, Claudiene Rodrigues; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Div Nephrol, Lab Clin & Expt Immunol, Sao Paulo, Brazil; [Grassmann Bechara, Luiz Roberto; Brum, Patricia Chakur] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Fujihara, Clarice; Zatz, Roberto] Univ Sao Paulo, Fac Med, Dept Clin Med, Div Renal, Sao Paulo, Brazil; [Pacheco-Silva, Alvaro] Albert Einstein Hosp, Renal Transplantat Unit, Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil; [Zamboni, Dario S.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Cell Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Universidade de Sao Paulo	Correa-Costa, M (corresponding author), Univ Sao Paulo, Inst Biomed Sci 4, Dept Immunol, Lab Transplantat Immunobiol, Sao Paulo, Brazil.	niels@icb.usp.br	Braga, Tarcio/AAG-4475-2020; Fujihara, Clarice/H-9565-2012; camara, niels olsen saraiva/AAX-3269-2020; Correa-Costa, Matheus/B-2006-2014; Brum, Patricia C/E-6605-2011; Camara, Niels OS/G-8336-2011; Zatz, Roberto/D-5716-2012; Braga, Tarcio T/E-4827-2014; Semedo-Kuriki, Patricia/D-2429-2010; Zamboni, Dario S/D-3024-2012; Complexos, INCT Fluidos/H-9172-2013; Pacheco-Silva, Alvaro/K-3583-2013; Bechara, Luiz R G/K-4095-2012	camara, niels olsen saraiva/0000-0001-5436-1248; Brum, Patricia C/0000-0002-4750-6506; Camara, Niels OS/0000-0001-5436-1248; Braga, Tarcio T/0000-0002-2989-1076; Zamboni, Dario S/0000-0002-7856-7512; Semedo-Kuriki, Patricia/0000-0002-2136-3308; Bechara, Luiz/0000-0002-1642-1008	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [07/07139-3, 09/54474-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; National Institute for Science and Technology - Complex Fluids; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institute for Science and Technology - Complex Fluids; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (07/07139-3 and 09/54474-8), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Programa Nacional de Pos Doutorado, National Institute for Science and Technology - Complex Fluids and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Anders HJ, 2010, J AM SOC NEPHROL, V21, P1270, DOI 10.1681/ASN.2010030233; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Burne-Taney MJ, 2005, KIDNEY INT, V67, P1002, DOI 10.1111/j.1523-1755.2005.00163.x; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Eleftheriadis Theodoros, 2009, Inflammation & Allergy Drug Targets, V8, P191; Engle SJ, 1996, P NATL ACAD SCI USA, V93, P5307, DOI 10.1073/pnas.93.11.5307; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; PFEFFER KD, 1994, J IMMUNOL, V153, P1789; Praga M, 2010, KIDNEY INT, V77, P956, DOI 10.1038/ki.2010.89; Pritsos CA, 2000, CHEM-BIOL INTERACT, V129, P195, DOI 10.1016/S0009-2797(00)00203-9; Stockelman MG, 1998, AM J PHYSIOL-RENAL, V275, pF154, DOI 10.1152/ajprenal.1998.275.1.F154; Tamura M, 2009, HISTOCHEM CELL BIOL, V131, P483, DOI 10.1007/s00418-009-0557-5; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3	21	71	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29004	10.1371/journal.pone.0029004	http://dx.doi.org/10.1371/journal.pone.0029004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194975	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100139
J	Fowler, DW; Freedman, EA; Scannella, JB; Kambic, RE				Fowler, Denver W.; Freedman, Elizabeth A.; Scannella, John B.; Kambic, Robert E.			The Predatory Ecology of Deinonychus and the Origin of Flapping in Birds	PLOS ONE			English	Article							DROMAEOSAURID DINOSAUR; FUNCTIONAL-MORPHOLOGY; OLDMAN FORMATION; EVOLUTION; ARCHAEOPTERYX; THEROPODA; SPECIMEN; FLIGHT; PREY; CLAW	Most non-avian theropod dinosaurs are characterized by fearsome serrated teeth and sharp recurved claws. Interpretation of theropod predatory ecology is typically based on functional morphological analysis of these and other physical features. The notorious hypertrophied 'killing claw' on pedal digit (D) II of the maniraptoran theropod Deinonychus (Paraves: Dromaeosauridae) is hypothesized to have been a predatory adaptation for slashing or climbing, leading to the suggestion that Deinonychus and other dromaeosaurids were cursorial predators specialized for actively attacking and killing prey several times larger than themselves. However, this hypothesis is problematic as extant animals that possess similarly hypertrophied claws do not use them to slash or climb up prey. Here we offer an alternative interpretation: that the hypertrophied D-II claw of dromaeosaurids was functionally analogous to the enlarged talon also found on D-II of extant Accipitridae (hawks and eagles; one family of the birds commonly known as "raptors"). Here, the talon is used to maintain grip on prey of subequal body size to the predator, while the victim is pinned down by the body weight of the raptor and dismembered by the beak. The foot of Deinonychus exhibits morphology consistent with a grasping function, supportive of the prey immobilisation behavior model. Opposite morphological trends within Deinonychosauria (Dromaeosauridae + Troodontidae) are indicative of ecological separation. Placed in context of avian evolution, the grasping foot of Deinonychus and other terrestrial predatory paravians is hypothesized to have been an exaptation for the grasping foot of arboreal perching birds. Here we also describe "stability flapping", a novel behaviour executed for positioning and stability during the initial stages of prey immobilisation, which may have been pivotal to the evolution of the flapping stroke. These findings overhaul our perception of predatory dinosaurs and highlight the role of exaptation in the evolution of novel structures and behaviours.	[Fowler, Denver W.; Freedman, Elizabeth A.; Scannella, John B.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Fowler, Denver W.; Freedman, Elizabeth A.; Scannella, John B.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Kambic, Robert E.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Brown University	Fowler, DW (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	df9465@yahoo.co.uk	Freedman, Elizabeth/J-1752-2012	Freedman, Elizabeth/0000-0002-5763-5272; Kambic, Robert/0000-0002-1303-0896; Fowler, Denver/0000-0001-9188-4371				ABLER WL, 1992, PALEOBIOLOGY, V18, P161, DOI 10.1017/S0094837300013956; Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; ALFORD JR, 1972, WILSON BULL, V84, P487; BOND RICHARD M., 1936, CONDOR, V38, P72, DOI 10.2307/1363552; Bunce M, 2005, PLOS BIOL, V3, P44, DOI 10.1371/journal.pbio.0030009; Burgers P, 1999, NATURE, V399, P60, DOI 10.1038/19967; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; COOPER AB, 1969, J ZOOL, V158, P215; Csermely D, 1998, CONDOR, V100, P757, DOI 10.2307/1369762; Csermely D, 2006, ITAL J ZOOL, V73, P43, DOI 10.1080/11250000500502368; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2224, DOI 10.1139/e93-193; Currie PJ, 2001, CAN J EARTH SCI, V38, P1753, DOI 10.1139/e01-065; Dececchi TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022292; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; FEDUCCIA A, 1993, SCIENCE, V259, P790, DOI 10.1126/science.259.5096.790; Feduccia A, 2007, AUK, V124, P373, DOI 10.1642/0004-8038(2007)124[373:PIOAQV]2.0.CO;2; FISHER HI, 1946, AM MIDL NAT, V35, P545, DOI 10.2307/2421553; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Fowler DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007999; Gamauf A, 1998, AUK, V115, P713; Gatesy SM, 2005, PALEOBIOLOGY, V31, P382, DOI 10.1666/0094-8373(2005)031[0382:TOOTAF]2.0.CO;2; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; Gishlick AD, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P301; Glen CL, 2007, CURR BIOL, V17, pR911, DOI 10.1016/j.cub.2007.09.026; GOSLOW GE, 1971, AUK, V88, P815, DOI 10.2307/4083840; GOSLOW GE, 1972, AUK, V89, P47, DOI 10.2307/4084059; Green RE, 2009, J ZOOL, V277, P126, DOI 10.1111/j.1469-7998.2008.00518.x; Harris T., 1984, P 2 S AFR PRED BIRDS, P195; Hertel F, 1995, AUK, V112, P890, DOI 10.2307/4089021; HOLTZ TR, 1995, J VERTEBR PALEONTOL, V14, P408, DOI DOI 10.1080/02724634.1995.10011574; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Johnsgard P. A., 1990, HAWKS EAGLES FALCONS; JOLLIE M, 1977, Evolutionary Theory, V3, P1; Kurzanov S.M., 1987, T JOINT SOVIET MONGO, V31, P5; Longrich Nick, 2008, P135; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Manning PL, 2006, BIOL LETTERS, V2, P110, DOI 10.1098/rsbl.2005.0395; Manning PL, 2009, ANAT REC, V292, P1397, DOI 10.1002/ar.20986; MAXWELL DW, 1995, J VERT PALEONTOL, V5, P707; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Middleton KM, 2001, J MORPHOL, V250, P51, DOI 10.1002/jmor.1058; Moreno K, 2007, J MORPHOL, V268, P50, DOI 10.1002/jmor.10498; Newton I., 1986, SPARROWHAWK; Norberg UML, 2002, J MORPHOL, V252, P52, DOI 10.1002/jmor.10013; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell Mark A., 1997, American Museum Novitates, V3215, P1; OSMOLSKA H, 1987, ACTA PALAEONTOLOGICA, V31, P133; Osmolska H., 1972, PALAEONTOLOGIA POLON, V27, P103; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Ostrom J.H., 1976, BREVIORA, V439, P1; Padian K, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P255; Padian K, 2009, CR PALEVOL, V8, P257, DOI 10.1016/j.crpv.2008.11.007; PAUL GS, 2002, DINOSAURS AIR EVOLUT, P472; PETERS DS, 1992, PAPERS AVIAN PALEONT, P29; Phillips RL, 1996, WILDLIFE SOC B, V24, P468; RAIKOW RJ, 1985, FORM FUNCTION BIRDS, V3, P87; Rasmussen DT, 2001, PALAEONTOLOGY, V44, P325, DOI 10.1111/1475-4983.00182; RATCLIFFE PR, 1979, J ZOOL, V189, P532; Roach Brian T., 2007, Bulletin of the Peabody Museum of Natural History, V48, P103, DOI 10.3374/0079-032X(2007)48[103:AROCPH]2.0.CO;2; RUSSELL DA, 1969, CAN J EARTH SCI, V6, P595, DOI 10.1139/e69-059; Sakamoto M, 2010, P ROY SOC B-BIOL SCI, V277, P3327, DOI 10.1098/rspb.2010.0794; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Senter Phil, 2009, Bulletin of Gunma Museum of Natural History, V13, P1; Snively E, 2004, ZOOL J LINN SOC-LOND, V142, P525, DOI 10.1111/j.1096-3642.2004.00137.x; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; Sustaita D, 2008, J MORPHOL, V269, P283, DOI 10.1002/jmor.10577; Therrien F, 2005, LIFE O PAST, P179; TOBIAS JA, 2003, GRZIMEKS ANIMAL LIFE, V9, P91; Turner AH, 2007, SCIENCE, V317, P1721, DOI 10.1126/science.1145076; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; VANVALKENBURGH, 1987, J VERTEBR PALEONTOL, V7, P162; WALKER M, 2009, BBC NEWS; Ward AB, 2002, AUK, V119, P1052, DOI 10.1642/0004-8038(2002)119[1052:FMORHI]2.0.CO;2; Wellnhofer P, 2004, LIFE O PAST, P282; WILSON MC, 1985, CAN J EARTH SCI, V22, P1813, DOI 10.1139/e85-192; Wright JL, 2004, LIFE O PAST, P167; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X., 2000, SPECIAL PUBLICATION, V2000, P179; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zheng XT, 2010, P ROY SOC B-BIOL SCI, V277, P211, DOI 10.1098/rspb.2009.1178; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2003, NATURWISSENSCHAFTEN, V90, P220, DOI 10.1007/s00114-003-0416-5; Zhou ZH, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P237; [No title captured]	98	58	61	1	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28964	10.1371/journal.pone.0028964	http://dx.doi.org/10.1371/journal.pone.0028964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194962	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100132
J	Liguori, AP; Warrington, SD; Ginther, JL; Pearson, T; Bowers, J; Glass, MB; Mayo, M; Wuthiekanun, V; Engelthaler, D; Peacock, SJ; Currie, BJ; Wagner, DM; Keim, P; Tuanyok, A				Liguori, Andrew P.; Warrington, Stephanie D.; Ginther, Jennifer L.; Pearson, Talima; Bowers, Jolene; Glass, Mindy B.; Mayo, Mark; Wuthiekanun, Vanaporn; Engelthaler, David; Peacock, Sharon J.; Currie, Bart J.; Wagner, David M.; Keim, Paul; Tuanyok, Apichai			Diversity of 16S-23S rDNA Internal Transcribed Spacer (ITS) Reveals Phylogenetic Relationships in Burkholderia pseudomallei and Its Near-Neighbors	PLOS ONE			English	Article							OPERON COPY NUMBER; SEQUENCE-ANALYSIS; IDENTIFICATION; SOIL; MELIOIDOSIS; EPIDEMIOLOGY; REGION; DIFFERENTIATION; RECOMBINATION; PLASTICITY	Length polymorphisms within the 16S-23S ribosomal DNA internal transcribed spacer (ITS) have been described as stable genetic markers for studying bacterial phylogenetics. In this study, we used these genetic markers to investigate phylogenetic relationships in Burkholderia pseudomallei and its near-relative species. B. pseudomallei is known as one of the most genetically recombined bacterial species. In silico analysis of multiple B. pseudomallei genomes revealed approximately four homologous rRNA operons and ITS length polymorphisms therein. We characterized ITS distribution using PCR and analyzed via a high-throughput capillary electrophoresis in 1,191 B. pseudomallei strains. Three major ITS types were identified, two of which were commonly found in most B. pseudomallei strains from the endemic areas, whereas the third one was significantly correlated with worldwide sporadic strains. Interestingly, mixtures of the two common ITS types were observed within the same strains, and at a greater incidence in Thailand than Australia suggesting that genetic recombination causes the ITS variation within species, with greater recombination frequency in Thailand. In addition, the B. mallei ITS type was common to B. pseudomallei, providing further support that B. mallei is a clone of B. pseudomallei. Other B. pseudomallei near-neighbors possessed unique and monomorphic ITS types. Our data shed light on evolutionary patterns of B. pseudomallei and its near relative species.	[Liguori, Andrew P.; Warrington, Stephanie D.; Ginther, Jennifer L.; Pearson, Talima; Wagner, David M.; Keim, Paul; Tuanyok, Apichai] No Arizona Univ, Dept Biol Sci, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Bowers, Jolene; Engelthaler, David] Translat Genom Res Inst N, Div Pathogen Genom, Flagstaff, AZ USA; [Glass, Mindy B.] Ctr Dis Control & Prevent, Bacterial Zoonoses Branch, Div Foodborne Bacterial & Mycot Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA USA; [Mayo, Mark; Currie, Bart J.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Wuthiekanun, Vanaporn; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Northern Arizona University; Translational Genomics Research Institute; Centers for Disease Control & Prevention - USA; Charles Darwin University; Menzies School of Health Research; Mahidol University	Liguori, AP (corresponding author), No Arizona Univ, Dept Biol Sci, Ctr Microbial Genet & Genom, Box 5640, Flagstaff, AZ 86011 USA.	apichai.tuanyok@nau.edu	Pacific-Southwest, RCE/B-6155-2009; Pearson, Talima/O-7840-2019; Peacock, Sharon J/ABE-6331-2020	Pearson, Talima/0000-0003-3696-041X; Wagner, David/0000-0003-2684-6007; Peacock, Sharon/0000-0002-1718-2782	National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI075568, U54 AI065359]; US Department of Homeland Security [HSHQDC-10-C-00149]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, U01AI075568] Funding Source: NIH RePORTER	National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Homeland Security(United States Department of Homeland Security (DHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) grant nos. U01 AI075568 (PI: Keim) and U54 AI065359 (PI: Tuanyok), and US Department of Homeland Security contract no. HSHQDC-10-C-00149 (PI: Tuanyok). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; APIRION D, 1993, BIOESSAYS, V15, P113, DOI 10.1002/bies.950150207; BERG KL, 1989, J MOL BIOL, V209, P345, DOI 10.1016/0022-2836(89)90002-8; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng AC, 2008, J CLIN MICROBIOL, V46, P249, DOI 10.1128/JCM.01725-07; Cheng Allen C, 2003, Commun Dis Intell Q Rep, V27, P272; Currie BJ, 2008, T ROY SOC TROP MED H, V102, P225, DOI 10.1016/j.trstmh.2007.11.005; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Gee JE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-54; Gee JE, 2003, J CLIN MICROBIOL, V41, P4647, DOI 10.1128/JCM.41.10.4647-4654.2003; Glass MB, 2006, INT J SYST EVOL MICR, V56, P2171, DOI 10.1099/ijs.0.63991-0; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Gurtler V, 1999, GENE, V238, P241, DOI 10.1016/S0378-1119(99)00224-3; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Kaestli M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000364; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; KOSTMAN JR, 1992, J CLIN MICROBIOL, V30, P2084, DOI 10.1128/JCM.30.8.2084-2087.1992; KUNAKORN M, 1995, J CLIN MICROBIOL, V33, P2131, DOI 10.1128/JCM.33.8.2131-2135.1995; Lan RT, 1998, MICROBIOL-UK, V144, P1213, DOI 10.1099/00221287-144-5-1213; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Nielsen XHC, 2009, J CLIN MICROBIOL, V47, P932, DOI 10.1128/JCM.01449-08; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Pearson T, 2007, INFECT GENET EVOL, V7, P416, DOI 10.1016/j.meegid.2006.12.002; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Pitt TL, 2000, ACTA TROP, V74, P181, DOI 10.1016/S0001-706X(99)00068-6; Rachman C, 2004, APPL ENVIRON MICROB, V70, P4468, DOI 10.1128/AEM.70.8.4468-4477.2004; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Sadeghifard N, 2006, APPL ENVIRON MICROB, V72, P7311, DOI 10.1128/AEM.01179-06; Sermswan RW, 2001, ACTA TROP, V80, P237, DOI 10.1016/S0001-706X(01)00176-0; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; SMITH MD, 1995, T ROY SOC TROP MED H, V89, P488, DOI 10.1016/0035-9203(95)90078-0; TAMBONG JT, 2009, MICROBIOLOGY; Tuanyok A, 2007, J BACTERIOL, V189, P9044, DOI 10.1128/JB.01264-07; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; TYLER SD, 1995, CLIN DIAGN LAB IMMUN, V2, P448, DOI 10.1128/CDLI.2.4.448-453.1995; Ulrich RL, 2006, DIAGN MICR INFEC DIS, V55, P37, DOI 10.1016/j.diagmicrobio.2005.11.007; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; WUTHIEKANUN V, 1995, T ROY SOC TROP MED H, V89, P41, DOI 10.1016/0035-9203(95)90651-7	48	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29323	10.1371/journal.pone.0029323	http://dx.doi.org/10.1371/journal.pone.0029323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195045	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100172
J	Xie, FL; Cheng, GJ; Xu, H; Wang, Z; Lei, L; Li, YG				Xie, Fuli; Cheng, Guojun; Xu, Hui; Wang, Zhi; Lei, Lei; Li, Youguo			Identification of a Novel Gene for Biosynthesis of a Bacteroid-Specific Electron Carrier Menaquinone	PLOS ONE			English	Article							TRIMETHYLAMINE N-OXIDE; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; NADH DEHYDROGENASE; RESPIRATION; TRANSPORT; NITRATE; DEMETHYLMENAQUINONE; UBIQUINONE; CYTOCHROME	Ubiquinone (UQ) has been considered as an electron mediator in electron transfer that generates ATP in Rhizobium under both free-living and symbiosis conditions. When mutated, the dmtH gene has a symbiotic phenotype of forming ineffective nodules on Astragalus sinicus. The gene was isolated from a Mesorhizobium huakuii 7653R transposon-inserted mutant library. The DNA sequence and conserved protein domain analyses revealed that dmtH encodes demethylmenaquinone (DMK) methyltransferase, which catalyzes the terminal step of menaquinone (MK) biosynthesis. Comparative analysis indicated that dmtH homologs were present in only a few Rhizobia. Real-time quantitative PCR showed dmtH is a bacteroid-specific gene. The highest expression was seen at 25 days after inoculation of strain 7653R. Gene disruption and complementation tests demonstrated that the dmtH gene was essential for bacteroid development and symbiotic nitrogen fixation ability. MK and UQ were extracted from the wild type strain 7653R and mutant strain HK116. MK-7 was accumulated under microaerobic condition and UQ-10 was accumulated under aerobic condition in M. huakuii 7653R. The predicted function of DmtH protein was confirmed by the measurement of methyltransferase activity in vitro. These results revealed that MK-7 was used as an electron carrier instead of UQ in M. huakuii 7653R bacteroids.	[Xie, Fuli; Cheng, Guojun; Xu, Hui; Wang, Zhi; Lei, Lei; Li, Youguo] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Xie, FL (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	youguoli@mail.hzau.edu.cn			National Natural Science Foundation of China [30970074]; National 973 Key Fundamental Research Program of China [2010CB126502]; State Key Laboratory of Agricultural Microbiology [AMLKF200909]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Key Fundamental Research Program of China(National Basic Research Program of China); State Key Laboratory of Agricultural Microbiology	This study was supported by National Natural Science Foundation of China (grant no. 30970074), the National 973 Key Fundamental Research Program of China (grant no. 2010CB126502), and the State Key Laboratory of Agricultural Microbiology (grant no. AMLKF200909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; BOLTON E, 1986, ARCH MICROBIOL, V144, P142, DOI 10.1007/BF00414724; BOTT M, 1992, ARCH MICROBIOL, V158, P335, DOI 10.1007/BF00245362; Brondijk THC, 2002, MOL MICROBIOL, V44, P245, DOI 10.1046/j.1365-2958.2002.02875.x; Cheng GJ, 2006, FEMS MICROBIOL LETT, V257, P152, DOI 10.1111/j.1574-6968.2006.00158.x; Cheng GJ, 2007, CURR MICROBIOL, V54, P371, DOI 10.1007/s00284-006-0471-1; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; DANIEL RM, 1979, J GEN MICROBIOL, V110, P333, DOI 10.1099/00221287-110-2-333; DEHOLLANDER JA, 1980, EUR J BIOCHEM, V111, P473, DOI 10.1111/j.1432-1033.1980.tb04962.x; GABEL C, 1990, NUCLEIC ACIDS RES, V18, P6143, DOI 10.1093/nar/18.20.6143; HARDY R W F, 1973, Soil Biology and Biochemistry, V5, P47, DOI 10.1016/0038-0717(73)90093-X; Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446; KoikeTakeshita A, 1997, J BIOL CHEM, V272, P12380, DOI 10.1074/jbc.272.19.12380; LANKHORST RMK, 1988, APPL ENVIRON MICROB, V54, P3008, DOI 10.1128/AEM.54.12.3008-3013.1988; Lee PT, 1997, J BACTERIOL, V179, P1748, DOI 10.1128/jb.179.5.1748-1754.1997; Lodwig EM, 2005, MOL PLANT MICROBE IN, V18, P67, DOI 10.1094/MPMI-18-0067; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; Nantapong N, 2005, BIOSCI BIOTECH BIOCH, V69, P149, DOI 10.1271/bbb.69.149; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; OBRIAN MR, 1982, J BACTERIOL, V152, P422; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Schoepp-Cothenet B, 2009, P NATL ACAD SCI USA, V106, P8549, DOI 10.1073/pnas.0813173106; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; SIMON R, 1984, MOL GEN GENET, V196, P413, DOI 10.1007/BF00436188; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Swearingen JW, 2006, APPL ENVIRON MICROB, V72, P963, DOI 10.1128/AEM.72.1.963-967.2006; Trainer MA, 2006, APPL MICROBIOL BIOT, V71, P377, DOI 10.1007/s00253-006-0354-1; Tran QH, 1997, EUR J BIOCHEM, V244, P155, DOI 10.1111/j.1432-1033.1997.00155.x; UNDEN G, 1988, ARCH MICROBIOL, V150, P499, DOI 10.1007/BF00422294; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; WISSENBACH U, 1990, ARCH MICROBIOL, V154, P60; WISSENBACH U, 1992, ARCH MICROBIOL, V158, P68, DOI 10.1007/BF00249068; WU FF, 2006, BIORADIATIONS, V119, P30; Xie B, 2006, APPL MICROBIOL BIOT, V71, P505, DOI 10.1007/s00253-005-0186-4; YOUNG IG, 1981, EUR J BIOCHEM, V116, P165, DOI 10.1111/j.1432-1033.1981.tb05314.x	39	6	6	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28995	10.1371/journal.pone.0028995	http://dx.doi.org/10.1371/journal.pone.0028995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194970	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100136
J	Ramer, R; Bublitz, K; Freimuth, N; Merkord, J; Rohde, H; Haustein, M; Borchert, P; Schmuhl, E; Linnebacher, M; Hinz, B				Ramer, Robert; Bublitz, Katharina; Freimuth, Nadine; Merkord, Jutta; Rohde, Helga; Haustein, Maria; Borchert, Philipp; Schmuhl, Ellen; Linnebacher, Michael; Hinz, Burkhard			Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1	FASEB JOURNAL			English	Article						cannabinoids; tissue inhibitor of metalloproteinases-1; experimental metastasis; ICAM-1	REGULATES ICAM-1 EXPRESSION; VASCULAR ENDOTHELIAL-CELLS; FACTOR-KAPPA-B; TISSUE INHIBITOR; GENE-EXPRESSION; UP-REGULATION; MATRIX METALLOPROTEINASES-1; DIFFERENTIAL EXPRESSION; CANNABINOIDS INHIBIT; LYMPHOCYTE ADHESION	Cannabinoids inhibit cancer cell invasion via increasing tissue inhibitor of matrix metallo-proteinases-1 (TIMP-1). This study investigates the role of intercellular adhesion molecule-1 (ICAM-1) within this action. In the lung cancer cell lines A549, H358, and H460, cannabidiol (CBD; 0.001-3 mu M) elicited concentration-dependent ICAM-1 up-regulation compared to vehicle via cannabinoid receptors, transient receptor potential vanilloid 1, and p42/44 mitogen-activated protein kinase. Up-regulation of ICAM-1 mRNA by CBD in A549 was 4-fold at 3 mu M, with significant effects already evident at 0.01 mu M. ICAM-1 induction became significant after 2 h, whereas significant TIMP-1 mRNA increases were observed only after 48 h. Inhibition of ICAM-1 by antibody or siRNA approaches reversed the anti-invasive and TIMP-1-upregulating action of CBD and the likewise ICAM-1-inducing cannabinoids Delta(9)-tetrahydrocannabinol and R(+)-methanandamide when compared to isotype or nonsilencing siRNA controls. ICAM-1-dependent antiinvasive cannabinoid effects were confirmed in primary tumor cells from a lung cancer patient. In athymic nude mice, CBD elicited a 2.6- and 3.0-fold increase of ICAM-1 and TIMP-1 protein in A549 xenografts, as compared to vehicle-treated animals, and an antimetastatic effect that was fully reversed by a neutralizing antibody against ICAM-1 [% metastatic lung nodules vs. isotype control (100%): 47.7% for CBD + isotype antibody and 106.6% for CBD + ICAM-1 antibody]. Overall, our data indicate that cannabinoids induce ICAM-1, thereby conferring TIMP-1 induction and subsequent decreased cancer cell invasiveness.-Ramer, R., Bublitz, K., Freimuth, N., Merkord, J., Rohde, H., Haustein, M., Borchert, P., Schmuhl, E., Linnebacher, M., Hinz, B. Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule- 1. FASEB J. 26, 1535-1548 (2012). www.fasebj.org	[Ramer, Robert; Bublitz, Katharina; Freimuth, Nadine; Merkord, Jutta; Rohde, Helga; Haustein, Maria; Borchert, Philipp; Schmuhl, Ellen; Hinz, Burkhard] Univ Rostock, Inst Pharmacol & Toxicol, D-18057 Rostock, Germany; [Linnebacher, Michael] Univ Rostock, Sect Mol Oncol & Immunotherapy, Dept Gen Surg, D-18057 Rostock, Germany	University of Rostock; University of Rostock	Hinz, B (corresponding author), Univ Rostock, Inst Pharmacol & Toxicol, Schillingallee 70, D-18057 Rostock, Germany.	burkhard.hinz@med.uni-rostock.de	Linnebacher, Michael/AAT-3763-2021	Linnebacher, Michael/0000-0001-8054-1402	Deutsche Forschungsgemeinschaft [Hi 813/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (Hi 813/6-1).	ALTOMONTE M, 1993, CANCER RES, V53, P3343; Bissett D, 2005, J CLIN ONCOL, V23, P842, DOI 10.1200/JCO.2005.03.170; Blaber R, 2003, J AM SOC NEPHROL, V14, P116, DOI 10.1097/01.ASN.0000040595.35207.62; Blazquez C, 2004, CANCER RES, V64, P5617, DOI 10.1158/0008-5472.CAN-03-3927; Blazquez C, 2003, FASEB J, V17, P529, DOI 10.1096/fj.02-0795fje; Blazquez C, 2008, CANCER RES, V68, P1945, DOI 10.1158/0008-5472.CAN-07-5176; Blazquez C, 2006, FASEB J, V20, P2633, DOI 10.1096/fj.06-6638fje; Bramhall SR, 2002, BRIT J CANCER, V87, P161, DOI 10.1038/sj.bjc.6600446; Bugno M, 1995, NUCLEIC ACIDS RES, V23, P5041, DOI 10.1093/nar/23.24.5041; Chen CC, 2001, CELL SIGNAL, V13, P543, DOI 10.1016/S0898-6568(01)00171-1; CONSROE P, 1991, PHARMACOL BIOCHEM BE, V40, P517, DOI 10.1016/0091-3057(91)90357-8; EDWARDS DR, 1992, BIOCHIM BIOPHYS ACTA, V1171, P41, DOI 10.1016/0167-4781(92)90138-P; Fujihara Tomofumi, 1999, Gastric Cancer, V2, P221, DOI 10.1007/s101200050067; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Hinz B, 2005, FASEB J, V19, P1929, DOI 10.1096/fj.04-3626fje; Hinz B, 2004, MOL PHARMACOL, V66, P1643, DOI 10.1124/mol.104.002618; Hosch S B, 1997, J Gastrointest Surg, V1, P316, DOI 10.1016/S1091-255X(97)80051-0; Huang WC, 2004, CARCINOGENESIS, V25, P1925, DOI 10.1093/carcin/bgh211; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Jacobsson SOP, 2001, J PHARMACOL EXP THER, V299, P951; KELLY CP, 1992, AM J PHYSIOL, V263, pG864, DOI 10.1152/ajpgi.1992.263.6.G864; Kogan NM, 2006, MOL PHARMACOL, V70, P51, DOI 10.1124/mol.105.021089; Koyama Y, 1996, J IMMUNOL, V157, P5097; Lawson C, 1999, J IMMUNOL, V162, P2990; Lee HM, 2008, EUR J PHARMACOL, V579, P260, DOI 10.1016/j.ejphar.2007.10.001; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Maeda K, 2002, ONCOL REP, V9, P511; Massi P, 2004, J PHARMACOL EXP THER, V308, P838, DOI 10.1124/jpet.103.061002; McAllister SD, 2007, MOL CANCER THER, V6, P2921, DOI 10.1158/1535-7163.MCT-07-0371; McKallip RJ, 2006, MOL PHARMACOL, V70, P897, DOI 10.1124/mol.106.023937; Melis M, 1996, EUR RESPIR J, V9, P1831, DOI 10.1183/09031936.96.09091831; MIELE ME, 1994, EXP CELL RES, V214, P231, DOI 10.1006/excr.1994.1253; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; NATALI P, 1990, CANCER RES, V50, P1271; Nithipatikom K, 2004, CANCER RES, V64, P8826, DOI 10.1158/0008-5472.CAN-04-3136; Ogawa Y, 1998, CLIN CANCER RES, V4, P31; Pisanti S, 2007, J CELL PHYSIOL, V211, P495, DOI 10.1002/jcp.20954; Preet A, 2008, ONCOGENE, V27, P339, DOI 10.1038/sj.onc.1210641; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH610, DOI 10.1152/ajpheart.00236.2007; Ramer R, 2007, ONCOGENE, V26, P5822, DOI 10.1038/sj.onc.1210358; Ramer R, 2008, J NATL CANCER I, V100, P59, DOI 10.1093/jnci/djm268; Ramer R, 2010, PHARM RES-DORDR, V27, P2162, DOI 10.1007/s11095-010-0219-2; Ramer R, 2010, BIOCHEM PHARMACOL, V79, P955, DOI 10.1016/j.bcp.2009.11.007; Rog DJ, 2007, CLIN THER, V29, P2068, DOI 10.1016/j.clinthera.2007.09.013; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Sano H, 1998, BIOCHEM BIOPH RES CO, V250, P694, DOI 10.1006/bbrc.1998.9385; Sapna S, 2007, MOL CELL BIOCHEM, V303, P259, DOI 10.1007/s11010-007-9475-9; Sawada T, 2006, Adv Med Sci, V51, P60; Scaldaferri F, 2009, EUR J IMMUNOL, V39, P290, DOI 10.1002/eji.200838316; Shepherd FA, 2002, J CLIN ONCOL, V20, P4434, DOI 10.1200/JCO.2002.02.108; Shin Hun Sub, 2004, Korean Journal of Internal Medicine, V19, P48; Sunami T, 2000, JPN J CANCER RES, V91, P925, DOI 10.1111/j.1349-7006.2000.tb01036.x; VANKY F, 1990, CANCER IMMUNOL IMMUN, V31, P19, DOI 10.1007/BF01742491; Xian XS, 2010, J CELL BIOCHEM, V110, P321, DOI 10.1002/jcb.22540; Yu MH, 2008, CANCER SCI, V99, P391, DOI 10.1111/j.1349-7006.2008.00696.x	59	101	105	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1535	1548		10.1096/fj.11-198184	http://dx.doi.org/10.1096/fj.11-198184			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22198381				2022-12-25	WOS:000302359700016
J	Aziz, Q; Thomas, AM; Khambra, T; Tinker, A				Aziz, Qadeer; Thomas, Alison M.; Khambra, Tapsi; Tinker, Andrew			Regulation of the ATP-sensitive Potassium Channel Subunit, Kir6.2, by a Ca2+-dependent Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; K+ CHANNELS; SULFONYLUREA RECEPTOR; ACETYLCHOLINE-RECEPTOR; PHOSPHORYLATION; ACTIVATION; INHIBITION; MECHANISM; IDENTIFICATION; MODULATION	The activity of ATP-sensitive potassium (K-ATP) channels is governed by the concentration of intracellular ATP and ADP and is thus responsive to the metabolic status of the cell. Phosphorylation of KATP channels by protein kinase A (PKA) or protein kinase C (PKC) results in the modulation of channel activity and is particularly important in regulating smooth muscle tone. At the molecular level the smooth muscle channel is composed of a sulfonylurea subunit (SUR2B) and a pore-forming subunit Kir6.1 and/or Kir6.2. Previously, Kir6.1/SUR2B channels have been shown to be inhibited by PKC, and Kir6.2/SUR2B channels have been shown to be activated or have no response to PKC. In this study we have examined the modulation of channel complexes formed of the inward rectifier subunit, Kir6.2, and the sulfonylurea subunit, SUR2B. Using a combination of biochemical and electrophysiological techniques we show that this complex can be inhibited by protein kinase C in a Ca2+-dependent manner and that this inhibition is likely to be as a result of internalization. We identify a residue in the distal C terminus of Kir6.2 (Ser-372) whose phosphorylation leads to down-regulation of the channel complex. This inhibitory effect is distinct from activation which is seen with low levels of channel activity.	[Aziz, Qadeer; Thomas, Alison M.; Khambra, Tapsi; Tinker, Andrew] Barts & London Queen Marys Sch Med & Dent, William Harvey Heart Ctr, London EC1M 6BQ, England	University of London; Queen Mary University London	Tinker, A (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Heart Ctr, Rm 1-02,Charterhouse Sq, London EC1M 6BQ, England.	a.tinker@qmul.ac.uk		Aziz, Qadeer/0000-0002-7636-6813	British Heart Foundation; British Heart Foundation [RG/10/10/28447] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Alekseev AE, 2005, J MOL CELL CARDIOL, V38, P895, DOI 10.1016/j.yjmcc.2005.02.022; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; BAZZI MD, 1989, BIOCHEMISTRY-US, V28, P9317, DOI 10.1021/bi00450a011; BEECH DJ, 1993, BRIT J PHARMACOL, V110, P573, DOI 10.1111/j.1476-5381.1993.tb13849.x; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Cole WC, 2000, CIRC RES, V87, P112, DOI 10.1161/01.RES.87.2.112; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; Damron DS, 1998, AM J PHYSIOL-LUNG C, V274, pL278, DOI 10.1152/ajplung.1998.274.2.L278; Farzaneh T, 2008, CARDIOVASC RES, V79, P621, DOI 10.1093/cvr/cvn138; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; French AD, 2009, INT J MED SCI, V6, P93; Garlid KD, 1997, CIRC RES, V81, P1072; Giblin JP, 2002, EUR J BIOCHEM, V269, P5303, DOI 10.1046/j.1432-1033.2002.03249.x; Gopalakrishnan M, 1999, J PHARMACOL EXP THER, V289, P551; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; Ito K, 2001, J PHYSIOL-LONDON, V532, P165, DOI 10.1111/j.1469-7793.2001.0165g.x; Jiao JD, 2008, HYPERTENSION, V52, P499, DOI 10.1161/HYPERTENSIONAHA.108.110817; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Jun JY, 2001, AM J PHYSIOL-CELL PH, V281, pC857, DOI 10.1152/ajpcell.2001.281.3.C857; Koh SD, 1998, BIOPHYS J, V75, P1793, DOI 10.1016/S0006-3495(98)77621-0; Leaney JL, 2001, J PHYSIOL-LONDON, V534, P367, DOI 10.1111/j.1469-7793.2001.00367.x; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; Light P, 1996, BBA-REV BIOMEMBRANES, V1286, P65, DOI 10.1016/0304-4157(96)00004-4; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Light PE, 1996, CIRC RES, V79, P399, DOI 10.1161/01.RES.79.3.399; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Meimaridou E, 2011, MOL ENDOCRINOL, V25, P1650, DOI 10.1210/me.2011-1020; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Muzyamba M, 2007, CLIN ENDOCRINOL, V67, P115, DOI 10.1111/j.1365-2265.2007.02847.x; Nelson CP, 2008, AM J PHYSIOL-CELL PH, V295, pC1590, DOI 10.1152/ajpcell.00365.2008; Ohanian V, 1996, CIRC RES, V78, P806, DOI 10.1161/01.RES.78.5.806; Park WS, 2005, J CARDIOVASC PHARM, V45, P99, DOI 10.1097/01.fjc.0000150442.49051.f7; QUAYLE JM, 1994, CARDIOVASC RES, V28, P797, DOI 10.1093/cvr/28.6.797; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; Quinn KV, 2003, CIRC RES, V93, P646, DOI 10.1161/01.RES.0000095247.81449.8E; Rainbow RD, 2009, CARDIOVASC RES, V83, P493, DOI 10.1093/cvr/cvp143; Rodrigo GC, 2005, CURR PHARM DESIGN, V11, P1915, DOI 10.2174/1381612054021015; SAFRAN A, 1990, BIOCHEMISTRY-US, V29, P6730, DOI 10.1021/bi00480a024; SAFRAN A, 1987, J BIOL CHEM, V262, P10506; Sampson LJ, 2007, CARDIOVASC RES, V76, P61, DOI 10.1016/j.cardiores.2007.05.020; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Shi Y, 2008, J BIOL CHEM, V283, P2488, DOI 10.1074/jbc.M708769200; Thomas AM, 2006, J MEMBRANE BIOL, V211, P43, DOI 10.1007/s00232-006-0014-5; Thorneloe KS, 2002, J PHYSIOL-LONDON, V541, P65, DOI 10.1113/jphysiol.2002.018101; Trapp S, 2003, EMBO J, V22, P2903, DOI 10.1093/emboj/cdg282; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Yamada M, 2010, J PHYSIOL-LONDON, V588, P283, DOI 10.1113/jphysiol.2009.179028; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Zhang HL, 1996, BRIT J PHARMACOL, V118, P105, DOI 10.1111/j.1476-5381.1996.tb15372.x	57	24	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6196	6207		10.1074/jbc.M111.243923	http://dx.doi.org/10.1074/jbc.M111.243923			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207763	Green Published, hybrid			2022-12-25	WOS:000300791800013
J	Marcinkiewicz, MM; Sinha, D; Walsh, PN				Marcinkiewicz, Mariola M.; Sinha, Dipali; Walsh, Peter N.			Productive Recognition of Factor IX by Factor XIa Exosites Requires Disulfide Linkage between Heavy and Light Chains of Factor XIa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; PLASMA THROMBOPLASTIN ANTECEDENT; CATALYTIC DOMAIN; CHRISTMAS-FACTOR; TISSUE FACTOR; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE RECOGNITION; BINDING-SITE; FACTOR XA; ACTIVATION	In the intrinsic pathway of blood coagulation factor XIa (FXIa) activates factor IX (FIX) by cleaving the zymogen at Arg(145)-Ala(146) and Arg(180)-Val(181) bonds releasing an 11-kDa activation peptide. FXIa and its isolated light chain (FXIa-LC) cleave S-2366 at comparable rates, but FXIa-LC is a very poor activator of FIX, possibly because FIX undergoes allosteric modification on binding to an exosite on the heavy chain of FXIa (FXIa-HC) required for optimal cleavage rates of the two scissile bonds of FIX. However preincubation of FIX with a saturating concentration of isolated FXIa-HC did not result in any potentiation in the rate of FIX cleavage by FXIa-LC. Furthermore, if FIX binding via the heavy chain exosite of FXIa determines the affinity of the enzyme-substrate interaction, then the isolated FXIa-HC should inhibit the rate of FIX activation by depleting the substrate. However, whereas FXIa/S557A inhibited FIX activation of by FXIa, FXIa-HC did not. Therefore, we examined FIX binding to FXIa/S557A, FXIa-HC, FXIa-LC, FXIa/C362S/C482S, and FXIa/S557A/C362S/C482S. The heavy and light chains are disulfide-linked in FXIa/S557A but not in FXIa/C362S/C482S and FXIa/S557A/C362S/C482S. In an ELISA assay only FXI/S557A ligated FIX with high affinity. Partial reduction of FXIa/S557A to produce heavy and light chains resulted in decreased FIX binding, and this function was regained upon reformation of the disulfide linkage between the heavy and the light chains. We therefore conclude that substrate recognition by the FXIa exosite(s) requires disulfide-linked heavy and light chains.	[Marcinkiewicz, Mariola M.; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Walsh, Peter N.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Walsh, Peter N.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sinha, D (corresponding author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, 3400 N Broad St, Philadelphia, PA 19140 USA.	dipali@temple.edu; pnw@temple.edu			National Institutes of Health [HL74124, HL46213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046213, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in whole or in part, by National Institutes of Health Grants HL74124 and HL46213 (to P. N. W.).	BAJAJ SP, 1983, BIOCHEMISTRY-US, V22, P4047, DOI 10.1021/bi00286a009; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Betz A, 1997, BIOCHEMISTRY-US, V36, P181, DOI 10.1021/bi962060g; BROZE GJ, 1988, BLOOD, V71, P335; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; Edgington TS, 1997, THROMB HAEMOSTASIS, V78, P401; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P4508, DOI 10.1021/bi00719a006; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Jin L, 2005, J BIOL CHEM, V280, P4704, DOI 10.1074/jbc.M411309200; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; Miller TN, 2007, BIOCHEMISTRY-US, V46, P14450, DOI 10.1021/bi701310x; NAITO K, 1991, J BIOL CHEM, V266, P7353; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; NEMERSON Y, 1992, SEMIN HEMATOL, V29, P170; Ogawa T, 2005, J BIOL CHEM, V280, P23523, DOI 10.1074/jbc.M500894200; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Renne T, 2002, J BIOL CHEM, V277, P4892, DOI 10.1074/jbc.M105221200; Samuel D, 2007, P NATL ACAD SCI USA, V104, P15693, DOI 10.1073/pnas.0703080104; Sinha D, 2005, BIOCHEMISTRY-US, V44, P10416, DOI 10.1021/bi050361x; SINHA D, 1985, J BIOL CHEM, V260, P714; SINHA D, 1987, BIOCHEMISTRY-US, V26, P3768, DOI 10.1021/bi00387a005; Sinha D, 2007, BIOCHEMISTRY-US, V46, P9830, DOI 10.1021/bi062296c; Smith SB, 2008, J BIOL CHEM, V283, P6696, DOI 10.1074/jbc.M707234200; Sun MF, 1999, J BIOL CHEM, V274, P36373, DOI 10.1074/jbc.274.51.36373; Sun YH, 1996, J BIOL CHEM, V271, P29023, DOI 10.1074/jbc.271.46.29023; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; VANDERGRAAF F, 1983, J BIOL CHEM, V258, P9669; WAGENVOORD R, 1990, HAEMOSTASIS, V20, P276; Wolberg AS, 1997, BIOCHEMISTRY-US, V36, P4074, DOI 10.1021/bi962274y; Wu WM, 2008, J BIOL CHEM, V283, P18655, DOI 10.1074/jbc.M802275200	37	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6187	6195		10.1074/jbc.M111.291989	http://dx.doi.org/10.1074/jbc.M111.291989			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207756	Green Published, hybrid			2022-12-25	WOS:000300791800012
J	Emara, M; Royer, PJ; Mahdavi, J; Shakib, F; Ghaemmaghami, AM				Emara, Mohamed; Royer, Pierre-Joseph; Mahdavi, Jafar; Shakib, Farouk; Ghaemmaghami, Amir M.			Retagging Identifies Dendritic Cell-specific Intercellular Adhesion Molecule-3 (ICAM3)-grabbing Non-integrin (DC-SIGN) Protein as a Novel Receptor for a Major Allergen from House Dust Mite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTINS; MEMBRANE CHOLESTEROL DEPLETION; MANNOSE RECEPTOR; RECOGNITION; DER-P-1; POLARIZATION; MECHANISMS; PROFILES; BINDING; ICAM-3	Dendritic cells (DCs) have been shown to play a key role in the initiation and maintenance of immune responses to microbial pathogens as well as to allergens, but the exact mechanisms of their involvement in allergic responses and Th2 cell differentiation have remained elusive. Using retagging, we identified DC-SIGN as a novel receptor involved in the initial recognition and uptake of the major house dust mite and dog allergens Der p 1 and Can f 1, respectively. To confirm this, we used gene silencing to specifically inhibit DC-SIGN expression by DCs followed by allergen uptake studies. Binding and uptake of Der p 1 and Can f 1 allergens was assessed by ELISA and flow cytometry. Intriguingly, our data showed that silencing DC-SIGN on DCs promotes a Th2 phenotype in DC/T cell co-cultures. These findings should lead to better understanding of the molecular basis of allergen-induced Th2 cell polarization and in doing so paves the way for the rational design of novel intervention strategies by targeting allergen receptors on innate immune cells or their carbohydrate counterstructures on allergens.	[Emara, Mohamed; Royer, Pierre-Joseph; Mahdavi, Jafar; Shakib, Farouk; Ghaemmaghami, Amir M.] Univ Nottingham, Sch Mol Med Sci, Queens Med Ctr, Nottingham NG7 2UH, England; [Shakib, Farouk; Ghaemmaghami, Amir M.] Univ Nottingham, Resp Biomed Res Unit, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Ghaemmaghami, AM (corresponding author), Univ Nottingham, Sch Mol Med Sci, Queens Med Ctr, Nottingham NG7 2UH, England.	amg@nottingham.ac.uk	Ghaemmaghami, Amir/S-2627-2019; Ghaemmaghami, Amir/AAP-2968-2020; Emara, Mohamed M./C-8220-2013; Royer, Pierre-Joseph/D-4768-2015	Ghaemmaghami, Amir/0000-0003-3160-8759; Emara, Mohamed M./0000-0001-7708-9435; Royer, Pierre-Joseph/0000-0001-5534-7982	University of Nottingham School of Molecular Medical Sciences; Wellcome Trust; Asthma UK [06/001] Funding Source: researchfish	University of Nottingham School of Molecular Medical Sciences; Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK	This study was supported in part by the University of Nottingham School of Molecular Medical Sciences.; Recipient of a Wellcome Trust Value In People (VIP) award.	Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bleijs DA, 1999, EUR J IMMUNOL, V29, P2248, DOI 10.1002/(SICI)1521-4141(199907)29:07<2248::AID-IMMU2248>3.0.CO;2-9; Broide DH, 2011, J ALLERGY CLIN IMMUN, V127, P689, DOI 10.1016/j.jaci.2011.01.027; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Coelho V, 2010, P NATL ACAD SCI USA, V107, P18587, DOI 10.1073/pnas.1009388107; De Wit D, 2000, J ALLERGY CLIN IMMUN, V105, P346, DOI 10.1016/S0091-6749(00)90086-1; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Eisenbarth SC, 2003, CURR OPIN IMMUNOL, V15, P620, DOI 10.1016/j.coi.2003.09.003; Emara M, 2011, J BIOL CHEM, V286, P13033, DOI 10.1074/jbc.M111.220657; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Furmonaviciene R, 2007, CLIN EXP ALLERGY, V37, P231, DOI 10.1111/j.1365-2222.2007.02651.x; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Gold S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011360; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Hammad H, 2001, BLOOD, V98, P1135, DOI 10.1182/blood.V98.4.1135; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Hsu SC, 2010, J BIOL CHEM, V285, P7903, DOI 10.1074/jbc.M109.058370; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Lambrecht BN, 2001, CURR OPIN ALLERGY CL, V1, P51, DOI 10.1097/00130832-200102000-00010; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Potocnik SJ, 2007, J VASC RES, V44, P292, DOI 10.1159/000101451; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Soares CP, 2010, CELLS TISSUES ORGANS, V192, P187, DOI 10.1159/000316005; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Van Gestel RA, 2005, MOL REPROD DEV, V72, P386, DOI 10.1002/mrd.20351; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002	39	44	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5756	5763		10.1074/jbc.M111.312520	http://dx.doi.org/10.1074/jbc.M111.312520			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22205703	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000300638000051
J	Inada, K; Kohsaka, H; Takasu, E; Matsunaga, T; Nose, A				Inada, Kengo; Kohsaka, Hiroshi; Takasu, Etsuko; Matsunaga, Teruyuki; Nose, Akinao			Optical Dissection of Neural Circuits Responsible for Drosophila Larval Locomotion with Halorhodopsin	PLOS ONE			English	Article							MUSHROOM BODY; GENETIC DISSECTION; PATTERN GENERATION; COURTSHIP BEHAVIOR; SENSORY NEURONS; NERVOUS-SYSTEM; EXPRESSION; MEMORY; COORDINATION; ACTIVATION	Halorhodopsin (NpHR), a light-driven microbial chloride pump, enables silencing of neuronal function with superb temporal and spatial resolution. Here, we generated a transgenic line of Drosophila that drives expression of NpHR under control of the Gal4/UAS system. Then, we used it to dissect the functional properties of neural circuits that regulate larval peristalsis, a continuous wave of muscular contraction from posterior to anterior segments. We first demonstrate the effectiveness of NpHR by showing that global and continuous NpHR-mediated optical inhibition of motor neurons or sensory feedback neurons induce the same behavioral responses in crawling larvae to those elicited when the function of these neurons are inhibited by Shibire ts, namely complete paralyses or slowed locomotion, respectively. We then applied transient and/or focused light stimuli to inhibit the activity of motor neurons in a more temporally and spatially restricted manner and studied the effects of the optical inhibition on peristalsis. When a brief light stimulus (1-10 sec) was applied to a crawling larva, the wave of muscular contraction stopped transiently but resumed from the halted position when the light was turned off. Similarly, when a focused light stimulus was applied to inhibit motor neurons in one or a few segments which were about to be activated in a dissected larva undergoing fictive locomotion, the propagation of muscular constriction paused during the light stimulus but resumed from the halted position when the inhibition (>5 sec) was removed. These results suggest that (1) Firing of motor neurons at the forefront of the wave is required for the wave to proceed to more anterior segments, and (2) The information about the phase of the wave, namely which segment is active at a given time, can be memorized in the neural circuits for several seconds.	[Inada, Kengo; Matsunaga, Teruyuki; Nose, Akinao] Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba, Japan; [Kohsaka, Hiroshi; Takasu, Etsuko; Nose, Akinao] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Inada, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba, Japan.	nose@k.u-tokyo.ac.jp	Kohsaka, Hiroshi/AAT-4177-2021	Kohsaka, Hiroshi/0000-0003-1087-9680; Inada, Kengo/0000-0002-0859-4582; Matsunaga, Teruyuki/0000-0002-6433-622X	Ministry of Education, Culture, Sports, Science and Technology [221S0003];  [22115002]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry" (No. 22115002; web sites: http:// www.mext.go.jp/english/; http://www.meso-neurocircuitry.jp/index_ eng. html) and "Comprehensive Brain Science Network" of the Ministry of Education, Culture, Sports, Science and Technology (No. 221S0003; web sites: http://www.mext.go.jp/english/; http://hokatsu-nou.nips.ac.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cattaert D, 2001, J NEUROBIOL, V48, P58, DOI 10.1002/neu.1042; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Fei H, 2010, J EXP BIOL, V213, P1717, DOI 10.1242/jeb.036053; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Friesen WO, 2007, CURR OPIN NEUROBIOL, V17, P704, DOI 10.1016/j.conb.2008.01.006; Friesen WO, 2001, CURR OPIN NEUROBIOL, V11, P678, DOI 10.1016/S0959-4388(01)00268-9; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; HEGEMANN P, 1985, EMBO J, V4, P2347, DOI 10.1002/j.1460-2075.1985.tb03937.x; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Ito K, 1997, DEVELOPMENT, V124, P761; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JAN YN, 1993, DEV DROSOPHILA MELAN, V2, P1207; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Nose A, 1997, DEVELOPMENT, V124, P1433; Peron S, 2009, COMP BIOCHEM PHYS A, V154, P173, DOI 10.1016/j.cbpa.2009.04.626; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Sugimura K, 2003, J NEUROSCI, V23, P3752; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang W, 2007, EUR J NEUROSCI, V26, P2405, DOI 10.1111/j.1460-9568.2007.05862.x; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	46	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29019	10.1371/journal.pone.0029019	http://dx.doi.org/10.1371/journal.pone.0029019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216159	Green Submitted, Green Published, gold			2022-12-25	WOS:000300676300023
J	Richard, E; Said, S; Hamann, JL; Gaillard, JM				Richard, Emmanuelle; Said, Sonia; Hamann, Jean-Luc; Gaillard, Jean-Michel			Toward an Identification of Resources Influencing Habitat Use in a Multi-Specific Context	PLOS ONE			English	Article							HOME-RANGE SIZE; DEER CERVUS-ELAPHUS; FEMALE ROE DEER; CAPREOLUS-CAPREOLUS; SIKA-DEER; HURRICANE LOTHAR; DIET COMPOSITION; SITE FIDELITY; GPS DATA; PATTERNS	Interactions between animal behaviour and the environment are both shaping observed habitat use. Despite the importance of inter-specific interactions on the habitat use performed by individuals, most previous analyses have focused on case studies of single species. By focusing on two sympatric populations of large herbivores with contrasting body size, we went one step beyond by studying variation in home range size and identifying the factors involved in such variation, to define how habitat features such as resource heterogeneity, resource quality, and openness created by hurricane or forest managers, and constraints may influence habitat use at the individual level. We found a large variability among individual's home range size in both species, particularly in summer. Season appeared as the most important factor accounting for observed variation in home range size. Regarding habitat features, we found that (i) the proportion of area damaged by the hurricane was the only habitat component that inversely influenced roe deer home range size, (ii) this habitat type also influenced both diurnal and nocturnal red deer home range sizes, (iii) home range size of red deer during the day was inversely influenced by the biomass of their preferred plants, as were both diurnal and nocturnal core areas of the red deer home range, and (iv) we do not find any effect of resource heterogeneity on home range size in any case. Our results suggest that a particular habitat type (i. e. areas damaged by hurricane) can be used by individuals of sympatric species because it brings both protected and dietary resources. Thus, it is necessary to maintain the openness of these areas and to keep animal density quite low as observed in these hunted populations to limit competition between these sympatric populations of herbivores.	[Richard, Emmanuelle; Gaillard, Jean-Michel] Univ Lyon 1, UMR 5558, F-69622 Villeurbanne, France; [Richard, Emmanuelle; Said, Sonia; Hamann, Jean-Luc] Ctr Natl Etud & Rech Appl Cervide Sanglier, Off Natl Chasse & Faune Sauvage, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Richard, E (corresponding author), Univ Lyon 1, UMR 5558, Batiment 711, F-69622 Villeurbanne, France.	emmanuelle.richard@biomserv.univ-lyon1.fr		Gaillard, Jean-Michel/0000-0003-0174-8451; SAID, Sonia/0000-0003-1485-8297	Office Natinal de la Chasse et de la Faune Sauvage; CNRS, the National Research Center	Office Natinal de la Chasse et de la Faune Sauvage; CNRS, the National Research Center	This study was financed by a research agreement between the Office Natinal de la Chasse et de la Faune Sauvage and CNRS, the National Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrados C, 2002, CR BIOL, V325, P165, DOI 10.1016/S1631-0691(02)01414-2; Adrados C, 2008, EUR J WILDLIFE RES, V54, P487, DOI 10.1007/s10344-008-0174-y; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; ARMLEDER HM, 1994, CAN J ZOOL, V72, P1721, DOI 10.1139/z94-232; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Borkowski J, 1998, ANN ZOOL FENN, V35, P181; Borkowski J, 2000, CAN J ZOOL, V78, P1369, DOI 10.1139/cjz-78-8-1369; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; CEDERLUND G, 1994, J MAMMAL, V75, P1005, DOI 10.2307/1382483; Courtois R, 1998, CAN FIELD NAT, V112, P602; Crampe JP, 2007, CAN J ZOOL, V85, P16, DOI 10.1139/Z06-185; Duncan P, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P91; Elkie P., 1999, PATCH ANALYST USERS; Gaillard JM, 2003, J WILDLIFE MANAGE, V67, P767, DOI 10.2307/3802684; Gebert C, 2001, MAMMAL REV, V31, P189, DOI 10.1046/j.1365-2907.2001.00090.x; GEORGII B, 1983, OECOLOGIA, V58, P238, DOI 10.1007/BF00399224; GEORGII B, 1980, OECOLOGIA, V47, P278, DOI 10.1007/BF00346833; Godvik IMR, 2010, J ANIM ECOL, V79, P1280; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Hall LS, 1997, WILDLIFE SOC B, V25, P173; Hamann J. L., 1997, Gibier Faune Sauvage, V14, P1; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Hellickson MW, 2008, SOUTHWEST NAT, V53, P1, DOI 10.1894/0038-4909(2008)53[1:SRASFO]2.0.CO;2; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Kie JG, 2005, LANDSCAPE ECOL, V20, P289, DOI 10.1007/s10980-005-3165-3; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Lamberti P, 2006, J ETHOL, V24, P181, DOI 10.1007/s10164-005-0179-x; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lesage L, 2000, CAN J ZOOL, V78, P1930, DOI 10.1139/cjz-78-11-1930; Licoppe AM, 2006, EUR J WILDLIFE RES, V52, P164, DOI 10.1007/s10344-006-0027-5; LOFT ER, 1993, CALIF FISH GAME, V79, P145; LOFT ER, 1991, J WILDLIFE MANAGE, V55, P16, DOI 10.2307/3809236; Lovari S, 1997, BEHAV PROCESS, V40, P239, DOI 10.1016/S0376-6357(97)00019-3; Manly B.F.J., 2002, RESOURCE SELECTION A; MCGARIGAL K, 1995, PNWGTR351 USDA PAC N; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Mitchell MS, 2004, ECOL MODEL, V177, P209, DOI 10.1016/j.ecolmodel.2004.01.015; Miyashita T, 2008, POPUL ECOL, V50, P111, DOI 10.1007/s10144-007-0068-y; Morellet N, 1997, INGENIERIE EAT, V7, P25; Mysterud A, 2001, OECOLOGIA, V127, P30, DOI 10.1007/s004420000562; Mysterud A, 1997, WILDLIFE BIOL, V3, P27, DOI 10.2981/wlb.1997.004; Pellerin M, 2008, WILDLIFE BIOL, V14, P101, DOI 10.2981/0909-6396(2008)14[101:RDCCHS]2.0.CO;2; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2009, R FDN STAT COMP; Ramanzin M, 2007, CAN J ZOOL, V85, P280, DOI 10.1139/Z06-210; Relyea RA, 2000, J WILDLIFE MANAGE, V64, P146, DOI 10.2307/3802984; Rettie WJ, 2001, CAN J ZOOL, V79, P1933, DOI 10.1139/cjz-79-11-1933; Richard E, 2008, BEHAV PROCESS, V79, P28, DOI 10.1016/j.beproc.2008.04.008; Richard E, 2010, OECOLOGIA, V163, P91, DOI 10.1007/s00442-009-1538-z; Said S, 2005, EUR J WILDLIFE RES, V51, P242, DOI 10.1007/s10344-005-0115-y; Said S, 2005, J ZOOL, V267, P301, DOI 10.1017/S0952836905007454; Said S, 2005, LANDSCAPE ECOL, V20, P1003, DOI 10.1007/s10980-005-7518-8; Said S, 2009, OIKOS, V118, P1299, DOI 10.1111/j.1600-0706.2009.17346.x; SARGEANT AB, 1987, J WILDLIFE MANAGE, V51, P285, DOI 10.2307/3801004; Storms D, 2008, WILDLIFE BIOL, V14, P237, DOI 10.2981/0909-6396(2008)14[237:SVIDCA]2.0.CO;2; Sunde P, 2009, WILDLIFE BIOL, V15, P454, DOI 10.2981/09-012; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; WAHLSTROM LK, 1995, OECOLOGIA, V103, P302, DOI 10.1007/BF00328618; WALLACE LL, 1995, LANDSCAPE ECOL, V10, P75, DOI 10.1007/BF00153825; Widmer O, 2004, FOREST ECOL MANAG, V195, P237, DOI 10.1016/j.foreco.2004.02.021; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	61	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29048	10.1371/journal.pone.0029048	http://dx.doi.org/10.1371/journal.pone.0029048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216164	Green Submitted, Green Published, gold			2022-12-25	WOS:000300674900008
J	Vonk, WIM; Bartuzi, P; de Bie, P; Kloosterhuis, N; Wichers, CGK; Berger, R; Haywood, S; Klomp, LWJ; Wijmenga, C; van de Sluis, B				Vonk, Willianne I. M.; Bartuzi, Paulina; de Bie, Prim; Kloosterhuis, Niels; Wichers, Catharina G. K.; Berger, Ruud; Haywood, Susan; Klomp, Leo W. J.; Wijmenga, Cisca; van de Sluis, Bart			Liver-Specific Commd1 Knockout Mice Are Susceptible to Hepatic Copper Accumulation	PLOS ONE			English	Article							NF-KAPPA-B; WILSONS-DISEASE; BEDLINGTON TERRIERS; MURR1; GENE; TRANSPORT; TOXICOSIS; PROTEINS; MOUSE; IDENTIFICATION	Canine copper toxicosis is an autosomal recessive disorder characterized by hepatic copper accumulation resulting in liver fibrosis and eventually cirrhosis. We have identified COMMD1 as the gene underlying copper toxicosis in Bedlington terriers. Although recent studies suggest that COMMD1 regulates hepatic copper export via an interaction with the Wilson disease protein ATP7B, its importance in hepatic copper homeostasis is ill-defined. In this study, we aimed to assess the effect of Commd1 deficiency on hepatic copper metabolism in mice. Liver-specific Commd1 knockout mice (Commd1(Delta hep)) were generated and fed either a standard or a copper-enriched diet. Copper homeostasis and liver function were determined in Commd1(Delta hep) mice by biochemical and histological analyses, and compared to wild-type littermates. Commd1(Delta hep) mice were viable and did not develop an overt phenotype. At six weeks, the liver copper contents was increased up to a 3-fold upon Commd1 deficiency, but declined with age to concentrations similar to those seen in controls. Interestingly, Commd1(Delta hep) mice fed a copper-enriched diet progressively accumulated copper in the liver up to a 20-fold increase compared to controls. These copper levels did not result in significant induction of the copper-responsive genes metallothionein I and II, neither was there evidence of biochemical liver injury nor overt liver pathology. The biosynthesis of ceruloplasmin was clearly augmented with age in Commd1(Delta hep) mice. Although COMMD1 expression is associated with changes in ATP7B protein stability, no clear correlation between Atp7b levels and copper accumulation in Commd1(Delta hep) mice could be detected. Despite the absence of hepatocellular toxicity in Commd1(Delta hep) mice, the changes in liver copper displayed several parallels with copper toxicosis in Bedlington terriers. Thus, these results provide the first genetic evidence for COMMD1 to play an essential role in hepatic copper homeostasis and present a valuable mouse model for further understanding of the molecular mechanisms underlying hepatic copper homeostasis.	[Vonk, Willianne I. M.; de Bie, Prim; Wichers, Catharina G. K.; Berger, Ruud; Klomp, Leo W. J.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands; [Vonk, Willianne I. M.; de Bie, Prim; Wichers, Catharina G. K.; Berger, Ruud; Klomp, Leo W. J.] Netherlands Metabol Ctr, Utrecht, Netherlands; [Vonk, Willianne I. M.; de Bie, Prim; Wijmenga, Cisca] Univ Med Ctr Utrecht, Complex Genet Sect, Utrecht, Netherlands; [Bartuzi, Paulina; Kloosterhuis, Niels; van de Sluis, Bart] Univ Groningen, Dept Pathol & Lab Med, Univ Med Ctr Groningen, Groningen, Netherlands; [Haywood, Susan] Univ Liverpool, Dept Vet Pathol, Fac Vet Sci, Liverpool L69 3BX, Merseyside, England; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Liverpool; University of Groningen	Vonk, WIM (corresponding author), Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands.	a.j.a.van.de.sluis@umcg.nl	Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365; Vonk, Willianne/0000-0002-5906-3933	Netherlands Organization for Scientific Research [40-00812-98-03106]; Pharmaceutical Department (University Medical Center Utrecht, Utrecht, The Netherlands)	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Pharmaceutical Department (University Medical Center Utrecht, Utrecht, The Netherlands)(Netherlands Government)	This work was supported by the Netherlands Organization for Scientific Research (grant number 40-00812-98-03106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the members of the Pharmaceutical Department (University Medical Center Utrecht, Utrecht, The Netherlands) for the use of the FAAS and their support. We acknowledge Dr. J. Gitlin for kindly providing the rabbit-anti-Atp7b antiserum. We thank Jackie Senior for critically reading the manuscript.	Allen KJ, 2006, BIOMETALS, V19, P555, DOI 10.1007/s10534-005-5918-5; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Burkhead JL, 2009, J BIOL CHEM, V284, P696, DOI 10.1074/jbc.M804766200; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Coronado VA, 2005, CLIN GENET, V68, P548, DOI 10.1111/j.1399-0004.2005.00524.x; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; He K, 2011, MAMM GENOME, V22, P703, DOI 10.1007/s00335-011-9359-x; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, MOL BIOSYST, V3, P816, DOI 10.1039/b711118p; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Lonnerdal B, 2007, ANNU REV NUTR, V27, P165, DOI 10.1146/annurev.nutr.27.061406.093809; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, CELL CYCLE, V6, P672, DOI 10.4161/cc.6.6.3989; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maine GN, 2009, BIOCHEM J, V417, P601, DOI 10.1042/BJ20080854; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Muller PAJ, 2009, TRAFFIC, V10, P514, DOI 10.1111/j.1600-0854.2009.00892.x; Muller T, 2003, J HEPATOL, V38, P164, DOI 10.1016/S0168-8278(02)00356-2; Muller T, 1996, LANCET, V347, P877, DOI 10.1016/S0140-6736(96)91351-3; OWEN CA, 1982, AM J PATHOL, V106, P432; Pankit Anand N, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS403, DOI 10.1046/j.1440-1746.17.s3.35.x; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Prohaska JR, 2004, J NUTR, V134, P1003, DOI 10.1093/jn/134.5.1003; SCHOSINSKY KH, 1974, CLIN CHEM, V20, P1556; SU LC, 1982, AM J PHYSIOL, V243, pG226, DOI 10.1152/ajpgi.1982.243.3.G226; Tanner MS, 1998, AM J CLIN NUTR, V67, p1074S, DOI 10.1093/ajcn/67.5.1074S; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Thoms HC, 2010, CANCER RES, V70, P139, DOI 10.1158/0008-5472.CAN-09-1397; Thornburg LP, 2000, J VET DIAGN INVEST, V12, P101, DOI 10.1177/104063870001200201; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; Vonk WI, 2011, CELL MOL LIFE SCI; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; Wijmenga C, 2004, P NUTR SOC, V63, P31, DOI 10.1079/PNS2003316	43	45	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29183	10.1371/journal.pone.0029183	http://dx.doi.org/10.1371/journal.pone.0029183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216203	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700036
J	Wada, H; Ura, S; Kitaoka, S; Satoh-Asahara, N; Horie, T; Ono, K; Takaya, T; Takanabe-Mori, R; Akao, M; Abe, M; Morimoto, T; Murayama, T; Yokode, M; Fujita, M; Shimatsu, A; Hasegawa, K				Wada, Hiromichi; Ura, Shuichi; Kitaoka, Shuji; Satoh-Asahara, Noriko; Horie, Takahiro; Ono, Koh; Takaya, Tomohide; Takanabe-Mori, Rieko; Akao, Masaharu; Abe, Mitsuru; Morimoto, Tatsuya; Murayama, Toshinori; Yokode, Masayuki; Fujita, Masatoshi; Shimatsu, Akira; Hasegawa, Koji			Distinct Characteristics of Circulating Vascular Endothelial Growth Factor-A and C Levels in Human Subjects	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; FACTOR VEGF; OVERWEIGHT; EXPRESSION; VESSELS; OBESITY; DISEASE	The mechanisms that lead from obesity to atherosclerotic disease are not fully understood. Obesity involves angiogenesis in which vascular endothelial growth factor-A (VEGF-A) plays a key role. On the other hand, vascular endothelial growth factor-C (VEGF-C) plays a pivotal role in lymphangiogenesis. Circulating levels of VEGF-A and VEGF-C are elevated in sera from obese subjects. However, relationships of VEGF-C with atherosclerotic risk factors and atherosclerosis are unknown. We determined circulating levels of VEGF-A and VEGF-C in 423 consecutive subjects not receiving any drugs at the Health Evaluation Center. After adjusting for age and gender, VEGF-A levels were significantly and more strongly correlated with the body mass index (BMI) and waist circumference than VEGF-C. Conversely, VEGF-C levels were significantly and more closely correlated with metabolic (e.g., fasting plasma glucose, hemoglobin A1c, immunoreactive insulin, and the homeostasis model assessment of insulin resistance) and lipid parameters (e.g., triglycerides, total cholesterol (TC), low-density-lipoprotein cholesterol (LDL-C), and non-high-density-lipoprotein cholesterol (non-HDL-C)) than VEGF-A. Stepwise regression analyses revealed that independent determinants of VEGF-A were the BMI and age, whereas strong independent determinants of VEGF-C were age, triglycerides, and non-HDL-C. In apolipoprotein E-deficient mice fed a high-fat-diet (HFD) or normal chow (NC) for 16 weeks, levels of VEGF-A were not significantly different between the two groups. However, levels of VEGF-C were significantly higher in HFD mice with advanced atherosclerosis and marked hypercholesterolemia than NC mice. Furthermore, immunohistochemistry revealed that the expression of VEGF-C in atheromatous plaque of the aortic sinus was significantly intensified by feeding HFD compared to NC, while that of VEGF-A was not. In conclusion, these findings demonstrate that VEGF-C, rather than VEGF-A, is closely related to dyslipidemia and atherosclerosis.	[Wada, Hiromichi; Ura, Shuichi; Ono, Koh; Takaya, Tomohide; Takanabe-Mori, Rieko; Akao, Masaharu; Abe, Mitsuru; Morimoto, Tatsuya; Hasegawa, Koji] Natl Hosp Org Kyoto Med Ctr, Div Translat Res, Kyoto, Japan; [Kitaoka, Shuji] Natl Hosp Org Kyoto Med Ctr, Hlth Evaluat Ctr, Kyoto, Japan; [Satoh-Asahara, Noriko] Natl Hosp Org Kyoto Med Ctr, Div Diabet Res, Kyoto, Japan; [Horie, Takahiro; Murayama, Toshinori; Yokode, Masayuki] Kyoto Univ Hosp, Dept Clin Innovat Med, Translat Res Ctr, Kyoto 606, Japan; [Ono, Koh; Takaya, Tomohide] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Akao, Masaharu; Abe, Mitsuru] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Morimoto, Tatsuya] Univ Shizuoka, Sch Pharmaceut Sci, Div Mol Med, Shizuoka 4228526, Japan; [Fujita, Masatoshi] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Shimatsu, Akira] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Kyoto, Japan	Kyoto University; Kyoto University; University of Shizuoka; Kyoto University	Wada, H (corresponding author), Natl Hosp Org Kyoto Med Ctr, Div Translat Res, Kyoto, Japan.	hwada@kuhp.kyoto-u.ac.jp	Shimatsu, Akira/I-3856-2019; Takaya, Tomohide/D-6372-2012	Takaya, Tomohide/0000-0002-3610-0906; Wada, Hiromichi/0000-0002-8980-224X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Research Foundation for Clinical Pharmacology; Smoking Research Foundation; Grants-in-Aid for Scientific Research [21590646] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Research Foundation for Clinical Pharmacology; Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Research Foundation for Clinical Pharmacology, and the Smoking Research Foundation (to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2000, J DIABETES COMPLICAT, V14, P154, DOI 10.1016/S1056-8727(00)00067-2; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Hausman GJ, 2004, J ANIM SCI, V82, P925; Inoue M, 1998, CIRCULATION, V98, P2108, DOI 10.1161/01.CIR.98.20.2108; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Loebig M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012610; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Mitsuhashi A, 2005, CANCER-AM CANCER SOC, V103, P724, DOI 10.1002/cncr.20819; Mouawad R, 2009, EUR J CANCER, V45, P1407, DOI 10.1016/j.ejca.2008.12.015; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Sandhofer A, 2009, ATHEROSCLEROSIS, V206, P265, DOI 10.1016/j.atherosclerosis.2009.01.031; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; Tamura M, 2004, CHEST, V126, P342, DOI 10.1378/chest.126.2.342; TAMURA M, 2003, CANCER, V9, P1217; Wada H, 2010, ATHEROSCLEROSIS, V208, P512, DOI 10.1016/j.atherosclerosis.2009.07.045; Wang TB, 2007, WORLD J GASTROENTERO, V13, P1794, DOI 10.3748/wjg.v13.i12.1794	22	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e29351	10.1371/journal.pone.0029351	http://dx.doi.org/10.1371/journal.pone.0029351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22206010	Green Published, gold, Green Submitted			2022-12-25	WOS:000298666200023
J	Mitchell, GW; Guglielmo, CG; Wheelwright, NT; Freeman-Gallant, CR; Norris, DR				Mitchell, Greg W.; Guglielmo, Christopher G.; Wheelwright, Nathaniel T.; Freeman-Gallant, Corey R.; Norris, D. Ryan			Early Life Events Carry Over to Influence Pre-Migratory Condition in a Free-Living Songbird	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; CURRENT REPRODUCTIVE EFFORT; BROOD SIZE; SAVANNA SPARROWS; BODY-COMPOSITION; NATAL DISPERSAL; HATCHING DATE; FAT RESERVES; CLUTCH SIZE; MOLT	Conditions experienced during development can have long-term consequences for individual success. In migratory songbirds, the proximate mechanisms linking early life events and survival are not well understood because tracking individuals across stages of the annual cycle can be extremely challenging. In this paper, we first use a 13 year dataset to demonstrate a positive relationship between 1st year survival and nestling mass in migratory Savannah sparrows (Passerculus sandwichensis). We also use a brood manipulation experiment to show that nestlings from smaller broods have higher mass in the nest relative to individuals from larger broods. Having established these relationships, we then use three years of field data involving multiple captures of individuals throughout the pre-migratory period and a multi-level path model to examine the hypothesis that conditions during development limit survival during migration by affecting an individual's ability to accumulate sufficient lean tissue and fat mass prior to migration. We found a positive relationship between fat mass during the pre-migratory period (Sept-Oct) and nestling mass and a negative indirect relationship between pre-migratory fat mass and fledging date. Our results provide the first evidence that conditions during development limit survival during migration through their effect on fat stores. These results are particularly important given recent evidence showing that body condition of songbirds at fledging is affected by climate change and anthropogenic changes to landscape structure.	[Mitchell, Greg W.; Norris, D. Ryan] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Guglielmo, Christopher G.] Univ Western Ontario, Adv Facil Avian Res, Dept Biol, London, ON, Canada; [Wheelwright, Nathaniel T.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Freeman-Gallant, Corey R.] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA	University of Guelph; Western University (University of Western Ontario); Bowdoin College; Skidmore College	Mitchell, GW (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	mitchelg@uoguelph.ca			American Ornithologist's Union; Animal Behavior Society; Global Forest Science Initiative [GFS-18-210-228]; Society of Canadian Ornithologists; American Museum of Natural History; Natural Sciences and Engineering Research Council; Canada Foundation for Innovation; Ontario Research Fund; University of Guelph	American Ornithologist's Union; Animal Behavior Society; Global Forest Science Initiative; Society of Canadian Ornithologists; American Museum of Natural History; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; University of Guelph	Funding for this study was provided by the American Ornithologist's Union (GM), the Animal Behavior Society (GM), the Global Forest Science Initiative (GM; GFS-18-210-228), the Society of Canadian Ornithologists, (GM), the American Museum of Natural History (GM), the Natural Sciences and Engineering Research Council (DN, CG), the Canada Foundation for Innovation (DN, CG), the Ontario Research Fund, and the University of Guelph (DN, GM). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, EVOLUTION, V40, P574, DOI 10.1111/j.1558-5646.1986.tb00508.x; Ardia DR, 2005, FUNCT ECOL, V19, P414, DOI 10.1111/j.1365-2435.2005.00997.x; AUSTIN GT, 1977, CONDOR, V79, P37, DOI 10.2307/1367528; BAGGOTT GK, 1975, J ZOOL, V175, P299; BAIRLEIN F, 1994, ANNU REV NUTR, V14, P187, DOI 10.1146/annurev.nu.14.070194.001155; Bauchinger U, 2006, J ORNITHOL, V147, P266, DOI 10.1007/s10336-006-0059-3; BEDARD J, 1983, CAN J ZOOL, V61, P2836, DOI 10.1139/z83-370; BEDNEKOFF PA, 1995, FUNCT ECOL, V9, P457, DOI 10.2307/2390009; Blondel J, 1998, OECOLOGIA, V117, P80, DOI 10.1007/s004420050634; Bojarinova JG, 1999, J AVIAN BIOL, V30, P437, DOI 10.2307/3677016; Bonier F, 2007, ECOLOGY, V88, P2729, DOI 10.1890/07-0696.1; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Burness GP, 2000, J EXP BIOL, V203, P3513; CHILGREN JD, 1977, AUK, V94, P677, DOI 10.2307/4085264; CONNELL CLYDE E., 1960, AUK, V77, P1; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; DIJKSTRA C, 1990, J ANIM ECOL, V59, P269, DOI 10.2307/5172; DIXON CL, 1978, AUK, V95, P235; Eichhorn G, 2008, PHYSIOL BIOCHEM ZOOL, V81, P508, DOI 10.1086/588170; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Ilmonen P, 2003, OECOLOGIA, V136, P148, DOI 10.1007/s00442-003-1243-2; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; JenniEiermann S, 1996, FUNCT ECOL, V10, P62, DOI 10.2307/2390263; Karasov WH, 1998, PHYSIOL ZOOL, V71, P435, DOI 10.1086/515428; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Klaassen M, 1996, J EXP BIOL, V199, P57; KOIVULA K, 1994, J AVIAN BIOL, V25, P178, DOI 10.2307/3677073; LANCE CE, 1988, APPL PSYCH MEAS, V12, P163, DOI 10.1177/014662168801200205; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; LINDSTROM A, 1993, IBIS, V135, P70, DOI 10.1111/j.1474-919X.1993.tb02811.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; Marra PP, 2000, BEHAV ECOL, V11, P299, DOI 10.1093/beheco/11.3.299; Merila J, 1997, J AVIAN BIOL, V28, P279, DOI 10.2307/3676940; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MILLER CK, 1994, AUK, V111, P962, DOI 10.2307/4088828; Mitchell GW, 2010, CONDOR, V112, P644, DOI 10.1525/cond.2010.090136; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Moreno J, 2005, J AVIAN BIOL, V36, P251, DOI 10.1111/j.0908-8857.2005.03413.x; MURPHY ME, 1988, CAN J ZOOL, V66, P1403, DOI 10.1139/z88-206; MURPHY ME, 1992, ORNIS SCAND, V23, P304, DOI 10.2307/3676654; Murphy ME, 1995, COMP BIOCH PHYSL A, V111A, P395; Murphy MT, 2000, ECOL MONOGR, V70, P1, DOI 10.1890/0012-9615(2000)070[0001:EOCSIT]2.0.CO;2; MYRCHA A, 1970, CONDOR, V72, P175, DOI 10.2307/1366628; Neto JM, 2006, IBIS, V148, P39, DOI 10.1111/j.1474-919X.2006.00477.x; Newton I, 2007, IBIS, V149, P453, DOI 10.1111/j.1474-919X.2007.00704.x; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; NEWTON I, 1966, IBIS, V108, P41, DOI 10.1111/j.1474-919X.1966.tb07251.x; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Norris DR, 2007, CONDOR, V109, P535; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; PAYNE RB, 1991, EVOLUTION, V45, P49, DOI 10.1111/j.1558-5646.1991.tb05265.x; Perez-Tris J, 2001, ANN ZOOL FENN, V38, P139; Pinheiro J., 2010, LINEAR NONLINEAR MIX; Pulido F, 2004, ANIM BEHAV, V68, P167, DOI 10.1016/j.anbehav.2003.11.006; Pyle P., 1997, IDENTIFICATION GUI 1; R Core Team, 2022, R LANG ENV STAT COMP; Rae LF, 2009, J FIELD ORNITHOL, V80, P419, DOI 10.1111/j.1557-9263.2009.00249.x; Ripley R., 2011, MASS SUPPORT FUNCTIO; RISING JD, 1989, AUK, V106, P666; Rivera JHV, 1998, CONDOR, V100, P69, DOI 10.2307/1369898; Rubolini D, 2002, J ZOOL, V258, P441, DOI 10.1017/S0952836902001590; Saino N, 1997, J ANIM ECOL, V66, P827, DOI 10.2307/5998; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; Shipley B., 2000, CAUSE CORRELATIONS B; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Siikamaki P, 1998, ECOLOGY, V79, P1789, DOI 10.1890/0012-9658(1998)079[1789:LORSBF]2.0.CO;2; SMITH HG, 1993, HEREDITY, V71, P318, DOI 10.1038/hdy.1993.142; Speakman John R., 2001, P56, DOI 10.1017/CBO9780511551741.005; SULLIVAN KA, 1988, ECOLOGY, V69, P118, DOI 10.2307/1943166; Svensson E, 1996, CONDOR, V98, P825, DOI 10.2307/1369863; Swaddle JP, 1997, CAN J ZOOL, V75, P1135, DOI 10.1139/z97-136; Tremblay I, 2003, ECOLOGY, V84, P3033, DOI 10.1890/02-0663; Verhulst S, 1997, AUK, V114, P134, DOI 10.2307/4089078; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Wheelwright N. T., 2008, BIRDS N AM ONLINE; WHEELWRIGHT NT, 1994, J ANIM ECOL, V63, P686, DOI 10.2307/5234; Wheelwright NT, 2003, CONDOR, V105, P279, DOI 10.1650/0010-5422(2003)105[0279:DOFSAT]2.0.CO;2; Wheelwright NT, 1998, ECOLOGY, V79, P755, DOI 10.1890/0012-9658(1998)079[0755:PNDAIA]2.0.CO;2; WILLIAMS JB, 1986, CONDOR, V88, P74, DOI 10.2307/1367756; WILLIAMS JB, 1985, PHYSIOL ZOOL, V58, P515, DOI 10.1086/physzool.58.5.30158579; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x; Zanette L, 2000, ECOLOGY, V81, P1654, DOI 10.1890/0012-9658(2000)081[1654:FSISFE]2.0.CO;2	87	39	39	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28838	10.1371/journal.pone.0028838	http://dx.doi.org/10.1371/journal.pone.0028838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194925	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400019
J	Kaakoush, NO; Deshpande, NP; Wilkins, MR; Tan, CG; Burgos-Portugal, JA; Raftery, MJ; Day, AS; Lemberg, DA; Mitchell, H				Kaakoush, Nadeem O.; Deshpande, Nandan P.; Wilkins, Marc R.; Tan, Chew Gee; Burgos-Portugal, Jose A.; Raftery, Mark J.; Day, Andrew S.; Lemberg, Daniel A.; Mitchell, Hazel			The Pathogenic Potential of Campylobacter concisus Strains Associated with Chronic Intestinal Diseases	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; IN-VIVO; ULCERATIVE-COLITIS; PROTEIN; JEJUNI; EXPRESSION; PROTEASOME; SUBUNIT	Campylobacter concisus has garnered increasing attention due to its association with intestinal disease, thus, the pathogenic potential of strains isolated from different intestinal diseases was investigated. A method to isolate C. concisus was developed and the ability of eight strains from chronic and acute intestinal diseases to adhere to and invade intestinal epithelial cells was determined. Features associated with bacterial invasion were investigated using comparative genomic analyses and the effect of C. concisus on host protein expression was examined using proteomics. Our isolation method from intestinal biopsies resulted in the isolation of three C. concisus strains from children with Crohn's disease or chronic gastroenteritis. Four C. concisus strains from patients with chronic intestinal diseases can attach to and invade host cells using mechanisms such as chemoattraction to mucin, aggregation, flagellum-mediated attachment, "membrane ruffling", cell penetration and damage. C. concisus strains isolated from patients with chronic intestinal diseases have significantly higher invasive potential than those from acute intestinal diseases. Investigation of the cause of this increased pathogenic potential revealed a plasmid to be responsible. 78 and 47 proteins were upregulated and downregulated in cells infected with C. concisus, respectively. Functional analysis of these proteins showed that C. concisus infection regulated processes related to interleukin-12 production, proteasome activation and NF-kappa B activation. Infection with all eight C. concisus strains resulted in host cells producing high levels of interleukin-12, however, only strains capable of invading host cells resulted in interferon-c production as confirmed by ELISA. These findings considerably support the emergence of C. concisus as an intestinal pathogen, but more significantly, provide novel insights into the host immune response and an explanation for the heterogeneity observed in the outcome of C. concisus infection. Moreover, response to infection with invasive strains has substantial similarities to that observed in the inflamed mucosa of Crohn's disease patients.	[Kaakoush, Nadeem O.; Wilkins, Marc R.; Tan, Chew Gee; Burgos-Portugal, Jose A.; Mitchell, Hazel] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Deshpande, Nandan P.; Wilkins, Marc R.] Univ New S Wales, Syst Biol Initiat, Sydney, NSW, Australia; [Raftery, Mark J.] Univ New S Wales, Biol Mass Spectrometry Facil, Sydney, NSW, Australia; [Day, Andrew S.] Univ Otago, Dept Paediat, Christchurch, New Zealand; [Day, Andrew S.; Lemberg, Daniel A.] Sydney Childrens Hosp, Dept Gastroenterol, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Otago; University of Sydney	Kaakoush, NO (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	Mitchell@unsw.edu.au	Kaakoush, Nadeem/ABG-9499-2020	Kaakoush, Nadeem Omar/0000-0003-4017-1077; Lemberg, Daniel/0000-0002-8583-0956	National Health and Medical Research Council, Australia [APP510113]; Education Investment Fund Super Science Scheme; New South Wales State Government; University of New South Wales	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Education Investment Fund Super Science Scheme; New South Wales State Government; University of New South Wales	This work was supported by the National Health and Medical Research Council, Australia (grant number APP510113). NPD and MRW wish to acknowledge funding support from the Education Investment Fund Super Science Scheme, the New South Wales State Government Science Leveraging Fund and The University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2002, SCAND J INFECT DIS, V34, P248, DOI 10.1080/00365540110080566; Barton LF, 2002, J IMMUNOL, V169, P3046, DOI 10.4049/jimmunol.169.6.3046; Bellezza Ilaria, 2010, Cancers (Basel), V2, P483, DOI 10.3390/cancers2020483; Bereswill Stefan, 2002, Molecular Microbiology, V45, P255, DOI 10.1046/j.1365-2958.2002.03002.x; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; Chikano S, 2000, GUT, V47, P779, DOI 10.1136/gut.47.6.779; Cho JH, 2007, ANNU REV MED, V58, P401, DOI 10.1146/annurev.med.58.061705.145024; Conner EM, 1997, J PHARMACOL EXP THER, V282, P1615; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Deshpande NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022170; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Fabunmi RP, 2001, J CELL SCI, V114, P29; Gunther NW, 2009, FOOD MICROBIOL, V26, P44, DOI 10.1016/j.fm.2008.07.012; Hardwick JM, 2000, NAT CELL BIOL, V2, pE203, DOI 10.1038/35041126; Hayes F, 1998, J BACTERIOL, V180, P6415; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kaakoush NO, 2010, HELICOBACTER, V15, P549, DOI 10.1111/j.1523-5378.2010.00792.x; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; Konkel ME, 2005, MOL MICROBIOL, V57, P1022, DOI 10.1111/j.1365-2958.2005.04744.x; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lastovica AJ, 2000, J CLIN MICROBIOL, V38, P2798; Loubinoux J, 2002, FEMS MICROBIOL ECOL, V40, P107, DOI 10.1111/j.1574-6941.2002.tb00942.x; Luber P, 2003, J CLIN MICROBIOL, V41, P1062, DOI 10.1128/JCM.41.3.1062-1068.2003; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; MAGOWAN C, 1995, BLOOD, V86, P3196; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; On SLW, 1996, CLIN MICROBIOL REV, V9, P405, DOI 10.1128/CMR.9.3.405; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Peluso I, 2006, WORLD J GASTROENTERO, V12, P5606, DOI 10.3748/wjg.v12.i35.5606; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Piotrowicz RS, 1998, FASEB J, V12, P1481, DOI 10.1096/fasebj.12.14.1481; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Puddu P, 1997, J IMMUNOL, V159, P3490; Quinn BJ, 2009, P NATL ACAD SCI USA, V106, P19842, DOI 10.1073/pnas.0906761106; RUSSELL RG, 1993, J INFECT DIS, V168, P210, DOI 10.1093/infdis/168.1.210; Sainsus N, 2008, EUR J CLIN MICROBIOL, V27, P1209, DOI 10.1007/s10096-008-0567-6; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Song MY, 2009, TOXICOL APPL PHARM, V235, P57, DOI 10.1016/j.taap.2008.11.007; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; THEODOSSI A, 1994, GUT, V35, P961, DOI 10.1136/gut.35.7.961; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Urata Teruo, 2008, Journal of Infection and Chemotherapy, V14, P368, DOI 10.1007/s10156-008-0629-9; van Deventer S, 2010, CELL, V142, P517, DOI 10.1016/j.cell.2010.08.002; Vandenberg O, 2006, J ANTIMICROB CHEMOTH, V57, P908, DOI 10.1093/jac/dkl080; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Waller KL, 2003, BLOOD, V102, P1911, DOI 10.1182/blood-2002-11-3513; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang YL, 2002, BIOCHEM J, V366, P79, DOI 10.1042/bj20020211; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08; Zhang ZQ, 2010, CANCER RES, V70, P2379, DOI 10.1158/0008-5472.CAN-09-4204	58	53	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29045	10.1371/journal.pone.0029045	http://dx.doi.org/10.1371/journal.pone.0029045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194985	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100147
J	Macagno, ALM; Pizzo, A; Parzer, HF; Palestrini, C; Rolando, A; Moczek, AP				Macagno, Anna L. M.; Pizzo, Astrid; Parzer, Harald F.; Palestrini, Claudia; Rolando, Antonio; Moczek, Armin P.			Shape - but Not Size - Codivergence between Male and Female Copulatory Structures in Onthophagus Beetles	PLOS ONE			English	Article							GENITAL MORPHOLOGY; REPRODUCTIVE STRUCTURES; SEXUAL TRAITS; EVOLUTION; PATTERNS; TAURUS; COVARIATION; POPULATIONS; INTEGRATION; DIVERGENCE	Genitalia are among the fastest evolving morphological traits in arthropods. Among the many hypotheses aimed at explaining this observation, some explicitly or implicitly predict concomitant male and female changes of genital traits that interact during copulation (i.e., lock and key, sexual conflict, cryptic female choice and pleiotropy). Testing these hypotheses requires insights into whether male and female copulatory structures that physically interact during mating also affect each other's evolution and patterns of diversification. Here we compare and contrast size and shape evolution of male and female structures that are known to interact tightly during copulation using two model systems: (a) the sister species O. taurus (1 native, 3 recently established populations) and O. illyricus, and (b) the species-complex O. fracticornis-similis-opacicollis. Partial Least Squares analyses indicated very little to no correlation between size and shape of copulatory structures, both in males and females. Accordingly, comparing shape and size diversification patterns of genitalia within each sex showed that the two components diversify readily - though largely independently of each other - within and between species. Similarly, comparing patterns of divergence across sexes showed that relative sizes of male and female copulatory organs diversify largely independent of each other. However, performing this analysis for genital shape revealed a signature of parallel divergence. Our results therefore suggest that male and female copulatory structures that are linked mechanically during copulation may diverge in concert with respect to their shapes. Furthermore, our results suggest that genital divergence in general, and co-divergence of male and female genital shape in particular, can evolve over an extraordinarily short time frame. Results are discussed in the framework of the hypotheses that assume or predict concomitant evolutionary changes in male and female copulatory organs.	[Macagno, Anna L. M.; Pizzo, Astrid; Palestrini, Claudia; Rolando, Antonio] Univ Turin, Dipartimento Biol Anim & Uomo, Turin, Italy; [Parzer, Harald F.; Moczek, Armin P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Macagno, Anna L. M.] Corpo Forestale Stato, Ctr Nazl Studio & Conservaz Biodiversita Forestal, Mantua, Italy; [Macagno, Anna L. M.] Corpo Forestale Stato, Ctr Nazl Studio & Conservaz Biodiversita Forestal, Verona, Italy; [Macagno, Anna L. M.] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy	University of Turin; Indiana University System; Indiana University Bloomington; Sapienza University Rome	Macagno, ALM (corresponding author), Univ Turin, Dipartimento Biol Anim & Uomo, Turin, Italy.	armin@indiana.edu		Macagno, Anna Lorenza Maria/0000-0003-4133-2098; ROLANDO, Antonio/0000-0002-3432-1780	Italian Ministry of University and Research; National Science Foundation [IOS 0445661, IOS 0718522]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); National Science Foundation(National Science Foundation (NSF))	ALM Macagno was funded by a PhD grant of the Italian Ministry of University and Research. Additional support was provided in part by National Science Foundation grants IOS 0445661 and IOS 0718522 to AP Moczek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Arnqvist G, 1998, GENET RES, V71, P193, DOI 10.1017/S0016672398003279; Arnqvist Goran, 2005, pUnpaginated; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Chen EH, 2005, DEV BIOL, V281, P270, DOI 10.1016/j.ydbio.2005.02.032; Chen EH, 1997, DEVELOPMENT, V124, P205; Collyer ML, 2007, ECOLOGY, V88, P683, DOI 10.1890/06-0727; Dryden I., 1998, STAT ANAL SHAPE; Dupuis F, 2005, ZOOSYSTEMA, V27, P733; Eberhard W, 2009, J EVOLUTION BIOL, V22, P435, DOI 10.1111/j.1420-9101.2008.01654.x; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Eberhard WG, 1985, SEXUAL SELECTION ANI; Eberhard WG, 2011, TRENDS ECOL EVOL, V26, P17, DOI 10.1016/j.tree.2010.10.009; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; Eberhard WG, 2009, EVOLUTION, V63, P48, DOI 10.1111/j.1558-5646.2008.00528.x; EMLEN DJ, 1994, COLEOPTERA, V256, P131; ESCOUFIER Y, 1973, BIOMETRICS, V29, P751, DOI 10.2307/2529140; Estrada B, 2003, DIFFERENTIATION, V71, P299, DOI 10.1046/j.1432-0436.2003.03017.x; Falster D. S., 2006, SMATR STANDARDISED M; Foronda D, 2006, DEVELOPMENT, V133, P117, DOI 10.1242/dev.02173; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; House CM, 2005, J EVOLUTION BIOL, V18, P1281, DOI 10.1111/j.1420-9101.2005.00926.x; House CM, 2005, BEHAV ECOL, V16, P889, DOI 10.1093/beheco/ari066; House CM, 2003, P ROY SOC B-BIOL SCI, V270, P447, DOI 10.1098/rspb.2002.2266; Kendall D.G., 1981, INTERPRETING MULTIVA, P75; KENDALL DG, 1984, B LOND MATH SOC, V16, P81, DOI 10.1112/blms/16.2.81; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Macagno ALM, 2011, ZOOL J LINN SOC-LOND, V162, P482, DOI 10.1111/j.1096-3642.2010.00684.x; Macdonald SJ, 1999, GENETICS, V153, P1683; McPeek MA, 2011, EVOLUTION, V65, P419, DOI 10.1111/j.1558-5646.2010.01138.x; McPeek MA, 2009, EVOLUTION, V63, P73, DOI 10.1111/j.1558-5646.2008.00527.x; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moczek AP, 2003, EVOL DEV, V5, P259, DOI 10.1046/j.1525-142X.2003.03033.x; Moczek AP, 2004, AM NAT, V163, P184, DOI 10.1086/381741; Moczek AP, 1998, BEHAV ECOL, V9, P636, DOI 10.1093/beheco/9.6.636; Moczek AP, 2009, P NATL ACAD SCI USA, V106, P8992, DOI 10.1073/pnas.0809668106; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Parzer HF, 2008, EVOLUTION, V62, P2423, DOI 10.1111/j.1558-5646.2008.00448.x; Pizzo A, 2008, EVOL DEV, V10, P166, DOI 10.1111/j.1525-142X.2008.00224.x; Pizzo A, 2006, BIOL J LINN SOC, V89, P197, DOI 10.1111/j.1095-8312.2006.00674.x; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Rohlf, 2006, TPSDIG2 VERSION 2 10; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; ROHLF FJ, 2003, TPSSMALL 1 20; Rohlf J., 1990, SPECIAL PUBLICATION, V2; Simmons LW, 2009, CURR BIOL, V19, P1442, DOI 10.1016/j.cub.2009.06.056; Song HJ, 2008, BIOL J LINN SOC, V94, P289, DOI 10.1111/j.1095-8312.2008.00983.x; Soto IM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-77; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Wasik BR, 2011, DEV GENES EVOL, V221, P17, DOI 10.1007/s00427-011-0355-7; Werner M, 2008, BIOL J LINN SOC, V93, P257, DOI 10.1111/j.1095-8312.2007.00924.x; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	55	32	32	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28893	10.1371/journal.pone.0028893	http://dx.doi.org/10.1371/journal.pone.0028893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194942	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100119
J	Wang, Q; Hillwig, ML; Okada, K; Yamazaki, K; Wu, YS; Swaminathan, S; Yamane, H; Peters, RJ				Wang, Qiang; Hillwig, Matthew L.; Okada, Kazunori; Yamazaki, Kohei; Wu, Yisheng; Swaminathan, Sivakumar; Yamane, Hisakazu; Peters, Reuben J.			Characterization of CYP76M5-8 Indicates Metabolic Plasticity within a Plant Biosynthetic Gene Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPALYL DIPHOSPHATE SYNTHASES; CULTURED RICE CELLS; BILE-ACID ELICITOR; PHYTOALEXIN BIOSYNTHESIS; SECONDARY METABOLISM; CHOLIC-ACID; ENT-COPALYL; PATHWAY; GIBBERELLIN; DEFENSE	Recent reports have revealed genomic clustering of enzymatic genes for particular biosynthetic pathways in plant specialized/secondary metabolism. Rice (Oryza sativa) carries two such clusters for production of antimicrobial diterpenoid phytoalexins, with the cluster on chromosome 2 containing four closely related/homologous members of the cytochrome P450 CYP76M subfamily (CYP76M5-8). Notably, the underlying evolutionary expansion of these CYP appears to have occurred after assembly of the ancestral biosynthetic gene cluster, suggesting separate roles. It has been demonstrated that CYP76M7 catalyzes C11 alpha-hydroxylation of ent-cassadiene, and presumably mediates an early step in biosynthesis of the derived phytocassane class of phytoalexins. Here we report biochemical characterization of CYP76M5, -6, and -8. Our results indicate that CYP76M8 is a multifunctional/promiscuous hydroxylase, with CYP76M5 and -7 seeming to provide only redundant activity, while CYP76M6 seems to provide both redundant and novel activity, relative to CYP76M8. RNAi-mediated double knockdown of CYP76M7 and -8 suppresses elicitor inducible phytocassane production, indicating a role for these monooxygenases in phytocassane biosynthesis. In addition, our data suggests that CYP76M5, -6, and -8 may play redundant roles in production of the oryzalexin class of phytoalexins as well. Intriguingly, the preceding diterpene synthase for oryzalexin biosynthesis, unlike that for the phytocassanes, is not found in the chromosome 2 diterpenoid biosynthetic gene cluster. Accordingly, our results not only uncover a complex evolutionary history, but also further suggest some intriguing differences between plant biosynthetic gene clusters and the seemingly similar microbial operons. The implications for the underlying metabolic evolution of plants are then discussed.	[Wang, Qiang; Hillwig, Matthew L.; Wu, Yisheng; Swaminathan, Sivakumar; Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Okada, Kazunori; Yamazaki, Kohei; Yamane, Hisakazu] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	Iowa State University; University of Tokyo	Peters, RJ (corresponding author), Rm 4216, Ames, IA 50011 USA.	rjpeters@iastate.edu	Peters, Reuben J./D-1196-2010; Wu, Yisheng/D-2937-2014; Wang, Qiang/GOE-4599-2022	Peters, Reuben J./0000-0003-4691-8477; Hillwig, Matthew/0000-0002-1168-4191; Swaminathan, Sivakumar/0000-0003-3931-275X	National Institutes of Health [GM086281]; USDA-NIFA-NRI/AFRI [2008-35318-05027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-NIFA-NRI/AFRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM086281 (to R. J. P.) and USDA-NIFA-NRI/AFRI Grant 2008-35318-05027.	Cho EM, 2004, PLANT J, V37, P1, DOI 10.1046/j.1365-313X.2003.01926.x; Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; Cyr A, 2007, J AM CHEM SOC, V129, P6684, DOI 10.1021/ja071158n; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kanno Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1702, DOI 10.1271/bbb.60044; KATO H, 1995, ARCH BIOCHEM BIOPHYS, V316, P707, DOI 10.1006/abbi.1995.1094; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Koga J, 2006, PLANT PHYSIOL, V140, P1475, DOI 10.1104/pp.105.070334; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Morrone D, 2011, BIOCHEM J, V435, P589, DOI 10.1042/BJ20101429; Morrone D, 2010, BIOCHEM J, V431, P337, DOI 10.1042/BJ20100597; Morrone D, 2010, APPL MICROBIOL BIOT, V85, P1893, DOI 10.1007/s00253-009-2219-x; Okada A, 2007, PLANT MOL BIOL, V65, P177, DOI 10.1007/s11103-007-9207-2; OMURA T, 1964, J BIOL CHEM, V239, P2379; Osbourn A, 2010, PLANT PHYSIOL, V154, P531, DOI 10.1104/pp.110.161315; Osbourn AE, 2009, CELL MOL LIFE SCI, V66, P3755, DOI 10.1007/s00018-009-0114-3; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peters RJ, 2006, PHYTOCHEMISTRY, V67, P2307, DOI 10.1016/j.phytochem.2006.08.009; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Prisic S, 2004, PLANT PHYSIOL, V136, P4228, DOI 10.1104/pp.104.050567; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; REN YY, 1992, PLANT PHYSIOL, V99, P1169, DOI 10.1104/pp.99.3.1169; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sato Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-127; Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Toyomasu T, 2008, BIOSCI BIOTECH BIOCH, V72, P1168, DOI 10.1271/bbb.80044; Wang QA, 2011, PLANT J, V65, P87, DOI 10.1111/j.1365-313X.2010.04408.x; Watanabe M, 1996, BIOSCI BIOTECH BIOCH, V60, P1460, DOI 10.1271/bbb.60.1460; Wilderman PR, 2004, PLANT PHYSIOL, V135, P2098, DOI 10.1104/pp.104.045971; Xu MM, 2007, P NATL ACAD SCI USA, V104, P7397, DOI 10.1073/pnas.0611454104; Xu MM, 2007, PHYTOCHEMISTRY, V68, P312, DOI 10.1016/j.phytochem.2006.10.016; Zhang JW, 2006, NUCLEIC ACIDS RES, V34, pD745, DOI 10.1093/nar/gkj016	39	88	96	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6159	6168		10.1074/jbc.M111.305599	http://dx.doi.org/10.1074/jbc.M111.305599			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215681	Green Published, hybrid			2022-12-25	WOS:000300791800009
J	Yang, XH; Qiao, DH; Meyer, K; Pier, T; Keles, S; Friedl, A				Yang, Xinhai; Qiao, Dianhua; Meyer, Kristy; Pier, Thomas; Keles, Sunduz; Friedl, Andreas			Angiogenesis Induced by Signal Transducer and Activator of Transcription 5A (STAT5A) Is Dependent on Autocrine Activity of Proliferin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; GENE-EXPRESSION; ENDOTHELIAL-CELLS; MESSENGER-RNA; GROWTH; PROLACTIN; RECEPTOR; PROTEIN; FAMILY; FIBROSARCOMA	Multiple secreted factors induce the formation of new blood vessels (angiogenesis). The signal transduction events that orchestrate the numerous cellular activities required for angiogenesis remain incompletely understood. We have shown previously that STAT5 plays a pivotal role in angiogenesis induced by FGF2 and FGF8b. To delineate the signaling pathway downstream of STAT5, we expressed constitutively active (CA) or dominant-negative (DN) mutant STAT5A in mouse brain endothelial cells (EC). We found that the conditioned medium from CA-STAT5A but not from dominant-negative STAT5A overexpressing EC is sufficient to induce EC invasion and tube formation, indicating that STAT5A regulates the secretion of autocrine proangiogenic factors. Conversely, CA-STAT5A-induced conditioned medium had no effect on EC proliferation. Using a comparative genome-wide transcription array screen, we identified the prolactin family member proliferin (PLF1 and PLF4) as a candidate autocrine factor. The CA-STAT5A-dependent transcription and secretion of PLF by EC was confirmed by quantitative RT-PCR and Western blotting, respectively. CA-STAT5A binds to the PLF1 promoter region, suggesting a direct transcriptional regulation. Knockdown of PLF expression by shRNA or by blocking of PLF activity with neutralizing antibodies removed the CA-STAT5A-dependent proangiogenic activity from the conditioned medium of EC. Similarly, the ability of concentrated conditioned medium from CA-STAT5A transfected EC to induce angiogenesis in Matrigel plugs in vivo was abolished when PLF was depleted from the medium. These observations demonstrate a FGF/STAT5/PLF signaling cascade in EC and implicate PLF as autocrine regulator of EC invasion and tube formation.	[Yang, Xinhai; Qiao, Dianhua; Meyer, Kristy; Pier, Thomas; Friedl, Andreas] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53792 USA; [Keles, Sunduz] Univ Wisconsin, Dept Stat & Biostat & Med Informat, Madison, WI 53792 USA; [Friedl, Andreas] William S Middleton Mem Vet Adm Med Ctr, Pathol & Lab Med Serv, Dept Vet Affairs Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Friedl, A (corresponding author), WIMR Rm 6051,1111 Highland Ave, Madison, WI 53705 USA.	afriedl@wisc.edu			National Institutes of Health [RO1NS048921-01]; Biomedical Laboratory Research and Development Service of the VA Office of Research and Development [I01BX000137]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048921] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research and Development Service of the VA Office of Research and Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1NS048921-01. This work was also based upon work supported in part by Award I01BX000137 from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development.	Auerbach R, 2000, CANCER METAST REV, V19, P167, DOI 10.1023/A:1026574416001; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CLAPP C, 1992, ENDOCRINOLOGY, V130, P1380, DOI 10.1210/en.130.3.1380; Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219; DaSilva L, 1996, MOL CELL ENDOCRINOL, V117, P131, DOI 10.1016/0303-7207(95)03738-1; Deo DD, 2002, J BIOL CHEM, V277, P21237, DOI 10.1074/jbc.M110955200; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fassett JT, 2000, ENDOCRINOLOGY, V141, P1863, DOI 10.1210/en.141.5.1863; Groskopf JC, 1997, ENDOCRINOLOGY, V138, P2835, DOI 10.1210/en.138.7.2835; GROSKOPF JC, 1994, MOL CELL BIOL, V14, P6013, DOI 10.1128/MCB.14.9.6013; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hemberger M, 2003, DEV DYNAM, V227, P185, DOI 10.1002/dvdy.10291; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JACKSON D, 1994, SCIENCE, V266, P1581, DOI 10.1126/science.7527157; KANDEL J, 1991, CELL, V66, P1095, DOI 10.1016/0092-8674(91)90033-U; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633; Langley RR, 2003, CANCER RES, V63, P2971; LINZER DIH, 1985, P NATL ACAD SCI USA, V82, P4356, DOI 10.1073/pnas.82.13.4356; LINZER DIH, 1984, P NATL ACAD SCI-BIOL, V81, P4255, DOI 10.1073/pnas.81.14.4255; MORDACQ JC, 1989, GENE DEV, V3, P760, DOI 10.1101/gad.3.6.760; MUSCAT GEO, 1991, MOL ENDOCRINOL, V5, P802, DOI 10.1210/mend-5-6-802; NELSON JT, 1995, ENDOCRINOLOGY, V136, P283, DOI 10.1210/en.136.1.283; Peles E, 2004, NEUROSURGERY, V55, P562, DOI 10.1227/01.NEU.0000134383.27713.9A; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; Toft DJ, 2001, P NATL ACAD SCI USA, V98, P13055, DOI 10.1073/pnas.231364798; TOURKINE N, 1995, J BIOL CHEM, V270, P20952, DOI 10.1074/jbc.270.36.20952; Volpert O, 1996, ENDOCRINOLOGY, V137, P3871, DOI 10.1210/en.137.9.3871; Wang JW, 2006, NEUROSCI RES, V56, P80, DOI 10.1016/j.neures.2006.05.011; WELTE T, 1994, MOL ENDOCRINOL, V8, P1091, DOI 10.1210/me.8.8.1091; Wiemers DO, 2003, ENDOCRINOLOGY, V144, P313, DOI 10.1210/en.2002-220724; Yang XH, 2009, CANCER RES, V69, P1668, DOI 10.1158/0008-5472.CAN-07-6385	33	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6490	6502		10.1074/jbc.M111.254631	http://dx.doi.org/10.1074/jbc.M111.254631			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22199350	Green Published, hybrid			2022-12-25	WOS:000300791800038
J	Matsubara, T; Ikeda, M; Kiso, Y; Sakuma, M; Yoshino, K; Sakane, F; Merida, I; Saito, N; Shirai, Y				Matsubara, Takehiro; Ikeda, Momo; Kiso, Yuko; Sakuma, Megumi; Yoshino, Ken-ichi; Sakane, Fumio; Merida, Isabel; Saito, Naoaki; Shirai, Yasuhito			c-Abl Tyrosine Kinase Regulates Serum-induced Nuclear Export of Diacylglycerol Kinase alpha by Phosphorylation at Tyr-218	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; SUBTYPE-SPECIFIC TRANSLOCATION; PHOSPHATIDIC-ACID; FAMILY KINASES; IMPORTIN-ALPHA; I-ALPHA; ACTIVATION; CELLS; DOMAINS; ZETA	c-Abl is a tyrosine kinase involved in many cellular processes, including cell cycle control and proliferation. However, little is known about its substrates. Here, we show that c-Abl directly phosphorylates diacylglycerol kinase alpha (DGK alpha), an important regulator of many cellular events through its conversion of diacylglycerol to phosphatidic acid. We found that DGK alpha was transported from the cytoplasm to the nucleus in response to serum starvation, and serum restoration induced the nuclear export of the enzyme to the cytoplasm. This serum-induced export involves two tyrosine kinases, c-Src and c-Abl. The latter, c-Abl, is activated by c-Src, phosphorylates DGK alpha, and shuttles between the nucleus and the cytoplasm in a direction opposite to that of DGK alpha in response to serum restoration. Moreover, an in vitro phosphorylation assay using purified mutants of DGK alpha identified Tyr-218 as a site of phosphorylation by c-Abl. We confirmed these results for endogenous DGK alpha using an antibody specific for phospho-Tyr-218, and this phosphorylation was necessary for the serum-induced export of DGK alpha. These results demonstrate that the nucleo-cytoplasmic shuttling of DGK alpha is orchestrated by tyrosine phosphorylation by the Src-activated tyrosine kinase c-Abl and that this phosphorylation is important for regulating the function of cytoplasmic and/or nuclear DGK alpha.	[Shirai, Yasuhito] Kobe Univ, Grad Sch Agr Sci, Dept Appl Chem Biosci, Lab Chem & Utilizat Anim Prod Resources,Nada Ku, Kobe, Hyogo 6578501, Japan; [Matsubara, Takehiro; Ikeda, Momo; Kiso, Yuko; Sakuma, Megumi; Yoshino, Ken-ichi; Saito, Naoaki; Shirai, Yasuhito] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Nada Ku, Kobe, Hyogo 6578501, Japan; [Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan; [Merida, Isabel] CSIC, Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28049 Madrid, Spain	Kobe University; Kobe University; Chiba University; Consejo Superior de Investigaciones Cientificas (CSIC)	Shirai, Y (corresponding author), Kobe Univ, Grad Sch Agr Sci, Dept Appl Chem Biosci, Lab Chem & Utilizat Anim Prod Resources,Nada Ku, Rokkodai Cho 1-1, Kobe, Hyogo 6578501, Japan.	shirai@kobe-u.ac.jp	Sakane, Fumio/H-2693-2017; Merida, Isabel/A-9713-2014; Shirai, Yasuhito/O-3255-2018	Sakane, Fumio/0000-0003-0857-0377; Merida, Isabel/0000-0003-2762-6241; 	Global Center of Excellence of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	Global Center of Excellence of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported in part by a Grant-in-aid for Scientific Research (C) and the Global Center of Excellence Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Baldanzi G, 2008, ONCOGENE, V27, P942, DOI 10.1038/sj.onc.1210717; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Bregoli L, 2002, ADV ENZYME REGUL, V42, P213, DOI 10.1016/S0065-2571(01)00032-2; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Deacon EM, 2002, J CELL SCI, V115, P983; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fukunaga-Takenaka R, 2005, GENES CELLS, V10, P311, DOI 10.1111/j.1365-2443.2005.00842.x; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; GOTO K, 1992, MOL BRAIN RES, V16, P75, DOI 10.1016/0169-328X(92)90196-I; Goto K, 1996, P NATL ACAD SCI USA, V93, P11196, DOI 10.1073/pnas.93.20.11196; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; Irie N, 2002, BIOCHEM BIOPH RES CO, V298, P738, DOI 10.1016/S0006-291X(02)02531-7; IRVINE R, 2000, SCI STKE, pRE1; Jones DR, 2000, FEBS LETT, V476, P160, DOI 10.1016/S0014-5793(00)01702-6; Kamio N, 2011, FREE RADICAL RES, V45, P336, DOI 10.3109/10715762.2010.532495; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Martelli AM, 2004, CELL MOL LIFE SCI, V61, P1143, DOI 10.1007/s00018-004-3414-7; Martelli AM, 2000, CANCER RES, V60, P815; Matsubara T, 2006, J BIOL CHEM, V281, P6152, DOI 10.1074/jbc.M509873200; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; Merino E, 2007, J BIOL CHEM, V282, P35396, DOI 10.1074/jbc.M702085200; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; ROSTI V, 1995, BLOOD, V86, P3387, DOI 10.1182/blood.V86.9.3387.bloodjournal8693387; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Shirai Y, 2000, J BIOL CHEM, V275, P24760, DOI 10.1074/jbc.M003151200; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tabellini G, 2003, EXP CELL RES, V287, P143, DOI 10.1016/S0014-4827(03)00115-0; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Wada I, 1996, FEBS LETT, V393, P48, DOI 10.1016/0014-5793(96)00857-5; WANG JYJ, 1984, CELL, V36, P349; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	37	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5507	5517		10.1074/jbc.M111.296897	http://dx.doi.org/10.1074/jbc.M111.296897			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22199356	Green Published, hybrid			2022-12-25	WOS:000300638000030
J	Pandit, A; Sinha, S				Pandit, Aridaman; Sinha, Somdatta			Differential Trends in the Codon Usage Patterns in HIV-1 Genes	PLOS ONE			English	Article							TRANSACTIVATOR GENE; ACCESSORY PROTEINS; TRANSFER-RNAS; EVOLUTION; BIAS; SELECTION; TRANSLATION; EXPRESSION; VIRUSES; CONSEQUENCES	Host-pathogen interactions underlie one of the most complex evolutionary phenomena resulting in continual adaptive genetic changes, where pathogens exploit the host's molecular resources for growth and survival, while hosts try to eliminate the pathogen. Deciphering the molecular basis of host-pathogen interactions is useful in understanding the factors governing pathogen evolution and disease propagation. In host-pathogen context, a balance between mutation, selection, and genetic drift is known to maintain codon bias in both organisms. Studies revealing determinants of the bias and its dynamics are central to the understanding of host-pathogen evolution. We considered the Human Immunodeficiency Virus (HIV) type 1 and its human host to search for evolutionary signatures in the viral genome. Positive selection is known to dominate intra-host evolution of HIV-1, whereas high genetic variability underlies the belief that neutral processes drive inter-host differences. In this study, we analyze the codon usage patterns of HIV-1 genomes across all subtypes and clades sequenced over a period of 23 years. We show presence of unique temporal correlations in the codon bias of three HIV-1 genes illustrating differential adaptation of the HIV-1 genes towards the host preferred codons. Our results point towards gene-specific translational selection to be an important force driving the evolution of HIV-1 at the population level.	[Pandit, Aridaman; Sinha, Somdatta] Ctr Cellular & Mol Biol CSIR, Math Modeling & Computat Biol Grp, Hyderabad, Andhra Pradesh, India; [Sinha, Somdatta] Indian Inst Sci Educ & Res Mohali, Mohali, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Indian Institute of Science Education & Research (IISER) - Mohali	Pandit, A (corresponding author), Ctr Cellular & Mol Biol CSIR, Math Modeling & Computat Biol Grp, Hyderabad, Andhra Pradesh, India.	sinha@ccmb.res.in	Pandit, Aridaman/ABH-1221-2021	Pandit, Aridaman/0000-0003-2057-9737	Council of Scientific and Industrial Research (CSIR); Santa Fe Institute, New Mexico, USA	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Santa Fe Institute, New Mexico, USA	The work was performed in Centre for Cellular and Molecular Biology (CCMB), Hyderabad, which is a nonprofit research organization. AP is a PhD student in CCMB and receives a fellowship from the Council of Scientific and Industrial Research (CSIR), an autonomous body under the Government of India, to support his PhD work. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SS thanks the Santa Fe Institute, New Mexico, USA for the Senior International Fellowship, and Andreas Wagner, Tanmoy Bhattacharya, and Bette Korber for discussions. The authors thank the anonymous referees for their critical comments.	Ahn I, 2006, EXP MOL MED, V38, P643, DOI 10.1038/emm.2006.76; Anderson Jenny L, 2004, Curr HIV/AIDS Rep, V1, P47, DOI 10.1007/s11904-004-0007-x; Andre S, 1998, J VIROL, V72, P1497; ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chamary JV, 2009, SCI AM, V30, P46; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; Gilchrist MA, 2006, THEOR POPUL BIOL, V69, P145, DOI 10.1016/j.tpb.2005.07.002; GRANTHAM R, 1981, NUCLEIC ACIDS RES, V9, pR43; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; He J., 2003, CLUSTERING INFORM RE, P105; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168; Kijak GH, 2004, AIDS REV, V6, P54; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; Krakauer DC, 2002, J THEOR BIOL, V218, P97, DOI 10.1006/jtbi.2002.3054; Lucks JB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000001; MARTINEZ MA, 1994, P NATL ACAD SCI USA, V91, P11787, DOI 10.1073/pnas.91.25.11787; Meintjes Peter L., 2005, Journal of Bioinformatics and Computational Biology, V3, P157, DOI 10.1142/S0219720005000953; Miller RH, 1997, NAT MED, V3, P389, DOI 10.1038/nm0497-389; Muller V, 2005, TRENDS GENET, V21, P264, DOI 10.1016/j.tig.2005.03.004; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Perriere G, 2002, NUCLEIC ACIDS RES, V30, P4548, DOI 10.1093/nar/gkf565; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rencher AC, 2002, METHODS MULTIVARIATE; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Shankarappa R, 1999, EVOLUTION OF HIV, P469; Stoletzki N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-224; Suzuki H, 2005, FEBS LETT, V579, P6499, DOI 10.1016/j.febslet.2005.10.032; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; TRONO D, 1995, CELL, V82, P189, DOI 10.1016/0092-8674(95)90306-2; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; van Weringh A, 2011, MOL BIOL EVOL, V28, P1827, DOI 10.1093/molbev/msr005; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Williamson S, 2005, MOL BIOL EVOL, V22, P456, DOI 10.1093/molbev/msi029; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; Woo J, 2010, J VIROL, V84, P12995, DOI 10.1128/JVI.00702-10; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Worobey M, 2007, ANNU REV ECOL EVOL S, V38, P515, DOI 10.1146/annurev.ecolsys.38.091206.095722; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	57	28	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28889	10.1371/journal.pone.0028889	http://dx.doi.org/10.1371/journal.pone.0028889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216135	Green Published, Green Submitted, gold			2022-12-25	WOS:000299684700015
J	Wang, YJ; Mo, XK; Piper, MG; Wang, HM; Parinandi, NL; Guttridge, D; Marsh, CB				Wang, Yijie; Mo, Xiaokui; Piper, Melissa G.; Wang, Hongmei; Parinandi, Narasimham L.; Guttridge, Denis; Marsh, Clay B.			M-CSF Induces Monocyte Survival by Activating NF-kappa B p65 Phosphorylation at Ser276 via Protein Kinase C	PLOS ONE			English	Article							IKK-ALPHA; TRANSCRIPTIONAL ACTIVITY; INDUCED APOPTOSIS; CELLS; EXPRESSION; RELA/P65; DIFFERENTIATION; MACROPHAGES; DEATH; BETA	Macrophage colony-stimulating factor (M-CSF) promotes mononuclear phagocyte survival and proliferation. The transcription factor Nuclear Factor-kappaB (NF-kappa B) is a key regulator of genes involved in M-CSF-induced mononuclear phagocyte survival and this study focused at identifying the mechanism of NF-kappa B transcriptional activation. Here, we demonstrate that M-CSF stimulated NF-kappa B transcriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKC alpha/beta inhibitor Go-6976, overexpression of dominant negative PKC alpha constructs and PKC alpha siRNA reduced NF-kappa B activity in response to M-CSF. Interestingly, Ro-31-8220 reduced Ser276 phosphorylation of NF-kappa Bp65 leading to decreased M-CSF-induced monocyte survival. In this report, we identify conventional PKCs, including PKC alpha as important upstream kinases for M-CSF-induced NF-kappa B transcriptional activation, NF-kappa B-regulated gene expression, NF-kappa B p65 Ser276 phosphorylation, and macrophage survival. Lastly, we find that NF-kappa B p65 Ser276 plays an important role in basal and M-CSF-stimulated NF-kappa B activation in human mononuclear phagocytes.	[Wang, Yijie; Mo, Xiaokui; Piper, Melissa G.; Wang, Hongmei; Parinandi, Narasimham L.; Marsh, Clay B.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Guttridge, Denis] Ohio State Univ, Dept Human Canc Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wang, YJ (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	clay.marsh@osumc.edu	Piper, Melissa/E-3872-2011	Guttridge, Denis/0000-0002-7276-6609	National Institutes of Health (NIH) [HL067176, HL63800, HL66108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066108, R01HL063800, R01HL067176] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants HL067176, HL63800, and HL66108 to Dr. Marsh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2004, CANCER RES, V64, P5378, DOI 10.1158/0008-5472.CAN-04-0961; Attar RM, 1997, SEMIN CANCER BIOL, V8, P93, DOI 10.1006/scbi.1997.0060; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BRACH MA, 1991, PATHOBIOLOGY, V59, P284, DOI 10.1159/000163664; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; CLINE MJ, 1978, J INVEST DERMATOL, V71, P56, DOI 10.1111/1523-1747.ep12543945; Dempsey EC, 2007, PHARMACOL RES, V55, P545, DOI 10.1016/j.phrs.2007.04.010; Dixit V, 2002, CELL, V111, P615, DOI 10.1016/S0092-8674(02)01166-2; Dos Santos S, 2007, ANN NY ACAD SCI, V1096, P70, DOI 10.1196/annals.1397.071; Farver CF, 1998, CYTOKINE, V10, P868, DOI 10.1006/cyto.1998.0373; FRANKENBERGER M, 1994, BIOCHEM J, V304, P87, DOI 10.1042/bj3040087; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gilmore TD, 1996, ONCOGENE, V13, P1367; Goyal A, 2002, AM J RESP CELL MOL, V26, P224, DOI 10.1165/ajrcmb.26.2.4640; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hertlein E, 2005, MOL CELL BIOL, V25, P4956, DOI 10.1128/MCB.25.12.4956-4968.2005; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; Laouar A, 1999, J BIOL CHEM, V274, P23526, DOI 10.1074/jbc.274.33.23526; Le XF, 2001, ONCOGENE, V20, P8258, DOI 10.1038/sj.onc.1205039; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; MANGAN DF, 1991, J IMMUNOL, V147, P3408; Matassa A, 2003, CELL DEATH DIFFER, V10, P269, DOI 10.1038/sj.cdd.4401149; Mohamad N, 2005, BIOCELL, V29, P149; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nihira K, 2010, CELL DEATH DIFFER, V17, P689, DOI 10.1038/cdd.2009.174; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Podar K, 2007, EXPERT OPIN INV DRUG, V16, P1693, DOI 10.1517/13543784.16.10.1693; PONGRACZ J, 1995, EXP CELL RES, V218, P430, DOI 10.1006/excr.1995.1176; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schultz H, 1997, J CELL PHYSIOL, V173, P310, DOI 10.1002/(SICI)1097-4652(199712)173:3<310::AID-JCP2>3.0.CO;2-Q; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Shi CW, 1996, P NATL ACAD SCI USA, V93, P4051, DOI 10.1073/pnas.93.9.4051; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; St-Denis A, 1998, J BIOL CHEM, V273, P32787, DOI 10.1074/jbc.273.49.32787; Takahashi N, 2002, EUR J BIOCHEM, V269, P4559, DOI 10.1046/j.1432-1033.2002.03157.x; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	51	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e28081	10.1371/journal.pone.0028081	http://dx.doi.org/10.1371/journal.pone.0028081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216091	Green Submitted, Green Published, gold			2022-12-25	WOS:000299684700004
J	Bruning-Richardson, A; Langford, KJ; Ruane, P; Lee, T; Askham, JM; Morrison, EE				Bruening-Richardson, Anke; Langford, Kelly J.; Ruane, Peter; Lee, Tracy; Askham, Jon M.; Morrison, Ewan E.			EB1 Is Required for Spindle Symmetry in Mammalian Mitosis	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; MICROTUBULE PLUS-END; APC TUMOR-SUPPRESSOR; STRUCTURAL BASIS; PROTEIN; P150(GLUED); BINDING; INSTABILITY; WNT; CIN	Most information about the roles of the adenomatous polyposis coli protein (APC) and its binding partner EB1 in mitotic cells has come from siRNA studies. These suggest functions in chromosomal segregation and spindle positioning whose loss might contribute to tumourigenesis in cancers initiated by APC mutation. However, siRNA-based approaches have drawbacks associated with the time taken to achieve significant expression knockdown and the pleiotropic effects of EB1 and APC gene knockdown. Here we describe the effects of microinjecting APC- or EB1- specific monoclonal antibodies and a dominant-negative EB1 protein fragment into mammalian mitotic cells. The phenotypes observed were consistent with the roles proposed for EB1 and APC in chromosomal segregation in previous work. However, EB1 antibody injection also revealed two novel mitotic phenotypes, anaphase-specific cortical blebbing and asymmetric spindle pole movement. The daughters of microinjected cells displayed inequalities in microtubule content, with the greatest differences seen in the products of mitoses that showed the severest asymmetry in spindle pole movement. Daughters that inherited the least mobile pole contained the fewest microtubules, consistent with a role for EB1 in processes that promote equality of astral microtubule function at both poles in a spindle. We propose that these novel phenotypes represent APC-independent roles for EB1 in spindle pole function and the regulation of cortical contractility in the later stages of mitosis. Our work confirms that EB1 and APC have important mitotic roles, the loss of which could contribute to CIN in colorectal tumour cells.	[Bruening-Richardson, Anke; Langford, Kelly J.; Ruane, Peter; Lee, Tracy; Askham, Jon M.; Morrison, Ewan E.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Bruning-Richardson, A (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England.	bgyar@leeds.ac.uk	Ruane, Peter/L-1524-2018	Bruning-Richardson, Anke/0000-0002-9862-9805	Cancer Research United Kingdom	Cancer Research United Kingdom(Cancer Research UK)	This work was funded by Cancer Research United Kingdom, http://www.cancerresearchuk.org/. The funders had no role in study design, data collection and anlysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Behrens J, 2005, BIOCHEM SOC T, V33, P672, DOI 10.1042/BST0330672; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Brocardo M, 2005, EMBO REP, V6, P184, DOI 10.1038/sj.embor.7400329; Bruning-Richardson A, 2007, CURR COLORECT CANC R, V3, P82, DOI 10.1007/s11888-007-0005-7; Chen CS, 2000, EUR PHYS J-APPL PHYS, V11, P3, DOI 10.1051/epjap:2000139; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Dikovskaya D, 2004, MOL BIOL CELL, V15, P2978, DOI 10.1091/mbc.E03-08-0613; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Dong X, 2010, J PATHOL, V220, P361, DOI 10.1002/path.2662; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fong KW, 2009, MOL BIOL CELL, V20, P3660, DOI 10.1091/mbc.E09-01-0009; Glotzer M, 2004, J CELL BIOL, V164, P347, DOI 10.1083/jcb.200310112; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Gupta KK, 2010, J MOL BIOL, V395, P1049, DOI 10.1016/j.jmb.2009.11.014; Hadjihannas MV, 2006, CELL CYCLE, V5, P2077, DOI 10.4161/cc.5.18.3282; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2007, NAT STRUCT MOL BIOL, V14, P980, DOI 10.1038/nsmb1299; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; King JS, 2010, J CELL SCI, V123, P2246, DOI 10.1242/jcs.063735; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Langford KJ, 2006, CELL MOTIL CYTOSKEL, V63, P483, DOI 10.1002/cm.20139; Langford KJ, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-3; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lee T, 2008, ONCOGENE, V27, P2494, DOI 10.1038/sj.onc.1210867; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Liu M, 2009, MOL CARCINOGEN, V48, P212, DOI 10.1002/mc.20471; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Morrison EE, 2001, EUR J CELL BIOL, V80, P749, DOI 10.1078/0171-9335-00221; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nathke I, 2004, J CELL SCI, V117, P4873, DOI 10.1242/jcs.01313; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Orimo T, 2008, HEPATOLOGY, V48, P1851, DOI 10.1002/hep.22552; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Rajagopalan H, 2004, CANCER CHEMOTH PHARM, V54, pS65, DOI 10.1007/s00280-004-0889-8; Riess NP, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-17; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Rusan NM, 2008, J CELL BIOL, V181, P719, DOI 10.1083/jcb.200802107; Schober JM, 2009, CANCER LETT, V284, P30, DOI 10.1016/j.canlet.2009.04.007; SMITH KJ, 1994, CANCER RES, V54, P3672; Strickland LI, 2005, CURR BIOL, V15, P2249, DOI 10.1016/j.cub.2005.10.073; SU LK, 1995, CANCER RES, V55, P2972; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; von Dassow G, 2009, TRENDS CELL BIOL, V19, P165, DOI 10.1016/j.tcb.2009.01.008; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Zhang JY, 2007, J CELL BIOL, V178, P773, DOI 10.1083/jcb.200702138; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	71	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28884	10.1371/journal.pone.0028884	http://dx.doi.org/10.1371/journal.pone.0028884			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216133	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600048
J	Alfaro, C; Suarez, N; Onate, C; Perez-Gracia, JL; Martinez-Forero, I; Hervas-Stubbs, S; Rodriguez, I; Perez, G; Bolanos, E; Palazon, A; de Sanmamed, MF; Morales-Kastresana, A; Gonzalez, A; Melero, I				Alfaro, Carlos; Suarez, Natalia; Onate, Carmen; Perez-Gracia, Jose L.; Martinez-Forero, Ivan; Hervas-Stubbs, Sandra; Rodriguez, Inmaculada; Perez, Guiomar; Bolanos, Elixabet; Palazon, Asis; Fernandez de Sanmamed, Miguel; Morales-Kastresana, Aizea; Gonzalez, Alvaro; Melero, Ignacio			Dendritic Cells Take up and Present Antigens from Viable and Apoptotic Polymorphonuclear Leukocytes	PLOS ONE			English	Article							IN-VIVO; NEUTROPHILS; INTERLEUKIN-8; ADHESION; MAC-1	Dendritic cells (DC) are endowed with the ability to cross-present antigens from other cell types to cognate T cells. DC are poised to meet polymorphonuclear leukocytes (PMNs) as a result of being co-attracted by interleukin-8 (IL-8), for instance as produced by tumor cells or infected tissue. Human monocyte-derived and mouse bone marrow-derived DC can readily internalize viable or UV-irradiated PMNs. Such internalization was abrogated at 4 degrees C and partly inhibited by anti-CD18 mAb. In mice, DC which had internalized PMNs containing electroporated ovalbumin (OVA) protein, were able to cross-present the antigen to CD8 (OT-1) and CD4 (OT-2) TCR-transgenic T cells. Moreover, in humans, tumor cell debris is internalized by PMNs and the tumor-cell material can be subsequently taken up from the immunomagnetically re-isolated PMNs by DC. Importantly, if human neutrophils had endocytosed bacteria, they were able to trigger the maturation program of the DC. Moreover, when mouse PMNs with E. coli in their interior are co-injected in the foot pad with DC, many DC loaded with fluorescent material from the PMNs reach draining lymph nodes. Using CT26 (H-2(d)) mouse tumor cells, it was observed that if tumor cells are intracellularly loaded with OVA protein and UV-irradiated, they become phagocytic prey of H-2(d) PMNs. If such PMNs, that cannot present antigens to OT-1 T cells, are immunomagnetically re-isolated and phagocytosed by H-2(b) DC, such DC productively cross-present OVA antigen determinants to OT-1 T cells. Cross-presentation to adoptively transferred OT-1 lymphocytes at draining lymph nodes also take place when OVA-loaded PMNs (H-2(d)) are coinjected in the footpad of mice with autologous DC (H-2(b)). In summary, our results indicate that antigens phagocytosed by short-lived PMNs can be in turn internalized and productively cross-presented by DC.	[Alfaro, Carlos; Suarez, Natalia; Onate, Carmen; Martinez-Forero, Ivan; Hervas-Stubbs, Sandra; Rodriguez, Inmaculada; Perez, Guiomar; Bolanos, Elixabet; Palazon, Asis; Fernandez de Sanmamed, Miguel; Morales-Kastresana, Aizea; Melero, Ignacio] Univ Navarra, Gene Therapy Unit, CIMA, E-31080 Pamplona, Spain; [Perez-Gracia, Jose L.; Fernandez de Sanmamed, Miguel; Melero, Ignacio] Univ Navarra, Dept Med Oncol, Clin Univ Navarra, E-31080 Pamplona, Spain; [Gonzalez, Alvaro] Univ Navarra, Dept Biochem, Clin Univ Navarra, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra	Alfaro, C (corresponding author), Univ Navarra, Gene Therapy Unit, CIMA, E-31080 Pamplona, Spain.	imelero@unav.es	González, Álvaro/T-8122-2018; Bolaños, Elixabet/I-8225-2017; López, Inmaculada R Rodríguez/J-5920-2017; Alfaro, Carlos/K-3566-2014; OÑATE, CARMEN/AAC-5696-2021; Perez, Guiomar/J-4596-2017; F Sanmamed, Miguel/I-5572-2017; Palazon, Asis/ABI-1748-2020; Perez-Gracia, Jose Luis/I-8372-2017; Oñate, Carmen/J-4262-2017; Melero, Ignacio/T-7600-2019; Hervas-Stubbs, Sandra/C-9053-2018	González, Álvaro/0000-0002-1423-273X; Bolaños, Elixabet/0000-0003-3780-9244; López, Inmaculada R Rodríguez/0000-0002-8025-462X; Alfaro, Carlos/0000-0002-4812-7153; Perez, Guiomar/0000-0002-2096-2093; F Sanmamed, Miguel/0000-0002-7295-6074; Palazon, Asis/0000-0002-7172-7229; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Oñate, Carmen/0000-0001-6877-529X; Melero, Ignacio/0000-0002-1360-348X; ONATE, CARMEN/0000-0001-6949-3462; Hervas-Stubbs, Sandra/0000-0003-3391-1516	MEC/MICINN [SAF2005-03131, SAF2008-03294]; Departamento de Educacion del Gobierno de Navarra; Departamento de Salud del Gobierno de Navarra (Beca Ortiz de Landazuri); programa "Tu eliges: tu decides" de Caja Navarra; Redes tematicas de investigacion cooperativa RETIC [RD06/0020/0065]; Fondo de investigacion sanitaria (FIS) [PI060932]; European commission; Fundacion Mutua Madrilena; UTE for project FIMA; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC); Ministerio de Educacion y Ciencia	MEC/MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departamento de Educacion del Gobierno de Navarra; Departamento de Salud del Gobierno de Navarra (Beca Ortiz de Landazuri); programa "Tu eliges: tu decides" de Caja Navarra; Redes tematicas de investigacion cooperativa RETIC; Fondo de investigacion sanitaria (FIS)(Instituto de Salud Carlos III); European commission(European CommissionEuropean Commission Joint Research Centre); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); UTE for project FIMA; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC); Ministerio de Educacion y Ciencia(Spanish Government)	Financial support was from MEC/MICINN (SAF2005-03131 and SAF2008-03294), Departamento de Educacion del Gobierno de Navarra, Departamento de Salud del Gobierno de Navarra (Beca Ortiz de Landazuri), programa "Tu eliges: tu decides" de Caja Navarra, Redes tematicas de investigacion cooperativa RETIC (RD06/0020/0065), Fondo de investigacion sanitaria (FIS PI060932), European commission 7th framework program (ENCITE) and SUDOE-IMMUNONET, Fundacion Mutua Madrilena, and "UTE for project FIMA". CA is supported by Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC). SH-S receives a contract (Ramon y Cajal) from Ministerio de Educacion y Ciencia and AP a scholarship from FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro C, 2009, BRIT J CANCER, V100, P1111, DOI 10.1038/sj.bjc.6604965; Alfaro C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017922; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carbone FR, 2010, J IMMUNOL, V185, P1353, DOI 10.4049/jimmunol.1090065; Culshaw S, 2008, IMMUNOL LETT, V118, P49, DOI 10.1016/j.imlet.2008.02.008; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Feijoo E, 2005, INT J CANCER, V116, P275, DOI 10.1002/ijc.21046; Granucci F, 2005, ADV IMMUNOL, V88, P193, DOI 10.1016/S0065-2776(05)88006-X; Hoffmann TK, 2000, CANCER RES, V60, P3542; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mazzolini G, 2005, J CLIN ONCOL, V23, P999, DOI 10.1200/JCO.2005.00.463; Mukaida N, 2000, INT J HEMATOL, V72, P391; Murillo O, 2009, EUR J IMMUNOL, V39, P2424, DOI 10.1002/eji.200838958; Rouzaut A, 2010, EUR J IMMUNOL, V40, P3054, DOI 10.1002/eji.201040523; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P511, DOI 10.1016/j.it.2009.07.002; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Tewary P, 2010, BLOOD, V116, P3465, DOI 10.1182/blood-2010-03-273953; Tirapu I, 2004, INT J CANCER, V110, P51, DOI 10.1002/ijc.20093; van Gisbergen KPJM, 2005, TRENDS IMMUNOL, V26, P626, DOI 10.1016/j.it.2005.09.007; van Gisbergen KPJM, 2005, FEBS LETT, V579, P6159, DOI 10.1016/j.febslet.2005.09.089; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004	39	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e29300	10.1371/journal.pone.0029300	http://dx.doi.org/10.1371/journal.pone.0029300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22206007	gold, Green Published			2022-12-25	WOS:000298666200021
J	Huang, CY; Gu, HM; Yu, Q; Manukyan, MC; Poynter, JA; Wang, MJ				Huang, Chunyan; Gu, Hongmei; Yu, Qing; Manukyan, Mariuxi C.; Poynter, Jeffrey A.; Wang, Meijing			Sca-1+Cardiac Stem Cells Mediate Acute Cardioprotection via Paracrine Factor SDF-1 following Myocardial Ischemia/Reperfusion	PLOS ONE			English	Article							CARDIAC PROGENITOR CELLS; ESTROGEN-RECEPTOR-ALPHA; SIGNAL TRANSDUCER; ISCHEMIC-HEART; FEMALE HEARTS; INFARCTION; ACTIVATION; PROTECTION; ADULT; VEGF	Background: Cardiac stem cells (CSCs) promote myocardial recovery following ischemia through their regenerative properties. However, little is known regarding the implication of paracrine action by CSCs in the setting of myocardial ischemia/reperfusion (I/R) injury although it is well documented that non-cardiac stem cells mediate cardioprotection via the production of paracrine protective factors. Here, we studied whether CSCs could initiate acute protection following global myocardial I/R via paracrine effect and what component from CSCs is critical to this protection. Methodology/Principal Findings: A murine model of global myocardial I/R was utilized to investigate paracrine effect of Sca-1+ CSCs on cardiac function. Intracoronary delivery of CSCs or CSC conditioned medium (CSC CM) prior to ischemia significantly improved myocardial function following I/R. siRNA targeting of VEGF in CSCs did not affect CSC-preserved myocardial function in response to I/R injury. However, differentiation of CSCs to cardiomyocytes (DCSCs) abolished this protection. Through direct comparison of the protein expression profiles of CSCs and DCSCs, SDF-1 was identified as one of the dominant paracrine factors secreted by CSCs. Blockade of the SDF-1 receptor by AMD3100 or downregulated SDF-1 expression in CSCs by specific SDF-1 siRNA dramatically impaired CSC-induced improvement in cardiac function and increased myocardial damage following I/R. Of note, CSC treatment increased myocardial STAT3 activation after I/R, whereas downregulation of SDF-1 action by blockade of the SDF-1 receptor or SDF-1 siRNA transfection abolished CSC-induced STAT3 activation. In addition, inhibition of STAT3 activation attenuated CSC-mediated cardioprotection following I/R. Finally, post-ischemic infusion of CSC CM was shown to significantly protect I/R-caused myocardial dysfunction. Conclusions/Significance: This study suggests that CSCs acutely improve post-ischemic myocardial function through paracrine factor SDF-1 and up-regulated myocardial STAT3 activation.	[Huang, Chunyan; Gu, Hongmei; Manukyan, Mariuxi C.; Poynter, Jeffrey A.; Wang, Meijing] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN USA; [Yu, Qing] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Yu, Qing] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Huang, CY (corresponding author), Indiana Univ Sch Med, Dept Surg, Indianapolis, IN USA.	meiwang@iupui.edu		Wang, Meijing/0000-0002-9360-5468	National Institutes of Health [R00 HL0876077]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partly supported by National Institutes of Health R00 HL0876077 (MW). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr B, 2005, J BIOL CHEM, V280, P6692, DOI 10.1074/jbc.M408481200; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Brar BK, 1999, J MOL CELL CARDIOL, V31, P135, DOI 10.1006/jmcc.1998.0857; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Burger M, 2005, BLOOD, V106, P1824, DOI 10.1182/blood-2004-12-4918; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Goodman MD, 2008, AM J PHYSIOL-HEART C, V295, pH1649, DOI 10.1152/ajpheart.00692.2008; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; HUANG C, 2011, AM J PHYSL IN PRESS; Huang CY, 2011, AM J PHYSIOL-HEART C, V301, pH1496, DOI 10.1152/ajpheart.00365.2011; Huang CY, 2011, SURGERY, V150, P197, DOI 10.1016/j.surg.2011.05.010; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lim SY, 2006, CARDIOVASC RES, V70, P530, DOI 10.1016/j.cardiores.2006.02.016; Llamas B, 2007, PHYSIOL GENOMICS, V31, P176, DOI 10.1152/physiolgenomics.00072.2007; Markel TA, 2008, AM J PHYSIOL-HEART C, V295, pH2308, DOI 10.1152/ajpheart.00565.2008; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Meldrum DR, 1999, SURGERY, V126, P135, DOI 10.1016/S0039-6060(99)70146-7; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Miyamoto S, 2010, STEM CELLS DEV, V19, P105, DOI 10.1089/scd.2009.0041; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; Mueller P, 2008, CARDIOVASC RES, V77, P151, DOI 10.1093/cvr/cvm037; Negoro S, 2000, CARDIOVASC RES, V47, P797, DOI 10.1016/S0008-6363(00)00138-3; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Osugi T, 2002, J BIOL CHEM, V277, P6676, DOI 10.1074/jbc.M108246200; Pfeiffer M, 2009, BRIT J CANCER, V100, P1949, DOI 10.1038/sj.bjc.6605068; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; SCHWARZE MMK, 1995, CANCER RES, V55, P2262; Stephanou A, 1999, GENE EXPRESSION, V7, P311; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; Wang MJ, 2008, CIRCULATION, V118, pS38, DOI 10.1161/CIRCULATIONAHA.107.756890; Wang MJ, 2007, J MOL CELL CARDIOL, V42, P1009, DOI 10.1016/j.yjmcc.2007.04.010; Wang MJ, 2006, CIRCULATION, V114, pI282, DOI 10.1161/CIRCULATIONAHA.105.001164; Wang MJ, 2006, AM J PHYSIOL-HEART C, V290, pH2204, DOI 10.1152/ajpheart.01219.2005; Wang MJ, 2009, P NATL ACAD SCI USA, V106, P17499, DOI 10.1073/pnas.0908924106; Wang MJ, 2009, AM J PHYSIOL-REG I, V296, pR972, DOI 10.1152/ajpregu.00045.2009; WANG Y, PLOS ONE, V5, pE4206; Wang YG, 2006, J MOL CELL CARDIOL, V40, P736, DOI 10.1016/j.yjmcc.2006.02.004	48	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29246	10.1371/journal.pone.0029246	http://dx.doi.org/10.1371/journal.pone.0029246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195033	Green Submitted, gold, Green Published			2022-12-25	WOS:000298370400044
J	Knape, K; Linder, T; Wolschann, P; Beyer, A; Stary-Weinzinger, A				Knape, Kirsten; Linder, Tobias; Wolschann, Peter; Beyer, Anton; Stary-Weinzinger, Anna			In silico Analysis of Conformational Changes Induced by Mutation of Aromatic Binding Residues: Consequences for Drug Binding in the hERG K+ Channel	PLOS ONE			English	Article							LONG QT SYNDROME; MOLECULAR-DYNAMICS SIMULATIONS; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; STRUCTURAL BASIS; BLOCK; DETERMINANTS; PROLONGATION; ACTIVATION; METHANESULFONANILIDE	Pharmacological inhibition of cardiac hERG K(+) channels is associated with increased risk of lethal arrhythmias. Many drugs reduce hERG current by directly binding to the channel, thereby blocking ion conduction. Mutation of two aromatic residues (F656 and Y652) substantially decreases the potency of numerous structurally diverse compounds. Nevertheless, some drugs are only weakly affected by mutation Y652A. In this study we utilize molecular dynamics simulations and docking studies to analyze the different effects of mutation Y652A on a selected number of hERG blockers. MD simulations reveal conformational changes in the binding site induced by mutation Y652A. Loss of pi-pi-stacking between the two aromatic residues induces a conformational change of the F656 side chain from a cavity facing to cavity lining orientation. Docking studies and MD simulations qualitatively reproduce the diverse experimentally observed modulatory effects of mutation Y652A and provide a new structural interpretation for the sensitivity differences.	[Knape, Kirsten; Wolschann, Peter; Beyer, Anton] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Linder, Tobias; Stary-Weinzinger, Anna] Univ Vienna, Dept Pharmacol & Toxicol, Vienna, Austria	University of Vienna; University of Vienna	Knape, K (corresponding author), Univ Vienna, Inst Theoret Chem, Vienna, Austria.	anna777@gmx.at	Linder, Tobias/B-7941-2014; Wolschann, Peter/AAX-3365-2020; Stary-Weinzinger, Anna/A-3629-2014	Linder, Tobias/0000-0001-7979-2220; Stary-Weinzinger, Anna/0000-0002-9202-0484	Wiener Hochschuljubilaumsstiftung [H-2246/2010]; Austrian Science Fund (FWF) [P22395, W1232]; Austrian Science Fund (FWF) [P 22395] Funding Source: researchfish	Wiener Hochschuljubilaumsstiftung; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Wiener Hochschuljubilaumsstiftung (Grant H-2246/2010) and The Austrian Science Fund (FWF; Grants P22395, W1232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPH SYST; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; *CAMBR CRYST DAT C, GOLD VERS 4 0; Case D.A., 2022, AMBER 2020; Chen J, 2002, P NATL ACAD SCI USA, V99, P12461, DOI 10.1073/pnas.192367299; Chiang CE, 2000, J AM COLL CARDIOL, V36, P1, DOI 10.1016/S0735-1097(00)00716-6; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Durdagi S, 2010, CURR MED CHEM, V17, P3514, DOI 10.2174/092986710792927886; Durdagi S, 2011, J CHEM INF MODEL, V51, P463, DOI 10.1021/ci100409y; Fermini B, 2003, NAT REV DRUG DISCOV, V2, P439, DOI 10.1038/nrd1108; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Garg V, 2011, MOL PHARMACOL, V80, P630, DOI 10.1124/mol.111.073809; Guo J, 2006, J PHARMACOL EXP THER, V317, P865, DOI 10.1124/jpet.105.098103; Haverkamp W, 2000, EUR HEART J, V21, P1216, DOI 10.1053/euhj.2000.2249; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang XQ, 2005, J AM CHEM SOC, V127, P6836, DOI 10.1021/ja042641q; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JURKIEWICZ NK, 1993, CIRC RES, V72, P75, DOI 10.1161/01.RES.72.1.75; Kamiya K, 2006, MOL PHARMACOL, V69, P1709, DOI 10.1124/mol.105.020990; Kamiya K, 2008, J PHARMACOL SCI, V108, P301, DOI 10.1254/jphs.08102FP; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Lees-Miller JP, 2009, BIOPHYS J, V96, P3600, DOI 10.1016/j.bpj.2009.01.028; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Milnes JT, 2003, BRIT J PHARMACOL, V139, P887, DOI 10.1038/sj.bjp.0705335; Mitcheson JS, 2008, CHEM RES TOXICOL, V21, P1005, DOI 10.1021/tx800035b; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Mitcheson JS, 2003, BRIT J PHARMACOL, V139, P883, DOI 10.1038/sj.bjp.0705336; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Perry M, 2004, MOL PHARMACOL, V66, P240, DOI 10.1124/mol.104.000117; Ridley JM, 2004, J MOL CELL CARDIOL, V36, P701, DOI 10.1016/j.yjmcc.2004.02.009; Sanchez-Chapula JA, 2004, N-S ARCH PHARMACOL, V370, P484, DOI 10.1007/s00210-004-0995-5; Sanchez-Chapula JA, 2003, MOL PHARMACOL, V63, P1051, DOI 10.1124/mol.63.5.1051; Sanchez-Chapula JA, 2002, J BIOL CHEM, V277, P23587, DOI 10.1074/jbc.M200448200; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; Stansfeld PJ, 2007, PROTEINS, V68, P568, DOI 10.1002/prot.21400; Stary A, 2010, CHEMMEDCHEM, V5, P455, DOI 10.1002/cmdc.200900461; Subbotina J, 2010, PROTEINS, V78, P2922, DOI 10.1002/prot.22815; Tseng GN, 2001, J MOL CELL CARDIOL, V33, P835, DOI 10.1006/jmcc.2000.1317; Tsuzuki S, 2002, J AM CHEM SOC, V124, P104, DOI 10.1021/ja0105212; Vandenberg JI, 2001, TRENDS PHARMACOL SCI, V22, P240, DOI 10.1016/S0165-6147(00)01662-X; WINDISCH A, 2011, BRIT J PHARMACOL, V62, P1542; Xing JL, 2010, EUR J PHARMACOL, V630, P1, DOI 10.1016/j.ejphar.2009.11.009; Zachariae U, 2009, J MED CHEM, V52, P4266, DOI 10.1021/jm900002x; Zhou HX, 2010, TRENDS BIOCHEM SCI, V35, P179, DOI 10.1016/j.tibs.2009.10.007	54	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28778	10.1371/journal.pone.0028778	http://dx.doi.org/10.1371/journal.pone.0028778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194911	Green Published, Green Submitted, gold			2022-12-25	WOS:000298370400020
J	Vincent, JJ; Li, ZW; Lee, SA; Liu, X; Etter, MO; Diaz-Perez, SV; Taylor, SK; Gkountela, S; Lindgren, AG; Clark, AT				Vincent, John J.; Li, Ziwei; Lee, Serena A.; Liu, Xian; Etter, Marisabel O.; Diaz-Perez, Silvia V.; Taylor, Sara K.; Gkountela, Sofia; Lindgren, Anne G.; Clark, Amander T.			Single Cell Analysis Facilitates Staging of Blimp1-Dependent Primordial Germ Cells Derived from Mouse Embryonic Stem Cells	PLOS ONE			English	Article							DROSOPHILA-VASA; IN-VITRO; EXPRESSION; SPECIFICATION; DYNAMICS; BLIMP1; DIFFERENTIATION; LOCALIZATION; HOMOLOG; PROTEIN	The cell intrinsic programming that regulates mammalian primordial germ cell (PGC) development in the pre-gonadal stage is challenging to investigate. To overcome this we created a transgene-free method for generating PGCs in vitro (iPGCs) from mouse embryonic stem cells (ESCs). Using labeling for SSEA1 and cKit, two cell surface molecules used previously to isolate presumptive iPGCs, we show that not all SSEA1+/cKit+ double positive cells exhibit a PGC identity. Instead, we determined that selecting for cKit(bright) cells within the SSEA1+ fraction significantly enriches for the putative iPGC population. Single cell analysis comparing SSEA1+/cKit(bright) iPGCs to ESCs and embryonic PGCs demonstrates that 97% of single iPGCs co-express PGC signature genes Blimp1, Stella, Dnd1, Prdm14 and Dazl at similar levels to e9.5-10.5 PGCs, whereas 90% of single mouse ESC do not co-express PGC signature genes. For the 10% of ESCs that co-express PGC signature genes, the levels are significantly lower than iPGCs. Microarray analysis shows that iPGCs are transcriptionally distinct from ESCs and repress gene ontology groups associated with mesoderm and heart development. At the level of chromatin, iPGCs contain 5-methyl cytosine bases in their DNA at imprinted and non-imprinted loci, and are enriched in histone H3 lysine 27 trimethylation, yet do not have detectable levels of Mvh protein, consistent with a Blimp1-positive pre-gonadal PGC identity. In order to determine whether iPGC formation is dependent upon Blimp1, we generated Blimp1 null ESCs and found that loss of Blimp1 significantly depletes SSEA1/cKit(bright) iPGCs. Taken together, the generation of Blimp1-positive iPGCs from ESCs constitutes a robust model for examining cell-intrinsic regulation of PGCs during the Blimp1-positive stage of development.	[Vincent, John J.; Li, Ziwei; Lee, Serena A.; Liu, Xian; Etter, Marisabel O.; Diaz-Perez, Silvia V.; Taylor, Sara K.; Gkountela, Sofia; Lindgren, Anne G.; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [Vincent, John J.; Li, Ziwei; Lee, Serena A.; Etter, Marisabel O.; Diaz-Perez, Silvia V.; Gkountela, Sofia; Lindgren, Anne G.; Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Vincent, John J.; Clark, Amander T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Clark, Amander T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Vincent, JJ (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA.	clarka@ucla.edu		Liu, Xian/0000-0001-6546-3725; Taylor, Sara/0000-0002-4086-3471	NIH [R01HD058047]; UCLA Eli; Edythe Broad Center of Regenerative Medicine and Stem Cell Research; California Institute for Regenerative Medicine [T1-0005, TG2-01169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Eli; Edythe Broad Center of Regenerative Medicine and Stem Cell Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH R01HD058047 and a research award from the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (http://stemcell.ucla.edu). Training grant support was provided to JJV and AGL by the California Institute for Regenerative Medicine Grants T1-0005 and TG2-01169 (http://www.cirm.ca.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Chu LF, 2011, CURR BIOL, V21, P1759, DOI 10.1016/j.cub.2011.09.010; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Haston KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005654; HAYASHI K, 2011, CELL, P1; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Imamura M, 2010, MOL REPROD DEV, V77, P802, DOI 10.1002/mrd.21223; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lindgren AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016478; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Maye P, 2000, MECH DEVELOP, V94, P117, DOI 10.1016/S0925-4773(00)00304-X; Mizuno K, 2006, MOL REPROD DEV, V73, P437, DOI 10.1002/mrd.20395; Morita-Fujimura Y, 2009, DEV GROWTH DIFFER, V51, P567, DOI 10.1111/j.1440-169X.2009.01119.x; Nicholas CR, 2009, GENESIS, V47, P74, DOI 10.1002/dvg.20460; Oatley MJ, 2011, BIOL REPROD, V85, P347, DOI 10.1095/biolreprod.111.091330; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Qing TT, 2007, DIFFERENTIATION, V75, P902, DOI 10.1111/j.1432-0436.2007.00181.x; SABOUR D, 2010, HUM MOL GENET; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Tanaka SS, 2000, GENE DEV, V14, P841; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Wei W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004013; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yokomizo T, 2011, BLOOD, V117, P6132, DOI 10.1182/blood-2011-02-334037; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Young JC, 2010, BIOL REPROD, V82, P390, DOI 10.1095/biolreprod.109.078493; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	46	26	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28960	10.1371/journal.pone.0028960	http://dx.doi.org/10.1371/journal.pone.0028960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194959	Green Published, gold, Green Submitted			2022-12-25	WOS:000298370400025
J	Chappell, TM; Rausher, MD				Chappell, Thomas M.; Rausher, Mark D.			Genetics of Resistance to the Rust Fungus Coleosporium ipomoeae in Three Species of Morning Glory (Ipomoea)	PLOS ONE			English	Article							RACE-SPECIFIC RESISTANCE; DISEASE RESISTANCE; PHAKOPSORA-PACHYRHIZI; LINUM-MARGINALE; MELAMPSORA-LINI; MAJOR-GENE; EVOLUTION; HOST; COEVOLUTION; PATHOGENS	We examined the genetic basis of resistance to the rust pathogen Coleosporium ipomoea in three host species: Ipomoea purpurea, I. hederacea, and I. coccinea (Convolvulaceae). In crosses between resistant and susceptible individuals, second-generation selfed offspring segregated in ratios that did not differ statistically from the 3:1 ratio indicative of single-gene resistance with the resistant allele dominant. One out of three crosses between resistant individuals from two different populations revealed that resistance loci differed in the two populations, as evidenced by the production of susceptible individuals among the S(2) generation. These results suggest that gene-for-gene interactions contribute substantially to the dynamics of coevolution in this natural pathosystem. They also suggest that evolution of resistance to the same pathogen strain may involve different loci in different Ipomoea populations.	[Chappell, Thomas M.; Rausher, Mark D.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Chappell, TM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	thomas.chappell@duke.edu			NSF DDIG [0909946]	NSF DDIG(National Science Foundation (NSF))	This study was supported by an NSF DDIG, award number 0909946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRIOS GN, 1997, PLANT PATHOLOGY; Bergelson J, 2001, ANNU REV GENET, V35, P469, DOI 10.1146/annurev.genet.35.102401.090954; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Burdon JJ, 2009, SCIENCE, V324, P755, DOI 10.1126/science.1171663; BURDON JJ, 1987, OECOLOGIA, V73, P257, DOI 10.1007/BF00377516; BURDON JJ, 1994, EVOLUTION, V48, P1564, DOI 10.1111/j.1558-5646.1994.tb02196.x; CHAPPELL TM, 2010, THESIS DUKE U DURHAM; DEWIT PJGM, 1992, ANNU REV PHYTOPATHOL, V30, P391, DOI 10.1146/annurev.py.30.090192.002135; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; HARRY IB, 1987, NEW PHYTOL, V107, P715, DOI 10.1111/j.1469-8137.1987.tb00909.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; JAROSZ AM, 1990, HEREDITY, V64, P347, DOI 10.1038/hdy.1990.43; Kaloshian I, 2004, J CHEM ECOL, V30, P2419, DOI 10.1007/s10886-004-7943-1; Kaltz O, 2002, J EVOLUTION BIOL, V15, P850, DOI 10.1046/j.1420-9101.2002.00433.x; KEEN NT, 1990, ANNU REV GENET, V24, P447, DOI 10.1146/annurev.ge.24.120190.002311; Kniskern JM, 2006, ECOLOGY, V87, P675, DOI 10.1890/05-1327; Kniskern JM, 2006, NEW PHYTOL, V171, P137, DOI 10.1111/j.1469-8137.2006.01729.x; LITTLEFIELD LJ, 1981, BIOL PLANT RUSTS; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; PARKER MA, 1994, EVOL ECOL, V8, P560, DOI 10.1007/BF01238258; PARKER MA, 1988, HEREDITY, V60, P27, DOI 10.1038/hdy.1988.5; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; Song WY, 1997, PLANT CELL, V9, P1279, DOI 10.1105/tpc.9.8.1279; Takken FLW, 2000, EUR J PLANT PATHOL, V106, P699, DOI 10.1023/A:1026571130477; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; Thrall PH, 2002, PLANT PATHOL, V51, P169, DOI 10.1046/j.1365-3059.2002.00683.x; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Thrall PH, 2002, EVOLUTION, V56, P1340	30	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28875	10.1371/journal.pone.0028875	http://dx.doi.org/10.1371/journal.pone.0028875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194936	gold, Green Published			2022-12-25	WOS:000298369100115
J	Lin, CH; Chen, YC; Pan, TM				Lin, Chih-Hui; Chen, Yu-Chieh; Pan, Tzu-Ming			Quantification Bias Caused by Plasmid DNA Conformation in Quantitative Real-Time PCR Assay	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; GENETICALLY-MODIFIED ORGANISMS; GENE; METHYLATION; TECHNOLOGY; EVENT	Quantitative real-time PCR (qPCR) is the gold standard for the quantification of specific nucleic acid sequences. However, a serious concern has been revealed in a recent report: supercoiled plasmid standards cause significant over-estimation in qPCR quantification. In this study, we investigated the effect of plasmid DNA conformation on the quantification of DNA and the efficiency of qPCR. Our results suggest that plasmid DNA conformation has significant impact on the accuracy of absolute quantification by qPCR. DNA standard curves shifted significantly among plasmid standards with different DNA conformations. Moreover, the choice of DNA measurement method and plasmid DNA conformation may also contribute to the measurement error of DNA standard curves. Due to the multiple effects of plasmid DNA conformation on the accuracy of qPCR, efforts should be made to assure the highest consistency of plasmid standards for qPCR. Thus, we suggest that the conformation, preparation, quantification, purification, handling, and storage of standard plasmid DNA should be described and defined in the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) to assure the reproducibility and accuracy of qPCR absolute quantification.	[Lin, Chih-Hui; Chen, Yu-Chieh; Pan, Tzu-Ming] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 10764, Taiwan	National Taiwan University	Lin, CH (corresponding author), Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	tmpan@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	PAN, TZU-MING/0000-0002-9865-1893; Lin, Chih-Hui/0000-0002-6456-2649				Ahmed FE, 2002, TRENDS BIOTECHNOL, V20, P215, DOI 10.1016/S0167-7799(01)01920-5; ANDRUS A, 2001, CURR PROTOC NUCL ACI, V10, pCH10; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Demeke T, 2010, ANAL BIOANAL CHEM, V396, P1977, DOI 10.1007/s00216-009-3150-9; Gallagher S.R., 2006, CURR PROTOC MOL BIOL; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Holst-Jensen A, 2003, ANAL BIOANAL CHEM, V375, P985, DOI 10.1007/s00216-003-1767-7; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Johnston JW, 2005, PLANT PHYSIOL BIOCH, V43, P844, DOI 10.1016/j.plaphy.2005.07.015; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Magana AA, 2008, ANAL BIOCHEM, V374, P378, DOI 10.1016/j.ab.2007.11.026; Maniatis T., 1982, MOL CLONING LAB MANU; MATASSI G, 1992, GENE, V122, P239, DOI 10.1016/0378-1119(92)90211-7; Nogva HK, 2004, BIOTECHNIQUES, V37, P246, DOI 10.2144/04372RR01; Shimelis O, 2006, J CHROMATOGR A, V1117, P132, DOI 10.1016/j.chroma.2006.03.071; Weighardt F, 2004, J AOAC INT, V87, P1342; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yang LT, 2007, J AGR FOOD CHEM, V55, P15, DOI 10.1021/jf0615754	19	51	53	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29101	10.1371/journal.pone.0029101	http://dx.doi.org/10.1371/journal.pone.0029101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194997	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100154
J	Ogiwara, H; Kohno, T				Ogiwara, Hideaki; Kohno, Takashi			Essential Factors for Incompatible DNA End Joining at Chromosomal DNA Double Strand Breaks In Vivo	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; V(D)J RECOMBINATION; DAMAGE RESPONSE; HISTONE ACETYLATION; MAMMALIAN-CELLS; LIGASE IV; POL-MU; REPAIR; MECHANISM; REARRANGEMENTS	Non-homologous end joining (NHEJ) is a major pathway for the repair of DNA double strand break (DSBs) with incompatible DNA ends, which are often generated by ionizing irradiation. In vitro reconstitution studies have indicated that NHEJ of incompatible DNA ends requires not only the core steps of synapsis and ligation, employing KU80/DNA-PKcs and LIG4, but also additional DNA end processing steps, such as DNA end resection by Artemis and gap-filling by POL lambda and POL mu. It seems that DNA end processing steps are important for joining of incompatible DNA ends rather than compatible ends. Despite the fact that DNA end processing is important for incompatible DNA end joining in vitro, the role of DNA processing in NHEJ of incompatible DSBs in vivo has not yet been demonstrated. Here we investigated the in vivo roles of proteins implicated in each step of NHEJ using an assay in which NHEJ of incompatible DNA ends on chromosomal DNA can be assessed in living human cells. siRNA-or inhibitor-mediated impairment of factors in each NHEJ step resulted in a reduction in joining efficiency. Strikingly, stronger effects were observed when DNA end resection and ligation protein functions were impaired. Disruption of synapsis by KU80 and DNA-PKcs impairment, or the disruption of gap filling by POLl and POLm depletion, resulted in higher levels of microhomology-mediated joining. The present study indicates that DNA end resection and ligation factors are critical for the efficient joining of incompatible ends in vivo, further emphasizing the importance of synapsis and gap-filling factors in preventing illegitimate joining.	[Ogiwara, Hideaki; Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan	National Cancer Center - Japan	Ogiwara, H (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan.	tkkohno@ncc.go.jp		Ogiwara, Hideaki/0000-0003-0860-1807	Ministry of Education, Culture, Sports, Science and Technology of Japan [22131006]; Japan Society for the Promotion of Science for Young Scientists [23701110]; National Cancer Center	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan for Scientific Research on Innovative Areas (22131006) and from the Japan Society for the Promotion of Science for Young Scientists (B) KAKENHI (23701110); and the National Cancer Center Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Covo S, 2004, J BIOL CHEM, V279, P859, DOI 10.1074/jbc.M310447200; Daley JM, 2005, J BIOL CHEM, V280, P29030, DOI 10.1074/jbc.M505277200; Davis BJ, 2008, NUCLEIC ACIDS RES, V36, P3085, DOI 10.1093/nar/gkn164; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Katsura Y, 2007, DNA REPAIR, V6, P639, DOI 10.1016/j.dnarep.2006.12.002; Kohno T, 2006, DNA REPAIR, V5, P1273, DOI 10.1016/j.dnarep.2006.05.021; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Smith J, 2003, NUCLEIC ACIDS RES, V31, P2157, DOI 10.1093/nar/gkg317; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Vandersickel V, 2010, INT J RADIAT BIOL, V86, P114, DOI 10.3109/09553000903419940; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; Veuger SJ, 2003, CANCER RES, V63, P6008; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003	35	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28756	10.1371/journal.pone.0028756	http://dx.doi.org/10.1371/journal.pone.0028756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194904	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100092
J	Pincheira-Donoso, D				Pincheira-Donoso, Daniel			Predictable Variation of Range-Sizes across an Extreme Environmental Gradient in a Lizard Adaptive Radiation: Evolutionary and Ecological Inferences	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; CLIMATE-CHANGE; BODY-SIZE; SPECIES RICHNESS; PHYLOGENETIC INERTIA; GEOGRAPHIC-VARIATION; LIOLAEMUS LIZARDS; BOULENGERI CLADE; GENUS LIOLAEMUS; RAPOPORTS RULE	Large-scale patterns of current species geographic range-size variation reflect historical dynamics of dispersal and provide insights into future consequences under changing environments. Evidence suggests that climate warming exerts major damage on high latitude and elevation organisms, where changes are more severe and available space to disperse tracking historical niches is more limited. Species with longer generations (slower adaptive responses), such as vertebrates, and with restricted distributions (lower genetic diversity, higher inbreeding) in these environments are expected to be particularly threatened by warming crises. However, a well-known macroecological generalization (Rapoport's rule) predicts that species range-sizes increase with increasing latitude-elevation, thus counterbalancing the impact of climate change. Here, I investigate geographic range-size variation across an extreme environmental gradient and as a function of body size, in the prominent Liolaemus lizard adaptive radiation. Conventional and phylogenetic analyses revealed that latitudinal (but not elevational) ranges significantly decrease with increasing latitude-elevation, while body size was unrelated to range-size. Evolutionarily, these results are insightful as they suggest a link between spatial environmental gradients and range-size evolution. However, ecologically, these results suggest that Liolaemus might be increasingly threatened if, as predicted by theory, ranges retract and contract continuously under persisting climate warming, potentially increasing extinction risks at high latitudes and elevations.	Univ Exeter, Ctr Ecol & Conservat, Coll Life & Environm Sci, Exeter, Devon, England	University of Exeter	Pincheira-Donoso, D (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Coll Life & Environm Sci, Streatham Campus, Exeter, Devon, England.	D.PincheiraDonoso@exeter.ac.uk		Pincheira-Donoso, Daniel/0000-0002-0050-6410	Leverhulme Trust; CRIDESAT (University of Atacama)	Leverhulme Trust(Leverhulme Trust); CRIDESAT (University of Atacama)	The author is indebted to the Leverhulme Trust for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I thank Jan Stipala and anonymous referees for thoughtful critical comments on earlier versions of this manuscript. I am also indebted to J.M. Cei (JMC-DC), M. Contreras, E. Solar and J. Artigas (MZUC), R. Gemel and H. Grillitsch (NHMV), N. Ibarguengoytia (UNComahue), I. Ineich (MNHNP), C. McCarthy (NHML), J. Navarro (DBGUCH), H. Nunez (MNHN), M. Oliver-Roedel (ZMB), E. Pereyra (IBAUNC), J. Scolaro (CENPAT, JAS-DC), F. Videla (IADIZA), for providing unrestricted access to Liolaemus specimens, and to J.M. Cei for unpublished data on some species. Finally, I thank CRIDESAT (University of Atacama) for an honorary fellowship.	Abdala CS, 2007, ZOOTAXA, P1; Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Bauwens D, 1996, ECOLOGY, V77, P1818, DOI 10.2307/2265786; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Brown JH, 2006, P NATL ACAD SCI USA, V103, P17595, DOI 10.1073/pnas.0608522103; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; Brown RP, 1999, ECOGRAPHY, V22, P277, DOI 10.1111/j.1600-0587.1999.tb00503.x; Carothers JH, 2001, REV CHIL HIST NAT, V74, P313; Cei J.M., 1986, REPTILES CTR CTR OES; Cei JM, 1993, REPTILES NOROESTE NO; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Cruz FB, 2005, J EVOLUTION BIOL, V18, P1559, DOI 10.1111/j.1420-9101.2005.00936.x; del Barrio G, 2006, ENVIRON SCI POLICY, V9, P129, DOI 10.1016/j.envsci.2005.11.005; Gomez JMD, 2009, ZOOL SCR, V38, P1, DOI 10.1111/j.1463-6409.2008.00357.x; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; Etienne RS, 2004, AM NAT, V163, P69, DOI 10.1086/380582; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FUENTES ER, 1979, ARCH BIOL MED EXP, V12, P179; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Gaston KJ, 1998, TRENDS ECOL EVOL, V13, P70, DOI 10.1016/S0169-5347(97)01236-6; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gomez Molina E., 1981, Mountain Research and Development, V1, P115, DOI 10.2307/3673119; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hewitt Godfrey M., 2005, P176; Hoglund J, 2009, EVOLUTIONARY CONSERVATION GENETICS, P1; Huey RB, 2010, SCIENCE, V328, P832, DOI 10.1126/science.1190374; Hughes Kimberly A., 2004, P119, DOI 10.1017/CBO9780511542022.010; Ibarguengoytia NR, 2010, J THERM BIOL, V35, P21, DOI 10.1016/j.jtherbio.2009.10.003; IPCC, 2007, CONTRIBUTION WORKING; JAKSIC F. M., 1998, ECOLOGIA VERTEBRADOS; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Korner C, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P3; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Labra A, 2009, AM NAT, V174, P204, DOI 10.1086/600088; Lee MSY, 1998, EVOLUTION, V52, P1441, DOI 10.1111/j.1558-5646.1998.tb02025.x; Losos JB, 2003, LIZARD SOCIAL BEHAVIOR, P356; Lutgens F. K., 1998, ATMOSPHERE INTRO MET; Martins E. P., 2004, COMPARE VERSION 4 6B; MARTINS EP, 1991, EVOLUTION, V45, P534, DOI [10.2307/2409910, 10.1111/j.1558-5646.1991.tb04328.x]; Massot M, 2008, GLOBAL CHANGE BIOL, V14, P461, DOI 10.1111/j.1365-2486.2007.01514.x; Meiri S, 2010, J ZOOL, V281, P218, DOI 10.1111/j.1469-7998.2010.00696.x; Meiri S, 2008, GLOBAL ECOL BIOGEOGR, V17, P724, DOI 10.1111/j.1466-8238.2008.00414.x; Miles DB, 2000, EVOLUTION, V54, P1386; Nagy L, 2009, BIOL ALPINE HABITATS; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan Camille, 2005, P41; Pincheira-Donoso D, 2007, J EVOLUTION BIOL, V20, P2067, DOI 10.1111/j.1420-9101.2007.01394.x; Pincheira-Donoso D, 2011, HERPETOL J, V21, P35; Pincheira-Donoso D, 2008, EVOL ECOL RES, V10, P11; Pincheira-Donoso D, 2007, ZOOTAXA, P25; Pincheira-Donoso D, 2008, ZOOTAXA, P1; Pincheira-Donoso D, 2011, EVOL BIOL, V38, P197, DOI 10.1007/s11692-011-9118-7; Pincheira-Donoso D, 2009, ECOL RES, V24, P1223, DOI 10.1007/s11284-009-0607-4; Pincheira-Donoso D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-68; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pough FH, 2004, HERPETOLOGY; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rapoport E. H., 1982, AREOGRAPHY GEOGRAPHI, P269; Reed RN, 2003, ECOGRAPHY, V26, P107, DOI 10.1034/j.1600-0587.2003.03388.x; ROHDE K, 1993, AM NAT, V142, P1, DOI 10.1086/285526; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Schulte JA, 2000, BIOL J LINN SOC, V69, P75, DOI 10.1006/bijl.1999.0346; Scolaro J.A., 2006, REPTILES PATAGONICOS; SCOLARO JA, 2005, REPTILES PATAGONICOS; Scolaro JA, 2010, ZOOTAXA, P17; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; SQUEO FA, 1993, MT RES DEV, V13, P203, DOI 10.2307/3673638; STEVEN AJ, 1983, COLEOPTERISTS B, V37, P232; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thomas Chris D., 2005, P75; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Zani PA, 2005, ECOLOGY, V86, P1206, DOI 10.1890/04-1248; Zar J.H., 2009, BIOSTATISTICAL ANAL	89	17	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28942	10.1371/journal.pone.0028942	http://dx.doi.org/10.1371/journal.pone.0028942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194953	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100129
J	Wang, J; Richards, DA				Wang, Jie; Richards, David A.			Spatial Regulation of Exocytic Site and Vesicle Mobilization by the Actin Cytoskeleton	PLOS ONE			English	Article							CORTICAL F-ACTIN; KISS-AND-RUN; MYOSIN-II; NEUROPEPTIDE RELEASE; CHROMAFFIN CELLS; POLYMERIZATION; PATHWAYS; GRANULES; DYNAMICS; FUSION	Numerous studies indicate a role for the actin cytoskeleton in secretion. Here, we have used evanescent wave and widefield fluorescence microscopy to study the involvement of the actin cytoskeleton in secretion from PC12 cells. Secretion was assayed as loss of ANF-EmGFP in widefield mode. Under control conditions, depolarization induced secretion showed two phases: an initial rapid rate of loss of vesicular cargo (tau = 1.4 s), followed by a slower, sustained drop in fluorescence (tau = 34.1 s). Pretreatment with Latrunculin A changed the kinetics to a single exponential, slightly faster than the fast component of control cells (1.2 s). Evanescent wave microscopy allowed us to examine this at the level of individual events, and revealed equivalent changes in the rates of vesicular arrival at the plasma membrane immediately following and during the sustained phase of release. Co-transfection of mCherry labeled beta-actin and ANF-EmGFP demonstrated that sites of exocytosis had an inverse relationship with sites of actin enrichment. Disruption of visualized actin at the membrane resulted in the loss of specificity of exocytic site.	[Wang, Jie; Richards, David A.] Cincinnati Childrens Hosp Med Ctr, Dept Anesthesia, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center	Wang, J (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Anesthesia, Cincinnati, OH USA.	david.richards@cchmc.org		Richards, David/0000-0001-6154-7112	National Institutes of Health [NS054750]; Department of Anesthesia at CCHMC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anesthesia at CCHMC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health R01 grant NS054750 (to DAR) and the Department of Anesthesia at CCHMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; DANCKER P, 1975, BIOCHIM BIOPHYS ACTA, V400, P407, DOI 10.1016/0005-2795(75)90196-8; Doreian BW, 2008, J NEUROSCI, V28, P4470, DOI 10.1523/JNEUROSCI.0008-08.2008; Doreian BW, 2009, MOL BIOL CELL, V20, P3142, DOI 10.1091/mbc.E09-03-0197; Felmy F, 2007, TRAFFIC, V8, P983, DOI 10.1111/j.1600-0854.2007.00583.x; Felmy F, 2009, PFLUG ARCH EUR J PHY, V458, P403, DOI 10.1007/s00424-008-0623-1; Gaffield MA, 2007, J NEUROSCI, V27, P13691, DOI 10.1523/JNEUROSCI.3910-07.2007; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Michael DJ, 2004, BIOPHYS J, V87, pL3, DOI 10.1529/biophysj.104.052175; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; NAKATA T, 1992, J NEUROSCI, V12, P2186; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Neco P, 2008, J BIOL CHEM, V283, P10949, DOI 10.1074/jbc.M709058200; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Ng YK, 2002, J PHYSIOL-LONDON, V542, P395, DOI 10.1113/jphysiol.2002.021733; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Richards DA, 2004, J PHYSIOL-LONDON, V557, P77, DOI 10.1113/jphysiol.2004.062158; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Trifaro JM, 2000, BIOCHIMIE, V82, P339, DOI 10.1016/S0300-9084(00)00193-0; Trifaro JM, 2002, NEUROCHEM RES, V27, P1371, DOI 10.1023/A:1021627800918; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e29162	10.1371/journal.pone.0029162	http://dx.doi.org/10.1371/journal.pone.0029162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22195014	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100165
J	Wurch, LL; Bertrand, EM; Saito, MA; Van Mooy, BAS; Dyhrman, ST				Wurch, Louie L.; Bertrand, Erin M.; Saito, Mak A.; Van Mooy, Benjamin A. S.; Dyhrman, Sonya T.			Proteome Changes Driven by Phosphorus Deficiency and Recovery in the Brown Tide-Forming Alga Aureococcus anophagefferens	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; ORGANIC NITROGEN; SIGNAL PEPTIDES; GENE-EXPRESSION; PHYTOPLANKTON; DIATOM; GROWTH; IDENTIFICATION; LIMITATION; PCR	Shotgun mass spectrometry was used to detect proteins in the harmful alga, Aureococcus anophagefferens, and monitor their relative abundance across nutrient replete (control), phosphate-deficient (-P) and -P refed with phosphate (P-refed) conditions. Spectral counting techniques identified differentially abundant proteins and demonstrated that under phosphate deficiency, A. anophagefferens increases proteins involved in both inorganic and organic phosphorus (P) scavenging, including a phosphate transporter, 5'-nucleotidase, and alkaline phosphatase. Additionally, an increase in abundance of a sulfolipid biosynthesis protein was detected in -P and P-refed conditions. Analysis of the polar membrane lipids showed that cellular concentrations of the sulfolipid sulphoquinovosyldiacylglycerol (SQDG) were nearly two-fold greater in the -P condition versus the control condition, while cellular phospholipids were approximately 8-fold less. Transcript and protein abundances were more tightly coupled for gene products involved in P metabolism compared to those involved in a range of other metabolic functions. Comparison of protein abundances between the -P and P-refed conditions identified differences in the timing of protein degradation and turnover. This suggests that culture studies examining nutrient starvation responses will be valuable in interpreting protein abundance patterns for cellular nutritional status and history in metaproteomic datasets.	[Wurch, Louie L.; Dyhrman, Sonya T.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Bertrand, Erin M.; Saito, Mak A.; Van Mooy, Benjamin A. S.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	Wurch, LL (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	sdyhrman@whoi.edu	Saito, Mak/ADT-4986-2022		National Oceanic and Atmospheric Administration [NA09NOS4780206]; National Science Foundation [OCE-0723667, 2007037200]; U.S. Environmental Protection Agency [R-83041501-0]; Woods Hole Coastal Ocean Institute; Environmental Protection Agency [FP916901, F6E20324]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); Woods Hole Coastal Ocean Institute; Environmental Protection Agency(United States Environmental Protection Agency)	Research for this work was supported by a National Oceanic and Atmospheric Administration ECOHAB grant (#NA09NOS4780206) and National Science Foundation grant (#OCE-0723667) and a STAR Research Assistance Agreement No. R-83041501-0 awarded by the U.S. Environmental Protection Agency. Further support came from the Woods Hole Coastal Ocean Institute. LLW was supported by a Environmental Protection Agency STAR Fellowship (#FP916901). EMB was supported by a National Science Foundation (NSF) Graduate Research Fellowship (#2007037200) and an Environmental Protection Agency STAR Fellowship (#F6E20324). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; AMMERMAN JW, 1985, SCIENCE, V227, P1338, DOI 10.1126/science.227.4692.1338; Ballihaut G, 2007, ANAL BIOANAL CHEM, V388, P585, DOI 10.1007/s00216-007-1257-4; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berg GM, 1997, MAR BIOL, V129, P377, DOI 10.1007/s002270050178; Berg GM, 2008, J PHYCOL, V44, P1235, DOI 10.1111/j.1529-8817.2008.00571.x; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chung CC, 2003, APPL ENVIRON MICROB, V69, P754, DOI 10.1128/AEM.69.2.754-759.2003; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dennison W. C., 1989, NOVEL PHYTOPLANKTON, V35, P675; Dyhrman ST, 2008, HARMFUL ALGAE, V8, P167, DOI 10.1016/j.hal.2008.08.016; Dyhrman ST, 2006, APPL ENVIRON MICROB, V72, P252, DOI 10.1128/AEM.72.1.252-260.2006; Dyhrman ST, 2003, J PLANKTON RES, V25, P1215, DOI 10.1093/plankt/fbg086; Dyhrman ST, 1999, APPL ENVIRON MICROB, V65, P3205; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Fan C, 2003, MAR BIOL, V142, P949, DOI 10.1007/s00227-003-1017-8; FLYNN KJ, 1986, J GEN MICROBIOL, V132, P289; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Gobler CJ, 2005, ESTUARIES, V28, P726, DOI 10.1007/BF02732911; Gobler CJ, 2004, AQUAT MICROB ECOL, V35, P31, DOI 10.3354/ame035031; Gobler CJ, 2002, LIMNOL OCEANOGR, V47, P129, DOI 10.4319/lo.2002.47.1.0129; Gobler CJ, 2001, MAR ECOL PROG SER, V209, P19, DOI 10.3354/meps209019; Greenfield DI, 2004, MAR ECOL PROG SER, V274, P171, DOI 10.3354/meps274171; Greenfield DI, 2002, MAR BIOL, V141, P1045, DOI 10.1007/s00227-002-0890-x; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; HARE JF, 1991, P NATL ACAD SCI USA, V88, P5902, DOI 10.1073/pnas.88.13.5902; Jones BM, 2011, MAR BIOTECHNOL, V13, P496, DOI 10.1007/s10126-010-9320-0; Kall L, 2008, BIOINFORMATICS, V24, pI42, DOI 10.1093/bioinformatics/btn294; Kamennaya NA, 2011, APPL ENVIRON MICROB, V77, P291, DOI 10.1128/AEM.01272-10; Kamennaya NA, 2008, LIMNOL OCEANOGR, V53, P2485, DOI 10.4319/lo.2008.53.6.2485; Kana TM, 2004, HARMFUL ALGAE, V3, P377, DOI 10.1016/j.hal.2004.06.008; KATO M, 2006, ADV RES PLANT LIPIDS, P19; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KELLER AA, 1989, J PHYCOL, V25, P636, DOI 10.1111/j.0022-3646.1989.00636.x; Kim HY, 2006, BIOCHEMISTRY-US, V45, P13697, DOI 10.1021/bi0611614; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Laroche J, 1997, GLOB CHANGE BIOL, V3, P397, DOI 10.1046/j.1365-2486.1997.00117.x; Le Bihan T, 2011, J PROTEOMICS, V74, P2060, DOI 10.1016/j.jprot.2011.05.028; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XN, 2005, MOL CELL PROTEOMICS, V4, P1948, DOI 10.1074/mcp.M500138-MCP200; Ma S, 2003, J AM SOC MASS SPECTR, V14, P593, DOI 10.1016/S1044-0305(03)00141-7; MALAMY M, 1961, BIOCHEM BIOPH RES CO, V5, P104, DOI 10.1016/0006-291X(61)90020-1; Martin P, 2011, ISME J, V5, P1057, DOI 10.1038/ismej.2010.192; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Mulholland MR, 2002, LIMNOL OCEANOGR, V47, P1094, DOI 10.4319/lo.2002.47.4.1094; NAGANO M, 1994, Z NATURFORSCH C, V49, P742; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nunn BL, 2009, AQUAT MICROB ECOL, V55, P241, DOI 10.3354/ame01284; Palenik B, 1997, LIMNOL OCEANOGR, V42, P1544, DOI 10.4319/lo.1997.42.7.1544; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; PAXTON WC, 1996, ANNU REV PLANT PHYS, V47, P185; PEARSE BMF, 1975, J MOL BIOL, V97, P93, DOI 10.1016/S0022-2836(75)80024-6; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Popendorf KJ, 2011, ORG GEOCHEM, V42, P803, DOI 10.1016/j.orggeochem.2011.05.003; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Sunda WG, 2006, J PHYCOL, V42, P963, DOI 10.1111/j.1529-8817.2006.00261.x; THEODOROU ME, 1991, PLANT PHYSIOL, V95, P1089, DOI 10.1104/pp.95.4.1089; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843; Wurch LL, 2011, ENVIRON MICROBIOL, V13, P468, DOI 10.1111/j.1462-2920.2010.02351.x; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	51	53	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28949	10.1371/journal.pone.0028949	http://dx.doi.org/10.1371/journal.pone.0028949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194955	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100131
J	Yu, YM; Zitzner, JR; Houlihan, J; Herrera, N; Xu, LT; Miller, J; Mathew, JM; Tambur, AR; Luo, XR				Yu, Yuming; Zitzner, Jennifer R.; Houlihan, Josetta; Herrera, Nancy; Xu, Luting; Miller, Joshua; Mathew, James M.; Tambur, Anat R.; Luo, Xunrong			Common Gamma Chain Cytokines Promote Rapid In Vitro Expansion of Allo-Specific Human CD8(+) Suppressor T Cells	PLOS ONE			English	Article							DENDRITIC CELLS; REGULATORY CELLS; RHEUMATOID-ARTHRITIS; ALLOGRAFT-REJECTION; UP-REGULATION; IFN-GAMMA; GENERATION; CTLA-4; LYMPHOCYTES; ACTIVATION	Human CD8(+) regulatory T cells, particularly the CD8(+)CD28(-) T suppressor cells, have emerged as an important modulator of alloimmunity. Understanding the conditions under which these cells are induced and/or expanded would greatly facilitate their application in future clinical trials. In the current study, we develop a novel strategy that combines common gamma chain (gamma C) cytokines IL-2, IL-7 and IL-15 and donor antigen presenting cells (APCs) to stimulate full HLA-mismatched allogeneic human CD8(+) T cells which results in significant expansions of donor-specific CD8(+)CD28(-) T suppressor cells in vitro. The expanded CD8(+)CD28(-) T cells exhibit increased expressions of CTLA-4, FoxP3, and CD25, while down-regulate expressions of CD56, CD57, CD127, and perforin. Furthermore, these cells suppress proliferation of CD4(+) T cells in a contact-dependent and cytokine-independent manner. Interestingly, the specificity of suppression is restricted by the donor HLA class I antigens but promiscuous to HLA class II antigens, providing a potential mechanism for linked suppression. Taken together, our results demonstrate a novel role for common cc cytokines in combination with donor APCs in the expansion of donor-specific CD8(+)CD28(-) T suppressor cells, and represent a robust strategy for in vitro generation of such cells for adoptive cellular immunotherapy in transplantation.	[Yu, Yuming; Zitzner, Jennifer R.; Houlihan, Josetta; Herrera, Nancy; Xu, Luting; Miller, Joshua; Mathew, James M.; Tambur, Anat R.; Luo, Xunrong] Northwestern Univ, Feinberg Sch Med, Comprehens Transplant Ctr, Chicago, IL 60611 USA; [Yu, Yuming] So Med Univ, Nanfang Hosp, Dept Organ Transplantat, Guangzhou, Guangdong, Peoples R China; [Luo, Xunrong] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Southern Medical University - China; Northwestern University; Feinberg School of Medicine	Yu, YM (corresponding author), Northwestern Univ, Feinberg Sch Med, Comprehens Transplant Ctr, Chicago, IL 60611 USA.	xunrongluo@northwestern.edu		Mathew, James/0000-0002-5667-750X	National Institutes of Health [T32 DK077662, K08 DK070029, DP2 DK083099]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK077662, K08DK070029, DP2DK083099, R01DK025243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health Training Grant T32 DK077662 (JH), NIH K08 DK070029 (XL) and NIH Directors New Innovator Award DP2 DK083099 (XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Bedke T, 2010, J IMMUNOL, V184, P5562, DOI 10.4049/jimmunol.0902458; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Borthwick NJ, 2000, INT IMMUNOL, V12, P1005, DOI 10.1093/intimm/12.7.1005; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chiu WK, 2006, J IMMUNOL, V177, P7802, DOI 10.4049/jimmunol.177.11.7802; Cobbold SP, 2010, IMMUNOL REV, V236, P203, DOI 10.1111/j.1600-065X.2010.00913.x; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; DAMLE NK, 1989, CLIN IMMUNOL IMMUNOP, V53, pS17, DOI 10.1016/0090-1229(89)90066-4; Davila E, 2005, J IMMUNOL, V174, P7292, DOI 10.4049/jimmunol.174.11.7292; Dijke IE, 2009, AM J TRANSPLANT, V9, P397, DOI 10.1111/j.1600-6143.2008.02498.x; Fife BT, 2006, J CLIN INVEST, V116, P2252, DOI 10.1172/JCI27856; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Godlove J, 2007, EXP GERONTOL, V42, P412, DOI 10.1016/j.exger.2006.11.015; Guillonneau C, 2007, J CLIN INVEST, V117, P1096, DOI 10.1172/JCI28801; Hahn BH, 2005, J IMMUNOL, V175, P7728, DOI 10.4049/jimmunol.175.11.7728; He H, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-53; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; HIPPEN KL, 2011, AM J TRANSPLANT; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Kapp JA, 2006, INT IMMUNOL, V18, P1549, DOI 10.1093/intimm/dxl088; KOIDE J, 1990, J IMMUNOL, V144, P32; Konya C, 2009, EXPERT OPIN BIOL TH, V9, P951, DOI 10.1517/14712590903020759; Li XL, 2010, J IMMUNOL, V185, P823, DOI 10.4049/jimmunol.1000120; Liu Z, 1998, INT IMMUNOL, V10, P775, DOI 10.1093/intimm/10.6.775; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; Martin AJ, 2010, J IMMUNOL, V185, P3326, DOI 10.4049/jimmunol.1000802; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Myers L, 2005, J IMMUNOL, V174, P7625, DOI 10.4049/jimmunol.174.12.7625; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rifa'i M, 2004, J EXP MED, V200, P1123, DOI 10.1084/jem.20040395; Saito M, 2011, J EXP MED, V208, P235, DOI 10.1084/jem.20100799; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shi Z, 2009, EUR J IMMUNOL, V39, P2106, DOI 10.1002/eji.200939314; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Trzonkowski P, 2009, CLIN IMMUNOL, V133, P22, DOI 10.1016/j.clim.2009.06.001; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Tsang JYS, 2009, TRANSPL IMMUNOL, V21, P203, DOI 10.1016/j.trim.2009.05.003; Uss E, 2006, J IMMUNOL, V177, P2775, DOI 10.4049/jimmunol.177.5.2775; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zhang L, 2009, J IMMUNOL, V183, P6346, DOI 10.4049/jimmunol.0901773; Zheng J, 2009, J IMMUNOL, V183, P3742, DOI 10.4049/jimmunol.0901329	49	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28948	10.1371/journal.pone.0028948	http://dx.doi.org/10.1371/journal.pone.0028948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194954	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100130
J	Plumb, DA; Ferrara, L; Torbica, T; Knowles, L; Mironov, A; Kadler, KE; Briggs, MD; Boot-Handford, RP				Plumb, Darren A.; Ferrara, Laila; Torbica, Tanja; Knowles, Lynnette; Mironov, Aleksandr, Jr.; Kadler, Karl E.; Briggs, Michael D.; Boot-Handford, Raymond P.			Collagen XXVII Organises the Pericellular Matrix in the Growth Plate	PLOS ONE			English	Article							VERTEBRATE FIBRILLAR COLLAGEN; MURINE MODEL; EXPRESSION; GENE; CARTILAGE; COL27A1; BONE; PROLIFERATION; MUTATIONS; APOPTOSIS	In order to characterise the function of the novel fibrillar type XXVII collagen, a series of mice expressing mutant forms of the collagen were investigated. Mice harboring a glycine to cysteine substitution in the collagenous domain were phenotypically normal when heterozygote and displayed a mild disruption of growth plate architecture in the homozygous state. Mice expressing an 87 amino acid deletion in the collagenous domain of collagen XXVII were phenotypically normal as heterozygotes whereas homozygotes exhibited a severe chondrodysplasia and died perinatally from a lung defect. Animals expressing the 87 amino acid deletion targeted specifically to cartilage were viable but severely dwarfed. The pericellular matrix of proliferative chondrocytes was disrupted and the proliferative cells exhibited a decreased tendency to flatten and form vertical columns. Collagen XXVII plays an important structural role in the pericellular extracellular matrix of the growth plate and is required for the organisation of the proliferative zone.	[Plumb, Darren A.; Ferrara, Laila; Torbica, Tanja; Kadler, Karl E.; Briggs, Michael D.; Boot-Handford, Raymond P.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Plumb, Darren A.; Ferrara, Laila; Torbica, Tanja; Knowles, Lynnette; Mironov, Aleksandr, Jr.; Kadler, Karl E.; Briggs, Michael D.; Boot-Handford, Raymond P.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	Plumb, DA (corresponding author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.	ray.boot-handford@manchester.ac.uk	KADLER, KARL/ABI-2403-2020	KADLER, KARL/0000-0003-4977-4683; Boot-Handford, Raymond/0000-0002-6167-8419; Mironov, Aleksandr/0000-0002-1497-328X	AR UK [17243]; National Institutes of Health [RO1 AR49547-01]; Eurogrow [LSHM-CT-2007-037471]; MRC; Wellcome Trust [071161/Z/03/Z]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049547] Funding Source: NIH RePORTER	AR UK(Alzheimer's Research UK (ARUK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eurogrow; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors are grateful for the following support for this study: AR UK grant (17243 to RBH), National Institutes of Health grant (RO1 AR49547-01 to MDB, RBH and KEK), Eurogrow (LSHM-CT-2007-037471), MRC, and the Wellcome Trust (071161/Z/03/Z to MDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; Christiansen HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008481; Dreier R, 2008, MATRIX BIOL, V27, P319, DOI 10.1016/j.matbio.2008.01.006; GAGNON ML, 1992, DEVELOPMENT, V114, P457; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; KIMMEL CA, 1981, STAIN TECHNOL, V56, P271, DOI 10.3109/10520298109067325; Koch M, 2003, J BIOL CHEM, V278, P43236, DOI 10.1074/jbc.M302112200; Leighton MP, 2007, HUM MOL GENET, V16, P1728, DOI 10.1093/hmg/ddm121; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mayo JL, 2009, EXP CELL RES, V315, P2293, DOI 10.1016/j.yexcr.2009.04.020; Pace JM, 2003, MATRIX BIOL, V22, P3, DOI 10.1016/S0945-053X(03)00007-6; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Plumb DA, 2007, J BIOL CHEM, V282, P12791, DOI 10.1074/jbc.C700021200; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Sakai K, 2001, MATRIX BIOL, V19, P761, DOI 10.1016/S0945-053X(00)00122-0; Talts JF, 1999, METH MOL B, V129, P153; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200	23	37	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29422	10.1371/journal.pone.0029422	http://dx.doi.org/10.1371/journal.pone.0029422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22206015	Green Published, gold, Green Submitted			2022-12-25	WOS:000298665600038
J	Heitz, T; Widemann, E; Lugan, R; Miesch, L; Ullmann, P; Desaubry, L; Holder, E; Grausem, B; Kandel, S; Miesch, M; Werck-Reichhart, D; Pinot, F				Heitz, Thierry; Widemann, Emilie; Lugan, Raphael; Miesch, Laurence; Ullmann, Pascaline; Desaubry, Laurent; Holder, Emilie; Grausem, Bernard; Kandel, Sylvie; Miesch, Michel; Werck-Reichhart, Daniele; Pinot, Franck			Cytochromes P450 CYP94C1 and CYP94B3 Catalyze Two Successive Oxidation Steps of Plant Hormone Jasmonoyl-isoleucine for Catabolic Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; KEY ENZYME; ARABIDOPSIS; RECEPTOR; GENES; COI1; (+)-7-ISO-JASMONOYL-L-ISOLEUCINE; INACTIVATION; METABOLISM; PERCEPTION	The jasmonate hormonal pathway regulates important defensive and developmental processes in plants. Jasmonoyl-isoleucine (JA-Ile) has been identified as a specific ligand binding the COI1-JAZ co-receptor to relieve repression of jasmonate responses. Two JA-Ile derivatives, 12OH-JA-Ile and 12COOH-JA-Ile, accumulate in wounded Arabidopsis leaves in a COI1- and JAR1-dependent manner and reflect catabolic turnover of the hormone. Here we report the biochemical and genetic characterization of two wound-inducible cytochromes P450, CYP94C1 and CYP94B3, that are involved in JA-Ile oxidation. Both enzymes expressed in yeast catalyze two successive oxidation steps of JA-Ile with distinct characteristics. CYP94B3 performed efficiently the initial hydroxylation of JA-Ile to 12OH-JA-Ile, with little conversion to 12COOH-JA-Ile, whereas CYP94C1 catalyzed preferentially carboxy-derivative formation. Metabolic analysis of loss-and gain-of-function plant lines were consistent with in vitro enzymatic properties. cyp94b3 mutants were largely impaired in 12OH-JA-Ile levels upon wounding and to a lesser extent in 12COOH-JA-Ile levels. In contrast, cyp94c1 plants showed wild-type 12OH-JA-Ile accumulation but lost about 60% 12COOH-JA-Ile. cyp94b3cyp94c1 double mutants hyperaccumulated JA-Ile with near abolition of 12COOH-JA-Ile. Distinct JA-Ile oxidation patterns in different plant genotypes were correlated with specific JA-responsive transcript profiles, indicating that JA-Ile oxidation status affects signaling. Interestingly, exaggerated JA-Ile levels were associated with JAZ repressor hyperinduction but did not enhance durably defense gene induction, revealing a novel negative feedback signaling loop. Finally, interfering with CYP94 gene expression affected root growth sensitivity to exogenous jasmonic acid. These results identify CYP94B3/C1-mediated oxidation as a major catabolic route for turning over the JA-Ile hormone.	[Heitz, Thierry; Widemann, Emilie] Univ Strasbourg, Unite Propre Rech CNRS 2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Widemann, Emilie; Lugan, Raphael; Ullmann, Pascaline; Grausem, Bernard; Kandel, Sylvie; Werck-Reichhart, Daniele; Pinot, Franck] Univ Strasbourg, Unite Propre Rech CNRS 2357, Inst Biol Mol Plantes, F-67083 Strasbourg, France; [Miesch, Laurence; Holder, Emilie; Miesch, Michel] Univ Strasbourg, CNRS, Unite Mixte Rech 7177, Inst Chim,Lab Chim Organ Synthet, F-67008 Strasbourg, France; [Desaubry, Laurent] Univ Strasbourg, CNRS, Unite Mixte Rech 7200, Lab Innovat Therapeut, F-67401 Illkirch Graffenstaden, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Heitz, T (corresponding author), Univ Strasbourg, Unite Propre Rech CNRS 2357, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	thierry.heitz@ibmp-cnrs.unistra.fr	Desaubry, Laurent G/R-5446-2017; WERCK-REICHHART, Danièle/U-3713-2019; Widemann, Emilie/AAH-3825-2020	Desaubry, Laurent G/0000-0002-1192-2970; WERCK-REICHHART, Danièle/0000-0003-2869-4262; Widemann, Emilie/0000-0002-6732-5497; Heitz, Thierry/0000-0001-6238-8264; Kandel, Sylvie/0000-0002-8059-8035	Ministere de l'Enseignement Superieur et de la Recherche; CNRS; Universite de Strasbourg; Region Alsace; Institut National de la Recherche Agronomique; Tepral Company	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Region Alsace(Region Grand-Est); Institut National de la Recherche Agronomique; Tepral Company	Supported by a doctoral fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.; We are grateful to Michel Legrand for critical reading of the manuscript. We thank Dimitri Heintz for initial jasmonate analysis, Malek Alioua for help with real-time PCR and DNA sequencing, the gardener team for producing the numerous plants used in this study, and the Nottingham Arabidopsis Stock Center for providing seeds of T-DNA insertion lines. The UPLC-MS/MS system was cofinanced by the CNRS, the Universite de Strasbourg, the Region Alsace, the Institut National de la Recherche Agronomique, and the Tepral Company.	Berr A, 2010, PLANT PHYSIOL, V154, P1403, DOI 10.1104/pp.110.161497; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Ehlting J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-47; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Guranowski A, 2007, FEBS LETT, V581, P815, DOI 10.1016/j.febslet.2007.01.049; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Kandel S, 2007, FEBS J, V274, P5116, DOI 10.1111/j.1742-4658.2007.06032.x; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kitaoka N, 2011, PLANT CELL PHYSIOL, V52, P1757, DOI 10.1093/pcp/pcr110; Koo AJK, 2011, P NATL ACAD SCI USA, V108, P9298, DOI 10.1073/pnas.1103542108; Le Bouquin R, 2001, EUR J BIOCHEM, V268, P3083, DOI 10.1046/j.1432-1327.2001.02207.x; Leon J, 1998, MOL GEN GENET, V258, P412, DOI 10.1007/s004380050749; Miersch O, 2008, NEW PHYTOL, V177, P114, DOI 10.1111/j.1469-8137.2007.02252.x; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; OMURA T, 1964, J BIOL CHEM, V239, P2370; Paschold A, 2008, PLANT CELL PHYSIOL, V49, P1165, DOI 10.1093/pcp/pcn091; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pinot F, 2011, FEBS J, V278, P195, DOI 10.1111/j.1742-4658.2010.07948.x; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Scheller U, 1998, J BIOL CHEM, V273, P32528, DOI 10.1074/jbc.273.49.32528; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Suza WP, 2010, PLANTA, V231, P717, DOI 10.1007/s00425-009-1080-6; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; VanDoorn A, 2011, NEW PHYTOL, V190, P640, DOI 10.1111/j.1469-8137.2010.03622.x; Wasternack C, 2010, PLANT SIGNAL BEHAV, V5, P337, DOI 10.4161/psb.5.4.11574; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455; Ziegler J, 2000, J BIOL CHEM, V275, P19132, DOI 10.1074/jbc.M002133200	46	160	168	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6296	6306		10.1074/jbc.M111.316364	http://dx.doi.org/10.1074/jbc.M111.316364			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215670	Green Published, hybrid			2022-12-25	WOS:000300791800022
J	Johnson, JL; Erickson, JW; Cerione, RA				Johnson, Jared L.; Erickson, Jon W.; Cerione, Richard A.			C-terminal Di-arginine Motif of Cdc42 Protein Is Essential for Binding to Phosphatidylinositol 4,5-Bisphosphate-containing Membranes and Inducing Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; IN-VIVO; DIFFERENTIAL LOCALIZATION; PLECKSTRIN HOMOLOGY; PLASMA-MEMBRANE; SURFACE-CHARGE; RAC; PHOSPHOINOSITIDES; PIP2; PHOSPHOLIPIDS	Rho GTPases regulate a diverse range of processes that are dependent on their proper cellular localization. The membrane localization of these GTPases is due in large part to their carboxyl-terminal geranylgeranyl moiety. In addition, most of the Rho family members contain a cluster of positively charged residues (i.e. a "polybasic domain"), directly preceding their geranylgeranyl moiety, and it has been suggested that this domain serves to fine-tune their localization among different cellular membrane sites. Here, we have taken a closer look at the role of the polybasic domain of Cdc42 in its ability to bind to membranes and induce the transformation of fibroblasts. A FRET assay for the binding of Cdc42 to liposomes of defined composition showed that Cdc42 associates more strongly with liposomes containing phosphatidylinositol 4,5-bisphosphate (PIP2) when compared either with uncharged control membranes or with liposomes containing a charge-equivalent amount of phosphatidylserine. The carboxyl-terminal di-arginine motif (Arg-186 and Arg-187) was shown to play an essential role in the binding of Cdc42 to PIP2-containing membranes. We further showed that substitutions for the di-arginine motif, when introduced within a constitutively active ("fast cycling") Cdc42(F28L) background, had little effect on the ability of the activated Cdc42 mutant to induce microspikes/filopodia in NIH 3T3 cells, whereas they eliminated its ability to transform fibroblasts. Taken together, these findings suggest that the di-arginine motif within the carboxyl terminus of Cdc42 is necessary for this GTPase to bind at membrane sites containing PIP2, where it can initiate signaling activities that are essential for the oncogenic transformation of cells.	[Johnson, Jared L.; Erickson, Jon W.; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	rac1@cornell.edu		Johnson, Jared/0000-0003-1802-6527	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM047458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Baumeister MA, 2003, J BIOL CHEM, V278, P11457, DOI 10.1074/jbc.M211901200; Bertin A, 2010, J MOL BIOL, V404, P711, DOI 10.1016/j.jmb.2010.10.002; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Buboltz JT, 1999, BBA-BIOMEMBRANES, V1417, P232, DOI 10.1016/S0005-2736(99)00006-1; Cho H, 2005, P NATL ACAD SCI USA, V102, P15241, DOI 10.1073/pnas.0408851102; Crompton AM, 2000, J BIOL CHEM, V275, P25751, DOI 10.1074/jbc.M002050200; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Fooksman DR, 2009, J IMMUNOL, V182, P5179, DOI 10.4049/jimmunol.0801797; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gadi D, 2011, MOL BIOL CELL, V22, P4908, DOI 10.1091/mbc.E11-07-0614; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Gwanyanya A, 2006, AM J PHYSIOL-CELL PH, V291, pC627, DOI 10.1152/ajpcell.00074.2006; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janetopoulos C, 2006, J CELL BIOL, V174, P485, DOI 10.1083/jcb.200603156; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; Magalhaes MAO, 2010, J LEUKOCYTE BIOL, V87, P545, DOI 10.1189/jlb.0609390; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Redfern DA, 2005, J LIPID RES, V46, P504, DOI 10.1194/jlr.M400367-JLR200; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Struckhoff AP, 2011, FRONT BIOSCI-LANDMRK, V16, P1915, DOI 10.2741/3830; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Yamauchi A, 2005, J BIOL CHEM, V280, P953, DOI 10.1074/jbc.M408820200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307	48	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5764	5774		10.1074/jbc.M111.336487	http://dx.doi.org/10.1074/jbc.M111.336487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215673	Green Published, hybrid			2022-12-25	WOS:000300638000052
J	Qin, L; Hu, CP; Feng, JT; Xia, Q				Qin, Ling; Hu, Cheng-ping; Feng, Jun-tao; Xia, Qian			Activation of Lymphocytes Induced by Bronchial Epithelial Cells with Prolonged RSV Infection	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; REGULATORY T-CELLS; IMMUNE-RESPONSES; UP-REGULATION; EXPRESSION; AIRWAY; ASTHMA	Respiratory syncytial virus (RSV) preferentially infects airway epithelial cells, which might be responsible for susceptibility to asthma; however, the underlying mechanism is not clear. This study determined the activation of lymphocytes and drift of helper T (Th) subsets induced by RSV-infected human bronchial epithelial cells (HBECs) in vitro. HBECs had prolonged infection with RSV, and lymphocytes isolated from human peripheral blood were co-cultured with RSV-infected HBECs. Four groups were established, as follows: lymphocytes (group L); lymphocytes infected with RSV (group RL); co-culture of lymphocytes with non-infected HBECs (group HL); and co-culture of lymphocytes with infected HBECs (group HRL). After coculture with HBECs for 24 hours, lymphocytes were collected and the following were determined in the 4 groups: cell cycle status; apoptosis rate; and concentrations of IL-4, IFN-gamma, and IL-17 in the supernatants. Cell cycle analysis for lymphocytes showed a significant increase in S phase cells, a decrease in G1 phase cells, and a higher apoptosis rate in group HRL compared with the other three groups. In group HRL, the levels of IL-4, IFN-gamma, and IL-17 in supernatants were also higher than the other three groups. For further study, lymphocytes were individually treated with supernatants from non-infected and RSV-infected HBECs for 24 h. We showed that supernatants from RSV-infected HBECs induced the differentiation of Th2 and Th17 subsets, and suppressed the differentiation of Treg subsets. Our results showed that HBECs with prolonged RSV infection can induce lymphocyte proliferation and apoptosis, and enhance the release of cytokines by lymphocytes. Moreover, subset drift might be caused by RSV-infected HBECs.	[Qin, Ling; Hu, Cheng-ping; Feng, Jun-tao; Xia, Qian] Cent S Univ, Xiangya Hosp, Resp Dept, Changsha, Hunan, Peoples R China	Central South University	Qin, L (corresponding author), Cent S Univ, Xiangya Hosp, Resp Dept, Changsha, Hunan, Peoples R China.	huchengp28@yahoo.com.cn			National Program on Key Basic Research Project 973 program [2009CB522104]; grant of Postgraduates Innovations in Hunan Province [CX20098055]	National Program on Key Basic Research Project 973 program(National Basic Research Program of China); grant of Postgraduates Innovations in Hunan Province	This work was supported by the National Program on Key Basic Research Project (973 program no. 2009CB522104) and the grant of Postgraduates Innovations in Hunan Province (no. CX20098055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker S, 1997, AM J PHYSIOL-LUNG C, V272, pL512, DOI 10.1152/ajplung.1997.272.3.L512; Bertorelli G, 1998, CLIN EXP ALLERGY, V28, P551; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Busse WW, 2000, J ALLERGY CLIN IMMUN, V105, pS593; Castro M, 2000, AM J RESP CELL MOL, V22, P143, DOI 10.1165/ajrcmb.22.2.f174; Finn Patricia W, 2009, Proc Am Thorac Soc, V6, P260, DOI 10.1513/pats.200807-064RM; Gern JE, 2000, J ALLERGY CLIN IMMUN, V106, P201, DOI 10.1067/mai.2000.108604; Guerrero-Plata A, 2004, VIRUS RES, V99, P95, DOI 10.1016/j.virusres.2003.10.005; Hacking D, 2002, J INFECTION, V45, P18, DOI 10.1053/jinf.2002.1015; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holub M, 1967, Mod Trends Immunol, V2, P119; Hu CP, 2002, AM J PHYSIOL-LUNG C, V283, pL494, DOI 10.1152/ajplung.00414.2001; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; KALB TH, 1991, AM J RESP CELL MOL, V4, P320, DOI 10.1165/ajrcmb/4.4.320; KAWANO Y, 1995, BRIT J PHARMACOL, V115, P1141, DOI 10.1111/j.1476-5381.1995.tb15016.x; Kim CH, 2006, EXP HEMATOL, V34, P1033, DOI 10.1016/j.exphem.2006.03.014; Kurosawa S, 2003, AM J RESP CELL MOL, V28, P563, DOI 10.1165/rcmb.2002-0199OC; Larche M, 2007, CHEST, V132, P1007, DOI 10.1378/chest.06-2434; Mejias A, 2008, PEDIATR INFECT DIS J, V27, pS60, DOI 10.1097/INF.0b013e3181684d52; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nakagome K, 2009, J IMMUNOL, V183, P209, DOI 10.4049/jimmunol.0802712; Nakajima Hiroshi, 2010, Immune Netw, V10, P1, DOI 10.4110/in.2010.10.1.1; NOAH TL, 1995, J INFECT DIS, V171, P584, DOI 10.1093/infdis/171.3.584; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Padigel UM, 2001, J IMMUNOL, V167, P5874, DOI 10.4049/jimmunol.167.10.5874; Papi A, 2000, J INFECT DIS, V181, P1780, DOI 10.1086/315463; PATEL JA, 1995, AM J RESP CELL MOL, V13, P602, DOI 10.1165/ajrcmb.13.5.7576697; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Schwarze J, 2004, AM J RESP CRIT CARE, V169, P801, DOI 10.1164/rccm.200308-1203OC; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Shi X, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-57; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Strasser A, 2004, TRENDS IMMUNOL, V25, P610, DOI 10.1016/j.it.2004.08.012; Tristram DA, 1998, ARCH OTOLARYNGOL, V124, P777, DOI 10.1001/archotol.124.7.777; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; WEBB MSC, 1985, ARCH DIS CHILD, V60, P1064, DOI 10.1136/adc.60.11.1064; Yin SH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-166; Yoon JS, 2007, PEDIATR PULM, V42, P277, DOI 10.1002/ppul.20574; Yoshimura C, 2002, J CANCER RES CLIN, V128, P29, DOI 10.1007/s004320100270; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	44	26	29	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e27113	10.1371/journal.pone.0027113	http://dx.doi.org/10.1371/journal.pone.0027113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216085	gold, Green Published, Green Submitted			2022-12-25	WOS:000300676300001
J	Imam, S; Chen, ZQ; Roos, DS; Pohlschroder, M				Imam, Saheed; Chen, Zhongqiang; Roos, David S.; Pohlschroeder, Mechthild			Identification of Surprisingly Diverse Type IV Pili, across a Broad Range of Gram-Positive Bacteria	PLOS ONE			English	Article							PATHOGEN CLOSTRIDIUM-PERFRINGENS; PSEUDOMONAS-AERUGINOSA; PREPILIN PEPTIDASE; VIBRIO-CHOLERAE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; NEISSERIA-GONORRHOEAE; PROTEIN SECRETION; BACILLUS-SUBTILIS; SIGNAL PEPTIDES; GENE-CLUSTER	Background: In Gram-negative bacteria, type IV pili (TFP) have long been known to play important roles in such diverse biological phenomena as surface adhesion, motility, and DNA transfer, with significant consequences for pathogenicity. More recently it became apparent that Gram-positive bacteria also express type IV pili; however, little is known about the diversity and abundance of these structures in Gram-positives. Computational tools for automated identification of type IV pilins are not currently available. Results: To assess TFP diversity in Gram-positive bacteria and facilitate pilin identification, we compiled a comprehensive list of putative Gram-positive pilins encoded by operons containing highly conserved pilus biosynthetic genes (pilB, pilC). A surprisingly large number of species were found to contain multiple TFP operons (pil, com and/or tad). The N-terminal sequences of predicted pilins were exploited to develop PilFind, a rule-based algorithm for genome-wide identification of otherwise poorly conserved type IV pilins in any species, regardless of their association with TFP biosynthetic operons (http://signalfind.org). Using PilFind to scan 53 Gram-positive genomes (encoding.187,000 proteins), we identified 286 candidate pilins, including 214 in operons containing TFP biosynthetic genes (TBG+ operons). Although trained on Gram-positive pilins, PilFind identified 55 of 58 manually curated Gram-negative pilins in TBG+ operons, as well as 53 additional pilin candidates in operons lacking biosynthetic genes in ten species (>38,000 proteins), including 27 of 29 experimentally verified pilins. False positive rates appear to be low, as PilFind predicted only four pilin candidates in eleven bacterial species (>13,000 proteins) lacking TFP biosynthetic genes. Conclusions: We have shown that Gram-positive bacteria contain a highly diverse set of type IV pili. PilFind can be an invaluable tool to study bacterial cellular processes known to involve type IV pilus-like structures. Its use in combination with other currently available computational tools should improve the accuracy of predicting the subcellular localization of bacterial proteins.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Grad Program Genom & Computat Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Imam, S (corresponding author), Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA.	pohlschr@sas.upenn.edu	Chen, Zhongqiang/Y-5954-2018; Pohlschroder, Mechy/P-3206-2019; Imam, Saheed/HHY-7406-2022	Roos, David Siker/0000-0001-6725-4089; Imam, Saheed/0000-0001-7508-5887	National Science Foundation [MCB02-39215]; National Institutes of Health [R01-AI05815]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding provided by the National Science Foundation (MCB02-39215) (nsf.gov) and the National Institutes of Health (R01-AI05815) (nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahane K, 2005, MOL GENET GENOMICS, V273, P350, DOI 10.1007/s00438-005-1143-8; Albers SV, 2009, EXTREMOPHILES, V13, P403, DOI 10.1007/s00792-009-0241-7; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; CHUNG YS, 1995, MOL MICROBIOL, V15, P543, DOI 10.1111/j.1365-2958.1995.tb02267.x; Chung YS, 1998, J BACTERIOL, V180, P41, DOI 10.1128/JB.180.1.41-45.1998; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Bentzmann S, 2006, J BACTERIOL, V188, P4851, DOI 10.1128/JB.00345-06; Desvaux M, 2005, BBA-MOL CELL RES, V1745, P223, DOI 10.1016/j.bbamcr.2005.04.006; Dietrich M, 2009, FEMS MICROBIOL LETT, V296, P248, DOI 10.1111/j.1574-6968.2009.01647.x; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Essex-Lopresti AE, 2005, INFECT IMMUN, V73, P1260, DOI 10.1128/IAI.73.2.1260-1264.2005; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Grynberg M, 2007, TRENDS MICROBIOL, V15, P191, DOI 10.1016/j.tim.2007.03.002; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Horiuchi T, 1998, J BACTERIOL, V180, P4613, DOI 10.1128/JB.180.17.4613-4620.1998; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Kline KA, 2010, TRENDS MICROBIOL, V18, P224, DOI 10.1016/j.tim.2010.03.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Marsh JW, 1998, MOL MICROBIOL, V29, P1481, DOI 10.1046/j.1365-2958.1998.01031.x; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Ng SYM, 2011, J BACTERIOL, V193, P804, DOI 10.1128/JB.00822-10; NUNN DN, 1993, J BACTERIOL, V175, P4375, DOI 10.1128/JB.175.14.4375-4382.1993; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pestova EV, 1998, J BACTERIOL, V180, P2701, DOI 10.1128/JB.180.10.2701-2710.1998; Pohlschroder M, 2011, CURR OPIN MICROBIOL, V14, P357, DOI 10.1016/j.mib.2011.03.002; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; Rodgers K, 2011, INFECT IMMUN; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Sauvonnet N, 2000, J BACTERIOL, V182, P848, DOI 10.1128/JB.182.3.848-854.2000; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stevenson A, 2003, VET MICROBIOL, V92, P121, DOI 10.1016/S0378-1135(02)00351-6; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Toma C, 2002, FEMS IMMUNOL MED MIC, V33, P35, DOI 10.1111/j.1574-695X.2002.tb00569.x; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Tomich M, 2006, J BACTERIOL, V188, P6899, DOI 10.1128/JB.00690-06; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005; Varga JJ, 2008, INFECT IMMUN, V76, P4944, DOI 10.1128/IAI.00692-08; Varga JJ, 2006, MOL MICROBIOL, V62, P680, DOI 10.1111/j.1365-2958.2006.05414.x; Winther-Larsen HC, 2007, J BACTERIOL, V189, P6676, DOI 10.1128/JB.00407-07; Zhang XL, 2000, INFECT IMMUN, V68, P3067, DOI 10.1128/IAI.68.6.3067-3073.2000	57	85	86	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28919	10.1371/journal.pone.0028919	http://dx.doi.org/10.1371/journal.pone.0028919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216142	Green Published, gold, Green Submitted			2022-12-25	WOS:000299113600052
J	Khor, BS; Jamil, MFA; Adenan, MI; Shu-Chien, AC				Khor, Beng-Siang; Jamil, Mohd Fadzly Amar; Adenan, Mohamad Ilham; Shu-Chien, Alexander Chong			Mitragynine Attenuates Withdrawal Syndrome in Morphine-Withdrawn Zebrafish	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; DYNORPHIN/KAPPA OPIOID SYSTEM; ANXIETY-LIKE BEHAVIOR; OPIATE WITHDRAWAL; FACTOR RECEPTOR-1; COCAINE WITHDRAWAL; GENE-EXPRESSION; ADULT ZEBRAFISH; SPECIOSA-KORTH; CRF RECEPTOR	A major obstacle in treating drug addiction is the severity of opiate withdrawal syndrome, which can lead to unwanted relapse. Mitragynine is the major alkaloid compound found in leaves of Mitragyna speciosa, a plant widely used by opiate addicts to mitigate the harshness of drug withdrawal. A series of experiments was conducted to investigate the effect of mitragynine on anxiety behavior, cortisol level and expression of stress pathway related genes in zebrafish undergoing morphine withdrawal phase. Adult zebrafish were subjected to two weeks chronic morphine exposure at 1.5 mg/L, followed by withdrawal for 24 hours prior to tests. Using the novel tank diving tests, we first showed that morphine-withdrawn zebrafish display anxiety-related swimming behaviors such as decreased exploratory behavior and increased erratic movement. Morphine withdrawal also elevated whole-body cortisol levels, which confirms the phenotypic stress-like behaviors. Exposing morphine-withdrawn fish to mitragynine however attenuates majority of the stress-related swimming behaviors and concomitantly lower whole-body cortisol level. Using real-time PCR gene expression analysis, we also showed that mitragynine reduces the mRNA expression of corticotropin releasing factor receptors and prodynorphin in zebrafish brain during morphine withdrawal phase, revealing for the first time a possible link between mitragynine's ability to attenuate anxiety during opiate withdrawal with the stress-related corticotropin pathway.	[Khor, Beng-Siang; Jamil, Mohd Fadzly Amar; Adenan, Mohamad Ilham; Shu-Chien, Alexander Chong] Malaysian Minist Sci Technol & Innovat, Malaysian Inst Pharmaceut & Nutraceut, Bukit Gambir, Penang, Malaysia; [Adenan, Mohamad Ilham] FRIM, Kepong, Selangor, Malaysia; [Shu-Chien, Alexander Chong] Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia	Institute Penyelidikan Perhutanan Malaysia; Universiti Sains Malaysia	Khor, BS (corresponding author), Malaysian Minist Sci Technol & Innovat, Malaysian Inst Pharmaceut & Nutraceut, Bukit Gambir, Penang, Malaysia.	alex@usm.my	Shu-Chien, Alexander Chong/D-4041-2009	Shu-Chien, Alexander Chong/0000-0003-3014-442X	Malaysian Ministry of Science, Technology and Innovation [311/IFN/6923013, 311/IFN/6922011]	Malaysian Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported by the Malaysian Ministry of Science, Technology and Innovation R&D Innovation Grant Scheme No 311/IFN/6923013 and 311/IFN/6922011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JE, 2011, CURR TOP MED CHEM, V11, P1165; Babu KM, 2008, CLIN TOXICOL, V46, P146, DOI 10.1080/15563650701241795; Barr AM, 2011, ANIMAL MODEL DRUG AD, V53; Beardsley PM, 2005, PSYCHOPHARMACOLOGY, V183, P118, DOI 10.1007/s00213-005-0167-4; Bearn J, 2001, ADDICT BIOL, V6, P157, DOI 10.1080/13556210020040235; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Boyer EW, 2008, ADDICTION, V103, P1048, DOI 10.1111/j.1360-0443.2008.02209.x; Bruchas MR, 2010, BRAIN RES, V1314, P44, DOI 10.1016/j.brainres.2009.08.062; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Chandrasekar G, 2007, J COMP NEUROL, V505, P337, DOI 10.1002/cne.21496; Contarino A, 2005, P NATL ACAD SCI USA, V102, P18649, DOI 10.1073/pnas.0506999102; Flik G, 2006, GEN COMP ENDOCR, V146, P36, DOI 10.1016/j.ygcen.2005.11.005; Gonzalez-Nunez V, 2007, NEUROSCIENCE, V144, P675, DOI 10.1016/j.neuroscience.2006.09.028; Hidayat MT, 2010, ADV MED DENT SCI, V3, P65; Idayu NF, 2011, PHYTOMEDICINE, V18, P402, DOI 10.1016/j.phymed.2010.08.011; Iredale PA, 1996, MOL PHARMACOL, V50, P1103; Iredale PA, 2000, J NEUROCHEM, V74, P199, DOI 10.1046/j.1471-4159.2000.0740199.x; JANSEN KLR, 1988, J ETHNOPHARMACOL, V23, P115, DOI 10.1016/0378-8741(88)90121-3; Kasagi Y, 2002, J NEUROENDOCRINOL, V14, P587, DOI 10.1046/j.1365-2826.2002.00816.x; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koob GF, 1997, PHARMACOL BIOCHEM BE, V57, P513, DOI 10.1016/S0091-3057(96)00438-8; Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617; Kreek MJ, 2002, NAT REV DRUG DISCOV, V1, P710, DOI 10.1038/nrd897; Kumarnsit E, 2007, FITOTERAPIA, V78, P182, DOI 10.1016/j.fitote.2006.11.012; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Lau B, 2006, GENES BRAIN BEHAV, V5, P497, DOI 10.1111/j.1601-183X.2005.00185.x; Li SX, 2008, AM J DRUG ALCOHOL AB, V34, P321, DOI 10.1080/00952990802013664; Liu TT, 2009, CELL MOL NEUROBIOL, V29, P17, DOI 10.1007/s10571-008-9290-1; Lopez-Patino MA, 2008, PHYSIOL BEHAV, V93, P160, DOI 10.1016/j.physbeh.2007.08.013; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; Mathur P, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.201; Matsumoto K, 1996, LIFE SCI, V59, P1149, DOI 10.1016/0024-3205(96)00432-8; McClung CA, 2005, J NEUROSCI, V25, P6005, DOI 10.1523/JNEUROSCI.0062-05.2005; McWhirter L, 2010, EUR ADDICT RES, V16, P229, DOI 10.1159/000320288; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Navarro-Zaragoza J, 2010, MOL PHARMACOL, V77, P864, DOI 10.1124/mol.109.062463; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Ninkovic J, 2006, METHODS, V39, P262, DOI 10.1016/j.ymeth.2005.12.007; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Papaleo F, 2008, NEUROPSYCHOPHARMACOL, V33, P2878, DOI 10.1038/npp.2008.8; Parmar A, 2011, NEUROMETHODS, V51, P75, DOI 10.1007/978-1-60761-953-6_6; Patino MAL, 2008, PHYSIOL BEHAV, V95, P36, DOI 10.1016/j.physbeh.2008.03.021; PERRIN MH, 1993, ENDOCRINOLOGY, V133, P3058, DOI 10.1210/en.133.6.3058; Pozzoli G, 1996, ENDOCRINOLOGY, V137, P65, DOI 10.1210/en.137.1.65; Prisinzano TE, 2009, J NAT PROD, V72, P581, DOI 10.1021/np8005748; Ramsay JM, 2006, AQUACULTURE, V258, P565, DOI 10.1016/j.aquaculture.2006.04.020; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; SARNYAI Z, 1995, BRAIN RES, V675, P89, DOI 10.1016/0006-8993(95)00043-P; Shaham Y, 1998, PSYCHOPHARMACOLOGY, V137, P184, DOI 10.1007/s002130050608; Shi J, 2006, ACTA PHARMACOL SIN, V27, P1303, DOI 10.1111/j.1745-7254.2006.00431.x; Stewart A, 2011, REV NEUROSCIENCE, V22, P95, DOI 10.1515/RNS.2011.011; Utar Z, 2011, J ETHNOPHARMACOL, V136, P75, DOI 10.1016/j.jep.2011.04.011; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE	55	55	57	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28340	10.1371/journal.pone.0028340	http://dx.doi.org/10.1371/journal.pone.0028340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205946	Green Submitted, Green Published, gold			2022-12-25	WOS:000299113600014
J	Ma, D; Tremblay, P; Mahngar, K; Collins, J; Hudlicky, T; Pandey, S				Ma, Dennis; Tremblay, Phillip; Mahngar, Kevinjeet; Collins, Jonathan; Hudlicky, Tomas; Pandey, Siyaram			Selective Cytotoxicity against Human Osteosarcoma Cells by a Novel Synthetic C-1 Analogue of 7-Deoxypancratistatin Is Potentiated by Curcumin	PLOS ONE			English	Article							PANCRATISTATIN INDUCES APOPTOSIS; OXYGEN SPECIES ROS; CANCER-CELLS; AUTOPHAGY; MITOCHONDRIA; BIOLOGY; GROWTH; CHEMOTHERAPY; ACTIVATION; CHILDHOOD	The natural compound pancratistatin (PST) is a non-genotoxic inducer of apoptosis in a variety of cancers. It exhibits cancer selectivity as non-cancerous cells are markedly less sensitive to PST. Nonetheless, PST is not readily synthesized and is present in very low quantities in its natural source to be applied clinically. We have previously synthesized and evaluated several synthetic analogues of 7-deoxypancratistatin, and found that JC-TH-acetate-4 (JCTH-4), a C-1 acetoxymethyl analogue, possessed similar apoptosis inducing activity compared to PST. In this study, notoriously chemoresistant osteosarcoma (OS) cells (Saos-2, U-2 OS) were substantially susceptible to JCTH-4-induced apoptosis through mitochondrial targeting; JCTH-4 induced collapse of mitochondrial membrane potential (MMP), increased reactive oxygen species (ROS) production in isolated mitochondria, and caused release of apoptosis inducing factor (AIF) and endonuclease G (EndoG) from isolated mitochondria. Furthermore, JCTH-4 selectively induced autophagy in OS cells. Additionally, we investigated the combinatory effect of JCTH-4 with the natural compound curcumin (CC), a compound found in turmeric spice, previously shown to possess antiproliferative properties. CC alone had no observable effect on Saos-2 and U-2 OS cells. However, when present with JCTH-4, CC was able to enhance the cytotoxicity of JCTH-4 selectively in OS cells. Such cytotoxicity by JCTH-4 alone and in combination with CC was not observed in normal human osteoblasts (HOb) and normal human fetal fibroblasts (NFF). Therefore, this report illustrates a new window in combination therapy, utilizing a novel synthetic analogue of PST with the natural compound CC, for the treatment of OS.	[Ma, Dennis; Tremblay, Phillip; Mahngar, Kevinjeet; Pandey, Siyaram] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada; [Collins, Jonathan; Hudlicky, Tomas] Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada; [Collins, Jonathan; Hudlicky, Tomas] Brock Univ, Ctr Biotechnol, St Catharines, ON L2S 3A1, Canada	University of Windsor; Brock University; Brock University	Ma, D (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	spandey@uwindsor.ca	Pandey, Siyaram/AAI-5491-2020	Collins, Jonathan/0000-0002-5591-5772	Canadian Institutes of Health Research (CIHR); Charles Best Canada Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Charles Best Canada Graduate Scholarship	Funding of this work has been provided as a generous gift by the Knights of Columbus Chapter 9671 (Windsor, ON, Canada). This work has also been supported by a Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarship awarded to Dennis Ma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2007, J CELL BIOCHEM, V102, P580, DOI 10.1002/jcb.21500; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; BAUM ES, 1981, CANCER TREAT REP, V65, P815; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Borst P, 2004, DRUG RESIST UPDATE, V7, P321, DOI 10.1016/j.drup.2004.11.003; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; Chatterjee SJ, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/129045; Chatterjee SJ, 2010, MELANOMA RES; Chen G, 2010, MITOCHONDRION, V10, P614, DOI 10.1016/j.mito.2010.08.001; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Collins J, 2010, J ORG CHEM, V75, P3069, DOI 10.1021/jo1003136; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Earnshaw WC, 1999, NATURE, V397, P387, DOI 10.1038/17015; Epelbaum R, 2010, NUTR CANCER, V62, P1137, DOI 10.1080/01635581.2010.513802; Flombaum CD, 1999, J CLIN ONCOL, V17, P1589, DOI 10.1200/JCO.1999.17.5.1589; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; GOORIN AM, 1991, J CLIN ONCOL, V9, P600, DOI 10.1200/JCO.1991.9.4.600; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gregory CD, 2004, IMMUNOLOGY, V113, P1, DOI 10.1111/j.1365-2567.2004.01959.x; Griffin C, 2011, INT J ONCOL, V38, P1549, DOI 10.3892/ijo.2011.977; Griffin C, 2011, MOL CANCER THER, V10, P57, DOI 10.1158/1535-7163.MCT-10-0735; Griffin C, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-6; Gurjal A, 1999, LUNG CANCER-J IASLC, V26, P109, DOI 10.1016/S0169-5002(99)00081-1; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kekre N, 2005, CANCER CHEMOTH PHARM, V56, P29, DOI 10.1007/s00280-004-0941-8; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kurien BT, 2007, ASSAY DRUG DEV TECHN, V5, P567, DOI 10.1089/adt.2007.064; KUTTAN R, 1985, CANCER LETT, V29, P197, DOI 10.1016/0304-3835(85)90159-4; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu JJ, 2011, CANCER LETT, V300, P105, DOI 10.1016/j.canlet.2010.10.001; Loebstein R, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.6.e8; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; McLachlan A, 2005, APOPTOSIS, V10, P619, DOI 10.1007/s10495-005-1896-x; MEISTRICH ML, 1989, CANCER, V63, P2115, DOI 10.1002/1097-0142(19890601)63:11<2115::AID-CNCR2820631108>3.0.CO;2-A; Navaraj A, 2005, CANCER BIOL THER, V4, P1409, DOI 10.4161/cbt.4.12.2378; Ovadje P, 2011, J ETHNOPHARMACOL, V133, P86, DOI 10.1016/j.jep.2010.09.005; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Patel BB, 2009, NUTR CANCER, V61, P842, DOI 10.1080/01635580903285106; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Pollack M, 2001, J GERONTOL, V11, P475; Rashmi R, 2005, CARCINOGENESIS, V26, P713, DOI 10.1093/carcin/bgi025; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Siedlakowski P, 2008, CANCER BIOL THER, V7, P376, DOI 10.4161/cbt.7.3.5364; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Singh S, 2007, CELL, V130, P765, DOI 10.1016/j.cell.2007.08.024; SMITH MA, 1991, JNCI-J NATL CANCER I, V83, P1460, DOI 10.1093/jnci/83.20.1460; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Walters DK, 2008, INVEST NEW DRUG, V26, P289, DOI 10.1007/s10637-007-9099-7; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	70	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28780	10.1371/journal.pone.0028780	http://dx.doi.org/10.1371/journal.pone.0028780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22205968	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600033
J	Mann, RS; Pelz-Stelinski, K; Hermann, SL; Tiwari, S; Stelinski, LL				Mann, Rajinder S.; Pelz-Stelinski, Kirsten; Hermann, Sara L.; Tiwari, Siddharth; Stelinski, Lukasz L.			Sexual Transmission of a Plant Pathogenic Bacterium, Candidatus Liberibacter asiaticus, between Conspecific Insect Vectors during Mating	PLOS ONE			English	Article							DIAPHORINA-CITRI HEMIPTERA; GREENING DISEASE; BEMISIA-TABACI; PSYLLIDAE; PCR; ACQUISITION; PROTEINS; ECOLOGY	Candidatus Liberibacter asiaticus is a fastidious, phloem-inhabiting, gram-negative bacterium transmitted by Asian citrus psyllid, Diaphorina citri Kuwayama (Hemiptera: Psyllidae). The bacterium is the presumed causal agent of huanglongbing (HLB), one of the most destructive and economically important diseases of citrus. We investigated whether Las is transmitted between infected and uninfected D. citri adults during courtship. Our results indicate that Las was sexually transmitted from Las-infected male D. citri to uninfected females at a low rate (< 4%) during mating. Sexual transmission was not observed following mating of infected females and uninfected males or among adult pairs of the same sex. Las was detected in genitalia of both sexes and also in eggs of infected females. A latent period of 7 days or more was required to detect the bacterium in recipient females. Rod shaped as well as spherical structures resembling Las were observed in ovaries of Las-infected females with transmission electron microscopy, but were absent in ovaries from uninfected D. citri females. The size of the rod shaped structures varied from 0.39 to 0.67 mm in length and 0.19 to 0.39 mm in width. The spherical structures measured from 0.61 to 0.80 mm in diameter. This investigation provides convincing evidence that a plant pathogenic bacterium is sexually transmitted from male to female insects during courtship and established evidence that bacteria persist in reproductive organs. Moreover, these findings provide an alternative sexually horizontal mechanism for the spread of Las within populations of D. citri, even in the absence of infected host trees.	[Mann, Rajinder S.; Pelz-Stelinski, Kirsten; Hermann, Sara L.; Tiwari, Siddharth; Stelinski, Lukasz L.] Univ Florida, Citrus Res & Educ Ctr, Dept Entomol & Nematol, Lake Alfred, FL USA	State University System of Florida; University of Florida	Mann, RS (corresponding author), Univ Florida, Citrus Res & Educ Ctr, Dept Entomol & Nematol, Lake Alfred, FL USA.	stelinski@ufl.edu			Citrus Research and Development Foundation Inc., Florida	Citrus Research and Development Foundation Inc., Florida	This research was supported by the Citrus Research and Development Foundation Inc., Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; [Anonymous], P 13 C INT ORG CITR; Aubert B., 1990, P 4 INT AS PAC CITR, P133; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chen J, 2011, [植物病理学报, Acta Phytopathologica Sinica], V41, P113; Damiani C, 2008, CURR BIOL, V18, pR1087, DOI 10.1016/j.cub.2008.10.040; Damsteegt VD, 2010, PLANT DIS, V94, P528, DOI 10.1094/PDIS-94-5-0528; Dossi FCA, 2010, NEOTROP ENTOMOL, V39, P414, DOI 10.1590/S1519-566X2010000300015; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Garnier M., 1984, P 9 C INT ORG CITR V, V9, P115; Ghanim M, 2000, J VIROL, V74, P4738, DOI 10.1128/JVI.74.10.4738-4745.2000; Ghanim M, 2007, ARTHROPOD-PLANT INTE, V1, P195, DOI 10.1007/s11829-007-9018-z; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2009, J ECON ENTOMOL, V102, P446, DOI 10.1603/029.102.0158; HALL DG, 2008, TALLER INT HUANGLONG, V1, P1; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hung TH, 2004, PLANT PATHOL, V53, P96, DOI 10.1111/j.1365-3059.2004.00948.x; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Knell RJ, 2004, BIOL REV, V79, P557, DOI 10.1017/S1464793103006365; LAFLECHE D., 1970, Fruits d'Outre Mer, V25, P455; LAFLECHE D, 1970, SCIENCES           D, V270, P1915; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Lung O, 2001, J INSECT PHYSIOL, V47, P617, DOI 10.1016/S0022-1910(00)00151-7; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Meyer JM, 2008, FLA ENTOMOL, V91, P294, DOI 10.1653/0015-4040(2008)91[294:MSOEIF]2.0.CO;2; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Onagbola EO, 2008, MICRON, V39, P1184, DOI 10.1016/j.micron.2008.05.002; Otti O, 2009, AM NAT, V174, P292, DOI 10.1086/600099; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Raddadi N, 2011, ENVIRON MICROBIOL, V13, P414, DOI 10.1111/j.1462-2920.2010.02347.x; SAMAKOVLIS C, 1991, EMBO J, V10, P163, DOI 10.1002/j.1460-2075.1991.tb07932.x; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Shokrollah H, 2010, AFR J BIOTECHNOL, V9, P5897; SHROYER DA, 1990, J MED ENTOMOL, V27, P334, DOI 10.1093/jmedent/27.3.334; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Tesh R.B., 1981, P122; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Wenninger EJ, 2007, FLA ENTOMOL, V90, P715, DOI 10.1653/0015-4040(2007)90[715:DTOMAA]2.0.CO;2; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Xu C.F., 1988, P 10 C INT ORG CITRU, P243	42	39	46	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29197	10.1371/journal.pone.0029197	http://dx.doi.org/10.1371/journal.pone.0029197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216209	Green Published, gold			2022-12-25	WOS:000299113600066
J	Kim, Y; Roh, S; Lawler, S; Friedman, A				Kim, Yangjin; Roh, Soyeon; Lawler, Sean; Friedman, Avner			miR451 and AMPK Mutual Antagonism in Glioma Cell Migration and Proliferation: A Mathematical Model	PLOS ONE			English	Article							GROWTH; COLLAGEN; PATTERN	Glioblastoma multiforme (GBM) is the most common and the most aggressive type of brain cancer; the median survival time from the time of diagnosis is approximately one year. GBM is characterized by the hallmarks of rapid proliferation and aggressive invasion. miR-451 is known to play a key role in glioblastoma by modulating the balance of active proliferation and invasion in response to metabolic stress in the microenvironment. The present paper develops a mathematical model of GBM evolution which focuses on the relative balance of growth and invasion. In the present work we represent the miR-451/AMPK pathway by a simple model and show how the effects of glucose on cells need to be "refined" by taking into account the recent history of glucose variations. The simulations show how variations in glucose significantly affect the level of miR-451 and, in turn, cell migration. The model predicts that oscillations in the levels of glucose increase the growth of the primary tumor. The model also suggests that drugs which upregulate miR-451, or block other components of the CAB39/AMPK pathway, will slow down glioma cell migration. The model provides an explanation for the growth-invasion cycling patterns of glioma cells in response to high/low glucose uptake in microenvironment in vitro, and suggests new targets for drugs, associated with miR-451 upregulation.	[Kim, Yangjin] Univ Michigan, Dept Math & Stat, Dearborn, MI 48128 USA; [Roh, Soyeon] Univ Michigan, Dept Nat Sci, Dearborn, MI 48128 USA; [Lawler, Sean] Univ Leeds, Leeds Inst Mol Med, Translat Neurooncol Grp, Leeds, W Yorkshire, England; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Leeds; University System of Ohio; Ohio State University	Kim, Y (corresponding author), Univ Michigan, Dept Math & Stat, Dearborn, MI 48128 USA.	yangjink@umd.umich.edu	Kim, Yangjin/C-9681-2014	Kim, Yangjin/0000-0002-8905-8481	National Science Foundation (Division of Mathematical Sciences) [112050]; Horace H. Rackham School of Graduate Studies, University of Michigan-Ann Arbor; University of Michigan-Dearborn	National Science Foundation (Division of Mathematical Sciences)(National Science Foundation (NSF)); Horace H. Rackham School of Graduate Studies, University of Michigan-Ann Arbor; University of Michigan-Dearborn(University of Michigan System)	The authors (Y. Kim and A. Friedman) are supported by National Science Foundation (Division of Mathematical Sciences) upon agreement 112050. Y. Kim was supported by a Rackham grant from the Horace H. Rackham School of Graduate Studies, University of Michigan-Ann Arbor and Faculty initial research seed grant, University of Michigan-Dearborn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Annabi B, 2005, CLIN EXP METASTAS, V22, P429, DOI 10.1007/s10585-005-2669-1; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Deisboeck TS, 2001, CELL PROLIFERAT, V34, P115, DOI 10.1046/j.1365-2184.2001.00202.x; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; LI CKN, 1982, CANCER-AM CANCER SOC, V50, P2066, DOI 10.1002/1097-0142(19821115)50:10<2066::AID-CNCR2820501017>3.0.CO;2-X; Mercapide J, 2003, INT J CANCER, V106, P676, DOI 10.1002/ijc.11286; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; Rong ZM, 2006, ANALYST, V131, P816, DOI 10.1039/b600334f; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; SHERRATT JA, 1990, P ROY SOC B-BIOL SCI, V241, P29, DOI 10.1098/rspb.1990.0061; Stein AM, 2007, BIOPHYS J, V92, P356, DOI 10.1529/biophysj.106.093468; Tyson R, 2000, J MATH BIOL, V41, P455, DOI 10.1007/s002850000038; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	24	60	64	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2011	6	12							e28293	10.1371/journal.pone.0028293	http://dx.doi.org/10.1371/journal.pone.0028293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JU	22205943	gold, Green Published, Green Submitted			2022-12-25	WOS:000298666200005
J	Sandberg, A; Skold, CM; Grunewald, J; Eklund, A; Wheelock, AM				Sandberg, AnnSofi; Skold, C. Magnus; Grunewald, Johan; Eklund, Anders; Wheelock, Asa M.			Assessing Recent Smoking Status by Measuring Exhaled Carbon Monoxide Levels	PLOS ONE			English	Article							CIGARETTE-SMOKING; EXPIRED AIR; SMOKERS; CARBOXYHEMOGLOBIN; BREATH; INFLAMMATION; ELIMINATION; NONSMOKERS; BLOOD	Background: Cigarette smoke causes both acute and chronic changes of the immune system. Excluding recent smoking is therefore important in clinical studies with chronic inflammation as primary focus. In this context, it is common to ask the study subjects to refrain from smoking within a certain time frame prior to sampling. The duration of the smoking cessation is typically from midnight the evening before, i.e. 8 hours from sampling. As it has been shown that a proportion of current smokers underestimates or denies smoking, objective assessment of recent smoking status is of great importance. Our aim was to extend the use of exhaled carbon monoxide (CObreath), a well-established method for separating smokers from nonsmokers, to assessment of recent smoking status. Methods and Findings: The time course of CObreath decline was investigated by hourly measurements during one day on non-symptomatic smokers and non-smokers (6+7), as well as by measurements on three separate occasions on nonsmokers (n = 29), smokers with normal lung function (n = 38) and smokers with chronic obstructive pulmonary disease (n = 19) participating in a clinical study. We used regression analysis to model the decay, and receiver operator characteristics analysis for evaluation of model performance. The decline was described as a mono-exponential decay (r(2) = 0.7) with a half-life of 4.5 hours. CO decline rate depends on initial CO levels, and by necessity a generic cut-off is therefore crude as initial CObreath varies a lot between individuals. However, a cut-off level of 12 ppm could classify recent smokers from smokers having refrained from smoking during the past 8 hours with a specificity of 94% and a sensitivity of 90%. Conclusions: We hereby describe a method for classifying recent smokers from smokers having refrained from smoking for >8 hours that is easy to implement in a clinical setting.	[Sandberg, AnnSofi] Karolinska Inst, Sci Life Lab, Dept Oncol Pathol, Stockholm, Sweden; [Skold, C. Magnus; Grunewald, Johan; Eklund, Anders; Wheelock, Asa M.] Karolinska Inst, Dept Med, Div Resp Med, Stockholm, Sweden; [Skold, C. Magnus; Grunewald, Johan; Eklund, Anders; Wheelock, Asa M.] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Sandberg, A (corresponding author), Karolinska Inst, Sci Life Lab, Dept Oncol Pathol, Stockholm, Sweden.	asa.wheelock@ki.se	Wheelock, Åsa/B-7904-2017; Grunewald, Johan/GQZ-8122-2022	Wheelock, Åsa/0000-0002-8013-2745; Grunewald, Johan/0000-0003-0473-3984	Swedish Heart Lung Foundation; EU; Swedish Foundation for Strategic Research; Stockholm County Council; King Oscar II Jubilee Foundation; Karolinska Institutet	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); EU(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Stockholm County Council(Stockholm County Council); King Oscar II Jubilee Foundation; Karolinska Institutet(Karolinska Institutet)	This study was supported by the Swedish Heart Lung Foundation, EU Marie Curie International Reintegration Grant, the Swedish Foundation for Strategic Research, Stockholm County Council, King Oscar II Jubilee Foundation, and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MF, 2010, EUR J ANAESTH, V27, P812, DOI 10.1097/EJA.0b013e32833a55ea; Bagaitkar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009323; Bakhru A, 2005, PLOS MED, V2, P528, DOI 10.1371/journal.pmed.0020160; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Bruce MC, 2006, J APPL PHYSIOL, V100, P1171, DOI 10.1152/japplphysiol.00512.2005; Christenhusz L, 2007, J AEROSOL MED, V20, P475, DOI 10.1089/jam.2007.0606; COULTAS DB, 1988, AM REV RESPIR DIS, V137, P810, DOI 10.1164/ajrccm/137.4.810; DELLER A, 1992, INFUSIONSTHERAPIE, V19, P121; Deveci SE, 2004, RESP MED, V98, P551, DOI 10.1016/j.rmed.2003.11.018; JARVIS MJ, 1980, BRIT MED J, V281, P484, DOI 10.1136/bmj.281.6238.484; Kharitonov SA, 2001, AM J RESP CRIT CARE, V163, P1693, DOI 10.1164/ajrccm.163.7.2009041; Koczulla AR, 2010, RESPIRATION, V79, P61, DOI 10.1159/000245325; Leitch DN, 2005, RESP MED, V99, P32, DOI 10.1016/j.rmed.2004.03.027; Liu J, 2011, CANC EPIDEMIOL BIOMA; Low E. C. T., 2004, SMJ Singapore Medical Journal, V45, P578; Marrone GF, 2010, HUM PSYCHOPHARM CLIN, V25, P80, DOI 10.1002/hup.1078; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pearce MS, 2005, CHEST, V128, P1233, DOI 10.1378/chest.128.3.1233; PETERSON JE, 1970, ARCH ENVIRON HEALTH, V21, P165, DOI 10.1080/00039896.1970.10667215; Sato S, 2003, CHEST, V124, P1749, DOI 10.1378/chest.124.5.1749; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; van der Vaart H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-22; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; WALD NJ, 1981, THORAX, V36, P366, DOI 10.1136/thx.36.5.366	25	87	87	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28864	10.1371/journal.pone.0028864	http://dx.doi.org/10.1371/journal.pone.0028864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194931	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400020
J	Fitzsimons, HL; Scott, MJ				Fitzsimons, Helen L.; Scott, Maxwell J.			Genetic Modulation of Rpd3 Expression Impairs Long-Term Courtship Memory in Drosophila	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; HISTONE DEACETYLASE; MUSHROOM BODY; TRANSCRIPTIONAL ACTIVATION; PHEROMONAL CUES; MICE; CONSOLIDATION; MELANOGASTER; P300; TRANSGENESIS	There is increasing evidence that regulation of local chromatin structure is a critical mechanism underlying the consolidation of long-term memory (LTM), however considerably less is understood about the specific mechanisms by which these epigenetic effects are mediated. Furthermore, the importance of histone acetylation in Drosophila memory has not been reported. The histone deacetylase (HDAC) Rpd3 is abundant in the adult fly brain, suggesting a post-mitotic function. Here, we investigated the role of Rpd3 in long-term courtship memory in Drosophila. We found that while modulation of Rpd3 levels predominantly in the adult mushroom body had no observed impact on immediate recall or one-hour memory, 24-hour LTM was severely impaired. Surprisingly, both overexpression as well as RNAi-mediated knockdown of Rpd3 resulted in impairment of long-term courtship memory, suggesting that the dose of Rpd3 is critical for normal LTM.	[Fitzsimons, Helen L.] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand; [Scott, Maxwell J.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	Massey University; University of North Carolina; North Carolina State University	Fitzsimons, HL (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	h.l.fitzsimons@massey.ac.nz	Scott, Maxwell J/J-1935-2015	Scott, Maxwell J/0000-0001-6536-4735; Fitzsimons, Helen/0000-0001-7825-3911	Neurological Foundation of New Zealand; New Zealand Foundation for Research, Science and Technology	Neurological Foundation of New Zealand; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	This research was conducted during the tenure of a Repatriation Fellowship of the Neurological Foundation of New Zealand (www.neurological.org.nz) and a Postdoctoral Fellowship of the New Zealand Foundation for Research, Science and Technology (www.frst.govt.nz) to HLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Dovey OM, 2010, CELL CYCLE, V9, P2700, DOI 10.4161/cc.9.14.12626; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Fass DM, 2003, J BIOL CHEM, V278, P43014, DOI 10.1074/jbc.M305905200; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fontan-Lozano A, 2008, MOL CELL NEUROSCI, V39, P193, DOI 10.1016/j.mcn.2008.06.009; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Ishimoto H, 2009, P NATL ACAD SCI USA, V106, P6381, DOI 10.1073/pnas.0810213106; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lee H, 2010, MOL CELL BIOL, V30, P2563, DOI 10.1128/MCB.01075-09; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Marek R, 2011, J NEUROSCI, V31, P7486, DOI 10.1523/JNEUROSCI.0133-11.2011; Mastushita-Sakai T, 2010, P NATL ACAD SCI USA, V107, P11987, DOI 10.1073/pnas.1004433107; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; MCGUIRE SE, 2004, SCI STKE, pPL6; McQuown SC, 2011, NEUROBIOL LEARN MEM, V96, P27, DOI [10.1016/j.nlm.2011.04.005, 10.1016/j.nlm.2011.04.002]; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Mehren JE, 2004, J NEUROSCI, V24, P10584, DOI 10.1523/JNEUROSCI.3560-04.2004; Mershin A, 2004, LEARN MEMORY, V11, P277, DOI 10.1101/lm.70804; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Oliveira AMM, 2011, LEARN MEMORY, V18, P161, DOI 10.1101/lm.1939811; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Sarkar A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-27; Sarkar M, 2006, J BIOL CHEM, V281, P12776, DOI 10.1074/jbc.M512769200; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; YANG MY, 1995, NEURON, V15, P45	54	33	33	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e29171	10.1371/journal.pone.0029171	http://dx.doi.org/10.1371/journal.pone.0029171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22195015	gold, Green Submitted, Green Published			2022-12-25	WOS:000298370400035
J	Kuhn, S; Nenchev, I; Haggard, P; Brass, M; Gallinat, J; Voss, M				Kuhn, Simone; Nenchev, Ivan; Haggard, Patrick; Brass, Marcel; Gallinat, Juergen; Voss, Martin			Whodunnit? Electrophysiological Correlates of Agency Judgements	PLOS ONE			English	Article							BRAIN; LOCALIZATION; P300; POTENTIALS; COMPONENT; STIMULUS; MODEL; P3A	Sense of agency refers to the feeling that "I'' am responsible for those external events that are directly produced by one's own voluntary actions. Recent theories distinguish between a non-conceptual "feeling'' of agency linked to changes in the processing of self-generated sensory events, and a higher-order judgement of agency, which attributes sensory events to the self. In the current study we explore the neural correlates of the judgement of agency by means of electrophysiology. We measured event-related potentials to tones that were either perceived or not perceived as triggered by participants' voluntary actions and related these potentials to later judgements of agency over the tones. Replicating earlier findings on predictive sensory attenuation, we found that the N1 component was attenuated for congruent tones that corresponded to the learned action-effect mapping as opposed to incongruent tones that did not correspond to the previously acquired associations between actions and tones. The P3a component, but not the N1, directly reflected the judgement of agency: deflections in this component were greater for tones judged as self-generated than for tones judged as externally produced. The fact that the outcome of the later agency judgement was predictable based on the P3a component demonstrates that agency judgements incorporate early information processing components and are not purely reconstructive, post-hoc evaluations generated at time of judgement.	[Kuhn, Simone; Brass, Marcel] Univ Ghent, Dept Expt Psychol, Fac Psychol & Educ Sci, B-9000 Ghent, Belgium; [Kuhn, Simone; Brass, Marcel] Univ Ghent, Ghent Inst Funct & Metab Imaging, B-9000 Ghent, Belgium; [Kuhn, Simone; Haggard, Patrick] UCL, Dept Psychol, Inst Cognit Neurosci, London, England; [Kuhn, Simone; Nenchev, Ivan; Gallinat, Juergen; Voss, Martin] Charite, St Hedwig Krankenhaus, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany	Ghent University; Ghent University; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kuhn, S (corresponding author), Univ Ghent, Dept Expt Psychol, Fac Psychol & Educ Sci, B-9000 Ghent, Belgium.	simone.kuhn@ugent.be	Kuehn, Simone/P-6145-2014; Brass, Marcel/J-7082-2012; Keil, Julian/I-3337-2016	Brass, Marcel/0000-0002-3364-4019; Voss, Martin/0000-0002-5221-4647; Haggard, Patrick/0000-0001-7798-793X; Nenchev, Ivan/0000-0002-9860-3250; Kuhn, Simone/0000-0001-6823-7969; Keil, Julian/0000-0003-4195-7397	Research Foundation Flanders (FWO); European Platform for Life Sciences, Mind Sciences, and the Humanities; Volkswagen Stiftung	Research Foundation Flanders (FWO)(FWO); European Platform for Life Sciences, Mind Sciences, and the Humanities; Volkswagen Stiftung(Volkswagen)	SK is a Postdoctoral Fellow of the Research Foundation Flanders (FWO). MV is supported by the "European Platform for Life Sciences, Mind Sciences, and the Humanities'' grant by the Volkswagen Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass P, 2008, INT J PSYCHOPHYSIOL, V70, P137, DOI 10.1016/j.ijpsycho.2008.06.005; BASS P, 2009, EUROPEAN J NEUROSCIE, V29, P1513; Bays PM, 2006, PLOS BIOL, V4, P281, DOI 10.1371/journal.pbio.0040028; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; GENTSCH A, J COGNITIVE IN PRESS; HARI R, 1980, EXP BRAIN RES, V40, P237, DOI 10.1007/BF00237543; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Horvath J, 2008, BIOL PSYCHOL, V79, P139, DOI 10.1016/j.biopsycho.2008.04.001; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Michotte A., 1946, PERCEPTION CAUSALITY; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rinne T, 2006, BRAIN RES, V1077, P135, DOI 10.1016/j.brainres.2006.01.043; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; SCHAFER EWP, 1973, SCIENCE, V181, P175, DOI 10.1126/science.181.4095.175; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Spengler S, 2009, NEUROIMAGE, V46, P290, DOI 10.1016/j.neuroimage.2009.01.047; Sperduti M, 2011, BRAIN STRUCT FUNCT, V216, P151, DOI 10.1007/s00429-010-0298-1; STARR A, 1985, BRAIN RES, V348, P183, DOI 10.1016/0006-8993(85)90377-4; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Synofzik M, 2008, CONSCIOUS COGN, V17, P411, DOI 10.1016/j.concog.2008.03.008; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Tarkka IM, 1998, BRAIN TOPOGR, V11, P141, DOI 10.1023/A:1022258606418; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	29	58	58	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28657	10.1371/journal.pone.0028657	http://dx.doi.org/10.1371/journal.pone.0028657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GS	22194878	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100072
J	Algar, E; Dagar, V; Sebaj, M; Pachter, N				Algar, Elizabeth; Dagar, Vinod; Sebaj, Menka; Pachter, Nicholas			An 11p15 Imprinting Centre Region 2 Deletion in a Family with Beckwith Wiedemann Syndrome Provides Insights into Imprinting Control at CDKN1C	PLOS ONE			English	Article							GROWTH-FACTOR-II; WILMS-TUMOR; DEFECTS; KVDMR1; MECHANISMS; TRANSCRIPT; KCNQ1OT1; LIT1; MICRODELETION; P57(KIP2)	We report a three generation family with Beckwith Wiedemann syndrome (BWS) in whom we have identified a 330 kb deletion within the KCNQ1 locus, encompassing the 11p15.5 Imprinting Centre II (IC2). The deletion arose on the paternal chromosome in the first generation and was only associated with BWS when transmitted maternally to subsequent generations. The deletion on the maternal chromosome was associated with a lower median level of CDKN1C expression in the peripheral blood of affected individuals when compared to a cohort of unaffected controls (p<0.05), however was not significantly different to the expression levels in BWS cases with loss of methylation (LOM) within IC2 (p<0.78). Moreover the individual with a deletion on the paternal chromosome did not show evidence of elevated CDKN1C expression or features of Russell Silver syndrome. These observations support a model invoking the deletion of enhancer elements required for CDKN1C expression lying within or close to the imprinting centre and importantly extend and validate a single observation from an earlier study. Analysis of 94 cases with IC2 loss of methylation revealed that KCNQ1 deletion is a rare cause of loss of maternal methylation, occurring in only 3% of cases, or in 1.5% of BWS overall.	[Algar, Elizabeth; Dagar, Vinod; Sebaj, Menka] Murdoch Childrens Res Inst, Mol Oncol Lab, Melbourne, Vic, Australia; [Pachter, Nicholas] King Edward Mem Hosp, Genet Serv Western Australia, Perth, WA, Australia; [Algar, Elizabeth] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Murdoch Children's Research Institute; King Edward Memorial Hospital; University of Western Australia; University of Melbourne	Algar, E (corresponding author), Murdoch Childrens Res Inst, Mol Oncol Lab, Melbourne, Vic, Australia.	elizabeth.algar@rch.org.au	Algar, Elizabeth/B-3770-2012		Children's Cancer Centre Foundation; Victorian Government	Children's Cancer Centre Foundation; Victorian Government	This work was supported by a grant to EA from the Children's Cancer Centre Foundation. The Murdoch Children's Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algar E, 2000, HUM MUTAT, V15, P497, DOI 10.1002/1098-1004(200006)15:6<497::AID-HUMU2>3.0.CO;2-F; Algar EM, 2007, CANCER RES, V67, P2360, DOI 10.1158/0008-5472.CAN-06-3383; Bliek J, 2004, J PEDIATR-US, V145, P796, DOI 10.1016/j.jpeds.2004.08.007; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; Demars J, 2010, HUM MOL GENET, V19, P803, DOI 10.1093/hmg/ddp549; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; Enklaar Thorsten, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000020; Fitzpatrick GV, 2007, MOL CELL BIOL, V27, P2636, DOI 10.1128/MCB.02036-06; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; John RM, 2001, HUM MOL GENET, V10, P1601, DOI 10.1093/hmg/10.15.1601; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mohammad F, 2008, MOL CELL BIOL, V28, P3713, DOI 10.1128/MCB.02263-07; Niemitz EL, 2004, AM J HUM GENET, V75, P844, DOI 10.1086/425343; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Prawitt D, 2005, NAT GENET, V37, P785, DOI 10.1038/ng0805-785; Riccio A, 2009, ENDOCR DEV, V14, P1, DOI 10.1159/000207461; Shin JY, 2008, EMBO J, V27, P168, DOI 10.1038/sj.emboj.7601960; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Sparago A, 2007, HUM MOL GENET, V16, P254, DOI 10.1093/hmg/ddl448; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989	25	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e29034	10.1371/journal.pone.0029034	http://dx.doi.org/10.1371/journal.pone.0029034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205991	Green Published, gold, Green Submitted			2022-12-25	WOS:000298665600023
J	Gerhardt, E; Graber, S; Szego, EM; Moisoi, N; Martins, LM; Outeiro, TF; Kermer, P				Gerhardt, Ellen; Graeber, Simone; Szego, Eva M.; Moisoi, Nicoleta; Martins, L. Miguel; Outeiro, Tiago F.; Kermer, Pawel			Idebenone and Resveratrol Extend Lifespan and Improve Motor Function of HtrA2 Knockout Mice	PLOS ONE			English	Article							INDUCED APOPTOSIS; PROTEASE ACTIVITY; BINDING-PROTEIN; STRESS; DEATH; NEURONS; DISEASE; MITOCHONDRIA; DYSFUNCTION; BRAIN	Heterozygous loss-of-function mutation of the human gene for the mitochondrial protease HtrA2 has been associated with increased risk to develop mitochondrial dysfunction, a process known to contribute to neurodegenerative disorders such as Huntington's disease (HD) and Parkinson's disease (PD). Knockout of HtrA2 in mice also leads to mitochondrial dysfunction and to phenotypes that resemble those found in neurodegenerative disorders and, ultimately, lead to death of animals around postnatal day 30. Here, we show that Idebenone, a synthetic antioxidant of the coenzyme Q family, and Resveratrol, a bioactive compound extracted from grapes, are both able to ameliorate this phenotype. Feeding HtrA2 knockout mice with either compound extends lifespan and delays worsening of the motor phenotype. Experiments conducted in cell culture and on brain tissue of mice revealed that each compound has a different mechanism of action. While Idebenone acts by downregulating the integrated stress response, Resveratrol acts by attenuating apoptosis at the level of Bax. These activities can account for the delay in neuronal degeneration in the striata of these mice and illustrate the potential of these compounds as effective therapeutic approaches against neurodegenerative disorders such as HD or PD.	[Gerhardt, Ellen; Szego, Eva M.; Outeiro, Tiago F.] Univ Gottingen, Dept NeuroDegenerat & Restorat Res, DFG Res Ctr Mol Physiol Brain, Univ Med Gottingen, Gottingen, Germany; [Graeber, Simone] Leibniz Inst Mol Pharmacol, High Throughput Screening Unit, Berlin, Germany; [Moisoi, Nicoleta; Martins, L. Miguel] MRC, Cell Death Regulat Lab, Toxicol Unit, Leicester, Leics, England; [Kermer, Pawel] Univ Med Gottingen, Dept Neurol, DFG Res Ctr Mol Physiol Brain, Gottingen, Germany	German Research Foundation (DFG); University of Gottingen; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Leicester; German Research Foundation (DFG); University of Gottingen	Gerhardt, E (corresponding author), Univ Gottingen, Dept NeuroDegenerat & Restorat Res, DFG Res Ctr Mol Physiol Brain, Univ Med Gottingen, Gottingen, Germany.	egerhar1@gwdg.de	Outeiro, Tiago/L-7351-2019; Martins, Miguel/AAH-3971-2019; Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019	Outeiro, Tiago/0000-0003-1679-1727; Martins, Miguel/0000-0002-3019-4809; Outeiro, Tiago F/0000-0003-1679-1727; Moisoi, Nicoleta/0000-0002-0400-9227; Szego, Eva Monika/0000-0002-2629-2131	Deutsche Forschungsgemeinschaft through the DFG-Research Center for Molecular Physiology of the Brain; Medical Research Council [MC_U132674518] Funding Source: researchfish; MRC [MC_U132674518] Funding Source: UKRI	Deutsche Forschungsgemeinschaft through the DFG-Research Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Deutsche Forschungsgemeinschaft through the DFG-Research Center for Molecular Physiology of the Brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Anekonda Thimmappa S, 2008, BMC Res Notes, V1, P122, DOI 10.1186/1756-0500-1-122; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Becker C, 2010, EXPERT OPIN DRUG MET, V6, P1437, DOI 10.1517/17425255.2010.530656; Branco DM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00017; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Geromel V, 2002, MOL GENET METAB, V77, P21, DOI 10.1016/S1096-7192(02)00145-2; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Grieb P, 1998, RESUSCITATION, V39, P107, DOI 10.1016/S0300-9572(98)00128-2; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; KAPETANOVIC IM, 2010, CANC CHEMOTHER PHARM; Kelly G, 2010, ALTERN MED REV, V15, P245; Kieper N, 2010, EXP CELL RES, V316, P1213, DOI 10.1016/j.yexcr.2010.01.005; Kowsky S, 2007, P NATL ACAD SCI USA, V104, P20049, DOI 10.1073/pnas.0706177104; Kruger R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.11.021; Li B, 2010, CELL DEATH DIFFER, V17, P1773, DOI 10.1038/cdd.2010.55; Long JG, 2009, REJUV RES, V12, P321, DOI 10.1089/rej.2009.0877; Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212; MacFarlane M, 2004, EMBO REP, V5, P674, DOI 10.1038/sj.embor.7400191; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166; Mukherjee S, 2010, DOSE-RESPONSE, V8, P478, DOI 10.2203/dose-response.09-015.Mukherjee; Myers L, 2008, J NEUROL SCI, V267, P174, DOI 10.1016/j.jns.2007.10.008; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Quincozes-Santos A, 2011, ANN NY ACAD SCI, V1215, P72, DOI 10.1111/j.1749-6632.2010.05857.x; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Roth W, 2003, CELL DEATH DIFFER, V10, P1178, DOI 10.1038/sj.cdd.4401287; Schulz JB, 1996, J NEUROSCI, V16, P4696; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szego EM, 2006, J NEUROSCI, V26, P4104, DOI 10.1523/JNEUROSCI.0222-06.2006; SZEGO EM, 2011, J NEUROL SCI; Tillerson JL, 2003, J NEUROSCI METH, V123, P189, DOI 10.1016/S0165-0270(02)00360-6; TORII H, 1985, J PHARMACOBIO-DYNAM, V8, P457; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693	41	41	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28855	10.1371/journal.pone.0028855	http://dx.doi.org/10.1371/journal.pone.0028855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JO	22205977	gold, Green Submitted, Green Published			2022-12-25	WOS:000298665600012
J	Verhulst, NO; Qiu, YT; Beijleveld, H; Maliepaard, C; Knights, D; Schulz, S; Berg-Lyons, D; Lauber, CL; Verduijn, W; Haasnoot, GW; Mumm, R; Bouwmeester, HJ; Claas, FHJ; Dicke, M; van Loon, JJA; Takken, W; Knight, R; Smallegange, RC				Verhulst, Niels O.; Qiu, Yu Tong; Beijleveld, Hans; Maliepaard, Chris; Knights, Dan; Schulz, Stefan; Berg-Lyons, Donna; Lauber, Christian L.; Verduijn, Willem; Haasnoot, Geert W.; Mumm, Roland; Bouwmeester, Harro J.; Claas, Frans H. J.; Dicke, Marcel; van Loon, Joop J. A.; Takken, Willem; Knight, Rob; Smallegange, Renate C.			Composition of Human Skin Microbiota Affects Attractiveness to Malaria Mosquitoes	PLOS ONE			English	Article							HUMAN AXILLARY ODOR; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; PREFERENCES; SPECTROMETRY; MICROFLORA; RESPONSES; SELECTION; BEHAVIOR; ATTRACTS	The African malaria mosquito Anopheles gambiae sensu stricto continues to play an important role in malaria transmission, which is aggravated by its high degree of anthropophily, making it among the foremost vectors of this disease. In the current study we set out to unravel the strong association between this mosquito species and human beings, as it is determined by odorant cues derived from the human skin. Microbial communities on the skin play key roles in the production of human body odour. We demonstrate that the composition of the skin microbiota affects the degree of attractiveness of human beings to this mosquito species. Bacterial plate counts and 16S rRNA sequencing revealed that individuals that are highly attractive to An. gambiae s.s. have a significantly higher abundance, but lower diversity of bacteria on their skin than individuals that are poorly attractive. Bacterial genera that are correlated with the relative degree of attractiveness to mosquitoes were identified. The discovery of the connection between skin microbial populations and attractiveness to mosquitoes may lead to the development of new mosquito attractants and personalized methods for protection against vectors of malaria and other infectious diseases.	[Verhulst, Niels O.; Qiu, Yu Tong; Beijleveld, Hans; Dicke, Marcel; van Loon, Joop J. A.; Takken, Willem; Smallegange, Renate C.] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Beijleveld, Hans] Univ Wageningen & Res Ctr, Subdept Environm Technol, Wageningen, Netherlands; [Maliepaard, Chris] Univ Wageningen & Res Ctr, Wageningen UR Plant Breeding, Wageningen, Netherlands; [Knights, Dan; Knight, Rob] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Schulz, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, Braunschweig, Germany; [Berg-Lyons, Donna; Lauber, Christian L.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Verduijn, Willem; Haasnoot, Geert W.; Claas, Frans H. J.] Leiden Univ, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Mumm, Roland] Univ Wageningen & Res Ctr, Business Unit Biosci, Wageningen, Netherlands; [Mumm, Roland] Ctr BioSyst Gen, Wageningen, Netherlands; [Bouwmeester, Harro J.] Univ Wageningen & Res Ctr, Lab Plant Physiol, Wageningen, Netherlands; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; University of Colorado System; University of Colorado Boulder; Braunschweig University of Technology; University of Colorado System; University of Colorado Boulder; Leiden University; Leiden University - Excl LUMC; Wageningen University & Research; Centre for BioSystems Genomics; Wageningen University & Research; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Verhulst, NO (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	Niels.Verhulst@wur.nl	Maliepaard, Chris/G-6041-2015; Pollet, Thomas V/H-3397-2012; Verhulst, Simon/B-1613-2009; Verhulst, Simon/S-3404-2019; Dicke, Marcel/B-2300-2010; Bouwmeester, Harro J/C-1414-2008; Smallegange, Renate C./L-1566-2019; Knight, Rob/D-1299-2010; Pollet, Thomas/M-6346-2019; Verhulst, Niels/AAH-4288-2019; Nettle, Daniel/B-2259-2008; van Loon, Joop J.A./B-3744-2009	Pollet, Thomas V/0000-0002-4210-935X; Verhulst, Simon/0000-0002-1143-6868; Verhulst, Simon/0000-0002-1143-6868; Dicke, Marcel/0000-0001-8565-8896; Smallegange, Renate C./0000-0002-6946-9777; Pollet, Thomas/0000-0002-4210-935X; Nettle, Daniel/0000-0001-9089-2599; Stulp, Gert/0000-0003-0173-5554; Bouwmeester, Harro/0000-0003-0907-2732; Schulz, Stefan/0000-0002-4810-324X; Mumm, Roland/0000-0002-0603-1508; van Loon, Joop J.A./0000-0002-4260-0501; Verhulst, Niels/0000-0002-1106-9711; Knight, Rob/0000-0002-0975-9019	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH) [121]; Earth and Life Science Foundation of the Netherlands Organization for Scientific Research	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Earth and Life Science Foundation of the Netherlands Organization for Scientific Research	This study was funded by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH# 121), and a grant from the Earth and Life Science Foundation of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501; Ara K, 2006, CAN J MICROBIOL, V52, P357, DOI 10.1139/W05-130; Bernier UR, 1999, ANAL CHEM, V71, P1, DOI 10.1021/ac980990v; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748; Bruinsma M, 2010, OECOLOGIA, V162, P393, DOI 10.1007/s00442-009-1459-x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carde RT, 2010, ECOL CONT VECTOR-BOR, V2, P115; Costantini C, 1998, AM J TROP MED HYG, V58, P56, DOI 10.4269/ajtmh.1998.58.56; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; KHAN AA, 1968, MOSQ NEWS, V28, P462; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546; Logan J. G., 2008, Outlooks on Pest Management, V19, P280, DOI 10.1564/19dec14; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Olanga EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-6; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; RENNIE PJ, 1991, BRIT J DERMATOL, V124, P596, DOI 10.1111/j.1365-2133.1991.tb04958.x; Savelev SU, 2008, J CHEM ECOL, V34, P1253, DOI 10.1007/s10886-008-9524-1; SHELLEY WB, 1953, AMA ARCH DERM SYPH, V68, P430, DOI 10.1001/archderm.1953.01540100070012; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Taylor D., 2003, International Journal of Cosmetic Science, V25, P137, DOI 10.1046/j.1467-2494.2003.00181.x; Tims S, 2010, INT J LEGAL MED, V124, P477, DOI 10.1007/s00414-009-0352-9; Torr S, 2008, MED VET ENTOMOL, V22, P93, DOI 10.1111/j.1365-2915.2008.00723.x; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Verhulst NO, 2010, FEMS MICROBIOL ECOL, V74, P1, DOI 10.1111/j.1574-6941.2010.00908.x; Verhulst NO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-302; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; WHITE GB, 1980, T ROY SOC TROP MED H, V74, P683; Wold S., 2006, MULTI MEGAVARIATE DA; Xu Y, 2007, METABOLOMICS, V3, P427, DOI 10.1007/s11306-007-0054-6; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324	45	199	201	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28991	10.1371/journal.pone.0028991	http://dx.doi.org/10.1371/journal.pone.0028991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	21738577	Green Published, gold			2022-12-25	WOS:000300676300020
J	Chen, ZG; Phillips, LK; Gould, E; Campisi, J; Lee, SW; Ormerod, BK; Zwierzchoniewska, M; Martinez, OM; Palmer, TD				Chen, Zhiguo; Phillips, Lori K.; Gould, Elizabeth; Campisi, Jay; Lee, Star W.; Ormerod, Brandi K.; Zwierzchoniewska, Monika; Martinez, Olivia M.; Palmer, Theo D.			MHC Mismatch Inhibits Neurogenesis and Neuron Maturation in Stem Cell Allografts	PLOS ONE			English	Article							PROGENITOR CELLS; DOPAMINE NEURONS; TRANSPLANTATION; RAT; TISSUE; BRAIN; ANTIGENS; DIFFERENTIATION; IMMUNOGENICITY; RECOGNITION	Background: The role of histocompatibility and immune recognition in stem cell transplant therapy has been controversial, with many reports arguing that undifferentiated stem cells are protected from immune recognition due to the absence of major histocompatibility complex (MHC) markers. This argument is even more persuasive in transplantation into the central nervous system (CNS) where the graft rejection response is minimal. Methodology/Principal Findings: In this study, we evaluate graft survival and neuron production in perfectly matched vs. strongly mismatched neural stem cells transplanted into the hippocampus in mice. Although allogeneic cells survive, we observe that MHC-mismatch decreases surviving cell numbers and strongly inhibits the differentiation and retention of graft-derived as well as endogenously produced new neurons. Immune suppression with cyclosporine-A did not improve outcome but non-steroidal anti-inflammatory drugs, indomethacin or rosiglitazone, were able to restore allogeneic neuron production, integration and retention to the level of syngeneic grafts. Conclusions/Significance: These results suggest an important but unsuspected role for innate, rather than adaptive, immunity in the survival and function of MHC-mismatched cellular grafts in the CNS.	[Chen, Zhiguo; Gould, Elizabeth; Lee, Star W.; Ormerod, Brandi K.; Palmer, Theo D.] Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Chen, Zhiguo; Gould, Elizabeth; Lee, Star W.; Ormerod, Brandi K.; Palmer, Theo D.] Dept Neurosurg, Stanford, CA USA; [Phillips, Lori K.; Campisi, Jay; Zwierzchoniewska, Monika; Martinez, Olivia M.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA	Stanford University	Chen, ZG (corresponding author), Merrimack Coll, N Andover, MA 01845 USA.	zchen1@stanford.edu	Palmer, Theo/GSI-6635-2022; Ormerod, Brandi/H-7037-2012; Whittaker, Anna/A-3577-2013	Ormerod, Brandi/0000-0003-0982-0788; , Olivia/0000-0002-2798-0251; Palmer, Theo/0000-0002-6266-1862; Chen, Zhiguo/0000-0003-1508-510X; Whittaker, Anna/0000-0002-5461-0598	National Institutes of Health [R01NS045113, R21NS050549, R01MH071472]; California Institute for Regenerative Medicine [RC1-00134-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045113, R21NS050549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by research grants from the National Institutes of Health (R01NS045113, R21NS050549, and R01MH071472) and the California Institute for Regenerative Medicine (RC1-00134-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker RA, 2000, J NEUROSCI, V20, P3415, DOI 10.1523/JNEUROSCI.20-09-03415.2000; Bechmann I, 1999, GLIA, V27, P62, DOI 10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Chaturvedi RK, 2008, J NEUROCHEM, V106, P506, DOI 10.1111/j.1471-4159.2008.05388.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CORRY RJ, 1973, TRANSPLANT P, V5, P733; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; DUAN WM, 1995, NEUROSCIENCE, V64, P629, DOI 10.1016/0306-4522(94)00416-3; Duan WM, 1997, EXP NEUROL, V148, P334, DOI 10.1006/exnr.1997.6656; FEITOZA CQ, 2009, INFLAMM RES; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gould DS, 1999, IMMUNOL TODAY, V20, P77, DOI 10.1016/S0167-5699(98)01394-2; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Han Ruolan, 2008, J Biol, V7, P12, DOI 10.1186/jbiol69; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imitola J, 2004, AM J PATHOL, V164, P1615, DOI 10.1016/S0002-9440(10)63720-0; Keohane A, 2010, MOL CELL NEUROSCI, V43, P127, DOI 10.1016/j.mcn.2009.10.003; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mammolenti M, 2004, STEM CELLS, V22, P1101, DOI 10.1634/stemcells.22-6-1101; MASON DW, 1986, NEUROSCIENCE, V19, P685, DOI 10.1016/0306-4522(86)90292-7; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pan Y, 2005, EXP NEUROL, V192, P365, DOI 10.1016/j.expneurol.2004.11.011; RAO K, 1989, TRANSPLANTATION, V48, P1018, DOI 10.1097/00007890-198912000-00025; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sayles M, 2004, TRANSPL IMMUNOL, V12, P321, DOI 10.1016/j.trim.2003.12.012; Schwarz SC, 2006, PARKINSONISM RELAT D, V12, P302, DOI 10.1016/j.parkreldis.2006.01.003; Shetty AK, 1999, J NEUROBIOL, V38, P391, DOI 10.1002/(SICI)1097-4695(19990215)38:3<391::AID-NEU8>3.0.CO;2-4; SLOAN DJ, 1990, PROG BRAIN RES, V82, P141; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TZE WJ, 1989, TRANSPLANTATION, V47, P1053, DOI 10.1097/00007890-198906000-00027; WIDNER H, 1993, CELL TRANSPLANT, V2, P307, DOI 10.1177/096368979300200413; WIDNER H, 1989, EXP BRAIN RES, V76, P187; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	49	105	109	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e14787	10.1371/journal.pone.0014787	http://dx.doi.org/10.1371/journal.pone.0014787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	22205957	gold, Green Submitted, Green Published			2022-12-25	WOS:000289055700001
J	Wang, YL; An, LL; Jiang, YD; Hang, HY				Wang, Yulan; An, Lili; Jiang, Yuanda; Hang, Haiying			Effects of Simulated Microgravity on Embryonic Stem Cells	PLOS ONE			English	Article							MODELED MICROGRAVITY; DNA-DAMAGE; HUMAN-LYMPHOCYTES; NUCLEAR ANTIGEN; DIFFERENTIATION; PROLIFERATION; CULTURE; REPAIR; ESTABLISHMENT; SPACEFLIGHT	There have been many studies on the biological effects of simulated microgravity (SMG) on differentiated cells or adult stem cells. However, there has been no systematic study on the effects of SMG on embryonic stem (ES) cells. In this study, we investigated various effects (including cell proliferation, cell cycle distribution, cell differentiation, cell adhesion, apoptosis, genomic integrity and DNA damage repair) of SMG on mouse embryonic stem (mES) cells. Mouse ES cells cultured under SMG condition had a significantly reduced total cell number compared with cells cultured under 1 g gravity (1G) condition. However, there was no significant difference in cell cycle distribution between SMG and 1G culture conditions, indicating that cell proliferation was not impaired significantly by SMG and was not a major factor contributing to the total cell number reduction. In contrast, a lower adhesion rate cultured under SMG condition contributed to the lower cell number in SMG. Our results also revealed that SMG alone could not induce DNA damage in mES cells while it could affect the repair of radiation-induced DNA lesions of mES cells. Taken together, mES cells were sensitive to SMG and the major alterations in cellular events were cell number expansion, adhesion rate decrease, increased apoptosis and delayed DNA repair progression, which are distinct from the responses of other types of cells to SMG.	[Wang, Yulan; An, Lili; Hang, Haiying] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Wang, Yulan; An, Lili; Hang, Haiying] Chinese Acad Sci, Inst Biophys, Ctr Computat & Syst Biol, Beijing 100080, Peoples R China; [Jiang, Yuanda] Chinese Acad Sci, Ctr Space Sci & Appl Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences	Wang, YL (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	hh91@sun5.ibp.ac.cn	jiang, anyi/GPT-0379-2022	Huang, Yelin/0000-0002-2514-0144	Chinese Academy of Sciences [KSCX2-YW-R63]	Chinese Academy of Sciences(Chinese Academy of Sciences)	The study is supported by grants from Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-YW-R63). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Coinu R, 2006, FEBS LETT, V580, P2465, DOI 10.1016/j.febslet.2006.03.078; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Degan P, 2005, J CELL BIOCHEM, V94, P460, DOI 10.1002/jcb.20302; Estrov Z, 2009, CLIN LYMPHOMA MYELOM, V9, pS319, DOI 10.3816/CLM.2009.s.031; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fridley KM, 2010, TISSUE ENG PT A, V16, P3285, DOI [10.1089/ten.tea.2010.0166, 10.1089/ten.TEA.2010.0166]; Guignandon A, 2001, FASEB J, V15, P2036, DOI 10.1096/fj.00-0837fje; Gundel A, 1997, J SLEEP RES, V6, P1, DOI 10.1046/j.1365-2869.1997.00028.x; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; HANG HY, 2003, METH MOL B, V241, P23; Hatton DC, 2002, J APPL PHYSIOL, V92, P3, DOI 10.1152/jappl.2002.92.1.3; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; JASKULSKI D, 1988, J BIOL CHEM, V263, P10175; [蒋远大 JIANG Yuanda], 2008, [航天医学与医学工程, Space Medicine & Medical Engineering], V21, P368; Kawahara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006343; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Li J, 2009, PROTOPLASMA, V238, P23, DOI 10.1007/s00709-009-0068-1; LI YH, 2007, CELL PROLIFERAT, V40, P671; Lou YJ, 2011, ACTA PHARMACOL SIN, V32, P152, DOI 10.1038/aps.2010.194; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; Makihira S, 2008, CELL BIOL INT, V32, P1176, DOI 10.1016/j.cellbi.2008.04.027; MATISE MP, 2000, GENE TARGETING, P111; Mognato M, 2005, MUTAT RES-FUND MOL M, V578, P417, DOI 10.1016/j.mrfmmm.2005.06.011; Mognato M, 2009, MUTAT RES-FUND MOL M, V663, P32, DOI 10.1016/j.mrfmmm.2009.01.002; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Navran S, 2008, BIOTECHNOL ANN REV, V14, P275, DOI 10.1016/S1387-2656(08)00011-2; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Sarkar Devanand, 1999, Environmental Medicine (Nagoya), V43, P22; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sun LW, 2008, ACTA ASTRONAUT, V63, P968, DOI 10.1016/j.actaastro.2007.12.008; Takeda M, 2009, NEUROSCI LETT, V463, P54, DOI 10.1016/j.neulet.2009.07.045; Uva BM, 2002, EUR J HISTOCHEM, V46, P209; van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; YUGE L, 2003, CELL DIFFER, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921; Zhang CB, 2011, PROTEIN CELL, V2, P410, DOI 10.1007/s13238-011-1049-7	41	78	89	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29214	10.1371/journal.pone.0029214	http://dx.doi.org/10.1371/journal.pone.0029214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216215	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600067
J	Stulp, G; Verhulst, S; Pollet, TV; Nettle, D; Buunk, AP				Stulp, Gert; Verhulst, Simon; Pollet, Thomas V.; Nettle, Daniel; Buunk, Abraham P.			Parental Height Differences Predict the Need for an Emergency Caesarean Section	PLOS ONE			English	Article							MATERNAL HEIGHT; BIRTH-WEIGHT; SHOULDER DYSTOCIA; RISK; DELIVERY; SIZE; STATURE; WOMEN; PERFORMANCE; LABOR	More than 30% of all pregnancies in the UK require some form of assistance at delivery, with one of the more severe forms of assistance being an emergency Caesarean section (ECS). Previously it has been shown that the likelihood of a delivery via ECS is positively associated with the birth weight and size of the newborn and negatively with maternal height. Paternal height affects skeletal growth and mass of the fetus, and thus might also affect pregnancy outcomes. We hypothesized that the effect of newborn birth weight on the risk of ECS would decrease with increasing maternal height. Similarly, we predicted that there would be an increase in ECS risk as a function of paternal height, but that this effect would be relative to maternal height (i.e., parental height differences). We used data from the Millennium Cohort Study: a large-scale survey (N = 18,819 births) with data on babies born and their parents from the United Kingdom surveyed 9 to 12-months after birth. We found that in primiparous women, both maternal height and parental height differences interacted with birth weight and predicted the likelihood of an ECS. When carrying a heavy newborn, the risk of ECS was more than doubled for short women (46.3%) compared to tall women (21.7%), in agreement with earlier findings. For women of average height carrying a heavy newborn while having a relatively short compared to tall partner reduced the risk by 6.7%. In conclusion, the size of the baby, the height of the mother and parental height differences affect the likelihood of an ECS in primiparous women.	[Stulp, Gert; Pollet, Thomas V.; Nettle, Daniel; Buunk, Abraham P.] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Stulp, Gert; Verhulst, Simon] Univ Groningen, Dept Behav Biol, Groningen, Netherlands; [Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behaviour & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Buunk, Abraham P.] Royal Netherlands Acad Arts & Sci, Amsterdam, Netherlands	University of Groningen; University of Groningen; Newcastle University - UK	Stulp, G (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	g.stulp@rug.nl	Maliepaard, Chris/G-6041-2015; Pollet, Thomas V/H-3397-2012; Verhulst, Simon/B-1613-2009; Verhulst, Simon/S-3404-2019; Dicke, Marcel/B-2300-2010; Bouwmeester, Harro J/C-1414-2008; Smallegange, Renate C./L-1566-2019; Knight, Rob/D-1299-2010; Pollet, Thomas/M-6346-2019; Verhulst, Niels/AAH-4288-2019; Nettle, Daniel/B-2259-2008; van Loon, Joop J.A./B-3744-2009	Pollet, Thomas V/0000-0002-4210-935X; Verhulst, Simon/0000-0002-1143-6868; Verhulst, Simon/0000-0002-1143-6868; Dicke, Marcel/0000-0001-8565-8896; Smallegange, Renate C./0000-0002-6946-9777; Pollet, Thomas/0000-0002-4210-935X; Nettle, Daniel/0000-0001-9089-2599; Stulp, Gert/0000-0003-0173-5554; Bouwmeester, Harro/0000-0003-0907-2732; Schulz, Stefan/0000-0002-4810-324X; Mumm, Roland/0000-0002-0603-1508; van Loon, Joop J.A./0000-0002-4260-0501; Verhulst, Niels/0000-0002-1106-9711; Knight, Rob/0000-0002-0975-9019	Wellcome Trust; Royal Netherlands Academy of Arts and Sciences; NWO [451.10.032]	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Netherlands Academy of Arts and Sciences; NWO(Netherlands Organization for Scientific Research (NWO))	The Millennium Cohort Study was commissioned by the Economic and Social Research Council (ESRC), whose funding has been supplemented by a consortium of government departments and the Wellcome Trust. This research was supported by grants to APB and DN from the Royal Netherlands Academy of Arts and Sciences and an NWO Veni grant to TVP (451.10.032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADADEVOH SWK, 1989, INT J GYNECOL OBSTET, V28, P243, DOI 10.1016/0020-7292(89)90725-X; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Awonuga Awoniyi O., 2007, Archives of Gynecology and Obstetrics, V276, P523, DOI 10.1007/s00404-007-0370-0; BAIRD D, 1949, LANCET, V256, P1079; BARKEMA HW, 1992, THERIOGENOLOGY, V37, P489, DOI 10.1016/0093-691X(92)90206-7; BELLOWS RA, 1982, J ANIM SCI, V55, P18, DOI 10.2527/jas1982.55118x; Brabin L, 2002, ACTA OBSTET GYN SCAN, V81, P502, DOI 10.1034/j.1600-0412.2002.810605.x; BRESLER JB, 1962, AM J PHYS ANTHROPOL, V20, P515, DOI 10.1002/ajpa.1330200412; CAMILLERI AP, 1981, EUR J OBSTET GYN R B, V12, P347, DOI 10.1016/0028-2243(81)90080-0; CATALANO PM, 1995, AM J OBSTET GYNECOL, V172, P1459, DOI 10.1016/0002-9378(95)90478-6; Chan BCP, 2009, J OBSTET GYNAECOL RE, V35, P307, DOI 10.1111/j.1447-0756.2008.00939.x; Colburn DJ, 1997, J ANIM SCI, V75, P1452; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; DEX S, 2004, MILLENNIUM COHORT ST, P1; Godfrey K, 2001, J BONE MINER RES, V16, P1694, DOI 10.1359/jbmr.2001.16.9.1694; Guegan JF, 2000, P ROY SOC B-BIOL SCI, V267, P2529, DOI 10.1098/rspb.2000.1316; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; JAMES DK, 1979, BRIT MED J, V1, P10, DOI 10.1136/bmj.1.6155.10; KAPPEL B, 1987, ACTA OBSTET GYN SCAN, V66, P153, DOI 10.3109/00016348709083038; Kirchengast S., 2007, ACTA MED LITU, V14, P1; Knight B, 2005, EARLY HUM DEV, V81, P823, DOI 10.1016/j.earlhumdev.2005.06.003; LANGER O, 1991, AM J OBSTET GYNECOL, V165, P831, DOI 10.1016/0002-9378(91)90424-P; McGuinness BJ, 1999, AUST NZ J OBSTET GYN, V39, P152, DOI 10.1111/j.1479-828X.1999.tb03360.x; Mee I, 2008, VET J, V176, P93, DOI 10.1016/j.tvjl.2007.12.032; Merchant KM, 2001, BRIT J OBSTET GYNAEC, V108, P689, DOI 10.1111/j.1471-0528.2001.00181.x; Mocanu EV, 2000, EUR J OBSTET GYN R B, V92, P229, DOI 10.1016/S0301-2115(99)00280-8; *NAT HLTH STAT MAT, 2005, MAT STAT; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Nesbitt TS, 1998, AM J OBSTET GYNECOL, V179, P476, DOI 10.1016/S0002-9378(98)70382-5; PARRISH KM, 1994, JAMA-J AM MED ASSOC, V271, P443, DOI 10.1001/jama.271.6.443; Pawlowski B, 2003, P ROY SOC B-BIOL SCI, V270, P709, DOI 10.1098/rspb.2002.2294; READ AW, 1994, AM J PUBLIC HEALTH, V84, P37, DOI 10.2105/AJPH.84.1.37; SANDMIRE HF, 1988, INT J GYNECOL OBSTET, V26, P65, DOI 10.1016/0020-7292(88)90198-1; Shields Beverley M, 2006, BMC Pediatr, V6, P24, DOI 10.1186/1471-2431-6-24; Shy K, 2000, AM J OBSTET GYNECOL, V182, P1363, DOI 10.1067/mob.2000.106175; THOMSON AM, 1963, P NUTR SOC, V22, P55, DOI 10.1079/PNS19630013; Trevathan W, 2000, J HUM EVOL, V39, P583, DOI 10.1006/jhev.2000.0434; TURNER MJ, 1990, OBSTET GYNECOL, V76, P159; VANROOSMALEN J, 1992, INT J GYNECOL OBSTET, V37, P169, DOI 10.1016/0020-7292(92)90377-U; Veena SR, 2004, PAEDIATR PERINAT EP, V18, P361, DOI 10.1111/j.1365-3016.2004.00579.x; WHO, 2005, MAK EV MOTH CHILD CO; Wills AK, 2010, EARLY HUM DEV, V86, P535, DOI 10.1016/j.earlhumdev.2010.07.002; WITTER FR, 1995, OBSTET GYNECOL, V85, P947, DOI 10.1016/0029-7844(95)00082-3	43	199	201	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20497	10.1371/journal.pone.0020497	http://dx.doi.org/10.1371/journal.pone.0020497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21738577	Green Published, gold, Green Accepted			2022-12-25	WOS:000292290100004
J	Hu, AYC; Tseng, YF; Weng, TC; Liao, CC; Wu, J; Chou, AH; Chao, HJ; Gu, AN; Chen, J; Lin, SC; Hsiao, CH; Wu, SC; Chong, P				Hu, Alan Yung-Chih; Tseng, Yu-Fen; Weng, Tsai-Chuan; Liao, Chien-Chun; Wu, Johnson; Chou, Ai-Hsiang; Chao, Hsin-Ju; Gu, Anna; Chen, Janice; Lin, Su-Chen; Hsiao, Chia-Hsin; Wu, Suh-Chin; Chong, Pele			Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium	PLOS ONE			English	Article							SCALE MICROCARRIER CULTURE; VIRUS PRODUCTION; ANIMAL-CELLS; VERO CELLS; RABIES VACCINE; WHOLE VIRUS; CULTIVATION; BIOREACTOR; SYSTEM; GROWTH	Background: Highly pathogenic influenza viruses pose a constant threat which could lead to a global pandemic. Vaccination remains the principal measure to reduce morbidity and mortality from such pandemics. The availability and surging demand for pandemic vaccines needs to be addressed in the preparedness plans. This study presents an improved high-yield manufacturing process for the inactivated influenza H5N1 vaccines using Madin-Darby canine kidney (MDCK) cells grown in a serum-free (SF) medium microcarrier cell culture system. Principal Finding: The current study has evaluated the performance of cell adaptation switched from serum-containing (SC) medium to several commercial SF media. The selected SF medium was further evaluated in various bioreactor culture systems for process scale-up evaluation. No significant difference was found in the cell growth in different sizes of bioreactors studied. In the 7.5 L bioreactor runs, the cell concentration reached to 2.3x10(6) cells/mL after 5 days. The maximum virus titers of 1024 Hemagglutinin (HA) units/50 mu L and 7.1 +/- 0.3x10(8) pfu/mL were obtained after 3 days infection. The concentration of HA antigen as determined by SRID was found to be 14.1 mu g/mL which was higher than those obtained from the SC medium. A mouse immunogenicity study showed that the formalin-inactivated purified SF vaccine candidate formulated with alum adjuvant could induce protective level of virus neutralization titers similar to those obtained from the SC medium. In addition, the H5N1 viruses produced from either SC or SF media showed the same antigenic reactivity with the NIBRG14 standard antisera. Conclusions: The advantages of this SF cell-based manufacturing process could reduce the animal serum contamination, the cost and lot-to-lot variation of SC medium production. This study provides useful information to manufacturers that are planning to use SF medium for cell-based influenza vaccine production.	[Hu, Alan Yung-Chih; Tseng, Yu-Fen; Weng, Tsai-Chuan; Liao, Chien-Chun; Wu, Johnson; Chou, Ai-Hsiang; Chao, Hsin-Ju; Gu, Anna; Chen, Janice; Lin, Su-Chen; Hsiao, Chia-Hsin; Wu, Suh-Chin; Chong, Pele] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Taiwan; [Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Hu, AYC (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Taiwan.	pelechong@nhri.org.tw	Chong, Pele/E-3855-2010; Hu, Alan Yung-Chih/G-3708-2011; Wu, Suh-Chin/AAV-6233-2021		Taiwan Pandemic Influenza Vaccine Research and Development Program [DOH95-DC-1408]	Taiwan Pandemic Influenza Vaccine Research and Development Program	This study was funded by the Taiwan Pandemic Influenza Vaccine Research and Development Program (Grant no. DOH95-DC-1408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; Croughan MS, 2000, BIOTECHNOL BIOENG, V67, P841, DOI 10.1002/(SICI)1097-0290(20000320)67:6<841::AID-BIT19>3.0.CO;2-K; FISHBEIN DB, 1993, VACCINE, V11, P1390, DOI 10.1016/0264-410X(93)90167-V; Frazatti-Gallina NM, 2004, VACCINE, V23, P511, DOI 10.1016/j.vaccine.2004.06.014; Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023; Genzel Y, 2006, VACCINE, V24, P3261, DOI 10.1016/j.vaccine.2006.01.019; Genzel Y, 2004, VACCINE, V22, P2202, DOI 10.1016/j.vaccine.2003.11.041; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Hu AYC, 2008, VACCINE, V26, P5736, DOI 10.1016/j.vaccine.2008.08.015; Kistner O, 1999, WIEN KLIN WOCHENSCHR, V111, P207; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Liu J, 2009, VACCINE, V27, P6460, DOI 10.1016/j.vaccine.2009.06.024; Merten O W, 2002, Dev Biol (Basel), V111, P233; Merten OW, 2000, CYTOTECHNOLOGY, V34, P181, DOI 10.1023/A:1008160817560; Merten OW, 1999, CYTOTECHNOLOGY, V30, pIX; Minor PD, 2009, VACCINE, V27, P2907, DOI 10.1016/j.vaccine.2009.02.064; Nerome K, 1999, Dev Biol Stand, V98, P53; Rourou S, 2007, VACCINE, V25, P3879, DOI 10.1016/j.vaccine.2007.01.086; Toriniwa H, 2007, BIOLOGICALS, V35, P221, DOI 10.1016/j.biologicals.2007.02.002; Tree JA, 2001, VACCINE, V19, P3444, DOI 10.1016/S0264-410X(01)00053-6; van der Pol L, 1998, TRENDS BIOTECHNOL, V16, P323, DOI 10.1016/S0167-7799(98)01209-8; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; WOOD JM, 1989, VIROLOGY, V171, P214, DOI 10.1016/0042-6822(89)90528-X; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Wright PF, 2008, NEW ENGL J MED, V358, P2540, DOI 10.1056/NEJMp0803650; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; ZHANG S, 1992, J BIOTECHNOL, V25, P289, DOI 10.1016/0168-1656(92)90162-3	29	88	102	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e14578	10.1371/journal.pone.0014578	http://dx.doi.org/10.1371/journal.pone.0014578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	22216221	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400002
J	Lu, R; Zhang, XC; Huang, DP; Huang, B; Gao, N; Wang, ZC; Ge, J				Lu, Rong; Zhang, Xinchun; Huang, Danping; Huang, Bing; Gao, Nan; Wang, Zhichong; Ge, Jian			Conjunctival Reconstruction with Progenitor Cell-Derived Autologous Epidermal Sheets in Rhesus Monkey	PLOS ONE			English	Article							AMNIOTIC MEMBRANE TRANSPLANTATION; MUCIN GENE-EXPRESSION; STEM-CELLS; OCULAR SURFACE; EPITHELIAL EQUIVALENT; CORNEAL EPITHELIUM; IN-VITRO; SKIN; IDENTIFICATION; CULTURE	Severe ocular surface diseases are some of the most challenging problems that the clinician faces today. Conventional management is generally unsatisfactory, and the long-term ocular consequences of these conditions are devastating. It is significantly important to find a substitute for conjunctival epithelial cells. This study was to explore the possibility of progenitor cell-derived epidermal sheets on denuded amniotic membrane to reconstruct ocular surface of conjunctiva damaged monkeys. We isolated epidermal progenitor cells of rhesus monkeys by type IV collagen adhesion, and then expanded progenitor cell-derived epidermal sheets on denuded amniotic membrane ex vivo. At 3 weeks after the conjunctiva injury, the damaged ocular surface of four monkeys was surgically reconstructed by transplanting the autologous cultivated epidermal progenitor cells. At 2 weeks after surgery, transplants were removed and examined with Hematoxylin-eosin staining, Periodic acid Schiff staining, immunofluorescent staining, scanning and transmission electron microscopy. Histological examination of transplanted sheets revealed that the cell sheets were healthy alive, adhered well to the denuded amniotic membrane, and had several layers of epithelial cells. Electron microscopy showed that the epithelial cells were very similar in appearance to those of normal conjunctival epithelium, even without goblet cell detected. Epithelial cells of transplants had numerous desmosomal junctions and were attached to the amniotic membrane with hemidesmosomes. Immunohistochemistry confirmed the presence of the conjunctival specific markers, mucin 4 and keratin 4, in the transplanted epidermal progenitor cells. In conclusion, our present study successfully reconstructed conjunctiva with autologous transplantation of progenitor cell-derived epidermal sheets on denuded AM in conjunctival damaged monkeys, which is the first step toward assessing the use of autologous transplantation of progenitor cells of nonocular surface origin. Epidermal progenitor cells could be provided as a new substitute for conjunctival epithelial cells to overcome the problems of autologous conjunctiva shortage.	[Lu, Rong; Huang, Danping; Huang, Bing; Gao, Nan; Wang, Zhichong; Ge, Jian] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xinchun] Sun Yat Sen Univ, Guanghua Coll Stomatol, Hosp Stomatol, Dept Prosthodont, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Lu, R (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	gejian@mail.sysu.edu.cn		Schmidtko, Achim/0000-0001-7270-5075	National Natural Science Foundation of China [30901634]; Natural Science Foundation of Guangdong Province [9151008901000210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by National Natural Science Foundation of China (30901634) and the Natural Science Foundation of Guangdong Province (9151008901000210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2000, J INVEST DERMATOL, V114, P321, DOI 10.1046/j.1523-1747.2000.00857.x; Ang LPK, 2004, INVEST OPHTH VIS SCI, V45, P1789, DOI 10.1167/iovs.03-1361; Arora R, 2005, EYE, V19, P273, DOI 10.1038/sj.eye.6701490; BALAGUE C, 1994, GASTROENTEROLOGY, V106, P1054, DOI 10.1016/0016-5085(94)90767-6; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Berry M, 1996, INVEST OPHTH VIS SCI, V37, P2559; Bickenbach J R, 2000, Adv Dermatol, V16, P159; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Burman Sanghamitra, 2004, Cell and Tissue Banking, V5, P161, DOI 10.1023/B:CATB.0000046067.25057.0a; Chiou AGY, 1998, SURV OPHTHALMOL, V43, P19, DOI 10.1016/S0039-6257(98)00005-8; Corrales RM, 2003, Arch Soc Esp Oftalmol, V78, P375; Corrales RM, 2003, CURR EYE RES, V27, P323, DOI 10.1076/ceyr.27.5.323.17221; Daniels JT, 2001, WOUND REPAIR REGEN, V9, P483, DOI 10.1046/j.1524-475x.2001.00483.x; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Fukuda K, 1999, CORNEA, V18, P73, DOI 10.1097/00003226-199901000-00013; Gao N, 2007, SCI CHINA SER C, V50, P101, DOI 10.1007/s11427-007-0006-4; GIPSON IK, 1992, INVEST OPHTH VIS SCI, V33, P218; Gonnering R S, 1987, Ophthalmic Plast Reconstr Surg, V3, P99, DOI 10.1097/00002341-198703020-00009; Grinnell KL, 2007, CELL PROLIFERAT, V40, P685, DOI 10.1111/j.1365-2184.2007.00464.x; Gunduz K, 2006, EYE, V20, P351, DOI 10.1038/sj.eye.6701890; Huang Bing, 2004, Zhonghua Yi Xue Za Zhi, V84, P838; Islam MS, 2007, EUR J DERMATOL, V17, P302, DOI 10.1684/ejd.2007.0204; Janes SM, 2002, J PATHOL, V197, P479, DOI 10.1002/path.1156; Jones PH, 1996, CLIN SCI, V91, P141, DOI 10.1042/cs0910141; Kippenberger S, 2000, J INVEST DERMATOL, V114, P408, DOI 10.1046/j.1523-1747.2000.00915.x; Krenzer KL, 1997, INVEST OPHTH VIS SCI, V38, P142; KRUSE FE, 1998, OPHTHALMOLOGY, V122; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Li W, 2006, INVEST OPHTH VIS SCI, V47, P2381, DOI 10.1167/iovs.05-1491; Liu YC, 2008, INT J DERMATOL, V47, P551, DOI 10.1111/j.1365-4632.2008.03647.x; Lu R, 2011, INT J BIOCHEM CELL B, V43, P751, DOI 10.1016/j.biocel.2011.01.018; Lu Rong, 2005, Zhonghua Yi Xue Za Zhi, V85, P2554; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296, DOI 10.1038/sj.jidsp.5640233; Nakamura T, 2001, INVEST OPHTH VIS SCI, V42, P549; Pflugfelder SC, 2000, INVEST OPHTH VIS SCI, V41, P1316; Pflugfelder SC, 2007, CURR OPIN ALLERGY CL, V7, P450, DOI 10.1097/ACI.0b013e3282ef69e3; Reiisi S, 2010, IN VITRO CELL DEV-AN, V46, P54, DOI 10.1007/s11626-009-9245-y; Shimazaki J, 1998, BRIT J OPHTHALMOL, V82, P235, DOI 10.1136/bjo.82.3.235; SHORE JW, 1992, OPHTHALMOLOGY, V99, P383; Tan DTH, 2004, TRANSPLANTATION, V77, P1729, DOI 10.1097/01.TP.0000127593.65888.A6; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9; Tseng SCG, 2001, BIOSCIENCE REP, V21, P481, DOI 10.1023/A:1017995810755; van Rossum MM, 2002, J IMMUNOL METHODS, V267, P109, DOI 10.1016/S0022-1759(02)00151-5; WEISE RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1736, DOI 10.1001/archopht.1985.01050110132041; Yu CJ, 1996, ONCOLOGY, V53, P118; Zhang LL, 2011, INT J BIOCHEM CELL B, V43, P1383, DOI 10.1016/j.biocel.2011.06.003; Zhou JX, 2004, CELL BIOL INT, V28, P523, DOI 10.1016/j.cellbi.2004.04.007	51	32	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e25713	10.1371/journal.pone.0025713	http://dx.doi.org/10.1371/journal.pone.0025713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096478	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900001
J	Dai, JN; Zong, Y; Zhong, LM; Li, YM; Zhang, W; Bian, LG; Ai, QL; Liu, YD; Sun, J; Lu, D				Dai, Ji-Nan; Zong, Yi; Zhong, Lian-Mei; Li, Yue-Min; Zhang, Wei; Bian, Li-Gong; Ai, Qing-Long; Liu, Yi-Dan; Sun, Jun; Lu, Di			Gastrodin Inhibits Expression of Inducible NO Synthase, Cyclooxygenase-2 and Proinflammatory Cytokines in Cultured LPS-Stimulated Microglia via MAPK Pathways	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; ADAPTIVE IMMUNE-RESPONSES; P-HYDROXYBENZYL ALCOHOL; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; SIGNALING PATHWAYS; CELLS; INFLAMMATION	Background: Microglial activation plays an important role in neurodegenerative diseases by producing several proinflammatory enzymes and proinflammatory cytokines. The phenolic glucoside gastrodin, a main constituent of a Chinese herbal medicine, has been known to display anti-inflammatory properties. The current study investigates the potential mechanisms whereby gastrodin affects the expression of potentially pro-inflammatory proteins by cultured murine microglial BV-2 cells stimulated with lipopolysaccharide (LPS). Methodology/Principal Findings: BV-2 cells were pretreated with gastrodin (30, 40, and 60 mu M) for 1 h and then stimulated with LPS (1 mu g/ml) for another 4 h. The effects on proinflammatory enzymes, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and proinflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha), and interleukin-1 beta (IL-1 beta), are analysed by double-immunofluorescence labeling and RT-PCR assay. To reveal the mechanisms of action of gastrodin we investigated the involvement of mitogen-activated protein kinases (MAPKs) cascades and their downstream transcription factors, nuclear factor-kappa B (NF-kappa B) and cyclic AMP-responsive element (CRE)-binding protein (CREB). Gastrodin significantly reduced the LPS-induced protein and mRNA expression levels of iNOS, COX-2, TNF-alpha, IL-1 beta and NF-kappa B. LPS (1 mu g/ml, 30 min)-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) and this was inhibited by pretreatment of BV-2 cells with different concentrations of gastrodin (30, 40, and 60 mu M). In addition, gastrodin blocked LPS-induced phosphorylation of inhibitor kappa B-alpha (I kappa B-alpha) (and hence the activation of NF-kappa B) and of CREB, respectively. Conclusion and Implications: This study indicates that gastrodin significantly attenuate levels of neurotoxic proinflammatory mediators and proinflammatory cytokines by inhibition of the NF-kappa B signaling pathway and phosphorylation of MAPKs in LPS-stimulated microglial cells. Arising from the above, we suggest that gastrodin has a potential as an anti-inflammatory drug candidate in neurodegenerative diseases.	[Dai, Ji-Nan; Zong, Yi; Li, Yue-Min; Bian, Li-Gong; Sun, Jun; Lu, Di] Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China; [Zhong, Lian-Mei; Zhang, Wei; Ai, Qing-Long] Kunming Med Univ, Affiliated Hosp 1, Dept Neurol, Kunming, Yunnan, Peoples R China; [Liu, Yi-Dan] Kunming Pharmaceut Corp, Kunming, Yunnan, Peoples R China; [Lu, Di] Kunming Med Univ, Rehabil Engn Res Lab, Biomed Engn Res Ctr, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University	Dai, JN (corresponding author), Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China.	sunjun91@hotmail.com; ludi20040609@126.com		FRANCK, Gregory/0000-0002-4288-9034; Michineau, Stephanie/0000-0001-7752-2956; GERVAIS, Marianne/0000-0002-4431-789X	National Natural Sciences Foundation of China [30860336, 30560170]; Department of Science and Technology of Yunnan Province [2008CC007, 2009CI033]; Department of Science and Technology of Yunnan Province-Kunming Medical University [2008CD016, 2010CD156]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province; Department of Science and Technology of Yunnan Province-Kunming Medical University	This work was supported in part by grants (30860336 and 30560170) from the National Natural Sciences Foundation of China, the grants (2008CC007 and 2009CI033) from the Department of Science and Technology of Yunnan Province, and the grants (2008CD016 and 2010CD156) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ajmone-Cat MA, 2003, J NEUROCHEM, V84, P413, DOI 10.1046/j.1471-4159.2003.01562.x; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Asanuma M, 2004, CURR PHARM DESIGN, V10, P695, DOI 10.2174/1381612043453072; Bal-Price A, 2002, J NEUROCHEM, V80, P73, DOI 10.1046/j.0022-3042.2001.00675.x; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Chen SR, 2010, BIOL PHARM BULL, V33, P1307, DOI 10.1248/bpb.33.1307; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Fontana A, 2010, BRAIN, V133, P1300, DOI 10.1093/brain/awq086; Giovannini MG, 2003, INT J IMMUNOPATH PH, V16, P31; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hatziieremia S, 2006, BRIT J PHARMACOL, V149, P188, DOI 10.1038/sj.bjp.0706856; Hsieh MT, 1997, J ETHNOPHARMACOL, V56, P45, DOI 10.1016/S0378-8741(96)01501-2; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Lee MJ, 2009, J PHARMACOL SCI, V111, P216, DOI 10.1254/jphs.09153SC; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Lim JY, 2010, EUR J PHARMACOL, V642, P10, DOI 10.1016/j.ejphar.2010.05.047; Lin LC, 2008, J PHARMACEUT BIOMED, V48, P909, DOI 10.1016/j.jpba.2008.07.013; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; Miller RL, 2009, NEUROCHEM RES, V34, P55, DOI 10.1007/s11064-008-9656-2; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Nakajima K, 1998, Hum Cell, V11, P141; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nam KN, 2008, EUR J PHARMACOL, V589, P53, DOI 10.1016/j.ejphar.2008.03.034; Nam KN, 2010, EUR J PHARMACOL, V648, P110, DOI 10.1016/j.ejphar.2010.09.003; Ojemann LM, 2006, EPILEPSY BEHAV, V8, P376, DOI 10.1016/j.yebeh.2005.12.009; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Son HY, 2009, J PHARMACOL SCI, V109, P368, DOI 10.1254/jphs.08197FP; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Szczepanik AM, 2003, J ALZHEIMERS DIS, V5, P105, DOI 10.3233/JAD-2003-5205; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Vaillancourt F, 2007, J CELL BIOCHEM, V100, P1217, DOI 10.1002/jcb.21110; Vitor CE, 2009, BRIT J PHARMACOL, V157, P1034, DOI 10.1111/j.1476-5381.2009.00271.x; Wang JY, 2003, J NEUROSCI RES, V72, P508, DOI 10.1002/jnr.10597; Wang MJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-99; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Wu CR, 1996, PLANTA MED, V62, P317, DOI 10.1055/s-2006-957892; Xu X, 2007, PLANTA MED, V73, P650, DOI 10.1055/s-2007-981523; Yabe T, 2005, GLIA, V50, P223, DOI 10.1002/glia.20171; Zeng XH, 2006, PLANTA MED, V72, P1359, DOI 10.1055/s-2006-951709	49	185	205	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21891	10.1371/journal.pone.0021891	http://dx.doi.org/10.1371/journal.pone.0021891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	22194945	Green Published, Green Submitted, gold			2022-12-25	WOS:000292699000014
J	Wang, YT; Huang, YL; Qiu, Q; Xin, GR; Yang, ZY; Shi, SH				Wang, Yutao; Huang, Yelin; Qiu, Qiu; Xin, Guorong; Yang, Zhongyi; Shi, Suhua			Flooding Greatly Affects the Diversity of Arbuscular Mycorrhizal Fungi Communities in the Roots of Wetland Plants	PLOS ONE			English	Article							MOLECULAR DIVERSITY; COLONIZATION; GLOMEROMYCOTA; BIODIVERSITY; SPECIFICITY; GRASSLAND; ECOSYSTEM; PATTERNS; SOILS; MODEL	The communities of arbuscular mycorrhizal fungi (AMF) colonizing the roots of three mangrove species were characterized along a tidal gradient in a mangrove swamp. A fragment, designated SSU-ITS-LSU, including part of the small subunit (SSU), the entire internal transcribed spacer (ITS) and part of the large subunit (LSU) of rDNA from samples of AMF-colonized roots was amplified, cloned and sequenced using AMF-specific primers. Similar levels of AMF diversity to those observed in terrestrial ecosystems were detected in the roots, indicating that the communities of AMF in wetland ecosystems are not necessarily low in diversity. In total, 761 Glomeromycota sequences were obtained, which grouped, according to phylogenetic analysis using the SSU-ITS-LSU fragment, into 23 phylotypes, 22 of which belonged to Glomeraceae and one to Acaulosporaceae. The results indicate that flooding plays an important role in AMF diversity, and its effects appear to depend on the degree (duration) of flooding. Both host species and tide level affected community structure of AMF, indicating the presence of habitat and host species preferences.	[Wang, Yutao; Huang, Yelin; Qiu, Qiu; Xin, Guorong; Yang, Zhongyi; Shi, Suhua] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Yutao] S China Normal Univ, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; South China Normal University	Wang, YT (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lssxgr@mail.sysu.edu.cn	jiang, anyi/GPT-0379-2022	Huang, Yelin/0000-0002-2514-0144	National Natural Science Foundation of China (NSFC) [U0633002, 30871475]; Sun Yat-sen University; Project of Science and Technology of Guangdong Province and Zhuhai City [2010B020311005, 200901022]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Sun Yat-sen University; Project of Science and Technology of Guangdong Province and Zhuhai City	This research was financially supported by the National Natural Science Foundation of China (NSFC, U0633002; 30871475), Zhang Hong-da Science Research Fund of Sun Yat-sen University, the Project of Science and Technology of Guangdong Province and Zhuhai City (2010B020311005; 200901022), and the Reserve Key Project of Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Baar J, 2011, AQUAT BOT, V94, P53, DOI 10.1016/j.aquabot.2010.09.006; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bidartondo MI, 2002, NATURE, V419, P389, DOI 10.1038/nature01054; Borowicz VA, 2001, ECOLOGY, V82, P3057; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; de la Pena E, 2006, NEW PHYTOL, V169, P829, DOI 10.1111/j.1469-8137.2005.01602.x; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 2007, J ECOL, V95, P623, DOI 10.1111/j.1365-2745.2007.01239.x; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Ipsilantis I, 2007, APPL SOIL ECOL, V35, P261, DOI 10.1016/j.apsoil.2006.09.003; Juniper S, 2006, MYCORRHIZA, V16, P371, DOI 10.1007/s00572-006-0046-9; JUSTIN SHFW, 1987, NEW PHYTOL, V106, P465, DOI 10.1111/j.1469-8137.1987.tb00153.x; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kozlowski T. T., 1984, Flooding and plant growth, P129; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Li LF, 2010, FEMS MICROBIOL ECOL, V71, P418, DOI 10.1111/j.1574-6941.2009.00815.x; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Martinez-Garcia LB, 2011, SOIL BIOL BIOCHEM, V43, P682, DOI 10.1016/j.soilbio.2010.12.006; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Merryweather J, 1998, NEW PHYTOL, V138, P117, DOI 10.1046/j.1469-8137.1998.00888.x; Miller SP, 2000, NEW PHYTOL, V145, P145, DOI 10.1046/j.1469-8137.2000.00566.x; Nielsen KB, 2004, MYCOL RES, V108, P616, DOI 10.1017/S0953756204000073; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2003, NEW PHYTOL, V160, P581, DOI 10.1046/j.1469-8137.2003.00917.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Page A.L, 1982, METHODS SOIL ANAL PA, Vsecond, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Pi N, 2009, AQUAT BOT, V90, P222, DOI 10.1016/j.aquabot.2008.10.002; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2021, R LANG ENV STAT COMP; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosendahl S, 2008, NEW PHYTOL, V179, P1154, DOI 10.1111/j.1469-8137.2008.02535.x; Sanders IR, 2003, TRENDS PLANT SCI, V8, P143, DOI 10.1016/S1360-1385(03)00012-8; Santos JC, 2006, NEW PHYTOL, V172, P159, DOI 10.1111/j.1469-8137.2006.01799.x; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Sengupta A, 2002, MYCORRHIZA, V12, P169, DOI 10.1007/s00572-002-0164-y; Shannon CE., 1949, MATH THEORY COMMUNIC; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Sudova R, 2011, AQUAT BOT, V94, P183, DOI 10.1016/j.aquabot.2011.02.003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Wang YT, 2010, PLANT SOIL, V331, P181, DOI 10.1007/s11104-009-0244-2; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Wirsel SGR, 2004, FEMS MICROBIOL ECOL, V48, P129, DOI 10.1016/j.femsec.2004.01.006; Wubet T, 2004, NEW PHYTOL, V161, P517, DOI 10.1046/j.1469-8137.2003.00924.x	63	78	89	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24512	10.1371/journal.pone.0024512	http://dx.doi.org/10.1371/journal.pone.0024512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	22216215	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803200023
J	Li, JS; Bi, YT; Dong, C; Yang, JF; Liang, WD				Li, Jin-song; Bi, Yun-tian; Dong, Cheng; Yang, Ji-feng; Liang, Wan-dong			Transcriptome Analysis of Adaptive Heat Shock Response of Streptococcus thermophilus	PLOS ONE			English	Article							GROWTH TEMPERATURE; LACTOCOCCUS-LACTIS; GENE-EXPRESSION; CLPL; METABOLISM; BULGARICUS; REGULATORS; TOLERANCE; BACTERIA; SYSTEMS	Streptococcus thermophilus, a gram-positive facultative anaerobe, is one of the most important lactic acid bacteria widely used in the dairy fermentation industry. In this study, we have analyzed the global transcriptional profiling of S. thermophilus upon temperature change. During a temperature shift from 42 degrees C to 50 degrees C, it is found that 196 (10.4%) genes show differential expression with 102 up-regulated and 94 down-regulated at 50 degrees C. In particular, 1) Heat shock genes, such as DnaK, GroESL and clpL, are identified to be elevated at 50 degrees C; 2) Transcriptional regulators, such as HrcA, CtsR, Fur, MarR and MerR family, are differentially expressed, indicating the complex molecular mechanisms of S. thermophilus adapting to heat shock; 3) Genes associated with signal transduction, cell wall genes, iron homeostasis, ABC transporters and restriction-modification system were induced; 4) A large number of the differentially expressed genes are hypothetical genes of unknown function, indicating that much remains to be investigated about the heat shock response of S. thermophilus. Experimental investigation of selected heat shock gene ClpL shows that it plays an important role in the physiology of S. thermophilus at high temperature and meanwhile we confirmed ClpL as a member of the CtsR regulon. Overall, this study has contributed to the underlying adaptive molecular mechanisms of S. thermophilus upon temperature change and provides a basis for future in-depth functional studies.	[Li, Jin-song; Yang, Ji-feng; Liang, Wan-dong] Wenzhou Med Coll, Coll Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China; [Bi, Yun-tian] Wenzhou Med Coll, Sch Basic Med Sci, Wenzhou, Peoples R China; [Dong, Cheng] Harbin Med Univ, Hosp 4, Harbin, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Harbin Medical University	Li, JS (corresponding author), Wenzhou Med Coll, Coll Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China.	liliang2011@yahoo.com	; Zhang, Yanfeng/E-6971-2016	Mao, Bingyu/0000-0002-7993-3158; li, Jinsong/0000-0003-0764-3706; Zhang, Yanfeng/0000-0002-3859-3839; Sun, Jian/0000-0002-4732-3152; Maity, Sankar/0000-0002-2387-6545	Natural Science Foundation of Zhejiang Province [Y2090642]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA140388] Funding Source: NIH RePORTER	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Natural Science Foundation of Zhejiang Province (Y2090642), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizoglu RO, 2009, APPL ENVIRON MICROB, V75, P5315, DOI 10.1128/AEM.00458-09; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Ferenci T, 2007, ANN NY ACAD SCI, V1113, P105, DOI 10.1196/annals.1391.003; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Herve-Jimenez L, 2009, APPL ENVIRON MICROB, V75, P2062, DOI 10.1128/AEM.01984-08; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Novak L, 1997, APPL ENVIRON MICROB, V63, P2665, DOI 10.1128/AEM.63.7.2665-2670.1997; O'Connell-Motherway M, 2000, MICROBIOL-SGM, V146, P935, DOI 10.1099/00221287-146-4-935; Pysz MA, 2004, EXTREMOPHILES, V8, P209, DOI 10.1007/s00792-004-0379-2; Rodrigues DF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-547; Sieuwerts S, 2010, APPL ENVIRON MICROB, V76, P7775, DOI 10.1128/AEM.01122-10; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Suokko A, 2008, PROTEOMICS, V8, P1029, DOI 10.1002/pmic.200700925; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Varcamonti M, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-6; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; ZEILSTRARYALLS J, 1991, ANNU REV MICROBIOL, V45, P301, DOI 10.1146/annurev.mi.45.100191.001505; Zotta T, 2009, INT J FOOD MICROBIOL, V129, P211, DOI 10.1016/j.ijfoodmicro.2008.11.024; ZUBER U, 1994, J BACTERIOL, V176, P1359, DOI 10.1128/jb.176.5.1359-1363.1994	28	140	145	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25777	10.1371/journal.pone.0025777	http://dx.doi.org/10.1371/journal.pone.0025777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22194926	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600030
J	Li, J; Ding, ZY; Wang, ZX; Lu, JF; Maity, SN; Navone, NM; Logothetis, CJ; Mills, GB; Kim, J				Li, Jin; Ding, Zhiyong; Wang, Zhengxin; Lu, Jing-Fang; Maity, Sankar N.; Navone, Nora M.; Logothetis, Christopher J.; Mills, Gordon B.; Kim, Jeri			Androgen Regulation of 5 alpha-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention	PLOS ONE			English	Article							DIFFERENTIAL REGULATION; DEPENDENT INHIBITION; SERUM TESTOSTERONE; GENE-EXPRESSION; MESSENGER-RNA; ADULT-RAT; FINASTERIDE; RECEPTOR; DUTASTERIDE; TYPE-1	The enzyme 5 alpha-reductase, which converts testosterone to dihydrotestosterone (DHT), performs key functions in the androgen receptor (AR) signaling pathway. The three isoenzymes of 5 alpha-reductase identified to date are encoded by different genes: SRD5A1, SRD5A2, and SRD5A3. In this study, we investigated mechanisms underlying androgen regulation of 5 alpha-reductase isoenzyme expression in human prostate cells. We found that androgen regulates the mRNA level of 5 alpha-reductase isoenzymes in a cell type-specific manner, that such regulation occurs at the transcriptional level, and that AR is necessary for this regulation. In addition, our results suggest that AR is recruited to a negative androgen response element (nARE) on the promoter of SRD5A3 in vivo and directly binds to the nARE in vitro. The different expression levels of 5 alpha-reductase isoenzymes may confer response or resistance to 5 alpha-reductase inhibitors and thus may have importance in prostate cancer prevention.	[Li, Jin; Ding, Zhiyong; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lu, Jing-Fang; Maity, Sankar N.; Navone, Nora M.; Logothetis, Christopher J.; Kim, Jeri] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Li, J (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA.	jekim@mdanderson.org	; Zhang, Yanfeng/E-6971-2016	Mao, Bingyu/0000-0002-7993-3158; li, Jinsong/0000-0003-0764-3706; Zhang, Yanfeng/0000-0002-3859-3839; Sun, Jian/0000-0002-4732-3152; Maity, Sankar/0000-0002-2387-6545	MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA140388] Funding Source: NIH RePORTER	MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Prostate Cancer Research Program at MD Anderson Cancer Center and supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant, CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole G, 2004, J UROLOGY, V172, P1314, DOI 10.1097/01.ju.0000139320.78673.2a; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Aparicio A, 2011, PROSTATE, V71, P846, DOI 10.1002/pros.21301; Bjelfman C, 1997, J CLIN ENDOCR METAB, V82, P2210, DOI 10.1210/jc.82.7.2210; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; DAI WS, 1981, AM J EPIDEMIOL, V114, P804, DOI 10.1093/oxfordjournals.aje.a113251; El-Awady MK, 2004, ENDOCR J, V51, P37, DOI 10.1507/endocrj.51.37; Fitzpatrick JM, 2009, BJU INT, V103, P864, DOI 10.1111/j.1464-410X.2008.08206.x; George FW, 1997, ENDOCRINOLOGY, V138, P871, DOI 10.1210/en.138.3.871; GEORGE FW, 1991, P NATL ACAD SCI USA, V88, P8044, DOI 10.1073/pnas.88.18.8044; Godoy A, 2011, PROSTATE, V71, P1033, DOI 10.1002/pros.21318; Kahrizi K, 2011, EUR J HUM GENET, V19, P115, DOI 10.1038/ejhg.2010.132; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Makridakis N, 2005, J MOL ENDOCRINOL, V34, P617, DOI 10.1677/jme.1.01725; Makridakis NM, 2000, PHARMACOGENETICS, V10, P407, DOI 10.1097/00008571-200007000-00004; Melcangi RC, 1998, J STEROID BIOCHEM, V65, P295, DOI 10.1016/S0960-0760(98)00030-2; Morava E, 2010, BRAIN, V133, P3210, DOI 10.1093/brain/awq261; Noss KR, 2002, GENE, V285, P247, DOI 10.1016/S0378-1119(02)00397-9; Parsons JK, 2005, CANCER EPIDEM BIOMAR, V14, P2257, DOI 10.1158/1055-9965.EPI-04-0715; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Pratis K, 2003, J ENDOCRINOL, V176, P393, DOI 10.1677/joe.0.1760393; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Reddy G Kesava, 2004, Clin Prostate Cancer, V2, P209; Reid J, 2002, J BIOL CHEM, V277, P41247, DOI 10.1074/jbc.M205220200; Rittmaster R, 2008, UROLOGY, V72, P808, DOI 10.1016/j.urology.2008.06.032; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Schatzl G, 2001, PROSTATE, V47, P52; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; SILVER RI, 1994, J UROLOGY, V152, P433, DOI 10.1016/S0022-5347(17)32757-X; Steiner JF, 1996, CLIN PHARMACOKINET, V30, P16, DOI 10.2165/00003088-199630010-00002; STONER E, 1990, J STEROID BIOCHEM, V37, P375, DOI 10.1016/0960-0760(90)90487-6; Thomas LN, 2005, PROSTATE, V63, P231, DOI 10.1002/pros.20188; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; TIAN GC, 1995, BIOCHEMISTRY-US, V34, P13453, DOI 10.1021/bi00041a024; TITUS MA, 2009, 5ALPHA REDUCTASE I 2, P175; Torres JM, 2003, FASEB J, V17, P1428, DOI 10.1096/fj.02-1119com; Torres JM, 2003, BIOCHEM BIOPH RES CO, V308, P469, DOI 10.1016/S0006-291X(03)01423-2; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906; WILBERT DM, 1983, J CLIN ENDOCR METAB, V56, P113, DOI 10.1210/jcem-56-1-113; WILSON EM, 1976, J BIOL CHEM, V251, P5620; Wilson JD, 1996, PROSTATE, P88; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184; Yamana K, 2010, HORM MOL BIOL CLIN I, V2, P293, DOI 10.1515/HMBCI.2010.035; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhou ZF, 1999, MOL GENET METAB, V68, P410, DOI 10.1006/mgme.1999.2898; Zhu YS, 2009, ANN NY ACAD SCI, V1155, P43, DOI 10.1111/j.1749-6632.2009.04115.x	49	140	145	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28840	10.1371/journal.pone.0028840	http://dx.doi.org/10.1371/journal.pone.0028840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194926	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100109
